0.29273772.15849318.html.plaintext.txt	0	COUP TF interacting protein 2 represses initial phase HIV 1 gene transcription human microglial cells Celine Marban1 Laetitia Redel1 Stella Suzanne1 Carine Van Lint2 Dominique Lecestre1 Sylvette Chasserot Golaz3 Mark Leid4 Dominique Aunis1 Evelyne Schaeffer1 Olivier Rohr15
0.29273772.15849318.html.plaintext.txt	1	1INSERM unite 575 Pathophysiology Nervous System Centre de Neurochimie 5 rue Blaise Pascal 67084 Strasbourg France 2Institute Molecular Biology Medicine Laboratory Molecular Virology 12 rue des Professeurs Jeener et Brachet 6041 Gosselies Belgium 3Unite CNRS UPR 2356 5 rue Blaise Pascal 67084 Strasbourg France 4Laboratory Molecular Pharmacology College Pharmacy Environmental Health Sciences Center Oregon State University Corvallis Oregon 97331 3507 France 5IUT Louis Pasteur de Schiltigheim 1 Allee dAthenes 67300 Schiltigheim France
0.29273772.15849318.html.plaintext.txt	2	To correspondence addressed
0.29273772.15849318.html.plaintext.txt	3	Tel 33 388 45 66 01 Fax 33 388 60 08 06 Email rohratneurochem
0.29273772.15849318.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Human immunodeficiency virus type 1 HIV 1 gene transcription characterized two temporally distinct phases
0.29273772.15849318.html.plaintext.txt	5	While initial phase relies solely cellular transcription factors subsequent phase activated viral Tat transactivator
0.29273772.15849318.html.plaintext.txt	6	We previously reported subsequent phase viral gene transcription repressed chicken ovalbumin upstream promoter transcription factor COUP TF interacting protein 2 CTIP2 human microglial cells O
0.29273772.15849318.html.plaintext.txt	7	Here demonstrate CTIP proteins also repress initial phase HIV 1 gene transcription mainly supported cellular transcription factors Sp1 COUP TF microglial cells
0.29273772.15849318.html.plaintext.txt	8	We report CTIP2 represses Sp1 COUP TF mediated activation HIV 1 gene transcription viral replication result physical interactions COUP TF Sp1 microglial nuclei
0.29273772.15849318.html.plaintext.txt	9	Using laser confocal microscopy CTIP2 found colocalize Sp1 COUP TF heterochromatin associated protein Hp1 mainly detected transcriptionally repressed heterochromatic region
0.29273772.15849318.html.plaintext.txt	10	Moreover describe CTIP2 recruited HIV 1 promoter via association Sp1 bound GC box sequences long terminal repeat LTR
0.29273772.15849318.html.plaintext.txt	11	Since findings demonstrate CTIP2 interacts HIV 1 proximal promoter likely CTIP2 promotes HIV 1 gene silencing forcing transcriptionally repressed heterochromatic environment viral LTR region
0.29273772.15849318.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Infection central nervous system CNS human immunodeficiency virus type 1 HIV 1 associated spectrum neurological damage ranging acute encephalopathies AIDS dementia 12
0.29273772.15849318.html.plaintext.txt	13	The CNS constitutes sanctuary reservoir virus despite antiretroviral therapies 3
0.29273772.15849318.html.plaintext.txt	14	Microglial cells CNS resident macrophages may particularly suitable purpose long lived HIV productive several weeks relatively immune virus induced cytopathology reviewed 4
0.29273772.15849318.html.plaintext.txt	15	Since microglial cells primary targets HIV 1 productive infection within CNS 56 investigation HIV 1 repression cells important global understanding HIV pathogenesis development anti HIV strategies
0.29273772.15849318.html.plaintext.txt	16	HIV 1 gene transcription key step control virus life cycle reviewed 7
0.29273772.15849318.html.plaintext.txt	17	Viral gene transcription characterized two temporally distinct phases
0.29273772.15849318.html.plaintext.txt	18	The initial phase occurs immediately integration relies solely cellular transcription factors
0.29273772.15849318.html.plaintext.txt	19	Most transcripts cannot elongate efficiently terminate rapidly initiation
0.29273772.15849318.html.plaintext.txt	20	However transcripts elongate throughout genome resulting transcription expression viral transactivator Tat
0.29273772.15849318.html.plaintext.txt	21	The subsequent phase transcription occurs enough Tat protein accumulated
0.29273772.15849318.html.plaintext.txt	22	Tat binds TAR recruits pTEFb complex dramatically stimulates HIV 1 gene transcription reviewed 89
0.29273772.15849318.html.plaintext.txt	23	We previously studied cellular transcription factors impact HIV 1 gene transcription microglial cells
0.29273772.15849318.html.plaintext.txt	24	Chicken ovalbumin upstream promoter transcription factor I COUP TFIEar3 Arp1COUP TFII Ear2COUP TFIII proteins three members COUP TF orphan nuclear receptors superfamily
0.29273772.15849318.html.plaintext.txt	25	We described orphan nuclear receptor COUP TFIEar3 1011 expressed numerous human CNS cell lineages including microglial cells
0.29273772.15849318.html.plaintext.txt	26	COUP TFI activator HIV 1 gene transcription oligodendrocytes 12 microglia 13 T lymphocytes 14
0.29273772.15849318.html.plaintext.txt	27	Moreover revealed importance functional interactions nuclear factor interleukin 6 NF Il6 Sp1 COUP TFI regulation initial phase HIV 1 gene transcription brain cells 15
0.29273772.15849318.html.plaintext.txt	28	The transcription factor Sp1 one crucial cellular proteins efficient HIV 1 gene transcription 16 18
0.29273772.15849318.html.plaintext.txt	29	A number studies reported Sp1 serve anchor indirect binding transcription factors HIV 1 long terminal repeat LTR region
0.29273772.15849318.html.plaintext.txt	30	In cell types interaction Sp1 Tat required optimal HIV enhancer activation 19
0.29273772.15849318.html.plaintext.txt	31	Moreover Sp1 able recruit Cyclin T1 subunit P TEFb LTR helps bypass requirement TARTat promotes processive transcription without Tat 20
0.29273772.15849318.html.plaintext.txt	32	In microglial cells main HIV 1 target cells brain 6 Sp1 anchors COUP TF 13 NF IL6 15 three GC boxes adjacent viral CATA box
0.29273772.15849318.html.plaintext.txt	33	The CATA box used instead TATAA box optimal HIV 1 gene transcription replication 21
0.29273772.15849318.html.plaintext.txt	34	We shown Sp1 COUP TF interact cooperate transcriptional activation HIV 1 gene transcription 13
0.29273772.15849318.html.plaintext.txt	35	Moreover COUP TF substitute Sp1 association viral Tat protein restore Tat function HIV 1 replication microglial cells 22
0.29273772.15849318.html.plaintext.txt	36	These results highlight key roles Sp1 COUP TF proteins HIV 1 expression microglial cells
0.29273772.15849318.html.plaintext.txt	37	Members COUP TF family shown bind related zinc finger proteins named COUP TF interacting protein 1 CTIP1 2 CTIP2 highly expressed brain immune systems 2324
0.29273772.15849318.html.plaintext.txt	38	Recent results support selective contribution proteins development function nervous immune systems 24
0.29273772.15849318.html.plaintext.txt	39	We recently described nuclear cofactor CTIP2 inhibits subsequent phase HIV 1 gene transcription viral replication relocating viral transactivator Tat protein transcriptionally inactive regions chromatin via Hp1 25
0.29273772.15849318.html.plaintext.txt	40	In present work CTIP2 overexpression leads repression HIV 1 replication
0.29273772.15849318.html.plaintext.txt	41	In contrast CTIP1 unable affect Tat function
0.29273772.15849318.html.plaintext.txt	42	Using confocal microscopy visualize Tat subcellular distribution presence CTIP proteins found CTIP2 CTIP1 leads disruption Tat nuclear localization recruitment within CTIP2 induced nuclear ball like structures
0.29273772.15849318.html.plaintext.txt	43	In addition showed CTIP2 Hp1 associate Tat form three protein complex
0.29273772.15849318.html.plaintext.txt	44	These findings suggest inhibition HIV 1 expression CTIP2 correlates recruitment Tat within CTIP2 induced structures relocalization within inactive regions chromatin
0.29273772.15849318.html.plaintext.txt	45	On line study noticed CTIP proteins also affect HIV 1 gene transcription absence Tat means CTIP proteins may also impair endogenous cellular transcription factor functions importance initial phase HIV 1 gene transcription
0.29273772.15849318.html.plaintext.txt	46	Here report CTIP proteins repress HIV 1 gene transcription via proximal LTR region binds Sp1 COUP TF transactivators
0.29273772.15849318.html.plaintext.txt	47	Since COUP TF Sp1 cellular transcription factors two major contributors HIV 1 gene transcription microglial cells postulated Sp1 COUP TF mediated LTR driven activation may impaired CTIP1 CTIP2
0.29273772.15849318.html.plaintext.txt	48	We report CTIP1 CTIP2 repress Sp1 COUP TF mediated stimulation HIV 1 gene expression
0.29273772.15849318.html.plaintext.txt	49	Since CTIP2 repressive activity much stronger CTIP1 mediated inhibition HIV 1 replication focused study CTIP2
0.29273772.15849318.html.plaintext.txt	50	CTIP2 mediated repression Sp1 COUP TF functions results direct physical interactions cellular transcription factors CTIP2
0.29273772.15849318.html.plaintext.txt	51	Association CTIP2 forces Sp1 COUP TF relocation CTIP2 induced subnuclear structures containing heterochromatin associated protein Hp1
0.29273772.15849318.html.plaintext.txt	52	Moreover CTIP2 recruited HIV 1 promoter physical association Sp1 bound GC box regions LTR
0.29273772.15849318.html.plaintext.txt	53	Since Sp1 COUP TF transcription factors necessary Tat function microglial cells 22 CTIP2 mediated repression COUP TF Sp1 functions may largely contribute previously described CTIP2 mediated impairment Tat activity viral replication microglial cells 25
0.29273772.15849318.html.plaintext.txt	54	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Plasmids Most constructs used assays described previously HIV 1 LAI 5 LTR chloramphenicol acetyltransferase pLTR CAT 22 pGC WAP CAT 26 pLTR LUC 287 535 13 pLTR CAT mutGC pLTR CAT GC 22 pcDNA3 full length constructs HA CTIP1 Flag CTIP2 GST CTIP2 23 deletions constructs Flag CTIP2 25 RSV COUP TF CMV Sp1 GST COUP TF1 GST COUP TF2 GST COUP TF3 13
0.29273772.15849318.html.plaintext.txt	55	Several plasmids kindly provided following investigators GST Sp1 constructs provided H
0.29273772.15849318.html.plaintext.txt	56	Rotheneder Vienna Austria 27 pLTR LUC C
0.29273772.15849318.html.plaintext.txt	57	pNL4 3 28 obtained AIDS Research Reference Reagent Program division AIDS National Institute Allergy Infectious Diseases NIAID NIH
0.29273772.15849318.html.plaintext.txt	58	To construct RFP CTIP2 expression vector Flag CTIP2 digested EcoRI CTIP2 insert subcloned EcoRI site pDSRed vector Clontech
0.29273772.15849318.html.plaintext.txt	59	The GFP Sp1 constructed isolating XhoI HindIII Sp1 insert GST Sp1 expression vector subcloned XhoI HindIII sites pEGFP C1 vector Clontech
0.29273772.15849318.html.plaintext.txt	60	Cell culture The human microglial provided M
0.29273772.15849318.html.plaintext.txt	61	Tardieu Paris France 29 TZM bl 30 32 HEK 293T cell lines maintained DMEM containing 10 fetal calf serum 100 Uml penicillin streptomycin
0.29273772.15849318.html.plaintext.txt	62	Viral replication Microglial cells cultured 12 well plates transfected using calcium phosphate coprecipitation method HIV 1 pNL4 3 1
0.29273772.15849318.html.plaintext.txt	63	5 microg CMV Sp1 1 microg RSV COUP TF 1 microg plasmids indicated HA CTIP1 Flag CTIP2 expression vectors 0
0.29273772.15849318.html.plaintext.txt	64	Total amounts DNA identical experiment
0.29273772.15849318.html.plaintext.txt	65	Compensations made adding corresponding empty vectors
0.29273772.15849318.html.plaintext.txt	66	Each transfection carried duplicate repeated minimum three separate times two different plasmid preparations
0.29273772.15849318.html.plaintext.txt	67	HIV 1 replication monitored described previously 25
0.29273772.15849318.html.plaintext.txt	68	CAT assays Microglial cells cultured 12 well plates transfected using calcium phosphate coprecipitation method pLTR CAT 3 microg pGC WAP CAT 3 microg pLTR CAT GC 3 microg CMV Sp1 1 microg RSV COUP TF 1 microg plasmids indicated HA CTIP1 Flag CTIP2 0
0.29273772.15849318.html.plaintext.txt	69	5 1 microg expression vectors
0.29273772.15849318.html.plaintext.txt	70	Total amounts DNA identical experiments
0.29273772.15849318.html.plaintext.txt	71	Compensations made adding corresponding empty vectors
0.29273772.15849318.html.plaintext.txt	72	Each transfection carried duplicate repeated minimum three separate times two different plasmid preparations
0.29273772.15849318.html.plaintext.txt	73	CAT assays carried using standard techniques
0.29273772.15849318.html.plaintext.txt	74	Co immunoprecipitation assays Microglial cells cultured 100 mm diameter dishes transfected using LipofectamineTM 2000 Reagent Invitrogen indicated Flag CTIP2 30 microg
0.29273772.15849318.html.plaintext.txt	75	Twenty four hours post transfection cells washed twice cold phosphate buffered saline harvested prepared nuclear extracts 12
0.29273772.15849318.html.plaintext.txt	76	Nuclear proteins first diluted TNE buffer 50 mM Tris pH 8 1 Nonidet 2 mM EDTA protease inhibitors cocktail Roche cleared Protein AG Plus Agarose Santa Cruz Biotechnology finally incubated overnight primary antibodies anti Sp1 Sigma anti COUP TF kindly provided J
0.29273772.15849318.html.plaintext.txt	77	Mertz Madison WI anti Hp1 kindly provided R
0.29273772.15849318.html.plaintext.txt	78	Losson IGBMC Strasbourg France
0.29273772.15849318.html.plaintext.txt	79	The extracts immunoprecipitated addition Protein AG Plus Agarose Santa Cruz Biotechnology
0.29273772.15849318.html.plaintext.txt	80	After extensive washing TNE buffer immunoprecipitates processed SDS PAGE western blot analysis
0.29273772.15849318.html.plaintext.txt	81	Glutathione S transferase GST pull assays Production GST fusion proteins described previously 13 visualized Coomassie blue staining
0.29273772.15849318.html.plaintext.txt	82	The 35S labeled proteins prepared vitro transcription translation using TNT T7 Coupled Wheat Germ Extract System Promega
0.29273772.15849318.html.plaintext.txt	83	GST pull assays performed described previously 25
0.29273772.15849318.html.plaintext.txt	84	SDS PAGE western blot analysis SDS PAGE performed using standard techniques
0.29273772.15849318.html.plaintext.txt	85	Proteins detected using antibodies directed Flag epitope M2 mouse monoclonal Sigma COUP TF protein kindly provided J
0.29273772.15849318.html.plaintext.txt	86	Mertz Sp1 protein Sigma
0.29273772.15849318.html.plaintext.txt	87	Proteins visualized chemiluminescence using Super Signal Chemiluminescence Detection System Pierce
0.29273772.15849318.html.plaintext.txt	88	Electrophoretic mobility shift assays EMSA The probe used experiments described previously 13 corresponds three Sp1 binding sites HIV 1 proximal LTR region
0.29273772.15849318.html.plaintext.txt	89	Once produced GST fusion proteins eluted glutathione buffer 50 mM Tris pH 8 20 mM reduced glutathione
0.29273772.15849318.html.plaintext.txt	90	Purified Sp1 Promega GST fusion proteins incubated 32P labeled probe binding buffer 20 mM HEPES pH 7
0.29273772.15849318.html.plaintext.txt	91	5 mM EDTA 1 mM DTT 10 glycerol 4 degrees C 15 min
0.29273772.15849318.html.plaintext.txt	92	For supershift experiments GST fusion proteins incubated primary antibodies anti COUP TF kindly provided J
0.29273772.15849318.html.plaintext.txt	93	Mertz anti CTIP2 anti Sp1 Santa Cruz Biotechnology 16 h adding probe
0.29273772.15849318.html.plaintext.txt	94	EMSA assays performed described previously 25
0.29273772.15849318.html.plaintext.txt	95	Indirect immunofluorescence confocal microscopy Microglial cells cultured 48 well plates transfected using LipofectamineTM 2000 Reagent Invitrogen Flag CTIP2 RFP CTIP2 andor GFP Sp1 expression vectors
0.29273772.15849318.html.plaintext.txt	96	Cells fixed permeabilized described previously 25
0.29273772.15849318.html.plaintext.txt	97	The coverslips incubated 1 h room temperature primary antibodies directed COUP TF Santa Cruz Biotechnology kindly provided J
0.29273772.15849318.html.plaintext.txt	98	Mertz Sp1 sigma Hp1 proteins andor Flag epitope M2 mouse monoclonal Sigma
0.29273772.15849318.html.plaintext.txt	99	The primary immunocomplexes revealed CY2 CY3 labeled secondary anti species antibodies
0.29273772.15849318.html.plaintext.txt	100	The stained cells analyzed confocal microscopy using Zeiss laser scanning microscope model 510 invert equipped Planapo oil 63x immersion lens numerical aperture 1
0.29273772.15849318.html.plaintext.txt	101	Chromatin immunoprecipitation ChIP assays TZM bl HEK 293T cells cultured 100 mm diameter dishes transfected using calcium phosphate coprecipitation method indicated pLTR LUC pLTR CAT mutGC Flag CTIP2 30 microg expression vector
0.29273772.15849318.html.plaintext.txt	102	ChIP assays performed using ChIP Assay Kit Upstate 48 h post transfection
0.29273772.15849318.html.plaintext.txt	103	The primary antibodies used ChIP anti Sp1 Upstate anti Hp1 Upstate anti COUP TF Santa Cruz Biotechnology anti Flag M2 mouse monoclonal Sigma
0.29273772.15849318.html.plaintext.txt	104	DNA subjected PCR amplification using 5 primer 5 GATAAGGTAGAAGAGGCC 3 corresponding LTR sequence located 293 nt downstream transcriptional start site 3 primer 5 CTAACCAGAGAGACCCAGTAC 3 corresponding region upstream transcriptional start site
0.29273772.15849318.html.plaintext.txt	105	The resulting PCR product 307 bp analyzed agarose gel electrophoresis ethidium bromide staining
0.29273772.15849318.html.plaintext.txt	106	Three separate experiments performed
0.29273772.15849318.html.plaintext.txt	107	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES CTIP1 CTIP2 proteins repress HIV 1 gene transcription via LTR proximal region As previously shown CTIP1 CTIP2 proteins inhibited LTR driven transcription transient transfection assays Figure 1 lanes 2 3 25
0.29273772.15849318.html.plaintext.txt	108	To delineate LTR region responsible CTIP1 CTIP2 mediated HIV 1 gene transcriptional repression microglial cells transfected 5 deleted pLTR CAT reporter plasmid presence absence CTIP1 CTIP2 expression vectors
0.29273772.15849318.html.plaintext.txt	109	Deletion 5 region downstream two proximal GC box sequences affect CTIP1 CTIP2 ability repress LTR driven CAT activity Figure 1 lanes 5 6 indicating CTIP proteins repressive function mediated proximal region LTR encompassing two GC box sequences CATA sequence 21 TAR region
0.29273772.15849318.html.plaintext.txt	110	We previously observed cellular transcription factors Sp1 Sp3 directly bound LTR GC box sequences microglial cells 13
0.29273772.15849318.html.plaintext.txt	111	Moreover orphan nuclear receptor COUP TF indirectly anchored region via association Sp1 13
0.29273772.15849318.html.plaintext.txt	112	We largely described Sp1 COUP TF transcription factors two major contributors initial phase HIV 1 gene transcription microglial cells 91322
0.29273772.15849318.html.plaintext.txt	113	Taken together findings strongly suggest CTIP repressive activity may result impairment endogenous Sp1 COUP TF protein functions
0.29273772.15849318.html.plaintext.txt	114	View larger version 12K Figure 1 CTIP1 CTIP2 proteins repress HIV 1 gene transcription via proximal LTR region
0.29273772.15849318.html.plaintext.txt	115	Microglial cells transfected 3 microg pLTR CAT 3 microg pLTR CAT 287 535 presence absence 1 microg HA CTIP1 Flag CTIP2
0.29273772.15849318.html.plaintext.txt	116	Two days post transfection CAT activities measured expressed relative CAT activity obtained pLTR CAT alone standard deviations indicated values correspond average least three independent experiments performed duplicate
0.29273772.15849318.html.plaintext.txt	117	CTIP1 CTIP2 cofactors inhibit Sp1 COUP TF mediated activation HIV 1 gene transcription related viral replication To decipher mechanism whereby CTIP proteins affect initial phase HIV 1 gene transcription investigated impacts CTIP proteins Sp1 COUP TF functions
0.29273772.15849318.html.plaintext.txt	118	Microglial cells transfected pLTR CAT plasmid together vectors expressing COUP TF Figure 2A Sp1 Figure 2B proteins increasing amounts HA CTIP1 Flag CTIP2 expression vectors
0.29273772.15849318.html.plaintext.txt	119	The two proteins able repress COUP TF Sp1 mediated stimulations CAT activity
0.29273772.15849318.html.plaintext.txt	120	As control performed western blot experiments indicating COUP TF Sp1 expressions downregulated slightly upregulated cofactors
0.29273772.15849318.html.plaintext.txt	121	Since overexpression COUP TF Sp1 stimulates HIV 1 gene expression modest upregulation could responsible CTIPs repressive function
0.29273772.15849318.html.plaintext.txt	122	To correlate CTIP1 CTIP2 repressive activity LTR driven transcription level HIV 1 replication studied impacts Sp1 COUP TF mediated stimulations viral replication
0.29273772.15849318.html.plaintext.txt	123	Cells transfected HIV 1 pNL4 3 COUP TF Figure 2C Sp1 Figure 2D expression vectors presence increasing amounts CTIP1 CTIP2 expression vectors
0.29273772.15849318.html.plaintext.txt	124	The level viral replication investigated quantifying p24 Gag expression culture supernatants 2 days transfection
0.29273772.15849318.html.plaintext.txt	125	While CTIP1 CTIP2 inhibited COUP TF Figure 2C Sp1 Figure 2D activation HIV 1 NL4 3 replication strongest repression observed CTIP2 Figure 2C D lanes 6 8 indicating repressing activity CTIP2 HIV 1 replication cannot explained previously described capacity repress viral Tat protein 25
0.29273772.15849318.html.plaintext.txt	126	These results strongly suggest CTIP1 CTIP2 repress initial phase HIV 1 gene transcription direct indirect interactions endogenous Sp1 COUP TF proteins
0.29273772.15849318.html.plaintext.txt	127	View larger version 32K Figure 2 CTIP1 CTIP2 inhibit Sp1 COUP TF mediated activation HIV 1 gene transcription related viral replication
0.29273772.15849318.html.plaintext.txt	128	Microglial cells cotransfected 3 microg pLTR CAT A B 3 microg pNL4 3 C D 1 microg RSV COUP TF A C CMV Sp1 B D expression vectors increasing amounts HA CTIP1 Flag CTIP2 0
0.29273772.15849318.html.plaintext.txt	129	A B Two days post transfection CAT activities measured expressed relative value obtained pLTR CAT alone standard deviation indicated values correspond average least three independent experiments performed duplicate
0.29273772.15849318.html.plaintext.txt	130	Western blot experiments performed nuclear extracts antibodies directed COUP TF Sp1 proteins indicated
0.29273772.15849318.html.plaintext.txt	131	C D Two days post transfection culture supernatants analyzed p24 Gag contents expressed relative value obtained pNL4 3 alone taken 1
0.29273772.15849318.html.plaintext.txt	132	Depending cell confluency value varied 500 5000 pgml
0.29273772.15849318.html.plaintext.txt	133	Values correspond average least three independent experiments performed duplicate
0.29273772.15849318.html.plaintext.txt	134	The HIV 1 Tat function subsequent phase HIV 1 gene transcription also depend Tat association Sp1 COUP TF microglial cells 22
0.29273772.15849318.html.plaintext.txt	135	Since CTIP2 mediated repressive activities much stronger observed CTIP1 since CTIP2 CTIP1 inhibits subsequent phase HIV 1 gene transcription focused mechanistic investigation CTIP2
0.29273772.15849318.html.plaintext.txt	136	CTIP2 interacts COUP TF Sp1 vitro two interfaces To decipher mechanism whereby CTIP2 represses COUP TF Sp1 stimulatory activities first examined whether proteins able interact vitro
0.29273772.15849318.html.plaintext.txt	137	GST pull assays performed vitro translated 35S labeled CTIP2 equal amounts full length truncated GST COUP TF GST Sp1 fusion proteins Figure 3A
0.29273772.15849318.html.plaintext.txt	138	Results show CTIP2 bound specifically GST COUP TF GST Sp1 Figure 3A lanes 3 8 respectively control GST protein Figure 3A lanes 2 7 respectively
0.29273772.15849318.html.plaintext.txt	139	Approximately 2 5 1 2 35S labeled CTIP2 interacted GST COUP TF GST Sp1 respectively
0.29273772.15849318.html.plaintext.txt	140	Moreover 49 148 region COUP TF Figure 3A lane 5 622 788 region Sp1 Figure 3A lane 11 still able mediate association CTIP2 indicating CTIP2 interacted N terminal region COUP TF C terminal region Sp1 include zinc finger domains
0.29273772.15849318.html.plaintext.txt	141	View larger version 22K Figure 3 CTIP2 interacts vitro COUP TF Sp1 two interfaces
0.29273772.15849318.html.plaintext.txt	142	A Upper panels schematic representation COUP TF Sp1 proteins lower panels GST pull assays performed 35S labeled CTIP2 incubated GST lanes 2 7 GST fusion proteins indicated COUP TF domains lanes 3 5 Sp1 domains lanes 8 11
0.29273772.15849318.html.plaintext.txt	143	Approximately 1 total 35S labeled CTIP2 obtained loaded input control lanes 1 6
0.29273772.15849318.html.plaintext.txt	144	B GST pull assays performed 35S labeled full length truncated CTIP2 proteins incubated GST lanes 2 5 GST COUP TF lane 6 GST Sp1 lane 3 fusion proteins
0.29273772.15849318.html.plaintext.txt	145	Approximately 1 total 35S labeled proteins used loaded input control lanes 1 4
0.29273772.15849318.html.plaintext.txt	146	Representative Coomassie stainings GST GST Sp1 GST COUP TF proteins presented B lower panels
0.29273772.15849318.html.plaintext.txt	147	To precisely delineate region CTIP2 protein associates Sp1 COUP TF GST pull assays performed full length GST COUP TF GST Sp1 fusion proteins series vitro translated 35S labeled full length deletion mutants CTIP2 Figure 3B
0.29273772.15849318.html.plaintext.txt	148	The full length well deletion mutants starting position 350 610 717 mediate interaction GST COUP TF Figure 3B lane 6 GST Sp1 Figure 3B lane 3 control GST protein Figure 3B lanes 2 5
0.29273772.15849318.html.plaintext.txt	149	These results show CTIP2 able interact Sp1 COUP TF via C terminal zinc finger domain region
0.29273772.15849318.html.plaintext.txt	150	We previously shown CTIP2 harbors two independent interaction domains viral Tat protein 25
0.29273772.15849318.html.plaintext.txt	151	This prompted us determine whether additional interaction interface located N terminal central region CTIP2
0.29273772.15849318.html.plaintext.txt	152	To end GST pull experiments performed additional deletion constructs
0.29273772.15849318.html.plaintext.txt	153	As expected deletion mutant 350 716 able interact COUP TF Sp1 confirming C terminal region CTIP2 containing residues 717 813 mediates binding transcription factors
0.29273772.15849318.html.plaintext.txt	154	However 1 354 145 434 constructs appeared able restore interactions suggesting central region CTIP2 located residues 145 354 might sufficient COUP TF Sp1 association
0.29273772.15849318.html.plaintext.txt	155	Thus findings indicate CTIP2 interacts vitro zinc finger domains COUP TF Sp1 two interfaces located central region residues 145 354 C terminal region residues 717 813
0.29273772.15849318.html.plaintext.txt	156	CTIP2 colocalizes Sp1 COUP TF within Hp1 associated structures To visualize association CTIP2 Sp1 COUP TF within nucleus Flag CTIP2 transfected microglial cells observed immunofluorescence confocal laser microscopy Figure 4A
0.29273772.15849318.html.plaintext.txt	157	As previously described 25 anti Flag immunostaining Flag CTIP2 revealed formation CTIP2 induced nuclear ball like structures microglial cells nuclei Figure 4A images 3 8 13
0.29273772.15849318.html.plaintext.txt	158	Flag CTIP2 appeared concentrated periphery absent within structures
0.29273772.15849318.html.plaintext.txt	159	Interestingly observations RFP CTIP2 Figure 4B images 1 5 fusion protein revealed presence CTIP2 periphery also within previously described nuclear structures suggesting Flag epitopes within ball like structures probably accessible anti Flag antibodies
0.29273772.15849318.html.plaintext.txt	160	To control nuclear location RFP CTIP2 expression cells transfected RFP CTIP2 GFP Lamin B expression vectors
0.29273772.15849318.html.plaintext.txt	161	As previously described 25 CTIP2 induced nuclear structures located nucleus microglial cells C
0.29273772.15849318.html.plaintext.txt	162	In absence CTIP2 endogenous COUP TF Sp1 proteins expressed nucleoplasm speckled diffused staining pattern images 1 6
0.29273772.15849318.html.plaintext.txt	163	Moreover presence Flag CTIP2 transcription factors least partially located CTIP2 induced nuclear structures Figure 4A images 2 7
0.29273772.15849318.html.plaintext.txt	164	Endogenous Sp1 Figure 4A images 9 10 COUP TF Figure 4A images 4 5 proteins colocalized CTIP2 periphery immunostained structures
0.29273772.15849318.html.plaintext.txt	165	Up 87 70 endogenous COUP TF Sp1 proteins colocalized CTIP2 respectively
0.29273772.15849318.html.plaintext.txt	166	No staining observed inside ball like structures
0.29273772.15849318.html.plaintext.txt	167	We reported CTIP2 relocates viral Tat transactivator heterochromatin associated protein Hp1 25
0.29273772.15849318.html.plaintext.txt	168	Endogenous Hp1 exhibited diffused speckled nuclear distribution absence CTIP2 Figure 4A image 11
0.29273772.15849318.html.plaintext.txt	169	To visualize presence Hp1 CTIP2 induced structures absence Tat performed immunodetection endogenous Hp1 microglial cells expressing Flag CTIP2
0.29273772.15849318.html.plaintext.txt	170	As shown Figure 4A images 14 15 endogenous Hp1 colocalized CTIP2 suggesting endogenous COUP TF Sp1 Hp1 proteins relocated CTIP2 induced nuclear structures
0.29273772.15849318.html.plaintext.txt	171	To address whether COUP TF Sp1 also colocalized CTIP2 inside ball like structures performed immunodetection endogenous COUP TF protein different polyclonal antibodies kindly provided J
0.29273772.15849318.html.plaintext.txt	172	Mertz presence RFP CTIP2 GFP Sp1 fusion proteins
0.29273772.15849318.html.plaintext.txt	173	As shown Figure 4B image 2 endogenous COUP TF observed inside structures confirming epitope accessibility antibodies determinant COUP TF immunodetection
0.29273772.15849318.html.plaintext.txt	174	Since RFP CTIP2 expressed ball like structures Figure 4B images 1 5 GFP Sp1 expressed alone localized nucleoplasm diffused staining pattern Figure 4B image 6
0.29273772.15849318.html.plaintext.txt	175	Moreover presence RFP CTIP2 GFP Sp1 relocated CTIP2 induced structures Figure 4B image 3
0.29273772.15849318.html.plaintext.txt	176	COUP TF GFP Sp1 relocation restricted periphery CTIP2 induced nuclear structures since also detected inside structures shown presence white staining resulting colocalized red blue green staining Figure 4B image 4
0.29273772.15849318.html.plaintext.txt	177	Thus endogenous Sp1 proteins probably relocated within heterochromatic structures
0.29273772.15849318.html.plaintext.txt	178	However remained unaccessible currently used antibodies Figure 4A images 7 9
0.29273772.15849318.html.plaintext.txt	179	These results strongly suggest cellular transcription factors Sp1 COUP TF associate CTIP2 microglial cells
0.29273772.15849318.html.plaintext.txt	180	View larger version 37K Figure 4 CTIP2 colocalizes Sp1 COUP TF within Hp1 associated structures
0.29273772.15849318.html.plaintext.txt	181	A Microglial cells transfected Flag CTIP2 indicated
0.29273772.15849318.html.plaintext.txt	182	After treated endogenous Sp1 COUP TF Hp1 proteins immunodetected primary anti COUP TF Santa Cruz Biotechnology images 1 2 anti Sp1 images 6 7 anti Hp1 antibodies images 11 12
0.29273772.15849318.html.plaintext.txt	183	Overexpressed Flag CTIP2 detected antibodies directed Flag epitope images 3 8 13
0.29273772.15849318.html.plaintext.txt	184	The primary immunocomplexes revealed CY2 CY3 labeled anti species secondary antibodies green red staining
0.29273772.15849318.html.plaintext.txt	185	Mask column images 5 10 15 shows colocalized CY2 CY3 stainings
0.29273772.15849318.html.plaintext.txt	186	B Microglial cells expressing RFP CTIP2 image 1 GFP Sp1 image 3 subjected endogenous COUP TF immunodetection anti COUP TF antibodies kindly provided J
0.29273772.15849318.html.plaintext.txt	187	COUP TF immunocomplexes stained CY5 blue staining labeled anti species secondary antibodies image 2
0.29273772.15849318.html.plaintext.txt	188	Pattern RFP CTIP2 GFP Sp1 expressed alone presented images 5 6 respectively
0.29273772.15849318.html.plaintext.txt	189	A B Coverslips subjected confocal microscopy analysis
0.29273772.15849318.html.plaintext.txt	190	CTIP2 interacts Sp1 COUP TF Hp1 microglial cells We observed CTIP2 colocalizes Sp1 COUP TF heterochromatin associated protein HP1 microglial cells
0.29273772.15849318.html.plaintext.txt	191	To test whether Sp1 COUP TF CTIP2 Hp1 present complex performed co immunoprecipitation experiments microglial nuclear extracts expressing Flag CTIP2 protein Figure 5A
0.29273772.15849318.html.plaintext.txt	192	Anti Flag western blot immunodetections performed anti COUP TF lanes 3 4 anti Sp1 lanes 6 7 anti Hp1 lanes 9 10 immunoprecipitated nuclear extracts indicated CTIP2 interacted COUP TF lane 4 Sp1 lane 7 Hp1 lane 10 microglial cells
0.29273772.15849318.html.plaintext.txt	193	As control experiments performed CTIP2 non expressing extracts lanes 3 6 9 non immune serum NIS immunoprecipitated nuclear extracts lanes 2 5 8 confirmed specificity Flag immunodetection specificity COUP TF Sp1 Hp1 immunoprecipitation experiments respectively
0.29273772.15849318.html.plaintext.txt	194	Thus CTIP2 may able recruit protein complex including three proteins nucleus microglial cells
0.29273772.15849318.html.plaintext.txt	195	To address CTIP2 links COUP TF Sp1 Hp1 performed competition pull assays Figure 5B
0.29273772.15849318.html.plaintext.txt	196	GST COUP TF GST Sp1 fusion proteins incubated 35S labeled CTIP2 145 434 CTIP2 717 813 presence increasing amounts 35S Hp1
0.29273772.15849318.html.plaintext.txt	197	Results clearly show CTIP2 145 434 remained bound GST COUP TF GST Sp1 CTIP2 717 813 displaced Hp1
0.29273772.15849318.html.plaintext.txt	198	This displacement increased amount GST fusion proteins available CTIP2 145 434 binding
0.29273772.15849318.html.plaintext.txt	199	Hp1 competed COUP TF Sp1 binding C terminal domain CTIP2
0.29273772.15849318.html.plaintext.txt	200	These findings indicate 145 434 region CTIP2 stronger binding affinity COUP TF Sp1 717 813 domain preferentially binds Hp1
0.29273772.15849318.html.plaintext.txt	201	Thus CTIP2 may link COUP TF Sp1 bound 145 434 domain Hp1 bound 717 813 domain
0.29273772.15849318.html.plaintext.txt	202	To precisely examine formation ternary complex Sp1 COUP TF CTIP2 performed GST pull experiments mixed 35S labeled Sp1 COUP TF proteins GST CTIP2
0.29273772.15849318.html.plaintext.txt	203	As shown Figure 5C Sp1 COUP TF interacted together CTIP2
0.29273772.15849318.html.plaintext.txt	204	Moreover addition increasing amounts 145 434 CTIP2 COUP TF proteins compete Sp1 binding Figure 5D
0.29273772.15849318.html.plaintext.txt	205	Thus COUP TF CTIP2 compete Sp1 binding vitro
0.29273772.15849318.html.plaintext.txt	206	Taken together findings strongly suggest formation ternary complex occurring Sp1 COUP TF CTIP2
0.29273772.15849318.html.plaintext.txt	207	View larger version 22K Figure 5 CTIP2 interacts COUP TF Sp1 Hp1 microglial cells
0.29273772.15849318.html.plaintext.txt	208	A Nuclear extracts microglial cells expressing lanes 2 4 5 7 8 10 lanes 3 6 9 Flag CTIP2 immunoprecipitated antibodies directed COUP TF lanes 3 4 Sp1 lanes 6 7 Hp1 lanes 9 10 proteins
0.29273772.15849318.html.plaintext.txt	209	Proteins separated SDS PAGE western blot analysis anti Flag antibodies performed
0.29273772.15849318.html.plaintext.txt	210	B GST pull competition assays performed equal amounts 35S labeled 145 434 717 813 CTIP2 proteins increasing amounts 35S labeled Hp1
0.29273772.15849318.html.plaintext.txt	211	Proteins incubated GST COUP TF GST Sp1 fusion proteins indicated
0.29273772.15849318.html.plaintext.txt	212	C GST pull assays performed equal amounts 35S labeled Sp1 COUP TF proteins GST GST CTIP2 fusion proteins indicated
0.29273772.15849318.html.plaintext.txt	213	D GST pull competition assays performed indicated amounts 35S labeled 145 434 CTIP2 COUP TF proteins GST Sp1
0.29273772.15849318.html.plaintext.txt	214	A D Approximately 1 total 35S labeled proteins used loaded input control
0.29273772.15849318.html.plaintext.txt	215	CTIP2 anchored HIV 1 LTR direct interactions Sp1 bound LTR proximal region CTIP proteins DNA binding proteins bind consensus sequence related canonical GC box 33
0.29273772.15849318.html.plaintext.txt	216	Moreover previously described COUP TF activates HIV 1 transcription direct protein protein interactions Sp1 bound proximal region HIV 1 LTR 13
0.29273772.15849318.html.plaintext.txt	217	The association CTIP2 Sp1 COUP TF Figure 5 led us examine CTIP2 interacts HIV 1 LTR promote viral repression
0.29273772.15849318.html.plaintext.txt	218	To performed EMSA experiments pure Sp1 proteins bacterially produced GST CTIP2 GST COUP TF proteins incubated 32P labeled probe corresponding three Sp1 binding sites GC box HIV 1 LTR proximal region
0.29273772.15849318.html.plaintext.txt	219	As expected Sp1 bound probe form shifted nucleoproteic complex Figure 6A lanes 1 7
0.29273772.15849318.html.plaintext.txt	220	Interestingly addition GST CTIP2 lane 2 GST COUP lane 3 GST lane 4 separately promoted formation supershifted complexes indicating previously reported COUP TF 13 CTIP2 anchored LTR physical interaction Sp1
0.29273772.15849318.html.plaintext.txt	221	As control GST COUP TF GST CTIP2 proteins incubated alone unable directly interact probe lanes 5 6
0.29273772.15849318.html.plaintext.txt	222	To confirm whether COUP TF CTIP2 Sp1 form ternary complex performed additional gel shift experiments increasing amounts CTIP2 proteins added binary Sp1COUP TF complex lanes 9 10
0.29273772.15849318.html.plaintext.txt	223	As shown shifted complex formed COUP TF Sp1 bound template lane 8 supershifted increasing amount CTIP2 dose dependent manner
0.29273772.15849318.html.plaintext.txt	224	Moreover intensity supershifted complexes also increased CTIP2 quantity
0.29273772.15849318.html.plaintext.txt	225	Those findings favor formation ternary complex anchored HIV 1 Sp1 binding sites
0.29273772.15849318.html.plaintext.txt	226	To precisely examine complex mixed three proteins incubated respective antibody
0.29273772.15849318.html.plaintext.txt	227	EMSA experiments demonstrated complex observed presence three proteins Figure 6A lane 10 Figure 6B lane 1 supershifted antibodies directed CTIP2 Figure 6B lane 2 COUP TF Figure 6B lane 3 non immune serum Figure 6B lane 5 confirming presence two proteins complex
0.29273772.15849318.html.plaintext.txt	228	Moreover incubation mixed three proteins anti Sp1 antibodies Figure 6B lane 4 inhibited formation nucleoprotein complex
0.29273772.15849318.html.plaintext.txt	229	Thus impairing Sp1 binding proxixmal region HIV 1 LTR results total abolition CTIP2 COUP TF ability bind region viral promoter
0.29273772.15849318.html.plaintext.txt	230	These results confirm CTIP2 COUP TF interact Sp1 bound LTR vitro
0.29273772.15849318.html.plaintext.txt	231	Previously published EMSA experiments performed nuclear extracts microglial cells revealed region viral promoter binds cellular transcription factors Sp1 Sp3 microglial cells 13
0.29273772.15849318.html.plaintext.txt	232	EMSA experiments performed nuclear extracts microglial cells expressing CTIP2 could allow us observe CTIP2 indirect binding LTR C
0.29273772.15849318.html.plaintext.txt	233	To bypass technical issue address whether CTIP2 interacts viral promoter vivo ChIP assays conducted TZM bl cells contain chromatin integrated LTR transiently transfected HEK 293T cells
0.29273772.15849318.html.plaintext.txt	234	Although nature andor extent chromatin formation transiently transfected templates likely differ chromosomal genes previous reports validated ChIP studies transiently transfected cells 3435
0.29273772.15849318.html.plaintext.txt	235	The amplified proximal LTR region includes three Sp1 binding sites previously described COUP TF binding site 12
0.29273772.15849318.html.plaintext.txt	236	As expected absence CTIP2 endogenous Sp1 COUP TF interact proximal LTR region chromatin integrated Figure 6C transiently transfected contexts Figure 6D left panel
0.29273772.15849318.html.plaintext.txt	237	Moreover presence CTIP2 abolish Sp1 COUP TF recruitment Figure 6C row 2 Figure 6D left panel row 3 agreement vitro results described
0.29273772.15849318.html.plaintext.txt	238	However presence CTIP2 lesser extent template immunoprecipitated antibodies directed Sp1 COUP TF context integrated LTR Figure 6C row 2
0.29273772.15849318.html.plaintext.txt	239	The observations made antibodies directed Sp1 transiently transfected LTR context Figure 6D left panel
0.29273772.15849318.html.plaintext.txt	240	As shown Figure 6C D left panel CTIP2 interacted proximal region viral promoter
0.29273772.15849318.html.plaintext.txt	241	In addition mutation Sp1 binding sites abolished interaction Sp1 COUP TF CTIP2 region viral LTR Figure 6D right panel
0.29273772.15849318.html.plaintext.txt	242	Taken together vitro vivo findings suggest Sp1 mediated recruitment CTIP2 LTR occurs cellular context
0.29273772.15849318.html.plaintext.txt	243	We could detect Hp1 interactions proximal region LTR absence CTIP2 suggesting CTIP2 significantly increase recruitment Hp1 HIV 1 proximal promoter Figure 6D left panel
0.29273772.15849318.html.plaintext.txt	244	In addition mutation Sp1 binding sites also abolished CTIP2 mediated recruitment Hp1 Figure 6D right panel
0.29273772.15849318.html.plaintext.txt	245	Since Hp1 associates heterochromatic regions likely CTIP2 promotes transcriptionally repressed heterochromatic environment viral LTR region
0.29273772.15849318.html.plaintext.txt	246	View larger version 31K Figure 6 CTIP2 anchored HIV 1 LTR direct interactions Sp1 bound LTR proximal region
0.29273772.15849318.html.plaintext.txt	247	A B EMSA experiments performed using purified Sp1 GST GST COUP TF GST CTIP2 fusion proteins
0.29273772.15849318.html.plaintext.txt	248	Proteins incubated 32P labeled probe corresponding three Sp1 binding sites located downstream LTR LAI TATAA sequence
0.29273772.15849318.html.plaintext.txt	249	A Increasing amounts GST CTIP2 proteins correspond 5 microl lane 9 10 microl lane 10 used GST CTIP2 preparation
0.29273772.15849318.html.plaintext.txt	250	Supershift experiments performed B carried non immune serum lane 5 antibodies directed CTIP2 lane 2 COUP TF lane 3 Sp1 lane 4
0.29273772.15849318.html.plaintext.txt	251	The specific shifted supershifted complexes presented
0.29273772.15849318.html.plaintext.txt	252	C The TZM bl cells contain stably integrated LTR transfected 30 microg indicated Flag CTIP2 expression vector
0.29273772.15849318.html.plaintext.txt	253	D HEK 293T cells transfected 5 microg indicated pLTR left panel pLTR mutGC right panel constructs 10 microg Flag CTIP2 expression vector indicated
0.29273772.15849318.html.plaintext.txt	254	C D Input lanes correspond positive controls conduced fraction lysates used immunoprecipitation
0.29273772.15849318.html.plaintext.txt	255	Control lanes correspond negative controls immunoprecipitation reactions performed without antibodies
0.29273772.15849318.html.plaintext.txt	256	Anti Flag anti Sp1 anti COUP TF anti Hp1 lanes represent amplification reactions samples immunoprecipitated indicated antibodies
0.29273772.15849318.html.plaintext.txt	257	Results representative three independent experiments
0.29273772.15849318.html.plaintext.txt	258	Sp1 binding sites dominant sufficient absolutely necessary transcriptional repression mediated CTIP2 To address importance HIV 1 LTR GC box sequence CTIP2 repressive function transfected microglial cells pGC WAP CAT reporter plasmid presence Sp1 CTIP2 expression vectors Figure 7A
0.29273772.15849318.html.plaintext.txt	259	As expected heterologous promoter containing three consensus binding sites Sp1 highly inducible ectopic Sp1 overexpression lane 3
0.29273772.15849318.html.plaintext.txt	260	Interestingly overexpression CTIP2 also repressed Sp1 mediated transcriptional stimulation context GC WAP promoter lane 4 indicating Sp1 binding sites sufficient CTIP2 activity
0.29273772.15849318.html.plaintext.txt	261	These results also suggest CTIP2 may able repress transcription Sp1 sensitive cellular genes
0.29273772.15849318.html.plaintext.txt	262	View larger version 12K Figure 7 Sp1 binding sites dominant sufficient absolutely necessary transcriptional repression mediated CTIP2
0.29273772.15849318.html.plaintext.txt	263	A Microglial cells transfected 3 microg pGC WAP CAT reporter vector 1 microg expression vectors indicated
0.29273772.15849318.html.plaintext.txt	264	B Microglial cells transfected 3 microg pLTR CAT pLTR CAT mutGC pLTR CAT GC 1 microg indicated Flag CTIP2 vector
0.29273772.15849318.html.plaintext.txt	265	Two days post transfection CAT activities measured expressed relative value obtained reporter plasmids pGC WAP CAT pLTR CAT alone standard deviations indicated values correspond average least three independent experiments carried duplicate
0.29273772.15849318.html.plaintext.txt	266	To decipher whether CTIP2 repressive function exclusively mediated Sp1 binding sites examined LTR sequences responsible CTIP2 mediated transcriptional repression
0.29273772.15849318.html.plaintext.txt	267	To transfected microglial cells pLTR CAT vectors containing mutated deleted GC boxes presence absence CTIP2
0.29273772.15849318.html.plaintext.txt	268	As previously shown CTIP2 expression resulted strong repression basal LTR driven CAT activity Figure 7B lane 2
0.29273772.15849318.html.plaintext.txt	269	Mutation lane 3 deletion lane 5 Sp1 binding sites resulted 90 impairment LTR transcriptional activity confirming importance endogenous Sp1 COUP TF proteins bind region stimulate initial phase LTR driven transcription microglial cells 13
0.29273772.15849318.html.plaintext.txt	270	Surprisingly CTIP2 still able repress low remaining transcriptional activity mutated lane 4 deleted lane 6 LTR suggesting CTIP2 may also affect HIV 1 gene transcription via association cellular transcription factors yet characterized
0.29273772.15849318.html.plaintext.txt	271	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In recent work revealed importance cellular transcription factors Sp1 COUP TFIEar3 regulation HIV 1 gene transcription replication microglial cells 13
0.29273772.15849318.html.plaintext.txt	272	We shown orphan nuclear receptor COUP TF associates cooperates Sp1 activation LTR driven transcription
0.29273772.15849318.html.plaintext.txt	273	CTIP1 Bcl11a Evi9 CTIP2 Bcl11b Rit1ss related transcriptional regulatory proteins shown bind members COUP TF family 23
0.29273772.15849318.html.plaintext.txt	274	In recent work described nuclear cofactor CTIP2 inhibits subsequent phase HIV 1 gene transcription relocating viral Tat protein transcriptionally inactive regions chromatin via Hp1 25
0.29273772.15849318.html.plaintext.txt	275	Here addressed mechanism whereby CTIP2 impairs initial phase prior Tat expression HIV 1 gene transcription microglial cells
0.29273772.15849318.html.plaintext.txt	276	We report CTIP proteins inhibit Sp1 COUP TF mediated activation HIV 1 gene transcription replication microglial cells
0.29273772.15849318.html.plaintext.txt	277	To decipher mechanism whereby CTIP2 alters COUP TF Sp1 functions examined whether proteins interact vitro cells
0.29273772.15849318.html.plaintext.txt	278	GST pull experiments revealed CTIP2 associates N terminal region COUP TF C terminal region Sp1 vitro
0.29273772.15849318.html.plaintext.txt	279	In way CTIP2 presents two interfaces Sp1 COUP TF interactions
0.29273772.15849318.html.plaintext.txt	280	COUP TF Sp1 proteins bind central C terminal region CTIP2 vitro
0.29273772.15849318.html.plaintext.txt	281	These results consistent previously reported interface domains Arp1 COUP TFII CTIP1 23
0.29273772.15849318.html.plaintext.txt	282	Confocal microscopy observations COUP TF Sp1 location presence absence CTIP2 reveal CTIP2 colocalizes COUP TF Sp1 within nuclear ball like structures
0.29273772.15849318.html.plaintext.txt	283	Moreover heterochromatin associated protein Hp1 also present structures
0.29273772.15849318.html.plaintext.txt	284	There three Hp1 protein family members mammals Hp1 Hp1ss Hp1
0.29273772.15849318.html.plaintext.txt	285	The Hp1 isoform mainly detected transcriptionally repressed heterochromatic region 36
0.29273772.15849318.html.plaintext.txt	286	Thus colocalization CTIP2 endogenous Sp1 COUP TF Hp1 proteins reported strongly suggests proteins relocated transcriptionally inactive regions heterochromatin microglial cells
0.29273772.15849318.html.plaintext.txt	287	Those CTIP2 induced structures may represent new class nuclear structures 25
0.29273772.15849318.html.plaintext.txt	288	Moreover observations may favor hypothesis suggesting formation nuclear bodies inhibits HIV 1 gene transcription sequestering variety factors required transcriptional activation reviewed 37
0.29273772.15849318.html.plaintext.txt	289	Co immunoprecipitation data indicate described subnuclear colocalization results physical interactions Sp1 COUP TF Hp1 CTIP2 nucleus microglial cells
0.29273772.15849318.html.plaintext.txt	290	Since Hp1 Sp1 COUP TF proteins associate CTIP2 microglial cells address respective interaction interfaces vitro
0.29273772.15849318.html.plaintext.txt	291	Our findings show central zinc finger domain CTIP2 may preferentially bind Sp1 COUP TF proteins C terminal region may bind Hp1
0.29273772.15849318.html.plaintext.txt	292	In presence viral Tat transactivator CTIP2 also associates Hp1 via C terminal region
0.29273772.15849318.html.plaintext.txt	293	Taken together findings suggest permanent association CTIP2 Hp1 via C terminal region
0.29273772.15849318.html.plaintext.txt	294	The central domain CTIP2 may reserved interactions functionally repressed transcription factors
0.29273772.15849318.html.plaintext.txt	295	Our observations indicate COUP TF Sp1 could bind together CTIP2 COUP TF CTIP2 compete Sp1 binding
0.29273772.15849318.html.plaintext.txt	296	Those findings suggest formation ternary complex including COUP TF Sp1 CTIP2 proteins
0.29273772.15849318.html.plaintext.txt	297	Thereby CTIP2 links transcriptional activators transcriptionally repressed heterochromatic region
0.29273772.15849318.html.plaintext.txt	298	CTIP1 CTIP2 proteins described sequence specific DNA binding proteins 33
0.29273772.15849318.html.plaintext.txt	299	The core binding site identified study highly related canonical GC box sequence
0.29273772.15849318.html.plaintext.txt	300	Since Sp1 anchors COUP TF GC box sequence viral LTR region 12 addressed CTIP2 interacts HIV 1 promoter
0.29273772.15849318.html.plaintext.txt	301	Our findings demonstrate CTIP2 able directly bind three viral GC box sequences vitro
0.29273772.15849318.html.plaintext.txt	302	CTIP2 recruited HIV 1 LTR via association Sp1 bound region
0.29273772.15849318.html.plaintext.txt	303	Moreover CTIP2 competition COUP TF Sp1 mediated anchorage viral promoter indicating three proteins linked together LTR vitro
0.29273772.15849318.html.plaintext.txt	304	The ChIP experiments conducted cellular context confirm CTIP2 Sp1 COUP TF proteins bind proximal region HIV 1 promoter chromatin integrated non integrated contexts
0.29273772.15849318.html.plaintext.txt	305	The surprising reduction Sp1 COUP TF binding viral promoter presence CTIP2 apparently agree vitro observations
0.29273772.15849318.html.plaintext.txt	306	We show Sp1 anchors CTIP2 COUP TF HIV 1 LTR Sp1 binding GC box sequence necessary CTIP2 recruitment region
0.29273772.15849318.html.plaintext.txt	307	Nevertheless since Sp1 COUP TF proteins accessible related antibodies CTIP2 induced nuclear structures one wonders whether observation reduced binding LTR may result protein sequestration andor chromatin environment
0.29273772.15849318.html.plaintext.txt	308	ChIP experiments also indicate CTIP2 promotes Hp1 recruitment LTR encompassing Sp1 binding sequences
0.29273772.15849318.html.plaintext.txt	309	Mutation Sp1 binding sites abolished recruitment
0.29273772.15849318.html.plaintext.txt	310	Taken together results suggest Sp1 mediated anchorage CTIP2 HIV 1 LTR region may recruit large complex promotes Hp1 association heterochromatin environment viral gene transcriptional silencing
0.29273772.15849318.html.plaintext.txt	311	In Jurkat cells CTIP2 associates histone deacetylase SirT1 large complex
0.29273772.15849318.html.plaintext.txt	312	CTIP2 mediated recruitment SirT1 promoter template results deacetylation bound histones H3 H4 transcriptional repression 35
0.29273772.15849318.html.plaintext.txt	313	The chromatin structure close HIV 1 gene promoter involved viral post integration latency phenomenon 38
0.29273772.15849318.html.plaintext.txt	314	Further studies necessary examine CTIP2 recruited complex promotes HIV 1 gene silencing
0.29273772.15849318.html.plaintext.txt	315	To control whether CTIP2 repressive function mediated Sp1 binding sites examined ability repress heterologous promoter containing three consensus GC boxes
0.29273772.15849318.html.plaintext.txt	316	Our findings reveal GC box sequences sufficient CTIP2 mediated repression Sp1 stimulation suggesting CTIP2 may impact transcriptional activity GC box containing promoters
0.29273772.15849318.html.plaintext.txt	317	In agreement observations CTIP2 still able repress LTR driven transcriptional activity LTR deleted downstream GC box sequences
0.29273772.15849318.html.plaintext.txt	318	Recruitment CTIP1 template COUP TF family member found result transcriptional repression reporter gene harboring COUP TF binding site 23
0.29273772.15849318.html.plaintext.txt	319	In context HIV 1 promoter deletion previously described COUP TF binding site impact CTIP2 repressive function
0.29273772.15849318.html.plaintext.txt	320	Moreover EMSA ChIP experiments demonstrate CTIP2 interacts proximal region LTR excluding COUP TF binding sequence
0.29273772.15849318.html.plaintext.txt	321	Taken together findings indicate COUP TF binding sequence located downstream GC box region might implicated CTIP2 repressive functions
0.29273772.15849318.html.plaintext.txt	322	As widely reported deletion LTR GC box region results drastic 90 reduction LTR driven transcriptional activity 13 1522
0.29273772.15849318.html.plaintext.txt	323	These observations confirm crucial contribution Sp1 COUP TF transcription factors support viral gene transcription microglial cells
0.29273772.15849318.html.plaintext.txt	324	Moreover highlight importance CTIP2 mediated repression Sp1 COUP TF protein functions
0.29273772.15849318.html.plaintext.txt	325	Most 80 CTIP2 mediated reduction basal transcriptional level may charged repressive activity
0.29273772.15849318.html.plaintext.txt	326	Surprisingly CTIP2 still able repress 10 remaining transcriptional activity driven GC box deleted LTR suggesting CTIP2 may also able repress expression mutated strains virus
0.29273772.15849318.html.plaintext.txt	327	This remaining activity represents 10 global CTIP2 mediated repressive activity
0.29273772.15849318.html.plaintext.txt	328	Nevertheless previously suggested COUP TF restores viral Tat function context GC box mutated LTR anchoring Tat basal transcriptional machinery 22
0.29273772.15849318.html.plaintext.txt	329	Interestingly observed CTIP2 also able repress functional cooperation C
0.29273772.15849318.html.plaintext.txt	330	These results suggest context COUP TF may bind CTIP2 via N terminal region general transcription factor TFIIB via C terminal part described previously 39
0.29273772.15849318.html.plaintext.txt	331	Thus absence Sp1 mediated linkage GC box region HIV 1 LTR CTIP2 may bypass Sp1 association COUP TF mediated linkage basal transcriptional machinery
0.29273772.15849318.html.plaintext.txt	332	Moreover proposed indirect linkage might weak since appeared undetectable ChIP experiments
0.29273772.15849318.html.plaintext.txt	333	Along line CTIP2 might also associate cellular transcription factors yet characterized
0.29273772.15849318.html.plaintext.txt	334	These studies fully complete reporting CTIP2 mediated repression viral Tat function 25
0.29273772.15849318.html.plaintext.txt	335	Since Sp1 COUP TF association necessary Tat function microglial cells 22 postulated CTIP2 mediated impairment Sp1 COUP TF function contributes previously observed repression Tat function
0.29273772.15849318.html.plaintext.txt	336	The chromatin structure site provirus integration reminiscent post integration latency phenomenon 38
0.29273772.15849318.html.plaintext.txt	337	In vitro latent T cell clones frequently contain HIV 1 genome integrated heterochromatin structures
0.29273772.15849318.html.plaintext.txt	338	This contrast productive infection integration near heterochromatin disfavored 40
0.29273772.15849318.html.plaintext.txt	339	No antiretroviral drugs currently available inhibit transcription HIV RNA integrated HIV proviral DNA infected cells
0.29273772.15849318.html.plaintext.txt	340	Nevertheless HDAC inhibitors able induce quiescent provirus suggesting derepression heterochromatin structures may force viral expression latently infected reservoirs 4142
0.29273772.15849318.html.plaintext.txt	341	Thus investigation factors may promote heterochromatin structures viral gene promoter CTIP2 appears crucial understanding phenomena development new anti HIV strategies
0.29273772.15849318.html.plaintext.txt	342	At stage studies necessary precisely examine CTIP2 associated enzymatic activities promote transcriptional silencing
0.29273772.15849318.html.plaintext.txt	343	In addition since investigations restricted transcriptional step viral life cycle cannot excluded CTIP2 also counteracts critical steps necessary optimal viral replication
0.29273772.15849318.html.plaintext.txt	344	This possibility needs clarification
0.29273772.15849318.html.plaintext.txt	345	ACKNOWLEDGEMENTS The authors thank R
0.29273772.15849318.html.plaintext.txt	346	Losson providing Hp1 vectors anti Hp1 antibodies H
0.29273772.15849318.html.plaintext.txt	347	Rotheneder providing GST SP1 vectors J
0.29273772.15849318.html.plaintext.txt	348	Mertz providing anti COUP TF antibodies Ann Dekoninck technical support
0.29273772.15849318.html.plaintext.txt	349	The following reagents obtained NIH AIDS Research Reference Reagent Program Division AIDS NIAID NIH TZM bl Dr John C
0.29273772.15849318.html.plaintext.txt	350	Kappes Dr Xiaoyun Wu Tranzyme Inc
0.29273772.15849318.html.plaintext.txt	351	pNL4 3 Dr Malcolm Martin
0.29273772.15849318.html.plaintext.txt	352	This work supported Institut National de la Sante et de la Recherche Medicale INSERM Agence Nationale de Recherches sur le SIDA ANRS grants French Ministry Research ACI JC 5364 O
0.29273772.15849318.html.plaintext.txt	353	Conseil Regional dAlsace
0.29273772.15849318.html.plaintext.txt	354	Maicirctre de Recherches Fonds National de la Recherche Scientifique FNRS Belgium O
0.29273772.15849318.html.plaintext.txt	355	Maicirctre de Conferences IUT Louis Pasteur de Schiltigheim University Strasbourg I France
0.29273772.15849318.html.plaintext.txt	356	Work Leid Laboratory supported grant NIH GM60852 part grant number P30 ES00210 National Institute Environmental Health Sciences NIH
0.29273772.15849318.html.plaintext.txt	357	Funding pay Open Access publication charges article provided INSERM
0.29273772.15849318.html.plaintext.txt	358	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Fauci A
0.29273772.15849318.html.plaintext.txt	359	1988 The human immunodeficiency virus infectivity mechanisms pathogenesis Science 239 617 622ISIMedline
0.29273772.15849318.html.plaintext.txt	360	1991 Update HIV related neurological illness AIDS 5 Suppl
0.29273772.15849318.html.plaintext.txt	361	1997 Central nervous system sanctuary HIV 1 infection despite treatment zidovudine lamivudine indinavir AIDS 11 1302 1303ISIMedline
0.29273772.15849318.html.plaintext.txt	362	1998 The effects human immunodeficiency virus central nervous system Adv
0.29273772.15849318.html.plaintext.txt	363	1991 Human microglial cells characterization cerebral tissue primary culture study susceptibility HIV 1 infection Ann
0.29273772.15849318.html.plaintext.txt	364	29 152 161CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	365	1994 Biology mononuclear phagocyte system central nervous system HIV infection J
0.29273772.15849318.html.plaintext.txt	366	2002 Charting HIVs remarkable voyage cell Basic science passport future therapy Nature Med
0.29273772.15849318.html.plaintext.txt	367	8 673 680CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	368	2000 A compilation cellular transcription factor interactions HIV 1 LTR promoter Nucleic Acids Res
0.29273772.15849318.html.plaintext.txt	369	28 663 668AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	370	2003 Regulation HIV 1 gene transcription lymphocytes microglial cells J
0.29273772.15849318.html.plaintext.txt	371	74 736 749AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	372	1989 COUP transcription factor member steroid receptor superfamily Nature 340 163 166CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	373	1987 Purification characterization chicken ovalbumin upstream promoter transcription factor HeLa cells J
0.29273772.15849318.html.plaintext.txt	374	262 16080 16086AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	375	1996 Chicken ovalbumin upstream promoter transcription factor transcriptional activator HIV 1 gene expression human brain cells J
0.29273772.15849318.html.plaintext.txt	376	271 23572 23576AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	377	1997 COUP TF Sp1 interact cooperate transcriptional activation human immunodeficiency virus type 1 long terminal repeat human microglial cells J
0.29273772.15849318.html.plaintext.txt	378	272 31149 31155AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	379	1999 CREB COUP TF mediate transcriptional activation human immunodeficiency virus type 1 genome Jurkat T cells response cyclic AMP dopamine J
0.29273772.15849318.html.plaintext.txt	380	CO2 GlinktypeDOI CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	381	2000 Functional interactions CEBP Sp1 COUP TF regulate human immunodeficiency virus type 1 gene transcription human brain cells J
0.29273772.15849318.html.plaintext.txt	382	74 65 73AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	383	1986 Activation AIDS retrovirus promoter cellular transcription factor Sp1 Science 232 755 759ISIMedline
0.29273772.15849318.html.plaintext.txt	384	1989 Role SP1 binding domains vivo transcriptional regulation human immunodeficiency virus type 1 long terminal repeat J
0.29273772.15849318.html.plaintext.txt	385	63 2585 2591ISIMedline
0.29273772.15849318.html.plaintext.txt	386	1995 Transcriptional trans activation human immunodeficiency virus type 1 Tat requires specific coactivators basal factors J
0.29273772.15849318.html.plaintext.txt	387	1993 A cooperative interaction NF kappa B Sp1 required HIV 1 enhancer activation EMBO J
0.29273772.15849318.html.plaintext.txt	388	2003 Tat trans activation responsive TAR RNA independent induction HIV 1 long terminal repeat human murine cyclin T1 requires Sp1 J
0.29273772.15849318.html.plaintext.txt	389	278 6404 6410AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	390	2004 The human immunodeficiency virus type 1 promoter contains CATA box instead TATA box optimal transcription replication J
0.29273772.15849318.html.plaintext.txt	391	78 6883 6890AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	392	2000 The nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts HIV 1 Tat stimulates viral replication human microglial cells J
0.29273772.15849318.html.plaintext.txt	393	275 2654 2660AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	394	2000 Isolation novel family C2H2 zinc finger proteins implicated transcriptional repression mediated chicken ovalbumin upstream promoter transcription factor COUP TF orphan nuclear receptors J
0.29273772.15849318.html.plaintext.txt	395	275 10315 10322AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	396	2004 CTIP1 CTIP2 differentially expressed mouse embryogenesis Gene Expr
0.29273772.15849318.html.plaintext.txt	397	Patterns 4 733 739CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	398	2003 Recruitment Tat heterochromatin protein HP1 via interaction CTIP2 inhibits human immunodeficiency virus type 1 replication microglial cells J
0.29273772.15849318.html.plaintext.txt	399	77 5415 5427AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	400	1999 Dopamine stimulates expression human immunodeficiency virus type 1 via NF kappaB cells immune system Nucleic Acids Res
0.29273772.15849318.html.plaintext.txt	401	27 3291 3299AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	402	1996 Interaction Sp1 growth cell cycle regulated transcription factor E2F Mol
0.29273772.15849318.html.plaintext.txt	403	1987 Productive persistent infection human colorectal cell lines human immunodeficiency virus J
0.29273772.15849318.html.plaintext.txt	404	1995 Establishment human microglial cell lines transfection primary cultures embryonic microglial cells SV40 large T antigen Neurosci
0.29273772.15849318.html.plaintext.txt	405	195 105 108CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	406	2000 Sensitivity human immunodeficiency virus type 1 fusion inhibitor T 20 modulated coreceptor specificity defined V3 loop gp120 J
0.29273772.15849318.html.plaintext.txt	407	74 8358 8367AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	408	1998 Effects CCR5 CD4 cell surface concentrations infections macrophagetropic isolates human immunodeficiency virus type 1 J
0.29273772.15849318.html.plaintext.txt	409	72 2855 2864AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	410	2002 Emergence resistant human immunodeficiency virus type 1 patients receiving fusion inhibitor T 20 monotherapy Antimicrob
0.29273772.15849318.html.plaintext.txt	411	46 1896 1905AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	412	2002 COUP TF chicken ovalbumin upstream promoter transcription factor interacting protein 1 CTIP1 sequence specific DNA binding protein Biochem
0.29273772.15849318.html.plaintext.txt	413	368 555 563CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	414	1998 Rb interacts histone deacetylase repress transcription Cell 92 463 473CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	415	2003 Involvement histone deacetylase SIRT1 chicken ovalbumin upstream promoter transcription factor COUP TF interacting protein 2 mediated transcriptional repression J
0.29273772.15849318.html.plaintext.txt	416	278 43041 43050AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	417	2001 Heterochromatin formation mammalian cells interaction histones HP1 proteins Mol
0.29273772.15849318.html.plaintext.txt	418	Cell 7 729 739CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	419	2004 Nuclear organization control HIV 1 transcription Gene 326 1 11CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	420	2001 The site HIV 1 integration human genome determines basal transcriptional activity response Tat transactivation EMBO J
0.29273772.15849318.html.plaintext.txt	421	20 1726 1738AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	422	1992 Members steroid hormone receptor superfamily interact TFIIB S300 II J
0.29273772.15849318.html.plaintext.txt	423	267 17617 17623AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	424	2003 HIV reproducibly establishes latent infection acute infection T cells vitro EMBO J
0.29273772.15849318.html.plaintext.txt	425	22 1868 1877AbstractFree Full Text
0.29273772.15849318.html.plaintext.txt	426	2004 Coaxing HIV 1 resting CD4 T cells histone deacetylase inhibition allows latent viral expression AIDS 18 1101 1108CrossRefISIMedline
0.29273772.15849318.html.plaintext.txt	427	2002 Synergistic activation human immunodeficiency virus type 1 promoter activity NF kappaB inhibitors deacetylases potential perspectives development therapeutic strategies J
0.29273772.15849318.html.plaintext.txt	428	76 11091 11103AbstractFree Full Text
0.2712022.9171235.html.plaintext.txt	0	Gene Silencing Chicken Ovalbumin Upstream Promoter Transcription Factor I COUP TFI Is Mediated Transcriptional Corepressors Nuclear Receptor Corepressor N CoR Silencing Mediator Retinoic Acid Receptor Thyroid Hormone Receptor SMRT Hirotaka Shibata Zafar Nawaz Sophia Y
0.2712022.9171235.html.plaintext.txt	1	Department Cell Biology Baylor College Medicine Houston Texas 77030
0.2712022.9171235.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Chicken ovalbumin upstream promoter transcription factors COUP TFs orphan receptors belong steroidthyroid hormone receptor TR superfamily repress transcriptional activity several target genes however precise mechanism repression unknown
0.2712022.9171235.html.plaintext.txt	3	Transfection Gal4 DNA binding domain fused putative ligand binding domain COUP TFI Gal4 COUP TFI significantly represses basal transcriptional activity reporter gene containing Gal4 binding sites
0.2712022.9171235.html.plaintext.txt	4	Cotransfection COUP TFI relieve Gal4 COUP TFI repression dose dependent manner
0.2712022.9171235.html.plaintext.txt	5	In contrast COUP TFI35 lacks repressor domain C terminal 35 amino acids fails relieve repression
0.2712022.9171235.html.plaintext.txt	6	This finding suggests repressor domain COUP TFI may squelch limiting amount corepressor HeLa cells
0.2712022.9171235.html.plaintext.txt	7	In addition increasing concentrations TRss also relieve COUP TFI repression hormone sensitive manner
0.2712022.9171235.html.plaintext.txt	8	Similarly overexpression increasing concentration COUP TFI COUP TFI35 squelch silencing activity unliganded TRss
0.2712022.9171235.html.plaintext.txt	9	Collectively results indicate COUP TFI TRss share common corepressors silencing activity
0.2712022.9171235.html.plaintext.txt	10	To determine corepressor involved COUP TF silencing activity used yeast two hybrid vitro GST pull assays demonstrate COUP TFI interact fragment N CoR nuclear receptor corepressor encoding amino acids 921 2453 fragments SMRT silencing mediator retinoic acid receptor TR encoding amino acids 29 564 565 1289 respectively
0.2712022.9171235.html.plaintext.txt	11	Interestingly fragment SMRT encoding amino acids 1192 1495 strongly interacts TRss interacts weakly COUP TFI
0.2712022.9171235.html.plaintext.txt	12	Furthermore overexpression N CoR SMRT potentiates silencing activity COUP TFI relieve COUP TFI mediated squelching Gal4 COUP TFI activity
0.2712022.9171235.html.plaintext.txt	13	Therefore studies indicate N CoR SMRT act corepressors COUP TFI silencing activity
0.2712022.9171235.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Steroidthyroid hormone receptors ligand dependent transcription factors regulate diverse aspects growth development homeostasis binding monomer homodimers heterodimers cognate DNA response elements modulate transcription target genes 1 2 3
0.2712022.9171235.html.plaintext.txt	15	Thyroid hormone TR retinoic acid receptors RAR bind cognate DNA response elements repress basal promoter activity absence ligand 3 4 5
0.2712022.9171235.html.plaintext.txt	16	The region important repression may represent unique interaction surface contacting particular target within basal transcriptional machinery
0.2712022.9171235.html.plaintext.txt	17	Highly charged regions common feature repression motifs
0.2712022.9171235.html.plaintext.txt	18	These charged regions consist basic residues 6 acidic residues 7 8
0.2712022.9171235.html.plaintext.txt	19	In contrast well defined small repression motifs homologous repression regions TR RAR large appear include multiple regions within ligand binding domains LBDs hinge regions
0.2712022.9171235.html.plaintext.txt	20	Many interacting proteins identified proposed important mediating repressor function
0.2712022.9171235.html.plaintext.txt	21	The identified molecular targets repressors categorized three groups 9 basal transcription factors activators coregulators coactivators corepressors
0.2712022.9171235.html.plaintext.txt	22	Silencing activity unliganded TR RAR requires limiting factors termed corepressors 5
0.2712022.9171235.html.plaintext.txt	23	Recently two corepressors bind unliganded TR RAR cloned using yeast two hybrid screen N CoR nuclear receptor corepressor 10 11 SMRT silencing mediator RAR TR 12 13 14 15
0.2712022.9171235.html.plaintext.txt	24	Binding corepressors necessary unliganded receptors silence activity target promoters
0.2712022.9171235.html.plaintext.txt	25	Prevailing evidence suggests binding hormone changes conformation receptors results release corepressor recruitment coactivators thereby abolishing silencing activity
0.2712022.9171235.html.plaintext.txt	26	These two corepressors exhibit significant sequence homologies receptor interacting domains suggesting existence corepressor gene family
0.2712022.9171235.html.plaintext.txt	27	COUP TFs chicken ovalbumin upstream promoter transcription factors belong steroid receptor superfamily classified orphan receptors ligand yet defined
0.2712022.9171235.html.plaintext.txt	28	There two COUP TF genes mammals COUP TFI COUP TFII
0.2712022.9171235.html.plaintext.txt	29	COUP TFs implicated neurogenesis organogenesis cell fate determination 16 17 18 19
0.2712022.9171235.html.plaintext.txt	30	COUP TFs form stable homodimers bind variety hormone response elements recognized members steroid receptor superfamily RAR retinoid X receptor RXR TR vitamin D receptor VDR peroxisome proliferator activated receptor hepatocyte nuclear factor 4
0.2712022.9171235.html.plaintext.txt	31	COUP TFs thereby inhibit transcriptional activities receptors consensus natural response elements 17 20
0.2712022.9171235.html.plaintext.txt	32	Four mechanisms proposed address COUP TF ability inhibit transactivation function members steroid receptor superfamily
0.2712022.9171235.html.plaintext.txt	33	First COUP TFs repress hormone dependent transactivation target genes VDR TR RAR direct competition occupancy response elements 21 22 23
0.2712022.9171235.html.plaintext.txt	34	Second COUP TFs heterodimerize RXR reduce available concentration RXR heterodimerization TR VDR RAR peroxisome proliferator activated receptor thus indirectly interfere receptors transactivate target genes 21 22 24 25 26 27
0.2712022.9171235.html.plaintext.txt	35	Third COUP TFs tether DNA via LBD LBD interactions TR RAR RXR transrepress activities 27
0.2712022.9171235.html.plaintext.txt	36	Finally COUP TFs shown repress basal activator dependent transcriptional activities various promoters binding site placed upstream downstream promoters 27
0.2712022.9171235.html.plaintext.txt	37	The silencing domain COUP TFs localized C terminus putative LBD transferred heterologous Gal4 DNA binding domain DBD
0.2712022.9171235.html.plaintext.txt	38	Activators repressed COUP TFs include acidic Gal4 RII glutamine rich Gal4 ftzQ proline rich Gal4 CTF1P SerThr rich Gal4 ZenST transactivators 27
0.2712022.9171235.html.plaintext.txt	39	Because COUP TF repress diverse group transactivators unlikely COUP TF repression direct quenching transactivators interfering respective targets
0.2712022.9171235.html.plaintext.txt	40	It rather likely COUP TFs interact common target putative corepressors mediates repression
0.2712022.9171235.html.plaintext.txt	41	To substantiate hypothesis address two major questions paper 1 Does COUP TFI mediated repression require corepressors 2 If COUP TFI share corepressors receptors TR RAR To answer questions first examined whether cofactors involved COUP TFI mediated repression using either self squelching TRCOUP TF mediated mutual squelching experiments
0.2712022.9171235.html.plaintext.txt	42	Next examined whether COUP TFI interact N CoR SMRT
0.2712022.9171235.html.plaintext.txt	43	Finally examined whether N CoR SMRT function corepressor COUP TFI mediated repression
0.2712022.9171235.html.plaintext.txt	44	Results experiments indicate N CoR SMRT function corepressors COUP TFI mediated repression target genes
0.2712022.9171235.html.plaintext.txt	45	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES COUP TFI Mediated Transcriptional Repression Requires Corepressors The putative LBD COUP TFI amino acid 184 423 previously shown contain transcriptional repression domain
0.2712022.9171235.html.plaintext.txt	46	To repress transcription generally believed COUP TFI interacts basal transcriptional machinery either directly indirectly cofactor molecules
0.2712022.9171235.html.plaintext.txt	47	To determine whether cofactors required repressor activity carried transfection experiments
0.2712022.9171235.html.plaintext.txt	48	Transfection Gal4 DBD fused COUP TFI amino acid 184 423 cDNA designated Gal4 COUP TFI significantly repressed basal promoter activity 17 mer x 4 thymidine kinase promoter linked luciferase reporter DNA shown previously Fig
0.2712022.9171235.html.plaintext.txt	49	This repression activity reversed exogenously expressed LBD COUP TFI 184 423 bind reporter construct dose dependent manner
0.2712022.9171235.html.plaintext.txt	50	The observed release repression cannot attributed nonspecific effect overexpression COUP TFI Gal DNA binding activity overexpression COUP TFI little effect basal promoter activity cotransfected Gal4 DBD alone 27
0.2712022.9171235.html.plaintext.txt	51	In contrast COUP TFI mutant COUP TFI35 amino acid 184 388 contain repressor domain cannot reverse Gal4 COUP TFI mediated repression
0.2712022.9171235.html.plaintext.txt	52	Overexpression COUP TFI COUP TFI35 affect basal promoter activity Gal4 data shown
0.2712022.9171235.html.plaintext.txt	53	These results clearly indicate limiting factor termed corepressors required activity COUP TFI mediated repression
0.2712022.9171235.html.plaintext.txt	54	These results also suggest C terminal 35 amino acids required interaction putative corepressors
0.2712022.9171235.html.plaintext.txt	55	View larger version 14K Figure 1
0.2712022.9171235.html.plaintext.txt	56	COUP TFI Is Able Squelch Repressor Activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	57	HeLa cells transfected 0
0.2712022.9171235.html.plaintext.txt	58	1 microg Gal4 COUP TFI cDNA 0
0.2712022.9171235.html.plaintext.txt	59	3 microg 17 mer x 4 tk luciferase reporter DNA increasing amounts COUP TFI COUP TFI35 expression plasmid 0
0.2712022.9171235.html.plaintext.txt	60	1 microg transfected instead Gal4 COUP TFI lane 1
0.2712022.9171235.html.plaintext.txt	61	COUP TFI Shares Common Corepressors TRss To elucidate whether COUP TFI shares common corepressors TRss squelching experiments performed
0.2712022.9171235.html.plaintext.txt	62	Overexpression TRss absence T3 reverse basal repression activity Gal4 COUP TFI squelching endogenous corepressors dose dependent manner
0.2712022.9171235.html.plaintext.txt	63	In contrast liganded TRss cannot squelch repression lines 3 8 Fig
0.2712022.9171235.html.plaintext.txt	64	Similarly overexpression TR mutant TR168 456V174AD177A loses silencing activity retains hormone dependent transactivation 28 cannot relieve basal repression activity Gal4 COUP TFI lines 9 11 Fig
0.2712022.9171235.html.plaintext.txt	65	These findings strongly suggest TRss COUP TFI mediated repression share corepressors
0.2712022.9171235.html.plaintext.txt	66	View larger version 17K Figure 2
0.2712022.9171235.html.plaintext.txt	67	Unliganded TRss Not Liganded TRss TR168 456 V174AD177A Is Able Squelch Repressor Activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	68	HeLa cells transfected 0
0.2712022.9171235.html.plaintext.txt	69	1 microg Gal4 COUP TFI cDNA 0
0.2712022.9171235.html.plaintext.txt	70	3 microg 17 mer x 4 tk luciferase reporter DNA increasing amounts TRss TR168 456 V174AD177A expression plasmids 0
0.2712022.9171235.html.plaintext.txt	71	Cells treated 10 7 M T3 24 h lanes 6 8
0.2712022.9171235.html.plaintext.txt	72	1 microg transfected instead Gal4 COUP TFI lane 1
0.2712022.9171235.html.plaintext.txt	73	In reverse experiment examined whether COUP TFI squelch repression activity Gal4 TRss
0.2712022.9171235.html.plaintext.txt	74	3 transfection Gal4 TRss HeLa cells significantly repressed basal promoter activity reporter construct
0.2712022.9171235.html.plaintext.txt	75	Overexpression COUP TFI reverse repression dose dependent manner
0.2712022.9171235.html.plaintext.txt	76	As expected observe reversal TRss mediated repression overexpression repression defective COUP TFI mutant COUP TFI35
0.2712022.9171235.html.plaintext.txt	77	These results suggest common corepressors shared COUP TFI TRss repression activity
0.2712022.9171235.html.plaintext.txt	78	View larger version 14K Figure 3
0.2712022.9171235.html.plaintext.txt	79	COUP TFI Not COUP TFI35 Is Able Squelch Repressor Activity Gal4 TRss
0.2712022.9171235.html.plaintext.txt	80	HeLa cells transfected 0
0.2712022.9171235.html.plaintext.txt	81	3 microg 17 mer x 4 tk luciferase reporter DNA increasing amounts COUP TFI COUP TFI35 0
0.2712022.9171235.html.plaintext.txt	82	1 microg transfected instead Gal4 COUP TFI lane 1
0.2712022.9171235.html.plaintext.txt	83	Both N CoR SMRT Interact COUP TFI Using LBD TRss bait yeast two hybrid screen TR interacting protein SMRT cloned 12 14 15
0.2712022.9171235.html.plaintext.txt	84	10 cloned another TR interacting protein N CoR sequence similarity SMRT
0.2712022.9171235.html.plaintext.txt	85	Both N CoR SMRT identified corepressors TR RAR
0.2712022.9171235.html.plaintext.txt	86	We asked whether two corepressors function corepressors COUP TFI
0.2712022.9171235.html.plaintext.txt	87	First examined whether COUP TFI interact specifically authentic corepressors
0.2712022.9171235.html.plaintext.txt	88	Using yeast two hybrid assay confirmed corepressors interact TRss hormone dependent manner
0.2712022.9171235.html.plaintext.txt	89	4 A B fragment N CoR encoding amino acids 921 2453 fragments SMRT encoding amino acids 565 1495 1192 1495 interact TRss hormone dependent manner previously described 10 12 14
0.2712022.9171235.html.plaintext.txt	90	It pointed surprise larger fragment N CoR encoding amino acids 190 2453 contains fragment N CoR encoding amino acids 921 2453 cannot interact TRss yeast two hybrid assay
0.2712022.9171235.html.plaintext.txt	91	Although reason discrepancy clear present possible N terminal repression domain N CoR encoding amino acids 190 920 potent overrides activation function Gal4 yeast two hybrid assay
0.2712022.9171235.html.plaintext.txt	92	This notion supported observation fragment N CoR encoding amino acids 190 2453 interact TRss vitro data shown
0.2712022.9171235.html.plaintext.txt	93	View larger version 34K Figure 4
0.2712022.9171235.html.plaintext.txt	94	Interaction TRss COUP TFI N CoR SMRT Yeast Two Hybrid Assays
0.2712022.9171235.html.plaintext.txt	95	A Various fragments SMRT N CoR constructs
0.2712022.9171235.html.plaintext.txt	96	The fragments SMRT encoding amino acids 29 564 565 1289 565 1495 1192 1495 constructed
0.2712022.9171235.html.plaintext.txt	97	The fragment SMRT encoding amino acids 1192 1495 obtained yeast two hybrid screen bait LBD TRss
0.2712022.9171235.html.plaintext.txt	98	The fragments N CoR encoding amino acids 190 2453 921 2453 constructed
0.2712022.9171235.html.plaintext.txt	99	In N CoR two repression domains RD1 RD2 shown N terminal region
0.2712022.9171235.html.plaintext.txt	100	The acidic basic motif AB serine glycine rich domain SG central region indicated
0.2712022.9171235.html.plaintext.txt	101	Glutamine rich regions Q predicted amphipathic helix H regions also indicated
0.2712022.9171235.html.plaintext.txt	102	The N terminal region SMRT amino acids 1 483 contains four putative repeated motifs 44 identity N CoR
0.2712022.9171235.html.plaintext.txt	103	A series deletion mutants N CoR SMRT illustrated Fig
0.2712022.9171235.html.plaintext.txt	104	4A created tested interaction yeast two hybrid system TRss B COUP TFI C
0.2712022.9171235.html.plaintext.txt	105	For experiments presented Gal4 DBD TR168 456 Gal4 DBD COUP TFI constructs coexpressed Gal4 AD N CoR SMRT deletion mutants
0.2712022.9171235.html.plaintext.txt	106	Each two hybrid pair transformed yeast y190 transformants propagated ss galactosidase activity determined
0.2712022.9171235.html.plaintext.txt	107	The effects T3 TRN CoR SMRT interaction presence 1 microM T3 culture medium also tested
0.2712022.9171235.html.plaintext.txt	108	Cotransformation Gal4 DBD COUP TFI Gal4 AD TFIIB used positive control
0.2712022.9171235.html.plaintext.txt	109	At least two independent yeast transformants analyzed results determined mean plus minus SEM
0.2712022.9171235.html.plaintext.txt	110	Next examined interaction COUP TFI N CoR SMRT
0.2712022.9171235.html.plaintext.txt	111	We first demonstrated interaction Gal4 DBD COUP TFI amino acids 184 423 fusion Gal4 activation domain AD empty vector shown negative control lane 1 Fig
0.2712022.9171235.html.plaintext.txt	112	In contrast positive control showed strong interaction Gal4 DBD COUP TFI Gal4 AD TFIIB lane 7 Fig
0.2712022.9171235.html.plaintext.txt	113	We examined interaction various deletion fragments N CoR SMRT COUP TFI Fig
0.2712022.9171235.html.plaintext.txt	114	In yeast two hybrid assay system interaction COUP TFI N CoR SMRT detected COUP TFI bound DNA response element
0.2712022.9171235.html.plaintext.txt	115	In absence DNA response element interaction observed data shown
0.2712022.9171235.html.plaintext.txt	116	A fragment N CoR encoding amino acids 921 2453 strongly interacts COUP TFI however fragment N CoR encoding amino acids 190 2453 interact COUP TFI yeast two hybrid assay
0.2712022.9171235.html.plaintext.txt	117	Similar TRss interaction study Fig
0.2712022.9171235.html.plaintext.txt	118	4B repression domains N CoR encoding amino acids 190 920 may interfere Gal4 activation domain function yeast two hybrid assay thus fragment N CoR encoding amino acids 190 2453 able activate ss galactosidase activity reporter
0.2712022.9171235.html.plaintext.txt	119	However N CoR fragments encoding amino acids 190 2453 921 2453 found interact COUP TFI vitro glutathione S transferase GST pull assay vitro interactions presumably influenced repressor function N CoR
0.2712022.9171235.html.plaintext.txt	120	Thus fragment COUP TFI encoding amino acids 56 423 interact specifically N CoR yeast vitro
0.2712022.9171235.html.plaintext.txt	121	On hand fragments SMRT encoding amino acids 29 564 565 1495 strongly interact COUP TFI Fig
0.2712022.9171235.html.plaintext.txt	122	In contrast fragment SMRT encoding amino acids 1192 1495 interacts well TR interacts weakly COUP TFI yeast two hybrid assay Fig
0.2712022.9171235.html.plaintext.txt	123	These results suggest COUP TFI interacting domain SMRT located mainly amino acids 29 564 565 1191
0.2712022.9171235.html.plaintext.txt	124	These interaction data yeast supported vitro protein protein interactions shown Fig
0.2712022.9171235.html.plaintext.txt	125	Both fragments SMRT encoding amino acids 29 564 565 1289 able interact GST COUP TFI whereas fragment SMRT encoding amino acids 1192 1495 fails interact GST COUP TFI
0.2712022.9171235.html.plaintext.txt	126	View larger version 39K Figure 5
0.2712022.9171235.html.plaintext.txt	127	Interaction COUP TFI N CoR SMRT Vitro GST Pull Down Assays
0.2712022.9171235.html.plaintext.txt	128	Radiolabeled N CoR SMRT TFIIB tested abilities bind immobilized GST COUP TFI fusion protein GST control protein
0.2712022.9171235.html.plaintext.txt	129	GST GST COUP TFI fusion protein expressed yeast purified adsorption glutathione Sepharose beads
0.2712022.9171235.html.plaintext.txt	130	A The fragments N CoR encoding amino acids 190 2453 921 2453 TFIIB translated vitro incubated GST control protein lanes 2 5 8 GST COUP TFI lanes 3 6 9 30 60 min 4 C rocking
0.2712022.9171235.html.plaintext.txt	131	The GST GST COUP TFI Sepharose beads extensively washed radiolabeled corepressor proteins lanes 3 6 TFIIB lane 9 bound matrix eluted SDS loading buffer analyzed SDS PAGE autoradiography
0.2712022.9171235.html.plaintext.txt	132	Lanes 1 4 7 represent input protein
0.2712022.9171235.html.plaintext.txt	133	B The fragments SMRT encoding amino acids 29 564 lanes 1 3 565 1285 lanes 4 6 1192 1495 lanes 7 9 radiolabeled tested abilities bind immobilized GST COUP TFI lanes 3 6 9 GST control protein lanes 2 5 8 Lanes 1 4 7 represent input protein
0.2712022.9171235.html.plaintext.txt	134	The molecular weight protein indicated
0.2712022.9171235.html.plaintext.txt	135	N CoR SMRT Potentiate Basal Repression Gal4 COUP TFI From studies shown N CoR SMRT interact COUP TFI specifically
0.2712022.9171235.html.plaintext.txt	136	We asked whether two corepressors required mediate COUP TFI repression activity mammalian cells
0.2712022.9171235.html.plaintext.txt	137	6 neither N CoR SMRT significant effect transcription activity reporter construct absence cotransfected Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	138	However N CoR SMRT potentiate repressor function Gal4 COUP TFI dose dependent manner HeLa cells
0.2712022.9171235.html.plaintext.txt	139	These data suggest N CoR SMRT function corepressors COUP TFI HeLa cells
0.2712022.9171235.html.plaintext.txt	140	Thus likely endogenous corepressors COUP TFI HeLa cells
0.2712022.9171235.html.plaintext.txt	141	View larger version 9K Figure 6
0.2712022.9171235.html.plaintext.txt	142	N CoR SMRT Can Potentiate Basal Repression Activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	143	HeLa cells transfected 0
0.2712022.9171235.html.plaintext.txt	144	1 microg Gal4 Gal4 COUP TFI cDNA 0
0.2712022.9171235.html.plaintext.txt	145	3 microg 17 mer x 4 tk luciferase reporter DNA increasing amounts N CoR SMRT expression plasmid 0
0.2712022.9171235.html.plaintext.txt	146	N CoR SMRT Can Reverse Squelching COUP TFI Mediated Repression As shown earlier Fig
0.2712022.9171235.html.plaintext.txt	147	1 overexpression COUP TFI squelch repressor activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	148	If N CoR SMRT limiting factors required COUP TFI mediated repression expect overexpression N CoR SMRT reverse squelching activity
0.2712022.9171235.html.plaintext.txt	149	7 overexpression N CoR SMRT able relieve squelching effects COUP TFI Gal4 COUP TFI repression function dose dependent manner
0.2712022.9171235.html.plaintext.txt	150	On hand overexpression N CoR SMRT significant effect transcription activity reporter construct absence cotransfected Gal4 COUP TFI data shown
0.2712022.9171235.html.plaintext.txt	151	Therefore N CoR SMRT substitute endogenous corepressors mediating COUP TFI repressor function
0.2712022.9171235.html.plaintext.txt	152	View larger version 17K Figure 7
0.2712022.9171235.html.plaintext.txt	153	Reversal COUP TFI Mediated Squelching Basal Repression Activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	154	HeLa cells transfected 0
0.2712022.9171235.html.plaintext.txt	155	1 microg Gal4 Gal4 COUP TFI cDNA 0
0.2712022.9171235.html.plaintext.txt	156	3 microg 17 mer x 4 tk luciferase reporter DNA 1
0.2712022.9171235.html.plaintext.txt	157	0 microg COUP TFI cDNA increasing amounts N CoR SMRT expression plasmid 50 100 200 ng
0.2712022.9171235.html.plaintext.txt	158	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES We shown N CoR SMRT function corepressors COUP TFI mediated gene silencing
0.2712022.9171235.html.plaintext.txt	159	Since COUP TFI shown interact TFIIB vitro 29 30 proposed COUP TFI interact TFIIB nonproductive manner interfere basal transcription
0.2712022.9171235.html.plaintext.txt	160	However many coactivators corepressors identified positive negative cofactors transcriptional control target genes members steroidTR superfamily 15 31
0.2712022.9171235.html.plaintext.txt	161	Therefore tempting speculate cofactors may also involved gene silencing mechanisms orphan receptors COUP TFI
0.2712022.9171235.html.plaintext.txt	162	Initial evidence mediators nuclear receptor transactivation came finding transiently transfecting increasing amounts ER expressing plasmid cultured cells results bell shaped curve transcriptional activation attributed squelching coactivators excessive amounts estrogen receptor 32
0.2712022.9171235.html.plaintext.txt	163	By analogy demonstrated putative corepressors may involved COUP TFI mediated basal repression overexpression COUP TFI COUP TFI35 lost repression domain squelch repression activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	164	Previously showed 15 amino acid deletion C terminus Gal4 COUP TF15 little effect Gal4 COUP TF activity whereas 25 amino acid Gal4 COUP TF25 35 amino acid Gal4 COUP TF35 deletion largely impaired active repression function 27
0.2712022.9171235.html.plaintext.txt	165	Therefore data suggested C terminal border major active repression function COUP TF located within amino acids 408 398 region may interact corepressors
0.2712022.9171235.html.plaintext.txt	166	In addition repressor domain COUP TFI may directly target basal transcriptional machinery
0.2712022.9171235.html.plaintext.txt	167	To examine whether corepressors shared TRss COUP TFI squelching experiments performed
0.2712022.9171235.html.plaintext.txt	168	2 unliganded liganded TRss squelch basal repression Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	169	The evidence TR mutant TR168 456 V174AD177A 28 interact putative corepressors cannot squelch basal repression Gal4 COUP TFI supports notion common corepressors may involved basal repression TRss COUP TFI
0.2712022.9171235.html.plaintext.txt	170	Furthermore overexpression COUP TFI COUP TFI35 squelch basal repression activity Gal4 TRss also suggesting common corepressors function COUP TFI TRss
0.2712022.9171235.html.plaintext.txt	171	Theoretically target transcriptional interference may either basal transcription factors corepressors
0.2712022.9171235.html.plaintext.txt	172	Transfection COUP TFI TRss change basal transcription PRE tk luciferase reporter lacking proper response element data shown suggesting squelchers unlikely interfere directly function basal transcriptional machinery
0.2712022.9171235.html.plaintext.txt	173	Therefore targets interference COUP TF TRss likely one transcriptional corepressor proteins
0.2712022.9171235.html.plaintext.txt	174	Because COUP TFI form homodimers form heterodimers TRss 27 possible squelchers form non DNA binding heterodimers repressors used Figs
0.2712022.9171235.html.plaintext.txt	175	1 2 3 Gal4 COUP TFICOUP TFI Fig
0.2712022.9171235.html.plaintext.txt	176	2 Gal4 TRssCOUP TFI Fig
0.2712022.9171235.html.plaintext.txt	177	If case inhibition repressor activity may due inhibition DNA binding rather squelching limiting corepressors
0.2712022.9171235.html.plaintext.txt	178	However several lines evidence suggest case
0.2712022.9171235.html.plaintext.txt	179	First COUP TFI TRss ability bind specifically corepressors
0.2712022.9171235.html.plaintext.txt	180	Second mutant form TRss TR168 456 V174AD177A loses ability interact corepressor retains intact dimerization domain able inhibit repression activity Gal4 COUP TFI
0.2712022.9171235.html.plaintext.txt	181	Third COUP TF mutant COUP TFI35 loses ability silencing also loses ability squelch repressor activity TRss
0.2712022.9171235.html.plaintext.txt	182	Finally importantly demonstrated directly N CoR SMRT mediate repressor activity COUP TFI Fig
0.2712022.9171235.html.plaintext.txt	183	6 reverse self squelching activity Fig
0.2712022.9171235.html.plaintext.txt	184	Therefore inhibition repression activity squelchers Figs
0.2712022.9171235.html.plaintext.txt	185	1 2 3 indeed results squelching limiting corepressors
0.2712022.9171235.html.plaintext.txt	186	Because squelching experiments showed COUP TFI may share corepressors TRss examined protein protein interaction COUP TFI N CoR SMRT yeast two hybrid assay vitro GST pull assays shown Figs
0.2712022.9171235.html.plaintext.txt	187	The amino acid 921 2453 fragment N CoR interacts COUP TFI
0.2712022.9171235.html.plaintext.txt	188	This result consistent observed TR interaction studies 10 33
0.2712022.9171235.html.plaintext.txt	189	Interaction COUP TFI amino acid 190 2453 fragment N CoR detected yeast two hybrid assay detected vitro GST pull assay
0.2712022.9171235.html.plaintext.txt	190	This discrepancy likely due potent repressor domain N terminal portion N CoR suppresses Gal4 activation function resulting interference ss galactosidase expression
0.2712022.9171235.html.plaintext.txt	191	Consistent interpretation Seol et al
0.2712022.9171235.html.plaintext.txt	192	33 also recently demonstrated repressor domain N CoR strongly interferes mammalian two hybrid assay study protein protein interaction N CoR TR RAR
0.2712022.9171235.html.plaintext.txt	193	On hand amino acid 29 564 amino acid 565 1289 amino acid 1192 1495 fragments SMRT strongly interact COUP TF yeast vitro assays
0.2712022.9171235.html.plaintext.txt	194	Based data concluded least two COUP TFI interacting domains within SMRT molecules
0.2712022.9171235.html.plaintext.txt	195	The lack interaction COUP TFI SMRT 1192 1495 surprising region interacts strongly TRss
0.2712022.9171235.html.plaintext.txt	196	Thus different repressors may interact differentially SMRT
0.2712022.9171235.html.plaintext.txt	197	Finally corepressor interacting region COUP TFI localized extreme C terminus quite different region TR RAR hinge N terminal portions LBD involved interaction
0.2712022.9171235.html.plaintext.txt	198	Thus repression function COUP TFs may act different way TR RAR Fig
0.2712022.9171235.html.plaintext.txt	199	View larger version 27K Figure 8
0.2712022.9171235.html.plaintext.txt	200	Structure Domains Repressors Corepressors
0.2712022.9171235.html.plaintext.txt	201	A Functional domains COUP TFI TRss RevErb A
0.2712022.9171235.html.plaintext.txt	202	AB C D EF functional domains receptors 3
0.2712022.9171235.html.plaintext.txt	203	CID corepressor interacting domain sequence important repressor function contains region interacts corepressors
0.2712022.9171235.html.plaintext.txt	204	The CoR box conserved region human TR TRss RAR RevErb A
0.2712022.9171235.html.plaintext.txt	205	The CoR box TRss repressor domain interacts corepressors however CIDs RevErb A different region CoR box
0.2712022.9171235.html.plaintext.txt	206	B Receptor interacting domains SMRT N CoR
0.2712022.9171235.html.plaintext.txt	207	Receptor interacting domains corepressors indicated scheme SMRT N CoR
0.2712022.9171235.html.plaintext.txt	208	In N CoR two repression domains RD1 RD2 shown N terminal region
0.2712022.9171235.html.plaintext.txt	209	The N terminal region SMRT amino acids 1 483 contains four putative repeated motifs 44 identity N CoR
0.2712022.9171235.html.plaintext.txt	210	The acidic basic motif serine glycine rich domain SG central region indicated
0.2712022.9171235.html.plaintext.txt	211	Glutamine rich regions Q predicted amphipathic helix H regions also indicated
0.2712022.9171235.html.plaintext.txt	212	In support observation N CoR shown function corepressor RevErb A 34
0.2712022.9171235.html.plaintext.txt	213	However region homologous CoR box RevErb A necessary TR RAR interact N CoR required RevErb A mediated repression
0.2712022.9171235.html.plaintext.txt	214	N CoR contains two adjacent distinct interaction domains amino acids 2040 2239 2239 2296
0.2712022.9171235.html.plaintext.txt	215	The former fragment N CoR strongly interacts TR RevErb A however latter fragment N CoR interacts weakly preferentially RevErb A
0.2712022.9171235.html.plaintext.txt	216	Taken together data suggest different nuclear receptors utilizing different amino acid sequences repress transcription interacting different region N CoR SMRT shown Fig
0.2712022.9171235.html.plaintext.txt	217	Recently activator COUP TFII identified using yeast two hybrid screen designated ORCA orphan receptor coactivator 35 factor identical recently described ligand p62 tyrosine kinase signaling molecule p56lck suggesting ORCA may link COUP TFII cell surface signal transduction pathways
0.2712022.9171235.html.plaintext.txt	218	This integrating role may similar observed cAMP response element binding protein CBP related protein p300
0.2712022.9171235.html.plaintext.txt	219	CBP plays role integrating cAMP second messenger nuclear hormone receptor signal transduction pathways
0.2712022.9171235.html.plaintext.txt	220	Of interest ORCAp62 shares small region homology CBP suggesting potential similarity mechanism action
0.2712022.9171235.html.plaintext.txt	221	However based data ORCAp62 bind directly COUP TFII binding sites COUP TFIIORCA complex detected gel retardation assays
0.2712022.9171235.html.plaintext.txt	222	Therefore possible ORCAp62 may function directly indirectly phosphorylating COUP TFII ORCAp62 may overcome function specific COUP TFII associated corepressor
0.2712022.9171235.html.plaintext.txt	223	Because ORCAp62 convert COUP TFII transcriptional activator ligand independent manner mammalian cells possible COUP TFI also activated coactivators ligand independent manner
0.2712022.9171235.html.plaintext.txt	224	Our preliminary data showed overexpression hSRC 1a 36 general coactivator members steroid receptors cannot relieve repressor activity Gal4 COUP TFI HeLa cells data shown
0.2712022.9171235.html.plaintext.txt	225	In conclusion demonstrated corepressors involved mechanisms COUP TFI mediated gene silencing N CoR SMRT function corepressors COUP TFI mammalian cells
0.2712022.9171235.html.plaintext.txt	226	Therefore orphan receptors COUP TFI RevErb A function repressor vivo utilizing corepressors common members TR RAR subfamily
0.2712022.9171235.html.plaintext.txt	227	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mammalian Cell Culture Transient Transfections Luciferase Assays HeLa cells routinely maintained DMEM supplemented 10 FBS
0.2712022.9171235.html.plaintext.txt	228	Twenty four hours transfection 2 x 105 cells plated per well six well dish DMEM containing 5 dextran coated charcoal stripped serum
0.2712022.9171235.html.plaintext.txt	229	Cells transfected indicated DNAs using Lipofectin Life Technologies Grand Island NY according manufacturer guidelines
0.2712022.9171235.html.plaintext.txt	230	8 microg total DNA including 0
0.2712022.9171235.html.plaintext.txt	231	0 microg expression vector used per 35 mm diameter dish
0.2712022.9171235.html.plaintext.txt	232	Within 24 h DNALipofectin mixture removed cells fed DMEM containing 5 stripped serum indicated hormones cells harvested 24 h later
0.2712022.9171235.html.plaintext.txt	233	Cells extracts assayed luciferase activity using Luciferase Assay System Promega Madison WI
0.2712022.9171235.html.plaintext.txt	234	Data presented average three separate experiments plus minus SEM
0.2712022.9171235.html.plaintext.txt	235	All transfections performed least three times triplicate
0.2712022.9171235.html.plaintext.txt	236	Cloning SMRT Yeast Two Hybrid System Yeast strains used follows
0.2712022.9171235.html.plaintext.txt	237	y190 MATa leu2 3 112 ura3 52 trp1 901 his2 D200 ade2 101 gal4gal180URA3 GAL lacZ LYS GAL HIS3 cyhr
0.2712022.9171235.html.plaintext.txt	238	y187 MAT gal4 gal80 his3 trp1 901 ade2 101 ura3 52 leu2 3 112 URA3 GAL lacZ met
0.2712022.9171235.html.plaintext.txt	239	BJ2168 MATa prc1 407 Prb1 1122 pep4 3 leu2 trp1 ura 3 52
0.2712022.9171235.html.plaintext.txt	240	Yeast selective media plates prepared according Guthrie Fink 37
0.2712022.9171235.html.plaintext.txt	241	The yeast strain y190 containing pAS1cyh2 TR168 456 transformed human brain cDNA library pGAD10 Clontech Palo Alto CA plated synthetic complete medium lacking tryptophan leucine histidine containing 25 mM 3 aminotriazole described Durfee et al
0.2712022.9171235.html.plaintext.txt	242	His colonies exhibiting ss galactosidase activity using filter lift assay characterized
0.2712022.9171235.html.plaintext.txt	243	ss Galactosidase activity determined using chlorophenol red ss D galactopyranoside described 38
0.2712022.9171235.html.plaintext.txt	244	To recover library plasmids total DNA yeast isolated used transform Escherichia coli HB101 lacks leu2 gene
0.2712022.9171235.html.plaintext.txt	245	Transformants identified minimal medium lacking leucine containing ampicillin
0.2712022.9171235.html.plaintext.txt	246	To ensure correct cDNAs identified library plasmids isolated retransformed y190 containing pAS1cyh2 TR168 456 ss galactosidase activity determined
0.2712022.9171235.html.plaintext.txt	247	The specificity interaction cor 10
0.2712022.9171235.html.plaintext.txt	248	1 SMRT 1192 1495 one 12 positive clones TR determined mating y190 containing pGAD10 cor 10
0.2712022.9171235.html.plaintext.txt	249	1 strain y187 containing either pAS1 SNF pAS1 cdk2 pAS1 p53 pAS1 lamin
0.2712022.9171235.html.plaintext.txt	250	The ss galactosidase activity diploids examined using filter lift chlorophenyl red ss D galactopyranoside methods
0.2712022.9171235.html.plaintext.txt	251	1 clone identical recently identified corepressor SMRT
0.2712022.9171235.html.plaintext.txt	252	The yeast two hybrid system also used determine protein protein interaction COUP TFI SMRT N CoR
0.2712022.9171235.html.plaintext.txt	253	Protein Protein Interaction GST Pulldown Assay GST COUP TFI pCBGST1 COUP TFI fusion protein expressed extracted yeast strain BJ2168 described previously 39
0.2712022.9171235.html.plaintext.txt	254	GST pulldown assay performed described modifications 4 39 30 microl glutathione Sepharose beads stored NENT buffer 500 mM NaCl 1 mM EDTA 20 mM Tris pH 8
0.2712022.9171235.html.plaintext.txt	255	5 NP 40 1 mM dithiothreitol 6 mM MgCl2 8 glycerol incubated yeast extracts containing GST fusion proteins 11 vol ratio together NENT buffer 30 60 min 4 C
0.2712022.9171235.html.plaintext.txt	256	Preparation yeast extracts containing GST fusion protein described previously 39
0.2712022.9171235.html.plaintext.txt	257	Subsequently supernatant removed beads washed twice 1 ml NENT buffer twice 1 ml transcription washing buffer 60 mM NaCl 1 mM EDTA 20 mM Tris pH 8
0.2712022.9171235.html.plaintext.txt	258	05 NP 40 1 mM dithiothreitol 6 mM MgCl2 8 glycerol
0.2712022.9171235.html.plaintext.txt	259	In vitro translated radiolabeled proteins obtained using TNT Coupled Reticulocyte Lysate Systems Promega
0.2712022.9171235.html.plaintext.txt	260	Five 10 microl crude lysate incubated beads 200 microl transcription washing buffer 2 h 4 C
0.2712022.9171235.html.plaintext.txt	261	Finally beads washed five times 1 ml NENT buffer proteins solubilized SDS loading buffer analyzed SDS PAGE
0.2712022.9171235.html.plaintext.txt	262	The input lane contains 10 labeled protein used binding
0.2712022.9171235.html.plaintext.txt	263	Plasmids Mammalian Expression Vectors The expression plasmids pABgal147 pABgal pABgalTRss pABgalTRss pABgal TR168 456 V174AD177A pRSV COUP TFI pRSV COUP TFI35 pRSVgalCOUP TFI described previously 5 20 21 27 28 40
0.2712022.9171235.html.plaintext.txt	264	pCMX N CoR 10 pCMX SMRT 12 generous gifts Dr
0.2712022.9171235.html.plaintext.txt	265	The 17 mer x 4 tk LUC reporter gene contains four copies 17 mer upstream activating sequence located upstream thymidine kinase promoter luciferase gene
0.2712022.9171235.html.plaintext.txt	266	pCR3 SMRT565 1289 constructed TA Cloning Invitrogen PCR amplified product primers 5 AGCTGACGTCGACGCCTCGTG 3 5 CTGCACCGCCTGGCTTCTAT 3 template cDNA made reverse transcription human skeletal muscle mRNA Clontech primer 5 GCTGGCATGTTCCTGCACCG 3
0.2712022.9171235.html.plaintext.txt	267	pCR3 SMRT565 1495 constructed inserting EcoRI filled BglII fragment pGAD10 SMRT1192 1495 BglII EcoRV site pCR3 SMRT565 1289
0.2712022.9171235.html.plaintext.txt	268	pCR3 SMRT29 564 constructed TA Cloning Invitrogen PCR amplified product primers 5 AAGATTCCGAGCTCTGCTAC 3 5 CACGAGGCGTCGACGTCAGC 3 template cDNA made reverse transcription human skeletal muscle mRNA Clontech primer 5 GTGCGGGGACTTGGCGATCT 3
0.2712022.9171235.html.plaintext.txt	269	pCR3 SMRT29 1495 constructed inserting SalI fragment pCR3 SMRT29 564 SalI site pCR3 SMRT565 1495
0.2712022.9171235.html.plaintext.txt	270	pABgalSMRT29 1495 constructed inserting SalI partial XbaI fragment PvuII site pABgal
0.2712022.9171235.html.plaintext.txt	271	All PCR generates clones sequenced ensure mutation occurred PCR reactions
0.2712022.9171235.html.plaintext.txt	272	Yeast Vectors The Gal4 DBD TRss168 456 yeast expression plasmid pAS1cyh2 TR168 456 constructed inserting HindIII SmaI blunt ended fragment pABgalTR168 456 SmaI site pAS1cyh2 38
0.2712022.9171235.html.plaintext.txt	273	The Gal4 DBD COUP TFI56 423 yeast expression plasmid pAS1cyh2 COUP TFI constructed inserting EcoRI SmaI filled fragment pGEM7Zf COUP TFI SmaI site pAS1cyh2
0.2712022.9171235.html.plaintext.txt	274	Yeast expression plasmid pCBGST1 COUP TFI56 423 constructed inserting EcoRI SmaI filled fragment amino acids 56 423 pGEM7Zf COUP TFI SmaI site pCBGST1 39
0.2712022.9171235.html.plaintext.txt	275	Yeast expression plasmid pACTII N CoR190 2453 constructed inserting PvuI SalI filled fragment pCMX N CoR NcoI XhoI site filled pACTII 38
0.2712022.9171235.html.plaintext.txt	276	Yeast expression plasmid pACTII N CoR921 2453 constructed inserting HincII SalI filled fragment pCMX N CoR SmaI site pACTII
0.2712022.9171235.html.plaintext.txt	277	pACTII SMRT29 564 constructed inserting SalI fragment filled pCR3 SMRT29 564 NcoI filled site pACTII
0.2712022.9171235.html.plaintext.txt	278	pACTII SMRT565 1495 constructed inserting SalI XhoI fragment pCR3 SMRT565 1495 NcoI filled site pACTII
0.2712022.9171235.html.plaintext.txt	279	Yeast expression plasmid pGAD10 SMRT1192 1495 recovered yeast two hybrid screen using pAS1cyh2 TR168 456 bait
0.2712022.9171235.html.plaintext.txt	280	Yeast expression plasmid pACTII TFIIB constructed inserting NcoI partial EcoRI fragment pGST TFIIB 4 NcoI EcoRI sites pACTII
0.2712022.9171235.html.plaintext.txt	281	In Vitro Transcription Translation Vectors pT7 N CoR190 2453 constructed inserting PvuI SalI fragment pCMX N CoR NcoI site filled pT7ssSal 41
0.2712022.9171235.html.plaintext.txt	282	PT7 N CoR921 2453 constructed inserting HincII SalI fragment pCMX N CoR AccI site filled pT7ssSal
0.2712022.9171235.html.plaintext.txt	283	pT7 SMRT29 564 constructed inserting SalI fragment filled pCR3 SMRT29 564 NcoI EcoRI filled site pT7ssSal
0.2712022.9171235.html.plaintext.txt	284	pT7 SMRT565 1289 constructed inserting SalI EcoRV fragment pCR3 SMRT565 1289 NcoI EcoRI filled site pT7ssSal
0.2712022.9171235.html.plaintext.txt	285	PT7 SMRT1192 1495 constructed inserting EcoRI fragment filled pGAD10 SMRT1192 1495 HincII site pT7ssSal
0.2712022.9171235.html.plaintext.txt	286	pT7 TFIIB constructed inserting NcoI partial EcoRI fragment filled pGST TFIIB 4 AccI site filled pT7ssSal
0.2712022.9171235.html.plaintext.txt	287	ACKNOWLEDGMENTS We thank members laboratories critically reading manuscript
0.2712022.9171235.html.plaintext.txt	288	Chen providing pCMX N CoR pCMX SMRT respectively
0.2712022.9171235.html.plaintext.txt	289	Stephen Elledge providing yeast two hybrid system
0.2712022.9171235.html.plaintext.txt	290	FOOTNOTES Address requests reprints Ming Jer Tsai Department Cell Biology Baylor College Medicine One Baylor Plaza Houston Texas 77030
0.2712022.9171235.html.plaintext.txt	291	This work supported NIH Grants DK 45641 M
0.2712022.9171235.html.plaintext.txt	292	Received publication January 15 1997
0.2712022.9171235.html.plaintext.txt	293	Accepted publication February 14 1997
0.2712022.9171235.html.plaintext.txt	294	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Evans RM 1988 The steroid thyroid hormone receptor superfamily
0.2712022.9171235.html.plaintext.txt	295	Science 240889 895Medline O Malley BW 1990 The steroid receptor superfamily excitement predicted future
0.2712022.9171235.html.plaintext.txt	296	Mol Endocrinol 4363 369Medline Tsai M J O Malley BW 1994 Molecular mechanisms action steroidthyroid receptor superfamily members
0.2712022.9171235.html.plaintext.txt	297	Annu Rev Biochem 63451 486CrossRefMedline Baniahmad A Ha I Reinberg D Tsai S Tsai M J O Malley BW 1993 Interaction human thyroid hormone receptor ss transcription factor TFIIB may mediate target gene derepression activation throid hormone
0.2712022.9171235.html.plaintext.txt	298	Proc Natl Acad Sci USA 908832 8836Abstract Baniahmad A Leng X Burris TP Tsai SY Tsai M J O Malley BW 1995 The 4 activation domain thyroid hormone receptor required release putative corepressors necessary transcriptional silencing
0.2712022.9171235.html.plaintext.txt	299	Mol Cell Biol 1576 86Abstract Saha S Brickman JM Lehming N Ptashne M 1993 New eukaryotic transcriptional repressors
0.2712022.9171235.html.plaintext.txt	300	Nature 363648 652CrossRefMedline Witzgall R O Leary E Leaf A Onaldi D Bonventre JV 1994 The Kruppel associated box A KRAB A domain zinc finger proteins mediates transcriptional repression
0.2712022.9171235.html.plaintext.txt	301	Proc Natl Acad Sci USA 914514 4518Abstract Margolin JF Friedman JR Meyer WK Vissing H Thiesen HJ Rauscher FJI 1994 Kruppel associated boxes potent transcriptional repression domains
0.2712022.9171235.html.plaintext.txt	302	Proc Natl Acad Sci USA 914509 4513Abstract Hanna Rose W Hansen U 1996 Active repression mechanisms eukaryotic transcription repressors
0.2712022.9171235.html.plaintext.txt	303	Trends Genet 12229 234CrossRefMedline Horlein AJ Naar AM Heinzel T Torchia J Gloss B Kurokawa R Ryan A Kamel Y Soderstrom M Glass CK Rosenfeld MG 1995 Ligand independent repression thyroid hormone receptor mediated nuclear receptor co repressor
0.2712022.9171235.html.plaintext.txt	304	Nature 377397 404CrossRefMedline Kurokawa R Soderstrom M Horlein A Halachmi S Brown M Rosenfeld MG Glass CK 1995 Polarity specific activities retinoic acid receptors determined co repressor
0.2712022.9171235.html.plaintext.txt	305	Nature 377451 454CrossRefMedline Chen JD Evans RM 1995 A transcriptional co repressor interacts nuclear hormone receptors
0.2712022.9171235.html.plaintext.txt	306	Nature 377454 457CrossRefMedline Chen JD Umesono K Evans RM 1996 SMRT isoforms mediate repression anti repression nuclear receptor heterodimers
0.2712022.9171235.html.plaintext.txt	307	Proc Natl Acad Sci USA 937567 7571AbstractFree Full Text Sande S Privalsky ML 1996 Identification TRACs T3 receptor assoaciating cofactors family cofactors associate modulate activity nuclear hormone receptors
0.2712022.9171235.html.plaintext.txt	308	Mol Endocrinol 10813 825Abstract Shibata H Spencer TE Onate SA Jenster G Tsai SY Tsai M J O Malley BW Role coactivators corepressors mechanisms steroidthyroid receptor action
0.2712022.9171235.html.plaintext.txt	309	Recent Prog Horm Res press Mlodzik M Hiromi Y Weber U Goodman C Rubin GR 1990 The Drosophila seven gene member steroid receptor gene superfamily controls photoreceptor cell fates
0.2712022.9171235.html.plaintext.txt	310	Cell 60211 224Medline Qiu Y Tsai SY Tsai M J 1994 COUP TF orphan member steroidthyroid hormone receptor superfamily
0.2712022.9171235.html.plaintext.txt	311	Trends Endocrinol Metab 5234 239 Pereira F Qiu YH Tsai M J Tsai SY 1995 Expression COUP TFs mouse embryogenesis
0.2712022.9171235.html.plaintext.txt	312	J Steroid Biochem Mol Biol 53503 508CrossRefMedline Tsai SY Tsai M J 1997 COUP TFs coming age
0.2712022.9171235.html.plaintext.txt	313	Endocr Rev 18229 240AbstractFree Full Text Cooney AJ Tsai SY O Malley BW Tsai M J 1992 Chicken ovalbumin upstream promoter transcription factor COUP TF dimers bind different GGTCA response elements allowing COUP TF repress hormonal induction vitamin D3 thyroid hormone retinoic acid receptors
0.2712022.9171235.html.plaintext.txt	314	Mol Cell Biol 124153 4163Abstract Cooney AJ Leng X Tsai SY O Malley BW Tsai M J 1993 Multiple mechanisms chicken ovalbumin upstream promoter transcription factor dependent repression transactivation vitamin D thyroid hormone retinoic acid receptors
0.2712022.9171235.html.plaintext.txt	315	J Biol Chem 2684152 4160AbstractFree Full Text Kliewer SA Umesono K Heyman RA Mangelsdorf DJ Dyck JA Evans RM 1992 Retinoid X receptor COUP TF interactions modulate retinoic acid signalling
0.2712022.9171235.html.plaintext.txt	316	Proc Natl Acad Sci USA 891448 1452Abstract Tran PBV Zhang XK Salbert G Hermann T Lehmann JM Pfahl M 1992 COUP orphan receptors negative regulators retinoic acid response pathways
0.2712022.9171235.html.plaintext.txt	317	Mol Cell Biol 124666 4676Abstract Kliewer SA Umesono K Noonan DJ Heyman RA Evans RM 1992 Convergence 9 cis retinoic acid peroxisome proliferator signalling pathways heterodimer formation receptors
0.2712022.9171235.html.plaintext.txt	318	Nature 358771 774CrossRefMedline Berrodin TJ Marks MS Ozato K Linney E Lazar MA 1992 Heterodimerization among thyroid hormone receptor retinoic acid receptor retinoid X receptor chicken ovalbumin upstream promoter transcription factor endogenous liver protein
0.2712022.9171235.html.plaintext.txt	319	Mol Endocrinol 61468 1478Abstract Casanova J Helmer E Selmi Ruby S Oi JS Au Fliegner M Desai Yajmihn V Koudinova N Yarm F Raaha BM Samuels HH 1994 Functional evidence ligand dependent dissociation thyroid hormone retinoic acid receptors inhibitory cellular factor
0.2712022.9171235.html.plaintext.txt	320	Mol Cell Biol 145756 5765Abstract Leng X Cooney AJ Tsai SY Tsai M J 1996 Molecular mechanisms COUP TF mediated transcriptional repression Evidence transrepression active repression
0.2712022.9171235.html.plaintext.txt	321	Mol Cell Biol 162332 2340Abstract Nawaz Z Tsai M J O Malley BW 1995 Specific mutations ligand binding domain selectively abolish silencing function human thyroid hormone receptor ss
0.2712022.9171235.html.plaintext.txt	322	Proc Natl Acad Sci USA 9211691 11695Abstract Tsai SY Sagami I Wang LH Tsai M J O Malley BW 1987 Interactions DNA binding transcription factor COUP non DNA binding factor S300 II
0.2712022.9171235.html.plaintext.txt	323	Cell 50701 709Medline Ing NH Beekman JM Tsai SY Tsai M J O Malley BW 1992 Members steroid hormone receptor superfamily interact TFIIB S300II
0.2712022.9171235.html.plaintext.txt	324	J Biol Chem 26717617 17623AbstractFree Full Text Horwitz KB Jackson TA Bain DL Richer JK Takimoto GS Tung L 1996 Nuclear receptor coactivators corepressors
0.2712022.9171235.html.plaintext.txt	325	Mol Endocrinol 101167 1177Abstract Bocquel MT Kumar V Stricker C Chambon P Gronemeyer H 1989 The contribution N C terminal regions steroid receptors activation transcription receptor cell specific
0.2712022.9171235.html.plaintext.txt	326	Nucleic Acids Res 172581 2595Abstract Seol W Mahon MJ Lee Y K Moore DD 1996 Two receptor interacting domains nuclear hormone receptor corepressor RIP13N CoR
0.2712022.9171235.html.plaintext.txt	327	Mol Endocrinol 101646 1655Abstract Zamir I Harding HP Atkins GG Horlein A Glass CK Rosenfeld MG Lazar MA 1996 A nuclear hormone receptor corepressor mediates transcriptional silencing receptors distinct repression domains
0.2712022.9171235.html.plaintext.txt	328	Mol Cell Biol 165458 5465Abstract Marcus SL Winrow CJ Capone JP Rachubinski RA 1996 A p56lck ligand serves coactivator orphan nuclear hormone receptor
0.2712022.9171235.html.plaintext.txt	329	J Biol Chem 27127197 27200AbstractFree Full Text Onate SA Tsai SY Tsai M J O Malley BW 1995 Sequence characterization coactivator steroid hormone receptor superfamily
0.2712022.9171235.html.plaintext.txt	330	Science 2701354 1357Abstract Guthrie C Fink GR 1991 Getting started yeast
0.2712022.9171235.html.plaintext.txt	331	In Guthrie C Fink GR eds Methods Enzymology
0.2712022.9171235.html.plaintext.txt	332	Orlando FL pp 3 21 Durfee T Becherer K Chen PL Yeh SH Yang Y Kilburn AE Lee WH Elledge SJ 1993 The retinoblastoma protein associates protein phosphatase type 1 catalytic subunit
0.2712022.9171235.html.plaintext.txt	333	Genes Dev 7555 569Abstract Baniahmad C Baniahmad A O Mallye BW 1994 A rapid method combines functional test fusion protein vivo purification
0.2712022.9171235.html.plaintext.txt	334	Biotechniques 16194 196Medline Baniahmad A Kohne AC Renkawitz R 1992 A transferable silencing domain present thyroid hormone receptor v erbA oncogene product retinoic acid receptor
0.2712022.9171235.html.plaintext.txt	335	EMBO J 111015 1023Abstract Norman C Runswick M Pollock R Treisman R 1988 Isolation properties cDNA clones encoding SRF transcription factor binds c fos serum response element
0.21709998.11994285.html.plaintext.txt	0	Activation Insulin Gene Promoter Direct Effect Hepatocyte Nuclear Factor 4 Reut Bartoov Shifman Rachel Hertz Haiyan Wang Claes B
0.21709998.11994285.html.plaintext.txt	1	Wollheim Jacob Bar Tana Michael D
0.21709998.11994285.html.plaintext.txt	2	From Department Biological Chemistry Weizmann Institute Science Rehovot 76100 Israel Department Human Nutrition Metabolism Faculty Medicine Hebrew University Jerusalem 91120 Israel Division Clinical Biochemistry Department Internal Medicine University Medical Center CH 1211 Geneva 4 Switzerland
0.21709998.11994285.html.plaintext.txt	3	Received publication February 15 2002 revised form May 1 2002
0.21709998.11994285.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.21709998.11994285.html.plaintext.txt	5	Maturity onset diabetes young subtype 1 MODY1 associated defective glucose dependent insulin secretion pancreatic beta cells
0.21709998.11994285.html.plaintext.txt	6	MODY1 caused mutation transcription factor hepatocyte nuclear factor 4 HNF4
0.21709998.11994285.html.plaintext.txt	7	To understand better MODY1 phenotype tested whether HNF4 able modulate directly insulin gene promoter
0.21709998.11994285.html.plaintext.txt	8	Transfection cultured 293T cells HNF4 expression vector led 10 fold activation cotransfected reporter plasmid containing rat insulin I gene promoter
0.21709998.11994285.html.plaintext.txt	9	Computer analysis revealed potential HNF4 binding site nucleotides 57 69 promoter mutation sequence led reduced ability HNF4 activate promoter
0.21709998.11994285.html.plaintext.txt	10	The ability HNF4 bind sequence confirmed using gel shift analysis
0.21709998.11994285.html.plaintext.txt	11	In transfected INS 1 beta cells mutation either HNF1 site HNF4 site insulin gene promoter led 50 75 reduction reporter gene activity expression dominant negative HNF4 led significant reduction activity wild type mutated promoters
0.21709998.11994285.html.plaintext.txt	12	Thus addition previously described indirect action HNF4 insulin gene expression mediated elevated HNF1 levels HNF4 also activates insulin gene directly previously unrecognized cis element
0.21709998.11994285.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.21709998.11994285.html.plaintext.txt	14	In adult mammals insulin gene expressed exclusively beta cells endocrine pancreas 1 3
0.21709998.11994285.html.plaintext.txt	15	This selectivity controlled primarily transcriptional level well defined promoter elements 4 6
0.21709998.11994285.html.plaintext.txt	16	Although number transcription factors defined interact insulin promoter activate synergistic fashion 7 10 action factors alone sufficient explain remarkable degree cell specificity observed vivo 9
0.21709998.11994285.html.plaintext.txt	17	Most likely additional transcription factors participate achieving specificity
0.21709998.11994285.html.plaintext.txt	18	MODY1 monogenic form diabetes characterized impaired glucose dependent insulin secretion absence insulin resistance peripheral tissues 11 12
0.21709998.11994285.html.plaintext.txt	19	This indicates beta cell defect primary cause MODY implies MODY genes role insulin production andor secretion
0.21709998.11994285.html.plaintext.txt	20	Consistent fact four five known MODY subtypes caused mutations distinct transcription factors expressed pancreatic beta cells 13
0.21709998.11994285.html.plaintext.txt	21	The striking MODY phenotype caused single gene disorders provides clear evidence important role transcription factors beta cell function
0.21709998.11994285.html.plaintext.txt	22	MODY1 caused mutation HNF4 transcription factor nuclear receptor subfamily 14
0.21709998.11994285.html.plaintext.txt	23	At least eight different mutations identified MODY1 patients 15
0.21709998.11994285.html.plaintext.txt	24	Four mutations result truncated HNF4 proteins two nonsense mutations 14 16 two frameshift mutations 17 18
0.21709998.11994285.html.plaintext.txt	25	The four mutations missense mutations affect various domains HNF4 protein 19 22
0.21709998.11994285.html.plaintext.txt	26	MODY3 caused mutation HNF1 gene encoding transcription factor homeodomain family 23
0.21709998.11994285.html.plaintext.txt	27	Like HNF4 HNF1 expressed liver beta cells
0.21709998.11994285.html.plaintext.txt	28	In fact HNF1 shown direct transcriptional target HNF4 liver 24
0.21709998.11994285.html.plaintext.txt	29	Furthermore mutation HNF4 binding site HNF1 gene promoter produces MODY phenotype 25
0.21709998.11994285.html.plaintext.txt	30	Consistent observations MODY1 MODY3 show similar clinical phenotype
0.21709998.11994285.html.plaintext.txt	31	Recent studies 26 shown induction dominant negative DN HNF1 beta cells leads alterations expression number beta cell genes including insulin gene
0.21709998.11994285.html.plaintext.txt	32	Because DN HNF4 led reduced activity Hnf1 promoter reduced insulin mRNA levels 27 hypothesized HNF4 increases insulin mRNA levels indirectly increasing HNF1 levels turn activate promoter binding HNF1 consensus sequence 28
0.21709998.11994285.html.plaintext.txt	33	Recently however strong evidence obtained indicating hypothesis may simplification actual relationship HNF4 HNF1 may complex shown 29 30 P2 major promoter Hnf4 gene beta cells regulated HNF1
0.21709998.11994285.html.plaintext.txt	34	Therefore activation beta cell genes HNF4 may involve simple transcriptional regulatory cascade mediated HNF1 previously envisaged
0.21709998.11994285.html.plaintext.txt	35	In study examined idea detailed analysis insulin gene promoter
0.21709998.11994285.html.plaintext.txt	36	In addition confirming HNF4 activates insulin gene expression indirect fashion HNF1 binding site identified novel cis element insulin gene promoter mediates direct activation promoter HNF4 beta cells
0.21709998.11994285.html.plaintext.txt	37	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Cell Culture
0.21709998.11994285.html.plaintext.txt	38	293T HeLa S3 Tet Off CLONTECH PT3001 1 COS7 cells cultured Dulbeccos modified Eagles medium supplemented 10 fetal calf serum penicillin 200 IUml streptomycin 100 microgml
0.21709998.11994285.html.plaintext.txt	39	INS 1 DN HNF4 26 cells 27 cultured RPMI 1640 medium containing 10 heat inactivated fetal calf serum 25 mM HEPES 2 mM L glutamine 1 mM sodium pyruvate 50 microM 2 mercaptoethanol penicillin 200 IUml streptomycin 100 microgml supplemented 150 microgml G418 100 microgml hygromycin
0.21709998.11994285.html.plaintext.txt	40	LUC plasmid containing luciferase LUC gene controlled rat insulin I gene promoter generated replacement SV40 promoter pGL3 promoter vector Promega insulin promoter fragment 410 1
0.21709998.11994285.html.plaintext.txt	41	LUC plasmid pGL3 promoter vector Promega containing luciferase gene controlled SV40 early promoter
0.21709998.11994285.html.plaintext.txt	42	LUC contains luciferase gene controlled RSV promoter 31
0.21709998.11994285.html.plaintext.txt	43	LUC contains luciferase gene controlled actin promoter
0.21709998.11994285.html.plaintext.txt	44	LUC contains luciferase gene controlled CMV enhancer herpes simplex virus thymidine kinase TK promoter
0.21709998.11994285.html.plaintext.txt	45	The reporter plasmids Synt 5 LUC Synt 6 LUC Synt 7 LUC Synt 8 LUC contain luciferase gene controlled Synt 5 8 block replacement mutants rat insulin I promoter 5
0.21709998.11994285.html.plaintext.txt	46	LUC generated PCR mediated site directed mutagenesis pGL3
0.21709998.11994285.html.plaintext.txt	47	The nucleotides mutated 57 69 ACGGCAAAGTCCA CATTACCCTGAAC
0.21709998.11994285.html.plaintext.txt	48	LUC generated subcloning mutated insulin promoter 410MFInsLUC pGL3 promoter vector Promega
0.21709998.11994285.html.plaintext.txt	49	The nucleotides mutated 222 218 TTAAT GTCCG
0.21709998.11994285.html.plaintext.txt	50	The Renilla luciferase internal control plasmid pRL
0.21709998.11994285.html.plaintext.txt	51	RSV contains Renilla luciferase coding sequence pRL null vector Promega controlled RSV promoter
0.21709998.11994285.html.plaintext.txt	52	HNF4 encodes rat HNF4 controlled SV40 early promoter
0.21709998.11994285.html.plaintext.txt	53	HNF4 encodes rat HNF4 controlled CMV promoter
0.21709998.11994285.html.plaintext.txt	54	PDX1 PDX1 expression vector controlled CMV promoter
0.21709998.11994285.html.plaintext.txt	55	E2A mouse E2A E47 expression vector 9 controlled CMV promoter
0.21709998.11994285.html.plaintext.txt	56	BETA BETA2 expression vector encoding hemagglutinin epitope tagged BETA2 controlled CMV promoter 9
0.21709998.11994285.html.plaintext.txt	57	Transfections 293T HeLa COS7 cells carried calcium phosphate coprecipitation technique 32
0.21709998.11994285.html.plaintext.txt	58	4 7 h addition DNA cells exposed 20 glycerol Dulbeccos modified Eagles medium 2 min
0.21709998.11994285.html.plaintext.txt	59	Cells harvested 40 48 h transfection cell extracts assayed reporter enzyme activity
0.21709998.11994285.html.plaintext.txt	60	INS 1 DN HNF4 26 cells 27 transfected using electroporation follows
0.21709998.11994285.html.plaintext.txt	61	Cells suspended 450 microl cold phosphate buffered saline calciummagnesium free plasmid DNA dissolved 50 microl H2O added
0.21709998.11994285.html.plaintext.txt	62	Cells incubated ice 10 min transferred 4 mm gap cuvettes BTX pulsed 6 ms 320 Vcm 975 microfarads using ECM 830 pulse generator
0.21709998.11994285.html.plaintext.txt	63	For induction DN HNF4 cells incubated 1 microgml doxycycline 24 h prior transfection
0.21709998.11994285.html.plaintext.txt	64	Following transfection cell extracts prepared 3 cycles freeze thawing followed centrifugation remove cell debris
0.21709998.11994285.html.plaintext.txt	65	The firefly Renilla luciferase assays carried follows extracts containing 5 50 microg 2 5 microl protein added 50 microl firefly luciferase assay buffer Promega E1501 100 microl Renilla luciferase assay buffer 33
0.21709998.11994285.html.plaintext.txt	66	The samples placed luminometer LUMAC Biocounter M2500 light output determined 10 interval
0.21709998.11994285.html.plaintext.txt	67	Statistical significance evaluated test using InStat software
0.21709998.11994285.html.plaintext.txt	68	Oligonucleotides synthesized corresponding HNF4 binding element HBE region 5 gatccGCCCTTAATGGGCCAAACGGCAAAGTCCAGGGa 3 rat insulin I promoter 5 positions 86 53 C3P region 5 agctGCAGGTGACCTTTGACCAGCTc 3 rat ApoCIII promoter 34
0.21709998.11994285.html.plaintext.txt	69	Radioactive probes generated incubation appropriate annealed oligonucleotides 5 pmol presence 50 microCi 32PdATP 3000 Cimmol 0
0.21709998.11994285.html.plaintext.txt	70	25 mM dCTP dGTP dTTP 5 units DNA polymerase I New England Biolabs Klenow fragment 40 min room temperature
0.21709998.11994285.html.plaintext.txt	71	The radiolabeled oligonucleotides separated free nucleotide spin dialysis using Sephadex G 50
0.21709998.11994285.html.plaintext.txt	72	Specific activity obtained typically 2000 cpmfmol
0.21709998.11994285.html.plaintext.txt	73	Electrophoretic Mobility Shift Assay EMSA
0.21709998.11994285.html.plaintext.txt	74	Cells transfected 10 microg expression plasmids described
0.21709998.11994285.html.plaintext.txt	75	Whole cell extracts 10 15 microg protein incubated 10 min ice binding buffer 10 mM HEPES pH 7
0.21709998.11994285.html.plaintext.txt	76	8 50 mM KCl 10 glycerol 1 mM dithiothreitol 2
0.21709998.11994285.html.plaintext.txt	77	5 mM MgCl2 containing 600 ng polydI dC 600 ng polydA dT Sigma final assay volume 14 microl
0.21709998.11994285.html.plaintext.txt	78	Subsequently 1 microl 32P labeled probe added 10 fmol incubation allowed continue ice additional 25 min
0.21709998.11994285.html.plaintext.txt	79	Samples subsequently resolved 6 polyacrylamide gels 37
0.21709998.11994285.html.plaintext.txt	80	51 acrylamidebisacrylamide 45 mM Tris borate 1 mM EDTA 0
0.21709998.11994285.html.plaintext.txt	81	5 x TBE 184 V 2 h 4 degrees C
0.21709998.11994285.html.plaintext.txt	82	The gel dried labeled DNA protein complexes visualized autoradiography
0.21709998.11994285.html.plaintext.txt	83	In supershift experiments 1 microl anti HNF4 antiserum preimmune serum added first 10 min incubation mixture incubated additional 10 min addition 32P labeled probe
0.21709998.11994285.html.plaintext.txt	84	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.21709998.11994285.html.plaintext.txt	85	HNF4 Can Activate Insulin Gene Promoter Because HNF4 previously shown affect insulin mRNA levels beta cells 27 involvement direct transcriptional regulation insulin gene examined
0.21709998.11994285.html.plaintext.txt	86	293T cells transfected reporter plasmid encoding luciferase gene controlled rat insulin I gene promoter 410 1 presence absence HNF4 expression plasmid
0.21709998.11994285.html.plaintext.txt	87	For comparison cells also transfected luciferase reporter plasmids controlled promoter promoters follows RSV actin CMV
0.21709998.11994285.html.plaintext.txt	88	TK SV40 presence absence HNF4 expression plasmid
0.21709998.11994285.html.plaintext.txt	89	HNF4 activated transcription insulin gene promoter 9
0.21709998.11994285.html.plaintext.txt	90	1 activate promoters tested indicating activation specific
0.21709998.11994285.html.plaintext.txt	91	Similar results obtained upon transfection HeLa cells shown
0.21709998.11994285.html.plaintext.txt	92	View larger version 27K Fig
0.21709998.11994285.html.plaintext.txt	93	Activation insulin gene promoter HNF4 protein
0.21709998.11994285.html.plaintext.txt	94	293T cells transfected 1 microg luciferase reporter plasmid containing either promoter pGL3
0.21709998.11994285.html.plaintext.txt	95	basic rat insulin I gene promoter pGL3
0.21709998.11994285.html.plaintext.txt	96	Synt one following promoters SV40 RSV actin CMV
0.21709998.11994285.html.plaintext.txt	97	TK presence 1 microg HNF4 expression plasmid pcDNA3
0.21709998.11994285.html.plaintext.txt	98	HNF4 empty expression plasmid control
0.21709998.11994285.html.plaintext.txt	99	Results expressed ratio luciferase activity observed presence compared absence HNF4
0.21709998.11994285.html.plaintext.txt	100	Each data point represents mean plus minus S
0.21709998.11994285.html.plaintext.txt	101	least three independent transfection experiments reporter plasmid
0.21709998.11994285.html.plaintext.txt	102	The asterisk indicates statistical significance p 0
0.21709998.11994285.html.plaintext.txt	103	0001 presence compared absence HNF4
0.21709998.11994285.html.plaintext.txt	104	Identification Region Insulin Gene Promoter Important HNF4 Activation In order characterize HNF4 dependent activation insulin gene promoter scanned presence HNF4 consensus binding sequence using TESS software www
0.21709998.11994285.html.plaintext.txt	105	Such consensus site found nucleotides 57 69 Fig
0.21709998.11994285.html.plaintext.txt	106	2 suggesting presence HNF4 binding site promoter insulin gene
0.21709998.11994285.html.plaintext.txt	107	To determine whether putative HNF4 binding site necessary HNF4 activation insulin gene promoter examined ability HNF4 activate insulin gene promoter mutated site
0.21709998.11994285.html.plaintext.txt	108	Four block replacement mutants insulin promoter spanning consensus binding sequence designated Synt 5 8 used 5 Fig
0.21709998.11994285.html.plaintext.txt	109	As 293T cells transfected reporter plasmids encoding luciferase gene controlled wild type rat insulin I promoter one mutated variants Synt 5 8 presence absence HNF4 expression plasmid
0.21709998.11994285.html.plaintext.txt	110	HNF4 activation mutants Synt 5 Synt 8 mutations located outside putative HNF4 binding site reduced compared wild type promoter activation
0.21709998.11994285.html.plaintext.txt	111	In contrast mutation Synt 6 Synt 7 abolishing part HNF4 consensus site showed significantly attenuated activation Fig
0.21709998.11994285.html.plaintext.txt	112	These results indicate nucleotides mutated mutants Synt 6 Synt 7 important HNF4 activation insulin gene promoter
0.21709998.11994285.html.plaintext.txt	113	View larger version 30K Fig
0.21709998.11994285.html.plaintext.txt	114	A consensus binding site HNF4 insulin gene promoter
0.21709998.11994285.html.plaintext.txt	115	An HNF4 consensus site boldface letters located nucleotides 57 69 adjacent PDX1 binding site boldface letters
0.21709998.11994285.html.plaintext.txt	116	Block replacement mutants insulin promoter designated Synt 5 8 5 generated mutation nucleotides relevant portion wild type sequence follows A C G T
0.21709998.11994285.html.plaintext.txt	117	The location HBE probe also shown
0.21709998.11994285.html.plaintext.txt	118	View larger version 42K Fig
0.21709998.11994285.html.plaintext.txt	119	Block replacement mutations HNF4 consensus binding site insulin gene promoter reduce HNF4 activation promoter
0.21709998.11994285.html.plaintext.txt	120	293T cells transfected 1 microg luciferase LUC reporter plasmid containing wild type rat insulin I promoter block replacement mutants Synt 5 8 presence 1 microg HNF4 expression plasmid pcDNA3
0.21709998.11994285.html.plaintext.txt	121	HNF4 empty expression plasmid control
0.21709998.11994285.html.plaintext.txt	122	The nucleotides mutated Synt 5 8 43 53 54 63 64 68 79 88 respectively 5
0.21709998.11994285.html.plaintext.txt	123	Results expressed ratio luciferase activity observed presence compared absence HNF4
0.21709998.11994285.html.plaintext.txt	124	Each data point represents mean plus minus S
0.21709998.11994285.html.plaintext.txt	125	least three independent transfection experiments reporter plasmid
0.21709998.11994285.html.plaintext.txt	126	Asterisks indicate statistical significance p 0
0.21709998.11994285.html.plaintext.txt	127	0006 Synt 7 compared values obtained wild type promoter
0.21709998.11994285.html.plaintext.txt	128	HNF4 Can Bind Insulin Gene Promoter We next tested ability HNF4 bind putative binding sequence insulin gene promoter
0.21709998.11994285.html.plaintext.txt	129	An EMSA performed using probe containing putative HNF4 binding site designated HBE element Fig
0.21709998.11994285.html.plaintext.txt	130	Whole cell extracts made HeLa cells transfected HNF4 expression plasmid untransfected HeLa cells
0.21709998.11994285.html.plaintext.txt	131	Incubation transfected extracts radiolabeled HBE probe resulted strong band absent extracts mock transfected cells used Fig
0.21709998.11994285.html.plaintext.txt	132	Competition unlabeled HBE oligonucleotide abolished band lane 3
0.21709998.11994285.html.plaintext.txt	133	Addition anti HNF4 serum generated supershifted band observed preimmune serum confirming presence HNF4 complex lanes 4 5
0.21709998.11994285.html.plaintext.txt	134	Apolipoprotein C III ApoCIII well characterized target gene HNF4 35 36
0.21709998.11994285.html.plaintext.txt	135	Competition unlabeled oligonucleotide containing C3P element HNF4 binding site ApoCIII gene promoter 37 also abolished observed band lane 6
0.21709998.11994285.html.plaintext.txt	136	Competition increasing amounts unlabeled HBE C3P probes indicates HNF4 affinity binding site ApoCIII gene higher affinity binding site insulin gene Fig
0.21709998.11994285.html.plaintext.txt	137	View larger version 44K Fig
0.21709998.11994285.html.plaintext.txt	138	HNF4 bind insulin gene promoter demonstrated EMSA
0.21709998.11994285.html.plaintext.txt	139	A whole cell extracts mock transfected HeLa cells lane 1 HeLa cells transfected HNF4 expression vector lanes 2 6 incubated 32P labeled HBE probe separated non denaturing polyacrylamide gel
0.21709998.11994285.html.plaintext.txt	140	Specificity binding analyzed adding 100 60 fold molar excess unlabeled HBE probe lane 3 C3P probe lane 6 respectively
0.21709998.11994285.html.plaintext.txt	141	The formation immune complex shown addition anti HNF4 serum lane 4 compared addition preimmune serum lane 5
0.21709998.11994285.html.plaintext.txt	142	B affinity HNF4 HBE probe lower affinity C3P probe
0.21709998.11994285.html.plaintext.txt	143	Whole cell extracts made untransfected COS7 cells lane 1 COS7 cells transfected HNF4 expression vector lanes 2 10 incubated 32P labeled HBE probe separated non denaturing polyacrylamide gel
0.21709998.11994285.html.plaintext.txt	144	Competition performed using 10 20 50 100 fold molar excess unlabeled HBE oligonucleotide lanes 3 6 respectively 3 10 20 50 fold molar excess unlabeled C3P oligonucleotide lanes 7 10 respectively
0.21709998.11994285.html.plaintext.txt	145	HNF4 Other Insulin Gene Transcription Factors E2A 38 40 BETA2 NeuroD 41 42 PDX1 also known IPF1 STF1 IDX1 43 45 well characterized insulin gene transcription factors synergistically activate insulin gene promoter cotransfected HeLa cells reporter gene controlled promoter however insulin promoter construct transfected beta cells 4 times active 9
0.21709998.11994285.html.plaintext.txt	146	This implies additional factors present beta cells may important insulin gene regulation
0.21709998.11994285.html.plaintext.txt	147	In light data showing HNF4 bind activate insulin gene promoter possible cooperation three known insulin gene transcription factors examined
0.21709998.11994285.html.plaintext.txt	148	293T cells transfected luciferase reporter plasmid controlled rat insulin I gene promoter expression plasmids encoding four transcription factors E2A BETA2 PDX1 HNF4
0.21709998.11994285.html.plaintext.txt	149	Expression HNF4 E2A BETA2 PDX1 produced synergistic activation insulin gene promoter 2 fold higher activation generated three factors alone Fig
0.21709998.11994285.html.plaintext.txt	150	Similar results obtained upon transfecting HeLa cells shown
0.21709998.11994285.html.plaintext.txt	151	View larger version 32K Fig
0.21709998.11994285.html.plaintext.txt	152	A HNF4 enhances insulin gene promoter activation generated E2A BETA2 PDX1
0.21709998.11994285.html.plaintext.txt	153	293T cells cotransfected 1 microg luciferase reporter plasmid containing rat insulin I promoter presence absence 0
0.21709998.11994285.html.plaintext.txt	154	1 microg expression vectors encoding HNF4 E2A BETA2 PDX1 indicated
0.21709998.11994285.html.plaintext.txt	155	Results expressed relative activity observed presence E2A BETA2 PDX1
0.21709998.11994285.html.plaintext.txt	156	Each bar represents mean plus minus S
0.21709998.11994285.html.plaintext.txt	157	The asterisk indicates statistical significance p 0
0.21709998.11994285.html.plaintext.txt	158	005 compared value obtained upon transfection E2A BETA2 PDX1
0.21709998.11994285.html.plaintext.txt	159	B HNF4 enhances PDX1 activation promoter synergistic manner
0.21709998.11994285.html.plaintext.txt	160	293T cells cotransfected 1 microg luciferase reporter plasmid containing rat insulin I gene promoter presence absence 0
0.21709998.11994285.html.plaintext.txt	161	1 microg expression plasmids encoding indicated transcription factors
0.21709998.11994285.html.plaintext.txt	162	Results expressed relative activity observed presence HNF4 PDX1
0.21709998.11994285.html.plaintext.txt	163	Each data point represents mean plus minus S
0.21709998.11994285.html.plaintext.txt	164	8 independent transfection experiments
0.21709998.11994285.html.plaintext.txt	165	Asterisks indicate statistical significance p 0
0.21709998.11994285.html.plaintext.txt	166	0001 HNF4 PDX1 compared HNF4 PDX1
0.21709998.11994285.html.plaintext.txt	167	To investigate augmented activation generated HNF4 effect HNF4 PDX1 tested absence E2A BETA2
0.21709998.11994285.html.plaintext.txt	168	293T cells cotransfected reporter plasmid encoding luciferase gene controlled rat insulin I promoter expression vectors encoding PDX1 HNF4
0.21709998.11994285.html.plaintext.txt	169	Expression HNF4 PDX1 generated synergistic activation promoter Fig
0.21709998.11994285.html.plaintext.txt	170	Synergistic activation also observed HeLa cells shown
0.21709998.11994285.html.plaintext.txt	171	This cooperativity HNF4 PDX1 probably responsible synergistic activation observed previously upon coexpression HNF4 E2A BETA2 PDX1
0.21709998.11994285.html.plaintext.txt	172	Mechanism Action HNF4 Beta Cells Expression dominant negative HNF1 beta cell line INS 1 reduced expression several beta cell genes including insulin gene 26 similar effects dominant negative HNF4 27
0.21709998.11994285.html.plaintext.txt	173	Furthermore HNF4 transcription activator HNF1 24 27 mutations HNF1 responsible MODY3 23
0.21709998.11994285.html.plaintext.txt	174	This raises possibility HNF4 may activate insulin gene indirectly Hnf1 gene function
0.21709998.11994285.html.plaintext.txt	175	In non beta cells HNF4 dependent activation observed Fig
0.21709998.11994285.html.plaintext.txt	176	1 may mediated part HNF1 substantial reduction activation promoter mutated HNF4 binding site Fig
0.21709998.11994285.html.plaintext.txt	177	3 indicates significant portion effect mediated directly
0.21709998.11994285.html.plaintext.txt	178	To assess significance HNF4 site insulin gene promoter beta cells test whether beta cells HNF4 activates insulin gene promoter directly indirectly HNF1 used INS 1 DN HNF4 26 cells derivative INS 1 cells contains plasmid encoding doxycycline inducible dominant negative HNF4 27
0.21709998.11994285.html.plaintext.txt	179	This dominant negative protein possesses functional dimerization domain lacks DNA binding domain therefore suppresses activity endogenous wild type HNF4
0.21709998.11994285.html.plaintext.txt	180	Luciferase reporter plasmids controlled wild type rat insulin I gene promoter promoter mutated either HNF1 HNF4 binding sites electroporated cells
0.21709998.11994285.html.plaintext.txt	181	In absence doxycycline
0.21709998.11994285.html.plaintext.txt	182	expression DN HNF4 mutations either HNF4 site HNF1 site led reduced activity insulin gene promoter Fig
0.21709998.11994285.html.plaintext.txt	183	Thus sites important full transcriptional activation beta cells
0.21709998.11994285.html.plaintext.txt	184	View larger version 32K Fig
0.21709998.11994285.html.plaintext.txt	185	Effect DN HNF4 wild type mutated insulin gene promoter beta cells
0.21709998.11994285.html.plaintext.txt	186	A luciferase reporter genes containing wild type insulin gene promoter wild type WT insulin gene promoter containing mutations HNF1 site HNF1 HNF4 site HNF4 electroporated INS 1 DN HNF4 26 cells presence light bars absence dark bars doxycycline Dox
0.21709998.11994285.html.plaintext.txt	187	Cells harvested 48 h following electroporation normalized luciferase activity determined
0.21709998.11994285.html.plaintext.txt	188	Results expressed relative activity obtained wild type promoter absence doxycycline
0.21709998.11994285.html.plaintext.txt	189	Each data point represents mean plus minus S
0.21709998.11994285.html.plaintext.txt	190	least three independent electroporation experiments
0.21709998.11994285.html.plaintext.txt	191	Asterisks indicate statistical significance p 0
0.21709998.11994285.html.plaintext.txt	192	02 HNF1 presence compared absence doxycycline
0.21709998.11994285.html.plaintext.txt	193	B model depicting possible effects DN HNF4 insulin gene expression
0.21709998.11994285.html.plaintext.txt	194	To confirm role HNF4 distinguish direct action HNF4 compared indirect action mediated HNF1 compared activity wild type mutated promoters presence absence doxycycline
0.21709998.11994285.html.plaintext.txt	195	If HNF4 acts exclusively indirect manner HNF1 induction DN HNF4 affect activity promoter mutated HNF1 site
0.21709998.11994285.html.plaintext.txt	196	In fact induction DN HNF4 significantly reduced activity wild type promoter promoter mutated HNF1 binding site Fig
0.21709998.11994285.html.plaintext.txt	197	6A confirming involvement HNF4 insulin promoter activation showing least part effect involve HNF1
0.21709998.11994285.html.plaintext.txt	198	Furthermore expression DN HNF4 led significant reduction activity promoter fragment mutated HNF4 site Fig
0.21709998.11994285.html.plaintext.txt	199	6A confirming HNF4 also increases insulin gene transcription indirect effect via HNF1 Fig
0.21709998.11994285.html.plaintext.txt	200	Although experimental system permit quantitative comparison relative contribution direct effects compared indirect effects HNF4 significant DN HNF4 dependent reduction observed activity HNF1 HNF4 promoter clearly indicates effects substantial
0.21709998.11994285.html.plaintext.txt	201	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.21709998.11994285.html.plaintext.txt	202	Identification HNF1 HNF4 mutated genes responsible MODY3 MODY1 respectively prompted efforts establish precise role factors health disease
0.21709998.11994285.html.plaintext.txt	203	Because MODY phenotype involves primary defect beta cells defective function transcription factors must manifested cells
0.21709998.11994285.html.plaintext.txt	204	Indeed expression DN HNF1 DN HNF4 leads clear alterations expression key beta cell genes including insulin gene 26 27
0.21709998.11994285.html.plaintext.txt	205	Because previous studies shown HNF4 activator HNF1 24 MODY3 caused mutation HNF4 binding site HNF1 promoter 25 proposed effect HNF4 insulin gene promoter indirect mediated activation HNF1 27
0.21709998.11994285.html.plaintext.txt	206	In report examined hypothesis
0.21709998.11994285.html.plaintext.txt	207	Expression DN HNF4 beta cells led reduced activity wild type insulin gene promoter promoter mutated HNF1 binding site strongly suggesting presence HNF4 binding site elsewhere promoter region
0.21709998.11994285.html.plaintext.txt	208	Indeed identified sequence nucleotides 57 69 promoter able show capable binding HNF4 vitro
0.21709998.11994285.html.plaintext.txt	209	We showed site essential full activation promoter beta cells efficient HNF4 dependent activation non beta cells
0.21709998.11994285.html.plaintext.txt	210	Expression DN HNF4 beta cells also led reduced activity promoter construct bearing mutations HNF4 site
0.21709998.11994285.html.plaintext.txt	211	The data therefore indicate addition previously recognized indirect action HNF4 insulin gene expression mediated HNF1 also direct action mediated binding novel HNF4 consensus sequence promoter
0.21709998.11994285.html.plaintext.txt	212	These results consistent recent reports 29 30 indicating epistatic relationship HNF4 HNF1 beta cells complex previously appreciated may differ liver
0.21709998.11994285.html.plaintext.txt	213	It shown Hnf4 promoter contains upstream beta cell specific promoter whose activity regulated HNF1
0.21709998.11994285.html.plaintext.txt	214	This promoter also contains binding site PDX1 mutations strongly correlate diabetic phenotype MODY family 30
0.21709998.11994285.html.plaintext.txt	215	Taken together data consistent idea HNF1 HNF4 PDX1 participate complex autoregulatory transcriptional network controls many functional properties developing mature beta cells
0.21709998.11994285.html.plaintext.txt	216	Of central importance regard insulin gene whose expression modulated three factors
0.21709998.11994285.html.plaintext.txt	217	Interestingly observed synergistic activation insulin gene promoter HNF4 PDX1 adjacent binding sites promoter thus adding additional level complexity transcriptional control network
0.21709998.11994285.html.plaintext.txt	218	The current results indicating HNF4 activates insulin gene direct indirect actions permit detailed understanding MODY phenotype
0.21709998.11994285.html.plaintext.txt	219	Gerber assistance plasmid construction Dr
0.21709998.11994285.html.plaintext.txt	220	Dikstein gifts plasmids
0.21709998.11994285.html.plaintext.txt	221	This work supported part grants Roy Ellen Rosenthal Family Foundation Israel Academy Sciences Humanities M
0.21709998.11994285.html.plaintext.txt	222	Swiss National Science Foundation Grant 32 49755
0.21709998.11994285.html.plaintext.txt	223	The costs publication article defrayed part payment page charges
0.21709998.11994285.html.plaintext.txt	224	The article must therefore hereby marked advertisement accordance 18 U
0.21709998.11994285.html.plaintext.txt	225	Section 1734 solely indicate fact
0.21709998.11994285.html.plaintext.txt	226	Holds Marvin Meyer Jenny Cyker Chair Diabetes Research
0.21709998.11994285.html.plaintext.txt	227	To correspondence addressed
0.21709998.11994285.html.plaintext.txt	228	972 8 934 3597 Fax 972 8 934 4118 E mail m
0.21709998.11994285.html.plaintext.txt	229	Published JBC Papers Press May 6 2002 DOI 10
0.21709998.11994285.html.plaintext.txt	230	The abbreviations used MODY maturity onset diabetes young HNF4 hepatocyte nuclear factor 4 DN dominant negative HNF1 hepatocyte nuclear factor 1 EMSA electrophoretic mobility shift assay RSV Rous sarcoma virus CMV cytomegalovirus TK thymidine kinase LUC luciferase HBE HNF4 binding element
0.21709998.11994285.html.plaintext.txt	231	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.21709998.11994285.html.plaintext.txt	232	19 463 484CrossRefMedline Order article via Infotrieve 2
0.21709998.11994285.html.plaintext.txt	233	11 227 233CrossRefMedline Order article via Infotrieve 3
0.21709998.11994285.html.plaintext.txt	234	2002 Diabetologia 45 309 326CrossRefMedline Order article via Infotrieve 4
0.21709998.11994285.html.plaintext.txt	235	1983 Nature 306 557 561Medline Order article via Infotrieve 5
0.21709998.11994285.html.plaintext.txt	236	1995 Diabetes 44 1002 1004Medline Order article via Infotrieve 7
0.21709998.11994285.html.plaintext.txt	237	275 2199 2204AbstractFree Full Text 10
0.21709998.11994285.html.plaintext.txt	238	22 412 420AbstractFree Full Text 11
0.21709998.11994285.html.plaintext.txt	239	1994 Diabetes 43 40 46Abstract 12
0.21709998.11994285.html.plaintext.txt	240	1995 Diabetes 44 699 704Abstract 13
0.21709998.11994285.html.plaintext.txt	241	98 14189 14191Free Full Text 14
0.21709998.11994285.html.plaintext.txt	242	1996 Nature 384 458 460CrossRefMedline Order article via Infotrieve 15
0.21709998.11994285.html.plaintext.txt	243	27 11 29AbstractFree Full Text 16
0.21709998.11994285.html.plaintext.txt	244	100 1400 1405AbstractFree Full Text 17
0.21709998.11994285.html.plaintext.txt	245	84 367 369AbstractFree Full Text 18
0.21709998.11994285.html.plaintext.txt	246	1999 Diabetes 48 423 425Free Full Text 19
0.21709998.11994285.html.plaintext.txt	247	1997 Diabetes 46 1652 1657Abstract 20
0.21709998.11994285.html.plaintext.txt	248	16 193 200CrossRefMedline Order article via Infotrieve 21
0.21709998.11994285.html.plaintext.txt	249	1997 Diabetologia 40 980 983CrossRefMedline Order article via Infotrieve 22
0.21709998.11994285.html.plaintext.txt	250	1997 Diabetologia 40 859 862CrossRefMedline Order article via Infotrieve 23
0.21709998.11994285.html.plaintext.txt	251	1996 Nature 384 455 458CrossRefMedline Order article via Infotrieve 24
0.21709998.11994285.html.plaintext.txt	252	1992 Nature 355 457 461CrossRefMedline Order article via Infotrieve 25
0.21709998.11994285.html.plaintext.txt	253	1997 Diabetes 46 1648 1651Abstract 26
0.21709998.11994285.html.plaintext.txt	254	17 6701 6713AbstractFree Full Text 27
0.21709998.11994285.html.plaintext.txt	255	275 35953 35959AbstractFree Full Text 28
0.21709998.11994285.html.plaintext.txt	256	98 14481 14486AbstractFree Full Text 30
0.21709998.11994285.html.plaintext.txt	257	10 2089 2097AbstractFree Full Text 31
0.21709998.11994285.html.plaintext.txt	258	7 725 737Medline Order article via Infotrieve 32
0.21709998.11994285.html.plaintext.txt	259	270 13470 13475AbstractFree Full Text 35
0.21709998.11994285.html.plaintext.txt	260	267 15849 15860AbstractFree Full Text 37
0.21709998.11994285.html.plaintext.txt	261	264 16132 16137AbstractFree Full Text 38
0.21709998.11994285.html.plaintext.txt	262	1989 Cell 56 777 783Medline Order article via Infotrieve 39
0.21709998.11994285.html.plaintext.txt	263	1995 Science 268 836 844Medline Order article via Infotrieve 42
0.21709998.11994285.html.plaintext.txt	264	Copyright 2002 The American Society Biochemistry Molecular Biology Inc
0.25199053.11292834.html.plaintext.txt	0	Peroxisome Proliferator activated Receptor mediated Transcriptional Up regulation Hepatocyte Growth Factor Gene Promoter via Novel Composite cis Acting Element Jie Gen Jiang Carla Johnson Reza Zarnegar
0.25199053.11292834.html.plaintext.txt	1	From Department Pathology Division Cellular Molecular Pathology University Pittsburgh School Medicine Pittsburgh Pennsylvania 15261
0.25199053.11292834.html.plaintext.txt	2	Received publication February 21 2001 revised form April 4 2001
0.25199053.11292834.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.25199053.11292834.html.plaintext.txt	4	Hepatocyte growth factor HGF pleotropic polypeptide function morphogen motogen mitogen angiogen carcinogen tumor suppressor depending target cell tissue
0.25199053.11292834.html.plaintext.txt	5	Previous studies laboratory using transgenic mice shown HGF gene expression tightly regulated transcriptional level upstream regulatory elements crucial control HGF gene transcription
0.25199053.11292834.html.plaintext.txt	6	In present study identified characterized one elements peroxisome proliferator activated receptor PPAR responsive element
0.25199053.11292834.html.plaintext.txt	7	This regulatory element localized 246 233 base pairs upstream transcription start site HGF gene promoter sequence GGGCCAGGTGACCT
0.25199053.11292834.html.plaintext.txt	8	Gel mobility shift supershift assays demonstrated cis acting element strongly binds PPAR isoforms well chicken ovalbumin upstream promoter transcription factor member orphan nuclear receptor subfamily
0.25199053.11292834.html.plaintext.txt	9	Mutational analysis gel mobility band shift assays indicated binding site inverted repeat AGGTCA motif two spacers inverted repeat 2 configuration two spacers important PPAR binding
0.25199053.11292834.html.plaintext.txt	10	This binding site overlaps functional binding sites activating protein 2 nuclear factor 1 upstream stimulatory factor together constitute multifunctional composite binding site different transcription factors exert regulatory effects HGF promoter activity
0.25199053.11292834.html.plaintext.txt	11	Functional assays revealed PPAR ligand 15 deoxy prostaglandin J2 strongly stimulates HGF promoter activity
0.25199053.11292834.html.plaintext.txt	12	On hand nuclear factor 1 activating protein 2 chicken ovalbumin upstream promoter transcription factor transcription factors repress stimulatory action PPAR competing PPAR overlapping binding sites
0.25199053.11292834.html.plaintext.txt	13	Furthermore first time studies demonstrate PPAR ligand 15 deoxy prostaglandin J2 induces endogenous HGF mRNA protein expression fibroblasts culture
0.25199053.11292834.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.25199053.11292834.html.plaintext.txt	15	Hepatocyte growth factor HGF1 expressed stromal cell compartment variety tissues acts neighboring epithelial cells paracrine fashion
0.25199053.11292834.html.plaintext.txt	16	HGF stimulates cell growth cell motility morphogenesis target cells binding activating specific tyrosine kinase cell surface receptor known Met 1 5
0.25199053.11292834.html.plaintext.txt	17	Gene knockout studies shown HGF essential role liver growth embryonic development 6 7
0.25199053.11292834.html.plaintext.txt	18	In adulthood HGF also plays important role supporting maintenance renewal cells various organs liver lung kidney
0.25199053.11292834.html.plaintext.txt	19	HGF gene expression regulated extracellular cues hormones cytokines 8 12
0.25199053.11292834.html.plaintext.txt	20	In vivo level HGF mRNA dramatically increases response cell loss facilitate tissue regeneration
0.25199053.11292834.html.plaintext.txt	21	For example HGF mRNA increases liver well distal organs lung spleen loss hepatic tissue induced partial hepatectomy hepatotoxin treatment
0.25199053.11292834.html.plaintext.txt	22	Similarly injury lung kidney toxins surgical procedures unilateral pneumonectomy nephrectomy respectively HGF gene expression induced organs promote regeneration 13 14
0.25199053.11292834.html.plaintext.txt	23	Several studies shown HGF gene expression controlled tightly transcriptional level
0.25199053.11292834.html.plaintext.txt	24	In vivo analyses HGF gene promoter regulation transgenic mice 15 well vitro transient transfection studies shown important regulatory elements exist proximal promoter region HGF gene 16 20
0.25199053.11292834.html.plaintext.txt	25	In recent studies partially characterized region revealed harbors composite element located position 260 230 bp transcriptional start site
0.25199053.11292834.html.plaintext.txt	26	We showed composite site binds members nuclear factor 1 NF1 activating protein 2 AP2 upstream stimulatory factor USF families regulate HGF gene transcription
0.25199053.11292834.html.plaintext.txt	27	Functional studies show NF1 AP2 suppress activity HGF gene promoter whereas USF activating function 21 22
0.25199053.11292834.html.plaintext.txt	28	In present studies discovered region 260 230 also harbors functional PPAR responsive element 246 233 bp 1 site HGF gene promoter sequence GGGCCAGGTGACCT
0.25199053.11292834.html.plaintext.txt	29	This apparently novel PPAR site inverted RGGTCA motif two spacer IR2 rather well described DR1 direct RGGTCA motif one spacer 23 24
0.25199053.11292834.html.plaintext.txt	30	Gel mobility shift supershift assays using nuclear extracts various sources whole liver isolated non parenchymal liver cells fibroblast cell lines vitro translated PPAR1 PPAR2 protein demonstrated element binds nuclear receptor PPAR family
0.25199053.11292834.html.plaintext.txt	31	Additionally found COUP TF orphan nuclear receptor also binds nuclear hormone binding site negates stimulatory effects PPAR
0.25199053.11292834.html.plaintext.txt	32	Functional studies revealed PPAR ligand 15 deoxy PGJ2 strongly stimulates HGF promoter activity
0.25199053.11292834.html.plaintext.txt	33	On hand NF1 AP2 transcription factors repress stimulatory function PPAR competing PPAR individual overlapping binding sites present within composite element
0.25199053.11292834.html.plaintext.txt	34	Moreover first time studies demonstrated PPAR ligand 15 deoxy PGJ2 induces expression endogenous HGF mRNA protein cultured fibroblasts
0.25199053.11292834.html.plaintext.txt	35	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.25199053.11292834.html.plaintext.txt	36	7 mouse HGF CAT promoter construct 699 29 bp described earlier work laboratory 16
0.25199053.11292834.html.plaintext.txt	37	7 HGF CATNF1 M NF1 binding site mutated created sequential PCR mutagenesis method 21
0.25199053.11292834.html.plaintext.txt	38	COUP TFI AP2 expression vectors gifts Dr
0.25199053.11292834.html.plaintext.txt	39	Tsai Baylor Medical College Dr
0.25199053.11292834.html.plaintext.txt	40	Buettner University Regensberg Germany respectively
0.25199053.11292834.html.plaintext.txt	41	COUP TFI vitro expression vectors Dr
0.25199053.11292834.html.plaintext.txt	42	Xiao Kan Zhang University San Diego San Diego CA
0.25199053.11292834.html.plaintext.txt	43	Bin Gao Medical College Virginia generously provided NF1X expression vector
0.25199053.11292834.html.plaintext.txt	44	Mouse PPAR1 PPAR2 PPAR expression vectors well RXR generous gifts Dr
0.25199053.11292834.html.plaintext.txt	45	Bruce Spiegelman Dana Farber Cancer Institute Harvard Medical School Boston MA
0.25199053.11292834.html.plaintext.txt	46	Preparation Nuclear Extracts Mouse NIH3T3 3T3 L1 fibroblasts originally obtained American Type Culture Collection Manassas VA cultured conditions suggested American Type Culture Collection
0.25199053.11292834.html.plaintext.txt	47	Cells grown 90 confluence washed twice cold phosphate buffered saline scraped rubber policeman buffer
0.25199053.11292834.html.plaintext.txt	48	Nuclear protein extracts prepared described previously 20
0.25199053.11292834.html.plaintext.txt	49	Rat liver non parenchymal cells prepared collagenase perfused rat liver followed centrifugation 50 x g remove hepatocytes provided Dr
0.25199053.11292834.html.plaintext.txt	50	Michalopoulos department
0.25199053.11292834.html.plaintext.txt	51	They used prepare nuclear protein extract
0.25199053.11292834.html.plaintext.txt	52	A rat liver stellate cell line Ito cell line kindly provided Dr
0.25199053.11292834.html.plaintext.txt	53	Rojkind Albert Einstein College Medicine cultured described previously 25 26
0.25199053.11292834.html.plaintext.txt	54	For preparation mouse liver nuclear protein extracts livers removed mice homogenized buffer A containing protease inhibitors 20
0.25199053.11292834.html.plaintext.txt	55	The nuclei collected nuclear proteins extracted method described
0.25199053.11292834.html.plaintext.txt	56	DNA Transfection CAT Assay Mouse 3T3 L1 fibroblasts cultured 6 well plates 24 h transfected various mouse HGF promoter CAT chimerical plasmids using DNA calcium phosphate method according instructions CellPhect transfection kit Amersham Pharmacia Biotech described previously 19
0.25199053.11292834.html.plaintext.txt	57	The galactosidase reference plasmid pCH110 Amersham Pharmacia Biotech used internal control monitoring transfection efficiency normalizing data accordingly
0.25199053.11292834.html.plaintext.txt	58	The amount plasmid used per well transfection follows 5 microg one chimerical CAT construct 1 microg pCH110
0.25199053.11292834.html.plaintext.txt	59	After coprecipitation cells DNA calcium phosphate 16 h serum containing medium cells washed twice serum free medium kept serum containing medium additional 24 h harvesting determination CAT activity
0.25199053.11292834.html.plaintext.txt	60	CAT activity determined described previously 19 20
0.25199053.11292834.html.plaintext.txt	61	Transfections performed least three separate times two independent preparations purified plasmid DNA
0.25199053.11292834.html.plaintext.txt	62	For cotransfection COUP TFI AP2 NF1X RXR PPAR1 3T3 L1 cells amount plasmid used per well transfection follows 5 microg one chimerical CAT construct 1 microg pCH110 different amounts expression plasmids
0.25199053.11292834.html.plaintext.txt	63	The total amount DNA per well equilibrated addition corresponding empty insert expression plasmid
0.25199053.11292834.html.plaintext.txt	64	Oligonucleotides Antibodies The following oligonucleotides antibodies purchased Santa Cruz Biotechnology Inc
0.25199053.11292834.html.plaintext.txt	65	used gel mobility shift supershift assays NF1 5 TTTTGGATTGAAGCCAATATGATAA 3 USF 5 CACCCGGTCACGTGGCCTACACC 3 RXRE DR 1 5 AGCTTCAGGTCAGAGGTCAGAGAGCT 3 anti PPAR anti PPAR anti Sp1 anti RXR anti thyroid hormone anti COUP TF react COUP TFI COUP TFII anti nerve growth factor induced B anti vitamin D receptor antibodies
0.25199053.11292834.html.plaintext.txt	66	Gel Retardation Assays The double stranded oligonucleotides used gel mobility shift assays labeled 32PdCTP end labeling Klenow fragment DNA polymerase
0.25199053.11292834.html.plaintext.txt	67	The labeled oligonucleotide probes gel purified used gel mobility shift assays described previously 21
0.25199053.11292834.html.plaintext.txt	68	Two microg polydI dC Amersham Pharmacia Biotech used nonspecific competitor 10 microl reaction mixture
0.25199053.11292834.html.plaintext.txt	69	When antibodies supershift used 1 microl incubated nuclear extracts room temperature 20 min performing DNA binding shift assays
0.25199053.11292834.html.plaintext.txt	70	The binding reactions carried room temperature another 20 min loading onto 5 nondenaturing polyacrylamide 191 acrylamidebisacrylamide gels
0.25199053.11292834.html.plaintext.txt	71	The amount nuclear protein extract used reaction 4 microg labeled probe 0
0.25199053.11292834.html.plaintext.txt	72	For competition experiments 100 fold molar excess unlabeled oligonucleotides included reaction mixtures
0.25199053.11292834.html.plaintext.txt	73	001 M EDTA constant voltage 210 V dried autoradiographed intensifying screens
0.25199053.11292834.html.plaintext.txt	74	RNA Isolation Analysis Total RNA isolated using RNAzol B solution CinnaBiotecx Friendswood TX according manufacturers instructions
0.25199053.11292834.html.plaintext.txt	75	The RNA concentration determined measuring absorbance 260 nm
0.25199053.11292834.html.plaintext.txt	76	For quantitative RT PCR 1 microg total RNA reverse transcribed using AMV reverse transcriptase Roche Molecular Biochemicals reverse transcriptase reaction amplified 25 cycles number cycles optimized ensure quantitative assessment could performed Taq DNA polymerase Roche Molecular Biochemicals per manufacturers instructions using primers specific HGF sense 5 ATCAGACACCACACCGGCACAAAT 3 antisense 5 GAAATAGGGCAATAATCCCAAGGAA 3 actin CLONTECH Laboratories
0.25199053.11292834.html.plaintext.txt	77	actin served RNA integrity normalization control
0.25199053.11292834.html.plaintext.txt	78	In Vitro TranscriptionTranslation A transcription translation coupled reticulocyte lysate system used prepare vitro translated COUP TFI mouse PPAR1 PPAR2 PPAR mRXR proteins cognate expression vectors driven T7 promoter 27
0.25199053.11292834.html.plaintext.txt	79	Transcriptiontranslation reactions carried 50 microl reaction volume recommended supplier Promega
0.25199053.11292834.html.plaintext.txt	80	The authenticity translation products always confirmed parallel experiments including radioactive 35Smethionine radioactive 35Scysteine translation reaction followed SDS polyacrylamide gel electrophoresis autoradiography
0.25199053.11292834.html.plaintext.txt	81	Translation reactions using empty vectors always included negative controls analyses including gel shift assays exclude potential false signals
0.25199053.11292834.html.plaintext.txt	82	Translation products stored 80 degrees C
0.25199053.11292834.html.plaintext.txt	83	For gel mobility shift assay 1 microl used translated reaction
0.25199053.11292834.html.plaintext.txt	84	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.25199053.11292834.html.plaintext.txt	85	Identification Binding Site PPAR Transcription Factor HGF Gene Promoter Our recent studies HGF promoter revealed proximal promoter region position 260 230 multifunctional composite site different transcription factors NF1 USF AP2 bind regulate HGF gene transcription 21 22
0.25199053.11292834.html.plaintext.txt	86	During studies found distinct factors also specifically bind element related NF1 USF AP2 families 21
0.25199053.11292834.html.plaintext.txt	87	Within 30 bp region 260 230 promoter identified RGGTCA hexanucleotide motifs potential binding sites nuclear hormone receptor superfamily 23 28
0.25199053.11292834.html.plaintext.txt	88	To characterize composite binding site cognate transcription factors radiolabeled HGF promoter composite element 260 230 32P used oligonucleotide probe perform gel mobility band shift assays
0.25199053.11292834.html.plaintext.txt	89	In experiments nuclear protein extracts 3T3 L1 NIH3T3 fibroblast cell lines used
0.25199053.11292834.html.plaintext.txt	90	1 DNA element forms several specific complexes major complexes shown large arrow head efficiently abrogated excess amount binding site NF1 compare lane 2 lane 4 lane 7 lane 9 respectively
0.25199053.11292834.html.plaintext.txt	91	The remaining two complexes labeled figure C1 C2 formed nuclear protein extract NIH3T3 cells abolished excess amount USF nuclear hormone binding sites RXRE respectively Fig
0.25199053.11292834.html.plaintext.txt	92	We previously shown super shift assays major complexes C contain NF1 isoforms C1 complex composed USF1 USF2 isoforms 21
0.25199053.11292834.html.plaintext.txt	93	1 3T3 L1 fibroblasts detectable C1 form C2 complex totally abrogated RXRE DR1 direct AGGTCA repeat one spacing Fig
0.25199053.11292834.html.plaintext.txt	94	Thus results extend previous observation demonstrate complex C2 may contain nuclear hormone receptors competed binding site AGGTCA motif please see Ref
0.25199053.11292834.html.plaintext.txt	95	To better define binding site complex C2 several mutant versions promoter element synthesized see Fig
0.25199053.11292834.html.plaintext.txt	96	2E nucleotide sequences used competitors electrophoretic mobility band shift assays using NF1 depleted 3T3 L1 nuclear protein extracts
0.25199053.11292834.html.plaintext.txt	97	2A deletion 11 base pairs 5 region notable effect binding activity oligonucleotides still effectively competed radiolabeled wild type probe Fig
0.25199053.11292834.html.plaintext.txt	98	2A lanes 3 4 oligonucleotides designated S1 S2
0.25199053.11292834.html.plaintext.txt	99	However six nucleotides 3 region truncated resulting oligonucleotide totally lost competitive ability Fig
0.25199053.11292834.html.plaintext.txt	100	These results revealed binding site C2 249 230
0.25199053.11292834.html.plaintext.txt	101	Close examination promoter element 249 230 indicated harbors potential RGGTCA inverted repetitive sequence separated two nucleotides IR2 Fig
0.25199053.11292834.html.plaintext.txt	102	The AGGTCA site known perfect nuclear hormone binding half site although almost every case variation sequence known imperfect motif 28
0.25199053.11292834.html.plaintext.txt	103	Indeed comparison nucleotide sequence 31 base pair element among mouse rat human HGF promoters revealed perfect conservation site Fig
0.25199053.11292834.html.plaintext.txt	104	To define binding site C2 complex detail several mutated oligonucleotides synthesized used gel shift competition assays using fibroblast nuclear extracts Fig
0.25199053.11292834.html.plaintext.txt	105	Mutations AGGTCA half site 3 region abolished binding capability mutant oligonucleotides named M4 M5 AGGTCA mutated AGGGAC CTTTCA respectively Fig
0.25199053.11292834.html.plaintext.txt	106	Conservative mutations 5 half site RGGTCA motif GGGCCA AAGCCA GGGAAA also mutations two spacers GG AT oligonucleotides named M1 M2 M3 respectively dramatically affect binding oligonucleotides still competed labeled probe binding Fig
0.25199053.11292834.html.plaintext.txt	107	However mutation 5 half site totally changes hexanucleotide GGGCCA TTTGGC completely abolished binding activity Fig
0.25199053.11292834.html.plaintext.txt	108	To define role two spacers IR2 configuration generated additional mutant oligonucleotides indicated Fig
0.25199053.11292834.html.plaintext.txt	109	2E used competitors
0.25199053.11292834.html.plaintext.txt	110	2D deleting one spacer nucleotides GG dramatically reduced binding activity Fig
0.25199053.11292834.html.plaintext.txt	111	On hand mutating two putative spacers GG TT affect binding activity Fig
0.25199053.11292834.html.plaintext.txt	112	These results implied RGGTCA half sites two spacer configuration important binding complex C2 region
0.25199053.11292834.html.plaintext.txt	113	As mentioned well known RGGTCA binding half site members nuclear receptor superfamily 23 28
0.25199053.11292834.html.plaintext.txt	114	Therefore several antibodies members nuclear receptor superfamily used identify complex C2 supershift assays using fibroblast nuclear extract antibodies retinoic acid receptor OR 1 thyroid hormone receptor COUP TF vitamin D receptor nerve growth factor induced B
0.25199053.11292834.html.plaintext.txt	115	None antibodies reacted C2 complex data shown
0.25199053.11292834.html.plaintext.txt	116	Further analysis using additional antibodies nuclear receptors revealed anti PPAR antibody reacted totally supershifted complex C2 formed fibroblast nuclear extracts Fig
0.25199053.11292834.html.plaintext.txt	117	Neither anti RXR antibody unrelated antibody anti Sp1 see Fig
0.25199053.11292834.html.plaintext.txt	118	3 lanes 4 8 reacted complex C2
0.25199053.11292834.html.plaintext.txt	119	Taken together data clearly show PPAR binds HGF promoter element located 246 233 bp transcription start site
0.25199053.11292834.html.plaintext.txt	120	View larger version 21K Fig
0.25199053.11292834.html.plaintext.txt	121	Identification nuclear receptor binding site composite regulatory element HGF promoter region
0.25199053.11292834.html.plaintext.txt	122	Synthetic oligonucleotides corresponding 31 bp DNA fragment 260 230 bp HGF gene promoter labeled 32P incubated nuclear protein extract NPE NIH3T3 3T3 L1 fibroblasts
0.25199053.11292834.html.plaintext.txt	123	The binding reactions performed room temperature 20 min presence nonspecific competitor polydI dC
0.25199053.11292834.html.plaintext.txt	124	Consensus NF1 USF RXRE DR1 well unlabeled self double stranded oligonucleotides used competitors
0.25199053.11292834.html.plaintext.txt	125	The complexes labeled C indicated large arrow contain NF1 isoforms complex labeled C1 contains USF1 USF2 21 C2 complex contains putative nuclear receptor F denotes free 32P labeled oligonucleotide probe
0.25199053.11292834.html.plaintext.txt	126	View larger version 38K Fig
0.25199053.11292834.html.plaintext.txt	127	Characterization binding motifs nuclear receptor HGF promoter regulatory region
0.25199053.11292834.html.plaintext.txt	128	A truncated shortened 5 3 ends indicated E oligonucleotides S1 S2 S3 corresponding promoter element synthesized used competitors gel mobility competition assays using NF1 depleted nuclear protein extract 3T3 L1 fibroblasts wild type HGF promoter element 260 230 probe
0.25199053.11292834.html.plaintext.txt	129	B analysis potential RGGTCA motifs within regulatory region 260 230 bp mouse HGF gene promoter
0.25199053.11292834.html.plaintext.txt	130	RGGTCA inverted repeats separated two nucleotides IR2 identified indicated arrows
0.25199053.11292834.html.plaintext.txt	131	For comparison nucleotide sequences rat human HGF promoter element also presented
0.25199053.11292834.html.plaintext.txt	132	The functional binding sites NF1 USF AP2 E box
0.25199053.11292834.html.plaintext.txt	133	USF binding site also shown
0.25199053.11292834.html.plaintext.txt	134	C mutated oligonucleotides M1 M5 sequence information please see E synthesized used competitors described A
0.25199053.11292834.html.plaintext.txt	135	D S2 oligonucleotide labeled used probe NIH3T3 nuclear extracts define IR2 site
0.25199053.11292834.html.plaintext.txt	136	The nuclear extract used gel shift assay depleted NF1
0.25199053.11292834.html.plaintext.txt	137	The DR1 site direct AGGTCA motif one spacing also used competitor
0.25199053.11292834.html.plaintext.txt	138	E nucleotide sequences wild type mutant versions promoter element used define PPAR binding site shown
0.25199053.11292834.html.plaintext.txt	139	The mutated nucleotides underlined
0.25199053.11292834.html.plaintext.txt	140	Self competitor wild type unlabeled probe used positive control
0.25199053.11292834.html.plaintext.txt	141	View larger version 27K Fig
0.25199053.11292834.html.plaintext.txt	142	Identification nuclear receptor PPAR binding motif IR2
0.25199053.11292834.html.plaintext.txt	143	Supershift assays complex C2 bound HGF promoter regulatory element using antibodies various nuclear receptors indicated figure
0.25199053.11292834.html.plaintext.txt	144	NF1 depleted nuclear protein extracts NIH3T3 fibroblasts 3T3 L1 fibroblasts used indicated figure
0.25199053.11292834.html.plaintext.txt	145	C1 denotes complex C1 C2 denotes complex C2 F denotes free probe S denotes supershift complex
0.25199053.11292834.html.plaintext.txt	146	Regulatory Function PPAR Its Ligand 15 Deoxy PGJ2 HGF Gene Promoter Activity To demonstrate whether PPAR binding site binding transcription factor PPAR regulatory function HGF gene promoter performed cotransfection experiments HGF CAT promoter constructs PPAR1 expression vector
0.25199053.11292834.html.plaintext.txt	147	Because PPAR binding site overlaps NF1 USF shown NF1 strongly suppresses HGF gene promoter activity 21 decided eliminate interference NF1 PPAR function
0.25199053.11292834.html.plaintext.txt	148	To two different HGF CAT constructs generated used wild type 0
0.25199053.11292834.html.plaintext.txt	149	7 HGF CAT construct mutated version 0
0.25199053.11292834.html.plaintext.txt	150	7 HGF CATNF1 M construct NF1 site mutated PPAR binding site remains intact
0.25199053.11292834.html.plaintext.txt	151	1 HGF CAT NF1 PPAR binding sites also used negative control
0.25199053.11292834.html.plaintext.txt	152	We selected 3T3 L1 cell line nuclear protein extract cell line form USF complex C1 see Figs
0.25199053.11292834.html.plaintext.txt	153	1 3 element may interfere PPAR function
0.25199053.11292834.html.plaintext.txt	154	4 15 deoxy PGJ2 PPAR ligand significantly induced promoter activities 0
0.25199053.11292834.html.plaintext.txt	155	7 HGF CATNF1 M constructs 0
0.25199053.11292834.html.plaintext.txt	156	Overexpression PPAR1 treatment ligand 15 deoxy PGJ2 even stronger stimulatory effect 0
0.25199053.11292834.html.plaintext.txt	157	7 HGF CATNF1 M constructs Fig
0.25199053.11292834.html.plaintext.txt	158	It believed RXR functional partner PPAR heterodimer formation 28
0.25199053.11292834.html.plaintext.txt	159	Even though see obvious supershift complex anti RXR antibody using fibroblast nuclear extracts see Fig
0.25199053.11292834.html.plaintext.txt	160	3 possible nuclear protein extracts NIH3T3 3T3 L1 cells contain sufficient amount RXR binding activity
0.25199053.11292834.html.plaintext.txt	161	In fact show HGF PPAR element binds PPAR RXR using liver nuclear protein extract presumably rich RXR see
0.25199053.11292834.html.plaintext.txt	162	To find whether RXR regulate HGF gene promoter binding IR2 element partner PPAR RXR expression vector ligand 9 cis RA used cotransfection CAT assay experiments using fibroblast cell line
0.25199053.11292834.html.plaintext.txt	163	4 9 cis RA modest effect combination 9 cis RA plus receptor RXR strongly stimulated HGF promoter activity similar 15 deoxy PGJ2 receptor PPAR
0.25199053.11292834.html.plaintext.txt	164	The strongest induction promoter achieved cotransfection PPAR RXR expression vectors presence 15 deoxy PGJ2 PPAR ligand 9 cis RA RXR ligand Fig
0.25199053.11292834.html.plaintext.txt	165	Because PPARRXR could induce promoter activity 0
0.25199053.11292834.html.plaintext.txt	166	7 HGF CATNF1 M construct results indicate PPARRXR may indirectly via competing NF1 binding also directly stimulate HGF promoter binding functional RGGTCA motif HGF proximal promoter
0.25199053.11292834.html.plaintext.txt	167	View larger version 30K Fig
0.25199053.11292834.html.plaintext.txt	168	Functional analysis PPAR binding site HGF gene promoter
0.25199053.11292834.html.plaintext.txt	169	Wild type HGF CAT reporter construct 0
0.25199053.11292834.html.plaintext.txt	170	7 HGF CAT mutated HGF CAT reporter plasmid 0
0.25199053.11292834.html.plaintext.txt	171	7 HGF CATNF1 M harbors mutation NF1 binding site used determine function PPAR activity HGF promoter
0.25199053.11292834.html.plaintext.txt	172	3T3 L1 cells transiently transfected HGF CAT constructs described
0.25199053.11292834.html.plaintext.txt	173	For cotransfection 5 microg RXR PPAR1 expression vectors per reaction added
0.25199053.11292834.html.plaintext.txt	174	RXR ligand 9 cis RA PPAR ligand 15 deoxy PGJ2 also added activate cognate receptors
0.25199053.11292834.html.plaintext.txt	175	1 HGF CAT construct used negative control
0.25199053.11292834.html.plaintext.txt	176	The data presented relative CAT activity percent conversion three independent experiments performed duplicate
0.25199053.11292834.html.plaintext.txt	177	Error bars represent standard deviation
0.25199053.11292834.html.plaintext.txt	178	Binding Nuclear Hormone Element RXR PPAR COUP TF Liver Tissue Related Cells It well known HGF gene expressed mesenchymal epithelial cells given tissue
0.25199053.11292834.html.plaintext.txt	179	In liver HGF expressed non parenchymal mesenchymal cells especially stellate cells also known Ito cells lipocytes store lipids vitamin A
0.25199053.11292834.html.plaintext.txt	180	We tested whether HGF promoter element could bind PPAR possibly transcription factors present non parenchymal liver cells
0.25199053.11292834.html.plaintext.txt	181	Nuclear protein extracts whole liver cells isolated liver freshly isolated non parenchymal cells well Ito cell line 25 26 prepared
0.25199053.11292834.html.plaintext.txt	182	We subjected extracts gel mobility shift assay using HGF promoter composite site probe
0.25199053.11292834.html.plaintext.txt	183	The probe bound PPAR present three different nuclear protein extracts shown supershift assays Fig
0.25199053.11292834.html.plaintext.txt	184	5 lanes 2 7 data shown whole liver
0.25199053.11292834.html.plaintext.txt	185	A surprising finding experiments element could also strongly bind COUP TF member orphan nuclear receptor subfamily also binds RGGTCA motif see Fig
0.25199053.11292834.html.plaintext.txt	186	The fact anti COUP TF totally supershifted C2 complex whereas anti PPAR partially Fig
0.25199053.11292834.html.plaintext.txt	187	5 compare lanes 2 3 suggests PPAR COUP TF may form heterodimers HGF promoter element
0.25199053.11292834.html.plaintext.txt	188	Of course known COUP TF also forms homodimers thus likely C2 complex nuclear extract liver cells mainly composed COUP TF homodimer well COUP TF PPAR heterodimers
0.25199053.11292834.html.plaintext.txt	189	On hand C2 complex produced fibroblast nuclear extracts lacks COUP TF react anti COUP TF data shown also see Fig
0.25199053.11292834.html.plaintext.txt	190	Anti RXR antibody also used experiments RXR believed partner PPAR mentioned
0.25199053.11292834.html.plaintext.txt	191	We detect weak RXR binding element nuclear protein extracts whole liver tissue shifted band faint required long exposure film data shown
0.25199053.11292834.html.plaintext.txt	192	Taken together results imply PPAR binding site HGF gene promoter also binds COUP TF RXR depending cell typestissues analyzed
0.25199053.11292834.html.plaintext.txt	193	fibroblasts versus liver cells
0.25199053.11292834.html.plaintext.txt	194	View larger version 61K Fig
0.25199053.11292834.html.plaintext.txt	195	The IR2 element HGF promoter composite site binds nuclear receptors PPAR COUP TF present nuclear protein extracts liver cells
0.25199053.11292834.html.plaintext.txt	196	Supershift assays carried using various antibodies indicated nuclear protein extracts Ito cell line derived rat liver freshly isolated non parenchymal rat liver cells NPC
0.25199053.11292834.html.plaintext.txt	197	In experiment HGF promoter composite element used probe
0.25199053.11292834.html.plaintext.txt	198	Unlabeled probe cold self used competitor confirm specificity
0.25199053.11292834.html.plaintext.txt	199	S denotes supershifted complex
0.25199053.11292834.html.plaintext.txt	200	To confirm COUP TF truly binds HGF proximal promoter composite element vitro translated COUP TF transcription factor prepared used gel mobility shift assays
0.25199053.11292834.html.plaintext.txt	201	Indeed vitro translated COUP TF could specifically avidly bind region shown Fig
0.25199053.11292834.html.plaintext.txt	202	Unlabeled excess probe totally competed complex Fig
0.25199053.11292834.html.plaintext.txt	203	Moreover anti COUP TF antibody reacted shifted complex Fig
0.25199053.11292834.html.plaintext.txt	204	On hand anti PPAR antibody react complex Fig
0.25199053.11292834.html.plaintext.txt	205	These results prove COUP TF binds specifically region
0.25199053.11292834.html.plaintext.txt	206	To define binding motifs COUP TF region gel shift competition assays performed using truncated oligonucleotides S1 S3 mutated oligonucleotides M1 M5 see Fig
0.25199053.11292834.html.plaintext.txt	207	S1 oligonucleotide retained binding activity
0.25199053.11292834.html.plaintext.txt	208	S2 oligonucleotide retained binding ability S3 oligonucleotide totally lost binding ability COUP TF data shown
0.25199053.11292834.html.plaintext.txt	209	Similarly competitive ability M1 M2 M3 mutated oligonucleotides reduced modestly
0.25199053.11292834.html.plaintext.txt	210	However binding ability COUP TF totally abrogated AGGTCA motif 3 end element mutated oligonucleotides M4 M5 data shown
0.25199053.11292834.html.plaintext.txt	211	Combining results conclude COUP TF also binds composite site regulatory region HGF gene promoter see Fig
0.25199053.11292834.html.plaintext.txt	212	It added specific binding PPAR isoforms PPAR1 PPAR2 HGF promoter element also confirmed series gel mobility band shift super shift assays using vitro translated mouse PPAR1 PPAR2 RXR data shown
0.25199053.11292834.html.plaintext.txt	213	View larger version 18K Fig
0.25199053.11292834.html.plaintext.txt	214	Characterization COUP TF binding motif HGF promoter composite element
0.25199053.11292834.html.plaintext.txt	215	In vitro translated COUP TFI protein used experiments
0.25199053.11292834.html.plaintext.txt	216	Supershift assays performed antibody COUP TF wild type HGF promoter element probe
0.25199053.11292834.html.plaintext.txt	217	Self competitor used show specific binding COUP TFI element
0.25199053.11292834.html.plaintext.txt	218	Antibody PPAR used negative control
0.25199053.11292834.html.plaintext.txt	219	The COUP TF1 complex indicated arrow
0.25199053.11292834.html.plaintext.txt	220	S denotes supershift complex
0.25199053.11292834.html.plaintext.txt	221	Negative controls vitro translation product empty vector control subjected vitro translation reaction gel shift assays also carried also ensure specificity data shown
0.25199053.11292834.html.plaintext.txt	222	Modulation PPAR Function HGF Gene Promoter COUP TF NF1 AP2 Because data showed COUP TF binds binding site PPAR reasonable suppose COUP TF homodimers could modify stimulatory function PPARRXR competing one another common binding site
0.25199053.11292834.html.plaintext.txt	223	Additionally published data demonstrate COUP TF form heterodimers RXR solution absence binding site
0.25199053.11292834.html.plaintext.txt	224	In manner COUP TF sequesters RXR preventing PPARRXR heterodimer formation stimulatory function PPARRXR
0.25199053.11292834.html.plaintext.txt	225	Furthermore binding sites COUP TF PPARRXR overlap binding sites suppressive transcription factors NF1 AP2
0.25199053.11292834.html.plaintext.txt	226	Therefore functionality unique composite element regulate HGF gene expression given tissue cell may dependent specific combination andor various concentrations transcription factors
0.25199053.11292834.html.plaintext.txt	227	To show individual functions transcription factors interact exert effects used 0
0.25199053.11292834.html.plaintext.txt	228	3 HGF CAT promoter construct basal promoter proximal region HGF promoter composite site containing NF1 AP2 IR2 binding motifs
0.25199053.11292834.html.plaintext.txt	229	1 HGF CAT construct negative control contains basal promoter
0.25199053.11292834.html.plaintext.txt	230	7 COUP TF dose dependently repressed stimulatory function PPARRXR HGF gene promoter 0
0.25199053.11292834.html.plaintext.txt	231	It significant repressive function 0
0.25199053.11292834.html.plaintext.txt	232	In similar experiments using expression vectors NF1X isoform AP2 co transfected HGF CAT constructs found also inhibited stimulatory function PPARRXR HGF gene promoter 0
0.25199053.11292834.html.plaintext.txt	233	3 HGF CAT construct 0
0.25199053.11292834.html.plaintext.txt	234	1 HGF CAT construct data shown
0.25199053.11292834.html.plaintext.txt	235	In experiments empty vector controls effect activity either HGF CAT construct data shown
0.25199053.11292834.html.plaintext.txt	236	These experiments indicate NF1 AP2 COUP TFI could individually regulate stimulatory function PPARRXR HGF gene expression may competing PPARRXR overlapping composite binding site HGF proximal promoter region
0.25199053.11292834.html.plaintext.txt	237	View larger version 48K Fig
0.25199053.11292834.html.plaintext.txt	238	Repression stimulatory function PPAR COUP TFI HGF gene promoter
0.25199053.11292834.html.plaintext.txt	239	1 HGF CAT reporter plasmids cotransfected along 2 microg PPAR1 2 microg RXR increasing amounts COUP TFI expression vector 3T3 L1 fibroblast cell line
0.25199053.11292834.html.plaintext.txt	240	The activity promoter construct determined expressed relative CAT activity normalized galactosidase
0.25199053.11292834.html.plaintext.txt	241	The results three independent experiments performed duplicate
0.25199053.11292834.html.plaintext.txt	242	Error bars represent standard error mean
0.25199053.11292834.html.plaintext.txt	243	Induction Endogenous HGF mRNA Protein Expression PPAR Ligand 15 Deoxy PGJ2 To determine whether 15 deoxy PGJ2 induce endogenous HGF gene expression mRNA protein levels treated fibroblasts naturally express PPAR 15 deoxy PGJ2 determined level HGF mRNA semi quantitative RT PCR level HGF protein sensitive sandwich enzyme linked immunosorbent assay
0.25199053.11292834.html.plaintext.txt	244	The results demonstrated HGF expression significantly regulated treatment 15 deoxy PGJ2 Fig
0.25199053.11292834.html.plaintext.txt	245	View larger version 17K Fig
0.25199053.11292834.html.plaintext.txt	246	Induction endogenous HGF mRNA protein PPAR ligand 15 deoxy PGJ2 fibroblasts
0.25199053.11292834.html.plaintext.txt	247	A total mRNA isolated 3T3 L1 cells treated 15 deoxy PGJ2 different lengths time indicated
0.25199053.11292834.html.plaintext.txt	248	Semi quantitative RT PCR carried described Materials Methods
0.25199053.11292834.html.plaintext.txt	249	The size internal control actin 870 bp bottom panel
0.25199053.11292834.html.plaintext.txt	250	RT PCR HGF yields 300 bp HGF product top panel
0.25199053.11292834.html.plaintext.txt	251	The left lane molecular weight marker X174HaeIII
0.25199053.11292834.html.plaintext.txt	252	B MRC 5 human fibroblasts cultured 6 well plates treated without control 15 deoxy PGJ2 duplicates
0.25199053.11292834.html.plaintext.txt	253	Culture medium collected indicated time points subjected sensitive sandwich enzyme linked immunosorbent assay using R D HGF enzyme linked immunosorbent assay kit
0.25199053.11292834.html.plaintext.txt	254	The amounts HGF determined culture medium standard curve using pure HGF standard recommended supplier
0.25199053.11292834.html.plaintext.txt	255	Asterisks indicate statistically significant differences control treated samples p 0
0.25199053.11292834.html.plaintext.txt	256	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.25199053.11292834.html.plaintext.txt	257	In study demonstrated nuclear receptors PPAR COUP TF bind composite regulatory element HGF upstream promoter region located 246 233 bp transcription start site
0.25199053.11292834.html.plaintext.txt	258	This binding site also overlapsharbors functional binding sites NF1 AP2 USF family transcription factors 21 22 together constitute multifunctional composite site various transcription factors bind regulate activity HGF promoter
0.25199053.11292834.html.plaintext.txt	259	Cotransfection assays showed PPAR1 partner RXR presence corresponding ligands 15 deoxy PGJ2 9 cis RA respectively strongly stimulated HGF promoter activity
0.25199053.11292834.html.plaintext.txt	260	NF1 AP2 COUP TFI suppressed stimulatory function PPAR competing individual binding sites
0.25199053.11292834.html.plaintext.txt	261	Moreover demonstrated 15 deoxy PGJ2 ligand PPAR induces expression endogenous HGF gene mRNA protein levels cultured fibroblasts
0.25199053.11292834.html.plaintext.txt	262	PPAR member nuclear receptor superfamily includes receptors steroid thyroid retinoid hormones 23 28
0.25199053.11292834.html.plaintext.txt	263	It known three related quite distinct PPAR proteins PPAR PPAR PPAR
0.25199053.11292834.html.plaintext.txt	264	Two forms PPAR 1 2 exist products alternative promoter usage 29 30
0.25199053.11292834.html.plaintext.txt	265	Like members superfamily PPAR contains central DNA binding domain binds cis acting element promoter target genes
0.25199053.11292834.html.plaintext.txt	266	Most PPAR response elements described composed directly repeating core site separated one nucleotide RGGTCA N RGGTCA called DR1 24 28
0.25199053.11292834.html.plaintext.txt	267	Interestingly PPAR response element HGF promoter region inverted repeating core site separated two nucleotides GGGCCA NN TGACCT called IR2
0.25199053.11292834.html.plaintext.txt	268	Published data indicate PPAR heterodimerizes RXR PARRXR heterodimer binds response element activates target genes 23 31
0.25199053.11292834.html.plaintext.txt	269	Our results indicated IR2 site HGF gene promoter also binds RXR though weakly
0.25199053.11292834.html.plaintext.txt	270	Generally RXR said silent partner
0.25199053.11292834.html.plaintext.txt	271	Nonetheless several examples RXR active partner 31
0.25199053.11292834.html.plaintext.txt	272	Similarly RXR PPAR RXRPPAR heterodimers bound IR2 element HGF gene promoter region independently responsive synergistically activated presence ligands 15 deoxy PGJ2 9 cis RA
0.25199053.11292834.html.plaintext.txt	273	PPAR plays essential role cell growth differentiation well oncogenesis
0.25199053.11292834.html.plaintext.txt	274	Controversies exist whether PPAR acts tumor promoter tumor suppressor
0.25199053.11292834.html.plaintext.txt	275	For example ligand activation PPAR causes colon cancer cell lines undergo differentiating response reverse malignant phenotype 32
0.25199053.11292834.html.plaintext.txt	276	Paradoxically ligand activation PPAR min mice animal model familial adenomatous polyposis seemed cause increased polyposis 33 34
0.25199053.11292834.html.plaintext.txt	277	It demonstrated loss function mutations PPAR also associated human colon cancer 35
0.25199053.11292834.html.plaintext.txt	278	It clear whether association colon cancer PPAR involved HGF expression colon cancer tissue HGF expression also aberrant colon cancer tissues
0.25199053.11292834.html.plaintext.txt	279	Additionally HGF also function paradoxically tumor suppressor tumor promoter different settings 2 3
0.25199053.11292834.html.plaintext.txt	280	Little known target genes activated PPAR present findings shed significant light matter sense HGF may mediate functions PPAR tissue growth differentiation cancer
0.25199053.11292834.html.plaintext.txt	281	Like HGF PPAR expressed various tissues predominantly mesenchymal cells namely adipocytesfibroblasts 36
0.25199053.11292834.html.plaintext.txt	282	Interestingly liver HGF expressed specialized fibroblastic cell type called Ito cells also known lipocytes store lipids vitamin A
0.25199053.11292834.html.plaintext.txt	283	Like HGF PPAR also expressed placenta deficiency leads placental dysfunction death E10 37
0.25199053.11292834.html.plaintext.txt	284	A qualitatively similar placental abnormality seen RXR knockout mice suggesting phenotypes may due impaired PPAR mediated signaling placenta 37
0.25199053.11292834.html.plaintext.txt	285	Interestingly HGF knockout mice revealed homozygous HGF mutant embryos severely impaired placentas markedly reduced numbers labyrinthine trophoblast cells embryos die birth E15 6 7
0.25199053.11292834.html.plaintext.txt	286	Combining data seems possible HGF may one mediators growth regulatory action PPARRXR
0.25199053.11292834.html.plaintext.txt	287	So far identified several functional regulatory elements binding transcription factors act HGF gene promoter Fig
0.25199053.11292834.html.plaintext.txt	288	Based current findings previous published results believe transcriptional regulation HGF gene complex dependent combination transcription factors including COUP TF CCAATenhancer binding protein Sp1 estrogen receptor NF1 AP2 USF PPAR 15 22
0.25199053.11292834.html.plaintext.txt	289	CCAATenhancer binding protein SP1 estrogen receptor USF PPAR positive regulators
0.25199053.11292834.html.plaintext.txt	290	COUP TF AP2 NF1 mainly negative regulators
0.25199053.11292834.html.plaintext.txt	291	COUP TFs compete estrogen receptor PPAR respective binding sites suppress stimulatory functions estrogen receptor PPAR presence ligands estrogen 15 deoxy PGJ2 respectively
0.25199053.11292834.html.plaintext.txt	292	This result implies COUP TFs NF1 family play important role regulation HGF gene expression
0.25199053.11292834.html.plaintext.txt	293	As mentioned PPAR CCAATenhancer binding protein believed play important role adipocyte differentiation 38
0.25199053.11292834.html.plaintext.txt	294	Interestingly noted 3T3 L1 fibroblasts differentiate adipocytes placed differentiation medium marked increase PPAR CCAATenhancer binding protein binding HGF promoter elements occurred depicted Fig
0.25199053.11292834.html.plaintext.txt	295	The increase binding activity correlated well increase HGF HGF receptor Met expression cells implying HGFMet signaling system may role adipocyte differentiation
0.25199053.11292834.html.plaintext.txt	296	A summary positive negative regulators HGF gene promoter identified characterized thus far presented Fig
0.25199053.11292834.html.plaintext.txt	297	View larger version 22K Fig
0.25199053.11292834.html.plaintext.txt	298	A diagram depicting several functional cis acting elements cognate transcription factors within murine HGF promoter region
0.25199053.11292834.html.plaintext.txt	299	NHR nuclear hormone receptor Rep unknown repressor GTF general transcription factors CEBP CCAAT IL 1 interleukin 1 TNF tumor necrosis factor EGF enhancer binding protein
0.25199053.11292834.html.plaintext.txt	300	Tsai providing us COUP TFI expression vector antibody COUP TF Dr
0.25199053.11292834.html.plaintext.txt	301	Rojkind Ito cell line Dr
0.25199053.11292834.html.plaintext.txt	302	Xiao Kan Zhang vitro transcriptiontranslation vector COUP TFI Dr
0.25199053.11292834.html.plaintext.txt	303	Spiegelman PPAR RXR expression vectors
0.25199053.11292834.html.plaintext.txt	304	DeFrances critical review manuscript
0.25199053.11292834.html.plaintext.txt	305	Michalopoulos valuable discussions continuous enthusiasm course work
0.25199053.11292834.html.plaintext.txt	306	This work supported Grant R01ES 06109 NIEHS National Institutes Health R
0.25199053.11292834.html.plaintext.txt	307	The costs publication article defrayed part payment page charges
0.25199053.11292834.html.plaintext.txt	308	The article must therefore hereby marked advertisement accordance 18 U
0.25199053.11292834.html.plaintext.txt	309	Section 1734 solely indicate fact
0.25199053.11292834.html.plaintext.txt	310	To correspondence addressed Dept
0.25199053.11292834.html.plaintext.txt	311	Pathology South Biomedical Science Tower Rm
0.25199053.11292834.html.plaintext.txt	312	S411A University Pittsburgh School Medicine Pittsburgh PA 15261
0.25199053.11292834.html.plaintext.txt	313	412 648 8657 Fax 412 648 1916 E mail rezazarpitt
0.25199053.11292834.html.plaintext.txt	314	Published JBC Papers Press April 5 2001 DOI 10
0.25199053.11292834.html.plaintext.txt	315	The abbreviations used HGF hepatocyte growth factor bp base pairs NF1 nuclear factor 1 AP2 activating protein 2 USF upstream stimulatory factor PPAR peroxisome proliferator activated receptor IR inverted repeat COUP TF chicken ovalbumin upstream promoter transcription factor CAT chloramphenicol acetyltransferase PCR polymerase chain reaction RT PCR reverse transcription PCR kb kilobase pairs PGJ2 prostaglandin J2 RXR retinoic X receptor RA retinoic acid
0.25199053.11292834.html.plaintext.txt	316	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1
0.25199053.11292834.html.plaintext.txt	317	Acta 1155 357 371CrossRefMedline Order article via Infotrieve 2
0.25199053.11292834.html.plaintext.txt	318	129 1177 1180Medline Order article via Infotrieve 3
0.25199053.11292834.html.plaintext.txt	319	1997 Cytokine Growth Factor Rev
0.25199053.11292834.html.plaintext.txt	320	8 129 142CrossRefMedline Order article via Infotrieve 4
0.25199053.11292834.html.plaintext.txt	321	Tokyo 119 591 600Abstract 5
0.25199053.11292834.html.plaintext.txt	322	1997 Science 276 60 66AbstractFree Full Text 6
0.25199053.11292834.html.plaintext.txt	323	1995 Nature 373 699 702CrossRefMedline Order article via Infotrieve 7
0.25199053.11292834.html.plaintext.txt	324	1995 Nature 373 702 705CrossRefMedline Order article via Infotrieve 8
0.25199053.11292834.html.plaintext.txt	325	188 235 243Medline Order article via Infotrieve 9
0.25199053.11292834.html.plaintext.txt	326	267 24917 24920AbstractFree Full Text 10
0.25199053.11292834.html.plaintext.txt	327	268 8140 8145AbstractFree Full Text 11
0.25199053.11292834.html.plaintext.txt	328	104 173 181CrossRefMedline Order article via Infotrieve 12
0.25199053.11292834.html.plaintext.txt	329	1994 Cytokine 6 633 640Medline Order article via Infotrieve 13
0.25199053.11292834.html.plaintext.txt	330	186 991 998Medline Order article via Infotrieve 14
0.25199053.11292834.html.plaintext.txt	331	177 559 565Medline Order article via Infotrieve 15
0.25199053.11292834.html.plaintext.txt	332	273 6900 6908AbstractFree Full Text 16
0.25199053.11292834.html.plaintext.txt	333	269 4152 4160AbstractFree Full Text 17
0.25199053.11292834.html.plaintext.txt	334	270 830 836AbstractFree Full Text 18
0.25199053.11292834.html.plaintext.txt	335	1997 Oncogene 14 3039 3049CrossRefMedline Order article via Infotrieve 19
0.25199053.11292834.html.plaintext.txt	336	272 3928 3934AbstractFree Full Text 21
0.25199053.11292834.html.plaintext.txt	337	2000 Oncogene 19 2786 2790CrossRefMedline Order article via Infotrieve 22
0.25199053.11292834.html.plaintext.txt	338	272 882 886CrossRefMedline Order article via Infotrieve 23
0.25199053.11292834.html.plaintext.txt	339	1995 Cell 83 835 839Medline Order article via Infotrieve 24
0.25199053.11292834.html.plaintext.txt	340	1999 Cell 99 239 242Medline Order article via Infotrieve 25
0.25199053.11292834.html.plaintext.txt	341	69 210 216Medline Order article via Infotrieve 26
0.25199053.11292834.html.plaintext.txt	342	65 644 653Medline Order article via Infotrieve 27
0.25199053.11292834.html.plaintext.txt	343	16 1656 1669AbstractFree Full Text 28
0.25199053.11292834.html.plaintext.txt	344	1995 Cell 83 841 850Medline Order article via Infotrieve 29
0.25199053.11292834.html.plaintext.txt	345	1998 Diabetes 47 507 514Abstract 30
0.25199053.11292834.html.plaintext.txt	346	1999 Lancet 354 141 148CrossRefMedline Order article via Infotrieve 31
0.25199053.11292834.html.plaintext.txt	347	1992 Nature 358 771 774CrossRefMedline Order article via Infotrieve 32
0.25199053.11292834.html.plaintext.txt	348	4 1046 1052CrossRefMedline Order article via Infotrieve 33
0.25199053.11292834.html.plaintext.txt	349	4 1053 1057CrossRefMedline Order article via Infotrieve 34
0.25199053.11292834.html.plaintext.txt	350	4 1058 1061CrossRefMedline Order article via Infotrieve 35
0.25199053.11292834.html.plaintext.txt	351	Cell 3 799 804CrossRefMedline Order article via Infotrieve 36
0.25199053.11292834.html.plaintext.txt	352	268 26817 26820AbstractFree Full Text 37
0.25199053.11292834.html.plaintext.txt	353	Cell 4 585 595Medline Order article via Infotrieve 38
0.25199053.11292834.html.plaintext.txt	354	Copyright 2001 The American Society Biochemistry Molecular Biology Inc
0.37651846.11934895.html.plaintext.txt	0	Regulation Retinoic Acid induced Inhibition AP 1 Activity Orphan Receptor Chicken Ovalbumin Upstream Promoter Transcription Factor Feng Lin Siva Kumar Kolluri Guo quan Chen Xiao kun Zhang
0.37651846.11934895.html.plaintext.txt	1	From Burnham Institute Cancer Center La Jolla California 92037
0.37651846.11934895.html.plaintext.txt	2	Received publication February 25 2002 revised form April 2 2002
0.37651846.11934895.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.37651846.11934895.html.plaintext.txt	4	Retinoids therapeutically effective treatment various cancers therapeutic action retinoids ascribed potent inhibition AP 1 activity regulates transcription genes associated cell growth
0.37651846.11934895.html.plaintext.txt	5	We recently reported expression orphan receptor chicken ovalbumin upstream promoter transcription factor COUP TF plays role mediating growth inhibitory effect trans retinoic acid trans RA cancer cells
0.37651846.11934895.html.plaintext.txt	6	To gain insight molecular mechanism COUP TF regulates trans RA activity evaluated effect COUP TF antagonism AP 1 activity trans RA
0.37651846.11934895.html.plaintext.txt	7	Our results demonstrated positive correlation COUP TF expression ability trans RA inhibit AP 1 activity various cancer cell lines
0.37651846.11934895.html.plaintext.txt	8	In transient transfection assay expression COUP TF strongly inhibited tumor promoter 12 O tetradecanoylphorbol 13 acetate induced AP 1 transactivation activity transactivation c Junc Fos trans RA dependent independent manner
0.37651846.11934895.html.plaintext.txt	9	In vitro studies demonstrated addition COUP TF inhibited c Jun DNA binding direct protein protein interaction mediated DNA binding domain COUP TF leucine zipper c Jun
0.37651846.11934895.html.plaintext.txt	10	Stable expression COUP TF COUP TF negative MDA MB231 breast cancer cells restored ability trans RA inhibit 12 O tetradecanoylphorbol 13 acetate induced c Jun expression
0.37651846.11934895.html.plaintext.txt	11	The effect COUP TF enhancing trans RA induced antagonism AP 1 activity required expression retinoic acid receptors RARs since stable expression COUP TF COUP TF negative HT 1376 bladder cancer cells express RAR RAR failed restore trans RA induced AP 1 repression
0.37651846.11934895.html.plaintext.txt	12	Thus COUP TF physical interaction AP 1 promotes anticancer effects retinoids potentiating anti AP 1 activity
0.37651846.11934895.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.37651846.11934895.html.plaintext.txt	14	Retinoids natural synthetic vitamin A analogs exert profound effects many biological processes including cell proliferation differentiation 1 2 recognized promising agents prevention treatment various cancers
0.37651846.11934895.html.plaintext.txt	15	The effects retinoids mainly mediated two nuclear receptor classes retinoic acid receptor RAR1 retinoid X receptor RXR 3 5
0.37651846.11934895.html.plaintext.txt	16	Both encoded three different genes function ligand inducible transcription factors vivo mainly RXRRAR heterodimers
0.37651846.11934895.html.plaintext.txt	17	trans Retinoic acid trans RA binds RARs whereas 9 cis RA binds RARs RXRs
0.37651846.11934895.html.plaintext.txt	18	Binding retinoids receptors induces receptor conformational changes switch transcription genes containing RA response elements RAREs 3 5
0.37651846.11934895.html.plaintext.txt	19	In addition positive regulation RARE containing genes retinoid receptors response ligands inhibit effects induced tumor promoter 12 O tetradecanoylphorbol 13 acetate TPA transcriptional activity proto oncogenes c Jun c Fos 6 components AP 1 complex often role cancer cell proliferation 7
0.37651846.11934895.html.plaintext.txt	20	The activation AP 1 responsive genes TPA c Junc Fos TPA response elements TREs repressed retinoid receptors ligand dependent manner 8 10
0.37651846.11934895.html.plaintext.txt	21	Conversely AP 1 represses transactivation retinoid receptors 8 9
0.37651846.11934895.html.plaintext.txt	22	This mutual antagonism appears play critical role regulating cell growth differentiation 6
0.37651846.11934895.html.plaintext.txt	23	For example overexpression c Jun conferred retinoid resistance breast cancer cells 11 overexpression retinoid receptors enabled trans RA inhibit AP 1 activity ovarian cancer cells growth 12
0.37651846.11934895.html.plaintext.txt	24	The functional interaction AP 1 retinoid receptors also observed nuclear receptors including glucocorticoid receptor 13 16 thyroid hormone receptor 17 vitamin D receptor estrogen receptor 18 19 androgen receptor AR 18
0.37651846.11934895.html.plaintext.txt	25	The anti AP 1 activities shown liganded retinoid receptors appear contribute significantly therapeutic efficacy retinoids hyperproliferative diseases 6
0.37651846.11934895.html.plaintext.txt	26	Transcription various AP 1 responsive genes collagenase stromelysin roles tumor progression invasiveness 20 inhibited retinoids 8 10 reported contribute reversal human bronchial epithelial squamous differentiation 21
0.37651846.11934895.html.plaintext.txt	27	Retinyl methyl ether effectively prevents mammary cancer animals strongly suppressed AP 1 activity breast cancer cell 22
0.37651846.11934895.html.plaintext.txt	28	Interestingly RAR negative regulator cancer cell growth 23 potently inhibits AP 1 activity collagenase expression breast lung cancer cells 24
0.37651846.11934895.html.plaintext.txt	29	Recent studies demonstrate retinoids specifically inhibit AP 1 activity antagonize RAR transactivation RAREs inhibited growth many different types cancer cells 25 27
0.37651846.11934895.html.plaintext.txt	30	Anti AP 1 retinoids inhibited squamous differentiation human bronchial epithelial cells 21 TPA induced transformation clonal growth promotion sensitive JB6 mouse epidermal cell line 28 papilloma formation animals 29
0.37651846.11934895.html.plaintext.txt	31	Thus anti AP 1 activity retinoids contributes chemopreventive chemotherapeutic effects presumably blocking processes tumor promotion cell transformation
0.37651846.11934895.html.plaintext.txt	32	The mechanism retinoids inhibit AP 1 activity remains largely unclear
0.37651846.11934895.html.plaintext.txt	33	Unlike effect retinoid receptors RAREs inhibition AP 1 activity retinoid receptors independent retinoid receptor RARE interaction 8 10
0.37651846.11934895.html.plaintext.txt	34	Previous studies suggested several possible mechanisms AP 1 inhibition retinoid receptors
0.37651846.11934895.html.plaintext.txt	35	First retinoid receptors reported physically interact c Jun andor c Fos 8 9
0.37651846.11934895.html.plaintext.txt	36	This interaction results mutual inhibition DNA binding transactivation functions could explain cross talk occurring AP 1 retinoid signaling
0.37651846.11934895.html.plaintext.txt	37	However large excess either retinoid receptor protein c Jun c Fos proteins required inhibit vitro binding TRE RARE respectively 8 9
0.37651846.11934895.html.plaintext.txt	38	Because vivo footprint assay glucocorticoid receptor AP 1 interaction reveal effect DNA binding 30 whether RAR AP 1 directly interact vivo remains established
0.37651846.11934895.html.plaintext.txt	39	Subsequently suggested blocking activation Jun N terminal kinase signaling pathway activates AP 1 might responsible AP 1 inhibition retinoid nuclear receptors 31
0.37651846.11934895.html.plaintext.txt	40	Although mechanism may explain retinoids inhibit AP 1 activity conditions address mutual inhibition occurs
0.37651846.11934895.html.plaintext.txt	41	Recent results suggest molecular basis receptor mediated inhibition AP 1 transcriptional activation might due competition common coactivator cAMP response element binding protein CBP required transcriptional activation AP 1 complex RARs 32
0.37651846.11934895.html.plaintext.txt	42	However domain RAR capable inhibiting AP 1 activity DNA binding domain 33 interact CBP 32
0.37651846.11934895.html.plaintext.txt	43	The development retinoids specifically inhibit AP 1 activity without transactivating RARs 25 26 also argues involvement RAR coactivators RARs AP 1 cross talk
0.37651846.11934895.html.plaintext.txt	44	Thus availability CBP unlikely sole modulator RAR AP 1 signaling pathways adapter proteins may involved antagonism AP 1 activity RARs
0.37651846.11934895.html.plaintext.txt	45	Recent studies demonstrate orphan receptor COUP TF involved regulation retinoid responses 34 35
0.37651846.11934895.html.plaintext.txt	46	COUP TF encoded two distinct genes COUP TFI EAR 3 36 37 COUP TFII ARP 1 38
0.37651846.11934895.html.plaintext.txt	47	Both show exceptional homology overlapping expression patterns suggesting redundant functions 39
0.37651846.11934895.html.plaintext.txt	48	COUP TF modulate retinoid responses either high affinity binding various RAREs heterodimerization RXR 40 43
0.37651846.11934895.html.plaintext.txt	49	We previously reported COUP TF expression required cancer cell growth inhibition trans RA 35
0.37651846.11934895.html.plaintext.txt	50	We demonstrated effect COUP TF partly due induction RAR mediates growth inhibition retinoids various cancer cells 35
0.37651846.11934895.html.plaintext.txt	51	To understand COUP TF involved regulation trans RA activity cancer cells investigated effect COUP TF antagonism AP 1 activity trans RA
0.37651846.11934895.html.plaintext.txt	52	Our data demonstrate COUP TF expression various cancer cell lines correlated ability trans RA suppress AP 1 transcriptional activity
0.37651846.11934895.html.plaintext.txt	53	In addition found COUP TF effectively suppressed AP 1 transcriptional activity interacting c Jun cause loss c Jun DNA binding
0.37651846.11934895.html.plaintext.txt	54	This interaction required COUP TF DNA binding domain c Jun leucine zipper domain
0.37651846.11934895.html.plaintext.txt	55	Although AP 1 inhibition COUP TF require trans RA COUP TF strongly potentiated AP 1 antagonism trans RA RARs expressed
0.37651846.11934895.html.plaintext.txt	56	Our results demonstrate interaction COUP TF AP 1 involved regulating anti AP 1 activity retinoids cancer cells suggest COUP TF plays role cross talk retinoid AP 1 signalings
0.37651846.11934895.html.plaintext.txt	57	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.37651846.11934895.html.plaintext.txt	58	Cell Culture HeLa ovarian MDA MB231 breast cancer cells grown Dulbeccos modified Eagles medium DMEM supplemented 10 fetal calf serum FCS Calu 6 lung cancer HT 1376 bladder cancer cells grown MEM containing 10 FCS T 47D ZR 75 1 breast cancer H292 lung cancer cells grown RPMI 1460 medium 10 FCS
0.37651846.11934895.html.plaintext.txt	59	Plasmid Construction CAT reporter constructs TRE tk CAT 73Col CAT described 8 17 22 24 expression vectors RAR COUP TF c Jun c Fos 8 17 22 24 44
0.37651846.11934895.html.plaintext.txt	60	pcDNA3 COUP TFII C terminal deletion mutants pcDNA3 COUP TFII7 pcDNA3 COUP TFII30 pcDNA3 COUP TFII108 generated described 35
0.37651846.11934895.html.plaintext.txt	61	pcDNA3 COUP TFII N terminal deletion mutants constructed cloning PCR products COUP TFII pcDNA3 Stratagene using following forward primers TATAGGTACCATGGCGCCGCCCGTGCCC pcDNA3 COUP TFIIN25 ATATGGTACCATGACGCCAGCCCAGACG pcDNA3 COUP TFIIN50 AATTGGTACCATGCACATCGAGTGCGTG pcDNA3 COUP TFIIN75 ATTAGGTACCATGCACCATCGCAACCAG pcDNA3COUPTFIIN125
0.37651846.11934895.html.plaintext.txt	62	The oligonucleotide GTGGCAGTTGAGGGGATCC used reverse primer mutants
0.37651846.11934895.html.plaintext.txt	63	Transient Stable Transfection Assays HeLa cells 1 x 105 cellswell plated 24 well plates 16 24 h transfection described 34 35 45 cancer cells 5 x 105 cellwell seeded six well plates
0.37651846.11934895.html.plaintext.txt	64	A modified calcium phosphate precipitation procedure used transient transfections 34 35 45
0.37651846.11934895.html.plaintext.txt	65	Briefly 200 ng reporter plasmid 100 ng galactosidase expression vector pCH 110 Amersham Biosciences various amounts expression vector mixed carrier DNA pBluescript give 1000 ng total DNAwell
0.37651846.11934895.html.plaintext.txt	66	CAT activity normalized transfection efficiency responding Gal activity
0.37651846.11934895.html.plaintext.txt	67	For stable transfections pRCCMV COUP TF recombinant transfected MDA MB231 HT 1376 cells calcium phosphate precipitation method stable clones screened G418 Invitrogen described 35
0.37651846.11934895.html.plaintext.txt	68	Integration expression transfected cDNA determined Southern blotting Northern blotting respectively
0.37651846.11934895.html.plaintext.txt	69	Preparation Receptor Proteins Receptor proteins RAR TR3 COUP TF mutants synthesized vitro transcription translation using rabbit reticulocyte lysates Promega described previously 34
0.37651846.11934895.html.plaintext.txt	70	Amounts translated proteins determined 35Smethionine incorporation SDS PAGE quantitation incorporated radioactivity normalization relative methionine content
0.37651846.11934895.html.plaintext.txt	71	Gel Retardation Assay A fragment collagenase promoter region 73 63 containing one AP 1 binding site TRE excised collagenase CAT construct 8
0.37651846.11934895.html.plaintext.txt	72	In addition AP 1 binding sequence 5 GATCCGGATGAGTCACCA 3 synthesized
0.37651846.11934895.html.plaintext.txt	73	Two fragments labeled 32PdCTP use probes protein DNA interaction
0.37651846.11934895.html.plaintext.txt	74	In vitro translated protein incubated probe 20 microl reaction mixture containing 10 mM HEPES pH 7
0.37651846.11934895.html.plaintext.txt	75	9 50 mM KCl 1 mM dithiothreitol 2
0.37651846.11934895.html.plaintext.txt	76	5 mM MgCl2 10 glycerol 1 microg polydI dC 25 degrees C 15 min
0.37651846.11934895.html.plaintext.txt	77	DNA protein complexes resolved 5 nondenaturing polyacrylamide gels gels dried analyzed autoradiography
0.37651846.11934895.html.plaintext.txt	78	GST Pull Assay To prepare glutathione S transferase GST c Jun GST c Jun mutant fusion proteins c Jun DNA c Jun mutant fragment cloned frame expression vector pGEX 3X Amersham Biosciences
0.37651846.11934895.html.plaintext.txt	79	Fusion proteins expressed bacteria using manufacturers procedure analyzed gel retardation assays Western blotting data shown
0.37651846.11934895.html.plaintext.txt	80	To determine interaction COUP TF c Jun fusion proteins immobilized glutathione Sepharose beads
0.37651846.11934895.html.plaintext.txt	81	The vector protein GST prepared conditions control also immobilized
0.37651846.11934895.html.plaintext.txt	82	Beads preincubated bovine serum albumin 1 mgml room temperature 5 min
0.37651846.11934895.html.plaintext.txt	83	35S labeled vitro translated COUP TF proteins 2 5 microl depending translation efficiency added beads
0.37651846.11934895.html.plaintext.txt	84	The beads 200 microl EBC buffer 140 mM NaCl 0
0.37651846.11934895.html.plaintext.txt	85	5 Nonidet P 40 100 mM NaF 200 mM sodium orthovanadate 50 mM Tris pH 8
0.37651846.11934895.html.plaintext.txt	86	0 rocked continuously 1 h 4 degrees C
0.37651846.11934895.html.plaintext.txt	87	After washing 5 times NETN buffer 100 mM NaCl 1 mM EDTA 20 mM Tris pH 8
0.37651846.11934895.html.plaintext.txt	88	5 Nonidet P 40 bound proteins analyzed SDS PAGE autoradiography
0.37651846.11934895.html.plaintext.txt	89	Northern Blotting For Northern analysis total RNAs prepared using RNeasy Mini Kit Qiagen Hilden Germany
0.37651846.11934895.html.plaintext.txt	90	Total RNA 30 microg different cell lines treated without trans RA 106 M presence absence TPA 100 ngml analyzed Northern blotting described 46
0.37651846.11934895.html.plaintext.txt	91	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.37651846.11934895.html.plaintext.txt	92	Correlation COUP TF Expression Inhibition AP 1 Activity trans RA We recently reported expression COUP TF required growth inhibition apoptosis induction trans RA various cancer cells 35
0.37651846.11934895.html.plaintext.txt	93	Since inhibition AP 1 activity retinoids known contribute anticancer effects studied whether COUP TF expression involved process
0.37651846.11934895.html.plaintext.txt	94	The effect trans RA inhibiting AP 1 activity Fig
0.37651846.11934895.html.plaintext.txt	95	1A evaluated COUP TF positive T 47D ZR 75 1 breast cancer Calu 6 lung cancer cell lines COUP TF negative MDA MB231 breast cancer H292 lung cancer HT 1376 bladder cancer cell lines 35
0.37651846.11934895.html.plaintext.txt	96	AP 1 activity induced TPA determined transient transfection using reporter 73Col CAT contains TRE binds AP 1 8
0.37651846.11934895.html.plaintext.txt	97	TPA induced reporter activity strongly inhibited trans RA dependent manner COUP TF positive ZR 75 1 T 47D Calu 6 cell lines
0.37651846.11934895.html.plaintext.txt	98	In contrast trans RA showed little effect TPA induced 73Col CAT activity COUP TF negative MDA MB231 H292 HT 1376 cell lines
0.37651846.11934895.html.plaintext.txt	99	Thus COUP TF expression correlates positively ability trans RA inhibit AP 1 transcriptional activity
0.37651846.11934895.html.plaintext.txt	100	View larger version 40K Fig
0.37651846.11934895.html.plaintext.txt	101	COUP TF expression trans RA induced anti AP 1 activity correlate cancer cell lines
0.37651846.11934895.html.plaintext.txt	102	A inhibition TPA induced collagenase promoter activity trans RA
0.37651846.11934895.html.plaintext.txt	103	The 73Col CAT reporter transfected indicated cancer cell lines
0.37651846.11934895.html.plaintext.txt	104	After transfection cells incubated DMEM medium containing 0
0.37651846.11934895.html.plaintext.txt	105	5 FCS 24 h treated either TPA 100 ngml alone indicated concentrations trans RA
0.37651846.11934895.html.plaintext.txt	106	After 12 h cells harvested CAT activity determined
0.37651846.11934895.html.plaintext.txt	107	The activities cotransfected galactosidase used controls transfection efficiency
0.37651846.11934895.html.plaintext.txt	108	B effect COUP TF expression COUP TF negative cancer cell lines inhibition AP 1 activity trans RA
0.37651846.11934895.html.plaintext.txt	109	The 73Col CAT reporter transfected without COUP TF COUP TF negative cancer cell lines MDA MB231 H292 HT 1376
0.37651846.11934895.html.plaintext.txt	110	Cells incubated medium see Experimental Procedures containing 0
0.37651846.11934895.html.plaintext.txt	111	5 FCS 24 h treated either TPA 100 ngml alone 106 M trans RA
0.37651846.11934895.html.plaintext.txt	112	After 12 h cells harvested CAT activity determined
0.37651846.11934895.html.plaintext.txt	113	The activities cotransfected galactosidase used reference values
0.37651846.11934895.html.plaintext.txt	114	Trans RA dependent independent Antagonism AP 1 Activity COUP TF The positive association COUP TF expression trans RA induced anti AP 1 activity suggested COUP TF required trans RA inhibit AP 1 activity absence COUP TF expression MDA MB231 H292 HT 1376 cells might responsible lack trans RA activity
0.37651846.11934895.html.plaintext.txt	115	Therefore transiently transfected COUP TF expression vector 73Col CAT reporter COUP TF negative cell lines trans RA inhibit AP 1 transcriptional activity Fig
0.37651846.11934895.html.plaintext.txt	116	Upon COUP TF transfection trans RA inhibited TPA induced reporter activity MDA MB231 H292 cells COUP TF concentration dependent manner
0.37651846.11934895.html.plaintext.txt	117	Interestingly COUP TF transfection alone produced inhibition AP 1 activity
0.37651846.11934895.html.plaintext.txt	118	This observation suggested COUP TF inhibited AP 1 activity trans RA dependent independent manners MDA MB231 H292 cells
0.37651846.11934895.html.plaintext.txt	119	When evaluated HT 1376 cells COUP TF expression able inhibit AP 1 activity independently trans RA Fig
0.37651846.11934895.html.plaintext.txt	120	However failed confer ability trans RA inhibit TPA induced reporter activity even high transfection levels suggesting trans RA dependent inhibition AP 1 activity COUP TF impaired cell line
0.37651846.11934895.html.plaintext.txt	121	The results suggested COUP TF alone inhibited AP 1 activity
0.37651846.11934895.html.plaintext.txt	122	We examined anti AP 1 activity COUP TF HeLa cells TPA strongly induced transcription transfected 73Col CAT reporter
0.37651846.11934895.html.plaintext.txt	123	Similar observed cancer cell lines Fig
0.37651846.11934895.html.plaintext.txt	124	1B COUP TFI cotransfection inhibited TPA induced reporter activity COUP TFI concentration dependent manner Fig
0.37651846.11934895.html.plaintext.txt	125	Cotransfection COUP TFII produced almost identical results data shown
0.37651846.11934895.html.plaintext.txt	126	Activation collagenase promoter TPA occurs mainly induction AP 1 activity activates TRE promoter 7
0.37651846.11934895.html.plaintext.txt	127	We therefore examined whether COUP TF expression also interfered transactivation activity c Jun homodimer c Junc Fos heterodimer
0.37651846.11934895.html.plaintext.txt	128	Cotransfection 73Col CAT c Jun expression vector HeLa cells led 5 fold induction reporter expression Fig
0.37651846.11934895.html.plaintext.txt	129	2B presumably due activation collagenase promoter c Jun homodimer
0.37651846.11934895.html.plaintext.txt	130	The c Jun induced 73Col CAT reporter activity repressed COUP TFI expression vector cotransfected
0.37651846.11934895.html.plaintext.txt	131	Similarly 73Col CAT reporter activity induced c Junc Fos heterodimers inhibited COUP TFI COUP TFII Fig
0.37651846.11934895.html.plaintext.txt	132	To determine inhibition collagenase promoter activity COUP TF mediated TRE evaluated COUP TFI affected TRE tk CAT reporter TRE sequence fused thymidine kinase promoter Fig
0.37651846.11934895.html.plaintext.txt	133	Our result showed cotransfection COUP TFI significantly inhibited c Jun induced TRE tk CAT activity Fig
0.37651846.11934895.html.plaintext.txt	134	These results clearly demonstrate COUP TF inhibits transcriptional activity c Jun homodimer c Junc Fos heterodimer inhibition AP 1 activity COUP TF TRE responsible antagonism TPA activity
0.37651846.11934895.html.plaintext.txt	135	View larger version 27K Fig
0.37651846.11934895.html.plaintext.txt	136	Inhibition AP 1 activity COUP TF
0.37651846.11934895.html.plaintext.txt	137	A inhibition TPA induced collagenase promoter activity COUP TF HeLa cells
0.37651846.11934895.html.plaintext.txt	138	The 73Col CAT reporter cotransfected without COUP TFI expression vector 10 20 50 ng control pcDNA3 vector cells
0.37651846.11934895.html.plaintext.txt	139	After transfection cells incubated DMEM medium containing 0
0.37651846.11934895.html.plaintext.txt	140	5 FCS 24 h treated without TPA 100 ngml
0.37651846.11934895.html.plaintext.txt	141	After 12 h cells harvested CAT activity determined
0.37651846.11934895.html.plaintext.txt	142	B inhibition c Jun induced 73Col CAT TRE tk CAT activity COUP TF HeLa cells
0.37651846.11934895.html.plaintext.txt	143	The 73Col CAT TRE tk CAT reporter cotransfected withwithout c Jun presence absence COUP TFI expression vector 10 20 50 ng cells
0.37651846.11934895.html.plaintext.txt	144	After transfection cells incubated DMEM medium containing 0
0.37651846.11934895.html.plaintext.txt	145	5 FCS 24 h CAT activity determined
0.37651846.11934895.html.plaintext.txt	146	C inhibition c Jun c Fos activities COUP TF HeLa cells
0.37651846.11934895.html.plaintext.txt	147	The 73Col CAT reporter cotransfected withwithout c Jun 50 ng andor c Fos 50 ng expression vectors either presence absence COUP TFI COUP TFII expression vector 10 20 50 ng HeLa cells
0.37651846.11934895.html.plaintext.txt	148	The cells harvested CAT activity determined
0.37651846.11934895.html.plaintext.txt	149	Inhibition c Jun Binding DNA COUP TF Inhibition AP 1 activity several nuclear receptors shown due inhibition AP 1 binding DNA 8 9 13 15 17 22 47
0.37651846.11934895.html.plaintext.txt	150	To study whether inhibition AP 1 DNA binding COUP TF involved inhibition AP 1 activity purified collagenase promoter fragment used probe gel shift assays binding vitro synthesized c Jun protein absence presence COUP TF protein Fig
0.37651846.11934895.html.plaintext.txt	151	c Jun alone formed strong complex promoter
0.37651846.11934895.html.plaintext.txt	152	However upon preincubation COUP TF protein c Jun binding significantly inhibited
0.37651846.11934895.html.plaintext.txt	153	The addition COUP TF protein show new complex formed collagenase promoter indicating inhibitory effect COUP TF due direct binding collagenase promoter
0.37651846.11934895.html.plaintext.txt	154	We also studied effect COUP TF binding c Jun TRE
0.37651846.11934895.html.plaintext.txt	155	Preincubation COUP TF protein similarly inhibited c Jun binding TRE derived collagenase promoter Fig
0.37651846.11934895.html.plaintext.txt	156	As comparison preincubation c Jun TR3 orphan receptor 34 could antagonize c Jun transactivation data shown inhibit c Jun binding TRE
0.37651846.11934895.html.plaintext.txt	157	This result demonstrated inhibitory effect COUP TF c Jun binding collagenase promoter due regions TRE promoter
0.37651846.11934895.html.plaintext.txt	158	Next compared inhibitory effect COUP TF RAR known repress AP 1 activity inhibit c Jun binding TRE 8
0.37651846.11934895.html.plaintext.txt	159	Whereas equal amount COUP TF significantly inhibited c Jun binding collagenase promoter equal amount RAR show detectable inhibition Fig
0.37651846.11934895.html.plaintext.txt	160	Inhibition c Jun binding required 5 fold excess RAR similar observed 8
0.37651846.11934895.html.plaintext.txt	161	The addition trans RA enhance inhibitory effect RAR Ref
0.37651846.11934895.html.plaintext.txt	162	Together results demonstrate inhibition c Jun binding TRE contributes suppression AP 1 transcriptional activity COUP TF COUP TF effective inhibitor RAR
0.37651846.11934895.html.plaintext.txt	163	View larger version 44K Fig
0.37651846.11934895.html.plaintext.txt	164	Inhibition c Jun binding DNA COUP TF
0.37651846.11934895.html.plaintext.txt	165	In vitro synthesized c Jun preincubated indicated molar excess COUP TF RAR TR3
0.37651846.11934895.html.plaintext.txt	166	Unprogrammed reticulocyte lysate added maintain equal protein concentration reaction
0.37651846.11934895.html.plaintext.txt	167	Following preincubation reaction mixtures incubated 32P labeled collagenase promoter A TRE B analyzed gel retardation
0.37651846.11934895.html.plaintext.txt	168	The arrowhead indicates c Jun binding complex
0.37651846.11934895.html.plaintext.txt	169	Interaction c Jun COUP TF Our observation COUP TF inhibits transactivation DNA binding c Jun prompted us examine whether COUP TF c Jun interact directly using GST pull assay Fig
0.37651846.11934895.html.plaintext.txt	170	In vitro synthesized radiolabeled COUP TFII specifically pulled bacterially expressed GST c Jun hybrid protein GST protein Fig
0.37651846.11934895.html.plaintext.txt	171	4B demonstrating COUP TF c Jun interact solution
0.37651846.11934895.html.plaintext.txt	172	To identify domain COUP TFII responsible interacting c Jun COUP TFII deletion mutants Fig
0.37651846.11934895.html.plaintext.txt	173	4A constructed analyzed 73Col CAT reporter antagonism AP 1 activity HeLa cells Fig
0.37651846.11934895.html.plaintext.txt	174	4A interaction c Jun using GST pull assay Fig
0.37651846.11934895.html.plaintext.txt	175	Cotransfection c Jun expression vector alone induced reporter transcription Fig
0.37651846.11934895.html.plaintext.txt	176	4A whereas cotransfection one C terminal deletion mutants COUP TFII7 COUP TFII30 COUP TFII108 strongly inhibited c Jun induced reporter activity observed using wild type COUP TFII
0.37651846.11934895.html.plaintext.txt	177	N terminal domain deletion mutants COUP TFIIN25 COUP TFIIN50 COUP TFIIN75 also retained inhibitory effect AP 1 activity COUP TFII
0.37651846.11934895.html.plaintext.txt	178	In contrast partial COUP TFIIN125 complete deletion DNA binding domain COUP TFIIDBD abrogated anti c Jun activity completely
0.37651846.11934895.html.plaintext.txt	179	In GST pull assay COUP TFII mutants effectively suppressed AP 1 activity COUP TFII7 COUP TFII30 COUP TFII108 COUP TFIIN25 COUP TFIIN50 COUP TFIIN75 pulled GST c Jun protein whereas COUP TFIIDBD failed suppress AP 1 activity Fig
0.37651846.11934895.html.plaintext.txt	180	Thus inhibition AP 1 transcriptional activity COUP TFII mutants correlated ability interact c Jun
0.37651846.11934895.html.plaintext.txt	181	These observations suggest direct c JunCOUP TF interaction accounts inhibition AP 1 activity COUP TF DBD COUP TF essential
0.37651846.11934895.html.plaintext.txt	182	View larger version 44K Fig
0.37651846.11934895.html.plaintext.txt	183	Interaction c Jun COUP TF domain requirements
0.37651846.11934895.html.plaintext.txt	184	A inhibition transcriptional activity AP 1 COUP TF mutants HeLa cells
0.37651846.11934895.html.plaintext.txt	185	Left schematic representation COUP TFII mutants
0.37651846.11934895.html.plaintext.txt	186	The DNA binding domain DBD ligand binding domain LBD COUP TFII indicated
0.37651846.11934895.html.plaintext.txt	187	Right effect COUP TFII mutants AP 1 activity
0.37651846.11934895.html.plaintext.txt	188	The 73Col CAT reporter cotransfected without c Jun 100 ng alone together indicated COUP TFII mutants 50 ng
0.37651846.11934895.html.plaintext.txt	189	After transfection cells incubated DMEM containing 0
0.37651846.11934895.html.plaintext.txt	190	After 12 h cells harvested CAT activity determined
0.37651846.11934895.html.plaintext.txt	191	Reporter activity shown percentage inhibition
0.37651846.11934895.html.plaintext.txt	192	B interaction c Jun COUP TFs
0.37651846.11934895.html.plaintext.txt	193	c Jun synthesized bacteria using pGEX 3X expression vector
0.37651846.11934895.html.plaintext.txt	194	GST c Jun fusion protein immobilized glutathione Sepharose beads
0.37651846.11934895.html.plaintext.txt	195	As control amount glutathione S transferase also immobilized beads
0.37651846.11934895.html.plaintext.txt	196	In vitro translated 35S labeled COUP TF mutant proteins mixed beads
0.37651846.11934895.html.plaintext.txt	197	After extensive washing bound proteins analyzed SDS PAGE
0.37651846.11934895.html.plaintext.txt	198	The input proteins shown comparison
0.37651846.11934895.html.plaintext.txt	199	We also identified region c Jun required COUP TF interaction Fig
0.37651846.11934895.html.plaintext.txt	200	Deletion amino acids 73 232 c Jun c JunAvaI affect ability pull COUP TFII
0.37651846.11934895.html.plaintext.txt	201	In contrast deletion C terminal domain c Jun amino acid 191 331 c JunbZIP encompasses leucine zipper region basic region completely abolished ability pull COUP TFII
0.37651846.11934895.html.plaintext.txt	202	Thus C terminal domain N terminal domain c Jun responsible COUP TF interaction
0.37651846.11934895.html.plaintext.txt	203	View larger version 14K Fig
0.37651846.11934895.html.plaintext.txt	204	The domain c Jun required interaction COUP TF
0.37651846.11934895.html.plaintext.txt	205	A schematic representation c Jun mutants
0.37651846.11934895.html.plaintext.txt	206	The amino terminus NH2 basic region leucine zipper bZIP carboxyl terminus C indicated
0.37651846.11934895.html.plaintext.txt	207	B interaction COUP TF c Jun mutants
0.37651846.11934895.html.plaintext.txt	208	c Jun mutant proteins synthesized bacteria using pGEX 3X expression vector Amersham Biosciences
0.37651846.11934895.html.plaintext.txt	209	GST c Jun mutant fusion proteins GST c JunAvaI GST c JunbZIP immobilized glutathione Sepharose beads
0.37651846.11934895.html.plaintext.txt	210	As control amount glutathione transferase immobilized beads
0.37651846.11934895.html.plaintext.txt	211	In vitro translated 35S labeled COUP TFII mixed beads
0.37651846.11934895.html.plaintext.txt	212	After extensive washing bound proteins analyzed SDS PAGE
0.37651846.11934895.html.plaintext.txt	213	Input proteins shown comparison
0.37651846.11934895.html.plaintext.txt	214	Stable Expression COUP TF COUP TF negative MDA MB231 Cells Restores Ability trans RA Inhibit AP 1 Activity To examine role COUP TF trans RA induced inhibition AP 1 activity analyzed effect trans RA TPA induced c Jun expression MDA MB231 breast cancer cells MDA MB231 cells stably transfected COUP TF MB231COUP16 35
0.37651846.11934895.html.plaintext.txt	215	Treatment cell lines TPA strongly induced c Jun expression determined Northern blotting Fig
0.37651846.11934895.html.plaintext.txt	216	Induction c Jun expression TPA probably due AP 1 binding site c Jun promoter 7
0.37651846.11934895.html.plaintext.txt	217	Treatment trans RA affect basal c Jun expression lines inhibit TPA induced c Jun expression MDA MB231 cells
0.37651846.11934895.html.plaintext.txt	218	However pretreatment MB231COUP16 cells trans RA completely abolished TPA induced c Jun expression
0.37651846.11934895.html.plaintext.txt	219	These results demonstrate COUP TF expression required inhibition AP 1 activity MDA MB231 cells trans RA
0.37651846.11934895.html.plaintext.txt	220	View larger version 29K Fig
0.37651846.11934895.html.plaintext.txt	221	Stable expression COUP TF COUP TF negative RAR positive MDA MB231 cells restores ability trans RA inhibit AP 1 activity
0.37651846.11934895.html.plaintext.txt	222	Total RNAs prepared MDA MB 231 MDA MB231 cells stably expressing COUP TF MB231COUP16 35 treated without indicated agents analyzed expression c Jun
0.37651846.11934895.html.plaintext.txt	223	The expression actin shown confirm similar loading RNA lane
0.37651846.11934895.html.plaintext.txt	224	Stable Expression COUP TF Does Not Lead trans RA dependent Inhibition AP 1 Activity HT 1376 Cells Lacking RAR Expression We also evaluated whether stable expression COUP TF affected TPA induced c Jun expression HT 1376 bladder cancer cells Fig
0.37651846.11934895.html.plaintext.txt	225	The stable clone HT 1376COUP7 expresses high levels COUP TF analyzed effect trans RA TPA activity Fig
0.37651846.11934895.html.plaintext.txt	226	About 4 fold induction c Jun expression TPA observed HT 1376 cells
0.37651846.11934895.html.plaintext.txt	227	However induction c Jun expression largely reduced HT 1376COUP7 cells 2 fold induction
0.37651846.11934895.html.plaintext.txt	228	Interestingly basal level c Jun expression also slightly reduced HT 1376COUP7 cells
0.37651846.11934895.html.plaintext.txt	229	Despite reduction c Jun expression absence presence TPA trans RA failed inhibit basal TPA induced c Jun expression wild type COUP TF expressing cells
0.37651846.11934895.html.plaintext.txt	230	Thus COUP TF expression sufficient confer trans RA induced anti AP 1 activity HT 1376 cells
0.37651846.11934895.html.plaintext.txt	231	View larger version 80K Fig
0.37651846.11934895.html.plaintext.txt	232	Stable expression COUP TF COUP TF RAR negative HT 1376 cells lead trans RA dependent inhibition AP 1 activity
0.37651846.11934895.html.plaintext.txt	233	Total RNAs prepared HT 1376 HT 1376 cells stably expressing COUP TF HT 1376COUP 7 treated without indicated agents analyzed expression c Jun RAR RAR
0.37651846.11934895.html.plaintext.txt	234	The expression actin shown confirm similar loading RNA lane
0.37651846.11934895.html.plaintext.txt	235	RAR Expression Is Required COUP TF Facilitate Antagonism AP 1 Activity trans RA Our observations transient Fig
0.37651846.11934895.html.plaintext.txt	236	7 expression COUP TF HT 1376 cells failed modulate antagonism AP 1 activity trans RA led us investigate RAR expression
0.37651846.11934895.html.plaintext.txt	237	Unlike MDA MB231 cells express RAR 48 RAR COUP TF expressed 35 HT 1376 cells express detectable RAR RAR Fig
0.37651846.11934895.html.plaintext.txt	238	7 although RAR expressed data shown
0.37651846.11934895.html.plaintext.txt	239	This result suggested modulation trans RA induced anti AP 1 activity COUP TF might require RAR RAR
0.37651846.11934895.html.plaintext.txt	240	The effect RAR expression ability COUP TF regulate trans RA activity examined using transient transfection HT 1376 cells
0.37651846.11934895.html.plaintext.txt	241	The 73Col CAT reporter transfected HT 1376 cells without c Jun COUP TF andor RAR vector
0.37651846.11934895.html.plaintext.txt	242	Transfected cells treated without trans RA
0.37651846.11934895.html.plaintext.txt	243	8A transfected COUP TF repressed AP 1 activity absence trans RA
0.37651846.11934895.html.plaintext.txt	244	In contrast transfected RAR 10 ng led inhibition AP 1 activity trans RA dependent manner
0.37651846.11934895.html.plaintext.txt	245	The addition COUP TF significantly enhanced trans RA induced inhibition AP 1 activity RAR Fig
0.37651846.11934895.html.plaintext.txt	246	Similar results observed using HeLa cells Fig
0.37651846.11934895.html.plaintext.txt	247	Thus efficient inhibition AP 1 activity trans RA activity COUP TF requires COUP TF RAR
0.37651846.11934895.html.plaintext.txt	248	View larger version 23K Fig
0.37651846.11934895.html.plaintext.txt	249	Effect COUP TF RAR coexpression antagonism AP 1 activity trans RA
0.37651846.11934895.html.plaintext.txt	250	The 73Col CAT reporter transfected together c Jun alone together COUP TF andor RAR expression vectors HT 1376 A HeLa B cells
0.37651846.11934895.html.plaintext.txt	251	After transfection cells incubated medium containing 0
0.37651846.11934895.html.plaintext.txt	252	5 FCS 24 h treated without trans RA
0.37651846.11934895.html.plaintext.txt	253	After 12 h cells harvested CAT activity determined
0.37651846.11934895.html.plaintext.txt	254	The top panels show percentage inhibition c Jun activity trans RA based data shown bottom panels filled bars represent control open bars represent trans RA treatment
0.37651846.11934895.html.plaintext.txt	255	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.37651846.11934895.html.plaintext.txt	256	Retinoids effective growth inhibitors cancer cells
0.37651846.11934895.html.plaintext.txt	257	Inhibition AP 1 activity proposed one mechanism retinoids exert anticancer effects 6
0.37651846.11934895.html.plaintext.txt	258	Despite extensive studies last years retinoids specifically antagonize AP 1 activity remains largely unknown
0.37651846.11934895.html.plaintext.txt	259	Here provide evidence COUP TF involved regulating antagonism AP 1 transactivational activity trans RA
0.37651846.11934895.html.plaintext.txt	260	COUP TF physically interacting c Jun inhibits AP 1 DNA binding transactivation required efficient inhibition AP 1 activity liganded RARs
0.37651846.11934895.html.plaintext.txt	261	Our results suggest COUP TF plays role cross talk retinoid AP 1 signaling pathways
0.37651846.11934895.html.plaintext.txt	262	We recently reported expression COUP TF positively correlates inhibition growth various cancer cell lines trans RA COUP TF underexpressed many trans RA resistant cancer cell lines 35
0.37651846.11934895.html.plaintext.txt	263	Stable expression COUP TF COUP TF negative cancer cells restores sensitivity trans RA demonstrating COUP TF mediate anticancer effects trans RA 35
0.37651846.11934895.html.plaintext.txt	264	By studying anti AP 1 activity trans RA various cancer cell lines found close correlation COUP TF expression anti AP 1 activity trans RA Fig
0.37651846.11934895.html.plaintext.txt	265	In COUP TF positive ZR 75 1 T 47D Calu 6 cancer cell lines 35 trans RA strongly inhibited ability TPA activate transcription collagenase promoter whereas COUP TF negative MDA MB231 H292 HT 1376 cell lines trans RA failed suppress TPA activity Fig
0.37651846.11934895.html.plaintext.txt	266	This finding consistent previous study showing trans RA effectively inhibited AP 1 activity ZR 75 1 T 47D cells MDA MB231 cells 49
0.37651846.11934895.html.plaintext.txt	267	The requirement COUP TF trans RA mediated AP 1 inhibition demonstrated findings transient expression COUP TF COUP TF negative cells Fig
0.37651846.11934895.html.plaintext.txt	268	1B restored ability trans RA inhibit TPA induced AP 1 transactivation stable expression COUP TF MBA MB231 cells enabled trans RA inhibit TPA induced c Jun expression Fig
0.37651846.11934895.html.plaintext.txt	269	We reported COUP TF expression contributes growth inhibition trans RA cancer cells COUP TF binding RAR promoter induces RAR expression 35
0.37651846.11934895.html.plaintext.txt	270	RAR reported potent AP 1 inhibitor 24 suggesting COUP TF induced RAR probably contributes inhibition AP 1 activity Fig
0.37651846.11934895.html.plaintext.txt	271	Our observations COUP TF effectively interact c Jun vitro Figs
0.37651846.11934895.html.plaintext.txt	272	3 4 inhibit AP 1 transcriptional activity transient transfection Fig
0.37651846.11934895.html.plaintext.txt	273	2 also suggest COUP TF directly involved antagonizing AP 1 activity
0.37651846.11934895.html.plaintext.txt	274	Inhibition AP 1 activity appears common characteristic nuclear receptors demonstrated progesterone estrogen androgen thyroid hormone glucocorticoid retinoid receptors functionally interact AP 1 complex
0.37651846.11934895.html.plaintext.txt	275	This study reveals orphan receptor COUP TF behaves similarly
0.37651846.11934895.html.plaintext.txt	276	The molecular basis interaction nuclear receptors AP 1 pathways remains largely unknown
0.37651846.11934895.html.plaintext.txt	277	Models proposed include direct protein protein interaction 8 9 13 15 inhibition Jun N terminal kinase activity 31 competition CBP 32
0.37651846.11934895.html.plaintext.txt	278	Our results GST pull assays Figs
0.37651846.11934895.html.plaintext.txt	279	4B 5 mutation analysis Figs
0.37651846.11934895.html.plaintext.txt	280	4 5 support first model
0.37651846.11934895.html.plaintext.txt	281	The requirement COUP TF DBD c Jun binding similar observations DBDs glucocorticoid receptor 14 15 RAR 47 essential interaction AP 1
0.37651846.11934895.html.plaintext.txt	282	Interestingly vitro DNA binding study showed COUP TF effective inhibitor AP 1 binding RAR Fig
0.37651846.11934895.html.plaintext.txt	283	3 basis levels receptor exert effect
0.37651846.11934895.html.plaintext.txt	284	In contrast inhibition AP 1 activity receptors require respective ligands COUP TF effectively inhibited AP 1 transactivation absence ligand Fig
0.37651846.11934895.html.plaintext.txt	285	Such ligand independent inhibition AP 1 activity may restrict expression levels AP 1 responsive genes cancer cells Figs
0.37651846.11934895.html.plaintext.txt	286	Interestingly observed COUP TF expression potentiates antagonism AP 1 activity trans RA
0.37651846.11934895.html.plaintext.txt	287	However regulation trans RA activity COUP TF appears require RAR RAR transiently transfected COUP TF unable confer anti AP 1 activity trans RA HT 1376 cells lacking RAR Fig
0.37651846.11934895.html.plaintext.txt	288	8B unless RAR cotransfected
0.37651846.11934895.html.plaintext.txt	289	In addition stable expression COUP TF restored trans RA induced anti AP 1 activity MDA MB231 cells Fig
0.37651846.11934895.html.plaintext.txt	290	6 RARs 48 HT 1376 cells lacking RAR Fig
0.37651846.11934895.html.plaintext.txt	291	Thus expression RAR COUP TF required optimal inhibition AP 1 activity trans RA
0.37651846.11934895.html.plaintext.txt	292	Although fully understand COUP TF RAR coexpression maximizes inhibition AP 1 activity trans RA finding physical interaction COUP TF RAR 35 50 suggests involvement process
0.37651846.11934895.html.plaintext.txt	293	Based observation COUP TF effectively inhibits c Jun binding DNA RAR Fig
0.37651846.11934895.html.plaintext.txt	294	3 tempting speculate COUP TF ability interact RAR 35 50 c Jun Fig
0.37651846.11934895.html.plaintext.txt	295	3 may function bridging factor mediate RARAP 1 interaction
0.37651846.11934895.html.plaintext.txt	296	In model COUP TFRAR heterodimer would strongly interact AP 1 presence trans RA inhibit DNA binding AP 1 transactivation
0.37651846.11934895.html.plaintext.txt	297	Similarly COUP TF interacting c Jun might also potentiate inhibition RAR transactivation AP 1
0.37651846.11934895.html.plaintext.txt	298	Unfortunately perhaps due rapid formation COUP TF homodimer COUP TF expression vitro 40 51 unsuccessful demonstrating interaction RARCOUP TF heterodimer c Jun gel shift GST pull assays data shown
0.37651846.11934895.html.plaintext.txt	299	Another possible mechanism inhibiting AP 1 transactivation COUP TF may involve recruiting transcriptional corepressor
0.37651846.11934895.html.plaintext.txt	300	COUP TF widely considered potent negative transcriptional regulator 40 43 due effective interaction corepressors N CoR SMRT 52
0.37651846.11934895.html.plaintext.txt	301	The interaction COUP TF RAR AP 1 may recruit transcriptional corepressors complex thereby enhancing mutual repression AP 1 RAR transcriptional activity
0.37651846.11934895.html.plaintext.txt	302	Interestingly COUP TF interacts variety nuclear receptors including RXR 41 TR 40 50 estrogen receptor 53 54 peroxisome proliferator activated receptor 55
0.37651846.11934895.html.plaintext.txt	303	It remains determined whether COUP TF involved modulating anti AP 1 activity ligands
0.37651846.11934895.html.plaintext.txt	304	Dawson reviewing manuscript
0.37651846.11934895.html.plaintext.txt	305	This work supported part grants National Institutes Health United States Army Medical Research Material Command X
0.37651846.11934895.html.plaintext.txt	306	The costs publication article defrayed part payment page charges
0.37651846.11934895.html.plaintext.txt	307	The article must therefore hereby marked advertisement accordance 18 U
0.37651846.11934895.html.plaintext.txt	308	Section 1734 solely indicate fact
0.37651846.11934895.html.plaintext.txt	309	To correspondence addressed Burnham Institute Cancer Center 10901 North Torrey Pines Rd
0.37651846.11934895.html.plaintext.txt	310	858 646 3141 Fax 858 646 3195 E mail xzhangburnham
0.37651846.11934895.html.plaintext.txt	311	Published JBC Papers Press April 4 2002 DOI 10
0.37651846.11934895.html.plaintext.txt	312	The abbreviations used RAR retinoic acid receptor RXR retinoid X receptor RA retinoic acid RARE RA response element TPA 12 O tetradecanoylphorbol 13 acetate TRE TPA response element CBP cAMP response element binding protein DMEM Dulbeccos modified Eagles medium FCS fetal calf serum GST glutathione S transferase
0.37651846.11934895.html.plaintext.txt	313	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.37651846.11934895.html.plaintext.txt	314	Acta 605 33 91CrossRefMedline Order article via Infotrieve 2
0.37651846.11934895.html.plaintext.txt	315	1994 The Retinoids Sporn M
0.37651846.11934895.html.plaintext.txt	316	443 520 Raven Press New York 3
0.37651846.11934895.html.plaintext.txt	317	1995 Cell 83 841 850Medline Order article via Infotrieve 4
0.37651846.11934895.html.plaintext.txt	318	1995 Cell 83 859 869Medline Order article via Infotrieve 5
0.37651846.11934895.html.plaintext.txt	319	1993 Receptor 3 183 191Medline Order article via Infotrieve 6
0.37651846.11934895.html.plaintext.txt	320	14 651 658Medline Order article via Infotrieve 7
0.37651846.11934895.html.plaintext.txt	321	Acta 1072 129 157CrossRefMedline Order article via Infotrieve 8
0.37651846.11934895.html.plaintext.txt	322	3 1206 1219Medline Order article via Infotrieve 9
0.37651846.11934895.html.plaintext.txt	323	1996 Oncogene 12 577 584Medline Order article via Infotrieve 13
0.37651846.11934895.html.plaintext.txt	324	1990 Cell 62 1189 1204Medline Order article via Infotrieve 14
0.37651846.11934895.html.plaintext.txt	325	1990 Cell 62 1205 1215Medline Order article via Infotrieve 15
0.37651846.11934895.html.plaintext.txt	326	1990 Cell 62 1217 1226Medline Order article via Infotrieve 16
0.37651846.11934895.html.plaintext.txt	327	266 8248 8254AbstractFree Full Text 17
0.37651846.11934895.html.plaintext.txt	328	11 6016 6025Medline Order article via Infotrieve 18
0.37651846.11934895.html.plaintext.txt	329	276 36361 36369AbstractFree Full Text 20
0.37651846.11934895.html.plaintext.txt	330	1996 Enzyme Protein 49 20 37Medline Order article via Infotrieve 21
0.37651846.11934895.html.plaintext.txt	331	350 267 277CrossRefMedline Order article via Infotrieve 24
0.37651846.11934895.html.plaintext.txt	332	60 3271 3280AbstractFree Full Text 25
0.37651846.11934895.html.plaintext.txt	333	1994 Nature 372 107 111CrossRefMedline Order article via Infotrieve 26
0.37651846.11934895.html.plaintext.txt	334	56 277 291CrossRefMedline Order article via Infotrieve 28
0.37651846.11934895.html.plaintext.txt	335	94 5826 5830AbstractFree Full Text 30
0.37651846.11934895.html.plaintext.txt	336	11 3351 3364AbstractFree Full Text 32
0.37651846.11934895.html.plaintext.txt	337	1996 Cell 85 403 414Medline Order article via Infotrieve 33
0.37651846.11934895.html.plaintext.txt	338	1 7 13CrossRefMedline Order article via Infotrieve 34
0.37651846.11934895.html.plaintext.txt	339	16 1656 1669AbstractFree Full Text 35
0.37651846.11934895.html.plaintext.txt	340	20 957 970AbstractFree Full Text 36
0.37651846.11934895.html.plaintext.txt	341	1989 Nature 340 163 166CrossRefMedline Order article via Infotrieve 38
0.37651846.11934895.html.plaintext.txt	342	1991 Science 251 561 565Medline Order article via Infotrieve 39
0.37651846.11934895.html.plaintext.txt	343	56 81 85CrossRefMedline Order article via Infotrieve 40
0.37651846.11934895.html.plaintext.txt	344	1992 Nature 355 441 446CrossRefMedline Order article via Infotrieve 45
0.37651846.11934895.html.plaintext.txt	345	18 4719 4731AbstractFree Full Text 47
0.37651846.11934895.html.plaintext.txt	346	13 276 285AbstractFree Full Text 48
0.37651846.11934895.html.plaintext.txt	347	112 143 152CrossRefMedline Order article via Infotrieve 50
0.37651846.11934895.html.plaintext.txt	348	11 714 724AbstractFree Full Text 53
0.37651846.11934895.html.plaintext.txt	349	272 31465 31474AbstractFree Full Text 54
0.37651846.11934895.html.plaintext.txt	350	71 1 19CrossRefMedline Order article via Infotrieve 55
0.37651846.11934895.html.plaintext.txt	351	1999 Endocrinology 140 1586 1593AbstractFree Full Text
0.37651846.11934895.html.plaintext.txt	352	Copyright 2002 The American Society Biochemistry Molecular Biology Inc
0.37651846.11934895.html.plaintext.txt	353	This Article Abstract Full Text PDF All Versions Article 2772421414 recent M201885200v1 Purchase Article View Shopping Cart Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Copyright Permissions Google Scholar Articles Lin F
0.37651846.11934895.html.plaintext.txt	354	Articles citing Article PubMed PubMed Citation Articles Lin F
0.37651846.11934895.html.plaintext.txt	355	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular Cellular Proteomics Journal Lipid Research Biochemistry Molecular Biology Education Copyright 2002 American Society Biochemistry Molecular Biology
0.30958837.10644726.html.plaintext.txt	0	The Nuclear Receptor Chicken Ovalbumin Upstream Promoter Transcription Factor Interacts HIV 1 Tat Stimulates Viral Replication Human Microglial Cells Olivier Rohr Christian Schwartz Christiane Hery Dominique Aunis Marc Tardieu Evelyne Schaeffer
0.30958837.10644726.html.plaintext.txt	1	From Unite 338 INSERM 5 rue Blaise Pascal 67084 Strasbourg Cedex France Laboratoire Virus Neurone et Immunite CRI 96 12 Faculte de Medecine Paris Sud 63 rue Gabriel Peri 94276 Le Kremlin Bicetre France
0.30958837.10644726.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.30958837.10644726.html.plaintext.txt	3	Human immunodeficiency virus type 1 HIV 1 infects central nervous system plays direct role pathogenesis AIDS dementia
0.30958837.10644726.html.plaintext.txt	4	However molecular mechanisms underlying HIV 1 expression central nervous system poorly understood
0.30958837.10644726.html.plaintext.txt	5	We recently reported nuclear receptor chicken ovalbumin upstream promoter transcription factor COUP TF orphan member nuclear receptor superfamily activator HIV 1 gene transcription
0.30958837.10644726.html.plaintext.txt	6	Here results show COUP TF stimulates HIV 1 transcription primary cultured human microglial cells primary target HIV 1 infection brain
0.30958837.10644726.html.plaintext.txt	7	Run assays indicated COUP TF acts initiation step transcription
0.30958837.10644726.html.plaintext.txt	8	Results reverse transcription polymerase chain reaction immunocytochemistry analysis revealed importance factor demonstrating overexpression COUP TF leads initiation viral replication primary HIV infected human microglia
0.30958837.10644726.html.plaintext.txt	9	In addition COUP TF able physically interact cooperate viral transactivator Tat
0.30958837.10644726.html.plaintext.txt	10	The combination COUP TF Tat leads NF B Sp1 independent enhanced transcriptional stimulation
0.30958837.10644726.html.plaintext.txt	11	In vitro binding studies showed COUP TF interacts Tat amino acids within N terminal DNA binding domain COUP TF
0.30958837.10644726.html.plaintext.txt	12	Amino acids 48 72 basic C terminal regions Tat required binding Tat COUP TF
0.30958837.10644726.html.plaintext.txt	13	These results suggest COUP TF essential transcription factor involved HIV 1 expression microglia reveal novel interplay Tat COUP TF regulation viral expression
0.30958837.10644726.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.30958837.10644726.html.plaintext.txt	15	Human immunodeficiency virus type 1 HIV 11 infects central nervous system CNS leads wide range neurological complications 1 2
0.30958837.10644726.html.plaintext.txt	16	Although astrocytes oligodendrocytes perhaps neurons capable harboring restricted infection HIV 1 3 5 CNS resident macrophages microglial cells 6 primary target HIV 1 infection brain 7 10
0.30958837.10644726.html.plaintext.txt	17	HIV 1 infection established CNS viruses present early infection 11
0.30958837.10644726.html.plaintext.txt	18	Macrophage tropic isolates infect microglial cells efficiently lymphotropic isolates 12
0.30958837.10644726.html.plaintext.txt	19	We therefore performed studies macrophage tropic lymphotropic strain
0.30958837.10644726.html.plaintext.txt	20	The regulation HIV 1 gene expression governed interactions viral host cell transcription factors long terminal repeat LTR region review see Refs
0.30958837.10644726.html.plaintext.txt	21	Recent studies focused cellular factors regulate HIV 1 expression CNS cells 15 18
0.30958837.10644726.html.plaintext.txt	22	Our previous studies highlighted importance members steroidthyroidretinoid receptor family regulation HIV 1 gene transcription brain cells
0.30958837.10644726.html.plaintext.txt	23	We shown orphan nuclear receptor COUP TFEar3 19 function potent HIV 1 transcriptional activator different human brain cell lines
0.30958837.10644726.html.plaintext.txt	24	Whereas oligodendrocytes COUP TF acts direct interaction nuclear receptor responsive element located 352320 LTR region 17 microglial cells COUP TF enhances transcription via minimal 6829 LTR region direct association Sp1 protein 18
0.30958837.10644726.html.plaintext.txt	25	These transcription factors activate LTR driven transcription immediate early phase HIV infection viral transcription proceeds low rate dependence solely cellular transcription factors
0.30958837.10644726.html.plaintext.txt	26	This leads early phase dramatic increase transcription results accumulation primary transactive viral protein Tat 14 20
0.30958837.10644726.html.plaintext.txt	27	A number studies shown Tat increases rate transcription initiation elongation translation TAR containing mRNAs
0.30958837.10644726.html.plaintext.txt	28	The ability Tat function transcriptional activator mediated interaction number different cellular proteins review see Ref
0.30958837.10644726.html.plaintext.txt	29	The general transcription factors TBPTFIID 21 TFIIH 22 elongation factors TAKPTEFb 23 24 cyclin T 25 associate Tat
0.30958837.10644726.html.plaintext.txt	30	In addition transcriptional activation Tat requires concerted action Tat factors binding Sp1 B LTR region
0.30958837.10644726.html.plaintext.txt	31	The importance Sp1 factor Tat mediated transactivation well established 26 27 direct interaction occurs Sp1 amino acids 30 72 Tat transactivation 26 28 29
0.30958837.10644726.html.plaintext.txt	32	Specific NF B subunits also act concert Tat enhance LTR driven transcription 30 31
0.30958837.10644726.html.plaintext.txt	33	Moreover thyroid hormone receptor T3R member nuclear receptor superfamily found interact Tat amino acids located DNA binding domain T3R amino acids 49 72 basic C terminal region Tat 32
0.30958837.10644726.html.plaintext.txt	34	These data explain mutations within LTR sequence decrease abolish Tat mediated activation 33 34
0.30958837.10644726.html.plaintext.txt	35	Interestingly TAR independent Tat transactivation also described presence intact NF B element 35 36
0.30958837.10644726.html.plaintext.txt	36	In report investigated functional effect nuclear receptor COUP TF HIV 1 gene expression primary cultured human microglial cells
0.30958837.10644726.html.plaintext.txt	37	Our results reveal importance COUP TF activator HIV 1 gene transcription replication primary microglia
0.30958837.10644726.html.plaintext.txt	38	In addition provide evidence novel functional physical interaction COUP TF Tat
0.30958837.10644726.html.plaintext.txt	39	This interaction leads enhanced synergistic NF B Sp1 independent transactivation LTR
0.30958837.10644726.html.plaintext.txt	40	Our data suggest model alternative pathway Tat transactivation microglia independent NF B Sp1 direct interactions Tat nuclear receptor COUP TF
0.30958837.10644726.html.plaintext.txt	41	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.30958837.10644726.html.plaintext.txt	42	Plasmids LTR chloramphenicol acetyltransferase CAT vectors described previously 16 18
0.30958837.10644726.html.plaintext.txt	43	LTR CAT Sp1mut LTR CAT BSp1 pCMVp53 gift Dr
0.30958837.10644726.html.plaintext.txt	44	The GST COUP 1 GST COUP 3 vectors described 18
0.30958837.10644726.html.plaintext.txt	45	To construct T7 Tat Tat fragment excised pCMV Tat vector gift Dr
0.30958837.10644726.html.plaintext.txt	46	Israel Institut Pasteur Paris France subcloned pCDNA3 vector Invitrogen
0.30958837.10644726.html.plaintext.txt	47	To construct T7 COUP TF plasmid RSV COUP TF gift Dr
0.30958837.10644726.html.plaintext.txt	48	Tsai Houston TX digested EcoRI COUP TF insert subcloned EcoRI site pCDNA3
0.30958837.10644726.html.plaintext.txt	49	To construct pCMV Tat 72R P18IS Tat 72R P18IS sequence Dr
0.30958837.10644726.html.plaintext.txt	50	Rice AIDS Research Reference Reagent Program Division AIDS NIAID National Institutes Health excised GST Tat 72R P18IS vector subcloned pCDNA3 vector
0.30958837.10644726.html.plaintext.txt	51	To construct 4080 SV40 TATA CAT vector 4080 HIV 1 LTR containing HIV 1 LAI TATA box TATAAGC mutated PCR SV40 virus TATA box TATTTAT subcloned pMOSBlue T vector Amersham Pharmacia Biotech
0.30958837.10644726.html.plaintext.txt	52	6 kilobase region containing CAT reporter gene polyadenylation signals subcloned HindIII site front modified 4080 LTR
0.30958837.10644726.html.plaintext.txt	53	Cell Culture Transfections CAT Assays Two types microglial cell cultures tested primary cells cell line
0.30958837.10644726.html.plaintext.txt	54	Primary human fetal microglial cells prepared described previously 37
0.30958837.10644726.html.plaintext.txt	55	They plated 6 cm diameter dishes transfected either calcium phosphate precipitation method Escort reagent Sigma following manufacturers instructions
0.30958837.10644726.html.plaintext.txt	56	The human microglial cell line 38 grown Dulbeccos modified Eagles medium supplemented 10 fetal calf serum 10 mM HEPES presence penicillin streptomycin 100 unitsml transfected calcium phosphate coprecipitation method
0.30958837.10644726.html.plaintext.txt	57	Cells either transfected 1 pmol plasmid reporter DNA cotransfected 1 pmol reporter DNA 0
0.30958837.10644726.html.plaintext.txt	58	5 pmol indicated expression vector RSV COUP TF gift Dr
0.30958837.10644726.html.plaintext.txt	59	Tsai Houston TX CMV p53 gift Dr
0.30958837.10644726.html.plaintext.txt	60	Sawaya Philadelphia PA pEF NF IL6 gift Dr
0.30958837.10644726.html.plaintext.txt	61	Akira Hyogo Japan CMV Sp1 gift Dr
0.30958837.10644726.html.plaintext.txt	62	Each transfection done duplicate repeated minimum three separate times two different plasmid preparations
0.30958837.10644726.html.plaintext.txt	63	CAT assays done using standard techniques 16
0.30958837.10644726.html.plaintext.txt	64	Infection Cells RT PCR Analysis Primary cells 3 4 x 105 incubated HIV 1 LAI 95
0.30958837.10644726.html.plaintext.txt	65	33 titer 15 20 ngml p24 18 h 37 degrees C washed four times remove residual virus
0.30958837.10644726.html.plaintext.txt	66	When indicated cells transfected 18 h postinfection
0.30958837.10644726.html.plaintext.txt	67	At 24 48 h posttransfection total RNA prepared RNable kit Eurobio gp120 mRNA detection performed RT PCR analysis using gp120 5 biotinylated primer TAGGACGAGCAATGTATGCC 0
0.30958837.10644726.html.plaintext.txt	68	25 pmol 3 primer TATATAATTCACTTCTCCAATTGTCCCTCAT 0
0.30958837.10644726.html.plaintext.txt	69	PCR performed 50 microl PCR mixture containing 10 nmol dNTP 0
0.30958837.10644726.html.plaintext.txt	70	25 units Taq DNA polymerase AmpliTaq gold Perkin Elmer
0.30958837.10644726.html.plaintext.txt	71	PCR products visualized ethidium bromide staining agarose gel electrophoresis
0.30958837.10644726.html.plaintext.txt	72	Immunocytochemistry Primary cells incubated HIV 1 LAI transfected described tested immunochemistry 24 h posttransfection fixation acetone 8 min
0.30958837.10644726.html.plaintext.txt	73	Primary antibodies mouse IgG1 directed HIV 1 p24 HIV 1 Tat 1200 AIDS Research Reference Reagent Program Rockville MD
0.30958837.10644726.html.plaintext.txt	74	The immunostaining revealed secondary peroxidase conjugated antibodies visualized diaminobenzidine 0
0.30958837.10644726.html.plaintext.txt	75	GST Pull Assays GST GST fusion proteins expressed Escherichia coli BL 21DE3
0.30958837.10644726.html.plaintext.txt	76	GST Tat expression vectors obtained AIDS Research Reference Reagent Program Division AIDS NIAID National Institutes Health Dr
0.30958837.10644726.html.plaintext.txt	77	Overnight cultures bacteria newly transformed plasmids diluted 20 volumes medium cultured several hours absorbance 600 nm 0
0.30958837.10644726.html.plaintext.txt	78	4 mM isopropyl D thiogalactopyranoside 37 degrees C 3 h
0.30958837.10644726.html.plaintext.txt	79	Bacteria 125 ml culture harvested resuspended 1
0.30958837.10644726.html.plaintext.txt	80	5 ml NETN 20 mM Tris pH 8 100 mM NaCl 1 mM EDTA 0
0.30958837.10644726.html.plaintext.txt	81	5 Nonidet P 40 10 microg leupeptin per ml 10 microg pepstatin per ml 10 microg aprotinin per ml 1 mM phenylmethylsulfonyl fluoride
0.30958837.10644726.html.plaintext.txt	82	The lysates sonicated centrifugation supernatants mixed glutathione Sepharose 8A beads 40 microl Pharmacia 4 degrees C overnight NETN buffer
0.30958837.10644726.html.plaintext.txt	83	The 35S labeled input Tat COUP TF protein prepared vitro translation using TNT T7 system Promega according manufacturers suggestions
0.30958837.10644726.html.plaintext.txt	84	The coated beads 40 microl washed NETN incubated 2 h 4 degrees C 15 microl total vitro translated protein reaction mixture final volume 300 microl binding buffer 50 mM Tris HCl pH 7
0.30958837.10644726.html.plaintext.txt	85	02 bovine serum albumin containing antiproteases NETN
0.30958837.10644726.html.plaintext.txt	86	After extensive washing washing buffer 50 mM Tris HCl pH 7
0.30958837.10644726.html.plaintext.txt	87	02 Tween 20 containing antiproteases bound proteins dissociated boiling 3 min Laemmli sample buffer subjected SDS polyacrylamide gel electrophoresis
0.30958837.10644726.html.plaintext.txt	88	Immunoprecipitations Western Blot Analysis Lysates prepared cells plated 10 cm dish described 18
0.30958837.10644726.html.plaintext.txt	89	Cell lysates resuspended 400 microl TNE 50 mM Tris pH 8
0.30958837.10644726.html.plaintext.txt	90	0 1 Nonidet 2 mM EDTA mixture protease inhibitors mixed protein A agarose beads 20 microl gently shaken 1 h 4 degrees C
0.30958837.10644726.html.plaintext.txt	91	The suspension briefly centrifuged supernatant mixed 3 microl monoclonal antibodies HIV 1 BH10 Tat obtained AIDS Research Reference Reagent Program Division AIDS NIAID National Institutes Health Drs
0.30958837.10644726.html.plaintext.txt	92	After overnight incubation 4 degrees C protein A agarose 30 microl added mixed 2 h
0.30958837.10644726.html.plaintext.txt	93	After extensive washing beads TNE 15 microl beads mixed 5 microl Buffer Z 20 mM HEPES pH 7
0.30958837.10644726.html.plaintext.txt	94	5 mM EDTA 1 mM dithiothreitol 10 glycerol processed Western blotting COUP TF antibodies gift Dr
0.30958837.10644726.html.plaintext.txt	95	Karathanasis Philadelphia PA
0.30958837.10644726.html.plaintext.txt	96	Run Analysis Microglial cells harvested suspended lysis Buffer A 0
0.30958837.10644726.html.plaintext.txt	97	3 M sucrose 60 mM KCl 15 mM NaCl 15 mM Tris pH 7
0.30958837.10644726.html.plaintext.txt	98	5 mM EGTA 14 mM mercaptoethanol spun 1500 x g 5 min
0.30958837.10644726.html.plaintext.txt	99	The pellet resuspended 3 ml Buffer B Buffer A plus 0
0.30958837.10644726.html.plaintext.txt	100	1 Triton X poured gently 4 ml Buffer C Buffer A 0
0.30958837.10644726.html.plaintext.txt	101	7 M sucrose spun 2500 x g 10 min
0.30958837.10644726.html.plaintext.txt	102	The permeabilized nuclei resuspended storage Buffer D 50 mM HEPES pH 8 1 mM MgCl2 0
0.30958837.10644726.html.plaintext.txt	103	5 mM dithiothreitol 1 mgml bovine serum albumin 25 glycerol stored 80 degrees C
0.30958837.10644726.html.plaintext.txt	104	1 microg CAT LTR CAT HindIII excised total CAT gene 1 microg CAT I 4079 LTR CAT AlwNIHindIII fragment 1 microg CAT II 79229 HindIIIPvuII CAT fragment excised LTR CAT vector single stranded applied onto nitrocellulose filter preincubated 2 M ammonium acetate
0.30958837.10644726.html.plaintext.txt	105	After 2 h vacuum oven 80 degrees C filters washed 1 x SSC 0
0.30958837.10644726.html.plaintext.txt	106	1 SDS prehybridized 1 h reaction buffer 50 mM HEPES pH 8 1 mM MgCl2 2 mM MnCl2 4 mM dithiothreitol 200 mM KCl 300 mM NH4Cl containing 20 microgml tRNA
0.30958837.10644726.html.plaintext.txt	107	Filters boiled 1 min cooled ice cold water use stored plastic bag 4 degrees C
0.30958837.10644726.html.plaintext.txt	108	The elongation reaction carried 50 microl isolated permeabilized nuclei 20 min 26 degrees C reaction buffer supplemented 1 microg LTR CAT vector 200 microCi 32PUTP 0
0.30958837.10644726.html.plaintext.txt	109	5 mM NTP 30 units RNasin inhibitor New England Biolabs
0.30958837.10644726.html.plaintext.txt	110	The mRNA transcripts phenol extracted precipitated successively 10 ww trichloroacetic acid ethanol
0.30958837.10644726.html.plaintext.txt	111	The pellet dissolved 10 mM Tris pH 7
0.30958837.10644726.html.plaintext.txt	112	5 supplemented 1 SDS applied previously prepared nitrocellulose filters hybridization buffer 0
0.30958837.10644726.html.plaintext.txt	113	5 mM NaCl 50 mM PIPES pH 7 33 formamide 0
0.30958837.10644726.html.plaintext.txt	114	4 SDS 2 mM EDTA 20 microgml tRNA incubated 45 degrees C 72 h
0.30958837.10644726.html.plaintext.txt	115	Filters washed twice 2 x SSC 0
0.30958837.10644726.html.plaintext.txt	116	1 SDS room temperature 30 min twice 0
0.30958837.10644726.html.plaintext.txt	117	1 SDS 55 degrees C 15 min
0.30958837.10644726.html.plaintext.txt	118	Filters exposed overnight BIOMAX MR film Eastman Kodak Co
0.30958837.10644726.html.plaintext.txt	119	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.30958837.10644726.html.plaintext.txt	120	COUP TF Stimulates HIV 1 Transcription Primary Human Microglial Cells We previously shown transcription factor COUP TF stimulates HIV 1 LTR driven transcription microglial cell line 18
0.30958837.10644726.html.plaintext.txt	121	Because also detected endogenous COUP TF primary cultures microglial cells results shown appeared essential examine COUP TF regulates HIV 1 gene transcription viral replication cells
0.30958837.10644726.html.plaintext.txt	122	Transfection experiments performed LTR CAT reporter vector primary cultures microglial cells containing CAT gene control HIV 1 LTR region
0.30958837.10644726.html.plaintext.txt	123	When cells cultured absence cytokine stimulation transfected calcium coprecipitation method basal transcriptional activity barely detectable Fig
0.30958837.10644726.html.plaintext.txt	124	This consistent recent results showed HIV 1 expression cultured microglial cells dependent prestimulation proinflammatory cytokines 37
0.30958837.10644726.html.plaintext.txt	125	Upon cotransfection COUP TF expression vector LTR driven CAT expression induced 20 fold
0.30958837.10644726.html.plaintext.txt	126	As control overexpression tumor suppressor p53 known repress HIV 1 transcription 41 induce CAT activity Fig
0.30958837.10644726.html.plaintext.txt	127	When cells transfected cationic liposome Fig
0.30958837.10644726.html.plaintext.txt	128	1B transfection efficiency better
0.30958837.10644726.html.plaintext.txt	129	The basal transcription activity remained quite low
0.30958837.10644726.html.plaintext.txt	130	Interestingly level induction following COUP TF overexpression 19 fold similar one obtained Fig
0.30958837.10644726.html.plaintext.txt	131	Moreover upon overexpression positive transactivators Sp1 NF IL6 CAT activity induced 25 27 fold
0.30958837.10644726.html.plaintext.txt	132	These results confirm similar situation observed brain cell lines COUP TF Sp1 NF IL6 function HIV 1 transcriptional activators primary microglia
0.30958837.10644726.html.plaintext.txt	133	View larger version 48K Fig
0.30958837.10644726.html.plaintext.txt	134	COUP TF stimulates HIV 1 LTR driven transcription primary cultured human microglial cells
0.30958837.10644726.html.plaintext.txt	135	Transfection experiments performed primary microglia HIV 1 LTR CAT vector absence presence vector expressing COUP TF p53 NF IL6 Sp1 indicated
0.30958837.10644726.html.plaintext.txt	136	One typical CAT assay shown transfection calcium phosphate coprecipitation method A Escort reagent Sigma B
0.30958837.10644726.html.plaintext.txt	137	At top autoradiograms indicated percentage conversion acetylated forms chloramphenicol CAT activities expressed relative value obtained LTR CAT reporter vector alone
0.30958837.10644726.html.plaintext.txt	138	COUP TF Stimulates Initiation Step HIV 1 Gene Transcription To investigate step COUP TF enhances HIV 1 gene expression performed run assays using isolated nuclei microglial cells transfected COUP TF left untransfected Fig
0.30958837.10644726.html.plaintext.txt	139	In absence COUP TF overexpression transcription CAT reporter gene low overexpression COUP TF led large increase transcription rate Fig
0.30958837.10644726.html.plaintext.txt	140	2A confirming transcriptional stimulatory activity
0.30958837.10644726.html.plaintext.txt	141	To test whether COUP TF acted initiation elongation step transcription run assays performed CAT I 4079 LTR CAT AlwNIHindIII fragment CAT II 79229 HindIIIPvuII CAT fragment
0.30958837.10644726.html.plaintext.txt	142	COUP TF increased amount small mRNAs amount transcripts CAT I higher CAT II Fig
0.30958837.10644726.html.plaintext.txt	143	This result indicates COUP TF acts initiation step transcription
0.30958837.10644726.html.plaintext.txt	144	View larger version 12K Fig
0.30958837.10644726.html.plaintext.txt	145	Microglial cells transfected COUP TF expression vector left untransfected
0.30958837.10644726.html.plaintext.txt	146	Nuclei permeabilized subjected 15 min vitro transcription assay
0.30958837.10644726.html.plaintext.txt	147	A two aliquots 1 microg CAT gene excised LTR CAT vector spotted onto nitrocellulose papers used hybridization assays described Materials Methods
0.30958837.10644726.html.plaintext.txt	148	B aliquots 1 microg CAT I 4079 LTR CAT AlwNIHindIII DNA fragment CAT II 79229 HindIIIPvuII LTR CAT DNA fragment spotted onto nitrocellulose paper indicated Materials Methods used hybridization assays
0.30958837.10644726.html.plaintext.txt	149	COUP TF Stimulates Replication Primary Human Microglial Cells To investigate effect COUP TF viral replication devised novel experimental procedure
0.30958837.10644726.html.plaintext.txt	150	Primary cultures microglial cells first infected either lymphotropic LAI macrophage tropic 95
0.30958837.10644726.html.plaintext.txt	151	After 18 h cells either treated transfection reagent alone transfected COUP TF vector
0.30958837.10644726.html.plaintext.txt	152	Expression viral gp120 mRNA 24 48 h monitored RT PCR analysis
0.30958837.10644726.html.plaintext.txt	153	Results clearly showed overexpression COUP TF induces gp120 expression peaking 24 h similar expression obtained T lymphocytes Fig
0.30958837.10644726.html.plaintext.txt	154	As control transfection vector expressing tumor suppressor p53 known repress LTR driven transcription 42 induce gp120 expression results shown
0.30958837.10644726.html.plaintext.txt	155	View larger version 22K Fig
0.30958837.10644726.html.plaintext.txt	156	COUP TF stimulates HIV 1 mRNA production primary cultured human microglial cells
0.30958837.10644726.html.plaintext.txt	157	Cells 4 x 105 infected HIV 1LAI 18 h transfected COUP TF vector left untransfected
0.30958837.10644726.html.plaintext.txt	158	Expression HIV 1 gp120 mRNA measured 24 48 h posttransfection RT PCR analysis
0.30958837.10644726.html.plaintext.txt	159	PCR products visualized gel electrophoresis
0.30958837.10644726.html.plaintext.txt	160	HIV 1 gp120 mRNA detected 160 base pair fragment 160 base pairs
0.30958837.10644726.html.plaintext.txt	161	mRNA infected T cells used control
0.30958837.10644726.html.plaintext.txt	162	In addition performed immunocytochemistry experiments primary cultured microglial cells infected HIV 1 transfected COUP TF vector left untransfected
0.30958837.10644726.html.plaintext.txt	163	The percentage transfected cells Escort reagent determined transfection green fluorescent protein 5 10 results shown
0.30958837.10644726.html.plaintext.txt	164	Results showed cells transfected COUP TF expressed HIV 1 antigen proteins p24 Fig
0.30958837.10644726.html.plaintext.txt	165	As control cells infected transfected COUP TF express HIV 1 antigen Fig
0.30958837.10644726.html.plaintext.txt	166	4 B D selected area transfected cells cells expressing viral antigens found mostly clusters scattered preparation
0.30958837.10644726.html.plaintext.txt	167	Taken together findings demonstrate consistent effect transcription overexpression COUP TF able initiate viral replication
0.30958837.10644726.html.plaintext.txt	168	Interestingly effect observed lymphotropic strain HIV 1 otherwise replicates poorly microglia macrophage tropic strain
0.30958837.10644726.html.plaintext.txt	169	View larger version 160K Fig
0.30958837.10644726.html.plaintext.txt	170	COUP TF stimulates HIV 1 replication primary cultured human microglial cells
0.30958837.10644726.html.plaintext.txt	171	Immunostaining anti p24 HIV 1 antigen microglial cells infected HIV 1 LAI either left untransfected A transfected COUP TF B
0.30958837.10644726.html.plaintext.txt	172	Photographs low magnification x 100 show staining brown cluster transfected cells whereas control infected cells remained unstained
0.30958837.10644726.html.plaintext.txt	173	At higher magnification x 400 aspect infected transfected cells stained either anti p24 HIV 1 antigen C anti Tat HIV 1 antigen D
0.30958837.10644726.html.plaintext.txt	174	Effect COUP TF HIV 1 Expression Presence Viral Tat It well established early phase HIV infection dramatic increase transcription results accumulation viral protein Tat 14 20
0.30958837.10644726.html.plaintext.txt	175	We therefore investigated COUP TF affects LTR driven transcription presence Tat
0.30958837.10644726.html.plaintext.txt	176	Because transcription results obtained primary cells could compared obtained microglial cell line 38 used cell line perform series experiments necessitated large number cells
0.30958837.10644726.html.plaintext.txt	177	Microglial cells transfected various LTR CAT reporter vectors presented Fig
0.30958837.10644726.html.plaintext.txt	178	5 either alone presence vectors expressing COUP TF Tat combination vectors
0.30958837.10644726.html.plaintext.txt	179	View larger version 25K Fig
0.30958837.10644726.html.plaintext.txt	180	Tat COUP TF synergistically activate HIV 1 gene transcription directed NF B Sp1 deleted mutated LTR region
0.30958837.10644726.html.plaintext.txt	181	Microglial cells cotransfected indicated LTR CAT expression vectors 1 pmol presence absence vectors expressing COUP TF 2 microg Tat 10 ng indicated
0.30958837.10644726.html.plaintext.txt	182	Histograms represent CAT activities expressed relative value obtained corresponding LTR CAT reporter vector
0.30958837.10644726.html.plaintext.txt	183	Values correspond average least three independent experiments done duplicate
0.30958837.10644726.html.plaintext.txt	184	With LTR CAT containing full length 48980 LTR region COUP TF alone activated transcription 4 fold
0.30958837.10644726.html.plaintext.txt	185	Tat alone combination COUP TF activated transcription 30 fold results shown
0.30958837.10644726.html.plaintext.txt	186	As shown previously truncated 6880 region containing two Sp1 sites TATA box still able mediate COUP TF responsiveness Fig
0.30958837.10644726.html.plaintext.txt	187	5 lane 2 result direct interaction COUP TF Sp1 protein 18
0.30958837.10644726.html.plaintext.txt	188	With 6880 LTR CAT vector Tat alone combination COUP TF stimulated CAT activity 35 fold Fig
0.30958837.10644726.html.plaintext.txt	189	Deletion TAR region binding site Tat 43 6829LTR CAT significantly affect COUP TF mediated stimulation Fig
0.30958837.10644726.html.plaintext.txt	190	5 lane 6 expected abolished Tat induced activation lanes 7 8
0.30958837.10644726.html.plaintext.txt	191	Deletion mutation Sp1 sites truncated 4080 LTR 28380 LTRSp1mut 28380BSp1 led abolition COUP TF induced activation Fig
0.30958837.10644726.html.plaintext.txt	192	5 lanes 10 14 18 Sp1 required COUP TF transactivation microglial cells 18 similarly Tat induced activation abolished lanes 11 15 19 Sp1 required efficient Tat transactivation 26 28
0.30958837.10644726.html.plaintext.txt	193	Surprisingly overexpression combination Tat COUP TF resulted 8 14 fold transcriptional stimulation lanes 12 16 20
0.30958837.10644726.html.plaintext.txt	194	To determine whether COUP TFTat cooperation requires cognate HIV 1 TATAA region constructed vector containing 4080 LTR region HIV 1 TATA sequence TATAAGC replaced SV40 TATA box TATTTAT
0.30958837.10644726.html.plaintext.txt	195	Transfection experiments performed 4080 SV40 TATA CAT vector showed COUP TF Tat overexpression unable stimulate transcription similar results obtained nonmutated vector
0.30958837.10644726.html.plaintext.txt	196	However overexpression COUP TF Tat presence mutated vector lead increase CAT activity indicating COUP TF able discriminate different versions TATAAs result shown
0.30958837.10644726.html.plaintext.txt	197	These findings reveal functional synergism COUP TF Tat able transactivate LTR absence NF B Sp1 sites
0.30958837.10644726.html.plaintext.txt	198	These results suggest Tat COUP TF able interact directly indirectly
0.30958837.10644726.html.plaintext.txt	199	Domains COUP TF Tat Involved Synergistic Transcriptional Activation To investigate region COUP TF involved synergistic effect Tat used pRSV COUPdel148 vector expressing C terminal truncated form COUP TF
0.30958837.10644726.html.plaintext.txt	200	Transfection experiments performed 6880 LTR CAT pRSV COUPdel148 presence absence CMV Tat Fig
0.30958837.10644726.html.plaintext.txt	201	The truncated COUP TF unable stimulate CAT activity lane 2 shown previously C terminal domain COUP TF essential transcriptional activity 18
0.30958837.10644726.html.plaintext.txt	202	Interestingly presence Tat overexpression truncated COUP TF led 50 inhibition Tat mediated activation lane 4
0.30958837.10644726.html.plaintext.txt	203	This result reveals dominant negative role C terminal truncated protein Tat activity well importance C terminal region synergistic effect Tat
0.30958837.10644726.html.plaintext.txt	204	View larger version 41K Fig
0.30958837.10644726.html.plaintext.txt	205	Domains COUP TF Tat involved synergistic transcriptional activation
0.30958837.10644726.html.plaintext.txt	206	A microglial cells transfected 1 pmol 6880 LTR CAT vector 0
0.30958837.10644726.html.plaintext.txt	207	5 pmol pRSV COUPdel148 lane 2 presence lane 4 absence lane 3 10 ng CMV Tat
0.30958837.10644726.html.plaintext.txt	208	B cells transfected 0
0.30958837.10644726.html.plaintext.txt	209	5 pmol pCMV Tat 72RP18IS vector expressing transactivation negative Tat protein presence lane 4 absence lane 3 0
0.30958837.10644726.html.plaintext.txt	210	Histograms represent CAT activities expressed relative value obtained corresponding 6880 LTR CAT reporter vector
0.30958837.10644726.html.plaintext.txt	211	Values correspond average least three independent experiments done duplicate
0.30958837.10644726.html.plaintext.txt	212	To examine role transactivation negative form Tat COUP TF activity performed cotransfection experiments using 6880 LTR CAT pCMV Tat 72RP18IS expressing transactivation negative Tat protein presence absence RSV COUP TF Fig
0.30958837.10644726.html.plaintext.txt	213	As expected transactivation negative Tat mutant unable stimulate CAT activity lane 3
0.30958837.10644726.html.plaintext.txt	214	Interestingly overexpression Tat mutant led 50 inhibition COUP TF mediated transcriptional stimulation lane 4
0.30958837.10644726.html.plaintext.txt	215	This result suggests mutated form Tat able inhibit binding COUP TF Sp1 proteins either masking DBD domain COUP TF competing interactions Sp1
0.30958837.10644726.html.plaintext.txt	216	COUP TF Tat Interact Vitro Cells To decipher mechanism whereby COUP TF Tat mediate Sp1 B independent transcriptional synergistic activation examined whether COUP TF Tat interact vitro
0.30958837.10644726.html.plaintext.txt	217	We performed GST pull experiments GST COUP fusion proteins 35S labeled Tat
0.30958837.10644726.html.plaintext.txt	218	Results showed 35S labeled Tat Fig
0.30958837.10644726.html.plaintext.txt	219	7B lane 1 associates GST COUP 1 fusion protein lane 3
0.30958837.10644726.html.plaintext.txt	220	Under experimental conditions 1 2 total added Tat bound GST COUP
0.30958837.10644726.html.plaintext.txt	221	This association specific Tat bound GST COUP 1 control GST protein alone Fig
0.30958837.10644726.html.plaintext.txt	222	To localize domain COUP TF mediates interaction Tat used GST COUP 3 expression vector encoding residues 49 148 COUP TF
0.30958837.10644726.html.plaintext.txt	223	The truncated GST COUP 3 still able mediate association Tat Fig
0.30958837.10644726.html.plaintext.txt	224	7A lane 4 indicating N terminal part COUP TF containing DNA binding domain Fig
0.30958837.10644726.html.plaintext.txt	225	7A sufficient interaction Tat vitro
0.30958837.10644726.html.plaintext.txt	226	View larger version 38K Fig
0.30958837.10644726.html.plaintext.txt	227	The viral protein Tat nuclear receptor COUP TF interact vitro vivo
0.30958837.10644726.html.plaintext.txt	228	A schematic representation domains present Tat protein GST COUP TF constructs
0.30958837.10644726.html.plaintext.txt	229	B GST COUP 1 3 fusion proteins interact vitro translated 35S Tat GST pull assays
0.30958837.10644726.html.plaintext.txt	230	35S Tat 1 microl lane 1 translated wheat germ lysate using TNT kit Promega incubated bacterially expressed GST 5 microg lane 2 GST COUP 1 3 3 microg lanes 3 4 immobilized glutathione Sepharose beads
0.30958837.10644726.html.plaintext.txt	231	After extensive washing bound proteins eluted analyzed SDS polyacrylamide gel electrophoresis followed autoradiography
0.30958837.10644726.html.plaintext.txt	232	Lane 1 input Tat 1 microl lanes 2 4 GST GST COUP incubated 35S Tat 15 microl
0.30958837.10644726.html.plaintext.txt	233	C interactions vitro translated 35S COUP TF different GST Tat mutants GST pull assays
0.30958837.10644726.html.plaintext.txt	234	1 microl lane 1 incubated GST 5 microg lane 2 GST Tat proteins 3 microg lanes 3 7 immobilized glutathione Sepharose beads
0.30958837.10644726.html.plaintext.txt	235	After washing bound proteins eluted analyzed SDS polyacrylamide gel electrophoresis followed autoradiography
0.30958837.10644726.html.plaintext.txt	236	1 microl lanes 2 7 GST GST Tat mutants incubated 35S COUP TF 15 microl
0.30958837.10644726.html.plaintext.txt	237	D co immunoprecipitation Tat COUP TF
0.30958837.10644726.html.plaintext.txt	238	Nuclear extracts microglial cells previously transfected CMV Tat immunoprecipitated monoclonal anti Tat antibodies
0.30958837.10644726.html.plaintext.txt	239	Nuclear protein extracts 10 microg lane 1 immunoprecipitates 50 microg nuclear proteins lanes 2 3 analyzed presence COUP TF Western blot analysis
0.30958837.10644726.html.plaintext.txt	240	The Tat protein composed distinct structural domains presented Fig
0.30958837.10644726.html.plaintext.txt	241	We examined domain Tat associates COUP TF using various GST Tat mutants
0.30958837.10644726.html.plaintext.txt	242	7C shows GST fusion proteins containing 86R Tat lane 3 truncated 72R Tat lane 4 mutant 72RP18IS Tat containing exon 1 insertion amino acids 18 19 lane 5 able interact COUP TF contrast GST fusion proteins Tat 48 48P18IS truncated amino acid 48 unable bind COUP TF lanes 6 7 similar GST control lane 2
0.30958837.10644726.html.plaintext.txt	243	About 1 2 total added COUP bound GST Tat
0.30958837.10644726.html.plaintext.txt	244	These results indicate vitro association Tat COUP TF depend exon 2 requires Tat region located amino acids 48 72
0.30958837.10644726.html.plaintext.txt	245	This region formed basic domain amino acids 48 58 known mediate specific binding TAR RNA C terminal domain amino acids 58 72
0.30958837.10644726.html.plaintext.txt	246	We next investigated whether COUP TF Tat able associate within cells
0.30958837.10644726.html.plaintext.txt	247	Microglial cells transfected CMV Tat expression vector Fig
0.30958837.10644726.html.plaintext.txt	248	7D lane 3 left untransfected lane 2
0.30958837.10644726.html.plaintext.txt	249	Nuclear extracts used co immunoprecipitation experiments
0.30958837.10644726.html.plaintext.txt	250	The ability monoclonal anti Tat antibodies coimmunoprecipitate COUP TF protein visualized Western blotting COUP TF antibodies Fig
0.30958837.10644726.html.plaintext.txt	251	These data confirm existence direct association Tat COUP TF within cells
0.30958837.10644726.html.plaintext.txt	252	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.30958837.10644726.html.plaintext.txt	253	In present work established importance nuclear receptor COUP TF activator HIV 1 gene transcription replication primary microglia main target HIV 1 brain
0.30958837.10644726.html.plaintext.txt	254	Overexpression COUP TF able stimulate viral expression macrophage tropic 95
0.30958837.10644726.html.plaintext.txt	255	33 strain also lymphotropic LAI HIV 1 strain previously described poorly replicate microglia 44
0.30958837.10644726.html.plaintext.txt	256	Our findings highlight unexpected role COUP TF appears possess transactive ability similar transcription factors Sp1 NF IL6
0.30958837.10644726.html.plaintext.txt	257	These nuclear factors essential inducing HIV 1 gene transcription immediate early phase HIV infection viral transcription proceeds low rate prior participation viral activating proteins
0.30958837.10644726.html.plaintext.txt	258	Our run data show COUP TF stimulates transcription acting level initiation
0.30958837.10644726.html.plaintext.txt	259	The action cellular proteins leads early phase HIV infection production viral protein Tat 14 20
0.30958837.10644726.html.plaintext.txt	260	By series vitro vivo experiments demonstrated existence novel physical functional interaction transcription factor COUP TF viral transactivator Tat
0.30958837.10644726.html.plaintext.txt	261	In vitro GST pull experiments indicate N terminal part COUP TF containing DNA binding domain sufficient interaction Tat
0.30958837.10644726.html.plaintext.txt	262	In vitro association Tat COUP TF depend exon 2 requires Tat region located amino acids 48 72 formed basic domain mediates specific binding TAR RNA C terminal domain amino acids 58 72
0.30958837.10644726.html.plaintext.txt	263	Interestingly regions involved protein protein interaction similar described thyroid hormone receptor another member nuclear receptor superfamily
0.30958837.10644726.html.plaintext.txt	264	T3R also interacts Tat amino acids present DNA binding domain receptor basic C terminal regions Tat involved binding T3R 32
0.30958837.10644726.html.plaintext.txt	265	In addition data obtained microglial cells transfected Tat expression vector confirm Tat COUP TF able interact directly within cells
0.30958837.10644726.html.plaintext.txt	266	Recent data showed Sp1 binds Tat amino acids 20 55 45
0.30958837.10644726.html.plaintext.txt	267	When data considered together one could suspect ternary complex COUP TF Sp1 Tat represents functionally important molecule
0.30958837.10644726.html.plaintext.txt	268	However show synergistic effect COUP TF Tat observed absence Sp1 sites whereas Sp1 COUP TF proteins lead synergistic transcriptional increase presence Sp1 sites 18
0.30958837.10644726.html.plaintext.txt	269	This suggests COUP TF interacts preferentially either Sp1 bound DNA site Tat bound TAR element
0.30958837.10644726.html.plaintext.txt	270	Moreover Tat Sp1 interact N terminal region COUP TF strengthens idea binary complexes COUP TFSp1 COUP TFTat functionally important
0.30958837.10644726.html.plaintext.txt	271	A number reports demonstrated Sp1 B sequences required TAR dependent transactivation Tat 26 28 31 33
0.30958837.10644726.html.plaintext.txt	272	Here studies various LTR mutants reveal interaction COUP TF Tat lead NF B Sp1 independent enhanced transactivation HIV 1 LTR presence intact TAR element
0.30958837.10644726.html.plaintext.txt	273	Previous reports shown replication HIV 1 Sp1 sites deleted efficient MT4 lymphocytes activated peripheral blood lymphocytes appeared require NF B substitute Sp1 46
0.30958837.10644726.html.plaintext.txt	274	Here data suggest alternative regulatory pathway Tat transactivation microglia independent NF B Sp1 direct interactions Tat nuclear receptor COUP TF
0.30958837.10644726.html.plaintext.txt	275	The following model may account interaction nuclear receptor COUP TF viral Tat regulating HIV 1 LTR
0.30958837.10644726.html.plaintext.txt	276	In presence Sp1 sites DNA binding domain COUP TF associates Sp1 protein bound DNA binding site 18
0.30958837.10644726.html.plaintext.txt	277	In situation COUP TF unable interact Tat thus unable synergize Tat
0.30958837.10644726.html.plaintext.txt	278	In contrast absence Sp1 sites COUP TF appears able recruit Tat substitute Sp1 protein
0.30958837.10644726.html.plaintext.txt	279	However effect TAR dependent requires binding Tat TAR
0.30958837.10644726.html.plaintext.txt	280	As shown DNA binding domain COUP TF binds Tat whereas C terminus COUP TF interacts general transcription factor TFIIB described previously 47
0.30958837.10644726.html.plaintext.txt	281	These interactions may thus anchor Tat transcriptional apparatus
0.30958837.10644726.html.plaintext.txt	282	However recruitment insufficient Tat activity permit TAR independent transactivation
0.30958837.10644726.html.plaintext.txt	283	It clear precise molecular mechanisms need investigated
0.30958837.10644726.html.plaintext.txt	284	The nuclear receptor COUP TF known ubiquitously expressed including T lymphocytes main target HIV 1 immune system
0.30958837.10644726.html.plaintext.txt	285	Similar action microglia COUP TF functions transcriptional activator lymphocytes acting Sp1 element HIV 1 LTR 48
0.30958837.10644726.html.plaintext.txt	286	Because data CNS cells revealed unexpected role COUP TF presence Tat interesting studies examine role COUP TF regulation various HIV 1 strains cells immune system
0.30958837.10644726.html.plaintext.txt	287	Israel providing vector containing LAI LTR
0.30958837.10644726.html.plaintext.txt	288	Sawaya providing expression vectors COUP TF LTR CAT mutants K
0.30958837.10644726.html.plaintext.txt	289	Karathanasis providing COUP TF antibodies
0.30958837.10644726.html.plaintext.txt	290	This work supported INSERM U338 CRI 96 12 Agence Nationale des Recherches sur le SIDA Fondation pour la Recherche Medicale Universite Paris Sud association Le Cercle dEmeraude
0.30958837.10644726.html.plaintext.txt	291	The costs publication article defrayed part payment page charges
0.30958837.10644726.html.plaintext.txt	292	The article must therefore hereby marked advertisement accordance 18 U
0.30958837.10644726.html.plaintext.txt	293	Section 1734 solely indicate fact
0.30958837.10644726.html.plaintext.txt	294	Recipient financial support association Ensemble contre le SIDA Fondation pour la Recherche Medicale Sidaction
0.30958837.10644726.html.plaintext.txt	295	To correspondence addressed Gladstone Institute Virology Immunology P
0.30958837.10644726.html.plaintext.txt	296	Box 419100 San Francisco CA 94141 9100
0.30958837.10644726.html.plaintext.txt	297	415 695 3806 Fax 415 826 1514 E mail eschaeffergladstone
0.30958837.10644726.html.plaintext.txt	298	The abbreviations used HIV 1 human immunodeficiency virus type 1 CNS central nervous system LTR long terminal repeat COUP TF chicken ovalbumin upstream promoter transcription factor CAT chloramphenicol acetyltransferase PIPES 14 piperazinediethanesulfonic acid
0.30958837.10644726.html.plaintext.txt	299	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1
0.30958837.10644726.html.plaintext.txt	300	1988 Science 239 617 622Medline Order article via Infotrieve 2
0.30958837.10644726.html.plaintext.txt	301	2 S211 S217Medline Order article via Infotrieve 3
0.30958837.10644726.html.plaintext.txt	302	1996 Virology 217 211 219CrossRefMedline Order article via Infotrieve 4
0.30958837.10644726.html.plaintext.txt	303	Retroviruses 10 1597 1607Medline Order article via Infotrieve 5
0.30958837.10644726.html.plaintext.txt	304	1988 Science 239 586 592Medline Order article via Infotrieve 9
0.30958837.10644726.html.plaintext.txt	305	1990 Science 249 549 553Medline Order article via Infotrieve 10
0.30958837.10644726.html.plaintext.txt	306	29 152 161Medline Order article via Infotrieve 11
0.30958837.10644726.html.plaintext.txt	307	1997 Nature 385 645 649CrossRefMedline Order article via Infotrieve 13
0.30958837.10644726.html.plaintext.txt	308	49 157 196Medline Order article via Infotrieve 14
0.30958837.10644726.html.plaintext.txt	309	4 291 303Medline Order article via Infotrieve 16
0.30958837.10644726.html.plaintext.txt	310	271 22895 22900AbstractFree Full Text 17
0.30958837.10644726.html.plaintext.txt	311	271 23572 23576AbstractFree Full Text 18
0.30958837.10644726.html.plaintext.txt	312	272 31149 31155AbstractFree Full Text 19
0.30958837.10644726.html.plaintext.txt	313	1989 Nature 340 163 166CrossRefMedline Order article via Infotrieve 20
0.30958837.10644726.html.plaintext.txt	314	193 51 77Medline Order article via Infotrieve 21
0.30958837.10644726.html.plaintext.txt	315	1996 Nature 384 375 378CrossRefMedline Order article via Infotrieve 23
0.30958837.10644726.html.plaintext.txt	316	11 2633 2644AbstractFree Full Text 25
0.30958837.10644726.html.plaintext.txt	317	1998 Cell 92 451 462Medline Order article via Infotrieve 26
0.30958837.10644726.html.plaintext.txt	318	1986 Science 232 755 759Medline Order article via Infotrieve 28
0.30958837.10644726.html.plaintext.txt	319	1990 Cell 62 757 767Medline Order article via Infotrieve 35
0.30958837.10644726.html.plaintext.txt	320	CO2 2 2 GlinktypeDOI CrossRefMedline Order article via Infotrieve
0.30958837.10644726.html.plaintext.txt	321	Copyright 2000 The American Society Biochemistry Molecular Biology Inc
0.37514272.11981036.html.plaintext.txt	0	Characterization Human PPAR Promoter Identification Functional Nuclear Receptor Response Element Ines Pineda Torra Yalda Jamshidi David M
0.37514272.11981036.html.plaintext.txt	1	Flavell Jean Charles Fruchart Bart Staels
0.37514272.11981036.html.plaintext.txt	2	545 Institut National de la Sante et de la Recherche Medicale I
0.37514272.11981036.html.plaintext.txt	3	Departement d Atherosclerose Institut Pasteur de Lille 59019 Lille Faculte de Pharmacie Universite de Lille II 59006 Lille France Centre Cardiovascular Genetics Y
0.37514272.11981036.html.plaintext.txt	4	Department Medicine Royal Free University College London Medical School The Rayne Institute London WC1E 6JJ United Kingdom
0.37514272.11981036.html.plaintext.txt	5	Address correspondence requests reprints Bart Staels U
0.37514272.11981036.html.plaintext.txt	6	545 INSERM Institut Pasteur de Lille 1 Rue Calmette BP245 59019 Lille France
0.37514272.11981036.html.plaintext.txt	7	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES PPAR nuclear receptor controls lipid glucose metabolism exerts antiinflammatory activities
0.37514272.11981036.html.plaintext.txt	8	The factors regulating human PPAR hPPAR gene expression remain largely unexplored
0.37514272.11981036.html.plaintext.txt	9	To study mechanisms controlling hPPAR expression hPPAR gene promoter identified characterized
0.37514272.11981036.html.plaintext.txt	10	First alternatively spliced exon within 5 untranslated region hPPAR gene identified RT PCR
0.37514272.11981036.html.plaintext.txt	11	Next transcription start site mapped hPPAR gene promoter cloned functionally analyzed
0.37514272.11981036.html.plaintext.txt	12	Because PPAR levels elevated tissues expressing hepatocyte nuclear factor 4 HNF4 liver regulation hPPAR HNF4 examined
0.37514272.11981036.html.plaintext.txt	13	Transient transfections HepG2 Cos cells showed HNF4 enhances hPPAR promoter activity
0.37514272.11981036.html.plaintext.txt	14	5 Deletion mutation analysis hPPAR promoter identified regulatory element RE consisting degenerate hexamer repeat single nucleotide spacer direct repeat 1 termed HNF4 RE
0.37514272.11981036.html.plaintext.txt	15	Gel shift assays demonstrated HNF4 binds HNF4 RE
0.37514272.11981036.html.plaintext.txt	16	Furthermore HNF4 increased activity heterologous promoter driven two copies HNF4 RE
0.37514272.11981036.html.plaintext.txt	17	The nuclear receptor COUP TFII also bound site regulated basal well HNF4 induced hPPAR promoter activity
0.37514272.11981036.html.plaintext.txt	18	Finally PPAR shown bind HNF4 RE leading induction PPAR expression hepatocytes
0.37514272.11981036.html.plaintext.txt	19	In summary organization 5 flanking untranslated region hPPAR gene characterized hPPAR promoter region identified
0.37514272.11981036.html.plaintext.txt	20	Furthermore data demonstrate hPPAR gene regulated nuclear receptors HNF 4 COUP TFII PPAR
0.37514272.11981036.html.plaintext.txt	21	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES PPAR NR1C1 IS ligand activated transcription factor belonging nuclear receptor superfamily regulates gene transcription heterodimerizing RXR
0.37514272.11981036.html.plaintext.txt	22	PPARRXR heterodimers bind PPAR response elements PPREs consisting direct repeat core AGGTCA sequence spaced 1 2 bp direct repeat 1 2 DR1 DR2 preceded 5 AT rich flanking sequence 1
0.37514272.11981036.html.plaintext.txt	23	In addition PPAR represses gene transcription interfering nuclear factor B NFB activating protein 1 AP1 signaling pathways DNA binding independent fashion 2
0.37514272.11981036.html.plaintext.txt	24	PPAR mediated transcriptional regulation target genes tightly controlled ligand activation
0.37514272.11981036.html.plaintext.txt	25	Fatty acid FA derivatives hypolipidemic fibrates natural synthetic PPAR ligands respectively 3
0.37514272.11981036.html.plaintext.txt	26	PPAR mediates action fibrates plasma lipid levels regulating transcription genes controlling lipoprotein metabolism 4
0.37514272.11981036.html.plaintext.txt	27	Moreover PPAR pivotal modulator intracellular lipid metabolism regulating gene expression proteins involved FA uptake FA esterification FA entry mitochondria peroxisomal mitochondrial FA catabolism ketone body synthesis 1
0.37514272.11981036.html.plaintext.txt	28	In addition intra extracellular lipid metabolism glucose energy homeostasis well body weight also reported influenced PPAR activators 5 6
0.37514272.11981036.html.plaintext.txt	29	Furthermore PPAR important regulator vascular inflammation
0.37514272.11981036.html.plaintext.txt	30	PPAR inhibits expression various inducible factors implicated promotion local inflammatory response within developing atherosclerotic plaque 2
0.37514272.11981036.html.plaintext.txt	31	In addition PPAR regulates expression lipoprotein receptors cholesterol transporters involved reverse cholesterol transport pathway macrophages 7 8
0.37514272.11981036.html.plaintext.txt	32	PPAR activators reduce plasma concentrations inflammatory cytokines vivo 9 10 reduce progression coronary atherosclerosis humans 11 12 13 14
0.37514272.11981036.html.plaintext.txt	33	In addition ligand activation transcriptional control PPAR target genes depends expression levels
0.37514272.11981036.html.plaintext.txt	34	High levels PPAR expression observed tissues elevated FA catabolic rates liver heart kidney muscle large intestine 15 16 17
0.37514272.11981036.html.plaintext.txt	35	In rodents PPAR regulated stress 18 different hormones GH glucocorticoids insulin leptin 19 20 21 22
0.37514272.11981036.html.plaintext.txt	36	PPAR expression oscillates diurnally 18 diminished age 23 induced brown adipocyte differentiation 24
0.37514272.11981036.html.plaintext.txt	37	Furthermore starvation increases PPAR expression levels liver leading changes mRNA levels PPAR target genes 25
0.37514272.11981036.html.plaintext.txt	38	Low PPAR mRNA levels result decreased PPAR activity pancreatic islets obese Zucker diabetic fafa rats 22 rat cardiomyocytes cardiac hypertrophy 26 livers male Syrian hamsters upon lipopolysaccharide administration 27 intestinal epithelial cells hypoxia 28
0.37514272.11981036.html.plaintext.txt	39	Moreover PPAR expression levels correlate human apo AI gene induction response fibrate treatment demonstrated human apo AI transgenic mice crossed PPAR deficient mice 29
0.37514272.11981036.html.plaintext.txt	40	However date studies addressing regulation PPAR gene expression largely performed either rodent cells animal models
0.37514272.11981036.html.plaintext.txt	41	Although regulation PPAR expression humans remains largely unknown observation hepatic PPAR mRNA levels vary significantly among individuals 30 31 suggests PPAR also regulated transcriptional level humans
0.37514272.11981036.html.plaintext.txt	42	Indeed hPPAR mRNA levels induced monocyte differentiation macrophages 32 high glucose concentrations regulate PPAR gene expression human macrophages healthy control subjects well type 2 diabetic patients 33
0.37514272.11981036.html.plaintext.txt	43	To understand molecular mechanisms governing PPAR regulation decided identify functionally characterize 5 flanking region hPPAR gene
0.37514272.11981036.html.plaintext.txt	44	In present manuscript transcription start site determined upstream 5 flanking region hPPAR gene identified cloned transcriptional activity examined
0.37514272.11981036.html.plaintext.txt	45	1 In course studies sequence 5 untranslated region UTR hPPAR gene completed alternatively spliced exon within 5 UTR gene identified
0.37514272.11981036.html.plaintext.txt	46	Finally hPPAR promoter activity shown regulated nuclear receptors hepatocyte nuclear factor 4 HNF4 chicken ovalbumin upstream promoter transcription factor II COUP TFII PPAR
0.37514272.11981036.html.plaintext.txt	47	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Characterization 5 UTR Structure hPPAR Gene Identification Alternatively Spliced 5 UTR Variant The hPPAR gene contains least eight exons exons 1 2 5 end exon 3 3 end exon 8 translated 34 35
0.37514272.11981036.html.plaintext.txt	48	The aim study determine 5 UTR structure hPPAR gene identify characterize hPPAR promoter
0.37514272.11981036.html.plaintext.txt	49	To identify noncoding exons within region different primers designed PCRs carried reverse transcribed human liver RNA two different subjects
0.37514272.11981036.html.plaintext.txt	50	Using approach novel exon discovered
0.37514272.11981036.html.plaintext.txt	51	When PCR performed using primer designed 3 end exon 2 primer 13 Fig
0.37514272.11981036.html.plaintext.txt	52	1A primer hybridizing 3 end exon 1 primer 15C Fig
0.37514272.11981036.html.plaintext.txt	53	1A fragment 158 bp containing exon 1 exon 2 amplified Fig
0.37514272.11981036.html.plaintext.txt	54	Additionally second fragment 150 bp longer repeatedly coamplified even stringent PCR conditions
0.37514272.11981036.html.plaintext.txt	55	Similar results obtained four human liver adipose tissue mRNA samples data shown indicating unexpected additional PCR product corresponded rather common transcript
0.37514272.11981036.html.plaintext.txt	56	Cloning sequencing PCR fragment revealed presence 156 bp novel sequence downstream sequence previously known exon 1 Fig
0.37514272.11981036.html.plaintext.txt	57	Furthermore PCR performed using primer within novel sequence primer IP3 exon 1 specific primer 15C fragment amplified indicating existence additional exon Fig
0.37514272.11981036.html.plaintext.txt	58	The novel sequence located exon 1 2 bacterial artificial chromosome BAC clone containing hPPAR gene flanked aggt consensus acceptor donor splice sites respectively Fig
0.37514272.11981036.html.plaintext.txt	59	The newly identified exon named exon 1b analogy nomenclature used alternatively spliced exon present 5 UTR mouse PPAR gene 36 whereas previously known exon 1 renamed exon 1a Fig
0.37514272.11981036.html.plaintext.txt	60	In addition 5 RACE rapid amplification cDNA ends reactions carried using primer IP3 located exon 1b gene specific primer fragment covering novel exon plus sequence corresponding exon 1a amplified data shown corroborating existence second alternative transcript containing exon 1b addition exon 1a
0.37514272.11981036.html.plaintext.txt	61	This suggests exon 1b spliced alternatively giving rise two different transcripts distinct 5 UTRs Fig
0.37514272.11981036.html.plaintext.txt	62	Thus mouse human PPAR hPPAR genes display similar 5 UTR genomic organization
0.37514272.11981036.html.plaintext.txt	63	However noncoding exons show significant degree sequence homology among species 38 exon 1a 29 exon 1b
0.37514272.11981036.html.plaintext.txt	64	View larger version 29K Figure 1
0.37514272.11981036.html.plaintext.txt	65	Intron Exon Structure 5 UTR hPPAR Gene Identification Alternative Spliced 5 UTR Variant
0.37514272.11981036.html.plaintext.txt	66	A Schematic representation 5 UTR hPPAR gene identified spliced variants
0.37514272.11981036.html.plaintext.txt	67	The first coding exon filled box 5 noncoding exons hatched boxes depicted
0.37514272.11981036.html.plaintext.txt	68	Numbers boxes represent exon length base pairs
0.37514272.11981036.html.plaintext.txt	69	Oligonucleotides used RT PCR analysis indicated arrows
0.37514272.11981036.html.plaintext.txt	70	B RT PCR analysis human liver RNA isolated two different subjects
0.37514272.11981036.html.plaintext.txt	71	Total RNA extracted reverse transcribed amplified using primers 15C 13 left 15C IP13 right
0.37514272.11981036.html.plaintext.txt	72	PCR corresponds PCR carried absence RT product
0.37514272.11981036.html.plaintext.txt	73	C Genomic sequence corresponding alternatively spliced exon 1b
0.37514272.11981036.html.plaintext.txt	74	Oligonucleotides IP3 IP7 used 5 RACE analysis indicated arrows
0.37514272.11981036.html.plaintext.txt	75	The acceptor donor splice sites depicted bold
0.37514272.11981036.html.plaintext.txt	76	Nucleotides uppercase lowercase letters correspond exon intron sequences respectively
0.37514272.11981036.html.plaintext.txt	77	Determination Transcription Start Site To determine hPPAR transcription start site 5RACE PCR analysis performed
0.37514272.11981036.html.plaintext.txt	78	Genomic sequence upstream previously reported exon 1a sequence 37 obtained primer walking BAC clone containing hPPAR gene
0.37514272.11981036.html.plaintext.txt	79	Despite overall low degree homology shown PPAR 5 UTRs among different species sequence around 60 bp found 88 homologous region close transcription start site mouse PPAR 5 UTR Fig
0.37514272.11981036.html.plaintext.txt	80	This prompted us examine whether transcription start site human gene could also upstream region
0.37514272.11981036.html.plaintext.txt	81	Accordingly primer close sequence primer IP18 Fig
0.37514272.11981036.html.plaintext.txt	82	2A used gene specific primer 5 RACE PCR
0.37514272.11981036.html.plaintext.txt	83	A 213 bp DNA fragment amplified human liver RNA Fig
0.37514272.11981036.html.plaintext.txt	84	2B subsequently sequenced
0.37514272.11981036.html.plaintext.txt	85	The 5 nucleotide poly dC tail introduced 5 RACE procedure mapped T designated nucleotide 1 Fig
0.37514272.11981036.html.plaintext.txt	86	Similar results obtained different gene specific primer primer 5 GSP used 5 RACE PCR data shown
0.37514272.11981036.html.plaintext.txt	87	To confirm results 5 RACE experiments ribonuclease RNase protection analysis performed
0.37514272.11981036.html.plaintext.txt	88	RNase mapping 337 nucleotide labeled cRNA probe complementary bp 22 213 Fig
0.37514272.11981036.html.plaintext.txt	89	2C gave major protected band 213 bp Fig
0.37514272.11981036.html.plaintext.txt	90	2D thus confirming transcription start site identified 5 RACE
0.37514272.11981036.html.plaintext.txt	91	These data indicate exon 1a considerably longer partially sequenced exon 1 previously reported 34 35 37 exon 1a identified mouse PPAR gene 36
0.37514272.11981036.html.plaintext.txt	92	View larger version 64K Figure 2
0.37514272.11981036.html.plaintext.txt	93	Mapping Transcription Start Site hPPAR Gene 5 RACE RNase Protection Analysis
0.37514272.11981036.html.plaintext.txt	94	A Sequence corresponding exon 1a 5 UTR region
0.37514272.11981036.html.plaintext.txt	95	The oligonucleotides YGSP1 IP24 IP18 5 GSP used 5 RACE RNase protection analysis cloning indicated arrows
0.37514272.11981036.html.plaintext.txt	96	The donor splice site depicted bold lowercase
0.37514272.11981036.html.plaintext.txt	97	The previously reported 5 UTR sequence 37 indicated italics
0.37514272.11981036.html.plaintext.txt	98	Transcription start site 1 shown arrow
0.37514272.11981036.html.plaintext.txt	99	The sequence bold uppercase represents region showing 88 homology rat mouse 5 UTRs see text 5 RACE products agarose gel
0.37514272.11981036.html.plaintext.txt	100	Total RNA human liver reverse transcribed cDNA poly dC tailed terminal deoxynucleotide transferase TdT described Materials Methods
0.37514272.11981036.html.plaintext.txt	101	dC tailed cDNA TdT untailed cDNA TdT amplified using universal primer AAP gene specific primer IP18
0.37514272.11981036.html.plaintext.txt	102	C Schematic representation probe used RNase protection analysis
0.37514272.11981036.html.plaintext.txt	103	A genomic DNA fragment 22 213 amplified oligonucleotides IP24 IP18 depicted panel A cloned pBluescript SK
0.37514272.11981036.html.plaintext.txt	104	Subsequently antisense RNA probe transcribed
0.37514272.11981036.html.plaintext.txt	105	The size protected fragment predicted 5 RACE experiment shown panel B indicated
0.37514272.11981036.html.plaintext.txt	106	D Mapping transcription start site RNase protection analysis
0.37514272.11981036.html.plaintext.txt	107	Autoradiograph RNase protection analysis carried 20 microg human liver total RNA extracted two different subjects
0.37514272.11981036.html.plaintext.txt	108	The protected probe fragments indicated arrow correspond predicted panel B
0.37514272.11981036.html.plaintext.txt	109	Cloning Analysis 5 Flanking Region hPPAR Gene To identify potential binding sites transcription factors may important regulation hPPAR gene expression 1
0.37514272.11981036.html.plaintext.txt	110	6 kb hPPAR sequence upstream transcription start site cloned
0.37514272.11981036.html.plaintext.txt	111	No consensus TATA CCAAT boxes found within first 100 bp although CCAAT box observed 472 bp Fig
0.37514272.11981036.html.plaintext.txt	112	Furthermore region possesses characteristics TATA less promoter namely GC rich sequences multiple putative Sp1 binding sites
0.37514272.11981036.html.plaintext.txt	113	Computer assisted analysis 38 revealed several potential transcription factor binding sites including AP2 Egr 1 Egr 2 E box NFB MZF 1 among others Fig
0.37514272.11981036.html.plaintext.txt	114	View larger version 57K Figure 3
0.37514272.11981036.html.plaintext.txt	115	Nucleotide Sequence 5 Flanking Region hPPAR Gene
0.37514272.11981036.html.plaintext.txt	116	Numbers relative transcription start site 1
0.37514272.11981036.html.plaintext.txt	117	The putative HNF4 RE underlined
0.37514272.11981036.html.plaintext.txt	118	Putative transcription factor binding sites indicated open boxes
0.37514272.11981036.html.plaintext.txt	119	Functional Characterization hPPAR Promoter To determine ability hPPAR 5 flanking region drive basal transcriptional activity sequences fused luciferase reporter gene
0.37514272.11981036.html.plaintext.txt	120	Because hPPAR highly expressed liver 17 1664 bp promoter containing plasmid pH H pGL3 transiently transfected human HepG2 hepatoma cells
0.37514272.11981036.html.plaintext.txt	121	Activity construct 8 fold activity parental promoterless construct pGL3 basic cells Fig
0.37514272.11981036.html.plaintext.txt	122	Next promoter activity different 5 deletion constructs evaluated
0.37514272.11981036.html.plaintext.txt	123	Deletion 1664 1206 significantly affect promoter activity
0.37514272.11981036.html.plaintext.txt	124	Truncation 648 significantly reduced luciferase activity HepG2 cells
0.37514272.11981036.html.plaintext.txt	125	By contrast agreement hPPAR tissue selective expression luciferase activities pH H pGL3 construct 5 deletion mutants 2 fold higher pGL3 basic Cos 1 cells cell line express PPAR
0.37514272.11981036.html.plaintext.txt	126	These experiments suggest cells devoid factors driving basal hPPAR expression compared HepG2 cells
0.37514272.11981036.html.plaintext.txt	127	The shortest construct pP H pGL3 containing GC rich proximal promoter 2 fold active relative pGL3 basic vector cell lines compared 6 fold activity shown pE H pGL3 construct suggests sequences 536 1664 may contain binding sites key transcription factors driving basal hPPAR gene expression
0.37514272.11981036.html.plaintext.txt	128	View larger version 11K Figure 4
0.37514272.11981036.html.plaintext.txt	129	Functional Analysis hPPAR Promoter 5 Deletion Mutants
0.37514272.11981036.html.plaintext.txt	130	The region spanning 1664 bp promoter first 83 bp exon 1a progressively deleted 5 end fused pGL3 basic vector transfected indicated cell types described Materials Methods
0.37514272.11981036.html.plaintext.txt	131	Values mean plus minus SD represent firefly luciferase activity normalized relative Renilla luciferase transfection internal control
0.37514272.11981036.html.plaintext.txt	132	Luciferase activities shown relative activity pGL3 basic vector arbitrarily set 1
0.37514272.11981036.html.plaintext.txt	133	Identification Functional HNF4 Regulatory Element HNF4 RE hPPAR Promoter Because hPPAR highly expressed liver hPPAR 5 flanking region shows significant promoter activity HepG2 cells regulation hPPAR promoter activity HNF4 nuclear receptor abundantly expressed liver examined
0.37514272.11981036.html.plaintext.txt	134	To purpose transient transfection studies performed pH H pGL3 construct HepG2 cells
0.37514272.11981036.html.plaintext.txt	135	In presence increasing concentrations HNF4 hPPAR promoter activity induced dose dependent fashion Fig
0.37514272.11981036.html.plaintext.txt	136	To localize region confers HNF4 responsiveness within hPPAR promoter cotransfection assays repeated series 5 deletion hPPAR promoter constructs Fig
0.37514272.11981036.html.plaintext.txt	137	These experiments revealed HNF4 responsive region resides within fragment flanked HindIII XhoI sites
0.37514272.11981036.html.plaintext.txt	138	Analysis sequence region hPPAR promoter revealed two potential hexamer binding sites separated single nucleotide nucleotide 1492 1483 Fig
0.37514272.11981036.html.plaintext.txt	139	3 conforming DR1 response elements HNF4 HNF4 RE
0.37514272.11981036.html.plaintext.txt	140	To unequivocally characterize imperfect DR1 HNF4 response element HepG2 Cos cells transfected hPPAR promoter construct bearing two nucleotide mutations 5 hexamer DR1 element pH HHNF4 REmut pGL3
0.37514272.11981036.html.plaintext.txt	141	In contrast wild type promoter construct pH H pGL3 mutated promoter influenced HNF4 cotransfection cell lines Fig
0.37514272.11981036.html.plaintext.txt	142	5C thus demonstrating hPPAR HNF4 RE HNF4 RE indeed confers HNF4 response hPPAR promoter
0.37514272.11981036.html.plaintext.txt	143	View larger version 17K Figure 5
0.37514272.11981036.html.plaintext.txt	144	HNF4 Mediated Transcriptional Regulation hPPAR via DR1 Element
0.37514272.11981036.html.plaintext.txt	145	A HNF4 increases hPPAR promoter activity
0.37514272.11981036.html.plaintext.txt	146	HepG2 cells transfected indicated reporter construct presence absence increasing amounts 3 10 30 ng HNF4 expression plasmid
0.37514272.11981036.html.plaintext.txt	147	When hPPAR promoter plasmid cotransfected pGL3 basic empty vector added transfection mixture
0.37514272.11981036.html.plaintext.txt	148	Relative luciferase activities shown described Fig
0.37514272.11981036.html.plaintext.txt	149	B Deletion analysis hPPAR promoter
0.37514272.11981036.html.plaintext.txt	150	HepG2 cells transfected indicated reporter constructs presence absence 30 ng HNF4 expression plasmid
0.37514272.11981036.html.plaintext.txt	151	Relative luciferase activities presence HNF4 shown fold induction activity reporter constructs absence HNF4
0.37514272.11981036.html.plaintext.txt	152	C Schematic representation constructs pH H pGL3 pH HHNF4 REmut pGL3
0.37514272.11981036.html.plaintext.txt	153	The bases mutated pH HHNF4 REmut pGL3 underlined
0.37514272.11981036.html.plaintext.txt	154	D Localization functional HNF4 RE hPPAR promoter
0.37514272.11981036.html.plaintext.txt	155	HepG2 Cos cells transfected indicated reporter constructs presence absence HNF4 expression plasmid 50 ng
0.37514272.11981036.html.plaintext.txt	156	Relative luciferase activities shown fold induction activity pH H pGL3 reporter construct absence HNF4
0.37514272.11981036.html.plaintext.txt	157	The data presented panels A B D represent mean plus minus SD firefly luciferase activity normalized relative Renilla luciferase transfection internal control
0.37514272.11981036.html.plaintext.txt	158	Binding Analysis HNF4 DR1 Element To demonstrate direct binding HNF4 HNF4 RE EMSAs performed radiolabeled DR1 oligonucleotide probe vitro translated HNF4 proteins
0.37514272.11981036.html.plaintext.txt	159	6 HNF4 bound HNF4 RE Fig
0.37514272.11981036.html.plaintext.txt	160	6A lane 4 well characterized C3P site present apo CIII promoter 39 similar efficacy Fig
0.37514272.11981036.html.plaintext.txt	161	DNA binding almost completely abolished two point mutations introduced HNF4 RE labeled oligonucleotide GCAGCAAAGTTCA instead GGGGCAAAGTTCA underlined letters indicate mutated nucleotides Fig
0.37514272.11981036.html.plaintext.txt	162	Furthermore specificity HNF4 DR1 interaction demonstrated competition studies
0.37514272.11981036.html.plaintext.txt	163	Inhibition formation complex shown addition increasing concentrations either unlabeled HNF4 RE Fig
0.37514272.11981036.html.plaintext.txt	164	6B lanes 9 11 oligonucleotides whereas competition equivalent amount unlabeled mutated HNF4 RE significantly displace labeled wild type element Fig
0.37514272.11981036.html.plaintext.txt	165	View larger version 69K Figure 6
0.37514272.11981036.html.plaintext.txt	166	A HNF4 binds HNF4 RE C3P oligonucleotide probes similar efficacy
0.37514272.11981036.html.plaintext.txt	167	Autoradiograph EMSA performed end labeled oligonucleotides probe using vitro translated HNF4
0.37514272.11981036.html.plaintext.txt	168	B Competition experiments performed presence 1 10 100 fold molar excess indicated unlabeled oligonucleotides HNF4 RE radiolabeled probe
0.37514272.11981036.html.plaintext.txt	169	The HNF4 RE Confers HNF4 Responsiveness Heterologous Promoter To explore activation HNF4 RE HNF4 context heterologous promoter cotransfection studies performed HNF4 REx2S TKpGL3 construct contains two copies DR1 sense orientation front thymidine kinase TK promoter Fig
0.37514272.11981036.html.plaintext.txt	170	Upon cotransfection HNF4 HepG2 RK13 cells HNF4 REx2S TKpGL3 transcriptional activity significantly enhanced Fig
0.37514272.11981036.html.plaintext.txt	171	By contrast reporter activity similar heterologous promoter construct containing two copies mutated HNF4 RE influenced HNF4 cotransfection Fig
0.37514272.11981036.html.plaintext.txt	172	Taken together data show DR1 site bona fide HNF4 RE mediates HNF4 induction hPPAR promoter activity
0.37514272.11981036.html.plaintext.txt	173	View larger version 17K Figure 7
0.37514272.11981036.html.plaintext.txt	174	The HNF4 RE Confers HNF4 Responsiveness Heterologous Promoter
0.37514272.11981036.html.plaintext.txt	175	A Schematic representation HNF4 REx2S TKpGL3 HNF4 REmutx2S TKpGL3 constructs
0.37514272.11981036.html.plaintext.txt	176	The bases mutated HNF4 REmutx2S TKpGL3 underlined
0.37514272.11981036.html.plaintext.txt	177	B The HNF4 REx2S TKpGL3 construct transfected either HepG2 RK13 cells presence absence HNF4
0.37514272.11981036.html.plaintext.txt	178	When HNF4 RE heterologous construct cotransfected TK pGL3 empty vector added transfection mixture
0.37514272.11981036.html.plaintext.txt	179	Data represent mean plus minus SD firefly luciferase activity normalized relative Renilla luciferase transfection internal control
0.37514272.11981036.html.plaintext.txt	180	Relative luciferase activities shown fold induction activity TK pGL3 absence HNF4 arbitrarily set 1
0.37514272.11981036.html.plaintext.txt	181	C HepG2 cells transfected either HNF4 REx2S TKpGL3 HNF4 REmutx2S TKpGL3 constructs presence absence HNF4
0.37514272.11981036.html.plaintext.txt	182	The data represent mean plus minus SD firefly luciferase activity normalized relative Renilla luciferase transfection internal control shown described Fig
0.37514272.11981036.html.plaintext.txt	183	COUP TFII Binds HNF4 RE Represses Basal HNF4 Induced hPPAR Promoter Activity DR1 elements recognized HNF4 also members nuclear receptor superfamily including transcription factor COUP TFII also known apo A 1 regulatory protein 1 ARP1 40
0.37514272.11981036.html.plaintext.txt	184	In addition COUP TFII shown actively repress modulate effects HNF4 transcription several genes liver 39 41 42 43 44
0.37514272.11981036.html.plaintext.txt	185	Therefore ability COUP TFII bind HNF4 RE evaluated gel shift analysis
0.37514272.11981036.html.plaintext.txt	186	COUP TFII proteins bound radiolabeled HNF4 RE probe competition 50 fold molar excess unlabeled HNF4 RE oligonucleotide completely inhibited formation COUP TFII DNA complex Fig
0.37514272.11981036.html.plaintext.txt	187	View larger version 29K Figure 8
0.37514272.11981036.html.plaintext.txt	188	COUP TFII Binds DR1 Modulates Basal HNF4 Induced hPPAR Promoter Activity
0.37514272.11981036.html.plaintext.txt	189	A EMSA performed end labeled HNF4 RE oligonucleotide presence vitro translated COUP TFII
0.37514272.11981036.html.plaintext.txt	190	The unlabeled oligonucleotide 50 fold molar excess added binding reactions indicated
0.37514272.11981036.html.plaintext.txt	191	B The indicated reporter constructs cotransfected either HepG2 Cos cells without HNF4 COUP TFII indicated
0.37514272.11981036.html.plaintext.txt	192	When either HNF4 COUP TFII expression plasmids cotransfected pSG5 pCDNA3 empty vectors respectively added transfection mixture
0.37514272.11981036.html.plaintext.txt	193	Relative luciferase activities mean plus minus SD shown fold induction activity pH H pGL3 reporter construct absence HNF4 COUP TFII
0.37514272.11981036.html.plaintext.txt	194	The influence COUP TFII hPPAR promoter activity investigated cotransfection experiments HepG2 Cos cells
0.37514272.11981036.html.plaintext.txt	195	Transient transfection COUP TFII alone decreased activity hPPAR promoter construct containing HNF4 RE site HepG2 Cos cells Fig
0.37514272.11981036.html.plaintext.txt	196	As previously observed upon cotransfection HNF4 hPPAR promoter activity induced cell lines
0.37514272.11981036.html.plaintext.txt	197	However overexpression COUP TFII presence HNF4 abrogated HNF4 induced transcriptional activity
0.37514272.11981036.html.plaintext.txt	198	On contrary identical experiments performed promoter construct bearing mutation HNF4 RE promoter activity affected cotransfection either COUP TFII HNF4 alone added together Fig
0.37514272.11981036.html.plaintext.txt	199	These data demonstrate repression PPAR promoter COUP TFII antagonism HNF4 induction dependent HNF4 RE
0.37514272.11981036.html.plaintext.txt	200	Altogether results indicate COUP TFII negatively regulates PPAR gene transcription
0.37514272.11981036.html.plaintext.txt	201	hPPAR Binds HNF4 RE Regulates Its Own Expression Next direct binding PPARRXR heterodimers hPPAR HNF4 RE examined
0.37514272.11981036.html.plaintext.txt	202	To purpose gel shift analysis performed radiolabeled HNF4 RE probe vitro translated PPAR RXR proteins
0.37514272.11981036.html.plaintext.txt	203	PPARRXR heterodimers bound HNF4 RE oligonucleotide Fig
0.37514272.11981036.html.plaintext.txt	204	DNA binding could competed increasing amounts unlabeled HNF4 RE oligonucleotide Fig
0.37514272.11981036.html.plaintext.txt	205	9A lanes 3 5 whereas incubation mutated HNF4 RE oligonucleotide compete binding Fig
0.37514272.11981036.html.plaintext.txt	206	View larger version 28K Figure 9
0.37514272.11981036.html.plaintext.txt	207	PPAR Positively Regulates Its Own Expression
0.37514272.11981036.html.plaintext.txt	208	EMSA performed end labeled HNF4 RE oligonucleotide presence vitro translated PPAR RXR
0.37514272.11981036.html.plaintext.txt	209	Competition experiments performed presence 10 25 50 fold molar excess indicated unlabeled oligonucleotides
0.37514272.11981036.html.plaintext.txt	210	B PPAR modulates hPPAR promoter activity via HNF4 RE
0.37514272.11981036.html.plaintext.txt	211	Cos cells transfected either pH H pGL3 hPPAR pH H HNF4 REmut pGL3 hPPAR promoter construct without PPAR expression plasmid presence absence 100 microM Wy 14643 indicated
0.37514272.11981036.html.plaintext.txt	212	Relative luciferase activities mean plus minus SD construct shown relative promoter activity absence PPAR activator arbitrarily set 1
0.37514272.11981036.html.plaintext.txt	213	C The HNF4 REx2S TKpGL3 plasmid transfected Cos cells without PPAR presence absence 50 microM Wy 14643 indicated
0.37514272.11981036.html.plaintext.txt	214	Relative luciferase activities mean plus minus SD shown panel B
0.37514272.11981036.html.plaintext.txt	215	D Fenofibric acid enhances hPPAR mRNA levels primary cultures human hepatocytes
0.37514272.11981036.html.plaintext.txt	216	Human hepatocytes isolated treated 24 h FF without CON 250 microM fenofibric acid
0.37514272.11981036.html.plaintext.txt	217	One microgram total RNA reversed transcribed subjected Real Time PCR analysis described Materials Methods
0.37514272.11981036.html.plaintext.txt	218	Specific hPPAR mRNA normalized 28S content expressed relative untreated cells mean plus minus SD n 3
0.37514272.11981036.html.plaintext.txt	219	To determine effect PPAR hPPAR promoter activity transient transfection assays performed using hPPAR promoter construct containing HNF4 RE
0.37514272.11981036.html.plaintext.txt	220	Cotransfection PPAR induced hPPAR reporter activity approximately 2 fold effect enhanced presence Wy 14643
0.37514272.11981036.html.plaintext.txt	221	By contrast effect either PPAR ligand could observed construct containing mutated HNF4 RE employed indicating intact HNF4 RE site required PPAR mediated induction
0.37514272.11981036.html.plaintext.txt	222	To investigate whether HNF4 RE could function PPRE front heterologous promoter transient transfection assays performed using HNF4 REx2S TKpGL3 construct Fig
0.37514272.11981036.html.plaintext.txt	223	Incubation cells Wy 14643 presence cotransfected PPAR resulted 5 fold activation HNF4 REx2S TKpGL3 construct indicating HNF4 RE site functional PPRE
0.37514272.11981036.html.plaintext.txt	224	Finally analyze whether hPPAR mRNA expression regulated PPAR agonists primary hepatocytes isolated human liver cultured 24 h medium containing fenofibric acid
0.37514272.11981036.html.plaintext.txt	225	hPPAR mRNA levels markedly regulated upon treatment fenofibric acid Fig
0.37514272.11981036.html.plaintext.txt	226	Taken together data show PPAR positively autoregulates expression
0.37514272.11981036.html.plaintext.txt	227	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES PPAR transcription factor regulates lipid glucose energy homeostasis controls body weight vascular inflammation
0.37514272.11981036.html.plaintext.txt	228	Thus PPAR may play modulatory role onset evolution different metabolic vascular disorders dyslipidemia obesity insulin resistance atherosclerosis 1
0.37514272.11981036.html.plaintext.txt	229	Dysregulation PPAR expression may contribute development disorders well response fibrate agonists
0.37514272.11981036.html.plaintext.txt	230	Indeed PPAR expression levels shown influence transcriptional activity well response fibrate treatment rodents 22 25 26 27
0.37514272.11981036.html.plaintext.txt	231	However study molecular mechanisms governing PPAR regulation humans addressed date
0.37514272.11981036.html.plaintext.txt	232	To study PPAR regulation humans characterized 5 flanking region hPPAR gene identified hPPAR promoter
0.37514272.11981036.html.plaintext.txt	233	The genomic organization hPPAR recently reported 34 35
0.37514272.11981036.html.plaintext.txt	234	The hPPAR gene contains least eight exons exons 1 2 5 end exon 3 3 end exon 8 translated 34 35
0.37514272.11981036.html.plaintext.txt	235	As initial step study 5 UTR hPPAR gene characterized resulting completion 5 end sequence exon 1 renamed exon 1a identification alternatively spliced 5 variant
0.37514272.11981036.html.plaintext.txt	236	An alternatively spliced exon mouse PPAR 5 UTR previously reported 36
0.37514272.11981036.html.plaintext.txt	237	However alignment mouse human 5 UTR sequences revealed significant degree homology despite coding exons similar species
0.37514272.11981036.html.plaintext.txt	238	The transcription start site hPPAR gene mapped
0.37514272.11981036.html.plaintext.txt	239	The proximal promoter hPPAR gene contains typical TATA CCAAT boxes high GC content including several consensus Sp1 sites features also present mouse PPAR promoter 36
0.37514272.11981036.html.plaintext.txt	240	Excluding proximal GC rich region promoters show high degree sequence homology 40
0.37514272.11981036.html.plaintext.txt	241	However small fragment mouse PPAR promoter sequenced date 36
0.37514272.11981036.html.plaintext.txt	242	This sequence disparity 5 UTR promoter regions may indicate PPAR gene expression among species could regulated different manner although sufficient data establish thorough comparison species lacking stage
0.37514272.11981036.html.plaintext.txt	243	Computer assisted analysis hPPAR promoter sequence identified various putative transcription factor binding sites sites members early growth response Egr gene family involved induction monocytic differentiation 45
0.37514272.11981036.html.plaintext.txt	244	Egr proteins could thus involved regulation hPPAR expression upon monocyte differentiation macrophages 32 although studies needed confirm hypothesis
0.37514272.11981036.html.plaintext.txt	245	Furthermore potential sites NFB AP1 factors involved transduction several cytokine proinflammatory signals well myeloid zinc finger gene MZF 1 found hPPAR promoter
0.37514272.11981036.html.plaintext.txt	246	PPAR inhibition NFB AP1 induced expression inflammatory response genes 46 lies basis antiinflammatory activities
0.37514272.11981036.html.plaintext.txt	247	It tempting speculate hPPAR expression turn controlled inflammatory cytokines
0.37514272.11981036.html.plaintext.txt	248	Because rodent PPAR mRNA levels increased glucocorticoids 20 21 putative GR response elements searched
0.37514272.11981036.html.plaintext.txt	249	No obvious GR response element could detected within hPPAR regulatory region analyzed however regulation studies human tissues cell lines would necessary determine whether hPPAR expression also modulated glucocorticoids humans
0.37514272.11981036.html.plaintext.txt	250	HNF4 nuclear receptor plays key role liver specific gene expression 47 required mammalian hepatocyte differentiation normal metabolic regulation liver 48
0.37514272.11981036.html.plaintext.txt	251	HNF4 expressed high levels liver kidney intestine 47
0.37514272.11981036.html.plaintext.txt	252	It binds homodimers DR1 like response elements thereby modulating expression several liver enriched genes encoding apolipoproteins coagulation factors serum proteins proteins cytochrome P450 family genes involved FA glucose metabolism 49
0.37514272.11981036.html.plaintext.txt	253	Regulation hPPAR HNF4 consistent tissue expression pattern shown PPAR
0.37514272.11981036.html.plaintext.txt	254	In present study induction hPPAR promoter activity HNF4 reported
0.37514272.11981036.html.plaintext.txt	255	A HNF4 RE identified nt 1492 1483 within hPPAR promoter
0.37514272.11981036.html.plaintext.txt	256	This element closely resembles several HNF4 REs found genes GGGGCA A AGGTCA consensus HNF4 binding site 50
0.37514272.11981036.html.plaintext.txt	257	Moreover regulation PPAR gene expression HNF4 vivo mice recently demonstrated using HNF4 deficient mice 51
0.37514272.11981036.html.plaintext.txt	258	These mice display significantly lower PPAR mRNA levels compared wild type mice thus demonstrating PPAR expression regulated HNF4 also mice
0.37514272.11981036.html.plaintext.txt	259	Nevertheless promoter experiments performed hPPAR promoter indicate HNF4 site identified responsible activity hPPAR promoter liver promoter construct lacking site still possesses significant activity HepG2 cells Fig
0.37514272.11981036.html.plaintext.txt	260	This may suggest site binds well factors COUP TF present cells negatively regulate hPPAR promoter either result direct repression promoter due competition factors HNF4 binding site
0.37514272.11981036.html.plaintext.txt	261	In addition negative factors may bind sites located 1664 1206 bp hPPAR promoter
0.37514272.11981036.html.plaintext.txt	262	Future studies regulation promoter required elucidate factors governing hPPAR gene expression liver
0.37514272.11981036.html.plaintext.txt	263	Members COUP TF family orphan nuclear receptors reported bind DR1 sites also recognized HNF4 52
0.37514272.11981036.html.plaintext.txt	264	COUP TF actively represses antagonizes HNF4 mediated transcriptional activation several genes 39 41 42 43 44
0.37514272.11981036.html.plaintext.txt	265	COUP TF II shown play role cardiac energy metabolism heart development 53 54
0.37514272.11981036.html.plaintext.txt	266	In study COUP TFII also shown bind HNF4 RE within hPPAR regulatory region repress basal HNF4 induced hPPAR promoter activity
0.37514272.11981036.html.plaintext.txt	267	The COUP TFII antagonism may finely tune HNF4 dependent gene expression
0.37514272.11981036.html.plaintext.txt	268	The expression level COUP TFIIHNF4 target gene would therefore depend relative concentrations transcription factors given cell type certain condition
0.37514272.11981036.html.plaintext.txt	269	For instance age dependent diminution apo AI gene expression shown occur transcriptional level associated decrease binding capacity expression HNF4 parallel increase COUP TFII binding concentration levels 55
0.37514272.11981036.html.plaintext.txt	270	Interestingly PPAR gene expression also diminished aged rats 23
0.37514272.11981036.html.plaintext.txt	271	Further studies required demonstrate whether molecular mechanisms described age dependent decline apo AI also explain decreased expression PPAR age
0.37514272.11981036.html.plaintext.txt	272	Finally PPAR also capable binding HNF4 RE
0.37514272.11981036.html.plaintext.txt	273	Induction PPAR gene expression PPAR agonists reported different rodent cell lines 22 24 56
0.37514272.11981036.html.plaintext.txt	274	Our data indicate PPAR agonists fenofibrate induce hPPAR mRNA levels primary cultures human hepatocytes well hPPAR promoter activity suggesting effects exerted transcriptional level
0.37514272.11981036.html.plaintext.txt	275	Furthermore induction hPPAR promoter activity dependent identified HNF4 RE
0.37514272.11981036.html.plaintext.txt	276	Autoregulation common feature among nuclear receptors
0.37514272.11981036.html.plaintext.txt	277	For instance GRs regulated glucocorticoids glucocorticoids exert actions mainly level transcription 57
0.37514272.11981036.html.plaintext.txt	278	AR another nuclear receptor autoregulated 58 three different ER promoters shown regulated estrogens 59
0.37514272.11981036.html.plaintext.txt	279	The coding exons hPPAR gene screened polymorphisms
0.37514272.11981036.html.plaintext.txt	280	A leucine valine missense mutation codon 162 exon 5 hPPAR gene L162V recently identified 34 35
0.37514272.11981036.html.plaintext.txt	281	This polymorphism shows enhanced transactivation activity 34 associated altered plasma lipid lipoprotein concentrations type 2 diabetic subjects 34 supporting role PPAR dyslipidemia diabetes humans also
0.37514272.11981036.html.plaintext.txt	282	Variants identified exons introns hPPAR gene Ref
0.37514272.11981036.html.plaintext.txt	283	Staels unpublished observations
0.37514272.11981036.html.plaintext.txt	284	However polymorphisms either show low frequency populations studied directly affect PPAR activity due location intronic sequences gene
0.37514272.11981036.html.plaintext.txt	285	Thus interesting search polymorphisms promoter sequences gene may affect PPAR expression function
0.37514272.11981036.html.plaintext.txt	286	Taken together 5 flanking region hPPAR gene characterized cloned functionally studied
0.37514272.11981036.html.plaintext.txt	287	HNF4 induces hPPAR expression via DR1 element present hPPAR promoter whereas effect antagonized orphan receptor COUP TFII
0.37514272.11981036.html.plaintext.txt	288	In addition PPAR modulates expression
0.37514272.11981036.html.plaintext.txt	289	Knowledge hPPAR promoter structure allow studies molecular mechanisms governing hPPAR gene regulation
0.37514272.11981036.html.plaintext.txt	290	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES DNA Sequencing Sequencing BAC clone containing hPPAR gene kind gift B
0.37514272.11981036.html.plaintext.txt	291	Wilkinson Glaxo Welcome Research Triangle Park NC performed using dRhodamine terminator cycle sequencing kit ABI Prism 377 DNA sequencer Perkin Elmer Corp
0.37514272.11981036.html.plaintext.txt	292	Rapid Amplification cDNA Ends 5 RACE PCR RT PCR Analysis Total human liver RNA isolated using guanidinium isothiocyanate method 61
0.37514272.11981036.html.plaintext.txt	293	5 RACE performed 1 microg total RNA using 5 RACE System Rapid Amplification cDNA Ends kit Life Technologies Inc
0.37514272.11981036.html.plaintext.txt	294	Gaithersburg MD according manufacturer instructions
0.37514272.11981036.html.plaintext.txt	295	For determination 5 end exon 1a first strand synthesis hPPAR cDNA carried using IP7 oligonucleotide 5 CAAGCAGTCCTCCTACCTCAGCCTTCCAAG 3 located exon 1b Fig
0.37514272.11981036.html.plaintext.txt	296	After RNase H treatment polydC tailing cDNA terminal deoxynucleotide transferase resulting cDNA 5 microl amplified PCR using Abridged Anchor Primer AAP internal gene specific primer YGSP1 5 AGTTCTGAGCTTCTCTTGCCACAAACAGTTGAGTCC 3 located exon 1a Fig
0.37514272.11981036.html.plaintext.txt	297	PCR cycling parameters follows initial denaturation 95 C 5 min followed 35 cycles 1 min 95 C 40 sec 57 C 40 sec 72 C final elongation 72 C 3 min
0.37514272.11981036.html.plaintext.txt	298	The PCR product diluted 100 fold diluted PCR 5 microl used nested PCR conditions described Abridged Universal Amplification Primer AUAP nested AAP oligonucleotide IP18 5 AGAGTCGCTGCGGTCCCCAGAC 3 nested YGSP1
0.37514272.11981036.html.plaintext.txt	299	Oligonucleotides AUAP AAP provided 5 RACE kit
0.37514272.11981036.html.plaintext.txt	300	PCR products visualized 2 agarose gel sequenced described
0.37514272.11981036.html.plaintext.txt	301	RT PCR amplification hPPAR 5 UTR performed described 31 using oligonucleotides 15C 5 CAGGGCCCTGTCTGCTCTGTGCA 3 13 5 CTCTTATCTATGAAGCAGGAAGCACG 3 IP3
0.37514272.11981036.html.plaintext.txt	302	RNase Protection Analysis The RNase protection probe used map transcription initiation site hPPAR gene amplified PCR BAC hPPAR clone using oligonucleotides IP24 5 CGCGGGGCCCGGGGTCTCGGGGTCTCCG 3 IP18 cloned EcoRV site pBluescript SK Stratagene La Jolla CA
0.37514272.11981036.html.plaintext.txt	303	After linearizing XhoI antisense RNA transcribed T3 polymerase using Maxiscript Kit Ambion Inc
0.37514272.11981036.html.plaintext.txt	304	Austin TX described manufacturer
0.37514272.11981036.html.plaintext.txt	305	This 337 nucleotide probe contains cRNA complementary hPPAR 5 flanking region bp 22 213 polylinker pBluescript SK vector 102 bp
0.37514272.11981036.html.plaintext.txt	306	RNase protection analysis carried using Hybspeed RNase protection Kit Ambion Inc
0.37514272.11981036.html.plaintext.txt	307	Real Time PCR mRNA Quantification PPAR 28S mRNAs quantified reverse transcription followed Real Time PCR using LightCycler Roche Diagnostics Meylan France oligonucleotide primers specific hPPAR 5 ATATCTCCCTTTTTGTGGCTGCTA 3 5 TCCGACTCCGTCTTCTYGATGA 3 28S 62
0.37514272.11981036.html.plaintext.txt	308	Reactions carried 20 microl reaction containing 500 nM concentration primer 4 mM MgCl2 LightCycler FastStart DNA Master SYBR Green I mix recommended manufacturer following conditions 95 C 8 min followed 40 cycles 10 sec 95 C 10 sec 55 C 14 sec hPPAR 15 sec 28S 72 C
0.37514272.11981036.html.plaintext.txt	309	hPPAR mRNA levels normalized 28S mRNA
0.37514272.11981036.html.plaintext.txt	310	Cloning hPPAR Promoter Construction Reporter Plasmids Genomic sequences 3593 83 numbered basis distance transcription initiation site obtained direct sequencing BAC hPPAR clone amplified PCR using oligonucleotides IP34 5 GCCAGGAGCAGCCACCAGGGAAATC 3 5 GSP 5 AGTCCTCGGTGTGTGTCCTCGCTCCTC 3 BAC clone DNA
0.37514272.11981036.html.plaintext.txt	311	The resulting product cloned blunt EcoRV site pBluescript SK Stratagene
0.37514272.11981036.html.plaintext.txt	312	Reporter constructs generated thereafter digestion using restriction sites within hPPAR promoter
0.37514272.11981036.html.plaintext.txt	313	The pBSIP34 5GSP construct digested HindIII HindIII XhoI resulting promoter digestion products gel purified cloned HindIII XhoI plus HindIII digested pGL3 basic plasmid Promega Corp
0.37514272.11981036.html.plaintext.txt	314	Madison WI creating reporter vectors pH H pGL3 pX H pGL3 respectively
0.37514272.11981036.html.plaintext.txt	315	Plasmids pE H pGL3 pP H pGL3 generated digestion pX H pGL3 EcoRI plus XhoI PstI plus XhoI Klenow fill cohesive ends subsequent ligation obtained blunt ends
0.37514272.11981036.html.plaintext.txt	316	HNF4 REx2S TKpGL3 HNF4 REmutx2S TKpGL3 created ligating two copies corresponding double stranded oligonucleotides 5 GATCCTGGAGGGTGGGGCAAAGTTCACCATAGGTA 3 HNF4 REx2S TKpGL3 5 GATCCTGGAGGGTGCAGCAAAGTTCACCATAGGTA 3 HNF4 REmutx2S TKpGL3 sense orientation BamHI site TK pGL3
0.37514272.11981036.html.plaintext.txt	317	All constructs verified restriction site digestion sequence analysis
0.37514272.11981036.html.plaintext.txt	318	Transcription factor analysis promoter performed using MatInspector program httpgenomatix
0.37514272.11981036.html.plaintext.txt	319	decgi binmatinspectormatinspector
0.37514272.11981036.html.plaintext.txt	320	Site Directed Mutagenesis To create pH HHNF4 REmut pGL3 mutation HNF4 RE generated using QuikChange Site Directed Mutagenesis Kit Stratagene oligonucleotide 5 GGTGTCTGGAGGCTGCAGCAAAGTTCACCATAG 3 complementary oligonucleotide according manufacturer recommendations
0.37514272.11981036.html.plaintext.txt	321	Cell Culture Transient Transfection Assays Human liver specimens collected transplantation Moscow Center hepatocytes obtained two step collagenase perfusion previously described 63
0.37514272.11981036.html.plaintext.txt	322	Donors physically healthy subjects died traumatic brain injury
0.37514272.11981036.html.plaintext.txt	323	Permission use remaining untransplanted donor liver scientific research purposes obtained Ministry Health Russian Federation
0.37514272.11981036.html.plaintext.txt	324	After 20 h culture medium discarded 250 microM fenofibric acid Laboratories Fournier Daix France vehicle added indicated concentration serum free medium 24 h
0.37514272.11981036.html.plaintext.txt	325	HepG2 human hepatoblastoma RK13 rabbit kidney Cos cells cultured previously described 31
0.37514272.11981036.html.plaintext.txt	326	HepG2 105 RK13 8 x 104 Cos 4 x 104 cells transfected using cationic lipid RPR 120535B kind gift Aventis Vitry France described previously 64
0.37514272.11981036.html.plaintext.txt	327	One hundred nanograms indicated pGL3 basic firefly luciferase reporter constructs 10 ng TK pGL3 reporters cotransfected without 30 50 ng pSG5 hHNF41 termed HNF4 throughout manuscript kindly provided B
0.37514272.11981036.html.plaintext.txt	328	Laine pcDNA3 COUP TFII subcloned pMT2 COUP TFII 65 pcDNA3 pSG5 hPPAR either 20 ng 5 ng internal control Renilla luciferase reporter plasmids pRL Null basal promoter activities different deletion constructs examined Promega Corp
0.37514272.11981036.html.plaintext.txt	329	pRL C remaining transfection experiments respectively
0.37514272.11981036.html.plaintext.txt	330	pRL C obtained replacing luc cassette pGL3 C Promega Corp
0.37514272.11981036.html.plaintext.txt	331	When either HNF4 COUP TFII plasmid cotransfected pSG5 Stratagene pcDNA3 Invitrogen empty vectors added transfection mixture
0.37514272.11981036.html.plaintext.txt	332	Luciferase activity assayed 36 h later using Dual Luciferase Reporter Assay System Promega Corp
0.37514272.11981036.html.plaintext.txt	333	Transfections carried triplicate experiment repeated least twice
0.37514272.11981036.html.plaintext.txt	334	EMSAs HNF4 COUP TFII PPAR RXR synthesized vitro using TNT Quick Coupled TranscriptionTranslation System Promega Corp
0.37514272.11981036.html.plaintext.txt	335	Double stranded oligonucleotides end labeled 32PATP using T4 polynucleotide kinase
0.37514272.11981036.html.plaintext.txt	336	Proteins 2 microl incubated 15 min room temperature total volume 20 microl 2
0.37514272.11981036.html.plaintext.txt	337	5 microg poly dI dC 1 microg herring sperm DNA binding buffer 10 mM HEPES NaOH pH 7
0.37514272.11981036.html.plaintext.txt	338	1 mM EDTA 10 glycerol 1 mgml BSA 0
0.37514272.11981036.html.plaintext.txt	339	5 mM dithiothreitol radiolabeled probe 0
0.37514272.11981036.html.plaintext.txt	340	Binding reactions incubated 15 min resolved 4 nondenaturing polyacrylamide gel electrophoresis 0
0.37514272.11981036.html.plaintext.txt	341	25x Tris borate EDTA buffer room temperature
0.37514272.11981036.html.plaintext.txt	342	For competition experiments increasing amounts unlabeled oligonucleotide HNF4 RE HNF4 REmut C3P 39 included binding reaction addition labeled oligonucleotide
0.37514272.11981036.html.plaintext.txt	343	ACKNOWLEDGMENTS We thank Christian Duhem Odile Vidal Eric Raspe expert technical assistance
0.37514272.11981036.html.plaintext.txt	344	We grateful Lluis Fajas Raphael Darteil Olivier Barbier helpful advice discussions
0.37514272.11981036.html.plaintext.txt	345	FOOTNOTES This work supported European Community Grant ERBFMBICT983214 I
0.37514272.11981036.html.plaintext.txt	346	BIOMED 2 Grant PL963324 Y
0.37514272.11981036.html.plaintext.txt	347	also supported British Heart Foundation Grant FS98058
0.37514272.11981036.html.plaintext.txt	348	Abbreviations AP1 2 Activating protein 1 2 AAP abridged anchor primer BAC bacterial chromosomal clone COUP TFII chicken ovalbumin upstream promoter transcription factor II DR1 direct repeat 1 FA fatty acid HNF4 hepatocyte nuclear factor 4 HNF4 RE HNF4 regulatory element NFB nuclear factor B PPRE PPAR response element RACE rapid amplification cDNA ends RNase ribonuclease TK thymidine kinase UTR untranslated region
0.37514272.11981036.html.plaintext.txt	349	1 The sequence data hPPAR exon 1a 1b promoter submitted GenBank database GenBank accession numbers AF323915 AF323916 AF323917 respectively
0.37514272.11981036.html.plaintext.txt	350	Received publication August 31 2001
0.37514272.11981036.html.plaintext.txt	351	Accepted publication January 17 2001
0.37514272.11981036.html.plaintext.txt	352	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Desvergne B Wahli W 1999 Peroxisome proliferator activated receptors nuclear control metabolism
0.37514272.11981036.html.plaintext.txt	353	Endocr Rev 20649 688AbstractFree Full Text Chinetti G Fruchart JC Staels B 2000 Peroxisome proliferator activated receptors PPARs nuclear receptors crossroads lipid metabolism inflammation
0.37514272.11981036.html.plaintext.txt	354	Inflamm Res 49497 505CrossRefMedline Willson TM Brown PJ Sternbach DD Henke BR 2000 The PPARs orphan receptors drug discovery
0.37514272.11981036.html.plaintext.txt	355	J Med Chem 43527 550CrossRefMedline Staels B Dallongeville J Auwerx J Schoonjans K Leitersdorf E Fruchart J C 1998 Mechanism action fibrates lipid lipoprotein metabolism
0.37514272.11981036.html.plaintext.txt	356	Circulation 982088 2093AbstractFree Full Text Guerre Millo M Gervois P Raspe E Madsen L Poulain P Derudas B Herbert JM Winegar DA Willson TM Fruchart JC Berge RK Staels B 2000 Peroxisome proliferator activated receptor activators improve insulin sensitivity reduce adiposity
0.37514272.11981036.html.plaintext.txt	357	J Biol Chem 27516638 16642AbstractFree Full Text Ye JM Doyle PJ Iglesias MA Watson DG Cooney GJ Kraegen EW 2001 Peroxisome proliferator activated receptor PPAR activation lowers muscle lipids improves insulin sensitivity high fat fed rats comparison PPAR activation
0.37514272.11981036.html.plaintext.txt	358	Diabetes 50411 417AbstractFree Full Text Chinetti G Gbaguidi FG Griglio S Mallat Z Antonucci M Poulain P Chapman J Fruchart JC Tedgui A Najib Fruchart J Staels B 2000 CLA 1SR BI expressed atherosclerotic lesion macrophages regulated activators peroxisome proliferator activated receptors
0.37514272.11981036.html.plaintext.txt	359	Circulation 1012411 2417AbstractFree Full Text Chinetti G Lestavel S Bocher V Remaley AT Neve B Pineda Torra I Teissier E Minnich A Jaye M Duverger N Brewer HB Fruchart JC Clavey V Staels B 2001 PPAR PPAR activators induce cholesterol removal human macrophage foam cells stimulation ABCA1 pathway
0.37514272.11981036.html.plaintext.txt	360	Nat Med 753 58CrossRefMedline Staels B Koenig W Habib A Merval R Lebret M Pineda Torra I Delerive P Fadel A Chinetti G Fruchart J C Najib J Maclouf J Tedgui A 1998 Activation human aortic smooth muscle cells inhibited PPAR PPAR activators
0.37514272.11981036.html.plaintext.txt	361	Nature 393790 793CrossRefMedline Madej A Okopien B Kowalski J Zielinski M Wysichi J Szygula B Kalina Z Herman ZS 1998 Effects fenofibrate plasma cytokine concentrations patients atherosclerosis hyperlipoproteinemia IIb
0.37514272.11981036.html.plaintext.txt	362	Int J Clin Pharmacol Ther 36345 349Medline Ericsson CG Hamsten A Nilsson J Grip L Svane B Defaire U 1996 Angiographic assessment effects bezafibrate progression coronary artery disease young male postinfarction patients
0.37514272.11981036.html.plaintext.txt	363	Lancet 347849 853Medline Frick MH Syvanne M Nieminen MS Kauma H Majahalme S Virtanen V Kesaniemi YA Pasternak A Taskinen MR 1997 Prevention angiographic progression coronary vein graft atherosclerosis gemfibrozil coronary bypass surgery men low levels HDL cholesterol
0.37514272.11981036.html.plaintext.txt	364	Circulation 962137 2143AbstractFree Full Text Rubins HB Robins SJ Collins D Fye CL Anderson JW Elam MB Faas FH Linares E Schaefer EJ Schectman G Wilt TJ Wittes J 1999 Gemfibrozil secondary prevention coronary heart disease men low levels high density lipoprotein cholesterol
0.37514272.11981036.html.plaintext.txt	365	Veterans Affairs High Density Lipoprotein Cholesterol Intervention Trial Study Group
0.37514272.11981036.html.plaintext.txt	366	N Engl J Med 341410 418AbstractFree Full Text Steiner G Hamsten A Hosking A Stewart J McLaugdstone P Sole M Syvanne M 2001 Effect fenofibrate progression coronary artery disease type 2 diabetes Diabetes Atherosclerosis Intervention Study randomised study
0.37514272.11981036.html.plaintext.txt	367	Lancet 357905 910CrossRefMedline Braissant O Foufelle F Scotto C Dauca M Wahli W 1996 Differential expression peroxisome proliferator activated receptors PPARs tissue distribution PPAR ss adult rat
0.37514272.11981036.html.plaintext.txt	368	Endocrinology 137354 366Abstract Auboeuf D Rieusset J Fajas L Vallier P Frering V Riou JP Staels B Auwerx J Laville M Vidal H 1997 Tissue distribution quantification expression mRNAs peroxisome proliferator activated receptors liver X receptor humans alteration adipose tissue obese NIDDM patients
0.37514272.11981036.html.plaintext.txt	369	Diabetes 461319 1327Abstract Mukherjee R Jow L Noonan D McDonnell DP 1994 Human rat peroxisome proliferator activated receptors PPARs demonstrate similar tissue distribution different responsiveness PPAR activators
0.37514272.11981036.html.plaintext.txt	370	J Steroid Biochem Mol Biol 51157 166CrossRefMedline Lemberger T Saladin R Vazquez M Assimacopoulos F Staels B Desvergne B Wahli W Auwerx J 1996 Expression peroxisome proliferator activated receptor gene stimulated stress follows diurnal rhythm
0.37514272.11981036.html.plaintext.txt	371	J Biol Chem 2711764 1769AbstractFree Full Text Yamada J Sugiyama H Watanabe T Suga T 1995 Suppressive effect growth hormone expression peroxisome proliferator activated receptor cultured rat hepatocytes
0.37514272.11981036.html.plaintext.txt	372	Res Commun Mol Pathol Pharmacol 90173 176Medline Steineger HH Sorensen HN Tugwood JD Skrede S Spydevold O Gautvik KM 1994 Dexamethasone insulin demonstrate marked opposite regulation steady state mRNA level peroxisomal proliferator activated receptor PPAR hepatic cells
0.37514272.11981036.html.plaintext.txt	373	Hormonal modulation fatty acid induced transcription
0.37514272.11981036.html.plaintext.txt	374	Eur J Biochem 225967 974Abstract Lemberger T Staels B Saladin R Desvergne B Auwerx J Wahli W 1994 Regulation peroxisome proliferator activated receptor gene glucocorticoids
0.37514272.11981036.html.plaintext.txt	375	J Biol Chem 26924527 24530AbstractFree Full Text Zhou YT Shimabukuro M Wang MY Lee Y Higa M Milburn JL Newgard CB Unger RH 1998 Role peroxisome proliferator activated receptor disease pancreatic ss cells
0.37514272.11981036.html.plaintext.txt	376	Proc Natl Acad Sci USA 958898 8903AbstractFree Full Text Poynter ME Daynes DA 1998 PPAR activation modulates cellular redox status represses NFB signalling reduces inflammatory cytokine production aging
0.37514272.11981036.html.plaintext.txt	377	J Biol Chem 27332833 32841AbstractFree Full Text Valmaseda A Carmona MC Barbera MJ Vinas O Mampel T Iglesias R Villarroya F Giralt M 1999 Opposite regulation PPAR gene expression ligands retinoic acid brown adipocytes
0.37514272.11981036.html.plaintext.txt	378	Mol Cell Endocrinol 154101 109CrossRefMedline Kersten S Seydoux J Peters JM Gonzalez FJ Desvergne B Wahli W 1999 Peroxisome proliferator activated receptor mediates adaptive response fasting
0.37514272.11981036.html.plaintext.txt	379	J Clin Invest 1031489 1498AbstractFree Full Text Barger PM Brandt JM Leone TC Weinheimer CJ Kelly DP 2000 Deactivation peroxisome proliferator activated receptor cardiac hypertrophic growth
0.37514272.11981036.html.plaintext.txt	380	J Clin Invest 1051723 1730AbstractFree Full Text Beigneux AP Moser AH Shigenaga JK Grunfeld C Feingold KR 2000 The acute phase response associated retinoid X receptor repression rodent liver
0.37514272.11981036.html.plaintext.txt	381	J Biol Chem 27516390 16399AbstractFree Full Text Narravula S Colgan SP 2001 Hypoxia inducible factor 1 mediated inhibition peroxisome proliferator activated receptor expression hypoxia
0.37514272.11981036.html.plaintext.txt	382	J Immunol 1667543 7548AbstractFree Full Text Duez HM Poulain P Fievet C Fruchart J C Staels B 2000 Peroxisome proliferator activated receptor PPAR required vivo regulation apo A I gene expression fibrates
0.37514272.11981036.html.plaintext.txt	383	Circulation 102II 47 Palmer CN Hsu MH Griffin KJ Raucy JL Johnson EF 1998 Peroxisome proliferator activated receptor expression human liver
0.37514272.11981036.html.plaintext.txt	384	Mol Pharmacol 5314 22AbstractFree Full Text Gervois P Pineda Torra I Chinetti G Grotzinger T Dubois G Fruchart JC Fruchart Najib J Leitersdorf E Staels B 1999 A truncated human peroxisome proliferator activated receptor splice variant dominant negative activity
0.37514272.11981036.html.plaintext.txt	385	Mol Endocrinol 131535 1549AbstractFree Full Text Chinetti G Griglio S Antonucci M Pineda Torra I Delerive P Majd Z Fruchart J C Chapman J Najib J Staels B 1998 Activation proliferator activated receptors induces apoptosis human monocyte derived macrophages
0.37514272.11981036.html.plaintext.txt	386	J Biol Chem 27325573 25581AbstractFree Full Text Sartippour MR Renier G 2000 Differential regulation macrophage peroxisome proliferator activated receptor expression glucose role peroxisome proliferator activated receptors lipoprotein lipase gene expression
0.37514272.11981036.html.plaintext.txt	387	Arterioscler Thromb Vasc Biol 20104 110AbstractFree Full Text Flavell DM Pineda Torra I Jamshidi Y Evans D Diamond JR Elkeles RS Bujac SR Miller G Talmud PJ Staels B Humphries SE 2000 Variation PPAR gene associated altered function vitro plasma lipid concentrations type II diabetic subjects
0.37514272.11981036.html.plaintext.txt	388	Diabetologia 43673 680CrossRefMedline Vohl MC Lepage P Gaudet D Brewer CG Betard C Perron P Houde G Cellier C Faith JM Despres JP Morgan K Hudson TJ 2000 Molecular scanning human PPARalpha gene association L162V mutation hyperapobetalipoproteinemia
0.37514272.11981036.html.plaintext.txt	389	J Lipid Res 41945 952AbstractFree Full Text Gearing KL Crickmore A Gustafsson JA 1994 Structure mouse peroxisome proliferator activated receptor gene
0.37514272.11981036.html.plaintext.txt	390	Biochem Biophys Res Commun 199255 263CrossRefMedline Sher T Yi HF McBride OW Gonzalez FJ 1993 cDNA cloning chromosomal mapping functional characterization human peroxisome proliferator activated receptor
0.37514272.11981036.html.plaintext.txt	391	Biochemistry 325598 5604Medline Quandt K Frech K Karas H Wingender E Werner T 1995 MatInd MatInspector new fast versatile tools detection consensus matches nucleotide sequence data
0.37514272.11981036.html.plaintext.txt	392	Nucleic Acids Res 234878 4884Abstract Mietus Snyder M Sladek FM Ginsburg GS Kuo CF Ladias JA Darnell JE Jr
0.37514272.11981036.html.plaintext.txt	393	Karathanasis SK 1992 Antagonism apolipoprotein AI regulatory protein 1 Ear3COUP TF hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression liver intestinal cells
0.37514272.11981036.html.plaintext.txt	394	Mol Cell Biol 121708 1718Abstract Ladias JA Karathanasis SK 1991 Regulation apolipoprotein AI gene ARP 1 novel member steroid receptor superfamily
0.37514272.11981036.html.plaintext.txt	395	Science 251561 565Medline Cairns W Smith CAD McLaren AW Wolf CR 1996 Characterization human cytochrome P4502D6 promoter
0.37514272.11981036.html.plaintext.txt	396	A potential role antagonistic interactions members nuclear receptor family
0.37514272.11981036.html.plaintext.txt	397	J Biol Chem 27125269 25276AbstractFree Full Text Galson DL Tsuchiya T Tendler DS Huang LE Ren Y Ogura T Bunn HF 1995 The orphan receptor hepatic nuclear factor 4 functions transcriptional activator tissue specific hypoxia specific erythropoietin gene expression antagonized EAR3COUP TF1
0.37514272.11981036.html.plaintext.txt	398	Mol Cell Biol 152135 2144Abstract Ladias JA Hadzopoulou Cladaras M Kardassis D Cardot P Cheng J Zannis V Cladaras C 1992 Transcriptional regulation human apolipoprotein genes ApoB ApoCIII ApoAII members steroid hormone receptor superfamily HNF 4 ARP 1 EAR 2 EAR 3
0.37514272.11981036.html.plaintext.txt	399	J Biol Chem 26715849 15860AbstractFree Full Text Kimura A Nishiyori A Murakami T Tsukamoto T Hata S Osumi T Okamura R Mori M Takiguchi M 1993 Chicken ovalbumin upstream promoter transcription factor COUP TF represses transcription promoter gene ornithine transcarbamylase manner antagonistic hepatocyte nuclear factor 4 HNF 4
0.37514272.11981036.html.plaintext.txt	400	J Biol Chem 26811125 11133AbstractFree Full Text Kharbanda S Nakamura T Stone R Hass R Bernstein S Datta R Sukhatme VP Kufe D 1991 Expression early growth response 1 2 zinc finger genes induction monocytic differentiation
0.37514272.11981036.html.plaintext.txt	401	J Clin Invest 88571 577Medline Fruchart JC Duriez P Staels B 1999 Peroxisome proliferator activated receptor activators regulate genes governing lipoprotein metabolism vascular inflammation atherosclerosis
0.37514272.11981036.html.plaintext.txt	402	Curr Opin Lipidol 10245 257CrossRefMedline Sladek FM Zhong WM Lai E Darnell Jr JE 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.37514272.11981036.html.plaintext.txt	403	Genes Dev 42353 2365Abstract Li J Ning G Duncan SA 2000 Mammalian hepatocyte differentiation requires transcription factor HNF 4
0.37514272.11981036.html.plaintext.txt	404	Genes Dev 14464 474AbstractFree Full Text Sladek FM Orphan receptor HNF4 liver specific gene expression
0.37514272.11981036.html.plaintext.txt	405	Receptor 3207 230 Fraser JD Martinez V Straney R Briggs MR 1998 DNA binding transcription activation specificity hepatocyte nuclear factor 4
0.37514272.11981036.html.plaintext.txt	406	Nucleic Acids Res 262702 2707AbstractFree Full Text Hayhurst GP Lee YH Lambert G Ward JM Gonzalez FJ 2001 Hepatocyte nuclear factor 4 nuclear receptor 2A1 essential maintenance hepatic gene expression lipid homeostasis
0.37514272.11981036.html.plaintext.txt	407	Mol Cell Biol 211393 1403AbstractFree Full Text Tsai SY Tsai MJ 1997 Chick ovalbumin upstream promoter transcription factors COUP TFs coming age
0.37514272.11981036.html.plaintext.txt	408	Endocr Rev 18229 240AbstractFree Full Text Sack MN Disch DL Rockman HA Kelly DP 1997 A role Sp nuclear receptor transcription factors cardiac hypertrophic growth program
0.37514272.11981036.html.plaintext.txt	409	Proc Natl Acad Sci USA 946438 6443AbstractFree Full Text Pereira FA Qiu Y Zhou G Tsai MJ Tsai SY 1999 The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.37514272.11981036.html.plaintext.txt	410	Genes Dev 131037 1049AbstractFree Full Text Nakamura T Fox Robichaud A Kikkawa R Kashiwagi A Kojima H Fujimiya M Wong NC 1999 Transcription factors age related decline apolipoprotein A I expression
0.37514272.11981036.html.plaintext.txt	411	J Lipid Res 401709 1718AbstractFree Full Text Sterchele PF Sun H Peterson RE Vanden Heuvel JP 1996 Regulation peroxisome proliferator activated receptor mRNA rat liver
0.37514272.11981036.html.plaintext.txt	412	Arch Biochem Biophys 326281 289CrossRefMedline Eisen LP Elsasser MS Harmon JM 1988 Positive regulation glucocorticoid receptor human T cells sensitive cytolytic effects glucocorticoids
0.37514272.11981036.html.plaintext.txt	413	J Biol Chem 26312044 12048AbstractFree Full Text Dai JL Burnstein KL 1996 Two androgen response elements androgen receptor coding region required cell specific regulation receptor messenger RNA
0.37514272.11981036.html.plaintext.txt	414	Mol Endocrinol 101582 1594Abstract Donaghue C Westley BR May FE 1999 Selective promoter usage human estrogen receptor gene regulation estrogen
0.37514272.11981036.html.plaintext.txt	415	Mol Endocrinol 131934 1950AbstractFree Full Text Myers KA Lambe KG Aldridge TC Macdonald N Tugwood JD 1997 Amino acid residues DNA binding ligand binding domains influence transcriptional activity human peroxisome proliferator activated receptor
0.37514272.11981036.html.plaintext.txt	416	Biochem Biophys Res Commun 239522 526CrossRefMedline Chomczynski P Sacchi N 1987 Single step method RNA isolation acid guanidinium thiocyanate phenol chloroform extraction
0.37514272.11981036.html.plaintext.txt	417	Anal Biochem 162156 159CrossRefMedline Bonazzi A Mastyugin V Mieyal PA Dunn MW Laniado Schwartman M 2000 Regulation cyclooxygenase 2 hypoxia peroxisome proliferators corneal epithelium
0.37514272.11981036.html.plaintext.txt	418	J Biol Chem 2752837 2844AbstractFree Full Text Staels B Vu Dac N Kosykh VA Saladin R Fruchart JC Dallongeville J Auwerx J 1995 Fibrates downregulate apolipoprotein C III expression independent induction peroxisomal acyl coenzyme A oxidase
0.37514272.11981036.html.plaintext.txt	419	A potential mechanism hypolipidemic action fibrates
0.37514272.11981036.html.plaintext.txt	420	J Clin Invest 95705 712Medline Raspe E Madsen L Lefebvre AM Leitersdorf I Gelman L Peinado Onsurbe J Dallongeville J Fruchart JC Berge R Staels B 1999 Modulation rat liver apolipoprotein gene expression serum lipid levels tetradecylthioacetic acid TTA via PPAR activation
0.37514272.11981036.html.plaintext.txt	421	J Lipid Res 402099 2110AbstractFree Full Text Malik S Karathanasis S 1995 Transcriptional activation orphan nuclear receptor ARP 1
0.37514272.11981036.html.plaintext.txt	422	Nucleic Acids Res 231536 1543Abstract
0.4318962.15141028.html.plaintext.txt	0	Hepatocyte Nuclear Factor 4 enhances Hepatocyte Nuclear Factor 1 mediated activation transcription J
0.4318962.15141028.html.plaintext.txt	1	INSERM Unit 459 Laboratoire de Biologie Cellulaire Faculte de Medecine H
0.4318962.15141028.html.plaintext.txt	2	Warembourg 1 Place de Verdun F 59045 Lille France
0.4318962.15141028.html.plaintext.txt	3	To correspondence addressed
0.4318962.15141028.html.plaintext.txt	4	Tel 33 3 20 62 69 51 Fax 33 3 20 62 68 84 Email blaineatlille
0.4318962.15141028.html.plaintext.txt	5	Received March 2 2004 Revised April 2 2004 Accepted April 13 2004
0.4318962.15141028.html.plaintext.txt	6	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Hepatocyte Nuclear Factor 1 HNF1 Hepatocyte Nuclear Factor 4 HNF4 two liver enriched transcription factors coexpressed specific tissues play crucial role involvement complex cross regulatory network
0.4318962.15141028.html.plaintext.txt	7	HNF1 regulates HNF4 mediated activation transcription via direct protein protein interaction
0.4318962.15141028.html.plaintext.txt	8	Here show HNF4 enhances transcriptional activity HNF1 DNA binding independent manner thus indicating behaves HNF1 coactivator
0.4318962.15141028.html.plaintext.txt	9	Using mutations ligand binding domain LBD HNF4 confirmed involvement Activation Function 2 module demonstrated requirement integrity LBD interaction HNF1
0.4318962.15141028.html.plaintext.txt	10	Moreover show HNF4 cooperates p300 achieve highest HNF1 mediated transcription rates
0.4318962.15141028.html.plaintext.txt	11	Our findings highlight new way HNF4 regulate gene expression extend knowledge complexity transcriptional network involving HNF4 HNF1
0.4318962.15141028.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Hepatocyte Nuclear Factor 1 HNF1 Hepatocyte Nuclear Factor 4 HNF4 two liver enriched transcription factors also expressed kidney intestine endocrine pancreas 1
0.4318962.15141028.html.plaintext.txt	13	They involved complex cross regulatory networks determine phenotype hepatocytes pancreatic ss cells 1 3
0.4318962.15141028.html.plaintext.txt	14	HNF1 homeodomain containing transcription factor 1 whereas HNF4 belongs hormone nuclear receptor superfamily 4
0.4318962.15141028.html.plaintext.txt	15	Both transcription factors highly conserved evolution 45
0.4318962.15141028.html.plaintext.txt	16	HNF1 HNF4 directly modulate expression large number genes 467
0.4318962.15141028.html.plaintext.txt	17	They also modulate transcription indirectly mentioned transcription factor network including HNF1 mediated negative regulation genes activated HNF4 89
0.4318962.15141028.html.plaintext.txt	18	The roles transcription factors vivo confirmed defects linked invalidation genes mice 10 14
0.4318962.15141028.html.plaintext.txt	19	Further underscoring importance transcription factors mutations HNF1 HNF4 genes identified patients Maturity Onset Diabetes Young MODY3 MODY1 respectively 1516
0.4318962.15141028.html.plaintext.txt	20	MODY1 MODY3 mutations result loss function transcription factors 17
0.4318962.15141028.html.plaintext.txt	21	Moreover reported expression HNF1 dominant negative mutant linked MODY3 led impaired function pancreatic ss cells 18
0.4318962.15141028.html.plaintext.txt	22	HNF1 contains two domains involved DNA binding atypical homeodomain POU like domain N terminal dimerization domain C terminal transactivation domain 1
0.4318962.15141028.html.plaintext.txt	23	Several proteins interact various HNF1 domains play crucial roles HNF1 function
0.4318962.15141028.html.plaintext.txt	24	DcoH Dimerization Cofactor HNF1 small protein binds HNF1 dimerization domain involved dimer stabilization 19
0.4318962.15141028.html.plaintext.txt	25	The ability various HNF1 domains interact multiple coactivators allows formation platform recruitment transcriptional complex leading strong enhancement transcription
0.4318962.15141028.html.plaintext.txt	26	CBPp300 interacts DNA binding domain activation domain HNF1 PCAF SRC 1 RAC3 interact HNF1 activation domain 2021
0.4318962.15141028.html.plaintext.txt	27	Each coactivators independently increase activation transcription HNF1
0.4318962.15141028.html.plaintext.txt	28	In addition cooperate enhance HNF1 mediated activation transcription 21
0.4318962.15141028.html.plaintext.txt	29	HNF1 also interact GATA 4 GATA 5 Cdx 2 transcription factors 22
0.4318962.15141028.html.plaintext.txt	30	The interactions HNF1 GATA5 Cdx 2 lead cooperative enhancement HNF1 mediated activation transcription 22
0.4318962.15141028.html.plaintext.txt	31	A synergy HNF1 neurogenin 3 also recently reported 23
0.4318962.15141028.html.plaintext.txt	32	HNF1 regulates HNF4 mediated activation transcription via direct interaction transcription factors 89
0.4318962.15141028.html.plaintext.txt	33	In work show HNF4 enhances transcriptional activity HNF1 cooperation factors enhanced p300 recruitment
0.4318962.15141028.html.plaintext.txt	34	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES DNA constructs Plasmids pcDNA3 HNF42 pcDNA3 HNF42 E276Q previously described 24
0.4318962.15141028.html.plaintext.txt	35	Plasmid pcDNA3 HNF42 D126Y described Oxombre et al
0.4318962.15141028.html.plaintext.txt	36	Plasmids pcDNA3 HNF42 E262A pGEX2TK HNF42 described Eeckhoute et al
0.4318962.15141028.html.plaintext.txt	37	Plasmids pcDNA3 HNF1 pcDNA3 HNF1 P291fsinsC named HNF1 AD generous gifts Drs M
0.4318962.15141028.html.plaintext.txt	38	Plasmids pcDNA3 HNF42 A223F pcDNA3 HNF42 AF2mut obtained site directed mutagenesis using QuickChangeTM kit Stratagene introduce A223F three mutations E363K L365Q L366Q respectively
0.4318962.15141028.html.plaintext.txt	39	Plasmid pM3 VP16 Clontech pcDNA3 RXRss encoding full length human RXRss generous gift Dr R
0.4318962.15141028.html.plaintext.txt	40	Plasmid pGEX2TK HNF1 prepared strategy identical used cloning pGEX2TK COUP TFII 24 inserting PCR fragment encompassing human HNF1 cDNA
0.4318962.15141028.html.plaintext.txt	41	Plasmid pCMVss NHA p300 PGEX2TK p3001 595 PGEX2TK p300340 528 PGEX2TK p3001572 2370 kindly provided Dr S
0.4318962.15141028.html.plaintext.txt	42	Expression plasmids VP16 Np300 VP16 Cp300 VP16 gifts Dr D
0.4318962.15141028.html.plaintext.txt	43	Plasmid pGL3 9611 LPK generous gift Dr M
0.4318962.15141028.html.plaintext.txt	44	Plasmid pGL3 341183 human HNF1 gift Dr G
0.4318962.15141028.html.plaintext.txt	45	Plasmid GAL4x5 TATA Luc described Chang Gralla 29
0.4318962.15141028.html.plaintext.txt	46	Plasmid pGL3 HNF1 TATA Luc cloned inserting double stranded oligonucleotide encompassing HNF1 binding site 56 35 SRC promoter SacINheI sites pGL3 basic vector TATA box adenovirus major late promoter previously cloned described Suaud et al
0.4318962.15141028.html.plaintext.txt	47	All constructs verified DNA sequencing
0.4318962.15141028.html.plaintext.txt	48	GST pull assays GST pull assays performed described previously 24 using 35Smethionine labelled vitro synthesized HNF1 HNF4 bacterially expressed GST fusion proteins indicated legends figures
0.4318962.15141028.html.plaintext.txt	49	Cell culture transient transfection assays HeLa cells 5
0.4318962.15141028.html.plaintext.txt	50	5 x 104 cells per 24 well dish grown transfected described Eeckhoute et al
0.4318962.15141028.html.plaintext.txt	51	30 plasmid amounts indicated figure legends
0.4318962.15141028.html.plaintext.txt	52	Luciferase activities measured using Bright Glo Luciferase assay system Promega
0.4318962.15141028.html.plaintext.txt	53	Western blotting Western blotting performed whole cell extracts using 455 HNF4 antiserum carried indicated Eeckhoute et al
0.4318962.15141028.html.plaintext.txt	54	Data analysis Statistical analyses based Student test unpaired data using Prism software
0.4318962.15141028.html.plaintext.txt	55	Statistical significance set P 0
0.4318962.15141028.html.plaintext.txt	56	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Enhancement HNF1 mediated activation transcription HNF4 HNF1 HNF4 positively regulate one another expression cell types endogenously express two factors 36
0.4318962.15141028.html.plaintext.txt	57	To avoid interference endogenous proteins effect HNF4 transactivation activity HNF1 analysed HeLa cells
0.4318962.15141028.html.plaintext.txt	58	The experiments performed synthetic promoter consisting one HNF1 binding site located upstream TATA box HNF1 TATA promoter natural liver pyruvate kinase promoter 9611 LPK containing one HNF1 binding site site L1 position 96 72 lacking HNF4 response element 28
0.4318962.15141028.html.plaintext.txt	59	As expected promoters activated HNF1 HNF4 Fig
0.4318962.15141028.html.plaintext.txt	60	Cotransfection HNF1 HNF4 resulted marked increase HNF1 mediated activation promoters 2
0.4318962.15141028.html.plaintext.txt	61	4 fold activation synthetic LPK promoters respectively Fig
0.4318962.15141028.html.plaintext.txt	62	The enhancement HNF1 activity impaired introducing D126Y mutation HNF4 significantly decreases DNA binding transactivation activities 25 data shown thus confirming synergy HNF1 HNF4 require DNA binding dependent activities HNF4 Fig
0.4318962.15141028.html.plaintext.txt	63	This induction artefact linked expression protein since cotransfection unrelated factor failed enhance HNF1 mediated activation transcription compare second last columns Fig
0.4318962.15141028.html.plaintext.txt	64	View larger version 20K Figure 1
0.4318962.15141028.html.plaintext.txt	65	HNF4 enhanced HNF1 dependent activation transcription
0.4318962.15141028.html.plaintext.txt	66	HeLa cells transiently transfected 250 ng HNF1 TATA promoter A 9611 LPK promoter B 15 ng HNF1 20 ng HNF4 RXRss expression plasmids indicated
0.4318962.15141028.html.plaintext.txt	67	C HNF4 unable cooperate VP16 activation domain
0.4318962.15141028.html.plaintext.txt	68	HeLa cells transiently transfected 250 ng GAL4x5 TATA promoter 5 ng GAL4 VP16 20 ng HNF4 expression vectors indicated
0.4318962.15141028.html.plaintext.txt	69	In A B C total amounts transfected DNA equalized empty expression plasmids
0.4318962.15141028.html.plaintext.txt	70	Fold induction refers basal activities promoters left columns
0.4318962.15141028.html.plaintext.txt	71	Results means plus minus S
0.4318962.15141028.html.plaintext.txt	72	three experiments performed triplicate
0.4318962.15141028.html.plaintext.txt	73	The extent HNF4 mediated enhancement HNF1 dependent activation transcription indicated values bars
0.4318962.15141028.html.plaintext.txt	74	D In vitro interaction HNF1 HNF4 analysed pull assays
0.4318962.15141028.html.plaintext.txt	75	A schematic representation HNF1 HNF1 AD proteins presented AD denotes activation domain
0.4318962.15141028.html.plaintext.txt	76	35Smethionine labelled HNF1 HNF1 AD incubated immobilized GST GST HNF4
0.4318962.15141028.html.plaintext.txt	77	Bound proteins analysed SDS PAGE PhosphorImager Molecular Dynamics
0.4318962.15141028.html.plaintext.txt	78	Inputs correspond 10 amounts labelled proteins used assays
0.4318962.15141028.html.plaintext.txt	79	E Requirement activation domains HNF1 cooperation HNF4 HNF1
0.4318962.15141028.html.plaintext.txt	80	HeLa cells transfected A indicated HNF1 constructs
0.4318962.15141028.html.plaintext.txt	81	Fold induction refers basal activity promoter left column
0.4318962.15141028.html.plaintext.txt	82	Results means plus minus S
0.4318962.15141028.html.plaintext.txt	83	three experiments performed triplicate
0.4318962.15141028.html.plaintext.txt	84	To control possibility HNF4 act transcriptional partner another transcription factor analysed effect HNF4 VP16 activation domain fused GAL4 DBD construct GAL4 VP16
0.4318962.15141028.html.plaintext.txt	85	HNF4 unable enhance VP16 mediated activation transcription Fig
0.4318962.15141028.html.plaintext.txt	86	1C thus indicating selectivity cooperation HNF4 HNF1
0.4318962.15141028.html.plaintext.txt	87	As predicted results Ktistaki Talianidis 9 observed full length HNF1 HNF4 physically interact Fig
0.4318962.15141028.html.plaintext.txt	88	Interestingly pull experiments also showed HNF1 lacking activation domain HNF1 AD efficiently interacted HNF4 Fig
0.4318962.15141028.html.plaintext.txt	89	This result indicates sequence 1 291 HNF1 containing dimerization DNA binding domains able interact HNF4
0.4318962.15141028.html.plaintext.txt	90	This prompted us investigate whether coexpression HNF4 HNF1 AD could activate HNF1 TATA promoter
0.4318962.15141028.html.plaintext.txt	91	Despite efficient interaction HNF1 AD HNF4 unable activate transcription Fig
0.4318962.15141028.html.plaintext.txt	92	1E thus indicating cooperation HNF1 HNF4 requires HNF1 activation domain
0.4318962.15141028.html.plaintext.txt	93	AF2 sequence within HNF4 LBD required interaction cooperation HNF1 The repressive action HNF1 HNF4 unambiguously shown require HNF4 LBD 9
0.4318962.15141028.html.plaintext.txt	94	However using truncated fragments HNF4 Ktistaki Talianidis mapped sequence involved interaction HNF1 residues 337 368 leading conclusion HNF4 AF2 activation function necessary sufficient interaction HNF1 9
0.4318962.15141028.html.plaintext.txt	95	In fact sequence contain solely AF2 sequence 358 366 corresponding helix 12 LBD also fragment forming part large helix termed H10 H11 according conventional nomenclature 31
0.4318962.15141028.html.plaintext.txt	96	Indeed H10 H11 contiguous HNF4 form helix plays key role HNF4 function 31
0.4318962.15141028.html.plaintext.txt	97	Furthermore integrity helix crucial protein conformation 32
0.4318962.15141028.html.plaintext.txt	98	These recent findings begged re evaluation HNF4 sequence involved interaction HNF1
0.4318962.15141028.html.plaintext.txt	99	Using full length HNF4 analysed effects point mutations located HNF4 LBD Fig
0.4318962.15141028.html.plaintext.txt	100	2A interaction cooperation HNF1
0.4318962.15141028.html.plaintext.txt	101	The E262A mutation shown affect HNF4 dimerization 26
0.4318962.15141028.html.plaintext.txt	102	The E276Q mutation alter intrinsic HNF4 transcriptional activity impairs recruitment HNF4 transcriptional partners 2433
0.4318962.15141028.html.plaintext.txt	103	Owing bulky side chain phenylalanine A223F mutation hypothesized affect occupancy ligand binding pocket fatty acids act structural cofactors rather conventional ligands 31
0.4318962.15141028.html.plaintext.txt	104	Accord ingly A223F mutation mildly impaired HNF4 transcriptional activity interaction coactivators data shown
0.4318962.15141028.html.plaintext.txt	105	In AF2 module acidic group amino acid residue side chain position 363 hydrophobic nature amino acid residue side chain position 365 strictly conserved play key role nuclear receptor function 34
0.4318962.15141028.html.plaintext.txt	106	Residue L366 also important since L366Q mutation alters HNF4 transcriptional activity 35
0.4318962.15141028.html.plaintext.txt	107	Pull assays showed introducing three mutations E363K L365Q L366Q AF2 HNF4 AF2mut construct altered interaction HNF4 HNF1 Fig
0.4318962.15141028.html.plaintext.txt	108	Note however decrease interaction mild
0.4318962.15141028.html.plaintext.txt	109	This result confirms involvement AF2 interaction HNF1 HNF4 indicates module unique sequence required interaction proteins
0.4318962.15141028.html.plaintext.txt	110	Interaction HNF1 also significantly decreased A223F E276Q mutations mutation E262A effect Fig
0.4318962.15141028.html.plaintext.txt	111	Consistent data pull assays HNF4 mediated enhancement HNF1 dependent transcriptional activation 9611 LPK promoter impaired E262A mutation significantly decreased mutants A223F E276Q HNF4 AF2mut Fig
0.4318962.15141028.html.plaintext.txt	112	We controlled mutant wild type HNF4 expressed similar level transfected cells shown Figure 2D mutants A223F HNF4 AF2mut 2426 mutant E276Q E262A respectively
0.4318962.15141028.html.plaintext.txt	113	It appears therefore interaction cooperation HNF4 HNF1 depend AF2 module helix 12 integrity HNF4 LBD
0.4318962.15141028.html.plaintext.txt	114	View larger version 23K Figure 2
0.4318962.15141028.html.plaintext.txt	115	The AF2 sequence within HNF4 LBD required interaction cooperation HNF1
0.4318962.15141028.html.plaintext.txt	116	A Positions mutations used study
0.4318962.15141028.html.plaintext.txt	117	A scheme HNF4 structure various domains given DBD DNA binding domain LBD ligand binding domain AF2 activation function 2 module
0.4318962.15141028.html.plaintext.txt	118	B Effects HNF4 mutations physical interaction HNF1
0.4318962.15141028.html.plaintext.txt	119	35Smethionine labelled wild type mutated HNF4 incubated immobilized GST HNF1
0.4318962.15141028.html.plaintext.txt	120	Bound proteins analysed SDS PAGE PhosphorImager
0.4318962.15141028.html.plaintext.txt	121	Values photographs indicate binding HNF4 mutants relative wild type HNF4 three independent experiments
0.4318962.15141028.html.plaintext.txt	122	Inputs corresponding 5 amounts labelled proteins used assays taken account binding quantifications
0.4318962.15141028.html.plaintext.txt	123	C Effects HNF4 mutations cooperation HNF4 HNF1 9611 LPK promoter
0.4318962.15141028.html.plaintext.txt	124	HeLa cells transfected Figure 1B
0.4318962.15141028.html.plaintext.txt	125	Fold induction refers basal activity promoter left column
0.4318962.15141028.html.plaintext.txt	126	Results means plus minus S
0.4318962.15141028.html.plaintext.txt	127	three experiments performed triplicate
0.4318962.15141028.html.plaintext.txt	128	Statistical significance differences values obtained wild type HNF42 indicated stars P 0
0.4318962.15141028.html.plaintext.txt	129	D Western blotting wild type WT A223F AF2mut HNF4 expressed HeLa cells using 455 HNF4 antiserum 43
0.4318962.15141028.html.plaintext.txt	130	The star denotes non specific band obtained HeLa cells transfected empty vector
0.4318962.15141028.html.plaintext.txt	131	The number left indicates molecular mass marker size kDa
0.4318962.15141028.html.plaintext.txt	132	HNF4 cooperates coactivator p300 enhance HNF1 transcriptional activity Because CBPp300 key coactivators HNF1 hypothesized cooperation HNF4 HNF1 could involve p300
0.4318962.15141028.html.plaintext.txt	133	In absence HNF1 coactivator p300 alone coexpressed HNF4 unable activate HNF1 TATA promoter Fig
0.4318962.15141028.html.plaintext.txt	134	On promoter p300 slightly enhanced HNF1 transcriptional activity Fig
0.4318962.15141028.html.plaintext.txt	135	Note moderate increase due least part low ratio p300HNF1 expression vectors used experiments 31 compared used studies performed promoters e
0.4318962.15141028.html.plaintext.txt	136	We verified using higher ratio could obtain stronger enhancement HNF1 activity p300 alone data shown
0.4318962.15141028.html.plaintext.txt	137	Interestingly presence HNF4 p300 synergistically enhanced HNF1 mediated activation transcription activity promoter increased 18
0.4318962.15141028.html.plaintext.txt	138	7 fold higher additive value induction HNF1 activity p300 HNF4 alone 1
0.4318962.15141028.html.plaintext.txt	139	The marked p300 mediated enhancement cooperation HNF1 HNF4 could also observed 9611 LPK promoter Fig
0.4318962.15141028.html.plaintext.txt	140	On promoters enhanced cooperation HNF1 HNF4 significantly impaired mutations HNF4 AF2 module Fig
0.4318962.15141028.html.plaintext.txt	141	These results strongly argue involvement HNF4 p300 mediated activation promoters despite absence HNF4 response element sequences
0.4318962.15141028.html.plaintext.txt	142	The result obtained HNF4 AF2mut led us investigate whether mutations AF2 affect p300 binding
0.4318962.15141028.html.plaintext.txt	143	Pull experiments clearly showed much weaker interaction p300 HNF4 AF2mut wild type HNF4 Fig
0.4318962.15141028.html.plaintext.txt	144	This result line previous observation deletion AF2 resulted decrease interaction 70 HNF4 p300 33
0.4318962.15141028.html.plaintext.txt	145	Therefore cannot exclude impaired cooperativity HNF4 AF2mut also due reduced p300 recruitment
0.4318962.15141028.html.plaintext.txt	146	Because documented HNF4 CBPp300 form transcriptionally active complex 36 verified whether experimental conditions complex sufficient achieve strong cooperation
0.4318962.15141028.html.plaintext.txt	147	This question addressed use human HNF1 promoter containing HNF4 response element lacking HNF1 binding site
0.4318962.15141028.html.plaintext.txt	148	Using p300HNF4 expression vector amounts used Figure 3A B cotransfection p300 failed strongly enhance HNF4 mediated activation transcription Fig
0.4318962.15141028.html.plaintext.txt	149	It appears therefore strong activation transcription observed Figure 3A B requires ternary complex including HNF1 HNF4 p300
0.4318962.15141028.html.plaintext.txt	150	View larger version 16K Figure 3
0.4318962.15141028.html.plaintext.txt	151	Involvement p300 cooperation HNF1 HNF4
0.4318962.15141028.html.plaintext.txt	152	The cooperation analysed HNF1 TATA 9611 LPK promoters A B respectively
0.4318962.15141028.html.plaintext.txt	153	HeLa cells transiently transfected 250 ng promoter plasmids 10 ng HNF1 15 ng HNF4 HNF4 AF2mut 30 ng p300 expression plasmids indicated
0.4318962.15141028.html.plaintext.txt	154	Fold induction refers basal activity promoter left column
0.4318962.15141028.html.plaintext.txt	155	Values bars indicate enhancement HNF1 mediated activation transcription HNF4 p300 alone cooperation
0.4318962.15141028.html.plaintext.txt	156	Results means plus minus S
0.4318962.15141028.html.plaintext.txt	157	three experiments performed triplicate
0.4318962.15141028.html.plaintext.txt	158	C Effect mutations AF2 HNF4 interaction p300 analysed pull assay
0.4318962.15141028.html.plaintext.txt	159	35SMethionine labelled HNF4 HNF4 AF2mut incubated immobilized GST p300340 528
0.4318962.15141028.html.plaintext.txt	160	Bound proteins analysed SDS PAGE PhosphorImager
0.4318962.15141028.html.plaintext.txt	161	D HeLa cells transiently transfected expression vector amounts indicated A 250 ng human HNF1 promoter
0.4318962.15141028.html.plaintext.txt	162	Fold induction calculated three experiments performed triplicate refers basal activity promoter
0.4318962.15141028.html.plaintext.txt	163	With aim investigate mechanism underlying p300 mediated enhancement cooperation HNF1 HNF4 surveyed p300 domains involved interactions transcription factors
0.4318962.15141028.html.plaintext.txt	164	Using double hybrid approach previously shown sequences 180 662 1818 2079 p300 interact HNF1 transactivation domain 20
0.4318962.15141028.html.plaintext.txt	165	Using GST pull assays mapped precisely amino terminal sequence p300 involved interaction full length HNF1 residues 340 528 Fig
0.4318962.15141028.html.plaintext.txt	166	We also confirmed full length HNF1 interacts carboxy terminal region p300 Fig
0.4318962.15141028.html.plaintext.txt	167	We previously shown ability HNF4 interact amino terminal domain p300 33
0.4318962.15141028.html.plaintext.txt	168	HNF4 also interacted p300 carboxy terminal region shown Figure 4C
0.4318962.15141028.html.plaintext.txt	169	The presence multiple interaction surfaces proteins led us analyse effect HNF4 recruitment amino carboxy terminal regions p300 HNF1
0.4318962.15141028.html.plaintext.txt	170	The strategy consisted determining whether HNF4 affects cooperation HNF1 amino carboxy terminal fragments p300 fused VP16 activation domain named Np300 VP16 Cp300 VP16 respectively Fig
0.4318962.15141028.html.plaintext.txt	171	Expression VP16 activation domain affected neither basal activity promoter activity presence expression vectors HNF1 alone together HNF4 Fig
0.4318962.15141028.html.plaintext.txt	172	Expression Np300 VP16 failed affect basal activity promoter HNF1 mediated activation promoter Fig
0.4318962.15141028.html.plaintext.txt	173	Similar results obtained expression Cp300 VP16 Fig
0.4318962.15141028.html.plaintext.txt	174	Conversely presence HNF1 HNF4 Np300 VP16 Cp300 VP16 markedly enhanced promoter activity Fig
0.4318962.15141028.html.plaintext.txt	175	These results indicate cellular context p300 recruitment HNF1 HNF4 complex mediated amino carboxy terminal regions reinforce data obtained Figure 3 suggesting HNF4 improves p300 recruitment promoter containing HNF1 binding site Fig
0.4318962.15141028.html.plaintext.txt	176	View larger version 25K Figure 4
0.4318962.15141028.html.plaintext.txt	177	HNF4 enhanced cooperation HNF1 p300 interactions amino carboxy terminal sequences coactivator
0.4318962.15141028.html.plaintext.txt	178	A Schematic representation p300 fragments fused either GST VP16 activation domain used interaction studies HNF1 HNF4
0.4318962.15141028.html.plaintext.txt	179	B Interaction HNF1 amino terminal domain p300 analysed pull assays
0.4318962.15141028.html.plaintext.txt	180	35SMethionine labelled HNF1 incubated immobilized GST GST p3001 595 GST p300340 528
0.4318962.15141028.html.plaintext.txt	181	C Interaction HNF1 HNF4 carboxy terminal domain p300 analysed pull assays
0.4318962.15141028.html.plaintext.txt	182	35SMethionine labelled HNF1 HNF4 incubated immobilized GST GST p3001572 2370
0.4318962.15141028.html.plaintext.txt	183	In B C bound proteins analysed SDS PAGE PhosphorImager
0.4318962.15141028.html.plaintext.txt	184	D HNF4 potentiates enhancement HNF1 activity Np300 Cp300 VP16
0.4318962.15141028.html.plaintext.txt	185	HeLa cells transiently transfected 250 ng HNF1 TATA promoter 10 ng HNF1 15 ng HNF4 60 ng VP16 empty vector left VP16 Np300 VP16 middle VP16 Cp300 VP16 right expression plasmids
0.4318962.15141028.html.plaintext.txt	186	In case total amount transfected DNA kept constant using empty pcDNA3
0.4318962.15141028.html.plaintext.txt	187	Fold induction refers basal activity promoter left columns
0.4318962.15141028.html.plaintext.txt	188	Results means plus minus S
0.4318962.15141028.html.plaintext.txt	189	least three experiments performed triplicate
0.4318962.15141028.html.plaintext.txt	190	E Mechanisms HNF4 could enhance HNF1 transcriptional activity
0.4318962.15141028.html.plaintext.txt	191	The amino andor carboxy terminal domains p300 involved p300 mediated activation transcription
0.4318962.15141028.html.plaintext.txt	192	HNF4 could enhance p300 recruitment direct binding p300 fragments andor indirect effect HNF1 p300 interactions
0.4318962.15141028.html.plaintext.txt	193	HNF4 could also help recruitment coactivators transcriptional complex
0.4318962.15141028.html.plaintext.txt	194	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES It previously shown HNF1 acts repressor HNF4 mediated activation transcription 89
0.4318962.15141028.html.plaintext.txt	195	In study show HNF4 serve coactivator HNF1 since HNF4 able enhance HNF1 activity DNA binding independent manner
0.4318962.15141028.html.plaintext.txt	196	A synergy HNF1 HNF4 inferred data obtained undifferentiated Caco 2 cells promoter containing binding sites two HNFs
0.4318962.15141028.html.plaintext.txt	197	Since mutation HNF4 binding site affect synergy authors suggested effect probably involve HNF4 DNA binding 37
0.4318962.15141028.html.plaintext.txt	198	In light results data probably explained ability HNF4 directly act HNF1 coactivator
0.4318962.15141028.html.plaintext.txt	199	Analysis physiological role HNF4 coactivator function cell types endogenously express HNF1 HNF4 cannot realized conventional targeting HNF4 expression since HNF4 also positively regulates HNF1 expression
0.4318962.15141028.html.plaintext.txt	200	Therefore concern first require development experimental model permits distinguish HNF4 effects linked regulation HNF1 expression one hand regulation HNF1 transcriptional activity hand Fig
0.4318962.15141028.html.plaintext.txt	201	View larger version 11K Figure 5
0.4318962.15141028.html.plaintext.txt	202	Cross talk HNF1 HNF4
0.4318962.15141028.html.plaintext.txt	203	The cross talk involves expression activation binding promoters solid lines modulation transcriptional potential protein protein interactions dotted lines HNF transcription factor
0.4318962.15141028.html.plaintext.txt	204	Interplays two transcription factors activation repression transcription already documented
0.4318962.15141028.html.plaintext.txt	205	Indeed cross talk HNF6 HNF3ss two liver enriched transcription factors also results opposite effects activities proteins 38
0.4318962.15141028.html.plaintext.txt	206	Despite efficient interaction HNF4 HNF1 lacking activation function HNF1 AD unable cooperate
0.4318962.15141028.html.plaintext.txt	207	Such behaviour reminiscent CBP PCAF HNF1 1 280 21
0.4318962.15141028.html.plaintext.txt	208	Only simultaneous overexpression CBP PCAF together truncated HNF1 could activate transcription 21
0.4318962.15141028.html.plaintext.txt	209	This points critical role HNF1 activation domain could recruitment required coactivators andor stabilization transcriptional complex recruited HNF1
0.4318962.15141028.html.plaintext.txt	210	Our results indicate HNF4 AF2 involved interaction HNF1 also regions HNF4 LBD required full interaction proteins
0.4318962.15141028.html.plaintext.txt	211	Ktistaki Talianidis previously stated HNF4 AF2 sufficient interaction HNF1 9
0.4318962.15141028.html.plaintext.txt	212	The discrepancy conclusion results likely explained fact authors used deletion fragment residues 337 368 includes AF2 also part large helix H10 H11 integrity meanwhile shown crucial protein conformation 32
0.4318962.15141028.html.plaintext.txt	213	We observed two point mutations HNF4 LBD A223F E276Q significantly decreased interaction cooperation HNF1 thus demonstrating integrity HNF4 LBD required synergy HNF1
0.4318962.15141028.html.plaintext.txt	214	The similarity phenotypes exhibited diabetic patients carrying MODY1 MODY3 mutations ascribed mutual control transcription HNF1 HNF4
0.4318962.15141028.html.plaintext.txt	215	The ability HNF4 serve HNF1 coactivator could provide additional explanation closely related phenotypes MODY forms diabetes
0.4318962.15141028.html.plaintext.txt	216	Impairment interaction enhancement HNF1 transcriptional activity HNF4 E276Q mutation may physiologically relevant since mutation correlated MODY1
0.4318962.15141028.html.plaintext.txt	217	Unfortunately low transfection efficiency presence large amounts endogenous HNF4 pancreatic ss cells prevented us analysing effects mutation synergy HNF4 HNF1 cells
0.4318962.15141028.html.plaintext.txt	218	Our results support model involves combined action HNF4 coactivator p300 achieve highest rate transcription mediated HNF1
0.4318962.15141028.html.plaintext.txt	219	Our results also strongly suggest HNF4 improves p300 recruitment
0.4318962.15141028.html.plaintext.txt	220	The synergy HNF4 p300 may mediated two ways
0.4318962.15141028.html.plaintext.txt	221	The first involves simultaneous interactions HNF4 p300 HNF1 Fig
0.4318962.15141028.html.plaintext.txt	222	In case HNF4 could indirectly improve HNF1 p300 interaction induction HNF1 conformational change
0.4318962.15141028.html.plaintext.txt	223	Such mechanism reminiscent CBP mediated improvement interaction HNF1 PCAF 21
0.4318962.15141028.html.plaintext.txt	224	Similarly upon docking PPAR PGC 1 undergoes conformational change permits binding SRC 1 p300 39
0.4318962.15141028.html.plaintext.txt	225	The second involves docking p300 HNF4 bound HNF1 Fig
0.4318962.15141028.html.plaintext.txt	226	The recruitment p300 HNF1 HNF4 complex could mediated amino andor carboxy terminal regions contain CH1 CH3 domains respectively
0.4318962.15141028.html.plaintext.txt	227	These domains known involved protein protein interactions 40
0.4318962.15141028.html.plaintext.txt	228	The presence multiple interaction surfaces HNF1 HNF4 p300 probably facilitates formation ternary complex formed proteins Fig
0.4318962.15141028.html.plaintext.txt	229	The remaining synergy HNF1 HNF4 mutations HNF4 AF2 Fig
0.4318962.15141028.html.plaintext.txt	230	3 may accounted ability p300 interact activate HNF4 AF1 3341 fact two mentioned mechanisms may mutually exclusive
0.4318962.15141028.html.plaintext.txt	231	In conclusion results highlight new way HNF4 regulate gene expression
0.4318962.15141028.html.plaintext.txt	232	HNF4 directly binds promoters also interaction transcription factors already bound DNA facilitate coactivator recruitment enhance transcription
0.4318962.15141028.html.plaintext.txt	233	Recently shown HNF4 also serves coactivator Sterol Regulatory Element Binding protein 2 42
0.4318962.15141028.html.plaintext.txt	234	Furthermore results yield insights higher complexity transcriptional network primordial relationship HNF1 HNF4 Fig
0.4318962.15141028.html.plaintext.txt	235	In regulatory loop HNF1 HNF4 HNF4 activate HNF1 expression transcriptional activity
0.4318962.15141028.html.plaintext.txt	236	In contrast additive processes negative effect HNF1 HNF4 transcriptional activity attenuate HNF1 mediated activation expression
0.4318962.15141028.html.plaintext.txt	237	These regulatory feedback mechanisms taken account considering HNF1 HNF4 involved large diversity pathways controlling function multiple organs notably liver endocrine pancreas
0.4318962.15141028.html.plaintext.txt	238	Bell acknowledged generous gifts plasmids
0.4318962.15141028.html.plaintext.txt	239	Sacchetti helpful discussions I
0.4318962.15141028.html.plaintext.txt	240	Briche skillful technical assistance
0.4318962.15141028.html.plaintext.txt	241	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES CereghiniS
0.4318962.15141028.html.plaintext.txt	242	1996 Liver enriched transcription factors hepatocyte differentiation
0.4318962.15141028.html.plaintext.txt	243	1998 Regulation transcription factor network required differentiation metabolism
0.4318962.15141028.html.plaintext.txt	244	2002 A genetic switch pancreatic beta cells implications differentiation haploinsufficiency
0.4318962.15141028.html.plaintext.txt	245	2001 Hepatocyte Nuclear Factor 4alpha
0.4318962.15141028.html.plaintext.txt	246	eds Nuclear Receptors Genetic Disease
0.4318962.15141028.html.plaintext.txt	247	Academic Press San Francisco CA pp
0.4318962.15141028.html.plaintext.txt	248	1993 Developmental regulation tissue distribution liver transcription factor LFB1 HNF1 Xenopus laevis
0.4318962.15141028.html.plaintext.txt	249	2004 Control pancreas liver gene expression HNF transcription factors
0.4318962.15141028.html.plaintext.txt	250	1997 Analysis distribution binding sites tissue specific transcription factor vertebrate genome
0.4318962.15141028.html.plaintext.txt	251	1993 An indirect negative autoregulatory mechanism involved hepatocyte nuclear factor 1 gene expression
0.4318962.15141028.html.plaintext.txt	252	1997 Modulation hepatic gene expression hepatocyte nuclear factor 1
0.4318962.15141028.html.plaintext.txt	253	1996 Hepatocyte nuclear factor 1 inactivation results hepatic dysfunction phenylketonuria renal Fanconi syndrome
0.4318962.15141028.html.plaintext.txt	254	1998 Defective insulin secretion hepatocyte nuclear factor 1 alpha deficient mice
0.4318962.15141028.html.plaintext.txt	255	1998 Laron Dwarfism non insulin dependent diabetes mellitus Hnf 1 Knockout mouse
0.4318962.15141028.html.plaintext.txt	256	2001 Hepatocyte Nuclear Factor 4alpha Nuclear Receptor 2A1 essential maintenance hepatic gene expression lipid homeostasis
0.4318962.15141028.html.plaintext.txt	257	2003 Regulation hepatic fasting response PPARgamma coactivator 1alpha PGC 1 requirement hepatocyte nuclear factor 4alpha gluconeogenesis
0.4318962.15141028.html.plaintext.txt	258	1996 Mutations hepatocyte nuclear factor 1 alpha gene maturity onset diabetes young MODY3
0.4318962.15141028.html.plaintext.txt	259	1996 Mutations hepatocyte nuclear factor 4 alpha gene maturity onset diabetes young MODY1
0.4318962.15141028.html.plaintext.txt	260	2001 Mutations human genes encoding transcription factors hepatocyte nuclear factor HNF1 HNF4 families functional pathological consequences
0.4318962.15141028.html.plaintext.txt	261	2002 Experimental models transcription factor associated maturity onset diabetes young
0.4318962.15141028.html.plaintext.txt	262	1991 Characterization cofactor regulates dimerization mammalian homeodomain protein
0.4318962.15141028.html.plaintext.txt	263	2002 Hepatocyte nuclear factor 1alpha recruits transcriptional co activator p300 GLUT2 gene promoter
0.4318962.15141028.html.plaintext.txt	264	2000 Transcriptional activation hepatocyte nuclear factor 1 requires synergism multiple coactivator proteins
0.4318962.15141028.html.plaintext.txt	265	2000 Interaction homeodomain proteins Cdx2 HNF1alpha mediates expression lactase phlorizin hydrolase gene
0.4318962.15141028.html.plaintext.txt	266	2003 Neurogenin3 hepatic nuclear factor 1 cooperate activating pancreatic expression Pax4
0.4318962.15141028.html.plaintext.txt	267	1999 Functional study E276Q mutant Hepatocyte Nuclear Factor 4 found type 1 Maturity Onset Diabetes Young impaired synergy Chicken Ovalbumin Upstream Promoter Transcription Factor II Hepatocyte Nuclear factor 1 promoter
0.4318962.15141028.html.plaintext.txt	268	2002 Mutations hepatocyte nuclear factor 4alpha gene associated diabetes result greater loss HNF4alpha function pancreatic beta cells nonpancreatic beta cells reduced activation apolipoprotein CIII promoter hepatic cells
0.4318962.15141028.html.plaintext.txt	269	2003 Critical role charged residues helix 7 ligand binding domain hepatocyte nuclear factor 4 alpha
0.4318962.15141028.html.plaintext.txt	270	1998 Regulation human P450scc gene steroidogenic factor 1 mediated CBPp300
0.4318962.15141028.html.plaintext.txt	271	1991 cis acting DNA elements regulating expression liver pyruvate kinase gene hepatocytes hepatoma cells
0.4318962.15141028.html.plaintext.txt	272	Evidence tissue specific activators extinguisher
0.4318962.15141028.html.plaintext.txt	273	1993 Properties initiator associated transcription mediated GAL4 VP16
0.4318962.15141028.html.plaintext.txt	274	2003 Hepatocyte Nuclear Factor 4alpha isoforms originated P1 promoter expressed human pancreatic beta cells exhibit stronger transcriptional potentials P2 promoter driven isoforms
0.4318962.15141028.html.plaintext.txt	275	Endocrinology 144 1686 1694
0.4318962.15141028.html.plaintext.txt	276	2002 Crystal structure HNF4alpha ligand binding domain complex endogenous fatty acid ligand
0.4318962.15141028.html.plaintext.txt	277	2000 Analysis protein dimerization ligand binding orphan receptor HNF4alpha
0.4318962.15141028.html.plaintext.txt	278	2001 MODY1 diabetes associated mutations R154X E276Q HNF4alpha gene impair recruitment p300 key transcriptional coactivator
0.4318962.15141028.html.plaintext.txt	279	1997 Functional domains nuclear receptor Hepatocyte Nuclear Factor 4
0.4318962.15141028.html.plaintext.txt	280	1998 The activation function 2 domain hepatic nuclear factor 4 regulated short C terminal proline rich repressor domain
0.4318962.15141028.html.plaintext.txt	281	2000 Acetylation regulates transcription factor activity multiple levels
0.4318962.15141028.html.plaintext.txt	282	1999 Regulation alpha1 antitrypsin gene expression human intestinal epithelial cell line Caco 2 HNF 1alpha HNF 4
0.4318962.15141028.html.plaintext.txt	283	2003 Association hepatocyte nuclear factor 6 HNF 6 FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity inhibits HNF 6 DNA binding
0.4318962.15141028.html.plaintext.txt	284	1999 Activation PPARgamma coactivator 1 transcription factor docking
0.4318962.15141028.html.plaintext.txt	285	2002 Epstein Barr virus nuclear antigen 3C prothymosin alpha interact p300 transcriptional coactivator CH1 CH3HAT domains cooperate regulation transcription histone acetylation
0.4318962.15141028.html.plaintext.txt	286	2002 Developmentally regulated N terminal variants nuclear receptor HNF4alpha mediate multiple interactions coactivator corepressorHDAC complexes
0.4318962.15141028.html.plaintext.txt	287	2003 Sterol regulatory element binding protein 2 interacts hepatocyte nuclear factor 4 enhance sterol isomerase gene expression hepatocytes
0.4318962.15141028.html.plaintext.txt	288	Jr 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.22919919.9280061.html.plaintext.txt	0	Identification Novel Sonic Hedgehog Response Element Chicken Ovalbumin Upstream Promoter Transcription Factor II Promoter Venkatesh Krishnan Gerard Elberg Ming Jer Tsai Sophia Y
0.22919919.9280061.html.plaintext.txt	1	Department Cell Biology Baylor College Medicine Houston Texas 77030
0.22919919.9280061.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Sonic hedgehog Shh secreted morphogen regulates dorso ventral patterning within neural tube embryonic development
0.22919919.9280061.html.plaintext.txt	3	It well established Shh induce motor neuron differentiation coincides appearance specific motor neuron markers including chicken ovalbumin upstream promoter transcription factor II COUP TFII Isl1
0.22919919.9280061.html.plaintext.txt	4	However mechanism Shh induced signaling pathway vertebrates clearly defined
0.22919919.9280061.html.plaintext.txt	5	In report identified COUP TFII target gene Shh
0.22919919.9280061.html.plaintext.txt	6	6 kb region COUP TFII promoter identify target element mediates Shh induced activity
0.22919919.9280061.html.plaintext.txt	7	Extensive deletions introduced within region enabled us identify novel sonic hedgehog response element ShhRE COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	8	Point mutations introduced within ShhRE reveal key nucleotides essential proteins binding activity
0.22919919.9280061.html.plaintext.txt	9	Finally ShhRE capable functioning true enhancer element mediate Shh induced transactivation reporter gene via heterologous promoter
0.22919919.9280061.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Sonic hedgehog Shh vertebrate member Drosophila segment polarity gene family secreted morphogen responsible providing ventralizing signals within neural tube 1 2
0.22919919.9280061.html.plaintext.txt	11	The Drosophila homolog Shh called hedgehog Hh expressed 471 amino acid polypeptide subsequently cleaved amino acid 257 unique autoproteolytic mechanism 3
0.22919919.9280061.html.plaintext.txt	12	The C terminus Hh harbors proteolytic activity N terminus includes signal peptide sequence secreted form protein
0.22919919.9280061.html.plaintext.txt	13	Several reports indicate N terminal 20 kDa protein harbors signaling activity morphogen 4 5
0.22919919.9280061.html.plaintext.txt	14	Similar observations made murine homolog respect N terminal activity
0.22919919.9280061.html.plaintext.txt	15	Consistent observation high degree homology 94 99 N terminal 180 amino acids mouse chicken zebra fish members hedgehog gene family 1
0.22919919.9280061.html.plaintext.txt	16	It reported increased Shh expression notochord results increased expression HNF3ss floor plate subsequent appearance ventral markers neural tube 6
0.22919919.9280061.html.plaintext.txt	17	This results suppression dorsalizing signals induced BMP 24 originating neuroectoderm 7
0.22919919.9280061.html.plaintext.txt	18	The appearance ventral markers within neural tube establishes dorso ventral boundary broadly described dorso ventral patterning
0.22919919.9280061.html.plaintext.txt	19	The induction motor neuron markers within ventro lateral region coincident Shh mediated activity neural tube
0.22919919.9280061.html.plaintext.txt	20	Jessell co workers 8 demonstrated conditioned media COS 1 cells overexpress secrete Shh mediate motor neuron differentiation naive neural plate explants
0.22919919.9280061.html.plaintext.txt	21	Chicken ovalbumin upstream promoter transcription factors COUP TFs members nuclear receptor superfamily belong orphan receptor subclass 9 10
0.22919919.9280061.html.plaintext.txt	22	Two genes called COUP TFI COUP TFII identified mammals
0.22919919.9280061.html.plaintext.txt	23	COUP TFs capable dimerizing retinoid X receptor known affect regulation retinoic acid receptor retinoid X receptor vitamin D receptor responsive genes 9
0.22919919.9280061.html.plaintext.txt	24	COUP TFs general expressed embryonic development proposed mediate essential mesenchymal epithelial interactions crucial proper organogenesis 10
0.22919919.9280061.html.plaintext.txt	25	To effect mRNA COUP TFII detected mesenchymal compartment several developing organs kidney breast prostate 10
0.22919919.9280061.html.plaintext.txt	26	COUP TFs expressed developing murine central peripheral nervous systems
0.22919919.9280061.html.plaintext.txt	27	It hypothesized two genes play role regulating developmental fates diencephalic neuromeres altering expression key factors involved cell fate determination 11
0.22919919.9280061.html.plaintext.txt	28	Most importantly COUP TFII mRNA highly expressed differentiating motor neurons within neural tube developing chick embryo
0.22919919.9280061.html.plaintext.txt	29	Notochord transplantation experiments suggest increase COUP TFII mRNA within ventro lateral region chick neural tube mediated signals derived notochord 12
0.22919919.9280061.html.plaintext.txt	30	Hence hypothesize Shh secreted morphogen derived notochord elicit increase COUP TFII expression differentiating motor neurons
0.22919919.9280061.html.plaintext.txt	31	For studies used P19 mouse embryocarcinoma cells previously used study retinoid mediated regulation COUP TFs 13 14
0.22919919.9280061.html.plaintext.txt	32	Also cells exhibit characteristics neuronal cells treated extended periods trans retinoic acid 15
0.22919919.9280061.html.plaintext.txt	33	For initial experiments conditioned medium derived COS 1 cells transfected mouse Shh expression construct applied P19 cells
0.22919919.9280061.html.plaintext.txt	34	Later Escherichia coli expressed N terminal 20 kDa Shh protein fragment used studies
0.22919919.9280061.html.plaintext.txt	35	In report provide evidence Shh induce COUP TFII transcripts P19 cells evidence implicate novel target element COUP TFII promoter mediates Shh induced activity
0.22919919.9280061.html.plaintext.txt	36	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Induction COUP TFII mRNA Expression Conditioned Media Containing Shh To determine whether endogenous COUP TFII mRNA regulated Shh P19 cells overexpressed Shh COS 1 cells
0.22919919.9280061.html.plaintext.txt	37	These cells shown express process secrete N terminal fragment Shh medium 2
0.22919919.9280061.html.plaintext.txt	38	We transfected COS 1 cells pBKCMV Shh plasmid
0.22919919.9280061.html.plaintext.txt	39	Conditioned medium concentrated 120 volume applied onto P19 cells
0.22919919.9280061.html.plaintext.txt	40	Control medium obtained COS 1 cells transfected pBKCMV vector backbone without Shh used control
0.22919919.9280061.html.plaintext.txt	41	RNA cells used Northern blot assay
0.22919919.9280061.html.plaintext.txt	42	1A incubation P19 cells increasing amounts conditioned media containing Shh N terminal fragment results 5 7 fold increase COUP TFII mRNA lanes 1 2 3
0.22919919.9280061.html.plaintext.txt	43	View larger version 20K Figure 1
0.22919919.9280061.html.plaintext.txt	44	Induction COUP TFII mRNA Conditioned Media Containing Shh
0.22919919.9280061.html.plaintext.txt	45	A P19 cells treated 200 microl lane 2 400 microl lane 3 conditioned media containing Shh N terminal fragment pBKCMV Shh
0.22919919.9280061.html.plaintext.txt	46	Lane 1 control lane conditioned media vector transfected COS 1 cells pBKCMV
0.22919919.9280061.html.plaintext.txt	47	Densitometric analysis reveals 3 5 fold increase COUP TFII mRNA levels adjusting GAPDH internal control
0.22919919.9280061.html.plaintext.txt	48	B COS 1 cells transfected pBKCMV alone lane 1 pBKCMV Shh lane 2 3
0.22919919.9280061.html.plaintext.txt	49	The medium concentrated 120 volume separated 12 SDS PAGE gel
0.22919919.9280061.html.plaintext.txt	50	The gel subsequently transferred onto nitrocellulose membrane subjected Western analysis described Materials Methods
0.22919919.9280061.html.plaintext.txt	51	The 20 kDa band represents secreted form Shh N terminal fragment
0.22919919.9280061.html.plaintext.txt	52	Lane 3 represents membrane contains media lane 2 except probed primary antibody preblocked specific antigen
0.22919919.9280061.html.plaintext.txt	53	To ascertain presence secreted Shh conditioned media performed Western blot analysis using polyclonal antibody specifically recognizes secreted N terminal 20 kDa Shh protein fragment Fig
0.22919919.9280061.html.plaintext.txt	54	Results experiments suggest immunodetectable levels secreted 20 kDa N terminal fragment Shh present COS 1 cell conditioned media transfected pBKCMV Shh plasmid Fig
0.22919919.9280061.html.plaintext.txt	55	The N terminal protein used block antibody corroborate specificity Fig
0.22919919.9280061.html.plaintext.txt	56	Since signaling function Shh restricted N terminal secreted fragment shall refer fragment Shh remainder report
0.22919919.9280061.html.plaintext.txt	57	Induction COUP TFII Promoter Activity Conditioned Media Containing Shh To identify mechanism Shh mediated increase COUP TFII mRNA analyzed effect Shh containing conditioned media COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	58	6 kb promoter fragment includes transcription initiation site COUP TFII cloned upstream chloramphenicol acetyltransferase CAT reporter gene p1
0.22919919.9280061.html.plaintext.txt	59	6CII CAT transfected P19 cells 13
0.22919919.9280061.html.plaintext.txt	60	2 conditioned media containing Shh lanes 2 3 increase COUP TFII promoter activity
0.22919919.9280061.html.plaintext.txt	61	In separate experiment show increase elicited adding 1 nM N terminal 20 kDa Shh protein directly COS 1 cells transfected p1
0.22919919.9280061.html.plaintext.txt	62	Hence inferred P19 COS 1 cells possess necessary factors transduce Shh signal
0.22919919.9280061.html.plaintext.txt	63	These results indicate 1
0.22919919.9280061.html.plaintext.txt	64	6 kb fragment COUP TFII promoter harbors target elements mediates Shh activation
0.22919919.9280061.html.plaintext.txt	65	View larger version 46K Figure 2
0.22919919.9280061.html.plaintext.txt	66	Induction COUP TFII Promoter Activity Conditioned Media Containing Shh
0.22919919.9280061.html.plaintext.txt	67	P19 cells transfected p1
0.22919919.9280061.html.plaintext.txt	68	Increasing amounts conditioned media COS 1 cells containing Shh added P19 cells lane 2 200 microl lane 3 400 microl
0.22919919.9280061.html.plaintext.txt	69	Conditioned medium COS 1 cells Shh added separately P19 cells lane 1 400 microl transfected p1
0.22919919.9280061.html.plaintext.txt	70	A 10 fold increase observed lanes 1 3
0.22919919.9280061.html.plaintext.txt	71	Deletion Analysis COUP TFII Promoter To characterize target elements deletion mutants COUP TFII promoter various end points generated
0.22919919.9280061.html.plaintext.txt	72	COS 1 cells transfected plasmid treated 1 nM Shh protein
0.22919919.9280061.html.plaintext.txt	73	3A Shh mediated increase promoter activity restricted 5 1455 1212 nucleotide nt fragment compare lanes 3 4 lanes
0.22919919.9280061.html.plaintext.txt	74	In contrast p800CII tkCAT Fig
0.22919919.9280061.html.plaintext.txt	75	3A lanes 5 6 p900CII tkCAT Fig
0.22919919.9280061.html.plaintext.txt	76	3A lanes 7 8 tkCAT vector backbone Fig
0.22919919.9280061.html.plaintext.txt	77	3A lanes 9 10 showed increase CAT activity presence Shh
0.22919919.9280061.html.plaintext.txt	78	View larger version 35K Figure 3
0.22919919.9280061.html.plaintext.txt	79	Identification ShhRE COUP TFII Promoter
0.22919919.9280061.html.plaintext.txt	80	A COS 1 cells transfected following plasmids p1
0.22919919.9280061.html.plaintext.txt	81	6CII CAT lanes 1 2 p240CII tkCAT lanes 3 4 p800CII tkCAT lanes 5 6 p925CII tkCAT lanes 7 8 pBLCAT2 lanes 9 10
0.22919919.9280061.html.plaintext.txt	82	Cells treated 1 nM Shh 36 h cell lysate assayed enzyme activity described Materials Methods
0.22919919.9280061.html.plaintext.txt	83	A 4 6 fold increase CAT activity observed lanes 1 3 2 4 respectively
0.22919919.9280061.html.plaintext.txt	84	B COS 1 cells transfected described earlier plasmids indicated starting nucleotide COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	85	A 4 6 fold increase CAT activity observed lanes 1 3 2 4 respectively
0.22919919.9280061.html.plaintext.txt	86	C COS 1 cells transfected described earlier plasmids indicated region within COUP TFII promoter described Materials Methods
0.22919919.9280061.html.plaintext.txt	87	A 3 4 fold increase observed lanes 1 3 5 2 4 6 respectively
0.22919919.9280061.html.plaintext.txt	88	To define Shh response element ShhRE used nested primers PCR amplify specific 5 deleted fragments 1455 1212 region COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	89	These deletion fragments subsequently cloned upstream tkCAT reporter transfected COS 1 cells treated without 1 nM Shh protein
0.22919919.9280061.html.plaintext.txt	90	3B deletion first 112 nt 1455 1343 effect Shh inducibility compare lanes 2 4
0.22919919.9280061.html.plaintext.txt	91	In contrast deletion next 76 159 nt 1343 1267 1150 abolished Shh dependent activation reporter gene Fig
0.22919919.9280061.html.plaintext.txt	92	3B compare lanes 2 6 8
0.22919919.9280061.html.plaintext.txt	93	Also cells transfected tkCAT vector backbone showed increase CAT enzyme activity presence 1 nM Shh Fig
0.22919919.9280061.html.plaintext.txt	94	Results obtained studies suggest Shh induced activity mediated response element located 1343 1267 COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	95	Additional deletions made within region promoter localize target element mediates Shh activation
0.22919919.9280061.html.plaintext.txt	96	These fragments subsequently cloned upstream tkCAT reporter
0.22919919.9280061.html.plaintext.txt	97	COS 1 cells transfected plasmids treated 1 nM Shh
0.22919919.9280061.html.plaintext.txt	98	3C deletion 27 nt 1343 affect Shh activation compare lanes 4 6
0.22919919.9280061.html.plaintext.txt	99	However additional removal 18 nt 1316 1298 abolishes Shh activation compare lanes 6 8
0.22919919.9280061.html.plaintext.txt	100	These results indicate 19 bp region nucleotides 1316 1298 harbors activity
0.22919919.9280061.html.plaintext.txt	101	Collectively results indicate region 1316 1298 within COUP TFII promoter harbors ShhRE mediates Shh induced increase COUP TFII promoter activity leads increased steady state levels COUP TFII mRNA
0.22919919.9280061.html.plaintext.txt	102	Characterization ShhRE P19 Cells To confirm region 1316 1298 sufficient confer Shh response used sequence heterologous promoter function assay
0.22919919.9280061.html.plaintext.txt	103	A 42 bp oligonucleotide ShhRE includes region flanking sequences synthesized three copies oligo placed upstream tkLUC reporter gene determine whether element confers Shh inducibility heterologous promoter
0.22919919.9280061.html.plaintext.txt	104	In addition four specific mutations M1 M2 M3 M4 M5 introduced along element three copies mutant oligos cloned upstream tkLUC reporter Fig
0.22919919.9280061.html.plaintext.txt	105	The resulting plasmids transfected P19 cells reporter gene activity response 1 nM Shh analyzed
0.22919919.9280061.html.plaintext.txt	106	4B three copies ShhRE provide 5 7 fold increase reporter gene activity response Shh compare C Shh
0.22919919.9280061.html.plaintext.txt	107	4B M2 M3 M4 mutations abolish Shh response compare S S M1 S M2 S M3
0.22919919.9280061.html.plaintext.txt	108	In contrast M1 M5 mutants still capable mediating Shh induced reporter gene activity compare S S M1 S M5
0.22919919.9280061.html.plaintext.txt	109	These results indicate nucleotide sequences defined mutant oligos M2 M3 M4 important mediating Shh response
0.22919919.9280061.html.plaintext.txt	110	Hence point mutations introduced within ShhRE abolish transactivation must affect binding putative transcription factor DNA element
0.22919919.9280061.html.plaintext.txt	111	View larger version 27K Figure 4
0.22919919.9280061.html.plaintext.txt	112	Characterization ShhRE Heterologous Promoter
0.22919919.9280061.html.plaintext.txt	113	A Sequence information wild type ShhRE mutant oligonucleotides used transient transfection assay
0.22919919.9280061.html.plaintext.txt	114	B P19 cells transfected 3XShhRE tkCAT lanes 1 2 3XM1 tkCAT lanes 3 4 3XM2 tkCAT lanes 5 6 3XM3 tkCAT lanes 7 8 3XM4 tkCAT lanes 9 10
0.22919919.9280061.html.plaintext.txt	115	Cells treated S without C 1 nM Shh 24 h luciferase activity measured described Materials Methods
0.22919919.9280061.html.plaintext.txt	116	Results expressed mean plus minus SD three separate experiments
0.22919919.9280061.html.plaintext.txt	117	Electromobility Shift Assays EMSAs Using P19 Nuclear Extracts Radiolabeled ShhRE To understand nature protein DNA interaction element performed EMSAs using radiolabeled ShhRE
0.22919919.9280061.html.plaintext.txt	118	The resulting autoradiograph indicates two specific bands see arrows specifically enriched Shh treatment Fig
0.22919919.9280061.html.plaintext.txt	119	Also bands competed excess unlabeled ShhRE Fig
0.22919919.9280061.html.plaintext.txt	120	As expected mutant oligos M2 M3 M4 fail exhibit enhancer like activity also fail compete specific complexes used competitors Fig
0.22919919.9280061.html.plaintext.txt	121	Also expected oligo M1 M5 functional ShhREs could effectively compete binding two specific complexes Fig
0.22919919.9280061.html.plaintext.txt	122	These results suggest alterations TACATAATGCGCCG core residues bold ShhRE results decreased binding leads decreased enhancer activity transient transfection assays
0.22919919.9280061.html.plaintext.txt	123	View larger version 75K Figure 5
0.22919919.9280061.html.plaintext.txt	124	EMSA Using Radiolabeled ShhRE Nuclear Extracts P19 Cells
0.22919919.9280061.html.plaintext.txt	125	P19 cells treated lanes 2 8 without lane 1 1 nM Shh 36 h
0.22919919.9280061.html.plaintext.txt	126	Later cells harvested nuclear extract obtained
0.22919919.9280061.html.plaintext.txt	127	Five micrograms extract used EMSA using radiolabeled ShhRE performed described Materials Methods
0.22919919.9280061.html.plaintext.txt	128	Mutant competitor oligos 100 fold molar excess coincubated lanes 3 8 radiolabeled probe
0.22919919.9280061.html.plaintext.txt	129	The specific bands indicated arrowheads
0.22919919.9280061.html.plaintext.txt	130	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The notochord transplantation assays chick neural tube provided us rationale study possible regulation COUP TFII mRNA Shh
0.22919919.9280061.html.plaintext.txt	131	In experiment observe dorso laterally placed ectopic notochord induce motor neurons ectopic location within ventral tube coincides appearance COUP TFII transcripts 12
0.22919919.9280061.html.plaintext.txt	132	These results suggest notochord derived signals induce COUP TFII mRNA
0.22919919.9280061.html.plaintext.txt	133	In report provide evidence clearly indicate COUP TFII mRNA regulated Shh
0.22919919.9280061.html.plaintext.txt	134	In addition defined novel target element within COUP TFII promoter mediates activity
0.22919919.9280061.html.plaintext.txt	135	Also low dose Shh namely 1 nM capable inducing ShhRE mediated activity close agreement overall effect observed Jessell co workers 16 neural explant assays
0.22919919.9280061.html.plaintext.txt	136	The identification ShhRE provides us valuable tool study various signaling pathways induced Shh
0.22919919.9280061.html.plaintext.txt	137	Previously reported Ingham colleagues 17 binding site Ci cubidus interruptus protein consensus HhRE GACCACCCA since mediates activation ptc patched promoter Shh
0.22919919.9280061.html.plaintext.txt	138	Ptc downstream target gene Hh part putative membrane bound Shh receptor complex 18 19 20
0.22919919.9280061.html.plaintext.txt	139	However exact mechanism ptc activation via Ci element remains determined
0.22919919.9280061.html.plaintext.txt	140	Interestingly ShhRE found COUP TFII promoter bears little similarity Drosophila Ci binding site
0.22919919.9280061.html.plaintext.txt	141	In oligo competition experiments demonstrate changes core sequence TACATAATGCGCCG deleterious Shh induced binding
0.22919919.9280061.html.plaintext.txt	142	Also transcription factor data bank analysis revealed little information exact identity factors may bind element
0.22919919.9280061.html.plaintext.txt	143	The identification novel response element suggests higher vertebrates pleiotropic effects Shh mediated multiple pathways may target Gli mammalian homolog Ci binding site others may target novel elements one COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	144	5 DNA binding complexes P19 nuclear extracts induced Shh
0.22919919.9280061.html.plaintext.txt	145	The precise mechanism increase binding known
0.22919919.9280061.html.plaintext.txt	146	It possible Shh may simply modulate activity factors binds ShhRE
0.22919919.9280061.html.plaintext.txt	147	In agreement possible modulatory role Shh catalytic subunit protein kinase A PKA implicated Hh signaling pathway
0.22919919.9280061.html.plaintext.txt	148	In Drosophila believed PKA agonists suppress signaling mediated Hh
0.22919919.9280061.html.plaintext.txt	149	Also localized loss PKA activity Drosophila imaginal disc mimic Hh activity even absence Hh 21 22
0.22919919.9280061.html.plaintext.txt	150	Similar results obtained using dominant negative form PKA mouse dorsal central nervous system 23 24
0.22919919.9280061.html.plaintext.txt	151	These observations led popular belief reversal PKA repressed pathway one major mechanisms Hh activity Drosophila mammals
0.22919919.9280061.html.plaintext.txt	152	However observe significant decrease transient transfection assays COS 1 cells treated Shh forskolin 90 microM using 3X ShhRE tkCAT
0.22919919.9280061.html.plaintext.txt	153	Also forskolin fails decrease Shh induced binding EMSA using radiolabeled ShhRE data shown
0.22919919.9280061.html.plaintext.txt	154	These results suggest higher vertebrates additional pathways independent PKA may also induced Shh
0.22919919.9280061.html.plaintext.txt	155	The identification COUP TFII novel target gene characterization ShhRE within promoter may allow unraveling complex pathway
0.22919919.9280061.html.plaintext.txt	156	Our results provide novel target gene Shh namely COUP TFII exploited study intermediate steps Shh signaling pathway
0.22919919.9280061.html.plaintext.txt	157	In particular COUP TFII well characterized transcription factor whose ability affect function several nuclear receptors provides attractive target pleiotropic effects Shh signaling
0.22919919.9280061.html.plaintext.txt	158	However expression COUP TFII transcripts areas Shh exerts signaling activity may limited regions within developing embryo 1 10
0.22919919.9280061.html.plaintext.txt	159	The Shh homozygous null mice display predicted phenotype based expression profile protein
0.22919919.9280061.html.plaintext.txt	160	The Shh null mice display cyclopia phenotype along loss maintenance organization along axial midline structures developing embryo 25
0.22919919.9280061.html.plaintext.txt	161	However Shh null mice detect COUP TFII transcripts F
0.22919919.9280061.html.plaintext.txt	162	This observation suggests COUP TFII exclusively regulated Shh
0.22919919.9280061.html.plaintext.txt	163	These results surprising since COUP TFII expressed throughout mouse embryonic development wide variety tissues 10 11
0.22919919.9280061.html.plaintext.txt	164	Also others shown COUP TFs downstream target genes retinoic acid expression increased treatment 9 cis trans retinoic acid 13 14
0.22919919.9280061.html.plaintext.txt	165	We generated COUP TFII homozygous null mice study possible involvement COUP TFII motor neuron differentiation
0.22919919.9280061.html.plaintext.txt	166	However COUP TFII null mice die 10
0.22919919.9280061.html.plaintext.txt	167	Interestingly obvious change overall morphology within ventro lateral region neural tube observed F
0.22919919.9280061.html.plaintext.txt	168	We believe presence COUP TFI transcripts neural tube may allow functional compensation COUP TFII may obscure obvious defects motor neuron differentiation
0.22919919.9280061.html.plaintext.txt	169	We currently attempting localized knock COUP TFI COUP TFII ventro lateral region neural tube study possible involvement genes motor neuron differentiation
0.22919919.9280061.html.plaintext.txt	170	Our results provided novel target gene Shh signaling P19 mouse embryocarcinoma cells
0.22919919.9280061.html.plaintext.txt	171	Activation COUP TFII known harbor trans repressor domain C terminal 15 amino acids may important implications neural tube patterning 26
0.22919919.9280061.html.plaintext.txt	172	Shh implicated enabling notochord derived signals repress dorsalizing signals induced BMP 24 roof plate neural epithelium neural tube 7 27
0.22919919.9280061.html.plaintext.txt	173	It reported COUP TFI inhibit BMP 4 promoter fetal rat calvarial osteoblasts 28
0.22919919.9280061.html.plaintext.txt	174	It possible temporal induction COUP TFII expression Shh may serve mediate repression specific regions fated become motor neurons ventro lateral region neural tube
0.22919919.9280061.html.plaintext.txt	175	In conclusion results provide novel target gene COUP TFII novel target element ShhRE seem mediate Shh induced COUP TFII expression P19 mouse embryocarcinoma cells
0.22919919.9280061.html.plaintext.txt	176	This finding allow elucidation numerous signaling pathways induced Shh
0.22919919.9280061.html.plaintext.txt	177	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Plasmid Constructs The mouse Shh cDNA plasmid kindly provided Dr
0.22919919.9280061.html.plaintext.txt	178	6 kb fragment mouse Shh plasmid subcloned XhoIEcoRI site pBKCMV Stratagene La Jolla CA vector generate pBKCMV Shh plasmid
0.22919919.9280061.html.plaintext.txt	179	6CII CAT plasmid generated described earlier 13
0.22919919.9280061.html.plaintext.txt	180	6 kb promoter COUP TFII cut ApaI generate 800 bp 450 bp 240 bp fragments
0.22919919.9280061.html.plaintext.txt	181	These subcloned pBluescript KS plasmid
0.22919919.9280061.html.plaintext.txt	182	The 800 bp 1212 412 240 bp 1455 1212 fragments subsequently cloned pBLCAT2 plasmid HindIIIBamHI HindIIXbaI sites respectively generate p800CII tkCAT p240CII tkCAT plasmids
0.22919919.9280061.html.plaintext.txt	183	Oligonucleotide Sequences ShhRE CGGGATCC AGT GGG TTC TAC ATA ATG CGC CCG GGA AGATCTTCC
0.22919919.9280061.html.plaintext.txt	184	M1 CGGGATCC AGT GAA TTC TAC ATA ATG CGC CCG GGA AGATCTTCC
0.22919919.9280061.html.plaintext.txt	185	M2 CGGGATCC AGT GGG TTC CGC ATA ATG CGC CCG GGA AGATCTTCC
0.22919919.9280061.html.plaintext.txt	186	M3 CGGGATCC AGT GGG TTC TAC GTG ATG CGC CCG GGA AGATCTTCC
0.22919919.9280061.html.plaintext.txt	187	M4 CGGGATCC AGT GGG TTC TAC ATA ATG CGC ATT GGA AGATCTTCC
0.22919919.9280061.html.plaintext.txt	188	M5 CGGGATCC AGT GGG TTC TAC ATA ATG CGC CCG GAG AGATCTTCC
0.22919919.9280061.html.plaintext.txt	189	The ShhRE M1 M2 M3 M4 M5 oligos cut BamHI BglII ligated generate 3 copy insert
0.22919919.9280061.html.plaintext.txt	190	Later multimer excised gel subcloned BamHI site ptk109 plasmid contains luciferase reporter gene driven minimal tk promoter
0.22919919.9280061.html.plaintext.txt	191	PCR Primers 808 forward primer GCT CTA GAG CAG AGA GCT CAG TGA GCT
0.22919919.9280061.html.plaintext.txt	192	117 reverse primer TGA AGA TCT GAG TGT GCA GC
0.22919919.9280061.html.plaintext.txt	193	1343 forward primer GCT CTA GAG CGG AGA GCA TTA TTC AGT
0.22919919.9280061.html.plaintext.txt	194	1267 forward primer GCT CTA GAG CAA ACC ACT GTG CCC GAT
0.22919919.9280061.html.plaintext.txt	195	1150 forward primer GCT CTA GAG CAT TTA GAG GCA TCG CCA
0.22919919.9280061.html.plaintext.txt	196	1316 forward primer GCT CTA GAG CGT TCT ACA TAA TGC GCC
0.22919919.9280061.html.plaintext.txt	197	1298 forward primer GCT CTA GAG CAT GCG CCG GGA GTC CCG GGT GGA C
0.22919919.9280061.html.plaintext.txt	198	1070 reverse primer GAA GAT CTT CCT GGC CAC AGA GAG G
0.22919919.9280061.html.plaintext.txt	199	The mentioned primers used PCR amplify specific regions within COUP TFII promoter
0.22919919.9280061.html.plaintext.txt	200	6 kb region used template 100 ngml forward reverse primers used 50 microl reaction along 0
0.22919919.9280061.html.plaintext.txt	201	5 mM deoxynucleoside triphosphates final concentration 1 microl Taq polymerase
0.22919919.9280061.html.plaintext.txt	202	Ten percent dimethylsulfoxide included reactions regions amplified GC content greater 50
0.22919919.9280061.html.plaintext.txt	203	The amplified DNA fragments phenol chloroform purified followed overnight restriction enzyme digest appropriate enzymes
0.22919919.9280061.html.plaintext.txt	204	All forward primers digested XbaI reverse primers digested BglII
0.22919919.9280061.html.plaintext.txt	205	Later fragments subcloned pBluescript II KS plasmid vector XbaI BglII sites
0.22919919.9280061.html.plaintext.txt	206	T7 T3 primers used sequence PCR amplified fragments verification fragments subcloned pBLCAT2 tkCAT pBLCAT3 CAT alone plasmid XbaIBamHI site
0.22919919.9280061.html.plaintext.txt	207	The resultant plasmids sequenced using PCR primers subsequently used transient transfection assays
0.22919919.9280061.html.plaintext.txt	208	COS 1 Conditioned Media COS 1 cells plated density 2 x 106 cells per 10 cm plate
0.22919919.9280061.html.plaintext.txt	209	Cells transiently transfected using diethylaminoethyl Dextran method described previously 29
0.22919919.9280061.html.plaintext.txt	210	Briefly 1 microg pBKCMV Shh pBKCMV plasmid dissolved 60 microl Tris borate NaCl TBS buffer incubated along 120 microl diethylaminoethyl Dextran Sigma St
0.22919919.9280061.html.plaintext.txt	211	Louis MO 5 mgml TBS 30 min room temperature
0.22919919.9280061.html.plaintext.txt	212	Later DNA solution mixed 4 ml TBS buffer containing 10 NuSerum Collaborative Biomedical Products Bedford MA
0.22919919.9280061.html.plaintext.txt	213	This mixture applied 10 cm plate cells incubated mixture 6 h
0.22919919.9280061.html.plaintext.txt	214	Cells shocked 10 dimethylsulfoxide 2 min followed 4 h incubation DMEM serum containing 100 microM Chloroquine Sigma St
0.22919919.9280061.html.plaintext.txt	215	Cells washed fresh medium added containing 5 FBS
0.22919919.9280061.html.plaintext.txt	216	Conditioned medium obtained 24 36 48 h assayed Western blot medium concentrated 120 volume Amicon Beverly MA concentrator
0.22919919.9280061.html.plaintext.txt	217	The 48 h time point found optimal use assays
0.22919919.9280061.html.plaintext.txt	218	Northern Blot Analysis P19 cells grown density 5 x 105 cells per 10 cm plate
0.22919919.9280061.html.plaintext.txt	219	Cells used passage numbers 5 20
0.22919919.9280061.html.plaintext.txt	220	Late passage cells displayed significant variations experiments hence used reported studies
0.22919919.9280061.html.plaintext.txt	221	Conditioned media obtained appropriately transfected COS 1 cells applied specific time point 40 h later total RNA obtained using Trizol Life Technologies Gaithersburg MD reagent
0.22919919.9280061.html.plaintext.txt	222	This method modification guanidinium HCl method RNA isolation 30
0.22919919.9280061.html.plaintext.txt	223	RNA dissolved 100 deionized formamide used within short period stored 70 ethanol extended periods 70 C
0.22919919.9280061.html.plaintext.txt	224	Ten micrograms total RNA reprecipitated washed 70 ethanol redissolved diethyl pyrocarbonate treated water
0.22919919.9280061.html.plaintext.txt	225	This RNA heated 55 C 15 min loading buffer 35 formamide 10 formaldehyde 20 mM Na2HPO4 pH 6
0.22919919.9280061.html.plaintext.txt	226	8 loading dye containing 0
0.22919919.9280061.html.plaintext.txt	227	RNA quick cooled ice loaded onto 1 agarose gel containing 1 M formaldehyde SPC buffer 20 mM Na2HPO4 pH 6
0.22919919.9280061.html.plaintext.txt	228	The gel run 1x SPC buffer stained ethidium bromide 0
0.22919919.9280061.html.plaintext.txt	229	01 solution 1x SPC 20 min followed destaining 1 h
0.22919919.9280061.html.plaintext.txt	230	The separated RNA blotted onto Hybond N nylon membrane Amersham Arlington Heights IL
0.22919919.9280061.html.plaintext.txt	231	A RNA ladder 6 microg run along gel used estimate size transcript
0.22919919.9280061.html.plaintext.txt	232	The membrane UV cross linked Stratalinker Stratagene La Jolla CA 2 min dried gel dryer 80 C
0.22919919.9280061.html.plaintext.txt	233	The membrane prehybridized using QuikHyb solution Stratagene 1 h hybridized radiolabeled 500 bp 5 untranslated region fragment 31 COUP TFII 2 h
0.22919919.9280061.html.plaintext.txt	234	Later membrane washed twice 2x saline sodium citrate SSC buffer 0
0.22919919.9280061.html.plaintext.txt	235	This followed two high stringency washes using 0
0.22919919.9280061.html.plaintext.txt	236	The residual SDS removed using quick 2x SSC wash membrane exposed XOMAT AR film Eastman Kodak Rochester NY 6 12 h
0.22919919.9280061.html.plaintext.txt	237	The membrane stripped using 0
0.22919919.9280061.html.plaintext.txt	238	1x SSPE sodium phosphate EDTA 1 SDS solution 85 C 15 min
0.22919919.9280061.html.plaintext.txt	239	It rehybridized specific 5 1
0.22919919.9280061.html.plaintext.txt	240	Transient Transfection Assays COS 1 cells transiently transfected described earlier using 1 microg reporter plasmid
0.22919919.9280061.html.plaintext.txt	241	P19 cells transfected using replication deficient adenovirus described earlier 33
0.22919919.9280061.html.plaintext.txt	242	Briefly adenovirus 2 x 108 particles 100 ng reporter plasmid incubated room temperature 30 min buffer containing 20 mM HEPES pH 7
0.22919919.9280061.html.plaintext.txt	243	This followed infection P19 cells 400000 cells per well viral DNA mixture 2 h 37 C incubator DMEM containing 5 FBS
0.22919919.9280061.html.plaintext.txt	244	coli expressed Shh 1 nM added along fresh media supplemented 10 FBS transfection incubated 24 h cells harvested reporter gene activity
0.22919919.9280061.html.plaintext.txt	245	A Bio Rad Hercules CA protein assay reagent used quantitate amount protein
0.22919919.9280061.html.plaintext.txt	246	Five micrograms cell lysate used CAT assay performed described previously 34
0.22919919.9280061.html.plaintext.txt	247	For luciferase reporter gene assays 10 microg cell lysate incubated enzyme substrate 60 microl reaction mix according instructions provided Promega luciferase assay system kit Promega Madison WI
0.22919919.9280061.html.plaintext.txt	248	Enzyme activity measured Monolight analytical luminometer AnalyticalLuminescence Laboratory Ann Arbor MI 5 sec plotted relative luciferase units per 20 microg lysate
0.22919919.9280061.html.plaintext.txt	249	2 P19 cells transfected using 1 microg p1
0.22919919.9280061.html.plaintext.txt	250	6CII CAT plasmid along 6 microg Lipofectamine Life Technologies reagent 4 ml DMEM without serum 10 h
0.22919919.9280061.html.plaintext.txt	251	Later cells washed 12 ml fresh DMEM containing 10 FBS added along 200 microl 400 microl concentrated COS 1 conditioned media containing Shh
0.22919919.9280061.html.plaintext.txt	252	In parallel 400 microl concentrated COS 1 conditioned media without Shh along 12 ml DMEM also added P19 cells
0.22919919.9280061.html.plaintext.txt	253	After 36 h cells harvested cell lysate obtained
0.22919919.9280061.html.plaintext.txt	254	Protein concentration determined using Bio Rad protein assay reagent
0.22919919.9280061.html.plaintext.txt	255	Twenty micrograms cell lysate used analyze CAT activity described earlier
0.22919919.9280061.html.plaintext.txt	256	EMSAs P19 cells seeded 5 x 105 cells per 10 cm plate DME F12 media without 1 nM Shh
0.22919919.9280061.html.plaintext.txt	257	After 36 h cells harvested washed PBS
0.22919919.9280061.html.plaintext.txt	258	Cells incubated 200 microl hypotonic buffer containing 10 mM KCl 0
0.22919919.9280061.html.plaintext.txt	259	1 mM EDTA 1 mM dithiothreitol DTT 0
0.22919919.9280061.html.plaintext.txt	260	5 mM phenylmethylsulfonylfluoride 10 mM HEPES pH 7
0.22919919.9280061.html.plaintext.txt	261	Twenty five microliters 10 NP 40 added cells vortexed 30 sec
0.22919919.9280061.html.plaintext.txt	262	Later cells centrifuged 5000 rpm 4 C spin nuclei
0.22919919.9280061.html.plaintext.txt	263	Nuclei incubated 30 microl hypertonic buffer containing 0
0.22919919.9280061.html.plaintext.txt	264	4 M NaCl 1 mM EDTA 1 mM DTT 1 mM phenylmethylsulfonylfluoride 10 glycerol 20 mM HEPES pH 7
0.22919919.9280061.html.plaintext.txt	265	9 30 min gentle shaker 4 C
0.22919919.9280061.html.plaintext.txt	266	This mixture centrifuged 13000 rpm 4 C 10 min supernatant immediately dialyzed 4 h 500 ml buffer containing 10 mM Tris pH 7
0.22919919.9280061.html.plaintext.txt	267	5 50 mM NaCl 1 mM EDTA 1 mM DTT 5 glycerol 4 C
0.22919919.9280061.html.plaintext.txt	268	A 10 kDa molecular mass cut membrane used dialysis
0.22919919.9280061.html.plaintext.txt	269	A Bio Rad protein assay reagent used quantitate amount protein
0.22919919.9280061.html.plaintext.txt	270	Five micrograms nuclear extract incubated along 50000 cpm radiolabeled ShhRE 15 min buffer containing 10 mM Tris pH 7
0.22919919.9280061.html.plaintext.txt	271	5 80 mM NaCl 1 mM EDTA 1 mM DTT 0
0.22919919.9280061.html.plaintext.txt	272	1 mgml BSA 200 ng salmon sperm DNA 3 microg poly dG dC 1 microg poly dI dC 5 glycerol
0.22919919.9280061.html.plaintext.txt	273	One hundred molar excess competitor oligos incubated appropriate reaction mix along nuclear extract
0.22919919.9280061.html.plaintext.txt	274	The samples loaded onto 5 native polyacrylamide gel protein DNA complexes formed separated analyzed autoradiography
0.22919919.9280061.html.plaintext.txt	275	Western Blot Analysis Conditioned media appropriately transfected COS 1 cells concentrated 120 volume using Amicon concentrator applied onto 12 SDS polyacrylamide gel
0.22919919.9280061.html.plaintext.txt	276	The separating gel immediately transferred onto nitrocellulose membrane buffer containing 50 mM Tris 380 mM glycine 0
0.22919919.9280061.html.plaintext.txt	277	1 wtvol SDS 20 methanol
0.22919919.9280061.html.plaintext.txt	278	The transfer performed 65 V 16 h cold room
0.22919919.9280061.html.plaintext.txt	279	To confirm complete transfer gel stained Coomassie stain 20 min followed destaining 40 methanol 10 glacial acetic acid solution 1 2 h
0.22919919.9280061.html.plaintext.txt	280	The resultant membrane subjected standard enhanced chemiluminescence ECL Western blotting kit protocol Amersham Life Science
0.22919919.9280061.html.plaintext.txt	281	A rabbit polyclonal antibody specifically recognized N terminal 20 kDa Shh protein 3 used detect levels N terminal 20 kDa protein conditioned media
0.22919919.9280061.html.plaintext.txt	282	The primary antibody divided two groups blocked BSA 4 microgml N terminal Shh protein fragment 2 h 4 C gentle shaking
0.22919919.9280061.html.plaintext.txt	283	The membrane divided two halves incubated primary antibody preblocked antibody 13000 dilution 20 mM Tris 137 mM NaCl 0
0.22919919.9280061.html.plaintext.txt	284	The membrane washed incubated horseradish peroxidase labeled anti rabbit secondary antibody 11000 dilution 1 h
0.22919919.9280061.html.plaintext.txt	285	This followed another wash incubation detection mix provided ECL kit 1 min
0.22919919.9280061.html.plaintext.txt	286	The membrane immediately drained exposed film 30 sec
0.22919919.9280061.html.plaintext.txt	287	A prestained marker Bio Rad used estimate apparent molecular masses resultant bands
0.22919919.9280061.html.plaintext.txt	288	ACKNOWLEDGMENTS We grateful Dr
0.22919919.9280061.html.plaintext.txt	289	McMahon Harvard University Cambridge MA mouse Shh cDNA plasmid
0.22919919.9280061.html.plaintext.txt	290	Beachy Johns Hopkins University Baltimore MD N terminal 20 kDa protein fragment rabbit polyclonal antibody recognizes fragment
0.22919919.9280061.html.plaintext.txt	291	Carolyn Smith Cheryl Parker help preparation adenovirus Patrick Samora technical assistance Drs
0.22919919.9280061.html.plaintext.txt	292	Bramblett critical review manuscript
0.22919919.9280061.html.plaintext.txt	293	FOOTNOTES Address requests reprints Sophia Y
0.22919919.9280061.html.plaintext.txt	294	Professor Cell Biology Baylor College Medicine 1 Baylor Plaza Houston Texas 77030
0.22919919.9280061.html.plaintext.txt	295	This work supported NIH Grant DK 44988 S
0.22919919.9280061.html.plaintext.txt	296	NIH Grant DK 45641 M
0.22919919.9280061.html.plaintext.txt	297	Received publication February 20 1997
0.22919919.9280061.html.plaintext.txt	298	Revision received June 3 1997
0.22919919.9280061.html.plaintext.txt	299	Accepted publication June 9 1997
0.22919919.9280061.html.plaintext.txt	300	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Echelard Y Epstein DJ St Jacques B Shen L Mohler J McMahon JA Mc Mahon AP 1993 Sonic hedgehog member family putative signaling molecules implicated regulation CNA polarity
0.22919919.9280061.html.plaintext.txt	301	Cell 751417 1430Medline Tanabe Y Roelink H Jessell TM 1995 Induction motor neurons sonic hedgehog independent floor plate differentiation
0.22919919.9280061.html.plaintext.txt	302	Curr Biol 5651 658Medline Porter JA von Kessler DP Ekker SC Young KE Lee JJ Moses K Beachy PA 1995 The product hedgehog autoproteolytic cleavage active local long range signalling
0.22919919.9280061.html.plaintext.txt	303	Nature 374363 366CrossRefMedline Lai CJ Ekker SC Beachy PA Moon RT 1995 Patterning nerural ectoderm Xenopus laevis amino terminal product hedgehog autoproteolytic cleavage
0.22919919.9280061.html.plaintext.txt	304	Development 1212349 2360AbstractFree Full Text Lopez Martinez A Chang DT Chiang C Porter JA Ros MA Simandl BK Beachy PA Fallon JF 1995 Limb patterning activity restricted posterior localization amino terminal product sonic hedgehog cleavage
0.22919919.9280061.html.plaintext.txt	305	Curr Biol 5791 796Medline Altaba RA Placzek M Baldassare M Dodd J Jessell TM 1995 Early stages notochord floor plate development chick embryo defined normal induced expression HNF 3 beta
0.22919919.9280061.html.plaintext.txt	306	Dev Biol 170299 313CrossRefMedline Liem Jr KF G Tremml G Roelink H TM Jessell TM 1995 Dorsal differentiation neural plate cells induced BMP mediated signals epidermal ectoderm
0.22919919.9280061.html.plaintext.txt	307	Cell 82969 979Medline Roelink H Augsburger A Heemskerk J Altaba AR Tanabe Y Placzek M Edlund T Jessell TM Dodd J 1994 Floor plate motor neuron induction vhh 1 vertebrate homolog hedgehog expressed notochord
0.22919919.9280061.html.plaintext.txt	308	Cell 76761 775Medline Cooney A Leng X Tsai S O Malley BW Tsai M J 1993 Multiple mechanisms chicken ovalbumin upstream promoter transcription factor dependent repression transactivation vitamin D thryroid hormone retinoic acid receptors
0.22919919.9280061.html.plaintext.txt	309	J Biol Chem 2684152 4160AbstractFree Full Text Pereira FA Qiu Y Tsai M J Tsai SY 1994 Chicken ovalbumin upstream promoter transcription factor COUP TF expression mouse embryogenesis
0.22919919.9280061.html.plaintext.txt	310	J Steroid Biochem Mol Biol 53503 508CrossRef Qiu Y Cooney A Kuratani S DeMayo FJ Tsai SY Tsai M J 1994 Spatiotemporal expression patterns chicken ovalbumin upstream promoter transcription factors developing central nervous system evidence role segmental patterning diencephalon
0.22919919.9280061.html.plaintext.txt	311	Proc Natl Acad Sci USA 914451 4455Abstract Lutz B Kuratani S Cooney A Wawersik S Tsai SY Eichele G Tsai M J 1994 Motor neuron specific expression orphan receptor COUP TF early spinal cord development
0.22919919.9280061.html.plaintext.txt	312	Development 12025 36AbstractFree Full Text Qiu Y Krishnan V Pereira F Tsai SY Tsai M J 1995 Chicken ovalbumin upstream promoter transcription factors regulation
0.22919919.9280061.html.plaintext.txt	313	J Steroid Biochem Mol Biol 5681 86 Jonk LJC de Jonge MEJ Pals CEGM Wissink S Vervaart JMA Schoorlemmer J Kruijer W 1994 Cloning expression development three murine members COUP family nuclear orphan receptors
0.22919919.9280061.html.plaintext.txt	314	Mechan Dev 4781 97CrossRefMedline Rudnicki MA McBurney MW 1987 Cell Culture methods induction differentiation embryonal carcinoma cell lines
0.22919919.9280061.html.plaintext.txt	315	In Rickwood D Hames BD eds Practical Approach Series
0.22919919.9280061.html.plaintext.txt	316	IRL Press Washington DC pp 32 36 Roelink H Porter JA Chiang C Tanabe Y Chang DT Beachy PA Jessell TM 1995 Floor plate motor neuron induction different concentrations amino terminal cleavage product sonic hedgehog autoproteolysis
0.22919919.9280061.html.plaintext.txt	317	Cell 81445 455Medline Alexandre C Jacinto A Ingham PW 1996 Transcriptional activation hedgehog target genes Drosophila mediated directly Cubitus interruptus protein member GLI family zinc finger DNA binding proteins
0.22919919.9280061.html.plaintext.txt	318	Genes Dev 102003 2013Abstract Stone DM Hynes M Armanini M Swanson TA Gu Q Johnson Rl Scott MP Pennica D Goddard A Phillips H Noll M Hooper JE Sauvage F Rosenthal A 1996 The tumor suppressor gene patched encodes candidate receptor sonic hedgehog
0.22919919.9280061.html.plaintext.txt	319	Nature 384129 134CrossRefMedline Marigo V Tabin CJ 1996 Regulation patched Shh developing nerual tube
0.22919919.9280061.html.plaintext.txt	320	Proc Natl Acad Sci USA 939346 9351AbstractFree Full Text Marigo V Davey RA Zuo Y Cunningham JM Tabin CJ 1996 Biochemical evidence patched hedgehog receptor
0.22919919.9280061.html.plaintext.txt	321	Nature 384176 179CrossRefMedline Pan D Rubin GM 1995 cAMP dependent protein kinase hedgehog act antagonistically regulating decapentaplegic transcription Drosophila imaginal discs
0.22919919.9280061.html.plaintext.txt	322	Cell 80543 552Medline Li W Ohlmeyer JT Lane ME Kalderon D 1995 Function PKA hedgehog signal transduction Drosophila imaginal disc development
0.22919919.9280061.html.plaintext.txt	323	Cell 80553 562Medline Hammerschmidt M Bitgood MJ McMahon AP 1996 Protein kinase A common negative regulator hedgehog signaling vertebrate embryo
0.22919919.9280061.html.plaintext.txt	324	Genes Dev 10647 658Abstract Epstein DJ Marti E Scott MP McMahon AP 1996 Antagonizing cAMP dependent protein kinase A dorsal CNS activates conserved sonic hedgehog signaling pathway
0.22919919.9280061.html.plaintext.txt	325	Development 1222885 2894AbstractFree Full Text Chiang C Litingtung Y Lee E Young KE Cordern JL Westphal H Beachy PA 1996 cAMP dependent protein kinase hedgehog act antagonistically regulating decapentaplegic transcription Drosophila imaginal discs
0.22919919.9280061.html.plaintext.txt	326	Nature 383407 413CrossRefMedline Leng X Cooney AJ Tsai SY Tsai M J 1996 Molecular mechanisms COUP TF mediated transcriptional repression evidence transrepression active repression
0.22919919.9280061.html.plaintext.txt	327	Mol Cell Biol 162332 2340Abstract Bitgood MJ McMahon AP 1995 Hedgehog Bmp genes coexpressed many diverse sites cell cell interaction mouse embryo
0.22919919.9280061.html.plaintext.txt	328	Dev Biol 172126 138CrossRefMedline Feng JQ Harris MA Cooney A Tsai M J Christy B Chen D Mundy GR Harris SE 1995 The mouse bone morphogenetic protein 4 BMP 4 gene promoter analysis fetal rat calvarial osteoblasts
0.22919919.9280061.html.plaintext.txt	329	J Biol Chem 27028364 28373AbstractFree Full Text Lopata MA Cleveland DW Sollner Webb B 1984 High level transient expresison chloramphenicol acetyl transferase gene DEAE dextran mediated DNA transfection coupled dimethyl sulfoxide glycerol shock treatment
0.22919919.9280061.html.plaintext.txt	330	Nucleic Acids Res 125707 5717Abstract Chomczynski P Sacchi N 1987 Single step method RNA isolation acid guanidinium thiocyanate phenol chloroform extraction
0.22919919.9280061.html.plaintext.txt	331	Anal Biochem 162156 159CrossRefMedline Qiu Y Krishnan V Zeng Z Gilbert DJ Copeland NG Gibson L Yang Feng T Jenkins NA Tsai M J Tsai SY 1995 Isolation characterization chromosomal localization mouse human COUP TfI II genes
0.22919919.9280061.html.plaintext.txt	332	Genomics 29240 246CrossRefMedline Ward T Clemens MJ Taylor KW 1990 Effects diabetogenic strain encephalomyocarditis EMC virus protein synthesis mouse islets Langerhans
0.22919919.9280061.html.plaintext.txt	333	Biochem J 270777 781Medline Allgood VE Zhang Y O Malley BW Weigel NL 1997 Analysis chicken progesterone receptor function phosphorylation using adenovirus mediated procedure high efficiency DNA transfer
0.22919919.9280061.html.plaintext.txt	334	Biochemistry 36224 232CrossRefMedline Gorman CM Moffat LF Howard BH 1982 Recombinant genomes express chloramphenicol acetyltransferase mammalian cells
0.22919919.9280061.html.plaintext.txt	335	Mol Cell Biol 21044 1051Medline
0.26340848.12642604.html.plaintext.txt	0	Rockefeller University Press 0022 100720033763 5
0.26340848.12642604.html.plaintext.txt	1	00 The Journal Experimental Medicine Volume 197 Number 6 763 775 Detection Functional Hybrid Receptor cGM CSFRss Human Hematopoietic CD34 Cells J
0.26340848.12642604.html.plaintext.txt	2	1 U 506 Institut National de la Sante et de la Recherche Medicale INSERM Hopital Paul Brousse 94807 Villejuif France 2 Istituto Gaslini Largo Gerolamo Gaslini 516147 Genoa Italy 3 Istituto Nazionale per la Ricerca sul Cancro IST Largo Rosanna Benzi 16132 Genoa Italy 4 U 487 INSERM IGR 94800 Villejuif France 5 U 268 INSERM Hopital Paul Brousse 94807 Villejuif France 6 GenMab B
0.26340848.12642604.html.plaintext.txt	3	University Medical Center Immunotherapy Laboratory KC02
0.26340848.12642604.html.plaintext.txt	4	2 Lundlaan 6 3584 EA Utrecht Netherlands 7 Forshungzentrum Borstel Parkallee 22 D 23845 Borstel Germany 8 INSERM E 0109 Bicetre France 9 U 542 INSERM Hopital Paul Brousse 94807 Villejuif France
0.26340848.12642604.html.plaintext.txt	5	Bruno Azzarone INSERM U542 Batiment Lavoisier Hopital Paul Brousse 94807 Villejuif France
0.26340848.12642604.html.plaintext.txt	6	Phone 00 33 145595344 Fax 00 33 145595343 E mail bazzaroneathotmail
0.26340848.12642604.html.plaintext.txt	7	Abstract Top Abstract Introduction Materials Methods Results Discussion References A functional hybrid receptor associating common chain c granulocytemacrophage colony stimulating factor receptor ss GM CSFRss chain found mobilized human peripheral blood MPB CD34 hematopoietic progenitors SCFFlt3 L primed cord blood CB precursors CBPr CD34CD56 CD34 myeloid cell lines normal natural killer NK cells cytolytic NK L cell line nonhematopoietic cells
0.26340848.12642604.html.plaintext.txt	8	We demonstrated using CD34 TF1ss cells express interleukin IL 15Rssc receptor within hybrid receptor GM CSFRss chain inhibits IL 15 triggered cJAK3 specific signaling controlling TF1ss cell proliferation
0.26340848.12642604.html.plaintext.txt	9	However c chain part functional GM CSFR activating GM CSF dependent STAT5 nuclear translocation proliferation TF1ss cells
0.26340848.12642604.html.plaintext.txt	10	The hybrid receptor functional normal hematopoietic progenitors subunits control STAT5 activation
0.26340848.12642604.html.plaintext.txt	11	Finally parental TF1 cell line lacks IL 15Rss chain nevertheless expresses functional hybrid receptor controls JAK3 phosphorylation novel IL 15cTRAF2 complex triggers nuclear factor B activation
0.26340848.12642604.html.plaintext.txt	12	The lineage dependent distribution function receptors suggest involved hematopoiesis modify transduction pathways play major role differentiation hematopoietic progenitors
0.26340848.12642604.html.plaintext.txt	13	Key Words IL 15 GM CSF IL 15R signal transduction CD34 cells
0.26340848.12642604.html.plaintext.txt	14	Introduction Top Abstract Introduction Materials Methods Results Discussion References The development hematopoietic cells controlled hematopoietic growth factors cytokines chemokines produced bone marrow BM accessory cells T lymphocytes 1 2 several mechanisms 3
0.26340848.12642604.html.plaintext.txt	15	Hematopoietic factors constitute complex network cytokine may act various stages example myeloid growth factors G CSF GM CSF may also affect lymphoid compartment 4 5
0.26340848.12642604.html.plaintext.txt	16	GM CSF inhibits expansion NK cell progenitor population unprimed BM CD34 cells generation functioning NK cells vivo vitro 5 6
0.26340848.12642604.html.plaintext.txt	17	IL 15 powerful factor inducing differentiation CD34 hematopoietic progenitor cells CD56CD3 NK cells vivo 7 may also cause large increase number long term culture initiating cells LTC IC added IL 3SCFFlt3 L combination 8
0.26340848.12642604.html.plaintext.txt	18	Transgenic mice carrying mutation cytoplasmic domain common gamma chain c lacking signaling kinase JAK3 necessary IL 15 mediated signaling low lymphocyte counts display dysregulated myelopoiesis 9 10
0.26340848.12642604.html.plaintext.txt	19	Moreover erythroid burst forming cells mice larger normal fraction hematopoietic precursors CD34c phenotype 11
0.26340848.12642604.html.plaintext.txt	20	These data suggest cross talk myeloid growth factors IL 15 may regulate balance myeloid lymphoid lineages hematopoietic differentiation
0.26340848.12642604.html.plaintext.txt	21	This regulation may operate level signal transduction IL 15 GM CSF share signaling pathways JAK2STAT5 NF B heavily involved control hematopoiesis 12 16
0.26340848.12642604.html.plaintext.txt	22	Alternatively cross talk two cytokines may involve direct interactions receptor subunits suggested fact GM CSF almost totally inhibits IL 2 binding IL 2IL 15Rssc M07sb CD34 hematopoietic cell line 17
0.26340848.12642604.html.plaintext.txt	23	We investigated whether cross talk resulted physical interaction two receptors possibly involving c chain GM CSFRss chain
0.26340848.12642604.html.plaintext.txt	24	Indeed two subunits identify two families cytokines one c chain IL 2 IL 4 IL 7 IL 9 IL 13 IL 15 IL 21 references 7 18 GM CSFRss chain IL 3 IL 5 GM CSF reference 19
0.26340848.12642604.html.plaintext.txt	25	In study demonstrate normal CD34 cells nonhematopoietic cells express novel functional hybrid receptor composed c GM CSFRss chains GM CSFRss chain may inhibit cJAK3 signaling
0.26340848.12642604.html.plaintext.txt	26	This complex maintained CD34 myeloid cord blood CBPr CD34CD56 cells mature NK cells suggesting involved controlling hematopoietic differentiation
0.26340848.12642604.html.plaintext.txt	27	Materials Methods Top Abstract Introduction Materials Methods Results Discussion References Purification CD34 Cells
0.26340848.12642604.html.plaintext.txt	28	Mononuclear cells CB adult G CSF mobilized peripheral blood MPB isolated centrifugation Ficoll gradient Lymphoprep Nicomed Pharma SA
0.26340848.12642604.html.plaintext.txt	29	Adherent cells isolated adhesion plastic Petri dishes 2 h 37 degrees C
0.26340848.12642604.html.plaintext.txt	30	CD34 cells selected immunomagnetic method Miltenyi Biotec nonadherent mononuclear cells labeled mAb specific QBEND10 epitope CD34 antigen achieving purity 97 previously described 20
0.26340848.12642604.html.plaintext.txt	31	CB CD34 cells used unprimed treatment SCFFlt3 L expand population CD34CD56 primed progenitors CBPr frequency NK cell precursors may 65 235 times higher freshly prepared CD34 HPCs 7
0.26340848.12642604.html.plaintext.txt	32	Isolation Culture Normal Polyclonal NK Cells
0.26340848.12642604.html.plaintext.txt	33	Non adherent PBMCs healthy volunteers isolated centrifugation Ficoll gradient
0.26340848.12642604.html.plaintext.txt	34	CD3 CD4 CD8 cells purified negative depletion cultured 100 Uml rIL 2 Proleukin Chiron Corp
0.26340848.12642604.html.plaintext.txt	35	presence 105 irradiated allogenic PBMCswell 104 221 lymphoblastoid cellswell
0.26340848.12642604.html.plaintext.txt	36	By day 15 almost proliferating cells expressed CD16 CD56 antigens
0.26340848.12642604.html.plaintext.txt	37	Human TF1ss IL 15Rssc M07sb IL 15Rssc two IL 15 dependent leukemic cell lines whereas TF1 IL 15Rc GM CSF dependent cell line
0.26340848.12642604.html.plaintext.txt	38	TF1 TF1ss cells potential display proerythroid differentiation whereas M07Sb cells display promegakaryocytic differentiation
0.26340848.12642604.html.plaintext.txt	39	NK L functional human cytolytic NK cell line dependent rIL 2
0.26340848.12642604.html.plaintext.txt	40	Raji B cell line IL 15Rc depend growth factors proliferation
0.26340848.12642604.html.plaintext.txt	41	The growth characteristics phenotypes cells reported elsewhere 21 25
0.26340848.12642604.html.plaintext.txt	42	Cells maintained RPMI medium Eurobio supplemented 10 FCS ATGC Biotechnologie 2 mM glutamine 1 antibiotics GIBCO BRL 10 ngml rIL 15 rGM CSF R D Systems 37 degrees C atmosphere 5 CO295 air
0.26340848.12642604.html.plaintext.txt	43	Cells subcultured twice per week seeding fresh culture medium 105 cellsml
0.26340848.12642604.html.plaintext.txt	44	The human stromal fibroblast MS9 strain isolated culture spleen patient myeloproliferative syndrome used feeder layer hematopoietic cells
0.26340848.12642604.html.plaintext.txt	45	MS9 fibroblasts express bioactive membrane bound IL 15 induces NK cell differentiation CD34 cells also secrete GM CSF 26 27
0.26340848.12642604.html.plaintext.txt	46	MS9 cells passages 5 10 cultured 72 h density 2 x 105 cellsml RPMI medium supplemented 10 FCS 6 well plates brought contact hematopoietic cells 5 x 105 cellswell
0.26340848.12642604.html.plaintext.txt	47	TF1ss NK L cells kindly provided Drs
0.26340848.12642604.html.plaintext.txt	48	Human Oncology University Wisconsin Madison WI Alessandro Moretta Department Experimental Medicine University Genoa Genoa Italy respectively
0.26340848.12642604.html.plaintext.txt	49	TF1ss cells Raji cells 3 x 105 cellsml cultured 4 d complete growth medium supplemented rIL 15 rGM CSF 10 ngml
0.26340848.12642604.html.plaintext.txt	50	Sister cultures treated neutralizing anti IL 15R M162 developed Immunex Corp
0.26340848.12642604.html.plaintext.txt	51	provided Genmab AS Copenhagen Denmark rat anti c TUGh4 anti GM CSFRss BD BiosciencesBecton Dickinson mAbs
0.26340848.12642604.html.plaintext.txt	52	TF1ss cells 3 x 105 cellsml also cultured 4 d MS9 stromal cells feeder layer
0.26340848.12642604.html.plaintext.txt	53	Sister cultures treated anti IL 15 R D Systems anti IL 15R M162 anti IL 15Rss CF 1 gift Dr
0.26340848.12642604.html.plaintext.txt	54	Jacques U463 INSERM Nantes France anti c TUGh4 anti GM CSFRss anti GM CSFR S 20 Santa Cruz Biotechnology Inc
0.26340848.12642604.html.plaintext.txt	55	In inhibition experiments used low concentrations anti IL 15Rss anti c mAbs combination 1 microgml mAb efficient single dose 10 microgml mAb inhibiting IL 15 effects 23
0.26340848.12642604.html.plaintext.txt	56	Cells counted triplicate
0.26340848.12642604.html.plaintext.txt	57	The statistical significance differences determined using Students test P 0
0.26340848.12642604.html.plaintext.txt	58	Analysis IL 15 Signal Transduction Human Hematopoietic TF1ss Cell Line CBPr CD34CD56 Precursors
0.26340848.12642604.html.plaintext.txt	59	For signal transduction analysis cells incubated overnight low concentration rIL 15 0
0.26340848.12642604.html.plaintext.txt	60	5 ngml deprived growth factors 3 h 37 degrees C
0.26340848.12642604.html.plaintext.txt	61	Cells stimulated incubation 10 ngml rIL 15 5 15 min
0.26340848.12642604.html.plaintext.txt	62	In experiments cells initially treated 1 h either 10 microgml neutralizing antibody IL 15 IL 15Rss c GM CSFRss chains JAK3 specific inhibitor WHI P131 Calbiochem effect JAK1 JAK2
0.26340848.12642604.html.plaintext.txt	63	Immunoblotting Western Blotting
0.26340848.12642604.html.plaintext.txt	64	Experiments performed described previously 12 14 28 29
0.26340848.12642604.html.plaintext.txt	65	Briefly cultures serum starved reduce basal phosphorylation levels
0.26340848.12642604.html.plaintext.txt	66	Cells washed twice suspended lysis buffer supplemented 0
0.26340848.12642604.html.plaintext.txt	67	For immunoprecipitation lysates incubated anti c TUGh4 anti JAK3 Upstate Biotechnology polyclonal anti TRAF2 Santa Cruz Biotechnology Inc
0.26340848.12642604.html.plaintext.txt	68	antibody immune complexes captured incubation protein G Sepharose beads Amersham Biosciences overnight 4 degrees C
0.26340848.12642604.html.plaintext.txt	69	The captured immune complexes washed twice lysis buffer
0.26340848.12642604.html.plaintext.txt	70	Complexes lysates Western blotting dissolved Laemmli buffer boiled separated SDS PAGE 7
0.26340848.12642604.html.plaintext.txt	71	The protein bands transferred PVDF membranes NEN Life Science Products
0.26340848.12642604.html.plaintext.txt	72	Membranes blocked incubation 5 BSA probed following antibodies anti JAK1 anti JAK2 4G10 anti phosphotyrosine Upstate BiotechnologyUSA Euromodex anti pJAK1 Tyr 10221023 anti pJAK2 Tyr 1007Tyr 1008 anti STAT3 anti pSTAT3 Tyr705 anti STAT6 Santa Cruz Biotechnology Inc
0.26340848.12642604.html.plaintext.txt	73	anti STAT5 Transduction LaboratoriesBecton Dickinson anti pSTAT5 Tyr694 anti pSTAT6 Tyr641 Cell SignalingNew England Biolabs Inc
0.26340848.12642604.html.plaintext.txt	74	Primary antibody binding membrane detected incubation peroxidase conjugated secondary antibodies followed enhanced chemiluminescence ECL system Amersham Biosciences
0.26340848.12642604.html.plaintext.txt	75	The membrane subjected densitometry including correction background analysis using NIH Image software
0.26340848.12642604.html.plaintext.txt	76	To correct possible variations amount protein loaded values expressed pSTATSTAT ratios
0.26340848.12642604.html.plaintext.txt	77	Results expressed increases e
0.26340848.12642604.html.plaintext.txt	78	three times respect results obtained untreated cells
0.26340848.12642604.html.plaintext.txt	79	For double staining c GM CSFRss chains human MPB CB CD34 cells leukemic cell lines TF1 TF1ss M07sb MS9 cells washed permeabilized incubation ORTHOpermeafix Ortho Diagnostic Systems Inc
0.26340848.12642604.html.plaintext.txt	80	45 min room temperature
0.26340848.12642604.html.plaintext.txt	81	Cells stained anti c TUGh4 mAb biotinylated anti GM CSFRss secondary mAb incubated room temperature Alexa Fluor594 GAR streptavidin Alexa Fluor594 Molecular Probes
0.26340848.12642604.html.plaintext.txt	82	The extent association two chains assessed using colocalization option Methamorphe Software Universal Imagine
0.26340848.12642604.html.plaintext.txt	83	We also used confocal microscopy evaluate production activated transcription factor pSTAT5 TF1ss M07sb cells
0.26340848.12642604.html.plaintext.txt	84	Cells starved growth factors overnight stimulated rGM CSF described
0.26340848.12642604.html.plaintext.txt	85	Some samples pretreated anti IL 15ssc anti GM CSFRss mAbs
0.26340848.12642604.html.plaintext.txt	86	Cells permeabilized indirect immunofluorescence assessed means antibodies recognizing phosphorylated form transcription factor STAT5 pSTAT5
0.26340848.12642604.html.plaintext.txt	87	Samples washed incubated Alexa Fluor488 GARa antibody
0.26340848.12642604.html.plaintext.txt	88	Nuclei stained 2 microgml propidium iodide PI red staining
0.26340848.12642604.html.plaintext.txt	89	All antibodies dissolved PBS supplemented 10 mgml BSA block nonspecific binding
0.26340848.12642604.html.plaintext.txt	90	The stained cells washed PBS centrifuged Cytospin 3 Shandon onto glass slides mounted coverslip Prolong Antifade Molecular Probes mounting medium
0.26340848.12642604.html.plaintext.txt	91	The slides analyzed laser scanning confocal microscopy using Leica TCS Confocal System
0.26340848.12642604.html.plaintext.txt	92	Results Top Abstract Introduction Materials Methods Results Discussion References Human Hematopoietic CD34 Cells Express Hybrid cGM CSFRss Receptor
0.26340848.12642604.html.plaintext.txt	93	We investigated possible interactions IL 15R GM CSFR complexes human hematopoietic nonhematopoietic cells Western blotting Fig
0.26340848.12642604.html.plaintext.txt	94	1 A coimmunoprecipitation Fig
0.26340848.12642604.html.plaintext.txt	95	1 B confocal microscopy Fig
0.26340848.12642604.html.plaintext.txt	96	The Western blotting total lysates Fig
0.26340848.12642604.html.plaintext.txt	97	1 A showed cells analyzed TF1ss M07Sb MPB CD34 expressed c chain single band 64 kD GM CSFRss chain major band 130 kD corresponding mature protein second band 95 kD corresponding nonglycosylated precursor protein reference 30
0.26340848.12642604.html.plaintext.txt	98	View larger version 60K Figure 1
0.26340848.12642604.html.plaintext.txt	99	cGM CSFRss interaction human hematopoietic nonhematopoietic cells
0.26340848.12642604.html.plaintext.txt	100	A Western blots total lysates
0.26340848.12642604.html.plaintext.txt	101	MPB CD34 cells TF1 M07Sb promyeloid CD34 cell lines analyzed expression c GM CSFRss chains
0.26340848.12642604.html.plaintext.txt	102	Briefly cell lysates subjected electrophoresis protein bands transferred PVDF membranes
0.26340848.12642604.html.plaintext.txt	103	The total lysate membranes Tot
0.26340848.12642604.html.plaintext.txt	104	lys probed anti c anti GM CSFRss mAbs
0.26340848.12642604.html.plaintext.txt	105	The data shown representative three independent experiments
0.26340848.12642604.html.plaintext.txt	106	B Coimmunoprecipitation MPB CD34 cells CBPr CD34CD56 normal polyclonal NK cells panel TF1 TF1ss MO7sb promyeloid CD34and NK L cell lines panel b human skin myofibroblasts panel c analyzed cGM CSFRss interactions
0.26340848.12642604.html.plaintext.txt	107	Briefly total lysates subjected immunoprecipitation IP anti c antibody
0.26340848.12642604.html.plaintext.txt	108	Immunoprecipitates subjected electrophoresis protein bands transferred PVDF membranes
0.26340848.12642604.html.plaintext.txt	109	Membranes corresponding c immunoprecipitate total lysates Tot
0.26340848.12642604.html.plaintext.txt	110	lys probed anti c anti GM CSFRss mAb
0.26340848.12642604.html.plaintext.txt	111	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	112	Analysis confocal microscopy interactions c chain green staining GM CSFRss red staining MPB CD34 cells panel a1 CBPr CD34 cells panel a2 TF1 cells panel b1 TF1ss cells panel b2 M07Sb panel b3 MS9 spleen myofibroblasts panel c
0.26340848.12642604.html.plaintext.txt	113	As specificity controls analyzed interactions c chain green staining IL 6R gp130 red staining panel d c chain green staining ss1 integrin red staining panel e CB CD34 cells
0.26340848.12642604.html.plaintext.txt	114	The images presented compacted overlay pictures serial optical sections 1 microm thick outside inner compartments cell
0.26340848.12642604.html.plaintext.txt	115	The yellow staining indicates colocalization various molecules
0.26340848.12642604.html.plaintext.txt	116	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	117	Human MPB CD34 cells CBPr CD34CD56 progenitors normal polyclonal NK cells immunoprecipitated anti c mAb c membranes reprobed mAbs recognizing c GM CSFRss chains
0.26340848.12642604.html.plaintext.txt	118	Reprobing anti c mAb confirmed presence specific 64 kD band whereas reprobing anti GM CSFRss mAb resulted detection specific 130 kD band MPB CD34 CBPr CD34CD56 cells polyclonal NK cells normal donors Fig
0.26340848.12642604.html.plaintext.txt	119	Thus normal human CD34 cells express cGM CSFRss complex detectable mature NK cells
0.26340848.12642604.html.plaintext.txt	120	The cGM CSFRss association also detected proerythroid TF1 TF1ss cell lines expressed IL 15Rc IL 15Rssc respectively promegakaryocytic M07sb cells expressing IL 15Rssc whereas detected cytolytic NK L cell line Fig
0.26340848.12642604.html.plaintext.txt	121	In addition cGM CSFRss complex found human skin myofibroblasts despite presence c GM CSFRss chains cells Fig
0.26340848.12642604.html.plaintext.txt	122	Reprobing c membrane anti GM CSFR anti gp130 mAbs give specific signal unpublished data
0.26340848.12642604.html.plaintext.txt	123	We demonstrated confocal microscopy colocalization c green staining GM CSFRss red staining chains MPB CB CD34 progenitors well TF1 TF1ss M07sb cell lines Fig
0.26340848.12642604.html.plaintext.txt	124	The images presented overlay compacted images confocal analysis 1 microm serial optical sections cell surface inner compartment
0.26340848.12642604.html.plaintext.txt	125	In MPB CD34 unprimed CB CD34 cells Fig
0.26340848.12642604.html.plaintext.txt	126	1 C panels a1 a2 cells displayed strong colocalization two molecules yellow staining restricted membranesubmembrane compartment
0.26340848.12642604.html.plaintext.txt	127	1 C panels b1 b2 observed similar yellow staining membranesubmembrane compartment spotted yellow staining cytoplasm suggesting hybrid receptor taken cells
0.26340848.12642604.html.plaintext.txt	128	This punctate distribution cGM CSFRss complex cytoplasms predominant staining pattern M07sb cells Fig
0.26340848.12642604.html.plaintext.txt	129	No colocalization observed human MS9 myofibroblasts Fig
0.26340848.12642604.html.plaintext.txt	130	The specificity c GM CSFRss chain colocalization confirmed lack colocalization c chain IL 6R subunit gp130 Fig
0.26340848.12642604.html.plaintext.txt	131	1 C panel d ss1 integrin Fig
0.26340848.12642604.html.plaintext.txt	132	1 C panel e normal CB CD34 cells
0.26340848.12642604.html.plaintext.txt	133	Computerized quantification extent c chain GM CSFRss chain colocalized normal leukemic CD34 cells showed 74
0.26340848.12642604.html.plaintext.txt	134	3 M07sb GM CSFRss chain colocalized c chain whereas 94
0.26340848.12642604.html.plaintext.txt	135	6 M07sb c chain colocalized GM CSFRss chain
0.26340848.12642604.html.plaintext.txt	136	Our results indicate c chain almost completely associated GM CSFRss chain 30 40 GM CSFRss chain left free
0.26340848.12642604.html.plaintext.txt	137	The expression hybrid receptor constitutive seem influenced cytokine stimulation observed CB hematopoietic progenitors whether unprimed treated SCFFlt3 L MPB CD34 cells CD34 myeloid cell lines dependent GM CSF TF1 IL 15 TF1ss M07sb growth
0.26340848.12642604.html.plaintext.txt	138	IL 15 GM CSF dependent Proliferation TF1ss Cells Is Modified Anti GM CSFRss Anti c mAbs Respectively
0.26340848.12642604.html.plaintext.txt	139	The presence hybrid receptor CD34 cells dependent IL 15 GM CSF led us investigate role receptor cell proliferation
0.26340848.12642604.html.plaintext.txt	140	2 A TF1ss cells proliferated presence rIL 15 200 rGM CSF 300
0.26340848.12642604.html.plaintext.txt	141	IL 15 dependent proliferation inhibited anti IL 15R anti c mAbs
0.26340848.12642604.html.plaintext.txt	142	Anti GM CSFRss mAb slightly significantly increased 20 25 P 0
0.26340848.12642604.html.plaintext.txt	143	001 rate cell proliferation
0.26340848.12642604.html.plaintext.txt	144	View larger version 26K Figure 2
0.26340848.12642604.html.plaintext.txt	145	Proliferation induced rIL 15 rGM CSF IL 15RGM CSFR cross talk TF1ss cells
0.26340848.12642604.html.plaintext.txt	146	A Proliferative response TF1ss cells recombinant IL 15 GM CSF
0.26340848.12642604.html.plaintext.txt	147	TF1ss IL 15Rssc CD34 cells cultured 4 d rIL 15 rGM CSF 10 ngml proliferation potential analyzed
0.26340848.12642604.html.plaintext.txt	148	Sister cultures continuously incubated neutralizing mAbs recognizing IL 15R c GM CSFRss chains
0.26340848.12642604.html.plaintext.txt	149	In TF1ss cells cultured rIL 15 proliferation rates samples treated anti GM CSFRss mAb significantly higher 25 P 0
0.26340848.12642604.html.plaintext.txt	150	001 samples incubated rIL 15 alone rIL 15 plus anti c mAb
0.26340848.12642604.html.plaintext.txt	151	B Proliferative response Raji cells rIL 15
0.26340848.12642604.html.plaintext.txt	152	Raji cells IL 15Rc cultured 4 d rIL 15 10 ngml analyzed proliferation
0.26340848.12642604.html.plaintext.txt	153	Sister cultures continuously incubated neutralizing mAbs recognizing IL 15R c GM CSFRss chains
0.26340848.12642604.html.plaintext.txt	154	C Proliferative response TF1ss cells MS9 cells
0.26340848.12642604.html.plaintext.txt	155	TF1ss cells cocultured 4 d MS9 cells analyzed proliferation
0.26340848.12642604.html.plaintext.txt	156	Sister cultures continuously incubated neutralizing mAbs recognizing GM CSFR GM CSFRss IL 15Rssc IL 15R chains IL 15
0.26340848.12642604.html.plaintext.txt	157	Cells counted electronic Coulter counter data expressed difference proliferative potential respect control untreated samples
0.26340848.12642604.html.plaintext.txt	158	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	159	In contrast GM CSF dependent proliferation totally inhibited anti GM CSFRss mAb also anti c mAb suggesting cross talk two cytokine receptors cells
0.26340848.12642604.html.plaintext.txt	160	As control used Raji cell line growth dependent IL 15 expresses IL 15R c IL 15Rss chains reference 30 Fig
0.26340848.12642604.html.plaintext.txt	161	After 4 d culture Raji cells fed DMEM supplemented 10 FCS proliferated resulting 200 increase cell density
0.26340848.12642604.html.plaintext.txt	162	The addition 10 ngml rIL 15 increased proliferation cells 30
0.26340848.12642604.html.plaintext.txt	163	This effect inhibited anti IL 15R mAb anti c anti GM CSFRss mAbs
0.26340848.12642604.html.plaintext.txt	164	Anti IL 15 anti IL 15R mAbs shown similar effects Raji cells 25
0.26340848.12642604.html.plaintext.txt	165	We investigated whether growth TF1ss cells could stimulated contact human stromal MS9 cells shown secrete several hematopoietic growth factors 26 whether hybrid receptor involved interactions
0.26340848.12642604.html.plaintext.txt	166	TF1ss cells proliferated cultured contact MS9 cells doubling number 4 d Fig
0.26340848.12642604.html.plaintext.txt	167	The proliferation induced MS9 cells totally inhibited neutralizing mAbs GM CSFR GM CSFRss chains
0.26340848.12642604.html.plaintext.txt	168	Neutralizing mAbs directed IL 15 IL 15R chain effect whereas anti IL 15Rssc mAbs inhibited proliferation TF1ss cells 60
0.26340848.12642604.html.plaintext.txt	169	Thus TF1ss cell proliferation completely dependent GM CSF produced MS9 cells 26 efficiently inhibited anti IL 15Rssc mAbs consistent existence cross talk two cytokine receptors
0.26340848.12642604.html.plaintext.txt	170	IL 15 induced JAKSTAT Signaling Is Inhibited Anti GM CSFRss mAb
0.26340848.12642604.html.plaintext.txt	171	The inability anti c mAb block IL 15 dependent proliferation TF1ss cells suggests c chain cannot mediate effects IL 15 cells
0.26340848.12642604.html.plaintext.txt	172	We investigated signal transduction triggered IL 15 involvement various subunits IL 15R TF1ss cells
0.26340848.12642604.html.plaintext.txt	173	Densitometric analysis revealed rIL 15 10 ngml caused levels phosphorylation JAK1 STAT3 increase factor seven within 15 min Fig
0.26340848.12642604.html.plaintext.txt	174	Neutralizing anti IL 15Rss mAb totally inhibited phosphorylation JAK1 inhibited STAT3 50
0.26340848.12642604.html.plaintext.txt	175	In contrast anti c mAb effect either pathway
0.26340848.12642604.html.plaintext.txt	176	These data confirm results proliferation assays demonstrating incapacity c chain mediate IL 15 dependent functions TF1ss cells
0.26340848.12642604.html.plaintext.txt	177	View larger version 43K Figure 3
0.26340848.12642604.html.plaintext.txt	178	IL 15 signal transduction IL 15RGM CSFR cross talk TF1ss cells
0.26340848.12642604.html.plaintext.txt	179	Analysis JAKSTAT signal transduction Western blotting
0.26340848.12642604.html.plaintext.txt	180	TF1ss cells incubated 10 ngml rIL 15 15 min 37 degrees C
0.26340848.12642604.html.plaintext.txt	181	Sister cultures pretreated 1 h neutralizing anti IL 15Rssc anti GM CSFRss anti IL 6R gp130 mAbs
0.26340848.12642604.html.plaintext.txt	182	Cell extracts analyzed Western blotting using anti phospho JAK1 pJAK1 anti phospho JAK2 pJAK2 anti phospho TYK2 pTYK2 anti phospho STAT5 pSTAT5 anti phospho STAT6 pSTAT6 antibodies
0.26340848.12642604.html.plaintext.txt	183	Membranes reprobed antibodies recognizing native proteins
0.26340848.12642604.html.plaintext.txt	184	To correct possible variations amount protein loaded values expressed pJAKJAK pSTATSTAT ratios
0.26340848.12642604.html.plaintext.txt	185	pJAKJAK pSTATSTAT levels determined densitometry including correction background NIH Image software
0.26340848.12642604.html.plaintext.txt	186	Results expressed increases e
0.26340848.12642604.html.plaintext.txt	187	two times respect untreated cells
0.26340848.12642604.html.plaintext.txt	188	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	189	We investigated whether GM CSFRss chain interfered c chain activity suggested results proliferation assays
0.26340848.12642604.html.plaintext.txt	190	Constitutive levels JAK1 JAK2 STAT5 STAT6 phosphorylation low TF1ss cells Fig
0.26340848.12642604.html.plaintext.txt	191	Densitometric analysis showed rIL 15 10 ngml induced increase factor least two level phosphorylation molecules within 15 min
0.26340848.12642604.html.plaintext.txt	192	The phosphorylation JAK1 STAT5 STAT6 totally inhibited synergistic combination anti IL 15Rss anti c mAbs also neutralizing anti GM CSFRss mAb
0.26340848.12642604.html.plaintext.txt	193	In contrast JAK2 phosphorylation totally inhibited anti IL 15Rssc mAb inhibited 30 anti GM CSFRss mAb
0.26340848.12642604.html.plaintext.txt	194	The use isotype matched anti gp130 mAb significant effect level phosphorylation various molecules
0.26340848.12642604.html.plaintext.txt	195	In contrast observed TF1ss cells anti GM CSFRss mAb affect IL 15 signaling CD34 promegakaryocytic M07sb cells expressing low affinity IL 15Rssc receptor unpublished data
0.26340848.12642604.html.plaintext.txt	196	GM CSF induced pSTAT5 Nuclear Translocation Is Inhibited Anti IL 15Rssc mAbs TF1ss Cells
0.26340848.12642604.html.plaintext.txt	197	We analyzed effects anti IL 15Rssc mAbs signal transduction activated rGM CSF Fig
0.26340848.12642604.html.plaintext.txt	198	Densitometric analysis revealed rGM CSF concentration 10 ngml doubled phosphorylation JAK2 quadrupled STAT5 TF1ss cells 15 min period
0.26340848.12642604.html.plaintext.txt	199	In experiments anti IL 15Rssc mAbs specific JAK3 inhibitor WHI P31 irrelevant anti gp130 mAb observed significant inhibition either pathway demonstrated neither two chains IL 15R affected steps GM CSF signaling
0.26340848.12642604.html.plaintext.txt	200	The effects rGM CSF IL 15Rssc mAbs localization pSTAT5 analyzed confocal microscopy Fig
0.26340848.12642604.html.plaintext.txt	201	Cells stained pSTAT5 green staining propidium iodide specific nuclei red staining superimposition two stains gave yellow coloration
0.26340848.12642604.html.plaintext.txt	202	In basal culture conditions cells displayed green staining cytoplasm indicating presence pSTAT5 protein compartment
0.26340848.12642604.html.plaintext.txt	203	The intensity green staining increased GM CSF stimulation suggesting level STAT5 phosphorylation increased
0.26340848.12642604.html.plaintext.txt	204	No inhibition observed presence neutralizing anti IL 15Rssc mAbs specific JAK3 inhibitor WHI P31 unpublished data confirming results obtained Western blotting
0.26340848.12642604.html.plaintext.txt	205	View larger version 50K Figure 4
0.26340848.12642604.html.plaintext.txt	206	GM CSF signal transduction IL 15RGM CSFR cross talk TF1ss cells
0.26340848.12642604.html.plaintext.txt	207	A Analysis JAK2STAT5 signal transduction Western blotting
0.26340848.12642604.html.plaintext.txt	208	TF1ss cells incubated 10 ngml rGM CSF 15 min 37 degrees C
0.26340848.12642604.html.plaintext.txt	209	Sister cultures pretreated 1 h neutralizing anti IL 15Rssc mAbs specific JAK3 inhibitors
0.26340848.12642604.html.plaintext.txt	210	Cell extracts analyzed Western blotting anti phospho JAK2 pJAK2 anti phospho STAT5 pSTAT5 antibodies
0.26340848.12642604.html.plaintext.txt	211	Membranes reprobed antibodies recognizing native proteins
0.26340848.12642604.html.plaintext.txt	212	To correct possible variations amount protein loaded values expressed pJAKJAK pSTATSTAT ratios
0.26340848.12642604.html.plaintext.txt	213	pJAKJAK pSTATSTAT levels determined densitometry including correction background NIH Image software
0.26340848.12642604.html.plaintext.txt	214	Results expressed increase e
0.26340848.12642604.html.plaintext.txt	215	two times respect untreated cells
0.26340848.12642604.html.plaintext.txt	216	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	217	B Analysis pSTAT5 nuclear localization confocal microscopy
0.26340848.12642604.html.plaintext.txt	218	TF1ss cells incubated 10 ngml rGM CSF 15 min 37 degrees C
0.26340848.12642604.html.plaintext.txt	219	Sister cultures pretreated 1 h neutralizing anti IL 15Rssc mAbs
0.26340848.12642604.html.plaintext.txt	220	Control basal treated cultures analyzed confocal microscopy pSTAT5 distribution cell focusing particularly whether protein present nucleus
0.26340848.12642604.html.plaintext.txt	221	Propidium iodide stains nuclei red whereas pSTAT5 stained green
0.26340848.12642604.html.plaintext.txt	222	Yellow staining indicates presence pSTAT5 nucleus
0.26340848.12642604.html.plaintext.txt	223	In basal culture conditions cells displayed yellow staining indicating presence pSTAT5 nucleus
0.26340848.12642604.html.plaintext.txt	224	Control cultures displayed red nuclear staining treated PI second reagent
0.26340848.12642604.html.plaintext.txt	225	Short term stimulation rGM CSF 15 min induced massive nuclear translocation pSTAT5 30 cells demonstrated intense yellow staining nucleus
0.26340848.12642604.html.plaintext.txt	226	Finally anti IL 15Rssc mAbs efficiently inhibited effects rGM CSF pSTAT5 nuclear translocation shown loss yellow staining whereas isotype matched anti gp130 mAb effect unpublished data
0.26340848.12642604.html.plaintext.txt	227	The effects STAT5 anti IL 15Rssc mAbs specific JAK3 inhibitor WHI P31 also observed M07Sb cells unpublished data
0.26340848.12642604.html.plaintext.txt	228	TF1 Cells Express Functional IL 15Rc Complex Formation Is Controlled Hybrid cGM CSFRss Receptor
0.26340848.12642604.html.plaintext.txt	229	The absence proliferation IL 15Rc positive TF1 cells response IL 15 attributed lack IL 15Rss subunit 23 indispensable IL 15 binding c chain signaling 7
0.26340848.12642604.html.plaintext.txt	230	However recently reported IL 15R chain may transduce signal absence links receptor subunit 12 leading NF B activation via cytoplasmic interaction molecule signaling molecule TRAF2
0.26340848.12642604.html.plaintext.txt	231	We therefore investigated possible presence functional IL 15Rc receptor TF1 cells
0.26340848.12642604.html.plaintext.txt	232	Analysis total lysates showed TF1 TF1ss cell lines expressed c chain 64 kD least two IL 15R isoforms 58 38 kD size Fig
0.26340848.12642604.html.plaintext.txt	233	The two cell lines incubated anti c mAb immunoprecipitation
0.26340848.12642604.html.plaintext.txt	234	The c membrane reprobed anti c mAb
0.26340848.12642604.html.plaintext.txt	235	A strong specific signal identified 64 kD
0.26340848.12642604.html.plaintext.txt	236	In contrast two major bands 58 38 kD size identified membrane reprobed anti IL 15R mAb
0.26340848.12642604.html.plaintext.txt	237	Thus TF1 TF1ss cells c chain physically associated two IL 15R isoforms
0.26340848.12642604.html.plaintext.txt	238	View larger version 42K Figure 5
0.26340848.12642604.html.plaintext.txt	239	IL 15Rc interaction TF1 TF1ss cells
0.26340848.12642604.html.plaintext.txt	240	TF1 TF1ss cells analyzed IL 15Rc interactions
0.26340848.12642604.html.plaintext.txt	241	Briefly lysates subjected immunoprecipitation IP anti c antibody
0.26340848.12642604.html.plaintext.txt	242	Immunoprecipitates subjected electrophoresis protein bands transferred PVDF membranes
0.26340848.12642604.html.plaintext.txt	243	Membranes corresponding immunoprecipitated c total lysates Tot
0.26340848.12642604.html.plaintext.txt	244	probed anti c anti IL 15R mAbs
0.26340848.12642604.html.plaintext.txt	245	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	246	B Analysis JAK3 phosphorylation Western blotting
0.26340848.12642604.html.plaintext.txt	247	TF1 TF1ss cells incubated 10 ngml rIL 15 15 min 37 degrees C
0.26340848.12642604.html.plaintext.txt	248	Sister cultures pretreated 1 h neutralizing anti IL 15R anti GM CSFRss anti gp130 mAbs
0.26340848.12642604.html.plaintext.txt	249	Cell extracts subjected immunoprecipitation anti JAK3 mAb
0.26340848.12642604.html.plaintext.txt	250	JAK3 membranes re probed anti phosphotyrosine 4G10 anti JAK3 mAbs
0.26340848.12642604.html.plaintext.txt	251	To correct possible variations amount protein loaded values expressed pJAK3JAK3 ratios
0.26340848.12642604.html.plaintext.txt	252	pJAK3JAK3 levels determined densitometry including correction background NIH Image software
0.26340848.12642604.html.plaintext.txt	253	Results expressed increases e
0.26340848.12642604.html.plaintext.txt	254	two times respect untreated cells
0.26340848.12642604.html.plaintext.txt	255	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	256	TF1 cells analyzed interactions TRAF2 IL 15R c
0.26340848.12642604.html.plaintext.txt	257	Briefly lysates subjected immunoprecipitation IP anti TRAF2 antibody
0.26340848.12642604.html.plaintext.txt	258	Immunoprecipitates subjected electrophoresis protein bands transferred PVDF membranes
0.26340848.12642604.html.plaintext.txt	259	Membranes corresponding immunoprecipitated TRAF2 total lysates Tot
0.26340848.12642604.html.plaintext.txt	260	probed anti TRAF2 anti c anti IL 15R mAbs
0.26340848.12642604.html.plaintext.txt	261	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	262	D Analysis IB phosphorylation Western blotting
0.26340848.12642604.html.plaintext.txt	263	TF1 TF1ss cells incubated 10 ngml rIL 15 rIL 7 15 min 37 degrees C
0.26340848.12642604.html.plaintext.txt	264	Cell extracts analyzed Western blotting anti phospho IB pIB antibody
0.26340848.12642604.html.plaintext.txt	265	Membranes reprobed antibody recognizing ss actin
0.26340848.12642604.html.plaintext.txt	266	To correct possible variations amount protein loaded values expressed pIBss actin ratios
0.26340848.12642604.html.plaintext.txt	267	pIBss actin levels determined densitometry including correction background NIH Image software
0.26340848.12642604.html.plaintext.txt	268	Results expressed increases respect untreated cells
0.26340848.12642604.html.plaintext.txt	269	The data presented representative three independent experiments
0.26340848.12642604.html.plaintext.txt	270	Stimulation rIL 15 induced JAK3 phosphorylation increase factor 15 presence anti GM CSFRss mAb indicating IL 15Rc receptor potentially functional TF1 cells Fig
0.26340848.12642604.html.plaintext.txt	271	A similar result also obtained TF1ss cells
0.26340848.12642604.html.plaintext.txt	272	Total lysates TF1 TF1ss cell lines subjected immunoprecipitation anti JAK3 mAb JAK3 membranes probed anti phosphotyrosine mAb 4G10
0.26340848.12642604.html.plaintext.txt	273	A single phosphorylated band detected samples treated anti GM CSFRss mAb
0.26340848.12642604.html.plaintext.txt	274	Reprobing membrane anti JAK3 mAb resulted detection single protein migration characteristics identical phosphorylated band detected 4G10 Western blot indicating phosphorylated protein indeed JAK3
0.26340848.12642604.html.plaintext.txt	275	These data indicate c subunit IL 15Rc receptor functional TF1 cells even absence IL 15Rss chain signaling controlled GM CSFRss
0.26340848.12642604.html.plaintext.txt	276	The hybrid receptor therefore functional cells
0.26340848.12642604.html.plaintext.txt	277	We analyzed whether IL 15Rc complex associated signaling molecule TRAF2 Fig
0.26340848.12642604.html.plaintext.txt	278	Analysis total lysates anti TRAF2 anti c anti IL 15R mAbs showed TF1 cells expressed TRAF2 55 kD 58 kD IL 15R isoform c chain 64 kD
0.26340848.12642604.html.plaintext.txt	279	After immunoprecipitation anti TRAF2 antibody reprobing TRAF2 membranes mAbs recognizing IL 15R c chains resulted detection specific 58 64 kD bands respectively indicating TRAF2 physically associated IL 15R 58 kD standard isoform c chain
0.26340848.12642604.html.plaintext.txt	280	We also showed rIL 15 rIL 7 triggered phosphorylation p65 NF B subunit inhibitor IB 42 kD within 15 min TF1 TF1ss cells Fig
0.26340848.12642604.html.plaintext.txt	281	Reprobing membranes anti ss actin mAb identified band similar intensity 42 kD sample indicating gel evenly loaded terms amount protein
0.26340848.12642604.html.plaintext.txt	282	We also showed confocal microscopy rIL 15 rIL 7 induced translocation nucleus p65 NF B subunit unpublished data
0.26340848.12642604.html.plaintext.txt	283	These data indicate TF1 cells IL 15R chain functional able activate NF B factor
0.26340848.12642604.html.plaintext.txt	284	Moreover association c chain interfere NF B activation also probably renders c chain functional even absence IL 15Rss chain shown induction JAK3 phosphorylation rIL 15
0.26340848.12642604.html.plaintext.txt	285	IL 15 induced STAT5 Signaling Is Inhibited Anti GM CSFRss mAb Normal CBPr CD34CD56 Cells
0.26340848.12642604.html.plaintext.txt	286	Finally investigated functional significance hybrid receptor normal CB hematopoietic progenitors properties receptor cells
0.26340848.12642604.html.plaintext.txt	287	We used populations CB progenitors expanded 5 d presence SCF Flt3 L CBPr CD34CD56
0.26340848.12642604.html.plaintext.txt	288	This facilitates proliferation hematopoietic progenitors maintain CD34CD56 phenotype expression lineage specific markers 7
0.26340848.12642604.html.plaintext.txt	289	We found rIL 15 quadrupled levels STAT3 phosphorylation significantly affected anti GM CSFRss isotype matched control anti gp130 mAbs Fig
0.26340848.12642604.html.plaintext.txt	290	As expected rGM CSF induce STAT3 phosphorylation
0.26340848.12642604.html.plaintext.txt	291	In contrast anti c anti gp130 mAbs inhibited constitutive STAT3 phosphorylation suggesting interference autocrine IL 15 dependent loop
0.26340848.12642604.html.plaintext.txt	292	Indeed unprimed hematopoietic precursors secrete several hematopoietic cytokines regulate normal hematopoiesis 3 autocrineparacrine loops IL 15 belongs group 20
0.26340848.12642604.html.plaintext.txt	293	View larger version 51K Figure 6
0.26340848.12642604.html.plaintext.txt	294	IL 15 signal transduction IL 15RGM CSFR cross talk CBPr CD34CD56 cells
0.26340848.12642604.html.plaintext.txt	295	Analysis STAT signal transduction Western blotting
0.26340848.12642604.html.plaintext.txt	296	CB CD34 cell populations expanded incubation 5 d presence SCF Flt3 L
0.26340848.12642604.html.plaintext.txt	297	These cells displayed CD34CD56 phenotype expression lineage specific markers
0.26340848.12642604.html.plaintext.txt	298	These CBPr CD34CD56 progenitors incubated 10 ngml rIL 15 rGM CSF 15 min 37 degrees C
0.26340848.12642604.html.plaintext.txt	299	Sister cultures pretreated 1 h neutralizing anti IL 15Rssc anti GM CSFRss anti IL 6R gp130 mAbs
0.26340848.12642604.html.plaintext.txt	300	Cell extracts analyzed Western blotting anti phospho STAT3 pSTAT3 anti phospho STAT5 pSTAT5 anti phospho STAT6 pSTAT6 antibodies
0.26340848.12642604.html.plaintext.txt	301	Membranes reprobed antibodies recognizing native proteins
0.26340848.12642604.html.plaintext.txt	302	To correct possible variations amount protein loaded values expressed pSTATSTAT ratios
0.26340848.12642604.html.plaintext.txt	303	pSTATSTAT levels determined densitometry including correction background NIH Image software
0.26340848.12642604.html.plaintext.txt	304	Results expressed increases respect untreated cells
0.26340848.12642604.html.plaintext.txt	305	The data presented representative two independent experiments
0.26340848.12642604.html.plaintext.txt	306	Both rIL 15 rGM CSF induced STAT5 phosphorylation increases factors 10 7 respectively
0.26340848.12642604.html.plaintext.txt	307	Anti GM CSFRss mAb totally abolished effect rIL 15 whereas action rGM CSF action inhibited 35 anti c mAb
0.26340848.12642604.html.plaintext.txt	308	No significant inhibition observed anti gp130 mAb used
0.26340848.12642604.html.plaintext.txt	309	Finally CBPr CD34CD56 progenitors displayed discrete constitutive STAT6 phosphorylation 80 increase phosphorylation response rIL 15 effect rGM CSF
0.26340848.12642604.html.plaintext.txt	310	The various neutralizing mAbs significant effect STAT6 phosphorylation
0.26340848.12642604.html.plaintext.txt	311	Discussion Top Abstract Introduction Materials Methods Results Discussion References We found human CD34 hematopoietic progenitors express novel hybrid receptor composed c chain IL 2R GM CSFRss chain
0.26340848.12642604.html.plaintext.txt	312	This receptor also found CD34 hematopoietic cell lines proerythroid TF1 TF1ss promegakaryocytic M07sb differentiation potentials CBPr CD34CD56 precursors cytolytic NK L cell line normal NK cells nonhematopoietic human cells even though cells produce chains
0.26340848.12642604.html.plaintext.txt	313	The hybrid receptor functional mediates signal transduction IL 15 GM CSF pathways
0.26340848.12642604.html.plaintext.txt	314	Indeed results obtained anti GM CSFRss mAb suggested TF1ss cells GM CSFRss chain replaces c chain inhibiting specific signaling phosphorylation JAK3 chain cooperates IL 15Rss chain facilitating IL 15 dependent activation JAKSTAT pathways JAK1 JAK2 STAT5 STAT6 controlling proliferation cells
0.26340848.12642604.html.plaintext.txt	315	In contrast anti c mAb inhibited GM CSF dependent proliferation TF1ss cells treated recombinant cytokine cocultured human stromal hematopoietic cells secreting GM CSF
0.26340848.12642604.html.plaintext.txt	316	This suggests hybrid receptor may important effects vivo interfering interactions CD34 cells stromal cells play major role control normal pathological hematopoiesis 1 2
0.26340848.12642604.html.plaintext.txt	317	In addition anti IL 15Rssc mAbs specific JAK3 inhibitor WHI P31 inhibited nuclear translocation STAT5 induced rGM CSF inhibit phosphorylation STAT5
0.26340848.12642604.html.plaintext.txt	318	These effects STAT5 also observed M07Sb cells
0.26340848.12642604.html.plaintext.txt	319	Our observation c subunit hybrid receptor controls GM CSF dependent nuclear translocation pSTAT5 rather STAT5 phosphorylation consistent recent results showing tyrosine phosphorylation nuclear translocation STAT proteins regulated independently 31 32
0.26340848.12642604.html.plaintext.txt	320	Indeed human keratinocytes express type II IL 4R IL 4 induces phosphorylation STAT3 nuclear translocation 31 whereas prolactin receptor PRLR regulates STAT5 tyrosine phosphorylation nuclear translocation means two independent pathways 32
0.26340848.12642604.html.plaintext.txt	321	With PRLR number phosphorylated tyrosines receptor seems play critical role activation cellular component controls number STAT5 complexes cytoplasm controlling entry complexes nucleus 32
0.26340848.12642604.html.plaintext.txt	322	Moreover STAT5 tyrosine phosphorylation DNA binding via IL 2Rss chain requires receptor phosphotyrosines 33 whereas similar events mediated G CSFR independent receptor phosphotyrosines 34
0.26340848.12642604.html.plaintext.txt	323	Thus structural organization receptors subsequent activation particular signaling pathways may affect translocation STAT protein nucleus
0.26340848.12642604.html.plaintext.txt	324	On basis results propose model activation STAT5 rGM CSF via hybrid receptor cGM CSFRss
0.26340848.12642604.html.plaintext.txt	325	We suggest STAT5 tyrosine phosphorylation nuclear translocation regulated independently translocation pathway controlled cJAK3 complex cells type I IL 4R necessary translocation STAT5 nucleus 35
0.26340848.12642604.html.plaintext.txt	326	The hybrid receptor functional leukemic cell precursors also normal progenitors although functions appear limited normal cells
0.26340848.12642604.html.plaintext.txt	327	Indeed normal CBPr CD34CD56 progenitors hybrid receptor controls IL 15 dependent phosphorylation STAT5 STAT3 STAT6
0.26340848.12642604.html.plaintext.txt	328	Moreover levels GM CSF dependent STAT5 phosphorylation decreased anti c mAb CBPr CD34CD56 progenitors TF1ss cells
0.26340848.12642604.html.plaintext.txt	329	These differences may due differences origin normal versus pathological andor degree primitiveness two types CD34 cell
0.26340848.12642604.html.plaintext.txt	330	In case results emphasize involvement hybrid receptor control normal pathological hematopoiesis receptor probably displaying various functions hematopoietic development
0.26340848.12642604.html.plaintext.txt	331	The absence hybrid receptor nonhematopoietic cells strengthens evidence specific involvement hematopoiesis
0.26340848.12642604.html.plaintext.txt	332	The distribution receptor cells various lineages functions suggests involved development hematopoiesis probably affecting engagement myeloid rather lymphoid lineages
0.26340848.12642604.html.plaintext.txt	333	Indeed inhibition cJAK3 signaling GM CSFRss chain interpreted light inhibition lymphocyte maturation myelopoiesis dysregulation observed mice humans bearing c JAK3 deletions mutations 9 11
0.26340848.12642604.html.plaintext.txt	334	In erythrocytic TF1 cells describe first time novel IL 15RcTRAF2 complex triggers specific IL 15 signaling even though cells express IL 15Rss chain23 subunit indispensable c chain functions 7
0.26340848.12642604.html.plaintext.txt	335	Both subunits IL 15Rc heterodimer functional although behave differently would expected based results obtained cell types
0.26340848.12642604.html.plaintext.txt	336	It reported IL 15R associating signaling molecule TRAF2 activates transcription factor NF B absence link c chain 12 24
0.26340848.12642604.html.plaintext.txt	337	In contrast TF1 cells IL 15R c associated nevertheless observed phosphorylation IB also JAK3 factors
0.26340848.12642604.html.plaintext.txt	338	However phosphorylation JAK3 factor observed samples treated rIL 15 anti GM CSFRss mAb indicating cJAK3 pathway functional absence IL 15Rss chain controlled hybrid receptor
0.26340848.12642604.html.plaintext.txt	339	The association IL 15RcTRAF2 may play regulatory role certain stages hematopoiesis associating NF B activation involved control erythropoiesis 15 conditional activation JAK3 dependent pathways
0.26340848.12642604.html.plaintext.txt	340	Finally showed rIL 15 induced phosphorylation STAT6 leukemic TF1ss proerythroid precursors normal CBPr CD34CD56 progenitors
0.26340848.12642604.html.plaintext.txt	341	Our data suggest unusual IL 15 dependent pathway activation mast cells attributed high affinity p65 IL 15RX receptor 28 29 also triggered types CD34 precursor
0.26340848.12642604.html.plaintext.txt	342	However TF1ss cells pathway controlled classical IL 15Rssc receptor andor cGM CSFRss hybrid receptor whereas normal CBPr CD34CD56 IL 15 dependent STAT6 phosphorylation controlled hybrid receptor
0.26340848.12642604.html.plaintext.txt	343	Overall results suggest possible complex involvement STAT6 control hematopoiesis 36 provide evidence IL 15GM CSF involved cross talk
0.26340848.12642604.html.plaintext.txt	344	Recent data shown unprimed hematopoietic progenitors secrete several mediators activating autocrineparacrine regulatory loops 3
0.26340848.12642604.html.plaintext.txt	345	For instance CD34 cells may express GM CSF transcripts 3 biologically active IL 15 controls expression c chain competent inducing spontaneous differentiation cells NK cells 20
0.26340848.12642604.html.plaintext.txt	346	Thus IL 15 GM CSF may contribute means hybrid receptor autocrineparacrine cross talk controls development hematopoietic cells 3 perhaps inhibiting spontaneous engagement cells lymphoid lineage
0.26340848.12642604.html.plaintext.txt	347	In contrast leukemic hematopoiesis action hybrid receptor probably irreversible may involved molecular mechanisms responsible inhibition differentiation certain leukemic clones
0.26340848.12642604.html.plaintext.txt	348	Acknowledgments This work supported grants Association pour la Recherche sur le Cancer ARC N degrees 5801 NRB Vaincre le Cancer FE
0.26340848.12642604.html.plaintext.txt	349	FLUC Fondation de France N degrees 99 003929 Italian Association Cancer Research AIRC Italian National Council Research CNR
0.26340848.12642604.html.plaintext.txt	350	Submitted January 29 2002 Revised January 27 2003 Accepted January 28 2003
0.26340848.12642604.html.plaintext.txt	351	Footnotes Abbreviations used paper BM bone marrow CB cord blood MPB mobilized peripheral blood
0.26340848.12642604.html.plaintext.txt	352	References Top Abstract Introduction Materials Methods Results Discussion References Ratajczak M
0.26340848.12642604.html.plaintext.txt	353	The biology hemopoietic stem cells
0.26340848.12642604.html.plaintext.txt	354	Thymic regulation hematopoiesis isolation helper suppressor populations using counterflow centrifugal elutriation
0.26340848.12642604.html.plaintext.txt	355	Numerous growth factors cytokines chemokines secreted human CD34 cells myeloblasts erythroblasts megakaryoblasts regulate normal hematopoiesis autocrineparacrine manner
0.26340848.12642604.html.plaintext.txt	356	AbstractFree Full Text Shibuya A
0.26340848.12642604.html.plaintext.txt	357	Inhibitory effect granulocyte macrophage colony stimulating factor therapy generation natural killer cells
0.26340848.12642604.html.plaintext.txt	358	Natural killer NK cells functionally abnormal NK cell progenitors diminished granulocyte colony stimulating factor mobilized peripheral blood
0.26340848.12642604.html.plaintext.txt	359	AbstractFree Full Text Taguchi K
0.26340848.12642604.html.plaintext.txt	360	Suppressive effect granulocyte macrophage colony stimulating factor generation natural killer cells vitro
0.26340848.12642604.html.plaintext.txt	361	Interleukin 15 biology relevance human disease
0.26340848.12642604.html.plaintext.txt	362	Expansion granulocyte colony stimulating factorchemotherapy mobilized CD34 hematopoietic progenitors role granulocyte macrophage colony stimulating factorerythropoietin hybrid protein MEN11303 interleukin 15
0.26340848.12642604.html.plaintext.txt	363	Modulation hematopoiesis mice truncated mutant interleukin 2 receptor gamma chain
0.26340848.12642604.html.plaintext.txt	364	AbstractFree Full Text Grossman W
0.26340848.12642604.html.plaintext.txt	365	Dysregulated myelopoiesis mice lacking Jak3
0.26340848.12642604.html.plaintext.txt	366	AbstractFree Full Text Itano M
0.26340848.12642604.html.plaintext.txt	367	IL 2 receptor gamma chain expression CD34 positive hematopoietic progenitor cells bone marrow cord blood
0.26340848.12642604.html.plaintext.txt	368	Death deflected IL 15 inhibits TNF alpha mediated apoptosis fibroblasts TRAF2 recruitment IL 15Ralpha chain
0.26340848.12642604.html.plaintext.txt	369	AbstractFree Full Text McDonald P
0.26340848.12642604.html.plaintext.txt	370	Interleukin 15 IL 15 induces NF kappaB activation IL 8 production human neutrophils
0.26340848.12642604.html.plaintext.txt	371	AbstractFree Full Text Liu R
0.26340848.12642604.html.plaintext.txt	372	Constitutive activation JAK2STAT5 signal transduction pathway correlates growth factor independence megakaryocytic leukemic cell lines
0.26340848.12642604.html.plaintext.txt	373	NF kappaB transcription factors involved normal erythropoiesis
0.26340848.12642604.html.plaintext.txt	374	AbstractFree Full Text Ihle J
0.26340848.12642604.html.plaintext.txt	375	The Stat family cytokine signaling
0.26340848.12642604.html.plaintext.txt	376	CrossRefMedline Kanakura Y
0.26340848.12642604.html.plaintext.txt	377	Functional expression interleukin 2 receptor human factor dependent megakaryoblastic leukemia cell line evidence granulocyte macrophage colony stimulating factor inhibits interleukin 2 binding receptor
0.26340848.12642604.html.plaintext.txt	378	Cutting edge common gamma chain indispensable subunit IL 21 receptor complex
0.26340848.12642604.html.plaintext.txt	379	AbstractFree Full Text Oppenheim J
0.26340848.12642604.html.plaintext.txt	380	Cytokines past present future
0.26340848.12642604.html.plaintext.txt	381	Altered natural killer cell differentiation CD34 progenitors chronic myeloid leukemia patients
0.26340848.12642604.html.plaintext.txt	382	Selective growth response IL 3 human leukaemic cell line megakaryoblastic features
0.26340848.12642604.html.plaintext.txt	383	Alteration CD34 Tf 1 beta cell line profile response long term exposure IL 15
0.26340848.12642604.html.plaintext.txt	384	Interleukin IL 15 induces survival proliferation growth factor dependent acute myeloid leukemia M 07e IL 2 receptor betagamma
0.26340848.12642604.html.plaintext.txt	385	The IL 15Ralpha chain signals association Syk human B cells
0.26340848.12642604.html.plaintext.txt	386	AbstractFree Full Text Brouty Boye D
0.26340848.12642604.html.plaintext.txt	387	Effects human fibroblasts myelometaplasic non myelometaplasic hematopoietic tissues CD34 stem cells
0.26340848.12642604.html.plaintext.txt	388	CrossRefMedline Brouty Boye D
0.26340848.12642604.html.plaintext.txt	389	Phenotypic diversity human fibroblasts myelometaplasic non myelometaplasic hematopoietic tissues
0.26340848.12642604.html.plaintext.txt	390	AbstractFree Full Text Tagaya Y
0.26340848.12642604.html.plaintext.txt	391	Identification novel receptorsignal transduction pathway IL 15T mast cells
0.26340848.12642604.html.plaintext.txt	392	Molecular cloning second subunit receptor human granulocyte macrophage colony stimulating factor GM CSF reconstitution high affinity GM CSF receptor
0.26340848.12642604.html.plaintext.txt	393	Binding IL 4 IL 13Ralpha1IL 4Ralpha receptor complex leads STAT3 phosphorylation nuclear translocation
0.26340848.12642604.html.plaintext.txt	394	Prolactin receptor regulates Stat5 tyrosine phosphorylation nuclear translocation two separate pathways
0.26340848.12642604.html.plaintext.txt	395	AbstractFree Full Text Gaffen S
0.26340848.12642604.html.plaintext.txt	396	Distinct tyrosine residues within interleukin 2 receptor beta chain drive signal transduction specificity redundancy diversity
0.26340848.12642604.html.plaintext.txt	397	AbstractFree Full Text Fujitani Y
0.26340848.12642604.html.plaintext.txt	398	An alternative pathway STAT activation mediated direct interaction JAK STAT
0.26340848.12642604.html.plaintext.txt	399	The interleukin 4 receptor activates STAT5 mechanism relies upon common gamma chain
0.26340848.12642604.html.plaintext.txt	400	AbstractFree Full Text Soon L
0.26340848.12642604.html.plaintext.txt	401	Insulin like growth factor I synergizes interleukin 4 hematopoietic cell proliferation independent insulin receptor substrate expression
0.2994644.12089346.html.plaintext.txt	0	Polyamines Modulate Interaction Nuclear Receptors Vitamin D Receptor Interacting Protein 205 Yutaka Maeda Christophe Rachez1 Leo Hawel III Craig V
0.2994644.12089346.html.plaintext.txt	1	Environmental Toxicology Graduate Program Y
0.2994644.12089346.html.plaintext.txt	2	Departments Cell Biology Neuroscience F
0.2994644.12089346.html.plaintext.txt	3	University California Riverside California 92521 Cell Biology Program C
0.2994644.12089346.html.plaintext.txt	4	Memorial Sloan Kettering Cancer Center New York New York 10021
0.2994644.12089346.html.plaintext.txt	5	Address correspondence requests reprints Frances M
0.2994644.12089346.html.plaintext.txt	6	Department Cell Biology Neuroscience University California Riverside Riverside California 92521
0.2994644.12089346.html.plaintext.txt	7	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Nuclear receptors NR activate transcription interacting several different coactivator complexes primarily via LXXLL motifs NR boxes coactivator bind common region ligand binding domain nuclear receptors activation function 2 AF 2 ligand dependent fashion
0.2994644.12089346.html.plaintext.txt	8	However nuclear receptors distinguish different sets coactivators remains mystery mechanism orphan receptors hepatocyte nuclear factor 4 HNF4 activate transcription
0.2994644.12089346.html.plaintext.txt	9	In study show HNF4 interacts complex containing vitamin D receptor VDR interacting proteins DRIPs absence exogenously added ligand
0.2994644.12089346.html.plaintext.txt	10	However whereas full length DRIP205 construct enhanced activation HNF4 vivo interact well HNF4 ligand binding domain vitro
0.2994644.12089346.html.plaintext.txt	11	In investigating discrepancy found polyamine spermine significantly enhanced interaction HNF4 full length DRIP205 AF 2 NR box dependent manner
0.2994644.12089346.html.plaintext.txt	12	Spermine also enhanced interaction DRIP205 VDR even presence ligand decreased interaction HNF4 VDR p160 coactivator glucocorticoid receptor interacting protein 1 GR1P1
0.2994644.12089346.html.plaintext.txt	13	We also found GR1P1 DRIP205 synergistically activated HNF4 mediated transcription specific inhibitor polyamine biosynthesis difluoromethylornithine DFMO decreased ability HNF4 activate transcription vivo
0.2994644.12089346.html.plaintext.txt	14	These results lead us propose model polyamines may facilitate switch different coactivator complexes binding NRs
0.2994644.12089346.html.plaintext.txt	15	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES NUCLEAR RECEPTORS NRs comprise family transcription factors play role nearly every aspect growth development disease processes reviewed Refs
0.2994644.12089346.html.plaintext.txt	16	The best characterized members family steroid thyroid hormone vitamins A D receptors known regulate transcription binding cognate lipophilic ligands subsequently undergoing conformational change alters ability interact coregulatory proteins
0.2994644.12089346.html.plaintext.txt	17	These coregulatory proteins typically consist complexes either repress corepressors activate coactivators transcription
0.2994644.12089346.html.plaintext.txt	18	The coactivator complexes crudely divided complexes either contain histone acetyl transferase HAT activity e
0.2994644.12089346.html.plaintext.txt	19	p160 p300CBP PCAF complexes ones e
0.2994644.12089346.html.plaintext.txt	20	vitamin D receptor VDR interating protein DRIPthyroid hormone receptor associated protein TRAPARCmediator complexes
0.2994644.12089346.html.plaintext.txt	21	We others proposed previously nuclear receptors interact first coactivator complexes contain HAT activity allowing acetylation hence decondensation chromatin subsequently coactivator complexes bind receptors interact basal transcription machinery initiate transcription reviewed Refs
0.2994644.12089346.html.plaintext.txt	22	An increasing amount evidence indicates types coactivators interact activation function 2 AF 2 region ligand binding domain LBD NRs via LXXLL motifs NR interaction regions NR boxes
0.2994644.12089346.html.plaintext.txt	23	p160 family members glucocorticoid receptor interacting protein 1 GRIP1 steroid receptor coactivator 1 SRC1 bind AF 2 help recruit p300CBP also found bind via AF 2
0.2994644.12089346.html.plaintext.txt	24	DRIP205 also known TRAP220 RB18A PBP TRIP2 component DRIPTRAP complex also interacts AF 2 via LXXLL motifs 6 7 8
0.2994644.12089346.html.plaintext.txt	25	However clear given nuclear receptor makes switch p160p300 complex DRIP complex
0.2994644.12089346.html.plaintext.txt	26	Whereas switch corepressor coactivator binding apparently made conformational change receptor upon ligand binding types coactivators bind liganded receptor bind principally via AF 2
0.2994644.12089346.html.plaintext.txt	27	This suggests perhaps change receptor coactivators required make switch one complex another
0.2994644.12089346.html.plaintext.txt	28	However might cause switch completely unknown point
0.2994644.12089346.html.plaintext.txt	29	In attempt answer questions examined interaction orphan member nuclear receptor superfamily hepatocyte nuclear factor 4 HNF4 NR2A1 DRIP complex
0.2994644.12089346.html.plaintext.txt	30	HNF4 somewhat unusual receptor activates transcription constitutive fashion
0.2994644.12089346.html.plaintext.txt	31	absence exogenously added ligand
0.2994644.12089346.html.plaintext.txt	32	HNF4 highly conserved member superfamily critical early development directly linked several human diseases including diabetes hemophilia reviewed Ref
0.2994644.12089346.html.plaintext.txt	33	Whereas endogenous ligand yet definitively identified HNF4 10 11 others 12 13 14 15 16 shown HNF4 interacts coactivators GRIP1 p300CBP absence added ligand transactivation HNF4 completely dependent upon AF 2
0.2994644.12089346.html.plaintext.txt	34	In study show HNF4 LBD also interacts complex containing DRIP proteins absence exogenously added ligand
0.2994644.12089346.html.plaintext.txt	35	In investigating interaction found polyamine spermine enhanced interaction DRIP205 HNF4 also VDR LBD
0.2994644.12089346.html.plaintext.txt	36	In contrast spermine decreased interaction receptors p160 family member GRIP1
0.2994644.12089346.html.plaintext.txt	37	These results lead us propose model polyamines spermine help promote switch p160p300 complex DRIP complex
0.2994644.12089346.html.plaintext.txt	38	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES HNF4 Interacts DRIP Complex Absence Exogenously Added Ligand To determine whether HNF4 could interact DRIP complex absence exogenously added ligand pull assay using Namalwa B cell nuclear extracts glutathione S transferase GST
0.2994644.12089346.html.plaintext.txt	39	1 performed fashion similar originally used identify DRIP complex 17 18
0.2994644.12089346.html.plaintext.txt	40	The results indicate HNF4 LBD pulled complex similar identical pulled VDR LBD presence ligand 125 dihydroxy vitamin D3 125 OH2D3 Fig
0.2994644.12089346.html.plaintext.txt	41	2A top compare lane 4 lane 2
0.2994644.12089346.html.plaintext.txt	42	Immunoblot analysis indicated DRIP205 DRIP130 lesser extent DRIP150 present HNF4 complex Fig
0.2994644.12089346.html.plaintext.txt	43	Transient cotransfection analyses verified interaction DRIP complex functional one
0.2994644.12089346.html.plaintext.txt	44	Transfected DRIP205 wild type DRIP205
0.2994644.12089346.html.plaintext.txt	45	wt stimulated ability HNF41 activate reporter gene absence added ligand 4
0.2994644.12089346.html.plaintext.txt	46	2B compare lane 4 lane 3
0.2994644.12089346.html.plaintext.txt	47	Removal region C terminal LBD F domain resulted greater degree stimulation DRIP205 6
0.2994644.12089346.html.plaintext.txt	48	1 fold lanes 7 8 found previously GRIP1 CBP 12
0.2994644.12089346.html.plaintext.txt	49	The AF 2 required stimulation DRIP205
0.2994644.12089346.html.plaintext.txt	50	wt transactivation activity lanes 5 6
0.2994644.12089346.html.plaintext.txt	51	View larger version 25K Figure 1
0.2994644.12089346.html.plaintext.txt	52	Top wt rat HNF41 HNF4 constructs derived
0.2994644.12089346.html.plaintext.txt	53	Numbering indicates aa residues A F conventional nomenclature NR domains DBD DBD consisting zinc fingers Zn2 hinge region domain D
0.2994644.12089346.html.plaintext.txt	54	wt full length wt human DRIP205 sequence
0.2994644.12089346.html.plaintext.txt	55	mut contains double mutations two NR boxes
0.2994644.12089346.html.plaintext.txt	56	box encompasses aa 527 714 contains two wt NR boxes
0.2994644.12089346.html.plaintext.txt	57	View larger version 22K Figure 2
0.2994644.12089346.html.plaintext.txt	58	HNF4 Interacts DRIP Complex Absence Exogenously Added Ligand
0.2994644.12089346.html.plaintext.txt	59	5 mg Namalwa B cell nuclear extracts presence absence 1 microM 125 OH2D3 D3 indicated GST fusion proteins VDR LBD HNF4 DBD LBD GST control see Fig
0.2994644.12089346.html.plaintext.txt	60	1 described Materials Methods
0.2994644.12089346.html.plaintext.txt	61	Bottom Immunoblot analysis Western blots gel done parallel antisera DRIP205 1100 DRIP150 1500 DRIP130 1500 indicated 37
0.2994644.12089346.html.plaintext.txt	62	B Transient transfection assay described Materials Methods Saos2 cells 2
0.2994644.12089346.html.plaintext.txt	63	0 microg reporter construct ApoB
0.2994644.12089346.html.plaintext.txt	64	1 microg indicated HNF4 expression vector see Fig
0.2994644.12089346.html.plaintext.txt	65	Shown mean luciferase activity relative light units RLU plus minus SD triplicates one representative experiment three
0.2994644.12089346.html.plaintext.txt	66	wt also stimulated HNF4 mediated transcription absence added ligand 293T CV 1 cells data shown
0.2994644.12089346.html.plaintext.txt	67	Stimulation also observed normalized ss galactosidase control although great DRIP205
0.2994644.12089346.html.plaintext.txt	68	wt also enhanced expression ss galactosidase vector data shown
0.2994644.12089346.html.plaintext.txt	69	Polyamines Enhance Interaction HNF4 LBD DRIP205 Vitro To determine whether DRIP205 interacts directly LBD HNF4 nuclear receptors 17 19 20 21 22 GST pull assays performed using vitro translated DRIP205
0.2994644.12089346.html.plaintext.txt	70	wt interacted modestly HNF4 LBD construct 2
0.2994644.12089346.html.plaintext.txt	71	2 VDR LBD absence ligand 1
0.2994644.12089346.html.plaintext.txt	72	In contrast addition 125 OH2D3 significantly enhanced binding VDR LBD 21
0.2994644.12089346.html.plaintext.txt	73	5 lane 5 served positive control
0.2994644.12089346.html.plaintext.txt	74	View larger version 42K Figure 3
0.2994644.12089346.html.plaintext.txt	75	The Polyamine Spermine Enhances Binding DRIP205
0.2994644.12089346.html.plaintext.txt	76	A Pull assay described Materials Methods vitro synthesized 35S labeled DRIP205
0.2994644.12089346.html.plaintext.txt	77	wt immobilized GST fusion proteins HNF4 VDR LBD see Fig
0.2994644.12089346.html.plaintext.txt	78	1 absence presence 4 microM 125 OH2D3 D3 dissolved ethanol EtOH indicated
0.2994644.12089346.html.plaintext.txt	79	Shown autoradiograph SDS PAGE quantified phosphor imaging
0.2994644.12089346.html.plaintext.txt	80	10 input 10 amount lysate used reaction bound percentage total input bound normalized binding GST control GST
0.2994644.12089346.html.plaintext.txt	81	B Pull assay A 35S labeled DRIP205
0.2994644.12089346.html.plaintext.txt	82	Brackets Partial translation products DRIP205
0.2994644.12089346.html.plaintext.txt	83	10 input 10 amount lysate used reaction bound percentage input full length DRIP205 bound normalized GST control GST
0.2994644.12089346.html.plaintext.txt	84	To resolve apparent discrepancy ability HNF4 LBD bring DRIP complex cell extracts relative inability LBD interact vitro translated DRIP205
0.2994644.12089346.html.plaintext.txt	85	wt incubated 35S labeled DRIP205
0.2994644.12089346.html.plaintext.txt	86	wt cell extracts repeated pull assay
0.2994644.12089346.html.plaintext.txt	87	We found conditions DRIP205
0.2994644.12089346.html.plaintext.txt	88	wt could indeed interact HNF4 LBD addition cell extracts required effect addition extract buffer data shown
0.2994644.12089346.html.plaintext.txt	89	Because unusual components nuclear extraction buffer positively charged polyamines spermine spermidine tested pull assay
0.2994644.12089346.html.plaintext.txt	90	We found physiological concentrations spermine 1 mM markedly enhanced interaction 35S labeled DRIP205
0.2994644.12089346.html.plaintext.txt	91	5 22 negligible affect background binding GST control Fig
0.2994644.12089346.html.plaintext.txt	92	3B compare arrow lane 5 lane 3 lane 4 lane 2
0.2994644.12089346.html.plaintext.txt	93	1 mM resulted less binding 3
0.2994644.12089346.html.plaintext.txt	94	5 indicating dose effect lane 7
0.2994644.12089346.html.plaintext.txt	95	Interestingly truncated 35S labeled DRIP205 products present lysate bound relatively well HNF4 LBD irrespective addition spermine lanes 3 5 7 9 bracket
0.2994644.12089346.html.plaintext.txt	96	Similar effects observed spermidine although lesser degree data shown
0.2994644.12089346.html.plaintext.txt	97	In investigating nature effect spermine HNF4 DRIP205 interaction found several properties suggest effect specific one
0.2994644.12089346.html.plaintext.txt	98	For example spermine enhance binding DRIP205
0.2994644.12089346.html.plaintext.txt	99	wt GST HNF4 fusion construct lacking AF 2 C360 indicating AF 2 required Fig
0.2994644.12089346.html.plaintext.txt	100	4A top panel compare lane 6 lane 3
0.2994644.12089346.html.plaintext.txt	101	Spermine also marginally affected ability HNF4 LBD interact another protein namely 35S labeled HNF41 Fig
0.2994644.12089346.html.plaintext.txt	102	4A bottom panel compare lane 7 lane 4 1
0.2994644.12089346.html.plaintext.txt	103	3 fold effect binding DRIP205 effect require presence AF 2 compare lane 6 lane 3
0.2994644.12089346.html.plaintext.txt	104	The effect spermine also required presence NR boxes DRIP205 pull downs full length DRIP205 containing mutations two NR boxes DRIP205
0.2994644.12089346.html.plaintext.txt	105	mut affected addition spermine Fig
0.2994644.12089346.html.plaintext.txt	106	4B middle panel compare lane 7 lane 4
0.2994644.12089346.html.plaintext.txt	107	Likewise interaction small region DRIP205 encompasses NR boxes DRIP205
0.2994644.12089346.html.plaintext.txt	108	box greatly affected addition spermine compare lane 7 lane 4 bottom panel
0.2994644.12089346.html.plaintext.txt	109	These results indicate whereas effect spermine dependent presence AF 2 NR boxes due increased interaction two regions
0.2994644.12089346.html.plaintext.txt	110	This surprising spermine charged molecule AF 2 NR box interaction primarily hydrophobic one
0.2994644.12089346.html.plaintext.txt	111	View larger version 34K Figure 4
0.2994644.12089346.html.plaintext.txt	112	Spermine Enhances Binding DRIP205
0.2994644.12089346.html.plaintext.txt	113	wt NR LBDs AF 2 NR Box Dependent Manner
0.2994644.12089346.html.plaintext.txt	114	wt HNF41 full length immobilized GST fusion proteins C360 GST
0.2994644.12089346.html.plaintext.txt	115	1 absence presence 1 mM spermine indicated
0.2994644.12089346.html.plaintext.txt	116	10 input 10 amount lysate used reaction bound percentage total input bound normalized binding GST control GST
0.2994644.12089346.html.plaintext.txt	117	B Pull assay A 35S labeled DRIP205 constructs DRIP205
0.2994644.12089346.html.plaintext.txt	118	1 immobilized GST fusion proteins DBD GST
0.2994644.12089346.html.plaintext.txt	119	1 absence presence 1 mM spermine indicated
0.2994644.12089346.html.plaintext.txt	120	10 input 10 amount lysate used reaction bound percentage total input bound normalized binding GST control GST
0.2994644.12089346.html.plaintext.txt	121	C Pull assay B 35S labeled DRIP205 constructs DRIP205
0.2994644.12089346.html.plaintext.txt	122	LBD absence presence 1 mM spermine 125 OH2D3 D3 ethanol control EtOH indicated
0.2994644.12089346.html.plaintext.txt	123	10 input 10 amount lysate used reaction bound percentage total input bound normalized binding GST control GST
0.2994644.12089346.html.plaintext.txt	124	Additional studies support notion effect spermine may due simply enhancement AF 2 NR box interaction may fact involve entire DRIP205 molecule
0.2994644.12089346.html.plaintext.txt	125	Because coactivators found interact DNA binding domain DBD nuclear receptors 23 24 sought determine whether DRIP205 might also interact HNF4 DBD whether interaction affected addition spermine
0.2994644.12089346.html.plaintext.txt	126	Whereas HNF4 DBD bound remarkably well wt DRIP205 67 DRIP205 containing mutated NR boxes 54
0.2994644.12089346.html.plaintext.txt	127	4B top middle panels lane 3 spermine greatly decreased interactions lane 6
0.2994644.12089346.html.plaintext.txt	128	In contrast isolated DRIP205 NR box bind well HNF4 DBD either absence presence spermine bottom panel lanes 3 6
0.2994644.12089346.html.plaintext.txt	129	Whereas possible decrease binding full length DRIP205 HNF4 DBD related increased binding LBD equally possible two effects related
0.2994644.12089346.html.plaintext.txt	130	For example spermine could induce conformational change DRIP205
0.2994644.12089346.html.plaintext.txt	131	wt causes decrease interaction HNF4 DBD increase interaction LBD perhaps result increased access NR boxes
0.2994644.12089346.html.plaintext.txt	132	Such conformational change could also explain HNF4 LBD binds truncated DRIP205 products better full length DRIP205 binding affected spermine truncated products NR boxes may already fully accessible Fig
0.2994644.12089346.html.plaintext.txt	133	If spermine primarily affecting DRIP205 HNF4 one might expect see similar affect interaction nuclear receptors
0.2994644.12089346.html.plaintext.txt	134	This exactly found VDR LBD presence spermine enhanced interaction DRIP205
0.2994644.12089346.html.plaintext.txt	135	4 binding presence 125 OH2D3 Fig
0.2994644.12089346.html.plaintext.txt	136	4C top panel compare lane 7 lane 4
0.2994644.12089346.html.plaintext.txt	137	It also enhanced binding unliganded VDR although binding still considerably less presence ligand Fig 4C top panel lane 6 vs
0.2994644.12089346.html.plaintext.txt	138	Once affect spermine evident full length DRIP205 appreciable effect isolated NR boxes Fig
0.2994644.12089346.html.plaintext.txt	139	GRIP1 Decreased Binding Presence Polyamines Synergy DRIP205 To determine whether polyamines could increase interaction nuclear receptors NR box containing protein examined effect spermine binding p160 family member GRIP1
0.2994644.12089346.html.plaintext.txt	140	Much surprise addition spermine pull reaction reproducibly decreased interaction 35S labeled GRIP1 HNF4 VDR LBD Fig
0.2994644.12089346.html.plaintext.txt	141	5A top bottom panels compare lane 7 lane 4
0.2994644.12089346.html.plaintext.txt	142	View larger version 28K Figure 5
0.2994644.12089346.html.plaintext.txt	143	Spermine Switch p160 Family DRIP Complex Spermine Decreases Binding GRIP NR LBDs GRIP1 Synergizes DRIP205 Activate HNF4 Mediated Transcription
0.2994644.12089346.html.plaintext.txt	144	3 vitro translated 35S labeled GRIP1 GST
0.2994644.12089346.html.plaintext.txt	145	HNF4 DBD LBD top panel GST
0.2994644.12089346.html.plaintext.txt	146	LBD bottom panel absence presence 1 mM spermine indicated
0.2994644.12089346.html.plaintext.txt	147	D3 Reaction performed presence 4 microM 125 OH2D3 dissolved ethanol lanes 4 7
0.2994644.12089346.html.plaintext.txt	148	An equivalent amount ethanol added reactions lanes 3 6
0.2994644.12089346.html.plaintext.txt	149	B Transient transfection assay 293T cells described Materials Methods 2 microg Gal4 luciferase reporter construct pFR luc Stratagene La Jolla CA 0
0.2994644.12089346.html.plaintext.txt	150	1 microg expression plasmids containing Gal4
0.2994644.12089346.html.plaintext.txt	151	DBD fusion HNF4 LBD Gal4
0.2994644.12089346.html.plaintext.txt	152	LBD absence presence 5 microg pSG5
0.2994644.12089346.html.plaintext.txt	153	Shown mean luciferase activity relative light units RLU plus minus SD triplicates one representative experiment three
0.2994644.12089346.html.plaintext.txt	154	Because spermine decreased interaction GRIP1 increased interaction DRIP205 suggested two coactivator complexes could act together single pathway spermine acting switch two complexes
0.2994644.12089346.html.plaintext.txt	155	If case one might expect see synergistic effect two coactivators
0.2994644.12089346.html.plaintext.txt	156	In contrast GRIP1 DRIP205 act independently two parallel pathways one would expect see additive effect
0.2994644.12089346.html.plaintext.txt	157	Transient cotransfection analysis showed DRIP205 activated Gal4 fusion construct containing HNF4 LBD approximately 2
0.2994644.12089346.html.plaintext.txt	158	5B compare lane 6 lane 5 GRIP1 activated 2
0.2994644.12089346.html.plaintext.txt	159	6 fold compare lane 7 lane 5
0.2994644.12089346.html.plaintext.txt	160	In contrast GRIP1 DRIP205 present activation additive 8
0.2994644.12089346.html.plaintext.txt	161	LBD alone compare lane 8 lane 5 indicating synergistic effect coactivators supporting notion act pathway
0.2994644.12089346.html.plaintext.txt	162	In Vivo Evidence Role Polyamines Activated Transcription To determine whether effects spermine seen vitro also played role vivo transient transfection assay performed presence specific inhibitor polyamine biosynthesis difluoromethylornithine DFMO known decrease levels intracellular polyamines spermidine spermine blocking activity ornithine decarboxylase Ref
0.2994644.12089346.html.plaintext.txt	163	A 24 h treatment DFMO reduced intracellular levels spermidine spermine 293T cells 37 77 respectively Fig
0.2994644.12089346.html.plaintext.txt	164	6B decreased HNF41 mediated transcription nearly 50 Fig
0.2994644.12089346.html.plaintext.txt	165	6C top compare lane 3 lane 1 lane 4 lane 2
0.2994644.12089346.html.plaintext.txt	166	The effect HNF41 mediated transcription appeared specific DFMO slightly increased level background transcription reporter construct decrease HNF41 protein levels evidenced immunoblot analysis Fig
0.2994644.12089346.html.plaintext.txt	167	6C bottom compare lane 3 lane 2
0.2994644.12089346.html.plaintext.txt	168	Because addition polyamines gel shift reaction decreased ability HNF41 bind DNA vitro Seidel S
0.2994644.12089346.html.plaintext.txt	169	Sladek unpublished data unlikely decrease HNF4 mediated transcription DFMO treated cells due decrease DNA binding
0.2994644.12089346.html.plaintext.txt	170	Rather results suggest blocking synthesis polyamines spermine specifically decreased ability HNF41 activate transcription
0.2994644.12089346.html.plaintext.txt	171	View larger version 19K Figure 6
0.2994644.12089346.html.plaintext.txt	172	Polyamines Modulate Transcriptional Activation Vivo
0.2994644.12089346.html.plaintext.txt	173	A Pathway polyamine biosynthesis mammalian cells
0.2994644.12089346.html.plaintext.txt	174	ODC Ornithine decarboxylase 25
0.2994644.12089346.html.plaintext.txt	175	B Intracellular polyamine concentrations duplicate samples 293T cells absence control 1 2 DMEM alone presence 1 mM DFMO DMEM DFMO 1 2 measured described Materials Methods
0.2994644.12089346.html.plaintext.txt	176	Results given nanomoles polyamine per milligram total protein
0.2994644.12089346.html.plaintext.txt	177	Intracellular putrescine levels less 0
0.2994644.12089346.html.plaintext.txt	178	The effect DFMO comparable observed others another cell line 38 although starting levels spermine somewhat higher 293T cells
0.2994644.12089346.html.plaintext.txt	179	C Transient transfection 293T cells performed described Materials Methods 2 microg reporter construct ApoB
0.2994644.12089346.html.plaintext.txt	180	HNF41 HNF4 absence presence 1 mM DFMO added 24 h harvesting indicated B
0.2994644.12089346.html.plaintext.txt	181	Fold Induction Luciferase activity normalized ss gal activity
0.2994644.12089346.html.plaintext.txt	182	The experiment repeated twice similar results
0.2994644.12089346.html.plaintext.txt	183	The data presented mean plus minus SD triplicate
0.2994644.12089346.html.plaintext.txt	184	Bottom Immunoblot analysis transfected 293T cells detect HNF41 protein using 445 antibody 39 goat antirabbit antisera conjugated alkaline phosphatase
0.2994644.12089346.html.plaintext.txt	185	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES In current study show first time orphan receptor HNF4 interacts complex containing DRIP proteins vitro responds DRIP205 vivo absence exogenously added ligand Fig
0.2994644.12089346.html.plaintext.txt	186	We also show full length vitro translated DRIP205
0.2994644.12089346.html.plaintext.txt	187	wt interact well HNF4 LBD unless polyamine spermine added reaction Fig
0.2994644.12089346.html.plaintext.txt	188	The enhancement spermine appears specific dependent presence AF 2 HNF4 NR boxes DRIP205 Fig
0.2994644.12089346.html.plaintext.txt	189	Spermine also enhanced interaction DRIP205 VDR LBD decreased interaction HNF4 DBD Fig
0.2994644.12089346.html.plaintext.txt	190	An vivo role spermine activated transcription observed specific inhibitor polyamine biosynthesis DFMO decreased HNF41 mediated transcription basal transcription Fig
0.2994644.12089346.html.plaintext.txt	191	Finally spermine decreased interaction HNF4 VDR coactivator GRIP1 GRIP1 synergized DRIP205 vivo activate HNF4 mediated transcription Fig
0.2994644.12089346.html.plaintext.txt	192	We others 5 6 7 26 27 proposed previously p160 p300 coactivators DRIP complex act sequential fashion
0.2994644.12089346.html.plaintext.txt	193	Our current work supports model allows us propose mechanism might occur namely polyamines may play role switching one coactivator complex Fig
0.2994644.12089346.html.plaintext.txt	194	View larger version 21K Figure 7
0.2994644.12089346.html.plaintext.txt	195	Proposed Model Role Polyamines Transcriptional Activation
0.2994644.12089346.html.plaintext.txt	196	Polyamines spermine may decrease binding activators HNF4 VDR coactivators GRIP1 p160 family member increase binding DRIP205 shaded molecules
0.2994644.12089346.html.plaintext.txt	197	This would allow switch p160p300 complex DRIP complex interact nuclear receptors via common docking surface AF 2 black dot
0.2994644.12089346.html.plaintext.txt	198	As described text one potential source polyamines could chromatin
0.2994644.12089346.html.plaintext.txt	199	Polyamines small ubiquitous organic polycations found relatively high concentrations cell approximately 1 2 mM
0.2994644.12089346.html.plaintext.txt	200	They implicated wide variety physiological functions found bind proteins well nucleic acids reviewed Refs
0.2994644.12089346.html.plaintext.txt	201	Perhaps one intriguing elusive roles polyamines regulation gene expression
0.2994644.12089346.html.plaintext.txt	202	Polyamines implicated formation higher order chromosomal fibers facilitating condensation chromatin fragments interacting specifically nucleosome core particles DNA 31
0.2994644.12089346.html.plaintext.txt	203	Whereas would suggest increase polyamine levels would globally repress transcription fact results increase expression many genes 32 suggesting polyamines regulate gene expression additional mechanisms
0.2994644.12089346.html.plaintext.txt	204	One mechanism could via affecting interaction transcriptional activators HNF4 coactivators DRIP complex
0.2994644.12089346.html.plaintext.txt	205	The data presented study indicate p160 family member GRIP1 DRIP205 synergistically activate transcription Fig
0.2994644.12089346.html.plaintext.txt	206	5B suggesting act single pathway raising question switch made one coactivator
0.2994644.12089346.html.plaintext.txt	207	Our data also show polyamine spermine decrease binding least two different nuclear receptors GRIP1 Fig
0.2994644.12089346.html.plaintext.txt	208	5A increase binding DRIP205 Figs
0.2994644.12089346.html.plaintext.txt	209	3 4 suggesting polyamines may play role switch
0.2994644.12089346.html.plaintext.txt	210	Support role vivo observed blocking biosynthesis polyamines resulted decrease HNF4 mediated transcription Fig
0.2994644.12089346.html.plaintext.txt	211	If polyamines acting level chromatin level coactivators one would expect decrease polyamine levels decondense chromatin result increase decrease transcription
0.2994644.12089346.html.plaintext.txt	212	Therefore vivo well vitro results suggest polyamines may play role transcription activation altering state chromatin
0.2994644.12089346.html.plaintext.txt	213	However must noted interpretations vivo data possible additional experiments required definitively prove polyamines modulate synergy GRIP1 DRIP205 vivo
0.2994644.12089346.html.plaintext.txt	214	The model polyamines playing role switch different coactivator complexes intriguing provocative raises several important questions
0.2994644.12089346.html.plaintext.txt	215	One polyamines affect binding coactivators activators Whereas mechanism known results suggest due simple enhancement interaction AF 2 nuclear receptors NR boxes DRIP205 Fig
0.2994644.12089346.html.plaintext.txt	216	Rather truncated DRIP205 products bound HNF4 LBD equally well presence absence spermine Fig
0.2994644.12089346.html.plaintext.txt	217	3 favor model polyamines induce conformational change DRIP205 exposes otherwise buried NR boxes
0.2994644.12089346.html.plaintext.txt	218	There least one example already conformational change coactivator important function 33
0.2994644.12089346.html.plaintext.txt	219	Another important question polyamines come Most polyamines cell free bound negatively charged molecules chromatin 28 29 30
0.2994644.12089346.html.plaintext.txt	220	Because others shown hyperacetylation histones inhibits ability polyamines condense chromatin 31 possible acetylation histones coactivators p300 p300CBP associated factor may also cause release polyamines chromatin
0.2994644.12089346.html.plaintext.txt	221	If case upon activator binding DNA recruiting HAT containing coactivator complex would increase local polyamine concentration could mediate switch HAT containing complex DRIP complex
0.2994644.12089346.html.plaintext.txt	222	Some evidence already exists polyamine levels affect histone acetylation influencing action histone acetyltransferases deacetylases 32
0.2994644.12089346.html.plaintext.txt	223	Finally attractive feature model could apply nuclear receptors transcriptional activator recruits HAT containing coactivators DRIPTRAPARCmediator complex several examples 4 7
0.2994644.12089346.html.plaintext.txt	224	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Materials 125 OH2D3 generous gift A
0.2994644.12089346.html.plaintext.txt	225	Norman University California Riverside CA
0.2994644.12089346.html.plaintext.txt	226	Spermine purchased Sigma St
0.2994644.12089346.html.plaintext.txt	227	Louis MO DFMO provided Ilex Oncology San Antonio TX
0.2994644.12089346.html.plaintext.txt	228	Plasmids Transient Transfection Assays The following constructs previously described pMT7 expression vectors containing full length rat HNF41 pMT7
0.2994644.12089346.html.plaintext.txt	229	HNF41 amino acids aa 1 374 HNF4
0.2994644.12089346.html.plaintext.txt	230	1 vector containing aa 1 360 HNF41 HNF4
0.2994644.12089346.html.plaintext.txt	231	N1C360 12 HNF4 GST fusion constructs containing aa 127 374 GST
0.2994644.12089346.html.plaintext.txt	232	DBD reporter construct ApoB
0.2994644.12089346.html.plaintext.txt	233	Luc Gal4 DBD fusion construct containing HNF4 LBD Gal4
0.2994644.12089346.html.plaintext.txt	234	LBD 34 GST fusion construct containing aa 110 427 human VDR GST
0.2994644.12089346.html.plaintext.txt	235	1 expression vectors containing full length wt human DRIP205 cDNA DRIP205
0.2994644.12089346.html.plaintext.txt	236	wt small region spanning two NR boxes DRIP205 aa 527 714 DRIP205
0.2994644.12089346.html.plaintext.txt	237	box full length DRIP205 two mutated NR boxes LXXLL LXXAA DRIP205
0.2994644.12089346.html.plaintext.txt	238	GRIP1 containing full length mouse GRIP1 kindly provided M
0.2994644.12089346.html.plaintext.txt	239	Stallcup University Southern California Ref
0.2994644.12089346.html.plaintext.txt	240	Human embryonic kidney 293T Saos 2 cells maintained transfected Lipofectin Life Technologies Inc
0.2994644.12089346.html.plaintext.txt	241	Gaithersburg MD previously described 34
0.2994644.12089346.html.plaintext.txt	242	DNA mixtures typically contained 2 microg luciferase reporter 0
0.2994644.12089346.html.plaintext.txt	243	0 microg DRIP expression vectors pSG5
0.2994644.12089346.html.plaintext.txt	244	GRIP1 appropriate empty vector 2 microg RSV
0.2994644.12089346.html.plaintext.txt	245	GST Pull Down Assay In vitro protein protein interaction assays performed using GST fusion proteins previously described 34
0.2994644.12089346.html.plaintext.txt	246	In general 20 microl beads containing 10 20 microg protein incubated 4 C 2 5 microl vitro translated 35S methionine labeled protein rabbit reticulocyte lysate TNT Promega Corp
0.2994644.12089346.html.plaintext.txt	247	Madison WI 1 h gentle agitation extensive washing elution SDS buffer analysis 10 SDS PAGE followed autoradiography phosphor imaging
0.2994644.12089346.html.plaintext.txt	248	DBD beads prewashed buffer containing 1 M NaCl remove contaminating DNA
0.2994644.12089346.html.plaintext.txt	249	Pull downs Namalwa B cell nuclear extracts performed previously described 17
0.2994644.12089346.html.plaintext.txt	250	For pull downs ligand polyamines 125 OH2D3 spermine added 1 4 microM 1 mM respectively GST beads time lysate extract
0.2994644.12089346.html.plaintext.txt	251	The concentration Tris HCl increased 20 mM 50 mM experiments polyamines maintain pH 8
0.2994644.12089346.html.plaintext.txt	252	Measurement Intracellular Polyamine Levels Intracellular polyamine levels measured ion exchange chromatography followed reverse phase HPLC previously described 36
0.2994644.12089346.html.plaintext.txt	253	Briefly 3 x 106 293T cells plated 100 mm plate 1 d advance treated 1 mM DFMO DMEM cells approximately70 confluent
0.2994644.12089346.html.plaintext.txt	254	Twenty four hours later cells washed extensively PBS lysed 400 microl 0
0.2994644.12089346.html.plaintext.txt	255	2 N perchloric acid followed sonication
0.2994644.12089346.html.plaintext.txt	256	The extracted material subjected chromatography
0.2994644.12089346.html.plaintext.txt	257	ACKNOWLEDGMENTS We thank E
0.2994644.12089346.html.plaintext.txt	258	Martinez critical reading manuscript S
0.2994644.12089346.html.plaintext.txt	259	FOOTNOTES This work supported NIH Grants CA 79909 C
0.2994644.12089346.html.plaintext.txt	260	Japan Society Promotion Science University California Toxic Substances Research Teaching Program
0.2994644.12089346.html.plaintext.txt	261	1 Current address Institut National de la Sante et de la Recherche Medicale Unite 459 Faculte de Medicine H
0.2994644.12089346.html.plaintext.txt	262	Warembourg 1 Place de Verdun 59045 Lille cedex France
0.2994644.12089346.html.plaintext.txt	263	Abbreviations aa Amino acids AF 2 activation function 2 ARC activator recruited cofactor CBP cAMP response element binding protein binding protein DBD DNA binding domain DFMO difluoromethylornithine 125 OH2D3 125 dihydroxy vitamin D3 DRIP VDR interacting protein GRIP1 glucocorticoid receptor interacting protein 1 GST glutathione S transferase HAT histone acetyl transferase HNF4 hepatocyte nuclear factor 4 LBD ligand binding domain NR nuclear receptor PCAF p300CBP associated factor SRC1 steroid receptor coactivator TRAP thyroid hormone receptor associated protein VDR vitamin D receptor wt wild type
0.2994644.12089346.html.plaintext.txt	264	Received publication October 5 2001
0.2994644.12089346.html.plaintext.txt	265	Accepted publication March 14 2002
0.2994644.12089346.html.plaintext.txt	266	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mangelsdorf DJ Thummel C Beato M Herrlich P Schutz G Umesono K Blumberg B Kastner P Mark M Chambon P Evans RM 1995 The nuclear receptor superfamily second decade
0.2994644.12089346.html.plaintext.txt	267	Cell 83835 839Medline Whitfield GK Jurutka PW Haussler CA Haussler MR 1999 Steroid hormone receptors evolution ligands molecular basis biologic function
0.2994644.12089346.html.plaintext.txt	268	J Cell Biochem Suppl 32 33110 122 Lemon B Tjian R 2000 Orchestrated response symphony transcription factors gene control
0.2994644.12089346.html.plaintext.txt	269	Genes Dev 142551 2569Free Full Text Rachez C Freedman LP 2001 Mediator complexes transcription
0.2994644.12089346.html.plaintext.txt	270	Curr Opin Cell Biol 13274 280CrossRefMedline Glass CK Rosenfeld MG 2000 The coregulator exchange transcriptional functions nuclear receptors
0.2994644.12089346.html.plaintext.txt	271	Genes Dev 14121 141Free Full Text Freedman LP 1999 Increasing complexity coactivation nuclear receptor signaling
0.2994644.12089346.html.plaintext.txt	272	Cell 975 8Medline Ito M Roeder RG 2001 The TRAPSMCCMediator complex thyroid hormone receptor function
0.2994644.12089346.html.plaintext.txt	273	Trends Endocrinol Metab 12127 134CrossRefMedline Rachez C Gamble M Chang CP Atkins GB Lazar MA Freedman LP 2000 The DRIP complex SRC 1p160 coactivators share similar nuclear receptor binding determinants constitute functionally distinct complexes
0.2994644.12089346.html.plaintext.txt	274	Mol Cell Biol 202718 2726AbstractFree Full Text Sladek FM Seidel SD 2001 Hepatocyte nuclear factor 4
0.2994644.12089346.html.plaintext.txt	275	In Burris TP McCabe ERB eds
0.2994644.12089346.html.plaintext.txt	276	Nuclear receptors genetic diseases
0.2994644.12089346.html.plaintext.txt	277	London Academic Press 309 361 Bogan AA Dallas Yang Q Ruse Jr MD Maeda Y Jiang G Nepomuceno L Scanlan TS Cohen FE Sladek FM 2000 Analysis protein dimerization ligand binding orphan receptor HNF4
0.2994644.12089346.html.plaintext.txt	278	J Mol Biol 302831 851CrossRefMedline Wan YJ Cai Y Cowan C Magee TR 2000 Fatty acyl CoAs inhibit retinoic acid induced apoptosis Hep3B cells
0.2994644.12089346.html.plaintext.txt	279	Cancer Lett 15419 27CrossRefMedline Sladek FM Ruse MD Nepomuceno L Huang S M Stallcup MR 1999 Modulation transcriptional activation co activator interaction splicing variation F domain nuclear receptor hepatocyte nuclear factor 41
0.2994644.12089346.html.plaintext.txt	280	Mol Cell Biol 196509 6522AbstractFree Full Text Dell H Hadzopoulou Cladaras M 1999 CREB binding protein transcriptional coactivator hepatocyte nuclear factor 4 enhances apolipoprotein gene expression
0.2994644.12089346.html.plaintext.txt	281	J Biol Chem 2749013 9021AbstractFree Full Text Wang JC Stafford JM Granner DK 1998 SRC 1 GRIP1 coactivate transcription hepatocyte nuclear factor 4
0.2994644.12089346.html.plaintext.txt	282	J Biol Chem 27330847 30850AbstractFree Full Text Green VJ Kokkotou E Ladias JAA 1998 Critical structural elements multitarget protein interactions transcriptional activator AF 1 hepatocyte nuclear factor 4
0.2994644.12089346.html.plaintext.txt	283	J Biol Chem 27329950 29957AbstractFree Full Text Yoshida E Aratani S Itou H Miyagishi M Takiguchi M Osumu T Murakami K Fukamizu A 1997 Functional association CBP HNF4 trans activation
0.2994644.12089346.html.plaintext.txt	284	Biochem Biophys Res Comm 241664 669CrossRefMedline Rachez C Suldan Z Ward J Chang CP Burakov D Erdjument Bromage H Tempst P Freedman LP 1998 A novel protein complex interacts vitamin D3 receptor ligand dependent manner enhances VDR transactivation cell free system
0.2994644.12089346.html.plaintext.txt	285	Genes Dev 121787 1800AbstractFree Full Text Rachez C Lemon BD Suldan Z Bromleigh V Gamble M Naar AM Erdjument Bromage H Tempst P Freedman LP 1999 Ligand dependent transcription activation nuclear receptors requires DRIP complex
0.2994644.12089346.html.plaintext.txt	286	Nature 398824 828CrossRefMedline Atkins GB Hu X Guenther MG Rachez C Freedman LP Lazar MA 1999 Coactivators orphan nuclear receptor ROR
0.2994644.12089346.html.plaintext.txt	287	Mol Endocrinol 131550 1557AbstractFree Full Text Shao W Rosenauer A Mann K Chang CP Rachez C Freedman LP Miller Jr WH 2000 Ligand inducible interaction DRIPTRAP coactivator complex retinoid receptors retinoic acid sensitive resistant acute promyelocytic leukemia cells
0.2994644.12089346.html.plaintext.txt	288	Blood 962233 2239AbstractFree Full Text Burakov D Wong CW Rachez C Cheskis BJ Freedman LP 2000 Functional interactions estrogen receptor DRIP205 subunit heteromeric DRIP coactivator complex
0.2994644.12089346.html.plaintext.txt	289	J Biol Chem 27520928 20934AbstractFree Full Text Fondell JD Ge H Roeder RG 1996 Ligand induction transcriptionally active thyroid hormone receptor coactivator complex
0.2994644.12089346.html.plaintext.txt	290	Proc Natl Acad Sci USA 938329 8333AbstractFree Full Text Blanco JC Minucci S Lu J Yang XJ Walker KK Chen H Evans RM Nakatani Y Ozato K 1998 The histone acetylase PCAF nuclear receptor coactivator
0.2994644.12089346.html.plaintext.txt	291	Genes Dev 121638 1651AbstractFree Full Text Puigserver P Wu Z Park CW Graves R Wright M Spiegelman BM 1998 A cold inducible coactivator nuclear receptors linked adaptive thermogenesis
0.2994644.12089346.html.plaintext.txt	292	Cell 92829 839Medline Pegg AE McCann PP 1982 Polyamine metabolism function
0.2994644.12089346.html.plaintext.txt	293	Am J Physiol 243C212 C221 Lemon BD Freedman LP 1999 Nuclear receptor cofactors chromatin remodelers
0.2994644.12089346.html.plaintext.txt	294	Curr Opin Genet Dev 9499 504CrossRefMedline Sharma D Fondell JD 2000 Temporal formation distinct thyroid hormone receptor coactivator complexes HeLa cells
0.2994644.12089346.html.plaintext.txt	295	Mol Endocrinol 142001 2009AbstractFree Full Text Igarashi K Kashiwagi K 2000 Polyamines mysterious modulators cellular functions
0.2994644.12089346.html.plaintext.txt	296	Biochem Biophys Res Commun 271559 564CrossRefMedline Cohen SS 1998 A guide polyamines
0.2994644.12089346.html.plaintext.txt	297	New York Oxford University Press Tabor CW Tabor H 1984 Polyamines
0.2994644.12089346.html.plaintext.txt	298	Annu Rev Biochem 53749 790CrossRefMedline Pollard KJ Samuels ML Crowley KA Hansen JC Peterson CL 1999 Functional interaction GCN5 polyamines new role core histone acetylation
0.2994644.12089346.html.plaintext.txt	299	EMBO J 185622 5633AbstractFree Full Text Hobbs CA Gilmour SK 2000 High levels intracellular polyamines promote histone acetyltransferase activity resulting chromatin hyperacetylation
0.2994644.12089346.html.plaintext.txt	300	CO2 P Malley B Spiegelman BM 1999 Activation PPAR coactivator 1 transcription factor docking
0.2994644.12089346.html.plaintext.txt	301	Science 2861368 1371AbstractFree Full Text Maeda Y Seidel SD Wei G Liu X Sladek FM 2002 Repression hepatocyte nuclear factor 4 tumor suppressor p53 involvement ligand binding domain histone deacetylase activity
0.2994644.12089346.html.plaintext.txt	302	Mol Endocrinol 16402 410AbstractFree Full Text Ding XF Anderson CM Ma H Hong H Uht RM Kushner PJ Stallcup MR 1998 Nuclear receptor binding sites coactivators glucocorticoid receptor interacting protein 1 GRIP1 steroid receptor coactivator 1 SRC 1 multiple motifs different binding specificities
0.2994644.12089346.html.plaintext.txt	303	Mol Endocrinol 12302 313AbstractFree Full Text Gilbert RS Gonzalez GG Hawel III L Byus CV 1991 An ion exchange chromatography procedure isolation concentration basic amino acids polyamines complex biological samples prior high performance liquid chromatography
0.2994644.12089346.html.plaintext.txt	304	Anal Biochem 19986 92Medline Chiba N Suldan Z Freedman LP Parvin JD 2000 Binding liganded vitamin D receptor vitamin D receptor interacting protein coactivator complex induces interaction RNA polymerase II holoenzyme
0.2994644.12089346.html.plaintext.txt	305	J Biol Chem 27510719 10722AbstractFree Full Text Thomas T Shah N Klinge CM Faaland CA Adihkarakunnathu S Gallo MA Thomas TJ 1999 Polyamine biosynthesis inhibitors alter protein protein interactions involving estrogen receptor MCF 7 breast cancer cells
0.2994644.12089346.html.plaintext.txt	306	J Mol Endocrinol 22131 139AbstractFree Full Text Sladek FM Zhong W Lai E Darnell JE 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.2994644.12089346.html.plaintext.txt	307	Genes Dev 42353 2365Abstract
0.43481085.9514150.html.plaintext.txt	0	Identification Critical Residues Heterodimerization within Ligand Binding Domain Retinoid X Receptor Soo Kyung Lee Soon Young Na Han Jong Kim Jaemog Soh Hueng Sik Choi Jae Woon Lee
0.43481085.9514150.html.plaintext.txt	1	L Chonnam National University Kwangju 500 757 Korea
0.43481085.9514150.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Nuclear receptors regulate transcription binding specific DNA response elements homodimers heterodimers retinoid X receptors RXRs
0.43481085.9514150.html.plaintext.txt	3	The identity box I box 40 amino acid region within ligand binding domains RXRs nuclear receptors recently shown determine identity heterodimeric interactions
0.43481085.9514150.html.plaintext.txt	4	Here dissected region yeast two hybrid system analyzing series chimeric receptors human RXR rat hepatocyte nuclear factor 4 HNF4 distinct member nuclear receptor superfamily prefers homodimerization
0.43481085.9514150.html.plaintext.txt	5	We found C terminal 11 amino acid region RXR I box sufficient direct chimeric receptors based HNF4 ligand binding domain heterodimerize retinoic acid receptors thyroid hormone receptors
0.43481085.9514150.html.plaintext.txt	6	Furthermore identified hRXR amino acids A416 R421 11 amino acid subregion critical determinants heterodimeric interactions
0.43481085.9514150.html.plaintext.txt	7	mutant HNF4s incorporating hRXR A416 R421 heterodimerized retinoic acid receptor
0.43481085.9514150.html.plaintext.txt	8	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The nuclear receptor superfamily group transcriptional regulatory proteins linked conserved structure function 1
0.43481085.9514150.html.plaintext.txt	9	The superfamily includes receptors variety small hydrophobic ligands steroids T3 retinoids well large number related proteins known ligands referred orphan nuclear receptors 2
0.43481085.9514150.html.plaintext.txt	10	The receptor proteins direct regulators transcription function binding specific DNA sequences named hormone response elements HREs promoters target genes
0.43481085.9514150.html.plaintext.txt	11	Nearly superfamily members bind dimers DNA elements
0.43481085.9514150.html.plaintext.txt	12	While apparently bind homodimers thyroid hormone receptors TRs vitamin D receptor VDR retinoic acid receptors RARs peroxisome proliferator activated receptor several orphan nuclear receptors bind specific response elements high affinity heterodimers retinoid X receptors RXRs 3 4 5 6 7 8
0.43481085.9514150.html.plaintext.txt	13	Based high affinity binding heterodimers considered functionally active forms receptors vivo
0.43481085.9514150.html.plaintext.txt	14	These heterodimers display distinct HRE specificities mediate hormonal responsiveness target gene transcription distinct HREs comprised direct repeats DRs common half site variable spacing repeats playing critical role mediating specificity 2 9
0.43481085.9514150.html.plaintext.txt	15	Accordingly RARs activate preferentially DRs spaced two five nucleotides whereas VDR TR activate DRs spaced three four nucleotides respectively
0.43481085.9514150.html.plaintext.txt	16	RXR peroxisome proliferator activated receptor heterodimers well RXR homodimers activate preferentially DRs spaced one nucleotide referred DR1
0.43481085.9514150.html.plaintext.txt	17	In addition DRs response elements composed palindromes well inverted palindromes referred everted repeats ER shown mediate transcriptional activation RXR RAR RXR TR heterodimeric complexes 9
0.43481085.9514150.html.plaintext.txt	18	Such DNA binding flexibility stands contrast steroid hormone receptors bind exclusively homodimers inverted repeats IR spaced three nucleotides 10
0.43481085.9514150.html.plaintext.txt	19	Some orphan nuclear receptors bind DNA homodimers
0.43481085.9514150.html.plaintext.txt	20	In contrast steroid receptor homodimers orphan receptor homodimers bind palindromic DR response elements
0.43481085.9514150.html.plaintext.txt	21	In particular hepatocyte nuclear factor 4 HNF4 binds homodimer DR1 strong constitutive transcriptional activator 11
0.43481085.9514150.html.plaintext.txt	22	In contrast HNF4 homodimers chicken ovalbumin upstream promoter transcription factors COUP TFs EAR2 EAR3 ARP1 potent dominant repressors basal transcription transactivation several receptors including RXR RAR VDR TR 12
0.43481085.9514150.html.plaintext.txt	23	Repression pathways COUP TF believed accomplished part direct competitive binding presence strong carboxy terminal repressor domain 13
0.43481085.9514150.html.plaintext.txt	24	Interestingly COUP TF ability heterodimerize RXR thereby titrating RXR transcriptionally inactive complex 14
0.43481085.9514150.html.plaintext.txt	25	A dimerization interface previously identified within DNA binding domains DBDs RXRs RARs VDR TRs selectively promotes DNA binding cognate direct repeat HREs 15 16 17 18 19 20
0.43481085.9514150.html.plaintext.txt	26	An additional dimerization interface mediates cooperative binding DNA referred I box recently mapped 40 amino acid region within carboxy terminal ligand binding domains LBDs RAR TR COUP TF RXR 21
0.43481085.9514150.html.plaintext.txt	27	In contrast interface within DBDs dimerization motif promotes cooperative binding similar efficiency three classes repeats DR IR ER
0.43481085.9514150.html.plaintext.txt	28	The two dimerization domains appear work sequence led two step hypothesis binding heterodimers DNA 2 21
0.43481085.9514150.html.plaintext.txt	29	Accordingly LBD dimerization interface initiates formation solution heterodimers turn acquire capacity bind number differently organized repeats
0.43481085.9514150.html.plaintext.txt	30	However formation second dimer interface within DBD restricts receptors bind DRs
0.43481085.9514150.html.plaintext.txt	31	The I box sequences fairly well conserved among subset nuclear receptors including HNF4 member homodimer subclass 11
0.43481085.9514150.html.plaintext.txt	32	This led us test whether I box region HNF4 plays similar role homodimeric interactions importantly determine whether differences I box sequences contribute preferences HNF4 homodimerization RXR heterodimerization
0.43481085.9514150.html.plaintext.txt	33	To answer questions without complications associated HRE binding dimerization interface within DBDs exploited yeast two hybrid system LBDs nuclear receptors fused either DNA binding domain bacterial repressor LexA B42 transcriptional activation domain previously described 22 23 24
0.43481085.9514150.html.plaintext.txt	34	In report HNF4 I box found sufficient homodimeric interactions
0.43481085.9514150.html.plaintext.txt	35	In addition 11 amino acid subregion within RXR I box found essential heterodimeric interactions
0.43481085.9514150.html.plaintext.txt	36	From mutational analyses RXR amino acids A416 R421 11 amino acid subregion also identified particularly critical determinants heterodimeric interactions
0.43481085.9514150.html.plaintext.txt	37	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The HNF4 I Box Is Sufficient Mediate Homodimeric Interactions To characterize dimerization properties nuclear receptors exploited yeast two hybrid system previously described 22 23 24
0.43481085.9514150.html.plaintext.txt	38	In host strain used system expression ss galactosidase ss Gal controlled upstream LexA DNA binding sites operators
0.43481085.9514150.html.plaintext.txt	39	Thus yeast strain depends transcriptional activation LexA protein expression ss Gal
0.43481085.9514150.html.plaintext.txt	40	A series nuclear receptors fused full length LexA repressor B42 transactivation domain
0.43481085.9514150.html.plaintext.txt	41	As previously described 23 24 LexA fusions nuclear receptors transcriptionally inactive yeast
0.43481085.9514150.html.plaintext.txt	42	Protein protein interactions nuclear receptors however bring B42 transactivation domain LexA sites activate expression ss Gal construct
0.43481085.9514150.html.plaintext.txt	43	The LexA portion chimeras contains dimerization domain directs high affinity binding LexA operators dimer regardless status dimerization nuclear receptors
0.43481085.9514150.html.plaintext.txt	44	Therefore important merit system fact dimerization properties nuclear receptors directly assessed without complications associated HRE binding
0.43481085.9514150.html.plaintext.txt	45	However noted exact nature interactions instance dimer vs
0.43481085.9514150.html.plaintext.txt	46	A dimerization interface referred I box recently mapped 40 amino acid region within carboxy terminal LBDs RAR TR COUP RXR 21
0.43481085.9514150.html.plaintext.txt	47	The I box sequences moderately conserved among subset nuclear receptors including homodimerizing HNF4 leading us test whether HNF4 I box region plays similar role homodimeric interactions
0.43481085.9514150.html.plaintext.txt	48	To end constructed series chimeras HNF4 RXR
0.43481085.9514150.html.plaintext.txt	49	PCR used construct B42HNF chimeric protein consisting B42 transactivation domain fused entire hinge LBDs D E F amino acids 106 455 rat HNF4 Fig
0.43481085.9514150.html.plaintext.txt	50	Chimeric receptors B42HX 298389 B42HX 338429 B42X HHH B42H XXX B42XH 428339 similarly constructed Fig
0.43481085.9514150.html.plaintext.txt	51	Western blot analyses executed confirm expression levels mutants constructed comparable data shown
0.43481085.9514150.html.plaintext.txt	52	LexAHNF4 showed constitutive transcriptional activity yeast approximately 3
0.43481085.9514150.html.plaintext.txt	53	5 fold higher LexA alone data shown
0.43481085.9514150.html.plaintext.txt	54	1B coexpression B42HNF led approximately 5
0.43481085.9514150.html.plaintext.txt	55	5 fold enhancement constitutive activity faithfully reflecting HNF4 HNF4 homodimeric interactions yeast system
0.43481085.9514150.html.plaintext.txt	56	Furthermore coexpression B42HX 338429 B42X HHH led approximately 4 7 fold enhancements transcriptional activity LexAHNF4 respectively
0.43481085.9514150.html.plaintext.txt	57	In contrast RXR I box could substitute HNF4 I box homodimeric interactions shown inabilities B42HX 298389 B42H XXX B42XH 428339 enhance transcriptional activity LexAHNF4
0.43481085.9514150.html.plaintext.txt	58	These results demonstrate HNF4 I box indeed sufficient transferable interaction interface homodimeric interactions
0.43481085.9514150.html.plaintext.txt	59	View larger version 34K Figure 1
0.43481085.9514150.html.plaintext.txt	60	The I box Directs Specificity Dimerization
0.43481085.9514150.html.plaintext.txt	61	A Schematic diagrams chimeric nuclear receptors
0.43481085.9514150.html.plaintext.txt	62	Diagram shows chimeras containing indicated amino acids derived RXR open HNF4 stippled I box domains highlighted dotted RXR hatched HNF4
0.43481085.9514150.html.plaintext.txt	63	Numbers refer amino acid boundaries receptor fragments consisting hinge ligand binding DE domains I box domain C terminal F domain
0.43481085.9514150.html.plaintext.txt	64	B Dimerization probed yeast two hybrid system
0.43481085.9514150.html.plaintext.txt	65	Host cells ss galactosidase expression dependent presence transcriptional activator LexA DBD transformed plasmids expressing indicated LexA B42 chimeras grown liquid culture containing galactose since expression B42 chimeras control galactose inducible GAL1 promoter 22
0.43481085.9514150.html.plaintext.txt	66	ss Galactosidase readings determined corrected cell density time development A415 nmA600 nm x 1000min
0.43481085.9514150.html.plaintext.txt	67	Fold activations B42 chimera calculated defining reporter activity presence B42 1
0.43481085.9514150.html.plaintext.txt	68	The result average least six different experiments SDs less 5
0.43481085.9514150.html.plaintext.txt	69	As expected B42RXR able interact LexARAR LexATR Fig
0.43481085.9514150.html.plaintext.txt	70	1B similar results observed chimeric receptors containing RXR I box sequences B42HX 298389 B42H XXX B42XH 428339 Fig
0.43481085.9514150.html.plaintext.txt	71	In interactions LexARAR includes full length RAR contrast LexATR LexA chimeras consisting LBDs shows higher ss Gal activities LexATR probably due AF1 activation domain RAR AB domains 25
0.43481085.9514150.html.plaintext.txt	72	Since LexATR LexARAR show similar basal activities yeast difference results higher fold activations LexARAR LexATR
0.43481085.9514150.html.plaintext.txt	73	For instance coexpression B42RXR conferred approximately 44 fold activation LexARAR approximately 11 fold activation LexATR Fig
0.43481085.9514150.html.plaintext.txt	74	It noteworthy incorporation RXR I box sequences conferred resulting chimera ability heterodimerize RAR TR Fig
0.43481085.9514150.html.plaintext.txt	75	1B compare interactions B42HNF B42H XXX
0.43481085.9514150.html.plaintext.txt	76	Thus conclude RXR I box indeed transferable interaction interface heterodimerization reported previously 21
0.43481085.9514150.html.plaintext.txt	77	Localization Critical Region RXR I Box Heterodimerization As shown Fig
0.43481085.9514150.html.plaintext.txt	78	2 high degree sequence homology RXR I box HNF4 I box sequences
0.43481085.9514150.html.plaintext.txt	79	Nevertheless HNF4 I box directs homodimerization RXR I box directs heterodimerization 21
0.43481085.9514150.html.plaintext.txt	80	Thus set dissect RXR I box region identify sequences critical heterodimerization sequentially transferring part RXR I box sequences corresponding regions HNF4 vice versa
0.43481085.9514150.html.plaintext.txt	81	View larger version 23K Figure 2
0.43481085.9514150.html.plaintext.txt	82	Amino Acid Sequences I Box Region
0.43481085.9514150.html.plaintext.txt	83	The I box regions USP amino acids 429 468 human RXR amino acids 389 428 rat HNF4 amino acids 299 338 shown
0.43481085.9514150.html.plaintext.txt	84	Helix 9 H9 helix 10 H10 recently shown constitute interaction interface crystal structure RXR LBD 27 well three C terminal 7 8 9 nine heptad repeats previously shown involved dimerization 30 32 indicated
0.43481085.9514150.html.plaintext.txt	85	Sequence homology determined NIH BLAST program indicated sequences two receptors indicates conservative changes
0.43481085.9514150.html.plaintext.txt	86	Amino acids conserved USP RXR HNF4 shaded
0.43481085.9514150.html.plaintext.txt	87	Three artificial blocks designated facilitate subsequent chimera constructions boxed
0.43481085.9514150.html.plaintext.txt	88	Examination I box sequences reveals high level conservation RXR Drosophila counterpart ultraspiracle USP 26 heterodimerizes many different members superfamily
0.43481085.9514150.html.plaintext.txt	89	Therefore amino acids I box critical heterodimerization conserved RXR USP Fig
0.43481085.9514150.html.plaintext.txt	90	To facilitate analyses artificially divided I box region three separate subregions containing two four residues conserved betwen RXR USP HNF4 shaded Fig
0.43481085.9514150.html.plaintext.txt	91	These subregions sequentially exchanged B42HNF B42XH 428339 resulting series eight B42 fusion constructs shown Fig
0.43481085.9514150.html.plaintext.txt	92	Western blot analyses executed confirm expression levels mutants constructed comparable data shown
0.43481085.9514150.html.plaintext.txt	93	View larger version 39K Figure 3
0.43481085.9514150.html.plaintext.txt	94	An 11 Amino Acid Subregion RXR I Box Directs Heterodimeric Interactions
0.43481085.9514150.html.plaintext.txt	95	A Schematic diagrams chimeric nuclear receptors
0.43481085.9514150.html.plaintext.txt	96	Diagram shows chimeras containing indicated amino acids derived RXR dotted HNF4 hatched
0.43481085.9514150.html.plaintext.txt	97	Three smaller areas stippled around three blocks subjected exchanges identical RXR HNF4 shown Fig
0.43481085.9514150.html.plaintext.txt	98	B Dimerization properties chimera LexAHNF4 LexATR LexARAR probed yeast two hybrid system described Fig
0.43481085.9514150.html.plaintext.txt	99	Fold activations B42 chimera calculated defining reporter activity presence B42 1
0.43481085.9514150.html.plaintext.txt	100	The result average least six different experiments SDs less 5
0.43481085.9514150.html.plaintext.txt	101	3B two things evident analyses chimeric receptors yeast two hybrid system 22 23 24
0.43481085.9514150.html.plaintext.txt	102	First none chimeric receptors able enhance constitutive transcriptional activities LexAHNF4 demonstrating substitution HNF4 subregions RXR I box blocked homodimerization
0.43481085.9514150.html.plaintext.txt	103	This suggests important residues homodimeric interactions present throughout entire HNF4 I box
0.43481085.9514150.html.plaintext.txt	104	Second C terminal 11 amino acid subregion RXR I box sufficient direct chimeric receptors heterodimerize RARs TRs
0.43481085.9514150.html.plaintext.txt	105	B42H HHX B42X HHX B42H XHX B42X XHX efficiently interacted LexARAR LexATR Fig
0.43481085.9514150.html.plaintext.txt	106	Identification Critical Amino Acids Responsible Heterodimerization As shown Fig
0.43481085.9514150.html.plaintext.txt	107	4 11 amino acid subregion RXR identical HNF4 exception five residues RXR A416 K417 R421 A424 R426
0.43481085.9514150.html.plaintext.txt	108	Among RXR K417 A424 R426 indicated arrowheads Fig
0.43481085.9514150.html.plaintext.txt	109	4 conserved changes HNF4
0.43481085.9514150.html.plaintext.txt	110	HNF4 glutamic acid threonine glutamine HNF4 E327 T334 Q336 positions
0.43481085.9514150.html.plaintext.txt	111	However RXR A416 R421 shaded Fig
0.43481085.9514150.html.plaintext.txt	112	4 conserved USP nonconserved changes HNF4
0.43481085.9514150.html.plaintext.txt	113	HNF4 glycine leucine HNF4 G326 L331 positions
0.43481085.9514150.html.plaintext.txt	114	In contrast COUP TFs glycine arginine RARs TRs proline lysine positions Fig
0.43481085.9514150.html.plaintext.txt	115	Accordingly two residues identified primary candidates determining heterodimerizing properties RXR I box subjected mutational analyses
0.43481085.9514150.html.plaintext.txt	116	View larger version 21K Figure 4
0.43481085.9514150.html.plaintext.txt	117	Amino Acid Sequences 11 Amino Acid Subregion Various Receptors
0.43481085.9514150.html.plaintext.txt	118	Rat HNF4 amino acids 326 336 human RXR amino acids 416 426 USP amino acids 456 466 human COUP TF amino acids 363 373 human RAR amino acids 375 385 rat TRss amino acids 419 429 shown
0.43481085.9514150.html.plaintext.txt	119	Two amino acids subregion conserved USP RXR HNF4 shaded
0.43481085.9514150.html.plaintext.txt	120	Three amino acids conserved changes RXR HNF4 indicated open arrows
0.43481085.9514150.html.plaintext.txt	121	5A introduced series point mutations 11 amino acid subregion context HNF4 resulting three quadruple mutants AR AR AR KR AR KA three triple mutants AR K AR A AR R two double mutants AR PR three single mutants A326 P326 R331
0.43481085.9514150.html.plaintext.txt	122	Interactions point mutants LexAHNF4 largely unaffected among single double triple mutants exception AR K shown Fig
0.43481085.9514150.html.plaintext.txt	123	All quadruple mutants able interact LexAHNF4 Fig
0.43481085.9514150.html.plaintext.txt	124	In contrast quadruple mutants AR KA AR KR showed relatively strong interactions LexARAR Fig
0.43481085.9514150.html.plaintext.txt	125	Quaduple mutant AR AR triple mutants double mutant AR surprisingly two single mutants A326 R331 also able interact LexARAR
0.43481085.9514150.html.plaintext.txt	126	These interactions relatively weak highly specific mutants show interactions LexAGR either presence absence ligand deoxycortisol data shown
0.43481085.9514150.html.plaintext.txt	127	Addition RAR ligands trans retinoic acid 9 cis retinoic acid affect interactions data shown
0.43481085.9514150.html.plaintext.txt	128	The inherently weaker interactions LexATR heterodimerizing chimeras however evident point mutants
0.43481085.9514150.html.plaintext.txt	129	In contrast expected RAR based mutations P326 PR incorporate P326 R331 able stimulate ss galactosidase activities B42HNF coexpressed LexARAR Fig
0.43481085.9514150.html.plaintext.txt	130	Western blot analyses executed confirm expression levels mutants tested indeed comparable Fig
0.43481085.9514150.html.plaintext.txt	131	View larger version 25K Figure 5
0.43481085.9514150.html.plaintext.txt	132	Point Mutants 11 Amino Acid Subregion HNF4
0.43481085.9514150.html.plaintext.txt	133	A The HNF4 G326 E327 L331 T334 Q336 subjected point mutagenesis indicated conserved changes open arrows nonconserved changes closed arrows determined NIH BLAST program
0.43481085.9514150.html.plaintext.txt	134	All point mutants identical B42HNF except indicated amino acid changes
0.43481085.9514150.html.plaintext.txt	135	Dashed positions identical HNF4 residues
0.43481085.9514150.html.plaintext.txt	136	B Dimerization properties point mutants LexAHNF LexARAR probed yeast two hybrid system described Fig
0.43481085.9514150.html.plaintext.txt	137	All point mutants identical B42HNF except indicated amino acid changes
0.43481085.9514150.html.plaintext.txt	138	Fold activations B42 chimera calculated defining reporter activity presence B42 1
0.43481085.9514150.html.plaintext.txt	139	The result average least six different experiments SDs less 5
0.43481085.9514150.html.plaintext.txt	140	C Western blot analysis yeast strain EGY48 transformed plasmids encoding indicated B42 chimeras executed described 23
0.43481085.9514150.html.plaintext.txt	141	All point mutants identical B42HNF except indicated amino acid changes
0.43481085.9514150.html.plaintext.txt	142	Equivalent amounts 10 microg crude extracts samples well null extracts examined using antibody directed Flu tag described previously 22
0.43481085.9514150.html.plaintext.txt	143	To confirm interactions observed yeasts incubated glutathione S transferase GST alone GST HNF GST RXR GST H HHX GST AR GST A326 GST R331 TR LBD labeled 35Smethionine vitro translation
0.43481085.9514150.html.plaintext.txt	144	All point mutants identical GST HNF except indicated amino acid changes
0.43481085.9514150.html.plaintext.txt	145	6 TR LBD bound specifically GST RXR GST H HHX GST HNF GST alone independently confirming yeast results
0.43481085.9514150.html.plaintext.txt	146	In addition TR LBD able show relatively week specific binding GST AR GST A326 GST R331
0.43481085.9514150.html.plaintext.txt	147	In yeasts weak interactions evident LexARAR Fig
0.43481085.9514150.html.plaintext.txt	148	5 probably due AF1 activation domain AB domains 25
0.43481085.9514150.html.plaintext.txt	149	As expected luciferase labeled 35Smethionine interacted none GST proteins
0.43481085.9514150.html.plaintext.txt	150	Similar results also obtained RAR LBD labeled 35Smethionine data shown
0.43481085.9514150.html.plaintext.txt	151	Overall results along yeast results indicate RXR amino acids A416 R421 critical determine identity heterodimeric interactions
0.43481085.9514150.html.plaintext.txt	152	View larger version 35K Figure 6
0.43481085.9514150.html.plaintext.txt	153	Luciferase TR LBD labeled 35Smethionine vitro translation incubated glutathione beads containing GST alone GST fusions HNF4 LBD GSTHNF RXR LBD GSTRXR H HHX GSTH HHX A326 GST A326 R331 GSTR331 AR GSTAR
0.43481085.9514150.html.plaintext.txt	154	All point mutants identical HNF4 LBD except indicated amino acid changes
0.43481085.9514150.html.plaintext.txt	155	Beads washed specifically bound material eluted reduced glutathione resolved SDS PAGE
0.43481085.9514150.html.plaintext.txt	156	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES A dimerization interface identified within DNA binding domains DBDs RXRs RARs VDR TRs selectively promote DNA binding cognate direct repeat HREs 15 16 17 18 19 20
0.43481085.9514150.html.plaintext.txt	157	Another dimerization interface referred I box recently mapped transferable 40 amino acid region within carboxy terminal LBDs RAR TR COUP TF RXR mediates cooperative binding DNA 21
0.43481085.9514150.html.plaintext.txt	158	In contrast interface within DBDs dimerization motif promotes cooperative binding similar efficiency three classes repeats DR IR ER
0.43481085.9514150.html.plaintext.txt	159	In recently described crystal structure RXR LBD 27 rotationally symmetrical dimerization interface formed mainly helix 10 H10 lesser extent helix 9 H9 loop helix 7 H7 helix 8 H8
0.43481085.9514150.html.plaintext.txt	160	The I box nicely overlaps H9 H10 Fig
0.43481085.9514150.html.plaintext.txt	161	2 whose sequences well conserved among subset nuclear receptors including HNF4 11 COUP TF 12 prefer homodimerize
0.43481085.9514150.html.plaintext.txt	162	In addition crystal structures RAR TR LBDs 28 29 demonstrate I box regions adopt structure similar RXR 27 overall common fold summarized helical antiparallel sandwich composed 12 helices H1 H12
0.43481085.9514150.html.plaintext.txt	163	As expected common fold conservation I box sequences HNF4 I box expected play important role HNF4 HNF4 interactions
0.43481085.9514150.html.plaintext.txt	164	1 HNF4 I box region indeed sufficient homodimeric interactions see results B42HX 338429 B42X HHH Fig
0.43481085.9514150.html.plaintext.txt	165	However residues critical homodimerization clearly different heterodimerization since HNF4 HNF4 interactions affected HNF4 point mutations replacing two residues found critical heterodimeric interactions Fig
0.43481085.9514150.html.plaintext.txt	166	One potential explanation inability B42H HHX similar mutants shown Fig
0.43481085.9514150.html.plaintext.txt	167	3 interact LexAHNF4 overall structure chimeras disrupted
0.43481085.9514150.html.plaintext.txt	168	However ruled ability chimeras interact LexARAR Fig
0.43481085.9514150.html.plaintext.txt	169	The results described define 11 amino acid subregion I box major determinant dimerization specificity
0.43481085.9514150.html.plaintext.txt	170	This consistent fact subregion contained within H10 Fig
0.43481085.9514150.html.plaintext.txt	171	2 major interface recently described crystal structure RXR LBD 27 overlaps heptad 9 previously shown critical homo heterodimerization RXR 30 31 32
0.43481085.9514150.html.plaintext.txt	172	We also found chimeric RAR construct containing RXR 11 amino acid subregion readily interacted RAR lending support importance subregion heterodimeric interactions unpublished results
0.43481085.9514150.html.plaintext.txt	173	Within subregion RXR amino acids A416 R421 particularly critical consistent fact two residues conserved RXR USP homodimerizing HNF4
0.43481085.9514150.html.plaintext.txt	174	4 HNF4 glycine leucine COUP TF glycine arginine positions respectively
0.43481085.9514150.html.plaintext.txt	175	In contrast RAR TR heterodimeric partners RXR proline lysine positions
0.43481085.9514150.html.plaintext.txt	176	As expected mutant HNF4s incorporating RXR A416 R421 heterodimerized RAR
0.43481085.9514150.html.plaintext.txt	177	However HNF4 point mutants constructed showed distinct interactions different receptors
0.43481085.9514150.html.plaintext.txt	178	R331 resembles COUP TF two target positions weakly interacted LexARXR data shown consistent recent finding COUP TF shown ability heterodimerize RXR 14
0.43481085.9514150.html.plaintext.txt	179	In contrast PR resembles RAR TR positions interact LexARXR data shown
0.43481085.9514150.html.plaintext.txt	180	Similarly AR RXR sequences two positions interacted less efficiently LexARAR single mutants A326 R331 Fig
0.43481085.9514150.html.plaintext.txt	181	Overall results suggest two residues RXR A416 R421 clearly important identity heterodimerization
0.43481085.9514150.html.plaintext.txt	182	Finally noted changes two residues alone sufficient switch specificity dimeric interactions
0.43481085.9514150.html.plaintext.txt	183	homodimerization heterodimerization
0.43481085.9514150.html.plaintext.txt	184	The change specificity dimerization achieved least three mutations incorporated shown AR K weakly interacts LexARAR LexAHNF Fig
0.43481085.9514150.html.plaintext.txt	185	Similarly quadruple mutants changed specificity dimerization Fig
0.43481085.9514150.html.plaintext.txt	186	5B compare results LexAHNF4 LexARAR
0.43481085.9514150.html.plaintext.txt	187	It also noteworthy effects substitutions corresponding RXR sequences heterodimerizing potential resulting HNF4 chimeras largely accumulative
0.43481085.9514150.html.plaintext.txt	188	A326 R331 AR AR K AR A AR R AR AR show relatively weak fold activations LexARAR 3 7 fold shown Fig
0.43481085.9514150.html.plaintext.txt	189	5B quadruple mutants AR KR AR KA well quintuple mutant B42H HHX Fig
0.43481085.9514150.html.plaintext.txt	190	3B incorporates five RXR amino acids 11 amino acid subregion showed much stronger fold activations LexARAR 23 21 43 fold activations respectively
0.43481085.9514150.html.plaintext.txt	191	Accordingly identity seems determined context overall structures relation neighboring residues rather solely nature two residues
0.43481085.9514150.html.plaintext.txt	192	In addition interesting test effects identified mutations context full length receptors
0.43481085.9514150.html.plaintext.txt	193	In conclusion identified 11 amino acid subregion RXR I box critical domain heterodimeric interactions specifically identified two residues subregion determinants heterodimerization
0.43481085.9514150.html.plaintext.txt	194	Recently introduced random mutations two residues RXR effort make mutant RXR selective process heterodimerization
0.43481085.9514150.html.plaintext.txt	195	Consistent importance residues heterodimerization indeed able find series mutant RXRs significantly altered specificity S
0.43481085.9514150.html.plaintext.txt	196	To understand detail two residues fit overall structure I box nuclear receptor direct specificity dimerization mutational studies well structural information required
0.43481085.9514150.html.plaintext.txt	197	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Hormones Deoxycortisol 9 cis retinoic acid trans retinoic acid obtained Sigma Chemical Co St
0.43481085.9514150.html.plaintext.txt	198	Yeast Cells Plasmids Expressions EGY48 cells MATleu2 his3 trp1 ura3 LEU2pLexA op6 LEU2UASLEU2 lexA ss galactosidase reporter construct LexA B42 parental vectors reported 22
0.43481085.9514150.html.plaintext.txt	199	LexA B42 fusions full length RAR LBDs GR RXR HNF4 TR previously described 23 24
0.43481085.9514150.html.plaintext.txt	200	Two subsequent PCR steps according strategy described 33 employed following plasmid constructions using Vent Polymerase New England Biolabs Beverly MA capable proofreading minimize unwanted mutations
0.43481085.9514150.html.plaintext.txt	201	A forward vector primer B42 primer 5 GCC TCC TAC CCT TAT GAT 3 plus reverse mutagenic primer 5 CTT GAT CTT CCC GGG GTC ACT CAG 3 forward mutagenic primer 5 CTG AGT GAC CCC GGG AAG ATC AAG 3 plus reverse vector primer ADH primer 5 GAC AAG CCG ACA ACC 3 used amplify B42HNF wild type template DNA annealing temperature 55 C
0.43481085.9514150.html.plaintext.txt	202	Both PCR products mixed equal molar ratio amplified using B42 ADH vector primers
0.43481085.9514150.html.plaintext.txt	203	Accordingly B42HNF includes SmaI site upstream HNF4 I box codons amino acids Pro 296 CCA Gly 297 GGC silently changed CCC Pro GGG Gly facilitate subclonings
0.43481085.9514150.html.plaintext.txt	204	B42HX 298389 encodes rat HNF4 amino acids 106 298 followed human RXR amino acids 389 462 C terminus
0.43481085.9514150.html.plaintext.txt	205	Similarly B42HX 338429 encodes HNF4 amino acids 106 338 followed RXR amino acids 429 462 C terminus
0.43481085.9514150.html.plaintext.txt	206	B42X HHH identical B42RXR except RXR amino acids 389 428 replaced HNF4 amino acids 299 338
0.43481085.9514150.html.plaintext.txt	207	B42H XXX identical B42HNF except HNF4 amino acids 299 338 replaced RXR amino acids 389 428
0.43481085.9514150.html.plaintext.txt	208	B42XH 428339 encodes RXR amino acids 198 428 followed HNF4 amino acids 339 455 C terminus
0.43481085.9514150.html.plaintext.txt	209	B42H XHH identical B42HNF except HNF4 amino acids 299 308 replaced RXR amino acids 389 398
0.43481085.9514150.html.plaintext.txt	210	Similarly B42H HXH identical B42HNF except HNF4 amino acids 312 322 replaced RXR amino acids 402 412 B42H HHX identical B42HNF except HNF4 amino acids 326 336 replaced RXR amino acids 416 426
0.43481085.9514150.html.plaintext.txt	211	B42H XHX identical B42H HHX except HNF4 amino acids 299 308 replaced RXR amino acids 389 398
0.43481085.9514150.html.plaintext.txt	212	B42X XHH B42X HXH B42X HHX B42X XHX identical B42H XHH B42H HXH B42H HHX B42H XHX respectively except HNF4 amino acids 106 299 replaced RXR amino acids 198 389
0.43481085.9514150.html.plaintext.txt	213	A326 P326 identical B42HNF except amino acid Gly 326 replaced Ala Pro respectively
0.43481085.9514150.html.plaintext.txt	214	R331 identical B42HNF except amino acid Leu 331 replaced Arg
0.43481085.9514150.html.plaintext.txt	215	AR PR identical R331 except amino acid Gly 326 replaced Ala Pro respectively
0.43481085.9514150.html.plaintext.txt	216	AR R AR A AR K identical AR except amino acids Gln 336 Thr 334 Glu 327 replaced Arg Ala Lys respectively
0.43481085.9514150.html.plaintext.txt	217	AR AR identical AR A except amino acid Gln 336 replaced Arg
0.43481085.9514150.html.plaintext.txt	218	Similarly AR KR AR KA identical AR K except amino acid Gln 336 Thr 334 replaced Arg Ala respectively
0.43481085.9514150.html.plaintext.txt	219	All constructs described sequenced prevent unwanted PCR mutations
0.43481085.9514150.html.plaintext.txt	220	In addition expression levels B42 chimeras determined using monoclonal antibody directed Flu tagging gift Dr
0.43481085.9514150.html.plaintext.txt	221	Kyung Lim Lee resides upstream B42 transactivation domain described 22
0.43481085.9514150.html.plaintext.txt	222	HNF4 sequences B42HNF B42RXR B42H HHX A326 R331 AR transferred pGEX4T1 Pharmacia Piscataway NJ express GST fusions
0.43481085.9514150.html.plaintext.txt	223	Vector vitro translation TR LBD previously described 24
0.43481085.9514150.html.plaintext.txt	224	Yeast ss Galactosidase Assays The cotransformation transactivation assays yeast performed described previously 23
0.43481085.9514150.html.plaintext.txt	225	Quantitative liquid ss galactosidase assays performed following changes described 23
0.43481085.9514150.html.plaintext.txt	226	The yeast culture initially diluted A600 nm 0
0.43481085.9514150.html.plaintext.txt	227	05 plated 96 well culture dishes various concentrations hormone
0.43481085.9514150.html.plaintext.txt	228	The cultures incubated dark 30 C 16 h
0.43481085.9514150.html.plaintext.txt	229	The A600 nm determined cells lysed substrate added A415 nm read 10 30 min
0.43481085.9514150.html.plaintext.txt	230	The normalized galactosidase values determined follows A415 nmA600 nm x 1000min developed
0.43481085.9514150.html.plaintext.txt	231	For experiment least six independently derived colonies expressing chimeric receptors tested
0.43481085.9514150.html.plaintext.txt	232	Pull Down Assays GST fusion proteins produced Escherichia coli purified using glutathione Sepharose affinity chromatography essentially described 24
0.43481085.9514150.html.plaintext.txt	233	GST proteins bound glutathione Sepharose 4B beads Pharmacia binding buffer 50 mM KPO4 pH 6
0.43481085.9514150.html.plaintext.txt	234	0 100 mM KCl 10 mM MgCl2 10 glycerol 10 mgml E
0.43481085.9514150.html.plaintext.txt	235	Beads washed binding buffer incubated 60 min 4 C buffer equivalent amounts various proteins labeled 35Smethionine vitro translation
0.43481085.9514150.html.plaintext.txt	236	Nonbound proteins removed three washes binding buffer without E
0.43481085.9514150.html.plaintext.txt	237	coli extract specifically bound proteins eluted 50 mM reduced glutathione 0
0.43481085.9514150.html.plaintext.txt	238	Eluted proteins resolved PAGE visualized fluorography
0.43481085.9514150.html.plaintext.txt	239	ACKNOWLEDGMENTS We thank Dr
0.43481085.9514150.html.plaintext.txt	240	Kyung Lim Lee Flu antibody Drs
0.43481085.9514150.html.plaintext.txt	241	Moore rat HNF4 cDNAs critical reading manuscript
0.43481085.9514150.html.plaintext.txt	242	This research supported grants KOSEF 96 0401 08 01 3 Hormone Research Center Chonnam National University
0.43481085.9514150.html.plaintext.txt	243	FOOTNOTES Address requests reprints Jae Woon Lee Ph
0.43481085.9514150.html.plaintext.txt	244	College Pharmacy Chonnam National University Kwangju South Korea 500 757
0.43481085.9514150.html.plaintext.txt	245	Received publication June 27 1997
0.43481085.9514150.html.plaintext.txt	246	Revision received November 24 1997
0.43481085.9514150.html.plaintext.txt	247	Accepted publication November 26 1997
0.43481085.9514150.html.plaintext.txt	248	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mangelsdorf DJ Thummel C Beato M Herrlich P Schutz G Umesono K Blumberg B Kastner P Mark M Chambon P Evans RM 1995 The nuclear receptor superfamily second decade
0.43481085.9514150.html.plaintext.txt	249	Cell 83835 839Medline Mangelsdorf DJ Evans RM 1995 The RXR heterodimers orphan receptors
0.43481085.9514150.html.plaintext.txt	250	Cell 83841 850Medline Yu VC Delsert C Andersen B Holloway JM Devary OV Naar AM Kim SY Boutin JM Glass CK Rosenfeld MG 1991 RXR beta coregulator enhances binding retinoic acid thyroid hormone vitamin D receptors cognate response elements
0.43481085.9514150.html.plaintext.txt	251	Cell 651251 1266 Kliewer SA Umesono K Mangelsdorf DJ Evans RM 1992 Retinoid x receptor interacts nuclear receptors retinoic acid thyroid hormone vitamin D3 signalling
0.43481085.9514150.html.plaintext.txt	252	Nature 355446 449CrossRefMedline Leid MP Kastner R Lyons R Nakshatri H Saunders M Zacharewski T Chen JY Staub A Garnier JM Mader S Chambon P 1992 Purification cloning RXR identity HeLa cell factor RAR TR heterodimers bind target sequences efficiently
0.43481085.9514150.html.plaintext.txt	253	Cell 68377 395Medline Zhang XK Hoffmann B Tran PB Graupner G Pfahl M 1992 Retinoid x receptor auxiliary protein thyroid hormone retinoic acid receptors
0.43481085.9514150.html.plaintext.txt	254	Nature 355441 446CrossRefMedline Marks MS Hallenbeck PL Nagata T Segars JH Appella E Nikodem VM Ozato K 1992 H 2RIIBP RXR beta heterodimerization provides mechanism combinatorial diversity regulation retinoic acid thyroid hormone responsive genes
0.43481085.9514150.html.plaintext.txt	255	EMBO J 111419 1435Abstract Bugge TH Pohl J Lonnoy O Stunnenberg HG 1992 RXR alpha promiscuous partner retinoic acid thyroid hormone receptors
0.43481085.9514150.html.plaintext.txt	256	EMBO J 111409 1418Abstract Glass C 1994 Differential recognition target genes nuclear receptor monomers dimers heterodimers
0.43481085.9514150.html.plaintext.txt	257	Endocr Rev 15391 407Medline Beato M 1989 Gene regulation steroid hormones
0.43481085.9514150.html.plaintext.txt	258	Cell 56335 344Medline Jiang G Nepomuceno L Hopkins K Saldek FM 1995 Exclusive homodimerization orphan receptor hepatocyte nuclear factor 4 defines new subclass nuclear receptors
0.43481085.9514150.html.plaintext.txt	259	Mol Cell Biol 155131 5143Abstract Conneely OM O Malley BW 1994 Orphan receptors structure function relationships
0.43481085.9514150.html.plaintext.txt	260	In Tsai M J O Malley BW eds Molecular Biology Intelligence Unit Mechanism Steroid Hormone Regulation Gene Transcription RG Landes Co
0.43481085.9514150.html.plaintext.txt	261	Austin TX pp 111 133 Achatz G Holzl B Speckmayer R Hauser C Sandhofer F Paulweber B 1997 Functional domains human orphan receptor ARP 1COUP TFII involved active repression transrepression
0.43481085.9514150.html.plaintext.txt	262	Mol Cell Biol 174914 4932Abstract Kliewer SA Umesono K Heyman RA Mangelsdorf DJ Dyck JA Evans RM 1992 Retinoid x receptor COUP TF interactions modulate retinoic acid signalling
0.43481085.9514150.html.plaintext.txt	263	Proc Natl Acad Sci USA 891448 1451Abstract Towers TL Luisi BF Asianov A Freedman LP 1993 DNA target selectivity vitamin D3 receptor mechanism dimer binding asymmetric repeat element
0.43481085.9514150.html.plaintext.txt	264	Proc Natl Acad Sci USA 906310 6314Abstract Perlman T Rangarajan PN Umesono K Evans RM 1993 Determinants selective RAR TR recognition direct repeat HREs
0.43481085.9514150.html.plaintext.txt	265	Genes Dev 71411 1422Abstract Zechel C Shen X Q Chambon P Gronemeyer H 1994 Dimerization interfaces formed DNA binding domains determine cooperative binding RXRRAR RXRTR heterodimers DR5 DR4 elements
0.43481085.9514150.html.plaintext.txt	266	EMBO J 131414 1424Abstract Zechel C Shen X Q Chen J Y Chen Z P Chambon P Gronemeyer H 1994 The dimerization interfaces formed DNA binding domains RXR RAR TR determine binding specificity polarity full length receptors direct repeats
0.43481085.9514150.html.plaintext.txt	267	EMBO J 131425 1433Abstract Predki PF Zamble D Sarkar B Giguere V 1994 Ordered binding retinoic acid retinoid x receptors asymmetric response elements involves determinants adjacent DNA binding domain
0.43481085.9514150.html.plaintext.txt	268	Mol Endocrinol 831 39Abstract Rastinejad F Perlmann T Evans RM Sigler PB 1995 Structural determinants nuclear receptor assembly DNA direct repeats
0.43481085.9514150.html.plaintext.txt	269	Nature 375203 211CrossRefMedline Perlmann T Umesono K Rangarajan PN Forman BM Evans RM 1996 Two distinct dimerization interfaces differentially modulate target gene specificity nuclear hormone receptors
0.43481085.9514150.html.plaintext.txt	270	Mol Endocrinol 10958 966Abstract Gyuris J Golemis E Chertkov H Brent R 1993 Cdi1 human G1 S phase protein phosphatase associates Cdk2
0.43481085.9514150.html.plaintext.txt	271	Cell 75791 803Medline Lee JW Heyman RA Moore DD 1994 A chimeric T3 receptor constitutively bound DNA requires retinoid x receptor hormone dependent transcriptional activation yeast
0.43481085.9514150.html.plaintext.txt	272	Mol Endocrinol 81245 1253Abstract Lee JW Ryan F Swaffield J Johnston S Moore DD 1995 Interaction thyroid hormone receptor conserved transcriptional mediator
0.43481085.9514150.html.plaintext.txt	273	Nature 37391 94 Folkers GE Van der Leede BM Van der Saag PT 1993 The retinoic acid receptor beta 2 contains two separate cell specific transactivation domains N terminus ligand binding domain
0.43481085.9514150.html.plaintext.txt	274	Mol Endocrinol 7616 627Abstract Yao TP Segraves WA Oro AE McKeown M Evans RM 1992 Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation
0.43481085.9514150.html.plaintext.txt	275	Cell 7163 72Medline Bourguet W Ruff M Chambon P Gronemeyer H Moras D 1995 Crystal structure ligand binding domain human nuclear receptor RXR alpha
0.43481085.9514150.html.plaintext.txt	276	Nature 375377 382CrossRefMedline Renaud J P Rochel N Ruff M Vivat V Chambon P Gronemeyer H Moras D 1995 Crystal structure RAR gamma ligand binding domain bound trans retinoic acid
0.43481085.9514150.html.plaintext.txt	277	Nature 378681 689CrossRefMedline Wagner RL Apriletti JW McGrath ME West BL Baxter JD Fletterick RJ 1995 A structural role hormone thyroid hormone receptor
0.43481085.9514150.html.plaintext.txt	278	Nature 378690 697CrossRefMedline Forman BM Yang C R Au M Casanova J Ghysdael J Samuels HH 1989 A domain containing leucine zipper like motifs mediate novel vivo interactions thyroid hormone retinoic acid receptors
0.43481085.9514150.html.plaintext.txt	279	Mol Endocrinol 31610 1626Abstract Zhang XK Salbert G Lee MO Pfahl M 1994 Mutations alter ligand induced switches dimerization activities retinoid X receptor
0.43481085.9514150.html.plaintext.txt	280	Mol Cell Biol 144311 4323Abstract Leng X Blanco J Tsai SY Ozato K O Malley BW Tsai MJ 1995 Mouse retinoid x receptor contains separable ligand binding transactivation domain E region
0.43481085.9514150.html.plaintext.txt	281	Mol Cell Biol 15255 263Abstract Higuchi R 1990 Recombinant PCR
0.43481085.9514150.html.plaintext.txt	282	In Innis MA Gelfand DH Sninisky JJ White TJ eds PCR Protocols A Guide Methods Applications
0.21842672.15166231.html.plaintext.txt	0	The Synergistic Effect Dexamethasone All trans retinoic Acid Hepatic Phosphoenolpyruvate Carboxykinase Gene Expression Involves Coactivator p300 Xiaohui L
0.21842672.15166231.html.plaintext.txt	1	Wang Birger Herzog Mary Waltner Law Robert K
0.21842672.15166231.html.plaintext.txt	2	Hall Masakazu Shiota Daryl K
0.21842672.15166231.html.plaintext.txt	3	From Department Molecular Physiology Biophysics Vanderbilt University School Medicine Nashville Tennessee 37232 0615 Department Veterans Affairs Medical Center Nashville Tennessee 37212
0.21842672.15166231.html.plaintext.txt	4	Received publication March 29 2004 revised form May 25 2004
0.21842672.15166231.html.plaintext.txt	5	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Activation phosphoenolpyruvate carboxykinase PEPCK gene transcription response trans retinoic acid RA glucocorticoid dexamethasone Dex requires distinct arrangement DNA response elements cognate transcription activators gene promoter
0.21842672.15166231.html.plaintext.txt	6	Two accessory factor binding elements involved Dex response gAF1 gAF3 coincide DNA response elements involved RA response
0.21842672.15166231.html.plaintext.txt	7	We demonstrate combination DexRA synergistic effect endogenous PEPCK gene expression rat hepatocytes H4IIE hepatoma cells
0.21842672.15166231.html.plaintext.txt	8	Reporter gene studies show gAF3 element one two glucocorticoid receptor binding elements GR1 important effect
0.21842672.15166231.html.plaintext.txt	9	Chromatin immunoprecipitation assays revealed H4IIE cells treated DexRA ligand activated retinoic acid receptors retinoic acid receptorretinoid X receptor glucocorticoid receptors recruited gene promoter transcription coregulators p300 CREB binding protein pCIP SRC 1
0.21842672.15166231.html.plaintext.txt	10	Notably recruitment p300 RNA polymerase II PEPCK promoter increased combined DexRA treatment compared Dex RA treatment alone
0.21842672.15166231.html.plaintext.txt	11	The functional importance p300 DexRA response illustrated observation selective reduction coactivator CREB binding protein abolishes synergistic effect H4IIE cells
0.21842672.15166231.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Extracellular signals received eucaryotic cells transferred nucleus transcription specific sets genes modulated 1
0.21842672.15166231.html.plaintext.txt	13	The final targets signaling pathways different combinations transcription factors bind DNA response elements form various protein protein interactions gene promoters thereby either activate repress gene transcription
0.21842672.15166231.html.plaintext.txt	14	DNA response elements gene promoters often overlap adjacent one another 2
0.21842672.15166231.html.plaintext.txt	15	This provides various possibilities recruitment transcription factors cognate coregulators response distinct signals creates potential considerable flexibility gene regulation
0.21842672.15166231.html.plaintext.txt	16	Regulation phosphoenolpyruvate carboxykinase PEPCK1 gene provides excellent model system exploring mechanisms signal integration context gluconeogenesis important physiologic process 2
0.21842672.15166231.html.plaintext.txt	17	The expression hepatic PEPCK primarily accomplished transcriptional level 3
0.21842672.15166231.html.plaintext.txt	18	Glucagon acting cAMP glucocorticoids trans retinoic acid RA thyroid hormone activate PEPCK gene expression whereas insulin glucose inhibitory 3 6
0.21842672.15166231.html.plaintext.txt	19	Activation PEPCK gene transcription RA occurs multicomponent retinoic acid response unit RARU consists two separate retinoic acid response elements RARE1 RARE2 binds RARRXR heterodimer 4 7
0.21842672.15166231.html.plaintext.txt	20	Activation PEPCK gene transcription Dex also requires multicomponent glucocorticoid response unit GRU consists two nonconsensus glucocorticoid receptor binding sites GR1 GR2 8 four accessory factor binding sites gAF1 gAF2 gAF3 cAMP response element CRE bind COUP TFHNF4 HNF3 COUP TF CEBP respectively 9 12
0.21842672.15166231.html.plaintext.txt	21	A mutation one accessory elements results 50 60 reduction Dex induced PEPCK gene transcription H4IIE hepatoma cells 11
0.21842672.15166231.html.plaintext.txt	22	Any combination mutation two elements nearly abolishes response 11
0.21842672.15166231.html.plaintext.txt	23	Most interesting RARE1 RARE2 RARU coincident gAF1 gAF3 GRU 4 7 9 13
0.21842672.15166231.html.plaintext.txt	24	The respective transcription factors present abundance H4IIE cell nucleus binds approximately affinity elements
0.21842672.15166231.html.plaintext.txt	25	Thus interest understand cell responds either inducers whether different constellations accessory factors coregulators used response whether functional interaction two units presence ligands
0.21842672.15166231.html.plaintext.txt	26	In study demonstrate DexRA combination synergistic effect endogenous PEPCK gene expression primary hepatocytes H4IIE hepatoma cells
0.21842672.15166231.html.plaintext.txt	27	This response dependent gAF3 GR1 elements
0.21842672.15166231.html.plaintext.txt	28	Upon treatment DexRA ligand activated RARRXR heterodimers GR HNF3 HNF4 pCIP SRC 1 CBP p300 RNA polymerase II pol II present PEPCK gene promoter
0.21842672.15166231.html.plaintext.txt	29	Notably recruitment p300 pol II PEPCK promoter increased upon DexRA treatment
0.21842672.15166231.html.plaintext.txt	30	The important role p300 illustrated fact reduction results selective loss synergistic effect DexRA whereas similar reduction CBP effect
0.21842672.15166231.html.plaintext.txt	31	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Plasmids The PEPCK luciferase PEPCK LUC reporter gene construct made cloning PEPCK gene promoter 467 69 pGL3 basic Promega described previously 14
0.21842672.15166231.html.plaintext.txt	32	The gAF1 Gal4 PEPCK LUC gAF2 Gal4 PEPCK LUC gAF3 Gal4 PEPCK LUC reporter constructs constructed replacing gAF1 gAF2 gAF3 Gal4 DNA binding element described previously 15
0.21842672.15166231.html.plaintext.txt	33	gAF1 gAF3 Gal4 PEPCK LUC constructed mutating gAF1 element gAF3 Gal4 PEPCK LUC plasmid Gal4 DNA binding element using QuikChange site directed mutagenesis kit Stratagene
0.21842672.15166231.html.plaintext.txt	34	The sequence Gal4 DNA binding element 5 CGGAGGACTGTCCTCCGACCA 3
0.21842672.15166231.html.plaintext.txt	35	gAF3m PEPCK LUC gAF3m PEPCK LUC gAF3Em PEPCK LUC gAF1 COUP TF PEPCK LUC gAF1 HNF4 PEPCK LUC made described previously 15
0.21842672.15166231.html.plaintext.txt	36	mGR1 PEPCK LUC palGR1 PEPCK LUC made converting GR1 element block mutation palindromic GRbinding element respectively
0.21842672.15166231.html.plaintext.txt	37	mGR2 PEPCK LUC constructed replacing GR2 site block mutation
0.21842672.15166231.html.plaintext.txt	38	mGR12 PEPCK LUC made replacing GR1 site mGR2 PEPCK LUC block mutation
0.21842672.15166231.html.plaintext.txt	39	The oligonucleotides used construct mGR1 mGR2 palGR1 described previously 8
0.21842672.15166231.html.plaintext.txt	40	gAF1 cRARE PEPCK LUC gAF3 cRARE PEPCK LUC made replacing gAF1 gAF3 element individually consensus retinoic acid receptor binding element cRARE 16
0.21842672.15166231.html.plaintext.txt	41	The oligonucleotides used generate gAF1 cRARE PEPCK LUC gAF3 cRARE PEPCK LUC follows gAF1 cRARE 5 ATTCCCTTCTGGTTCACCGAAAGTTCAGGAGTGACACC 3 gAF3 cRARE 5 CGTCCCGGCCGGTTCACCGAAAGTTCACCACCTGACAA 3
0.21842672.15166231.html.plaintext.txt	42	The sequence constructs verified DNA sequence analysis
0.21842672.15166231.html.plaintext.txt	43	Cell Culture Transfection H4IIE hepatoma cells grown stationary culture Dulbeccos modified Eagles medium DMEM supplemented 10 fetal calf serum 37 degrees C 5 CO2
0.21842672.15166231.html.plaintext.txt	44	Transfection performed using calcium phosphate precipitation method described previously 17 using 10 microg reporter plasmid wild type mutations PEPCK LUC
0.21842672.15166231.html.plaintext.txt	45	The cells subsequently washed incubated 18 h DMEM containing 500 nM dexamethasone Dex andor 5 microM trans retinoic acid RA Sigma
0.21842672.15166231.html.plaintext.txt	46	Cells harvested trypsin digestion resuspended 200 microl lysis buffer Promega
0.21842672.15166231.html.plaintext.txt	47	Firefly luciferase activity measured corrected transfection efficiency Renilla luciferase activity using dual luciferase reporter assay system Promega
0.21842672.15166231.html.plaintext.txt	48	H4IIE cells transfected 1 efficiency therefore rat kidney fibroblast cell line KNRK cells employed
0.21842672.15166231.html.plaintext.txt	49	These cells express abundant amounts p300 CBP transfected 80 efficiency measured expression enhanced green fluorescent proteins
0.21842672.15166231.html.plaintext.txt	50	They therefore useful establishing efficacy selectivity candidate siRNA molecules
0.21842672.15166231.html.plaintext.txt	51	KNRK cells grown 37 degrees C DMEM supplemented 5 calf serum nonessential amino acids 4
0.21842672.15166231.html.plaintext.txt	52	These cells cultured 6 well plates 24 h transfected LipofectAMINE 2000 Invitrogen
0.21842672.15166231.html.plaintext.txt	53	2 microg siRNA vectors transfected 0
0.21842672.15166231.html.plaintext.txt	54	5 microg enhanced green fluorescent proteins cotransfected control transfection efficiency
0.21842672.15166231.html.plaintext.txt	55	Control cells transfected empty pSUPER vector
0.21842672.15166231.html.plaintext.txt	56	Cells assayed p300 CBP expression 72 h transfection using Western blot assays cell lysates
0.21842672.15166231.html.plaintext.txt	57	Actin used control differences cell numbers protein loading
0.21842672.15166231.html.plaintext.txt	58	Real Time PCR Primary hepatocytes deprived serum overnight either left untreated treated 500 nM Dex andor 5 microM RA 4 h
0.21842672.15166231.html.plaintext.txt	59	Total RNA extracted cells 0
0.21842672.15166231.html.plaintext.txt	60	5 microg transcribed using 50 units Taqman reverse transcriptase Applied Biosystems 125 microM random hexamer primers
0.21842672.15166231.html.plaintext.txt	61	Real time PCR reactions performed one tenth reverse transcribed RNA using primers specific PEPCK cyclophilin genes
0.21842672.15166231.html.plaintext.txt	62	A 50 microl master mix following reaction components prepared real time PCR 18 microl water 100 nM forward primer 100 nM reverse primer 25 microl 2x SYBR Green PCR master mix Applied Biosystems 5 microl one tenth reverse transcribed RNA
0.21842672.15166231.html.plaintext.txt	63	The sequence forward PEPCK primer 5 GAATCAGCCAGATGTAATCCCG 3 sequence reverse PEPCK primer 5 CATTGTGCTTGCTGGTTTGC 3
0.21842672.15166231.html.plaintext.txt	64	The sequence forward cyclophilin primer 5 AAGGTGAAAGAAGGCATGAGCA 3 sequence reverse cyclophilin primer 5 AGTTGTCCACAGTCGGAGATGG 3
0.21842672.15166231.html.plaintext.txt	65	The following real time PCR protocol used denaturation enzyme activation 95 degrees C 10 min followed two step amplification quantification program consisting 40 cycles denaturation 15 95 degrees C annealingextension 1 min 60 degrees C
0.21842672.15166231.html.plaintext.txt	66	Data analyzed using SDS version 1
0.21842672.15166231.html.plaintext.txt	67	Chromatin Immunoprecipitation Assays ChIP H4IIE cells 1 x 108 cells per treatment kept serum free DMEM 37 degrees C 5 CO2 48 h
0.21842672.15166231.html.plaintext.txt	68	After 2 h hormone treatment protein DNA cross linking performed 1 formaldehyde serum free DMEM room temperature 10 min
0.21842672.15166231.html.plaintext.txt	69	The cells harvested PBS buffer ice cold 1x PBS protease inhibitors 1 mM phenylmethylsulfonyl fluoride 1 microgml aprotinin 1 microgml leupeptin 1 microgml pepstatin
0.21842672.15166231.html.plaintext.txt	70	The cells pelleted resuspended SDS lysis buffer 1 SDS 10 mM EDTA 50 mM Tris HCl pH 8 protease inhibitors
0.21842672.15166231.html.plaintext.txt	71	After incubation ice 20 min lysates mixed 25 microm diameter glass beads MO SCI Corp
0.21842672.15166231.html.plaintext.txt	72	5 mm tip 4 degrees C 10 times 15 pulses setting 6 output 6 watts shear chromatin 500 bp fragments
0.21842672.15166231.html.plaintext.txt	73	The supernatant sample divided aliquots subsequent 10 fold dilution ChIP dilution buffer 0
0.21842672.15166231.html.plaintext.txt	74	7 mM Tris HCl pH 8 protease inhibitors
0.21842672.15166231.html.plaintext.txt	75	Each sample pre cleared reduce nonspecific background using 40 microl 11 protein AG agarose slurry Santa Cruz Biotechnology supplemented 100 microgml salmon sperm DNA Stratagene 3 h 4 degrees C rotating wheel
0.21842672.15166231.html.plaintext.txt	76	The beads pelleted supernatant transferred new tube
0.21842672.15166231.html.plaintext.txt	77	The precleared extracts incubated overnight 4 microg antibody without antibody negative control 4 degrees C rotating wheel
0.21842672.15166231.html.plaintext.txt	78	Immune complexes collected using 40 microl 11 protein AG agarose slurry plus 100 microgml salmon sperm DNA constant rotation 3 h 4 degrees C
0.21842672.15166231.html.plaintext.txt	79	The agarose beads pelleted 1000 x g 2 min washed 10 min room temperature 1 ml following buffers succession low salt wash buffer 0
0.21842672.15166231.html.plaintext.txt	80	1 SDS 1 Triton X 100 2 mM EDTA 20 mM Tris HCl 150 mM NaCl pH 8 high salt wash buffer 0
0.21842672.15166231.html.plaintext.txt	81	1 SDS 1 Triton X 100 2 mM EDTA pH 8 20 mM Tris HCl pH 8 500 mM NaCl pH 8 LiCl wash buffer 0
0.21842672.15166231.html.plaintext.txt	82	25 M LiCl 1 Nonidet P 40 1 sodium deoxycholate 1 mM EDTA 10 mM Tris HCl pH 8 2x TE buffer 10 mM Tris HCl 1 mM EDTA pH 8
0.21842672.15166231.html.plaintext.txt	83	Chromatin complexes eluted beads two 1 h incubations 160 microl elution buffer 1 SDS 0
0.21842672.15166231.html.plaintext.txt	84	1 M NaHCO3 room temperature
0.21842672.15166231.html.plaintext.txt	85	The DNA protein cross links reversed incubating samples 65 degrees C 12 h
0.21842672.15166231.html.plaintext.txt	86	The RNA protein samples digested using RNase mixture Ambion 50 microgml proteinase K respectively
0.21842672.15166231.html.plaintext.txt	87	The DNA purified using QIAquick PCR purification kit Qiagen resuspended 50 microl nuclease free water
0.21842672.15166231.html.plaintext.txt	88	Five microliter aliquots used PCR real time PCR utilizing primers specific PEPCK actin promoters
0.21842672.15166231.html.plaintext.txt	89	The forward primer used PEPCK gene promoter 5 GTTTCACGTCTCAGAGCTGA 3 reverse primer 5 ACCGTGACTGTTGCTGATGC 3
0.21842672.15166231.html.plaintext.txt	90	The forward reverse primers used actin gene promoter described previously 18
0.21842672.15166231.html.plaintext.txt	91	PCR products run 2 agarose gel visualized ethidium bromide staining
0.21842672.15166231.html.plaintext.txt	92	Real time PCR performed described
0.21842672.15166231.html.plaintext.txt	93	The antibodies used GR RAR RXR HNF3 HNF4 PCAF p300 CBP SRC 1 pCIP obtained Santa Cruz Biotechnology Santa Cruz CA anti RNA polymerase II Berkeley Antibody Co
0.21842672.15166231.html.plaintext.txt	94	Small Interfering RNA The mammalian vector pSUPER used expression siRNAs specifically targeted rat p300 CBP mRNAs
0.21842672.15166231.html.plaintext.txt	95	The pSUPER vector consists H1 RNA promoter directs synthesis siRNA transcripts 19
0.21842672.15166231.html.plaintext.txt	96	The target sequence p300 mRNA 21 nucleotide sequence corresponding nucleotide positions 88 108 downstream transcription start site gene separated 9 nucleotide noncomplementary spacer sequence followed reverse complement 21 nucleotide sequence
0.21842672.15166231.html.plaintext.txt	97	The cloning sequence facilitated BamHI HindIII flanking sites
0.21842672.15166231.html.plaintext.txt	98	This vector referred p300 siRNA
0.21842672.15166231.html.plaintext.txt	99	The siRNA specific CBP made similar way using 21 nucleotide sequence corresponding nucleotide positions 122 142 downstream transcription start site gene resulting vector referred CBP siRNA
0.21842672.15166231.html.plaintext.txt	100	Western Blot Analysis siRNA treated KNRK cells washed twice ice cold PBS
0.21842672.15166231.html.plaintext.txt	101	These cells disrupted detergent lysis buffer 20 mM Tris HCl pH 7
0.21842672.15166231.html.plaintext.txt	102	6 1 mM EDTA 1 mM EGTA 1 mM Na3VO4 20 mM Na4P2O7 0
0.21842672.15166231.html.plaintext.txt	103	2 Triton X 100 10 nM microcystin 0
0.21842672.15166231.html.plaintext.txt	104	1 M phenylmethylsulfonyl fluoride 1 microgml aprotinin 1 microgml pepstatin 1 microgml leupeptin
0.21842672.15166231.html.plaintext.txt	105	A 40 microg aliquot protein treatment loaded 6 Tris glycine gel Invitrogen
0.21842672.15166231.html.plaintext.txt	106	After electrophoresis separated proteins transferred nitrocellulose membrane Invitrogen
0.21842672.15166231.html.plaintext.txt	107	The membrane incubated 2 h appropriate antibody followed incubation anti rabbit anti mouse IgG conjugated horseradish peroxidase
0.21842672.15166231.html.plaintext.txt	108	Immunoreactive proteins detected using ECL immunodetection system Amersham Biosciences
0.21842672.15166231.html.plaintext.txt	109	To assess specificity siRNA membrane probed p300 antibody re probed CBP antibody vice versa
0.21842672.15166231.html.plaintext.txt	110	Statistical Analysis Statistical analyses performed using Students test significance level set p 0
0.21842672.15166231.html.plaintext.txt	111	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Dexamethasone Retinoic Acid Have Synergistic Effect PEPCK Gene Expression Dexamethasone Dex retinoic acid RA induce transcription PEPCK gene H4IIE hepatoma cells shared DNA elements 2 4 7 9 13
0.21842672.15166231.html.plaintext.txt	112	This clonal cell line 20 possible different populations cells culture respond inducer
0.21842672.15166231.html.plaintext.txt	113	If summed responses two ligands additive
0.21842672.15166231.html.plaintext.txt	114	To determine effect DexRA combination PEPCK gene expression real time RT PCR assays performed quantify PEPCK mRNA upon Dex andor RA treatment
0.21842672.15166231.html.plaintext.txt	115	Cyclophilin mRNA also measured normalization control
0.21842672.15166231.html.plaintext.txt	116	7 fold induction respectively combination resulted synergistic 13
0.21842672.15166231.html.plaintext.txt	117	3 fold effect H4IIE cells Fig
0.21842672.15166231.html.plaintext.txt	118	In rat primary hepatocytes PEPCK mRNA induced 15 7
0.21842672.15166231.html.plaintext.txt	119	4 fold upon treatment RA Dex respectively
0.21842672.15166231.html.plaintext.txt	120	When ligands present much greater additive 39 fold induction observed Fig
0.21842672.15166231.html.plaintext.txt	121	This indication effect mRNA induction within single population cells confirmed protein level immunofluorescent experiment performed primary hepatocytes
0.21842672.15166231.html.plaintext.txt	122	PEPCK expression induced 71 67 70 hepatocytes upon treatment RA Dex DexRA respectively data shown
0.21842672.15166231.html.plaintext.txt	123	Because 50 cells respond treatment either ligands conclude discrete populations hepatocytes respond either Dex RA combination
0.21842672.15166231.html.plaintext.txt	124	Also keeping observations noted Fig
0.21842672.15166231.html.plaintext.txt	125	1B intensity staining greater cells treated DexRA combination data shown
0.21842672.15166231.html.plaintext.txt	126	View larger version 20K FIG
0.21842672.15166231.html.plaintext.txt	127	Regulation PEPCK gene expression DexRA rat primary hepatocytes H4IIE hepatoma cells
0.21842672.15166231.html.plaintext.txt	128	A H4IIE cells serum deprived overnight either left untreated treated 500 nM Dex andor 5 microM RA 4 h
0.21842672.15166231.html.plaintext.txt	129	Total RNA extracted cells 0
0.21842672.15166231.html.plaintext.txt	130	5 microg RNA subjected reverse transcription
0.21842672.15166231.html.plaintext.txt	131	Real time PCRs performed reverse transcribed RNA using primers encoding cDNA sequences PEPCK cyclophilin described Materials Methods
0.21842672.15166231.html.plaintext.txt	132	B experiment described A performed using isolated rat hepatocytes
0.21842672.15166231.html.plaintext.txt	133	Data analyzed using SDS version 1
0.21842672.15166231.html.plaintext.txt	134	Results represent means plus minus S
0.21842672.15166231.html.plaintext.txt	135	four six independent experiments
0.21842672.15166231.html.plaintext.txt	136	The horizontal bar DexRA column figures indicates value would achieved result additive
0.21842672.15166231.html.plaintext.txt	137	RARRXR Heterodimers gAF3 Element Are Primarily Involved Synergistic Effect The involvement specific cis elements cognate transcription factors synergistic effect defined using number variations PEPCK LUC reporter plasmid contains wild type PEPCK promoter 467 69 ligated luciferase reporter gene
0.21842672.15166231.html.plaintext.txt	138	Upon treatment H4IIE cells 5 microM RA 500 nM Dex combination two PEPCK promoter driven luciferase reporter gene expression induced 3
0.21842672.15166231.html.plaintext.txt	139	This greater additive response qualitatively similar noted expression endogenous gene see Fig
0.21842672.15166231.html.plaintext.txt	140	1A hence transient transcription approach used define DNA elements associated transcription factors involved response
0.21842672.15166231.html.plaintext.txt	141	View larger version 35K FIG
0.21842672.15166231.html.plaintext.txt	142	The gAF3 element primarily involved synergistic effect
0.21842672.15166231.html.plaintext.txt	143	Mutations PEPCK LUC replace gAF1 gAF2 gAF3 Gal4 DNA binding elements individually gAF1 gAF3 combination made
0.21842672.15166231.html.plaintext.txt	144	H4IIE cells transfected 10 microg reporter plasmid wild type mutated forms PEPCK LUC 100 ng PRL SV40 Renilla luciferase vector control transfection efficiency
0.21842672.15166231.html.plaintext.txt	145	Cells left untreated treated 500 nM Dex andor 5 microM RA 18 h cell lysates prepared dual luciferase assays described Materials Methods
0.21842672.15166231.html.plaintext.txt	146	Data represent mean plus minus S
0.21842672.15166231.html.plaintext.txt	147	five eight independent experiments
0.21842672.15166231.html.plaintext.txt	148	Results illustrated normalized basal activity PEPCK LUC reporter gene construct
0.21842672.15166231.html.plaintext.txt	149	Mutations PEPCK LUC replace gAF1 gAF2 gAF3 Gal4 DNA binding elements individually gAF1 gAF3 combination made identify involvement accessory elements synergistic effect
0.21842672.15166231.html.plaintext.txt	150	Results consistent previously published data laboratory show single mutation three gAFs reduces Dex induced response 50 mutation gAF1 gAF3 abolishes response Fig
0.21842672.15166231.html.plaintext.txt	151	By contrast major effect RA facilitated gAF3 although small effect mediated gAF1
0.21842672.15166231.html.plaintext.txt	152	gAF2 involved RA effect noted earlier 13
0.21842672.15166231.html.plaintext.txt	153	Correspondingly gAF2 qualitative effect synergistic response total effect reduced decreased response Dex whereas gAF1 especially gAF3 major effects Fig
0.21842672.15166231.html.plaintext.txt	154	The gAF1 element converted consensus binding element either HNF4 COUP TF bind RXR 9
0.21842672.15166231.html.plaintext.txt	155	In accordance previous observation presence consensus HNF4 COUP TF binding elements gAF1 decreases RA induced response 50 Fig
0.21842672.15166231.html.plaintext.txt	156	A significant synergistic effect DexRA achieved constructs
0.21842672.15166231.html.plaintext.txt	157	However presence consensus RARRXR binding element cRARE gAF1 excludes HNF4 COUP TF binding promotes significant increase RA response reduces Dex response 50 Fig
0.21842672.15166231.html.plaintext.txt	158	Nonetheless synergistic effect fully supported gAF1 replaced cRARE gAF1 cRARE PEPCK LUC
0.21842672.15166231.html.plaintext.txt	159	View larger version 34K FIG
0.21842672.15166231.html.plaintext.txt	160	cRARE gAF1 restores synergistic effect
0.21842672.15166231.html.plaintext.txt	161	H4IIE cells transiently transfected 10 microg wild type PEPCK LUC mutated forms PEPCK LUC gAF1 element replaced consensus binding element either HNF4 COUP TF homodimer RARRXR heterodimers
0.21842672.15166231.html.plaintext.txt	162	Cells left untreated treated 500 nM Dex andor 5 microM RA 18 h
0.21842672.15166231.html.plaintext.txt	163	Dual luciferase assays performed described Materials Methods
0.21842672.15166231.html.plaintext.txt	164	The results illustrated normalized basal activity PEPCK LUC reporter gene construct
0.21842672.15166231.html.plaintext.txt	165	Data represent mean plus minus S
0.21842672.15166231.html.plaintext.txt	166	five eight independent experiments
0.21842672.15166231.html.plaintext.txt	167	The gAF3 element includes two RARRXR sites separated 5 bp linker sequence see Fig
0.21842672.15166231.html.plaintext.txt	168	An E box binds transcription factor USF located immediately downstream Fig
0.21842672.15166231.html.plaintext.txt	169	The elements E box mutated context PEPCK LUC determine component gAF3 involved synergistic effect
0.21842672.15166231.html.plaintext.txt	170	As expected previous studies 11 E box mutation affect either Dex RA responses effect DexRA response
0.21842672.15166231.html.plaintext.txt	171	A mutation site slightly reduces RA induced response significant effect Dex induced response DexRA induced synergistic effect
0.21842672.15166231.html.plaintext.txt	172	By contrast mutation site gAF3 significantly reduces RA Dex effects abolishes synergistic effect DexRA PEPCK gene expression Fig
0.21842672.15166231.html.plaintext.txt	173	These data indicate transcription factors binding site gAF3 mediate synergistic effect DexRA PEPCK gene expression
0.21842672.15166231.html.plaintext.txt	174	View larger version 33K FIG
0.21842672.15166231.html.plaintext.txt	175	The element gAF3 important synergistic effect DexRA
0.21842672.15166231.html.plaintext.txt	176	The components gAF3 illustrated top panel
0.21842672.15166231.html.plaintext.txt	177	Transfection experiments performed described Fig
0.21842672.15166231.html.plaintext.txt	178	2 H4IIE cells using variations PEPCK LUC elements gAF3 E box individually mutated
0.21842672.15166231.html.plaintext.txt	179	The results illustrated normalized basal activity PEPCK LUC reporter gene construct
0.21842672.15166231.html.plaintext.txt	180	Data represent mean plus minus S
0.21842672.15166231.html.plaintext.txt	181	five eight independent experiments
0.21842672.15166231.html.plaintext.txt	182	The approach employed experiment described Fig
0.21842672.15166231.html.plaintext.txt	183	3 used infer binding transcription factors gAF3 element upon DexRA treatment Fig
0.21842672.15166231.html.plaintext.txt	184	The full synergistic effect supported gAF3 converted cRARE gAF3 cRARE PEPCK LUC
0.21842672.15166231.html.plaintext.txt	185	The cRARE binds RARRXR heterodimers higher affinity either HNF4 COUP TF 16 thus RA response construct gAF3 changed consensus RARRXR binding element greater obtained wild type PEPCK LUC 12 fold versus 3
0.21842672.15166231.html.plaintext.txt	186	The response constructs gAF1 gAF3 converted cRAREs gAF1gAF3 cRARE PEPCK LUC similar gAF3 cRARE PEPCK LUC data shown
0.21842672.15166231.html.plaintext.txt	187	This implies gAF3 important gAF1 promoting synergistic effect DexRA PEPCK gene expression ligand bound RARRXR heterodimers play critical role
0.21842672.15166231.html.plaintext.txt	188	View larger version 31K FIG
0.21842672.15166231.html.plaintext.txt	189	cRARE gAF3 restores synergistic effect
0.21842672.15166231.html.plaintext.txt	190	H4IIE cells transiently transfected 10 microg PEPCK LUC mutated forms PEPCK LUC gAF3 element replaced consensus binding element RARRXR heterodimers Gal4 DNA binding element
0.21842672.15166231.html.plaintext.txt	191	Cells left untreated treated 500 nM Dex andor 5 microM RA 18 h
0.21842672.15166231.html.plaintext.txt	192	Dual luciferase assays performed described Materials Methods
0.21842672.15166231.html.plaintext.txt	193	The results illustrated normalized basal activity PEPCK LUC reporter construct
0.21842672.15166231.html.plaintext.txt	194	Data presented mean plus minus S
0.21842672.15166231.html.plaintext.txt	195	five eight independent experiments
0.21842672.15166231.html.plaintext.txt	196	The GR1 Glucocorticoid Receptor binding Site Is Involved Synergistic Effect Block mutations GR1 andor GR2 prevent binding GR made context PEPCK LUC construct
0.21842672.15166231.html.plaintext.txt	197	6 reduces Dex induced PEPCK gene expression 60 whereas mGR2 little effect expected Fig
0.21842672.15166231.html.plaintext.txt	198	The synergistic effect DexRA PEPCK gene expression totally abolished mGR1 affected mGR2 Fig
0.21842672.15166231.html.plaintext.txt	199	These results indicate GR1 GR2 involved synergistic effect DexRA PEPCK gene expression consistent previous report 8 GR1 important Dex induced PEPCK gene expression
0.21842672.15166231.html.plaintext.txt	200	View larger version 37K FIG
0.21842672.15166231.html.plaintext.txt	201	GR1 involved synergistic effect
0.21842672.15166231.html.plaintext.txt	202	PEPCK LUC constructs made contain mutated GR1 mGR1 mutated GR2 mGR2 combined mutation GR1 GR2 mGR12 palindromic GR binding element pal GR1
0.21842672.15166231.html.plaintext.txt	203	H4IIE cells transiently transfected 10 microg PEPCK LUC mutant forms PEPCK LUC
0.21842672.15166231.html.plaintext.txt	204	The results illustrated normalized basal activity PEPCK LUC reporter gene construct
0.21842672.15166231.html.plaintext.txt	205	Data represent mean plus minus S
0.21842672.15166231.html.plaintext.txt	206	five eight independent experiments
0.21842672.15166231.html.plaintext.txt	207	GR1 weak nonconsensus GR binding site cannot induce Dex response PEPCK gene expression 8
0.21842672.15166231.html.plaintext.txt	208	The accessory factor elements gAF1 gAF3 associated transcription factors increase affinity binding liganded GR GR1GR2 stabilize binding 21
0.21842672.15166231.html.plaintext.txt	209	The gAF1 gAF3 accessory elements necessary GR1GR2 replaced high affinity palindromic GR binding elements 21
0.21842672.15166231.html.plaintext.txt	210	To test whether ligand activated RARRXR heterodimers necessary presence high affinity GR binding element GR1 converted palindromic glucocorticoid response element palGRE context PEPCK LUC
0.21842672.15166231.html.plaintext.txt	211	PEPCK luciferase activity induced 80 fold Dex context palGR1 PEPCK LUC Dex RA present PEPCK gene expression augmented Fig
0.21842672.15166231.html.plaintext.txt	212	Most interesting synergistic effect DexRA seen GR1 converted palindromic high affinity GR binding site independent gAF1 gAF3 8
0.21842672.15166231.html.plaintext.txt	213	By contrast either gAF1 gAF3 converted consensus RARRXR binding element context wild type GR1GR2 elements synergistic effect DexRA PEPCK gene expression actually augmented see Figs
0.21842672.15166231.html.plaintext.txt	214	Taken together conclude synergistic effect DexRA involves enhanced GR binding nonconsensus GR1 element may facilitated binding RARRXR heterodimers
0.21842672.15166231.html.plaintext.txt	215	DexRA Treatment Affects Binding Transcription Factors PEPCK Gene Promoter Vivo ChIPs performed untreated hormone treated H4IIE cells identify vivo binding profile accessory factors nuclear receptors coregulators PEPCK gene promoter
0.21842672.15166231.html.plaintext.txt	216	GR recruited PEPCK gene promoter Dex present 1 versus 13
0.21842672.15166231.html.plaintext.txt	217	0 fold shown previously Fig
0.21842672.15166231.html.plaintext.txt	218	This association increased combined DexRA treatment 13
0.21842672.15166231.html.plaintext.txt	219	7 Table I consistent functional data illustrated
0.21842672.15166231.html.plaintext.txt	220	This leads us hypothesize RARRXR heterodimers enhance GR bindingfunction
0.21842672.15166231.html.plaintext.txt	221	View larger version 28K FIG
0.21842672.15166231.html.plaintext.txt	222	GR RARRXR HNF3 HNF4 present PEPCK gene promoter upon treatment DexRA
0.21842672.15166231.html.plaintext.txt	223	A association GR RAR RXR HNF3 HNF4 endogenous PEPCK gene promoter measured ChIP H4IIE cells treated 2 h following conditions hormone 5 microM RA 500 nM Dex 500 nM Dex5 microM RA
0.21842672.15166231.html.plaintext.txt	224	No Ab lanes show results immunoprecipitations performed parallel without application primary antibodies
0.21842672.15166231.html.plaintext.txt	225	Input lanes show results samples subjected immunoprecipitation
0.21842672.15166231.html.plaintext.txt	226	B association GR RAR RXR HNF3 HNF4 endogenous actin gene promoter measured ChIP negative control
0.21842672.15166231.html.plaintext.txt	227	Results representative four six independent experiments
0.21842672.15166231.html.plaintext.txt	228	View table TABLE I The occupancy PEPCK gene promoter transcription factors coregulators changes upon treatment Dex andor RA
0.21842672.15166231.html.plaintext.txt	229	The numbers shown derived quantitative real time PCR analysis PEPCK promoter fragments co immunoprecipitated indicated antibody ChIP
0.21842672.15166231.html.plaintext.txt	230	The data expressed fold difference relative control untreated samples four six independent assays
0.21842672.15166231.html.plaintext.txt	231	In genes RA thought bind DNA bound RARRXR heterodimers RA RAR interaction results release corepressor complex subsequent association coactivator complex 22 23
0.21842672.15166231.html.plaintext.txt	232	There significant association RAR RXR PEPCK gene promoter absence ligand substantial increase binding 2 fold increase RA added cells Fig
0.21842672.15166231.html.plaintext.txt	233	This association increased concomitant administration Dex
0.21842672.15166231.html.plaintext.txt	234	HNF3 binds PEPCK gene promoter constitutively presumably gAF2 Fig
0.21842672.15166231.html.plaintext.txt	235	7 10 18 consistent functional data shown element involved either RA DexRA induced synergistic responses PEPCK gene expression Fig
0.21842672.15166231.html.plaintext.txt	236	HNF4 also bound PEPCK gene promoter untreated cells cells treated Dex andor RA Fig
0.21842672.15166231.html.plaintext.txt	237	SRC 1 pCIP members p160 nuclear receptor family recruited PEPCK gene promoter upon treatment Dex andor RA Fig
0.21842672.15166231.html.plaintext.txt	238	Although Dex causes somewhat greater recruitment SRC 1 pCIP PEPCK gene promoter RA 3
0.21842672.15166231.html.plaintext.txt	239	8 versus 2 fold respectively Table I recruitment proteins increased ligands present
0.21842672.15166231.html.plaintext.txt	240	PCAF HAT family protein present H4IIE cells located PEPCK gene promoter treatment conditions
0.21842672.15166231.html.plaintext.txt	241	This probably due epitope masking antibodies specific different epitopes PCAF used
0.21842672.15166231.html.plaintext.txt	242	CBP p300 recruited PEPCK gene promoter upon Dex andor RA treatment despite structural homology binding CBP p300 differs
0.21842672.15166231.html.plaintext.txt	243	The recruitment CBP induced 3
0.21842672.15166231.html.plaintext.txt	244	9 fold upon treatment Dex RA respectively Fig
0.21842672.15166231.html.plaintext.txt	245	The recruitment CBP increased 6
0.21842672.15166231.html.plaintext.txt	246	5 fold combined treatment DexRA
0.21842672.15166231.html.plaintext.txt	247	By contrast recruitment p300 increased 4
0.21842672.15166231.html.plaintext.txt	248	7 fold upon treatment DexRA combination compared 2
0.21842672.15166231.html.plaintext.txt	249	0 fold increase upon treatment either RA Dex alone respectively
0.21842672.15166231.html.plaintext.txt	250	Antibodies specific different epitopes CBP p300 also used experiment similar recruitment profiles CBP p300 observed case data shown
0.21842672.15166231.html.plaintext.txt	251	The increased recruitment RNA pol II 2 2 5 fold upon treatment RA Dex RADex respectively parallels change p300 binding Fig
0.21842672.15166231.html.plaintext.txt	252	Similar changes binding patterns nuclear proteins noted primary hepatocytes data shown
0.21842672.15166231.html.plaintext.txt	253	View larger version 32K FIG
0.21842672.15166231.html.plaintext.txt	254	Recruitment p300 PEPCK gene promoter increased upon treatment DexRA
0.21842672.15166231.html.plaintext.txt	255	A association PCAF SRC 1 pCIP CBP p300 pol II endogenous PEPCK gene promoter measured ChIP H4IIE cells treated 2 h following conditions hormone 5 microM RA 500 nM Dex 500 nM Dex5 microM RA
0.21842672.15166231.html.plaintext.txt	256	No Ab lanes show results immunoprecipitations performed parallel without application primary antibodies
0.21842672.15166231.html.plaintext.txt	257	Input lanes show results samples subjected immunoprecipitation
0.21842672.15166231.html.plaintext.txt	258	B association proteins endogenous actin gene promoter measured ChIP negative control
0.21842672.15166231.html.plaintext.txt	259	Results representative four six independent experiments
0.21842672.15166231.html.plaintext.txt	260	p300 Is Specifically Involved Synergistic Effect The difference association p300 CBP H4IIE cells exposed DexRA interesting view observation proteins interact many transcription factors nuclear receptors regulation gene transcription often considered interchangeable
0.21842672.15166231.html.plaintext.txt	261	Selective reduction p300 CBP used establish role proteins synergistic effect DexRA PEPCK gene expression
0.21842672.15166231.html.plaintext.txt	262	siRNAs directed p300 CBP mRNA cloned pSUPER mammalian expression vector designated p300 siRNA CBP siRNA respectively
0.21842672.15166231.html.plaintext.txt	263	A Western blot analysis performed using cell lysates prepared 72 h transfection siRNAs KNRK cells shows siRNA directed either p300 CBP mRNA inhibited endogenous expression proteins Fig
0.21842672.15166231.html.plaintext.txt	264	To validate specificity siRNAs nitrocellulose membrane used p300 analysis re blotted CBP antibody vice versa
0.21842672.15166231.html.plaintext.txt	265	The p300 siRNA affect CBP gene expression CBP siRNA affect p300 gene expression
0.21842672.15166231.html.plaintext.txt	266	Actin expression affected either treatment
0.21842672.15166231.html.plaintext.txt	267	Thus siRNAs cause major selective reduction cognate proteins
0.21842672.15166231.html.plaintext.txt	268	View larger version 26K FIG
0.21842672.15166231.html.plaintext.txt	269	Selective reduction p300 CBP results loss synergistic effect
0.21842672.15166231.html.plaintext.txt	270	A 2 microg either siRNA vector targeted p300 empty pSUPER vector control transiently transfected rat KNRK cells see Materials Methods
0.21842672.15166231.html.plaintext.txt	271	Cells assayed p300 expression 72 h transfection using Western blot analysis cell lysates
0.21842672.15166231.html.plaintext.txt	272	The nitrocellulose membrane used p300 analysis re blotted CBP antibody assess specificity siRNA
0.21842672.15166231.html.plaintext.txt	273	Actin used control protein loading
0.21842672.15166231.html.plaintext.txt	274	The data shown representative four separate experiments
0.21842672.15166231.html.plaintext.txt	275	B transfection experiment performed described A using siRNA vector targeted CBP
0.21842672.15166231.html.plaintext.txt	276	The nitrocellulose membrane used CBP analysis re blotted p300 antibody assess specificity siRNA
0.21842672.15166231.html.plaintext.txt	277	C H4IIE cells transiently transfected 10 microg PEPCK LUC 100 ng PRL SV40 0
0.21842672.15166231.html.plaintext.txt	278	5 microg RSV GR CMX RAR CMX RXR expression vectors 15 microg either pSUPER alone control p300 siRNA CBP siRNA 72 h
0.21842672.15166231.html.plaintext.txt	279	Cells left untreated treated 500 nM Dex andor 5 microM RA 18 h harvested
0.21842672.15166231.html.plaintext.txt	280	Dual luciferase assays performed described Materials Methods
0.21842672.15166231.html.plaintext.txt	281	Results illustrated normalized basal activity PEPCK LUC
0.21842672.15166231.html.plaintext.txt	282	Data represent mean plus minus S
0.21842672.15166231.html.plaintext.txt	283	four independent experiments
0.21842672.15166231.html.plaintext.txt	284	H4IIE cells transfected PEPCK LUC RSV GR CMX RAR CMX RXR expression vectors either pSUPER alone control p300 siRNA CBP siRNA
0.21842672.15166231.html.plaintext.txt	285	5 microM RA 500 nM Dex combination two added cells 18 h harvest
0.21842672.15166231.html.plaintext.txt	286	By using PEPCK LUC reporter gene expression DexRA treatment 100 induction RA Dex 10 65 respectively Fig
0.21842672.15166231.html.plaintext.txt	287	This quantitatively similar pattern endogenous PEPCK gene expression
0.21842672.15166231.html.plaintext.txt	288	The Dex induced response reduced 35 maximal response p300 siRNA transfected H4IIE cells
0.21842672.15166231.html.plaintext.txt	289	By contrast RA induced response changed
0.21842672.15166231.html.plaintext.txt	290	The DexRA induced response however reduced 37 similar reduction Dex induced response
0.21842672.15166231.html.plaintext.txt	291	This result indicates synergy achieved DexRA abolished p300 expression reduced
0.21842672.15166231.html.plaintext.txt	292	The Dex induced response also reduced 29 CBP siRNA transfected H4IIE cells RA induced response affected
0.21842672.15166231.html.plaintext.txt	293	The DexRA induced response reduced 53 mainly decreased response Dex however synergistic effect DexRA PEPCK gene expression still remained Fig
0.21842672.15166231.html.plaintext.txt	294	These results indicate p300 CBP involved synergistic effect DexRA PEPCK gene expression
0.21842672.15166231.html.plaintext.txt	295	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES The GRU RARU PEPCK gene promoter consist several overlapping DNA elements described Introduction
0.21842672.15166231.html.plaintext.txt	296	Although DNA elements associated factors could involved synergistic action DexRA appears gAF3 lesser extent gAF1 importance gAF2 involved Fig
0.21842672.15166231.html.plaintext.txt	297	In particular site gAF3 binds RARRXR heterodimer critical Fig
0.21842672.15166231.html.plaintext.txt	298	The role RARRXR binding supported observation substitution element gAF1 selectively binds RARRXR promotes synergism elements selectively bind either HNF4 COUP TF bind wild type gAF1 Fig
0.21842672.15166231.html.plaintext.txt	299	Finally substitution consensus RARE gAF1 Fig
0.21842672.15166231.html.plaintext.txt	300	3 especially gAF3 Fig
0.21842672.15166231.html.plaintext.txt	301	5 markedly enhances synergistic effect cRARE gAF3 results 4 fold greater synergistic response obtained wild type promoter Fig
0.21842672.15166231.html.plaintext.txt	302	The Dex response reduced 50 60 experiment cRARE substituted gAF3 normally binds COUP TF accessory factor Dex response 11 13
0.21842672.15166231.html.plaintext.txt	303	Thus unliganded RARRXR bound cRARE cannot serve accessory factor Dex response
0.21842672.15166231.html.plaintext.txt	304	However RA added robust synergistic effect obtained noted Fig
0.21842672.15166231.html.plaintext.txt	305	Although indirect suggests ligand bound RARRXR serve accessory factor Dex response
0.21842672.15166231.html.plaintext.txt	306	The role accessory factors gAF1 gAF2 gAF3 HNF4COUP TF HNF3 COUP TF respectively increase affinity binding GR GR1 element 21
0.21842672.15166231.html.plaintext.txt	307	Thus GR1 converted high affinity site gAF1 gAF3 additional effect GR binding 21
0.21842672.15166231.html.plaintext.txt	308	Likewise GR1 converted palindromic GRE PEPCK gene expression maximal rate additional synergistic effect RA Fig
0.21842672.15166231.html.plaintext.txt	309	It reasonable presume Dex RA induce formation unique transcription complexes combination DexRA results yet another complex
0.21842672.15166231.html.plaintext.txt	310	We began exploration topic using ChIP assay
0.21842672.15166231.html.plaintext.txt	311	As noted previously 18 GR absent PEPCK gene promoter absence ligand
0.21842672.15166231.html.plaintext.txt	312	The addition Dex results 13 fold increase GR occupancy promoter Table I
0.21842672.15166231.html.plaintext.txt	313	Small amounts RAR RXR appear promoter absence ligand 2 2
0.21842672.15166231.html.plaintext.txt	314	5 fold increase binding occurs addition RA
0.21842672.15166231.html.plaintext.txt	315	Interestingly DexRA combination effect RAR RXR occupancy GR binding increases 13 21 fold
0.21842672.15166231.html.plaintext.txt	316	This concert observation RARRXR acts accessory factor increase affinity GR binding enhance transcription Fig
0.21842672.15166231.html.plaintext.txt	317	The occupancy accessory factors HNF4 HNF3 affected treatment noted previously 18
0.21842672.15166231.html.plaintext.txt	318	The promoter occupancy PCAF SRC 1 pCIP p300 CBP analyzed various hormone treatments
0.21842672.15166231.html.plaintext.txt	319	There binding PCAF treatment conditions Fig
0.21842672.15166231.html.plaintext.txt	320	This somewhat surprising view observations RA activated RARRXR heterodimers recruit PCAF DNA segments contain typical DR5 RARE vitro 26
0.21842672.15166231.html.plaintext.txt	321	RA Dex recruit pCIP SRC 1 however additional binding DexRA combination employed
0.21842672.15166231.html.plaintext.txt	322	Indeed binding p160 family members DexRA Dex treated cells Fig
0.21842672.15166231.html.plaintext.txt	323	A different pattern noted CBP
0.21842672.15166231.html.plaintext.txt	324	RA treatment resulted recruitment CBP Dex treatment DexRA level equivalent RA alone
0.21842672.15166231.html.plaintext.txt	325	The interesting observation concerns binding p300 PEPCK gene promoter
0.21842672.15166231.html.plaintext.txt	326	RA Dex increase binding p300 2 fold however combination results 5 fold increase Fig
0.21842672.15166231.html.plaintext.txt	327	A similar quantitative change occurs binding pol II promoter Table I
0.21842672.15166231.html.plaintext.txt	328	In concert observation McGrane co workers 27 recently showed pol II association PEPCK gene promoter reduced vitamin A deficient mice
0.21842672.15166231.html.plaintext.txt	329	A key role p300 synergistic action DexRA established selectively reducing cellular levels p300 CBP siRNA
0.21842672.15166231.html.plaintext.txt	330	Elimination either effect RA response whereas reduced Dex effect 50
0.21842672.15166231.html.plaintext.txt	331	The absence CBP effect synergistic effect DexRA combination removal p300 abolished response Fig
0.21842672.15166231.html.plaintext.txt	332	CBP p300 closely related proteins
0.21842672.15166231.html.plaintext.txt	333	Although encoded different genes several functional domains common
0.21842672.15166231.html.plaintext.txt	334	The designation CBPp300 implies common overall function however recent reports 28 suggest may govern unique cellular events
0.21842672.15166231.html.plaintext.txt	335	Mice inactivation single allele CBP develop variety hematological abnormalities seen mice similar inactivating mutation one p300 alleles
0.21842672.15166231.html.plaintext.txt	336	By contrast selective reduction p300 makes F9 cells resistant RA induced differentiation whereas similar reduction CBP effect 29
0.21842672.15166231.html.plaintext.txt	337	The linear increase recruitment p300 pol II conjunction nonlinear increase transcription response unexpected
0.21842672.15166231.html.plaintext.txt	338	Veitia 30 explained context series cooperative interactions promoter elementsenhancers transcription factors succession coregulator proteins ultimately basal transcription apparatus
0.21842672.15166231.html.plaintext.txt	339	The activation interferon gene response viral infection case point
0.21842672.15166231.html.plaintext.txt	340	The synergistic transcription response gene thought result formation unique activating surface composed domain p65 subunit NFB activation domains IRF1 ATF 2c Jun architectural protein HMGIY
0.21842672.15166231.html.plaintext.txt	341	This enhanceosome recruits CBPp300 basal transcription complex 31
0.21842672.15166231.html.plaintext.txt	342	The likely participation components unique complex assembled PEPCK gene promoter response DexRA awaits investigation
0.21842672.15166231.html.plaintext.txt	343	In addition PEPCK gene number genes encode enzymes involved metabolic processes promoters allow range gene expression
0.21842672.15166231.html.plaintext.txt	344	Examples include tyrosine aminotransferase fatty acid synthase L type pyruvate kinase insulin like growth factor binding proteins glucose 6 phosphate catalytic subunit genes 32 37
0.21842672.15166231.html.plaintext.txt	345	We used phrase metabolic control domain MCD describe array DNA elements associated transcription factors provide integrated response variety signals 2 15
0.21842672.15166231.html.plaintext.txt	346	As PEPCK gene MCD elucidated central importance one element gAF3 become apparent
0.21842672.15166231.html.plaintext.txt	347	4 involved accessory factor glucocorticoid response 8 important element retinoic acid response 7 thyroid hormone response 5 component cyclic AMP response unit 15 amplifying effect PGC 1 38 synergistic effect DexRA Figs
0.21842672.15166231.html.plaintext.txt	348	The proteins known bind gAF3 include COUP TF RARRXR
0.21842672.15166231.html.plaintext.txt	349	It remains seen whether proteins account roles played interesting element MCD
0.21842672.15166231.html.plaintext.txt	350	Insulin glucose inhibiting basal hormone induced transcription 3 6 25 set lower end expression PEPCK gene
0.21842672.15166231.html.plaintext.txt	351	The synergistic effect DexRA sets upper end expands repertoire responses available MCD
0.21842672.15166231.html.plaintext.txt	352	In regard interesting RA affords additional response presence high affinity GR binding element cGRE Fig
0.21842672.15166231.html.plaintext.txt	353	6 elicits exaggerated response otherwise wild type promoter
0.21842672.15166231.html.plaintext.txt	354	When considered context MCD PEPCK gene promoter may evolved weak GRE GR1 combined variety elements cognate transcription factors described allows graduated response fully therefore flexible means adjusting rate gluconeogenesis
0.21842672.15166231.html.plaintext.txt	355	FOOTNOTES This work supported National Institutes Health Grants DK35107 DK20593 Vanderbilt Diabetes Research Training Center Mentor based fellowship award American Diabetes Association B
0.21842672.15166231.html.plaintext.txt	356	The costs publication article defrayed part payment page charges
0.21842672.15166231.html.plaintext.txt	357	This article must therefore hereby marked advertisement accordance 18 U
0.21842672.15166231.html.plaintext.txt	358	Section 1734 solely indicate fact
0.21842672.15166231.html.plaintext.txt	359	To correspondence addressed Dept
0.21842672.15166231.html.plaintext.txt	360	Molecular Physiology Biophysics Vanderbilt University School Medicine Nashville TN 37232 0615
0.21842672.15166231.html.plaintext.txt	361	615 322 7004 Fax 615 322 7236
0.21842672.15166231.html.plaintext.txt	362	1 The abbreviations used PEPCK phosphoenolpyruvate carboxykinase RA trans retinoic acid Dex dexamethasone GR glucocorticoid receptor CBP CREB binding protein CREB cAMP response element binding protein ChIP chromatin immunoprecipitation assays RAR retinoic acid receptors RARE retinoic acid response element RARU retinoic acid response unit cRARE consensus RARE RXR retinoid X receptor siRNA small interfering RNA DMEM Dul beccos modified Eagles medium MCD metabolic control domain pol polymerase
0.21842672.15166231.html.plaintext.txt	363	ACKNOWLEDGMENTS We thank Deborah Brown help preparation manuscript Sam Wells Vanderbilt cell imaging core
0.21842672.15166231.html.plaintext.txt	364	Evans providing CMX RARCMX RXR plasmids Richard OBrien providing pSUPER plasmid
0.21842672.15166231.html.plaintext.txt	365	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Levine M
0.21842672.15166231.html.plaintext.txt	366	2003 Nature 424 147 151CrossRefMedline Order article via Infotrieve Lucas P
0.21842672.15166231.html.plaintext.txt	367	61 1131 1173CrossRefMedline Order article via Infotrieve Sasaki K
0.21842672.15166231.html.plaintext.txt	368	259 15242 15251AbstractFree Full Text Lucas P
0.21842672.15166231.html.plaintext.txt	369	88 2184 2188Abstract Park E
0.21842672.15166231.html.plaintext.txt	370	309 913 919Medline Order article via Infotrieve Scott D
0.21842672.15166231.html.plaintext.txt	371	273 24145 24151AbstractFree Full Text Scott D
0.21842672.15166231.html.plaintext.txt	372	271 6260 6264AbstractFree Full Text Scott D
0.21842672.15166231.html.plaintext.txt	373	12 482 491AbstractFree Full Text Hall R
0.21842672.15166231.html.plaintext.txt	374	92 412 416Abstract Wang J
0.21842672.15166231.html.plaintext.txt	375	10 794 800Abstract Scott D
0.21842672.15166231.html.plaintext.txt	376	271 31909 31914AbstractFree Full Text Yamada K
0.21842672.15166231.html.plaintext.txt	377	274 5880 5887AbstractFree Full Text Sugiyama T
0.21842672.15166231.html.plaintext.txt	378	12 1487 1498AbstractFree Full Text Stafford J
0.21842672.15166231.html.plaintext.txt	379	276 3811 3819AbstractFree Full Text Waltner Law M
0.21842672.15166231.html.plaintext.txt	380	278 10427 10435AbstractFree Full Text Nakashatri H
0.21842672.15166231.html.plaintext.txt	381	269 890 902AbstractFree Full Text OBrien R
0.21842672.15166231.html.plaintext.txt	382	15 1747 1758Abstract Duong D
0.21842672.15166231.html.plaintext.txt	383	277 32234 32242AbstractFree Full Text Brummelkamp T
0.21842672.15166231.html.plaintext.txt	384	2002 Science 296 550 553AbstractFree Full Text Pitot H
0.21842672.15166231.html.plaintext.txt	385	276 39885 39891AbstractFree Full Text Chen J
0.21842672.15166231.html.plaintext.txt	386	1995 Nature 377 454 457CrossRefMedline Order article via Infotrieve Schulman I
0.21842672.15166231.html.plaintext.txt	387	16 3807 3813Abstract Deleted proof Granner D
0.21842672.15166231.html.plaintext.txt	388	1983 Nature 305 545 549Medline Order article via Infotrieve Blanco J
0.21842672.15166231.html.plaintext.txt	389	12 1638 1651AbstractFree Full Text Scribner K
0.21842672.15166231.html.plaintext.txt	390	133 4112 4117AbstractFree Full Text Kung A
0.21842672.15166231.html.plaintext.txt	391	14 272 277AbstractFree Full Text Ugai H
0.21842672.15166231.html.plaintext.txt	392	77 481 494CrossRefMedline Order article via Infotrieve Veitia R
0.21842672.15166231.html.plaintext.txt	393	78 149 170CrossRefMedline Order article via Infotrieve Yie J
0.21842672.15166231.html.plaintext.txt	394	18 3074 3089AbstractFree Full Text Ganss R
0.21842672.15166231.html.plaintext.txt	395	8 895 903Abstract Schweizer M
0.21842672.15166231.html.plaintext.txt	396	30 1070 1072CrossRefMedline Order article via Infotrieve Yamada K
0.21842672.15166231.html.plaintext.txt	397	337 1 11CrossRefMedline Order article via Infotrieve Goswami R
0.21842672.15166231.html.plaintext.txt	398	1994 Endocrinology 134 736 743Abstract Suwanichkul A
0.21842672.15166231.html.plaintext.txt	399	269 30835 30841AbstractFree Full Text Vander Kooi B
0.21842672.15166231.html.plaintext.txt	400	278 11782 11793AbstractFree Full Text Herzog B
0.21842672.15166231.html.plaintext.txt	401	18 807 819AbstractFree Full Text
0.49352923.14602925.html.plaintext.txt	0	Critical role charged residues helix 7 ligand binding domain Hepatocyte Nuclear Factor 4 dimerisation transcriptional activity Jerome Eeckhoute Benedicte Oxombre Pierre Formstecher Philippe Lefebvre Bernard Laine
0.49352923.14602925.html.plaintext.txt	1	INSERM U459 Faculte de Medecine Henri Warembourg 1 Place de Verdun F 59045 Lille Cedex France
0.49352923.14602925.html.plaintext.txt	2	To correspondence addressed
0.49352923.14602925.html.plaintext.txt	3	Tel 33 03 20 62 69 51 Fax 33 03 20 62 68 84 Email blaineatlille
0.49352923.14602925.html.plaintext.txt	4	Received June 18 2003 Revised August 25 2003
0.49352923.14602925.html.plaintext.txt	5	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Hepatocyte Nuclear Factor 4 HNF4 NR2A1 central hepatocyte pancreatic ss cell functions
0.49352923.14602925.html.plaintext.txt	6	Along retinoid X receptor RXR HNF4 belongs nuclear receptor subfamily 2 NR2 characterised conserved arginyl residue glutamate residue insert helix 7 H7 ligand binding domain LBD
0.49352923.14602925.html.plaintext.txt	7	Crystallographic studies indicate R348 E352 residues RXR H7 involved charge driven interactions improve dimerisation
0.49352923.14602925.html.plaintext.txt	8	Consistent findings showed removing charge corresponding residues HNF4 H7 R258 E262 impaired dimerisation solution
0.49352923.14602925.html.plaintext.txt	9	Moreover results provide new concept according helices HNF4 LBD dimerisation interface contribute differently dimerisation required DNA binding unlike H9 H10 H7 involved DNA binding
0.49352923.14602925.html.plaintext.txt	10	Substitutions E262 decreased repression HNF4 transcriptional activity dominant negative HNF4 mutant highlighting importance residue dimerisation cell context
0.49352923.14602925.html.plaintext.txt	11	The E262 insert crucial HNF4 function since deletion abolished HNF4 transcriptional activity coactivator recruitment
0.49352923.14602925.html.plaintext.txt	12	The glutamate residue insert conserved arginyl residue H7 probably represent signature NR2 subfamily nuclear receptors
0.49352923.14602925.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Hepatocyte Nuclear Factor 4 transcription factor encoded two genes HNF4 HNF4 leading two subtypes proteins HNF4 NR2A1 HNF4 NR2A2 1
0.49352923.14602925.html.plaintext.txt	14	HNF4 central embryogenesis 23 required normal function hepatocytes pancreatic ss cells 45
0.49352923.14602925.html.plaintext.txt	15	HNF4 occupies key position complex transcription factor network directly regulates expression genes involved transport metabolism various nutrients well genes coding serum proteins 1
0.49352923.14602925.html.plaintext.txt	16	HNF4 linked human diseases mutations HNF4 response elements promoters factors VII IX correlated haemophilia mutations HNF4 gene found patients carrying syndrome maturity onset diabetes young 1 MODY1 16
0.49352923.14602925.html.plaintext.txt	17	Like members nuclear receptor superfamily HNF4 modular structure consisting functional domains 7
0.49352923.14602925.html.plaintext.txt	18	Two domains DNA binding domain DBD ligand binding domain LBD involved dimerisation HNF4 behaves homodimer 8
0.49352923.14602925.html.plaintext.txt	19	Dimerisation via DBD involved HNF4 dimerisation DNA whereas dimerisation via LBD essential dimerisation solution strongly stabilises HNF4 DNA complex 910
0.49352923.14602925.html.plaintext.txt	20	The LBD also involved functions including transcriptional activation interaction transcriptional partners
0.49352923.14602925.html.plaintext.txt	21	Both domains well conserved HNF4 11
0.49352923.14602925.html.plaintext.txt	22	Crystal structures LBDs HNF4 HNF4 recently resolved 1213
0.49352923.14602925.html.plaintext.txt	23	These LBDs adopt canonical fold helices 10 helices numbered H1 H12 follow conventional nomenclature ss sheets arranged antiparallel helical sandwich three layer structure shared LBD nuclear receptors 14
0.49352923.14602925.html.plaintext.txt	24	The LBD structures HNF4 HNF4 similar closely resemble RXR another member nuclear receptor subfamily 2 NR2
0.49352923.14602925.html.plaintext.txt	25	Indeed 194 core carbons LBD HNF4 RXR superimpose root mean square deviation rmsd 1
0.49352923.14602925.html.plaintext.txt	26	26 A 223 core carbons LBD HNF4 RXR superimpose r
0.49352923.14602925.html.plaintext.txt	27	In structures LBD dimerisation interface made residues helices 7 H7 9 H9 10 H10 major part interface made H10
0.49352923.14602925.html.plaintext.txt	28	HNF4 HNF4 activate transcription absence exogenous ligands considered constitutive transcriptional activators 111131516
0.49352923.14602925.html.plaintext.txt	29	Their LBDs tightly associated endogenous fatty acids act classical ligands likely required stability protein conformation 1213
0.49352923.14602925.html.plaintext.txt	30	HNF4 transcriptional activity enhanced transcription factors including COUP TF 17 Smad3 Smad4 18 coactivators members p160 family 1920 CBPp300 20 22 PGC 1 23
0.49352923.14602925.html.plaintext.txt	31	The HNF4 transcriptional activity also repressed negative transcriptional partners SHP 24 p53 25 SMRT 26
0.49352923.14602925.html.plaintext.txt	32	In crystal structure RXR LBD H7 adopts unusual helical geometry forces glutamic acid residue position 352 bulge outward H7 axis 27
0.49352923.14602925.html.plaintext.txt	33	This structure gives rise formation series intramolecular intermolecular hydrogen bonds improve RXR LBD homodimerisation 27
0.49352923.14602925.html.plaintext.txt	34	In particular residues E352 R348 directly involved dimerisation interface forming charge driven interactions
0.49352923.14602925.html.plaintext.txt	35	The helical conformation near E352 RXR homodimer resulting interactions also observed PPARRXR LBD heterodimer 28
0.49352923.14602925.html.plaintext.txt	36	Sequence alignment indicates glutamic acid residue arginyl residue also encountered equivalent positions human rat HNF4 E262 R258
0.49352923.14602925.html.plaintext.txt	37	Figure 1 shows residues conserved remote species Drosophila Xenopus HNF4ss specifically encountered members NR2 subfamily 27 29
0.49352923.14602925.html.plaintext.txt	38	Interestingly crystal structure HNF4 LBD bulge near E262 also observed H7 12
0.49352923.14602925.html.plaintext.txt	39	described glutamate single residue E insert H7 hypothesised may play crucial role function nuclear receptors belonging NR2 subfamily including HNF4 2728
0.49352923.14602925.html.plaintext.txt	40	We investigated role E262 R258 amino acid residues HNF4 function using biochemical mutagenesis studies
0.49352923.14602925.html.plaintext.txt	41	View larger version 29K Figure 1
0.49352923.14602925.html.plaintext.txt	42	Structure based amino acid sequence alignment H7 nuclear receptor LBDs adapted references 27 29
0.49352923.14602925.html.plaintext.txt	43	Usual names nuclear receptors indicated left side whereas names proposed Nuclear Receptor Nomenclature Committee indicated right side
0.49352923.14602925.html.plaintext.txt	44	The arrow boxed R indicate glutamate arginyl residues specifically found members NR2 subfamily
0.49352923.14602925.html.plaintext.txt	45	Positions functional domains I box activation function 2 AF 2 shown
0.49352923.14602925.html.plaintext.txt	46	position isoform 2 HNF4 HNF42 used study
0.49352923.14602925.html.plaintext.txt	47	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES DNA constructs Plasmid pcDNA3 HNF42 described Suaud et al
0.49352923.14602925.html.plaintext.txt	48	30 used template create pcDNA3 HNF42 R258M E262A E262M E262K E262 D261 E327M constructs site directed mutagenesis using QuickChangeTM kit Stratagene according supplier recommendations
0.49352923.14602925.html.plaintext.txt	49	Vectors pcDNA3 HNF4 AF 2 residues 1 358 pSG5 HNF43 described previously 3132
0.49352923.14602925.html.plaintext.txt	50	Vector pcDNA3 HNF4 AF 2 E262A generated site directed mutagenesis
0.49352923.14602925.html.plaintext.txt	51	Plasmid pGBKT7 HNF42 used express HNF42 fused c myc tag vitro obtained inserting PCR fragment encompassing human HNF42 cDNA EcoRI BamHI sites pGBKT7 Clontech
0.49352923.14602925.html.plaintext.txt	52	This vector used template create pGBKT7 HNF42 E262A E262 site directed mutagenesis
0.49352923.14602925.html.plaintext.txt	53	Plasmids pCMVss NHA p300 pGEX2TK p300340 528 kindly provided S
0.49352923.14602925.html.plaintext.txt	54	Plasmids pMT2 COUP TFII pTL1 myc COUP TFII AB pGEX5X2 PGC 136 797 pGEX2TK SRC 1a570 780 gifts S
0.49352923.14602925.html.plaintext.txt	55	Plasmid pGEX2TK HNF42 prepared strategy identical used cloning pGEX2TK COUP TFII 30 inserting PCR fragment encompassing human HNF42 cDNA
0.49352923.14602925.html.plaintext.txt	56	This pGEX2TK HNF42 construct used template generate pGEX2TK HNF42 E262A E262 site directed mutagenesis
0.49352923.14602925.html.plaintext.txt	57	The human HNF1 promoter 341183 cloned pGL3 gift G
0.49352923.14602925.html.plaintext.txt	58	All constructs verified DNA sequencing analysis
0.49352923.14602925.html.plaintext.txt	59	Co immunoprecipitation assays Wild type mutated HNF4 vitro synthesised reticulocyte lysates Promega
0.49352923.14602925.html.plaintext.txt	60	In co immunoprecipitation assays performed anti c myc tag antibody 5 microl non radiolabelled wild type mutated c myc HNF42 incubated 5 microl 35Smethionine labelled wild type mutated HNF42 1 h room temperature 30 microl final volume Ip buffer 50 mM Tris HCl pH 7
0.49352923.14602925.html.plaintext.txt	61	0 100 mM KCl 1 mM EDTA 1 mM DTT 0
0.49352923.14602925.html.plaintext.txt	62	5 mM phenylmethylsulphonyl fluoride 0
0.49352923.14602925.html.plaintext.txt	63	1 mgml leupeptin aprotinin pepstatin
0.49352923.14602925.html.plaintext.txt	64	Then 2 microg anti c myc tag antibody clone 9E10 Upstate Biotechnology added incubation continued 1 h
0.49352923.14602925.html.plaintext.txt	65	An aliquot 150 microl Ip buffer containing 3 mg hydrated protein A Sepharose CL 4B beads Sigma added samples incubated constant agitation additional 1 h
0.49352923.14602925.html.plaintext.txt	66	After extensive washing beads Ip buffer bound proteins resolved SDS PAGE
0.49352923.14602925.html.plaintext.txt	67	Co immunoprecipitation assays performed 455 antiserum 33 conducted similarly using 5 microl non radiolabelled wild type mutated HNF42 5 microl 35Smethionine labelled HNF43 0
0.49352923.14602925.html.plaintext.txt	68	Interactions quantified using ImageQuant software PhosphorImager Molecular Dynamics
0.49352923.14602925.html.plaintext.txt	69	GST pull assays GST pull assays performed described previously 30 using 35Smethionine labelled vitro synthesised HNF4 bacterially expressed GST fusion proteins
0.49352923.14602925.html.plaintext.txt	70	Interactions quantified using ImageQuant software PhosphorImager Molecular Dynamics
0.49352923.14602925.html.plaintext.txt	71	Electrophoretic mobility shift assays EMSA EMSA performed using vitro synthesised wild type mutated HNF42 32P labelled oligonucleotides 0
0.49352923.14602925.html.plaintext.txt	72	2 ng encompassing HNF4 response element human HNF1 promoter positions 66 48 1 mutated version response element denoted HNF1 HNF1 mt respectively site B position 67 85 1 human apolipoprotein CIII promoter denoted CIIIB
0.49352923.14602925.html.plaintext.txt	73	Mutations HNF1 mt site underlined following sequence half sites upper case tgaACTCCCaAGTTCAgtc
0.49352923.14602925.html.plaintext.txt	74	Complexes formed 20 microl final volume binding buffer 100 mM KCl 20 mM HEPES pH 7
0.49352923.14602925.html.plaintext.txt	75	1 mM EDTA 20 glycerol 1 mM DTT presence 1
0.49352923.14602925.html.plaintext.txt	76	25 microg polydI dC polydI dC
0.49352923.14602925.html.plaintext.txt	77	Complexes resolved non denaturing PAGE 1x TEA
0.49352923.14602925.html.plaintext.txt	78	DNA binding quantified using PhosphorImager
0.49352923.14602925.html.plaintext.txt	79	In supershift assays HNF4 proteins incubated 0
0.49352923.14602925.html.plaintext.txt	80	25 microl 455 HNF4 antiserum 33 15 min prior adding labelled probe
0.49352923.14602925.html.plaintext.txt	81	Cell culture transient transfection assays Human embryonic kidney HEK 293 1
0.49352923.14602925.html.plaintext.txt	82	5 x 105 cells per 24 well dishes COS 1 4 x 104 cells per 24 well dishes HeLa cells 5
0.49352923.14602925.html.plaintext.txt	83	5 x 104 cells per 24 well dishes grown transfected Suaud et al
0.49352923.14602925.html.plaintext.txt	84	31 plasmid amounts indicated figure legends
0.49352923.14602925.html.plaintext.txt	85	Luciferase activities measured using Bright Glo Luciferase assay system Promega
0.49352923.14602925.html.plaintext.txt	86	Western blot assays Aliquots 2
0.49352923.14602925.html.plaintext.txt	87	3 x 106 HeLa cells transfected 2 microg wild type mutated HNF42 expression vector whole cell extracts prepared Wang et al
0.49352923.14602925.html.plaintext.txt	88	Western blot assays carried Suaud et al
0.49352923.14602925.html.plaintext.txt	89	Data analysis Statistical analyses based Student test unpaired data using Prism software
0.49352923.14602925.html.plaintext.txt	90	The statistical significance differences values obtained mutant wild type HNF4 P indicated legends figures
0.49352923.14602925.html.plaintext.txt	91	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Residues E262 R258 important HNF42 dimerisation solution Figure 1 depicts amino acid sequence alignment H7 nuclear receptor LBDs
0.49352923.14602925.html.plaintext.txt	92	2728 inserted glutamate residue indicated arrow Fig
0.49352923.14602925.html.plaintext.txt	93	1 may facilitate RXR dimerisation helix conformation insertion generates ii carboxylic group forms salt bridge hydrogen bonds 2728
0.49352923.14602925.html.plaintext.txt	94	A similar conformation observed near corresponding E262 residue HNF4 LBD 12
0.49352923.14602925.html.plaintext.txt	95	We investigated role glutamate residue HNF42 dimerisation
0.49352923.14602925.html.plaintext.txt	96	To end HNF42 E262 residue deleted construct HNF42 E262 charge inverted construct HNF42 E262K removed constructs HNF42 E262A HNF42 E262M bulk residue conserved latter mutation
0.49352923.14602925.html.plaintext.txt	97	We analysed whether mutations affected ability labelled HNF42 mutants form dimers solution wild type HNF42 HNF42 WT
0.49352923.14602925.html.plaintext.txt	98	Dimerisation studied either co immunoprecipitation assays using c myc HNF42 WT GST pull assays using GST HNF42 WT
0.49352923.14602925.html.plaintext.txt	99	As expected HNF42 WT efficiently bound c myc HNF42 WT Fig
0.49352923.14602925.html.plaintext.txt	100	Conversely mutants failed bind efficiently c myc HNF42 WT Fig
0.49352923.14602925.html.plaintext.txt	101	Next analysed effects mutations dimerisation given mutant
0.49352923.14602925.html.plaintext.txt	102	For assays focused mutants E262A E262
0.49352923.14602925.html.plaintext.txt	103	In co immunoprecipitation assays dimer detectable either E262A E262 Fig
0.49352923.14602925.html.plaintext.txt	104	This result due lower expression mutated c myc HNF42 Fig
0.49352923.14602925.html.plaintext.txt	105	Impaired dimerisation mutants confirmed pull experiments performed increasingly stringent conditions
0.49352923.14602925.html.plaintext.txt	106	HNF42 WT dimerisation unaltered 300 mM KCl decreased 25 600 mM KCl Fig
0.49352923.14602925.html.plaintext.txt	107	In sharp contrast dimerisation dropped dramatically 300 600 mM KCl mutants Fig
0.49352923.14602925.html.plaintext.txt	108	Thus removing carboxylic group position 262 sufficient strongly impair HNF42 dimerisation solution
0.49352923.14602925.html.plaintext.txt	109	View larger version 31K Figure 2
0.49352923.14602925.html.plaintext.txt	110	E262 R258 involved HNF42 dimerisation solution
0.49352923.14602925.html.plaintext.txt	111	A B Analyses co immunoprecipitation assays GST pull assays respectively dimerisation immobilised wild type HNF42 fused c myc GST c myc HNF42 WT GST HNF42 WT wild type mutated 35Smethionine labelled HNF42
0.49352923.14602925.html.plaintext.txt	112	Graphs A B indicate means plus minus SE HNF42 mutant binding relative wild type protein three independent experiments
0.49352923.14602925.html.plaintext.txt	113	Inputs taken account binding quantifications
0.49352923.14602925.html.plaintext.txt	114	C Dimerisation analysed co immunoprecipitation assays HNF42 WT E262 E262A
0.49352923.14602925.html.plaintext.txt	115	For assay 35Smethionine labelled HNF42 incubated protein fused c myc tag
0.49352923.14602925.html.plaintext.txt	116	Control synthesis c myc HNF42 WT mutated proteins shown insert
0.49352923.14602925.html.plaintext.txt	117	D Dimerisation analysed GST pull assays HNF42 WT E262 E262A
0.49352923.14602925.html.plaintext.txt	118	For assay 35Smethionine labelled HNF42 incubated protein fused GST
0.49352923.14602925.html.plaintext.txt	119	Pull assays performed indicated ionic strength conditions
0.49352923.14602925.html.plaintext.txt	120	The graph indicates means plus minus SE HNF4 binding 300 600 mM KCl relative binding 100 mM KCl set 100 three independent experiments
0.49352923.14602925.html.plaintext.txt	121	E Dimerisation analysed co immunoprecipitation assays immobilised c myc HNF42 WT 35Smethionine labelled HNF42 WT R258M
0.49352923.14602925.html.plaintext.txt	122	The graph indicates mean plus minus SE HNF42 R258M binding relative wild type protein four independent experiments
0.49352923.14602925.html.plaintext.txt	123	Inputs taken account binding quantifications
0.49352923.14602925.html.plaintext.txt	124	In RXR R348 also involved dimerisation 2728
0.49352923.14602925.html.plaintext.txt	125	Interestingly arginyl residue specifically conserved members NR2 subfamily Fig
0.49352923.14602925.html.plaintext.txt	126	This led us investigate role corresponding R258 residue HNF42 dimerisation
0.49352923.14602925.html.plaintext.txt	127	When positive charge residue removed R258M mutant HNF4 dimerisation dropped Fig
0.49352923.14602925.html.plaintext.txt	128	2E although less markedly elicited E262 mutations compare decrease dimerisation Fig
0.49352923.14602925.html.plaintext.txt	129	Together results show involvement charged groups residues E262 R258 stabilisation HNF42 dimerisation solution
0.49352923.14602925.html.plaintext.txt	130	Mutations residues E262 R258 impair DNA binding Since HNF4 known bind DNA homodimer 8 analysed effect E262 R258 mutations HNF42 DNA binding
0.49352923.14602925.html.plaintext.txt	131	Surprisingly none mutations altered HNF42 binding HNF4 response element HNF1 promoter HNF1 site Fig
0.49352923.14602925.html.plaintext.txt	132	The specificity band shift ascertained supershifting HNF4 antiserum 455 33 Fig
0.49352923.14602925.html.plaintext.txt	133	Similar results obtained another HNF4 response element site B apoCIII promoter CIIIB site also direct repeat 1 DR1 Fig
0.49352923.14602925.html.plaintext.txt	134	3E results absence competitor
0.49352923.14602925.html.plaintext.txt	135	Results obtained increasing amounts labelled probe exclude lack detection DNA binding impairment E262A mutation due saturated binding Fig
0.49352923.14602925.html.plaintext.txt	136	Similar results obtained mutants data shown
0.49352923.14602925.html.plaintext.txt	137	Mutated wild type HNF4 yielded retarded band identical intensity electrophoretic mobility
0.49352923.14602925.html.plaintext.txt	138	More specifically observe band higher mobility corresponding HNF4 monomer bound DNA observed RAR monomer 15
0.49352923.14602925.html.plaintext.txt	139	In addition rule possibility mutants bound DNA two adjacent monomers performed EMSA HNF1 mt site containing one mutated half site obtained binding mutants Fig
0.49352923.14602925.html.plaintext.txt	140	Thus HNF4 mutants like wild type HNF4 bind DNA homodimers
0.49352923.14602925.html.plaintext.txt	141	To evidence possibly diminished interactions DNA performed EMSA less favorable conditions
0.49352923.14602925.html.plaintext.txt	142	First increased ionic strength 300 versus 100 mM KCl Fig
0.49352923.14602925.html.plaintext.txt	143	3A EMSA found difference DNA binding wild type mutated HNF4 data shown
0.49352923.14602925.html.plaintext.txt	144	Second carried competition experiments COUP TFII binds several HNF4 response elements
0.49352923.14602925.html.plaintext.txt	145	The rationale check whether nuclear receptor impinges DNA binding HNF42 E262A efficiently wild type HNF42
0.49352923.14602925.html.plaintext.txt	146	In assays truncated COUP TFII AB used distinguish complexes formed either HNF42 COUP TFII
0.49352923.14602925.html.plaintext.txt	147	EMSA performed CIIIB site since COUP TFII bind HNF1 site 1730
0.49352923.14602925.html.plaintext.txt	148	COUP TFII AB similarly competed HNF42 WT E262A DNA binding Fig
0.49352923.14602925.html.plaintext.txt	149	Also unlabelled DNA competed equally DNA binding proteins data shown
0.49352923.14602925.html.plaintext.txt	150	In addition observed mutations alter binding direct repeat 2 DR2 HNF4 binds less efficiently DR1 9 data shown
0.49352923.14602925.html.plaintext.txt	151	It appears therefore E262 residue play significant role HNF42 DNA binding
0.49352923.14602925.html.plaintext.txt	152	View larger version 49K Figure 3
0.49352923.14602925.html.plaintext.txt	153	Mutations E262 R258 residues impair HNF42 DNA binding
0.49352923.14602925.html.plaintext.txt	154	A DNA binding HNF42 mutants 32P labelled HNF4 response element HNF1 promoter HNF1 site
0.49352923.14602925.html.plaintext.txt	155	Control vitro synthesis wild type mutated HNF42 used EMSA shown insert values right end indicate molecular size markers
0.49352923.14602925.html.plaintext.txt	156	The graph indicates means plus minus SE mutated HNF42 DNA binding relative wild type protein three independent experiments
0.49352923.14602925.html.plaintext.txt	157	Unprogrammed reticulocyte lysate mock yielded shifted band
0.49352923.14602925.html.plaintext.txt	158	Supershifting performed presence specific 455 HNF4 antiserum
0.49352923.14602925.html.plaintext.txt	159	C EMSA performed constant amount HNF42 WT HNF42 E262A increasing amounts labelled HNF1 probe
0.49352923.14602925.html.plaintext.txt	160	D HNF42 E262A bind monomer half site HNF4 response element HNF1 mt
0.49352923.14602925.html.plaintext.txt	161	E Competition experiments COUP TFII AB
0.49352923.14602925.html.plaintext.txt	162	EMSA performed HNF4 response element apoCIII promoter CIIIB site using vitro synthesised HNF42 WT HNF42 E262A increasing amounts competitor COUP TFII AB
0.49352923.14602925.html.plaintext.txt	163	The amount reticulocyte lysate lane held constant appropriate addition unprogrammed lysate
0.49352923.14602925.html.plaintext.txt	164	The positions HNF42 COUP TFII AB homodimers bound DNA indicated
0.49352923.14602925.html.plaintext.txt	165	Differential effects dimerisation solution DNA binding mutations H7 H10 HNF4 LBD Within LBD I box shown constitute dimerisation interface mediates cooperative binding DNA nuclear receptors 35
0.49352923.14602925.html.plaintext.txt	166	The I box almost perfectly overlaps H9 H10 form major portion dimer interface RXR HNF4 homodimers 12132736
0.49352923.14602925.html.plaintext.txt	167	Mutagenesis studies also showed HNF4 I box important interaction interface homodimerisation solution 37 likely involved DNA binding 15
0.49352923.14602925.html.plaintext.txt	168	We therefore compared effects mutations H7 H10 HNF4 dimerisation solution DNA binding
0.49352923.14602925.html.plaintext.txt	169	Until role HNF4 I box studied using multiple double triple quadruple mutations 1537
0.49352923.14602925.html.plaintext.txt	170	For example K300E E327K HNF4 double mutant used show involvement salt bridge residues exclusive homodimerisation HNF4 15
0.49352923.14602925.html.plaintext.txt	171	For comparative study chose single mutation located H10 E327M
0.49352923.14602925.html.plaintext.txt	172	In co immunoprecipitation assays c myc HNF42 WT observed E327M mutation decreased HNF42 dimerisation solution 25 Fig
0.49352923.14602925.html.plaintext.txt	173	The extent decrease similar observed R258M mutation Fig
0.49352923.14602925.html.plaintext.txt	174	A similar drop HNF42 dimerisation solution E327M R258M mutations also observed GST pull assays Fig
0.49352923.14602925.html.plaintext.txt	175	Note impairment dimerisation E262 mutations stronger observed co immunoprecipitation GST pull assays Fig
0.49352923.14602925.html.plaintext.txt	176	The stronger effect E262A mutation HNF42 dimerisation solution confirmed different co immunoprecipitation assay unlabelled HNF42 WT R258M E262A E327M 455 antiserum raised common C terminus used co immunoprecipitate labelled HNF43 contains different C terminus recognised antiserum
0.49352923.14602925.html.plaintext.txt	177	R258M E262A E327M mutations strongly impaired ability HNF42 interact HNF43 Fig
0.49352923.14602925.html.plaintext.txt	178	4C thus confirming involvement three residues HNF4 dimerisation
0.49352923.14602925.html.plaintext.txt	179	Quantification indicated E262A mutation resulted strongest impairment HNF42 dimerisation solution Fig
0.49352923.14602925.html.plaintext.txt	180	View larger version 24K Figure 4
0.49352923.14602925.html.plaintext.txt	181	Differential effects dimerisation solution DNA binding mutations H7 H10 HNF4 LBD
0.49352923.14602925.html.plaintext.txt	182	A Dimerisation analysed co immunoprecipitation assays immobilised c myc HNF42 WT 35Smethionine labelled HNF42 WT E327M
0.49352923.14602925.html.plaintext.txt	183	The graph indicates mean plus minus SE HNF42 E327M binding relative wild type protein three independent experiments
0.49352923.14602925.html.plaintext.txt	184	Inputs taken account binding quantifications
0.49352923.14602925.html.plaintext.txt	185	B Dimerisation analysed GST pull assays immobilised GST HNF42 WT 35Smethionine labelled HNF42 WT R258M E327M
0.49352923.14602925.html.plaintext.txt	186	Pull assays performed various ionic strength conditions Figure 2D
0.49352923.14602925.html.plaintext.txt	187	The graph indicates means plus minus SE mutant binding relative wild type HNF4 three independent experiments
0.49352923.14602925.html.plaintext.txt	188	Inputs taken account binding quantifications
0.49352923.14602925.html.plaintext.txt	189	C Dimerisation analysed co immunoprecipitation assays using 455 antiserum immobilised HNF42 WT R258M E262A E327M 35Smethionine labelled HNF43 recognised 455 antiserum
0.49352923.14602925.html.plaintext.txt	190	Control HNF42 protein synthesis shown insert
0.49352923.14602925.html.plaintext.txt	191	The graph indicates means plus minus SE HNF43 retention HNF42 mutants relative HNF43 retention HNF42 WT four independent experiments
0.49352923.14602925.html.plaintext.txt	192	Control protein synthesis taken account binding quantifications
0.49352923.14602925.html.plaintext.txt	193	D DNA binding HNF42 E327M HNF1 site analysed EMSA performed Figure 3A
0.49352923.14602925.html.plaintext.txt	194	Supershifts obtained presence 455 HNF4 antiserum indicated
0.49352923.14602925.html.plaintext.txt	195	Control protein synthesis shown insert
0.49352923.14602925.html.plaintext.txt	196	The graph indicates mean plus minus SE HNF42 E327M DNA binding relative wild type protein three independent experiments
0.49352923.14602925.html.plaintext.txt	197	In contrast E262A R258M mutations E327M mutation moderately significantly decreased HNF42 DNA binding HNF1 site Fig
0.49352923.14602925.html.plaintext.txt	198	The specificity band shift ascertained supershifting 455 antiserum Fig
0.49352923.14602925.html.plaintext.txt	199	Interestingly intensities supershifted bands obtained wild type E327M HNF4 similar
0.49352923.14602925.html.plaintext.txt	200	It previously shown impaired DNA binding HNF4 mutants
0.49352923.14602925.html.plaintext.txt	201	K300E E327K R154X due decreased dimerisation could rescued presence antibodies facilitate dimerisation
0.49352923.14602925.html.plaintext.txt	202	This phenomenon likely due bivalency antigen recognition antibodies 1532
0.49352923.14602925.html.plaintext.txt	203	Conversely decreased DNA binding due loss dimerisation DNA binding recovered presence antibodies observed D126Y D126H HNF4 mutants 38
0.49352923.14602925.html.plaintext.txt	204	Therefore decreased DNA binding impaired dimerisation E327M mutant directly correlated
0.49352923.14602925.html.plaintext.txt	205	E327M mutation also impaired HNF42 DNA binding CIIIB site synthetic DR2 site data shown
0.49352923.14602925.html.plaintext.txt	206	Our results confirm H10 H9 constitute motif LBD dimerisation interface required efficient DNA binding HNF4 15 also show another region LBD dimerisation interface namely H7 required strong DNA binding protein
0.49352923.14602925.html.plaintext.txt	207	Deletion E262 residue dramatically impairs HNF42 transcriptional activity Next investigated effects mutations E262 R258 residues HNF42 transcriptional activity
0.49352923.14602925.html.plaintext.txt	208	The HNF42 mediated activation HNF1 promoter altered substitution mutations HeLa cells Fig
0.49352923.14602925.html.plaintext.txt	209	However HNF4 transcriptional activity abolished E262 deletion Fig
0.49352923.14602925.html.plaintext.txt	210	In HEK 293 COS 1 cells transcriptional activity unaffected substitution mutations dramatically impaired deletion mutation E262 Fig
0.49352923.14602925.html.plaintext.txt	211	5B C data wild type E262A E262 shown
0.49352923.14602925.html.plaintext.txt	212	The loss activation HNF42 E262 neither due lower protein expression controlled western blotting Fig
0.49352923.14602925.html.plaintext.txt	213	6D unfolding protein assessed limited protease mapping assays using chymotrypsin trypsin data shown
0.49352923.14602925.html.plaintext.txt	214	Deletion neighbouring residue D261 also abolished HNF4 transcriptional activity Fig
0.49352923.14602925.html.plaintext.txt	215	The dramatic drop HNF4 transcriptional activity caused E262 deletion prompted us determine whether mutant exhibits dominant negative effect wild type protein
0.49352923.14602925.html.plaintext.txt	216	However HNF42 E262 unable repress transcriptional activity wild type HNF4 Fig
0.49352923.14602925.html.plaintext.txt	217	View larger version 22K Figure 5
0.49352923.14602925.html.plaintext.txt	218	Deletion E262 strongly affects HNF42 transcriptional activity
0.49352923.14602925.html.plaintext.txt	219	HeLa A HEK 293 B COS 1 cells C transiently transfected 12
0.49352923.14602925.html.plaintext.txt	220	5 ng expression vector wild type mutated HNF42 corresponding empty vector together 250 ng HNF1 promoter construct
0.49352923.14602925.html.plaintext.txt	221	Fold induction refers activity HNF42 derivative set 1
0.49352923.14602925.html.plaintext.txt	222	Results means plus minus SE three independent experiments performed triplicate
0.49352923.14602925.html.plaintext.txt	223	0018 E262 mutant A C respectively P 0
0.49352923.14602925.html.plaintext.txt	224	0001 D261 mutant A
0.49352923.14602925.html.plaintext.txt	225	D Western blotting HeLa cell extracts
0.49352923.14602925.html.plaintext.txt	226	E HNF4 E262 exhibit dominant negative activity wild type HNF4
0.49352923.14602925.html.plaintext.txt	227	COS 1 cells transfected C except equal amounts wild type HNF4 HNF4 E262 control vector co transfected
0.49352923.14602925.html.plaintext.txt	228	F G Effects substitution mutations dominant negative activity HNF4 AF 2
0.49352923.14602925.html.plaintext.txt	229	COS 1 cells transfected C except F plasmids expressing wild type E262A E262K HNF4 co transfected equal amount vector expressing HNF4 AF 2 control vector whereas G pcDNA3 HNF42 WT co transfected equal amount vectors expressing HNF4 AF 2 HNF4 AF 2 E262A control vector
0.49352923.14602925.html.plaintext.txt	230	Activation HNF1 promoter expressed relative obtained full length proteins expressed
0.49352923.14602925.html.plaintext.txt	231	Results means plus minus SE three independent experiments performed triplicate
0.49352923.14602925.html.plaintext.txt	232	View larger version 23K Figure 6
0.49352923.14602925.html.plaintext.txt	233	Deletion E262 markedly decreases recruitment transcriptional partners
0.49352923.14602925.html.plaintext.txt	234	A GST pull assays performed using GST SRC 1a 570 780 GST p300 340 528 GST PGC 1 36 797 GST COUP TFII 35Smethionine labelled WT mutated HNF42
0.49352923.14602925.html.plaintext.txt	235	Inputs correspond 5 2 experiment GST SRC 1a amounts labelled proteins used assays
0.49352923.14602925.html.plaintext.txt	236	B C Effects mutations E262 residue enhancement HNF42 transcriptional activity p300 COUP TFII respectively
0.49352923.14602925.html.plaintext.txt	237	HeLa cells transiently transfected 12
0.49352923.14602925.html.plaintext.txt	238	5 ng wild type mutated HNF42 expression vector 250 ng HNF1 promoter construct 250 ng empty control vector white bars expression vectors black bars p300 COUP TFII
0.49352923.14602925.html.plaintext.txt	239	Shown per cent enhancements wild type mutated HNF4 activities
0.49352923.14602925.html.plaintext.txt	240	Results means plus minus SE three independent experiments performed triplicate
0.49352923.14602925.html.plaintext.txt	241	To gain insight consequences altered dimerisation HNF4 substitution mutations took advantage fact truncated HNF4 lacking AF 2 activation function module HNF4 AF 2 left part Fig
0.49352923.14602925.html.plaintext.txt	242	5F exhibits dominant negative effect ability dimerise wild type protein 7
0.49352923.14602925.html.plaintext.txt	243	In first set experiments compared HNF4 AF 2 repression transcriptional activities wild type HNF4 two mutants E262A E262K
0.49352923.14602925.html.plaintext.txt	244	The rationale dominant negative mutant would exhibit weaker repression mutant HNF4 impaired dimerisation wild type HNF4
0.49352923.14602925.html.plaintext.txt	245	HNF4 AF 2 reduced activity wild type HNF4 50 reduced E262A E262K mutants 29 26 respectively Fig
0.49352923.14602925.html.plaintext.txt	246	Accordingly compared HNF4 AF 2 HNF4 AF 2 bearing E262A mutation HNF4 AF 2 E262A exhibited weaker repressive activity wild type protein
0.49352923.14602925.html.plaintext.txt	247	Indeed HNF4 AF 2 reduced wild type HNF4 mediated activation transcription 50 HNF4 AF 2 E262A reduced 30 Fig
0.49352923.14602925.html.plaintext.txt	248	By demonstrating substitution mutations E262 affect repression HNF4 mediated activation transcription results highlight importance residue dimerisation cell context
0.49352923.14602925.html.plaintext.txt	249	The E262 insert required efficient recruitment coactivators HNF4 Next investigated effects mutations physical interaction HNF42 transcriptional coactivators
0.49352923.14602925.html.plaintext.txt	250	In study included interaction COUP TFII acts HNF4 transcriptional partner HNF1 promoter 17
0.49352923.14602925.html.plaintext.txt	251	GST pull assays showed E262 deletion markedly impaired HNF42 interaction SRC 1a p300 PGC 1 COUP TFII whereas substitution mutations E262 alter interactions Fig
0.49352923.14602925.html.plaintext.txt	252	In line data enhancement HNF42 transcriptional activity HNF1 promoter p300 COUP TFII altered substitution mutations abolished E262 deletion evidenced transient transfection assays Fig
0.49352923.14602925.html.plaintext.txt	253	Deletion E262 residue also disrupted functional cooperation HNF42 SRC 1a data shown
0.49352923.14602925.html.plaintext.txt	254	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES We observed two charged residues located H7 HNF4 LBD
0.49352923.14602925.html.plaintext.txt	255	R258 E262 involved HNF4 dimerisation solution
0.49352923.14602925.html.plaintext.txt	256	We failed detect significant impairment DNA binding substitution mutants
0.49352923.14602925.html.plaintext.txt	257	At first glance may seem striking since dimerisation via LBD thought crucial strong HNF4 DNA binding
0.49352923.14602925.html.plaintext.txt	258	However accuracy findings verified fact results obtained various pull co immunoprecipitation assays converge ii methods EMSA allowed us detect expected impairments due E327M mutation located H10
0.49352923.14602925.html.plaintext.txt	259	In addition results agreement recent crystallographic studies HNF4 LBD indicate H7 together H9 H10 constitute dimerisation interface nuclear receptor 1213
0.49352923.14602925.html.plaintext.txt	260	The interest work describe critical role charge R258 E262 residues dimerisation solution HNF4 role suggested Gampe et al
0.49352923.14602925.html.plaintext.txt	261	crystal structure RXR 2728
0.49352923.14602925.html.plaintext.txt	262	Mutants nuclear receptors deficient dimerisation solution vitro analysis still able efficiently bind DNA already described 39 41
0.49352923.14602925.html.plaintext.txt	263	To explain behaviour several mutants suggested dimers stabilised DNA via DBD dimerisation interface
0.49352923.14602925.html.plaintext.txt	264	However hypothesis unlikely since E327M mutation impaired DNA binding spite lower effect dimerisation solution E262 mutations
0.49352923.14602925.html.plaintext.txt	265	A probable explanation efficient DNA binding H7 mutants HNF4 dimerisation interface improved DNA binding induced conformational change LBD
0.49352923.14602925.html.plaintext.txt	266	An allosteric effect DNA modulated HNF4 recruitment co repressors recently documented 42
0.49352923.14602925.html.plaintext.txt	267	We also observed allosteric effect DNA likely occurs LBD modulates coactivator recruitment data shown
0.49352923.14602925.html.plaintext.txt	268	Like substitution mutants H7 several missense HNF4 mutants including naturally occurring mutants associated diabetes 63038 also exhibit unaltered slightly impaired transcriptional activities transient transfection assays
0.49352923.14602925.html.plaintext.txt	269	Failure detect subtle loss HNF4 function assays protein overexpressed exclude mutations may greater consequences HNF4 function protein expressed normal levels
0.49352923.14602925.html.plaintext.txt	270	Interestingly significant effect substitution mutants H7 HNF4 transcriptional activity could detected analysing repression activity HNF4 mutant exhibiting dominant negative activity
0.49352923.14602925.html.plaintext.txt	271	These results demonstrate importance E262 HNF4 dimerisation cell context
0.49352923.14602925.html.plaintext.txt	272	Moreover kept mind activity nuclear receptors repressed proteins prevent dimerisation 4344
0.49352923.14602925.html.plaintext.txt	273	HNF4 target AMP activated protein kinase inhibits HNF4 activity decreasing dimerisation 45
0.49352923.14602925.html.plaintext.txt	274	The ability HNF4 form highly stable homodimer solution 8 likely crucial type repressive mechanism exclusively occur DNA
0.49352923.14602925.html.plaintext.txt	275	Other pathways necessarily require DNA binding include cross regulatory mechanisms nuclear receptors frequently involved
0.49352923.14602925.html.plaintext.txt	276	In mechanisms dimerisation major importance 46
0.49352923.14602925.html.plaintext.txt	277	Since HNF4 known interact numerous transcription factors including Smad proteins 18 likely participates cross regulatory pathways
0.49352923.14602925.html.plaintext.txt	278	Therefore involvement H7 residues dimerisation solution may crucial HNF4 biological activities
0.49352923.14602925.html.plaintext.txt	279	Results obtained deletion mutant HNF4 E262 indicate E insert required HNF4 transcriptional activity recruitment transcriptional partners
0.49352923.14602925.html.plaintext.txt	280	Note probably due part impaired dimerisation HNF4 E262 exhibit dominant negative activity
0.49352923.14602925.html.plaintext.txt	281	None MODY1 associated HNF4 mutants repress wild type HNF4 activity 6
0.49352923.14602925.html.plaintext.txt	282	Even single double mutations AF 2 module crucial HNF4 transcriptional activity result dominant negative effect J
0.49352923.14602925.html.plaintext.txt	283	Eeckhoute unpublished results
0.49352923.14602925.html.plaintext.txt	284	Interestingly HNF4 D261 mutant deletion neighbouring residue exhibited abolished transcriptional activity unaltered DNA binding EMSA data shown behaviour similar E262 mutant
0.49352923.14602925.html.plaintext.txt	285	These findings may explained loss special conformation helix H7 hypothesised result presence additional residue E insert 28
0.49352923.14602925.html.plaintext.txt	286	The D261 E262 deletions probably modify orientation side chain residues H7
0.49352923.14602925.html.plaintext.txt	287	Several residues H7 point towards HNF4 ligand binding pocket probably participate fatty acid binding required stability function HNF4 HNF4 1213
0.49352923.14602925.html.plaintext.txt	288	The marked decrease HNF4 transcriptional activity recruitment transcriptional partners caused E262 deletion may reflect alteration fatty acid binding secondary loss helix conformation generated glutamate residue
0.49352923.14602925.html.plaintext.txt	289	From mechanistic point view results unravel distinct contributions H7 H9 H10 HNF4 dimerisation DNA binding
0.49352923.14602925.html.plaintext.txt	290	H9 H10 constitute core LBD dimerisation interface several non steroid nuclear receptors 27364748
0.49352923.14602925.html.plaintext.txt	291	This core required efficient DNA binding 35
0.49352923.14602925.html.plaintext.txt	292	In HNF4 core also involved dimerisation required DNA binding evidenced using double mutation H9 H10 15
0.49352923.14602925.html.plaintext.txt	293	We observed single mutation H10 E327M sufficient alter HNF4 dimerisation DNA binding
0.49352923.14602925.html.plaintext.txt	294	The role H7 nuclear receptors less extensively studied recent crystallographic data indicate contribution dimerisation varies according receptor RXR homodimeric heterodimeric state 47
0.49352923.14602925.html.plaintext.txt	295	Concerning HNF4 results clearly show H7 crucial role dimerisation solution contribute dimerisation activity required DNA binding
0.49352923.14602925.html.plaintext.txt	296	In conclusion results demonstrate key role H7 HNF4 dimerisation solution provide new concept helices HNF4 LBD dimerisation interface contribute differently dimerisation required DNA binding whereas H9 H10 required DNA binding H7 involved solely dimerisation solution
0.49352923.14602925.html.plaintext.txt	297	Our data also show key role E262 insert causes special conformation H7 observed RXR HNF4
0.49352923.14602925.html.plaintext.txt	298	The key role glutamate likely shared members NR2 subfamily specifically encountered probably E insert corresponds signature subfamily
0.49352923.14602925.html.plaintext.txt	299	ACKNOWLEDGEMENTS The authors indebted Drs S
0.49352923.14602925.html.plaintext.txt	300	Tsai generous gift plasmids
0.49352923.14602925.html.plaintext.txt	301	Lefebvre collaborators helpful discussions I
0.49352923.14602925.html.plaintext.txt	302	Briche technical assistance L
0.49352923.14602925.html.plaintext.txt	303	Hauffman Touzet proofreading
0.49352923.14602925.html.plaintext.txt	304	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES SladekF
0.49352923.14602925.html.plaintext.txt	305	2001 Hepatocyte Nuclear Factor 4alpha
0.49352923.14602925.html.plaintext.txt	306	eds Nuclear Receptors Genetic Disease
0.49352923.14602925.html.plaintext.txt	307	Academic Press San Francisco CA pp
0.49352923.14602925.html.plaintext.txt	308	1997 Murine gastrulation requires HNF 4 regulated gene expression visceral endoderm tetraploid rescue Hnf 4 embryos
0.49352923.14602925.html.plaintext.txt	309	1998 The embryonic expression tissue specific transcription factor HNF1 alpha Xenopus rapid activation HNF4 delayed induction mesoderm inducers
0.49352923.14602925.html.plaintext.txt	310	2001 Hepatocyte Nuclear Factor 4alpha Nuclear Receptor 2A1 essential maintenance hepatic gene expression lipid homeostasis
0.49352923.14602925.html.plaintext.txt	311	2000 HNF4alpha regulates expression pancreatic beta cell genes implicated glucose metabolism nutrient induced insulin secretion
0.49352923.14602925.html.plaintext.txt	312	2001 Mutations human genes encoding transcription factors hepatocyte nuclear factor HNF1 HNF4 families functional pathological consequences
0.49352923.14602925.html.plaintext.txt	313	1997 Functional domains nuclear receptor Hepatocyte Nuclear Factor 4
0.49352923.14602925.html.plaintext.txt	314	1995 Exclusive homodimerization orphan receptor hepatocyte nuclear factor 4 defines new subclass nuclear receptors
0.49352923.14602925.html.plaintext.txt	315	1997 The DNA binding domain Hepatocyte Nuclear Factor 4 mediates cooperative specific binding DNA heterodimerization retinoid X receptor
0.49352923.14602925.html.plaintext.txt	316	1997 Proposed mechanism stabilization nuclear receptor DNA binding via protein dimerization
0.49352923.14602925.html.plaintext.txt	317	1996 Human hepatocyte nuclear factor 4 isoforms encoded distinct differentially expressed genes
0.49352923.14602925.html.plaintext.txt	318	2002 Crystal structure HNF4alpha ligand binding domain complex endogenous fatty acid ligand
0.49352923.14602925.html.plaintext.txt	319	2002 Hepatocyte Nuclear Factor 4 transcription factor constitutively binds fatty acids
0.49352923.14602925.html.plaintext.txt	320	2000 Nuclear receptor ligand binding domains three dimensional structures molecular interactions pharmacological implications
0.49352923.14602925.html.plaintext.txt	321	2000 Analysis protein dimerization ligand binding orphan receptor HNF4alpha
0.49352923.14602925.html.plaintext.txt	322	2000 Inhibitor tissue specific transcription factor HNF4 potential regulator early Xenopus development
0.49352923.14602925.html.plaintext.txt	323	1997 Chicken ovalbumin upstream promoter transcription factors act auxiliary cofactors hepatocyte nuclear factor 4 enhance hepatic gene expression
0.49352923.14602925.html.plaintext.txt	324	2003 Mechanism transcriptional cross talk transforming growth factor beta regulated Smad3 Smad4 proteins orphan nuclear receptor Hepatocyte Nuclear Factor 4
0.49352923.14602925.html.plaintext.txt	325	1998 SRC 1 GRIP1 coactivate transcription hepatocyte nuclear factor 4
0.49352923.14602925.html.plaintext.txt	326	1999 Modulation transcriptional activation coactivator interaction splicing variation F domain nuclear receptor hepatocyte nuclear factor 4 alpha 1
0.49352923.14602925.html.plaintext.txt	327	1999 CREB binding protein transcriptional coactivator hepatocyte nuclear factor 4 enhances apolipoprotein gene expression
0.49352923.14602925.html.plaintext.txt	328	2000 Acetylation regulates transcription factor activity multiple levels
0.49352923.14602925.html.plaintext.txt	329	2001 Control hepatic gluconeogenesis transcriptional coactivator PGC 1
0.49352923.14602925.html.plaintext.txt	330	2000 The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 retinoid X receptor transactivation two mechanisms repression
0.49352923.14602925.html.plaintext.txt	331	2002 Repression hepatocyte nuclear factor 4alpha tumor suppressor p53 involvement ligand binding domain histone deacetylase activity
0.49352923.14602925.html.plaintext.txt	332	2002 Competitive cofactor recruitment orphan receptor hepatocyte nuclear factor 4alpha1 modulation F domain
0.49352923.14602925.html.plaintext.txt	333	2000 Structural basis autorepression retinoid X receptor tetramer formation AF 2 helix
0.49352923.14602925.html.plaintext.txt	334	2000 Asymmetry PPARgammaRXRalpha crystal structure reveals molecular basis heterodimerization among nuclear receptors
0.49352923.14602925.html.plaintext.txt	335	2001 The human nuclear xenobiotic receptor PXR structural determinants directed promiscuity
0.49352923.14602925.html.plaintext.txt	336	1999 Functional study E276Q mutant Hepatocyte Nuclear Factor 4 found type 1 maturity onset diabetes young impaired synergy Chicken Ovalbumin Upstream Promoter Transcription Factor II Hepatocyte Nuclear Factor 1 promoter
0.49352923.14602925.html.plaintext.txt	337	1999 The activity activation function 2 human hepatocyte nuclear factor 4 HNF 4 differently modulated F domains various origins
0.49352923.14602925.html.plaintext.txt	338	2000 Functional properties R154X HNF 4alpha protein generated mutation associated maturity onset diabetes young type 1
0.49352923.14602925.html.plaintext.txt	339	Jr 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.49352923.14602925.html.plaintext.txt	340	1999 The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit identification functional domains accessory factors HNF3 beta hepatic nuclear factor 3 beta HNF4 necessity proper alignment cognate binding sites
0.49352923.14602925.html.plaintext.txt	341	1996 Two distinct dimerization interfaces differentially modulate target gene specificity nuclear hormone receptors
0.49352923.14602925.html.plaintext.txt	342	1995 Crystal structure ligand binding domain human nuclear receptor RXR alpha
0.49352923.14602925.html.plaintext.txt	343	1998 Identification critical residues heterodimerization within ligand binding domain retinoid X receptor
0.49352923.14602925.html.plaintext.txt	344	2002 Mutations hepatocyte nuclear factor 4alpha gene associated diabetes result greater loss HNF4alpha function pancreatic beta cells nonpancreatic beta cells reduced activation apolipoprotein CIII promoter hepatic cells
0.49352923.14602925.html.plaintext.txt	345	1999 Conserved amino acids ligand binding taui domains peroxisome proliferator activated receptor alpha necessary heterodimerization RXR
0.49352923.14602925.html.plaintext.txt	346	1999 Vitamin D dependent suppression human atrial natriuretic peptide gene promoter activity requires heterodimer assembly
0.49352923.14602925.html.plaintext.txt	347	2001 Definition surface thyroid hormone receptor ligand binding domain association homodimers heterodimers retinoid X receptor
0.49352923.14602925.html.plaintext.txt	348	2002 Developmentally regulated N terminal variants nuclear receptor HNF4alpha mediate multiple interactions coactivator corepressorHDAC complexes
0.49352923.14602925.html.plaintext.txt	349	2000 The LIMhomeodomain protein islet 1 modulates estrogen receptor functions
0.49352923.14602925.html.plaintext.txt	350	2002 Modulation estrogen receptor mediated transactivation orphan receptor TR4 MCF 7 cells
0.49352923.14602925.html.plaintext.txt	351	2003 AMP activated protein kinase regulates HNF4alpha transcriptional activity inhibiting dimer formation decreasing protein stability
0.49352923.14602925.html.plaintext.txt	352	2000 Mutations estrogen receptor ligand binding domain discriminate hormone dependent transactivation transrepression
0.49352923.14602925.html.plaintext.txt	353	2000 Crystal structure heterodimeric complex RAR RXR ligand binding domains
0.49352923.14602925.html.plaintext.txt	354	1999 Nuclear receptor ligands ligand binding domains
0.2717503.15890675.html.plaintext.txt	0	Haploinsufficiency Chicken Ovalbumin Upstream Promoter Transcription Factor II Female Reproduction Norio Takamoto Isao Kurihara Kevin Lee Francesco J
0.2717503.15890675.html.plaintext.txt	1	DeMayo Ming Jer Tsai Sophia Y
0.2717503.15890675.html.plaintext.txt	2	Department Molecular Cellular Biology Program Development Baylor College Medicine Houston Texas 77030
0.2717503.15890675.html.plaintext.txt	3	Address correspondence requests reprints Sophia Y
0.2717503.15890675.html.plaintext.txt	4	Department Molecular Cellular Biology Baylor College Medicine One Baylor Plaza Houston Texas 77030
0.2717503.15890675.html.plaintext.txt	5	edu u d mtsaiatbcm
0.2717503.15890675.html.plaintext.txt	6	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The chicken ovalbumin upstream promoter transcription factor II COUP TFII member orphan nuclear receptor transcription factor family
0.2717503.15890675.html.plaintext.txt	7	Genetic ablation COUP TFII results early embryonic lethality demonstrates gene required cardiac vascular development
0.2717503.15890675.html.plaintext.txt	8	Expression COUP TFII persists throughout postnatal life various tissues including female reproductive tract
0.2717503.15890675.html.plaintext.txt	9	However physiological function COUP TFII female reproduction extensively analyzed
0.2717503.15890675.html.plaintext.txt	10	Here provide phenotypic evidences haploinsufficiency COUP TFII mice demonstrates important role COUP TFII normal female reproduction
0.2717503.15890675.html.plaintext.txt	11	COUP TFII females show significantly reduced fecundity irregular estrus cycles delayed puberty retarded postnatal growth
0.2717503.15890675.html.plaintext.txt	12	Analysis reduced fertility revealed although ovarian function normal respect ovulation ovaries reduced ability synthesize progesterone response exogenous gonadotropins
0.2717503.15890675.html.plaintext.txt	13	This reduction due reduction expression steroidogenic enzymes important progesterone synthesis reduction vascularization COUP TFII heterozygotes
0.2717503.15890675.html.plaintext.txt	14	Analysis uterine function demonstrated reduced response experimentally induced decidual cell reaction indicating ability uterus support embryo implantation reduced
0.2717503.15890675.html.plaintext.txt	15	Taken together data show global impact gene dosage effects COUP TFII female postnatal life indicates requirement COUP TFII normal female reproduction particular uterine endometrial functions periimplantation period
0.2717503.15890675.html.plaintext.txt	16	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES CHICKEN OVALBUMIN upstream promoter transcription factors COUP TFs NRF2 orphan members steroidthyroid hormone receptor superfamily 1
0.2717503.15890675.html.plaintext.txt	17	Two highly conserved COUP TF genes COUP TFI COUP TFII identified mammals 1
0.2717503.15890675.html.plaintext.txt	18	Biochemical studies showed proteins bind promiscuously direct repeat motifs preference DR1 sequences negatively positively regulate large number genes 2
0.2717503.15890675.html.plaintext.txt	19	The expression patterns COUP TFI COUP TFII distinctly different
0.2717503.15890675.html.plaintext.txt	20	COUP TFI expressed high levels neural system whereas COUP TFII expressed mesenchyme developing organs 3
0.2717503.15890675.html.plaintext.txt	21	Consistent expression pattern deletion COUP TFI mice results perinatal lethality mutants exhibiting neuronal deficits 4 5 6
0.2717503.15890675.html.plaintext.txt	22	COUP TFII null mutant mice die embryonic d 10
0.2717503.15890675.html.plaintext.txt	23	5 angiogenic cardiogenic defects 7
0.2717503.15890675.html.plaintext.txt	24	The embryo lethal phenotype COUP TFII impeded analysis role transcription factor adult physiology however COUP TFII mice exhibit several phenotypes
0.2717503.15890675.html.plaintext.txt	25	The analysis haploinsufficiency phenotype COUP TFII may shed light role orphan nuclear receptor adult
0.2717503.15890675.html.plaintext.txt	26	Haploinsufficiency caused heterozygosity targeted null allele occasionally reveals overall impact gene dosage effect traceable trait
0.2717503.15890675.html.plaintext.txt	27	Many COUP TFII mutants die weaning suggesting haploinsufficiency phenotype COUP TFII gene 7
0.2717503.15890675.html.plaintext.txt	28	Upon analyzing mating patterns COUP TFII mice found COUP TFII females reduced reproductive function
0.2717503.15890675.html.plaintext.txt	29	COUP TFII female mice exhibited reduced fecundity characterized reduced litter size genotype dependent reduction growth progeny
0.2717503.15890675.html.plaintext.txt	30	Because normal female reproduction requires functional coordination throughout female hypothalamo hypophyeal ovarian endocrine axis well endocrinological link ovary uterus subtle defects multiple organs axis could significantly alter normal reproduction
0.2717503.15890675.html.plaintext.txt	31	Therefore investigated ovarian uterine physiology COUP TFII mice determine cause reduction female fecundity
0.2717503.15890675.html.plaintext.txt	32	Here report phenotypic analysis COUP TFII mouse specifically related female ovarian uterine function
0.2717503.15890675.html.plaintext.txt	33	Analysis ovarian function conducted challenging COUP TFII control mice superovulatory regimen gonadotropins assaying ability ovary ovulate produce ovarian steroids
0.2717503.15890675.html.plaintext.txt	34	The COUP TFII mouse showed normal ovulation oocytes demonstrated reduced capability synthesizing sex steroid hormones
0.2717503.15890675.html.plaintext.txt	35	This reduction due reduction expression steroidogenic enzymes important P4 synthesis reduction vascularization COUP TFII heterozygotes
0.2717503.15890675.html.plaintext.txt	36	Analysis uterine function COUP TFII mice accomplished assaying response uterus endocrine induction decidual reaction
0.2717503.15890675.html.plaintext.txt	37	COUP TFII showed reduced decidual cell reaction response artificial stimulation indicating defect endometrial function
0.2717503.15890675.html.plaintext.txt	38	Analysis expression COUP TFII endometrium demonstrated steroid hormone dependent changes expression COUP TFII uterine endometrial stroma
0.2717503.15890675.html.plaintext.txt	39	This analysis demonstrates COUP TFII important regulation ovarian uterine function indicates COUP TFII required normal female reproductive functions
0.2717503.15890675.html.plaintext.txt	40	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES COUP TFII Female Mice Exhibit Reduced Fertility In maintaining COUP TFII mutant mouse colony noticed COUP TFII exhibited reduced fertility
0.2717503.15890675.html.plaintext.txt	41	To quantify reduction fertility overall reproductive performance COUP TFII female mice assessed continuous mating
0.2717503.15890675.html.plaintext.txt	42	COUP TFII male COUP TFII COUP TFII female mice continuously mated 3 months
0.2717503.15890675.html.plaintext.txt	43	The numbers litters pups born counted
0.2717503.15890675.html.plaintext.txt	44	The data summarized Table 1
0.2717503.15890675.html.plaintext.txt	45	Although first litter show significant difference COUP TFII COUP TFII females second third litter COUP TFII females showed significant decrease litter size contrast slight increase COUP TFII control
0.2717503.15890675.html.plaintext.txt	46	This result indicates heterozygous females exhibit abnormal fertility increase age
0.2717503.15890675.html.plaintext.txt	47	Overall Reproductive Performance COUP TFII Heterozygous Female
0.2717503.15890675.html.plaintext.txt	48	Delayed Puberty Growth Retardation Abnormal Estrus Cycles COUP TFII Female Mice To ascertain underlying cause reduced fertility COUP TFII females examined timing vaginal openings indication onset puberty
0.2717503.15890675.html.plaintext.txt	49	The results analysis shown Table 2
0.2717503.15890675.html.plaintext.txt	50	COUP TFII females exhibited slightly delayed vaginal opening 30
0.2717503.15890675.html.plaintext.txt	51	6 d birth compared 27
0.2717503.15890675.html.plaintext.txt	52	9 d birth wild type females Table 2
0.2717503.15890675.html.plaintext.txt	53	The delay puberty may result delayed growth COUP TFII mice
0.2717503.15890675.html.plaintext.txt	54	The postnatal growth COUP TFII COUP TFII pups nursed COUP TFII COUP TFII mothers measured
0.2717503.15890675.html.plaintext.txt	55	The results analysis shown Fig
0.2717503.15890675.html.plaintext.txt	56	Significant growth retardation COUP TFII clearly shown mutants compared wild type controls nursed either COUP TFII COUP TFII mothers Fig
0.2717503.15890675.html.plaintext.txt	57	However growth COUP TFII COUP TFII significantly lower nursed COUP TFII compared COUP TFII moms
0.2717503.15890675.html.plaintext.txt	58	Therefore growth retardation consequence genotype pup well ability mother nurture development pup
0.2717503.15890675.html.plaintext.txt	59	Delayed Onset Puberty COUP TFII Heterozygous Female
0.2717503.15890675.html.plaintext.txt	60	View larger version 28K Fig
0.2717503.15890675.html.plaintext.txt	61	Growth Retardation Delayed Onset Puberty COUP TFII Heterozygotes
0.2717503.15890675.html.plaintext.txt	62	A Gene dosage effect COUP TFII postnatal growth rate assessed daily monitoring body weight progeny wild type male X heterozygote female wild type heterozygous pups nursed heterozygous mother heterozygous female X wild type female wild type heterozygous pups nursed wild type mother
0.2717503.15890675.html.plaintext.txt	63	Normal growth assumed wild type pups nursed wild type female
0.2717503.15890675.html.plaintext.txt	64	Significantly retarded growth rate seen heterozygous pups nursed wild type mother better wild type pups nursed heterozygous mother
0.2717503.15890675.html.plaintext.txt	65	Most severe growth defect seen heterozygous pups nursed heterozygous mother
0.2717503.15890675.html.plaintext.txt	66	B Estrus cyclicity assessed daily inspection vaginal smear 20 wk old virgin females
0.2717503.15890675.html.plaintext.txt	67	Wild type female shows regular cyclicity heterozygous female showed irregular estrus cycles
0.2717503.15890675.html.plaintext.txt	68	P Proestrus E estrus M metestrus D diestrus
0.2717503.15890675.html.plaintext.txt	69	In analysis fecundity COUP TFII mice ability females normal reproductive cycles monitored recording estrus cycles 3 month old females daily inspection vaginal smears
0.2717503.15890675.html.plaintext.txt	70	The diagnostic difference facilitated modified Papanicolou staining
0.2717503.15890675.html.plaintext.txt	71	A representative estrus cycle schematized Fig
0.2717503.15890675.html.plaintext.txt	72	COUP TFII females showed regular cyclicity whereas COUP TFII female mice showed prolonged diestrus metestrus lack obvious estrus phase
0.2717503.15890675.html.plaintext.txt	73	Thus estrus cycles female heterozygote found irregular
0.2717503.15890675.html.plaintext.txt	74	To ensure expression COUP TFII expression reduced heterozygote isolated protein extracts ovariectomized wild type COUP TFII uteri performed Western blot analysis using COUP TFII specific antibodies
0.2717503.15890675.html.plaintext.txt	75	Figure 2 shows expression COUP TFII greatly reduced comparison control
0.2717503.15890675.html.plaintext.txt	76	The bar graph indicates expression levels COUP TFII reduced approximately 2 fold COUP TFII mice
0.2717503.15890675.html.plaintext.txt	77	Similar level reduction COUP TFII expression also shown ovaries COUP TFII comparison controls data shown
0.2717503.15890675.html.plaintext.txt	78	The results indicate COUP TFII expression correlates loss single allele COUP TFII mice
0.2717503.15890675.html.plaintext.txt	79	View larger version 26K Fig
0.2717503.15890675.html.plaintext.txt	80	Western Blot Analysis COUP TFII Expression Level Uteri COUP TF Heterozygous Wild Type Mice
0.2717503.15890675.html.plaintext.txt	81	A Representative data COUP TFII ss actin expression uterus wild type COUP TFII female mice 2 wk ovariectomized shown
0.2717503.15890675.html.plaintext.txt	82	B COUP TFII expression level normalized ss actin
0.2717503.15890675.html.plaintext.txt	83	Bar height represents ratio COUP TFII heterozygote control
0.2717503.15890675.html.plaintext.txt	84	COUP TFII expression reduced half COUP TFII mice
0.2717503.15890675.html.plaintext.txt	85	Expression COUP TFII Female Reproductive Axis The analysis demonstrates COUP TFII female mice shows abnormal reproductive cycles delayed puberty
0.2717503.15890675.html.plaintext.txt	86	Part phenotype may due expression COUP TFII uterus previous analysis shown COUP TFII expressed adult female endometrium 8
0.2717503.15890675.html.plaintext.txt	87	However determine else COUP TFII may acting expression COUP TFII female reproductive axis assessed
0.2717503.15890675.html.plaintext.txt	88	This accomplished using genetically engineered mouse LacZ reporter knocked COUP TFII gene 9
0.2717503.15890675.html.plaintext.txt	89	This mouse allows rapid sensitive assay expression pattern COUP TFII
0.2717503.15890675.html.plaintext.txt	90	Histological sections hypothalamus pituitaries ovaries uteri COUP TFII LacZ mice analyzed X gal staining
0.2717503.15890675.html.plaintext.txt	91	The results analysis shown Fig
0.2717503.15890675.html.plaintext.txt	92	COUP TFII expression seen X gal staining found ventromedial hypothalamus VMH Fig
0.2717503.15890675.html.plaintext.txt	93	3A whereas specific staining detected pituitary gland Fig
0.2717503.15890675.html.plaintext.txt	94	In adult ovary strong staining found theca cells layer surrounding granulosa cells ovarian follicles detected granulosa cells
0.2717503.15890675.html.plaintext.txt	95	Weaker staining detected mesenchymal cells surrounding corpus luteum Fig
0.2717503.15890675.html.plaintext.txt	96	To ensure X gal staining faithfully recapitulated endogenous COUP TFII expression used COUP TFII specific antibody immunostaining assess expression COUP TFII ovaries
0.2717503.15890675.html.plaintext.txt	97	Again strong staining found theca cells weak staining corpus luteum detectable staining granulosa cells Fig
0.2717503.15890675.html.plaintext.txt	98	The patterns COUP TFII expression using immunostaining virtually identical shown using X gal staining
0.2717503.15890675.html.plaintext.txt	99	Thus X gal staining could used alternative assays assess endogenous COUP TFII expression patterns
0.2717503.15890675.html.plaintext.txt	100	View larger version 130K Fig
0.2717503.15890675.html.plaintext.txt	101	Expression COUP TFII Female Reproductive Tract
0.2717503.15890675.html.plaintext.txt	102	Expression COUP TFII female reproductive tract assessed LacZ knock mice assessed immuohistochemical staining using COUP TFII specific antibodies
0.2717503.15890675.html.plaintext.txt	103	Cryosections various tissues LacZ knock female mice stained LacZ expression described Materials Methods
0.2717503.15890675.html.plaintext.txt	104	A Coronal section 3 wk old female brain showed specific staining VMH
0.2717503.15890675.html.plaintext.txt	105	B Mid sagittal section embryonic d 14
0.2717503.15890675.html.plaintext.txt	106	5 embryo brain showing abundant expression hypothalamus H mesenchyme surrounding pituitary gland pituitary gland Pit
0.2717503.15890675.html.plaintext.txt	107	C Ovary 8 wk old randomly cycling female showing strong expression theca cell surrounding follicles
0.2717503.15890675.html.plaintext.txt	108	Note specific staining corpus luteum CL granulosa cells
0.2717503.15890675.html.plaintext.txt	109	D Endogenous expression pattern COUP TFII examined immunohistochemical staining using COUP TFII specific antibody ovarian section 8 wk old female
0.2717503.15890675.html.plaintext.txt	110	COUP TFII highly expressed theca cells surrounding follicles weakly expressed corpus luteum staining detected granulosa cells
0.2717503.15890675.html.plaintext.txt	111	E Sagittal section uterus 8 wk old randomly cycling female
0.2717503.15890675.html.plaintext.txt	112	High expression longitudinal circular smooth muscle cells evident scattered staining seen endometrial stromal cells
0.2717503.15890675.html.plaintext.txt	113	Glandular luminal epithelial cells also showed weak staining
0.2717503.15890675.html.plaintext.txt	114	AM Antimesometrium Mes mesometrium arrowheads luminal epithelium arrows glandular epithelial cells smc smooth muscle cells
0.2717503.15890675.html.plaintext.txt	115	F Antimesometrial portion gestational d 8 deciduas shows strong nuclear staining decidualized cells
0.2717503.15890675.html.plaintext.txt	116	In uterus randomly cycling females strong staining evident myometrium weaker staining seen endometrial stromal cells weak positive staining shown glandular luminal epithelial cells Fig
0.2717503.15890675.html.plaintext.txt	117	There significant difference COUP TFII expression mesometrium anti mesometrium portions uterus
0.2717503.15890675.html.plaintext.txt	118	COUP TFII expression assessed LacZ activity decidualization using gestational d 8 uteri decidualized cells antimesometrium stained strongly positive Fig
0.2717503.15890675.html.plaintext.txt	119	Because uterine gene expression regulated steroid hormones also examined effects exogenous steroid hormones exogenous gonadotropins COUP TFII expression uterine endometrium Fig
0.2717503.15890675.html.plaintext.txt	120	In ovariectomized females COUP TFII expression high endometrial stroma Fig
0.2717503.15890675.html.plaintext.txt	121	4A whereas treatment 17ss estradiol E2 48 h drastically reduced COUP TFII expression Fig
0.2717503.15890675.html.plaintext.txt	122	Treatment P4 prevented reduction COUP TFII expression E2 endometrial stroma Fig
0.2717503.15890675.html.plaintext.txt	123	Note COUP TFII expression myometrium obviously altered exogenous steroid treatment
0.2717503.15890675.html.plaintext.txt	124	The expression COUP TFII E2 P4 treatment similar observed nonpregnant uterine horn gestational d 10 pregnant female mouse Fig
0.2717503.15890675.html.plaintext.txt	125	We also examined COUP TFII expression administration exogenous gonadotropins Fig
0.2717503.15890675.html.plaintext.txt	126	Twenty four hours pregnant mare serum gonadotropin PMSG injection COUP TFII expression endometrial stroma obviously decreased Fig
0.2717503.15890675.html.plaintext.txt	127	4E whereas 48 h PMSG injection COUP TFII expression endometrium recovered partially Fig
0.2717503.15890675.html.plaintext.txt	128	A increase COUP TFII expression endometrial stroma found 24 48 h human chorionic gonadotropin hCG injection Fig
0.2717503.15890675.html.plaintext.txt	129	View larger version 138K Fig
0.2717503.15890675.html.plaintext.txt	130	Hormonal Regulation COUP TFII Expression Endometrial Stroma
0.2717503.15890675.html.plaintext.txt	131	Effect steroid hormones expression COUP TFII endometrial stroma examined using ovariectomized LacZ knock mice COUP TFII
0.2717503.15890675.html.plaintext.txt	132	Effect gonadotropins PMSG hCG alter endogenous ovarian steroids also examined using intact LacZ knock mice
0.2717503.15890675.html.plaintext.txt	133	A COUP TFII highly expressed endometrial stroma ovariectomized mice
0.2717503.15890675.html.plaintext.txt	134	B Expression COUP TFII drastically reduced endometrial stroma E2 treatment 48 h
0.2717503.15890675.html.plaintext.txt	135	C Expression COUP TFII restored partially endometrial stroma P4 treatment addition E2 48 h
0.2717503.15890675.html.plaintext.txt	136	D COUP TFII expression nonpregnant horn gestational d 10 female
0.2717503.15890675.html.plaintext.txt	137	E Expression COUP TFII low 24 h PMSG
0.2717503.15890675.html.plaintext.txt	138	F Expression COUP TFII increased 48 h PMSG
0.2717503.15890675.html.plaintext.txt	139	G Expression COUP TFII became high 24 h hCG
0.2717503.15890675.html.plaintext.txt	140	H Expression COUP TFII increased 48 h hCG
0.2717503.15890675.html.plaintext.txt	141	L Lumen S endometrial stroma g endometrial glands
0.2717503.15890675.html.plaintext.txt	142	I Expression COUP TFII examined immunohistochemical staining wild type uterus 2 wk ovariectomy
0.2717503.15890675.html.plaintext.txt	143	COUP TFII highly expressed endometrial stroma myometrium low grandular luminal epithelial cells
0.2717503.15890675.html.plaintext.txt	144	The expression pattern COUP TFII uteri confirmed immunostaining using COUP TFII specific antibodies
0.2717503.15890675.html.plaintext.txt	145	Strong staining found endometrial stromal cells well myometrium whereas weaker staining seen glandular luminal epithelial cells ovariectomized COUP TFII uteri Fig
0.2717503.15890675.html.plaintext.txt	146	The endogenous COUP TFII expression patterns indistinguishable X gal expression pattern shown Fig
0.2717503.15890675.html.plaintext.txt	147	Normal Ovarian Function Reduced Progesterone Levels Are Found COUP TFII Females The analysis determined COUP TFII expressed hypothalamus ovary uterus
0.2717503.15890675.html.plaintext.txt	148	Therefore reduction fertility COUP TFII may due deficiencies three organs
0.2717503.15890675.html.plaintext.txt	149	To determine whether cause reduced fertilely may due reduction ovarian function ovarian function assayed determining ability ovaries respond superovulatory regimen hormones determining number oocytes ovulated well production progesterone superovulation well pregnancy
0.2717503.15890675.html.plaintext.txt	150	The results analysis shown Tables 3 4 respectively
0.2717503.15890675.html.plaintext.txt	151	There significant difference COUP TFII COUP TFII number oocytes ovulated response gonadotropins
0.2717503.15890675.html.plaintext.txt	152	Although ability COUP TFII mice ovulate normal perturbation level progesterone P4 production may contribute reduced fertility
0.2717503.15890675.html.plaintext.txt	153	As shown Table 4 P4 levels significantly decreased COUP TFII females subsequent exogenous hCG stimulation
0.2717503.15890675.html.plaintext.txt	154	Measurement P4 pregnenolone P5 levels pregnant gestational d 15 females shown lower heterozygous females although statistically significant
0.2717503.15890675.html.plaintext.txt	155	Therefore ovaries COUP TFII females able undergo normal ovulation reduction fertility may due impairment corpus luteum COUP TFII mouse ovaries produce P4 early pregnancy
0.2717503.15890675.html.plaintext.txt	156	Normal Ovulation Response Exogenous Gonadotropins
0.2717503.15890675.html.plaintext.txt	157	Circulating Ovarian Steroids COUP TFII Heterozygous Females
0.2717503.15890675.html.plaintext.txt	158	Reduction Expression Levels Steroidogenic Components Critical P4 Synthesis We showed predominant site expression COUP TFII ovary theca interna granulosa cells
0.2717503.15890675.html.plaintext.txt	159	Theca cells responsible synthesizing precursor C19 steroids preovulatory follicle response LH granulosa cells aromatize precursor steroids vivo regulation FSH 10
0.2717503.15890675.html.plaintext.txt	160	In corpus luteum however large luteal cells believed derived granulosa cells capable synthesizing P4 circulating low density lipoprotein LDL 10
0.2717503.15890675.html.plaintext.txt	161	Thus vascularization corpus luteum upon ovulation considered important supply luteal cells substrates synthesize P4
0.2717503.15890675.html.plaintext.txt	162	Considering importance COUP TFII angiogenesis 7 conducted microscopic examination COUP TFII wild type super ovulated ovaries determine whether vascularization perturbed
0.2717503.15890675.html.plaintext.txt	163	Although obvious microscopic abnormality could detected COUP TFII ovaries noted lumen vessels COUP TFII ovaries dilated COUP TFII control suggesting COUP TFII ovaries might well supplied blood Fig
0.2717503.15890675.html.plaintext.txt	164	We used endothelial specific marker platelet endothelial cell adhesion molecule PECAM immunostaining examine vessel closely
0.2717503.15890675.html.plaintext.txt	165	A considerable reduction CD31 PECAM 1 positive stained vessels seen COUP TFII corpus luteum Fig
0.2717503.15890675.html.plaintext.txt	166	5 B C suggesting vascularization compromised COUP TFII ovaries
0.2717503.15890675.html.plaintext.txt	167	This could contribute least partly reduction observable progesterone levels super ovulated COUP TF female mice
0.2717503.15890675.html.plaintext.txt	168	View larger version 49K Fig
0.2717503.15890675.html.plaintext.txt	169	Defective Vascularization Corpus Luteum Reduced Expression Cyp11a1 Hsd3b1 StAR COUP TFII ovaries
0.2717503.15890675.html.plaintext.txt	170	A C Microscopic evaluation vascularization superovulated COUP TFII heterozygous wild type ovaries
0.2717503.15890675.html.plaintext.txt	171	Dilated vessels seen COUP TFII heterozygous ovaries
0.2717503.15890675.html.plaintext.txt	172	B Vascularization assessed immunofluorescent signal using CD31 PECAM 1 specific antibody
0.2717503.15890675.html.plaintext.txt	173	Reduced vascularization seen COUP TFII corpus luteum
0.2717503.15890675.html.plaintext.txt	174	C Nuclear staining DAPI slide B
0.2717503.15890675.html.plaintext.txt	175	D The mRNA COUP TFII CYP11a1 HSD3b1 StAR quantified TaqMan based RT PCR
0.2717503.15890675.html.plaintext.txt	176	All mRNA quantities normalized 18S RNA using ABI rRNA control reagents
0.2717503.15890675.html.plaintext.txt	177	All experiments performed triplicate verified duplicate set mice
0.2717503.15890675.html.plaintext.txt	178	Means mRNA expression WT COUP TFII mice compared using Student test P values present figure
0.2717503.15890675.html.plaintext.txt	179	The impaired steroid production COUP TFII female mice could also due alteration expression levels steroidogenic components critical P4 biosynthesis
0.2717503.15890675.html.plaintext.txt	180	The impact COUP TFII haploinsufficiency expression levels genes involved steroid hormone biosynthesis ovaries COUP TFII wild type ovaries administered superovulatory regimen gonadotropin assayed quantitative RT PCR assays
0.2717503.15890675.html.plaintext.txt	181	As control first examined mRNA expression levels COUP TFII showed COUP TFII mRNA level reduced 30 heterozygote compared wild type controls Fig 5D
0.2717503.15890675.html.plaintext.txt	182	Similarly significant reduction 40 cytochrome P450 family 11 subfamily polypeptide 1 Cyp11a1 mRNA levels detected Fig
0.2717503.15890675.html.plaintext.txt	183	In addition steroidogenic acute regulatory protein StAR hydroxy 5 steroid dehydrogenase 3ss steroid isomerase 1 Hsd3b1 mRNA levels also greatly reduced COUP TFII female mice less 30 controls Fig
0.2717503.15890675.html.plaintext.txt	184	The reduction mRNA expression components important P4 biosynthesis doubt also contribute observed reduction P4 levels COUP TFII female mice
0.2717503.15890675.html.plaintext.txt	185	Defective Uterine Function COUP TFII Females COUP TFII expressed endometrium uterus well endometrial decidual cells pregnancy Figs
0.2717503.15890675.html.plaintext.txt	186	A defect ability endometrium undergo decidualization may greatly affect reproductive performance
0.2717503.15890675.html.plaintext.txt	187	To assay ability uterus undergo decidualization independent hypothalamus ovarian function COUP TFII COUP TFII mice challenged artificial decidual stimulus
0.2717503.15890675.html.plaintext.txt	188	This stimulus consisted administering mechanical trauma burred needle scratch uterus ovariectomized mice treated exogenous E2 P4
0.2717503.15890675.html.plaintext.txt	189	In animal left horn given mechanical trauma hormonal treatment whereas right horn traumatized could serve control
0.2717503.15890675.html.plaintext.txt	190	After experiments wet weight horn determined ratio scratched vs
0.2717503.15890675.html.plaintext.txt	191	6 uterus COUP TFII female mice exhibited significantly reduced decidual cell reaction compared COUP TFII mouse uteri
0.2717503.15890675.html.plaintext.txt	192	This analysis indicates reduced fertility COUP TFII mice may part due reduced ability endometrial stroma undergo necessary differentiation support embryo implantation
0.2717503.15890675.html.plaintext.txt	193	View larger version 28K Fig
0.2717503.15890675.html.plaintext.txt	194	Reduced Decidual Cell Reaction COUP TFII Heterozygote
0.2717503.15890675.html.plaintext.txt	195	Decidual cell reaction induced traumatizing left uterine horn L hormonal treatment ovariectomized wild type heterozygous females
0.2717503.15890675.html.plaintext.txt	196	Right horn R left intact control
0.2717503.15890675.html.plaintext.txt	197	A Typical deciduoma formation left uterine horn wild type female shown top panel whereas limited decidual cell reaction seen left uterine horn heterozygous female shown bottom panel
0.2717503.15890675.html.plaintext.txt	198	B Wet weight left horn right horn animal weighted ratio left stimulated horn right control horn LR ratio calculated
0.2717503.15890675.html.plaintext.txt	199	There significant decrease P 0
0.2717503.15890675.html.plaintext.txt	200	018 LR ratio COUP TFII heterozygous females
0.2717503.15890675.html.plaintext.txt	201	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The data demonstrate ablation one allele COUP TFII significantly impacts reproductive performance female mice
0.2717503.15890675.html.plaintext.txt	202	This altered reproductive performance seen delay puberty age dependent reduction litter size
0.2717503.15890675.html.plaintext.txt	203	Haploinsufficient phenotypes rarely reported result subtle phenotypes
0.2717503.15890675.html.plaintext.txt	204	This phenomenon usually results gene question subject imprinting holds rate limiting step pivotal pathway
0.2717503.15890675.html.plaintext.txt	205	The COUP TFII haploinsufficient phenotype independent parent transmitting mutant allele data shown
0.2717503.15890675.html.plaintext.txt	206	Therefore imprinting COUP TFII allele cause phenotype
0.2717503.15890675.html.plaintext.txt	207	The expression level COUP TFII reduced half measured Western blot analysis corresponding loss single allele COUP TFII
0.2717503.15890675.html.plaintext.txt	208	The reduction COUP TFII expression could affect function reproductive axis
0.2717503.15890675.html.plaintext.txt	209	Because female reproduction regulated interactions endocrine system level hypothalamus pituitary ovary uterus expression COUP TFII found hypothalamus VMH theca cells uterine endometrial stroma surprising haploinsufficiency reproductive phenotype seen COUP TFII heterozygous females
0.2717503.15890675.html.plaintext.txt	210	There abundant expression COUP TFII VMH central nervous system
0.2717503.15890675.html.plaintext.txt	211	Although significance VMH expression clear several observed haploinsufficiency phenotypes e
0.2717503.15890675.html.plaintext.txt	212	growth retardation delayed puberty consistent idea COUP TFII mouse may suffer mild hypopituitarism
0.2717503.15890675.html.plaintext.txt	213	However significant decrease IGF I heterozygotes data shown indicative potential growth perturbation
0.2717503.15890675.html.plaintext.txt	214	COUP TFII implicated interfere function orphan nuclear receptor steroidogenic factor 1 SF1 11
0.2717503.15890675.html.plaintext.txt	215	SF1 null mice resulted defective development VMH 12
0.2717503.15890675.html.plaintext.txt	216	Rescue experiments using SF1 null mutants indicated SF1 functions VMH regulate late onset obesity 13
0.2717503.15890675.html.plaintext.txt	217	Thus might interesting speculate COUP TFII SF1 reciprocally regulate growth VMH
0.2717503.15890675.html.plaintext.txt	218	Future specific deletion COUP TFII could elucidate aspect COUP TFII function
0.2717503.15890675.html.plaintext.txt	219	Although role COUP TFII VMH speculative role COUP TFII ovary investigated
0.2717503.15890675.html.plaintext.txt	220	COUP TFII mice demonstrate impairment ovulation show impairment ability P4 production
0.2717503.15890675.html.plaintext.txt	221	The reduced capability synthesize P4 response exogenous gonadotropin suggests potential defects ovarian function COUP TFII
0.2717503.15890675.html.plaintext.txt	222	Theca cells ovaries responsible synthesizing precursor C19 steroids preovulatory follicle response LH granulosa cells aromatize precursor steroids vivo regulation FSH 11
0.2717503.15890675.html.plaintext.txt	223	In corpus luteum however large luteal cells believed derived granulosa cells capable synthesizing P4 circulating LDL 11
0.2717503.15890675.html.plaintext.txt	224	Thus vascularization corpus luteum upon ovulation considered important supply luteal cells substrates synthesize P4
0.2717503.15890675.html.plaintext.txt	225	The high expression COUP TFII theca cells granulosa cells suggests COUP TFII might involved steroidogenic pathway might significant role vascularization corpus luteum
0.2717503.15890675.html.plaintext.txt	226	Here showed vascularization measured PECAM immunostaining perturbed COUP TFII mice compared controls
0.2717503.15890675.html.plaintext.txt	227	This might lead inefficient delivery LDL large luteal cells resulting reduced ability corpus luteum synthesize P4
0.2717503.15890675.html.plaintext.txt	228	In addition also show expression levels mRNA CYP11a1 HSD3b1 StAR significantly reduced COUP TFII female mice
0.2717503.15890675.html.plaintext.txt	229	All genes important biosynthesis P4
0.2717503.15890675.html.plaintext.txt	230	Thus reduction expression genes directly contribute observable reduced P4 levels COUP TFII female mice decrease circulating P4 pregnant COUP TFII females might result reduced ability uterus support pregnancy
0.2717503.15890675.html.plaintext.txt	231	The reduced levels P4 early pregnancy may impact COUP TFII expression uterus early pregnancy
0.2717503.15890675.html.plaintext.txt	232	Analysis expression COUP TFII uterus shows E2 treatment caused drastic decrease COUP TFII expression endometrial stroma whereas P4 treatment E2 attenuates E2 action restoring COUP TFII expression stroma
0.2717503.15890675.html.plaintext.txt	233	COUP TFII expression low treatment PMSG induces ovarian E2 synthesis COUP TFII expression endometrial stroma increased expression hCG induces ovarian P4 consistent steroid hormone regulation hormone treated ovariectomized females
0.2717503.15890675.html.plaintext.txt	234	The lower levels P4 COUP TFII mouse combined loss one COUP TFII allele uterine stromal cell may partial cause haploinsufficient decrease uterine function mice
0.2717503.15890675.html.plaintext.txt	235	However reduced uterine stromal cell function still observed exogenous administration P4 indicating part haploinsufficient phenotype specific uterus
0.2717503.15890675.html.plaintext.txt	236	During implantation endometrial stromal cells undergo series complex processes called decidualization 14 15
0.2717503.15890675.html.plaintext.txt	237	The process decidualization involves concurrent cell proliferation differentiation well angiogenesis
0.2717503.15890675.html.plaintext.txt	238	Based findings evident uterine function significantly affected COUP TFII heterozygous females
0.2717503.15890675.html.plaintext.txt	239	The relatively high expression COUP TFII endometrial stromal cells steroid regulation COUP TFII expression endometrial stroma reduced decidual cell reaction support notion
0.2717503.15890675.html.plaintext.txt	240	Identification role COUP TFII process decidualization may discerned analysis genes shown regulate process
0.2717503.15890675.html.plaintext.txt	241	Several targeted null mutant mice including progesterone receptor PR 16 Hoxa 10 17 11 18 exhibited defects decidual cell reaction
0.2717503.15890675.html.plaintext.txt	242	Consistent notion P4 required decidualization human endometrium decidual cell reaction absent PRKO female mice 16
0.2717503.15890675.html.plaintext.txt	243	One potential key genes regulated P4 Indian hedgehog IHH 8 well known morphogen
0.2717503.15890675.html.plaintext.txt	244	Hedgehog signaling known regulate cell proliferation differentiation embryonic development 19
0.2717503.15890675.html.plaintext.txt	245	The fact IHH expressed preimplantation endometrial epithelial cells expression rapidly induced P4 8 implicates role mediating PR function
0.2717503.15890675.html.plaintext.txt	246	Importantly demonstrated COUP TFII regulated hedgehog signaling 20
0.2717503.15890675.html.plaintext.txt	247	One intriguing possibilities P4 regulates IHH luminal epithelium priming stroma cells decidualization
0.2717503.15890675.html.plaintext.txt	248	COUP TFII downstream target IHH could mediate IHH signaling endometrium periimplantation 8
0.2717503.15890675.html.plaintext.txt	249	Importantly IHH COUP TFII implicated angiogenesis 7 21
0.2717503.15890675.html.plaintext.txt	250	It speculation artificially induced decidualization repeated remodeling endometrium first conception normal vascularization moderately functionally significantly affected COUP TFII
0.2717503.15890675.html.plaintext.txt	251	Taken together phenotypic analysis using haploinsufficiency model COUP TFII indicated several functions gene female reproductive tract
0.2717503.15890675.html.plaintext.txt	252	Combination haploinsufficiency phenotypes throughout female reproductive axis might additively affect female reproductive function
0.2717503.15890675.html.plaintext.txt	253	Although use model might limited overall phenotypic analysis perhaps could reveal global impact gene dosage effect human genetic conditions female reproduction
0.2717503.15890675.html.plaintext.txt	254	We propose COUP TFII plays important role endometrial stroma periimplantation period
0.2717503.15890675.html.plaintext.txt	255	Detailed molecular cellular mechanisms could elucidated conditional gene targeting approaches using endometrial specific Cre recombinase
0.2717503.15890675.html.plaintext.txt	256	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Animals Phenotypic Analysis Targeted null mutants COUP TFII generated described previously 7
0.2717503.15890675.html.plaintext.txt	257	The COUP TFII LacZ knock mice generated homologous recombination ES cells described previously 9
0.2717503.15890675.html.plaintext.txt	258	These mice maintained mixed genetic background 129S6C57B6 care Center Comparative Medicine Baylor College Medicine according institutional guidelines care use laboratory animals
0.2717503.15890675.html.plaintext.txt	259	Mating pairs COUP TFII male crossed COUP TFII females COUP TFII females 12 wk old continuously mated cage 3 months numbers newborn birth counted
0.2717503.15890675.html.plaintext.txt	260	Postnatal growth assessed weighing pups matings postnatal d 1 21 daily weaned d 21 genotyped PCR tail DNA 7
0.2717503.15890675.html.plaintext.txt	261	The estrus cycle 20 wk old females three wild type 10 heterozygous females monitored daily inspection vaginal smears 22
0.2717503.15890675.html.plaintext.txt	262	Vaginal openings recorded daily inspection postnatal d 14 natural opening observed
0.2717503.15890675.html.plaintext.txt	263	Circulating P4 levels analyzed RIA laboratory Dr
0.2717503.15890675.html.plaintext.txt	264	David Hess Oregon Health Science University Portland OR
0.2717503.15890675.html.plaintext.txt	265	LacZ Staining LacZ staining various tissues LacZ knock mice performed described previously 23
0.2717503.15890675.html.plaintext.txt	266	Tissues heterozygous COUP TFII LacZ knock dissected fixed 2 paraformaldehyde 30 min room temperature
0.2717503.15890675.html.plaintext.txt	267	After washing PBS embryos cryopreserved 30 sucrose embedded OCT compound Sakura Finetek USA Torrance CA
0.2717503.15890675.html.plaintext.txt	268	Cryostat sections 20 microm incubated room temperature 2 h staining solution containing 0
0.2717503.15890675.html.plaintext.txt	269	02 Nonidet P 40 5 mM potassium ferricyanide 5 mM potassium ferrocyanide 1 mgml X gal
0.2717503.15890675.html.plaintext.txt	270	Sections counterstained Eosin Y Sigma St
0.2717503.15890675.html.plaintext.txt	271	Nuclear localization signal used LacZ localization nucleus facilitated identification specific staining tissues except neural tissues control sections wild type mice show specific staining condition used study
0.2717503.15890675.html.plaintext.txt	272	Superovulation Artificial Decidual Cell Reaction Steroid Hormone Induction Superovulation achieved treating 21 d old female virgin mice PMSG 5 IU ip Sigma followed 48 h later hCG 5 IU ip Sigma
0.2717503.15890675.html.plaintext.txt	273	The mice euthanized ova harvested oviducts 24 h hCG administration
0.2717503.15890675.html.plaintext.txt	274	Induction artificial decidual cell reaction induced described previously 16
0.2717503.15890675.html.plaintext.txt	275	Briefly 8 wk old COUP TFII COUP TFII females ovariectomized d 0 treated E2 0
0.2717503.15890675.html.plaintext.txt	276	1 microg per mouse per day d 10 12 treated P4 1 mg per mouse per day E2 6
0.2717503.15890675.html.plaintext.txt	277	7 ng per mouse per day d 16 23
0.2717503.15890675.html.plaintext.txt	278	Mechanical decidualization left uterine horn performed 6 h hormone injection d 18
0.2717503.15890675.html.plaintext.txt	279	The whole uterus dissected 6 h hormone injection d 23
0.2717503.15890675.html.plaintext.txt	280	The ratio weights stimulated unstimulated control horns calculated
0.2717503.15890675.html.plaintext.txt	281	Steroid hormone regulation COUP TFII mouse uterus analyzed administering steroid hormones COUP TFII COUP TFII female mice follows
0.2717503.15890675.html.plaintext.txt	282	Hormone treatment conducted 6 wk old COUP TFII COUP TFII female mice bilateral ovariectomy 2 wk commencement hormone treatment
0.2717503.15890675.html.plaintext.txt	283	Mice treated E2 5 ng sc P4 1 mg sc 0
0.2717503.15890675.html.plaintext.txt	284	Animals anesthetized Avertin 222 tribromoethyl alcohol Sigma killed cervical dislocation
0.2717503.15890675.html.plaintext.txt	285	Immunohistochemical Staining Tissues COUP TFII COUP TFII mice fixed 4 paraformaldehyde 1 h 4 C cryopreserved 30 sucrose embedded OCT compound Sakura Finetek USA
0.2717503.15890675.html.plaintext.txt	286	Cryostat sections 7 microm incubated blocking buffer PBS 1 BSA 5 normal donkey serum 10 microg Fab fragment donkey antimouse IgG heavy light chains per ml 0
0.2717503.15890675.html.plaintext.txt	287	02 Triton X 100 1 h room temperature followed incubation primary antibody monoclonal anti COUP TFII 1100000 overnight 4 C
0.2717503.15890675.html.plaintext.txt	288	After incubation primary antibody slides incubated biotin SP conjugated donkey antimouse IgG heavy light chains Jackson ImmunoResearch Laboratories 1 h room temperature horseradish peroxidase conjugated strepavidin Molecular Probes Eugene OR 1 h room temperature
0.2717503.15890675.html.plaintext.txt	289	Signals visualized using DAB Kit Vector Laboratories Burlingame CA counterstained hematoxylin
0.2717503.15890675.html.plaintext.txt	290	For immunofluorescence cryosections incubated biotin conjugated polyclonal rat anti CD31 PECAM 1 antibody BD Biosciences Pharmingen San Diego CA 11000 2 h signals developed using TSA kit
0.2717503.15890675.html.plaintext.txt	291	22 Molecular Probes accordance manufacturer instruction
0.2717503.15890675.html.plaintext.txt	292	Western Blot Analysis Isolated tissues homogenized buffer composed 0
0.2717503.15890675.html.plaintext.txt	293	25 M sucrose 50 mM Tris HCl pH 7
0.2717503.15890675.html.plaintext.txt	294	5 25 mM KCl 5 mM MgCl2 0
0.2717503.15890675.html.plaintext.txt	295	5 mM phenylmethylsulfonyl fluoride
0.2717503.15890675.html.plaintext.txt	296	Protein concentrations determined BCA protein assay system Pierce Rockford IL
0.2717503.15890675.html.plaintext.txt	297	Ten micrograms protein mixed 2x Laemmli Sample Buffer Bio Rad Laboratories Hercules CA separated 7
0.2717503.15890675.html.plaintext.txt	298	5 polyacrylamide gels electroblotted onto nitrocellulose membranes
0.2717503.15890675.html.plaintext.txt	299	Membranes incubated primary antibody followed incubation horseradish peroxidase conjugated antimouse IgG antibody
0.2717503.15890675.html.plaintext.txt	300	Signals visualized ECL plus Western Blotting Detection System Amersham Biosciences Amersham Buckinghamshire UK
0.2717503.15890675.html.plaintext.txt	301	Intensities bands analyzed National Institutes Health Image software normalized ss actin expression level
0.2717503.15890675.html.plaintext.txt	302	Quantitative RT PCR Assays Total mRNA isolated snap frozen superovulated ovarian samples using TRIzol reagent Invitrogen Carlsbad CA according manufacturer instructions
0.2717503.15890675.html.plaintext.txt	303	The mRNA genes interest quantitated TaqMan based RT PCR using ABI Prism 7700 sequence detection system Applied Biosystems Foster City CA
0.2717503.15890675.html.plaintext.txt	304	RT PCRs performed using One step RT PCR Universal Master Mix reagent TaqMan Gene Expression Assays Applied Biosystems according manufacturer instructions
0.2717503.15890675.html.plaintext.txt	305	Cycling conditions 95 C 1 min followed 40 cycles 95 C 15 sec 60 C 1 min
0.2717503.15890675.html.plaintext.txt	306	All mRNA quantities normalized 18S RNA using ABI rRNA control reagents
0.2717503.15890675.html.plaintext.txt	307	The TaqMan Gene Expression Assays used include Mm00490735m1 Cyp11a1 Mm00441558m1 StAR Mm00476184g1 Hsd3b1 Mm00772789m1 Nr2f2 COUP TFII Eukaryotic 18S rRNA 4319413E
0.2717503.15890675.html.plaintext.txt	308	All experiments performed triplicate verified duplicate set mice
0.2717503.15890675.html.plaintext.txt	309	Means mRNA expression WT COUP TFII mice compared using Student test
0.2717503.15890675.html.plaintext.txt	310	ACKNOWLEDGMENTS We thank Wei Qian Chen Liu Grace Chen excellent technical help
0.2717503.15890675.html.plaintext.txt	311	FOOTNOTES This work supported National Institutes Health Grants DK55636 S
0.2717503.15890675.html.plaintext.txt	312	U01DK62434 Functional Atlas S
0.2717503.15890675.html.plaintext.txt	313	First Published Online May 12 2005
0.2717503.15890675.html.plaintext.txt	314	Abbreviations COUP TFII Chicken ovalbumin upstream promoter transcription factor II Cyp11a1 cytochrome P450 family 11 subfamily polypeptide 1 E2 17ss estradiol hCG human chorionic gonadotropin Hsd3b1 hydroxy 5 steroid dehydrogenase 3ss steroid isomerase 1 IHH Indian hedgehog LDL low density lipoprotein P4 progesterone PECAM platelet endothelial cell adhesion molecule PMSG pregnant mare serum gonadotropin PR progesterone receptor SF1 steroidogenic factor 1 StAR steroidogenic acute regulatory protein VMH ventromedial hypothalamus
0.2717503.15890675.html.plaintext.txt	315	Received publication January 10 2005
0.2717503.15890675.html.plaintext.txt	316	Accepted publication May 4 2005
0.2717503.15890675.html.plaintext.txt	317	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Tsai SY Tsai MJ 1997 Chick ovalbumin upstream promoter transcription factors COUP TFs coming age
0.2717503.15890675.html.plaintext.txt	318	Endocr Rev 18229 240AbstractFree Full Text Pereira FA Tsai MJ Tsai SY 2000 COUP TF orphan nuclear receptors development differentiation
0.2717503.15890675.html.plaintext.txt	319	Cell Mol Life Sci 571388 1398Medline Pereira FA Qiu Y Tsai MJ Tsai SY 1995 Chicken ovalbumin upstream promoter transcription factor COUP TF expression mouse embryogenesis
0.2717503.15890675.html.plaintext.txt	320	J Steroid Biochem Mol Biol 53503 508CrossRefMedline Qiu Y Pereira FA DeMayo FJ Lydon JP Tsai SY Tsai M J 1997 Null mutation mCOUP TFI results abnormal morphogenesis glossopharyngeal nerve
0.2717503.15890675.html.plaintext.txt	321	Genes Dev 111925 1937AbstractFree Full Text Zhou C Qiu Y Pereira FA Crair MC Tsai SY Tsai M J 1999 The nuclear orphan receptor COUP TFI required differentiation subplate neurons guidance thalamocortical axons
0.2717503.15890675.html.plaintext.txt	322	Neuron 24847 859CrossRefMedline Zhou C Tsai SY Tsai M J 2001 COUP TFI intrinsic factor early regionalization neocortex
0.2717503.15890675.html.plaintext.txt	323	Genes Dev 152054 2059AbstractFree Full Text Pereira FA Qiu Y Zhou G Tsai MJ Tsai SY 1999 The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.2717503.15890675.html.plaintext.txt	324	Genes Dev 131037 1049AbstractFree Full Text Takamoto N Zhao B Tsai SY DeMayo FJ 2002 Identification Indian hedgehog progesterone responsive gene murine uterus
0.2717503.15890675.html.plaintext.txt	325	Mol Endocrinol 162338 2348AbstractFree Full Text Lee CT Li R Takamoto N Martin JF DeMayo FJ Tsai M J Tsai SY 2004 The nuclear orphan receptor COUP TFII required limb skeletal muscle development
0.2717503.15890675.html.plaintext.txt	326	Mol Cell Biol 2410835 10843AbstractFree Full Text Richards JS 1994 Hormonal control gene expression ovary
0.2717503.15890675.html.plaintext.txt	327	Endocr Rev 15725 751CrossRefMedline Zeitoun K Takayama K Michael MD Bulun SE 1999 Stimulation aromatase P450 promoter II activity endometriosis inhibition endometrium regulated competitive binding steroidogenic factor 1 chicken ovalbumin upstream promoter transcription factor cis acting element
0.2717503.15890675.html.plaintext.txt	328	Mol Endocrinol 13239 253AbstractFree Full Text Ikeda Y Luo X Abbud R Nilson JH Parker KL 1995 The nuclear receptor steroidogenic factor 1 essential formation ventromedial hypothalamic nucleus
0.2717503.15890675.html.plaintext.txt	329	Mol Endocrinol 9478 486Abstract Majdic G Young M Gomez Sanchez E Anderson P Szczepaniak LS Dobbins RL McGarry JD Parker KL 2002 Knockout mice lacking steroidogenic factor 1 novel genetic model hypothalamic obesity
0.2717503.15890675.html.plaintext.txt	330	Endocrinology 143607 614AbstractFree Full Text Christian M Mak I White JO Brosens JJ 2002 Mechanisms decidualization
0.2717503.15890675.html.plaintext.txt	331	Reprod Biomed Online 4 Suppl 324 30 Dunn CL Kelly RW Critchley HO 2003 Decidualization human endometrial stromal cell enigmatic transformation
0.2717503.15890675.html.plaintext.txt	332	Reprod Biomed Online 7151 161Medline Lydon JP DeMayo FJ Funk CR Mani SK Hughes AR Montgomery Jr CA Shyamala G Conneely OM O Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
0.2717503.15890675.html.plaintext.txt	333	Genes Dev 92266 2278Abstract Benson GV Lim H Paria BC Satokata I Dey SK Maas RL 1996 Mechanisms reduced fertility Hoxa 10 mutant mice uterine homeosis loss maternal Hoxa 10 expression
0.2717503.15890675.html.plaintext.txt	334	Development 1222687 2696AbstractFree Full Text Gendron RL Paradis H Hsieh Li HM Lee DW Potter SS Markoff E 1997 Abnormal uterine stromal glandular function associated maternal reproductive defects Hoxa 11 null mice
0.2717503.15890675.html.plaintext.txt	335	Biol Reprod 561097 1105Abstract Ingham PW McMahon AP 2001 Hedgehog signaling animal development paradigms principles
0.2717503.15890675.html.plaintext.txt	336	Genes Dev 153059 3087Free Full Text Krishnan V Pereira FA Qiu Y Chen CH Beachy PA Tsai SY Tsai MJ 1997 Mediation sonic hedgehog induced expression COUP TFII protein phosphatase
0.2717503.15890675.html.plaintext.txt	337	Science 2781947 1950AbstractFree Full Text Byrd N Becker S Maye P Narasimhaiah R St Jacques B Zhang X McMahon J McMahon A Grabel L 2002 Hedgehog required murine yolk sac angiogenesis
0.2717503.15890675.html.plaintext.txt	338	Development 129361 372Medline Oksjoki S Sallinen S Vuorio E Anttila L 1999 Cyclic expression mRNA transcripts connective tissue components mouse ovary
0.2717503.15890675.html.plaintext.txt	339	Mol Hum Reprod 5803 808AbstractFree Full Text Navab R Wang Y Chow YH Wang A Jankov RP Takamoto N Tsai SY Tsai MJ Tanswell AK Hu J 2002 Regulation human Clara cell 10 kD protein expression chicken ovalbumin upstream promoter transcription factors COUP TFs
0.2717503.15890675.html.plaintext.txt	340	Am J Respir Cell Mol Biol 27273 825AbstractFree Full Text
0.24778366.9826778.html.plaintext.txt	0	The orphan nuclear receptor COUP TF II inhibits myogenesis post transcriptional regulation MyoD function COUP TF II directly interacts p300 MyoD
0.24778366.9826778.html.plaintext.txt	1	Peter Bailey Vittorio Sartorelli1 Yasou Hamamori1 George E
0.24778366.9826778.html.plaintext.txt	2	University Queensland Centre Molecular Cellular Biology Ritchie Research Laboratories B402A St Lucia 4072 Queensland Australia 1University Southern California Institute Genetic Medicine 1402250 Alcazar Street Los Angeles CA 90033 USA
0.24778366.9826778.html.plaintext.txt	3	Received June 11 1998 Revised Accepted October 15 1998
0.24778366.9826778.html.plaintext.txt	4	COUP TF II orphan nuclear receptor known ligand classical sense
0.24778366.9826778.html.plaintext.txt	5	COUP TF interacts corepressors N CoR SMRT RIP13 silences transcription active repression trans repression
0.24778366.9826778.html.plaintext.txt	6	Forced expression orphan nuclear receptor COUP TF II mouse C2 myogenic cells demonstrated inhibit morphological differentiation repress expression myoD gene family encodes myogenic basic helix loop helix bHLH proteins ii cell cycle regulator p21Waf 1Cip 1
0.24778366.9826778.html.plaintext.txt	7	In present study show COUP TF II efficiently inhibits myoD mediated myogenic conversion pluripotential C3H10T12 cells post transcriptional mechanisms
0.24778366.9826778.html.plaintext.txt	8	Furthermore repression MyoD dependent transcription COUP TF II occurs absence nuclear receptor cognate binding motif
0.24778366.9826778.html.plaintext.txt	9	The inhibition MyoD mediated trans activation involves direct binding DNA binding domainC region hingeD regions
0.24778366.9826778.html.plaintext.txt	10	amino acid aa residues 78 213 COUP TF II N terminal activation domain MyoD
0.24778366.9826778.html.plaintext.txt	11	Over expression cofactor p300 functions coactivator myoD mediated transcription alleviated repression COUP TF II
0.24778366.9826778.html.plaintext.txt	12	Further binding analysis demonstrated COUP TF II interacted N terminal 149 aa residues p300 encoded receptor interaction domain coactivator
0.24778366.9826778.html.plaintext.txt	13	Finally observed COUP TF II MyoD p300 interact competitive manner increasing amounts COUP TF II ability reduce interaction myoD p300 invitro
0.24778366.9826778.html.plaintext.txt	14	The experiments presented herein suggest thatCOUP TF II post transcriptionally regulates myoD activityfunction crosstalk orphan nuclear receptors myogenic bHLH proteins functional consequences differentiation
0.24778366.9826778.html.plaintext.txt	15	The process skeletal muscle differentiation involves activation induction large array muscle specific genes exit cell cycle
0.24778366.9826778.html.plaintext.txt	16	The myoD gene family encodes myogenic specific basic helix loop helix bHLH proteins activate control process reviewed 1 3
0.24778366.9826778.html.plaintext.txt	17	MyoD plays dual role myogenesis activating muscle specific gene transcription promoting cell cycle exit inducing expression p21Cip 1Waf 1 inhibitor cyclin dependent kinases cellular proliferation 4 6
0.24778366.9826778.html.plaintext.txt	18	Transactivation MyoD involves bHLH domain involved DNA binding dimerisation ii heterodimerisation MyoD ubiquitously expressed E2A gene products E12 E47 7 iii binding MyoD E2A heterodimers specific E box motifs CANNTG muscle specific enhancers reviewed 1 3 iv recruitment cofactors p300 PCAF 8 10
0.24778366.9826778.html.plaintext.txt	19	The cofactors p300 PCAF critical coactivators MyoD myogenic commitment differentiation
0.24778366.9826778.html.plaintext.txt	20	The N terminal acid rich activation domain MyoD directly interacts p300 recruits PCAF form ternary multimeric complex promoter elements 811
0.24778366.9826778.html.plaintext.txt	21	These events lead hyper acetylated transcriptionally permissive chromatin
0.24778366.9826778.html.plaintext.txt	22	Moreover p300 PCAF coactivate myoD mediated trans activation p21 gene necessary MyoD mediated cell cyle arrest 11
0.24778366.9826778.html.plaintext.txt	23	The transcriptional activity MyoD modulated environmental cues related concentration growth factors receptors oncogene products promote cell division reviewed 12
0.24778366.9826778.html.plaintext.txt	24	These agents inhibit transcriptional activity MyoD promoting direct phosphorylation bHLH region andor interaction c jun prevent DNA binding ii activation inhibitor differentiation expression Id bHLH protein lacks DNA binding ability functions dominant negative iii suppressionsequestering myogenic specific transcription factors cofactors
0.24778366.9826778.html.plaintext.txt	25	The orphan nuclear receptors COUP TF II Rev erbA RVR members nuclear receptor superfamily abundantly expressed proliferating myoblasts 12 15
0.24778366.9826778.html.plaintext.txt	26	However expression group receptors repressed differentiation
0.24778366.9826778.html.plaintext.txt	27	Constitutive expression COUP TF II cDNA mouse C2 myogenic cells blocks morphological differentiation suppressing levels myoD mRNA increasing cyclin D1 protein levels blocking induction myogenin p21 mRNAs serum withdrawal 1416
0.24778366.9826778.html.plaintext.txt	28	The molecular basis effects elucidated
0.24778366.9826778.html.plaintext.txt	29	COUP TF IIis ubiquitously expressed adult tissues regulated morphogen sonic hedgehog 17
0.24778366.9826778.html.plaintext.txt	30	During embryogenesis COUP TF II expressed developing CNS spatio temporal manner 1819 dermatomial region somite 10 days post coitum give rise axial skeletal tongue muscle 20
0.24778366.9826778.html.plaintext.txt	31	COUP TF proteins highly expressed many developing organs expression level decreases completion differentiation suggesting COUP TF involved organogenesis 2122
0.24778366.9826778.html.plaintext.txt	32	COUP TF binds direct inverted repeats RGGTCA motif spaced 0 12 nt 23 26
0.24778366.9826778.html.plaintext.txt	33	COUP TF isoforms I II demonstrated repress hormonal trans activation target genes nuclear receptor family 23 26 ii repress trans activation potent GAL4VP16 chimera 16 iii interact TFIIB iv negatively regulate transcription many genese
0.24778366.9826778.html.plaintext.txt	34	Apolipoprotein AI gene 2127 29
0.24778366.9826778.html.plaintext.txt	35	Inhibition trans cription COUP TF II shown mediated two main mechanisms active repression transrepression 30
0.24778366.9826778.html.plaintext.txt	36	Active repression COUP TF involves direct binding competition occupancy common response element 31
0.24778366.9826778.html.plaintext.txt	37	Transrepression involves inhibition transcription COUP TF II absence cognate binding motif independent nucleic acid binding 30
0.24778366.9826778.html.plaintext.txt	38	Interestingly 16 Achatz et al
0.24778366.9826778.html.plaintext.txt	39	30 demonstrated DNA binding domain DBDC region COUP TF II necessary transrepression
0.24778366.9826778.html.plaintext.txt	40	The molecular mechanism underlying COUP TF II transrepression unclear however suggested direct protein protein interactions COUP TF essential cofactors may involved
0.24778366.9826778.html.plaintext.txt	41	Whether COUP TF II directly regulates transcription bHLH regulators unclear
0.24778366.9826778.html.plaintext.txt	42	Furthermore fact COUP TF II represses transcription presence absence cognate binding motif raises scenario COUP TF II may control MyoD activity formation functional MyoD ternary complex
0.24778366.9826778.html.plaintext.txt	43	Active repression COUP TF II mediated nuclear corepressors
0.24778366.9826778.html.plaintext.txt	44	N CoRRIP13 SMRTTRAC 2 1632 35
0.24778366.9826778.html.plaintext.txt	45	Corepressors actively repress transcription interacting Sin3AB recruiting histone deacetylases
0.24778366.9826778.html.plaintext.txt	46	HDAc 1 Rpd3 actively promote chromatin condensation via hypo acetylation chromatin 36 39 ii binding key components basal transcriptional machinery
0.24778366.9826778.html.plaintext.txt	47	TFIIB TAFII32 TAFII70 40
0.24778366.9826778.html.plaintext.txt	48	In present study demonstrate repression MyoD mediated transactivation COUP TF II involves direct binding MyoD p300
0.24778366.9826778.html.plaintext.txt	49	Vectors used transfection experiments GST pulldowns described detail elsewhere 816
0.24778366.9826778.html.plaintext.txt	50	The construction new plasmids described herein
0.24778366.9826778.html.plaintext.txt	51	The oligonucleotides GMUQ371 5prime GCGGTCGACATATGTGCCGCCTCAAAAAGTGCCTC 3prime GMUQ372 5prime GCGGTCGACTTATTTATTGAATTGCCATATACGG 3prime synthesised allow PCR amplification COUP TF II region spanning amino acids aa 134 414
0.24778366.9826778.html.plaintext.txt	52	The oligonucleotides GMUQ371 GMUQ373 5prime GCGGTCGACCTAGGTTTTACCTACCAAACGG 3prime used amplify region spanning aa 134 389
0.24778366.9826778.html.plaintext.txt	53	PCR amplification performed Pfu DNA polymerase Stratagen La Jolla CA according manufacturers instructions
0.24778366.9826778.html.plaintext.txt	54	The resulting DNA fragments digested SalI ligated SalI digested pNLVP16
0.24778366.9826778.html.plaintext.txt	55	The plasmids described VP16 COUP TF II 12
0.24778366.9826778.html.plaintext.txt	56	aa 134 414 VP16 COUP TF II 13
0.24778366.9826778.html.plaintext.txt	57	aa 134 389 throughout text
0.24778366.9826778.html.plaintext.txt	58	The oligonucleotides GMUQ272 QMUQ273 described 16 used generate COUP TF II CD region
0.24778366.9826778.html.plaintext.txt	59	The resulting product digested EcoRI end filled Klenow DNA polymerase according manufacturers directions
0.24778366.9826778.html.plaintext.txt	60	The COUP TF II CD end filled fragment cloned pNLVP16 vector cleaved NdeI end filled Klenow DNA polymerase
0.24778366.9826778.html.plaintext.txt	61	To generate pSG5 COUP TF II AB ABCD CDE expression vectors GAL4 COUP TF II plasmids encoding AB ABCD CDE domains digested EcoRI resulting fragments cloned EcoRI site pSG5
0.24778366.9826778.html.plaintext.txt	62	pSG5 COUP TF II CD generated digesting COUP TF II CD PCR fragment EcoRI directly cloning EcoRI site pSG5
0.24778366.9826778.html.plaintext.txt	63	To create plasmids encoding GST COUP TF II AB ABCD CDE DE GAL4 COUP TF II plasmids encoding AB ABCD CDE DE domains digested EcoRI resulting fragments cloned EcoRI site pGEX 1lambdaT
0.24778366.9826778.html.plaintext.txt	64	GST COUP TF II CD wasgenerated digesting CD PCR fragment EcoRI cloning EcoRI site pGEX 1lambdaT
0.24778366.9826778.html.plaintext.txt	65	VP16 GAL GSTchimeras sequenced confirm orientation reading frame
0.24778366.9826778.html.plaintext.txt	66	JEG 3 cells cultured 24 h Dulbeccos Modified Eagles Medium DMEM containing 5 charcoal stripped fetal calf serum 6 CO2 37 degrees C prior transfection
0.24778366.9826778.html.plaintext.txt	67	JEG 3 cells grown 6 well dishes 60 70 confluence transiently transfected 3 microg reporter plasmid DNA G5E1b CAT 1 microg either GAL4 p300 aa 1 149 GAL4 p300 aa 595 1240 GAL4 p300 aa 1030 2414 1 microg either VP16O VP16 COUP TF II VP16 COUP TF II AB VP16 COUP TFII ABCD VP16 COUP TF II CD VP16 COUP TF II CDE VP16 COUP TF II DE VP16 COUP TF II 12 VP16 COUP TF II 13 DOTAPDOSPER Boehringer Mannheim mediated procedure described previously 41
0.24778366.9826778.html.plaintext.txt	68	The DNADOTAPDOSPER mixture added cells 3 ml fresh medium
0.24778366.9826778.html.plaintext.txt	69	The medium replaced 24 h transfection
0.24778366.9826778.html.plaintext.txt	70	Cells harvested assayed CAT enzyme activity previously described 24 h
0.24778366.9826778.html.plaintext.txt	71	Each transfection experiment performed least three times order overcome variability inherent transfections
0.24778366.9826778.html.plaintext.txt	72	NIH3T3 fibroblasts grown confluence 5 x 106 cells DMEM supplemented 10 fetal bovine serum
0.24778366.9826778.html.plaintext.txt	73	Cells transfected calcium phosphate precipitation procedure previously described
0.24778366.9826778.html.plaintext.txt	74	One microg 4RE tkLUC reporter coprecipitated either 100 ng EMSV 200 ng p300 andor 100 500 ng pSG5 COUP TF II sensepSG5 COUP TF II anti senseplasmid
0.24778366.9826778.html.plaintext.txt	75	5 mg CMV LacZ plasmid included transfection
0.24778366.9826778.html.plaintext.txt	76	Luciferase activity assayed previously described 8 corrected respect transfection efficiency beta galactosidase assay
0.24778366.9826778.html.plaintext.txt	77	Thequantitative beta galactosidase assay performed chlorophenol red beta d galactopyranoside substrate CPRG Boehringer Mannheim previously described 8
0.24778366.9826778.html.plaintext.txt	78	Each transfection experiment performed least three times order overcome variability inherent transfections
0.24778366.9826778.html.plaintext.txt	79	C3H10T12 cell myogenic conversion
0.24778366.9826778.html.plaintext.txt	80	For myogenic conversion assay C3H10T12 fibroblasts grown 60 confluence 12 well dishes
0.24778366.9826778.html.plaintext.txt	81	Cells well transfected DOTAPDOSPER Boehringer Mannheim mediated procedure using 1 microg EMSV MyoD combination either 1 microg pSG5 COUP TF II pSG5 COUP TF II AB pSG5 COUP TF II ABCD pSG5 COUP TF II CDE pSG5 carrier DNA total 2 microg per transfection
0.24778366.9826778.html.plaintext.txt	82	4 microg EMSV MyoD EMSV Myf 5 EMSV Myogenin EMSV MRF4 cotransfected either 0
0.24778366.9826778.html.plaintext.txt	83	4 microg pSG5 pSG5 COUP TF II
0.24778366.9826778.html.plaintext.txt	84	Twenty four hours transfection cells reefed 10 DMEM 100 confluent whereupon media changed DMEM plus 2 horse serum
0.24778366.9826778.html.plaintext.txt	85	Cells grown conditions 6 days media changes occurring every 2 days
0.24778366.9826778.html.plaintext.txt	86	Immunostaining performed using monoclonal antibody directed towards fast isoform major thick filament protein skeletal myosin heavy chain MHC Sigma clone MY32
0.24778366.9826778.html.plaintext.txt	87	This procedure described detail elsewhere 8
0.24778366.9826778.html.plaintext.txt	88	GST GST fusion proteins expressed Escherichia coli BL21 purified using glutathione agarose affinity chromatography described previously 15
0.24778366.9826778.html.plaintext.txt	89	The GST fusion proteins analysed 10 SDS PAGE gels integrity normalise amount protein
0.24778366.9826778.html.plaintext.txt	90	The Promega Madison WI TNT coupled transcription translation system used produce 35Smethionine labelled MyoD COUP TF II proteins visualised SDS PAGE
0.24778366.9826778.html.plaintext.txt	91	In vitro binding assays performed glutathione agarose beads Sigma St Louis MO coated 500 ng GST fusion protein 2 30 microl 35Smethionine labelled protein 200 ml binding buffer containing 100 mM NaCl 20 mM Tris HCl pH 8
0.24778366.9826778.html.plaintext.txt	92	5 NP 40 5 microg ethidium bromide 100 microg BSA
0.24778366.9826778.html.plaintext.txt	93	The reaction allowed proceed 1 2 h room temperature rocking
0.24778366.9826778.html.plaintext.txt	94	The affinity beads collected centrifugation washed five times 1 ml binding buffer without ethidium bromide BSA
0.24778366.9826778.html.plaintext.txt	95	The beads resuspended 20 ml SDS PAGE sample buffer boiled 5 min
0.24778366.9826778.html.plaintext.txt	96	The denatured proteins run 10 SDS PAGE gel subsequently treated Amersham Amplify fluor Amersham Arlington Heights IL dried autoradiographed
0.24778366.9826778.html.plaintext.txt	97	RESULTS COUP TF II inhibits myoD mediated myogenic conversion pluripotential C3H10T12 cells
0.24778366.9826778.html.plaintext.txt	98	We previously demonstrated proliferating C2C12 myoblasts express COUP TF II mRNA constitutive expression COUP TF II cDNA mouse C2 myogenic cells blocks morphological differentiation suppressing expression levels myoD gene family critical cell cycle regulators 1415
0.24778366.9826778.html.plaintext.txt	99	Moreover preliminary evidence suggests COUP TF II directly regulates transcription bHLHcontractile gene families andor cell cycle regulators P
0.24778366.9826778.html.plaintext.txt	100	However fact COUP TF II represses transcription presence absence cognate binding motif interacts corepressors N CoR SMRT raises scenario COUP TF II may control MyoD activity function post transcriptional mechanisms include transrepression
0.24778366.9826778.html.plaintext.txt	101	We tested hypothesis investigating impact SV40 driven COUP TF II expression MyoD mediated myogenic conversion pluripotential C3H10T12 cells
0.24778366.9826778.html.plaintext.txt	102	In system transient transfection EMSV MyoD expression vector control moloney sarcoma virus promoter leads phenotypicmyogenic conversion cells scored immunostaining monoclonal antibody directed muscle specific marker
0.24778366.9826778.html.plaintext.txt	103	The antibody fast isoform major thick filament protein skeletal MHC
0.24778366.9826778.html.plaintext.txt	104	MHC associated contractile phenotype expressed process muscle differentiation
0.24778366.9826778.html.plaintext.txt	105	Utilisation EMSV driven MyoD expression vector essentially refactory repression COUP TF II assured observed affects COUP TF II phenotypic conversion independent myoD regulation mediated post transcriptional events
0.24778366.9826778.html.plaintext.txt	106	We demonstrated identical moloney sarcoma virus promoter linked CAT reporter vector affectedregulated COUP TF II expression
0.24778366.9826778.html.plaintext.txt	107	We cotransfected increasing amounts either pSG5 SV40 expression vector alone pSG5 COUP TF II EMSV CAT
0.24778366.9826778.html.plaintext.txt	108	We observed concentrations DNA transfected experiment neither vector alone pSG5 COUP TF II affected activity EMSV promoter Fig
0.24778366.9826778.html.plaintext.txt	109	In initial experiment C3H10T12 cells transiently transfected EMSV MyoD combination either pSG5 vectorvehicle pSG5 COUP TF II
0.24778366.9826778.html.plaintext.txt	110	As expected cells transfected EMSV MyoD pSG5 found positively stained MHC antibody
0.24778366.9826778.html.plaintext.txt	111	In stark contrast cells transfected MyoD wild type COUP TF II undergo myogenic conversion Fig
0.24778366.9826778.html.plaintext.txt	112	To delimit region within COUP TF II involved ablation MyoD mediated acquisition myogenic phenotype cotransfected 10T12 cells EMSV MyoD expression vectors encoding AB ABCD CDE regions COUP TF II Fig
0.24778366.9826778.html.plaintext.txt	113	After immunostaining found ABCD CDE regions sufficient inhibit myogenic conversion Fig
0.24778366.9826778.html.plaintext.txt	114	In contrast AB region COUP TF II failed ablate MyoD mediated acquisition contractile phenotype Fig
0.24778366.9826778.html.plaintext.txt	115	This agreement previous studies show CD region COUP TF II encoding DBD hinge domain blocks trans activation GAL4 dependent reporter genes potent chimeric trans activator GAL4VP16 16
0.24778366.9826778.html.plaintext.txt	116	A COUP TF II expression affect activity EMSV promoter
0.24778366.9826778.html.plaintext.txt	117	C3H10T12 cells transiently co transfected EMSV CAT combination either increasing quantities 0
0.24778366.9826778.html.plaintext.txt	118	0 microg pSG5 alone pSG5 COUP TF II
0.24778366.9826778.html.plaintext.txt	119	They subsequently assayed CAT activity results shown mean plus minus standard deviation derived three independent transfections
0.24778366.9826778.html.plaintext.txt	120	B COUP TF II inhibits myoD mediated myogenic conversion pluripotential C3H10T12 cells
0.24778366.9826778.html.plaintext.txt	121	The ABCD CDE regions COUP TF II sufficient inhibit myogenic conversion
0.24778366.9826778.html.plaintext.txt	122	C3H10T12 cells transiently transfected EMSV MyoD combination either pSG5 alone panel b pSG5 COUP TF II panel c pSG5 COUP TF II AB panel d pSG5 COUP TF II ABCD panel e pSG5 COUP TF II CDE
0.24778366.9826778.html.plaintext.txt	123	Myogenic conversion scored respect untransfected control cells panel immunostaining monoclonal antibody directed towards fast isoform major thick filament protein skeletal alphaMHC 4 daysin 2 horse serum
0.24778366.9826778.html.plaintext.txt	124	C Diagrammatic representation COUP TF II highlighting key domains AB domaini
0.24778366.9826778.html.plaintext.txt	125	aa 79 144 D domain Hinge
0.24778366.9826778.html.plaintext.txt	126	aa 145 213 E domain putative LBD
0.24778366.9826778.html.plaintext.txt	127	D Inhibition 10T12 myogenic conversion COUP TF II overcome forced expression myogenic factors myoD myogenin myf 5 MRF 4
0.24778366.9826778.html.plaintext.txt	128	C3H10T12 cells transiently transfected expression vectors myogenic factors MyoD myogenin myf 5 MRF 4 absence panel b presence panel c COUP TF II
0.24778366.9826778.html.plaintext.txt	129	As myogenic conversion scored respect untransfected control cells panel immunostaining MHC antibody
0.24778366.9826778.html.plaintext.txt	130	MHC positive cells stained red highlighted arrow
0.24778366.9826778.html.plaintext.txt	131	We examined whether forced expression myogenic factors myoD myogenin myf 5 MRF 4 could overcome block mediated COUP TF II
0.24778366.9826778.html.plaintext.txt	132	C3H10T12 cells transiently transfected expression vectors myogenic factors myoD myogenin myf 5 MRF 4 presence absence COUP TF II
0.24778366.9826778.html.plaintext.txt	133	It found although cotransfection C3H10T12 cells complete repertoire myogenic factors results efficient myogenic conversion scored positive alphaMHC immunostaining COUP TF II still blocks acquistion contractile phenotype Fig
0.24778366.9826778.html.plaintext.txt	134	In summary experiments presented suggest CDE region COUP TF II involved inhibition myoD mediated myogenic conversion pluripotential C3H10T12 cells
0.24778366.9826778.html.plaintext.txt	135	Furthermore orphan nuclear receptor abrogates 10T12 myogenic conversion absence cognate binding motif
0.24778366.9826778.html.plaintext.txt	136	The ability COUP TF II ride entire repertoire myogenic factors also suggests may sequester bind essential cofactors
0.24778366.9826778.html.plaintext.txt	137	COUP TF II inhibits myoD mediated trans activation reporter gene downstream MyoD dependent heterologous promoter
0.24778366.9826778.html.plaintext.txt	138	The immunohistochemical analysis suggested COUP TF II acts repress 10T12 myogenic conversion mechanism independent MyoD gene expression
0.24778366.9826778.html.plaintext.txt	139	Hence interest determine whether COUP TF II could repress MyoD dependent transcription absence cognate binding site
0.24778366.9826778.html.plaintext.txt	140	To achieve utilised 4RE tkLUC reporter construct four copies right E box CANNTG motif muscle specific MCK enhancer placed upstream minimal thymidine kinase promoter linked LUC reporter gene
0.24778366.9826778.html.plaintext.txt	141	This reporter construct contain cognate binding site COUP TF II demonstrated facilitate MyoD dependent trans activation
0.24778366.9826778.html.plaintext.txt	142	C3H10T12 cells cotransfected 4RE tkLUC reporter combination either EMSV MyoD andor COUP TF II sense anti sense expression vectors
0.24778366.9826778.html.plaintext.txt	143	As expected co transfection reporter EMSV MyoD alone activated expression LUC reporter gene efficiently Fig
0.24778366.9826778.html.plaintext.txt	144	However cotransfection 10T12 cells EMSV MyoD increasing quantities pSG5 COUP TF II expression vector
0.24778366.9826778.html.plaintext.txt	145	100 300 500 ng significantly repressed MyoD mediated trans activation dose dependent fashion Fig
0.24778366.9826778.html.plaintext.txt	146	In contrast cotransfection EMSV MyoD anti sense COUP TF II construct affect MyoD trans activation
0.24778366.9826778.html.plaintext.txt	147	This result clearly shows COUP TF II capable blocking MyoD mediated trans activation dose dependent manner via trans repression mechanism independent COUP TF II DNA binding
0.24778366.9826778.html.plaintext.txt	148	A COUP TF II inhibits MyoD dependent transactivation 4RE reporter construct via mechanism independent DNA binding
0.24778366.9826778.html.plaintext.txt	149	NIH 3T3 cells transiently transfected 4RE tkLUC reporter 1 microg combination either MyoD 100 ng COUP TF II sense S 100 300 500 ng COUP TF II anti sense AS 500 ng indicated
0.24778366.9826778.html.plaintext.txt	150	After 48 h cells harvested assayed luciferase activity described Methods Materials
0.24778366.9826778.html.plaintext.txt	151	B COUP TF II directly interacts MyoD vitro CD region COUP TF II alone capable mediating interaction
0.24778366.9826778.html.plaintext.txt	152	MyoD radiolabelled 35Smethionine vitro transcriptiontranslation input lane 1 represents 10 total protein assayed ability interact glutathione immobilised GST alone lane 2 GST COUP TF II lane 3 GST COUP TF II AB lane 4 GST COUP TF II ABCD lane 5 GST COUP TF II CD lane 6 GST COUP TF II CDE lane 7 GST COUP TF II DE lane 8
0.24778366.9826778.html.plaintext.txt	153	The retained proteins shown lanes 3 8
0.24778366.9826778.html.plaintext.txt	154	COUP TF II directly interacts MyoD CD region nuclear receptor mediates interaction
0.24778366.9826778.html.plaintext.txt	155	We postulated COUP TF II could functioning repress MyoD activityfunction directly interacting MyoD
0.24778366.9826778.html.plaintext.txt	156	To determine utilised vitro GST pulldown assay glutathione agarose immobilised GST COUP TF II incubated vitro 35S radiolabelled full length MyoD
0.24778366.9826778.html.plaintext.txt	157	This assay clearly showed COUP TF II MyoD indeed capable direct interaction vitro Fig
0.24778366.9826778.html.plaintext.txt	158	To map region within COUP TF II involved mediating interaction variety COUP TF II domains sub cloned GEX 1 expression vector producing fusion protiens GST COUP TF II AB GST COUP TF II ABCD GST COUP TF II CD GST COUP TF II CDE GST COUP TF II DE
0.24778366.9826778.html.plaintext.txt	159	The full length deleted GST COUP TF II chimeric proteins incubated vitro translated MyoD
0.24778366.9826778.html.plaintext.txt	160	Interestingly COUP TF II domains ABCD CD CDE interacted strongly full length MyoD Fig
0.24778366.9826778.html.plaintext.txt	161	In contrast neither AB region DE region retained ability interact full length MyoD
0.24778366.9826778.html.plaintext.txt	162	This demonstrated CD region COUP TF II spans aa 78 213 encodes DBD hinge region required MyoD binding
0.24778366.9826778.html.plaintext.txt	163	This observation also confirmed examining ability vitro translated full length COUP TF II interact GST MyoD Fig
0.24778366.9826778.html.plaintext.txt	164	As expected observed specific binding 35S radiolabelled COUP TF II GST MyoD vitro
0.24778366.9826778.html.plaintext.txt	165	These experiments suggested protein protein interactions involved transrepression myoD mediated transcription
0.24778366.9826778.html.plaintext.txt	166	The N terminal acid rich activation domain MyoD mediates interaction COUP TF II vitro
0.24778366.9826778.html.plaintext.txt	167	A GST pulldown showing interaction 35S radiolabelled COUP TF II glutathione agarose immobilised GST MyoD
0.24778366.9826778.html.plaintext.txt	168	The input lane represents 10 total protein
0.24778366.9826778.html.plaintext.txt	169	B Diagrammatic representation MyoD protein highlighting key regulatory domains
0.24778366.9826778.html.plaintext.txt	170	C Glutathione agarose immobilised GST GST COUP TF II proteins incubated either 35S radiolabelled full length MyoD N terminal MyoD aa 1 100 C terminal MyoD aa 162 318
0.24778366.9826778.html.plaintext.txt	171	The input lanes represent 10 total protein
0.24778366.9826778.html.plaintext.txt	172	D COUP TF II directly interacts N terminal MyoD vitro
0.24778366.9826778.html.plaintext.txt	173	The CDE domain COUP TF II radiolabelled 35Smethionine vitro transcriptiontranslation input lane 1 represents 10 total protein assayed ability interact glutathione immobilised GST alone lane 2 GST MyoD full length lane 3 GST MyoD N terminal lane 4 GST MyoD C terminal lane 5 GST MyoD bHLH lane 6
0.24778366.9826778.html.plaintext.txt	174	The retained proteins shown lanes 3 6
0.24778366.9826778.html.plaintext.txt	175	The N terminal acid rich activation domain MyoD mediates interaction COUP TF II
0.24778366.9826778.html.plaintext.txt	176	To identify domain within MyoD Fig
0.24778366.9826778.html.plaintext.txt	177	3B interacts COUP TF II immobilised GST COUP TF II incubated combination either 35S radiolabelled N terminal MyoD aa 1 100 C terminal MyoD aa 162 318
0.24778366.9826778.html.plaintext.txt	178	It found N terminal acid rich activation domain MyoD C terminal region interacted COUP TF II Fig
0.24778366.9826778.html.plaintext.txt	179	It noted N terminal activation domain MyoD also demonstrated interact p300
0.24778366.9826778.html.plaintext.txt	180	To rigorously confirm N terminal MyoD interacts COUP TF II examined ability number GST MyoD fusion chimeras containing functional subdomains MyoD immobilised glutathione agrose beads
0.24778366.9826778.html.plaintext.txt	181	GST MyoD aa 1 318 GST N terminal MyoD aa 1 100 GST bHLH aa 102 161 GST C terminal MyoD aa 162 318 interact 35S radiolabelled CDE region COUP TF II Fig
0.24778366.9826778.html.plaintext.txt	182	As expected MyoD N terminal MyoD linked GST interacted strongly vitro translated COUP TF II CDE Fig
0.24778366.9826778.html.plaintext.txt	183	In contrast GST MyoD C terminal bHLH regions support significant interaction CDE domain COUP TF II
0.24778366.9826778.html.plaintext.txt	184	These experiments suggest N terminal acid rich activation domain MyoD represented first 100 aa protein required COUP TF II binding
0.24778366.9826778.html.plaintext.txt	185	The coactivator p300 alleviates COUP TF II mediated repression MyoD dependent trans activation
0.24778366.9826778.html.plaintext.txt	186	Nuclear receptors demonstrated inhibit AP 1 function absence observable affects DNA recognition competing limiting amounts p300CBP 42
0.24778366.9826778.html.plaintext.txt	187	Competition p300 case involves direct binding p300 nuclear receptors
0.24778366.9826778.html.plaintext.txt	188	In context muscle differentiation p300 functions coactivator MyoD mediated trans activation demonstrated augment trans activation genes contain E box elements enhancer regions
0.24778366.9826778.html.plaintext.txt	189	It therefore interest determine whether COUP TF II could functioning repress MyoD dependent trans activation competing limiting amounts p300
0.24778366.9826778.html.plaintext.txt	190	In examined effect p300 expression COUP TF II mediated repression MyoD dependent trans activation
0.24778366.9826778.html.plaintext.txt	191	NIH 3T3 cells cotransfected 4RE tkLUC construct COUP TF II presence either MyoD MyoD p300
0.24778366.9826778.html.plaintext.txt	192	If competition limiting quantities p300 also accounts inhibitory effect COUP TF II MyoD transcriptional activity increased levels p300 restorealleviate COUP TF II mediated repression
0.24778366.9826778.html.plaintext.txt	193	We found cotransfection p300 COUP TF II MyoD almost completely rescued myoD transcriptional activity Fig
0.24778366.9826778.html.plaintext.txt	194	4A suggesting repression COUP TF II involves competition limiting amounts p300 presumably protein protein interactions
0.24778366.9826778.html.plaintext.txt	195	The coactivator p300 alleviates COUP TF II mediated repression MyoD dependent trans activation
0.24778366.9826778.html.plaintext.txt	196	NIH 3T3 cells transiently transfected 1 microg 4RE tkLUC construct 100 ng CMV MyoD 200 ng CMV betap300 300 ng COUP TF II indicated
0.24778366.9826778.html.plaintext.txt	197	After 48 h cells harvested assayed luciferase activity
0.24778366.9826778.html.plaintext.txt	198	COUP TF II interacts N terminal 149 aa receptor interaction domain RID cofactor p300 vivo
0.24778366.9826778.html.plaintext.txt	199	Nuclear receptors shown directly interact N terminal RID encoded aa residues 1 149 p300 vivo Fig
0.24778366.9826778.html.plaintext.txt	200	To determine COUP TF II also interacts p300 vivo utilised mammalian two hybrid assay
0.24778366.9826778.html.plaintext.txt	201	In assay GAL4 DBD p300 domain fusion chimeras GAL4 p300 aa 1 149 p300 aa 595 1240 p300 aa 1030 2414 independently cotransfected JEG 3 cells either full length VP16 COUP TF II VP16 COUP TF II AB VP16 COUP TF II CDE
0.24778366.9826778.html.plaintext.txt	202	The capacity GAL p300 VP16 COUP TF II fusion products physically interact vivo assessed ability trans activate CAT reporter gene placed downstream GAL4 binding sites linked E1b promoter
0.24778366.9826778.html.plaintext.txt	203	It found like members nuclear receptor superfamily full length COUP TF II strongly interacts 20 fold N terminal RID p300 aa 1 149 Fig
0.24778366.9826778.html.plaintext.txt	204	In comparison nuclear receptor RXRgamma presence ligand interaction N terminal region p300 full length COUP TFII stronger 5 fold data shown similar reported Chakravarti et al
0.24778366.9826778.html.plaintext.txt	205	It also found RID p300 interacted efficiently C terminal region COUP TF II encodes CD E domains
0.24778366.9826778.html.plaintext.txt	206	DBD hinge putative ligand binding domain LBD
0.24778366.9826778.html.plaintext.txt	207	In contrast AB region COUP TF II interact RID p300 Fig
0.24778366.9826778.html.plaintext.txt	208	A Diagrammatic representation p300 protein highlighting regions involved protein protein interactions
0.24778366.9826778.html.plaintext.txt	209	B COUP TF II interacts RID p300 vivo
0.24778366.9826778.html.plaintext.txt	210	JEG 3 cells transiently transfected G5e1bCAT reporter construct expression vectors encoding either GAL4 p300 aa 1 149 GAL4 p300 aa 595 1240 GAL4 p300 aa 1030 2414 VP16 COUP TF II full length VP16 COUP TF II AB VP16 COUP TF II CDE indicated
0.24778366.9826778.html.plaintext.txt	211	After 48 h 10 charcoal stripped medium cells harvested assayed CAT activity
0.24778366.9826778.html.plaintext.txt	212	Results shown mean plus minus standard deviation derived least three independent experiments
0.24778366.9826778.html.plaintext.txt	213	In case fold activation relative GAL4 p300 chimeraVP160 CAT activity arbitrarily set 1
0.24778366.9826778.html.plaintext.txt	214	C The CD region COUP TF II spans aa 78 213 interacts N terminal 149 aa p300 vivo
0.24778366.9826778.html.plaintext.txt	215	JEG 3 cells transiently transfected 3 mg G5e1bCAT reporter construct 1 mg GAL4 p300 aa1 149 1 mg VP16 COUP TF II chimeras indicated
0.24778366.9826778.html.plaintext.txt	216	The results presented mean plus minus standard deviation derived least three independent experiments
0.24778366.9826778.html.plaintext.txt	217	In case fold activation relative GAL4 p300 aa 1 149VP160 CAT activity arbitarily set 1
0.24778366.9826778.html.plaintext.txt	218	D Direct binding CD region COUP TF II full length p300 vitro
0.24778366.9826778.html.plaintext.txt	219	p300 radiolabelled 35Smethionine vitro transcriptiontranslation assayed ability interact glutathione immobilised GST GST COUP TF II GST COUP TF II AB GST COUP TF II ABCD GST COUP TF II CD GST COUP TF II CDE GST COUP TF II DE
0.24778366.9826778.html.plaintext.txt	220	The cofactor p300 directly interacts COUP TF II CD region vivo vitro
0.24778366.9826778.html.plaintext.txt	221	To delimit region within COUP TF II interacts p300 RID vivo utilised mammalian two hybrid assay
0.24778366.9826778.html.plaintext.txt	222	In VP16 chimeras VP16 COUP TF AB ABCD CDE CD DE 12 13 depicted Fig
0.24778366.9826778.html.plaintext.txt	223	5C independently cotransfected GAL RID p300 assayed ability trans activate G5e1bCAT reporter
0.24778366.9826778.html.plaintext.txt	224	It found CD region COUP TF II encodes DBD hinge
0.24778366.9826778.html.plaintext.txt	225	aa 78 213 sufficient interact RID p300
0.24778366.9826778.html.plaintext.txt	226	Interestingly VP16 COUP TF II chimeras 12 13 contain part DBD
0.24778366.9826778.html.plaintext.txt	227	aa 134 able interact RID p300 suggesting entire DBD required binding
0.24778366.9826778.html.plaintext.txt	228	To confirm COUP TF II p300 interact directly used vitro GST pulldown assay
0.24778366.9826778.html.plaintext.txt	229	Equal quantities glutathione agarose immobilised GST negative control GST COUP TF II full length various sub domains GST COUP TF II AB GST COUP TF II ABCD GST COUP TF II CD GST COUP TF II CDE GST COUP TF II DE incubated vitro 35S radiolabelled full length p300
0.24778366.9826778.html.plaintext.txt	230	The resulting pulldown clearly showed direct interaction full length COUP TF II vitro translated p300 Fig
0.24778366.9826778.html.plaintext.txt	231	Furthermore CD region COUP TF II spanning aa 78 213 required interaction p300 Fig
0.24778366.9826778.html.plaintext.txt	232	Interestingly region interacts MyoD
0.24778366.9826778.html.plaintext.txt	233	It noted ABCD CDE regions COUP TF II also sufficient repress MyoD dependent conversion C3H10T12 cells DBD COUP TF II aa 79 144 essential repression trans activation absence cognate binding motif nucleic acid binding
0.24778366.9826778.html.plaintext.txt	234	COUP TF II p300 MyoD interact competitive manner
0.24778366.9826778.html.plaintext.txt	235	We embarked experiments designed analyse whether competitive binding interacting proteins issue respect formation ternary complex
0.24778366.9826778.html.plaintext.txt	236	We examined ability increasing amounts COUP TF II CDE affect efficiency interaction GST MyoD radiolabelled p300 Fig
0.24778366.9826778.html.plaintext.txt	237	We observed increasing amounts radiolabelled COUP TF II CDE reduced ability fixed amount 35S labelled p300 interact GST MyoD
0.24778366.9826778.html.plaintext.txt	238	Similarly observed increasing amounts myoD reduced ability p300 interact COUP TF II Fig
0.24778366.9826778.html.plaintext.txt	239	COUP TF II p300 MyoD interact competitive manner vitro
0.24778366.9826778.html.plaintext.txt	240	A Glutathione immobilised GST MyoD protein incubated 0
0.24778366.9826778.html.plaintext.txt	241	5 microl 35S radiolabelled p300 either 2 4 8 microl radiolabelled COUP TF II CDE indicated
0.24778366.9826778.html.plaintext.txt	242	In pulldown input lanes represent 10 total protein
0.24778366.9826778.html.plaintext.txt	243	B Glutathione immobilised GST COUP TF II protein incubated 1 microl 35S radiolabelled p300 either 2 4 8 microl radiolabelled MyoD indicated
0.24778366.9826778.html.plaintext.txt	244	This suggested interaction COUP TF II p300 myoD competitive nature COUP TF II may involved process regulates interaction MyoD cofactor p300 essential trans activation gene expression
0.24778366.9826778.html.plaintext.txt	245	The regulation myogenesis
0.24778366.9826778.html.plaintext.txt	246	muscle differentiation intimately controlled group muscle specific bHLH proteins encoded myoD gene family myoD myogenin myf 5 MRF 4 reviewed 1 3
0.24778366.9826778.html.plaintext.txt	247	The products myoD gene family involved variety protein protein interactions many factors mediate transcription e
0.24778366.9826778.html.plaintext.txt	248	E12 E47 TFIIB 744 control cell cycle e
0.24778366.9826778.html.plaintext.txt	249	RB 45 regulate chromatin accessibility architecture p300 PCAF 11
0.24778366.9826778.html.plaintext.txt	250	These protein protein interactions regulate cellular proliferation activate myogenic specific transcription encodes contractile phenotype
0.24778366.9826778.html.plaintext.txt	251	Insights process myogenesis provided myoD gene family transcription factors function nexus command circuits control mutually exclusive events division differentiation
0.24778366.9826778.html.plaintext.txt	252	The nuclear receptor superfamily potent regulators development differentiation homeostasis organ physiology however functional role mammalian muscle differentiation regulation MyoD myogenesis resolved descriptive level
0.24778366.9826778.html.plaintext.txt	253	The classical ligand activated nuclear receptors e
0.24778366.9826778.html.plaintext.txt	254	thyroid hormone receptor promote differentiation muscle maturation vivo 1246
0.24778366.9826778.html.plaintext.txt	255	However orphan nuclear receptors including Rev erbalpha RVR COUP TF II abundantly expressed skeletal muscle proliferating myogenic cells antagonistically regulate muscle differentiation appear involved maintenance proliferative state 13 15
0.24778366.9826778.html.plaintext.txt	256	This study directed toward identifying mechanistic aspects orphan nuclear receptor mediated repression muscle differentiation myogenic conversion
0.24778366.9826778.html.plaintext.txt	257	Our work suggested repression MyoD mediated trans activation myogenic conversion COUP TF II involves direct interactions MyoD coactivator p300
0.24778366.9826778.html.plaintext.txt	258	Furthermore study provides another line evidence biological context demonstrates COUP TF II mediated repression MyoD dependent trans activation occurs absence orphan receptor cognate binding motif
0.24778366.9826778.html.plaintext.txt	259	This observation strengthens view trans repression COUP TF II functional role mammalian muscle differentiation
0.24778366.9826778.html.plaintext.txt	260	Finally demonstrates direct crosstalk orphan nuclear receptor bHLH pathways functional consequences regulation differentiation phenotypic acquisition
0.24778366.9826778.html.plaintext.txt	261	This mode action crosstalk two central regulatory components may turn utilised pathways mammalian differentiation
0.24778366.9826778.html.plaintext.txt	262	Specifically study showed COUP TF II could repress MyoD mediated myogenic conversion pluripotential 10T12 cells myoD expression driven viral promoter refractory COUP TF II action
0.24778366.9826778.html.plaintext.txt	263	This immunochemical analysis suggested CDE region N terminal AB region COUP TF II necessary repression myoD mediated myogenic conversion
0.24778366.9826778.html.plaintext.txt	264	In particular C D regions orphan receptor aa residues 78 213 encode DBD hinge region respectively specifically involved events
0.24778366.9826778.html.plaintext.txt	265	We observed MyoD dependent reporter gene driven four multimerised MyoD binding sites MCK enhancer cloned upstream herpes simplex thymidine kinase promoter specifically inhibited COUP TF II expression
0.24778366.9826778.html.plaintext.txt	266	Our study suggested one mechanisms involved process repression direct interaction MyoD COUP TF II
0.24778366.9826778.html.plaintext.txt	267	Additional vitro experiments demonstrated interaction mediated acid rich N terminal activation domain MyoD also mediates p300 binding CD region COUP TF II
0.24778366.9826778.html.plaintext.txt	268	Furthermore COUP TF II interacted N terminal RID aa 1 149 cofactor p300
0.24778366.9826778.html.plaintext.txt	269	This perhaps surprising since many classical ligand activated nuclear receptors e
0.24778366.9826778.html.plaintext.txt	270	interact coactivator p300 42
0.24778366.9826778.html.plaintext.txt	271	However fact DBD C region hingeD region COUP TF II mediate interaction p300 MyoD novel perhaps suprising
0.24778366.9826778.html.plaintext.txt	272	With respect vitro vivo requirement COUP TF II DBD hinge region aa 79 213 dimerisation interface myoD p300 mentioned domain contains DR T box motifs implicated dimerisation interfaces RXR nuclear receptors
0.24778366.9826778.html.plaintext.txt	273	Furthermore highly homologous similar motifs found RXR expected since COUP TF II RXR belong nuclear receptor sub family 4748
0.24778366.9826778.html.plaintext.txt	274	The DR box strongly implicated heterodimerisation TR RAR RXR
0.24778366.9826778.html.plaintext.txt	275	The DR boxes RXRgamma COUP TF II highly homologous
0.24778366.9826778.html.plaintext.txt	276	Similarly T box sequence forms third helix RXR implicated homo heterodimerisation similar COUP TF II RXR 49 53
0.24778366.9826778.html.plaintext.txt	277	Recently COUP TF II SpI demonstrated synergistically regulate transcription HIV type I LTR 54
0.24778366.9826778.html.plaintext.txt	278	In support observations demonstrated vitro vivo physical interaction SpI mediated DBD COUP TF
0.24778366.9826778.html.plaintext.txt	279	Furthermore Octamer transcription factors recruited C region DBD glucocorticoid receptor 55
0.24778366.9826778.html.plaintext.txt	280	COUP TF II mediated repression trans activation involves cofactor p300 since co expression p300 alleviates silencing transcription
0.24778366.9826778.html.plaintext.txt	281	Our study suggested repression may involve sequestration vital cofactor myoD mediated trans activation since COUP TF II directly interacts p300
0.24778366.9826778.html.plaintext.txt	282	Whether inhibition MyoD dependent trans activation COUP TF II binding result conformational change MyoD detrimental function ii prevention p300cofactorcoactivator binding iii andor sequestering cofactors e
0.24778366.9826778.html.plaintext.txt	283	p300 COUP TF II unclear present
0.24778366.9826778.html.plaintext.txt	284	However vitro GST pulldown data suggest MyoD COUP TF II p300 interact competitive manner increasing amounts COUP TF II ability reduce interaction myoD p300 vitro
0.24778366.9826778.html.plaintext.txt	285	Achatz colleagues demonstrated repression transcription COUP TF II activity dependent DBD segment spanning aa residues 193 399 30
0.24778366.9826778.html.plaintext.txt	286	Single point mutations DBD ablated sequence specific binding affect silencing transcription
0.24778366.9826778.html.plaintext.txt	287	16 demonstrated repression GAL4VP16 mediated trans activation involves DBD COUP TF II absence cognate binding motif
0.24778366.9826778.html.plaintext.txt	288	Achatz suggested regions critical repression trans activation COUP TF II involved mediating protein protein interactions
0.24778366.9826778.html.plaintext.txt	289	In present study show DBD hinge region COUP TF II alone sufficient bind either MyoD p300
0.24778366.9826778.html.plaintext.txt	290	Deletions COUP TF II contain part DBD
0.24778366.9826778.html.plaintext.txt	291	aa 134 however able interact RID p300 suggesting entire DBD required binding
0.24778366.9826778.html.plaintext.txt	292	Although DBD hinge region functions dimerisation interface COUP TF II also observed presence E region strengthens specificity interaction G
0.24778366.9826778.html.plaintext.txt	293	While manuscript reviewed demonstrated Froeschle et al
0.24778366.9826778.html.plaintext.txt	294	56 DBD retinoic acid receptor also directly interacts MyoD
0.24778366.9826778.html.plaintext.txt	295	Our data data suggested DBD nuclear receptors may also encode dimerisation interface bHLH family proteins
0.24778366.9826778.html.plaintext.txt	296	Forced expression COUP TF II C2 myogenic cells blocks differentiation particular ablates induction p21 mRNA expression 14
0.24778366.9826778.html.plaintext.txt	297	Moreover normal proliferating C2 cells COUP TF II mRNA expressed however cell cycle withdrawal differentiation mRNA levels repressed 15
0.24778366.9826778.html.plaintext.txt	298	Transcription p21 gene specifically stimulated MyoD myogenic differentiation coactivated transcriptional complex contains p300 PCAF 11
0.24778366.9826778.html.plaintext.txt	299	In present study show MyoD mediated transcription significantly repressed COUP TF II
0.24778366.9826778.html.plaintext.txt	300	This suggests COUP TF II involved maintenance proliferative state controlling trans activation p21 gene
0.24778366.9826778.html.plaintext.txt	301	Nuclear receptors also shown interact growing family PASbHLH domain coactivators e
0.24778366.9826778.html.plaintext.txt	302	SRC1N CoA 1 TIF 2GRIP 1 ACTRRAC 3pCIP 57 59
0.24778366.9826778.html.plaintext.txt	303	However N terminal bHLHPAS domains coactivators function activation domains interact proteins involved target gene specificity
0.24778366.9826778.html.plaintext.txt	304	There documented interactions regions cofactors nuclear receptors
0.24778366.9826778.html.plaintext.txt	305	In conclusion present study provides evidence suggests one mechanisms mediates repression muscle differentiation myogenic conversion COUP TF II involves direct interactions MyoD coactivator p300
0.24778366.9826778.html.plaintext.txt	306	Whether direct crosstalk orphan nuclear receptor bHLH pathways target gene specificity developmental context remains elucidated focus future studies context mammalian differentiation
0.24778366.9826778.html.plaintext.txt	307	This investigation supported National Health Medical Research Council NHMRC Australia University Queensland Enabling Fund
0.24778366.9826778.html.plaintext.txt	308	NHMRC Supported Senior Research Fellow
0.24778366.9826778.html.plaintext.txt	309	The Centre Molecular Cellular Biology recipient Australia Research Council ARC special research grant
0.24778366.9826778.html.plaintext.txt	310	1995 Science 267 1018 1021
0.24778366.9826778.html.plaintext.txt	311	1995 Science 267 1024 1027
0.24778366.9826778.html.plaintext.txt	312	1997 Science 278 1947 1950
0.24778366.9826778.html.plaintext.txt	313	1994 Development 120 25 36
0.24778366.9826778.html.plaintext.txt	314	1993 Science 260 1117 1121
0.24778366.9826778.html.plaintext.txt	315	1998 Oncogene 16 3369 3378
0.24778366.9826778.html.plaintext.txt	316	1995 Science 270 1354 1357
0.24778366.9826778.html.plaintext.txt	317	To correspondence addressed
0.24778366.9826778.html.plaintext.txt	318	Tel 61 7 3365 4492 Fax 61 7 3365 4388 Email g
0.24778366.9826778.html.plaintext.txt	319	au This page run Oxford University Press Great Clarendon Street Oxford OX2 6DP part OUP Journals Comments feedback www adminatoup
0.24778366.9826778.html.plaintext.txt	320	uk u d Last modification 21 Nov 1998 Copyright Oxford University Press 1998
0.25421372.15829524.html.plaintext.txt	0	COUP TFII essential radial anteroposterior patterning stomach Norio Takamoto1 Li Ru You1 Kelvin Moses1 Chin Chiang2 Warren E
0.25421372.15829524.html.plaintext.txt	1	DeMayo14 Ming Jer Tsai14 Sophia Y
0.25421372.15829524.html.plaintext.txt	2	1 Department Molecular Cellular Biology Baylor College Medicine Houston TX 77030 USA 2 Department Cell Biology Neurosciences University South Alabama Mobile AL 36688 USA 3 Department Cell Developmental Biology Vanderbilt University Medical Center Nashville TN 37232USA 4 Developmental Biological Program Baylor College Medicine Houston TX 77030 USA
0.25421372.15829524.html.plaintext.txt	3	Authors correspondence e mail stsaiatbcm
0.25421372.15829524.html.plaintext.txt	4	edu u d mtsaiatbcm
0.25421372.15829524.html.plaintext.txt	5	SUMMARY TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES COUP TFII orphan member steroid receptor superfamily implicated mesenchymal epithelial interaction organogenesis
0.25421372.15829524.html.plaintext.txt	6	The generation lacZ knock allele COUP TFII locus mice allows us use X gal staining follow expression COUP TFII developing stomach
0.25421372.15829524.html.plaintext.txt	7	We found COUP TFII expressed mesenchyme epithelium developing stomach
0.25421372.15829524.html.plaintext.txt	8	Conditional ablation floxed COUP TFII Nkx3 2Cre recombinase gastric mesenchyme results dysmorphogenesis developing stomach manifested major patterning defects posteriorization radial patterning
0.25421372.15829524.html.plaintext.txt	9	The epithelial outgrowth expansion circular smooth muscle layer enteric neurons well posteriorization stomach resemble phenotypes exhibited inhibition hedgehog signaling pathways
0.25421372.15829524.html.plaintext.txt	10	Using organ cultures cyclopamine treatment showed downregulation COUP TFII level stomach suggesting COUP TFII target hedgehog signaling stomach
0.25421372.15829524.html.plaintext.txt	11	Our results consistent functional link hedgehog proteins COUP TFII factors vital epithelial mesenchymal interactions
0.25421372.15829524.html.plaintext.txt	12	Key words Nuclear orphan receptor Sonic hedgehog Organogenesis Stomach Mouse Nr2f1 Nr2f2
0.25421372.15829524.html.plaintext.txt	13	Introduction TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES Gut development depends upon crosstalk endoderm splanchnic mesenchyme cell layers along anteroposterior axis resulting subdivision gut foregut midgut hindgut Kedinger et al
0.25421372.15829524.html.plaintext.txt	14	1998a De Santa Barbara et al
0.25421372.15829524.html.plaintext.txt	15	The stomach becomes specified caudal end foregut emerges bulge developing GI tract Kaufman Bard 1999
0.25421372.15829524.html.plaintext.txt	16	The stomach undergoes progressive remodeling differentiation regionally specific fashion
0.25421372.15829524.html.plaintext.txt	17	The detailed genetic molecular pathways direct gastric organogenesis still unknown clear patterning GI tract requires elaborate cellular communication epithelium mesenchyme cell layers Fukuda Yasugi 2002
0.25421372.15829524.html.plaintext.txt	18	Sonic hedgehog Shh patterns variety embryonic tissues including fore stomach epithelium signaling mesenchyme prior organ regionalization Chiang et al
0.25421372.15829524.html.plaintext.txt	19	Shh null mice exhibit inappropriate expression alkaline phosphatase EAP epithelium hind stomach Ramalho Santos et al
0.25421372.15829524.html.plaintext.txt	20	2000 consistent stomach epithelium acquiring intestinal posteriorized character
0.25421372.15829524.html.plaintext.txt	21	Conversely stomach activin receptor IIA B compound mutant ActRIIAB mutant Acvr2aAcvr2b Mouse Genome Informatics exhibits posterior extension fore stomach epithelium expansion Shh expression Kim et al
0.25421372.15829524.html.plaintext.txt	22	2000 process referred anteriorization
0.25421372.15829524.html.plaintext.txt	23	These data suggest Shh expression fore stomach acts induce andor maintain non intestinal character resulting development gastric epithelium Ramalho Santos et al
0.25421372.15829524.html.plaintext.txt	24	COUP TF proteins nuclear orphan receptors highly conserved across species
0.25421372.15829524.html.plaintext.txt	25	Two members identified mice COUP TFI Nr2f1 Mouse Genome Informatics COUP TFII Nr2f2 Mouse Genome Informatics
0.25421372.15829524.html.plaintext.txt	26	The temporal spatial expression pattern COUP TFII mesenchyme led us hypothesize COUP TFII plays role mesenchymal epithelial interactions organogenesis Tsai Tsai 1997
0.25421372.15829524.html.plaintext.txt	27	In developing neural tube Shh shown regulate COUP TFII expression differentiation motoneurons Lutz et al
0.25421372.15829524.html.plaintext.txt	28	We also identified 5 regulatory element mediates Shh stimulation COUP TFII expression Krishnan et al
0.25421372.15829524.html.plaintext.txt	29	COUP TFII likely downstream target Shh signaling requirement Shh gastric organogenesis led us infer COUP TFII may play role stomach development
0.25421372.15829524.html.plaintext.txt	30	To circumvent early embryonic lethality COUP TFII null mutation investigate function gastric organogenesis generated conditional null mutant COUP TFII using CreLoxP system
0.25421372.15829524.html.plaintext.txt	31	Nkx3 2 Bapx1 homeobox containing gene Tribioli et al
0.25421372.15829524.html.plaintext.txt	32	1997 coexpressed COUP TFII stomach primordium thus Nkx3 2Cre knock recombinase used ablate COUP TFII gastric mesenchyme
0.25421372.15829524.html.plaintext.txt	33	The stomachs conditional mutant mice exhibited dysmorphogenesis accompanied abnormalities compartmentalization radial patterning demonstrating functional link Shh COUP TFII
0.25421372.15829524.html.plaintext.txt	34	Materials methods TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES Generation conditional mutant COUP TFII Genomic DNA fragments 7
0.25421372.15829524.html.plaintext.txt	35	4 kb XbaI EcoRI Q10 clone 2
0.25421372.15829524.html.plaintext.txt	36	6 kb EcoRI BamHI fragment D 3
0.25421372.15829524.html.plaintext.txt	37	6RI clone containing COUP TFII locus described Qiu et al
0.25421372.15829524.html.plaintext.txt	38	1995 subcloned pBlueScriptII KS
0.25421372.15829524.html.plaintext.txt	39	The first loxP site inserted BglI site 7
0.25421372.15829524.html.plaintext.txt	40	2 kb BamHI SalI fragment NsiI site 2
0.25421372.15829524.html.plaintext.txt	41	6 kb EcoRI BamHI fragment modified XhoI linker
0.25421372.15829524.html.plaintext.txt	42	These four genomic fragments reconstructed XhoI site 2
0.25421372.15829524.html.plaintext.txt	43	6 kb EcoRI BamHI region modified linker containing ClaI site 3 end
0.25421372.15829524.html.plaintext.txt	44	pNeoTKLoxP positive negative selection cassette modified ligated lacZ pDP46
0.25421372.15829524.html.plaintext.txt	45	This NeoTKLoxP lacZ construct inserted XhoI ClaI linker 3 UTR
0.25421372.15829524.html.plaintext.txt	46	5 SalI site NeoTKLoxP lacZ destroyed ligation XhoI ClaI site NotI site blunt end ligated fill reaction
0.25421372.15829524.html.plaintext.txt	47	Targeting construct consists 4 kb 5 arm 6
0.25421372.15829524.html.plaintext.txt	48	5 kb NeoTKLoxP lacZ 2 kb 3 arm total size 24 kb linearized NotI 3 end
0.25421372.15829524.html.plaintext.txt	49	Homologous recombination performed AB1
0.25421372.15829524.html.plaintext.txt	50	1997 ES cell clones screened two rounds Southern blot analysis
0.25421372.15829524.html.plaintext.txt	51	Correctly targeted clones first identified screening XbaI digest 5 external 3 external probes 5 ext 3 ext respectively subsequently transfected Cre recombinase expression vector followed screening HindIII digests 5 internal probe 5 int XbaI digest 3 external probe
0.25421372.15829524.html.plaintext.txt	52	Chimeric animals generated microinjection germline transmission achieved crossing C57Bl6 wild type female
0.25421372.15829524.html.plaintext.txt	53	Thereafter mutant mice carrying floxed allele maintained 129B6 mixed background
0.25421372.15829524.html.plaintext.txt	54	Specific primers designed floxed COUP TFII genotyping PCR
0.25421372.15829524.html.plaintext.txt	55	The primer sequences NT1 5 CAGTCGCCTCTCCTTCTCCTTCTCC 3 NT2 5 CATCCGGGATATGTTACTGTCCGG 3 NT3A 5 TTCTGGTCTTCACCCACCGGTACC 3 NT6A 5 TGGGGAAGCTAAGTGTTGTAGTGATTCC 3
0.25421372.15829524.html.plaintext.txt	56	The sizes PCR product 785 bp wild type 394 bp floxed allele
0.25421372.15829524.html.plaintext.txt	57	Nkx3 2Cre knock animal generated homologous recombination ES cells K
0.25421372.15829524.html.plaintext.txt	58	Cre recombinase inserted frame exon1 Nkx3 2 locus
0.25421372.15829524.html.plaintext.txt	59	No overt phenotype found heterozygous animals
0.25421372.15829524.html.plaintext.txt	60	X gal staining X gal staining performed according published methods Hogan et al
0.25421372.15829524.html.plaintext.txt	61	For whole mount staining embryos E10
0.25421372.15829524.html.plaintext.txt	62	5 dissected fixed 4 paraformaldehyde stained X gal staining solution room temperature
0.25421372.15829524.html.plaintext.txt	63	Histological sections whole mount stained embryos processed Histoclear embedded paraffin sectioned 10 12 microm
0.25421372.15829524.html.plaintext.txt	64	Sections cleared Histoclear rehydrated counterstained Eosin mounted Permount
0.25421372.15829524.html.plaintext.txt	65	5 later postnatal samples cryoprotected 20 sucrosePBS solution fixation 2 paraformaldehyde embedded OCT compound
0.25421372.15829524.html.plaintext.txt	66	Cryostat sections 16 microm briefly fixed 2 paraformaldehyde stained X gal staining solution counterstained Eosin
0.25421372.15829524.html.plaintext.txt	67	Histological analysis Tissues fixed 4 paraformaldehyde embedded paraffin sectioned 5 7 microm
0.25421372.15829524.html.plaintext.txt	68	Hematoxylin Eosin staining carried according regular protocol
0.25421372.15829524.html.plaintext.txt	69	For immunohistochemistry paraffin sections dewaxed rehydrated incubated primary antibodies
0.25421372.15829524.html.plaintext.txt	70	Antibodies human CK14 1500 gift Dr Roop Baylor College Medicine Houston TX
0.25421372.15829524.html.plaintext.txt	71	Polyclonal anti serum PGP9
0.25421372.15829524.html.plaintext.txt	72	Antibodies TUJ1 Convance 11000 GATA4 Santa Crutz 1400 HK ATPase ss subunit Affinity BioReagents 1500 used immunostaining
0.25421372.15829524.html.plaintext.txt	73	Texas Red tagged Griffonia simplicifolia II GSII lectin used stain stomach tissue
0.25421372.15829524.html.plaintext.txt	74	Positive staining CK14 PGP9
0.25421372.15829524.html.plaintext.txt	75	5 visualized using biotinylated secondary antibody streptavidin horseraddish peroxidase conjugate NovaRed Vector chromogen
0.25421372.15829524.html.plaintext.txt	76	SMA TUJ1 GATA4 HK ATPase ss subunit visualized using biotinylated secondary antibody streptavidin horseraddish peroxidase conjugate DAB Vector chromogen
0.25421372.15829524.html.plaintext.txt	77	Monoclonal anti smooth muscle actin SMA 1A4 11000 purchased Sigma Aldrich immunostaining performed using Mouse On Mouse kit Vector according manufacturers instruction detected AlxaFluor488 Molecular Probes
0.25421372.15829524.html.plaintext.txt	78	For ultrastructural study disorganized smooth muscle layer 0
0.25421372.15829524.html.plaintext.txt	79	5 microm semi thin sections stained Toluidine Blue
0.25421372.15829524.html.plaintext.txt	80	Endogenous alkaline phosphatase staining performed previously described Ramalho Santos et al
0.25421372.15829524.html.plaintext.txt	81	2002 counterstained Methyl Green
0.25421372.15829524.html.plaintext.txt	82	The glycoconjugated production parietal cells stomach marked DBA lectin
0.25421372.15829524.html.plaintext.txt	83	Whole mount situ hybridization COUP TFII carried described Qiu et al
0.25421372.15829524.html.plaintext.txt	84	Probe Shh gift Dr M
0.25421372.15829524.html.plaintext.txt	85	Scott Stanford University CA
0.25421372.15829524.html.plaintext.txt	86	For section situ hybridization Shh E11
0.25421372.15829524.html.plaintext.txt	87	5 embryos cross sectioned Shh expressions fore stomach detected using 35S UTP labeled probes
0.25421372.15829524.html.plaintext.txt	88	Positive signals pseudo colored red overlaid bright field image Hematoxylin staining described Pereira et al
0.25421372.15829524.html.plaintext.txt	89	Explants culture embryonic foregut Foreguts dissected E10
0.25421372.15829524.html.plaintext.txt	90	5 lacZ knock heterozygous embryos cultured tissue culture insert Corning defined serum free medium Opti MEMI Invitrogen Life Technologies
0.25421372.15829524.html.plaintext.txt	91	Explants incubated vehicle DMSO 1 5 10 microM cyclopamine Toronto Research Chemicals 48 hours fixed 2 paraformaldehyde whole mount lacZ staining
0.25421372.15829524.html.plaintext.txt	92	Explants wild type embryos fixed 4 paraformaldehyde used whole mount situ hybridization
0.25421372.15829524.html.plaintext.txt	93	Results TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES Expression COUP TFII stomach To facilitate profiling COUP TFII gene expression development generated targeted vector according scheme diagramed Fig
0.25421372.15829524.html.plaintext.txt	94	This targeting vector introduced ES cells together Cre recombinase
0.25421372.15829524.html.plaintext.txt	95	Upon recombination first last LoxP sites COUP TFII deleted expression lacZ reporter inserted 5 untranslated region COUP TFII locus activated
0.25421372.15829524.html.plaintext.txt	96	The ES cells subsequently injected blastocysts generate lacZ knock alleles mice
0.25421372.15829524.html.plaintext.txt	97	lacZ gene expression control COUP TFII promoter expression recapitulates expression endogenous COUP TFII gene
0.25421372.15829524.html.plaintext.txt	98	Using lacZ knock allele examined expression pattern COUP TFII gut development
0.25421372.15829524.html.plaintext.txt	99	View larger version 57K Fig
0.25421372.15829524.html.plaintext.txt	100	Expression COUP TFII stomach using lacZ knock model
0.25421372.15829524.html.plaintext.txt	101	Generation lacZ knock allele generation floxed COUP TFII allele
0.25421372.15829524.html.plaintext.txt	102	Using homologous recombination targeting construct containing nuclear lacZ NeoTK LoxP sites inserted genomic COUP TFII locus generating targeted allele ES cells
0.25421372.15829524.html.plaintext.txt	103	Treatment Cre recombinase FIAU selection resulted lacZ knock allele lacZ gene expression controlled endogenous COUP TFII promoter recombination took place first third loxP sites targeted allele
0.25421372.15829524.html.plaintext.txt	104	In addition floxed COUP TFII ES clones retains COUP TFII locus lacks selection markers generated recombination took place second third loxP sites
0.25421372.15829524.html.plaintext.txt	105	B BamHI H HindIII S SalI X XbaI
0.25421372.15829524.html.plaintext.txt	106	5 heterozygous COUP TFIIlacZ knock embryo stained 2 hours lacZ activity
0.25421372.15829524.html.plaintext.txt	107	There relatively high expression mesenchymal cells adjacent epithelium
0.25421372.15829524.html.plaintext.txt	108	The stomach 3 day old heterozygous knock animal dissected whole mount X gal staining performed
0.25421372.15829524.html.plaintext.txt	109	The boundary stomach duodenum indicated arrowhead
0.25421372.15829524.html.plaintext.txt	110	D A cryostat section stomach adult heterozygous knock animal stained lacZ activity blue counterstained propidium iodide red
0.25421372.15829524.html.plaintext.txt	111	DBA lectin immunostaining denotes parietal cells green
0.25421372.15829524.html.plaintext.txt	112	There strong X gal staining base layer negligible staining surface pit layer adult Zymogenic unit
0.25421372.15829524.html.plaintext.txt	113	m mesenchyme e epithelium fs fore stomach hs hind stomach d duodenum oe esophagus
0.25421372.15829524.html.plaintext.txt	114	5 X gal staining detected epithelium mesenchyme stomach
0.25421372.15829524.html.plaintext.txt	115	Brief staining cryostat sections revealed mesenchymal cells adjacent endoderm higher expression COUP TFII distal mesenchymal cells suggesting potential diffusible molecule secreted epithelium might regulate COUP TFII expression mesenchyme Fig
0.25421372.15829524.html.plaintext.txt	116	At postnatal day 3 COUP TFIIlacZ detected throughout stomach Fig
0.25421372.15829524.html.plaintext.txt	117	1C sharply downregulated duodenum red arrowhead indicates junction stomach duodenum
0.25421372.15829524.html.plaintext.txt	118	COUP TFIIlacZ also expressed glandular epithelium adult stomach
0.25421372.15829524.html.plaintext.txt	119	Adult glandular epithelium forms tubular structures referred zymogenic unit subdivided four regions surface pit isthmus neck base located proximal sub mucosa Karam Leblond 1993
0.25421372.15829524.html.plaintext.txt	120	Strong lacZ staining evident base much lower surface pit layer Fig
0.25421372.15829524.html.plaintext.txt	121	To ensure COUP TFII also expressed parietal cells used DBA lectin immunostaining
0.25421372.15829524.html.plaintext.txt	122	1D X gal lectin positive green cells colocalized indicating COUP TFII expressed parietal cells Zymogenic unit
0.25421372.15829524.html.plaintext.txt	123	The expression pattern COUP TFII Zymogenic unit mimics reported expression pattern Shh mouse stomach van den Brink et al
0.25421372.15829524.html.plaintext.txt	124	Thus COUP TFII abundantly expressed early developmental stage epithelium mesenchyme stomach parallel Shh
0.25421372.15829524.html.plaintext.txt	125	Nkx3 2Cre recombinase ablates COUP TFII gastric mesenchyme To examine role COUP TFII gastric development chose ablate COUP TFII gene tissue specific manner using CreLoxP system
0.25421372.15829524.html.plaintext.txt	126	The targeting vector depicted Fig
0.25421372.15829524.html.plaintext.txt	127	1A introduced ES cells
0.25421372.15829524.html.plaintext.txt	128	After excision Neo TK cassette Cre based recombination ES cells harboring conditional allele generated depicted Fig
0.25421372.15829524.html.plaintext.txt	129	1A used generate floxed COUP TFII mice
0.25421372.15829524.html.plaintext.txt	130	An Nkx3 2Cre mouse line also generated K
0.25421372.15829524.html.plaintext.txt	131	unpublished crossed floxed COUP TFII mice
0.25421372.15829524.html.plaintext.txt	132	As lacZ turned cells COUP TFII locus recombined deleted X gal staining used marker successful COUP TFII recombined deleted cells
0.25421372.15829524.html.plaintext.txt	133	5 stomach Nkx3 2Cre COUP TFIIflox embryo demonstrates COUP TFII ablated specifically gastric mesenchyme Fig
0.25421372.15829524.html.plaintext.txt	134	This expected X gal staining lacZ knock mice detected stomach primordium Fig
0.25421372.15829524.html.plaintext.txt	135	2A similar Nkx3 2 Cre expression E9
0.25421372.15829524.html.plaintext.txt	136	5 demonstrated product intercrossing Nkx3 2Cre ROSA26 reporter strain Fig
0.25421372.15829524.html.plaintext.txt	137	View larger version 74K Fig
0.25421372.15829524.html.plaintext.txt	138	Ablation COUP TFII mesenchyme developing stomach using Nkx3 2Cre COUP TFII floxed mice
0.25421372.15829524.html.plaintext.txt	139	A Whole mount X gal staining Nkx3 2Cre COUP TFIIflox embryo demonstrating ablation COUP TFII Nkx3 2Cre E9
0.25421372.15829524.html.plaintext.txt	140	lacZ expression represents Cre mediated recombination floxed COUP TFII
0.25421372.15829524.html.plaintext.txt	141	B The expression Nkx3 2Cre E9
0.25421372.15829524.html.plaintext.txt	142	5 detected whole mount X gal staining Nkx3 2Cre ROSA26R embryo
0.25421372.15829524.html.plaintext.txt	143	X gal staining represents Cre mediated ablation interfering stop sequence ROSA26 reporter gene
0.25421372.15829524.html.plaintext.txt	144	Specific staining observed developing stomach embryos
0.25421372.15829524.html.plaintext.txt	145	C A partially dissected Nkx3 2Cre COUP TFIIflox embryo stained whole mount X gal staining paraffin embedded serially sectioned
0.25421372.15829524.html.plaintext.txt	146	X gal staining indicates Cre mediated recombination detected throughout gastric mesenchyme epithelium demonstrating ablation COUP TFII gastric mesenchyme E12
0.25421372.15829524.html.plaintext.txt	147	Scale bars B 100 microm AB C 100 microm C
0.25421372.15829524.html.plaintext.txt	148	Conditional ablation COUP TFII gastric mesenchyme results dysmorphogenesis radial patterning defects developing stomach The size mutant stomach slightly smaller compared control littermate E12
0.25421372.15829524.html.plaintext.txt	149	Histological analysis Hematoxylin Eosin stained sagittal sections mutant stomach showed epithelium considerably thicker controls E12
0.25421372.15829524.html.plaintext.txt	150	In addition circular smooth layer stained smooth muscle actin antibody disorganized comparison controls E13
0.25421372.15829524.html.plaintext.txt	151	These abnormal morphological changes seen E14
0.25421372.15829524.html.plaintext.txt	152	5 data shown suggesting radial patterning stomach might perturbed
0.25421372.15829524.html.plaintext.txt	153	View larger version 59K Fig
0.25421372.15829524.html.plaintext.txt	154	Expansion smooth muscle layers enteric motoneurons conditional mutant stomach
0.25421372.15829524.html.plaintext.txt	155	A D Embryos obtained mating COUP TFII floxed homozygous males Nkx3 2Cre COUP TFIIflox females
0.25421372.15829524.html.plaintext.txt	156	COUP TFII floxed homozygote served controls Nkx3 2Cre COUP TFIIfloxflox designated conditional mutants
0.25421372.15829524.html.plaintext.txt	157	Histological analysis stomach dissected E12
0.25421372.15829524.html.plaintext.txt	158	5 controls A conditional mutants B showed epithelium conditional mutant thicker marked black arrows Hematoxylin Eosin stained sagittal sections
0.25421372.15829524.html.plaintext.txt	159	5 smooth muscle layers mutant stomach disorganized comparison controls seen smooth muscle actin immunostaining brown compare C D
0.25421372.15829524.html.plaintext.txt	160	E H smooth muscle actin staining sagittal sections E16
0.25421372.15829524.html.plaintext.txt	161	Smooth muscle cells immunoassayed smooth muscle actin green counterstained propidium iodide red
0.25421372.15829524.html.plaintext.txt	162	White arrows indicate extension smooth muscle actin staining submucosal mesenchyme conditional mutant F
0.25421372.15829524.html.plaintext.txt	163	EGH The thickened circular smooth muscle layer formation observed fore stomach F hind stomach H conditional mutant comparison control EG
0.25421372.15829524.html.plaintext.txt	164	IJ Semi thin section semi thin sections stomachs E15
0.25421372.15829524.html.plaintext.txt	165	The circular smooth muscle layer conditional mutant stomach J disorganized comparison control I
0.25421372.15829524.html.plaintext.txt	166	Enteric neurons stained protein gene product 9
0.25421372.15829524.html.plaintext.txt	167	5 antiserum brown counterstained Hematoxylin
0.25421372.15829524.html.plaintext.txt	168	Anti TUJ1 antibody employed immunostaining
0.25421372.15829524.html.plaintext.txt	169	An increase TUJ1 positive cells shown conditional mutant N comparison littermate control M
0.25421372.15829524.html.plaintext.txt	170	To assess potential radial patterning defects exhibited conditional COUP TFII null mutants examined differentiation smooth muscle enteric neurons mutant stomach later development
0.25421372.15829524.html.plaintext.txt	171	Immunostaining smooth muscle actin confirmed presence thickened circular smooth muscle layer formation fore stomach Fig
0.25421372.15829524.html.plaintext.txt	172	3EF hind stomach conditional mutant mice Fig
0.25421372.15829524.html.plaintext.txt	173	Moreover submucosal extension smooth muscle actin positive cells mutant fore stomach Fig
0.25421372.15829524.html.plaintext.txt	174	3F white arrows indicated precocious differentiation smooth muscle cells
0.25421372.15829524.html.plaintext.txt	175	To demonstrate smooth muscle layer conditional mutant stomach disorganized semi thin sections Fig
0.25421372.15829524.html.plaintext.txt	176	3IJ ultrastructure data shown stomachs E15
0.25421372.15829524.html.plaintext.txt	177	Again circular smooth muscle layer conditional mutant stomach disorganized Fig
0.25421372.15829524.html.plaintext.txt	178	3J comparison controls Fig
0.25421372.15829524.html.plaintext.txt	179	5 revealed semi thin sections
0.25421372.15829524.html.plaintext.txt	180	However cellular defects disorganization cell layers observed data shown
0.25421372.15829524.html.plaintext.txt	181	5 enteric neuron marker showed increased number positively stained cells conditional mutant mice Fig
0.25421372.15829524.html.plaintext.txt	182	To ensure expansion enteric neurons mutant stomach additional neuronal marker TUJ1 neuronal class III tubulin ss employed immunostaining
0.25421372.15829524.html.plaintext.txt	183	An increase TUJ1 positive cells shown conditional mutant Fig
0.25421372.15829524.html.plaintext.txt	184	3N comparison littermate control Fig
0.25421372.15829524.html.plaintext.txt	185	Taken together conditional ablation COUP TFII mesenchyme resulted least two patterning abnormalities epithelium outgrowth expansion circular smooth muscle enteric neuron radial patterning defects stomach
0.25421372.15829524.html.plaintext.txt	186	The fact COUP TFII deleted mesenchyme compartment epithelium mutant stomach expanded suggesting signals mesenchyme essential proper growth epithelium
0.25421372.15829524.html.plaintext.txt	187	Anteroposterior patterning stomach altered COUP TFII conditional null mutant The abnormal radial patterning stomach manifested COUP TFII mutants prompted us assess patterning defects also present developing mutant stomach
0.25421372.15829524.html.plaintext.txt	188	A whole mount view revealed dysmorphogenesis stomach conditional mutants Fig
0.25421372.15829524.html.plaintext.txt	189	The anatomical demarcation stratifying fore stomach epithelium columnar hind stomach epithelium referred limiting ridge indicated broken line begins develop forming presumptive margin fore stomach hind stomach
0.25421372.15829524.html.plaintext.txt	190	The size fore stomach compartment entire organ noticeably reduced conditional mutants Fig
0.25421372.15829524.html.plaintext.txt	191	4CD white arrowheads indicate junction fore hind stomach
0.25421372.15829524.html.plaintext.txt	192	Detailed histological examination reveals abnormalities epithelium mesenchyme
0.25421372.15829524.html.plaintext.txt	193	The glandular epithelium thicker mutants compared controls Fig
0.25421372.15829524.html.plaintext.txt	194	In control mice epithelium thickest pyloric region left Fig
0.25421372.15829524.html.plaintext.txt	195	4E thickness epithelium progressively decreased anteriorly towards right
0.25421372.15829524.html.plaintext.txt	196	By contrast epithelium conditional mutant mice remained thick even anterior regions Fig
0.25421372.15829524.html.plaintext.txt	197	The mesenchyme conditional mutant mice also thickened
0.25421372.15829524.html.plaintext.txt	198	The hind stomach epithelium showed several invaginations control mice Fig
0.25421372.15829524.html.plaintext.txt	199	4G extensive invagination associated thickened epithelial layer conditional mutant mice Fig
0.25421372.15829524.html.plaintext.txt	200	The morphological reduction fore stomach extension hind stomach suggest aberrant compartmentation stomach possible patterning defect anteroposterior axis
0.25421372.15829524.html.plaintext.txt	201	View larger version 103K Fig
0.25421372.15829524.html.plaintext.txt	202	Analysis AP patterning defects conditional COUP TFII mutant stomach
0.25421372.15829524.html.plaintext.txt	203	Controls conditional mutant embryos obtained mating COUP TFII floxed homozygous males Nkx3 2Cre COUP TFIIflox females described Fig
0.25421372.15829524.html.plaintext.txt	204	AB Stomachs dissected E16
0.25421372.15829524.html.plaintext.txt	205	5 embryos examined whole mount dissecting microscope
0.25421372.15829524.html.plaintext.txt	206	The presumptive margin fore stomach hind stomach indicated dots shifted slightly anteriorly mutant
0.25421372.15829524.html.plaintext.txt	207	CD Whole mount postnatal day 28 stomachs dissected examined dissecting microscope
0.25421372.15829524.html.plaintext.txt	208	Position limiting ridge indicated arrowhead
0.25421372.15829524.html.plaintext.txt	209	A clear anterior shift limited ridge observed conditional mutant
0.25421372.15829524.html.plaintext.txt	210	EF Dissected stomachs E16
0.25421372.15829524.html.plaintext.txt	211	5 embryos longitudinally sectioned stained Hematoxylin Eosin
0.25421372.15829524.html.plaintext.txt	212	G H Higher magnification similar regions indicated lines EF
0.25421372.15829524.html.plaintext.txt	213	e epithelium sm smooth muscle layer fs fore stomach hs hind stomach oe esophagus d duodenum
0.25421372.15829524.html.plaintext.txt	214	Histological analysis whole embryo sagittal sections carried examine indeed patterning anteroposterior axis conditional mutant perturbed Analysis E16
0.25421372.15829524.html.plaintext.txt	215	5 conditional mutants revealed alteration epithelial characteristics along AP axis Fig
0.25421372.15829524.html.plaintext.txt	216	The proximal duodenum exhibited typical characteristics stage control Fig
0.25421372.15829524.html.plaintext.txt	217	5A conditional mutant mice Fig
0.25421372.15829524.html.plaintext.txt	218	However pylorus conditional mutant mice exhibited disorganized thickened circular smooth muscle layer epithelium resembled epithelium duodenum devoid vacuoles Fig
0.25421372.15829524.html.plaintext.txt	219	5F unlike highly vacuolated control Fig
0.25421372.15829524.html.plaintext.txt	220	The hind stomach controls simple columnar epithelium invaginations tight circular smooth muscle layer Fig
0.25421372.15829524.html.plaintext.txt	221	By contrast hind stomach conditional mutant mice exhibited vacuolated epithelium Fig
0.25421372.15829524.html.plaintext.txt	222	5G resembling pyloric region control mice Fig
0.25421372.15829524.html.plaintext.txt	223	5B numerous invaginations thickened disorganized circular smooth muscle layer
0.25421372.15829524.html.plaintext.txt	224	In addition cell layer located distal circular smooth muscle layer Fig
0.25421372.15829524.html.plaintext.txt	225	5G indicated small arrows bottom enteric neurons normally located expanded conditional mutants
0.25421372.15829524.html.plaintext.txt	226	Finally fore stomach epithelium begins stratify E16
0.25421372.15829524.html.plaintext.txt	227	5 characteristic rough deep infolding evident control mice Fig
0.25421372.15829524.html.plaintext.txt	228	The conditional mutant mice showed similar infolding epithelium show clear signs stratification Fig
0.25421372.15829524.html.plaintext.txt	229	In fact fore stomach epithelium conditional mutant mice closely resembled hind stomach epithelium Fig
0.25421372.15829524.html.plaintext.txt	230	These observable morphological changes compartmentation different regions stomach consistent notion stomach posteriorized
0.25421372.15829524.html.plaintext.txt	231	View larger version 94K Fig
0.25421372.15829524.html.plaintext.txt	232	Morphological changes posteriorized conditional mutant stomach E16
0.25421372.15829524.html.plaintext.txt	233	5 whole embryos sectioned sagittally stained Hematoxylin Eosin histological assessment
0.25421372.15829524.html.plaintext.txt	234	Corresponding regions mutant control estimated morphological characteristics mesenchyme regions relative location anatomical structures
0.25421372.15829524.html.plaintext.txt	235	Oblique arrows across control conditional mutant panels indicate changes epithelial characteristics conditional mutants
0.25421372.15829524.html.plaintext.txt	236	e epithelium sm smooth muscle layer
0.25421372.15829524.html.plaintext.txt	237	Alteration AP patterning fore stomach If AP patterning stomach indeed disrupted conditional mutant anticipated specificationdifferentiation gastric epithelium might affected
0.25421372.15829524.html.plaintext.txt	238	To assess fore stomach altered examined fore stomach regions using stratified epithelial cell marker cytokeratin 14 CK14
0.25421372.15829524.html.plaintext.txt	239	Immunostaining using CK14 specific antibody showed intense staining E16
0.25421372.15829524.html.plaintext.txt	240	5 control fore stomach anterior region mutant fore stomach data shown
0.25421372.15829524.html.plaintext.txt	241	CK14 staining remained intense throughout fore stomach control Fig
0.25421372.15829524.html.plaintext.txt	242	However barely detectable caudal regions presumptive fore stomach mutant Fig
0.25421372.15829524.html.plaintext.txt	243	6B suggesting mutant stomach posteriorized anterior region stomach epithelium stratified expresses CK14 hind stomach morphologically expanded non stratified
0.25421372.15829524.html.plaintext.txt	244	View larger version 113K Fig
0.25421372.15829524.html.plaintext.txt	245	Marker gene analyses confirm morphological changes conditional mutant stomach
0.25421372.15829524.html.plaintext.txt	246	5 sagittal sections stained stratified epithelial cell marker CK14
0.25421372.15829524.html.plaintext.txt	247	Intense staining found basal cells control A faint staining observed anterior edge fore stomach COUP TFII conditional mutant B
0.25421372.15829524.html.plaintext.txt	248	5 embryos cross sectioned Shh expressions fore stomach examined section situ hybridization using 35S UTP labeled probes
0.25421372.15829524.html.plaintext.txt	249	Positive signals pseudo colored red overlaid bright field image Hematoxylin staining
0.25421372.15829524.html.plaintext.txt	250	E G Paraffin sections E18
0.25421372.15829524.html.plaintext.txt	251	5 stomachs stained anti CK14 antibody
0.25421372.15829524.html.plaintext.txt	252	CK14 staining dark brown remained intense throughout fore stomach control E mutant F
0.25421372.15829524.html.plaintext.txt	253	Again barely detectable caudal regions stomach mutant G comparison similar anatomical position fore stomach control E
0.25421372.15829524.html.plaintext.txt	254	Shh shown highly expressed fore stomach serve fore stomach marker
0.25421372.15829524.html.plaintext.txt	255	In controls Shh highly expressed fore stomach expression extends hind stomach Fig
0.25421372.15829524.html.plaintext.txt	256	By contrast expression Shh anteriorly restricted conditional mutant Fig
0.25421372.15829524.html.plaintext.txt	257	The anterior restriction Shh expression observed conditional mutants similar detected stomachs Hoxa5 mutant indicating posteriorization fore stomach Aubin et al
0.25421372.15829524.html.plaintext.txt	258	Similar result CK14 staining observed later stage development
0.25421372.15829524.html.plaintext.txt	259	CK14 staining remained intense throughout fore stomach control mutant E18
0.25421372.15829524.html.plaintext.txt	260	Again barely detectable caudal regions stomach mutant Fig
0.25421372.15829524.html.plaintext.txt	261	6G comparison similar anatomical position fore stomach control Fig
0.25421372.15829524.html.plaintext.txt	262	This result support notion mutant stomach posteriorized anterior region stomach epithelium stratified expresses CK14 whereas hind stomach expanded non stratified
0.25421372.15829524.html.plaintext.txt	263	The expression differentiated hind stomach markers remains unchanged conditional mutants As shown earlier radial patterning AP patterning stomach altered mutants E13
0.25421372.15829524.html.plaintext.txt	264	5 leading respective thickening epithelium expansion hind stomach Figs 3 4 5
0.25421372.15829524.html.plaintext.txt	265	To examine phenotypes persist later development examined mutant stomach E18
0.25421372.15829524.html.plaintext.txt	266	Similar early development clear epithelium thickened hind stomach mutant considerably expanded Fig
0.25421372.15829524.html.plaintext.txt	267	7B comparison controls Fig
0.25421372.15829524.html.plaintext.txt	268	To examine whether differentiation glandular epithelium perturbed mutant expression parietal cell marker HK ATPase ss subunit glandular gastric epithelium marker GATA4 analyzed E18
0.25421372.15829524.html.plaintext.txt	269	Although HK ATPase ss subunit positive parietal cells present glandular gastric epithelium controls Fig
0.25421372.15829524.html.plaintext.txt	270	7C conditional mutant mice Fig
0.25421372.15829524.html.plaintext.txt	271	7D number parietal cells increased thickened epithelial layer conditional mutant mice Fig
0.25421372.15829524.html.plaintext.txt	272	The expression GATA4 thickened glandular epithelial layer mutant Fig
0.25421372.15829524.html.plaintext.txt	273	7F similar controls Fig
0.25421372.15829524.html.plaintext.txt	274	7E suggesting differentiation glandular epithelium unchanged mutant
0.25421372.15829524.html.plaintext.txt	275	View larger version 71K Fig
0.25421372.15829524.html.plaintext.txt	276	AB Dissected stomachs E18
0.25421372.15829524.html.plaintext.txt	277	5 embryos longitudinally sectioned stained Hematoxylin Eosin
0.25421372.15829524.html.plaintext.txt	278	The thickness glandular epithelium increased mutant stomach compared littermate control
0.25421372.15829524.html.plaintext.txt	279	C F The adjacent tissue sections fore stomach hind stomach stained anti HK ATPase ss subunit antibody CD anti GATA4 EF antibodies
0.25421372.15829524.html.plaintext.txt	280	The transition zone oxyntic mucosa os stratified squamous epithelium sse fore stomach indicated arrows
0.25421372.15829524.html.plaintext.txt	281	G T Marker gene analyses adult stomachs G L Sections 4 microm prepared stomachs 35 day old mice staining Hematoxylin Eosin
0.25421372.15829524.html.plaintext.txt	282	The histological morphology zymogenic region GH mucoparietal zone IJ pure mucus zone KL showed obvious difference conditional mutant stomach HJL littermate control GIK
0.25421372.15829524.html.plaintext.txt	283	MN The secreted glycoprotein zymogenic zone stomachs visualized PAS staining discernable difference observed conditional mutant stomach N littermate control M
0.25421372.15829524.html.plaintext.txt	284	OP The gastric parietal cells stained anti HK ATPase ss subunit antibody
0.25421372.15829524.html.plaintext.txt	285	QR The neck pre neck cells red gastric units showed difference control Q conditional mutant R stomachs
0.25421372.15829524.html.plaintext.txt	286	ST Anti GATA4 antibody used mark glandular gastric epithelium
0.25421372.15829524.html.plaintext.txt	287	Positive signals found base glandular gastric epithelium pure mucus zone control S mutant T
0.25421372.15829524.html.plaintext.txt	288	To substantiate differentiation hind stomach largely intact mutant examined mutant hind stomach adulthood
0.25421372.15829524.html.plaintext.txt	289	Histological analysis stomachs 35 day old mutant mice littermate controls showed obvious difference hind stomachs regions Zymogenic zone Fig
0.25421372.15829524.html.plaintext.txt	290	7 IJ pure mucus zone Fig
0.25421372.15829524.html.plaintext.txt	291	7KL Hematoxylin Eosin
0.25421372.15829524.html.plaintext.txt	292	Mucins secretion analyzed periodic acid Schiff PAS staining similar PAS staining observed control Fig
0.25421372.15829524.html.plaintext.txt	293	To examine changes cell specification mutant hind stomach employed HK ATPase ss subunit parietal cells marker Fig
0.25421372.15829524.html.plaintext.txt	294	7OP GSII neck pre neck cell marker Fig
0.25421372.15829524.html.plaintext.txt	295	7QR GATA4 marker base pure mucus unit Fig
0.25421372.15829524.html.plaintext.txt	296	The expression profiles markers similar mutants compared controls
0.25421372.15829524.html.plaintext.txt	297	These results taken together support notion cell type changes conditional mutant comparison littermate control throughout development even though observable patterning defects stomach
0.25421372.15829524.html.plaintext.txt	298	Alteration caudal part mutant hind stomach As histological analysis indicated caudal part hind stomach might acquired pylorus characteristics used alkaline phosphatase EAP determine whether hind stomach indeed posteriorized
0.25421372.15829524.html.plaintext.txt	299	8A EAP mainly expressed duodenum pylorus region controls
0.25421372.15829524.html.plaintext.txt	300	By contrast high level EAP expression found duodenum pylorus also found hind stomach conditional mutant mice using longitudinally sectioned E16
0.25421372.15829524.html.plaintext.txt	301	Clear anterior extension EAP positive epithelium indicated brackets found hind stomach conditional mutant mice
0.25421372.15829524.html.plaintext.txt	302	Although expression markers HK ATPase ss subunit Fig
0.25421372.15829524.html.plaintext.txt	303	8EF different regions anterior junction pylorus duodenum E18
0.25421372.15829524.html.plaintext.txt	304	8DF stomachs higher level EAP activity found mutant hind stomach Fig
0.25421372.15829524.html.plaintext.txt	305	Taken together extended high levels EAP expression hind stomach indicate patterning AP axis abnormal conditional mutants
0.25421372.15829524.html.plaintext.txt	306	View larger version 92K Fig
0.25421372.15829524.html.plaintext.txt	307	AB Paraffin sections E16
0.25421372.15829524.html.plaintext.txt	308	5 stomachs stained EAP activity
0.25421372.15829524.html.plaintext.txt	309	The bracket indicates corresponding regions caudal end control mutant stomach
0.25421372.15829524.html.plaintext.txt	310	oe esophagus Py pylorus d duodenum
0.25421372.15829524.html.plaintext.txt	311	CD The junction region caudal end stomach duodenum show slight morphological differences
0.25421372.15829524.html.plaintext.txt	312	The gastric parietal cells stained anti HK ATPase ss subunit antibody
0.25421372.15829524.html.plaintext.txt	313	EF Anti GATA4 antibody used mark glandular gastric epithelium
0.25421372.15829524.html.plaintext.txt	314	G J Paraffin sections E18
0.25421372.15829524.html.plaintext.txt	315	5 stomachs stained EAP activity
0.25421372.15829524.html.plaintext.txt	316	The bracket indicates corresponding regions caudal end control mutant stomach
0.25421372.15829524.html.plaintext.txt	317	Very low positive signals found glandular gastric epithelium control GI highly intense signals seen mutant HJ
0.25421372.15829524.html.plaintext.txt	318	High magnification boxed corresponding regions control G mutant H shown I J respectively
0.25421372.15829524.html.plaintext.txt	319	Scale bar B 100 microm AB
0.25421372.15829524.html.plaintext.txt	320	Does COUP TFII mediate Hh signaling stomach The radial AP patterning defects elicited COUP TFII null mutants bear resemblance dysmorphogenesis stomach Shh null mutant mice Ramalho Santos et al
0.25421372.15829524.html.plaintext.txt	321	Because similarity asked COUP TFII expression altered Shh null mutant
0.25421372.15829524.html.plaintext.txt	322	Whole mount situ hybridization showed COUP TFII expression caudal region stomach Shh null mutant downregulated comparison control littermate
0.25421372.15829524.html.plaintext.txt	323	However expression COUP TFII regions stomach slightly downregulated Fig
0.25421372.15829524.html.plaintext.txt	324	An anterior shifting caudal margin COUP TFII expression gastro duodenal junction indicated broken lines presumptive gastro duodenal junction indicated arrowheads based morphology location dorsal mesogastrium evident Shh null mutant
0.25421372.15829524.html.plaintext.txt	325	In addition significant size reduction particularly fore stomach noted Shh null mutant stomachs even early E12
0.25421372.15829524.html.plaintext.txt	326	5 stage using esophagus guide Fig
0.25421372.15829524.html.plaintext.txt	327	View larger version 86K Fig
0.25421372.15829524.html.plaintext.txt	328	Effect inhibition Hh signaling COUP TFII expression
0.25421372.15829524.html.plaintext.txt	329	AB Developing stomachs dissected E12
0.25421372.15829524.html.plaintext.txt	330	5 Shh wild type null mutant expression COUP TFII mRNA detected whole mount situ hybridization
0.25421372.15829524.html.plaintext.txt	331	Caudal margins COUP TFII expression indicated dots presumptive anatomical boundaries stomach duodenum indicated arrowheads
0.25421372.15829524.html.plaintext.txt	332	The relative size fore stomach indicated white line top stomach
0.25421372.15829524.html.plaintext.txt	333	C F Foregut explants dissected E10
0.25421372.15829524.html.plaintext.txt	334	5 knock embryos cultured 48 hours increasing concentrations cyclopamine 0 10 microM D F
0.25421372.15829524.html.plaintext.txt	335	Strong lacZ expression detected mesenchyme lung bud fore stomach indicated arrowhead cyclopamine inhibited lacZ expression dose dependent manner
0.25421372.15829524.html.plaintext.txt	336	oe esophagus fs fore stomach hs hind stomach dmg dorsalmesogastrium lb lung bud St stomach Py pylorus d duodenum e hind stomach epithelium
0.25421372.15829524.html.plaintext.txt	337	As presence Ihh Shh null mutant stomach Bitgood McMahon 1995 might functionally compensate Shh influence COUP TFII expression used cyclopamine inhibit Hh signals Chen et al
0.25421372.15829524.html.plaintext.txt	338	2002 asked COUP TFII expression affected explants organ culture
0.25421372.15829524.html.plaintext.txt	339	5 lacZ knock embryos cultured 48 hours presence increasing amounts cyclopamine
0.25421372.15829524.html.plaintext.txt	340	Whole mount X gal staining COUP TFII illustrated significant dose dependent reduction COUP TFIIlacZ expression especially mesenchyme lung bud fore stomach indicated arrowheads Fig
0.25421372.15829524.html.plaintext.txt	341	At 1 microM cyclopamine slight reduction COUP TFII mRNA represented X gal staining detected stomach explants E11
0.25421372.15829524.html.plaintext.txt	342	At 5 microM 10 microM cyclopamine reduction X gal staining pronounced stomach compared controls Fig
0.25421372.15829524.html.plaintext.txt	343	9EF COUP TFII mRNA affected lung explants shown
0.25421372.15829524.html.plaintext.txt	344	The downregulation COUP TFII expression Hh signaling inhibited cyclopamine substantiates notion Hh signaling regulates COUP TFII expression stomach
0.25421372.15829524.html.plaintext.txt	345	Discussion TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES The lacZ knock mice allow us follow expression COUP TFII gastric development
0.25421372.15829524.html.plaintext.txt	346	It apparent COUP TFII expressed mesenchyme epithelium developing stomach
0.25421372.15829524.html.plaintext.txt	347	The graded mesenchymal expression profile highest levels mesenchyme subjacent epithelium suggests diffusible molecule secreted epithelium may regulate expression COUP TFII
0.25421372.15829524.html.plaintext.txt	348	COUP TFII also expressed glandular epithelium stomach highest expression base zymogenic cells localized expressed surface pit cells
0.25421372.15829524.html.plaintext.txt	349	The expression patterns zymogenic unit resemble Shh van den Brink et al
0.25421372.15829524.html.plaintext.txt	350	Taken together findings speculate Shh might regulate COUP TFII stomach similar manner previously shown motoneurons Krishnan et al
0.25421372.15829524.html.plaintext.txt	351	Conditional ablation COUP TFII mesenchyme developing stomach Nkx3
0.25421372.15829524.html.plaintext.txt	352	2 Cre recombinase firmly established COUP TFII essential radial patterning stomach
0.25421372.15829524.html.plaintext.txt	353	5 already apparent circular smooth muscles layers enteric neurons layers expanded disorganized conditional mutants
0.25421372.15829524.html.plaintext.txt	354	These defects persist later stages development
0.25421372.15829524.html.plaintext.txt	355	Although COUP TFII epithelial compartment deleted epithelium considerably thicker comparison control littermates indicating signals mesenchyme required appropriate epithelium growth
0.25421372.15829524.html.plaintext.txt	356	The defects display COUP TFII conditional mutants indicate COUP TFII essential radial patterning developing stomach defects seen compound heterozygote Nkx3
0.25421372.15829524.html.plaintext.txt	357	Instead inappropriate differentiation smooth muscles cells enteric neurons mesenchyme shown Hh signaling disrupted treatment cyclopamine Sukegawa et al
0.25421372.15829524.html.plaintext.txt	358	Shh believed epithelial signal inhibits gut mesenchyme differentiate smooth cells neural crest cells differentiate enteric neurons
0.25421372.15829524.html.plaintext.txt	359	Our findings indicate COUP TFII participates negative regulation differentiation smooth muscle cells enteric neurons gut mesenchyme
0.25421372.15829524.html.plaintext.txt	360	COUP TFII either serve downstream target Hh mediate negative function gut mesenchyme exert effect pathway parallel Hh regulate mesenchymal differentiation
0.25421372.15829524.html.plaintext.txt	361	In addition radial patterning stomach COUP TFII also required AP patterning stomach
0.25421372.15829524.html.plaintext.txt	362	The anterior shift limited ridge divides fore hind stomach reduced size fore stomach expansion hind stomach expansion EAP expression hind stomach consistent disruption AP axis patterning stomach
0.25421372.15829524.html.plaintext.txt	363	However differentiation epithelium fore hind stomach adult mutant remains unchanged molecular markers analyzed even mutant stomach posteriorized
0.25421372.15829524.html.plaintext.txt	364	The posteriorization ectopic extended expression EAP hind stomach conditional mutant demonstrated Shh null mutant mice Ramalho Santos et al
0.25421372.15829524.html.plaintext.txt	365	The striking similarity phenotypes exhibited conditional COUP TFII null mutants animals chick mouse Hh signaling disrupted implicates Hh COUP TFII act andor parallel pathways
0.25421372.15829524.html.plaintext.txt	366	Although general slight reduction expression COUP TFII Shh null mutant little surprising high expression Ihh expanded hind stomach Shh null mutant could compensated missing Shh induce COUP TFII expression
0.25421372.15829524.html.plaintext.txt	367	Indeed downregulation COUP TFII expression mesenchyme stomach pronounced explants treated cyclopamine supporting notion COUP TFII downstream target Hh signaling
0.25421372.15829524.html.plaintext.txt	368	In addition Shh signaling directly activate COUP TFII expression Shh N activates COUP TFII expression P19 cells without de novo protein synthesis Krishnan et al
0.25421372.15829524.html.plaintext.txt	369	Furthermore analysis COUP TFII promoter identified ShhRE distinct defined Gli binding site Krishnan et al
0.25421372.15829524.html.plaintext.txt	370	Thus results indicate COUP TFII mediates Hh signaling stomach
0.25421372.15829524.html.plaintext.txt	371	Taken together results established COUP TFII essential radial AP patterning stomach
0.25421372.15829524.html.plaintext.txt	372	Restriction anterior Shh expression attenuation Shh action epithelium COUP TFII conditional mutant turn suggests potential role COUP TFII stimulation maintenance Shh expression
0.25421372.15829524.html.plaintext.txt	373	Shh derived epithelium signals mesenchyme stomach mesenchymal factors influence endodermally expressed Shh unclear
0.25421372.15829524.html.plaintext.txt	374	The Hoxa5 null mutant phenotype provides evidence mesenchyme mediated regulation Shh expression developing stomach Aubin et al
0.25421372.15829524.html.plaintext.txt	375	Similarly chick suggested adjacent mesenchyme regulates Shh expression Narita et al
0.25421372.15829524.html.plaintext.txt	376	In study COUP TFII ablated mesenchyme observed dysmorphogenesis suggests COUP TFII potentially affects mesenchymal factors
0.25421372.15829524.html.plaintext.txt	377	One candidate Bmp4 belongs TGFss superfamily expressed mesenchyme developing murine stomach chick ortholog demonstrated play role gizzard patterning
0.25421372.15829524.html.plaintext.txt	378	Bmp4 important mesoderm development early lethality Bmp4 null mutants specific role Bmp4 gastric development elucidated Winnier et al
0.25421372.15829524.html.plaintext.txt	379	Interestingly shown COUP TFII binds mouse Bmp4 promoter regulates Bmp4 promoter activity transient transfection assays Feng et al
0.25421372.15829524.html.plaintext.txt	380	1995 suggesting COUP TFII might function BMP signaling
0.25421372.15829524.html.plaintext.txt	381	Another member TGFss super family activin governs embryonic axial patterning restricts Shh expression Hensens node Monsoro Burq Le Douarin 2001
0.25421372.15829524.html.plaintext.txt	382	Furthermore expansion Shh expression domain within stomach Acvr2aAcvr2b mutant mice indicates restriction Shh foregut potentially regulated TGFssBmp signaling
0.25421372.15829524.html.plaintext.txt	383	As Acvr2 able interact BMPs Kim et al
0.25421372.15829524.html.plaintext.txt	384	2000 mesenchymal expressed Bmp4 may restrict Shh expression
0.25421372.15829524.html.plaintext.txt	385	Alternatively possible COUP TFII may modulate expression activinactivin receptor
0.25421372.15829524.html.plaintext.txt	386	Enhanced activin signaling may restrict expression domain Shh anterior border perturb epithelial growth seen conditional mutant stomach
0.25421372.15829524.html.plaintext.txt	387	Further analysis TGFssBmpactivin signaling COUP TFII conditional mutant stomach may shed light mesenchymal factors regulate Shh expression affected absence COUP TFII
0.25421372.15829524.html.plaintext.txt	388	ACKNOWLEDGMENTS We thank Xiaoyan Huang Kikue Takamoto Wei Qian excellent technical help Dr Milton Finegold Mr James Barrish Core Morphology laboratory NIH Gulf Coast Digestive Disease Center thin section EM analysis Drs Zijian Lan Hong Wu Dennis Roop various suggestion discussion Drs Kimi Araki Takeshi Yagi Matthew Scott plasmid DNA Kurt Schillinger Debra Bramblett Peter Tsai preparation manuscript
0.25421372.15829524.html.plaintext.txt	389	REFERENCES TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES
0.25421372.15829524.html.plaintext.txt	390	Stomach regional specification requires Hoxa5 driven mesenchymal epithelial signaling
0.25421372.15829524.html.plaintext.txt	391	Hedgehog Bmp genes coexpressed many diverse sites cell cell interaction mouse embryo
0.25421372.15829524.html.plaintext.txt	392	Small molecule modulation Smoothened activity
0.25421372.15829524.html.plaintext.txt	393	Cyclopia defective axial patterning mice lacking Sonic hedgehog gene function
0.25421372.15829524.html.plaintext.txt	394	Molecular etiology gut malformations diseases
0.25421372.15829524.html.plaintext.txt	395	The mouse bone morphogenetic protein 4 gene
0.25421372.15829524.html.plaintext.txt	396	Analysis promoter utilization fetal rat calvarial osteoblasts regulation COUP TFI orphan receptor
0.25421372.15829524.html.plaintext.txt	397	Versatile roles sonic hedgehog gut development
0.25421372.15829524.html.plaintext.txt	398	Manipulating Mouse Embryo A Laboratory Manual
0.25421372.15829524.html.plaintext.txt	399	Cold Spring Harbor NY Cold Spring Harbor Laboratory Press
0.25421372.15829524.html.plaintext.txt	400	Dynamics epithelial cells corpus mouse stomach
0.25421372.15829524.html.plaintext.txt	401	Identification proliferative cell types pinpointing stem cell
0.25421372.15829524.html.plaintext.txt	402	The gut associated tissues
0.25421372.15829524.html.plaintext.txt	403	In The Anatomical Basis Mouse Development p
0.25421372.15829524.html.plaintext.txt	404	Intestinal epithelial mesenchymal cell interactions
0.25421372.15829524.html.plaintext.txt	405	Cellular molecular partners involved gut morphogenesis differentiation
0.25421372.15829524.html.plaintext.txt	406	Activin receptor patterning foregut organogenesis
0.25421372.15829524.html.plaintext.txt	407	Identification novel sonic hedgehog response element chicken ovalbumin upstream promoter transcription factor II promoter
0.25421372.15829524.html.plaintext.txt	408	Mediation Sonic hedgehog induced expression COUP TFII protein phosphatase
0.25421372.15829524.html.plaintext.txt	409	Developmental regulation orphan receptor COUP TF II gene spinal motor neurons
0.25421372.15829524.html.plaintext.txt	410	BMP4 plays key role left right patterning chick embryos maintaining Sonic Hedgehog asymmetry
0.25421372.15829524.html.plaintext.txt	411	Sonic hedgehog expression developing chicken digestive organs regulated epithelial mesenchymal interactions
0.25421372.15829524.html.plaintext.txt	412	The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.25421372.15829524.html.plaintext.txt	413	Isolation characterization chromosomal localization mouse human COUP TF I II genes
0.25421372.15829524.html.plaintext.txt	414	Null mutation mCOUP TFI results defects morphogenesis glossopharyngeal ganglion axonal projection arborization
0.25421372.15829524.html.plaintext.txt	415	Hedgehog signals regulate multiple aspects gastrointestinal development
0.25421372.15829524.html.plaintext.txt	416	The concentric structure developing gut regulated Sonic hedgehog derived endodermal epithelium
0.25421372.15829524.html.plaintext.txt	417	Bapx1 evolutionary conserved homologue Drosophila bagpipe homeobox gene expressed splanchnic mesoderm embryonic skeleton
0.25421372.15829524.html.plaintext.txt	418	Chick ovalbumin upstream promoter transcription factors COUP TFs coming age
0.25421372.15829524.html.plaintext.txt	419	Sonic hedgehog regulates gastric gland morphogenesis man mouse
0.25421372.15829524.html.plaintext.txt	420	Bone morphogenetic protein 4 required mesoderm formation patterning mouse
0.25574476.12040019.html.plaintext.txt	0	Multiple Phosphorylation Events Control Chicken Ovalbumin Upstream Promoter Transcription Factor I Orphan Nuclear Receptor Activity Frederique Gay1 Peter Barath Christine Desbois Le Peron Raphael Metivier2 Remy Le Guevel Darcy Birse Gilles Salbert
0.25574476.12040019.html.plaintext.txt	1	Equipe Information et Programmation Cellulaire F
0.25574476.12040019.html.plaintext.txt	2	et Equipe Endocrinologie Moleculaire de la Reproduction R
0.25574476.12040019.html.plaintext.txt	3	Unite Mixte de Recherche 6026 Centre National de la Recherche Scientifique Universite de Rennes I Campus de Beaulieu 35042 Rennes Cedex France Department Biochemistry Biophysics P
0.25574476.12040019.html.plaintext.txt	4	Arrhenius Laboratories Natural Sciences Stockholm University Stockholm SE 106 91 Sweden
0.25574476.12040019.html.plaintext.txt	5	Address correspondence requests reprints Dr
0.25574476.12040019.html.plaintext.txt	6	Gilles Salbert Equipe Information et Programmation Cellulaire Unite Mixte de Recherche 6026 Centre National de la Recherche Scientifique Universite de Rennes I Campus de Beaulieu 35042 Rennes cedex France
0.25574476.12040019.html.plaintext.txt	7	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Chicken ovalbumin upstream promoter transcription factor I COUP TFI orphan member nuclear hormone receptor superfamily comprises key regulators many biological functions embryonic development metabolism homeostasis reproduction
0.25574476.12040019.html.plaintext.txt	8	Although COUP TFI actively silence gene transcription antagonize functions various nuclear receptors COUP TFI orphan receptor also acts transcriptional activator certain contexts
0.25574476.12040019.html.plaintext.txt	9	Moreover COUP TFI recently shown serve accessory factor ligand bound nuclear receptors suggesting may modulate negatively positively wide range hormonal responses
0.25574476.12040019.html.plaintext.txt	10	In absence identified cognate ligand mechanisms involved regulation COUP TFI activity remain unclear
0.25574476.12040019.html.plaintext.txt	11	The elucidation several putative phosphorylation sites MAPKs PKC casein kinase II within sequence orphan receptor led us investigate phosphorylation events regulating various COUP TFI functions
0.25574476.12040019.html.plaintext.txt	12	After showing COUP TFI phosphorylated vivo provide evidence vivo inhibition either MAPK PKC signaling pathway leads specific pronounced decrease COUP TFI dependent transcriptional activation vitronectin gene promoter
0.25574476.12040019.html.plaintext.txt	13	Focusing molecular mechanisms underlying MAPK PKC mediated regulation COUP TFI activity show COUP TFI directly targeted PKC MAPK
0.25574476.12040019.html.plaintext.txt	14	These phosphorylation events differentially modulate COUP TFI functions PKC mediated phosphorylation enhances COUP TFI affinity DNA MAPK mediated phosphorylation positively regulates transactivation function COUP TFI possibly enhancing specific coactivator recruitment
0.25574476.12040019.html.plaintext.txt	15	These data provide evidence COUP TFI likely integrate distinct signaling pathways raise possibility multiple extracellular signals influence biological processes controlled COUP TFI
0.25574476.12040019.html.plaintext.txt	16	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES THE NUCLEAR RECEPTOR superfamily encompasses many ligand activated transcription factors addition also large number proteins whose ligands unknown thus termed orphan receptors 1 2
0.25574476.12040019.html.plaintext.txt	17	These receptors play crucial roles transcriptional activators repressors regulators wide range biological functions including development metabolism reproduction
0.25574476.12040019.html.plaintext.txt	18	Among nuclear orphan receptors chicken ovalbumin upstream promoter transcription factors COUP TFs encoded distinct genes sharing exceptionally high degree sequence homology 3 4 5 6 7 8 9 10
0.25574476.12040019.html.plaintext.txt	19	The expression patterns COUP TFs extensively studied several divergent species appear relatively similar suggesting conservation COUP TF function throughout evolution
0.25574476.12040019.html.plaintext.txt	20	Although COUP TF distinct expression pattern embryonic development adult mice patterns often overlapping genes widely expressed developing central nervous system 8 11 12 13
0.25574476.12040019.html.plaintext.txt	21	These findings suggest functional redundancy among COUP TFs classically considered act key factors neurogenesis
0.25574476.12040019.html.plaintext.txt	22	Overexpression COUP TFs gene disruption experiments performed Drosophila Xenopus mouse define major role orphan receptors formation anterior brain tetrapods patterning eye fly modulation axogenesis cranial neural crest cell behavior mammals respectively 3 9 14 15 16
0.25574476.12040019.html.plaintext.txt	23	The recent finding COUP TFI function required cortical layer IV cell survival correct guidance connection axons mouse thalamic neurons supports hypothesis COUP TFI functions transcriptional control axon guidance cues 17
0.25574476.12040019.html.plaintext.txt	24	Aside neuronal expression patterns COUP TFs show overlapping yet distinct expression patterns many tissues development suggesting involvement organogenesis 8 13
0.25574476.12040019.html.plaintext.txt	25	Consistent role nuclear receptors accessory neurogenesis recent data show COUP TFII involved angiogenesis vascular remodeling heart development 16 18
0.25574476.12040019.html.plaintext.txt	26	Initial studies identified COUP TFs transcriptional activators 19 20 21 22 nevertheless COUP TFs repress transcriptional activation mediated number ligand bound nuclear receptors including VDR TRs RXRs RARs 23 24 25 26
0.25574476.12040019.html.plaintext.txt	27	A functional cross talk COUP TFs retinoid signaling pathways development proposed based comprehensively documented antagonistic effects COUP TFs retinoid dependent gene expression observation COUP TF genes targeted retinoids 7 8 15 27 28
0.25574476.12040019.html.plaintext.txt	28	However recent data indicate orphan receptors also serve accessory factors ligand bound nuclear receptors GR ER RAR 29 30 31
0.25574476.12040019.html.plaintext.txt	29	In specific promoter contexts COUP TFs thus able enhance ligand induced transactivation function various receptors suggesting COUP TFs may required effectively establishing cues certain genetic responses exposure cell ligand
0.25574476.12040019.html.plaintext.txt	30	In respect surprising common phenotypes similar bone fusions generated COUP TFI RAR1 RARss independent knockout experiments 16 32
0.25574476.12040019.html.plaintext.txt	31	The recent finding COUP TFI required induction growth inhibition apoptosis retinoic acid cancer cells substantiates positive interaction COUP TFs retinoid receptors vivo 31
0.25574476.12040019.html.plaintext.txt	32	With exceptions ligand dependent nuclear receptors activated ligand independent manner phosphorylation events 33
0.25574476.12040019.html.plaintext.txt	33	As example ER activate transcription phosphorylation independent supplemented E2 33 34 35 36 37
0.25574476.12040019.html.plaintext.txt	34	In similar manner many ligand regulated nuclear receptors either activated repressed phosphorylation events 33 34 regulatory mechanisms seem relevant also orphan receptors Nur77NGFI B HNF 4 ROR 38 39 40 41
0.25574476.12040019.html.plaintext.txt	35	Although COUP TFs cloned 10 yr ago ligand yet elucidated characterized suggesting COUP TFs could true orphan nuclear receptors
0.25574476.12040019.html.plaintext.txt	36	The presence several putative phosphorylation sites MAPKs PKC casein kinase II CKII within sequence led us postulate COUP TFI could targeted cellular kinases
0.25574476.12040019.html.plaintext.txt	37	In report demonstrate COUP TFI directly phosphorylated PKC MAPK phosphorylation events differently modulating COUP TFI functions
0.25574476.12040019.html.plaintext.txt	38	COUP TFI thus likely regulated extracellular signals transduced distinct phosphorylation pathways
0.25574476.12040019.html.plaintext.txt	39	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Two Nuclear Receptor Half Binding Sites within Vitronectin Vn Gene Promoter Mediate Transcriptional Activation Orphan Nuclear Receptor COUP TFI Previously shown COUP TFI transactivate mouse Vn gene promoter P19 embryonal carcinoma cells 42
0.25574476.12040019.html.plaintext.txt	40	Figure 1 demonstrates ability COUP TFI activate promoter restricted P19 cells considering observation similar induction COS 7 cells Fig
0.25574476.12040019.html.plaintext.txt	41	To delineate promoter sequences involved phenomenon well mode activation COUP TFI mutated individually combination two consensus TGACCC half binding sites nuclear receptors present mouse promoter referred NR1 NR2 Fig
0.25574476.12040019.html.plaintext.txt	42	Whereas NR2 half site could generate direct repeat 3 bp spacer DR 3 combined degenerated TGACTT sequence located downstream NR2 site TGACCC related sequence could found vicinity NR1 sequence Fig
0.25574476.12040019.html.plaintext.txt	43	Thereby consensus half sites could organize DR 66 element stably interacting COUP TFI dimers
0.25574476.12040019.html.plaintext.txt	44	When cotransfected COS 7 cells COUP TFI expression vector promoter NR1 site mutated activated much lower level compared wt counterpart Fig
0.25574476.12040019.html.plaintext.txt	45	Mutation NR2 site moderately reduced COUP TFI induced activation Fig
0.25574476.12040019.html.plaintext.txt	46	The double NR1NR2 mutant show greater reduction COUP TFI induced activity compared single NR1 mutant Fig
0.25574476.12040019.html.plaintext.txt	47	These data strongly suggest NR1 site prevails NR2 site COUP TFI activation Vn promoter COS 7 cells
0.25574476.12040019.html.plaintext.txt	48	Because COS cells known overproduce proteins encoded transfected vectors relatively high amounts COUP TFI expressed COS 7 cells could attenuated impact mutations introduced Vn gene promoter
0.25574476.12040019.html.plaintext.txt	49	Based observation transfected P19 cells different mutants verify ability activated COUP TFI Fig
0.25574476.12040019.html.plaintext.txt	50	In cellular context NR1 NR2 mutations reduced COUP TFI activation 50
0.25574476.12040019.html.plaintext.txt	51	When combined NR1 NR2 mutations resulted loss COUP TFI activation 78 Fig
0.25574476.12040019.html.plaintext.txt	52	1C suggesting binding sites required COUP TFI transactivation P19 cells
0.25574476.12040019.html.plaintext.txt	53	Consistent transfection data indicating NR1 site involved Vn gene promoter regulation observed COUP TFI could effectively interact dimer suggested position proteinDNA complex NR1 half site EMSA experiments Fig
0.25574476.12040019.html.plaintext.txt	54	Although COUP TFI able interact NR1 containing oligonucleotide conferred low affinity element judged observation cold NR1 poor competitor compared high affinity DR1 binding element Fig
0.25574476.12040019.html.plaintext.txt	55	These experiments clearly indicate COUP TFI could transactivate mouse Vn gene promoter direct binding least one low affinity site including NR1 sequence possibly second site composed NR2 element
0.25574476.12040019.html.plaintext.txt	56	However residual activation COUP TFI observed double mutant suggests undetected binding sites could recognized orphan receptor part COUP TFI activity could unrelated DNA binding previously shown contexts 43
0.25574476.12040019.html.plaintext.txt	57	View larger version 49K Figure 1
0.25574476.12040019.html.plaintext.txt	58	The COUP TFI Orphan Receptor Activates Mouse Vn Gene Promoter Direct Binding Consensus Half Site
0.25574476.12040019.html.plaintext.txt	59	A Results representative experiment run COS 7 cells cotransfected wt Vn promoter linked Luc reporter gene increasing amounts 6
0.25574476.12040019.html.plaintext.txt	60	25 50 ng COUP TFI expression vector
0.25574476.12040019.html.plaintext.txt	61	Results shown means plus minus SEM n 4 Luc values corrected ss galactosidase activities
0.25574476.12040019.html.plaintext.txt	62	B The sequence mouse Vn gene proximal promoter
0.25574476.12040019.html.plaintext.txt	63	Putative binding sites transcription factors boxed
0.25574476.12040019.html.plaintext.txt	64	The transcription initiation site noted 1 changes introduced promoter site directed mutagenesis shown bold letters underneath wt sequence
0.25574476.12040019.html.plaintext.txt	65	C Transient transfection analysis mutated promoters
0.25574476.12040019.html.plaintext.txt	66	COS 7 P19 cells cotransfected indicated recombinant Vn Luc reporter plasmids 25 ng pcDNA3 hCOUP TFI expression vector
0.25574476.12040019.html.plaintext.txt	67	The induction obtained wt promoter presence vs
0.25574476.12040019.html.plaintext.txt	68	absence COUP TFI expression vector set 100 activation
0.25574476.12040019.html.plaintext.txt	69	Inductions obtained various mutated promoters expressed activation obtained wt promoter
0.25574476.12040019.html.plaintext.txt	70	Results shown mean plus minus SEM 12 COS 7 cells 6 P19 cells values obtained three two independent experiments respectively
0.25574476.12040019.html.plaintext.txt	71	EMSA analysis COUP TFI binding NR1 element shown panel D
0.25574476.12040019.html.plaintext.txt	72	WCEs COS 7 cells transfected empty pcDNA3 first lane pcDNA3 hCOUP TFI lanes incubated 32P labeled double stranded NR1 oligonucleotide complexes resolved nondenaturing electrophoresis
0.25574476.12040019.html.plaintext.txt	73	The position specific COUP TFINR1 complex assessed supershifting analysis anti hCOUP TFI antibody Ab indicated arrowhead
0.25574476.12040019.html.plaintext.txt	74	Nonspecific bands indicated asterisks
0.25574476.12040019.html.plaintext.txt	75	To estimate affinity COUP TFI NR1 sequence increasing amounts 2 10 fold molar excess NR1 DR1 AP1 cold competitor oligonucleotides added
0.25574476.12040019.html.plaintext.txt	76	Prediction Multiple Putative Phosphorylation Sites Distinct Signaling Pathways within Human COUP TFI Sequence Vivo Phosphorylation COUP TFI As shown Fig
0.25574476.12040019.html.plaintext.txt	77	2A silico analysis human COUP TFI protein sequence revealed several putative phosphorylation sites targeted distinct cellular kinases namely CKII PKC proline directed kinases MAPKs
0.25574476.12040019.html.plaintext.txt	78	The consensus phosphorylation sites defined STXXDE CKII 44 STXRK PKC 45 PX1 2STP three distinct MAPK pathways identified mammalian cells 46
0.25574476.12040019.html.plaintext.txt	79	These pathways include members extracellular signal regulated kinases ERK1p44MAPK ERK2p42MAPK Jun NH2 terminal kinase p38 kinase 47 48 49
0.25574476.12040019.html.plaintext.txt	80	The three putative MAPK phosphorylation sites identified within human COUP TFI sequence found highly conserved throughout evolution 8 clustered amino terminal AB domain Fig
0.25574476.12040019.html.plaintext.txt	81	The putative CKII PKC phosphorylation sites also evolutionarily conserved 8 contrast distributed throughout COUP TFI sequence Fig
0.25574476.12040019.html.plaintext.txt	82	The DNA binding domain DBD contained exclusively PKC target sites whereas AB putative ligand binding domain LBD receptor displayed CKII PKC potential target sequences Fig
0.25574476.12040019.html.plaintext.txt	83	The presence several putative phosphorylation sites various cellular kinases human COUP TFI sequence raises possibility similar posttranslational modifications described several nuclear receptors COUP TFI could phosphoprotein vivo whose activity may regulated specific phosphorylation events
0.25574476.12040019.html.plaintext.txt	84	To test hypothesis cloned human COUP TFI cDNA encoding residues 57 423 frame glutathione S transferase GST coding sequence mammalian expression vector pBCGST
0.25574476.12040019.html.plaintext.txt	85	After mutation PKA site present GST sequence recombinant vector transfected COS 7 cells
0.25574476.12040019.html.plaintext.txt	86	32P Labeled orthophosphate added label phosphoproteins vivo
0.25574476.12040019.html.plaintext.txt	87	Cell extracts purified glutathione agarose beads analyzed SDS PAGE
0.25574476.12040019.html.plaintext.txt	88	The positions GST GSTCOUP TFI determined western blotting anti GST antibody data shown
0.25574476.12040019.html.plaintext.txt	89	Results indicate GST GSTCOUP TFI labeled vivo Fig
0.25574476.12040019.html.plaintext.txt	90	Although slight incorporation 32P observed GST GSTCOUP TFI fusion protein approximately 90 times radioactive free GST indicating COUP TFI indeed phosphoprotein vivo
0.25574476.12040019.html.plaintext.txt	91	View larger version 29K Figure 2
0.25574476.12040019.html.plaintext.txt	92	The Human COUP TFI Sequence Contains Multiple Putative Phosphorylation Sites Is Phosphorylated Vivo
0.25574476.12040019.html.plaintext.txt	93	A Positions potential target sites CKII black arrowheads PKC open arrowheads MAPK gray arrowheads identified within sequence human COUP TFI receptor
0.25574476.12040019.html.plaintext.txt	94	B In vivo phosphorylation COUP TFI
0.25574476.12040019.html.plaintext.txt	95	COS 7 cells transfected pBCGST pBCGST COUP TFI 57 423 treated 32P orthophosphate
0.25574476.12040019.html.plaintext.txt	96	Proteins extracted purified glutathione agarose beads SDS PAGE
0.25574476.12040019.html.plaintext.txt	97	Autoradiogram b Coomassie Brilliant blue staining gel
0.25574476.12040019.html.plaintext.txt	98	The positions GST GSTCOUP TFI assessed Western blot anti GST antibodies data shown
0.25574476.12040019.html.plaintext.txt	99	The autoradiographic signals well protein levels quantified estimate relative specific activity labeled proteins
0.25574476.12040019.html.plaintext.txt	100	These activities expressed OD arbitrary unit per picomole protein
0.25574476.12040019.html.plaintext.txt	101	Multiple Phosphorylation Pathways Regulate COUP TFI Mediated Transcriptional Activation Vn Gene Promoter The functional relevance phosphorylation events regulation COUP TFI activity first assessed using specific inhibitors three described kinases transfection experiments Fig
0.25574476.12040019.html.plaintext.txt	102	COS 7 cells cotransfected COUP TFI dependent reporter gene Vn luciferase Luc containing wt Vn gene promoter sequence see Fig
0.25574476.12040019.html.plaintext.txt	103	1 presence absence increasing amounts human COUP TFI expression vector
0.25574476.12040019.html.plaintext.txt	104	Cells treated treated DRB 5 6 dichloro 1 ss D ribofuranosyl benzimidazole CKII inhibitor Fig
0.25574476.12040019.html.plaintext.txt	105	3A p42MAPKp44MAPK signaling pathway specific inhibitor PD980059 PKC inhibitor GF 109203X Fig
0.25574476.12040019.html.plaintext.txt	106	Consistent previous results cotransfection increasing amounts COUP TFI expression plasmid led dose dependent induction reporter gene activity
0.25574476.12040019.html.plaintext.txt	107	Neither basal stimulated transcriptional activity reporter gene modified treatment cells DRB Fig
0.25574476.12040019.html.plaintext.txt	108	The expression level COUP TFI also unaffected treatment data shown see Fig
0.25574476.12040019.html.plaintext.txt	109	Based experiments defining inhibition CKII pathway vivo affect COUP TFI mediated transcriptional activation seems unlikely kinase regulates COUP TFI function
0.25574476.12040019.html.plaintext.txt	110	Whereas basal activity altered treatment cells PD980059 led significant decrease 76 inhibition activation reporter gene activity observed presence 50 ng COUP TFI expression vector Fig
0.25574476.12040019.html.plaintext.txt	111	As assessed Western blotting inhibition due decrease nuclear receptor expression data shown see Fig
0.25574476.12040019.html.plaintext.txt	112	The inhibitory effect specific MAPK inhibitor induction Vn gene promoter COUP TFI restricted COS 7 cells similar results obtained experiments utilizing P19 cells data shown
0.25574476.12040019.html.plaintext.txt	113	3B treating cotransfected COS 7 cells GF 109203X absence expression vector influence basal activity
0.25574476.12040019.html.plaintext.txt	114	In contrast GF 109203X induced marked reduction 60 inhibition activation reporter gene activity observed presence 50 ng COUP TFI expression vector Fig
0.25574476.12040019.html.plaintext.txt	115	Concurrent previous observation inhibition COUP TFI induced reporter gene activity due reduced expression COUP TFI COS 7 cells treated GF 109203X data shown see Fig
0.25574476.12040019.html.plaintext.txt	116	Thus blocking either p42MAPKp44MAPK PKC signaling pathway results strong inhibition COUP TFI dependent transcription suggesting COUP TFI function may positively regulated kinases vivo
0.25574476.12040019.html.plaintext.txt	117	View larger version 33K Figure 3
0.25574476.12040019.html.plaintext.txt	118	Specific Inhibitors MAPK PKC Decrease COUP TFI Mediated Transcription
0.25574476.12040019.html.plaintext.txt	119	A B Effects specific inhibitors CKII DRB panel A MAPK PD980059 panel B PKC GF 109203X panel B COUP TFI mediated transcriptional activation Vn gene promoter
0.25574476.12040019.html.plaintext.txt	120	COS 7 cells cotransfected Vn Luc reporter gene absence presence increasing amounts 6
0.25574476.12040019.html.plaintext.txt	121	25 50 ng indicated pcDNA3 hCOUP TFI panels A B pcDNA3 hCOUP TFI 57 423 panel B pcDNA3 hCOUP TFI 84 423 panel B expression vectors
0.25574476.12040019.html.plaintext.txt	122	Kinase inhibitors added 4 h cells harvested
0.25574476.12040019.html.plaintext.txt	123	Results expressed fold inductions reporter gene activities presence various expression vectors compared activity absence expression vector
0.25574476.12040019.html.plaintext.txt	124	Results shown means plus minus SEM three values obtained representative experiment
0.25574476.12040019.html.plaintext.txt	125	The expression level various proteins transfected COS 7 cells assessed Western blotting B right panel
0.25574476.12040019.html.plaintext.txt	126	The positions specific band corresponding COUP TFI COUP TFI 57 423 COUP TFI 84 423 proteins expressed COS 7 cells indicated black gray open arrowhead respectively asterisk indicating nonspecific band Fig
0.25574476.12040019.html.plaintext.txt	127	View larger version 58K Figure 5
0.25574476.12040019.html.plaintext.txt	128	The Selective Inhibitor PKC Specifically Decreases COUP TFI Binding DNA Dose Dependent Manner
0.25574476.12040019.html.plaintext.txt	129	The potential effects inhibitors CKII DRB panel A MAPK PD980059 panel B PKC GF 109203X panel C COUP TFI DNA binding assessed EMSA
0.25574476.12040019.html.plaintext.txt	130	COS 7 cells untransfected lanes 1 transfected pcDNA3 hCOUP TFI expression vector lanes 2 6 treated absence presence increasing amounts indicated kinase inhibitors
0.25574476.12040019.html.plaintext.txt	131	WCEs incubated 32P labeled double stranded NR1 oligonucleotide
0.25574476.12040019.html.plaintext.txt	132	The position specific COUP TFINR1 complex assessed supershifting analysis anti hCOUP TFI antibody lanes 3 indicated arrowhead whereas nonspecific bands indicated asterisks
0.25574476.12040019.html.plaintext.txt	133	The expression level COUP TFI WCEs used EMSA controlled Western blotting lower panels anti HA antibody
0.25574476.12040019.html.plaintext.txt	134	The position COUP TFI receptor indicated arrowhead whereas nonspecific bands indicated asterisks
0.25574476.12040019.html.plaintext.txt	135	To determine functional requirement phosphorylation mediated regulation COUP TFI activity similar cotransfection experiments performed using expression vectors encoding truncated COUP TFI receptors Fig
0.25574476.12040019.html.plaintext.txt	136	The COUP TFI 57 423 protein truncated amino terminal region AB domain lacking putative CKII PKC phosphorylation sequence S7 well two amino terminal T51 T54 MAPK phosphorylation sites
0.25574476.12040019.html.plaintext.txt	137	In addition four sites COUP TFI 84 423 protein deleted almost entire AB domain 86 first amino acids devoid third putative MAPK phosphorylation site T63 CKII phosphorylation site T66
0.25574476.12040019.html.plaintext.txt	138	Western blotting showed three constructs efficiently expressed COS 7 displayed similar expression levels Fig
0.25574476.12040019.html.plaintext.txt	139	Independent amount expression vector used COUP TFI 57 423 able stimulate reporter gene activity similar extent observed equivalent dose wild type wt COUP TFI expression vector Fig
0.25574476.12040019.html.plaintext.txt	140	Moreover PD980059 GF 109203X efficiently counteracted reporter gene activation mediated 50 ng COUP TFI 57 423 expression vector
0.25574476.12040019.html.plaintext.txt	141	This observation suggests region spanning residues 1 56 COUP TFI including one PKC two MAPK potential phosphorylation sites dispensable transactivation involved regulation COUP TFI activity PKC MAPK pathways
0.25574476.12040019.html.plaintext.txt	142	Cotransfection COS 7 cells increasing amounts COUP TFI 84 423 expression vector resulted weak stimulation reporter gene Fig
0.25574476.12040019.html.plaintext.txt	143	Experiments run P19 cells gave similar results data shown
0.25574476.12040019.html.plaintext.txt	144	These data suggest residues 57 83 play crucial role directly indirectly COUP TFI mediated transactivation raise possibility third T63 MAPK phosphorylation site could hierarchal requisite COUP TFI activity MAPK mediated regulation nuclear receptor functions
0.25574476.12040019.html.plaintext.txt	145	This extent confirmed observation PD980059 significantly less efficient inhibiting COUP TFI 84 423 mediated transcriptional activation decreasing COUP TFI 57 423 induced activation Fig
0.25574476.12040019.html.plaintext.txt	146	Indeed inhibition COUP TFI 84 423 COUP TFI 57 423 activity due PD980059 58 89 respectively
0.25574476.12040019.html.plaintext.txt	147	The residual effect PD980059 COUP TFI 84 423 mediated transactivation suggests involvement additional nonconsensus MAPK phosphorylation site located residues 84 423 MAPK indirectly modulates COUP TFI activity
0.25574476.12040019.html.plaintext.txt	148	Finally cells cotransfected 50 ng COUP TFI 84 423 expression vector treatment GF 109203X reduced reporter gene activity basal level Fig
0.25574476.12040019.html.plaintext.txt	149	This last result implies potential phosphorylation sites targeted PKC located outside AB domain
0.25574476.12040019.html.plaintext.txt	150	All together findings strongly suggest COUP TFI activity positively regulated phosphorylation events vivo events may mediated p42MAPKp44MAPK PKC pathways
0.25574476.12040019.html.plaintext.txt	151	In Vitro Dephosphorylation Inhibits COUP TFI Binding Its DNA Target Sequences In attempt identify functions COUP TFI controlled phosphorylation events first focused DNA binding activity investigated whether vitro dephosphorylation COUP TFI could affect ability bind DNA elements Fig
0.25574476.12040019.html.plaintext.txt	152	In study COUP TFI expressed COS 7 cells whole cell extracts WCEs either untransfected COUP TFI expressing cells treated vitro calf intestinal phosphatase CIP
0.25574476.12040019.html.plaintext.txt	153	4A incubation untreated WCEs COUP TFI expressing cells labeled double stranded DR1 oligonucleotide led formation complex species shifted EMSA experiments single band indicated arrowhead
0.25574476.12040019.html.plaintext.txt	154	Supershifting experiments anti COUP TFI antibody reduced electrophoretic mobility retarded complex confirming presence COUP TFI complex
0.25574476.12040019.html.plaintext.txt	155	In vitro treatment WCEs prepared COUP TFI expressing cells CIP buffer alone CIP buffer phosphate effect intensity shifted band showing neither compounds affected binding COUP TFI DNA elements
0.25574476.12040019.html.plaintext.txt	156	In contrast treatment WCEs CIP strongly decreased intensity shifted band providing evidence CIP mediated decrease formation COUP TFIDR1 complex
0.25574476.12040019.html.plaintext.txt	157	The hypothesis CIP mediated dephosphorylation COUP TFI inhibited nuclear receptor binding specific DNA elements substantiated observation addition phosphate dephosphorylation mixture abolished effect CIP
0.25574476.12040019.html.plaintext.txt	158	View larger version 29K Figure 4
0.25574476.12040019.html.plaintext.txt	159	Dephosphorylation COUP TFI Inhibits Its Ability Bind DNA
0.25574476.12040019.html.plaintext.txt	160	Effects vitro treatment CIP COUP TFI binding DNA assessed EMSA
0.25574476.12040019.html.plaintext.txt	161	Equivalent amounts 2 microg WCEs untransfected lanes 1 COUP TFI expressing COS 7 cells lanes 2 7 incubated CIP buffer lanes 4 7 absence lanes 4 5 presence lanes 6 7 CIP 2
0.25574476.12040019.html.plaintext.txt	162	5 U competitive inhibitor CIP NaPO4 lanes 5 7
0.25574476.12040019.html.plaintext.txt	163	Control incubations lanes 1 3 performed absence CIP buffer
0.25574476.12040019.html.plaintext.txt	164	The samples incubated 32P labeled double stranded DR1 NR1 oligonucleotides indicated bottom gels
0.25574476.12040019.html.plaintext.txt	165	The position specific retarded complex assessed supershifting analysis anti hCOUP TFI antibody lanes 3 indicated arrowhead whereas nonspecific bands indicated asterisks
0.25574476.12040019.html.plaintext.txt	166	Similar gel shift experiments performed using proximal half binding site nuclear receptors NR1 identified within Vn gene promoter probe Fig
0.25574476.12040019.html.plaintext.txt	167	4B COUP TF recognition sequences EREs data shown
0.25574476.12040019.html.plaintext.txt	168	Dephosphorylation COUP TFI containing cell extracts systematically reduced COUP TFI binding various response elements Fig
0.25574476.12040019.html.plaintext.txt	169	The CIP mediated inhibition DNA binding also observed COUP TFI 84 423 data shown
0.25574476.12040019.html.plaintext.txt	170	These data suggest COUP TFI specific DNA binding activity directly positively regulated phosphorylation events vivo
0.25574476.12040019.html.plaintext.txt	171	In Vivo Inhibition PKC Signaling Pathway Specifically Decreases DNA Binding Activity COUP TFI The potential effects CKII MAPK PKC kinase inhibitors COUP TFI specific DNA binding function assessed EMSA experiments Fig
0.25574476.12040019.html.plaintext.txt	172	COS 7 cells transfected COUP TFI expression vector subsequently treated untreated increasing amounts different kinase inhibitors described
0.25574476.12040019.html.plaintext.txt	173	WCEs untransfected COUP TFI expressing cells incubated labeled double stranded NR1 oligonucleotide
0.25574476.12040019.html.plaintext.txt	174	Neither vehicle alone tested concentrations DRB significantly modified intensity specific shifted band Fig
0.25574476.12040019.html.plaintext.txt	175	As assessed Western blotting amounts DRB affect expression COUP TFI COS 7 cells Fig
0.25574476.12040019.html.plaintext.txt	176	Similar results obtained using selective p42MAPKp44MAPK inhibitor PD980059 Fig
0.25574476.12040019.html.plaintext.txt	177	Conversely treating transfected cells selective PKC inhibitor GF 109203X influence binding COUP TFI specific DNA elements Fig
0.25574476.12040019.html.plaintext.txt	178	Indeed treatment cells increasing amounts PKC inhibitor led pronounced gradual decrease intensity specific shifted band Fig
0.25574476.12040019.html.plaintext.txt	179	This reduction COUP TFI binding DNA due decreased expression nuclear receptor treated cells revealed Western blotting Fig
0.25574476.12040019.html.plaintext.txt	180	Similar results obtained three kinase inhibitors using DR1 oligonucleotide probe data shown
0.25574476.12040019.html.plaintext.txt	181	These observations clearly indicate specific inhibition PKC pathway significantly reduces COUP TFI binding distinct response elements raising possibility PKC positively regulate DNA binding activity COUP TFI vivo
0.25574476.12040019.html.plaintext.txt	182	PKC Phosphorylates COUP TFI Vitro Enhances Its Binding Affinity DNA To support previous observations wanted determine PKC could directly target COUP TFI subsequently regulate binding DNA
0.25574476.12040019.html.plaintext.txt	183	The ability purified PKC phosphorylate COUP TFI vitro assessed vitro phosphorylation assays performed bacterially expressed COUP TFI Fig
0.25574476.12040019.html.plaintext.txt	184	The GSTCOUP TFI 57 423 fusion protein incubated absence presence increasing amounts purified PKC
0.25574476.12040019.html.plaintext.txt	185	In reactions 32P ATP used donor phosphate PKC mediated phosphorylation monitored incorporation 32P
0.25574476.12040019.html.plaintext.txt	186	As expected 32P incorporation detected GSTCOUP TFI 57 423 treated absence purified kinase
0.25574476.12040019.html.plaintext.txt	187	In contrast incubation GSTCOUP TFI 57 423 increasing amounts PKC allowed dose dependent incorporation 32P leading gradual appearance band expected molecular weight indicated arrowhead
0.25574476.12040019.html.plaintext.txt	188	Because GST moiety phosphorylated purified PKC data shown see Fig
0.25574476.12040019.html.plaintext.txt	189	7B data show PKC directly specifically phosphorylates COUP TFI one target sites located residues 57 423 vitro
0.25574476.12040019.html.plaintext.txt	190	View larger version 29K Figure 6
0.25574476.12040019.html.plaintext.txt	191	PKC Phosphorylates COUP TFI Vitro Enhances Its Affinity DNA
0.25574476.12040019.html.plaintext.txt	192	Panel A shows dose dependent phosphorylation bacterially expressed COUP TFI purified PKC vitro monitored incorporation 32P
0.25574476.12040019.html.plaintext.txt	193	Glutathione agarose beads containing 250 ng bacterially expressed GSTCOUP TFI 57 423 lanes 1 5 fusion proteins incubated absence lane 1 presence lanes 2 5 increasing amounts 0
0.25574476.12040019.html.plaintext.txt	194	3125 25 ng indicated bottom gel purified PKC 32P ATP 5 microCi
0.25574476.12040019.html.plaintext.txt	195	The samples analyzed SDS PAGE position phosphorylated GSTCOUP TFI 57 423 fusion protein indicated arrowhead
0.25574476.12040019.html.plaintext.txt	196	Panels B C show effects vitro phosphorylation purified PKC COUP TFI DNA binding
0.25574476.12040019.html.plaintext.txt	197	The GST GSTCOUP TFI 57 423 fusion proteins eluted beads 500 ng fusion protein incubated cold ATP absence presence 25 ng purified PKC
0.25574476.12040019.html.plaintext.txt	198	As shown panel B increasing amounts 0
0.25574476.12040019.html.plaintext.txt	199	625 20 ng unphosphorylated GST lane 1 GSTCOUP TFI 57 423 lanes 2 7 vitro phosphorylated GST lane 8 GSTCOUP TFI 57 423 lanes 9 14 incubated 32P labeled double stranded DR1 oligonucleotide
0.25574476.12040019.html.plaintext.txt	200	The autoradiogram shows intensity retarded complex Fig
0.25574476.12040019.html.plaintext.txt	201	The intensity shifted band quantified phosphorimaging normalized corresponding free probe
0.25574476.12040019.html.plaintext.txt	202	Results expressed boundfree probe 100 corresponding binding 20 ng phosphorylated GSTCOUP TFI 57 423 fusion protein Fig
0.25574476.12040019.html.plaintext.txt	203	Panel C shows gel shift experiments run 10 ng GSTCOUP TFI increasing amounts labeled DR 1 probe left side
0.25574476.12040019.html.plaintext.txt	204	For lane bound free probes quantified phosphorimager used calculate Kd shown right side panel C
0.25574476.12040019.html.plaintext.txt	205	View larger version 28K Figure 7
0.25574476.12040019.html.plaintext.txt	206	The Modulation COUP TFI DNA Binding PKC Is Direct Mechanism May Involve Phosphorylation DBD
0.25574476.12040019.html.plaintext.txt	207	Panel A shows SDS PAGE analysis 35S methionine labeled vitro translated full length COUP TFI retained unphosphorylated vitro phosphorylated GST GSTCOUP TFI 57 423 fusion protein
0.25574476.12040019.html.plaintext.txt	208	The input lane lane 1 represents half amount 35S methionine labeled COUP TFI protein used pull assay
0.25574476.12040019.html.plaintext.txt	209	Glutathione agarose beads containing 125 ng bacterially expressed GST lanes 2 3 GSTCOUP TFI 57 423 lanes 4 5 fusion proteins incubated cold ATP absence lanes 2 4 presence lanes 3 5 12
0.25574476.12040019.html.plaintext.txt	210	5 ng purified PKC pull protocol
0.25574476.12040019.html.plaintext.txt	211	Panel B shows vitro phosphorylation bacterially expressed truncated COUP TFI proteins purified PKC monitored incorporation 32P
0.25574476.12040019.html.plaintext.txt	212	Glutathione agarose beads containing 250 ng bacterially expressed GST lane 1 GSTCOUP TFI 1 57 lane 2 GSTCOUP TFI 57 153 lane 3 GSTCOUP TFI 153 423 lanes 4 fusion proteins incubated presence 12
0.25574476.12040019.html.plaintext.txt	213	5 ng purified PKC 32P ATP 5 microCi
0.25574476.12040019.html.plaintext.txt	214	The samples analyzed SDS PAGE
0.25574476.12040019.html.plaintext.txt	215	The positions phosphorylated GSTCOUP TFI 1 57 GSTCOUP TFI 57 153 fusion proteins indicated open gray arrowhead respectively
0.25574476.12040019.html.plaintext.txt	216	In panel C MALDI MS spectra obtained tryptic digestion unphosphorylated upper spectra PKC phosphorylated GSTCOUP TF 57 423 lower spectra shown
0.25574476.12040019.html.plaintext.txt	217	The peaks correponding tryptic peptides 116 NLTYTCR 124 116 NLTYpTCR 124 indicated arrows
0.25574476.12040019.html.plaintext.txt	218	Note spectrum upper right correspond tryptic peptide unphosphorylated sample shown comparison lower right spectrum
0.25574476.12040019.html.plaintext.txt	219	In attempt confirm PKC positively regulates COUP TFI binding DNA vitro phosphorylated GSTCOUP TFI 57 423 fusion protein subsequently submitted EMSA experiments Fig
0.25574476.12040019.html.plaintext.txt	220	In first set experiments increasing amounts unphosphorylated vitro phosphorylated GSTCOUP TFI 57 423 fusion protein incubated labeled double stranded DR1 oligonucleotides Fig
0.25574476.12040019.html.plaintext.txt	221	Independent amount GSTCOUP TFI 57 423 fusion protein used intensity specific shifted band consistently higher phosphorylated protein unphosphorylated counterpart Fig
0.25574476.12040019.html.plaintext.txt	222	The intensity shifted band quantified phosphoimaging normalized corresponding free probe
0.25574476.12040019.html.plaintext.txt	223	Results expressed boundfree probe binding 20 ng phosphorylated GSTCOUP TFI 57 423 fusion protein DR1 oligonucleotide normalized 100
0.25574476.12040019.html.plaintext.txt	224	This analysis confirmed DNA binding ability phosphorylated fusion protein 2 fold greater unphosphorylated protein Fig
0.25574476.12040019.html.plaintext.txt	225	Because data suggested phosphorylation COUP TFI modulated affinity receptor DNA designed gel shift experiments calculate dissociation constant Kd PKC phosphorylated vs
0.25574476.12040019.html.plaintext.txt	226	unphosphorylated COUP TFI 57 423 association DNA
0.25574476.12040019.html.plaintext.txt	227	Ten nanograms recombinant protein incubated increasing amounts DR 1 probe Fig
0.25574476.12040019.html.plaintext.txt	228	After electrophoresis bound probe free probe quantified phosphoimager using Fujifilm FLA 300 Image Gauge 3
0.25574476.12040019.html.plaintext.txt	229	The ratio boundfree probes plotted bound probe concentration allowing calculation Kd COUP TFIDNA interactions
0.25574476.12040019.html.plaintext.txt	230	Linear transformation clearly revealed existence two different protein species differed ability bind DNA PKC modified sample thus generating kink curve
0.25574476.12040019.html.plaintext.txt	231	In specific experiment shown Fig
0.25574476.12040019.html.plaintext.txt	232	6C unphosphorylated COUP TFI Kd value 1
0.25574476.12040019.html.plaintext.txt	233	8 nM PKC modified COUP TFI Kd values 0
0.25574476.12040019.html.plaintext.txt	234	0 nM suggesting phosphorylated form COUP TF interacts DNA binds lowest Kd value
0.25574476.12040019.html.plaintext.txt	235	Such experiments replicated several times different preparations GSTCOUP TFI 57 423 protein
0.25574476.12040019.html.plaintext.txt	236	The average Kd calculated experiments 2
0.25574476.12040019.html.plaintext.txt	237	33 nM n 6 unphosphorylated COUP TI 0
0.25574476.12040019.html.plaintext.txt	238	1 nM n 5 PKC phosphorylated COUP TI
0.25574476.12040019.html.plaintext.txt	239	These data clearly demonstrate COUP TFI directly targeted PKC vitro PKC mediated phosphorylation enhances affinity nuclear receptor DNA approximately 3 fold
0.25574476.12040019.html.plaintext.txt	240	Enhancement COUP TFI DNA Binding Activity PKC Is Direct Mechanism Is Likely Be Mediated Phosphorylation within DBD Having demonstrated COUP TFI 57 423 substrate PKC vitro phosphorylation enhances binding nuclear receptor DNA interest determine whether PKC mediated phosphorylation events affected DNA binding function directly indirectly
0.25574476.12040019.html.plaintext.txt	241	via dimerization function
0.25574476.12040019.html.plaintext.txt	242	The potential effects PKC mediated phosphorylation ability GSTCOUP TFI 57 423 fusion protein retain 35S methionine labeled vitro translated COUP TFI determined GST pull assays Fig
0.25574476.12040019.html.plaintext.txt	243	Bacterially expressed GST GSTCOUP TFI 57 423 fusion proteins treated vitro absence presence purified PKC incubation 35S methionine labeled COUP TFI programmed lysate
0.25574476.12040019.html.plaintext.txt	244	7A unphosphorylated GSTCOUP TFI 57 423 fusion protein retained significant amount 35S methionine labeled COUP TFI compared input lane showing phosphorylation required dimerization nuclear receptor
0.25574476.12040019.html.plaintext.txt	245	In vitro phosphorylation GSTCOUP TFI 57 423 fusion protein purified PKC affect amount labeled COUP TFI retained fusion protein bound glutathione agarose beads Fig
0.25574476.12040019.html.plaintext.txt	246	The PKC induced enhancement DNA binding therefore unlikely result increase ability COUP TFI homodimerize
0.25574476.12040019.html.plaintext.txt	247	To delineate mechanism PKC mediated regulation aimed map functional domains COUP TFI targeted PKC vitro
0.25574476.12040019.html.plaintext.txt	248	COUP TFI functional domain mapping assessed using various truncated bacterially expressed GSTCOUP TFI fusion proteins Fig
0.25574476.12040019.html.plaintext.txt	249	Glutathione agarose beads containing either GST GSTCOUP TFI 1 57 GSTCOUP TFI 57 153 GSTCOUP TFI 153 423 fusion proteins incubated purified PKC presence 32P ATP Fig
0.25574476.12040019.html.plaintext.txt	250	The GST moiety GSTCOUP TFI 153 423 fusion protein phosphorylated purified PKC
0.25574476.12040019.html.plaintext.txt	251	In contrast incorporation 32P observed GSTCOUP TFI 1 57 GSTCOUP TFI 57 153 fusion proteins incubated purified PKC kinase omitted reaction mixture data shown
0.25574476.12040019.html.plaintext.txt	252	The positions specific bands corresponding phosphorylated GSTCOUP TFI 1 57 GSTCOUP TFI 57 153 assessed Coomassie Brilliant blue staining data shown indicated open gray arrowhead respectively Fig
0.25574476.12040019.html.plaintext.txt	253	We therefore conclude multiple functional domains COUP TFI selectively phosphorylated PKC vitro
0.25574476.12040019.html.plaintext.txt	254	Consistent result PKC positively regulates DNA binding activity COUP TFI without affecting dimerization function provide evidence DBD COUP TFI LBD directly targeted PKC
0.25574476.12040019.html.plaintext.txt	255	Mass spectrometry confirmed effect PKC phosphorylation status DBD allowed specifically identify modified amino acid residues Fig
0.25574476.12040019.html.plaintext.txt	256	Phosphorylation S94 S113 could detected experiments mass spectrometry data showed definitively T121 phosphorylated PKC
0.25574476.12040019.html.plaintext.txt	257	Mass spectrometry data indicated posttranslational modified peptide position mass 927
0.25574476.12040019.html.plaintext.txt	258	The spectra showed additional peak 80 Da 1007
0.25574476.12040019.html.plaintext.txt	259	5 indicating phosphorylation modification T121 position
0.25574476.12040019.html.plaintext.txt	260	The presence peaks mz 927
0.25574476.12040019.html.plaintext.txt	261	4 indicates unphosphorylated phosphorylated COUP TFI present PKC action consistent observed gel shift experiments
0.25574476.12040019.html.plaintext.txt	262	These data demonstrate T121 target PKC vitro
0.25574476.12040019.html.plaintext.txt	263	MAPK Directly Targets Distinct Phosphorylation Sites within COUP TFI Vitro Previous results strongly suggested p42MAPKp44MAPK signaling pathway could also involved regulation COUP TFI activity vivo possibly phosphorylation events occurring AB domain
0.25574476.12040019.html.plaintext.txt	264	To investigate hypothesis performed vitro phosphorylation assays determine functional domains COUP TFI could targeted purified MAPK ERK2p42MAPK vitro
0.25574476.12040019.html.plaintext.txt	265	8 GSTCOUP TFI 1 57 open arrowhead GSTCOUP TFI 57 153 gray arrowhead fusion proteins labeled whereas GSTCOUP TFI 153 423 protein incorporate 32P presence purified MAPK
0.25574476.12040019.html.plaintext.txt	266	These data clearly show purified ERK2p42MAPK directly targets COUP TFI vitro least two distinct phosphorylation sites located residues 1 57 57 153 respectively
0.25574476.12040019.html.plaintext.txt	267	In light previous results particularly tempting speculate third putative MAPK phosphorylation site T63 identified within C terminal region AB domain COUP TFI could involved regulation COUP TFI activity MAPK p42MAPKp44MAPK signaling pathway vivo
0.25574476.12040019.html.plaintext.txt	268	View larger version 31K Figure 8
0.25574476.12040019.html.plaintext.txt	269	MAPK Directly Targets COUP TFI Vitro Multiple Phosphorylation Sites
0.25574476.12040019.html.plaintext.txt	270	The ability purified MAPK phosphorylate bacterially expressed truncated COUP TFI proteins vitro monitored incorporation 32P
0.25574476.12040019.html.plaintext.txt	271	Glutathione agarose beads containing 250 ng bacterially expressed GST lane 1 GSTCOUP TFI 1 57 lane 2 GSTCOUP TFI 57 153 lane 3 GSTCOUP TFI 153 423 lane 4 fusion proteins incubated presence 25 ng purified MAPK 32P ATP 5 microCi
0.25574476.12040019.html.plaintext.txt	272	The samples analyzed SDS PAGE positions phosphorylated GSTCOUP TFI 1 57 GSTCOUP TFI 57 153 fusion proteins indicated open gray arrowhead respectively
0.25574476.12040019.html.plaintext.txt	273	Cell Specific Enhancement COUP TFI Transactivation Function Phosphorylation Its Amino Terminal T63 Residue MAPK Pathway Considering treatment specific MAPK inhibitor resulted pronounced decrease COUP TFI mediated transcriptional activation Vn gene promoter vivo see Fig
0.25574476.12040019.html.plaintext.txt	274	3B various experiments completed delineate functions COUP TFI could targeted MAPK mediated phosphorylation events
0.25574476.12040019.html.plaintext.txt	275	Transfection experiments performed COS 7 cells revealed neither deletion AB domain COUP TFI
0.25574476.12040019.html.plaintext.txt	276	deletion residues 1 84 encompassing three conserved putative MAPK target sites treatment cells expressing full length COUP TFI selective MAPK inhibitor modified subcellular distribution nuclear receptor data shown
0.25574476.12040019.html.plaintext.txt	277	Distinct sets experiments demonstrated vivo inhibition MAPK pathway see Fig
0.25574476.12040019.html.plaintext.txt	278	5B vitro phosphorylation purified MAPK data shown affect DNA binding activity COUP TFI specifically targeted PKC
0.25574476.12040019.html.plaintext.txt	279	Our next objective determine whether MAPK mediated phosphorylation could directly regulate transactivation function COUP TFI
0.25574476.12040019.html.plaintext.txt	280	Based results obtained using COS 7 cells Fig
0.25574476.12040019.html.plaintext.txt	281	3B P19 cells data shown showing COUP TFI dependent transcription inhibited deletion AB domain
0.25574476.12040019.html.plaintext.txt	282	deletion residues 1 84 remaining unaffected deletion N terminal region spanning amino acids 1 57 postulated third consensus phosphorylation site T63 identified within sequence COUP TFI could targeted MAPK pathway vivo
0.25574476.12040019.html.plaintext.txt	283	This putative MAPK phosphorylation site therefore inactivated replacement conserved threonine residue nonphosphorylatable alanine residue
0.25574476.12040019.html.plaintext.txt	284	The ability mutated COUP TFI receptor activate Vn gene promoter assessed cotransfection experiments performed COS 7 cells Fig
0.25574476.12040019.html.plaintext.txt	285	Cotransfection increasing amounts wtCOUP TFI expression vector led dose dependent increase Vn Luc reporter gene activity COS 7 cells Fig
0.25574476.12040019.html.plaintext.txt	286	Moreover cellular contexts treatment PD980059 significantly inhibited COUP TFI dependent transcription Fig
0.25574476.12040019.html.plaintext.txt	287	9A mutation third putative MAPK phosphorylation site effect transcriptional activation Vn Luc reporter gene mediated COUP TFI COS 7 cells Fig
0.25574476.12040019.html.plaintext.txt	288	Furthermore mutating third putative MAPK phosphorylation site prevent inhibitory effect MAPK inhibitor Fig
0.25574476.12040019.html.plaintext.txt	289	This sharp contrast results obtained P19 cells
0.25574476.12040019.html.plaintext.txt	290	Indeed cellular context mutation third MAPK phosphorylation site resulted significant decrease transactivation Vn gene promoter COUP TFI Fig
0.25574476.12040019.html.plaintext.txt	291	Furthermore consistent involvement third MAPK phosphorylation site positive regulation COUP TFI transactivation function MAPK pathway P19 cells mutation conserved T63 residue completely abolished effect selective p42MAPKp44MAPK pathway inhibitor COUP TFI dependent transcription Fig
0.25574476.12040019.html.plaintext.txt	292	All together data demonstrate MAPK pathway positively regulates COUP TFI transactivation function context Vn gene promoter cell specific manner
0.25574476.12040019.html.plaintext.txt	293	While regulation likely mediated direct phosphorylation third evolutionarily conserved MAPK target site COUP TFI p42MAPKp44MAPK signaling pathway P19 cells phosphorylation site seem involved modulation COUP TFI transcriptional activity COS 7 cells
0.25574476.12040019.html.plaintext.txt	294	View larger version 31K Figure 9
0.25574476.12040019.html.plaintext.txt	295	Mutation Third Putative Target Site MAPK T63 Located N Terminal Region COUP TFI Inhibits Its Transactivation Function Cell Specific Manner
0.25574476.12040019.html.plaintext.txt	296	The evolutionarily conserved threonine residue T63 third consensus MAPK phosphorylation site identified within N terminal AB domain hCOUP TFI mutated unphosphorylatable alanine residue T63A
0.25574476.12040019.html.plaintext.txt	297	COS 7 cells A P19 cells B cotransfected Vn Luc reporter gene absence presence increasing amounts 6
0.25574476.12040019.html.plaintext.txt	298	25 50 ng indicated pcDNA3 hCOUP TFI pcNDA3 hCOUP TFI T63A expression vectors
0.25574476.12040019.html.plaintext.txt	299	Transfected cells treated selective p42MAPKp44MAPK pathway inhibitor PD980059 50 microM
0.25574476.12040019.html.plaintext.txt	300	Results expressed fold inductions reporter gene activities presence various expression vectors compared activity absence expression vector
0.25574476.12040019.html.plaintext.txt	301	Results shown means plus minus SEM three values obtained representative experiment
0.25574476.12040019.html.plaintext.txt	302	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Among posttranslational modifications phosphorylation frequently occurring potent mechanism rapid modulation transcription factor activity response environmental conditions hormonal signals 50
0.25574476.12040019.html.plaintext.txt	303	Most nuclear receptors studied date phosphoproteins whose functions regulated phosphorylation
0.25574476.12040019.html.plaintext.txt	304	Indeed apart participation conventional hormone dependent activation process phosphorylation mediated ligand independent regulation nuclear receptors activity well documented 33 34
0.25574476.12040019.html.plaintext.txt	305	Despite findings mechanism may ubiquitous indeed GR appears refractory activation absence cognate ligand
0.25574476.12040019.html.plaintext.txt	306	This mode action seems relevant steroidthyroid hormone retinoid receptors well various orphan receptors 33 38 39 40 41
0.25574476.12040019.html.plaintext.txt	307	The identification several putative phosphorylation sites CKII PKC MAPK led us study potential involvement signaling pathways regulation COUP TFI function
0.25574476.12040019.html.plaintext.txt	308	Our data first show COUP TFI phosphoprotein vivo
0.25574476.12040019.html.plaintext.txt	309	Despite observation human COUP TFI sequence contains eight putative target sites CKII data strongly suggest kinase unlikely regulate nuclear receptor activity cellular promoter contexts considered
0.25574476.12040019.html.plaintext.txt	310	In contrast provide evidence involvement PKC MAPK p42MAPKp44MAPK transduction pathways modulation COUP TFI functions vivo
0.25574476.12040019.html.plaintext.txt	311	Focusing PKC pathway demonstrated selective inhibition pathway vivo actively decreases COUP TFI dependent activation Vn gene promoter
0.25574476.12040019.html.plaintext.txt	312	In study provide data clearly show PKC directly targets COUP TFI vitro enhances binding various response elements
0.25574476.12040019.html.plaintext.txt	313	Precedents positive negative regulations DNA binding phosphorylation exist numerous nuclear receptors including ER GR RAR TR2 TRss1 Nur77NGFI B HNF 4
0.25574476.12040019.html.plaintext.txt	314	These regulatory mechanisms yet fully understood highly complex involve wide range protein kinases target sites located within nearby far DBD
0.25574476.12040019.html.plaintext.txt	315	While phosphorylation mediated PKA enhances GR binding DNA 51 kinase shown inhibit binding HNF 4 vitro vivo 40
0.25574476.12040019.html.plaintext.txt	316	Consistent involvement A box high affinity DNA binding HNF 4 52 phosphorylation consensus PKA dependent site located within region results modification receptor binding DNA 40
0.25574476.12040019.html.plaintext.txt	317	Similarly phosphorylation NGFI B within A box also decreases DNA binding 38 39
0.25574476.12040019.html.plaintext.txt	318	In cases reduction DNA binding receptor likely reflect local effect phosphorylations occurring nearby DBD could either induce local conformational change impairing DNA recognition inhibit proteinDNA contacts steric hindrance electrostatically hinder interactions phosphate groups protein similarly charged phosphate backbone DNA
0.25574476.12040019.html.plaintext.txt	319	In contrast phosphorylation TR2 variant thyroid hormone receptor within unique carboxy terminal region mediated CKII decreases binding DNA via mechanism likely involve phosphorylation induced change overall conformation protein 53
0.25574476.12040019.html.plaintext.txt	320	A similar mechanism likely underlie positive regulation exerted CKII binding ER response element involves phosphorylation events occurring amino acid residue located within amino terminal AB domain receptor resulting intramolecular interactions affecting DNA binding domain function 54 55
0.25574476.12040019.html.plaintext.txt	321	In addition direct mechanisms indirect phosphorylation mediated regulations DNA binding also reported often due modulation dimerization interface nuclear receptors phosphorylation events
0.25574476.12040019.html.plaintext.txt	322	For example phosphorylation TRss1 enhances TRss1RXR heterodimerization leading increase DNA binding 56 57
0.25574476.12040019.html.plaintext.txt	323	Such indirect regulation DNA binding also relevant RARRXR heterodimers PKC mediated phosphorylation event serine residue located T box RAR prevents heterodimerization 58 59
0.25574476.12040019.html.plaintext.txt	324	Based finding T box RAR engages dimerization contacts DBD RXR 60 phosphorylation occurring within region may introduce strong conformational constraints dimerization interface thus impairing heterodimerization subsequent DNA binding 58 59
0.25574476.12040019.html.plaintext.txt	325	While PKC shown regulate DNA binding members nuclear receptor superfamily direct indirect mechanisms knowledge evidence PKC mediated positive effects DNA binding member superfamily
0.25574476.12040019.html.plaintext.txt	326	In report demonstrate phosphorylation COUP TFI PKC increases affinity orphan receptor specific DNA elements
0.25574476.12040019.html.plaintext.txt	327	Moreover show enhancement DNA binding result modification ability COUP TFI homodimerize rather appears direct mechanism
0.25574476.12040019.html.plaintext.txt	328	Consistent idea DBD COUP TFI targeted PKC vitro whereas LBD contains major homodimerization surface 61
0.25574476.12040019.html.plaintext.txt	329	Mass spectrometry analysis allowed us ascertain T121 target PKC whereas modifications detected
0.25574476.12040019.html.plaintext.txt	330	Although region spanning amino acids 1 57 also contains least one target site PKC data demonstrate amino terminal AB domain nuclear receptor dispensable DNA binding phosphorylation dependent regulation
0.25574476.12040019.html.plaintext.txt	331	We propose COUP TFI binding DNA positively directly regulated PKC mediated phosphorylation targeting T121 within DNA binding domain receptor
0.25574476.12040019.html.plaintext.txt	332	COUP TFI may integrate multiple signaling pathways considering finding MAPK pathway specifically regulates COUP TFI transactivation function
0.25574476.12040019.html.plaintext.txt	333	While effect nuclear translocation DNA binding function inhibition p42MAPKp44MAPK pathway vivo strongly inhibits COUP TFI mediated transcriptional activation Vn gene promoter
0.25574476.12040019.html.plaintext.txt	334	Moreover showed ERK2p42MAPK directly targets COUP TFI distinct phosphorylation sites vitro
0.25574476.12040019.html.plaintext.txt	335	While LBD phosphorylated MAPK least one target site present amino terminal region AB domain
0.25574476.12040019.html.plaintext.txt	336	amino acids 1 57 COUP TFI
0.25574476.12040019.html.plaintext.txt	337	The functional relevance phosphorylation event vivo remains unclear deletion amino terminal region residue 57 affect subcellular distribution DNA binding activity transactivation function receptor MAPK mediated regulation COUP TFI dependent transcription
0.25574476.12040019.html.plaintext.txt	338	Other phosphorylation sites located residues 57 153 directly targeted ERK2p42MAPK vitro ERK2 mediated phosphorylation event might specifically target T63 vivo shown play active role cell specific transcriptional activation COUP TFI
0.25574476.12040019.html.plaintext.txt	339	Such modulation MAPK mediated phosphorylation could result modifications coactivator recruitment previously reported various nuclear receptors
0.25574476.12040019.html.plaintext.txt	340	Indeed ERss activated Ras dependent MAPK pathway absence cognate ligand via direct phosphorylation within AB domain 62 63
0.25574476.12040019.html.plaintext.txt	341	Recent studies shown phosphorylation MAPK target sites located AF 1 region stimulates ligand AF 2 independent interaction ERss SRC 1 thus allowing ligand independent activation ERss 63
0.25574476.12040019.html.plaintext.txt	342	In addition ERss several authors reported observations functional cross talk growth factors ER signaling pathways absence presence ligand 64 65 66 67 68
0.25574476.12040019.html.plaintext.txt	343	Consistent requirement AF 1 region activation apo form ER response growth factors one serine residue S118 located AB domain ER directly targeted MAPK response EGF phosphorylation events increase AF 1 activity 66 67 68
0.25574476.12040019.html.plaintext.txt	344	The mechanism underlying enhancement recently elucidated involves MAPK dependent recruitment coactivator p68 AF 1 region ER 69
0.25574476.12040019.html.plaintext.txt	345	In addition local effects MAPK pathway intramolecular communication different nuclear receptor domains positively negatively regulate coactivator binding domains distinct ones targeted specific phosphorylation events 70 71
0.25574476.12040019.html.plaintext.txt	346	For example phosphorylation serine residue located within hinge region SF 1 required maximal interaction LBD coactivator GRIP 1 results ligand independent activation SF 1 71
0.25574476.12040019.html.plaintext.txt	347	Similarly MAPK mediated phosphorylation single amino acid residue AB domain PPAR alters overall conformation apo form receptor way impairs ligand binding thereby indirectly preventing recruitment coactivators SRC 1 70
0.25574476.12040019.html.plaintext.txt	348	Thus interdomain communication allows phosphorylation events targeting amino terminal AB domain PPAR regulate independent properties LBD
0.25574476.12040019.html.plaintext.txt	349	This regulatory mechanism involved MAPK mediated inhibition PPAR ligand dependent transactivation function response various growth factors cytokines important repercussions PPAR activity vivo 70 72 73
0.25574476.12040019.html.plaintext.txt	350	Taken together results show MAPK mediated phosphorylation events play crucial roles modulation nuclear receptorcoactivator interactions regulatory mechanism according recent data may also relevant nuclear receptorcorepressor interactions 74 75
0.25574476.12040019.html.plaintext.txt	351	Further experiments tell ERK2 modify COUP TFIcoactivator interactions
0.25574476.12040019.html.plaintext.txt	352	Integration multiple signaling pathways human COUP TFI nuclear receptor would undoubtedly repercussions wide range biological processes involve COUP TFI cellular growth differentiation apoptosis well embryonic development 8 11 13 16 17 31 76
0.25574476.12040019.html.plaintext.txt	353	Results described study indicate possibility variety extracellular stimuli transduced MAPK PKC signaling pathways participate multifactorial regulation diverse biological processes controlled COUP TFI
0.25574476.12040019.html.plaintext.txt	354	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Chemicals Materials The affinity purified rabbit polyclonal anti hemagglutinin HA antibody HA probe Y 11 goat polyclonal anti human h COUP TFI antibody COUP TFI N 19 TEBU Le Perray en Yvelines France
0.25574476.12040019.html.plaintext.txt	355	Klenow fragment Escherichia coli DNA polymerase I CIP T4 DNA polymerase T4 DNA ligase fugene transfection reagent Roche Molecular Biochemicals Mannheim Germany
0.25574476.12040019.html.plaintext.txt	356	The TNT coupled reticulocyte lysate purified PKC Promega Corp
0.25574476.12040019.html.plaintext.txt	357	Recombinant MAPK phosphatidyl serine DRB reduced glutathione glutathione agarose beads protease inhibitors antibiotics Sigma St
0.25574476.12040019.html.plaintext.txt	358	PD980059 2 Amino 3 methoxyflavone GF 109203X Bisindolylmaleimide purchased Calbiochem La Jolla CA
0.25574476.12040019.html.plaintext.txt	359	T4 polynucleotide kinase culture media FCS Life Technologies Inc
0.25574476.12040019.html.plaintext.txt	360	The phosphatase inhibitors okadaic acid sodium orthovanadate Na3VO4 32P ATP 32P deoxy CTP dCTP 32P orthophosphate 35S methionine ICN Pharmaceuticals Inc
0.25574476.12040019.html.plaintext.txt	361	The Luc assay system Promega Corp
0.25574476.12040019.html.plaintext.txt	362	Luc activity measured Dynatech Corp
0.25574476.12040019.html.plaintext.txt	363	luminometer Guyancourt France
0.25574476.12040019.html.plaintext.txt	364	The chemiluminescent substrate protein detection kit Hybond C nitrocellulose membrane Amersham Pharmacia Biotech Orsay France
0.25574476.12040019.html.plaintext.txt	365	Oligonucleotides Oligonucleotides synthesized Genset Oligos Paris France
0.25574476.12040019.html.plaintext.txt	366	Double stranded oligonucleotides used EMSA whereas site directed mutagenesis SDM performed single stranded oligonucleotides exception PKA site pBCGST mutated PCR
0.25574476.12040019.html.plaintext.txt	367	The oligonucleotides used follows DR1 EMSA 5 TCGATGACCTCTGACCCA 3 AP1 EMSA 5 TCGACGCTT GATGACTCAGCCGGAA 3 NR1 EMSA 5 TCGAGGGGTTCTGGGAATGTGACCCTTTGC 3 mutant mNR1 SDM 5 TGCAGCAAAGTTTCACATTCCCAG 3 mNR2 SDM 5 AAAGTCAGTAGTTTCACGGGCAGGA 3 COUP 3m SDM 5 GTGCCGGGGGCGGCGGGCGCT 3 pBCGST PKAm SDM 5 GGTCGTGGGATCAGAAGAGCATGCGTGCATATGGATATC 3
0.25574476.12040019.html.plaintext.txt	368	The double stranded oligonucleotides used gel shift assays end labeled 32P dCTP Klenow fill purified Sephadex G 50 column
0.25574476.12040019.html.plaintext.txt	369	The single stranded oligonucleotides used SDM phosphorylated T4 polynucleotide kinase ATP annealing single stranded DNA templates
0.25574476.12040019.html.plaintext.txt	370	Plasmids The GSTCOUP TFI 1 57 GSTCOUP TFI 57 153 GSTCOUP TFI 153 423 GSTCOUP TFI 57 423 fusion proteins expressed E
0.25574476.12040019.html.plaintext.txt	371	coli isopropyl 1 thio ss D galactopyranoside IPTG induction using pGEX 2T plasmid Amersham Pharmacia Biotech
0.25574476.12040019.html.plaintext.txt	372	The pGEX 2T COUP TFI 1 57 pGEX 2T COUP TFI 57 153 pGEX 2T COUP TFI 153 423 pGEX 2T COUP TFI 57 423 recombinant plasmids contain human COUP TFI coding sequence spanning amino acids 1 57 57 153 153 423 57 423 respectively
0.25574476.12040019.html.plaintext.txt	373	The pcDNA3 hCOUP TFI pcDNA3 hCOUP TFI 57 423 pcDNA3 hCOUP TFI 84 423 expression vectors encode either full length various truncated human COUP TFI constructs fusion proteins HA epitope tag peptide
0.25574476.12040019.html.plaintext.txt	374	The corresponding fragments COUP TFI coding sequence amplified PCR generated enzymatic cleavage first inserted pACT2 vector CLONTECH Laboratories Inc
0.25574476.12040019.html.plaintext.txt	375	Palo Alto CA downstream HA epitope coding sequence introduced pcDNA3 expression vector Invitrogen
0.25574476.12040019.html.plaintext.txt	376	The pcDNA3 hCOUP TFI recombinant plasmid used generate pcDNA3 hCOUP TFI T63A expression vector site directed mutagenesis
0.25574476.12040019.html.plaintext.txt	377	For mammalian GST fusion protein expression PKA site pBCGST 77 first mutated human COUP TFI cDNA lacking coding region corresponding amino acid residues 1 56 inserted HpaI linearized vector
0.25574476.12040019.html.plaintext.txt	378	The p19 Vn Luc Vn Luc reporter plasmid 78 contains 5 flanking region bp 528 47 mouse Vn gene inserted p19 Luc plasmid 79
0.25574476.12040019.html.plaintext.txt	379	For SDM two putative half binding sites nuclear receptors NR1 bp 89 84 NR2 bp 162 157 identified within Vn gene promoter Vn gene promoter insert transferred Bluescript vector Stratagene La Jolla CA contains f1 origin replication therefore allows production single stranded DNA
0.25574476.12040019.html.plaintext.txt	380	The mutated promoter sequences reinserted p19 Luc plasmid generate mNR1 Vn Luc mNR2 Vn Luc mNR1mNR2 Vn Luc recombinant reporter genes
0.25574476.12040019.html.plaintext.txt	381	SDM SDM performed previously described 30 using mNR1 mNR2 oligonucleotides Bluescript Vn construct containing 5 flanking region bp 528 47 murine Vn gene mutate one two putative nuclear receptors half binding sites NR1 NR2 TGACCCTGAAAC identified within promoter
0.25574476.12040019.html.plaintext.txt	382	Similarly COUP 3m oligonucleotide used pcDNA3 hCOUP TFI expression vector encoding full length human COUP TFI receptor fused HA epitope inactivate third consensus phosphorylation site MAPK located N terminal AB domain COUP TFI
0.25574476.12040019.html.plaintext.txt	383	This achieved replacing putative targeted threonine residue T63 nonphosphorylatable alanine residue
0.25574476.12040019.html.plaintext.txt	384	For SDM reactions 1 microg single stranded uracil containing DNA templates prepared annealed corresponding mutagenic primer 10 pmol
0.25574476.12040019.html.plaintext.txt	385	The annealed primer elongated T4 DNA polymerase ligation reaction mixture used transform E
0.25574476.12040019.html.plaintext.txt	386	All resulting point mutations confirmed sequencing
0.25574476.12040019.html.plaintext.txt	387	The two mutated Vn gene promoter inserts transferred p19 Luc reporter plasmid transfection experiments
0.25574476.12040019.html.plaintext.txt	388	The QuikChange site directed mutagenesis kit Stratagene used mutate PKA site S C substitution pBCGST 77
0.25574476.12040019.html.plaintext.txt	389	Generation Proteins The TNT coupled reticulocyte lysate allowed us produce 35S methionine labeled COUP TFI protein used GST pull assay
0.25574476.12040019.html.plaintext.txt	390	Translation efficiencies 35S labeled proteins checked SDS PAGE analysis 2 microl translation products
0.25574476.12040019.html.plaintext.txt	391	The GST GSTCOUP TFI fusion proteins generated using pGEX 2T vector allows bacterial expression IPTG induction
0.25574476.12040019.html.plaintext.txt	392	After IPTG induction cells collected centrifugation 4000 rpm 20 min 4 C
0.25574476.12040019.html.plaintext.txt	393	The supernatant discarded pellet resuspended NETN buffer 20 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	394	5 Nonidet P 40 1 mM phenylmethylsulfonyl fluoride PMSF 10 microgml aprotinin 10 microgml leupeptin 10 microgml pepstatin sonicated twice 30 sec
0.25574476.12040019.html.plaintext.txt	395	The suspension centrifuged 15 min 12000 rpm soluble fraction containing GST fusion proteins incubated overnight 4 C 100 microl glutathione agarose beads prepared stored NETN buffer
0.25574476.12040019.html.plaintext.txt	396	The beads washed twice NETN buffer fraction sample loaded onto SDS 10 polyacrylamide gel analyzed Coomassie Brilliant blue staining
0.25574476.12040019.html.plaintext.txt	397	The bead bound GST fusion proteins collected centrifugation directly used vitro phosphorylation pull assays
0.25574476.12040019.html.plaintext.txt	398	For EMSA fusion proteins eluted beads competition reduced glutathione
0.25574476.12040019.html.plaintext.txt	399	Briefly GST fusion proteins bound beads incubated 10 microl elution buffer Tris HCl 100 mM pH 8 NaCl 120 mM 50 mM reduced glutathione 4 C 30 min
0.25574476.12040019.html.plaintext.txt	400	After centrifugation fraction eluted proteins loaded onto SDS 10 polyacrylamide gel analyzed Coomassie Brilliant blue staining remaining eluted proteins phosphorylated vitro submitted EMSA
0.25574476.12040019.html.plaintext.txt	401	Preparation WCEs Transfected COS 7 cells harvested 36 h transfection PBS collected centrifugation 2000 rpm 4 C 15 min
0.25574476.12040019.html.plaintext.txt	402	Cells resuspended WCE buffer 20 mM HEPES pH 7
0.25574476.12040019.html.plaintext.txt	403	9 2 mM dithiothreitol DTT 20 glycerol 0
0.25574476.12040019.html.plaintext.txt	404	4 M KCl containing 5 microgml aprotinin leupeptin pepstatin 0
0.25574476.12040019.html.plaintext.txt	405	After three cycles freezing 80 C thawing 37 C cellular debris pelleted centrifugation 12000 rpm 15 min 4 C
0.25574476.12040019.html.plaintext.txt	406	The protein concentration supernatant assessed Bradford assay ranged 2 6 microg microl
0.25574476.12040019.html.plaintext.txt	407	These WCEs used EMSA Western blot analysis
0.25574476.12040019.html.plaintext.txt	408	In Vitro Phosphorylation hCOUP TFI For vitro phosphorylation PKC purified rat brain 125 500 ng bacterially expressed GST GSTCOUP TFI fusion proteins bound beads incubated 5 microCi 32P ATP 50 microl phosphorylation buffer 20 mM HEPES pH 7
0.25574476.12040019.html.plaintext.txt	409	7 mM CaCl2 600 microgml phosphatidyl serine 1 mM DTT 50 microM ATP absence presence increasing amounts PKC 3
0.25574476.12040019.html.plaintext.txt	410	For vitro phosphorylation activated recombinant MAPK fusion proteins incubated 5 microCi 32P ATP 50 microl phosphorylation buffer 50 mM Tris HCl pH 8 0
0.25574476.12040019.html.plaintext.txt	411	5 mM EDTA 25 mM MgCl2 1 mM DTT 50 microM ATP 10 glycerol absence presence 25 ng MAPK
0.25574476.12040019.html.plaintext.txt	412	All phosphorylation reactions carried 30 C 30 min presence proteases phosphatases inhibitors 1 microM okadaic acid 200 microM Na3VO4
0.25574476.12040019.html.plaintext.txt	413	The glutathione agarose beads washed twice washing buffer 50 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	414	02 Tween 20 1 mM PMSF 10 microgml aprotinin 10 microgml leupeptin 10 microgml pepstatin solublized 1x SDS loading buffer heated 100 C 5 min
0.25574476.12040019.html.plaintext.txt	415	The vitro phosphorylated proteins resolved SDS 10 polyacrylamide gel dried exposed radiographic film
0.25574476.12040019.html.plaintext.txt	416	For GST pull assay EMSA cold ATP 250 microM added instead 32P ATP donor phosphate
0.25574476.12040019.html.plaintext.txt	417	Mass Spectrometry Purified GSTCOUP TFI phosphorylated PKC Promega Corp
0.25574476.12040019.html.plaintext.txt	418	according manufacturer instructions subjected SDS PAGE
0.25574476.12040019.html.plaintext.txt	419	Samples prepared according Shevchenko et al
0.25574476.12040019.html.plaintext.txt	420	After tryptic digest phosphorylated control samples peptides extracted analyzed matrix assisted laser desorptionionization mass spectrometry using Voyager Biospectrometry Workstation Delayed Extraction Technology PerSeptive Biosystems Inc
0.25574476.12040019.html.plaintext.txt	421	Obtained data analyzed using Moverz software Proteometrics LLC Winnipeg Canada
0.25574476.12040019.html.plaintext.txt	422	GST Pull Down Assay For vitro protein protein interactions 125 250 ng unphosphorylated vitro phosphorylated GSTCOUP TFI fusion proteins bound beads incubated 4 h 4 C 35S methionine labeled vitro translated hCOUP TFI 400 microl binding buffer 50 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	423	02 BSA 1 mM PMSF 10 microgml aprotinin 10 microgml leupeptin 10 microgml pepstatin
0.25574476.12040019.html.plaintext.txt	424	The beads washed washing buffer 50 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	425	02 Tween 20 1 mM PMSF 10 microgml aprotinin 10 microgml leupeptin 10 microgml pepstatin proteins solubilized 1x SDS loading buffer heated 100 C 5 min resolved SDS polyacrylamide gel
0.25574476.12040019.html.plaintext.txt	426	In Vitro Dephosphorylation hCOUP TFI To study potential effect vitro dephosphorylation COUP TFI ability bind DNA human COUP TFI expressed transfected COS 7 cells treated vitro CIP EMSA protocol
0.25574476.12040019.html.plaintext.txt	427	Two micrograms WCEs incubated 2
0.25574476.12040019.html.plaintext.txt	428	5 units CIP 10 microl CIP buffer 10 mM Tris acetate pH 8 10 mM magnesium acetate 50 mM potassium acetate control reactions performed without CIP buffer CIP buffer absence enzyme
0.25574476.12040019.html.plaintext.txt	429	Some incubations also performed absence presence NaPO4 100 mM inhibit CIP activity
0.25574476.12040019.html.plaintext.txt	430	All dephosphorylation reactions carried 25 C 1 h dephosphorylation mixture submitted EMSA protocol
0.25574476.12040019.html.plaintext.txt	431	EMSA EMSA experiments performed WCEs prepared transfected COS 7 cells bacterially expressed COUP TFI proteins
0.25574476.12040019.html.plaintext.txt	432	When WCEs transfected cells treated specific kinase inhibitors used expression levels hCOUP TFI receptor controlled Western blot analysis EMSA
0.25574476.12040019.html.plaintext.txt	433	Two micrograms WCEs COUP TFI expressing COS 7 cells increasing amounts 0
0.25574476.12040019.html.plaintext.txt	434	625 20 ng glutathione agarose beads purified GSTCOUPTFI fusion proteins incubated 20 min room temperature 1 microg poly deoxyinosine deoxycytidine 20 microl binding buffer 20 mM HEPES pH 7
0.25574476.12040019.html.plaintext.txt	435	5 mM MgCl2 10 glycerol incubation samples 0
0.25574476.12040019.html.plaintext.txt	436	2 ng double stranded oligonucleotide labeled 32P dCTP 20000 cpm
0.25574476.12040019.html.plaintext.txt	437	After 20 min room temperature protein DNA complexes resolved 4 polyacrylamide gel 0
0.25574476.12040019.html.plaintext.txt	438	5x TBE 45 mM Tris base 45 mM boric acid 1 mM EDTA
0.25574476.12040019.html.plaintext.txt	439	For Kd calculation 10 ng GSTCOUP TFI 57 423 incubated increasing amounts 32P labeled DR1 double stranded oligonucleotide
0.25574476.12040019.html.plaintext.txt	440	The gels dried autoradiography intensity specific retarded complex assessed phosphoimaging
0.25574476.12040019.html.plaintext.txt	441	In experiments presence hCOUP TFI specific shifted complex controlled supershifting analysis performed 2 microg anti hCOUP TFI antibody
0.25574476.12040019.html.plaintext.txt	442	Western Blot Analysis WCEs 10 30 microg transfected COS 7 cells fractioned SDS PAGE electrotransferred nitrocellulose membrane
0.25574476.12040019.html.plaintext.txt	443	The membrane stained Ponceau S locate molecular weight markers washed PBS containing 0
0.25574476.12040019.html.plaintext.txt	444	All washes incubations performed room temperature
0.25574476.12040019.html.plaintext.txt	445	The nonspecific sites membrane blocked PBS containing 0
0.25574476.12040019.html.plaintext.txt	446	1 Tween 20 1 BSA 5 nonfat milk powder 2 h
0.25574476.12040019.html.plaintext.txt	447	Because human COUP TFI protein expressed transfected cells fused eleven amino acid peptide derived influenza HA protein membrane probed overnight 0
0.25574476.12040019.html.plaintext.txt	448	5 microgml anti HA PBS containing 0
0.25574476.12040019.html.plaintext.txt	449	Immunodetection carried horseradish peroxidase conjugated goat antirabbit antibodies revealed electrochemiluminescence protein detection kit according manufacturer protocol
0.25574476.12040019.html.plaintext.txt	450	Cell Culture Transient Transfection COS 7 P19 cells routinely grown 37 C DMEM containing 10 FCS 100 Uml penicillin 100 microgml streptomycin 25 microgml Amphotericin
0.25574476.12040019.html.plaintext.txt	451	Cells transfected 24 well plates using calcium phosphateDNA method
0.25574476.12040019.html.plaintext.txt	452	Briefly 300 ng recombinant Vn Luc reporter plasmids containing either wt wtVn mutated mNR1 Vn mNR2 Vn mNR1mNR2 Vn gene promoter sequences bp 528 47 cotransfected 150 ng pCH110 control plasmid ss galactosidase expression vector
0.25574476.12040019.html.plaintext.txt	453	25 50 ng per well pcDNA3 expression vectors pcDNA3 hCOUP TFI pcDNA3 hCOUP TFI T63A pcDNA3 hCOUP TFI 57 423 pcDNA3 hCOUP TFI 84 423 cotransfected expression levels proteins checked Western blot analysis
0.25574476.12040019.html.plaintext.txt	454	In wells total amount CMV promoter 100 ng per well total amount DNA 1 microg per well maintained constant addition pcDNA3 Bluescript plasmids respectively
0.25574476.12040019.html.plaintext.txt	455	After 18 h cells washed PBS fresh medium added cells harvested 36 h calcium phosphateDNA precipitate removed
0.25574476.12040019.html.plaintext.txt	456	In experiments specific kinase inhibitors incubated transfected COS 7 cells last 4 h culture MEK12 inhibitor PD98059 Me2SO PKC inhibitor GF109203X Me2SO CK II inhibitor DRB ethanol added medium give final concentration 50 microM 5 microM 50 microM respectively
0.25574476.12040019.html.plaintext.txt	457	The control incubations performed dimethyl sulfoxide Me2SO ethanol instead corresponding protein kinase inhibitor final concentration vehicle experiment never exceeding 0
0.25574476.12040019.html.plaintext.txt	458	After harvesting cells 10 cellular extract used measure Luc activity half remaining extract taken perform ss galactosidase assay
0.25574476.12040019.html.plaintext.txt	459	Luc activities normalized transfection efficiency ss galactosidase activities
0.25574476.12040019.html.plaintext.txt	460	For COUP TFI expression COS 7 cells plated 5 cm diameter petri dishes transfected 5 microg expression plasmid calcium phosphateDNA coprecipitation technique
0.25574476.12040019.html.plaintext.txt	461	After 18 h cells rinsed PBS medium renewed
0.25574476.12040019.html.plaintext.txt	462	In experiments treatment various specific kinase inhibitors performed last 4 h culture conditions described
0.25574476.12040019.html.plaintext.txt	463	To prepare WCEs cells harvested 36 h transfection PBS
0.25574476.12040019.html.plaintext.txt	464	In Vivo Metabolic Labeling COS 7 cells transfected 10 cm dishes fugene reagent pBCGST pBCGST COUP TFI 57 423
0.25574476.12040019.html.plaintext.txt	465	After 36 h cells transferred phosphate free DMEM
0.25574476.12040019.html.plaintext.txt	466	One hour later medium replaced phosphate free DMEM containing 75 microCiml 32P labeled orthophosphate
0.25574476.12040019.html.plaintext.txt	467	This medium left cells 4 h
0.25574476.12040019.html.plaintext.txt	468	Cells washed scraped lysed 20 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	469	3 M NaCl 1 mM EDTA 2 mM DTT 0
0.25574476.12040019.html.plaintext.txt	470	5 NP 40 20 glycerol containing protease inhibitors 10 microgml aprotinin leupeptin pepstatin 0
0.25574476.12040019.html.plaintext.txt	471	The cell lysate incubated overnight 4 C 100 microl 50 glutathione agarose bead suspension binding buffer 50 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	472	5 NP 40 protease inhibitors
0.25574476.12040019.html.plaintext.txt	473	The beads washed twice Washing buffer I 50 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	474	5 NP 40 protease inhibitors twice Washing buffer II 50 mM Tris HCl pH 8
0.25574476.12040019.html.plaintext.txt	475	8 M NaCl 1 NP 40 protease inhibitors
0.25574476.12040019.html.plaintext.txt	476	The proteins bound beads resuspended 1x SDS loading buffer heated 100 C 5 min resolved SDS polyacrylamide gel
0.25574476.12040019.html.plaintext.txt	477	After Coomassie Brilliant blue staining drying gel incorporation 32P monitored autoradiography
0.25574476.12040019.html.plaintext.txt	478	The resulting signal quantified Scion Image software Scion Corp
0.25574476.12040019.html.plaintext.txt	479	Frederick MD normalized corresponding amount purified GST GSTCOUP TFI 53 423 fusion proteins
0.25574476.12040019.html.plaintext.txt	480	ACKNOWLEDGMENTS We thank M
0.25574476.12040019.html.plaintext.txt	481	Pfahl Sidney Kimmel Cancer Center La Jolla CA providing us hCOUP TFI expression vector D
0.25574476.12040019.html.plaintext.txt	482	Loskutoff Scripps Research Institute La Jolla CA gift p19 Vn Luc reporter construct
0.25574476.12040019.html.plaintext.txt	483	FOOTNOTES This work supported grants Ministere de la Recherche et de l Enseignement Centre National de la Recherche Scientifique
0.25574476.12040019.html.plaintext.txt	484	supported fellowships G
0.25574476.12040019.html.plaintext.txt	485	5982 Association pour la Recherche sur le Cancer
0.25574476.12040019.html.plaintext.txt	486	also thank Fondation Langlois financial support
0.25574476.12040019.html.plaintext.txt	487	supported fellowship G
0.25574476.12040019.html.plaintext.txt	488	supported research grant European Union 5th Framework Programme NORTh No
0.25574476.12040019.html.plaintext.txt	489	1 Present address Harvard Medical School Department Pathology WAB 120 200 Longwood Avenue Boston Massachusetts 02115
0.25574476.12040019.html.plaintext.txt	490	2 Present Address European Molecular Biology Laboratory Meyerhofstrasse 1 Postfasch 102209 Heidelberg D 69012 Germany
0.25574476.12040019.html.plaintext.txt	491	Abbreviations CIP Calf intestinal phosphatase CKII casein kinase II COUP TFI chicken ovalbumin upstream promoter transcription factor I DBD DNA binding domain DRB 5 6 dichloro 1 ss D ribofuranosyl benzimidazole dCTP deoxy CTP DTT dithiothreitol E2 estradiol GST glutathione S transferase h human HA hemagglutinin IPTG isopropyl 1 thio ss D galactopyranoside Kd dissociation constant LBD ligand binding domain Luc luciferase m mutant PMSF phenylmethylsulfonyl fluoride NR1 2 nuclear receptor half binding site 1 2 SDM site directed mutagenesis Vn vitronectin WCE whole cell extracts wt wild type
0.25574476.12040019.html.plaintext.txt	492	Received publication April 20 2001
0.25574476.12040019.html.plaintext.txt	493	Accepted publication January 31 2002
0.25574476.12040019.html.plaintext.txt	494	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mangelsdorf DJ Thummel C Beato M Herrlich P Schutz G Umesono K Blumberg B Kastner P Mark M Chambon P 1995 The nuclear receptor superfamily second decade
0.25574476.12040019.html.plaintext.txt	495	Cell 83835 839Medline Giguere V 1999 Orphan nuclear receptors gene function
0.25574476.12040019.html.plaintext.txt	496	Endocr Rev 20689 725AbstractFree Full Text Mlodzik M Hiromi Y Weber U Goodman CS Rubin GM 1990 The Drosophila seven gene member steroid receptor gene superfamily controls photoreceptor cell fates
0.25574476.12040019.html.plaintext.txt	497	Cell 60211 224Medline Ritchie HH Wang LH Tsai SY O Malley BW Tsai MJ 1990 COUP TF gene structure unique steroidthyroid receptor superfamily
0.25574476.12040019.html.plaintext.txt	498	Nucleic Acids Res 186857 6862Abstract Chan SM Xu N Niemeyer CC Bone JR Flytzanis CN 1992 SpCOUP TF sea urchin member steroidthyroid hormone receptor family
0.25574476.12040019.html.plaintext.txt	499	Proc Natl Acad Sci USA 8910568 10572Abstract Matharu PJ Sweeney GE 1992 Cloning sequencing COUP transcription factor gene expressed xenopus embryos
0.25574476.12040019.html.plaintext.txt	500	Biochim Biophys Acta 1129331 334Medline Fjose A Nornes S Weber U Mlodzik M 1993 Functional conservation vertebrate seven related genes neurogenesis eye development
0.25574476.12040019.html.plaintext.txt	501	EMBO J 121403 1414Abstract Jonk LJ de Jonge ME Pals CE Wissink S Vervaart JM Schoorlemmer J Kruijer W 1994 Cloning expression development three murine members COUP family nuclear orphan receptors
0.25574476.12040019.html.plaintext.txt	502	Mech Dev 4781 97CrossRefMedline Fjose A Weber U Mlodzik M 1995 A novel vertebrate svp related nuclear receptor expressed step gradient developing rhombomeres affected retinoic acid
0.25574476.12040019.html.plaintext.txt	503	Mech Dev 52233 246CrossRefMedline Qiu Y Krishnan V Zeng Z Gilbert DJ Copeland NG Gibson L Yang Feng T Jenkins NA Tsai MJ Tsai SY 1995 Isolation characterization chromosomal localization mouse human COUP TF I II genes
0.25574476.12040019.html.plaintext.txt	504	Genomics 29240 246CrossRefMedline Qiu Y Cooney AJ Kuratani S DeMayo FJ Tsai SY Tsai MJ 1994 Spatiotemporal expression patterns chicken ovalbumin upstream promoter transcription factors developing mouse central nervous system evidence role segmental patterning diencephalon
0.25574476.12040019.html.plaintext.txt	505	Proc Natl Acad Sci USA 914451 4455Abstract Lopes da Silva S Cox JJ Jonk LJ Kruijer W Burbach JP 1995 Localization transcripts related nuclear orphan receptors COUP TF I ARP 1 adult mouse brain
0.25574476.12040019.html.plaintext.txt	506	Brain Res Mol Brain Res 30131 136CrossRefMedline Pereira FA Qiu Y Tsai MJ Tsai SY 1995 Chicken ovalbumin upstream promoter transcription factor COUP TF expression mouse embryogenesis
0.25574476.12040019.html.plaintext.txt	507	J Steroid Biochem Mol Biol 53503 508CrossRefMedline Hiromi Y Mlodzik M West SR Rubin GM Goodman CS 1993 Ectopic expression seven causes cell fate changes ommatidial assembly
0.25574476.12040019.html.plaintext.txt	508	Development 1181123 1135AbstractFree Full Text Schuh TJ Kimelman D 1995 COUP TFI potential regulator retinoic acid modulated development Xenopus embryos
0.25574476.12040019.html.plaintext.txt	509	Mech Dev 5139 49CrossRefMedline Qiu Y Pereira FA DeMayo FJ Lydon JP Tsai SY Tsai MJ 1997 Null mutation mCOUP TFI results defects morphogenesis glossopharyngeal ganglion axonal projection arborization
0.25574476.12040019.html.plaintext.txt	510	Genes Dev 111925 1937AbstractFree Full Text Zhou C Qiu Y Pereira FA Crair MC Tsai SY Tsai MJ 1999 The nuclear orphan receptor COUP TFI required differentiation subplate neurons guidance thalamocortical axons
0.25574476.12040019.html.plaintext.txt	511	Neuron 24847 859Medline Pereira FA Qiu Y Zhou G Tsai MJ Tsai SY 1999 The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.25574476.12040019.html.plaintext.txt	512	Genes Dev 131037 1049AbstractFree Full Text Pastorcic M Wang H Elbrecht A Tsai SY Tsai MJ O Malley BW 1986 Control transcription initiation vitro requires binding transcription factor distal promoter ovalbumin gene
0.25574476.12040019.html.plaintext.txt	513	Mol Cell Biol 62784 2791Medline Sagami I Tsai SY Wang H Tsai MJ O Malley BW 1986 Identification two factors required transcription ovalbumin gene
0.25574476.12040019.html.plaintext.txt	514	Mol Cell Biol 64259 4267Medline Wang LH Tsai SY Cook RG Beattie WG Tsai MJ O Malley BW 1989 COUP transcription factor member steroid receptor superfamily
0.25574476.12040019.html.plaintext.txt	515	Nature 340163 166CrossRefMedline Ladias JA Karathanasis SK 1991 Regulation apolipoprotein AI gene ARP 1 novel member steroid receptor superfamily
0.25574476.12040019.html.plaintext.txt	516	Science 251561 565Medline Cooney AJ Tsai SY O Malley BW Tsai MJ 1992 Chicken ovalbumin upstream promoter transcription factor COUP TF dimers bind different GGTCA response elements allowing COUP TF repress hormonal induction vitamin D3 thyroid hormone retinoic acid receptors
0.25574476.12040019.html.plaintext.txt	517	Mol Cell Biol 124153 4163Abstract Kliewer SA Umesono K Heyman RA Mangelsdorf DJ Dyck JA Evans RM 1992 Retinoid X receptor COUP TF interactions modulate retinoic acid signaling
0.25574476.12040019.html.plaintext.txt	518	Proc Natl Acad Sci USA 891448 1452Abstract Tran P Zhang XK Salbert G Hermann T Lehmann JM Pfahl M 1992 COUP orphan receptors negative regulators retinoic acid response pathways
0.25574476.12040019.html.plaintext.txt	519	Mol Cell Biol 124666 4676Abstract Widom RL Ladias JA Kouidou S Karathanasis SK 1991 Synergistic interactions transcription factors control expression apolipoprotein AI gene liver cells
0.25574476.12040019.html.plaintext.txt	520	Mol Cell Biol 11677 687Medline Neuman K Soosaar A Nornes HO Neuman T 1995 Orphan receptor COUP TF I antagonizes retinoic acid induced neuronal differentiation
0.25574476.12040019.html.plaintext.txt	521	J Neurosci Res 4139 48Medline Van der Wees J Matharu PJ de Roos K Destree OH Godsave SF Durston AJ Sweeney GE 1996 Developmental expression differential regulation retinoic acid xenopus COUP TF A COUP TF B
0.25574476.12040019.html.plaintext.txt	522	Mech Dev 54173 184CrossRefMedline Hall RK Sladek FM Granner DK 1995 The orphan receptors COUP TF HNF 4 serve accessory factors required induction phosphoenolpyruvate carboxykinase gene transcription glucocorticoids
0.25574476.12040019.html.plaintext.txt	523	Proc Natl Acad Sci USA 92412 416Abstract Lazennec G Kern L Valotaire Y Salbert G 1997 The nuclear orphan receptors COUP TF ARP 1 positively regulate trout estrogen receptor gene enhancing autoregulation
0.25574476.12040019.html.plaintext.txt	524	Mol Cell Biol 175053 5066Abstract Lin B Chen GQ Xiao D Kolluri SK Cao X Su H Zhang XK 2000 Orphan receptor COUP TF required induction retinoic acid receptor ss growth inhibition apoptosis retinoic acid cancer cells
0.25574476.12040019.html.plaintext.txt	525	Mol Cell Biol 20957 970AbstractFree Full Text Luo J Sucov HM Bader JA Evans RM Giguere V 1996 Compound mutants retinoic acid receptor RAR ssand RAR 1 reveal developmental functions multiple RAR ss isoforms
0.25574476.12040019.html.plaintext.txt	526	Mech Dev 5533 44CrossRefMedline Weigel NL Zhang Y 1998 Ligand independent activation steroid hormone receptors
0.25574476.12040019.html.plaintext.txt	527	J Mol Med 76469 479CrossRefMedline Weigel NL 1996 Steroid hormone receptors regulation phosphorylation
0.25574476.12040019.html.plaintext.txt	528	Biochem J 319 657 667 Chen D Pace PE Coombes RC Ali S 1999 Phosphorylation human estrogen receptor protein kinase A regulates dimerization
0.25574476.12040019.html.plaintext.txt	529	Mol Cell Biol 191002 1015AbstractFree Full Text Rogatsky I Trowbridge JM Garabedian MJ 1999 Potentiation human estrogen receptor alpha transcriptional activation phosphorylation serines 104 106 cyclin A CDK2 complex
0.25574476.12040019.html.plaintext.txt	530	J Biol Chem 27422296 22302AbstractFree Full Text Chen D Riedl T Washbrook E Pace PE Coombes RC Egly JM Ali S 2000 Activation estrogen receptor S118 phosphorylation involves ligand dependent interaction TFIIH participation CDK7
0.25574476.12040019.html.plaintext.txt	531	Mol Cell 6127 137Medline Hirata Y Kiuchi K Chen HC Milbrandt J Guroff G 1993 The phosphorylation DNA binding DNA binding domain orphan nuclear receptor NGFI B
0.25574476.12040019.html.plaintext.txt	532	J Biol Chem 26824808 24812AbstractFree Full Text Li Y Lau LF 1997 Adrenocorticotropic hormone regulates activities orphan nuclear receptor Nur77 modulation phosphorylation
0.25574476.12040019.html.plaintext.txt	533	Endocrinology 1384138 4146AbstractFree Full Text Viollet B Kahn A Raymondjean M 1997 Protein kinase A dependent phosphorylation modulates DNA binding activity hepatocyte nuclear factor 4
0.25574476.12040019.html.plaintext.txt	534	Mol Cell Biol 174208 4219Abstract Kane CD Means AR 2000 Activation orphan receptor mediated transcription Ca2calmodulin dependent protein kinase IV
0.25574476.12040019.html.plaintext.txt	535	EMBO J 19691 701AbstractFree Full Text Adam F Sourisseau T Metivier R Le Page Y Desbois C Michel D Salbert G 2000 COUP TFI chicken ovalbumin upstream promoter transcription factor I regulates cell migration axogenesis differentiating P19 embryonal carcinoma cells
0.25574476.12040019.html.plaintext.txt	536	Mol Endocrinol 141918 1933AbstractFree Full Text Power SC Cereghini S 1996 Positive regulation vHNF1 promoter orphan receptors COUP TFIEar3 COUP TFIIArp1
0.25574476.12040019.html.plaintext.txt	537	Mol Cell Biol 16778 791Abstract Pinna LA 1990 Casein kinase 2 eminence grise cellular regulation
0.25574476.12040019.html.plaintext.txt	538	Biochim Biophys Acta 1054267 284Medline Kishimoto A Nishiyama K Nakanishi H Uratsuji Y Nomura H Takeyama Y Nishizuka Y 1985 Studies phosphorylation myelin basic protein protein kinase C adenosine 35 monophosphate dependent protein kinase
0.25574476.12040019.html.plaintext.txt	539	J Biol Chem 26012492 12499AbstractFree Full Text Gonzalez FA Raden DL Davis RJ 1991 Identification substrate recognition determinants human ERK1 ERK2 protein kinases
0.25574476.12040019.html.plaintext.txt	540	J Biol Chem 26622159 22163AbstractFree Full Text Davis RJ 1994 MAPKs new JNK expands group
0.25574476.12040019.html.plaintext.txt	541	Trends Biochem Sci 19470 473CrossRefMedline Marshall CJ 1995 Specificity receptor tyrosine kinase signaling transient vs
0.25574476.12040019.html.plaintext.txt	542	sustained extracellular signal regulated kinase activation
0.25574476.12040019.html.plaintext.txt	543	Cell 80179 185Medline Raingeaud J Gupta S Rogers JS Dickens M Han J Ulevitch RJ Davis RJ 1995 Pro inflammatory cytokines environmental stress cause p38 mitogen activated protein kinase activation dual phosphorylation tyrosine threonine
0.25574476.12040019.html.plaintext.txt	544	J Biol Chem 2707420 7426AbstractFree Full Text Hunter T Karin M 1992 The regulation transcription phosphorylation
0.25574476.12040019.html.plaintext.txt	545	Cell 70375 387Medline Rangarajan PN Umesono K Evans RM 1992 Modulation glucocorticoid receptor function protein kinase A
0.25574476.12040019.html.plaintext.txt	546	Mol Endocrinol 61451 1457Abstract Jiang G Sladek FM 1997 The DNA binding domain hepatocyte nuclear factor 4 mediates cooperative specific binding DNA heterodimerization retinoid X receptor
0.25574476.12040019.html.plaintext.txt	547	J Biol Chem 2721218 1225AbstractFree Full Text Katz D Reginato MJ Lazar MA 1995 Functional regulation thyroid hormone receptor variant TR 2 phosphorylation
0.25574476.12040019.html.plaintext.txt	548	Mol Cell Biol 152341 2348Abstract Arnold SF Obourn JD Jaffe H Notides AC 1995 Phosphorylation human estrogen receptor mitogen activated protein kinase casein kinase II consequence DNA binding
0.25574476.12040019.html.plaintext.txt	549	J Steroid Biochem Mol Biol 55163 172CrossRefMedline Castano E Vorojeikina DP Notides AC 1997 Phosphorylation serine 167 human oestrogen receptor important oestrogen response element binding transcriptional activation
0.25574476.12040019.html.plaintext.txt	550	Biochem J 326149 157Medline Lin KH Ashizawa K Cheng SY 1992 Phosphorylation stimulates transcriptional activity human ss 1 thyroid hormone nuclear receptor
0.25574476.12040019.html.plaintext.txt	551	Proc Natl Acad Sci USA 897737 7741Abstract Bhat MK Ashizawa K Cheng SY 1994 Phosphorylation enhances target gene sequence dependent dimerization thyroid hormone receptor retinoid X receptor
0.25574476.12040019.html.plaintext.txt	552	Proc Natl Acad Sci USA 917927 7931Abstract Tahayato A Lefebvre P Formstecher P Dautrevaux M 1993 A protein kinase C dependent activity modulates retinoic acid induced transcription
0.25574476.12040019.html.plaintext.txt	553	Mol Endocrinol 71642 1653Abstract Delmotte MH Tahayato A Formstecher P Lefebvre P 1999 Serine 157 retinoic acid receptor residue phosphorylated protein kinase C vitro involved RXR
0.25574476.12040019.html.plaintext.txt	554	RAR heterodimerization transcriptional activity
0.25574476.12040019.html.plaintext.txt	555	J Biol Chem 27438225 38231AbstractFree Full Text Rastinejad F Perlmann T Evans RM Sigler PB 1995 Structural determinants nuclear receptor assembly DNA direct repeats
0.25574476.12040019.html.plaintext.txt	556	Nature 375203 211CrossRefMedline Perlmann T Umesono K Rangarajan PN Forman BM Evans RM 1996 Two distinct dimerization interfaces differentially modulate target gene specificity nuclear hormone receptors
0.25574476.12040019.html.plaintext.txt	557	Mol Endocrinol 10958 966Abstract Tremblay GB Tremblay A Copeland NG Gilbert DJ Jenkins NA Labrie F Giguere V 1997 Cloning chromosomal localization functional analysis murine estrogen receptor ss
0.25574476.12040019.html.plaintext.txt	558	Mol Endocrinol 11353 365AbstractFree Full Text Tremblay A Tremblay GB Labrie F Giguere V 1999 Ligand independent recruitment SRC 1 estrogen receptor ss phosphorylation activation function AF 1
0.25574476.12040019.html.plaintext.txt	559	Mol Cell 3513 519Medline Ali S Metzger D Bornert JM Chambon P 1993 Modulation transcriptional activation ligand dependent phosphorylation human oestrogen receptor AB region
0.25574476.12040019.html.plaintext.txt	560	EMBO J 121153 1160Abstract Kato S Endoh H Masuhiro Y Kitamoto T Uchiyama S Sasaki H Masushige S Gotoh Y Nishida E Kawashima H Metzger D Chambon P 1995 Activation estrogen receptor phosphorylation mitogen activated protein kinase
0.25574476.12040019.html.plaintext.txt	561	Science 2701491 1494Abstract Bunone G Briand PA Miksicek RJ Picard D 1996 Activation unliganded estrogen receptor EGF involves MAP kinase pathway direct phosphorylation
0.25574476.12040019.html.plaintext.txt	562	EMBO J 152174 2183Abstract El Tanani MK Green CD 1997 Two separate mechanisms ligand independent activation estrogen receptor
0.25574476.12040019.html.plaintext.txt	563	Mol Endocrinol 11928 937AbstractFree Full Text Smith CL 1998 Cross talk peptide growth factor estrogen receptor signaling pathways
0.25574476.12040019.html.plaintext.txt	564	Biol Reprod 58627 632Abstract Endoh H Maruyama K Masuhiro Y Kobayashi Y Goto M Tai H Yanagisawa J Metzger D Hashimoto S Kato S 1999 Purification identification p68 RNA helicase acting transcriptional coactivator specific activation function 1 human estrogen receptor
0.25574476.12040019.html.plaintext.txt	565	Mol Cell Biol 195363 5372AbstractFree Full Text Shao D Rangwala SM Bailey ST Krakow SL Reginato MJ Lazar MA 1998 Interdomain communication regulating ligand binding PPAR
0.25574476.12040019.html.plaintext.txt	566	Nature 396377 380CrossRefMedline Hammer GD Krylova I Zhang Y Darimont BD Simpson K Weigel NL Ingraham HA 1999 Phosphorylation nuclear receptor SF 1 modulates cofactor recruitment integration hormone signaling reproduction stress
0.25574476.12040019.html.plaintext.txt	567	Mol Cell 3521 526Medline Hu E Kim JB Sarraf P Spiegelman BM 1996 Inhibition adipogenesis MAP kinase mediated phosphorylation PPAR
0.25574476.12040019.html.plaintext.txt	568	Science 2742100 2103AbstractFree Full Text Adams M Reginato MJ Shao D Lazar MA Chatterjee VK 1997 Transcriptional activation peroxisome proliferator activated receptor inhibited phosphorylation consensus mitogen activated protein kinase site
0.25574476.12040019.html.plaintext.txt	569	J Biol Chem 2725128 5132AbstractFree Full Text Lavinsky RM Jepsen K Heinzel T Torchia J Mullen TM Schiff R Del Rio AL Ricote M Ngo S Gemsch J Hilsenbeck SG Osborne CK Glass SK Rosenfeld MG Rose DW 1998 Diverse signaling pathways modulate nuclear receptor recruitment N CoR SMRT complexes
0.25574476.12040019.html.plaintext.txt	570	Proc Natl Acad Sci USA 952920 2925AbstractFree Full Text Juge Aubry CE Hammar E Siegrist Kaiser C Pernin A Takeshita A Chin WW Burger AG Meier CA 1999 Regulation transcriptional activity peroxisome proliferator activated receptor phosphorylation ligand independent trans activating domain
0.25574476.12040019.html.plaintext.txt	571	J Biol Chem 27410505 10510AbstractFree Full Text Lu XP Salbert G Pfahl M 1994 An evolutionary conserved COUP TF binding element neural specific gene COUP TF expression patterns support major role COUP TF neural development
0.25574476.12040019.html.plaintext.txt	572	Mol Endocrinol 81774 1788Abstract Chatton B Bahr A Acker J Kedinger C 1995 Eukaryotic GST fusion vector study protein protein associations vivo application interaction ATFa Jun Fos
0.25574476.12040019.html.plaintext.txt	573	BioTechniques 18142 145Medline Seiffert D Curriden SA Jenne D Binder BR Loskutoff DJ 1996 Differential regulation vitronectin mice humans vitro
0.25574476.12040019.html.plaintext.txt	574	J Biol Chem 2715474 5480AbstractFree Full Text Van Zonneveld AJ Curriden SA Loskutoff DJ 1988 Type 1 plasminogen activator inhibitor gene functional analysis glucocorticoid regulation promoter
0.25574476.12040019.html.plaintext.txt	575	Proc Natl Acad Sci USA 855525 5529Abstract Shevchenko A Chernushevich I Wilm M Mann M 2000 De Novo peptide sequencing nanoelectrospray tandem mass spectrometry using triple quadrupole quadrupoletime flight instruments
0.25574476.12040019.html.plaintext.txt	576	Methods Mol Biol 1461 16Medline
0.21701698.10098492.html.plaintext.txt	0	A Corepressor Chicken Ovalbumin Upstream Promoter Transcriptional Factor Proteins Modulate Peroxisome Proliferator Activated Receptor 2Retinoid X Receptor Activated Transcription Murine Lipoprotein Lipase Promoter1 Claudius E
0.21701698.10098492.html.plaintext.txt	1	Robinson Xiying Wu2 Zafar Nawaz Sergio A
0.21701698.10098492.html.plaintext.txt	2	Zoology Department University Oklahoma C
0.21701698.10098492.html.plaintext.txt	3	Norman Oklahoma 73019 Departments Surgery X
0.21701698.10098492.html.plaintext.txt	4	University Oklahoma Health Sciences Center Oklahoma City Oklahoma 73190 Department Cell Biology Baylor College Medicine Z
0.21701698.10098492.html.plaintext.txt	5	Address correspondence requests reprints Jeffrey M
0.21701698.10098492.html.plaintext.txt	6	Department Surgery University Oklahoma Health Sciences Center P
0.21701698.10098492.html.plaintext.txt	7	Box 26901 Oklahoma City Oklahoma 73190
0.21701698.10098492.html.plaintext.txt	8	E mail jeffrey gimbleatouhsc
0.21701698.10098492.html.plaintext.txt	9	Abstract Top Abstract Introduction Materials Methods Results Discussion References Complex physiological stimuli differentially regulate tissue specific transcription lipoprotein lipase LPL gene
0.21701698.10098492.html.plaintext.txt	10	A conserved DNA recognition element 171 149 bp within promoter functions transcriptional enhancer bound peroxisome proliferator activated receptor 2 PPAR2retinoid X receptor RXR heterodimer serves transcriptional silencer presence unidentified double single stranded DNA binding proteins
0.21701698.10098492.html.plaintext.txt	11	To address apparent paradox current study examined effect two classes candidate comodulatory proteins COUP TF chicken ovalbumin upstream promoter transcriptional factor corepressor SMRT silencing mediator retinoic acid receptor thyroid receptor
0.21701698.10098492.html.plaintext.txt	12	The expression COUP TF detected Western Northern blots preadipocyte 3T3 L1 cell model periods corresponding increased LPL transcription
0.21701698.10098492.html.plaintext.txt	13	Cotransfection COUP TF expression constructs renal epithelial 293T cell line significantly increased transcription LPL promoter synergy PPAR2RXR heterodimers
0.21701698.10098492.html.plaintext.txt	14	The COUP TFII ARP 1 protein specifically bound LPL PPAR recognition element electromobility shift assays interacted directly ligand binding domain PPAR pull experiments
0.21701698.10098492.html.plaintext.txt	15	In contrast cotransfection SMRT repressed PPAR2RXR mediated LPL transcription absence presence COUP TFII ARP 1
0.21701698.10098492.html.plaintext.txt	16	The interaction PPAR2 SMRT localized receptor interactive domain 2 amino acids 1260 1495 SMRT protein based cotransfection pull assays
0.21701698.10098492.html.plaintext.txt	17	These vitro data indicate COUP TF proteins SMRT modulate PPAR mediated LPL transcription 293T cell line
0.21701698.10098492.html.plaintext.txt	18	Introduction Top Abstract Introduction Materials Methods Results Discussion References LIPOPROTEIN lipase LPL EC 3
0.21701698.10098492.html.plaintext.txt	19	34 enzyme hydrolyzes triglycerides FFA 1
0.21701698.10098492.html.plaintext.txt	20	It responsible clearance chylomicrons circulation dysregulation contributes cardiovascular disease 1
0.21701698.10098492.html.plaintext.txt	21	A multitude hormonal cytokine cues account complex physiological expression LPL mammary epithelial cells macrophages hepatocytes adipocytes 1
0.21701698.10098492.html.plaintext.txt	22	Nuclear hormone receptor ligands thiazolidinediones peroxisome proliferator activated receptors PPARs hydrocortisone glucocorticoid receptor induce LPL transcription whereas proinflammatory cytokines tumor necrosis factor inhibitory 1
0.21701698.10098492.html.plaintext.txt	23	These actions mediated specific DNA recognition elements located within LPL promoter
0.21701698.10098492.html.plaintext.txt	24	Recent studies determined peroxisome proliferator activated receptor 2 PPAR2retinoid X receptor RXR heterodimer binds murine human LPL promoters 171 149 bp relative transcriptional start site 2 3 identical sequence conserved rat LPL promoter 4
0.21701698.10098492.html.plaintext.txt	25	In cotransfection analyses performed 293T cell line PPAR2RXR binding murine LPL promoter increased reporter gene expression 13 fold absence exogenous ligand 2
0.21701698.10098492.html.plaintext.txt	26	5 fold induction upon addition thiazolidinediones demonstrating PPAR recognition element PPRE acts enhancer 3
0.21701698.10098492.html.plaintext.txt	27	However independent transfection studies performed HeLa cells associated identical sequence element 169 151 bp human LPL promoter silencer function 5
0.21701698.10098492.html.plaintext.txt	28	This repressor activity attributed unknown double single stranded DNA binding proteins 5
0.21701698.10098492.html.plaintext.txt	29	Two classes proteins could account paradoxical association single PPRE enhancer silencer activities
0.21701698.10098492.html.plaintext.txt	30	One class chicken ovalbumin upstream promoter transcription factor COUP TF family includes COUP TFI erbA related protein 3 EAR3 COUP TFII apolipoprotein AI regulatory protein 1 ARP 1 EAR2 6 7 8
0.21701698.10098492.html.plaintext.txt	31	The COUP TF proteins bind nuclear receptor recognition elements separated single nucleotide DR1 similar recognized PPAR proteins 7 9
0.21701698.10098492.html.plaintext.txt	32	The COUP TF proteins associated repression reviewed Ref
0.21701698.10098492.html.plaintext.txt	33	8 activation 8 10 11 12 13 promoters regulated nuclear hormone receptors
0.21701698.10098492.html.plaintext.txt	34	The COUP TF proteins expressed number tissues including preadipocytes 8 14
0.21701698.10098492.html.plaintext.txt	35	A second class candidate proteins recently described corepressors 15 16
0.21701698.10098492.html.plaintext.txt	36	These proteins interact directly nuclear hormone receptors absence ligand repress transcriptional activation promoters regulated nuclear hormone receptors 15 16
0.21701698.10098492.html.plaintext.txt	37	The messenger RNAs mRNAs silencing mediator retinoic acid thyroid hormone receptor SMRT nuclear corepressor N CoR expressed ubiquitously tissues examined well 293 HeLa 3T3 cell lines 17
0.21701698.10098492.html.plaintext.txt	38	Although PPAR2RXR heterodimer found bind strongly SMRT N CoR solution interactions DNA reported weak SMRT nonexistent N CoR 18
0.21701698.10098492.html.plaintext.txt	39	In cotransfection analyses performed 293T cells SMRT exhibited less 2 fold repression acyl coenzyme A oxidase PPRE presence PPAR whereas N CoR significant effect 18
0.21701698.10098492.html.plaintext.txt	40	This led conclusion weak binding PPAR corepressors DNA resulted inability protein complex repress transcription acyl coenzyme A oxidase PPRE however ability PPAR interact corepressor solution raised possibility PPAR could repress transcription sites cell types 18
0.21701698.10098492.html.plaintext.txt	41	This study set investigate modulatory effects COUP TF family members SMRT PPAR2RXR mediated transcriptional activation murine LPL promoter
0.21701698.10098492.html.plaintext.txt	42	The data demonstrate COUP TF proteins potentiated PPAR2RXR mediated transcriptional activation 293T cells
0.21701698.10098492.html.plaintext.txt	43	In contrast SMRT repressed PPAR2RXR mediated transcription LPL promoter independent presence COUP TFII ARP 1
0.21701698.10098492.html.plaintext.txt	44	Materials Methods Top Abstract Introduction Materials Methods Results Discussion References Materials All reagents obtained Sigma Chemical Co
0.21701698.10098492.html.plaintext.txt	45	Louis MO Fisher Scientific International Inc
0.21701698.10098492.html.plaintext.txt	46	Dallas TX unless noted otherwise
0.21701698.10098492.html.plaintext.txt	47	Plasmids Constructs containing varying segments wild type murine LPL promoter linked luciferase reporter gene prepared p19Luc vector provided D
0.21701698.10098492.html.plaintext.txt	48	Helinski University California San Diego La Jolla CA 19 previously described 3
0.21701698.10098492.html.plaintext.txt	49	The pEF BOS plasmid 20 used prepare eukaryotic expression vectors containing following complementary DNAs cDNAs murine PPAR2 21 murine RXR 22 provided R
0.21701698.10098492.html.plaintext.txt	50	Evans The Salk Institute La Jolla CA human COUP TFII ARP 1 23 human COUP TFI EAR 3 human EAR 2 24 human cDNAs provided J
0.21701698.10098492.html.plaintext.txt	51	Ladias Beth Israel Hospital Boston MA
0.21701698.10098492.html.plaintext.txt	52	The pABgal vector used prepare eukarytoic expression constructs containing cDNAs encoding following amino acids human SMRT protein full length construct 1 1495 29 564 565 1289 565 1495
0.21701698.10098492.html.plaintext.txt	53	The pT7 vector used prepare bacterial expression constructs encoding following amino acids human SMRT protein full length construct 1 1495 29 564 565 1289 565 1495 1192 1495 25
0.21701698.10098492.html.plaintext.txt	54	The pBluescript SKII vector used prepare human COUP TFII ARP 1 26 bacterial expression construct full length cDNA inserted EcoRI site polylinker T7 promoter
0.21701698.10098492.html.plaintext.txt	55	The bacterial expression vector pGEX2T containing glutathione S transferase GST PPAR1 ligand binding domain fusion protein amino acids 174 475 provided S
0.21701698.10098492.html.plaintext.txt	56	Kliewer GlaxoWellcome Research Triangle Park NC 21 used prepare PPAR ligand binding domain GST fusion protein
0.21701698.10098492.html.plaintext.txt	57	Transient transfections The human embryonic kidney cell line 293T 27 provided K
0.21701698.10098492.html.plaintext.txt	58	Oritani Oklahoma Medical Research Foundation Oklahoma City OK maintained DMEM supplemented 10 FBS HyClone Laboratories Inc
0.21701698.10098492.html.plaintext.txt	59	Logan UT 100 Uml penicillin 100 microgml streptomycin
0.21701698.10098492.html.plaintext.txt	60	A total 8 x 104 cells 2 ml volume plated 35 mm dishes 18 h transfection
0.21701698.10098492.html.plaintext.txt	61	A calcium phosphateDNA coprecipitate prepared mixing 83 microl 1 mM Tris HCl pH 8
0.21701698.10098492.html.plaintext.txt	62	0 containing 12 microg DNA 12
0.21701698.10098492.html.plaintext.txt	63	5 microl 2 x HEPES buffered saline 280 mM NaCl 10 mM KCl 1
0.21701698.10098492.html.plaintext.txt	64	5 mM Na2PO4 12 mM dextrose 50 mM HEPES pH 7
0.21701698.10098492.html.plaintext.txt	65	After 25 min entire volume added cells fresh medium
0.21701698.10098492.html.plaintext.txt	66	After overnight incubation cell medium replaced
0.21701698.10098492.html.plaintext.txt	67	Cells harvested 48 h transfection 100 microl volume 25 mM glycylglycine 15 mM MgSO4 1 mM dithiothreitol DTT 1 Triton X 100
0.21701698.10098492.html.plaintext.txt	68	Protein concentrations determined using bicinchonic acid method Pierce Chemical Co
0.21701698.10098492.html.plaintext.txt	69	Luciferase assays performed 20 sec reaction period using aliquots 87
0.21701698.10098492.html.plaintext.txt	70	5 microg protein 125 microl volume containing 0
0.21701698.10098492.html.plaintext.txt	71	Assays performed using Monolight 2010 Luminometer Analytical Luminescence Laboratory San Diego CA
0.21701698.10098492.html.plaintext.txt	72	All transfection analyses performed minimum three times analyzed one way ANOVA Student Newman Keuls multiple comparison test
0.21701698.10098492.html.plaintext.txt	73	Minimal criteria significance determined P 0
0.21701698.10098492.html.plaintext.txt	74	Adipocyte differentiation tissue culture The murine preadipocyte cell line 3T3 L1 plated 2 ml DMEM supplemented 10 bovine serum 100 Uml penicillin 100 microgml streptomycin density 2
0.21701698.10098492.html.plaintext.txt	75	After 4 7 days cells reached confluence medium replaced fresh medium containing 10 FBS supplemented 1 microM dexamethasone 500 microM methylisobutylxanthine 5 microgml insulin
0.21701698.10098492.html.plaintext.txt	76	Cells maintained induction medium 3 4 days returning unsupplemented medium
0.21701698.10098492.html.plaintext.txt	77	Individual cultures harvested varying time intervals 0 8 days RNA 0
0.21701698.10098492.html.plaintext.txt	78	5 ml 4 M guanidine isothiocyanate solution immunoblots 100 microl 50 mM Tris pH 7
0.21701698.10098492.html.plaintext.txt	79	25 deoxycholate 1 mM phenylmethylsulfonylfluoride 0
0.21701698.10098492.html.plaintext.txt	80	1 mM sodium molybdate 1 microgml leupeptin aprotinin
0.21701698.10098492.html.plaintext.txt	81	Electromobility shift assays The DNA electromobility shift assays performed using 67 bp HindIIISspI DNA fragment spanning bp 181 113 murine LPL promoter 3
0.21701698.10098492.html.plaintext.txt	82	DNA labeling performed using T4 polynucleotide kinase 32Pdeoxy ATP ICN Irvine CA
0.21701698.10098492.html.plaintext.txt	83	Probes labeled specific activity 105 106 cpmpmol
0.21701698.10098492.html.plaintext.txt	84	Reactions conducted 30 microl volume containing 10 mM Tris pH 8
0.21701698.10098492.html.plaintext.txt	85	05 Nonidet P 40 1 mM DTT 6 glycerol 0
0.21701698.10098492.html.plaintext.txt	86	5 ng recombinant COUP TFII ARP 1 provided R
0.21701698.10098492.html.plaintext.txt	87	Kelly Washington University St
0.21701698.10098492.html.plaintext.txt	88	Louis MO 2 10 x 105 cpm probe 20 min period room temperature
0.21701698.10098492.html.plaintext.txt	89	Reactions performed absence presence competitor DNA fragments spanning bp 181 187 LPL promoter
0.21701698.10098492.html.plaintext.txt	90	In addition wild type sequence following mutations underlined PPAR recognition element used DNA sequence mutation sites wild type 181 bp gctttccttcctgccctttccccttcttctcgctgg mutant A 181 bp gctttccttaaaaaaatttccccttcttctcgctgg 172 166 bp mutant B 181 bp gctttccttcctgaaaaaaacccttcttctcgctgg 168 162 bp mutant C 181 bp gctttccttcctgccctaaaaaaatcttctcgctgg 164 158 bp mutant D 181 bp gctttccttcctgccctttccaaaaaaactcgctgg 160 154 bp mutant E 181 bp gctttccttcctgccctttccccttaaaaaaactgg 156 150 bp
0.21701698.10098492.html.plaintext.txt	91	Samples separated 5 acrylamidebis acrylamide 241 gel electrophoresis 100 V 3 h
0.21701698.10098492.html.plaintext.txt	92	Gels dried 80 C 90 min exposed Kodak XAR film Eastman Kodak Co
0.21701698.10098492.html.plaintext.txt	93	Rochester NY 18 h without intensifying screen
0.21701698.10098492.html.plaintext.txt	94	In vitro transcriptiontranslation In vitro transcription performed using T7 RNA polymerase circular plasmids containing varying segments human SMRT cDNA pT7 vector containing full length coding region human COUP TFII ARP 1 cDNA pBluescript SKII vector
0.21701698.10098492.html.plaintext.txt	95	In vitro translation performed rabbit reticulocyte lysates Promega Corp
0.21701698.10098492.html.plaintext.txt	96	Protein products radiolabeled 35Smethionine ICN
0.21701698.10098492.html.plaintext.txt	97	Control reactions performed luciferase cDNA provided manufacturer yielded 62 kDa product
0.21701698.10098492.html.plaintext.txt	98	In vitro pull assays The pGEX2T vectors containing either insert PPAR1 cDNA encoding amino acids 174 475 transformed bacterial strain BL21 DE3 pLysS cultured 20 24 C OD592 0
0.21701698.10098492.html.plaintext.txt	99	8 induced final concentration 1 mM isopropyl ss D thiogalactopyranoside pelleted centrifugation 4 C stored 70 C
0.21701698.10098492.html.plaintext.txt	100	Aliquots 200 ml bacterial culture suspended 20 ml lysis buffer 50 mM Tris pH 8
0.21701698.10098492.html.plaintext.txt	101	0 250 mM KCl 1 mM dithiothreitol 1 mM phenylmethylsulfonylfluoride 1 Triton X 100 frozen thawed three times centrifuged
0.21701698.10098492.html.plaintext.txt	102	Expression GST fusion proteins confirmed electrophoresis lysates SDS PAGE gels followed either Coomassie staining immunoblotting polyclonal antibodies directed either GST C terminal peptide PPAR 28
0.21701698.10098492.html.plaintext.txt	103	The cleared lysate mixed 300 microl prewashed glutathione Sepharose 4B beads Pharmacia Biotech Alameda CA rocked overnight 4 C
0.21701698.10098492.html.plaintext.txt	104	4 ml washing buffer 60 mM NaCl 20 mM Tris pH 8
0.21701698.10098492.html.plaintext.txt	105	0 6 mM MgCl2 1 mM DTT 1 mM EDTA 8 glycerol 0
0.21701698.10098492.html.plaintext.txt	106	05 Nonidet P 40 200 microl aliquots beads mixed 10 microl volumes vitro transcribed translated proteins incubated overnight 4 C
0.21701698.10098492.html.plaintext.txt	107	The samples washed five times NENT buffer 500 mM NaCl 20 mM Tris pH 8
0.21701698.10098492.html.plaintext.txt	108	0 6 mM MgCl2 1 mM DTT 1 mM EDTA 8 glycerol 0
0.21701698.10098492.html.plaintext.txt	109	5 Nonidet P 40 suspended 20 microl SDS loading buffer heated 95 C 5 min resolved 12 acrylamide SDS PAGE gel
0.21701698.10098492.html.plaintext.txt	110	Control lanes contained 10 input labeled protein used binding
0.21701698.10098492.html.plaintext.txt	111	The gel fixed treated EN3HANCE New England Nuclear DuPont Boston MA dried 60 C exposed autoradiographic film 1 7 days enhancer screen
0.21701698.10098492.html.plaintext.txt	112	Northern Western blots Total RNA harvested 3T3 L1 cells days 0 6 prepared previously described 28 29
0.21701698.10098492.html.plaintext.txt	113	Northern blots performed aliquots 10 microg total RNA electrophoresed 1 agarose 0
0.21701698.10098492.html.plaintext.txt	114	66 formaldehyde gels transferred ZetaProbe membranes Bio Rad Laboratories Inc
0.21701698.10098492.html.plaintext.txt	115	Richmond CA hybridized overnight 55 C 500 mM sodium phosphate pH 7
0.21701698.10098492.html.plaintext.txt	116	4 7 SDS 30 random primed radiolabeled probes murine LPL murine COUP TFII actin 31
0.21701698.10098492.html.plaintext.txt	117	Blots washed 40 mM sodium phosphate 1 SDS maximum stringency 55 C exposed 1 day enhancer screen 70 C
0.21701698.10098492.html.plaintext.txt	118	Western blots performed aliquots 50 microg 3T3 L1 protein lysates electrophoresed 10 acrylamide SDS PAGE gels transferred nitrocellulose paper blocked 5 nonfat dry milk PBS 0
0.21701698.10098492.html.plaintext.txt	119	1 Tween PBST immunoblotted overnight 4 C primary rabbit antibody directed COUP TF 32 CEBP SC061 Santa Cruz Biotechnology Inc
0.21701698.10098492.html.plaintext.txt	120	Santa Cruz CA 1 nonfat dry milk PBST
0.21701698.10098492.html.plaintext.txt	121	The blots rinsed PBST incubated goat antirabbit antibody coupled horseradish peroxidase 110000 dilution PBST 0
0.21701698.10098492.html.plaintext.txt	122	25 nonfat dry milk Bio Rad Laboratories Inc
0.21701698.10098492.html.plaintext.txt	123	protein immunostaining detected chemiluminescence ECL kit Amersham Arlington Heights IL
0.21701698.10098492.html.plaintext.txt	124	Results Top Abstract Introduction Materials Methods Results Discussion References Effect adipogenic agonists expression COUP TFII ARP 1 3T3 L1 preadipocytes Initial studies performed document expression COUP TFII ARP 1 mRNA protein response agents known induce LPL transcription
0.21701698.10098492.html.plaintext.txt	125	Northern blot analysis demonstrated preadipocyte cell line 3T3 L1 rapidly increased LPL transcription exposure adipogenic agonists dexamethasone insulin methylisobutylxanthine Fig
0.21701698.10098492.html.plaintext.txt	126	The confluent 3T3 L1 cells expressed COUP TFII mRNA throughout induction period signal remained present days 0 8 Fig
0.21701698.10098492.html.plaintext.txt	127	Actin served control relative RNA loading lanes
0.21701698.10098492.html.plaintext.txt	128	Western blot analysis performed protein extracts similarly treated cells detected COUP TF protein throughout induction period 0 48 h
0.21701698.10098492.html.plaintext.txt	129	The protein remained detectable levels 96 h induction
0.21701698.10098492.html.plaintext.txt	130	This coincided peak expression late appearing adipogenic transcription factor CEBP Fig
0.21701698.10098492.html.plaintext.txt	131	These studies document presence COUP TF protein times corresponding induction LPL transcript preadipocyte cell model 33 34
0.21701698.10098492.html.plaintext.txt	132	View larger version 26K Figure 1
0.21701698.10098492.html.plaintext.txt	133	Evidence COUP TF mRNA protein expression preadipocyte adipocyte 3T3 L1 cells
0.21701698.10098492.html.plaintext.txt	134	The 3T3 L1 cells induced dexamethasone insulin methylisobutylxanthine periods 0 8 days
0.21701698.10098492.html.plaintext.txt	135	Cells harvested indicated times total RNA examined 10 microg aliquots per lane Northern blots A protein examined Western immunoblots 50 microg aliquots per lane B
0.21701698.10098492.html.plaintext.txt	136	Equivalent Northern blots hybridized probes LPL COUP TFII actin
0.21701698.10098492.html.plaintext.txt	137	Western blots examined polyclonal antibodies directed COUP TF CEBP
0.21701698.10098492.html.plaintext.txt	138	Members COUP TF family activate transcription murine LPL promoter synergy PPAR2RXR In next series experiments cotransfections designed determine effects COUP TFI EAR3 COUP TFII ARP 1 EAR2 murine LPL transcription absence presence PPAR2RXR Fig
0.21701698.10098492.html.plaintext.txt	139	Transfections performed 293T cells individual nuclear hormone receptor expression constructs alone varied combinations
0.21701698.10098492.html.plaintext.txt	140	The reporter construct contained 1824 187 bp LPL promoter linked luciferase
0.21701698.10098492.html.plaintext.txt	141	The COUP TF family members alone increased expression LPL promoter less order magnitude potent COUP TFII ARP 1 9
0.21701698.10098492.html.plaintext.txt	142	9 fold activation PPAR2 RXR together
0.21701698.10098492.html.plaintext.txt	143	Overexpression COUP TF member either PPAR2 RXR expression construct alone increase transcription
0.21701698.10098492.html.plaintext.txt	144	However simultaneous expression either COUP TFII ARP 1 COUP TFI EAR3 PPAR2 RXR increased luciferase activity 101 45 fold relative baseline
0.21701698.10098492.html.plaintext.txt	145	Control experiments substituting vitamin D3 expression constructs COUP TF increase PPAR2RXR mediated activation LPL promoter n 2 data shown
0.21701698.10098492.html.plaintext.txt	146	The actions COUP TFII ARP 1 concentration dependent Fig
0.21701698.10098492.html.plaintext.txt	147	Transcription rose dose dependent manner ratio COUP TFII ARP 1 expression plasmid increased relative PPAR2 RXR plasmids
0.21701698.10098492.html.plaintext.txt	148	View larger version 26K Figure 2
0.21701698.10098492.html.plaintext.txt	149	Activation LPL gene promoter COUP TF proteins conjunction PPAR2 RXR
0.21701698.10098492.html.plaintext.txt	150	Cultures 293T cells transfected 0
0.21701698.10098492.html.plaintext.txt	151	1 microg 1824 187 bp LPL promoterluciferase reporter construct calcium phosphate coprecipitation presence 10 FBS
0.21701698.10098492.html.plaintext.txt	152	Cells additionally transfected 2 microg pEF BOS expression vectors containing PPAR2 RXR COUP TFII ARP 1 COUP TFI EAR3 andor EAR2
0.21701698.10098492.html.plaintext.txt	153	All plates transfected total 12 microg DNA empty pEF BOS vector used make difference total amount necessary
0.21701698.10098492.html.plaintext.txt	154	Fold activation calculated relative luciferase baseline activity absence nuclear hormone receptor expression constructs defined 1
0.21701698.10098492.html.plaintext.txt	155	Data normalized relative constant protein concentration per assay 87
0.21701698.10098492.html.plaintext.txt	156	5 microg represent mean plus minus SE three experiments
0.21701698.10098492.html.plaintext.txt	157	View larger version 25K Figure 3
0.21701698.10098492.html.plaintext.txt	158	Dose dependent activation LPL promoter COUP TFII ARP 1 presence PPAR2 RXR
0.21701698.10098492.html.plaintext.txt	159	Individual plates 293T cells cotransfected 0
0.21701698.10098492.html.plaintext.txt	160	1 microg 1824 187 bp LPL promoterluciferase reporter construct 2 microg PPAR2 RXR expression constructs increasing concentrations 0
0.21701698.10098492.html.plaintext.txt	161	2 8 microg COUP TFII ARP 1 expression construct
0.21701698.10098492.html.plaintext.txt	162	The relative ratio COUP TFII PPAR2 plasmid concentrations indicated x axis
0.21701698.10098492.html.plaintext.txt	163	The total concentration DNA held constant addition appropriate amount empty pEF BOS vector
0.21701698.10098492.html.plaintext.txt	164	Fold activation calculated relative luciferase baseline absence nuclear hormone receptor expression constructs defined 1
0.21701698.10098492.html.plaintext.txt	165	Data normalized relative constant protein concentration per assay 87
0.21701698.10098492.html.plaintext.txt	166	5 microg represent mean plus minus SE three experiments
0.21701698.10098492.html.plaintext.txt	167	Additional investigations examined interaction COUP TFII ARP 1 PPRE presence PPAR2 RXR
0.21701698.10098492.html.plaintext.txt	168	Cotransfection analyses LPL promoter deletion constructs combination PPAR2 RXR COUP TFII ARP 1 Fig
0.21701698.10098492.html.plaintext.txt	169	4A indicated deletions bp 181 101 significantly reduced fold activation
0.21701698.10098492.html.plaintext.txt	170	Levels decreased factor 5 comparable observed deletion constructs cotransfected PPAR2RXR heterodimer alone 3
0.21701698.10098492.html.plaintext.txt	171	These data suggested PPRE localized bp 171 149 critical COUP TFII ARP 1 activation
0.21701698.10098492.html.plaintext.txt	172	Recombinant COUP TFII ARP 1 protein directly bound LPL promoter PPRE electromobility shift assays giving rise two mobility shifted bands A B Fig
0.21701698.10098492.html.plaintext.txt	173	Competition analyses performed panel equivalent PCR generated DNA fragments bp 181 187
0.21701698.10098492.html.plaintext.txt	174	These included wild type control five mutants A E spanning PPRE 5 mutant A 3 mutant E direction
0.21701698.10098492.html.plaintext.txt	175	The wild type control specifically competed complexes A B
0.21701698.10098492.html.plaintext.txt	176	In contrast DNA fragments containing mutations within 14 bp 5 end PPRE mutants A C bind COUP TFII ARP 1 protein
0.21701698.10098492.html.plaintext.txt	177	Biochemical studies performed determine whether PPAR COUP TFII ARP 1 protein interacted directly
0.21701698.10098492.html.plaintext.txt	178	In vitro pull assays detected binding vitro transcribed translated COUP TFII ARP 1 protein ligand binding domain PPAR fused GST protein Fig
0.21701698.10098492.html.plaintext.txt	179	Control studies detect binding COUP TFII ARP 1 protein GST protein alone
0.21701698.10098492.html.plaintext.txt	180	Together data indicate COUP TFII ARP 1 interact PPRE ligand binding domain PPAR protein
0.21701698.10098492.html.plaintext.txt	181	View larger version 30K Figure 4
0.21701698.10098492.html.plaintext.txt	182	Evidence COUP TFII ARP 1 interactions LPL PPRE PPAR2
0.21701698.10098492.html.plaintext.txt	183	A Activation analysis LPL promoter deletion constructs COUP TFII ARP 1 expression construct
0.21701698.10098492.html.plaintext.txt	184	The 293T cells transfected aliquots 0
0.21701698.10098492.html.plaintext.txt	185	1 microg LPL promoterluciferase reporter constructs containing 1824 564 181 101 bp 5 flanking region extending 187 bp
0.21701698.10098492.html.plaintext.txt	186	Cells cotransfected 6 microg empty pEF BOS vector 2 microg PPAR2 RXR COUP TFII ARP 1 expression constructs
0.21701698.10098492.html.plaintext.txt	187	Fold activation calculated relative luciferase baseline absence nuclear hormone receptor expression constructs defined 1
0.21701698.10098492.html.plaintext.txt	188	Results normalized protein concentration maintained 87
0.21701698.10098492.html.plaintext.txt	189	5 microg per reaction represent mean plus minus SE three experiments
0.21701698.10098492.html.plaintext.txt	190	B Effect mutations PPAR2 recognition element COUP TFII ARP 1 binding
0.21701698.10098492.html.plaintext.txt	191	Electromobility shift assays conducted using 67 bp wild type LPL promoter probe spanning bp 181 113
0.21701698.10098492.html.plaintext.txt	192	Competition experiments performed using PCR generated DNA fragments equivalent size 181 187 bp containing either wild type sequence individual overlapping 7 bp mutations A E spanning region 172 150 bp listed inMaterials Methods
0.21701698.10098492.html.plaintext.txt	193	Reactions conducted recombinant COUP TFII ARP 1 protein
0.21701698.10098492.html.plaintext.txt	194	Electromobility shifted complexes labeled A B
0.21701698.10098492.html.plaintext.txt	195	C Evidence direct interaction COUP TFII ARP 1 PPAR ligand binding domain
0.21701698.10098492.html.plaintext.txt	196	In vitro pull assays conducted using 35Smethionine labeled vitro transcribedtranslated COUP TFII ARP 1 protein bacterially expressed protein GST vectors without insert containing PPAR1 ligand binding domain amino acids 175 475
0.21701698.10098492.html.plaintext.txt	197	Reaction products separated 12 SDS PAGE gel contain 10 input COUP TFII ARP 1 protein I material bound control GST protein G material bound GST PPAR LBD fusion protein
0.21701698.10098492.html.plaintext.txt	198	Protein size markers indicated
0.21701698.10098492.html.plaintext.txt	199	Data representative two experiments
0.21701698.10098492.html.plaintext.txt	200	SMRT represses PPAR2RXR activation transcription murine LPL promoter Previous cotransfection studies others 293T cells demonstrated corepressor SMRT bound PPAR2RXR heterodimer solution minimal repressive effect acyl coenzyme A oxidase PPRE 18
0.21701698.10098492.html.plaintext.txt	201	To determine effect SMRT transcription murine LPL promoter identical cell line cotransfected increasing amounts SMRT expression construct absence Fig
0.21701698.10098492.html.plaintext.txt	202	As ratio full length SMRT expression construct increased relative PPAR2 RXR plasmids fold activation reduced baseline levels observed absence PPAR2RXR heterodimer Fig
0.21701698.10098492.html.plaintext.txt	203	Likewise ratio full length SMRT expression plasmid increased relative COUP TFII ARP1 PPAR2 RXR plasmids fold activation progressively decreased Fig
0.21701698.10098492.html.plaintext.txt	204	Thus SMRT repressed transcription LPL PPRE independent presence COUP TFII ARP 1
0.21701698.10098492.html.plaintext.txt	205	View larger version 29K Figure 5
0.21701698.10098492.html.plaintext.txt	206	Effect cotransfected SMRT LPL promoter function
0.21701698.10098492.html.plaintext.txt	207	Cotransfections using 293T cells performed using 1824 187 bp LPL promoterluciferase construct 0
0.21701698.10098492.html.plaintext.txt	208	All cells transfected 2 microg PPAR2 RXR expression vectors either alone A together 2 microg COUP TFII ARP 1 expression vector B
0.21701698.10098492.html.plaintext.txt	209	Cells cotransfected varied concentrations full length SMRT expression construct 0
0.21701698.10098492.html.plaintext.txt	210	The relative ratio SMRT PPAR2 A SMRT COUP TFII B plasmid concentrations indicated along x axis
0.21701698.10098492.html.plaintext.txt	211	The total amount DNA transfected held constant addition empty pEF BOS vector
0.21701698.10098492.html.plaintext.txt	212	Fold activation calculated relative luciferase baseline absence nuclear hormone receptor expression constructs defined 1
0.21701698.10098492.html.plaintext.txt	213	Results normalized protein concentration maintained 87
0.21701698.10098492.html.plaintext.txt	214	5 microg per reaction represent mean plus minus SE three experiments
0.21701698.10098492.html.plaintext.txt	215	To determine domains SMRT critical repression LPL PPRE cotransfection experiments performed several SMRT deletion mutants wild type PPAR2 RXR Fig
0.21701698.10098492.html.plaintext.txt	216	In absence SMRT PPAR2RXR expression constructs induced luciferase activity order magnitude relative baseline
0.21701698.10098492.html.plaintext.txt	217	Constructs containing either amino acids 29 564 565 1289 SMRT reduced fold activation 40 60
0.21701698.10098492.html.plaintext.txt	218	In contrast constructs containing carboxyl terminus SMRT protein amino acids 565 1495 1 1495 completely abolished activation
0.21701698.10098492.html.plaintext.txt	219	Further studies employed vitro pull assays determine whether direct interaction existed SMRT PPAR Fig
0.21701698.10098492.html.plaintext.txt	220	Strong interactions indicated arrows A B C observed ligand binding domain PPARGST fusion protein vitro transcribed translated proteins containing amino acids 1289 1495 SMRT
0.21701698.10098492.html.plaintext.txt	221	Radiolabeled proteins lacking carboxyl terminal domain SMRT bind PPAR GST fusion protein
0.21701698.10098492.html.plaintext.txt	222	View larger version 42K Figure 6
0.21701698.10098492.html.plaintext.txt	223	Localization SMRT domain interacting PPAR2
0.21701698.10098492.html.plaintext.txt	224	A Cotransfection analysis 293T cells performed empty pABgal expression vector 8 microgplate constructs encoding full length amino acids 1 1495 deleted versions amino acids 29 564 565 1289 565 1495 SMRT protein together 1824 187 LPL promoter luciferase construct 0
0.21701698.10098492.html.plaintext.txt	225	1 microgplate PPAR2 RXR expression constructs 2 microgplate
0.21701698.10098492.html.plaintext.txt	226	Fold activation calculated relative luciferase baseline absence nuclear hormone receptor expression constructs defined 1
0.21701698.10098492.html.plaintext.txt	227	Results normalized protein concentration maintained 87
0.21701698.10098492.html.plaintext.txt	228	5 microg per reaction represent mean plus minus SE three experiments
0.21701698.10098492.html.plaintext.txt	229	B GST pull experiments using varied deletions SMRT protein
0.21701698.10098492.html.plaintext.txt	230	Lanes 12 SDS PAGE gel contained 20 input 35S labeled SMRT proteins amino acids 1 1495 29 564 565 1289 565 1495 1192 1495 I labeled protein pulled GST protein coupled beads G GST PPAR2 ligand binding domain coupled beads P
0.21701698.10098492.html.plaintext.txt	231	Protein size markers indicated
0.21701698.10098492.html.plaintext.txt	232	Data representative two experiments
0.21701698.10098492.html.plaintext.txt	233	Arrows labeled A B C indicate association following 35S labeled SMRT proteins GST protein coupled beads pull assays lane P A 1 1495 B 565 1495 C 1192 1495
0.21701698.10098492.html.plaintext.txt	234	Discussion Top Abstract Introduction Materials Methods Results Discussion References PPAR interactions COUP TF proteins The COUP TF proteins increased expression LPL promoter synergistically PPAR2RXR 293T cells dependent presence intact PPRE
0.21701698.10098492.html.plaintext.txt	235	This contrasts many studies reported antagonistic actions COUP TF PPAR compared common promoter DNA recognition element
0.21701698.10098492.html.plaintext.txt	236	In majority cases transcription increased PPAR proteins decreased COUP TF proteins examples include promoters apolipoprotein AI 36 medium chain acyl coenzyme A dehydrogenase 37 38 hydratase dehydrogenase 39 40 malic enzyme 41 42 mitochondrial hydroxy methylglutaryl coenzyme A synthase 43
0.21701698.10098492.html.plaintext.txt	237	In contrast transferrin promoter sole example expression decreased PPAR proteins increased COUP TF proteins 13
0.21701698.10098492.html.plaintext.txt	238	Nevertheless likely promoters hepatic proteins repressed peroxisome proliferator compounds exhibit profile candidates include transthyretin 2u macroglobulin gene promoters 44
0.21701698.10098492.html.plaintext.txt	239	However actions PPAR COUP TF proteins necessarily antagonistic
0.21701698.10098492.html.plaintext.txt	240	There examples PPAR COUP TF actions increase transcription common DNA recognition element include human immunodeficiency virus long terminal repeat 10 phosphoenolpyruvate decarboxylase promoter 11 12 45
0.21701698.10098492.html.plaintext.txt	241	The murine LPL promoter exhibits pattern regulation 293T cell line
0.21701698.10098492.html.plaintext.txt	242	This conflicting pattern positive negative interactions COUP TF unique PPAR proteins PPREs
0.21701698.10098492.html.plaintext.txt	243	Similar findings COUP TF reported estrogen receptor estrogen receptor recognition elements EREs
0.21701698.10098492.html.plaintext.txt	244	In study examining consensus ERE COUP TF proteins observed bind DNA element repress estrogen ligand activation reporter gene 46
0.21701698.10098492.html.plaintext.txt	245	In contrast studies intact estrogen receptor gene promoter containing ERE COUP TF bound ERE increased transcription synergy estrogen receptor 47
0.21701698.10098492.html.plaintext.txt	246	Independent mechanism accounting disparate interactions COUP TF nuclear hormone receptors current findings support conclusion COUP TF proteins positively modulate LPL promoter transcription PPAR recognition element 293T cells
0.21701698.10098492.html.plaintext.txt	247	PPAR2 interactions SMRT The presence SMRT repressed PPAR2RXR mediated transcription LPL promoter 9 fold
0.21701698.10098492.html.plaintext.txt	248	This contrasts reported less 2 fold repression SMRT transcription isolated acyl coenyzme A oxidase PPRE 18
0.21701698.10098492.html.plaintext.txt	249	As studies employed 293T cells discrepancy cannot attributed differences cell model 18
0.21701698.10098492.html.plaintext.txt	250	Instead DNA site likely explanation 18
0.21701698.10098492.html.plaintext.txt	251	The compositions DNA recognition element 5 flanking sequences known influence PPAR protein binding affinity specificity 9 48 49 50
0.21701698.10098492.html.plaintext.txt	252	As postulated previously 18 alterations DNA sequence could result conformational changes DNA recognition elementPPAR protein complex
0.21701698.10098492.html.plaintext.txt	253	This could lead subsequent allosteric changes accessibility bound PPAR protein corepressor interactive domain SMRT protein
0.21701698.10098492.html.plaintext.txt	254	Thus SMRT protein may regulate PPREs differentially depending DNA compositions flanking sequences
0.21701698.10098492.html.plaintext.txt	255	The relative stoichiometry SMRT protein relative nuclear hormone receptor proteins PPAR RXR COUP TF may contribute tissue specific regulation LPL
0.21701698.10098492.html.plaintext.txt	256	Data supporting role SMRT PPAR corepressor comes recent microinjection experiments using anti SMRT anti N CoR antibodies 51
0.21701698.10098492.html.plaintext.txt	257	In cells transfected PPRE directed reporter gene injection anti SMRT antibody anti N CoR antibody relieved PPAR mediated repression induced stimulation mitogen activated protein kinase cascade 51
0.21701698.10098492.html.plaintext.txt	258	The current results mapping PPAR2 interactive domain SMRT amino acids 1289 1495 confirm extend earlier studies 18
0.21701698.10098492.html.plaintext.txt	259	This region corresponds one two distinct receptor interactive domains RID delineated SMRT carboxyl terminal RID2 amino acids 1260 1495 52
0.21701698.10098492.html.plaintext.txt	260	The PPAR2 interactive domain SMRT similar used thyroid receptor 52 differs used retinoic acid receptor RID1 corresponding amino acids 1086 1291 52 COUP TF1 amino terminal portion SMRT 25
0.21701698.10098492.html.plaintext.txt	261	In summary work demonstrates COUP TFII ARP 1 SMRT modulate transcription LPL promoter presence PPAR2 RXR vitro system
0.21701698.10098492.html.plaintext.txt	262	These observations consistent current models suggesting relative stochiometry nuclear receptors corepressors regulates promoter function accounts cell specific gene expression 18
0.21701698.10098492.html.plaintext.txt	263	Both COUP TF SMRT proteins may play vivo role complex physiological regulation LPL
0.21701698.10098492.html.plaintext.txt	264	However current studies limited single cell line
0.21701698.10098492.html.plaintext.txt	265	The 293T cells constitutively express simian virus 40 T antigen 27 possibility exists contributed current findings
0.21701698.10098492.html.plaintext.txt	266	Future studies extend test observations primary adipose tissues sites LPL expression
0.21701698.10098492.html.plaintext.txt	267	Acknowledgments The authors thank following individuals D
0.21701698.10098492.html.plaintext.txt	268	Webb critical comments review manuscript P
0.21701698.10098492.html.plaintext.txt	269	Young graphic photographic assistance J
0.21701698.10098492.html.plaintext.txt	270	Footnotes 1 This work supported Grant Aid 9808013S American Heart Association Oklahoma Affiliate Inc
0.21701698.10098492.html.plaintext.txt	271	USPHS Grant CA 50898 NCI J
0.21701698.10098492.html.plaintext.txt	272	well past support Oklahoma Medical Research Foundation
0.21701698.10098492.html.plaintext.txt	273	This work submitted partial fulfillment Ph
0.21701698.10098492.html.plaintext.txt	274	Department Zoology University Oklahoma
0.21701698.10098492.html.plaintext.txt	275	2 Current address Eli Lilly Co
0.21701698.10098492.html.plaintext.txt	276	3 Current address University Pittsburgh Pittsburgh Pennsylvania 15261
0.21701698.10098492.html.plaintext.txt	277	References Top Abstract Introduction Materials Methods Results Discussion References Enerback S Gimble JM 1993 Lipoprotein lipase gene expression physiological regulators transcriptional post transcriptional level
0.21701698.10098492.html.plaintext.txt	278	Biochim Biophys Acta 1169107 125Medline Schoonjans K Peinado Onsurbe J Lefebvre A M Heyman RA Briggs M Deeb S Staels B Auwerx J 1996 PPAR PPAR activators direct distinct tissue specific transcriptional response via PPRE lipoprotein lipase gene
0.21701698.10098492.html.plaintext.txt	279	EMBO J 155336 5348Abstract Robinson CE Wu X Morris DC Gimble JM 1998 DNA bending induced binding peroxisome proliferator activated receptor 2 heterodimer response element murine lipoprotein lipase promoter
0.21701698.10098492.html.plaintext.txt	280	Biochem Biophys Res Commun 244671 677CrossRefMedline Bey L Etienne J Tse C Brault D Noe L Raisonnier A Arnault F Hamilton MT Galibert F 1998 Cloning sequencing structural analysis 976 base pairs promoter sequence rat lipoprotein lipase gene
0.21701698.10098492.html.plaintext.txt	281	Comparison mouse human sequences
0.21701698.10098492.html.plaintext.txt	282	Gene 20931 38CrossRefMedline Tanuma Y Nakabayashi H Esumi M Endo H 1995 A silencer element lipoprotein lipase gene promoter cognate double single stranded DNA binding proteins
0.21701698.10098492.html.plaintext.txt	283	Mol Cell Biol 15517 523Abstract Qui Y Tsai SY Tsai M J 1994 COUP TF orphan member steroidthyroid hormone receptor superfamily
0.21701698.10098492.html.plaintext.txt	284	Trends Endocrinol Metab 5234 239 Tsai M J O Malley BW 1994 Molecular mechanisms action steroidthyroid receptor superfamily members
0.21701698.10098492.html.plaintext.txt	285	Annu Rev Biochem 63451 486CrossRefMedline Tsai SY Tsai M J 1997 Chicken ovalbumin upstream promoter transcription factors COUP TF coming age
0.21701698.10098492.html.plaintext.txt	286	Endocr Rev 18229 240AbstractFree Full Text Nakshatri H Bhat Nakshatri P 1998 Multiple parameters determine specificity transcriptional response nuclear receptors HNF 4 ARP 1 PPAR RAR RXR common response elements
0.21701698.10098492.html.plaintext.txt	287	Nucleic Acids Res 262491 2499AbstractFree Full Text Ladias JAA 1994 Convergence multiple nuclear receptor signaling pathways onto long terminal repeat human immunodeficiency virus 1
0.21701698.10098492.html.plaintext.txt	288	J Biol Chem 2695944 5951AbstractFree Full Text Hall RK Sladek FM Granner DK 1995 The orphan receptors COUP TF HNF 4 serve accessory factors required induction phosphoenolpyruvate carboxykinase gene transcription glucocorticoids
0.21701698.10098492.html.plaintext.txt	289	Proc Natl Acad Sci USA 92412 416Abstract Tontonoz P Hu E Devine J Beale EG Spiegelman BM 1995 PPAR2 regulates adipose expression phosphoenolpyruvate carboxykinase gene
0.21701698.10098492.html.plaintext.txt	290	Mol Cell Biol 15351 357Abstract Hertz R Seckbach M Zakin MM Bar Tana J 1996 Transcriptional repression transferrin gene hypolipidemic peroxisome proliferators
0.21701698.10098492.html.plaintext.txt	291	J Biol Chem 271218 224AbstractFree Full Text Brodie AE Manning VA Hu CY 1996 Inhibitors preadipocyte differentiation induce COUP TF binding PPARRXR binding sequence
0.21701698.10098492.html.plaintext.txt	292	Biochem Biophys Res Commun 228655 661CrossRefMedline Horowitz KB Jackson TA Bain DL Richer JK Takimoto GS Tung L 1996 Nuclear receptor coactivators corepressors
0.21701698.10098492.html.plaintext.txt	293	Mol Endocrinol 101167 1177Abstract Shibata H Spencer TE Onate SA Jenster G Tsai SY Tsai M J O Malley BW 1997 Role coactivators corepressors mechanisms steroidthyroid receptor action
0.21701698.10098492.html.plaintext.txt	294	Recent Prog Horm Res 52141 164Medline Misiti S Schomburg L Yen PM Chin WW 1998 Expression hormonal regulation coactivator corepressor genes
0.21701698.10098492.html.plaintext.txt	295	Endocrinology 1392493 2500AbstractFree Full Text Zamir I Zhang J Lazar MA 1997 Stoichiometric steric principles governing repression nuclear hormone receptors
0.21701698.10098492.html.plaintext.txt	296	Genes Dev 11835 846Abstract DeWet JR Wood KV DeLuca M Helinski DR Subramani S 1987 Firefly luciferase gene structure expression mammalian cells
0.21701698.10098492.html.plaintext.txt	297	Mol Cell Biol 7725 737Medline Mizushima S Nagata S 1990 pEF BOS powerful mammalian expression vector
0.21701698.10098492.html.plaintext.txt	298	Nucleic Acids Res 185322Medline Lehmann JM Moore LB Smith Oliver TA Wilkison WO Willson TM Kliewer SA 1995 An antidiabetic thiazolidinedione high affinity ligand peroxisome proliferator activated receptor PPAR
0.21701698.10098492.html.plaintext.txt	299	J Biol Chem 27012953 12956AbstractFree Full Text Mangelsdorf DJ Borgmeyer U Heyman RA Zhou JY Ong ES Oro AE Kakizuka A Evans RM 1992 Characterization three RXR genes mediate action 9 cis retinoic acid
0.21701698.10098492.html.plaintext.txt	300	Genes Dev 6329 344Abstract Tran P Zhang X Salbert G Hermann T Lehann JM Pfahl M 1992 COUP orphan receptors negative regulators retinoic acid response pathways
0.21701698.10098492.html.plaintext.txt	301	Mol Cell Biol 124666 4676Abstract Miyajima N Kadowaki Y Fukushige S I Shimizu S I Semba K Yamanashi Y Matsubara K I Toyoshima K Yamamoto T 1988 Identification two novel members erbA superfamily molecular cloning gene products two highly related
0.21701698.10098492.html.plaintext.txt	302	Nucleic Acids Res 1611057 11074Abstract Shibata H Nawaz Z Tsai SY O Malley BW Tsai M J 1997 Gene silencing chicken ovalbumin upstream transcription factor I COUP TFI mediated transcriptional corepressors nuclear receptor corepressor N CoR silencing mediator retinoic acid receptor thyroid receptor SMRT
0.21701698.10098492.html.plaintext.txt	303	Mol Endocrinol 11714 724AbstractFree Full Text Ladias JAA Karathanasis SK 1991 Regulation apolipoprotein AI gene ARP 1 novel member steroid receptor superfamily
0.21701698.10098492.html.plaintext.txt	304	Science 251561 565Medline Graham FL Smiley J Russell WC Nairn R 1977 Characteristics human cell line transformed DNA human adenovirus type 5
0.21701698.10098492.html.plaintext.txt	305	J Gen Virol 3659 72Abstract Gimble JM Robinson CE Wu X Kelly KA Rodriguez BR Kliewer SA Lehmann JM Morris DC 1996 Peroxisome proliferator activated receptor activation thiazolidinediones induces adipogenesis bone marrow stromal cells
0.21701698.10098492.html.plaintext.txt	306	Mol Pharmacol 501087 1094Abstract Chomczynski P Sacchi N 1987 Single step method RNA isolation acid guanidium isothiocyanate phenol chloroform extraction
0.21701698.10098492.html.plaintext.txt	307	Anal Biochem 162156 159CrossRefMedline Church G Gilbert W 1984 Genomic sequencing
0.21701698.10098492.html.plaintext.txt	308	Proc Natl Acad Sci USA 811991 1995Abstract Feinberg AP Vogelstein B 1983 A technique radiolabeling DNA restriction endonuclease fragments high specific activity
0.21701698.10098492.html.plaintext.txt	309	Anal Biochem 1326 13Medline Kieback DG Runnelbaum IB Moebus VJ Kreienberg R McCamant SK Edwards CL Jones LA Tsai M J O Malley BW 1993 Chicken ovalbumin upstream promoter transcription factor COUP TF orphan steroid receptor specific pattern differential expression human ovarian cell lines
0.21701698.10098492.html.plaintext.txt	310	Gynecol Oncol 51167 170CrossRefMedline Chawla A Schwartz EJ Dimaculangan DD Lazar MA 1994 Peroxisome proliferator activated receptor PPAR adipose predominant expression induction early adipocyte differentiation
0.21701698.10098492.html.plaintext.txt	311	Endocrinology 135798 800Abstract Tontonoz P Hu E Graves RA Budavari AI Spiegelman BM 1994 mPPAR2tissue specific regulator adipocyte enhancer
0.21701698.10098492.html.plaintext.txt	312	Genes Dev 81224 1234Abstract Cao Z Umek RM McKnight SL 1991 Regulated expression three CEBP isoforms adipose conversion 3T3 L1 cells
0.21701698.10098492.html.plaintext.txt	313	Genes Dev 51539 1552 Graves RA Tontonoz P Spiegelman BM 1992 Analysis tissue specific enhancer ARF6 regulates adipogenic gene expression
0.21701698.10098492.html.plaintext.txt	314	Mol Cell Biol 121202 1208Abstract Disch DL Rader TA Cresci S Leone TC Barger PM Vega R Wood PA Kelly DP 1996 Transcriptional control nuclear gene encoding mitochondrial fatty acid oxidation enzyme transgenic mice role nuclear receptors cardiac brown adipose expression
0.21701698.10098492.html.plaintext.txt	315	Mol Cell Biol 164043 4051Abstract Gulick T Cresci S Caira T Moore DD Kelly DP 1994 The peroxisome proliferator activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression
0.21701698.10098492.html.plaintext.txt	316	Proc Natl Acad Sci USA 9111012 11016AbstractFree Full Text Miyata KS Zhang B Marcus SL Capone JP Rachubinski RA 1993 Chicken ovalbumin upstream promoter transcription factor COUP TF binds peroxisome proliferator response element antagonizes peroxisome proliferator mediated signaling
0.21701698.10098492.html.plaintext.txt	317	J Biol Chem 26819169 19172AbstractFree Full Text Marcus SL Capone JP Rachubinski RA 1996 Identification COUP TFII peroxisome proliferator response element binding protein using genetic selection yeast COUP TFII activates transcription yeast antagonizes PPAR signaling mammalian cells
0.21701698.10098492.html.plaintext.txt	318	Mol Cell Endocrinol 12031 39CrossRefMedline Castelein H Gulick T Declercq PE Mannaerts GP Moore DD Baes MI 1994 The peroxisome proliferator activated receptor regulates malic enzyme gene expression
0.21701698.10098492.html.plaintext.txt	319	J Biol Chem 26926754 26758AbstractFree Full Text Baes M Castelein H Desmet L Declercq PE 1995 Antagonism COUP TF PPARRXR activation malic enzyme promoter modulation 9 cis RA
0.21701698.10098492.html.plaintext.txt	320	Biochem Biophys Res Commun 215338 345CrossRefMedline Rodriguez JC Ortiz JA Hegardt FG Haro D 1997 Chicken ovalbumin upstream promoter transcription factor COUP TF could act transcriptional activator repressor mitochondrial 3 hydroxy 3 methylglutaryl CoA synthase gene
0.21701698.10098492.html.plaintext.txt	321	Biochem J 326587 592Medline Motojima K Peters JM Gonzalez FJ 1997 PPAR mediates peroxisome proliferator induced transcriptional repression nonperoxisomal gene expression mouse
0.21701698.10098492.html.plaintext.txt	322	Biochem Biophys Res Commun 230155 158CrossRefMedline Scott DK Mitchell JA Granner DK 1996 The orphan receptor COUP TF binds third glucocorticoid accessory factor element phosphoenolpyruvate carboxykinase gene promoter
0.21701698.10098492.html.plaintext.txt	323	J Biol Chem 27131909 319141996AbstractFree Full Text Klinge CM Silver BF Driscoll MD Sathya G Bambara RA Hilf R 1997 Chicken ovalbumin upstream promoter transcription factor interacts estrogen receptor binds estrogen response elements half sites inhibits estrogen induced gene expression
0.21701698.10098492.html.plaintext.txt	324	J Biol Chem 27231465 31474AbstractFree Full Text Lazennec G Kern L Valotaire Y Salbert G 1997 The nuclear orphan receptor COUP TF ARP 1 positively regulate trout estrogen receptor gene enhancing autoregulation
0.21701698.10098492.html.plaintext.txt	325	Mol Cell Biol 175053 5066Abstract Palmer CNA Hsu M H Griffin KJ Johnson EF 1995 Novel sequence determinants peroxisome proliferator signaling
0.21701698.10098492.html.plaintext.txt	326	J Biol Chem 27016114 16121AbstractFree Full Text Ijpenberg A Jeannin E Wahli W Desvergne B 1997 Polarity specific sequence requirements peroxisome proliferator activated receptor PPARretinoid X receptor heterodimer binding DNA
0.21701698.10098492.html.plaintext.txt	327	J Biol Chem 27220108 201117AbstractFree Full Text Juge Aubry C Pernin A Favez T Burger AG Wahli W Meier CA Desvergnes B 1997 DNA binding properties peroxisome proliferator activated receptor subtypes various natural peroxisome proliferator response elements
0.21701698.10098492.html.plaintext.txt	328	Importance 5 flanking region
0.21701698.10098492.html.plaintext.txt	329	J Biol Chem 27225252 25259AbstractFree Full Text Lavinsky RM Jepsen K Heinzel T Torchia J Mullen T M Schiff R Del Rio AL Ricote M Ngo S Gemsch J Hilsenbeck SG Osborne CK Glass CK Rosenfeld MG Rose DW 1998 Diverse signaling pathways modulate nuclear receptor recruitment N CoR SMRT complexes
0.21701698.10098492.html.plaintext.txt	330	Proc Natl Acad Sci USA 952920 2925AbstractFree Full Text Li H Leo C Schroen DJ Chen JD 1997 Characterization receptor interaction transcriptional repression corepressor SMRT
0.21701698.10098492.html.plaintext.txt	331	Mol Endocrinol 112025 2037AbstractFree Full Text
0.22530045.9717844.html.plaintext.txt	0	Estrogen Receptor Common Interaction Partner Subset Nuclear Receptors Soo Kyung Lee Hueng Sik Choi Mi Ryoung Song Mi Ock Lee Jae Woon Lee
0.22530045.9717844.html.plaintext.txt	1	Chonnam National University Kwangju 500 757 Korea Department Microbiology M R
0.22530045.9717844.html.plaintext.txt	2	College Medicine Yonsei University Seoul 120 752 Korea
0.22530045.9717844.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Nuclear receptors regulate transcription binding specific DNA response elements homodimers heterodimers
0.22530045.9717844.html.plaintext.txt	4	Herein yeast mammalian two hybrid tests well glutathione S transferase pull assays exploited demonstrate estrogen receptor ER directly binds subset nuclear receptors protein protein interactions ligand binding domains
0.22530045.9717844.html.plaintext.txt	5	These receptors include hepatocyte nuclear factor 4 thyroid hormone receptor TR retinoic acid receptor RAR ERss retinoid X receptor RXR
0.22530045.9717844.html.plaintext.txt	6	In yeast cells LexA fusion protein human ER ligand binding domain LexAER LBD inert transactivator LacZ reporter gene controlled upstream LexA binding sites
0.22530045.9717844.html.plaintext.txt	7	However LexAER LBD differentially modulated LacZ reporter gene expression coexpressed native TRs RARs RXRs
0.22530045.9717844.html.plaintext.txt	8	Similarly cotransfection receptors CV1 cells regulated transactivations ER
0.22530045.9717844.html.plaintext.txt	9	From results propose ER common interaction partner subset receptors interactions mediate novel signaling pathways vivo
0.22530045.9717844.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The nuclear receptor superfamily group transcriptional regulatory proteins linked conserved structure function 1
0.22530045.9717844.html.plaintext.txt	11	The superfamily includes receptors variety small hydrophobic ligands steroids T3 retinoids well large number related proteins known ligands referred orphan nuclear receptors 2
0.22530045.9717844.html.plaintext.txt	12	The receptor proteins direct regulators transcription function binding specific DNA sequences named hormone response elements HREs promoters target genes
0.22530045.9717844.html.plaintext.txt	13	Nearly superfamily members bind dimers HREs
0.22530045.9717844.html.plaintext.txt	14	A dimerization interface previously identified within DNA binding domains DBDs retinoid X receptors RXRs retinoic acid receptors RARs vitamin D receptor thyroid hormone receptors TRs selectively promotes DNA binding cognate HREs 3 4 5 6 7 8
0.22530045.9717844.html.plaintext.txt	15	An additional dimerization interface mediates cooperative binding DNA referred I box recently mapped 40 amino acid region within C terminal ligand binding domains LBDs RAR TR chicken ovalbumin upstream promoter COUP TF RXR hepatocyte nuclear factor 4 HNF4 9 10
0.22530045.9717844.html.plaintext.txt	16	The two dimerization domains appear work tandem led two step hypothesis binding dimers DNA 2 9
0.22530045.9717844.html.plaintext.txt	17	According hypothesis LBD dimerization interface initiates formation solution dimers turn acquire capacity bind number differently organized HREs
0.22530045.9717844.html.plaintext.txt	18	However formation second dimer interface within DBD restricts receptors bind cognate HREs 2 9
0.22530045.9717844.html.plaintext.txt	19	While nuclear receptors apparently bind HREs homodimers TRs vitamin D receptor RARs peroxisome proliferator activated receptors PPARs several orphan nuclear receptors bind specific response elements high affinity heterodimers RXRs 11 12 13 14 15 16
0.22530045.9717844.html.plaintext.txt	20	Based high affinity binding heterodimers considered functionally active forms receptors vivo
0.22530045.9717844.html.plaintext.txt	21	However RXR receptor capable forming heterodimers nuclear receptors
0.22530045.9717844.html.plaintext.txt	22	TR 17 18 COUP TF 19 20 21 PPAR 22 small heterodimer partner SHP 23 reported form heterodimers receptors
0.22530045.9717844.html.plaintext.txt	23	Interestingly although heterodimerization RXR usually results enhanced transactivation COUP TF SHP seem function primarily transcriptional repressors 23 24 25 26 27 28
0.22530045.9717844.html.plaintext.txt	24	Heterodimer formation generate many different combinations receptors particularly light fact multiple genes multiple isoforms exist RAR RXR TR COUP TF PPAR
0.22530045.9717844.html.plaintext.txt	25	As expression isoform depends cell type stage growth development heterodimerization among receptors results formation extremely diverse group receptors
0.22530045.9717844.html.plaintext.txt	26	In principle enormous number heterodimer combinations could cover wide range transcriptional activities thus generating significant diversity gene regulation
0.22530045.9717844.html.plaintext.txt	27	Herein show estrogen receptor ER directly binds protein protein interactions ligand binding domains HNF4 TR RAR RXR adding complexity already complicated list heteromeric interactions
0.22530045.9717844.html.plaintext.txt	28	We also confirmed results 29 30 newly cloned ER named ERss interacts ER
0.22530045.9717844.html.plaintext.txt	29	In parallel COUP TF 31 estrogen related receptor 1 ERR1 32 SHP D
0.22530045.9717844.html.plaintext.txt	30	Moore personal communications shown interact ER manuscript preparation
0.22530045.9717844.html.plaintext.txt	31	We show coexpression native TR RAR RXR differentially regulates transactivations ER yeast CV1 cells
0.22530045.9717844.html.plaintext.txt	32	These results suggest ER common interaction partner subset receptors interactions mediate novel signaling pathways vivo
0.22530045.9717844.html.plaintext.txt	33	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES ER Interacts Subset Nuclear Receptors Yeast We found coexpression previously described B42RXR LBD hybrid 33 stimulates LexAER LBD LexA fusion protein LBD ER mediated LacZ reporter gene expression yeast two hybrid tests suggesting ER LBD interacts RXR LBD Fig
0.22530045.9717844.html.plaintext.txt	34	This LacZ expression stimulated approximately 1
0.22530045.9717844.html.plaintext.txt	35	5 fold presence 1 microM 9 cis RA
0.22530045.9717844.html.plaintext.txt	36	We found LexAER LBD mediated LacZ expression stimulated coexpressed analogous B42 fusions several receptors including RAR TR HNF4 ERss suggesting ER also interacts receptors Fig
0.22530045.9717844.html.plaintext.txt	37	The expression slightly enhanced 1 microM T3 B42TR coexpression whereas significantly stimulated 1 microM E2 B42ERss coexpression 3 fold Fig
0.22530045.9717844.html.plaintext.txt	38	In addition showed inert transactivator LexAERss stimulated LacZ reporter gene expression approximately 6
0.22530045.9717844.html.plaintext.txt	39	5 fold coexpressed B42ERss confirming recently reported ERss homodimerization 29 30 yeast system Fig
0.22530045.9717844.html.plaintext.txt	40	In contrast coexpression B42 alone B42 fusions LBDs TRss glucocorticoid receptor GR orphan receptor CAR 34 stimulate LexAER LBD mediated LacZ expression attesting specificity interactions
0.22530045.9717844.html.plaintext.txt	41	Similarly expressions B42 fusions alone LexA fusion coexpressed transcriptionally inert LacZ reporter data shown
0.22530045.9717844.html.plaintext.txt	42	However B42TR LBD coexpression stimulated LexAER LBD mediated LacZ expression approximately 2
0.22530045.9717844.html.plaintext.txt	43	5 fold presence 1 microM T3 raising possibility TR LBD may contain T3 inducible interaction domain ER
0.22530045.9717844.html.plaintext.txt	44	From results concluded ER LBD may interact RAR RXR LBD TR TRss LBD presence T3 HNF4 LBD ERssL LBDs likely sufficient
0.22530045.9717844.html.plaintext.txt	45	It noteworthy LacZ expression strength coexpression ER heterocomplexes generally comparable previously described TRRXR heterodimer 33 Fig
0.22530045.9717844.html.plaintext.txt	46	1B compare results LexATR LBD B42RXR LBD
0.22530045.9717844.html.plaintext.txt	47	Overall similarities pattern interactions observed LexAER LBD LexARXR LBD 33 35 36 strongly suggest ER like RXRs common interaction partner members receptor superfamily
0.22530045.9717844.html.plaintext.txt	48	View larger version 25K Figure 1
0.22530045.9717844.html.plaintext.txt	49	ER Binds Subset Nuclear Receptors Yeast
0.22530045.9717844.html.plaintext.txt	50	EGY48 cells ss galactosidase expression dependent presence transcriptional activator LexA DNA binding domain transformed plasmids expressing indicated LexA B42 chimeras
0.22530045.9717844.html.plaintext.txt	51	These cells grown liquid culture containing galactose since expression B42 chimeras control galactose inducible GAL1 promoter 33
0.22530045.9717844.html.plaintext.txt	52	ss Galactosidase readings determined corrected cell density time development A415A600 x 1000min
0.22530045.9717844.html.plaintext.txt	53	The result average least three different experiments SDs less 5
0.22530045.9717844.html.plaintext.txt	54	A Open bars indicate hormone added
0.22530045.9717844.html.plaintext.txt	55	Light hatched bars indicate presence 1 microM E2
0.22530045.9717844.html.plaintext.txt	56	Thick hatched bars indicate presence 1 microM 9 cis RA B42RAR B42RXR LBD T3 B42TR B42TR LBD
0.22530045.9717844.html.plaintext.txt	57	Black bars indicate presence 1 microM E2 plus 1 microM T3 B42TR B42TR LBD 1 microM E2 plus 1 microM 9 cis RA B42RAR B42RXR LBD
0.22530045.9717844.html.plaintext.txt	58	B Open bars indicate hormone added
0.22530045.9717844.html.plaintext.txt	59	Light hatched bars indicate presence 1 microM T3
0.22530045.9717844.html.plaintext.txt	60	Thick hatched bars indicate presence 1 microM 9 cis RA
0.22530045.9717844.html.plaintext.txt	61	Black bars indicate presence 1 microM E2 plus 1 microM 9 cis RA
0.22530045.9717844.html.plaintext.txt	62	To confirm whether various ligand dependent stimulations LacZ expressions observed reflect genuine ligand dependent protein protein interactions simply ligand dependent transactivations mediated AF2 domains 1 reexamined LacZ expressions two previously defined AF2 mutant receptors LexATR LBD459 33 B42RXR LBDAF2 36
0.22530045.9717844.html.plaintext.txt	63	1B 9 cis RA dependent induction LacZ expression observed coexpression B42RXR LBD LexATR LBD lost B42RXR LBDAF2 coexpressed instead whereas T3 dependent induction specifically lost LexATR LBD459 used
0.22530045.9717844.html.plaintext.txt	64	When LexATR LBD459 B42RXR LBDAF2 coexpressed neither T3 9 cis RA depedent induction LacZ expression observed
0.22530045.9717844.html.plaintext.txt	65	These results along previous finding 33 interactions LexATR B42RXR affected mutations AF2 domain TR clearly demonstrate protein protein interaction TR RXR ligand independent
0.22530045.9717844.html.plaintext.txt	66	Therefore results yeast two hybrid tests taken caution may represent true ligand dependent interactions
0.22530045.9717844.html.plaintext.txt	67	Thus characterized interactions using two additional methods
0.22530045.9717844.html.plaintext.txt	68	mammalian two hybrid tests glutathione S transferase GST pull downs
0.22530045.9717844.html.plaintext.txt	69	ER Interacts TR RAR RXR Mammalian Cells To examine whether ER binds receptors mammalian cells employed mammalian two hybrid system reproduces heteromeric receptor receptor interactions 37
0.22530045.9717844.html.plaintext.txt	70	2 cotransfection CV1 cells expression vectors VP16TR VP16RAR VP16RXR significantly increased Gal4ER LBD mediated induction Gal4 TK Luc reporter gene activity 4 7
0.22530045.9717844.html.plaintext.txt	71	5 fold induction respectively
0.22530045.9717844.html.plaintext.txt	72	Similar results obtained presence 0
0.22530045.9717844.html.plaintext.txt	73	1 microM cognate ligand suggesting interact ligand independent manner
0.22530045.9717844.html.plaintext.txt	74	As expected VP16 alone ineffective
0.22530045.9717844.html.plaintext.txt	75	Thus concluded ER capable constitutively binding TR RAR RXR mammalian cells
0.22530045.9717844.html.plaintext.txt	76	These results suggest various ligand dependent stimulations LacZ expression yeast Fig
0.22530045.9717844.html.plaintext.txt	77	1A may reflected ligand dependent transactivations AF2 domains suggested results shown Fig
0.22530045.9717844.html.plaintext.txt	78	View larger version 22K Figure 2
0.22530045.9717844.html.plaintext.txt	79	ER Binds Subset Nuclear Receptors Mammalian Cells
0.22530045.9717844.html.plaintext.txt	80	CV1 cells transfected ss galactosidase expression vector VP16 alone VP16TR VP16RAR VP16RXR expression vectors along reporter gene Gal4 TK Luc 37
0.22530045.9717844.html.plaintext.txt	81	Open bars indicate hormone added whereas hatched black bars indicate addition 0
0.22530045.9717844.html.plaintext.txt	82	1 microM T3 9 cis RA respectively
0.22530045.9717844.html.plaintext.txt	83	Normalized luciferase expressions triplicate samples presented relative ss galactosidase expressions SDs less 5
0.22530045.9717844.html.plaintext.txt	84	ER Binds TR RAR RXR Vitro To characterize interactions vitro GST fusions full length rat TRss human RAR RXR expressed purified tested interaction vitro translated full length human ER luciferase labeled 35Smethionine
0.22530045.9717844.html.plaintext.txt	85	As expected luciferase able interact GST proteins data shown
0.22530045.9717844.html.plaintext.txt	86	However ER readily interacted GSTTR GSTRAR GSTRXR either presence absence ligand Fig
0.22530045.9717844.html.plaintext.txt	87	ER didn interact GST alone GSTGR expected
0.22530045.9717844.html.plaintext.txt	88	In contrast ER bound GST fusion receptor binding domain SRC 1 GSTSRC R 38 E2 stimulated manner Fig
0.22530045.9717844.html.plaintext.txt	89	The percentage total 35SER bound fusion proteins approximately 15 30 inputs data shown E2 dependent fold increase pull 35SER GSTSRC R approximately 4 5 fold
0.22530045.9717844.html.plaintext.txt	90	From results concluded ER constitutively binds TR RAR RXR direct protein protein interactions
0.22530045.9717844.html.plaintext.txt	91	In particular results along mammalian two hybrid tests Fig
0.22530045.9717844.html.plaintext.txt	92	2 suggest least ligand dependent stimulation LacZ expression observed yeast two hybrid tests Fig
0.22530045.9717844.html.plaintext.txt	93	1 resulted ligand induced transactivations rather ligand induced protein protein interactions
0.22530045.9717844.html.plaintext.txt	94	View larger version 20K Figure 3
0.22530045.9717844.html.plaintext.txt	95	Luciferase ER LBD labeled 35Smethionine vitro translation incubated glutathione beads containing GST alone GST fusions TRss A RAR B RXR C SRC R GR D
0.22530045.9717844.html.plaintext.txt	96	Beads washed specifically bound material eluted reduced glutathione resolved SDS PAGE
0.22530045.9717844.html.plaintext.txt	97	denotes hormone added 0
0.22530045.9717844.html.plaintext.txt	98	1 microM ligand added indicated
0.22530045.9717844.html.plaintext.txt	99	Function ER Heterocomplexes We previously shown LexATR LBD requires coexpression native RXR efficient T3 dependent transactivation yeast 33
0.22530045.9717844.html.plaintext.txt	100	Similar LexATR LBD LexAER LBD alone inert transactivator either presence absence E2 previously described LacZ reporter gene controlled upstream LexA binding sites yeast 33
0.22530045.9717844.html.plaintext.txt	101	To gain insights functional consequences interactions vivo coexpressed holo proteins ER interacting receptors LexAER LBD expressing yeast cells
0.22530045.9717844.html.plaintext.txt	102	Interestingly RAR RARss RXRss TR TRss dramatically enhanced basal transcriptional activities LexAER LBD Fig
0.22530045.9717844.html.plaintext.txt	103	Coexpression RAR led approximately 2 fold induction basal transcriptional activities enhanced approximately 2 fold addition 1 microM 9 cis RA
0.22530045.9717844.html.plaintext.txt	104	Interestingly coexpression RXR RXR induced LexAER LBD mediated LacZ expression presence 1 microM 9 cis RA
0.22530045.9717844.html.plaintext.txt	105	basal level expression affected coexpression two receptors Fig
0.22530045.9717844.html.plaintext.txt	106	These results indicate coexpression native receptors differentially regulate transactivations ER yeast attesting possible functional significance interactions vivo
0.22530045.9717844.html.plaintext.txt	107	View larger version 34K Figure 4
0.22530045.9717844.html.plaintext.txt	108	Modulation LexAER LBD Coexpressed Holo nuclear Receptors Yeast
0.22530045.9717844.html.plaintext.txt	109	EGY48 cells ss galactosidase expression dependent presence transcriptional activator LexA DBD transformed plasmids expressing LexAER LBD indicated holo nuclear receptors
0.22530045.9717844.html.plaintext.txt	110	Open bars indicate hormone added
0.22530045.9717844.html.plaintext.txt	111	Light hatched bars indicate presence 1 microM E2
0.22530045.9717844.html.plaintext.txt	112	Thick hatched bars indicate presence 1 microM 9 cis RA RARs RXRs T3 TRs
0.22530045.9717844.html.plaintext.txt	113	Black bars indicate presence 1 microM E2 plus 1 microM T3 TRs 1 microM E2 plus 1 microM 9 cis RA RARs RXRs
0.22530045.9717844.html.plaintext.txt	114	ss Galactosidase readings determined corrected cell density time development A415A600 x 1000min
0.22530045.9717844.html.plaintext.txt	115	The result average least three different experiments SDs less 5
0.22530045.9717844.html.plaintext.txt	116	To assess functional consequences interactions mammalian cells TR RAR RXR cotransfected CV1 cells along ER expression vector reporter construct controlled ERE ERE TK CAT ERE TK Luc
0.22530045.9717844.html.plaintext.txt	117	1 microM E2 stimulated ER mediated reporter gene expression approximately 5 7 fold absence cotransfected receptors
0.22530045.9717844.html.plaintext.txt	118	Coexpression TR however significantly stimulated basal E2 induced transactivations ER 4 2 fold respectively
0.22530045.9717844.html.plaintext.txt	119	Interestingly weak additive effect observed TR coexpression
0.22530045.9717844.html.plaintext.txt	120	E2 plus T3 resulted approximately 1
0.22530045.9717844.html.plaintext.txt	121	5 fold higher activities E2 alone Fig
0.22530045.9717844.html.plaintext.txt	122	5A see results 50 ng TR cotransfected
0.22530045.9717844.html.plaintext.txt	123	Coexpression RAR affect basal level transactivations ER
0.22530045.9717844.html.plaintext.txt	124	However repressed E2 induced transactivation almost basal level Fig
0.22530045.9717844.html.plaintext.txt	125	In contrast coexpression RXR modestly stimulated E2 induced transactivations ER
0.22530045.9717844.html.plaintext.txt	126	The basal level transactivations ER however affected RXR coexpression
0.22530045.9717844.html.plaintext.txt	127	Similarly coexpression ER inhibited 9 cis RA induced transactivations reporter construct controlled ss retinoic acid response element data shown
0.22530045.9717844.html.plaintext.txt	128	In addition cotransfection results varied depending cell types receptor isotypes suggesting factors contribute final phenotype ER heterocomplex M
0.22530045.9717844.html.plaintext.txt	129	These results along yeast coexpression results Fig
0.22530045.9717844.html.plaintext.txt	130	4 suggest ER heterocomplexes differentially modulate ER mediated transcriptional activites vivo
0.22530045.9717844.html.plaintext.txt	131	View larger version 20K Figure 5
0.22530045.9717844.html.plaintext.txt	132	Differential Activites ER Heterocompexes Mammalian Cells
0.22530045.9717844.html.plaintext.txt	133	CV1 cells transfected ss galactosidase expression vector increasing amounts TR RAR RXR expression vectors along reporter gene ERE TK LUC A ERE TK CAT B indicated
0.22530045.9717844.html.plaintext.txt	134	Cells unstimulated open bars stimulated 0
0.22530045.9717844.html.plaintext.txt	135	1 microM E2 light hatched bars 0
0.22530045.9717844.html.plaintext.txt	136	1 microM T3 thick hatched bars 0
0.22530045.9717844.html.plaintext.txt	137	Normalized luciferase expressions triplicate samples presented relative ss galactosidase expressions SDs less 5
0.22530045.9717844.html.plaintext.txt	138	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES It demonstrated control E2 responsive gene regulation quite complex reviewed Ref
0.22530045.9717844.html.plaintext.txt	139	Several lines evidence indicated gene regulation E2 ERE involves ER also transcription factors
0.22530045.9717844.html.plaintext.txt	140	For example nuclear receptors TR RXR COUP TF ERR1 RAR shown interact EREs addition cognate response elements 40 41 42
0.22530045.9717844.html.plaintext.txt	141	In report clearly shown ER along RXR common interaction partner subset receptors suggesting E2 responsive gene regulation may also involve direct protein protein interactions nuclear receptors
0.22530045.9717844.html.plaintext.txt	142	In particular interesting possibility different ER heterocomplexes may mediate novel signaling pathways DNA binding sites distinct conventional EREs
0.22530045.9717844.html.plaintext.txt	143	In contrast broad positive effects RXR ER heterointeractions led differential regulation transactivations ER Figs
0.22530045.9717844.html.plaintext.txt	144	In addition cotransfection results dramatically varied depending cell types CV1 vs
0.22530045.9717844.html.plaintext.txt	145	MCF7 cells instance receptor isotypes M
0.22530045.9717844.html.plaintext.txt	146	These differential regulations may result direct bindings ER heterodimers ERE either positively negatively regulates E2 induced gene expression
0.22530045.9717844.html.plaintext.txt	147	Alternatively formation non ERE binding heterodimer may simply inhibit E2 induced gene expression allow positive negative acting proteins occupy EREs instead
0.22530045.9717844.html.plaintext.txt	148	Despite extensive efforts however able find intermediate heterodimer bindings inhibitions ER bindings ERE ER interacting receptors electrophoresis mobility shift assays EMSA data shown
0.22530045.9717844.html.plaintext.txt	149	Similarly heterodimers COUP TFER 31 ERR1ER 32 SHPER D
0.22530045.9717844.html.plaintext.txt	150	Moore personal communications readily detected solution observed bind EREs EMSA
0.22530045.9717844.html.plaintext.txt	151	In parallel two recent reports showed interaction COUP TF orphan receptors nurr77 20 HNF4 21 solution bound DNA
0.22530045.9717844.html.plaintext.txt	152	These results consistent possibility ERreceptors may bind EREs heterodimer higher order complex stable enough sustain EMSA
0.22530045.9717844.html.plaintext.txt	153	These weak complexes may show distinct phenotypes differentially interacting proteins recently defined transcription cofactors often receptor cell type specific reviewed Ref
0.22530045.9717844.html.plaintext.txt	154	Consistent possibility xSRC 3 SRC 1 homolog recently isolated Xenopus found show unexpected specificity tissue distribution receptor interactions 44
0.22530045.9717844.html.plaintext.txt	155	Even though oligomeric status ER heterocomplexes currently known two lines evidence attest specificity protein protein interactions ER receptors
0.22530045.9717844.html.plaintext.txt	156	First series chimeric HNF4s recently constructed define HNF4 homodimeric interactions RXR heterodimeric interactions 10 differentially interacted ER unpublished results
0.22530045.9717844.html.plaintext.txt	157	Second isolated mutant RXRs show specifically impaired interactions ER maintaining wild type interactions receptors unpublished results
0.22530045.9717844.html.plaintext.txt	158	Similar chimeric HNF4s mutations also reside within I box RXR recently found essential homo heterodimer formations 9 10 suggesting HNF4 RXR exploit conventional dimerization domains I box interact ER
0.22530045.9717844.html.plaintext.txt	159	Recently DNA binding pattern RXR shown regulated ligand dependent modulation oligomeric state dimer vs
0.22530045.9717844.html.plaintext.txt	160	tetramer tetramerization domain defined distinct dimerization domain I box 45
0.22530045.9717844.html.plaintext.txt	161	Thus mutational studies within newly defined tetramerization domain RXR well mapping regions ER essential interactions required clearly decode oligomeric status ER heterocomplexes
0.22530045.9717844.html.plaintext.txt	162	The LexA based yeast two hybrid system presents two possible complications study protein protein interactions
0.22530045.9717844.html.plaintext.txt	163	First full length LexA used system contains dimerization domain could complicate interpretation interaction results particularly dimerization prerequisite two target proteins interact
0.22530045.9717844.html.plaintext.txt	164	Second system cannot distinguish genuine ligand dependent protein protein interactions ligand dependent transactivations
0.22530045.9717844.html.plaintext.txt	165	For instance ligand induced stimulations LacZ expressions LexATR B42RXR LBD coexpressed shown reflect ligand dependent transactivations mediated AF2 domains TR RXR Fig
0.22530045.9717844.html.plaintext.txt	166	With complications methods GST pull downs employed probe protein protein interactions
0.22530045.9717844.html.plaintext.txt	167	The interactions ER TR RAR RXR hormone independent mammalian two hybrid tests GST pull downs suggesting seemingly hormone dependent interactions yeast Fig
0.22530045.9717844.html.plaintext.txt	168	1 may hormone dependent transactivations AF2 domains
0.22530045.9717844.html.plaintext.txt	169	The T3 dependent stimulation LacZ expression TR LBD ER LBD coexpressed Fig
0.22530045.9717844.html.plaintext.txt	170	1A may also reflected T3 dependent transactivations AF2 domain TR
0.22530045.9717844.html.plaintext.txt	171	The basal interactions proteins might low detect yeast system however became detectable aid activated transactivations AF2 domain upon T3 addition Fig
0.22530045.9717844.html.plaintext.txt	172	1A see results LexAER LBD B42TR LBD
0.22530045.9717844.html.plaintext.txt	173	The physiological implications interactions accumulating
0.22530045.9717844.html.plaintext.txt	174	For instance manipulations T3 E2in vitro shown potentiate mutually inhibit effects gene expression 40 46 47
0.22530045.9717844.html.plaintext.txt	175	Environmental conditions alter levels circulating T3 cold temperature also shown alter E2 dependent female reproductive behavior 48 49 50 51
0.22530045.9717844.html.plaintext.txt	176	TR recently shown attenuate ER mediated transactivations vit A2 consensus ERE necessarily dependent DNA binding TR DNA binding mutant still able inhibit E2 dependent transactivation 52 53
0.22530045.9717844.html.plaintext.txt	177	However similar conditions observed modest enhancement ERE mediated transactivations either liganded unliganded ER cotransfected TR Fig
0.22530045.9717844.html.plaintext.txt	178	The reasons discrepancy currently known
0.22530045.9717844.html.plaintext.txt	179	In addition retinoids shown inhibit growth hormone dependent breast cancer cells vivo vitro 54 55 56
0.22530045.9717844.html.plaintext.txt	180	Nonadditive inhibition demonstrated retinoids antiestrogens suggesting agent may produce common antiestrogenic effects
0.22530045.9717844.html.plaintext.txt	181	Recently synergistic interactions HNF3 HNF4 mediating apolipoprotein AI gene expression shown potentiated cotransfected ER 57 physical association ER HNF4 described report may play role
0.22530045.9717844.html.plaintext.txt	182	However physiological implications ERSHP D
0.22530045.9717844.html.plaintext.txt	183	Moore personal communications ERCOUP TF 31 ERERR1 32 interactions currently known
0.22530045.9717844.html.plaintext.txt	184	In conclusion found ER directly binds subset nuclear receptors protein protein interactions ligand binding domains ER heterocomplexes led differential regulation transactivations ER
0.22530045.9717844.html.plaintext.txt	185	From results propose ER common interaction partner subset receptors different ER heterocomplexes mediate novel signaling pathways vivo
0.22530045.9717844.html.plaintext.txt	186	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Hormones Yeast Cells Plasmids E2 T3 9 cis RA obtained Sigma Chemical Co
0.22530045.9717844.html.plaintext.txt	187	EGY48 cells lexA ss galactosidase reporter construct LexA B42 parental vectors reported 33 58
0.22530045.9717844.html.plaintext.txt	188	LexA B42 fusions LBDs GR CAR HNF4 RXR TRss well B42 fusion full length RAR previously described 10 33 35 36
0.22530045.9717844.html.plaintext.txt	189	The entire hinge ligand binding domains D E F amino acids 245 595 human ER subcloned EcoRI SalI sites LexA vector PCR using EcoRI XhoI site bearing primers construct LexAER LBD
0.22530045.9717844.html.plaintext.txt	190	LexA B42 fusions full length mouse ERss gift Dr
0.22530045.9717844.html.plaintext.txt	191	Vincent Giguere human TR similarly constructed
0.22530045.9717844.html.plaintext.txt	192	Yeast expression vectors YEP RXR YEP RXRss YEP RXR YEP RAR YEP RARss YEP RAR YEP TR YEP TRss described 33 59
0.22530045.9717844.html.plaintext.txt	193	Expressions holo chimeric receptor constructs confirmed Western analyses 33 58 59
0.22530045.9717844.html.plaintext.txt	194	T7 vector express full length hER expression vector GST fusions full length TRss RXR RAR gifts Dr
0.22530045.9717844.html.plaintext.txt	195	David Moore Baylor College Medicine 36
0.22530045.9717844.html.plaintext.txt	196	A PCR fragment encoding GR LBD human GR amino acids 484 777 cloned EcoRI SalI restriction sites pGEM4T Pharmacia Piscataway NJ construct GSTGR LBD
0.22530045.9717844.html.plaintext.txt	197	Mammalian expression vectors ER TR RXR RAR reporter constructs ERE TK CAT ERE TK Luc transfection indicator construct pRSV ss gal described 34 52 53 58
0.22530045.9717844.html.plaintext.txt	198	Vectors mammalian two hybrid tests gifts Dr
0.22530045.9717844.html.plaintext.txt	199	Ron Evans Salk Institute 37
0.22530045.9717844.html.plaintext.txt	200	All PCR based constructs sequenced mutation might erroneously introduced amplification
0.22530045.9717844.html.plaintext.txt	201	Yeast ss Galactosidase Assays The cotransformation transactivation assays yeast well quantitative liquid ss galactosidase assays performed following changes described previously 33
0.22530045.9717844.html.plaintext.txt	202	The yeast culture initially diluted A600 0
0.22530045.9717844.html.plaintext.txt	203	05 plated 96 well culture dishes various concentrations hormone
0.22530045.9717844.html.plaintext.txt	204	The cultures incubated dark 30 C 16 h
0.22530045.9717844.html.plaintext.txt	205	The A600 determined cells lysed substrate added A415 read 10 30 min
0.22530045.9717844.html.plaintext.txt	206	The normalized galactosidase values determined follows A415A600 x 1000min developed
0.22530045.9717844.html.plaintext.txt	207	For experiment least six independently derived colonies expressing chimeric receptors tested
0.22530045.9717844.html.plaintext.txt	208	Pull Down Assays GST fusion proteins produced Escherichia coli purified using glutathione Sepharose affinity chromatography essentially described 36
0.22530045.9717844.html.plaintext.txt	209	GST proteins bound glutathione Sepharose 4B beads Pharmacia binding buffer 50 mM KPO4 pH 6
0.22530045.9717844.html.plaintext.txt	210	0 100 mM KCl 10 mM MgCl2 10 glycerol 10 mgml E
0.22530045.9717844.html.plaintext.txt	211	Beads washed binding buffer incubated 60 min 4 C buffer equivalent amounts various proteins labeled 35Smethionine vitro translation
0.22530045.9717844.html.plaintext.txt	212	Nonbound proteins removed three washes binding buffer without E
0.22530045.9717844.html.plaintext.txt	213	coli extract specifically bound proteins eluted 50 mM reduced glutathione 0
0.22530045.9717844.html.plaintext.txt	214	Eluted proteins resolved PAGE visualized fluorography
0.22530045.9717844.html.plaintext.txt	215	Cell Culture Transfections CV1 cells grown 24 well plates medium supplemented 10 charcoal stripped serum
0.22530045.9717844.html.plaintext.txt	216	After 24 h incubation cells transfected 150 ng ss galactosidase expression vector pRSV ss gal 100 ng reporter gene ERE TK CAT ERE TK Luc along 10 ng ER increasing amounts 50 100 ng TR RAR RXR expression vector
0.22530045.9717844.html.plaintext.txt	217	Total amount expression vectors kept constant adding decreasing amounts CDM8 expression vector transfections containing increasing amounts TR RAR RXR vector
0.22530045.9717844.html.plaintext.txt	218	For mammalian two hybrid tests reporter gene Gal4 TK Luc vectors expressing VP16 VP16TR VP16RAR VP16RXR Gal4DBDER LBD expression vector used described 37
0.22530045.9717844.html.plaintext.txt	219	After 12 h cells washed refed DMEM containing 10 charcoal stripped FBS
0.22530045.9717844.html.plaintext.txt	220	After 12 h cells left unstimulated stimulated 0
0.22530045.9717844.html.plaintext.txt	221	Cells harvested 24 h later CAT luciferase activity assayed described 58 results normalized ss galactosidase expression
0.22530045.9717844.html.plaintext.txt	222	Similar results obtained two similar experiments
0.22530045.9717844.html.plaintext.txt	223	ACKNOWLEDGMENTS We thank Drs
0.22530045.9717844.html.plaintext.txt	224	Wongi Seol Yoon Kwang Lee David D
0.22530045.9717844.html.plaintext.txt	225	Moore valuable advice plasmids communications results publication
0.22530045.9717844.html.plaintext.txt	226	Vincent Giguere mERss Dr
0.22530045.9717844.html.plaintext.txt	227	Ron Evans mammalian two hybrid vectors
0.22530045.9717844.html.plaintext.txt	228	FOOTNOTES Address requests reprints Jae Woon Lee Ph
0.22530045.9717844.html.plaintext.txt	229	College Pharmacy Hormone Research Center Chonnam National University Kwangju 500 757 Korea
0.22530045.9717844.html.plaintext.txt	230	This research supported grants KOSEF 96 0401 08 01 3 HRC
0.22530045.9717844.html.plaintext.txt	231	Received publication January 13 1998
0.22530045.9717844.html.plaintext.txt	232	Revision received April 6 1998
0.22530045.9717844.html.plaintext.txt	233	Accepted publication April 13 1998
0.22530045.9717844.html.plaintext.txt	234	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mangelsdorf DJ Thummel C Beato M Herrlich P Schutz G Umesono K Blumberg B Kastner P Mark M Chambon P Evans RM 1995 The nuclear receptor superfamily second decade
0.22530045.9717844.html.plaintext.txt	235	Cell 83835 839Medline Mangelsdorf DJ Evans RM 1995 The RXR heterodimers orphan receptors
0.22530045.9717844.html.plaintext.txt	236	Cell 83841 850Medline Towers TL Luisi BF Asianov A Freedman LP 1993 DNA target selectivity vitamin D3 receptor mechanism dimer binding asymmetric repeat element
0.22530045.9717844.html.plaintext.txt	237	Proc Natl Acad Sci USA 906310 6314Abstract Perlman T Rangarajan PN Umesono K Evans RM 1993 Determinants selective RAR TR recognition direct repeat HREs
0.22530045.9717844.html.plaintext.txt	238	Genes Dev 71411 1422Abstract Zechel C Shen X Q Chambon P Gronemeyer H 1994 Dimerization interfaces formed DNA binding domains determine cooperative binding RXRRAR RXRTR heterodimers DR5 DR4 elements
0.22530045.9717844.html.plaintext.txt	239	EMBO J 131414 1424Abstract Zechel C Shen X Q Chen J Y Chen Z P Chambon P Gronemeyer H 1994 The dimerization interfaces formed DNA binding domains RXR RAR TR determine binding specificity polarity full length receptors direct repeats
0.22530045.9717844.html.plaintext.txt	240	EMBO J 131425 1433Abstract Predki PF Zamble D Sarkar B Giguere V 1994 Ordered binding retinoic acid retinoid X receptors asymmetric response elements involves determinants adjacent DNA binding domain
0.22530045.9717844.html.plaintext.txt	241	Mol Endocrinol 831 39Abstract Rastinejad F Perlmann T Evans RM Sigler PB 1995 Structural determinants nuclear receptor assembly DNA direct repeats
0.22530045.9717844.html.plaintext.txt	242	Nature 375203 211CrossRefMedline Perlmann T Umesono K Rangarajan PN Forman BM Evans RM 1996 Two distinct dimerization interfaces differentially modulate target gene specificity nuclear hormone receptors
0.22530045.9717844.html.plaintext.txt	243	Mol Endocrinol 10958 966Abstract Lee S K Na S Y Kim H J Soh J Choi H S Lee JW 1998 Identification critical residues heterodimerization within ligand binding domain retinoid X receptor
0.22530045.9717844.html.plaintext.txt	244	Mol Endocrinol 12325 332AbstractFree Full Text Yu VC Delsert C Andersen B Holloway JM Devary OV Naar AM Kim SY Boutin JM Glass CK Rosenfeld MG 1991 RXR beta corregulator enhances binding retinoic acid thyroid hormone vitamin D receptors cognate response elements
0.22530045.9717844.html.plaintext.txt	245	Cell 671251 1266Medline Kliewer SA Umesono K Mangelsdorf DJ Evans RM 1992 Retinoid X receptor interacts nuclear receptors retinoic acid thyroid hormone vitamin D3 signalling
0.22530045.9717844.html.plaintext.txt	246	Nature 355446 449CrossRefMedline Leid MP Kastner R Lyons R Nakshatri H Saunders M Zacharewski T Chen JY Staub A Garnier JM Mader S Chambon P 1992 Purification cloning RXR identity HeLa cell factor RAR TR heterodimers bind target sequences efficiently
0.22530045.9717844.html.plaintext.txt	247	Cell 68377 395Medline Zhang XK Hoffmann B Tran PB Graupner G Pfahl M 1992 Retinoid X receptor auxiliary protein thyroid hormone retinoic acid receptors
0.22530045.9717844.html.plaintext.txt	248	Nature 355441 446CrossRefMedline Marks MS Hallenbeck PL Nagata T Segars JH Appella E Nikodem VM Ozato K 1992 H 2RIIBP RXR beta heterodimerization provides mechanism combinatorial diversity regulation retinoic acid thyroid hormone responsive genes
0.22530045.9717844.html.plaintext.txt	249	EMBO J 111419 1435Abstract Bugge TH Pohl J Lonnoy O Stunnenberg HG 1992 RXR alpha promiscuous partner retinoic acid thyroid hormone receptors
0.22530045.9717844.html.plaintext.txt	250	EMBO J 111409 1418Abstract Umesono K Giguere V Glass CK Rosenfeld MG Evans RM 1988 Retinoic acid thyroid hormone induce gene expression common responsive element
0.22530045.9717844.html.plaintext.txt	251	Nature 336262 265CrossRefMedline Schrader M Muller KM Nayeri S Kahlen JP Carlberg C 1994 Vitamin D3 thyroid hormone receptor heterodimer polarity directs ligand sensitivity transactivation
0.22530045.9717844.html.plaintext.txt	252	Nature 370382 386CrossRefMedline Berrodin TJ Marks MS Ozato K Linney E Lazar MA 1992 Heterodimerization among thyroid hormone receptor retinoic acid receptor retinoid X receptor chick ovalbumin upstream promoter transcription factor endogenous liver protein
0.22530045.9717844.html.plaintext.txt	253	Mol Endocrinol 61468 1478Abstract Wu Q Li Y Liu R Agadir A Lee MO Liu Y Zhang X 1997 Modulation retinoic acid sensitivity lung cancer cells dynamic balance orphan receptors nur77 COUP TF heterodimerization
0.22530045.9717844.html.plaintext.txt	254	EMBO J 161656 1669AbstractFree Full Text Ktistaki E Talianidis I 1997 Chicken ovalbumin upstream promoter transcription factors act auxiliary cofactors hepatocyte nuclear factor 4 enhance hepatic gene expression
0.22530045.9717844.html.plaintext.txt	255	Mol Cell Biol 172790 2797Abstract Bogazzi F Hudson LD Nikodem VM 1994 A novel heterodimerization partner thyroid hormone receptor
0.22530045.9717844.html.plaintext.txt	256	J Biol Chem 26911683 11686AbstractFree Full Text Seol W Choi H S Moore DD 1996 An orphan nuclear hormone receptor lacks DNA binding domain heterodimerizes receptors
0.22530045.9717844.html.plaintext.txt	257	Science 2721336 1339Abstract Cooney AJ Tsai SY O Malley BW Tsai M J 1992 Chicken ovalbumin upstream promoter transcription factor COUP TF dimer binds different GGTCA response elements allowing COUP TF repress hormonal induction vitamin D3 thyroid hormone retinoic acid receptors
0.22530045.9717844.html.plaintext.txt	258	Mol Cell Biol 124153 4163Abstract Cooney AJ Leng X Tsai SY O Malley BW Tsai M J 1993 Multiple mechanisms chicken ovalbumin upstream promoter transcription factor dependent repression transactivation vitamin D3 thyroid hormone retinoic acid receptors
0.22530045.9717844.html.plaintext.txt	259	J Biol Chem 2684152 4160AbstractFree Full Text Kliewer SA Umesono K Heyman RA Mangelsdorf DJ Dyck JA Evans RM 1992 Retinoid X receptor COUP TF interactions modulate retinoic acid signalling
0.22530045.9717844.html.plaintext.txt	260	Proc Natl Acad Sci USA 891448 1452Abstract Tran PBV Zhang XK Salbert G Hermann T Lehmann JM Pfahl M 1992 COUP orphan receptors negative regulators retinoic acid response pathways
0.22530045.9717844.html.plaintext.txt	261	Mol Cell Biol 124666 4676Abstract Widom RL Rhee M Karathanasis SK 1992 Repression ARP 1 sensitizes apolipoprotein A1 gene responsiveness RXR alpha retinoic acid
0.22530045.9717844.html.plaintext.txt	262	Mol Cell Biol 123380 3389Abstract Pace P Taylor J Suntharalingam S Coombes RC Ali S 1997 Human estrogen receptor beta binds DNA manner similar dimerizes estrogen receptor alpha
0.22530045.9717844.html.plaintext.txt	263	J Biol Chem 27225832 25838AbstractFree Full Text Pettersson K Grandien K Kuiper GG Gustafsson JA 1997 Mouse estrogen receptor beta forms estrogen response element binding heterodimers estrogen receptor alpha
0.22530045.9717844.html.plaintext.txt	264	Mol Endocrinol 111486 1496AbstractFree Full Text Klinge CM Silver BF Driscoll MD Sathya G Bambara RA Hilf R 1997 Chicken ovalbumin upstream promoter transcription factor interacts estrogen receptor binds estrogen response elements half sites inhibits estrogen induced gene expression
0.22530045.9717844.html.plaintext.txt	265	J Biol Chem 27231465 31474AbstractFree Full Text Johnston SD Liu X Zuo F Eisenbraun TL Wiley SR Kraus RJ Mertz JE 1997 Estrogen related receptor 1 functionally binds monomer extended half site sequences including ones contained within estrogen response elements
0.22530045.9717844.html.plaintext.txt	266	Mol Endocrinol 11342 352AbstractFree Full Text Lee JW Moore DD Heyman RA 1994 A chimeric T3 receptor constitutively bound DNA requires retinoid X receptor hormone dependent transcriptional activation yeast
0.22530045.9717844.html.plaintext.txt	267	Mol Endocrinol 81245 1253Abstract Choi HS Chung M Tzameli I Simha D Lee YK Seol W Moore DD 1997 Differential transactivation two isoforms orphan nuclear hormone receptor CAR
0.22530045.9717844.html.plaintext.txt	268	J Biol Chem 27223565 23571AbstractFree Full Text Lee JW Choi HS Gyuris J Brent R Moore DD 1995 Two classes proteins dependent either presence absence thyroid hormone interaction thyroid hormone receptor
0.22530045.9717844.html.plaintext.txt	269	Mol Endocrinol 9243 254Abstract Zavacki AM Lehmann JM Seol W Wilson TM Kliewer SA Moore DD 1997 Activation orphan receptor RIP14 retinoids
0.22530045.9717844.html.plaintext.txt	270	Proc Natl Acad Sci USA 947909 7914AbstractFree Full Text Forman BM Umesono K Chen J Evans RM 1995 Unique response pathways established allosteric interactions among nuclear hormone receptors
0.22530045.9717844.html.plaintext.txt	271	Cell 81541 550Medline Onate SA Tsai SY Tsai MJ O Malley BM 1995 Sequence characterization coactivator steroid hormone receptor superfamily
0.22530045.9717844.html.plaintext.txt	272	Science 2701354 1357Abstract Gronemeyer H 1991 Transcription activation estrogen progesterone receptors
0.22530045.9717844.html.plaintext.txt	273	Annu Rev Genet 2589 123CrossRefMedline Glass CK Holloway JM Devary OV Rosenfeld MG 1988 The thyroid hormone receptor binds opposite transcriptional effects common sequence motif thyroid hormone estrogen response elements
0.22530045.9717844.html.plaintext.txt	274	Cell 54313 323Medline Segars JH Marks MS Hirschfeld S Driggers PH Martinez E Grippo JF Wahli W Ozato K 1993 Inhibition estrogen responsive gene activation retinoid X receptor ss evidence multiple inhibitory pathways
0.22530045.9717844.html.plaintext.txt	275	Mol Cell Biol 132258 2268Abstract Savouret J F Rauch M Redeuilh G Sokhavuth S Chauchereau A Woodruff K Parker MG Milgrom E 1994 Interplay estrogens progestins retinoic aicd AP 1 single regulatory site progesterone receptor gene
0.22530045.9717844.html.plaintext.txt	276	J Biol Chem 26928955 28962AbstractFree Full Text Horwitz KB Jackson TA Bain DL Richer JK Takimoto GS Tung L 1996 Nuclear receptor coactivators corepressors
0.22530045.9717844.html.plaintext.txt	277	Mol Endocrinol 101167 1177Abstract Kim H J Lee S K Na S Y Choi H S Lee JW 1998 Molecular cloning xSRC 3 novel transcription coactivator Xenopus related AIB1 pCIP TIF2
0.22530045.9717844.html.plaintext.txt	278	Mol Endocrinol 121038 1047AbstractFree Full Text Kersten S Reczek PR Noy N 1997 The tetramerization region retinoid X receptor important transcriptional activation receptor
0.22530045.9717844.html.plaintext.txt	279	J Biol Chem 27229759 29768AbstractFree Full Text Zhou Li F 1992 Antiestrogens prevent stimulatory effects L triiodothyronine cell proliferation
0.22530045.9717844.html.plaintext.txt	280	Endocrinology 1301145 1152Abstract Zhou Li F 1993 Interference estradiol L triiodothyronine control proliferation pituitary tumor cell line
0.22530045.9717844.html.plaintext.txt	281	J Steroid Biochem Mol Biol 45275 279CrossRefMedline Hoar RM Goy RW Young WC 1957 Loci action thyroid hormone reproduction female guinea pig
0.22530045.9717844.html.plaintext.txt	282	Endocrinology 60337 346 Piacsek BE Nazian SJ Thermal influences sexual maturation rat
0.22530045.9717844.html.plaintext.txt	283	In Gilmore D Cooke B eds Environmental Factors Mammalian Reproduction
0.22530045.9717844.html.plaintext.txt	284	McMillan London pp 215 231 Bronson FH 1985 Mammalian reproduction ecological perspective
0.22530045.9717844.html.plaintext.txt	285	Biol Reprod 311 26Abstract Schneider JE Wade GN 1990 Effects diet body fat cold induced anestrus Syrian hamsters
0.22530045.9717844.html.plaintext.txt	286	Am J Physiol 259R1198 R1204 Shu Y S Yen PM Chin WW Pfaff DW 1996 Estrogen thyroid hormone interaction regulation gene expression
0.22530045.9717844.html.plaintext.txt	287	Proc Natl Acad Sci USA 9312587 12592AbstractFree Full Text Scott REM Wu Peng XS Yen PM Chin WW Pfaff DW 1997 Interactions estrogen thyroid hormone receptors progesterone receptor estrogen response elements ERE sequence comparison vitellogenin A2 consensus ERE
0.22530045.9717844.html.plaintext.txt	288	Mol Endocrinol 111581 1592AbstractFree Full Text Fonatana JA 1987 Interaction retinoids tamoxifen inhibition human mammary carcinoma cell proliferation
0.22530045.9717844.html.plaintext.txt	289	Exp Cell Biol 55136 144Medline Ueda H Takenawa T Millan JC Gesell MS Brandes D 1980 The effects retinoids proliferative capacities macromolecular synthesis human breast cancer MCF 7 cells
0.22530045.9717844.html.plaintext.txt	290	Cancer 462203 2209Medline Fontana JA Miranda D Burrows Mezu A 1990 Retinoic acid inhibition human breast carcinoma proliferation accompanied inhibition synthesis Mr 39000 protein
0.22530045.9717844.html.plaintext.txt	291	Cancer Res 501977 1982Abstract Harnish DC Malik S Kilbourne E Costa R Karathanasis SK 1996 Control apolipoprotein A1 gene expression synergistic interactions hepatocyte nuclear factors 3 4
0.22530045.9717844.html.plaintext.txt	292	J Biol Chem 27113621 13628AbstractFree Full Text Ausubel FM Brent R Kingston RE Moore DD Seidman JG Smith JA Struhl K eds 1995 Current Protocols Molecular Biology
0.22530045.9717844.html.plaintext.txt	293	Greene Assoc New York Allegretto EA McClurg MR Lazarchik SB Clemm DL Kerner SA Elgort MG Boehm MF White SK Pike JW Heyman RA 1993 Transactivation properties retinoic acid retinoid X receptors mammalian cells yeast
0.22530045.9717844.html.plaintext.txt	294	Correlation hormone binding effects metabolism
0.22530045.9717844.html.plaintext.txt	295	J Biol Chem 26826625 26633AbstractFree Full Text
0.4186047.15855320.html.plaintext.txt	0	Essential Role Chicken Ovalbumin Upstream Promoter Transcription Factor II Insulin Secretion Insulin Sensitivity Revealed Conditional Gene Knockout Pascale Bardoux1 Pili Zhang1 Daisy Flamez2 Anais Perilhou1 Tiphaine Aguirre Lavin1 Jean Francois Tanti3 Karine Hellemans4 Emmanuel Gomas1 Cecile Godard1 Fabrizio Andreelli5 Maria Antonietta Buccheri1 Axel Kahn1 Yannick Le Marchand Brustel3 Remy Burcelin6 Frans Schuit4 Mireille Vasseur Cognet1
0.4186047.15855320.html.plaintext.txt	1	1 Department Genetic Development Molecular Biology Universite Rene Descartes Institut Cochin INSERM U567 Institut National de la Sante et de la Recherche Medicale Centre National de la Recherche Scientifique UMR 8104 Paris France 2 Diabetes Research Center Faculty Medicine Vrije Universiteit Brussel Laarbeeklaan Brussels Belgium 3 Faculte de Medecine INSERM U568 Nice France 4 Gene Expression Unit Afdeling Biochemie Campus Gasthuisberg Katholieke Universiteit Leuven Leuven Belgium 5 Service de Diabetologie Nutrition Centre Hospitalier Universitaire de Bichat Claude Bernard Paris France 6 Unite Mixte de Recherche 5018 Centre National de la Recherche Scientifique UPS IFR 31 Paul Sabatier University Toulouse France
0.4186047.15855320.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT RESULTS AND DISCUSSION RESEARCH DESIGN AND METHODS REFERENCES Chicken ovalbumin upstream promoter transcription factor II COUP TFII implicated control blood glucose potent effect expression signaling various nuclear receptors
0.4186047.15855320.html.plaintext.txt	3	To understand role COUP TFII glucose homeostasis conditional COUP TFII deficient mice generated crossed mice expressing Cre control rat insulin II gene promoter resulting deletion COUP TFII pancreatic ss cells
0.4186047.15855320.html.plaintext.txt	4	Homozygous mutants died birth yet undetermined reasons
0.4186047.15855320.html.plaintext.txt	5	Heterozygous mice appeared healthy birth showed normal growth fertility
0.4186047.15855320.html.plaintext.txt	6	When challenged intraperitoneally animals glucose intolerance associated reduced glucose stimulated insulin secretion
0.4186047.15855320.html.plaintext.txt	7	Moreover heterozygous mice presented mild increase fasting random fed circulating insulin levels
0.4186047.15855320.html.plaintext.txt	8	In accordance islets isolated animals exhibited higher insulin secretion low glucose conditions markedly decreased glucose stimulated insulin secretion
0.4186047.15855320.html.plaintext.txt	9	Their pancreata presented normal microscopic architecture insulin content 16 weeks study
0.4186047.15855320.html.plaintext.txt	10	Altered insulin secretion associated peripheral insulin resistance whole animals
0.4186047.15855320.html.plaintext.txt	11	It concluded COUP TFII new important regulator glucose homeostasis insulin sensitivity
0.4186047.15855320.html.plaintext.txt	12	The function differentiated ss cells dependent upon network transcription factors required expression key genes involved glucose sensing insulin biosynthesis regulated exocytosis 1 4
0.4186047.15855320.html.plaintext.txt	13	Disturbance network even mutations causing modest decrease protein level shown lead important clinical manifestations diabetes andor obesity
0.4186047.15855320.html.plaintext.txt	14	Chicken ovalbumin upstream promoter transcription factor II COUP TFII also called NR2F ARP 1 orphan member steroidthyroid hormone receptor superfamily binds DNA Zn finger DNA binding domain 5
0.4186047.15855320.html.plaintext.txt	15	COUP TFII generally considered functional transcriptional repressor genes controlled nuclear hormone receptors peroxisome proliferator activated receptors hepatocyte nuclear factor HNF 4 well known play important roles glucose responsive phenotype ss cells 67
0.4186047.15855320.html.plaintext.txt	16	The possibility COUP TFII might play role glucose homeostasis supported vitro studies suggesting protein involved regulating insulin gene expression pancreatic ss cells 8 also expression several genes involved glucose lipid metabolism 910
0.4186047.15855320.html.plaintext.txt	17	It shown COUP TFII expressed early developing endocrine pancreas mature differentiated islet cells 11
0.4186047.15855320.html.plaintext.txt	18	However potential function COUP TFII pancreatic ss cells remains unknown
0.4186047.15855320.html.plaintext.txt	19	One way address issue generate COUP TFII deficient mice
0.4186047.15855320.html.plaintext.txt	20	Since global COUP TFII deficiency results embryonic lethality 12 generated study conditional knockout COUP TFII gene using Cre loxP system
0.4186047.15855320.html.plaintext.txt	21	Our data show inactivation one COUP TFII allele ss cells results disturbed insulin secretion peripheral insulin resistance
0.4186047.15855320.html.plaintext.txt	22	RESULTS AND DISCUSSION TOP ABSTRACT RESULTS AND DISCUSSION RESEARCH DESIGN AND METHODS REFERENCES Conditional inactivation COUP TFII pancreatic ss cells
0.4186047.15855320.html.plaintext.txt	23	To achieve conditional knockout COUP TFII gene pancreatic ss cells using Cre loxP system first generated heterozygous COUP TFII floxed flwild type wt mice carrying one fl one wt COUP TFII allele Fig
0.4186047.15855320.html.plaintext.txt	24	Genotype analysis offspring intercrossing mice indicated homozygous COUP TFII flfl heterozygous COUP TF flwt pups present normal Mendelian frequency days E11
0.4186047.15855320.html.plaintext.txt	25	However half COUP TFII flfl pups died birth Fig
0.4186047.15855320.html.plaintext.txt	26	The surviving homozygous COUP TFII flfl mice indistinguishable wt littermates visual inspection fertile normal lifespan
0.4186047.15855320.html.plaintext.txt	27	View larger version 30K FIG
0.4186047.15855320.html.plaintext.txt	28	Assessment COUP TFII deletion pancreatic ss cell extrapancreatic cells Rip2 Cre
0.4186047.15855320.html.plaintext.txt	29	A Schematic representation genomic structure COUP TFII shows genomic map wt COUP TFII allele
0.4186047.15855320.html.plaintext.txt	30	The lower panels show targeted locus b c excision neomycin selection cassette Neo flanked one loxP upstream two loxP sites downstream exon 1 also shows position different primers used PCR analysis
0.4186047.15855320.html.plaintext.txt	31	Individual letters represent restriction sites
0.4186047.15855320.html.plaintext.txt	32	B One representative PCR analysis DNA samples
0.4186047.15855320.html.plaintext.txt	33	B brain L liver H hypothalamus P pancreatic islet SC spinal cord hep HepCre
0.4186047.15855320.html.plaintext.txt	34	COUP TFII flfl hepatocytes control profile excised fragment
0.4186047.15855320.html.plaintext.txt	35	C Western blot analysis islet nuclear extracts wild type lane 1 Cre
0.4186047.15855320.html.plaintext.txt	36	The lower panel represents blot stained red Ponceau upper panel blot hybridized COUP TF antibody
0.4186047.15855320.html.plaintext.txt	37	View larger version 15K FIG
0.4186047.15855320.html.plaintext.txt	38	COUP TFII flfl embryos produced breedings COUP TFII flfl Cre
0.4186047.15855320.html.plaintext.txt	39	COUP TFII flwt mice COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	40	5 days post coitum birth
0.4186047.15855320.html.plaintext.txt	41	Values parentheses indicate Mendelian frequencies expected breedings
0.4186047.15855320.html.plaintext.txt	42	Mice carrying COUP TFII gene inactivation pancreatic ss cells generated breeding homozygous COUP TFII flfl mice transgenic mice expressing Cre driven rat insulin II promoter Rip2 Cre generated Magnuson colleagues 1314
0.4186047.15855320.html.plaintext.txt	43	COUP TFII flwt females mated COUP TFII flwt males generate mice different genotypes
0.4186047.15855320.html.plaintext.txt	44	COUP TFII flfl mice embryonic lethal
0.4186047.15855320.html.plaintext.txt	45	Since precedents embryonic lethal phenotypes resulting ss cell specific gene deletions lethality together observations Magnuson colleagues 14 led us examine possible Cre induced deletion floxed COUP TFII allele tissues endocrine pancreas
0.4186047.15855320.html.plaintext.txt	46	Multiplex PCR analysis performed DNA prepared liver hypothalamus brain spinal cord Fig
0.4186047.15855320.html.plaintext.txt	47	We detected gene deletion spinal cord Cre
0.4186047.15855320.html.plaintext.txt	48	COUP TFII flwt mice previously demonstrated COUP TFII gene expressed ventral neural tube 9
0.4186047.15855320.html.plaintext.txt	49	Therefore extrapancreatic COUP TFII gene knockout could contribute observed lethality homozygous Cre
0.4186047.15855320.html.plaintext.txt	50	Multiplex PCR analysis DNA prepared islets isolated Cre
0.4186047.15855320.html.plaintext.txt	51	COUP TFII flwt mice confirmed one floxed allele deleted Fig
0.4186047.15855320.html.plaintext.txt	52	As judged immunoblotting COUP TF levels decreased 45 nuclear extracts prepared islets Cre
0.4186047.15855320.html.plaintext.txt	53	1C lane 2 compared wt mice Fig
0.4186047.15855320.html.plaintext.txt	54	These results indicate Cre induced recombination heterozygous Cre
0.4186047.15855320.html.plaintext.txt	55	COUP TFII flwt mice leads efficient inactivation COUP TFII gene ss cells
0.4186047.15855320.html.plaintext.txt	56	The expression COUP TFI closely related family member altered suggesting adaptative upregulation isoform occur Fig
0.4186047.15855320.html.plaintext.txt	57	View larger version 12K FIG
0.4186047.15855320.html.plaintext.txt	58	Steady state mRNA levels target genes Cre
0.4186047.15855320.html.plaintext.txt	59	COUP TFII flwt COUP TFII flwt pancreatic islets 3 4 month old mice
0.4186047.15855320.html.plaintext.txt	60	RT PCR analysis islet glucose sensing proteins COUP TFI transcription factor isolated islets
0.4186047.15855320.html.plaintext.txt	61	Eight different animals genotype used RT PCR using 32P dCTP
0.4186047.15855320.html.plaintext.txt	62	MutantCre COUP TFII flwtCre indicate ratio expression levels mean values Cre
0.4186047.15855320.html.plaintext.txt	63	COUP TFII flwt mutant COUP TFII flwt controls Cre wt
0.4186047.15855320.html.plaintext.txt	64	Finally understand lethality COUP TFII flfl pups examined whether inclusion loxP sites might interfere COUP TFII gene expression
0.4186047.15855320.html.plaintext.txt	65	Semiquantitative RT PCR analysis using A5HF R5HF primers showed liver kidney mRNA decreased 20 heterozygous floxed mice respect normal animals data shown
0.4186047.15855320.html.plaintext.txt	66	Accordingly COUP TFII protein analyzed Western blot also slightly decreased 10 20 hepatocyte nuclear extracts heterozygous floxed mice
0.4186047.15855320.html.plaintext.txt	67	Therefore floxed COUP TFII allele hypomorphic could explain death homozygous floxed COUP TFII pups
0.4186047.15855320.html.plaintext.txt	68	The present study carried Cre
0.4186047.15855320.html.plaintext.txt	69	COUP TFII flwt mice floxed allele inactivated Cre expressing cells shows hypomorphic tissues
0.4186047.15855320.html.plaintext.txt	70	Therefore COUP TFII protein expected decreased half former cells 10 20 latter ones
0.4186047.15855320.html.plaintext.txt	71	All results obtained mutant Cre
0.4186047.15855320.html.plaintext.txt	72	COUP TFII flwt mice compared control Cre wt COUP TFII flwt mice
0.4186047.15855320.html.plaintext.txt	73	COUP TFII flwt mice exhibit altered insulin secretion glucose challenge
0.4186047.15855320.html.plaintext.txt	74	Body weight food intake body composition assessed biphotonic absorptiometry Cre
0.4186047.15855320.html.plaintext.txt	75	COUP TFII flwt mice comparable three groups mice suggesting energy metabolism animals grossly abnormal Fig
0.4186047.15855320.html.plaintext.txt	76	However detailed analysis metabolic parameters fasted fed states revealed differences shown Fig
0.4186047.15855320.html.plaintext.txt	77	In fasted state Cre
0.4186047.15855320.html.plaintext.txt	78	COUP TFII flwt mice exhibited slightly lower plasma glucose P 0
0.4186047.15855320.html.plaintext.txt	79	01 free fatty acids reach statistical significance higher plasma insulin P 0
0.4186047.15855320.html.plaintext.txt	80	01 control COUP TFII flwt mice
0.4186047.15855320.html.plaintext.txt	81	Despite observed hypoglycemia plasma insulin glucagon ratio increased twofold Cre
0.4186047.15855320.html.plaintext.txt	82	COUP TFII flwt mice compared COUP TFII flwt wt mice ratio 3 Cre
0.4186047.15855320.html.plaintext.txt	83	In fed state plasma glucose normal Cre
0.4186047.15855320.html.plaintext.txt	84	COUP TFII flwt mice plasma insulin P 0
0.4186047.15855320.html.plaintext.txt	85	01 levels remain higher COUP TFII flwt control mice
0.4186047.15855320.html.plaintext.txt	86	No difference found plasma leptin total HDL cholesterol glycerol albumin levels among three groups mice Fig
0.4186047.15855320.html.plaintext.txt	87	View larger version 44K FIG
0.4186047.15855320.html.plaintext.txt	88	Plasma hormones fuels body composition food intake wt COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	89	ABody composition assessed biphotonic absorptiometry
0.4186047.15855320.html.plaintext.txt	90	All data expressed means plus minus SE n 12 micegroup
0.4186047.15855320.html.plaintext.txt	91	COUP TFII flwt control mice
0.4186047.15855320.html.plaintext.txt	92	Intraperitoneal glucose tolerance tests overnight fasted Cre
0.4186047.15855320.html.plaintext.txt	93	COUP TFII flwt mice showed pronounced glucose intolerance markedly increased blood glucose levels first minutes following glucose challenge Fig
0.4186047.15855320.html.plaintext.txt	94	Moreover plasma insulin levels 20 min glucose administration found lower mutant mice 44 plus minus 10 microUml control mice 132 plus minus 27 microUml P 0
0.4186047.15855320.html.plaintext.txt	95	COUP TFII flwt mice showed elevated basal plasma insulin levels fasted random fed periods reduced acute glucose stimulated insulin secretion intraperitoneal glucose tolerance tests
0.4186047.15855320.html.plaintext.txt	96	To determine role played intrinsic defect glucose dependent insulin secretion insulin secretion isolated islets Langerhans Cre
0.4186047.15855320.html.plaintext.txt	97	COUP TFII flwt mice investigated
0.4186047.15855320.html.plaintext.txt	98	View larger version 25K FIG
0.4186047.15855320.html.plaintext.txt	99	Glucose intolerance insulin sensitivity
0.4186047.15855320.html.plaintext.txt	100	A Glucose tolerance tests performed 16 week old male wt COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	101	COUP TFII flwt mice fasted 14 h
0.4186047.15855320.html.plaintext.txt	102	Animals injected intraperitoneally 2 gkg body wt glucose
0.4186047.15855320.html.plaintext.txt	103	Blood glucose measured immediately 20 40 60 90 120 min injection
0.4186047.15855320.html.plaintext.txt	104	B Insulin tolerance tests performed 16 week old male controls Cre
0.4186047.15855320.html.plaintext.txt	105	COUP TFII flwt mice fasted 5 h
0.4186047.15855320.html.plaintext.txt	106	Animals injected intraperitoneally 0
0.4186047.15855320.html.plaintext.txt	107	Blood glucose measured immediately 15 30 60 min injection
0.4186047.15855320.html.plaintext.txt	108	C Glycogen synthesis isolated soleus muscles wt COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	109	Soleus muscles isolated male upper panel female lower panel mice
0.4186047.15855320.html.plaintext.txt	110	Values expressed nanomoles glucose incorporated glycogen per milligram muscle protein per hour presented means plus minus SE four female three male muscles
0.4186047.15855320.html.plaintext.txt	111	COUP TFII haploinsufficiency leads impaired insulin secretion isolated islets
0.4186047.15855320.html.plaintext.txt	112	To identify consequence COUP TFII haploinsufficiency level ss cell secretory function studied glucose L arginine induced insulin release islet perifusion protocol 15
0.4186047.15855320.html.plaintext.txt	113	In basal state measured 3 mmoll glucose Cre
0.4186047.15855320.html.plaintext.txt	114	COUP TFII flwt islets showed trend significant release insulin COUP TFII flwt islets especially early time points perifusion protocol Fig
0.4186047.15855320.html.plaintext.txt	115	Upon glucose challenge profound defect insulin release observed
0.4186047.15855320.html.plaintext.txt	116	In COUP TFII flwt islets glucose induced insulin release concentration dependent manner 5 10 mmoll glucose whereas Cre
0.4186047.15855320.html.plaintext.txt	117	COUP TFII flwt islets showed virtually response 7
0.4186047.15855320.html.plaintext.txt	118	5 mmoll glucose response 10 20 mmoll glucose one third seen control islets Figs
0.4186047.15855320.html.plaintext.txt	119	Finally insulin secretion response combined stimulation 20 mmoll arginine 10 mmoll glucose also significantly lower Cre
0.4186047.15855320.html.plaintext.txt	120	As stimulation arginine similar COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	121	5B conclude Cre
0.4186047.15855320.html.plaintext.txt	122	COUP TFII flwt islets glucose induced insulin secretion specifically affected
0.4186047.15855320.html.plaintext.txt	123	View larger version 36K FIG
0.4186047.15855320.html.plaintext.txt	124	Blunted glucose L arginine stimulated Arg insulin secretion isolated Cre
0.4186047.15855320.html.plaintext.txt	125	COUP TFII flwt pancreatic islets
0.4186047.15855320.html.plaintext.txt	126	A Dynamic insulin secretory response four successive nutrient stimulations 10 min alternating basal 3 mmoll glucose
0.4186047.15855320.html.plaintext.txt	127	B Integrated insulin release basal following stimulation
0.4186047.15855320.html.plaintext.txt	128	Results expressed mean insulin release percent islet insulin content plus minus SE n 4
0.4186047.15855320.html.plaintext.txt	129	These abnormalities insulin secretion COUP TFII deficient islets associated altered islet morphology data shown
0.4186047.15855320.html.plaintext.txt	130	Intensity insulin glucagon immunostaining appeared normal estimated size insulin storage pool Fig
0.4186047.15855320.html.plaintext.txt	131	In addition insulin glucagon mRNA concentrations assessed semiquantitative RT PCR Fig
0.4186047.15855320.html.plaintext.txt	132	7 changed mutant mice
0.4186047.15855320.html.plaintext.txt	133	This suggests reduced insulin release Cre
0.4186047.15855320.html.plaintext.txt	134	COUP TFII flwt islets unlikely caused abnormalities insulin glucagon gene expression
0.4186047.15855320.html.plaintext.txt	135	The ss cell mass estimated quantitative morphometric analysis showed differences wt COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	136	View larger version 10K FIG
0.4186047.15855320.html.plaintext.txt	137	Pancreatic insulin content ss cell mass ss cell density 14 week old mice
0.4186047.15855320.html.plaintext.txt	138	Results mean values plus minus SE three five animals per genotype
0.4186047.15855320.html.plaintext.txt	139	The effects COUP TFII haploinsufficiency ss cells expression genes critical glucose sensing insulin secretion examined semiquantitative RT PCR experiments
0.4186047.15855320.html.plaintext.txt	140	All transcripts studied similarly abundant controls wt COUP TFII flwt mice heterozygous mice except glucose responsive gene encoding GLUT2 whose mRNA abundance significantly increased 60 islet cells knockout animals Fig
0.4186047.15855320.html.plaintext.txt	141	The GLUT2 transporter shown play key role murine ss cells glucose signaling insulin secretion 16 rate limiting glucose entry ss cells 17
0.4186047.15855320.html.plaintext.txt	142	Nevertheless increased abundance GLUT2 mRNA islets Cre
0.4186047.15855320.html.plaintext.txt	143	COUP TFII flwt mice could result decreased repression COUP TFII maybe acting hepatocyte nuclear factor HNF 4 competitor 7
0.4186047.15855320.html.plaintext.txt	144	More biology ss cell genomewide expression analysis purified pancreatic ss cells necessary enable us define systematically potential mediators glucose recognition model
0.4186047.15855320.html.plaintext.txt	145	COUP TFII flwt mice exhibit altered insulin sensitivity vivo
0.4186047.15855320.html.plaintext.txt	146	Since altered insulin secretion modify insulin sensitivity vivo insulin tolerance test performed showing Cre
0.4186047.15855320.html.plaintext.txt	147	COUP TFII flwt animals resistant glucose lowering effect exogenous insulin Fig
0.4186047.15855320.html.plaintext.txt	148	The normal insulin sensitivity COUP TFII flwt mice allowed us rule role hypomorphic floxed allele
0.4186047.15855320.html.plaintext.txt	149	Interestingly isolated soleus muscle basal insulin stimulated glycogen synthesis similar wt compared COUP TFII flwt Cre
0.4186047.15855320.html.plaintext.txt	150	COUP TFII flwt mice indicating insulin resistance unlikely primary defect skeletal muscle Fig
0.4186047.15855320.html.plaintext.txt	151	In addition primary abnormalities hepatocytes ruled since mice hepatocyte specific conditional COUP TFII gene inactivation exhibit normal insulin sensitivity M
0.4186047.15855320.html.plaintext.txt	152	In conclusion observed insulin resistance heterozygous mice could least part consequence persistent higher insulin levels
0.4186047.15855320.html.plaintext.txt	153	In mice models humans chronic hyperinsulinemia shown self perpetuating cause defects insulin action compensatory response insulin resistance 18 21
0.4186047.15855320.html.plaintext.txt	154	Our results demonstrate heterozygous COUP TFII deletion islet ss cells leads impaired glucose sensitivity abnormal insulin secretion secondary insulin resistance
0.4186047.15855320.html.plaintext.txt	155	The results obtained vivo isolated islets allow us exclude participation autonomic nervous system alteration insulin secretion
0.4186047.15855320.html.plaintext.txt	156	In addition pleiotropic effects reduced intracellular COUP TFII activity ss cell metabolism may detrimental generation ATP seem excluded since genes analyzed RT PCR show major change expression level
0.4186047.15855320.html.plaintext.txt	157	Moreover COUP TFII deficiency genetically imposed upon ss cells interpret lack cell response hypoglycemia secondary e
0.4186047.15855320.html.plaintext.txt	158	caused high rate insulin release
0.4186047.15855320.html.plaintext.txt	159	It well known ss cells suppress cell function 22
0.4186047.15855320.html.plaintext.txt	160	Tissue specific deletion HNF 3ss pancreatic ss cells mice suggested vivo coupling cell function ss cells 23
0.4186047.15855320.html.plaintext.txt	161	It worthy note abnormalities due partial COUP TFII deficiency pancreatic ss cells mimic disorders observed type 2 diabetic patients
0.4186047.15855320.html.plaintext.txt	162	RESEARCH DESIGN AND METHODS TOP ABSTRACT RESULTS AND DISCUSSION RESEARCH DESIGN AND METHODS REFERENCES Gene targeting conditional allele generation
0.4186047.15855320.html.plaintext.txt	163	A mouse 129SV PAC genomic clone containing entire COUP TFII gene isolated screening RPCI21 library resource center German Human Genoma Project
0.4186047.15855320.html.plaintext.txt	164	A conditional allele generated flanking first exon loxP sites Cre recombinase
0.4186047.15855320.html.plaintext.txt	165	A loxP site inserted BglII site located 445 bp upstream Met ATG codon pgk neo selection gene flanked two additional loxP sites introduced NdeI site located first intron
0.4186047.15855320.html.plaintext.txt	166	The targeting construct obtained digestion HindIII AvrII insertion electroporated CK35 embryonic stem cells 24
0.4186047.15855320.html.plaintext.txt	167	After selection genotype G418 resistant clones identified Southern blot analysis XbaI digestion using external flanking 5 EcoRI EcoRI DNA fragment hybridization probe SpeI digestion using external 3 noncoding DNA fragment PCR analysis
0.4186047.15855320.html.plaintext.txt	168	Ten percent correctly recombined clones identified
0.4186047.15855320.html.plaintext.txt	169	Cre mediated recombination obtained electroporation 107 recombinant embryonic stem cells using 4 microg pIC Cre vector 25
0.4186047.15855320.html.plaintext.txt	170	Of 288 clones isolated Cre expression 4 lost selection gene identified Southern blot analysis XbaI digested DNA E1 probe
0.4186047.15855320.html.plaintext.txt	171	Two clones containing fl first exon isolated
0.4186047.15855320.html.plaintext.txt	172	Mice strains carrying COUP TFII fl allele established mixed C57BL6N x 129SVJ background
0.4186047.15855320.html.plaintext.txt	173	Genotyping performed PCR analysis using DNA isolated tail tip newborn mice using primers flanking 5 loxP site A5HF GCA AGT CGA TTG TCT GGC TTC R5HF AAC TCC TCC GCT GCA CAC TA
0.4186047.15855320.html.plaintext.txt	174	Rip Cre mediated recombination COUP TFII gene
0.4186047.15855320.html.plaintext.txt	175	Transgenic mice expressing Cre recombinase control rat insulin II promoter Rip Cre transgenic line 1314 used produce COUP TFII ss cell specific inactivation
0.4186047.15855320.html.plaintext.txt	176	The intercrossing COUP TFII fl mice Rip2 Cre mice genotyped PCR using primers described primers Cre transgene internal upstream stimulatory factor 1 control described previously 26
0.4186047.15855320.html.plaintext.txt	177	Cre recombination efficiency assessed liver brain spinal cord hypothalamus islet DNA prepared isolated islets described PCR
0.4186047.15855320.html.plaintext.txt	178	The first one 5 loxP site 1 located 5 noncoding region sequence TGA TTT CGA TGG CTT TCC TG second primer 3 located exon 1 sequence CGG AGG AAC CTG AGC TAC AC
0.4186047.15855320.html.plaintext.txt	179	The third primer intron 1 2 located 3 loxP site sequence TGC CCA CAC TTT CCT ACT CC Fig
0.4186047.15855320.html.plaintext.txt	180	An 850 bp indicated intact exon 1 fl allele 810 bp intact exon 1 wt allele 500 bp indicated Cre mediated recombination
0.4186047.15855320.html.plaintext.txt	181	Analysis COUP TFII expression Western blotting
0.4186047.15855320.html.plaintext.txt	182	A total 1000 islets cultured 16 h Ham F10 medium containing 10 mmoll glucose 10 FCS
0.4186047.15855320.html.plaintext.txt	183	Nuclear proteins prepared described 27 20 microg subjected standard Western blot protocol using COUP TF specific antibodies 11000 dilution 11
0.4186047.15855320.html.plaintext.txt	184	Control animals used study either wt Cre
0.4186047.15855320.html.plaintext.txt	185	Adult male mice studied 14 16 weeks age
0.4186047.15855320.html.plaintext.txt	186	Animals free access water standard mouse diet
0.4186047.15855320.html.plaintext.txt	187	All procedures performed accordance principles guidelines established European Convention Protection Laboratory Animals
0.4186047.15855320.html.plaintext.txt	188	For glucagon blood samples obtained retroorbital phlebotomy collected tubes containing aprotinin radioimmunoassay performed Biochem ImmunoSystems Pharmacia Upjohn France
0.4186047.15855320.html.plaintext.txt	189	In fed state blood collected 930 P
0.4186047.15855320.html.plaintext.txt	190	For fasting experiments food removed 900 A
0.4186047.15855320.html.plaintext.txt	191	mice kept 4 h blood sampling
0.4186047.15855320.html.plaintext.txt	192	Plasma insulin leptin concentrations assessed using rat insulin enzyme linked immunosorbent assay kit Crystal Chem Chicago IL mouse leptin enzyme linked immunosorbent assay kit Crystal Chem respectively
0.4186047.15855320.html.plaintext.txt	193	Plasma concentrations triglycerides free fatty acids glycerol total HDL cholesterol albumin determined using automated Monarch device Instrumentation Laboratory Lexington MA
0.4186047.15855320.html.plaintext.txt	194	Measurement insulin release perifused islets
0.4186047.15855320.html.plaintext.txt	195	Isolation islets Langerhans overnight culture measurement insulin release carried described previously 15
0.4186047.15855320.html.plaintext.txt	196	Approximately 200 islets loaded onto Biogel P2 column preperifused 20 min Ham F10 medium supplemented 0
0.4186047.15855320.html.plaintext.txt	197	5 BSA 2 mmoll glutamine 2 mmoll CaCl2 3 mmoll glucose equilibrated 95 air5 CO2
0.4186047.15855320.html.plaintext.txt	198	5 mlmin pulses 10 min given 7
0.4186047.15855320.html.plaintext.txt	199	5 10 20 mmoll glucose 10 mmoll glucose 20 mmoll L arginine
0.4186047.15855320.html.plaintext.txt	200	Samples collected every minute assayed immunoreactive insulin guinea pig anti insulin serum Linco Research St
0.4186047.15855320.html.plaintext.txt	201	As islet insulin contents models similar results expressed percentage islet insulin content
0.4186047.15855320.html.plaintext.txt	202	Insulin extracted sonicating Biogel P2 containing islets 5 ml 2 mmoll acetic acid0
0.4186047.15855320.html.plaintext.txt	203	Immunohistochemistry quantification ss cell mass ss cell density
0.4186047.15855320.html.plaintext.txt	204	ss Cell mass determined described previously 28 insulin immunostaining Dako 10 subsequent sections pancreas tissue separated 50 microm followed measurement surface area sections using Biocom VisioLb 1000 software
0.4186047.15855320.html.plaintext.txt	205	ss Cell mass calculated multiplying pancreatic weight relative ss cell volume
0.4186047.15855320.html.plaintext.txt	206	ss Cell density assessed counting number nuclei 30000 microm2 islet total area contained insulin positive cells
0.4186047.15855320.html.plaintext.txt	207	Values means plus minus SE five mice genotype
0.4186047.15855320.html.plaintext.txt	208	Total pancreatic islet RNA isolated using Trizol Gibco BRL treated RNase free DNase I use semiquantitative RT PCR
0.4186047.15855320.html.plaintext.txt	209	The PCR cycle numbers estimated primer pair assure linear range amplification
0.4186047.15855320.html.plaintext.txt	210	All results verified seven control COUP TFII flwt mutant mice
0.4186047.15855320.html.plaintext.txt	211	We quantified bands using STORM850 PhosphoImager Image Quant 5
0.4186047.15855320.html.plaintext.txt	212	Determination glycogen synthesis isolated muscle
0.4186047.15855320.html.plaintext.txt	213	The two soleus muscles isolated described previously 29 incubated without 10 nmoll insulin 60 min 37 degrees C 1 ml Krebs Ringer bicarbonate buffer pH 7
0.4186047.15855320.html.plaintext.txt	214	3 supplemented 1 BSA 3 3H glucose 5 mmoll 1 microCiml
0.4186047.15855320.html.plaintext.txt	215	Muscles dissolved 1 N NaOH aliquots spotted onto Whatmann paper filters washed three times ice cold 60 ethanol counting
0.4186047.15855320.html.plaintext.txt	216	Data expressed means plus minus SE
0.4186047.15855320.html.plaintext.txt	217	Statistical analyses carried using unpaired two tailed Student test dual samples Mann Whitney groups null hypothesis rejected 0
0.4186047.15855320.html.plaintext.txt	218	ACKNOWLEDGMENTS This work supported INSERM Institut National de la Sante et de la Recherche Medicale l Association de Langue Francaise pour l Etude du Diabete et des Maladies Metaboliques grant ALFEDIAM Glaxosmithkline Ministry Flemish Community Geconcerteerde Onderzoeksacties
0.4186047.15855320.html.plaintext.txt	219	1 2002 801 Juveline Diabetes Research Foundation F
0.4186047.15855320.html.plaintext.txt	220	supported Fonda tion pour la Recherche Medicale Association Francaise contre les Myopathies postdoctoral training grants respectively
0.4186047.15855320.html.plaintext.txt	221	The authors grateful Drs
0.4186047.15855320.html.plaintext.txt	222	Joshi critical reading manuscript Dr
0.4186047.15855320.html.plaintext.txt	223	Kress Pasteur Institut kind gift embryonic stem cells Drs
0.4186047.15855320.html.plaintext.txt	224	Bauchet Centre d Explorations Fonctionnelles Integre Faculte de Medecine Xavier Bichat Paris determination blood parameters Dr
0.4186047.15855320.html.plaintext.txt	225	Magnan Universite Paris 7 Centre National de la Recherche Scientifique UMR 7059 determining plasma glucagon General Electric Medical Systems access dual energy X ray absorptiometry F
0.4186047.15855320.html.plaintext.txt	226	Letourneur sequence analysis V
0.4186047.15855320.html.plaintext.txt	227	Faveau teaching orbital punctures
0.4186047.15855320.html.plaintext.txt	228	currently affiliated Department Biochemistry Molecular Biology Louisiana State University Health Sciences Center New Orleans Louisiana
0.4186047.15855320.html.plaintext.txt	229	currently affiliated Dipartimento di Biologia Animale Laboratorio di Genetica Molecolare Universita deggli Studi di Catania Catania Italy
0.4186047.15855320.html.plaintext.txt	230	contributed equally report
0.4186047.15855320.html.plaintext.txt	231	COUP TFII chicken ovalbumin upstream promoter transcription factor II HNF hepatocyte nuclear factor
0.4186047.15855320.html.plaintext.txt	232	Address correspondence reprint requests M
0.4186047.15855320.html.plaintext.txt	233	Vasseur Cognet Institut Cochin U
0.4186047.15855320.html.plaintext.txt	234	567INSERM UMR8104Centre National de la Recherche Scientifique Laboratoire de l Universite Rene Descartes Departement GDPM 24 rue du Faubourg Saint Jacques 75014 Paris France
0.4186047.15855320.html.plaintext.txt	235	Received publication August 16 2004 accepted revised form February 15 2005
0.4186047.15855320.html.plaintext.txt	236	REFERENCES TOP ABSTRACT RESULTS AND DISCUSSION RESEARCH DESIGN AND METHODS REFERENCES Odom D Zizlsperger N Gordon D Bell G Rinaldi N Murray H Volkert T Schreiber J Rolfe P Gifford D Fraenkel E Bell GRY Control pancreas liver gene expression HNF transcription factors
0.4186047.15855320.html.plaintext.txt	237	Science303 1378 13812004AbstractFree Full Text Boj S Parrizas M Maestro M Ferrer J A transcription factor regulatory circuit differentiated pancreatic cells
0.4186047.15855320.html.plaintext.txt	238	Proc Natl Acad Sci U S A98 14481 144862001AbstractFree Full Text Stoffel M Duncan SA The maturity onset diabetes young MODY1 transcription factor HNF4alpha regulates expression genes required glucose transport metabolism
0.4186047.15855320.html.plaintext.txt	239	Proc Natl Acad Sci U S A94 13209 132141997AbstractFree Full Text Wobser H Dussmann H Kogel D Wang H Reimertz C Wollheim C Byrne M Prehn J Dominant negative suppression HNF 1 alpha results mitochondrial dysfunction INS 1 cell apoptosis increased sensitivity ceramide high glucose induced cell death
0.4186047.15855320.html.plaintext.txt	240	J Biol Chem277 6413 64212002AbstractFree Full Text Chawla A Repa J Evans RM Mangelsdorf D Nuclear receptors lipid physiology opening X files
0.4186047.15855320.html.plaintext.txt	241	Science294 1866 19702001AbstractFree Full Text Roduit R Morin J Masse F Segall L Roche E Newgard C Assimacopoulos Jeannet F Prentki M Glucose regulates expression peroxisome proliferator activated receptor alpha gene pancreatic beta cell
0.4186047.15855320.html.plaintext.txt	242	J Biol Chem275 35799 358062000AbstractFree Full Text Wang H Maechler P Antinozzi P Hagenfeldt K Wollheim C Hepatocyte nuclear factor 4 regulates expression pancreatic ss cell genes implicated glucose metabolism nutrient induced insulin secretion
0.4186047.15855320.html.plaintext.txt	243	J Biol Chem275 35953 359592000AbstractFree Full Text Hwung Y P Crowe D Wang L H Tsai S Tsai M J The COUP transcription factor binds upstream promoter element rat insulin II gene
0.4186047.15855320.html.plaintext.txt	244	Mol Cell Biol8 2070 20771988Medline Pereira FA Tsai MJ Tsai SY COUP TF orphan nuclear receptors development differentiation
0.4186047.15855320.html.plaintext.txt	245	Cell Mol Life Sci57 1388 13982000Medline Lou DQ Tannour M Selig L Thomas D Kahn A Vasseur Cognet M Chicken ovalbumin upstream promoter transcription factor II new partner glucose response element L type pyruvate kinase gene acts inhibitor glucose response
0.4186047.15855320.html.plaintext.txt	246	J Biol Chem274 28385 283941999AbstractFree Full Text Zhang P Bennoun M Godard C Bossard P Leclerc I Kahn A Vasseur Cognet M Expression COUP TFII metabolic tissues development
0.4186047.15855320.html.plaintext.txt	247	Mech Dev119 109 1142002Medline Pereira FA Qiu Y Zhou G Tsai MJ Tsai SY The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.4186047.15855320.html.plaintext.txt	248	Genes Dev13 1037 10491999AbstractFree Full Text Postic C Shiota M Niswender K Jetton T Chen Y Moates J Shelton K Lindner J Cherrington A Magnuson M Dual roles glucokinase glucose homeostasis determined liver pancreatic ss cell specific gene knock outs using Cre recombinase
0.4186047.15855320.html.plaintext.txt	249	J Biol Chem274 305 3151999AbstractFree Full Text Gannon M Shiota C Postic C Wright C Magnuson M Analysis Cre mediated recombination driven rat insulin promoter embryonic adult mouse pancreas
0.4186047.15855320.html.plaintext.txt	250	Genesis26 139 1412000Medline Flamez D Berger V Kruhoffer M Orntoft T Pipeleers D Schuit F Critical role cataplerosis via citrate glucose regulated insulin release
0.4186047.15855320.html.plaintext.txt	251	Diabetes51 2018 20242002AbstractFree Full Text Guillam M Dupraz P Thorens B Glucose uptake utilisation signaling GLUT2 null islets
0.4186047.15855320.html.plaintext.txt	252	Diabetes49 1485 14912000Abstract Heimberg H De Vos A Pipeleers D Thorens B Schuit F Differences glucose transporter gene expression rat pancreatic alpha beta cells correlated differences glucose transport glucose utilization
0.4186047.15855320.html.plaintext.txt	253	J Biol Chem270 8971 89751995AbstractFree Full Text Fisher S Kahn R Insulin signaling required insulin direct indirect action hepatic glucose production
0.4186047.15855320.html.plaintext.txt	254	J Clin Invest111 463 4682003AbstractFree Full Text Hevener A He W Barak Y Le J Bandyopadhyay G Olson P Wilkes J Evans RM Olefsky J Muscle specific PPAR deletion causes insulin resistance
0.4186047.15855320.html.plaintext.txt	255	Nat Med9 1491 14972003Medline Nandi A Kitamura Y Kahn R Accili D Mouse models insulin resistance
0.4186047.15855320.html.plaintext.txt	256	Physiol Rev84 623 6472004AbstractFree Full Text Del Prato S Leonetti E Simonson D Sheehan P Matsuda M DeFronzo R Effect sustained physiologic hyperinsulinaemia hyperglycaemia insulin secretion insulin sensitivity man
0.4186047.15855320.html.plaintext.txt	257	Diabetologia37 1025 10351994Medline Samols E Stagner J Intra islet cell cell interactions insulin secretion
0.4186047.15855320.html.plaintext.txt	258	Diabetes Rev4 207 2231998 Sund N Vatamaniuk M Casey M Ang S L Magnuson M Stoffers D Matschinsky F Kaestner K Tissue specific deletion Foxa2 pancreatic b cells results huperinsulinemic hypoglycemia
0.4186047.15855320.html.plaintext.txt	259	Genes Dev15 1706 17152001AbstractFree Full Text Kress C Vandormael Pournin S Baldacci P Cohen Tannoudji M Babinet C Nonpermissiveness mouse embryonic srem ES cell derivation circumvented single backcross 129Sv strain establishment ES cell lines bearing Omd conditional lethal mutation
0.4186047.15855320.html.plaintext.txt	260	Mamm Genome9 998 10011998Medline Gu H Zhou Y Rajewsky K Independent control immunoglobulin switch individual switch regions evidenced Cre loxP mediated gene targeting
0.4186047.15855320.html.plaintext.txt	261	Cell73 1155 11641993Medline Tannour Louet M Porteu A Vaulont S Kahn A Vasseur Cognet M A tamoxifen inductible chimeric Cre recombinase specifically effective fetal adult mouse liver
0.4186047.15855320.html.plaintext.txt	262	Hepatology35 1072 10812002Medline Schreiber E Matthias P Muller M Schaffner W Rapid detection octamer binding proteins mini extracts prepared small number cells
0.4186047.15855320.html.plaintext.txt	263	Nucleic Acid Res17 6419 64251989Medline Jackerott M Baudry A Lamothe B Bucchini D Jami J Joshi R Endocrine pancreas insulin receptor deficient mouse pups
0.4186047.15855320.html.plaintext.txt	264	1 S146 S1492001Medline Stenbit A Burcelin R Katz E Tsao T Gautier N Charron M Le Marchand Brustel Y Diverse effects Glut 4 ablation glucose uptake glycogen synthesis red white skeletal muscle
0.4186047.15855320.html.plaintext.txt	265	J Clin Invest98 629 6341996AbstractFree Full Text
0.25489283.16188891.html.plaintext.txt	0	The Integrase Long Terminal Repeat Retrotransposon Tf1 Has Chromodomain That Modulates Integrase Activities Amnon Hizi1 Henry L
0.25489283.16188891.html.plaintext.txt	1	From Section Eukaryotic Transposable Elements Laboratory Gene Regulation Development NICHD National Institutes Health Bethesda Maryland 20892
0.25489283.16188891.html.plaintext.txt	2	Received publication June 10 2005 revised form August 11 2005
0.25489283.16188891.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Chromodomains variety proteins mediate formation heterochromatin interacting directly histone H3 DNA RNA
0.25489283.16188891.html.plaintext.txt	4	A diverse family long terminal repeat LTR retrotransposons possesses chromodomains integrases IN suggesting chromodomains may control integration
0.25489283.16188891.html.plaintext.txt	5	The LTR retrotransposon Tf1 Schizosaccharomyces pombe highly active possesses chromodomain COOH terminus IN
0.25489283.16188891.html.plaintext.txt	6	To test chromodomain role integration recombinant INs without chromodomain assayed activity vitro reactions
0.25489283.16188891.html.plaintext.txt	7	The full length IN integration activity oligonucleotide substrates modeled insertion reaction reverse reaction known disintegration
0.25489283.16188891.html.plaintext.txt	8	The INs retroviruses possess additional activity termed 3 processing must remove 2 3 nucleotides 3 ends viral cDNA insertion occur
0.25489283.16188891.html.plaintext.txt	9	These additional nucleotides added reverse transcription position minus strand primer downstream LTR
0.25489283.16188891.html.plaintext.txt	10	The position primer Tf1 suggests nucleotides added 3 LTR
0.25489283.16188891.html.plaintext.txt	11	It therefore surprising Tf1 IN capable 3 cleavage
0.25489283.16188891.html.plaintext.txt	12	The unexpected result reported IN lacking chromodomain significantly higher activity substantially reduced substrate specificity
0.25489283.16188891.html.plaintext.txt	13	These results reveal activity specificity enzymes modulated chromodomains
0.25489283.16188891.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Post translational modifications histones acetylation methylation lysines establish accessibility DNA transcription machinery 1 3
0.25489283.16188891.html.plaintext.txt	15	Conserved domains recognize specific modifications exist variety factors interact histones propagate structures chromatin 4 6
0.25489283.16188891.html.plaintext.txt	16	A large family proteins regulate chromatin structure bind specifically histone H3 methylated lysines using conserved module called chromodomain 6 7
0.25489283.16188891.html.plaintext.txt	17	Although chromodomains studied thus far function regulate chromatin structure sequence analyses revealed large families long terminal repeat LTR3 retrotransposons chromodomains COOH termini INs 8 9
0.25489283.16188891.html.plaintext.txt	18	This intriguing suggests transposons acquired chromodomains regulate integration
0.25489283.16188891.html.plaintext.txt	19	LTR retrotransposons closely related retroviruses
0.25489283.16188891.html.plaintext.txt	20	Both types elements encode Gag protease reverse transcriptase IN proteins depend IN insert cDNA genome host cell
0.25489283.16188891.html.plaintext.txt	21	The LTRs positioned ends cDNA subdivided upstream segment U3 central region R downstream segment U5
0.25489283.16188891.html.plaintext.txt	22	A large number biochemical studies purified IN characterized chemistry insertion 10 12
0.25489283.16188891.html.plaintext.txt	23	The INs retroviruses two activities necessary integration viral cDNA
0.25489283.16188891.html.plaintext.txt	24	At first 2 3 nucleotides removed 3 ends LTRs
0.25489283.16188891.html.plaintext.txt	25	This site specific nucleolytic cleavage 3 processing reaction required position CA dinucleotides 3 ends cDNA
0.25489283.16188891.html.plaintext.txt	26	The CA dinucleotides conserved among retroviruses position 3 ends cDNA required second step retrovirus integration strand transfer reaction
0.25489283.16188891.html.plaintext.txt	27	During second step 3 hydroxyls terminal A act nucleophiles pair transesterification reactions cleave phosphodiester bonds target DNA simultaneously make covalent bond 3 ends viral DNA 5 ends target DNA
0.25489283.16188891.html.plaintext.txt	28	In retroviruses minus strand primers initiate reverse transcription 2 3 nucleotides LTR results additional nucleotides cDNA termini IN removes processing reaction
0.25489283.16188891.html.plaintext.txt	29	In case LTR retrotransposons minus strand primers initiate reverse transcription added nucleotides
0.25489283.16188891.html.plaintext.txt	30	As result LTR retrotransposons thought proceed strand transfer reaction without processing step 13
0.25489283.16188891.html.plaintext.txt	31	The INs retroviruses three protease resistant domains functions domains studied extensively 12 14 15
0.25489283.16188891.html.plaintext.txt	32	The NH2 terminal domain contains conserved motif similar zinc fingers
0.25489283.16188891.html.plaintext.txt	33	Although domain bind zinc little else known function
0.25489283.16188891.html.plaintext.txt	34	The central domain catalytic core contains highly conserved acidic residues Asp Asp Glu juxtaposed RNase H like fold
0.25489283.16188891.html.plaintext.txt	35	These three amino acids conserved INs retroviruses LTR retrotransposons DNA transposons 16
0.25489283.16188891.html.plaintext.txt	36	The central domain HIV 1 IN shown sufficient catalytic activity vitro assays reverse reaction strand transfer known disintegration 17
0.25489283.16188891.html.plaintext.txt	37	The COOH terminal domain less well conserved nonspecific binding activity DNA
0.25489283.16188891.html.plaintext.txt	38	Although structure individual domains determined several INs single structure yet contains three domains 18
0.25489283.16188891.html.plaintext.txt	39	Tf1 Schizosaccharomyces pombe one LTR retrotransposons contains chromodomain COOH terminus IN 8
0.25489283.16188891.html.plaintext.txt	40	Its high level transposition activity allows Tf1 studied model reverse transcription integration
0.25489283.16188891.html.plaintext.txt	41	Expression Tf1 high copy plasmid results formation virus like particles reverse transcription Tf1 mRNA integration cDNA intergenic sequences 19 21
0.25489283.16188891.html.plaintext.txt	42	A novel mechanism self priming initiates minus strand reverse transcription upstream LTR 22
0.25489283.16188891.html.plaintext.txt	43	After initiation reverse transcription proceeds intermediates typical LTR elements
0.25489283.16188891.html.plaintext.txt	44	The IN Tf1 inserts cDNA genome S
0.25489283.16188891.html.plaintext.txt	45	pombe contains putative zinc binding catalytic core COOH terminal domains necessary integration 23
0.25489283.16188891.html.plaintext.txt	46	Mutation analysis indicated high level activity tools available study make Tf1 uniquely suited examining function chromodomain integration
0.25489283.16188891.html.plaintext.txt	47	In report activities Tf1 IN function chromodomain studied
0.25489283.16188891.html.plaintext.txt	48	IN IN without chromodomain CH expressed bacteria purified
0.25489283.16188891.html.plaintext.txt	49	Biochemical assays disintegration strand transfer showed IN possessed substantial activity
0.25489283.16188891.html.plaintext.txt	50	Because Tf1 cDNA predicted terminate CA surprising IN also strong 3 processing activity
0.25489283.16188891.html.plaintext.txt	51	This indicates position minus strand primer relative LTR sufficient predict presence processing activity
0.25489283.16188891.html.plaintext.txt	52	The unexpected result CH significantly higher specific activity IN
0.25489283.16188891.html.plaintext.txt	53	In addition CH much less dependent specific sequences termini donor DNA IN
0.25489283.16188891.html.plaintext.txt	54	These results reveal chromodomain Tf1 IN modulates level specificity integration
0.25489283.16188891.html.plaintext.txt	55	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Plasmid Constructions Cell Growth The construction pHL2468 plasmid expression full length Tf1 IN previously described 19
0.25489283.16188891.html.plaintext.txt	56	Briefly IN coding DNA segment Tf1 amplified PCR
0.25489283.16188891.html.plaintext.txt	57	The resulting fragment flanked SalI sites introduced BamHI site pET15B sequenced
0.25489283.16188891.html.plaintext.txt	58	The NH2 terminus Tf1 IN predicted based amino terminus IN closely related element Ty3 24
0.25489283.16188891.html.plaintext.txt	59	The NH2 terminus recombinant Tf1 IN started sequence TDDFK COOH terminus ended sequence NNLNI
0.25489283.16188891.html.plaintext.txt	60	The resulting protein 477 residues long fused amino terminus 21 residue peptide containing His6 tag thrombin cleavage site
0.25489283.16188891.html.plaintext.txt	61	The plasmid expressing CH pHL2469 generated similar method
0.25489283.16188891.html.plaintext.txt	62	The CH coding DNA segment amplified PCR primers HL1167 HL1168 using Pfu Turbo thermostable DNA polymerase Stratagene
0.25489283.16188891.html.plaintext.txt	63	The DNA generated cleaved NdeI BamHI cloned vector pET15b sequenced
0.25489283.16188891.html.plaintext.txt	64	The CH protein amino terminus full length IN ended sequence RHNSE
0.25489283.16188891.html.plaintext.txt	65	Altogether CH 406 21 tag residues long
0.25489283.16188891.html.plaintext.txt	66	Both plasmids introduced strain BL21
0.25489283.16188891.html.plaintext.txt	67	The bacteria grown LB broth supplemented 100 microgml carbenicillin
0.25489283.16188891.html.plaintext.txt	68	The culture temperature 32 degrees C cells grown reached A600 0
0.25489283.16188891.html.plaintext.txt	69	Induction performed 1 mM isopropyl 1 thio D galactopyranoside additional period 3 h 32 degrees C
0.25489283.16188891.html.plaintext.txt	70	The cells harvested pellets stored 80 degrees C
0.25489283.16188891.html.plaintext.txt	71	Purification Recombinant Full length IN CH Proteins All steps performed 4 degrees C unless otherwise stated
0.25489283.16188891.html.plaintext.txt	72	Lysis Bacteria The bacterial pellets brought 50 mM sodium phosphate buffer pH 8
0.25489283.16188891.html.plaintext.txt	73	1 M NaCl 1 mM phenylmethylsulfonyl fluoride 0
0.25489283.16188891.html.plaintext.txt	74	After thorough mixing solutions kept 15 min ice followed addition NaCl final concentration 0
0.25489283.16188891.html.plaintext.txt	75	Then solutions sonicated ice followed addition Triton X 100 final concentration 0
0.25489283.16188891.html.plaintext.txt	76	We found presence detergent critical dissociate recombinant INs bacterial DNA data shown
0.25489283.16188891.html.plaintext.txt	77	The insoluble material removed ultracentrifugation 1 h Beckman SW28 rotor 26000 rpm clear yellowish supernatants subjected affinity purification
0.25489283.16188891.html.plaintext.txt	78	Affinity Purification Sepharose Co2 Columns Sepharose Co2 columns BD Talon BD Biosciences bed volumes 5 ml equilibrated 50 mM sodium phosphate pH 8
0.25489283.16188891.html.plaintext.txt	79	5 M NaCl 10 vv glycerol 0
0.25489283.16188891.html.plaintext.txt	80	1 Triton X 100 loaded supernatant ultracentrifugation
0.25489283.16188891.html.plaintext.txt	81	The column washed twice 50 mM sodium phosphate pH 7
0.25489283.16188891.html.plaintext.txt	82	1 Triton X 100 second buffer supplemented 20 mM imidazole
0.25489283.16188891.html.plaintext.txt	83	Elution performed buffer final concentration 50 mM imidazole
0.25489283.16188891.html.plaintext.txt	84	The fractions analyzed SDS PAGE peak IN protein fractions pooled dialyzed 50 mM HEPES NaOH pH 7
0.25489283.16188891.html.plaintext.txt	85	5 10 glycerol 10 mM MgSO4 1 mM EDTA 2 mM dithiothreitol 0
0.25489283.16188891.html.plaintext.txt	86	The proteins fully soluble dialysis
0.25489283.16188891.html.plaintext.txt	87	Heparin Sepharose Column Purification Five ml heparin Sepharose 6 Fast Flow Amersham Biosciences columns pre washed 100 ml buffer used dialysis loaded dialyzed protein solution
0.25489283.16188891.html.plaintext.txt	88	The buffer also used extensive washing 500 ml column loading completed
0.25489283.16188891.html.plaintext.txt	89	Finally proteins eluted affinity resin similar buffer supplemented NaCl final concentration 0
0.25489283.16188891.html.plaintext.txt	90	The recombinant INs emerged columns sharp peaks protein concentrations high 1
0.25489283.16188891.html.plaintext.txt	91	The proteins stored 80 degrees C small aliquots
0.25489283.16188891.html.plaintext.txt	92	Each aliquot thawed conducting enzymatic assays
0.25489283.16188891.html.plaintext.txt	93	Oligonucleotides All oligonucleotides gel purified
0.25489283.16188891.html.plaintext.txt	94	Their sequences designations presented supplemental material
0.25489283.16188891.html.plaintext.txt	95	Substrates Used IN Assays The appropriate DNA oligonucleotides 5 end labeled
0.25489283.16188891.html.plaintext.txt	96	4 microg oligo 32P end labeled using 20 units T4 polynucleotide kinase New England Biolabs 100 microCi 32PATP final volume 20 microl using buffer supplied
0.25489283.16188891.html.plaintext.txt	97	After incubation 1 h 37 degrees C 1 microl 0
0.25489283.16188891.html.plaintext.txt	98	25 M EDTA added sample mixtures treated 5 min 95 degrees C inactivate enzyme
0.25489283.16188891.html.plaintext.txt	99	After adding NaCl final concentration 0
0.25489283.16188891.html.plaintext.txt	100	1 M increasing volume 40 microl labeled DNA annealed three times equimolar ratio appropriate non labeled DNA
0.25489283.16188891.html.plaintext.txt	101	After 5 min 95 degrees C mixtures allowed cool slowly room temperature 2 h
0.25489283.16188891.html.plaintext.txt	102	The duplexes generated stored 20 degrees C used freezing thawing 1 month
0.25489283.16188891.html.plaintext.txt	103	Assays IN Activities Unless otherwise stated assays IN CH performed final volumes 20 microl containing 25 mM MOPS NaOH pH 7
0.25489283.16188891.html.plaintext.txt	104	2 4 wv polyethylene glycol 8000 10 vv glycerol 5 mM dithiothreitol 6
0.25489283.16188891.html.plaintext.txt	105	25 vv freshly prepared dimethyl sulfoxide 1 mM MnCl2
0.25489283.16188891.html.plaintext.txt	106	Each reaction mixture contained 0
0.25489283.16188891.html.plaintext.txt	107	2 1 microg enzymes 1 pmol labeled DNA substrates
0.25489283.16188891.html.plaintext.txt	108	Incubations performed 1 h 37 degrees C reactions stopped adding 10 microl formamide loading buffer 95 formamide 20 mM EDTA 0
0.25489283.16188891.html.plaintext.txt	109	5 mgml xylene cyanole FF sample
0.25489283.16188891.html.plaintext.txt	110	The samples treated 3 min 95 degrees C quickly cooled ice loaded 8 M urea 13
0.25489283.16188891.html.plaintext.txt	111	5 wv polyacrylamide sequencing gel Tris borateEDTA buffer
0.25489283.16188891.html.plaintext.txt	112	After electrophoresis wet gels subjected phosphorimaging using Amersham Biosciences Storm 840 instrument
0.25489283.16188891.html.plaintext.txt	113	View larger version 26K FIGURE 1
0.25489283.16188891.html.plaintext.txt	114	SDS polyacrylamide gel electrophoresis purified recombinant Tf1 proteins
0.25489283.16188891.html.plaintext.txt	115	The purification Tf1 IN CH proteins performed described Experimental Procedures
0.25489283.16188891.html.plaintext.txt	116	One microg purified protein mixture size markers M containing 1 microg protein band loaded onto 10 polyacrylamide urea gel
0.25489283.16188891.html.plaintext.txt	117	Following electrophoresis proteins stained Coomassie Brilliant Blue R 250
0.25489283.16188891.html.plaintext.txt	118	Purified recombinant HIV 1 IN generous gift R
0.25489283.16188891.html.plaintext.txt	119	Craigie assayed specified substrates optimal conditions enzyme differ suitable Tf1 enzymes
0.25489283.16188891.html.plaintext.txt	120	Reactions performed 20 microl 25 mM MOPS NaOH pH 7
0.25489283.16188891.html.plaintext.txt	121	1 mgml bovine serum albumin 10 glycerol 10 mM mercaptoethanol 0
0.25489283.16188891.html.plaintext.txt	122	All steps including preparation substrates incubation times analyses reaction products performed described Tf1 INs
0.25489283.16188891.html.plaintext.txt	123	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Recombinant IN CH Tf1 Have Significant Levels Disintegration Activity To investigate function chromodomain Tf1 IN studied integration activities full length IN truncated IN lacked chromodomain CH
0.25489283.16188891.html.plaintext.txt	124	Both proteins expressed His6 tags bacteria purified high degree using chromatography Co2 agarose Talon BD Biosciences followed chromatography heparin Sepharose Fig
0.25489283.16188891.html.plaintext.txt	125	Under vitro conditions INs catalyze reverse DNA strand transfer reaction designated disintegration 10
0.25489283.16188891.html.plaintext.txt	126	This activity assayed using oligonucleotides mimic single ended insertion 25 27
0.25489283.16188891.html.plaintext.txt	127	The disintegration activity Tf1 IN studied first substrate sequence structural requirements reaction less stringent forward reactions
0.25489283.16188891.html.plaintext.txt	128	The model substrate designed measure disintegration activity shown Fig
0.25489283.16188891.html.plaintext.txt	129	The 5 end target DNA labeled 32P
0.25489283.16188891.html.plaintext.txt	130	The reaction results concerted cleavage ligation donor DNA excised disrupted target repaired
0.25489283.16188891.html.plaintext.txt	131	This results production 63 nt product labeled 32P 5 end
0.25489283.16188891.html.plaintext.txt	132	Because size 63 nt product could readily distinguished initial species labeled 32P 20 nt substrate
0.25489283.16188891.html.plaintext.txt	133	Separate substrates designed mimicked either U3 U5 ends Tf1 LTR
0.25489283.16188891.html.plaintext.txt	134	The IN CH proteins produced substantial amounts 63 nt product using either U3 U5 substrates Fig
0.25489283.16188891.html.plaintext.txt	135	We tested whether disintegration substrates designed Tf1 IN could recognized another IN HIV 1
0.25489283.16188891.html.plaintext.txt	136	Interestingly HIV 1 IN least active U3 U5 substrates two Tf1 INs Fig
0.25489283.16188891.html.plaintext.txt	137	This despite low homology Tf1 HIV 1 sequences ends donor DNAs
0.25489283.16188891.html.plaintext.txt	138	View larger version 39K FIGURE 2
0.25489283.16188891.html.plaintext.txt	139	The disintegration assay Tf1 IN CH
0.25489283.16188891.html.plaintext.txt	140	A schematic disintegration reaction
0.25489283.16188891.html.plaintext.txt	141	The substrates disintegration oligonucleotides mimicked one end Tf1 DNA inserted target
0.25489283.16188891.html.plaintext.txt	142	The 5 end target DNA indicated asterisk labeled 32P
0.25489283.16188891.html.plaintext.txt	143	The disintegration reaction results cleavage phosphodiester bond 3 terminal sequence ACA ligation labeled oligonucleotide remainder target molecule
0.25489283.16188891.html.plaintext.txt	144	This led increase length 5 end labeled oligonucleotide 20 63 nt
0.25489283.16188891.html.plaintext.txt	145	B disintegration activity Tf1 IN CH HIV 1 IN
0.25489283.16188891.html.plaintext.txt	146	Enzymatic reactions conducted equal amounts U3 U5 substrates 1
0.25489283.16188891.html.plaintext.txt	147	The reaction products resolved electrophoresis urea polyacrylamide sequencing gel
0.25489283.16188891.html.plaintext.txt	148	The control lane shows reaction mixture incubated enzyme U3 substrate
0.25489283.16188891.html.plaintext.txt	149	The control U5 substrate looked U3 data shown
0.25489283.16188891.html.plaintext.txt	150	The molecular weight markers M HinFI fragments X174 labeled 5 ends
0.25489283.16188891.html.plaintext.txt	151	To optimize reaction conditions measured influence NaCl MnCl2 MgCl2 activities IN CH Fig
0.25489283.16188891.html.plaintext.txt	152	NaCl greatly inhibited activities proteins strong preference MnCl2 MgCl2 observed
0.25489283.16188891.html.plaintext.txt	153	The highest disintegration activity obtained 25 mM MOPS NaOH pH 7
0.25489283.16188891.html.plaintext.txt	154	2 4 polyethylene glycol 8000 10 glycerol 5 mM dithiothreitol 6
0.25489283.16188891.html.plaintext.txt	155	Other additives often used enhance IN activities bovine serum albumin spermidine Triton X 100 Me2SO final concentrations 6
0.25489283.16188891.html.plaintext.txt	156	25 found inhibit Tf1 INs data shown
0.25489283.16188891.html.plaintext.txt	157	Having established assay conditions Tf1 IN CH enzymes dose dependent reactions performed increasing amounts protein
0.25489283.16188891.html.plaintext.txt	158	The quantitative data presented Fig
0.25489283.16188891.html.plaintext.txt	159	4 show U3 substrate activity IN increased protein content 275 ng whereas maximum observed U5 substrate
0.25489283.16188891.html.plaintext.txt	160	The data CH revealed surprising result CH protein substantially active full length IN
0.25489283.16188891.html.plaintext.txt	161	Although true U3 U5 substrates U3 substrate CH exhibited greatest increase activity IN
0.25489283.16188891.html.plaintext.txt	162	Recombinant IN CH Possess Strand Transfer Activities Strand transfer assays relevant measure IN activities represent forward reaction integration
0.25489283.16188891.html.plaintext.txt	163	The strand transfer activities IN CH assayed determine whether proteins capable mediating integration
0.25489283.16188891.html.plaintext.txt	164	The substrates assays double stranded oligonucleotides designated mimic either U3 U5 ends Tf1
0.25489283.16188891.html.plaintext.txt	165	Initially used double stranded oligonucleotides blunt ends terminated CA dinucleotide Fig
0.25489283.16188891.html.plaintext.txt	166	The oligonucleotide 3 CA labeled 5 end 32P
0.25489283.16188891.html.plaintext.txt	167	Strand transfer results insertion oligonucleotides identical molecules result oligonucleotides created bigger smaller original size Fig
0.25489283.16188891.html.plaintext.txt	168	We found conditions established disintegration reaction also optimal strand transfer activity Tf1 enzymes data shown
0.25489283.16188891.html.plaintext.txt	169	View larger version 17K FIGURE 3
0.25489283.16188891.html.plaintext.txt	170	The effect NaCl divalent cations disintegration activities IN CH
0.25489283.16188891.html.plaintext.txt	171	These assays performed U3 substrate
0.25489283.16188891.html.plaintext.txt	172	The reaction products subjected electrophoresis gels scanned phosphorimager
0.25489283.16188891.html.plaintext.txt	173	A dependence disintegration activity NaCl
0.25489283.16188891.html.plaintext.txt	174	Increasing amounts NaCl added reaction mixtures
0.25489283.16188891.html.plaintext.txt	175	Reactions performed 1
0.25489283.16188891.html.plaintext.txt	176	The disintegration activity expressed point percentage maximal activity observed lowest NaCl concentration
0.25489283.16188891.html.plaintext.txt	177	B effects divalent cations disintegration activity Tf1 IN
0.25489283.16188891.html.plaintext.txt	178	The disintegration activity 1
0.25489283.16188891.html.plaintext.txt	179	1 microg Tf1 IN measured increasing concentrations either MnCl2 MgCl2
0.25489283.16188891.html.plaintext.txt	180	The levels conversion calculated described A
0.25489283.16188891.html.plaintext.txt	181	The activity divalent cation expressed percentage maximal activity
0.25489283.16188891.html.plaintext.txt	182	C effects divalent cations disintegration activity CH
0.25489283.16188891.html.plaintext.txt	183	The disintegration activity assayed quantified described B except reaction contained 0
0.25489283.16188891.html.plaintext.txt	184	5B shows relative protein dose IN CH generated oligonucleotide products longer original U3 U5 substrates
0.25489283.16188891.html.plaintext.txt	185	The lengths products varied integration acceptor DNA relatively random
0.25489283.16188891.html.plaintext.txt	186	However apparent IN CH U5 substrate preferred positions
0.25489283.16188891.html.plaintext.txt	187	Interestingly significant fraction extended products longer twice size 24 nt substrate products long 70 mers observed
0.25489283.16188891.html.plaintext.txt	188	This indicates versions Tf1 INs capable three integration events products first round integration served substrates integration events
0.25489283.16188891.html.plaintext.txt	189	To knowledge multiple round integrations reported INs
0.25489283.16188891.html.plaintext.txt	190	We tested whether chromodomain played role strand transfer comparing activity IN CH
0.25489283.16188891.html.plaintext.txt	191	To evaluate levels strand transfer activity calculated amount oligonucleotide species longer 24 nt percentage total amount labeled oligonucleotides
0.25489283.16188891.html.plaintext.txt	192	5C shows CH substantially active IN U3 U5 ends
0.25489283.16188891.html.plaintext.txt	193	The elevated activity CH correlated well results disintegration assays
0.25489283.16188891.html.plaintext.txt	194	However difference strand transfer activity CH IN pronounced observed disintegration
0.25489283.16188891.html.plaintext.txt	195	The maximal differences activity CH IN approximately 7 4 fold observed U3 U5 end derived substrates respectively
0.25489283.16188891.html.plaintext.txt	196	These results indicate presence chromodomain inhibits disintegration strand transfer activities Tf1 IN
0.25489283.16188891.html.plaintext.txt	197	View larger version 18K FIGURE 4
0.25489283.16188891.html.plaintext.txt	198	The disintegration activities IN CH assays increasing amounts protein
0.25489283.16188891.html.plaintext.txt	199	The reactions conducted either U3 U5 substrates increasing amounts Tf1 IN CH
0.25489283.16188891.html.plaintext.txt	200	The proteins diluted buffer used store proteins 50 mM HEPES NaOH 10 glycerol 0
0.25489283.16188891.html.plaintext.txt	201	05 Me2SO 2 mM dithiothreitol 0
0.25489283.16188891.html.plaintext.txt	202	2 equal volumes protein samples added reaction
0.25489283.16188891.html.plaintext.txt	203	After reaction products subjected electrophoresis gels scanned phosphorimager
0.25489283.16188891.html.plaintext.txt	204	CH IN Possess 3 End Processing Activity It currently thought role 3 end processing activity INs solely remove 2 3 nucleotides 3 CA result position minus strand primer 2 3 nucleotides downstream first LTR
0.25489283.16188891.html.plaintext.txt	205	The primer minus strand Tf1 positioned adjacent LTR predicted processing activity required 28 29
0.25489283.16188891.html.plaintext.txt	206	However sequences Tf1 cDNA extracted particles revealed surprising result 85 3 ends one untemplated nucleotides
0.25489283.16188891.html.plaintext.txt	207	4 Because nucleotides added 3 ends CA dinucleotide expected block integration
0.25489283.16188891.html.plaintext.txt	208	We therefore speculated Tf1 IN would processing activity would remove nucleotides expose CA dinucleotides allow integration
0.25489283.16188891.html.plaintext.txt	209	We tested IN CH 3 processing activity using assay already described strand transfer activity
0.25489283.16188891.html.plaintext.txt	210	In case 5 end labeled substrates contained nucleotides positioned 3 critical CA Fig
0.25489283.16188891.html.plaintext.txt	211	Processing activity would cause reduction length labeled substrate extra sequences removed 3 end
0.25489283.16188891.html.plaintext.txt	212	Processing U5 End LTR The IN CH enzymes tested processing activity using set substrates mimicked U5 end LTR sequences extended past conserved CA
0.25489283.16188891.html.plaintext.txt	213	Each oligonucleotide pairs designed processing activity removes nucleotides 3 CA would produce 24 nt product
0.25489283.16188891.html.plaintext.txt	214	The 3 end extensions either form single stranded overhang Ov beyond CA base paired form blunt end Bl
0.25489283.16188891.html.plaintext.txt	215	The sequences extensions chosen based presence 3 ends DNAs isolated vivo particles
0.25489283.16188891.html.plaintext.txt	216	For example prominent sequences observed U3 U5 ends TT AT respectively
0.25489283.16188891.html.plaintext.txt	217	4 In addition longer stretches Ts observed
0.25489283.16188891.html.plaintext.txt	218	As indicated 24 nt product IN CH exhibited processing activity specifically removed nucleotides 3 CA Fig
0.25489283.16188891.html.plaintext.txt	219	The processing activity IN produced 24 nt sequence dominant product substrates tt ttt ttttt single stranded extensions
0.25489283.16188891.html.plaintext.txt	220	In one case substrate Bl end IN generated 24 nt species along several smaller products
0.25489283.16188891.html.plaintext.txt	221	These additional products seen lesser extent substrates likely nonspecific nuclease activity IN
0.25489283.16188891.html.plaintext.txt	222	This type nonspecific activity observed INs 30
0.25489283.16188891.html.plaintext.txt	223	It reported variety INs possess intrinsic DNA hydrolysis alcoholysis activity responsible nonspecific nuclease activity similar observed 31
0.25489283.16188891.html.plaintext.txt	224	View larger version 41K FIGURE 5
0.25489283.16188891.html.plaintext.txt	225	The strand transfer activities IN CH
0.25489283.16188891.html.plaintext.txt	226	A schematic diagram strand transfer assay Tf1 IN CH enzymes pre processed substrates
0.25489283.16188891.html.plaintext.txt	227	B electrophoretic analyses products strand transfer reactions
0.25489283.16188891.html.plaintext.txt	228	For U3 end oligonucleotide HL1034 5 end labeled annealed oligonucleotide HL1033
0.25489283.16188891.html.plaintext.txt	229	For U5 end oligonucleotide HL1039 5 end labeled annealed oligonucleotide HL1040
0.25489283.16188891.html.plaintext.txt	230	Decreasing amounts enzyme incubated either substrate
0.25489283.16188891.html.plaintext.txt	231	The products resolved electrophoretically
0.25489283.16188891.html.plaintext.txt	232	The lanes marked 0 contained reaction incubated enzyme
0.25489283.16188891.html.plaintext.txt	233	The following lane numbers amounts protein expressed microg used reaction IN 1 1
0.25489283.16188891.html.plaintext.txt	234	The protein dilutions done described legend Fig
0.25489283.16188891.html.plaintext.txt	235	The size markers included disintegration reaction performed U5 substrate Tf1 IN described legend Fig
0.25489283.16188891.html.plaintext.txt	236	Also included markers X174 DNA cleaved HinFI 5 end labeled
0.25489283.16188891.html.plaintext.txt	237	C quantitative analyses strand transfer activity
0.25489283.16188891.html.plaintext.txt	238	The radioactivity gel shown B scanned phosphorimager
0.25489283.16188891.html.plaintext.txt	239	The radioactivity bands larger 24 nt calculated percentage total radioactivity
0.25489283.16188891.html.plaintext.txt	240	The activities expressed percent conversion
0.25489283.16188891.html.plaintext.txt	241	For retrovirus INs product processing activity substrate suitable strand transfer
0.25489283.16188891.html.plaintext.txt	242	Therefore reactions efficient processing activity also exhibit strand transfer
0.25489283.16188891.html.plaintext.txt	243	The processing activity Tf1 IN either tt extensions high strand transfer detected Fig
0.25489283.16188891.html.plaintext.txt	244	The processing activity 3 5 nucleotide extensions less efficient strand transfer observed
0.25489283.16188891.html.plaintext.txt	245	Thus IN Tf1 similar INs retroviruses processing required strand transfer
0.25489283.16188891.html.plaintext.txt	246	The amounts processed products accumulated CH similar IN Fig
0.25489283.16188891.html.plaintext.txt	247	However CH generated substantially products strand transfer IN
0.25489283.16188891.html.plaintext.txt	248	The levels strand transfer products greater 24 nt quantified
0.25489283.16188891.html.plaintext.txt	249	The activity CH substrates significantly higher IN
0.25489283.16188891.html.plaintext.txt	250	For example activities tt Ov 57 Ov 38 relative produced pre processed substrate
0.25489283.16188891.html.plaintext.txt	251	The comparable figures IN 11 15 respectively
0.25489283.16188891.html.plaintext.txt	252	Because increase strand transfer requires enhanced 3 end processing data indicate 3 end processing activity CH higher IN
0.25489283.16188891.html.plaintext.txt	253	The efficient processing U5 substrates suggested Tf1 proteins specifically recognized removed extensions beyond CA dinucleotide
0.25489283.16188891.html.plaintext.txt	254	To test whether sequences substrate recognized IN CH assayed activity using substrate U5 sequence HIV 1 Fig
0.25489283.16188891.html.plaintext.txt	255	The HIV 1 substrate 21 nt long physiological GT extension 3 CA dinucleotide
0.25489283.16188891.html.plaintext.txt	256	Processing activity would reduce 21 nt species 19 nt
0.25489283.16188891.html.plaintext.txt	257	Compared processing activity HIV 1 IN substrate Tf1 proteins exhibited little activity
0.25489283.16188891.html.plaintext.txt	258	This indicates addition CA dinucleotide Tf1 proteins recognize sequence U5 substrate specific Tf1
0.25489283.16188891.html.plaintext.txt	259	It also seen HIV 1 IN utilize Tf1 pre processed substrates data shown
0.25489283.16188891.html.plaintext.txt	260	Processing U3 End LTR Retroviral INs processing activities remove extensions 3 CA U5 U3 ends cDNA
0.25489283.16188891.html.plaintext.txt	261	Because Tf1 proteins found processing activity U5 end tested whether could also process extensions U3 end Tf1
0.25489283.16188891.html.plaintext.txt	262	The results show CH IN remove nucleotides 3 CA U3 sequence Fig
0.25489283.16188891.html.plaintext.txt	263	As seen U5 substrates shorter extensions U3 substrates processed efficiently longer extensions
0.25489283.16188891.html.plaintext.txt	264	The cleavages Ov versions somewhat efficient Bl counterparts
0.25489283.16188891.html.plaintext.txt	265	The processing activity CH 3 5 6 nucleotide extensions significantly greater IN
0.25489283.16188891.html.plaintext.txt	266	However comparing activities proteins shorter extensions complex strong strand transfer activity CH reduced accumulation processed species
0.25489283.16188891.html.plaintext.txt	267	To approximate processing activities IN CH levels strand transfer quantified
0.25489283.16188891.html.plaintext.txt	268	As found U5 substrates CH exhibited substantially higher levels activity
0.25489283.16188891.html.plaintext.txt	269	For example activities tt Ov 88 tt Bl 32 ttt Ov 19 produced pre processed substrate
0.25489283.16188891.html.plaintext.txt	270	The comparable figures IN 11 4 detectable respectively
0.25489283.16188891.html.plaintext.txt	271	Strand Transfer Activities Require Pre processing Extensions 3 CA The processing activities IN CH estimated measuring products subsequent strand transfer
0.25489283.16188891.html.plaintext.txt	272	This done products processing readily converted strand transfer activity larger oligonucleotides
0.25489283.16188891.html.plaintext.txt	273	However accumulated products strand transfer would overestimate processing Tf1 proteins could mediate strand transfer substrates retained nucleotide extensions 3 CA
0.25489283.16188891.html.plaintext.txt	274	To test possibility strand transfer reactions conducted substrates possessed a23 dideoxynucleotide 3 end
0.25489283.16188891.html.plaintext.txt	275	Unless removed processing substrate would lack necessary 3 hydroxyl result would block strand transfer
0.25489283.16188891.html.plaintext.txt	276	View larger version 49K FIGURE 6
0.25489283.16188891.html.plaintext.txt	277	The 3 end processing strand transfer activities U5 substrates Tf1 HIV 1 substrate
0.25489283.16188891.html.plaintext.txt	278	A schematic diagram 3 processing assay shows oligonucleotides annealed mimic U5 U3 ends Tf1 DNA
0.25489283.16188891.html.plaintext.txt	279	The asterisk indicates 5 end oligonucleotide conserved CA labeled 32P
0.25489283.16188891.html.plaintext.txt	280	B electrophoretic analyses reaction products 3 processing assays
0.25489283.16188891.html.plaintext.txt	281	Reactions conducted equal amounts specified substrates
0.25489283.16188891.html.plaintext.txt	282	The sequence 3 end substrates shown lanes extensions 3 conserved ACA indicated lowercase
0.25489283.16188891.html.plaintext.txt	283	The substrate pre processed end ACA blunt ended one used Fig
0.25489283.16188891.html.plaintext.txt	284	Substrates marked Bl double stranded oligonucleotides blunt ends
0.25489283.16188891.html.plaintext.txt	285	Those marked Ov 3 overhangs corresponding sequence lowercase
0.25489283.16188891.html.plaintext.txt	286	Other reactions performed blunt ended substrate mimics U5 end HIV 1 DNA additional two nucleotides gt 3 conserved CA
0.25489283.16188891.html.plaintext.txt	287	To generate substrate oligonucleotide RZ132 5 end labeled annealed oligonucleotide RZ61
0.25489283.16188891.html.plaintext.txt	288	The enzymatic reactions performed Tf1 IN Tf1 CH HIV 1 IN marked without enzyme marked
0.25489283.16188891.html.plaintext.txt	289	The positions labeled oligonucleotides indicated 24 21 nt Tf1 HIV 1 substrates respectively
0.25489283.16188891.html.plaintext.txt	290	The experiment described Fig
0.25489283.16188891.html.plaintext.txt	291	8 tested U3 substrate Tf1 3 ends sequence ACA ttddc
0.25489283.16188891.html.plaintext.txt	292	This substrate compared control substrate ended c instead ddc
0.25489283.16188891.html.plaintext.txt	293	Two variants DNA one single stranded Ov Bl configuration tested
0.25489283.16188891.html.plaintext.txt	294	The CH protein exhibited high levels strand transfer blocked substrate ACAt2ddc Ov significantly different unblocked DNA ACAt2c Ov
0.25489283.16188891.html.plaintext.txt	295	This indicated strand transfer occurred efficient removal blocking sequence
0.25489283.16188891.html.plaintext.txt	296	The strand transfer activity Ov substrates substantially greater seen Bl versions
0.25489283.16188891.html.plaintext.txt	297	The full length IN show significant activity either modified unmodified substrates Fig
0.25489283.16188891.html.plaintext.txt	298	The Strand Transfer Activity Tf1 IN Not CH Specifically Requires That ACA Be Present 3 End Substrate The strand transfer activities retrovirus retrotransposon INs require highly conserved CA dinucleotide present 3 end donor substrate 30
0.25489283.16188891.html.plaintext.txt	299	We tested whether IN Tf1 requirement CA whether chromodomain contributed specificity
0.25489283.16188891.html.plaintext.txt	300	IN CH tested whether last three nucleotides LTRs ACA necessary strand transfer Fig
0.25489283.16188891.html.plaintext.txt	301	The substrates based U3 double stranded donor used Figs
0.25489283.16188891.html.plaintext.txt	302	7 8 lacked extensions 3 ACA
0.25489283.16188891.html.plaintext.txt	303	Thus 3 processing required
0.25489283.16188891.html.plaintext.txt	304	Single double triple substitutions made ACA test dependence triplet
0.25489283.16188891.html.plaintext.txt	305	All modifications introduced sequence led dramatic reduction strand transfer activity IN
0.25489283.16188891.html.plaintext.txt	306	In sharp contrast IN CH capable strand transfer substituted substrates
0.25489283.16188891.html.plaintext.txt	307	Except substrate three terminal nucleotides flipped tgt CH greater 10 activity observed unsubstituted substrate
0.25489283.16188891.html.plaintext.txt	308	The striking difference CH IN substrate 1 transition AtA
0.25489283.16188891.html.plaintext.txt	309	CH retained 50 activity observed ACA terminus whereas full length IN 1 activity
0.25489283.16188891.html.plaintext.txt	310	This large difference specificity two related proteins shows IN far stringent CH counterpart selecting DNA donor correct 3 end
0.25489283.16188891.html.plaintext.txt	311	View larger version 83K FIGURE 7
0.25489283.16188891.html.plaintext.txt	312	The 3 processing strand transfer activities Tf1 IN CH U3 substrates
0.25489283.16188891.html.plaintext.txt	313	The reactions conducted equal amounts specified substrates
0.25489283.16188891.html.plaintext.txt	314	The labeling substrates lane described legend Fig
0.25489283.16188891.html.plaintext.txt	315	The reactions performed specified enzymes marked without enzyme marked
0.25489283.16188891.html.plaintext.txt	316	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In study IN LTR retrotransposon Tf1 produced recombinant soluble enzymatically active protein
0.25489283.16188891.html.plaintext.txt	317	Tf1 IN exhibited vitro enzymatic activities expected IN either retrovirus LTR retrotransposon
0.25489283.16188891.html.plaintext.txt	318	The presence chromodomain COOH terminus Tf1 IN provided unique opportunity study impact domain IN activity
0.25489283.16188891.html.plaintext.txt	319	Our results demonstrate chromodomain surprising influence specific activity IN well recognition donor DNA
0.25489283.16188891.html.plaintext.txt	320	Although disintegration activity may direct biological relevance particularly useful biochemical characterization INs
0.25489283.16188891.html.plaintext.txt	321	It provides highly sensitive assay cleavage ligation activity IN
0.25489283.16188891.html.plaintext.txt	322	The disintegration assay developed Tf1 IN used optimize reaction conditions
0.25489283.16188891.html.plaintext.txt	323	The increased activities Tf1 IN low concentrations NaCl Fig
0.25489283.16188891.html.plaintext.txt	324	3A similar observed retroviral INs 26 33
0.25489283.16188891.html.plaintext.txt	325	Because magnesium thought important divalent metal vivo preference Tf1 IN manganese might result structural defects recombinant protein
0.25489283.16188891.html.plaintext.txt	326	However preference manganese could common property INs INs HIV 1 murine leukemia virus also exhibit strong preferences manganese magnesium vitro 26 33
0.25489283.16188891.html.plaintext.txt	327	The ability HIV IN react efficiently Tf1 substrate Fig
0.25489283.16188891.html.plaintext.txt	328	2 suggested disintegration activity HIV 1 IN little sequence specificity
0.25489283.16188891.html.plaintext.txt	329	This consistent data several studies indicating beyond requirement CA disintegration activity retroviral INs sequence specific 25 34 36
0.25489283.16188891.html.plaintext.txt	330	The full length version Tf1 IN found substantial levels strand transfer activity U3 U5 substrates
0.25489283.16188891.html.plaintext.txt	331	The genomes eukaryotes accumulate large numbers inactive retrotransposons
0.25489283.16188891.html.plaintext.txt	332	The strand transfer assay stringent test IN function activity Tf1 IN detected indicates protein fully active
0.25489283.16188891.html.plaintext.txt	333	Strand transfer assays substrates containing nucleotides 3 CA revealed Tf1 IN also 3 processing activity Figs
0.25489283.16188891.html.plaintext.txt	334	This observed U3 U5 substrates single double stranded extensions
0.25489283.16188891.html.plaintext.txt	335	As case 3 end processing activity HIV 1 IN extensions longer 2 nucleotides readily removed single stranded double stranded 37
0.25489283.16188891.html.plaintext.txt	336	View larger version 88K FIGURE 8
0.25489283.16188891.html.plaintext.txt	337	The 3 end processing strand transfer activities Tf1 IN CH substrates contained blocked 3 ends
0.25489283.16188891.html.plaintext.txt	338	Substrates ending 3 terminal dideoxy C indicated ddc
0.25489283.16188891.html.plaintext.txt	339	The experiment performed annotations described legend Fig
0.25489283.16188891.html.plaintext.txt	340	In one respect processing activity quite unexpected
0.25489283.16188891.html.plaintext.txt	341	It thought 3 end processing activity retroviruses LTR retrotransposons required cases priming minus strand reverse transcription adds nucleotides beyond conserved CA
0.25489283.16188891.html.plaintext.txt	342	For Tf1 3 end minus strand primer immediately adjacent U5 sequence upstream LTR 28 29
0.25489283.16188891.html.plaintext.txt	343	As result extensions processing thought occur
0.25489283.16188891.html.plaintext.txt	344	However recent analyses Tf1 cDNA extracted particles revealed 85 U3 U5 ends terminated nontemplated nucleotides
0.25489283.16188891.html.plaintext.txt	345	4 The processing activity IN observed could theory remove 3 extensions allow bulk cDNA participate integration
0.25489283.16188891.html.plaintext.txt	346	This model raises question would nontemplated nucleotides added could removed IN
0.25489283.16188891.html.plaintext.txt	347	One possibility nontemplated nucleotides could prevent aberrant annealing 3 end sequences opposite LTR subsequent extension
0.25489283.16188891.html.plaintext.txt	348	As result nontemplated nucleotides would protect completed cDNA IN initiates 3 processing
0.25489283.16188891.html.plaintext.txt	349	Another possibility nontemplated nucleotides could protect conserved CA attack nonspecific 3 exonucleases
0.25489283.16188891.html.plaintext.txt	350	View larger version 64K FIGURE 9
0.25489283.16188891.html.plaintext.txt	351	The strand transfer activities Tf1 IN CH U3 substrates contained sequence modifications terminal ACA
0.25489283.16188891.html.plaintext.txt	352	The modifications marked lowercase letters
0.25489283.16188891.html.plaintext.txt	353	The activities modified substrates compared pre processed substrate ACA
0.25489283.16188891.html.plaintext.txt	354	All substrates tested possessed blunt ends used equal amounts
0.25489283.16188891.html.plaintext.txt	355	The reactions conducted either presence specified enzyme absence enzyme
0.25489283.16188891.html.plaintext.txt	356	The LTR retrotransposon Ty3 Saccharomyces cerevisiae contain IN 3 processing activity predicted based position minus strand primer 38
0.25489283.16188891.html.plaintext.txt	357	Nevertheless LTR retrotransposons Ty1 minus strand primers immediately adjacent U5 sequence LTR thought processing 39
0.25489283.16188891.html.plaintext.txt	358	The finding Tf1 IN processing activity brings question predicted lack processing activity INs LTR retrotransposons
0.25489283.16188891.html.plaintext.txt	359	Approximately 25 Ty1 cDNA terminates nontemplated nucleotides 40
0.25489283.16188891.html.plaintext.txt	360	The cDNA nontemplated additions could participate integration IN processing activity
0.25489283.16188891.html.plaintext.txt	361	However analyses Ty1 IN failed detect processing activity 41 42
0.25489283.16188891.html.plaintext.txt	362	The removal nontemplated nucleotides IN may also occur retroviral cDNA
0.25489283.16188891.html.plaintext.txt	363	In vitro experiments show HIV 1 reverse transcriptase possesses terminal transferase activity adds nontemplated nucleotides 3 end nascent DNA 43 45
0.25489283.16188891.html.plaintext.txt	364	A time course reverse transcription HIV 1 infection identified prominent species cDNA one nucleotide extra 3 end plus strand 46
0.25489283.16188891.html.plaintext.txt	365	This led authors propose extra nucleotide result nontemplated addition 3 processing activity IN removed
0.25489283.16188891.html.plaintext.txt	366	Perhaps striking results presented report indicate role chromodomain modulating integration
0.25489283.16188891.html.plaintext.txt	367	Although removing 15 IN might expected reduce activity substantially deletion chromodomain resulted intriguing increase disintegration strand transfer activities
0.25489283.16188891.html.plaintext.txt	368	CH also greater 3 processing activity IN assuming greater amounts strand transfer products generated derived processed oligonucleotides
0.25489283.16188891.html.plaintext.txt	369	Evidence supporting assumption oligonucleotides blocking nucleotide ddc 3 CA efficiently converted products strand transfer CH oligonucleotides without ddc block Fig
0.25489283.16188891.html.plaintext.txt	370	These data indicate chromodomain Tf1 IN negatively modulates IN activities
0.25489283.16188891.html.plaintext.txt	371	In addition role limiting integration activity chromodomain significant impact restricting sequence 3 end donor DNA could function strand transfer
0.25489283.16188891.html.plaintext.txt	372	Only chromodomain present strict requirement ACA 3 end donor DNA Fig
0.25489283.16188891.html.plaintext.txt	373	The strong specificity intact IN contrast IN Ty1 similar types assays tolerate many alterations 3 end donor DNA 42
0.25489283.16188891.html.plaintext.txt	374	However INs retroviruses HIV 1 lack chromodomains yet exhibit strict requirements sequences 3 end donor DNA 35 37
0.25489283.16188891.html.plaintext.txt	375	Thus chromodomain means INs achieve strict requirement CA 3 end donor oligonucleotides
0.25489283.16188891.html.plaintext.txt	376	Therefore appears case Tf1 IN chromodomain evolved independently means restricting donor sequences
0.25489283.16188891.html.plaintext.txt	377	Both contributions chromodomain limiting IN activity increasing sequence specificity may result single mechanism restricts access active site IN
0.25489283.16188891.html.plaintext.txt	378	Although several examples chromodomains interact directly histone H3 lack histone proteins assays indicates interaction required restrictive properties Tf1 chromodomain
0.25489283.16188891.html.plaintext.txt	379	Functional analyses several chromodomains recently revealed unexpected diversity interaction targets DNA RNA 7
0.25489283.16188891.html.plaintext.txt	380	It possible chromodomain Tf1 restricts IN activity interactions donor DNA
0.25489283.16188891.html.plaintext.txt	381	Regardless mode inhibition interesting possibility vivo inhibition regulated
0.25489283.16188891.html.plaintext.txt	382	One intriguing hypothesis chromodomain interact histone H3 interaction target site relieves inhibitory function chromodomain
0.25489283.16188891.html.plaintext.txt	383	The chromodomain HP1 forms organized cluster strands helices response interaction NH2 terminus H3 32 47
0.25489283.16188891.html.plaintext.txt	384	This dramatic reorganization consistent role regulating integration
0.25489283.16188891.html.plaintext.txt	385	Although chromodomains known exist many INs LTR retrotransposons 8 9 results reported first direct effort identify function chromodomain IN
0.25489283.16188891.html.plaintext.txt	386	The restrictive role chromodomain identified may well true chromodomain containing INs
0.25489283.16188891.html.plaintext.txt	387	In addition INs chromodomains identified several enzymes
0.25489283.16188891.html.plaintext.txt	388	The H3 lysine 9 specific histone methyltransferase Suvar3 9 ATP dependent chromatin remodeling factors CHD DNA methyltransferase CMT histone acetylase CDY enzymes contain chromodomains 7
0.25489283.16188891.html.plaintext.txt	389	In light restrictive function chromodomain Tf1 IN interesting test chromodomains proteins affect enzymatic activities
0.25489283.16188891.html.plaintext.txt	390	The poor solubility recombinant INs studied thus far major obstacle producing high resolution structures
0.25489283.16188891.html.plaintext.txt	391	High concentrations salt introduction amino acid substitutions necessary solubilize individual domains INs
0.25489283.16188891.html.plaintext.txt	392	A number structures determined three domains INs retroviruses HIV 1 simian immunodeficiency virus avian sarcoma virus Rous sarcoma virus 18
0.25489283.16188891.html.plaintext.txt	393	However lack structure intact IN makes difficult model spatial relationships three domains
0.25489283.16188891.html.plaintext.txt	394	During purification Tf1 IN became clear IN substantially soluble integrases previously studied
0.25489283.16188891.html.plaintext.txt	395	It possible solubility lead first crystal structure full length IN
0.25489283.16188891.html.plaintext.txt	396	This would serve significant leap understanding structures INs general specifically HIV 1 IN
0.25489283.16188891.html.plaintext.txt	397	A structure intact IN would substantially facilitate design development new drugs HIV IN thus contribute ongoing fight AIDS
0.25489283.16188891.html.plaintext.txt	398	FOOTNOTES We dedicate article memory colleague good friend Dr
0.25489283.16188891.html.plaintext.txt	399	This work supported part Intramural Research Program National Institutes Health NICHD National Institutes Health Intramural AIDS Targeted Antiviral Program
0.25489283.16188891.html.plaintext.txt	400	The costs publication article defrayed part payment page charges
0.25489283.16188891.html.plaintext.txt	401	This article must therefore hereby marked advertisement accordance 18 U
0.25489283.16188891.html.plaintext.txt	402	Section 1734 solely indicate fact
0.25489283.16188891.html.plaintext.txt	403	The line version article available httpwww
0.25489283.16188891.html.plaintext.txt	404	org contains additional supplemental text
0.25489283.16188891.html.plaintext.txt	405	1 Recipient Oak Ridge Institute Science Education fellowship administered Oak Ridge Laboratories
0.25489283.16188891.html.plaintext.txt	406	Cell Developmental Biology Sackler School Medicine Tel Aviv University 69978 Israel
0.25489283.16188891.html.plaintext.txt	407	Incumbent The Gregorio Dora Shapira Chair Research Malignancies Tel Aviv University
0.25489283.16188891.html.plaintext.txt	408	2 To correspondence addressed 18 Library Dr
0.25489283.16188891.html.plaintext.txt	409	301 402 4281 Fax 301 402 1323 E mail henrylevinatnih
0.25489283.16188891.html.plaintext.txt	410	3 The abbreviations used LTR long terminal repeat IN integrase CH chromodomain deleted IN HIV 1 human immunodeficiency virus type 1 Me2SO dimethyl sulfoxide nt nucleotides RT reverse transcriptase Ov overhang MOPS 4 morpholinepropanesulfonic acid
0.25489283.16188891.html.plaintext.txt	411	ACKNOWLEDGMENTS We express gratitude Dr
0.25489283.16188891.html.plaintext.txt	412	Craigie helpful suggestions fruitful discussions providing purified HIV 1 IN substrates assay
0.25489283.16188891.html.plaintext.txt	413	Grandgenett valuable suggestions J
0.25489283.16188891.html.plaintext.txt	414	Myung help preparing figures
0.25489283.16188891.html.plaintext.txt	415	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Iizuka M
0.25489283.16188891.html.plaintext.txt	416	13 154 160CrossRefMedline Order article via Infotrieve Kurdistani S
0.25489283.16188891.html.plaintext.txt	417	4 276 284CrossRefMedline Order article via Infotrieve Fischle W
0.25489283.16188891.html.plaintext.txt	418	15 172 183CrossRefMedline Order article via Infotrieve Hampsey M
0.25489283.16188891.html.plaintext.txt	419	2003 Cell 113 429 432CrossRefMedline Order article via Infotrieve Robyr D
0.25489283.16188891.html.plaintext.txt	420	376 289 304Medline Order article via Infotrieve Bannister A
0.25489283.16188891.html.plaintext.txt	421	376 269 288Medline Order article via Infotrieve Brehm A
0.25489283.16188891.html.plaintext.txt	422	2004 Bioessays 26 133 140CrossRefMedline Order article via Infotrieve Malik H
0.25489283.16188891.html.plaintext.txt	423	73 5186 5190AbstractFree Full Text Gorinsek B
0.25489283.16188891.html.plaintext.txt	424	21 781 798AbstractFree Full Text Brown P
0.25489283.16188891.html.plaintext.txt	425	1997 Retroviruses Coffin J
0.25489283.16188891.html.plaintext.txt	426	161 204 Cold Spring Harbor Laboratory Press Plainview NY Hindmarsh P
0.25489283.16188891.html.plaintext.txt	427	63 836 843AbstractFree Full Text Craigie R
0.25489283.16188891.html.plaintext.txt	428	276 23213 23216Free Full Text Telesnitsky A
0.25489283.16188891.html.plaintext.txt	429	1997 Reverse Transcription Generation Retroviral DNA Cold Spring Harbor Press Plainview NY Grandgenett D
0.25489283.16188891.html.plaintext.txt	430	260 8243 8249AbstractFree Full Text Asante Appiah E
0.25489283.16188891.html.plaintext.txt	431	36 139 156CrossRefMedline Order article via Infotrieve Craig N
0.25489283.16188891.html.plaintext.txt	432	1995 Science 270 253 254Free Full Text Bushman F
0.25489283.16188891.html.plaintext.txt	433	90 3428 3432AbstractFree Full Text Chiu T
0.25489283.16188891.html.plaintext.txt	434	4 965 979CrossRefMedline Order article via Infotrieve Atwood A
0.25489283.16188891.html.plaintext.txt	435	16 338 346Abstract Singleton T
0.25489283.16188891.html.plaintext.txt	436	2002 Eukaryotic Cell 1 44 55AbstractFree Full Text Teysset L
0.25489283.16188891.html.plaintext.txt	437	77 5451 5463AbstractFree Full Text Levin H
0.25489283.16188891.html.plaintext.txt	438	1997 Cell 88 5 8CrossRefMedline Order article via Infotrieve Atwood A
0.25489283.16188891.html.plaintext.txt	439	72 1324 1333AbstractFree Full Text Kirchner J
0.25489283.16188891.html.plaintext.txt	440	1992 Science 255 723 726Medline Order article via Infotrieve Vincent K
0.25489283.16188891.html.plaintext.txt	441	361 557 566CrossRefMedline Order article via Infotrieve Levin H
0.25489283.16188891.html.plaintext.txt	442	15 3310 3317Abstract Levin H
0.25489283.16188891.html.plaintext.txt	443	16 5645 5654Abstract Craigie R
0.25489283.16188891.html.plaintext.txt	444	2002 Mobile DNA II Craig N
0.25489283.16188891.html.plaintext.txt	445	613 630 ASM Press Washington D
0.25489283.16188891.html.plaintext.txt	446	276 114 124AbstractFree Full Text Nielsen P
0.25489283.16188891.html.plaintext.txt	447	2002 Nature 416 103 107CrossRefMedline Order article via Infotrieve Dotan I
0.25489283.16188891.html.plaintext.txt	448	69 456 468Abstract Donzella G
0.25489283.16188891.html.plaintext.txt	449	67 7077 7087Abstract van den Ent F
0.25489283.16188891.html.plaintext.txt	450	68 7825 7832Abstract Balakrishnan M
0.25489283.16188891.html.plaintext.txt	451	71 1025 1035Abstract Vink C
0.25489283.16188891.html.plaintext.txt	452	65 4636 4644Medline Order article via Infotrieve Kirchner J
0.25489283.16188891.html.plaintext.txt	453	70 4737 4747Abstract Boeke J
0.25489283.16188891.html.plaintext.txt	454	1988 RNA Genetics Domingo E
0.25489283.16188891.html.plaintext.txt	455	59 103 CRC Press Boca Raton FL Mules E
0.25489283.16188891.html.plaintext.txt	456	72 6490 6503AbstractFree Full Text Eichinger D
0.25489283.16188891.html.plaintext.txt	457	69 4683 4692Abstract Peliska J
0.25489283.16188891.html.plaintext.txt	458	1992 Science 258 1112 1118Medline Order article via Infotrieve Patel P
0.25489283.16188891.html.plaintext.txt	459	91 549 553AbstractFree Full Text Golinelli M
0.25489283.16188891.html.plaintext.txt	460	2002 Biochemistry 41 5894 5906CrossRefMedline Order article via Infotrieve Miller M
0.25489283.16188891.html.plaintext.txt	461	71 5382 5390Abstract Jacobs S
0.25489283.16188891.html.plaintext.txt	462	2002 Science 295 2080 2083AbstractFree Full Text This Article Abstract Full Text PDF Supplemental Data All Versions Article 2804739086 recent M506363200v1 Purchase Article View Shopping Cart Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Copyright Permissions Google Scholar Articles Hizi A
0.25489283.16188891.html.plaintext.txt	463	PubMed PubMed Citation Articles Hizi A
0.25489283.16188891.html.plaintext.txt	464	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular Cellular Proteomics Journal Lipid Research Biochemistry Molecular Biology Education Copyright 2005 American Society Biochemistry Molecular Biology
0.22037566.14583614.html.plaintext.txt	0	Hepatocyte Nuclear Factor 4 Is Central Regulator Bile Acid Conjugation Yusuke Inoue Ai Ming Yu Junko Inoue Frank J
0.22037566.14583614.html.plaintext.txt	1	From Laboratory Metabolism Center Cancer Research NCI National Institutes Health Bethesda Maryland 20892
0.22037566.14583614.html.plaintext.txt	2	Received publication October 7 2003 revised form October 24 2003
0.22037566.14583614.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Hepatocyte nuclear factor 4 HNF4 important role regulating expression liver specific genes
0.22037566.14583614.html.plaintext.txt	4	Because bile acids produced cholesterol liver many enzymes involved biosynthesis preferentially expressed liver role HNF4 regulation bile acid production examined
0.22037566.14583614.html.plaintext.txt	5	In mice unconjugated bile acids conjugated taurine liver specific enzymes bile acid CoA ligase bile acid CoAamino acid N acyltransferase BAT
0.22037566.14583614.html.plaintext.txt	6	Mice lacking hepatic HNF4 expression exhibited markedly decreased expression long chain acyl CoA synthase related gene VLACSR mouse candidate bile acid CoA ligase BAT
0.22037566.14583614.html.plaintext.txt	7	This associated markedly elevated levels unconjugated glycine conjugated bile acids gallbladder
0.22037566.14583614.html.plaintext.txt	8	HNF4 found bind directly mouse VLACSR BAT gene promoters promoter activities dependent HNF4 binding sites HNF4 expression
0.22037566.14583614.html.plaintext.txt	9	In conclusion HNF4 plays central role bile acid conjugation direct regulation VLACSR BAT vivo
0.22037566.14583614.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Bile acids BAs1 synthesized cholesterol mainly hepatocytes cascade enzyme reactions
0.22037566.14583614.html.plaintext.txt	11	In humans reactions initiated steroid nucleus side chain hydroxylation cholesterol followed oxidation side chain resulting production primary BAs cholic acid chenodeoxycholic acid 1 2
0.22037566.14583614.html.plaintext.txt	12	In mice cholic acid murichoric acid predominant primary BAs 3
0.22037566.14583614.html.plaintext.txt	13	Following BA biosynthesis BAs conjugated glycine taurine resulting conjugates exported hepatocytes via hepatic BA transporters bile salt export pump located apical canalicular membrane 1 4 6
0.22037566.14583614.html.plaintext.txt	14	These BAs stored gallbladder transported small intestine
0.22037566.14583614.html.plaintext.txt	15	BAs biological detergents serve solubilize fats sterols fat soluble vitamins intestine
0.22037566.14583614.html.plaintext.txt	16	Most BAs recycled jejunum ileum transporters apical sodium dependent bile acid transporter 4 7 transported back hepatocytes portal circulation transporters including sodium taurocholate cotransporter polypeptide NTCP organic anion transporter polypeptide 1 OATP1 located basolateral membrane 4
0.22037566.14583614.html.plaintext.txt	17	Hepatocyte nuclear factor 4 HNF4 orphan member nuclear receptor hormone superfamily mainly expressed liver intestine kidney pancreas regulates expression target genes including several serum proteins apolipoproteins blood coagulation factors P450s enzymes involved glucose lipid ammonia steroid fatty acid metabolism binding direct repeat 1 elements promoter enhancer regions 8 9
0.22037566.14583614.html.plaintext.txt	18	Indeed expression hepatic apolipoproteins including A II A IV C II C III ornithine transcarbamylase involved ureagenesis CYP3A associated xenobiotic metabolism significantly reduced livers liver specific HNF4 null mice 10 12
0.22037566.14583614.html.plaintext.txt	19	A second line liver specific HNF4 null mice established Cre recombinase placed control albumin promoter fetoprotein enhancer 13
0.22037566.14583614.html.plaintext.txt	20	These mice exhibited marked reduction expression hepatic glycogen synthase phosphoenolpyruvate carboxykinase glucose 6 phosphatase involved gluconeogenesis reduced levels E cadherin ZO 1 CEACAM1 proteins critical normal liver morphology 13
0.22037566.14583614.html.plaintext.txt	21	Liver specific HNF4 null mice adult exhibited increased serum BAs expression BA transporters NTCP OATP1 also reduced mice 10
0.22037566.14583614.html.plaintext.txt	22	Whereas BA biosynthesis transport controlled degree HNF4 remains unknown whether HNF4 regulates BA conjugation pathway
0.22037566.14583614.html.plaintext.txt	23	Nuclear receptors involved control BA biosynthesis transport system 6 14 15 mechanism regulating BA conjugation pathways analyzed
0.22037566.14583614.html.plaintext.txt	24	BA conjugation reactions catalyzed two liver enriched enzymes bile acid CoA ligase BAL bile acid CoAamino acid N acyltransferase BAT 1 14
0.22037566.14583614.html.plaintext.txt	25	BAL activities associated rat BAL protein 16 human long chain acyl CoA synthase homolog 2 VLACSR H2 protein 17 enzymatic analysis BAL protein performed mouse
0.22037566.14583614.html.plaintext.txt	26	Because mouse long chain acyl CoA synthase related VLACSR gene highly expressed liver 18 well rat BAL human VLACSR H2 genes high homology proteins 16 reasonable assume VLACSR gene might mouse homolog BAL gene
0.22037566.14583614.html.plaintext.txt	27	On hand BAT genes cloned mouse 19 rat 20 human 21
0.22037566.14583614.html.plaintext.txt	28	The human BAT protein conjugation activity taurine glycine substrates 21 mouse BAT protein uses taurine substrate 19
0.22037566.14583614.html.plaintext.txt	29	In present study biological function HNF4 investigated vivo vitro using liver specific HNF4 null mice
0.22037566.14583614.html.plaintext.txt	30	These mice exhibit increased unconjugated glycine conjugated BAs gallbladder bile decreased expression VLACSR BAT
0.22037566.14583614.html.plaintext.txt	31	Expression VLACSR BAT shown regulated directly HNF4 via HNF4 binding sites promoter regions
0.22037566.14583614.html.plaintext.txt	32	These results indicate HNF4 important role maintenance BA homeostasis regulating BA conjugation pathways
0.22037566.14583614.html.plaintext.txt	33	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Animals Treatment Liver specific HNF4 null mice generated described previously 10
0.22037566.14583614.html.plaintext.txt	34	All experiments performed 45 day old HNF4floxflox x albumin Cre KO HNF4floxflox x albumin Cre FLOX mice
0.22037566.14583614.html.plaintext.txt	35	Mice housed pathogen free animal facility standard 12 h light12 h dark cycle water chow ad libitum
0.22037566.14583614.html.plaintext.txt	36	All experiments mice performed Association Assessment Accreditation Laboratory Animal Care guidelines approval NCI Animal Care Use Committee
0.22037566.14583614.html.plaintext.txt	37	Northern Blot Analysis Total liver RNA 10 microg extracted Trizol reagent Invitrogen fractionated electrophoresis formaldehyde agarose gel transferred GeneScreen Plus membranes DuPont
0.22037566.14583614.html.plaintext.txt	38	Blots hybridized 68 degrees C PerfectHyb plus solution Sigma random primer labeled cDNA probes exposed PhosphorImager screen cassette followed visualization using Storm 860 PhosphorImager system Amersham Biosciences
0.22037566.14583614.html.plaintext.txt	39	All probes amplified mouse cDNA library using gene specific primers cloned pCR II vector Invitrogen
0.22037566.14583614.html.plaintext.txt	40	Sequences verified using CEQ 2000 Dye Terminator cycle sequencing kits Beckman Coulter Fullerton CA CEQ 2000XL DNA Analysis System Beckman Coulter
0.22037566.14583614.html.plaintext.txt	41	Extraction Bile Acids Bile Three microl bile 1100 dilution methanol added 200 microl acetonitrile containing 20 microl 50 microM dehydrocholic acid
0.22037566.14583614.html.plaintext.txt	42	The sample vortexed 10 subsequently centrifuged 14000 x g 4 degrees C 5 min
0.22037566.14583614.html.plaintext.txt	43	The supernatant transferred new glass tube extracted 2 ml mixture ethyl acetate butyl methyl ether 21 vv
0.22037566.14583614.html.plaintext.txt	44	After centrifugation 3000 x g 4 degrees C 15 min organic phase evaporated stream nitrogen gas
0.22037566.14583614.html.plaintext.txt	45	The residue reconstituted 60 microl 50 methanol solution containing 0
0.22037566.14583614.html.plaintext.txt	46	Ten microl reconstituted sample injected liquid chromatography tandem mass spectrometrymass spectrometry LC MSMS analysis
0.22037566.14583614.html.plaintext.txt	47	Identification Quantitation Intact Free Conjugated Bile Acids LC MSMS LC MSMS analysis performed PE SCIEX API2000 ESI triple quadrupole mass spectrometer PerkinElmer Life Sciences controlled Analyst software
0.22037566.14583614.html.plaintext.txt	48	A Phenomenex Luna C18 3 microm 100 x 2 mm inner diameter column Torrance CA used separate free bile acids
0.22037566.14583614.html.plaintext.txt	49	The flow rate column ambient temperature 0
0.22037566.14583614.html.plaintext.txt	50	2 mlmin optimal resolution achieved elution linear gradient water containing 0
0.22037566.14583614.html.plaintext.txt	51	1 formic acid 45 0 methanol 55 100 10 min room temperature
0.22037566.14583614.html.plaintext.txt	52	Separation glycine taurine conjugated bile acids performed Aquasil C18 5 microm 50 x 2 mm inner diameter column Keystone Scientific Operations Bellefonte PA high pressure liquid chromatography system operated isocratically flow rate 0
0.22037566.14583614.html.plaintext.txt	53	2 mlmin mobile phase acetonitrilewatermethanol 304525 vvv containing 0
0.22037566.14583614.html.plaintext.txt	54	The mass spectrometer operated turbo ion spray mode positive ion detection
0.22037566.14583614.html.plaintext.txt	55	The turbo ion spray temperature maintained 350 degrees C voltage 4
0.22037566.14583614.html.plaintext.txt	56	8 kV applied sprayer needle
0.22037566.14583614.html.plaintext.txt	57	Nitrogen used turbo ion spray nebulizing gas
0.22037566.14583614.html.plaintext.txt	58	The detection quantification free conjugated bile acids internal standard accomplished multiple reactions monitoring transitions mz 403
0.22037566.14583614.html.plaintext.txt	59	2 deoxycholic acid chenodeoxycholic acid hyodeoxycholic acid ursodeoxycholic acid murideoxycholic acid 373
0.22037566.14583614.html.plaintext.txt	60	3 cholic acid hyocholic acid muricholic acid MCA 391
0.22037566.14583614.html.plaintext.txt	61	4 glycodeoxycholic acid GDCA glycochenodeoxycholic acid GCDCA 516
0.22037566.14583614.html.plaintext.txt	62	4 taurocholic acid TCA tauro muricholic acid T MCA 500
0.22037566.14583614.html.plaintext.txt	63	4 taurodeoxycholic acid TDCA taurochenodeoxycholic TCDCA
0.22037566.14583614.html.plaintext.txt	64	All raw data processed using Analyst software
0.22037566.14583614.html.plaintext.txt	65	Calibration curves linear free deoxycholic acid chenodeoxycholic acid hyodeoxycholic acid ursodeoxycholic acid murideoxycholic acid concentrations ranging 0
0.22037566.14583614.html.plaintext.txt	66	05 10 microM free cholic acid hyocholic acid MCA 0
0.22037566.14583614.html.plaintext.txt	67	2 20 microM GDCA GCDCA 0
0.22037566.14583614.html.plaintext.txt	68	1 10 microM TDCA TCDCA 1
0.22037566.14583614.html.plaintext.txt	69	0 200 microM glycocholic acid TCA T MCA 2
0.22037566.14583614.html.plaintext.txt	70	Determination Transcription Start Sites Mouse VLACSR BAT Genes 5 Rapid amplification cDNA ends performed determine transcription start site mouse VLACSR BAT genes using GeneRacer kit Invitrogen
0.22037566.14583614.html.plaintext.txt	71	PCR products cloned pCR TOPO II 20 individual clones sequenced
0.22037566.14583614.html.plaintext.txt	72	Based results major transcription start site determined
0.22037566.14583614.html.plaintext.txt	73	Construction Mouse VLACSR BAT Luciferase Reporter Plasmids The mouse VLACSR 2219 1435 1014 256 220 194 146 47 bp translation start site BAT 1972 1567 1447 1322 602 505 136 52178 bp transcription start site promoters amplified PCR using sequence data derived Celera data base Celera Genomics Rockville MD cloned KpnI XhoI sites pGL3basic vector Promega Madison WI
0.22037566.14583614.html.plaintext.txt	74	Mutations introduced putative HNF4 binding site VLACSR luciferase constructs PCR based site directed mutagenesis using following primer pair 5 acaaaCTGACAGAGTCCAtgggt 3 5 acccaTGGACTCTGTCAGtttgt 3 M2 mutations HNF4 binding site boldface underlined
0.22037566.14583614.html.plaintext.txt	75	Similarly mutations introduced Sp1 binding site VLACSR luciferase constructs PCR based site directed mutagenesis using following primer pair 5 tgtccaagTAAAGAAGTGag 3 5 ctCACTTCTTTActtggaca 3 mutations GC box boldface underlined
0.22037566.14583614.html.plaintext.txt	76	Similarly mutations introduced HNF4 binding site BAT luciferase constructs PCR based site directed mutagenesis using following primer pair 5 agtccaCTTTCCAAGGTCTtagtct 3 5 agactaAGACCTTGGAAAGtggact 3 mutations HNF4 binding site boldface underlined
0.22037566.14583614.html.plaintext.txt	77	Sequences verified using CEQ 2000XL DNA Analysis System Beckman Coulter
0.22037566.14583614.html.plaintext.txt	78	Transient Transfection Assay HepG2 CV 1 cell lines cultured 37 degrees C Dulbeccos modified Eagles medium Invitrogen containing 10 fetal bovine serum HyClone Logan UT 100 unitsml penicillinstreptomycin Invitrogen
0.22037566.14583614.html.plaintext.txt	79	Cells seeded 24 well tissue culture plates grown 90 95 confluency
0.22037566.14583614.html.plaintext.txt	80	For transfections 500 ngwell pGL3 basic wild type mutated BAL BAT promoters 200 ngwell pRLTK Promega used total amount DNA adjusted 900 ng addition pUC19 carrier DNA
0.22037566.14583614.html.plaintext.txt	81	For cotransfections 200 ngwell rat HNF4 expression plasmid pSG5HNF4 used
0.22037566.14583614.html.plaintext.txt	82	All transfections performed using LipofectAMINE 2000 reagent Invitrogen according manufacturers instructions
0.22037566.14583614.html.plaintext.txt	83	After 48 h cells washed phosphate buffered saline assayed dual luciferase activity using commercial kits Promega
0.22037566.14583614.html.plaintext.txt	84	Gel Shift Analysis Crude nuclear extracts prepared gel shift analysis carried described previously 11
0.22037566.14583614.html.plaintext.txt	85	The following three double stranded probes used HNF4 binding site mouse VLACSR promoter wild type 5 acaaaAGGACAGAGTCCAtgggt 3 5 acccaTGGACTCTGTCCTtttgt 3 mouse VLACSR promoter mutant 5 acaaaCTGACAGAGTCCAtgggt 3 5 acccaTGGACTCTGTCAGtttgt 3 mutations HNF4 binding site boldface underlined GC box mouse VLACSR promoter wild type 5 tgtccaagGGGGCGGGGCag 3 5 ctGCCCCGCCCCcttggacaC 3 HNF4 binding site mouse VLACSR promoter mutant 5 tgtccaagTAAAGAAGTGag 3 5 ctCACTTCTTTActtggaca 3 mutations GC box boldface underlined mouse BAT promoter wild type 5 agtccaAGTTCCAAGGTCTtagtct 3 5 agactaAGACCTTGGAACTtggact 3 mouse BAT promoter mutant 5 agtccaCTTTCCAAGGTCTtagtct 3 5 agactaAGACCTTGGAAAGtggact 3 mutations HNF4 binding site boldface underlined
0.22037566.14583614.html.plaintext.txt	86	End labeled double stranded oligonucleotide 2 x 105 cpm added reaction mixture incubated room temperature 30 min
0.22037566.14583614.html.plaintext.txt	87	For competition experiments 25 fold excess unlabeled oligonucleotide added reaction mixture mixture incubated room temperature 20 min prior addition 32P labeled oligonucleotide probe
0.22037566.14583614.html.plaintext.txt	88	For supershift analysis 1 microg anti HNF4 antibody Santa Cruz Biotechnology added reaction mixture mixture incubated room temperature 30 min addition 32P labeled oligonucleotide probe
0.22037566.14583614.html.plaintext.txt	89	Statistical Analysis All values expressed means plus minus S
0.22037566.14583614.html.plaintext.txt	90	3 4 6 7 standard deviation S
0.22037566.14583614.html.plaintext.txt	91	All data analyzed unpaired Students test significant differences mean values group
0.22037566.14583614.html.plaintext.txt	92	View larger version 38K FIG
0.22037566.14583614.html.plaintext.txt	93	Promoter analysis mouse VLACSR gene
0.22037566.14583614.html.plaintext.txt	94	A luciferase reporter plasmids containing mouse VLACSR promoter 146 194 220 256 1014 1435 2219 47 bp translation start site transfected HepG2 cells
0.22037566.14583614.html.plaintext.txt	95	The normalized activity plus minus S
0.22037566.14583614.html.plaintext.txt	96	n 4 construct presented arbitrary units
0.22037566.14583614.html.plaintext.txt	97	B CV 1 cells cotransfected HNF4 expression vector indicated
0.22037566.14583614.html.plaintext.txt	98	The normalized activity plus minus S
0.22037566.14583614.html.plaintext.txt	99	n 4 construct presented arbitrary units
0.22037566.14583614.html.plaintext.txt	100	C nuclear extracts 2 microg liver H4Flox left panel H4LivKO right panel mice incubated labeled HNF4 binding site oligonucleotide mouse VLACSR promoter absence lanes 1 6 presence 25 fold excess unlabeled oligonucleotide lanes 2 7 wild type HNF4 binding site mouse VLACSR promoter lanes 3 8 mutated site
0.22037566.14583614.html.plaintext.txt	101	Similarly labeled mutated HNF4 binding site oligonucleotide mouse VLACSR promoter incubated nuclear extracts H4FLOX lane 5 H4LivKO lane 10 mice
0.22037566.14583614.html.plaintext.txt	102	For supershift assays nuclear extracts incubated labeled probe presence anti HNF4 antibody lanes 4 9
0.22037566.14583614.html.plaintext.txt	103	HNF4 DNA complex supershifted complex caused HNF4 specific antibody shown lower upper arrow respectively
0.22037566.14583614.html.plaintext.txt	104	View larger version 17K FIG
0.22037566.14583614.html.plaintext.txt	105	Effects mutations HNF4 binding site GC box mouse VLACSR promoter
0.22037566.14583614.html.plaintext.txt	106	A schematic representation wild type WT mutated Mut HNF4 binding site GC box mouse VLACSR promoter
0.22037566.14583614.html.plaintext.txt	107	Mutations HNF4 binding site GC box represented boldface type
0.22037566.14583614.html.plaintext.txt	108	Plasmids transfected HepG2 B CV 1 C cells normalized activity plus minus S
0.22037566.14583614.html.plaintext.txt	109	n 4 construct presented relative activity
0.22037566.14583614.html.plaintext.txt	110	View larger version 52K FIG
0.22037566.14583614.html.plaintext.txt	111	Promoter analysis mouse BAT gene
0.22037566.14583614.html.plaintext.txt	112	A luciferase reporter plasmids containing mouse BAT promoter transfected HepG2 cells
0.22037566.14583614.html.plaintext.txt	113	The normalized activity plus minus S
0.22037566.14583614.html.plaintext.txt	114	n 4 construct presented arbitrary units
0.22037566.14583614.html.plaintext.txt	115	B CV 1 cells cotransfected HNF4 expression vector indicated
0.22037566.14583614.html.plaintext.txt	116	The normalized activity plus minus S
0.22037566.14583614.html.plaintext.txt	117	n 4 construct presented arbitrary units
0.22037566.14583614.html.plaintext.txt	118	C nuclear extracts liver H4Flox left panel H4LivKO right panel mice incubated labeled HNF4 binding site oligonucleotide mouse BAT promoter absence lanes 1 6 presence unlabeled oligonucleotide lanes 2 7 wild type HNF4 binding site mouse BAT promoter lanes 3 8 mutated site
0.22037566.14583614.html.plaintext.txt	119	Similarly labeled mutated HNF4 binding site oligonucleotide mouse BAT promoter incubated nuclear extracts H4Flox lane 5 H4LivKO lane 10 mice
0.22037566.14583614.html.plaintext.txt	120	For supershift assays nuclear extracts incubated labeled probe presence anti HNF4 lanes 4 9
0.22037566.14583614.html.plaintext.txt	121	HNF4 DNA complex supershifted complex caused HNF4 specific antibody shown lower upper arrow respectively
0.22037566.14583614.html.plaintext.txt	122	View larger version 15K FIG
0.22037566.14583614.html.plaintext.txt	123	Effects mutations HNF4 binding site mouse BAT promoter
0.22037566.14583614.html.plaintext.txt	124	A schematic representation wild type WT mutated Mut HNF4 binding site mouse BAT promoter
0.22037566.14583614.html.plaintext.txt	125	Mutations HNF4 binding site represented boldface type
0.22037566.14583614.html.plaintext.txt	126	Plasmids transfected HepG2 B CV 1 C cells normalized activity plus minus S
0.22037566.14583614.html.plaintext.txt	127	n 4 construct presented relative activity
0.22037566.14583614.html.plaintext.txt	128	View table TABLE I Analysis free bile acids gallbladder bile liver specific HNF4 null control mice
0.22037566.14583614.html.plaintext.txt	129	Amounts MCA combined
0.22037566.14583614.html.plaintext.txt	130	Data mean plus minus S
0.22037566.14583614.html.plaintext.txt	131	FLOX n 7 8 KO n 6 8
0.22037566.14583614.html.plaintext.txt	132	Significant differences compared FLOX mice p 0
0.22037566.14583614.html.plaintext.txt	133	View table TABLE II Analysis conjugated bile acids gallbladder bile liver specific HNF4 null control mice
0.22037566.14583614.html.plaintext.txt	134	Data mean plus minus S
0.22037566.14583614.html.plaintext.txt	135	FLOX n 7 8 KO n 6 8
0.22037566.14583614.html.plaintext.txt	136	Significant differences compared FLOX mice p 0
0.22037566.14583614.html.plaintext.txt	137	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Expression Genes Involved BA Conjugation Is Reduced Liver specific HNF4a null Mice Free BAs first esterified acetyl CoA BAL esterified BAs conjugated glycine taurine BAT
0.22037566.14583614.html.plaintext.txt	138	The enzyme activity BAL analyzed mouse mouse VLACSR gene might candidate mouse BAL since VLACSR high homology rat BAL human VLACSR H2 BAL activities
0.22037566.14583614.html.plaintext.txt	139	Human BAT able conjugate glycine taurine 21 mouse BAT conjugation specificity toward taurine glycine 19
0.22037566.14583614.html.plaintext.txt	140	Northern blots performed determine whether expression VLACSR BAT significantly different liver specific HNF4 null HNF4 floxedfloxed albumin Cre H4LivKO control HNF4 floxedfloxed without albumin Cre H4Flox mice
0.22037566.14583614.html.plaintext.txt	141	Expression VLACSR BAT markedly reduced livers H4LivKO mice compared H4Flox mice Fig
0.22037566.14583614.html.plaintext.txt	142	It also noteworthy expression alanineglyoxylate aminotransferase taurine transporter two enzymes determine levels cytosolic glycine taurine unchanged
0.22037566.14583614.html.plaintext.txt	143	View larger version 95K FIG
0.22037566.14583614.html.plaintext.txt	144	Northern blot analysis VLACSR BAT
0.22037566.14583614.html.plaintext.txt	145	Total liver RNA isolated 10 microg subjected electrophoresis 1 agarose gel transferred nylon membrane hybridized indicated 32P labeled cDNA probes
0.22037566.14583614.html.plaintext.txt	146	TAUT taurine transporter AGXT alanineglyoxylate aminotransferase
0.22037566.14583614.html.plaintext.txt	147	Free BAs Glycine conjugated BAs Are Increased Gallbladder Bile Liver specific HNF4 null Mice Because expression VLACSR BAT decreased H4LivKO mice expected free BAs increased conjugation patterns altered H4LivKO mice
0.22037566.14583614.html.plaintext.txt	148	Most BAs H4Flox mice also found conjugated derivatives gallbladder bile small amounts free BAs detected Table I
0.22037566.14583614.html.plaintext.txt	149	However free BAs significantly increased gallbladders H4LivKO mice Table I indicating conjugation enzymatic machinery BAs might impaired decreased expression VLACSR livers H4LivKO mice
0.22037566.14583614.html.plaintext.txt	150	The conjugation pattern BA gallbladder bile determined LC MSMS Table II
0.22037566.14583614.html.plaintext.txt	151	In male H4Flox mice taurocholic acid TCA tauro muricholic acid T MCA predominant BAs
0.22037566.14583614.html.plaintext.txt	152	The concentrations BAs Table II upper decreased H4LivKO mice total amounts Table II lower almost unchanged TCA increased T MCA
0.22037566.14583614.html.plaintext.txt	153	Most mammals secrete BAs conjugated taurine andor glycine mouse gallbladder bile contains taurine conjugated forms 18
0.22037566.14583614.html.plaintext.txt	154	However small amounts glycine conjugated BAs including glycocholic acid glycodeoxycholic acid GDCA glycochenodeoxycholic acid GCDCA detected H4Flox mice levels much lower compared taurine conjugated derivatives
0.22037566.14583614.html.plaintext.txt	155	In contrast results control mice taurodeoxycholic acid TDCA GDCA taurochenodeoxycholic acid TCDCA glycochenodeoxycholic acid GCDCA increased H4LivKO mice GDCA GCDCA markedly elevated
0.22037566.14583614.html.plaintext.txt	156	These results indicate conjugation pattern BAs H4LivKO mice significantly different H4Flox mice decreased expression BAT
0.22037566.14583614.html.plaintext.txt	157	Because glycine conjugated BAs increased taurine conjugated BAs maintained H4LivKO mice unidentified BAT use glycine taurine substrates might play important role H4LivKO mice
0.22037566.14583614.html.plaintext.txt	158	Expression Mouse VLACSR Gene Is Directly Regulated HNF4 To investigate expression VLACSR reduced H4LivKO mice promoter region mouse VLACSR gene cloned Fig
0.22037566.14583614.html.plaintext.txt	159	A transcription start site determined 5 rapid amplification cDNA ends five major sites identified 143 85 translation start site 1
0.22037566.14583614.html.plaintext.txt	160	A putative HNF4 binding site GC box found 162 150 238 229 respectively Fig
0.22037566.14583614.html.plaintext.txt	161	To determine whether HNF4 potential activate mouse VLACSR promoter several VLACSR promoter luciferase reporter plasmids constructed Fig
0.22037566.14583614.html.plaintext.txt	162	When HepG2 cells express HNF4 used transient transfections promoter activity 194 bp fragment containing putative HNF4 binding site higher promoterless construct pGL3basic 146 bp fragment Fig
0.22037566.14583614.html.plaintext.txt	163	The promoter activities 220 bp fragment higher 194 bp fragment indicating nucleotide sequence 220 195 bp GC rich regions similar GC box 238 229 bp might important promoter activity
0.22037566.14583614.html.plaintext.txt	164	Furthermore promoter activities 256 1014 1435 2219 bp fragments contain HNF4 binding site GC rich sequences much higher 194 220 bp fragments
0.22037566.14583614.html.plaintext.txt	165	To determine whether HNF4 positively regulates promoter activity CV 1 cells express HNF4 used
0.22037566.14583614.html.plaintext.txt	166	The promoter activity 146 bp fragment unchanged cotransfection HNF4 expression vector consistent absence HNF4 binding site Fig
0.22037566.14583614.html.plaintext.txt	167	However promoter activity 194 bp fragment increased cotransfection HNF4 expression vector
0.22037566.14583614.html.plaintext.txt	168	The results obtained using longer fragments indicating HNF4 positively regulates expression VLACSR gene
0.22037566.14583614.html.plaintext.txt	169	Interestingly basal promoter activity 220 bp fragment increased absence HNF4 expression activity 256 bp fragment much higher
0.22037566.14583614.html.plaintext.txt	170	Because GC rich sequence observed region 256 195 bp Sp1 family proteins might important activating maximal promoter activity presence HNF4
0.22037566.14583614.html.plaintext.txt	171	View larger version 39K FIG
0.22037566.14583614.html.plaintext.txt	172	Nucleotide sequence mouse VLACSR gene promoter
0.22037566.14583614.html.plaintext.txt	173	A localization HNF4 binding site GC box mouse VLACSR gene
0.22037566.14583614.html.plaintext.txt	174	B numbering nucleotides relative translation start site nucleotide 1 arrow
0.22037566.14583614.html.plaintext.txt	175	The asterisk marks transcription start sites
0.22037566.14583614.html.plaintext.txt	176	The putative binding site HNF4 162 150 GC box 238 229 indicated boldface underlined respectively
0.22037566.14583614.html.plaintext.txt	177	To determine whether HNF4 bind HNF4 binding site mouse VLACSR promoter gel shift analysis performed Fig
0.22037566.14583614.html.plaintext.txt	178	Liver nuclear extracts H4Flox mice contained proteins bound HNF4 binding site Fig
0.22037566.14583614.html.plaintext.txt	179	Binding diminished addition excess amounts unlabeled VLACSR probe wild type mutated probe indicating protein specifically bound site Fig
0.22037566.14583614.html.plaintext.txt	180	3C lanes 2 3 lower arrow
0.22037566.14583614.html.plaintext.txt	181	Furthermore bands supershifted addition anti HNF4 antibody indicating protein bound HNF4 binding site indeed HNF4 Fig
0.22037566.14583614.html.plaintext.txt	182	However supershifted bands detected using liver nuclear extracts H4LivKO mice Fig
0.22037566.14583614.html.plaintext.txt	183	3C lane 9 specific complex indicated lower arrow detected using labeled mutated probe Fig
0.22037566.14583614.html.plaintext.txt	184	These results indicate HNF4 binding site mouse VLACSR promoter capable binding HNF4
0.22037566.14583614.html.plaintext.txt	185	To determine whether disruption HNF4 binding site GC box decreases promoter activity mutations introduced HNF4 binding site GC box mouse VLACSR 1014 47 luciferase construct Fig
0.22037566.14583614.html.plaintext.txt	186	4B HepG2 cells used transient transfections promoter activity HNF4 mutant 1014HNF4 Mut decreased compared wild type construct 1024WT
0.22037566.14583614.html.plaintext.txt	187	The promoter activity GC box mutant 1014GC box Mut decreased double mutants HNF4 binding site GC box 1014HNF4GC box Mut almost promoter activity
0.22037566.14583614.html.plaintext.txt	188	When CV 1 cells used transient transfections promoter activity HNF4 mutant 1014HNF4 Mut decreased 40 compared wild type fragment 1014WT presence HNF4 Fig
0.22037566.14583614.html.plaintext.txt	189	The basal activity GC box mutant 1014GC box Mut decreased level promoterless vector activity still increased HNF4
0.22037566.14583614.html.plaintext.txt	190	Furthermore introduction mutations binding sites factors 1014HNF4GC box Mut caused marked reduction promoter activities even presence HNF4
0.22037566.14583614.html.plaintext.txt	191	These results indicate HNF4 GC box binding protein activate expression VLACSR gene needed maximal activation
0.22037566.14583614.html.plaintext.txt	192	Expression Mouse BAT Gene Is Directly Regulated HNF4 In order investigate expression BAT reduced H4LivKO mice promoter region mouse BAT gene cloned Fig
0.22037566.14583614.html.plaintext.txt	193	An HNF4 binding site found 68 56 transcription start site Fig
0.22037566.14583614.html.plaintext.txt	194	However promoter activity 3078 bp fragment beginning intron 1 translation start site induced HepG2 CV 1 cells cotransfection HNF4 data shown
0.22037566.14583614.html.plaintext.txt	195	To determine whether HNF4 potential activate mouse BAT promoter several BAT promoter luciferase reporter plasmids constructed Fig
0.22037566.14583614.html.plaintext.txt	196	When HepG2 cells used transient transfections promoter activity 136 bp fragment containing putative HNF4 binding site higher promoterless construct pGL3basic 52 bp fragment Fig
0.22037566.14583614.html.plaintext.txt	197	The promoter activities longer fragments much higher 136 bp fragment
0.22037566.14583614.html.plaintext.txt	198	To determine whether effect due HNF4 CV 1 cells used
0.22037566.14583614.html.plaintext.txt	199	The promoter activity 52 bp fragment unchanged cotransfection HNF4 expression vector consistent absence HNF4 binding site Fig
0.22037566.14583614.html.plaintext.txt	200	However promoter activity 136 bp fragment increased HNF4
0.22037566.14583614.html.plaintext.txt	201	The results obtained experiments using longer fragments
0.22037566.14583614.html.plaintext.txt	202	View larger version 38K FIG
0.22037566.14583614.html.plaintext.txt	203	Nucleotide sequence mouse BAT gene promoter
0.22037566.14583614.html.plaintext.txt	204	A localization HNF4 binding site mouse BAT gene
0.22037566.14583614.html.plaintext.txt	205	The asterisk marks translation start site exon 2
0.22037566.14583614.html.plaintext.txt	206	B numbering nucleotides relative transcription start site 1 arrow
0.22037566.14583614.html.plaintext.txt	207	The putative binding site HNF4 68 56 indicated boldface underlined
0.22037566.14583614.html.plaintext.txt	208	To determine whether HNF4 bind DR1 like elements mouse BAT promoter gel shift analysis performed Fig
0.22037566.14583614.html.plaintext.txt	209	Liver nuclear extracts H4Flox mice contained proteins bound HNF4 binding site Fig
0.22037566.14583614.html.plaintext.txt	210	Binding diminished addition excess amounts unlabeled BAT probe wild type mutated probe indicating protein specifically bound site Fig
0.22037566.14583614.html.plaintext.txt	211	6C lanes 2 3 lower arrow
0.22037566.14583614.html.plaintext.txt	212	Furthermore bands supershifted addition anti HNF4 antibody indicating protein bound HNF4 binding site indeed HNF4 Fig
0.22037566.14583614.html.plaintext.txt	213	Supershifted bands detected using liver nuclear extracts H4LivKO mice Fig
0.22037566.14583614.html.plaintext.txt	214	6C lane 9 specific complex indicated lower arrow detected using labeled mutated probe Fig
0.22037566.14583614.html.plaintext.txt	215	These results indicate HNF4 binding site mouse BAT promoter capable binding HNF4
0.22037566.14583614.html.plaintext.txt	216	To determine whether disruption HNF4 binding site decreases promoter activity mutations used Fig
0.22037566.14583614.html.plaintext.txt	217	6C introduced HNF4 binding site mouse BAT 602178 luciferase construct Fig
0.22037566.14583614.html.plaintext.txt	218	7B HepG2 cells used transient transfections promoter activity mutated 602 bp fragment 602Mut decreased 25 compared wild type fragment 602WT
0.22037566.14583614.html.plaintext.txt	219	When CV 1 cells used promoter activity mutated fragment decreased 15 cotransfection HNF4 compared wild type fragment Fig
0.22037566.14583614.html.plaintext.txt	220	7C indicating HNF4 binding site important activation mouse BAT promoter
0.22037566.14583614.html.plaintext.txt	221	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES BAs synthesized steroid nucleus side chain hydroxylation cholesterol followed oxidation side chain
0.22037566.14583614.html.plaintext.txt	222	Because serum BA levels significantly increased expression OATP1 NTCP decreased liver specific HNF4 null mice 10 HNF4 likely critical transcription factor regulating genes involved BA biosynthesis
0.22037566.14583614.html.plaintext.txt	223	In study HNF4 also found control BA conjugation pathway direct binding promoter regions VLACSR BAT genes activation transcription
0.22037566.14583614.html.plaintext.txt	224	Because levels unconjugated free BAs low gallbladder bile 22 increased levels unconjugated BAs liver specific HNF4 null mice appear due decreased expression VLACSR BAT
0.22037566.14583614.html.plaintext.txt	225	Because VLACSR BAT preferentially expressed liver 18 19 well HNF4 HNF4 central factor regulation VLACSR BAT vivo
0.22037566.14583614.html.plaintext.txt	226	An HNF4 binding site GC rich region identified promoter region mouse VLACSR gene
0.22037566.14583614.html.plaintext.txt	227	Indeed HNF4 binds HNF4 binding site promoter activities dependent site expression HNF4
0.22037566.14583614.html.plaintext.txt	228	Furthermore GC rich sequence also important maximal activation VLACSR gene mutated GC rich sequence reduced basal promoter activity
0.22037566.14583614.html.plaintext.txt	229	It reported HNF4 Sp1 prototypical GC box binding protein binds promoter regions genes including apolipoprotein C III CYP27 increases expression 23 24
0.22037566.14583614.html.plaintext.txt	230	In mouse VLACSR promoter HNF4 still activate promoter activity mutations introduced GC box resultant activity much lower compared wild type promoter
0.22037566.14583614.html.plaintext.txt	231	This result indicates cooperative binding HNF4 Sp1 promoter might required maximal induction VLACSR expression liver
0.22037566.14583614.html.plaintext.txt	232	Furthermore expression sterol carrier protein x involved side chain oxidation BA also reduced liver specific HNF4 null mice Sp1 identified critical factor regulating sterol carrier protein x gene HNF4 independent manner data shown
0.22037566.14583614.html.plaintext.txt	233	Because expression Sp1 Sp3 typical GC box binding proteins unchanged VLACSR expression markedly reduced liver specific HNF4 null mice data shown post transcriptional modification Sp1 andor Sp3 could reduce expression VLACSR null mice
0.22037566.14583614.html.plaintext.txt	234	In addition increased unconjugated BAs serum glycine conjugated BAs GDCA GCDCA significantly increased gallbladder liver specific HNF4 null mice
0.22037566.14583614.html.plaintext.txt	235	Because mouse BAT glycine conjugation activity 19 expression unidentified BAT gene might activated H4LivKO mice
0.22037566.14583614.html.plaintext.txt	236	Actually mouse genes exhibit similarity mouse BAT cloned function still unknown
0.22037566.14583614.html.plaintext.txt	237	Expression one genes GenBankTM accession number NM145368 GenBank found increased livers H4LivKO mice data shown
0.22037566.14583614.html.plaintext.txt	238	However remains unclear whether gene encodes enzyme glycine conjugation activity
0.22037566.14583614.html.plaintext.txt	239	Furthermore physiological role increased GDCA GCDCA H4LivKO mice also remains unclear BAs intestinal lumen might change many aspects intestinal whole body cholesterol homeostasis
0.22037566.14583614.html.plaintext.txt	240	Recently reported 25 mutation BAT coding sequence causes human familial hypercholanemia characterized elevated serum BA serum homozygous individuals mutation contains unconjugated BAs
0.22037566.14583614.html.plaintext.txt	241	Because serum unconjugated BAs increased BAs gallbladder conjugated forms liver specific HNF4 null mice protein enzyme activity VLACSR BAT might still active mice
0.22037566.14583614.html.plaintext.txt	242	In human disease mutations HNF4 binding sites reported HNF1 blood coagulation factor VII IX 9
0.22037566.14583614.html.plaintext.txt	243	Because HNF4 regulates many liver enriched genes human diseases might found caused mutations HNF4 binding sites VLACSR BAT genes
0.22037566.14583614.html.plaintext.txt	244	It reported expression BAL BAT induced treatment ligands farnesoid X receptor FXR rat induction due binding FXR FXR binding sites promoter regions 26
0.22037566.14583614.html.plaintext.txt	245	Because phenomenon observed mouse regulation genes FXR exhibits species difference rat mouse 26
0.22037566.14583614.html.plaintext.txt	246	Actually neither VLACSR BAT gene induced wild type mice treated cholic acid ligand FXR data shown
0.22037566.14583614.html.plaintext.txt	247	Unlike nuclear receptors including FXR HNF4 constitutively activated vivo vitro without exogenous compounds 9
0.22037566.14583614.html.plaintext.txt	248	Thus HNF4 positively regulates basal levels expression VLACSR BAT genes
0.22037566.14583614.html.plaintext.txt	249	It may also involved regulation transporters OATP1 NTCP required hepatocyte uptake conjugated BAs portal circulation Fig
0.22037566.14583614.html.plaintext.txt	250	View larger version 25K FIG
0.22037566.14583614.html.plaintext.txt	251	Schematic representation regulatory targets HNF4 bile acid transport conjugation
0.22037566.14583614.html.plaintext.txt	252	Bile acids conjugated VLACSR BAT exported hepatocytes transporters bile salt export pump located canalicular membrane
0.22037566.14583614.html.plaintext.txt	253	Most bile acids recycled transported portal circulation back hepatocytes transporters including NTCP OATP1 located basolateral membrane
0.22037566.14583614.html.plaintext.txt	254	Expression OATP1 NTCP VLACSR BAT reduced liver specific HNF4 null mice
0.22037566.14583614.html.plaintext.txt	255	Note HNF4 directly regulates expression VLACSR BAT via HNF4 binding sites promoters
0.22037566.14583614.html.plaintext.txt	256	Many nuclear receptors including FXR involved regulating BA biosynthesis pathway transport system 6 14 15
0.22037566.14583614.html.plaintext.txt	257	Thus nuclear receptors also might important roles inducing repressing expression VLACSR BAT regulate BA conjugation pathway
0.22037566.14583614.html.plaintext.txt	258	FOOTNOTES The costs publication article defrayed part payment page charges
0.22037566.14583614.html.plaintext.txt	259	This article must therefore hereby marked advertisement accordance 18 U
0.22037566.14583614.html.plaintext.txt	260	Section 1734 solely indicate fact
0.22037566.14583614.html.plaintext.txt	261	To correspondence addressed Laboratory Metabolism Center Cancer Research NCI National Institutes Health 9000 Rockville Pike Bldg
0.22037566.14583614.html.plaintext.txt	262	301 496 9067 Fax 301 496 8419 E mail fjgonzathelix
0.22037566.14583614.html.plaintext.txt	263	1 The abbreviations used BAs bile acids HNF4 hepatocyte nuclear factor 4 BAL bile acid CoA ligase BAT bile acid CoAamino acid N acyltransferase VLACSR long chain acyl CoA synthase related NTCP sodium taurocholate cotransporter polypeptide OATP1 organic anion transporter polypeptide 1 LC MSMS liquid chromatography tandem mass spectrometrymass spectrometry MCA muricholic acid GDCA glycodeoxycholic acid GCDCA glycochenodeoxycholic acid TCA taurocholic acid T MCA tauro muricholic acid TDCA taurodeoxycholic acid TCDCA taurochenodeoxycholic acid WT wild type FXR farnesoid X receptor
0.22037566.14583614.html.plaintext.txt	264	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Vlahcevic R
0.22037566.14583614.html.plaintext.txt	265	28 1 25Medline Order article via Infotrieve Bjorkhem I
0.22037566.14583614.html.plaintext.txt	266	12 97 103CrossRefMedline Order article via Infotrieve Wang D
0.22037566.14583614.html.plaintext.txt	267	276 G751 G760Medline Order article via Infotrieve Bahar J
0.22037566.14583614.html.plaintext.txt	268	28 27 57Medline Order article via Infotrieve St Pierre M
0.22037566.14583614.html.plaintext.txt	269	204 1673 1686AbstractFree Full Text Trauner M
0.22037566.14583614.html.plaintext.txt	270	83 633 671AbstractFree Full Text Meier P
0.22037566.14583614.html.plaintext.txt	271	64 635 661CrossRefMedline Order article via Infotrieve Schrem H
0.22037566.14583614.html.plaintext.txt	272	54 129 158AbstractFree Full Text Sladek F
0.22037566.14583614.html.plaintext.txt	273	2001 Nuclear Receptors Genetic Disease Burris T
0.22037566.14583614.html.plaintext.txt	274	309 361 Academic Press San Diego Hayhurst G
0.22037566.14583614.html.plaintext.txt	275	21 1393 1403AbstractFree Full Text Inoue Y
0.22037566.14583614.html.plaintext.txt	276	277 25257 25265AbstractFree Full Text Tirona R
0.22037566.14583614.html.plaintext.txt	277	9 220 224CrossRefMedline Order article via Infotrieve Parviz F
0.22037566.14583614.html.plaintext.txt	278	34 292 296CrossRefMedline Order article via Infotrieve Russell D
0.22037566.14583614.html.plaintext.txt	279	72 137 174CrossRef Chiang J
0.22037566.14583614.html.plaintext.txt	280	23 443 463AbstractFree Full Text Falany C
0.22037566.14583614.html.plaintext.txt	281	43 2062 2071AbstractFree Full Text Steinberg S
0.22037566.14583614.html.plaintext.txt	282	275 15605 15608AbstractFree Full Text Berger J
0.22037566.14583614.html.plaintext.txt	283	247 255 260CrossRefMedline Order article via Infotrieve Falany C
0.22037566.14583614.html.plaintext.txt	284	38 1139 1148Abstract Furutani M
0.22037566.14583614.html.plaintext.txt	285	311 203 208Medline Order article via Infotrieve Falany C
0.22037566.14583614.html.plaintext.txt	286	269 19375 19379AbstractFree Full Text Capocaccia L
0.22037566.14583614.html.plaintext.txt	287	26 513 517Medline Order article via Infotrieve Kardassis D
0.22037566.14583614.html.plaintext.txt	288	2002 Biochemistry 41 1217 1228CrossRefMedline Order article via Infotrieve Garuti R
0.22037566.14583614.html.plaintext.txt	289	283 133 143CrossRefMedline Order article via Infotrieve Carlton V
0.22037566.14583614.html.plaintext.txt	290	34 91 96CrossRefMedline Order article via Infotrieve Pircher P
0.22037566.14583614.html.plaintext.txt	291	278 27703 27711AbstractFree Full Text
0.48113066.11222753.html.plaintext.txt	0	Transcriptional activation hepatocyte nuclear factor 4 cell free system derived rat liver nuclei Srinivas Harish Tasneem Khanam Sendurai Mani Pundi Rangarajan
0.48113066.11222753.html.plaintext.txt	1	Department Biochemistry Indian Institute Science Bangalore 560 012 India
0.48113066.11222753.html.plaintext.txt	2	Received December 4 2000 Revised Accepted January 10 2001
0.48113066.11222753.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Hepatocyte nuclear factor 4 HNF4 regulates gene expression binding direct repeat motifs RGGTTCA sequence separated one nucleotide DR1
0.48113066.11222753.html.plaintext.txt	4	In study demonstrate endogenous HNF4 present rat liver nuclear extracts well purified recombinant HNF4 activates transcription naked DNA templates containing multiple copies DR1 element linked adenovirus major late promoter
0.48113066.11222753.html.plaintext.txt	5	Recombinant HNF4 also activates transcription rat cellular retinol binding protein II CRBPII promoter vitro
0.48113066.11222753.html.plaintext.txt	6	The region 105 63 bp promoter essential HNF mediated transactivation
0.48113066.11222753.html.plaintext.txt	7	The addition peptide containing LXXLL motif abolished HNF4 mediated transactivation vitro suggesting LXXLL containing protein factors involved HNF4 mediated transactivation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	8	This first report transactivation HNF4 cell free system derived rat liver nuclei
0.48113066.11222753.html.plaintext.txt	9	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Transcription factors belonging steroidnuclear hormone receptor superfamily regulate gene expression response variety signaling molecules steroids thyroid hormone retinoids vitamin D3 lipid metabolites binding specific response elements REs target genes 1 3
0.48113066.11222753.html.plaintext.txt	10	These REs include direct repeats RGGTTCA 0 5 base spacing palindromic RGGTTCA without spacing single half sites 23
0.48113066.11222753.html.plaintext.txt	11	Of REs direct repeats RGGTTCA one base spacing DR1 appear highly promiscuous bind number nuclear receptors including RXR hepatocyte nuclear factor 4 HNF4 COUP TFI apolipoprotein regulatory protein 1 ARP 1COUP TFII peroxisome proliferator activated receptor PPAR 34
0.48113066.11222753.html.plaintext.txt	12	These transcription factors bind DR1 homodimers RXR COUP TFI ARP 1 HNF4 heterodimers PPAR RXR RAR RXR COUP TFI RXR ARP 1 RXR result genes harboring DR1 element promoters activated constitutively HNF4 repressed COUP TFI ARP 1 activated ligands PPAR RXR 5 10
0.48113066.11222753.html.plaintext.txt	13	Nucleotides base positions 1 2 4 core motif spacer sequence location element within proper promoter context shown determine selective binding transcription factors 10
0.48113066.11222753.html.plaintext.txt	14	In addition relative abundance transcription factors given tissue also plays major role regulation target genes 57
0.48113066.11222753.html.plaintext.txt	15	Several studies demonstrate protein protein protein DNA interactions nuclear receptors binding DR1 element result positive negative regulation several hepatic genes 5611
0.48113066.11222753.html.plaintext.txt	16	For example HNF4 ARP 1 COUP TFI compete binding DR1 element within apolipoprotein CIII promoter HNF4 stimulates transcription ARP 1 COUP TFI function transcriptional repressors 56
0.48113066.11222753.html.plaintext.txt	17	Although COUP TFI generally known transcriptional repressor shown activate transcription SV40 promoter well DR1 element present promoter gene encoding ornithine transcarbamylase 12
0.48113066.11222753.html.plaintext.txt	18	In case gene encoding murine cellular retinol binding protein II CRBPII HNF4ARP 1 RE shown function promiscuous binding site RXR inducible retinoic acid cells expressing low levels HNF4ARP 1 7
0.48113066.11222753.html.plaintext.txt	19	Co expression PPAR HNF4 results suppression HNF4 mediated transactivation acyl CoA oxidase promoter HNF4 PPAR activate transcription apolipoprotein CIII promoter 11
0.48113066.11222753.html.plaintext.txt	20	Similarly ARP 1 COUP TFI repress HNF4 mediated transactivation human factor IX promoter impaired HNF4 binding one factors responsible regulation factor IX expression 13
0.48113066.11222753.html.plaintext.txt	21	These studies suggest cross talk amongst DR1 binding nuclear receptors lead significant differences level expression target genes different tissues
0.48113066.11222753.html.plaintext.txt	22	The fact almost receptors bind DR1 element expressed liver 7 suggests transcription target genes ultimately depend concentration affinity receptors recognition sites well protein protein interactions factors binding proximal distal regulatory elements
0.48113066.11222753.html.plaintext.txt	23	Thus regulation hepatic gene expression DR1 binding nuclear receptors appears complex process
0.48113066.11222753.html.plaintext.txt	24	Most data cross talk amongst receptors binding DR1 element generated studies involving co transfection reporter plasmids plasmids expressing nuclear receptors
0.48113066.11222753.html.plaintext.txt	25	However many control mechanisms operate differentiated tissues operate rapidly dividing cells culture even appropriate cell lines exist regulation exerted endogenous genes may reproduced transfected DNA 14
0.48113066.11222753.html.plaintext.txt	26	This especially true case liver cells rapidly lose transcription factors involved regulation liver specific genes albumin cultured vitro 14
0.48113066.11222753.html.plaintext.txt	27	One alternative methods involves study transcriptional regulation genes vitro using nuclear extracts prepared differentiated tissues
0.48113066.11222753.html.plaintext.txt	28	Cell free extracts prepared rat liver nuclei extensively used study tissue specific regulation several hepatic genes 15 17
0.48113066.11222753.html.plaintext.txt	29	However report transactivation nuclear receptors binding DR1 element liver nuclear extracts despite fact several receptors expressed high levels liver involved regulation expression hepatic genes 718 21
0.48113066.11222753.html.plaintext.txt	30	As first step towards understanding mechanism hepatic gene regulation DR1 element binding nuclear receptors developed cell free transcription system utilizing nuclear extracts derived rat liver examined DR1 dependent transactivation HNF4 vitro
0.48113066.11222753.html.plaintext.txt	31	We demonstrate endogenous HNF4 present rat liver nuclear extracts purified recombinant HNF4 activate transcription DR1 elements linked adenovirus major late promoter AdMLP native rat CRBPII promoter
0.48113066.11222753.html.plaintext.txt	32	Addition peptide containing LXXLL motif abolished HNF4 mediated transactivation vitro indicating LXXLL containing co activators may involved HNF4 mediated transactivation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	33	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Construction plasmid templates vitro transcription Plasmids containing minimal AdMLP linked 260 pAdMLP260 380 bp pAdMLP380 G free cassette used control templates vitro transcription described previously 2223
0.48113066.11222753.html.plaintext.txt	34	A consensus DR1 element synthesized complementary oligonucleotides 5 gatcAAGGTCAAAGGTCACTCGC 3 5 gatcGCGAGTGACCTTTGACCTT 3
0.48113066.11222753.html.plaintext.txt	35	The RXRE rat CRBPII promoter 8 present 639 605 bp synthesized complementary oligonucleotides 5 gatcGCTGTCACAGGTCACAGGTCACAG GTCACAGTTCA 3 5 gatcTGAACTGTGACCTGTGACCTGTGACCTGTGACCTGC 3
0.48113066.11222753.html.plaintext.txt	36	The half site sequence complementary oligonucleotides indicated bold
0.48113066.11222753.html.plaintext.txt	37	These oligonucleotides gatc overhangs phosphorylated 5 ends
0.48113066.11222753.html.plaintext.txt	38	Equimolar amounts annealed previously described 24 cloned upstream AdMLP BamHI site pAdMLP380
0.48113066.11222753.html.plaintext.txt	39	Clones containing four copies DR1 element two copies CRBPII RXRE oriented direction identified dideoxynucleotide sequencing designated pDR1 AdMLP380 pRXRE AdMLP380 respectively
0.48113066.11222753.html.plaintext.txt	40	The CRBPII promoter region 987 1 bp amplified pCRBPIICAT 8 PCR reaction using primer pair 5 GCCAAGCTTGGATCCGTCTGAGCTGAA 3 P1 5 GGGAAATATAGGGGAGACTG 3 P2
0.48113066.11222753.html.plaintext.txt	41	The G free cassette PCR amplified pAdMLP380 using primers 5 TATATTTCCCAAATCTATC 3 P3 5 AGTCGAATTCCCCGG GAGTGGAATGAGAAATGA 3 P4
0.48113066.11222753.html.plaintext.txt	42	The PCR products obtained two reactions purified used templates another PCR reaction P1 P4 used primers
0.48113066.11222753.html.plaintext.txt	43	The final PCR product consisting 987 bp rat CRBPII promoter linked 300 bp G free cassette digested BamHI EcoRI cloned BamHI EcoRI digested pUC19 plasmid
0.48113066.11222753.html.plaintext.txt	44	The nucleotide sequence final construct p987CRBPII300 verified dideoxynucleotide sequencing
0.48113066.11222753.html.plaintext.txt	45	The region 987 746 bp CRBPII promoter deleted digesting p987CRBPII300 SphI
0.48113066.11222753.html.plaintext.txt	46	The resulting vector purified agarose gels religated generate p747CRBPII300
0.48113066.11222753.html.plaintext.txt	47	Similarly construct p313CRBPII300 containing 313 bp CRBPII promoter generated PstI digestion p987CRBPII300 followed ligation purified vector
0.48113066.11222753.html.plaintext.txt	48	For construction p105CRBPII300 PCR reaction carried primers 5 ATGCCGGGATCCAAGGGCAATTCCTTTGAGTTGGG 3 P4 using p987CRBPII300 template
0.48113066.11222753.html.plaintext.txt	49	The PCR product digested BamHI EcoRI cloned BamHI EcoRI digested pUC19 plasmid
0.48113066.11222753.html.plaintext.txt	50	p53CRBPII300 constructed similar strategy except primers 5 AAGCCCGGGATCCTTTATACACCTGGTCCACTAA 3 P4 used PCR amplification
0.48113066.11222753.html.plaintext.txt	51	Overexpression purification receptors The cDNA encoding HNF4 amplified pLEN4S rHNF4 20 using primers 5 CGCGGATCCATGCATCACCATCACCATCACGACATGGCTGACTACAGT 3 5 CCGGAATTCCTAGATGGCTTCCTG 3 histidine codons underlined
0.48113066.11222753.html.plaintext.txt	52	The PCR product restricted BamHI EcoRI cloned BamHI EcoRI digested pThioC vector Invitrogen generate pThioHNF4
0.48113066.11222753.html.plaintext.txt	53	The plasmids transformed Escherichia coli BL21 DE3 pLysS Novagen
0.48113066.11222753.html.plaintext.txt	54	Recombinant protein expression induced 0
0.48113066.11222753.html.plaintext.txt	55	5 mM isopropylthiogalactoside Sigma cells resuspended lysis buffer 25 mM Tris HCl pH 7
0.48113066.11222753.html.plaintext.txt	56	1 mM PMSF 10 mM ss mercaptoethanol
0.48113066.11222753.html.plaintext.txt	57	Cells lysed repeated freezing thawing cell lysate obtained centrifugation 30 000 r
0.48113066.11222753.html.plaintext.txt	58	ultracentrifuge Beckman 30 min 4 degrees C using Ti50 rotor
0.48113066.11222753.html.plaintext.txt	59	The lysate obtained 1 l culture loaded onto 10 ml heparin agarose Sigma column equilibrated lysis buffer
0.48113066.11222753.html.plaintext.txt	60	After washing bound protein eluted buffer containing 25 mM Tris HCl pH 7
0.48113066.11222753.html.plaintext.txt	61	4 600 mM NaCl 10 glycerol 0
0.48113066.11222753.html.plaintext.txt	62	1 mM PMSF 10 mM ss mercaptoethanol
0.48113066.11222753.html.plaintext.txt	63	The eluate incubated 100 microl Ni2 nitrilotriacetic acid Ni2 NTA agarose beads Qiagen 1 h 4 degrees C
0.48113066.11222753.html.plaintext.txt	64	After washing buffer containing 25 mM Tris HCl pH 7
0.48113066.11222753.html.plaintext.txt	65	5 600 mM NaCl 20 mM imidazole 0
0.48113066.11222753.html.plaintext.txt	66	1 mM PMSF 10 mM ss mercaptoethanol bound protein eluted buffer containing 250 mM imidazole
0.48113066.11222753.html.plaintext.txt	67	The eluate dialyzed buffer containing 25 mM HEPES KOH pH 7
0.48113066.11222753.html.plaintext.txt	68	1 mM EDTA 10 mM ss mercaptoethanol 10 glycerol 0
0.48113066.11222753.html.plaintext.txt	69	2 mM PMSF protein stored 80 degrees C aliquots
0.48113066.11222753.html.plaintext.txt	70	Preparation rat liver nuclear extracts cell free transcription Rat liver nuclear extracts prepared essentially described previously 15 17
0.48113066.11222753.html.plaintext.txt	71	The final preparation stored aliquots 80 degrees C 6 months
0.48113066.11222753.html.plaintext.txt	72	Transcription reactions performed buffer containing 25 mM HEPES pH 7
0.48113066.11222753.html.plaintext.txt	73	4 25 mM KCl 6 mM MgCl2 3 glycerol supplemented 2
0.48113066.11222753.html.plaintext.txt	74	0 mgml rat liver nuclear extract 20 U RNasin Pharmacia 100 microM 3 O methyl GTP Pharmacia 10 microCi 32PUTP 800 Cimmol NEN DuPont 35 microM UTP 0
0.48113066.11222753.html.plaintext.txt	75	0 microg test DNA template andor 0
0.48113066.11222753.html.plaintext.txt	76	5 microg control DNA template final reaction volume 20 microl
0.48113066.11222753.html.plaintext.txt	77	In experiments involving addition recombinant receptors recombinant proteins first incubated plasmid DNA templates 15 min 30 degrees C added reaction mixture containing rest components
0.48113066.11222753.html.plaintext.txt	78	Transcription reactions carried 30 degrees C 45 min
0.48113066.11222753.html.plaintext.txt	79	Reactions stopped addition 280 microl solution containing 250 mM NaCl 1 SDS 20 mM Tris HCl pH 7
0.48113066.11222753.html.plaintext.txt	80	8 5 mM EDTA 20 microg yeast tRNA 30 microg Proteinase K
0.48113066.11222753.html.plaintext.txt	81	After incubation 37 degrees C 30 min samples extracted twice 250 microl phenol chloroform isoamyl alcohol 25241 vortexing
0.48113066.11222753.html.plaintext.txt	82	The RNA aqueous phase precipitated 2 vol ethanol pelleted microcentrifugation
0.48113066.11222753.html.plaintext.txt	83	The pellet dried resuspended 10 microl 80 formamide products separated electrophoresis 5 denaturing polyacrylamide acrylamide bisacrylamide 201 7 M urea gels 2 h 200 V 1x Tris borate EDTA buffer
0.48113066.11222753.html.plaintext.txt	84	The gels dried exposed Biomax MR autoradiography film Kodak 80 degrees C intensifying screen 8 h
0.48113066.11222753.html.plaintext.txt	85	Quantitation performed densitometric scanning autoradiograms exposure dried gels phosphorimager screens gathering data Fijix BAS 1000 phosphorimager analysis MacBAS version 2
0.48113066.11222753.html.plaintext.txt	86	All cell free transcription experiments repeated least twice two different batches rat liver nuclear extract preparations representative data presented paper
0.48113066.11222753.html.plaintext.txt	87	DR1 oligonucleotide affinity chromatography rat liver nuclear extracts Complementary oligonucleotides correponding CRBPII RXRE see kinased annealed concatamerized coupled cyanogen bromide activated Sepharose 4B Sigma essentially described previously 24
0.48113066.11222753.html.plaintext.txt	88	The Sepharose beads 1 g corresponding 3 ml swollen resin coupled 200 microg oligonucleotides
0.48113066.11222753.html.plaintext.txt	89	For depletion HNF4 DR1 binding receptors present rat liver nuclear extracts extract incubated given quantity oligonucleotide affinity resin 30 min 4 degrees C
0.48113066.11222753.html.plaintext.txt	90	After microcentifugation 4 degrees C supernatant transferred fresh tube used directly cell free transcription assays
0.48113066.11222753.html.plaintext.txt	91	Aliquots batch nuclear extract subjected western blot analysis using antibodies HNF4 445 kind gift Frances Sladek University California Riverside CA 20 binding oligonucleotide resin
0.48113066.11222753.html.plaintext.txt	92	Extracts showed substantial decrease HNF4 levels 90 used vitro transcription reactions
0.48113066.11222753.html.plaintext.txt	93	Peptide synthesis Peptides corresponding amino acids 685 699 SRC 1 sequence ERHKILHRLLQEGSP interact nuclear receptors ligand dependent manner well mutant peptide sequence ERHKILHRAAAEGSP shown incapable interacting nuclear receptors 2526 purchased Xcyton India
0.48113066.11222753.html.plaintext.txt	94	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES DR1 dependent transcriptional activation rat liver nuclear extracts Liver enriched several DR1 binding nuclear receptors shown involved regulation several hepatic genes
0.48113066.11222753.html.plaintext.txt	95	However ability receptors activate transcription cell free system derived rat liver nuclear extracts reported
0.48113066.11222753.html.plaintext.txt	96	In study first examined transactivation endogenous DR1 binding hepatic nuclear receptors naked DNA templates homologous cell free system derived rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	97	A series plasmid templates constructed use cell free transcription see Materials Methods
0.48113066.11222753.html.plaintext.txt	98	Plasmids containing minimal AdMLP linked 260 pAdMLP260 380 bp pAdMLP380 G free cassette used control templates
0.48113066.11222753.html.plaintext.txt	99	The pDR1 AdMLP380 pRXRE AdMLP380 test templates contain four copies consensus DR1 element two copies CRBPII RXRE upstream AdMLP linked 380 bp G free cassette respectively Fig
0.48113066.11222753.html.plaintext.txt	100	Transcription reactions contained specific control templates fold activation calculated ratio 32P labeled RNA obtained specific template obtained control template
0.48113066.11222753.html.plaintext.txt	101	Rat liver nuclear extracts capable accurate transcription initiation RNA polymerase II prepared 15 17 cell free transcription assays carried pDR1 AdMLP380 pRXRE AdMLP380 test templates along pAdMLP380 pAdMLP260 control templates
0.48113066.11222753.html.plaintext.txt	102	The results presented Figure 1B indicate pDR1 AdMLP380 lanes 2 3 pRXRE AdMLP380 lanes 4 5 transcribed 3 5 fold higher control templates respectively
0.48113066.11222753.html.plaintext.txt	103	Transcription pDR1 AdMLP380 pRXRE AdMLP380 always higher control templates varied 3 8 fold different batches extract
0.48113066.11222753.html.plaintext.txt	104	Thus endogenous DR1 binding transcription factors present rat liver nuclear extracts selectively activate transcription templates
0.48113066.11222753.html.plaintext.txt	105	View larger version 41K Figure 1
0.48113066.11222753.html.plaintext.txt	106	Transactivation DR1 binding proteins present rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	107	A Schematic representation plasmid templates used cell free transcription
0.48113066.11222753.html.plaintext.txt	108	Plasmids containing AdMLP linked G free cassettes 260 380 bp length used control templates
0.48113066.11222753.html.plaintext.txt	109	Four copies DR1 element two copies CRBPII RXRE cloned upstream AdMLP linked G free cassette 380 bp length
0.48113066.11222753.html.plaintext.txt	110	B Cell free transcription assays performed described Materials Methods control templates pAdMLP380 pAdMLP260 lane 1 pDR1 AdMLP380 pAdMLP260 lanes 2 3 pRXRE AdMLP380 pAdMLP260 lanes 4 5
0.48113066.11222753.html.plaintext.txt	111	The arrow asterisk represent transcripts generated 380 260 bp G free cassettes respectively
0.48113066.11222753.html.plaintext.txt	112	Addition 9 cis RA 10 5 M significant effect transactivation pDR1 AdMLP380 lane 3 pRXRE AdMLP380 lane 5
0.48113066.11222753.html.plaintext.txt	113	Transactivation recombinant HNF4 rat liver nuclear extracts It reported recombinant HNF4 expressed purified bacterial extracts activate transcription nuclear extracts derived HeLa cells cell type express HNF4 27
0.48113066.11222753.html.plaintext.txt	114	The fact liver nuclear extracts support DR1 dependent transcription vitro encouraged us study transactivation recombinant HNF4
0.48113066.11222753.html.plaintext.txt	115	We overexpressed full length HNF4 Fig
0.48113066.11222753.html.plaintext.txt	116	coli purified protein chromatography heparin agarose column followed chromatography Ni2 NTA column Fig
0.48113066.11222753.html.plaintext.txt	117	Addition recombinant HNF4 rat liver nuclear extracts resulted activation transcription pDR1 AdMLP380 Fig
0.48113066.11222753.html.plaintext.txt	118	Thus endogenous HNF4 present rat liver nuclear extracts recombinant HNF4 activate transcription pDR1 AdMLP380 Fig
0.48113066.11222753.html.plaintext.txt	119	2C compare lane 2 lanes 3 4
0.48113066.11222753.html.plaintext.txt	120	We examined ability recombinant HNF4 activate transcription rat liver nuclear extracts depleted levels endogenous DR1 binding proteins
0.48113066.11222753.html.plaintext.txt	121	Incubation liver nuclear extracts DR1 oligonucleotide affinity resin resulted significant depletion HNF4 levels evident western blotting extracts depletion Fig
0.48113066.11222753.html.plaintext.txt	122	3A compare lane 1 lane 2
0.48113066.11222753.html.plaintext.txt	123	A similar decrease also observed case RXR also binds DR1 element data shown
0.48113066.11222753.html.plaintext.txt	124	The ability extract activate transcription pDR1 AdMLP380 examined vitro transcription reaction
0.48113066.11222753.html.plaintext.txt	125	The results indicate transactivation pDR1 AdMLP380 drastically reduced extracts depleted levels endogenous DR1 binding proteins Fig
0.48113066.11222753.html.plaintext.txt	126	3B compare lane 2 lane 4
0.48113066.11222753.html.plaintext.txt	127	Addition recombinant HNF4 extracts resulted dose dependent increase transcription pDR1 AdMLP380 pAdMLP260 Fig
0.48113066.11222753.html.plaintext.txt	128	3C compare lane 1 lanes 2 3 4
0.48113066.11222753.html.plaintext.txt	129	Taken together results presented Figures 2C 3C indicate recombinant HNF4 activate transcription presence absence endogenous DR1 binding proteins including HNF4
0.48113066.11222753.html.plaintext.txt	130	View larger version 24K Figure 2
0.48113066.11222753.html.plaintext.txt	131	Transactivation recombinant HNF4 rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	132	A Schematic representation HNF4 consisting 455 amino acids
0.48113066.11222753.html.plaintext.txt	133	B SDS PAGE analysis recombinant His tagged thio HNF4 overexpressed purified bacterial extracts
0.48113066.11222753.html.plaintext.txt	134	Lane M molecular weight markers lane 1 recombinant HNF4
0.48113066.11222753.html.plaintext.txt	135	C Cell free transcription reactions carried absence lanes 1 2 presence 30 lane 3 45 pmol lane 4 recombinant HNF4
0.48113066.11222753.html.plaintext.txt	136	The arrow asterisk represent transcripts generated 380 260 bp G free cassettes respectively
0.48113066.11222753.html.plaintext.txt	137	View larger version 15K Figure 3
0.48113066.11222753.html.plaintext.txt	138	Depletion endogenous DR1 binding proteins HNF4 rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	139	A Western blot analysis rat liver nuclear extract anti HNF4 antibodies lane 1 lane 2 incubation DR1 oligonucleotide resin
0.48113066.11222753.html.plaintext.txt	140	B Cell free transcription pDR1 AdMLP380 pAdMLP260 templates lanes 1 2 lanes 3 4 depletion endogenous DR1 binding proteins rat liver nuclear extract
0.48113066.11222753.html.plaintext.txt	141	C Cell free transcription pDR1 AdMLP380 pAdMLP260 templates extracts depleted endogenous DR1 binding proteins absence lane 1 presence lanes 2 4 recombinant HNF4
0.48113066.11222753.html.plaintext.txt	142	The arrow asterisk represent transcripts generated 380 260 bp G free cassettes respectively
0.48113066.11222753.html.plaintext.txt	143	Transactivation native rat CRBPII promoter recombinant HNF4 The plasmid templates used thus far contain multiple copies DR1 element CRBPII RXRE cloned upstream heterologous promoter AdMLP thus may reflect regulation DR1 element context native promoter
0.48113066.11222753.html.plaintext.txt	144	We therefore examined transactivation native promoter containing DR1 elements
0.48113066.11222753.html.plaintext.txt	145	We selected rat CRBPII promoter since shown contain promiscuous binding sites HNF4 ARP 1 RXR COUP TFI 639 RE1 105 RE2 62 bp RE3 78 Fig
0.48113066.11222753.html.plaintext.txt	146	Different regions CRBPII promoter cloned upstream 300 bp G free cassette Fig
0.48113066.11222753.html.plaintext.txt	147	4A transactivation templates recombinant HNF4 examined rat liver nuclear extracts depleted endogenous DR1 binding proteins
0.48113066.11222753.html.plaintext.txt	148	The results indicate recombinant HNF4 activates transcription plasmid DNA templates containing 987 747 313 105 bp Fig
0.48113066.11222753.html.plaintext.txt	149	4B lanes 2 4 6 8 respectively rat CRBPII promoter
0.48113066.11222753.html.plaintext.txt	150	A drastic reduction HNF4 mediated transactivation observed case p53CRBPII300 contains 53 bp CRBPII promoter Fig
0.48113066.11222753.html.plaintext.txt	151	Thus region 105 54 bp essential HNF4 mediated transactivation rat CRBPII promoter cell free system
0.48113066.11222753.html.plaintext.txt	152	View larger version 75K Figure 4
0.48113066.11222753.html.plaintext.txt	153	HNF4 activates transcription rat CRBPII promoter cell free system
0.48113066.11222753.html.plaintext.txt	154	A Schematic representation rat CRBPII promoter containing putative RA REs RE1 RE2 RE3 previously described 78
0.48113066.11222753.html.plaintext.txt	155	The internal restriction sites CRBPII promoter indicated
0.48113066.11222753.html.plaintext.txt	156	The plasmid p987CRBPII300 containing 987 bp rat CRBPII promoter linked G free cassette 300 bp length constructed PCR using pCRBPIICAT 8 template
0.48113066.11222753.html.plaintext.txt	157	All constructs generated plasmid either making use internal restriction enzyme sites CRBPII promoter PCR using appropriate primers see Materials Methods
0.48113066.11222753.html.plaintext.txt	158	B Cell free transcription reactions carried rat liver nuclear extracts depleted endogenous DR1 binding proteins presence p987CRBPII300 lanes 1 2 p747CRBPII300 lanes 3 4 p313CRBPII300 lanes 5 6 p105CRBPII300 lanes 7 8 p53CRBPII300 lanes 9 10
0.48113066.11222753.html.plaintext.txt	159	Recombinant HNF4 45 pmol added indicated
0.48113066.11222753.html.plaintext.txt	160	pAdMLP380 used control template reactions
0.48113066.11222753.html.plaintext.txt	161	The arrow asterisk indicate transcripts arising 380 300 bp G free cassettes respectively
0.48113066.11222753.html.plaintext.txt	162	Addition peptide containing LXXLL motif inhibits HNF4 mediated transactivation cell free system Recent studies indicate coactivators RIP 140 TIF 1 SRC 1 CBP GRIP 1 involved transactivation nuclear receptors 2829
0.48113066.11222753.html.plaintext.txt	163	Amongst SRC 1 CBP GRIP 1 shown play role HNF4 mediated transactivation 30 32
0.48113066.11222753.html.plaintext.txt	164	These coactivators contain short sequence motif LXXLL necessary sufficient mediate binding proteins liganded nuclear receptors
0.48113066.11222753.html.plaintext.txt	165	Short peptides containing motif shown compete coactivators nuclear receptor binding 2528 33
0.48113066.11222753.html.plaintext.txt	166	We therefore examined effect addition peptide containing LXXLL motif HNF4 mediated transactivation cell free system
0.48113066.11222753.html.plaintext.txt	167	We synthesized peptide containing LXXLL motif another one containing mutations around LXXLL motif Fig
0.48113066.11222753.html.plaintext.txt	168	When equimolar amounts peptides added cell free transcription reactions HNF4 mediated transactivation p105CRBPII300 Fig
0.48113066.11222753.html.plaintext.txt	169	5B lane 2 pDR1AdMLP380 Fig
0.48113066.11222753.html.plaintext.txt	170	5C lane 2 inhibited wild type peptide containing LXXLL motif Fig
0.48113066.11222753.html.plaintext.txt	171	5B C lanes 6 8 mutant peptide Fig
0.48113066.11222753.html.plaintext.txt	172	View larger version 47K Figure 5
0.48113066.11222753.html.plaintext.txt	173	Addition peptide containing LXXLL motif results repression HNF4 mediated transactivation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	174	A Sequences peptides added cell free transcription reactions
0.48113066.11222753.html.plaintext.txt	175	The amino acids corresponding LXXLL motif underlined
0.48113066.11222753.html.plaintext.txt	176	B HNF4 mediated transactivation p105CRBPII300 template lane 2 repressed wild type peptide lanes 6 8 mutant peptide lanes 3 5
0.48113066.11222753.html.plaintext.txt	177	All tubes contained pAdMLP380 control template
0.48113066.11222753.html.plaintext.txt	178	Rat liver nuclear extract depleted levels endogenous DR1 binding proteins used experiment
0.48113066.11222753.html.plaintext.txt	179	The arrow asterisk indicate transcripts arising 380 300 bp G free cassettes respectively
0.48113066.11222753.html.plaintext.txt	180	C HNF4 mediated transactivation lane 2 pDR1 AdMLP380 repressed wild type peptide lanes 6 8 mutant peptide lanes 3 5
0.48113066.11222753.html.plaintext.txt	181	Rat liver nuclear extract without depletion endogenous DR1 binding proteins used experiment
0.48113066.11222753.html.plaintext.txt	182	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES One characteristic features nuclear receptors ability regulate gene expression binding unique REs promoters target genes 1
0.48113066.11222753.html.plaintext.txt	183	However certain REs recognized one receptor cases co existence receptors cell type results cross coupling nuclear receptor signaling 23
0.48113066.11222753.html.plaintext.txt	184	For example promiscuous binding HNF4 RXR COUP TFI ARP 1 PPAR RXR DR1 elements present promoters several genes alter gene expression patterns different tissues 4 21
0.48113066.11222753.html.plaintext.txt	185	Liver ideal tissue study cross talk amongst DR1 binding nuclear receptors since majority receptors expressed liver implicated regulation several hepatic genes 34
0.48113066.11222753.html.plaintext.txt	186	So far report study DR1 mediated vitro transcription using cell free extracts derived rat liver
0.48113066.11222753.html.plaintext.txt	187	In study demonstrate endogenous DR1 binding transcription factors present rat liver nuclear extracts activate transcription vitro
0.48113066.11222753.html.plaintext.txt	188	Addition recombinant HNF4 cell free system results enhancement DR1 mediated transcription observed endogenous HNF4
0.48113066.11222753.html.plaintext.txt	189	Depletion endogenous DR1 binding proteins abrogates DR1 dependent transactivation addition recombinant HNF4 extracts restores DR1 dependent transactivation
0.48113066.11222753.html.plaintext.txt	190	These observations indicate HNF4 major transcription factor involved DR1 dependent transactivation cell free transcription system
0.48113066.11222753.html.plaintext.txt	191	HNF4 activates transcription rat CRBPII promoter well harbors promiscuous binding sites RE1 RE2 RE3 several DR1 binding transcription factors 7
0.48113066.11222753.html.plaintext.txt	192	Deletion region containing RE1 RE2 effect HNF4 activation CRBPII promoter
0.48113066.11222753.html.plaintext.txt	193	However deletion region containing RE3 results drastic decrease HNF4 mediated transactivation
0.48113066.11222753.html.plaintext.txt	194	Thus RE3 present 105 52 bp major cis acting element involved HNF4 mediated transactivation rat CRBPII promoter
0.48113066.11222753.html.plaintext.txt	195	These results significant view conflicting reports murine CRBPII gene regulation 78
0.48113066.11222753.html.plaintext.txt	196	While RE1 shown mediate 9 cis retinoic acid RA dependent transactivation rat CRBPII gene RXR F9 cells 8 RE2 RE3 identified major regulatory elements mouse CRBPII gene 7
0.48113066.11222753.html.plaintext.txt	197	Our results indicate RE1 RE2 dispensable RE3 major regulatory element HNF4 activates rat CRBPII gene transcription
0.48113066.11222753.html.plaintext.txt	198	While results agreement reported Nakshatri Chambon 7 wish point CRBPII gene expressed neonatal liver adult intestine adult liver
0.48113066.11222753.html.plaintext.txt	199	Thus HNF4 able activate CRBPII gene transcription rat liver nuclear extracts tissue specific gene silencing mechanisms operational vivo may prevent HNF4 activating CRBPII gene transcription adult rat liver
0.48113066.11222753.html.plaintext.txt	200	The fact DR1 dependent transactivation restored liver nuclear extracts depleted levels endogenous DR1 binding proteins addition recombinant HNF4 indicates cell free system used dissect mechanism hepatic gene regulation HNF4 without interference DR1 binding receptors
0.48113066.11222753.html.plaintext.txt	201	To end examined role coactivators HNF4 mediated transactivation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	202	Research last decade led identification several nuclear receptor coactivators NCoAs well nuclear receptor corepressors 29
0.48113066.11222753.html.plaintext.txt	203	Analysis domains involved interaction NCoAs nuclear receptors indicated LXXLL motif necessary sufficient ligand dependent interaction several NCoAs nuclear receptors 2528 33
0.48113066.11222753.html.plaintext.txt	204	Since several NCoAs contain LXXLL motif examined involvement protein factors HNF4 mediated transactivation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	205	Our study indicates peptide containing LXXLL motif inhibits HNF4 mediated transactivation vitro
0.48113066.11222753.html.plaintext.txt	206	It logical conclude repression due competition endogenous LXXLL containing coactivators peptide binding HNF4
0.48113066.11222753.html.plaintext.txt	207	Thus LXXLL containing coactivators appears involved HNF4 mediated transactivation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	208	These results significant view reports LXXLL containing coactivators CBP SRC 1 GRIP 1 shown involved HNF4 function vivo 30 32
0.48113066.11222753.html.plaintext.txt	209	Whether coactivators involved transactivation HNF4 rat liver nuclear extracts clear
0.48113066.11222753.html.plaintext.txt	210	Our attempts characterize coactivator involved transactivation HNF4 rat liver nuclear extracts successful thus far
0.48113066.11222753.html.plaintext.txt	211	Addition antibodies CBP SRC 1 affect HNF4 mediated transactivation cell free system conditions addition HNF4 antibodies readily inhibited transactivation pDR1 AdMLP380 data shown
0.48113066.11222753.html.plaintext.txt	212	Thus studies needed characterize coactivators involved HNF4 activation rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	213	This study clearly demonstrates cell free system derived rat liver nuclear extracts useful tool study regulation hepatic gene expression DR1 binding nuclear receptors general HNF4 particular
0.48113066.11222753.html.plaintext.txt	214	While focussed attention HNF4 activation study cell free system also used study transactivation DR1 binding nuclear receptors RXR ARP 1 COUP TF PPAR RXR etc
0.48113066.11222753.html.plaintext.txt	215	We used naked DNA templates study interesting study transcriptional regulation HNF4 chromatin templates rat liver nuclear extracts
0.48113066.11222753.html.plaintext.txt	216	The ligand independent activation HNF4 demonstrated study also opens new opportunities study role ligands modulating HNF4 function since long chain fatty acyl CoA thioesters shown modulate HNF4 function HeLa nuclear extracts 35
0.48113066.11222753.html.plaintext.txt	217	The cell free system described study differs derived HeLa cells latter express HNF4
0.48113066.11222753.html.plaintext.txt	218	Since HNF4 major regulator several hepatic genes cell free system derived liver well suited study hepatic gene regulation HNF4 identification ligands
0.48113066.11222753.html.plaintext.txt	219	ACKNOWLEDGEMENTS We thank Ronald M
0.48113066.11222753.html.plaintext.txt	220	Evans providing cDNA clones HNF4 RXR COUP TFI rat CRBPII promoter Frances Sladek HNF4 antibodies G
0.48113066.11222753.html.plaintext.txt	221	Padmanaban help advice
0.48113066.11222753.html.plaintext.txt	222	This work supported research grant Department Science Technology New Delhi India
0.48113066.11222753.html.plaintext.txt	223	FOOTNOTES To correspondence addressed
0.48113066.11222753.html.plaintext.txt	224	Tel 91 80 360 1492 Fax 91 80 360 0814 Email rangaatbiochem
0.48113066.11222753.html.plaintext.txt	225	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1 EvansR
0.48113066.11222753.html.plaintext.txt	226	1988 The steroid thyroid hormone receptor superfamily
0.48113066.11222753.html.plaintext.txt	227	1996 A decade molecular biology retinoic acid receptors
0.48113066.11222753.html.plaintext.txt	228	1995 The RXR heterodimers orphan receptors
0.48113066.11222753.html.plaintext.txt	229	1995 9 cis retinoic acid signaling changing partners causes excitement
0.48113066.11222753.html.plaintext.txt	230	1992 Antagonism apolipoprotein AI regulatory protein 1 Ear3COUP TF hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression liver intestinal cells
0.48113066.11222753.html.plaintext.txt	231	1992 Transcriptional regulation human apolipoprotein genes ApoB ApoCIII ApoAII members steroid hormone receptor superfamily HNF 4 ARP 1 EAR 2 EAR 3
0.48113066.11222753.html.plaintext.txt	232	1994 The directly repeated RGGTTCA motifs rat mouse cellular retinol binding protein II genes promiscuous binding sites RAR RXR HNF 4 ARP 1 homo heterodimers
0.48113066.11222753.html.plaintext.txt	233	1991 A direct repeat cellular retinol binding protein type II gene confers differential regulation RXR RAR
0.48113066.11222753.html.plaintext.txt	234	1992 Convergence 9 cis retinoic acid peroxisome proliferator signalling pathways heterodimer formation receptors
0.48113066.11222753.html.plaintext.txt	235	1998 Multiple parameters determine specificity transcriptional response nuclear receptors HNF 4 ARP 1 PPAR RAR RXR common response elements
0.48113066.11222753.html.plaintext.txt	236	1998 Functional interactions nuclear receptors recognizing common sequence element direct repeat motif spaced one nucleotide DR 1
0.48113066.11222753.html.plaintext.txt	237	1993 Chicken ovalbumin upstream promoter transcription factor COUP TF represses transcription promoter gene ornithine transcarbamylase manner antagonistic hepatocyte nuclear factor 4 HNF 4
0.48113066.11222753.html.plaintext.txt	238	1996 Transcriptional regulation human factor IX promoter orphan receptor superfamily factor HNF4 ARP1 COUPEar3
0.48113066.11222753.html.plaintext.txt	239	1988 Transcription elements factors RNA polymerase B promoters higher eukaryotes
0.48113066.11222753.html.plaintext.txt	240	1986 Tissue specific vitro transcription mouse albumin promoter
0.48113066.11222753.html.plaintext.txt	241	1989 A glycosylated liver specific transcription factor stimulates transcription albumin gene
0.48113066.11222753.html.plaintext.txt	242	1996 In vitro transcription rat insulin like growth factor I gene
0.48113066.11222753.html.plaintext.txt	243	1991 Specificity retinoic acid response element phosphoenolpyruvate carboxykinase gene promoter consequences retinoic acid thyroid hormone receptor binding
0.48113066.11222753.html.plaintext.txt	244	1992 A transcriptional hierarchy involved mammalian cell type specification
0.48113066.11222753.html.plaintext.txt	245	Jr 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.48113066.11222753.html.plaintext.txt	246	1996 Retinoids increase human apolipoprotein A 11 expression activation retinoid X receptor retinoic acid receptor
0.48113066.11222753.html.plaintext.txt	247	1985 Factors involved specific transcription human RNA polymerase II analysis rapid quantitative vitro assay
0.48113066.11222753.html.plaintext.txt	248	2000 Receptor mediated gene delivery approach demonstrates role 5 proximal DNA region conferring phenobarbitone responsiveness CYP2B2 gene rat liver vivo
0.48113066.11222753.html.plaintext.txt	249	1986 Affinity purification sequence specific DNA binding proteins
0.48113066.11222753.html.plaintext.txt	250	1997 A signature motif transcriptional co activators mediates binding nuclear receptors
0.48113066.11222753.html.plaintext.txt	251	1999 Coactivator corepressor complexes nuclear receptor function
0.48113066.11222753.html.plaintext.txt	252	1996 TFIIB directed transcriptional activation orphan nuclear receptor hepatocyte nuclear factor 4
0.48113066.11222753.html.plaintext.txt	253	2000 The coregulator exchange transcriptional functions nuclear receptors
0.48113066.11222753.html.plaintext.txt	254	1999 Nuclear receptor coregulators cellular molecular biology
0.48113066.11222753.html.plaintext.txt	255	1999 CREB binding protein transcriptional coactivator hepatocyte nuclear factor 4 enhances apolipoprotein gene expression
0.48113066.11222753.html.plaintext.txt	256	1998 SRC 1 GRIP1 coactivate transcription hepatocyte nuclear factor 4
0.48113066.11222753.html.plaintext.txt	257	1997 Functional association CBP HNF4 trans activation
0.48113066.11222753.html.plaintext.txt	258	1999 Identification nuclear receptor bile acids
0.48113066.11222753.html.plaintext.txt	259	1999 Orphan nuclear receptors gene function
0.48113066.11222753.html.plaintext.txt	260	1998 Fatty acyl CoA thioesters ligands hepatic nuclear factor 4
0.22947337.11522818.html.plaintext.txt	0	An enhancer element 6 kb upstream mouse HNF41 promoter activated glucocorticoids liver enriched transcription factors Alain Bailly Maria Elena Torres Padilla Antoine P
0.22947337.11522818.html.plaintext.txt	1	Unite de Genetique de la Differenciation FRE 2364 du CNRS Institut Pasteur 25 Rue du Dr Roux 75724 Paris Cedex 15 France
0.22947337.11522818.html.plaintext.txt	2	Received May 31 2001 Revised Accepted July 9 2001
0.22947337.11522818.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES We characterized 700 bp enhancer element around 6 kb relative HNF41 transcription start
0.22947337.11522818.html.plaintext.txt	4	This element increases activity confers glucocorticoid induction heterologous well homologous promoters differentiated hepatoma cells transactivated HNF41 HNF47 HNF1 HNF1ss dedifferentiated hepatoma cells
0.22947337.11522818.html.plaintext.txt	5	A 240 bp sub region conserves basal hormone induced enhancer activity
0.22947337.11522818.html.plaintext.txt	6	It contains HNF1 HNF4 HNF3 CEBP binding sites shown DNase I footprinting electrophoretic mobility shift assays using nuclear extracts andor recombinant HNF1 HNF41
0.22947337.11522818.html.plaintext.txt	7	Mutation analyses showed HNF1 site essential HNF1 transactivation required full basal enhancer activity CEBP site
0.22947337.11522818.html.plaintext.txt	8	Glucocorticoid response element consensus sites overlap CEBP HNF4 HNF3 sites crucial optimal hormonal induction
0.22947337.11522818.html.plaintext.txt	9	We present model accounts weak expression HNF41 embryonic liver strong expression newbornadult liver via binding sites identified enhancer
0.22947337.11522818.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES HNF4 member steroid hormone receptor superfamily 1 one first liver enriched transcription factors LETF expressed course development
0.22947337.11522818.html.plaintext.txt	11	Indeed transcripts observed mouse embryonic day E4
0.22947337.11522818.html.plaintext.txt	12	5 extra embryonic visceral endoderm embryonic tissues liver gut primordia around E8
0.22947337.11522818.html.plaintext.txt	13	A somewhat earlier overlapping expression pattern characterizes HNF3ss HNF1ss respectively LETF precocious expression 3 6
0.22947337.11522818.html.plaintext.txt	14	Each three factors essential normal embryogenesis targeted mutation corresponding genes causes early embryonic lethal phenotype 3 7 due cases HNF4 HNF1ss disruption visceral endoderm function essential progression gastrulation 458
0.22947337.11522818.html.plaintext.txt	15	In addition HNF4 required expression number essential liver functions differentiated hepatocytes 9
0.22947337.11522818.html.plaintext.txt	16	Alteration functions may involved maturity onset diabetes young 1 MODY1 linked HNF4 insufficiency 1011
0.22947337.11522818.html.plaintext.txt	17	HNF4 mutations linked MODY1 affect coding region protein
0.22947337.11522818.html.plaintext.txt	18	However mutations regulatory regions gene may yet identified reviewed 12 providing strong impetus locate characterize sequences
0.22947337.11522818.html.plaintext.txt	19	In view importance HNF4 execution hepatocyte differentiation program well early expression pattern search regulators HNF4 gene inform us factors critical hepatocyte differentation function endoderm formation well
0.22947337.11522818.html.plaintext.txt	20	Relatively little information available concerning regulation expression HNF4 gene
0.22947337.11522818.html.plaintext.txt	21	A series 10 DNase I hypersensitive sites HS adult liver chromatin spread 15 kb DNA upstream start transcription HNF41 initially isolated isoform 1 implies regulation complex 1314
0.22947337.11522818.html.plaintext.txt	22	5 kb fragment DNA upstream transcription start site 5 deletions analyze expression transient transfection assays hepatoma cells well transgenic mice
0.22947337.11522818.html.plaintext.txt	23	While long fragment deletions 228 bp showed similar activity transient expression assays long fragment conferred appropriate activity reporter gene transgenic mice
0.22947337.11522818.html.plaintext.txt	24	These results imply distal HS harbor important regulatory sites HNF41 expression
0.22947337.11522818.html.plaintext.txt	25	Several splice variants HNF4 described reviewed 12 assumed HNF4 variants concern alternative splicing events within single gene region
0.22947337.11522818.html.plaintext.txt	26	However recently described HNF47 contains unique sequence encoding N terminal portion protein 5 untranslated region 5 UTR implying transcribed separate promoter 15
0.22947337.11522818.html.plaintext.txt	27	We analyzed regulatory role distal sequences upstream HNF41 promoter characterized 700 bp enhancer conferring high activity glucocorticoid induction heterologous HNF41 promoter
0.22947337.11522818.html.plaintext.txt	28	We found LETF binding sites glucocorticoid responsive sequences essential enhancer activity 240 bp sub region
0.22947337.11522818.html.plaintext.txt	29	Our results line requirement upstream sequences tissue specific activity HNF41 promoter 14 glucocorticoid induction HNF41 expression 1115 lead us propose model biphasic regulation enhancer involved HNF41 expression liver development
0.22947337.11522818.html.plaintext.txt	30	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Nucleotide sequence accession number The GenBank accession number mouse 700 bp HNF41 enhancer AF320052
0.22947337.11522818.html.plaintext.txt	31	Cell lines culture conditions FGC4 rat hepatoma cells 16 well differentiated whereas H5 cells 17 dedifferentiated variants
0.22947337.11522818.html.plaintext.txt	32	Cells grown modified Ham F12 medium 18 containing 5 fetal calf serum
0.22947337.11522818.html.plaintext.txt	33	Human epithelial carcinoma C33 cells 19 maintained Dulbecco modified Eagle medium containing 7 fetal calf serum
0.22947337.11522818.html.plaintext.txt	34	All cells cultured humidified 7 CO2
0.22947337.11522818.html.plaintext.txt	35	Transient transfections Fragments mouse HNF41 5 region see Figs 1A 2A derived SBII2
0.22947337.11522818.html.plaintext.txt	36	Zhong Yale University New Haven CT cloned front herpes simplex virus thymidine kinase tk promoter driving transcription chloramphenicol acetyltransferase gene CAT pBLCAT5 20
0.22947337.11522818.html.plaintext.txt	37	The 700 bp enhancer cloned 34pZLUC 14
0.22947337.11522818.html.plaintext.txt	38	8pZLUC described Zhong et al
0.22947337.11522818.html.plaintext.txt	39	Constructs 700 bp enhancer sub regions checked DNA sequencing
0.22947337.11522818.html.plaintext.txt	40	Standard transfections performed calcium phosphate procedure previously described 21 using 5 microg reporter plasmid internal control plasmid RSVlacZ
0.22947337.11522818.html.plaintext.txt	41	Cells harvested 64 h later
0.22947337.11522818.html.plaintext.txt	42	Where indicated 1 microM dexamethasone Dex added 48 h harvest
0.22947337.11522818.html.plaintext.txt	43	In co transfection experiments C33 cells 15 6 x 105 test control plasmids used 0
0.22947337.11522818.html.plaintext.txt	44	165 microg pBluescript plasmid added 3
0.22947337.11522818.html.plaintext.txt	45	In experiments FGC4 cells 5 x 106 cells 150 microl medium electroporated Bio Rad gene pulser capacitance extender 960 microF 0
0.22947337.11522818.html.plaintext.txt	46	2 kV using 5 microg test control plasmid
0.22947337.11522818.html.plaintext.txt	47	In co transfections expression vectors HNF1 RSV HNF1 22 HNF1ss RSV vHNF1 23 HNF41 HNF4tag 24 HNF47 M
0.22947337.11522818.html.plaintext.txt	48	Weiss submitted publication HNF3 kind gift R
0.22947337.11522818.html.plaintext.txt	49	Costa University Illinois Chicago IL used
0.22947337.11522818.html.plaintext.txt	50	The expression vector promoter kept constant addition appropriate vector DNA
0.22947337.11522818.html.plaintext.txt	51	CAT luciferase activities determined described 2526 ss galactosidase activity standard colorimetric method
0.22947337.11522818.html.plaintext.txt	52	CAT luciferase activities normalized ss galactosidase activity calculated relative pBLCAT5 34pZLUC respectively
0.22947337.11522818.html.plaintext.txt	53	View larger version 23K Figure 1
0.22947337.11522818.html.plaintext.txt	54	Enhancer activity Dex inducibility distal sequences upstream HNF41 transcription start
0.22947337.11522818.html.plaintext.txt	55	A Left Scheme HNF41 5 region showing positions liver kidney specific HS 1314 partial restriction map B BamHI E EcoRI G BglII X XbaI transcription start arrow
0.22947337.11522818.html.plaintext.txt	56	Below Cloned restriction fragments B1E4 cloned antisense direction
0.22947337.11522818.html.plaintext.txt	57	Right CAT activity corresponding reporter plasmids transfected differentiated FGC4 dedifferentiated H5 hepatoma cells non hepatic cells C33
0.22947337.11522818.html.plaintext.txt	58	Values means three FGC4 two three H5 one four C33 independent experiments
0.22947337.11522818.html.plaintext.txt	59	B Activity constructs transfected FGC4 H5 cells treated Dex
0.22947337.11522818.html.plaintext.txt	60	Means plus minus SD three FGC4 two three H5 independent experiments
0.22947337.11522818.html.plaintext.txt	61	C Activity transfected FGC4 cells treated Dex minimal HNF41 promoter 34 controlled 700 bp enhancer cloned orientations HNF41 5 sequences 6
0.22947337.11522818.html.plaintext.txt	62	Means plus minus SD two independent experiments
0.22947337.11522818.html.plaintext.txt	63	View larger version 26K Figure 2
0.22947337.11522818.html.plaintext.txt	64	A A 240 bp region 700 bp enhancer shows basal Dex induced enhancer activities transactivated HNF41 HNF1
0.22947337.11522818.html.plaintext.txt	65	Left Restriction map enhancer positions kb relative transcription start schemes cloned sub regions
0.22947337.11522818.html.plaintext.txt	66	Middle right Activities corresponding reporter plasmids either transfection FGC4 treated Dex co transfection H5 1 microg HNF41 HNF1 expression vector
0.22947337.11522818.html.plaintext.txt	67	Induction factor represents ratio CAT activity presence factor presence control expression vector
0.22947337.11522818.html.plaintext.txt	68	For 700 bp enhancer induction factor mean four five independent experiments
0.22947337.11522818.html.plaintext.txt	69	Induction factors fragments normalized mean value
0.22947337.11522818.html.plaintext.txt	70	Blanks indicate fragments tested activity
0.22947337.11522818.html.plaintext.txt	71	B The 700 bp enhancer transactivated HNF47 left HNF1ss right
0.22947337.11522818.html.plaintext.txt	72	H5 cells co transfected B1E5B2 reporter plasmid 0
0.22947337.11522818.html.plaintext.txt	73	3 1 microg expression vector HNF41 HNF47 HNF1ss HNF1 indicated
0.22947337.11522818.html.plaintext.txt	74	CAT activity expressed induction factor see A
0.22947337.11522818.html.plaintext.txt	75	DNase I footprinting electrophoretic mobility shift assays EMSA Nuclear protein extracts FGC4 H5 cells treated Dex 1 microM 2 days rat liver prepared described previously 27 except NH42SO4 precipitation dialysis omitted
0.22947337.11522818.html.plaintext.txt	76	Protein concentrations measured Bio Rad protein assay
0.22947337.11522818.html.plaintext.txt	77	Purified recombinant truncated rat HNF1 HNt rat HNF41 kind gifts C
0.22947337.11522818.html.plaintext.txt	78	Cheret Institut Pasteur Paris France F
0.22947337.11522818.html.plaintext.txt	79	Ringeisen Institut Pasteur respectively
0.22947337.11522818.html.plaintext.txt	80	The DNase I footprinting assay performed essentially described previously 28 except binding reaction contained 85 mM NaCl 10 mM KCl
0.22947337.11522818.html.plaintext.txt	81	Proteins incubated labeled DNA probe 1 ng 12 microl 1 h ice adding DNase I
0.22947337.11522818.html.plaintext.txt	82	Products analyzed 6 polyacrylamide 7 M urea gels
0.22947337.11522818.html.plaintext.txt	83	EMSA carried described previously 27 50 mM NaCl added reaction mix
0.22947337.11522818.html.plaintext.txt	84	Binding reactions performed 10 microg nuclear protein extracted FGC4 H5 0
0.22947337.11522818.html.plaintext.txt	85	4 ng labeled oligonucleotide
0.22947337.11522818.html.plaintext.txt	86	Double stranded oligonucleotides used contained HNF41 upstream sequences binding HNF1 oligo BS1 5 GCAAACTCATGCCCAGTTAATTTTTTAAAGCAAGACCAACAGGCTC protected DNase I footprinting experiments well binding sites HNF1 rat albumin promoter PE56 27 HNF3HNF6 mouse transthyretin promoter 85 110 TTR 29 31 HNF3Oct 1 HNF6 6 phosphofructo 2 kinase promoter PFK III PFK IV respectively 32 Oct 1 mouse light chain gene promoter Oct Ig 32 HNF4 human apolipoprotein CIII promoter 67 92 ApoCIII 33 rat 34 mouse 35 HNF1 promoter H1H4 5 GATCGGCTGAAGTCCAAAGTTCAGTCC CEBP rat albumin promoter 86 109 DEI 28 glucocorticoid receptor GR rat tyrosine aminotransferase gene 2491 2510 GRE 36
0.22947337.11522818.html.plaintext.txt	87	A double stranded oligonucleotide oligo BS1m containing four point mutations HNF1 consensus site oligoBS1 described mutant PE DS 34 PE 56 27 also used
0.22947337.11522818.html.plaintext.txt	88	In competition experiments 20 ng non labeled double stranded oligonucleotide added reaction mix except otherwise stated
0.22947337.11522818.html.plaintext.txt	89	A CEBP specific antibody sc 61 X Santa Cruz Biotechnology antibody raised N terminus rat HNF41 kind gift F
0.22947337.11522818.html.plaintext.txt	90	Sladek University California Riverside CA 37 used
0.22947337.11522818.html.plaintext.txt	91	Site directed mutagenesis Site directed mutagenesis B1E5B2 reporter performed using QuickChange kit Stratagene
0.22947337.11522818.html.plaintext.txt	92	All isolated clones analyzed DNA sequencing
0.22947337.11522818.html.plaintext.txt	93	We introduced clustered point mutation 38 mutant F1m1 5 GGAGAGGCCAATGGCCTCGAAGCTTCCCCAGGAGGCCTCCTGCCC two point mutations mutant F1m2 5 GGCCAATGGCCTCTAGAATAACCCAGGAGGCC CEBP consensus site F1
0.22947337.11522818.html.plaintext.txt	94	The HNF1 binding site BS1 mutated using oligo BS1m
0.22947337.11522818.html.plaintext.txt	95	Clustered point mutations according mutation HNF3 binding site TTR promoter 29 introduced HNF3 consensus site F3 mutant F3mH3 5 GCTGCCTTTATCTCCCTGTGGTAAAGATCTGAATATACTCAGGCCCTGGAGCAGGGC
0.22947337.11522818.html.plaintext.txt	96	Three point mutations introduced center HNF4 consensus site 12 F2 mutant F2mH4 5 GCTGTTGACTCTTGAGCTCCGTCTTCCCTCCGGAGG
0.22947337.11522818.html.plaintext.txt	97	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES A 700 bp enhancer located 6 kb upstream HNF41 transcription start increases activity confers Dex inducibility heterologous homologous promoters For transfection studies used differentiated FGC4 rat hepatoma cells containing HNF4 transcripts synthesized HNF41 promoter M
0.22947337.11522818.html.plaintext.txt	98	Weiss submitted publication therefore appropriate analyze HNF41 regulatory sequences
0.22947337.11522818.html.plaintext.txt	99	Activity two fragments covering sequences 5 11 kb upstream HNF41 transcription start cloned upstream tk promoter examined cells dedifferentiated H5 non hepatic C33 cells Fig
0.22947337.11522818.html.plaintext.txt	100	Both fragments exhibited strong enhancer activity FGC4 cells
0.22947337.11522818.html.plaintext.txt	101	The active fragment subdivided three fragments tested
0.22947337.11522818.html.plaintext.txt	102	Essentially full activity limited FGC4 cells conserved proximal fragment B1E5
0.22947337.11522818.html.plaintext.txt	103	Finally B1E5 divided two fragments full activity FGC4 cells retained proximal fragment B1E5B2
0.22947337.11522818.html.plaintext.txt	104	This fragment covering one HS 1314 therefore acts cell specific enhancer referred 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	105	Since observed transcription endogenous HNF4 gene rat hepatoma cells induced Dex treatment data shown fragments tested Dex inducibility Fig
0.22947337.11522818.html.plaintext.txt	106	Dex induction observed FGC4 2 3 fold H5 cells one exception found active fragments
0.22947337.11522818.html.plaintext.txt	107	The fragment low basal activity showed inducibility B1E4 covers HS V 13
0.22947337.11522818.html.plaintext.txt	108	This fragment yet studied
0.22947337.11522818.html.plaintext.txt	109	To test whether 700 bp enhancer act homologous promoter cloned front 34182 HNF41 sequence plasmid 34pZLUC 14
0.22947337.11522818.html.plaintext.txt	110	The 5 deletion 34 retained non tissue specific promoter activity 14
0.22947337.11522818.html.plaintext.txt	111	1C 700 bp enhancer whatever orientation increased activity 34pZLUC 5 fold relative activity 6
0.22947337.11522818.html.plaintext.txt	112	This last plasmid contains 6
0.22947337.11522818.html.plaintext.txt	113	Moreover Dex treatment increased activity 700 34pZLUC constructs 2 fold accounts totally Dex induction 6
0.22947337.11522818.html.plaintext.txt	114	A 240 bp region sufficient enhancer activity Dex inducibility transactivated HNF1 HNF41 Deletions performed 700 bp enhancer delineate sequences critical basal inducible expression Fig
0.22947337.11522818.html.plaintext.txt	115	Concerning 5 3 deletions BspEI B1E5A2 basal activity strongly reduced compared 700 bp enhancer hormone inducibility abolished
0.22947337.11522818.html.plaintext.txt	116	The sequences deleted HpaI DraI negative effect basal induced activity loss led increased activity
0.22947337.11522818.html.plaintext.txt	117	Further deletion DraI AvaI caused strong decline basal hormone induced activity
0.22947337.11522818.html.plaintext.txt	118	An internal deletion BspEI StuI also strongly reduced basal induced activities compared 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	119	Therefore three adjacent blocks sequence lying PvuII DraI sites important full basal hormone induced activity 700 bp enhancer 5 one PvuII BspEI critical Dex response
0.22947337.11522818.html.plaintext.txt	120	Analysis two central fragments PvuII DraI BspEI DraI confirmed element required hormone response located PvuII BspEI sites
0.22947337.11522818.html.plaintext.txt	121	None fragments shown Figure 2A exhibited strong enhancer activity dedifferentiated H5 cells absence presence Dex data shown
0.22947337.11522818.html.plaintext.txt	122	Because known HNF4 gene subject cross regulation HNF1 auto regulation 2439 42 several fragments tested transactivation HNF1 HNF41
0.22947337.11522818.html.plaintext.txt	123	The 700 bp enhancer transactivated factors H5 Fig
0.22947337.11522818.html.plaintext.txt	124	2A C33 data shown cells
0.22947337.11522818.html.plaintext.txt	125	Analysis deleted constructs H5 cells Fig
0.22947337.11522818.html.plaintext.txt	126	2A shows HNF4 response element located PvuII BspEI sites HNF1 element AvaI DraI sites
0.22947337.11522818.html.plaintext.txt	127	In addition H5 cells 700 bp enhancer transactivated similarly HNF41 HNF47 less efficiently HNF1ss HNF1 Fig
0.22947337.11522818.html.plaintext.txt	128	In conclusion results show 700 bp enhancer transactivated HNF41 HNF47 HNF1 HNF1ss
0.22947337.11522818.html.plaintext.txt	129	Furthermore 240 bp PvuII DraI sequence contains HNF4 HNF1 response elements acts cell specific enhancer whose activity increased glucocorticoids
0.22947337.11522818.html.plaintext.txt	130	Hepatoma cell nuclear proteins bind 240 bp enhancer DNase I footprint experiments performed search binding sites nuclear proteins 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	131	Figure 3A shows four footprints F1 F4 revealed nuclear extract FGC4 H5 cells
0.22947337.11522818.html.plaintext.txt	132	Due location F1 close labeled end probe 3 limit clearly visible
0.22947337.11522818.html.plaintext.txt	133	However using probe labeled downstream strand precisely located 3 end F1 data shown
0.22947337.11522818.html.plaintext.txt	134	There surprising similarity footprints obtained two extracts
0.22947337.11522818.html.plaintext.txt	135	3A data shown H5 extract clearly less active FGC4 F2 greater protection FGC4 extract evident 3 extremity footprint
0.22947337.11522818.html.plaintext.txt	136	As F1 F3 lie within 240 bp enhancer region characterized see Fig
0.22947337.11522818.html.plaintext.txt	137	3C mapped three footprints opposite strand using FGC4 extract Fig
0.22947337.11522818.html.plaintext.txt	138	The autoradiogram shows F2 F3 higher resolution
0.22947337.11522818.html.plaintext.txt	139	In addition Figure 3A B shows F1 particularly strong footprint strands
0.22947337.11522818.html.plaintext.txt	140	Positions sequences F1 F3 given Figure 3C D along sequences oligonucleotides used EMSA
0.22947337.11522818.html.plaintext.txt	141	View larger version 31K Figure 3
0.22947337.11522818.html.plaintext.txt	142	DNase I footprints generated FGC4 H5 nuclear extracts 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	143	A The BglII AvaI fragment see C 32P labeled upper strand 3 end AvaI site incubated absence F presence nuclear extract 20 microg protein adding DNase I final concentrations 0
0.22947337.11522818.html.plaintext.txt	144	7 F 13 20 Uml FGC4 H5
0.22947337.11522818.html.plaintext.txt	145	GA TC show chemical sequencing reaction products
0.22947337.11522818.html.plaintext.txt	146	Footprints bars hyperdigestion sites arrows generated FGC4 extract indicated
0.22947337.11522818.html.plaintext.txt	147	There differences DNase I digestion pattern using H5 extract see text
0.22947337.11522818.html.plaintext.txt	148	B The experiment using HindIII BamHI fragment 32P labeled 3 end HindIII site sites vector containing PvuII DraI fragment see C lower strand labeled FGC4 nuclear extract
0.22947337.11522818.html.plaintext.txt	149	C Positions DNase I footprints generated FGC4 nuclear extracts enhancer
0.22947337.11522818.html.plaintext.txt	150	Results A B data shown
0.22947337.11522818.html.plaintext.txt	151	D Sequences PvuII AvaI fragment DNase I footprints bracketed lines hyperdigestion sites arrows upper lower strand sequence respectively indicated
0.22947337.11522818.html.plaintext.txt	152	Oligonucleotides used analysis underlined
0.22947337.11522818.html.plaintext.txt	153	In F1 CEBP binding site essential basal enhancer activity overlaps Dex responsive sequences EMSA performed nuclear extracts FGC4 H5 cells treated Dex oligonucleotide containing F1 oligo F1 Fig
0.22947337.11522818.html.plaintext.txt	154	In FGC4 extracts complex pattern six bands observed two designated 1 3 restricted extracts
0.22947337.11522818.html.plaintext.txt	155	The H5 extract showed strong bands corresponding complexes 2 4 Dex treatment even though Dex inducibility restricted FGC4 cells hormone treatment change pattern FGC4
0.22947337.11522818.html.plaintext.txt	156	Interestingly three six bands observed FGC4 strongly represented liver extract Fig
0.22947337.11522818.html.plaintext.txt	157	Moreover complexes 1 3 appeared common liver FGC4
0.22947337.11522818.html.plaintext.txt	158	In competition experiments oligos F1 DEI containing CEBP site albumin promoter displaced bands three types extracts Fig
0.22947337.11522818.html.plaintext.txt	159	In contrast binding sites LETF GR compete Fig
0.22947337.11522818.html.plaintext.txt	160	Therefore CEBP family proteins bind F1
0.22947337.11522818.html.plaintext.txt	161	In agreement sequence homologous CEBP binding site consensus 43 found center F1
0.22947337.11522818.html.plaintext.txt	162	The two bands specific FGC4 liver extracts shown contain CEBP supershift assays specific antibody displaced bands 1 3 FGC4 liver extracts effect H5 extract Fig
0.22947337.11522818.html.plaintext.txt	163	Consequently conclude CEBP binds F1 FGC4 cells liver H5 cells
0.22947337.11522818.html.plaintext.txt	164	View larger version 70K Figure 4
0.22947337.11522818.html.plaintext.txt	165	CEBP binds F1 FGC4 cells rat liver nuclear extracts
0.22947337.11522818.html.plaintext.txt	166	A Nuclear extracts cells treated Dex incubated labeled oligo F1 EMSA indicated
0.22947337.11522818.html.plaintext.txt	167	Numbers designate retarded protein DNA complexes
0.22947337.11522818.html.plaintext.txt	168	B The experiment using nuclear extracts rat liver FGC4 cells
0.22947337.11522818.html.plaintext.txt	169	Protein concentration indicated
0.22947337.11522818.html.plaintext.txt	170	C EMSA labeled oligo F1 FGC4 nuclear proteins without minus competitor oligo F1 oligonucleotides containing binding sites HNF1 PE56 HNF4 ApoCIII H1H4 CEBP DEI GR GRE
0.22947337.11522818.html.plaintext.txt	171	D EMSA labeled oligo F1 FGC4 H5 nuclear extracts increasing amounts anti CEBP antibody
0.22947337.11522818.html.plaintext.txt	172	Antibody 1 3 microl undiluted 10 fold diluted preincubated nuclear extracts indicated 10 min room temperature reactions completed incubated 30 min ice
0.22947337.11522818.html.plaintext.txt	173	Cells treated Dex observe complexes 2 4 H5 cells
0.22947337.11522818.html.plaintext.txt	174	Complexes 1 3 supershifted antibody arrowhead
0.22947337.11522818.html.plaintext.txt	175	To determine whether CEBP plays role enhancer activity critical bases mutated CEBP consensus site 38 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	176	The activity mutant reporter plasmid F1m1 tested FGC4 cells
0.22947337.11522818.html.plaintext.txt	177	The mutant showed low basal activity reduced 6 fold compared wild type Fig
0.22947337.11522818.html.plaintext.txt	178	In addition Dex inducibility entirely destroyed mutation Fig
0.22947337.11522818.html.plaintext.txt	179	The mutant sequence failed bind proteins FGC4 H5 extracts shown EMSA DNase I footprint experiments data shown
0.22947337.11522818.html.plaintext.txt	180	However three seven mutated nucleotides F1m1 mutant belong glucocorticoid response element half site half GRE consensus overlapping CEBP consensus data shown
0.22947337.11522818.html.plaintext.txt	181	Consequently mutation could impair binding GR linked hormone
0.22947337.11522818.html.plaintext.txt	182	We performed two point mutations CEBP consensus site affect half GRE consensus impair CEBP binding analyzed competition experiments EMSA data shown
0.22947337.11522818.html.plaintext.txt	183	This mutation diminished basal activity mutant F1m2 Fig
0.22947337.11522818.html.plaintext.txt	184	5A left caused weak inhibition Dex effect Fig
0.22947337.11522818.html.plaintext.txt	185	We conclude CEBP binding site required full basal enhancer activity overlaps half GRE consensus site involved hormone inducibility
0.22947337.11522818.html.plaintext.txt	186	These data indicate CEBP involved enhancer activity FGC4 cells
0.22947337.11522818.html.plaintext.txt	187	View larger version 18K Figure 5
0.22947337.11522818.html.plaintext.txt	188	The CEBP site required full enhancer activity functional GRE consensus sites overlap CEBP HNF4 HNF3 sites
0.22947337.11522818.html.plaintext.txt	189	A Left FGC4 cells transfected B1E5B2 reporter plasmids either wild type bearing two different mutations CEBP binding site F1
0.22947337.11522818.html.plaintext.txt	190	An overlapping half GRE consensus site affected mutation F1m1 F1m2 mutant
0.22947337.11522818.html.plaintext.txt	191	Activity expressed relative B1E5B2
0.22947337.11522818.html.plaintext.txt	192	The means plus minus SD three F1m1 two F1m2 independent experiments shown
0.22947337.11522818.html.plaintext.txt	193	Right Same experiment except transfected cells treated Dex
0.22947337.11522818.html.plaintext.txt	194	Induction factor represents ratio CAT activity presence absence Dex
0.22947337.11522818.html.plaintext.txt	195	The means plus minus SD three B1E5B2 F1m1 two F1m2 independent experiments shown
0.22947337.11522818.html.plaintext.txt	196	B The experiment except B1E5B2 reporter plasmid mutated HNF4 consensus site F2 F2mH4
0.22947337.11522818.html.plaintext.txt	197	C The experiment except B1E5B2 reporter plasmid mutated HNF3 consensus site F3 F3mH3
0.22947337.11522818.html.plaintext.txt	198	In F2mH4 F3mH3 mutants GRE consensus sites affected
0.22947337.11522818.html.plaintext.txt	199	For F3mH3 mutant mean plus minus SD two independent experiments shown
0.22947337.11522818.html.plaintext.txt	200	F2 F3 contain HNF4 HNF3 binding sites respectively overlapping Dex responsive sequences An oligonucleotide spanning protected part F2 oligo F2 used EMSA FGC4 extract
0.22947337.11522818.html.plaintext.txt	201	Competition experiments suggested F2 binds HNF4 weakly data shown
0.22947337.11522818.html.plaintext.txt	202	To confirm HNF4 binds F2 used purified recombinant rat HNF41 labeled oligo F2 EMSA
0.22947337.11522818.html.plaintext.txt	203	Figure 6A shows complex displaced unlabeled ApoCIII oligo F2 unlabeled HNF1 site PE56
0.22947337.11522818.html.plaintext.txt	204	Moreover antibody rat HNF41 supershifted nearly complex compare lanes anti HNF4
0.22947337.11522818.html.plaintext.txt	205	This figure also shows oligo F2 binds HNF41 efficiency 60 fold lower ApoCIII
0.22947337.11522818.html.plaintext.txt	206	View larger version 47K Figure 6
0.22947337.11522818.html.plaintext.txt	207	Recombinant HNF41 binds F2 A HNF3 F3 B
0.22947337.11522818.html.plaintext.txt	208	A Labeled oligo F2 recombinant rat HNF41 0
0.22947337.11522818.html.plaintext.txt	209	7 microg incubated without minus plus anti HNF41 antibody without minus competitor oligonucleotides
0.22947337.11522818.html.plaintext.txt	210	The first lane shows migration without protein
0.22947337.11522818.html.plaintext.txt	211	For reaction antibody control 1 microl 10 fold diluted antibody PBS plus PBS alone minus added reaction mix preincubated 15 min ice
0.22947337.11522818.html.plaintext.txt	212	Incubations carried 25 min room temperature
0.22947337.11522818.html.plaintext.txt	213	Other reactions incubated ice 30 min
0.22947337.11522818.html.plaintext.txt	214	The arrowhead designates ternary complex antibody HNF4 DNA
0.22947337.11522818.html.plaintext.txt	215	Oligonucleotide amounts given nanograms
0.22947337.11522818.html.plaintext.txt	216	Protein DNA complexes indicated
0.22947337.11522818.html.plaintext.txt	217	B Labeled oligo F3 incubated without minus FGC4 nuclear extract competitor oligonucleotides
0.22947337.11522818.html.plaintext.txt	218	TTR PFK III contain binding sites HNF3 HNF6 HNF3 Oct 1 respectively whereas PFK IV Oct Ig bind HNF6 Oct 1 respectively
0.22947337.11522818.html.plaintext.txt	219	EMSA carried FGC4 extract oligonucleotide containing F3 oligo F3
0.22947337.11522818.html.plaintext.txt	220	One complex formed competed oligo F3 oligos TTR PFK III containing HNF3HNF6 3031 HNF3Oct 1 32 binding sites respectively Fig
0.22947337.11522818.html.plaintext.txt	221	6B left oligos PFK IV Oct Ig Fig
0.22947337.11522818.html.plaintext.txt	222	6B right binding HNF6 Oct 1 respectively 32
0.22947337.11522818.html.plaintext.txt	223	This shows HNF3 binds F3
0.22947337.11522818.html.plaintext.txt	224	In support functional role HNF3 binding HNF3 transactivates 700 bp enhancer co transfection experiments C33 cells data shown
0.22947337.11522818.html.plaintext.txt	225	HNF4 HNF3 consensus sites found oligos F2 F3 respectively
0.22947337.11522818.html.plaintext.txt	226	To examine functional roles sites introduced point mutations 700 bp enhancer tested resulting plasmids basal Dex induced activity FGC4 cells
0.22947337.11522818.html.plaintext.txt	227	5B caused slight reduction basal activity left significant reduction inducibility right
0.22947337.11522818.html.plaintext.txt	228	A slight reduction inducibility obtained HNF3 mutation F3 basal activity affected Fig
0.22947337.11522818.html.plaintext.txt	229	However mutations reduced abolish HNF41 HNF3 binding analyzed competition experiments EMSA data shown
0.22947337.11522818.html.plaintext.txt	230	Furthermore HNF4 consensus site included GRE consensus site affected HNF4 mutation HNF3 mutation touches half GRE consensus site
0.22947337.11522818.html.plaintext.txt	231	These data show GRE consensus sites intermingled LETF sites required maximal Dex inducibility 700 bp enhancer case CEBP site F1
0.22947337.11522818.html.plaintext.txt	232	A functional HNF1 binding site essential basal enhancer activity The 700 240 bp enhancers similarly transactivated HNF1
0.22947337.11522818.html.plaintext.txt	233	A computer search putative HNF1 binding sites 700 bp sequence using weighted matrix 44 revealed three sites high scores
0.22947337.11522818.html.plaintext.txt	234	The upstream contains DraI site three last bases consensus 15 bp replaced vector sequence cloned fragments cut DraI
0.22947337.11522818.html.plaintext.txt	235	The second HNF1 site located base pairs downstream DraI site third lies 70 bp downstream data shown
0.22947337.11522818.html.plaintext.txt	236	In DNase I footprinting experiments using purified recombinant truncated HNF1 protein HNt demonstrated two upstream consensus sites correspond authentic HNF1 binding sites BS1 BS2 respectively data shown
0.22947337.11522818.html.plaintext.txt	237	Then tested recombinant HNF1 protein EMSA using double stranded oligonucleotides containing BS1 wild type oligo BS1 mutated oligo BS1m order abolish HNF1 binding 27
0.22947337.11522818.html.plaintext.txt	238	A complex HNt labeled oligo BS1 formed competed PE56 oligo BS1 oligo BS1m Fig
0.22947337.11522818.html.plaintext.txt	239	From experiments conclude BS1 binds HNF1 efficiency 16 fold lower high affinity PE56 oligonucleotide
0.22947337.11522818.html.plaintext.txt	240	In constructs 3 deleted DraI site modified BS1 still binds HNt lower affinity data shown
0.22947337.11522818.html.plaintext.txt	241	In EMSA using FGC4 extracts third consensus BS3 proved also bind HNF1
0.22947337.11522818.html.plaintext.txt	242	View larger version 33K Figure 7
0.22947337.11522818.html.plaintext.txt	243	Recombinant HNF1 binds site 3 end 240 bp enhancer A site required HNF1 transactivation B full enhancer activity C
0.22947337.11522818.html.plaintext.txt	244	A Purified recombinant truncated rat HNF1 used 0
0.22947337.11522818.html.plaintext.txt	245	5 microg EMSA labeled oligo BS1 absence presence increasing amounts indicated ng competitor oligo PE56 BS1 BS1m mutated BS1
0.22947337.11522818.html.plaintext.txt	246	B CAT activity reporter plasmid B1E5B2 wild type mutated BS1 BS1m see text H5 co transfected HNF1
0.22947337.11522818.html.plaintext.txt	247	For mutant reporter mean plus minus SD three independent experiments shown
0.22947337.11522818.html.plaintext.txt	248	Expression vector amounts indicated
0.22947337.11522818.html.plaintext.txt	249	C CAT activity FGC4 reporter plasmid B1E5B2 wild type mutated BS1 BS1m BS1m
0.22947337.11522818.html.plaintext.txt	250	The mean plus minus SD two independent experiments shown
0.22947337.11522818.html.plaintext.txt	251	To investigate whether BS1 could mediate transactivation HNF1 used oligo BS1m mutate BS1 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	252	We obtained two mutant reporter plasmids one BS1m contains insertion two G residues within BS1 addition expected mutation
0.22947337.11522818.html.plaintext.txt	253	As shown Figure 7B H5 cells mutant plasmid exhibited low basal activity B1E5B2 reporter plasmid transactivation co transfected HNF1 severely compromised spite continued presence intact BS2 BS3 sites
0.22947337.11522818.html.plaintext.txt	254	Moreover activity mutant plasmids FGC4 strongly similarly reduced compared wild type Fig
0.22947337.11522818.html.plaintext.txt	255	These results thus show BS1 required transactivation HNF1 also enhancer activity 700 bp region differentiated hepatoma cells
0.22947337.11522818.html.plaintext.txt	256	In summary characterized several LETF binding sites Fig
0.22947337.11522818.html.plaintext.txt	257	8A within 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	258	CEBP HNF4 HNF3 binding sites located 240 bp minimal enhancer PvuII DraI whereas HNF1 binding site overlaps 3 end two HNF1 binding sites lie downstream
0.22947337.11522818.html.plaintext.txt	259	The CEBP site first BS1 HNF1 site required full basal activity
0.22947337.11522818.html.plaintext.txt	260	Several imperfect whole half GRE consensus sites found minimal enhancer Fig
0.22947337.11522818.html.plaintext.txt	261	Three overlapping LETF sites crucial maximal hormone inducibility 700 bp enhancer
0.22947337.11522818.html.plaintext.txt	262	View larger version 14K Figure 8
0.22947337.11522818.html.plaintext.txt	263	Overview 6 kb enhancer A model HNF41 regulation B
0.22947337.11522818.html.plaintext.txt	264	A A restriction map shown P PvuII B BspEI A AvaI D DraI H HpaI
0.22947337.11522818.html.plaintext.txt	265	Positions three imperfect whole five imperfect half GRE consensus sites minimal enhancer indicated
0.22947337.11522818.html.plaintext.txt	266	Protein binding sites characterized using DNase I footprinting assay EMSA FGC4 nuclear extract purified recombinant proteins represented
0.22947337.11522818.html.plaintext.txt	267	Footprints F1 F3 HNF1 binding sites LETF binding sites indicated
0.22947337.11522818.html.plaintext.txt	268	B Schematic representation showing model factors expressed could bind HNF41 6 kb enhancer promoter 14 regions resulting low expression early liver development strong regulation birth
0.22947337.11522818.html.plaintext.txt	269	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In work defined enhancer element upstream HNF41 promoter active well differentiated FGC4 rat hepatoma cells dedifferentiated variant hepatoma non hepatic cells
0.22947337.11522818.html.plaintext.txt	270	Fragments covering 5 11 kb upstream transcription start site tested upstream tk promoter full activity localized fragment 700 bp 700 bp enhancer around 6 kb corresponds HS liver kidney chromatin 1314
0.22947337.11522818.html.plaintext.txt	271	This fragment increases activity minimal HNF41 promoter HNF1 site 14 deleted
0.22947337.11522818.html.plaintext.txt	272	This result agrees requirement upstream sequences 7 kb obtain liver kidney restricted activity HNF41 promoter transgenic mice 14
0.22947337.11522818.html.plaintext.txt	273	Moreover 700 bp enhancer mediates glucocorticoid induction differentiated hepatoma cells
0.22947337.11522818.html.plaintext.txt	274	This agrees reported glucocorticoid induction HNF4 expression 1115
0.22947337.11522818.html.plaintext.txt	275	The 700 bp enhancer thus implicated physiological regulation HNF41 activity
0.22947337.11522818.html.plaintext.txt	276	The 700 bp enhancer contains 240 bp core sequence sufficient enhancer activity Dex induction within three footprints F1 F3 identified
0.22947337.11522818.html.plaintext.txt	277	CEBP binds F1 HNF4 F2 HNF3 F3
0.22947337.11522818.html.plaintext.txt	278	Finally functional HNF1 binding site 3 end core sequence
0.22947337.11522818.html.plaintext.txt	279	Figure 8A summarizes data
0.22947337.11522818.html.plaintext.txt	280	The sequence comprising minimal enhancer conserved
0.22947337.11522818.html.plaintext.txt	281	Blast analysis mouse human NCBI database accession
0.22947337.11522818.html.plaintext.txt	282	AL117382 sequences showed overall 86 identity
0.22947337.11522818.html.plaintext.txt	283	The F1 F3 HNF1 sites exhibit highest scores 90 100
0.22947337.11522818.html.plaintext.txt	284	This fact implies HNF41 enhancer important element plays similar role humans
0.22947337.11522818.html.plaintext.txt	285	The CEBP site strongest footprint enhancer
0.22947337.11522818.html.plaintext.txt	286	Its mutation significantly reduces enhancer activity cells produce CEBP implying site responds specifically binding CEBP
0.22947337.11522818.html.plaintext.txt	287	Previously proposed HNF4 regulates expression based studies stable transfectants 2442
0.22947337.11522818.html.plaintext.txt	288	Our data support direct auto regulation mechanism enhancer core sequence contains functional HNF4 response element
0.22947337.11522818.html.plaintext.txt	289	In addition HNF3 transactivates enhancer
0.22947337.11522818.html.plaintext.txt	290	However mutation HNF4 HNF3 sites small effects introduced mutations impaired binding factors partially
0.22947337.11522818.html.plaintext.txt	291	The HNF41 enhancer strongly transactivated HNF1 weakly HNF1ss
0.22947337.11522818.html.plaintext.txt	292	Transactivation HNF1 mediated weak HNF1 binding site also required high basal activity enhancer
0.22947337.11522818.html.plaintext.txt	293	A similar functional role weak HNF1 binding sites reported mouse phenylalanine hydroxylase gene enhancer 21
0.22947337.11522818.html.plaintext.txt	294	A functional HNF1 binding site HNF41 enhancer addition site described earlier promoter region 14 accords earlier reports cross regulation HNF4 HNF1 39 42
0.22947337.11522818.html.plaintext.txt	295	Based strong response HNF1 propose factor plays critical role enhancer activity
0.22947337.11522818.html.plaintext.txt	296	In agreement observations glucocorticoids shown activate HNF4 expression primary cultured rat hepatocytes 11
0.22947337.11522818.html.plaintext.txt	297	Moreover HNF41 HNF47 induced glucocorticoids murine hepatic cells 15
0.22947337.11522818.html.plaintext.txt	298	Maximal Dex induction enhancer requires F1 F3 region three imperfect GRE five imperfect half GRE consensus sites found overlapping F1 F3 footprints see Fig
0.22947337.11522818.html.plaintext.txt	299	Although competition EMSAs using GRE failed provide evidence binding GR presence GRE consensus sites responsiveness Dex imply GR binds enhancer
0.22947337.11522818.html.plaintext.txt	300	Indeed mutations introduced LETF binding sites affect GRE whole sites half sites compromised Dex induction implying sites functional
0.22947337.11522818.html.plaintext.txt	301	Moreover induction 700 bp enhancer restricted differentiated hepatoma cells implying liver specific proteins required glucocorticoid effect
0.22947337.11522818.html.plaintext.txt	302	Indeed LETF synergize GR achieve glucocorticoid induction tyrosine aminotransferase TAT 45 47 phosphoenolpyruvate carboxykinase PEPCK genes 48
0.22947337.11522818.html.plaintext.txt	303	A similar situation appears exist HNF41 enhancer
0.22947337.11522818.html.plaintext.txt	304	At first sight surprising observe major transactivators HNF41 enhancer hormone activated GR LETF expressed late development CEBP HNF1 even though known HNF4 transcripts first detected early 2
0.22947337.11522818.html.plaintext.txt	305	However probes distinguish HNF41 HNF47 isoforms used analysis early embryos
0.22947337.11522818.html.plaintext.txt	306	Recent work laboratory revealed expression HNF41 isoform strong liver end fetal life birth whereas HNF47 isoform predominant form HNF4 embryonic liver M
0.22947337.11522818.html.plaintext.txt	307	Weiss submitted publication
0.22947337.11522818.html.plaintext.txt	308	The dramatic activation HNF41 occurs birth could assured one hand CEBP whose expression also activated birth 49 glucocorticoids
0.22947337.11522818.html.plaintext.txt	309	Indeed TAT PEPCK genes like HNF41 enhancers glucocorticoid hormone response modules overlap LETF sites 46 48 strongly induced glucocorticoids birth
0.22947337.11522818.html.plaintext.txt	310	HNF41 thus expressed low levels embryonic liver
0.22947337.11522818.html.plaintext.txt	311	Binding sites HNF41 enhancer include transcription factors present developing liver
0.22947337.11522818.html.plaintext.txt	312	HNF3 ss among first LETF expressed tissue 50
0.22947337.11522818.html.plaintext.txt	313	HNF1ss known expressed HNF1 embryonic liver 45 transactivator enhancer HNF47
0.22947337.11522818.html.plaintext.txt	314	Although many studies contributed notion group LETF subject cross regulation auto regulation 458914243031343539 4251 63 first detailed study enhancer regulating expression one factors
0.22947337.11522818.html.plaintext.txt	315	Furthermore analysis concerns one first factors expressed HNF4 2
0.22947337.11522818.html.plaintext.txt	316	The results study entirely consistent observed behavior HNF4 gene vivo provide basis explain expression pattern
0.22947337.11522818.html.plaintext.txt	317	Indeed binding sites essentially LETF far identified present including factors expressed early development HNF3 ss HNF1ss HNF47 others expressed little later HNF1 particular regulated birth including CEBP HNF41 perhaps importantly activated GR
0.22947337.11522818.html.plaintext.txt	318	Consequently properties 6 kb enhancer consistent involved initiation expression HNF41 maintenance
0.22947337.11522818.html.plaintext.txt	319	Figure 8B presents model biphasic regulation HNF41 enhancer liver development
0.22947337.11522818.html.plaintext.txt	320	ACKNOWLEDGEMENTS We particularly thank Weimin Zhong James E
0.22947337.11522818.html.plaintext.txt	321	Darnell furnishing us clones plasmids starting work Gerhart Ryffel sharing unpublished data Claire Cheret Robert H
0.22947337.11522818.html.plaintext.txt	322	Costa Francois Ringeisen Frances M
0.22947337.11522818.html.plaintext.txt	323	Sladek reagents Marco Pontoglio help computer search HNF1 consensus sites
0.22947337.11522818.html.plaintext.txt	324	This work supported grants Association pour la Recherche sur le Cancer Human Frontiers Science Program RG03032000 M
0.22947337.11522818.html.plaintext.txt	325	supported fellowship CONACYT
0.22947337.11522818.html.plaintext.txt	326	FOOTNOTES To correspondence addressed
0.22947337.11522818.html.plaintext.txt	327	Tel 33 1 45 68 85 00 Fax 33 1 40 61 32 31 Email mweissatpasteur
0.22947337.11522818.html.plaintext.txt	328	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1 SladekF
0.22947337.11522818.html.plaintext.txt	329	Jr 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.22947337.11522818.html.plaintext.txt	330	Jr 1994 Expression transcription factor HNF 4 extraembryonic endoderm gut nephrogenic tissue developing mouse embryo HNF 4 marker primary endoderm implanting blastocyst
0.22947337.11522818.html.plaintext.txt	331	1994 HNF 3ss essential node notochord formation mouse development
0.22947337.11522818.html.plaintext.txt	332	1999 Variant hepatocyte nuclear factor 1 required visceral endoderm specification
0.22947337.11522818.html.plaintext.txt	333	Development 126 4795 4805
0.22947337.11522818.html.plaintext.txt	334	1999 Essential role homeoprotein vHNF1HNF1ss visceral endoderm differentiation
0.22947337.11522818.html.plaintext.txt	335	Development 126 4785 4794
0.22947337.11522818.html.plaintext.txt	336	Jr 1994 The winged helix transcription factor HNF 3ss required notochord development mouse embryo
0.22947337.11522818.html.plaintext.txt	337	Jr 1994 Disruption HNF 4 gene expressed visceral endoderm leads cell death embryonic ectoderm impaired gastrulation mouse embryos
0.22947337.11522818.html.plaintext.txt	338	1997 Murine gastrulation requires HNF 4 regulated gene expression visceral endoderm tetraploid rescue Hnf 4 embryos
0.22947337.11522818.html.plaintext.txt	339	2000 Mammalian hepatocyte differentiation requires transcription factor HNF 4
0.22947337.11522818.html.plaintext.txt	340	1997 The maturity onset diabetes young MODY1 transcription factor HNF4 regulates expression genes required glucose transport metabolism
0.22947337.11522818.html.plaintext.txt	341	2000 The gene hepatocyte nuclear factor HNF 4 activated glucocorticoids glucagon repressed insulin rat liver
0.22947337.11522818.html.plaintext.txt	342	2001 Hepatocyte nuclear factor 4
0.22947337.11522818.html.plaintext.txt	343	eds Nuclear Receptors Genetic Disease
0.22947337.11522818.html.plaintext.txt	344	Academic Press London UK pp
0.22947337.11522818.html.plaintext.txt	345	1994 Characterization mouse HNF 4 gene expression mouse embryogenesis
0.22947337.11522818.html.plaintext.txt	346	Jr 1994 Tissue specific regulation mouse hepatocyte nuclear factor 4 expression
0.22947337.11522818.html.plaintext.txt	347	1998 An alternative splice variant tissue specific transcription factor HNF4 predominates undifferentiated murine cell types
0.22947337.11522818.html.plaintext.txt	348	1990 An exogenous albumin promoter become silent dedifferentiated hepatoma variants well intertypic hybrids
0.22947337.11522818.html.plaintext.txt	349	1974 Characterization differentiated dedifferentiated clones rat hepatoma
0.22947337.11522818.html.plaintext.txt	350	1969 A quantitative comparison formation spontaneous virus produced viable hybrids
0.22947337.11522818.html.plaintext.txt	351	1964 Long term cultivation hypodiploid human tumor cells
0.22947337.11522818.html.plaintext.txt	352	1992 Reporter constructs low background activity utilizing cat gene
0.22947337.11522818.html.plaintext.txt	353	1996 The activity highly inducible mouse phenylalanine hydroxylase gene promoter dependent upon tissue specific hormone inducible enhancer
0.22947337.11522818.html.plaintext.txt	354	1990 A distal dimerization domain essential DNA binding atypical HNF1 homeodomain
0.22947337.11522818.html.plaintext.txt	355	1991 vHNF1 homeoprotein activates transcription forms heterodimers HNF1
0.22947337.11522818.html.plaintext.txt	356	1997 Hepatocyte nuclear factor 4 expression overcomes repression hepatic phenotype dedifferentiated hepatoma cells
0.22947337.11522818.html.plaintext.txt	357	1988 A simple phase extraction assay chloramphenicol acyltransferase activity
0.22947337.11522818.html.plaintext.txt	358	1987 Firefly luciferase gene structure expression mammalian cells
0.22947337.11522818.html.plaintext.txt	359	1988 A liver specific factor essential albumin transcription differs differentiated dedifferentiated rat hepatoma cells
0.22947337.11522818.html.plaintext.txt	360	1987 Factors involved control tissue specific expression albumin gene
0.22947337.11522818.html.plaintext.txt	361	1989 Multiple hepatocyte enriched nuclear factors function regulation transthyretin 1 antitrypsin genes
0.22947337.11522818.html.plaintext.txt	362	1998 Isoforms hepatocyte nuclear factor 6 differ DNA binding properties contain bifunctional homeodomain define new ONECUT class homeodomain proteins
0.22947337.11522818.html.plaintext.txt	363	1996 The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression
0.22947337.11522818.html.plaintext.txt	364	1993 Liver specific factor binding liver promoter 6 phosphofructo 2 kinasefructose 26 bisphosphatase gene
0.22947337.11522818.html.plaintext.txt	365	1992 Antagonism apolipoprotein AI regulatory protein 1 Ear3COUP TF hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression liver intestinal cells
0.22947337.11522818.html.plaintext.txt	366	1991 Tissue specific expression gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4
0.22947337.11522818.html.plaintext.txt	367	1992 A transcriptional hierarchy involved mammalian cell type specification
0.22947337.11522818.html.plaintext.txt	368	1987 Cooperativity glucocorticoid response elements located far upstream tyrosine aminotransferase gene
0.22947337.11522818.html.plaintext.txt	369	1999 Modulation transcriptional activation coactivator interaction splicing variation F domain nuclear receptor hepatocyte nuclear factor 41
0.22947337.11522818.html.plaintext.txt	370	1989 CCAATenhancer binding protein activates promoter serum albumin gene cultured hepatoma cells
0.22947337.11522818.html.plaintext.txt	371	1994 Genetic analysis transcriptional activation pathway using hepatoma cell variants
0.22947337.11522818.html.plaintext.txt	372	1997 Selective loss hepatic phenotype due absence transcriptional activation pathway
0.22947337.11522818.html.plaintext.txt	373	1997 Hepatocyte nuclear factor 4 prevents silencing hepatocyte nuclear factor 1 expression hepatoma x fibroblast cell hybrids
0.22947337.11522818.html.plaintext.txt	374	1998 Phenotypic effects forced expression HNF4 HNF1 conditioned properties recipient cell
0.22947337.11522818.html.plaintext.txt	375	1996 Liver enriched transcription factors hepatocyte differentiation
0.22947337.11522818.html.plaintext.txt	376	1997 Analysis distribution binding sites tissue specific transcription factor vertebrate genome
0.22947337.11522818.html.plaintext.txt	377	1991 Cell type specific activity two glucocorticoid responsive units rat tyrosine aminotransferase gene associated multiple binding sites CEBP novel liver specific nuclear factor
0.22947337.11522818.html.plaintext.txt	378	1993 Activation tyrosine aminotransferase gene dependent synergy liver specific hormone responsive elements
0.22947337.11522818.html.plaintext.txt	379	1995 Hepatocyte nuclear factor 3 determines amplitude glucocorticoid response rat tyrosine aminotransferase gene
0.22947337.11522818.html.plaintext.txt	380	1995 The orphan receptors COUP TF HNF 4 serve accessory factors required induction phosphoenolpyruvate carboxykinase gene transcription glucocorticoids
0.22947337.11522818.html.plaintext.txt	381	1989 Tissue specific expression developmental regulation genetic mapping gene encoding CCAATenhancer binding protein
0.22947337.11522818.html.plaintext.txt	382	1993 The formation maintenance definitive endoderm lineage mouse involvement HNF3forkhead proteins
0.22947337.11522818.html.plaintext.txt	383	Development 119 1301 1315
0.22947337.11522818.html.plaintext.txt	384	1991 CCAATenhancer binding protein gene promoter binding nuclear factors differentiation 3T3 L1 preadipocytes
0.22947337.11522818.html.plaintext.txt	385	1998 Regulation transcription factor network required differentiation metabolism
0.22947337.11522818.html.plaintext.txt	386	1993 An indirect negative autoregulatory mechanism involved hepatocyte nuclear factor 1 gene expression
0.22947337.11522818.html.plaintext.txt	387	2000 Involvement STAT5 signal transducer activator transcription 5 HNF 4 hepatocyte nuclear factor 4 transcriptional control hnf6 gene growth hormone
0.22947337.11522818.html.plaintext.txt	388	1997 HNF 6 expressed endoderm derivatives nervous system mouse embryo participates cross regulatory network liver enriched transcription factors
0.22947337.11522818.html.plaintext.txt	389	1993 Analysis rat hepatocyte nuclear factor HNF 1 gene promoter synergistic activation HNF4 HNF1 proteins
0.22947337.11522818.html.plaintext.txt	390	1992 The restricted promoter activity liver transcription factor hepatocyte nuclear factor 3ss involves cell specific factor positive autoactivation
0.22947337.11522818.html.plaintext.txt	391	1997 Hepatocyte nuclear factor 3 promoter regulation involves recognition cell specific factors thyroid transcription factor 1 autoactivation
0.22947337.11522818.html.plaintext.txt	392	1998 Hepatocyte nuclear factor 6 organization chromosomal assignment rat gene characterization promoter
0.22947337.11522818.html.plaintext.txt	393	2000 CCAATenhancer binding protein component growth hormone regulated network liver transcription factors
0.22947337.11522818.html.plaintext.txt	394	Endocrinology 141 1686 1692
0.22947337.11522818.html.plaintext.txt	395	1997 The cut homeodomain transcriptional activator HNF 6 coexpressed target gene HNF 3ss developing murine liver pancreas
0.22947337.11522818.html.plaintext.txt	396	1999 CEBP regulates generation CEBPss isoforms activation specific proteolytic cleavage
0.22947337.11522818.html.plaintext.txt	397	1993 Elements factors involved tissue specific embryonic expression liver transcription factor LFB1 Xenopus laevis
0.53388375.11435618.html.plaintext.txt	0	Maturity Onset Diabetes Young Type 1 MODY1 Associated Mutations R154X E276Q Hepatocyte Nuclear Factor 4 HNF4 Gene Impair Recruitment p300 Key Transcriptional Coactivator Jerome Eeckhoute Pierre Formstecher Bernard Laine
0.53388375.11435618.html.plaintext.txt	1	Unite 459 INSERM Laboratoire de Biologie Cellulaire Universite H
0.53388375.11435618.html.plaintext.txt	2	Warembourg Lille France F 59045
0.53388375.11435618.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Hepatocyte nuclear factor 4 HNF4 nuclear receptor involved glucose homeostasis required normal ss cell function
0.53388375.11435618.html.plaintext.txt	4	Mutations HNF4 gene associated maturity onset diabetes young type 1
0.53388375.11435618.html.plaintext.txt	5	E276Q R154X mutations previously shown impair intrinsic transcriptional activity without exogenously supplied coactivators HNF4
0.53388375.11435618.html.plaintext.txt	6	Given transcriptional partners HNF4 modulate intrinsic transcriptional activity play crucial roles HNF4 function investigated effects mutations potentiation HNF4 activity p300 key coactivator HNF4
0.53388375.11435618.html.plaintext.txt	7	We show loss HNF4 function mutations increased impaired physical interaction functional cooperation HNF4 p300
0.53388375.11435618.html.plaintext.txt	8	Impairment p300 mediated potentiation HNF4 transcriptional activity particular importance E276Q mutant since intrinsic transcriptional activity moderately affected
0.53388375.11435618.html.plaintext.txt	9	Together previous results obtained chicken ovalbumin upstream promoter transcription factor II results highlight impairment recruitment transcriptional partners represents important mechanism leading abnormal HNF4 function resulting MODY1 E276Q mutation
0.53388375.11435618.html.plaintext.txt	10	The impaired potentiations HNF4 activity observed promoter HNF1 transcription factor involved transcriptional network required ss cell function
0.53388375.11435618.html.plaintext.txt	11	Given involvement regulatory signaling cascade loss HNF4 function may cause reduced ss cell function secondary defective HNF1 expression
0.53388375.11435618.html.plaintext.txt	12	Our results also shed light better structure function relationship HNF4 p300 sequences involved interaction HNF4
0.53388375.11435618.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Hepatocyte nuclear factor 4 HNF4 transcription factor required normal early embryogenesis 1 2
0.53388375.11435618.html.plaintext.txt	14	HNF4 plays central role coordination complex transcription factor network defines hepatocyte phenotype 3 4 5 regulation normal pancreatic endocrine function 6
0.53388375.11435618.html.plaintext.txt	15	It controls expression transcription factors HNF1 HNF6 5 6 7 8 9 former required pancreatic endocrine cell function differentiation 10 11 whereas latter plays central role pancreatic endocrine differentiation precursor stage 12
0.53388375.11435618.html.plaintext.txt	16	HNF4 member hormone nuclear receptor superfamily 13
0.53388375.11435618.html.plaintext.txt	17	It modular structure comprising DNA binding domain DBD located C domain two activation function modules AF 1 residues 1 24 located A domain AF 2 residues 360 366 located E domain 14 15
0.53388375.11435618.html.plaintext.txt	18	The HNF4 AF 2 module exhibit autonomous transactivation activity requires sequence 128 366 located D E domains full activity 15
0.53388375.11435618.html.plaintext.txt	19	Protein protein interactions synergies transcription factors chicken ovalbumin upstream promoter transcription factors COUP TFs 16 nuclear transcription factor Y NPY 17 coactivators p160 family 18 19 CREB binding protein CBP 19 20 21 22 enhance transcriptional activity HNF4
0.53388375.11435618.html.plaintext.txt	20	CBP recently shown required HNF4 function acetylation HNF4 required nuclear retention CBP increases HNF4 DNA binding transcriptional activities 22
0.53388375.11435618.html.plaintext.txt	21	CBP closely related p300 protein together referred CBPp300 23 serve coactivators hormone nuclear receptors
0.53388375.11435618.html.plaintext.txt	22	CBPp300 contains three LXXLL motifs located N terminal receptor interaction domain RID near CH1 domain C terminal sequence respectively 24 scheme Fig
0.53388375.11435618.html.plaintext.txt	23	Requirement RID CBPp300 mediated activation nuclear receptors depends nuclear receptors
0.53388375.11435618.html.plaintext.txt	24	The RID initially shown interact thyroid hormone receptor TR retinoic acid receptor RAR homodimers 24 required enhance activity peroxisome proliferator activated receptor PPAR retinoid X receptor RXR heterodimer 25 dispensable enhanced transactivation TR RXR RAR RXR heterodimers 26 27
0.53388375.11435618.html.plaintext.txt	25	CBPp300 mediated transcriptional potentiation activities two latter heterodimers requires steroid receptor coactivator 1 SRC 1 26
0.53388375.11435618.html.plaintext.txt	26	On hand CBP mediated activation HNF4 acts homodimer 28 require SRC 1 21
0.53388375.11435618.html.plaintext.txt	27	The N terminal third CBP sequence 1 771 forms much stronger complex full length HNF4 C terminus 21
0.53388375.11435618.html.plaintext.txt	28	Regions HNF4 interacting CBP mapped AF 1 sequence required full activity AF 2 amino acids aa 128 366 21
0.53388375.11435618.html.plaintext.txt	29	For convenience latter sequence named D E domains hereafter
0.53388375.11435618.html.plaintext.txt	30	View larger version 20K Figure 1
0.53388375.11435618.html.plaintext.txt	31	Effect R154X Mutation Functional Cooperation Physical Interaction HNF4 p300
0.53388375.11435618.html.plaintext.txt	32	A Transactivation activity R154X HEK 293T cells transfected 1 microg HNF1 promoter 50 ng HNF4 expression vectors
0.53388375.11435618.html.plaintext.txt	33	Fold induction refers activity HNF4 derivative
0.53388375.11435618.html.plaintext.txt	34	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	35	B Enhancement HNF4 transcriptional activity p300 HNF1 promoter
0.53388375.11435618.html.plaintext.txt	36	Cells transfected A along 500 ng pCMVss p300 empty expression vector
0.53388375.11435618.html.plaintext.txt	37	For convenience activities promoter presence HNF42 alone R154X alone set 100 better visualize difference potentiation p300
0.53388375.11435618.html.plaintext.txt	38	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	39	Value statistically different observed wild type HNF4 P 0
0.53388375.11435618.html.plaintext.txt	40	C Schematic representation p300 coactivator three GST p300 chimeras GST p3001 595 GST p3001 340 GST p300340 528 used pull experiments
0.53388375.11435618.html.plaintext.txt	41	RID CH stand receptor interaction domain cysteinehistidine rich domain respectively circles represent LXXLL motifs
0.53388375.11435618.html.plaintext.txt	42	D Physical interaction R154X p300
0.53388375.11435618.html.plaintext.txt	43	35Smethionine labeled HNF42 R154X incubated GST GST p300 proteins depicted panel C immobilized glutathione Sepharose 4B beads
0.53388375.11435618.html.plaintext.txt	44	HNF4 proteins retained beads extensive washing analyzed SDS PAGE PhosphorImager
0.53388375.11435618.html.plaintext.txt	45	Shown PhosphorImage graph representing means plus minus SD R154X binding relative wild type HNF4 two independent experiments performed duplicate
0.53388375.11435618.html.plaintext.txt	46	Inputs 10 vitro synthesized proteins used incubation taken account binding quantification
0.53388375.11435618.html.plaintext.txt	47	To better visualize faint bands corresponding R154X intensity bottom part PhosphorImage enhanced
0.53388375.11435618.html.plaintext.txt	48	The GST proteins used experiments visualized Coomassie blue stained SDS polyacrylamide gel inset frame
0.53388375.11435618.html.plaintext.txt	49	HNF4 involved glucose homeostasis loss HNF4 function results decreased expression genes involved glucose transport metabolism 6 29 insulin secretion 6
0.53388375.11435618.html.plaintext.txt	50	Mutations HNF4 gene associated type 1 maturity onset diabetes young MODY1 monogenic form diabetes characterized abnormal pancreatic ss cell function 30
0.53388375.11435618.html.plaintext.txt	51	Studies functional properties several MODY1 associated mutations HNF4 shown mutations variable effects ability HNF4 transactivate reporter gene 29 31 32 33 34 35 36 37
0.53388375.11435618.html.plaintext.txt	52	We previously shown mutations E276Q R154X impair HNF4 functions
0.53388375.11435618.html.plaintext.txt	53	Mutation E276Q affects interaction synergy COUP TFII enhances HNF4 activity HNF1 promoter 33
0.53388375.11435618.html.plaintext.txt	54	Mutation R154X decreases transcriptional activity HNF4 decrease pronounced pancreatic ss cells compared non ss cells
0.53388375.11435618.html.plaintext.txt	55	In addition former cells R154X exhibits slight dominant negative behavior 36
0.53388375.11435618.html.plaintext.txt	56	HNF4 R154X intact AF 1 DNA binding domains lacks E domain involved interaction CBPp300
0.53388375.11435618.html.plaintext.txt	57	The E276Q mutation located E domain
0.53388375.11435618.html.plaintext.txt	58	Taking account crucial role CBPp300 investigated effects two mutations physical interaction functional cooperation HNF4 p300
0.53388375.11435618.html.plaintext.txt	59	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Effect R154X Mutation p300 Recruitment HNF4 We previously shown R154X mutation resulted strong impairment HNF4 transcriptional activity several promoters various cell lines
0.53388375.11435618.html.plaintext.txt	60	Interestingly transcriptional activity R154X remained equal one third wild type HNF4 HNF1 promoter HEK 293T cells Ref
0.53388375.11435618.html.plaintext.txt	61	We investigated whether low transcriptional activity could enhanced coactivator p300
0.53388375.11435618.html.plaintext.txt	62	Cotransfection p300 HNF42 increased HNF1 promoter activity 3
0.53388375.11435618.html.plaintext.txt	63	8 fold activation HNF42 alone Fig
0.53388375.11435618.html.plaintext.txt	64	Coexpression p300 R154X stimulated HNF1 promoter activity 2
0.53388375.11435618.html.plaintext.txt	65	3 fold activation R154X alone Fig
0.53388375.11435618.html.plaintext.txt	66	Transfection p300 absence transfected HNF4 increase activity HNF1 promoter HEK 293T cells data shown indicating effect p300 mediated HNF4
0.53388375.11435618.html.plaintext.txt	67	These results led us compare interactions wild type mutated HNF4 p300 pull assays using three glutathione S transferase GST p3001 595 GST p3001 340 GST p300340 528 chimeras
0.53388375.11435618.html.plaintext.txt	68	GST p3001 595 contains two LXXLL motifs located receptor interaction domain RID near CH1 domain respectively whereas GST p3001 340 GST p300340 528 contain one LXXLL motifs Fig
0.53388375.11435618.html.plaintext.txt	69	HNF42 R154X retained p300NOREF1 595 p30040 528 fragments Fig
0.53388375.11435618.html.plaintext.txt	70	Nevertheless quantification intensities bands indicated compared wild type HNF42 R154X bound three times less efficiently two p300 fragments Fig
0.53388375.11435618.html.plaintext.txt	71	The specificity complexes ascertained inability GST alone bind HNF42 R154X Fig
0.53388375.11435618.html.plaintext.txt	72	HNF42 R154X bound p3001 340 fragment Fig
0.53388375.11435618.html.plaintext.txt	73	1D lanes 7 8 although GST p3001 340 readily expressed Fig
0.53388375.11435618.html.plaintext.txt	74	A chimera comprising two copies HNF4 AF 1 module fused GAL4 DBD shown interact fragment 1 771 CBP 14
0.53388375.11435618.html.plaintext.txt	75	R154X binding p300 likely mediated AF 1 module located sequence 1 24 since shown HNF4 fragment spanning residues 45 142 interact CBP 21
0.53388375.11435618.html.plaintext.txt	76	To ascertain hypothesis mutation F19D abolishes transcriptional activity AF 1 module 14 introduced R154X
0.53388375.11435618.html.plaintext.txt	77	This amino acid residue located within sequence aa 13 24 involved interaction HNF4 AF 1 CBP 14
0.53388375.11435618.html.plaintext.txt	78	2A show mutation F19D strongly impaired transactivation activity R154X
0.53388375.11435618.html.plaintext.txt	79	The drop R154X F19D activity due decreased expression Fig
0.53388375.11435618.html.plaintext.txt	80	In addition R154X F19D activity poorly enhanced p300 activity enhanced 1
0.53388375.11435618.html.plaintext.txt	81	17 fold whereas R154X enhanced 2
0.53388375.11435618.html.plaintext.txt	82	By pull experiments observed F19D mutation nearly abolished interaction R154X p300 Fig
0.53388375.11435618.html.plaintext.txt	83	These results confirm AF 1 involved R154X transcriptional activity potentiation latter p300
0.53388375.11435618.html.plaintext.txt	84	View larger version 28K Figure 2
0.53388375.11435618.html.plaintext.txt	85	R154X Activities Are Markedly Decreased Mutation AF 1 Module
0.53388375.11435618.html.plaintext.txt	86	A HEK 293T cells transfected Fig
0.53388375.11435618.html.plaintext.txt	87	1A indicated HNF4 expression vectors
0.53388375.11435618.html.plaintext.txt	88	Fold induction R154X F19D expressed percentage relative R154X
0.53388375.11435618.html.plaintext.txt	89	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	90	Denotes significant difference P 0
0.53388375.11435618.html.plaintext.txt	91	Inset Control protein expression
0.53388375.11435618.html.plaintext.txt	92	B Enhancement R154X activity p300 impaired mutation AF 1 module
0.53388375.11435618.html.plaintext.txt	93	HEK 293T cells transfected A together 0
0.53388375.11435618.html.plaintext.txt	94	5 microg p300 empty expression vector
0.53388375.11435618.html.plaintext.txt	95	For convenience activities promoter presence R154X alone R154X F19D alone set 100 better visualize difference fold enhancement p300
0.53388375.11435618.html.plaintext.txt	96	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	97	Denotes significant difference P 0
0.53388375.11435618.html.plaintext.txt	98	C Physical interactions 35S methionine labeled R154X R154X F19D GST p300340 528 immobilized glutathione Sepharose beads
0.53388375.11435618.html.plaintext.txt	99	HNF4 mutants retained beads extensive washing analyzed SDS PAGE PhosphorImager
0.53388375.11435618.html.plaintext.txt	100	Shown PhosphorImage graph representing means plus minus SD R154X F19D binding relative R154X two independent experiments performed duplicate
0.53388375.11435618.html.plaintext.txt	101	Inputs 5 vitro synthesized proteins used incubation taken account binding quantification
0.53388375.11435618.html.plaintext.txt	102	Next introduced F19D mutation full length HNF4 investigate AF 1 contribution toward potentiation full length HNF4 activity p300
0.53388375.11435618.html.plaintext.txt	103	F19D mutation resulted drop 50 transactivation activity HNF42 Fig
0.53388375.11435618.html.plaintext.txt	104	Conversely F19D mutation alter p300 mediated enhancement HNF42 transcriptional activity Fig
0.53388375.11435618.html.plaintext.txt	105	3B despite decrease interaction p300340 528 Fig
0.53388375.11435618.html.plaintext.txt	106	These results show AF 1 required full intrinsic activity HNF4 without exogenously supplied coactivators exhibits secondary role p300 mediated potentiation transcription factor
0.53388375.11435618.html.plaintext.txt	107	View larger version 30K Figure 3
0.53388375.11435618.html.plaintext.txt	108	Contribution HNF42 AF 1 p300 Recruitment
0.53388375.11435618.html.plaintext.txt	109	A HEK 293T cells transfected Fig
0.53388375.11435618.html.plaintext.txt	110	1A HNF42 WT HNF42 F19D F19D expression vectors
0.53388375.11435618.html.plaintext.txt	111	Fold induction HNF42 F19D expressed percentage relative HNF42
0.53388375.11435618.html.plaintext.txt	112	Denotes significant difference P 0
0.53388375.11435618.html.plaintext.txt	113	01 compared wild type HNF4 value
0.53388375.11435618.html.plaintext.txt	114	Inset control protein expression
0.53388375.11435618.html.plaintext.txt	115	B HEK 293T cells transfected panel A together 0
0.53388375.11435618.html.plaintext.txt	116	5 microg p300 empty expression vector
0.53388375.11435618.html.plaintext.txt	117	For convenience activities promoter presence HNF42 alone HNF42 F19D alone set 100 better visualize difference fold enhancement p300
0.53388375.11435618.html.plaintext.txt	118	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	119	C Physical interactions 35Smethionine labeled HNF42 HNF42 F19D GST p300340 528 immobilized glutathione Sepharose beads
0.53388375.11435618.html.plaintext.txt	120	HNF4 proteins retained beads extensive washing analyzed SDS PAGE PhosphorImager
0.53388375.11435618.html.plaintext.txt	121	Shown PhosphorImage graph representing means plus minus SD HNF42 F19D binding relative wild type HNF42 three independent experiments performed duplicate
0.53388375.11435618.html.plaintext.txt	122	Inputs 10 vitro synthesized proteins used incubation taken account binding quantification
0.53388375.11435618.html.plaintext.txt	123	Effect E276Q Mutation p300 Recruitment HNF4 In HEK 293T cells HNF42 HNF42 E276Q expressed levels Fig
0.53388375.11435618.html.plaintext.txt	124	4A inset exhibited similar transactivation activities HNF1 promoter Fig
0.53388375.11435618.html.plaintext.txt	125	On hand p300 mediated enhancement activities markedly different much higher HNF42 E276Q mutant Fig
0.53388375.11435618.html.plaintext.txt	126	4B thus demonstrating E276Q mutation impairs cooperation HNF4 p300
0.53388375.11435618.html.plaintext.txt	127	We investigated whether impairment could correlated decrease physical interaction HNF4 coactivator pull experiments
0.53388375.11435618.html.plaintext.txt	128	In experiments used GST p3001 595 GST p300340 528 GST p3001 340 could bind HNF4 see Fig
0.53388375.11435618.html.plaintext.txt	129	We previously shown wild type E276Q HNF42 bind GST 33
0.53388375.11435618.html.plaintext.txt	130	The E276Q mutation significantly impaired HNF4 p300 interaction evidenced GST p3001 595 GST p300340 528 proteins Fig
0.53388375.11435618.html.plaintext.txt	131	View larger version 22K Figure 4
0.53388375.11435618.html.plaintext.txt	132	Effect E276Q Mutation Functional Cooperation Physical Interaction HNF42 p300
0.53388375.11435618.html.plaintext.txt	133	A Transactivation activity E276Q HEK 293T cells transfected Fig
0.53388375.11435618.html.plaintext.txt	134	Fold induction refers activity HNF4 derivative
0.53388375.11435618.html.plaintext.txt	135	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	136	Inset Control protein expression
0.53388375.11435618.html.plaintext.txt	137	B Enhancement HNF4 transcriptional activity p300 HNF1 promoter
0.53388375.11435618.html.plaintext.txt	138	Cells transfected panel A along 500 ng pCMVss p300 empty control vector
0.53388375.11435618.html.plaintext.txt	139	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	140	Denotes significant difference P 0
0.53388375.11435618.html.plaintext.txt	141	001 compared wild type HNF4 value
0.53388375.11435618.html.plaintext.txt	142	C Pull assays carried Fig
0.53388375.11435618.html.plaintext.txt	143	1D using 35Smethionine labeled HNF42 E276Q mutant analyze interactions GST p3001 595 GST p300340 528
0.53388375.11435618.html.plaintext.txt	144	Shown PhosphorImage graph representing means plus minus SD E276Q binding relative wild type HNF4 two independent experiments performed duplicate
0.53388375.11435618.html.plaintext.txt	145	Inputs 10 vitro synthesized proteins used incubation taken account binding quantification
0.53388375.11435618.html.plaintext.txt	146	The E276Q Mutation Affects Cooperation p300 D E Domains Required Full Activity HNF4 AF 2 Activation Function The HNF4 AF 2 activation function exhibit autonomous transcriptional activity requires sequence spanning residues 128 366 full activity 15
0.53388375.11435618.html.plaintext.txt	147	The E276Q mutation located within sequence encompasses HNF4 D E domains
0.53388375.11435618.html.plaintext.txt	148	We therefore investigated effect E276Q mutation activity D E domains
0.53388375.11435618.html.plaintext.txt	149	To end wild type mutated HNF4 fragments spanning sequence 128 369 fused GAL4 DBD expressed
0.53388375.11435618.html.plaintext.txt	150	These chimeras correspond GAL4 HNF4128 369 GAL4 HNF4128 369 E276Q denoted WT E276Q respectively Fig
0.53388375.11435618.html.plaintext.txt	151	In HEK 293T cells p300 alone elicited 3 fold activation UAS2xtk promoter containing two GAL4 response elements UAS Fig
0.53388375.11435618.html.plaintext.txt	152	GAL4 HNF4128 369 GAL4 HNF4128 369 E276Q exhibited indistinguishable activities promoter p300 cotransfected Fig
0.53388375.11435618.html.plaintext.txt	153	On hand cotransfection p300 resulted greater enhancement activity GAL4 HNF4128 369 GAL4 HNF4128 369 E276Q Fig
0.53388375.11435618.html.plaintext.txt	154	These experiments also carried Hela cells p300 mediated enhancement HNF4 activity previously documented 21
0.53388375.11435618.html.plaintext.txt	155	Again cells transactivation activities GAL4 HNF4128 369 GAL4 HNF4128 369 E276Q similar p300 cotransfected Fig
0.53388375.11435618.html.plaintext.txt	156	5B lanes c e cotransfection p300 resulted higher enhancement activity GAL4 HNF4128 369 GAL4 HNF4128 369 E276Q Fig
0.53388375.11435618.html.plaintext.txt	157	Therefore cell lines E276Q mutation markedly impaired cooperation p300 HNF4 D E domains
0.53388375.11435618.html.plaintext.txt	158	This impairment correlated decrease physical interaction p300 HNF4 D E domains evidenced pull assays Fig
0.53388375.11435618.html.plaintext.txt	159	View larger version 16K Figure 5
0.53388375.11435618.html.plaintext.txt	160	E276Q Mutation Affects Functional Cooperation Physical Interaction HNF4 D E Domains p300
0.53388375.11435618.html.plaintext.txt	161	HEK 293T cells A HeLa cells B transfected 500 ng UAS2x tk Luc 100 ng pCMVss p300 empty expression vector
0.53388375.11435618.html.plaintext.txt	162	In columns b cells cotransfected 50 ng empty pGAP vector whereas columns c f cells cotransfected 50 ng pGAP HNF4128 369 E276Q mutant denoted WT E276Q respectively
0.53388375.11435618.html.plaintext.txt	163	Numbers bars indicate activities promoter relative added p300 HNF4 derivatives lane
0.53388375.11435618.html.plaintext.txt	164	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	165	Denotes significant difference P 0
0.53388375.11435618.html.plaintext.txt	166	01 compared value obtained wild type HNF4 derivative presence p300
0.53388375.11435618.html.plaintext.txt	167	C Pull assays carried Fig
0.53388375.11435618.html.plaintext.txt	168	1D using 35Smethionine labeled GAL4 HNF4128 369 E276Q mutant incubated GST p3001 595 GST p300340 528
0.53388375.11435618.html.plaintext.txt	169	Shown PhosphorImage graph representing means plus minus SD GAL4 HNF4128 369 E276Q binding relative GAL4 HNF4128 369 two independent experiments performed duplicate
0.53388375.11435618.html.plaintext.txt	170	Inputs 10 vitro synthesized proteins used incubation taken account binding quantification
0.53388375.11435618.html.plaintext.txt	171	Mapping Sequences p300 Required Interaction HNF4 In course work observed HNF4 bound efficiently GST p3001 595 GST p300340 528 GST p3001 340 Fig
0.53388375.11435618.html.plaintext.txt	172	To determine precisely sequence p300 required interaction HNF4 compared abilities GST p300340 528 GST p300355 528 interact wild type HNF4
0.53388375.11435618.html.plaintext.txt	173	In experiment also analyzed binding R154X GAL4 HNF4128 369 contain one activation function modules AF 1 AF 2 respectively
0.53388375.11435618.html.plaintext.txt	174	Removal 15 amino acid residues N terminus p300340 528 fragment resulted dramatic decrease interaction full length HNF4 GAL4 HNF4128 369 Fig
0.53388375.11435618.html.plaintext.txt	175	6A lanes 3 9 compared lanes 2 8 respectively affect binding R154X lanes 5 6 Fig
0.53388375.11435618.html.plaintext.txt	176	The faint bands full length HNF4 GAL4 HNF4128 369 retained GST p300355 528 due low expression latter protein Fig
0.53388375.11435618.html.plaintext.txt	177	These results indicate p300 sequence 340 354 required efficient binding full length HNF4 HNF4128 369 dispensable binding R154X
0.53388375.11435618.html.plaintext.txt	178	To confirm role sequence p300 recruitment HNF4 functional context ex vivo tested whether p300302 443 fragment Fig
0.53388375.11435618.html.plaintext.txt	179	6B containing sequence 340 354 lacking domain involved histone acetyltransferase HAT activity dominant negative effect cooperation p300 HNF4
0.53388375.11435618.html.plaintext.txt	180	In assay fragment p300355 443 Fig
0.53388375.11435618.html.plaintext.txt	181	When cotransfected HNF4 full length p300 fragment p300302 443 exhibited dominant negative effect observed fragment p300355 443 Fig
0.53388375.11435618.html.plaintext.txt	182	Taken together results vitro protein protein interaction ex vivo transactivation experiments obviously demonstrated involvement sequence 340 354 p300 potentiation HNF4 activity
0.53388375.11435618.html.plaintext.txt	183	View larger version 20K Figure 6
0.53388375.11435618.html.plaintext.txt	184	The Sequence 340 354 p300 Is Involved Recruitment This Coactivator HNF4
0.53388375.11435618.html.plaintext.txt	185	A Pull assays carried Fig
0.53388375.11435618.html.plaintext.txt	186	1D using 35Smethionine labeled HNF42 left R154X middle GAL4 HNF4128 369 right either GST p300340 528 GST p300355 528
0.53388375.11435618.html.plaintext.txt	187	Due weak binding R154X GST p300 fragments see Fig
0.53388375.11435618.html.plaintext.txt	188	1D larger amount 8 microl vs
0.53388375.11435618.html.plaintext.txt	189	5 microl labeled R154X used better visualize bands
0.53388375.11435618.html.plaintext.txt	190	The GST proteins used experiments visualized Coomassie blue stained SDS polyacrylamide gel inset
0.53388375.11435618.html.plaintext.txt	191	B Schematic representation p300 fragments used panel C
0.53388375.11435618.html.plaintext.txt	192	The LXXLL motif position 342 346 depicted circle
0.53388375.11435618.html.plaintext.txt	193	C HEK 293T cells transfected wild type HNF42 HNF1 promoter Fig
0.53388375.11435618.html.plaintext.txt	194	1A along indicated p300 expression vectors
0.53388375.11435618.html.plaintext.txt	195	Results means plus minus SD three independent experiments performed triplicate
0.53388375.11435618.html.plaintext.txt	196	Denotes significant difference P 0
0.53388375.11435618.html.plaintext.txt	197	05 compared value obtained full length p300 alone
0.53388375.11435618.html.plaintext.txt	198	It previously documented interaction CBP 1 771 fragment HNF4 AF 2 independent 21
0.53388375.11435618.html.plaintext.txt	199	6A indicated p300 340 354 efficiently interacted HNF4 constructs containing AF 2 module full length HNF4 HNF4128 369 interact R154X lacking AF 2
0.53388375.11435618.html.plaintext.txt	200	The presence LXXLL motif within p300 sequence 340 354 position 342 346 involvement LXXLL motifs interaction coactivators AF 2 modules nuclear receptors 27 led us reevaluate role HNF4 AF 2 module binding p300340 528
0.53388375.11435618.html.plaintext.txt	201	To aim compared binding GST p300340 528 HNF4 F HNF4 AF 2 differ lack AF 2 latter Fig
0.53388375.11435618.html.plaintext.txt	202	Deletion AF 2 resulted significant decrease binding p300340 528 Fig
0.53388375.11435618.html.plaintext.txt	203	7B thus demonstrating crucial role HNF4 AF 2 binding p300 fragment
0.53388375.11435618.html.plaintext.txt	204	View larger version 29K Figure 7
0.53388375.11435618.html.plaintext.txt	205	Involvement HNF4 AF 2 Interaction p300340 528 Fragment
0.53388375.11435618.html.plaintext.txt	206	A Schematic representation HNF4 F HNF4 AF 2 constructs
0.53388375.11435618.html.plaintext.txt	207	B Pull assays carried Fig
0.53388375.11435618.html.plaintext.txt	208	1D using 35Smethionine labeled HNF4 F HNF4 AF 2 depicted panel A GST p300340 528
0.53388375.11435618.html.plaintext.txt	209	Shown PhosphorImage graph representing means plus minus SD HNF4 AF 2 binding relative HNF4 F three independent experiments performed duplicate
0.53388375.11435618.html.plaintext.txt	210	Inputs 10 vitro synthesized proteins used incubation taken account binding quantification
0.53388375.11435618.html.plaintext.txt	211	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Our results showed MODY1 associated mutations R154X E276Q HNF4 gene impair functional cooperation physical interaction HNF4 p300
0.53388375.11435618.html.plaintext.txt	212	In case R154X mutant impairment ascribed lack AF 2 plays crucial role recruitment p300 discussed
0.53388375.11435618.html.plaintext.txt	213	In case E276Q mutant impairment ascribed alteration interaction cooperation p300 D E domains required full activity HNF4 AF 2 activation function
0.53388375.11435618.html.plaintext.txt	214	Impairment p300 mediated potentiation HNF4 transcriptional activity particular importance E276Q mutant intrinsic transcriptional activity without exogenously supplied coactivators moderately affected 33 35 comparison R154X mutant 35 36
0.53388375.11435618.html.plaintext.txt	215	Another MODY1 associated HNF4 mutant R127W shown recently effect p300 mediated enhancement HNF4 activity 37
0.53388375.11435618.html.plaintext.txt	216	The localization mutation HNF4 DBD aa 50 142 interact CBPp300 21 may account lack change CBPp300 recruitment
0.53388375.11435618.html.plaintext.txt	217	Many authors study interaction cooperation nuclear receptors coactivators assume act synergistically combined effects enhancement transcription target promoter higher sum individual effects
0.53388375.11435618.html.plaintext.txt	218	Nevertheless cannot rule models interaction may involved p300 recruitment HNF4
0.53388375.11435618.html.plaintext.txt	219	Whatever mechanism involved interaction results clearly showed recruitment p300 shown essential transcription HNF4 impaired studied HNF4 mutations
0.53388375.11435618.html.plaintext.txt	220	The ability CBPp300 interact HNF4 AF 1 context chimera GAL4 AF 12x shown previously 14
0.53388375.11435618.html.plaintext.txt	221	CBPp300 interacts HNF4 fragments 1 128 21 1 153 present work contain AF 1
0.53388375.11435618.html.plaintext.txt	222	Our results showing significant decreases interaction cooperation R154X p300 mutation F19D indicate unambiguously AF 1 actually involved p300 recruitment truncated HNF4
0.53388375.11435618.html.plaintext.txt	223	In addition results extend findings demonstrating first time HNF4 AF 1 activity enhanced p300
0.53388375.11435618.html.plaintext.txt	224	Mutation F19D resulted 50 decrease full length HNF42 activity despite presence AF 2 result consistent Green et al
0.53388375.11435618.html.plaintext.txt	225	14 confirms crucial role AF 1 transcriptional activity full length HNF4
0.53388375.11435618.html.plaintext.txt	226	The AF 1 role full length HNF4 activity depend p300 recruitment since F19D mutation alter p300 mediated enhancement full length HNF4 transcriptional activity
0.53388375.11435618.html.plaintext.txt	227	This result fits obtained Dell Hadzopoulou Cladaras 21 using complete deletion AF 1
0.53388375.11435618.html.plaintext.txt	228	It appears therefore even p300 mediated potentiation truncated HNF4 lacking AF 2
0.53388375.11435618.html.plaintext.txt	229	R154X exerted AF 1 p300 mediated potentiation HNF4 proteins containing AF 2 exerted mainly latter activation function
0.53388375.11435618.html.plaintext.txt	230	This suggests context full length HNF4 p300 mediated enhancement AF 2 activity strong enough compensate decrease cooperation p300 AF 1 F19D mutation
0.53388375.11435618.html.plaintext.txt	231	This hypothesis supported drop 60 cooperation p300 full length HNF4 due E276Q mutation located D E domains required full activity AF 2
0.53388375.11435618.html.plaintext.txt	232	The role AF 1 CBPp300 action much crucial nuclear receptors HNF4
0.53388375.11435618.html.plaintext.txt	233	Indeed CBPp300 mediated potentiation AF 1 plays major role transcriptional activities androgen receptor estrogen receptor estrogen receptor ss since mutations AF 1 cause reductions ligand induced functional synergism AF 1 AF 2 mediated CBPp300 38 39
0.53388375.11435618.html.plaintext.txt	234	Previous mapping CBP sequences interacting full length truncated HNF4 used either CBP fragment spanning sequence 271 451 20 corresponding sequence 251 436 p300 23 CBP fragment spanning sequence 1 771 14 21
0.53388375.11435618.html.plaintext.txt	235	We shown p300 sequence 340 528 sufficient binding full length HNF4 well HNF4 fragments encompassing sequences 1 153 128 369 containing AF 1 AF 2 respectively
0.53388375.11435618.html.plaintext.txt	236	Interestingly observed within p300 fragment spanning residues 340 528 sequence 340 354 contains LXXLL motif required efficient interaction full length HNF4 HNF4128 369 fragment containing AF 2
0.53388375.11435618.html.plaintext.txt	237	Our results thus allow precise mapping sequences p300 involved interaction HNF4
0.53388375.11435618.html.plaintext.txt	238	We observed HNF4 AF 2 plays crucial role interaction p300340 528 fragment whereas Dell Hadzopoulou Cladaras shown interaction CBP1 771 fragment HNF4 AF 2 independent 21 referred AF 2 AD reference
0.53388375.11435618.html.plaintext.txt	239	This discrepancy due presence RID CBP1 771 fragment since results Yoshida et al
0.53388375.11435618.html.plaintext.txt	240	20 showed RID dispensable interaction CBPp300 HNF4
0.53388375.11435618.html.plaintext.txt	241	Nevertheless cannot exclude slight difference behavior CBP p300 despite close structures 23
0.53388375.11435618.html.plaintext.txt	242	Cooperation HNF4 transcription factors coactivators crucial HNF4 mediated transcriptional activation 16 17 18 40 41 42 43 44
0.53388375.11435618.html.plaintext.txt	243	Some transcriptional partners interact directly HNF4 16 17 18 44
0.53388375.11435618.html.plaintext.txt	244	In addition alteration p300 recruitment R154X E276Q mutations previously shown alteration synergy transcription factor COUP TFII E276Q mutation strongly impairs HNF4 function 33
0.53388375.11435618.html.plaintext.txt	245	Alteration recruitments probably occurs HNF4 partners since R154X E276Q mutations also impair vitro interaction GRIP 1 glucocorticoid receptor interacting protein 1 coactivator J
0.53388375.11435618.html.plaintext.txt	246	Eeckhoute unpublished results
0.53388375.11435618.html.plaintext.txt	247	Therefore results emphasize impairment recruitment transcriptional partners MODY1 associated HNF4 mutations likely represents key mechanism leading HNF4 loss function
0.53388375.11435618.html.plaintext.txt	248	The impairment p300 mediated enhancement HNF4 activity MODY1 mutations observed HNF1 promoter
0.53388375.11435618.html.plaintext.txt	249	HNF1 essential insulin gene transcription also regulates expression genes involved glucose transport metabolism insulin secretion 11
0.53388375.11435618.html.plaintext.txt	250	In addition loss HNF1 function results defective insulin secretion responses glucose 10 11 mutations HNF1 gene associated another form MODY MODY3 45
0.53388375.11435618.html.plaintext.txt	251	Interestingly patients MODY1 MODY3 exhibit similar clinical profiles 46
0.53388375.11435618.html.plaintext.txt	252	Also recent results showed phenotype gene expression patterns INS 1 ss cells expressing dominant negative HNF4 strikingly similar INS 1 ss cells expressing dominant negative HNF1 6 led authors suggest loss HNF4 function may cause abnormal ss cell function secondary defective HNF1 function
0.53388375.11435618.html.plaintext.txt	253	Therefore impairment R154X E276Q mutations p300 recruitment leading reduced activity HNF1 promoter major interest
0.53388375.11435618.html.plaintext.txt	254	Nevertheless MODY1 associated HNF4 mutations studies needed link mechanistic information comprehension ss cell dysfunction MODY1 physiopathology
0.53388375.11435618.html.plaintext.txt	255	Indeed whatever mechanisms underlying HNF4 loss function either deletion AF 2 activation function Q268X R154X mutations impaired recruitment HNF4 partners COUP TF p300 E276Q mutation scientific community still unable explain clearly HNF4 mutations lead ss cell abnormal function development diabetes
0.53388375.11435618.html.plaintext.txt	256	These mutations well mutations HNF1 gene supposed cause haploinsufficiency reduced gene dosage 35 47 since result proteins exhibiting dominant negative activities wild type protein expressed unaffected allele except slight dominant negative behavior R154X HIT T15 cells 36
0.53388375.11435618.html.plaintext.txt	257	Strikingly although Q268X exhibits complete lack transcriptional activity expression ss cells result deficient insulin secretion 6
0.53388375.11435618.html.plaintext.txt	258	Furthermore huge variability clinical characteristics patients MODY1 diabetes suggests existence factors environmental genetic influencing phenotype MODY1 patients 46
0.53388375.11435618.html.plaintext.txt	259	Advances clinical studies cell biology Langerhans islets together functional studies HNF4 mutants clearly required better understanding physiopathology MODY1 diabetes
0.53388375.11435618.html.plaintext.txt	260	The present work exploring mechanisms mutations E276Q R154X could affect function HNF4 represents one contribution achieve goal
0.53388375.11435618.html.plaintext.txt	261	This work also sheds new light crucial roles played glutamic acid residue position 276 AF 2 activation function module recruitment p300 coactivator therefore structure function relationship nuclear receptor
0.53388375.11435618.html.plaintext.txt	262	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES DNA Constructs Wild type human HNF42 mutants E276Q F AF 2 cloned expression vector pcDNA3 described previously 33 36 48
0.53388375.11435618.html.plaintext.txt	263	The wild type R154X human HNF42 cloned vector pcDNA3
0.53388375.11435618.html.plaintext.txt	264	Plasmids pcDNA3 HNF42 F19D pcDNA3
0.53388375.11435618.html.plaintext.txt	265	1HisB HNF4 R154X F19D cloned using QuikChange site directed mutagenesis kit Stratagene La Jolla CA primers spanning nucleotides 42 78 taking A ATG initiation methionine position 1 mutations TG TA positions 55 56 respectively
0.53388375.11435618.html.plaintext.txt	266	The plasmids pCMVss NHA p300 pCMVss control vector pCMVmycNLS p300302 443 pCMVmycNLS p300355 443 pGEX2TK p3001 595 p3001 340 p300340 528 p300355 528 generous gifts Dr
0.53388375.11435618.html.plaintext.txt	267	The pGAP HNF4128 369 vector expressing wild type HNF4128 369 fused GAL4 DBD aa 1 147 corresponds plasmid GAL AF 2 described Ref
0.53388375.11435618.html.plaintext.txt	268	48 name modified comply AF 2 terminology restricted highly conserved module helix 12 nuclear receptors
0.53388375.11435618.html.plaintext.txt	269	The plasmid pGAP HNF4128 369 E276Q prepared similar method using pcDNA3 HNF42 E276Q template
0.53388375.11435618.html.plaintext.txt	270	The mouse HNF1 promoter luciferase reporter construct described Ref
0.53388375.11435618.html.plaintext.txt	271	The UAS2xtkLUC containing two copies GAL4 binding element upstream thymidine kinase TK promoter gift V
0.53388375.11435618.html.plaintext.txt	272	All constructs verified DNA sequencing
0.53388375.11435618.html.plaintext.txt	273	Cell Culture Transient Transfection Assays HEK 293T Hela cells 2 x 105 cells 1
0.53388375.11435618.html.plaintext.txt	274	5 x 105 cells per 12 well dishes respectively grown transfected Ref
0.53388375.11435618.html.plaintext.txt	275	33 except 1 microg reporter plasmid 50 ng HNF4 expression plasmid 500 ng p300 expression vector used unless otherwise specified figure legends
0.53388375.11435618.html.plaintext.txt	276	Luciferase activities measured using SteadyGlo buffer Promega Corp
0.53388375.11435618.html.plaintext.txt	277	Madison WI Lumicount apparatus Packard Instruments Meriden CT
0.53388375.11435618.html.plaintext.txt	278	Western Blot Assays Western blot assays carried described previously 33
0.53388375.11435618.html.plaintext.txt	279	In Vitro Protein Protein Interaction Pull assays performed described previously 33 using immobilized GST p300 proteins 35S labeled wild type mutated HNF42 synthesized vitro using reticulocyte lysates Promega Corp
0.53388375.11435618.html.plaintext.txt	280	Binding proteins quantified PhosphorImager apparatus using ImageQuant software Molecular Dynamics Inc
0.53388375.11435618.html.plaintext.txt	281	Data Analysis Statistical analysis performed Student test unpaired data using Prism software
0.53388375.11435618.html.plaintext.txt	282	The significance considered P 0
0.53388375.11435618.html.plaintext.txt	283	ACKNOWLEDGMENTS Acknowledgements
0.53388375.11435618.html.plaintext.txt	284	Calos providing plasmids expressing p300 coactivator HEK 293T cells respectively
0.53388375.11435618.html.plaintext.txt	285	Lefebvre critically reading manuscript I
0.53388375.11435618.html.plaintext.txt	286	Briche skillful technical assistance
0.53388375.11435618.html.plaintext.txt	287	FOOTNOTES Address requests reprints B
0.53388375.11435618.html.plaintext.txt	288	U459 INSERM Laboratoire de Biologie Cellulaire Universite H
0.53388375.11435618.html.plaintext.txt	289	Warembourg 1 Place de Verdun F 59045 Lille France
0.53388375.11435618.html.plaintext.txt	290	Received publication November 13 2000
0.53388375.11435618.html.plaintext.txt	291	Revision received March 26 2001
0.53388375.11435618.html.plaintext.txt	292	Accepted publication March 29 2001
0.53388375.11435618.html.plaintext.txt	293	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Duncan SA Nagy A Chan W 1997 Murine gastrulation requires HNF 4 regulated gene expression visceral endoderm tetraploid rescue Hnf 4 embryos
0.53388375.11435618.html.plaintext.txt	294	Development 124279 287AbstractFree Full Text Nastos A vonStrandmann EP Weber H Ryffel GU 1998 The embryonic expression tissue specific transcription factor HNF1 Xenopus rapid activation HNF4 delayed induction mesoderm inducers
0.53388375.11435618.html.plaintext.txt	295	Nucleic Acids Res 265602 5608AbstractFree Full Text Duncan SA Navas MA Dufort D Rossant J Stoffel M 1998 Regulation transcription factor network required differentiation metabolism
0.53388375.11435618.html.plaintext.txt	296	Science 281692 695AbstractFree Full Text Spath GF Weiss MC 1998 Hepatocyte nuclear factor 4 provokes expression epithelial marker genes acting morphogen dedifferentiated hepatoma cells
0.53388375.11435618.html.plaintext.txt	297	J Cell Biol 140935 946AbstractFree Full Text Li J Ning G Duncan SA 2000 Mammalian hepatocyte differentiation requires transcription factor HNF 4
0.53388375.11435618.html.plaintext.txt	298	Genes Dev 14464 474AbstractFree Full Text Wang H Maechler P Antinozzi PA Hagenfeldt KA Wollheim CB 2000 HNF4 regulates expression pancreatic ss cell genes implicated glucose metabolism nutrient induced insulin secretion
0.53388375.11435618.html.plaintext.txt	299	J Biol Chem 27535953 35959AbstractFree Full Text Kuo CJ Conley PB Chen L Sladek FM Darnell JEJ Crabtree GR 1992 A transcriptional hierarchy involved mammalian cell type specification
0.53388375.11435618.html.plaintext.txt	300	Nature 355457 461CrossRefMedline Holewa B Pogge V Strandmann E Zapp D Lorenz P Ryffel GU 1996 Transcriptional hierarchy Xenopus embryogenesis HNF 4 maternal factor involved developmental activation gene encoding tissue specific transcription factor HNF1 LFB1
0.53388375.11435618.html.plaintext.txt	301	Mech Dev 5445 57CrossRefMedline Lahuna O Rastegar M Maiter D Thissen JP Lemaigre FP Rousseau GG 2000 Involvement STAT5 signal transducer activator transcription 5 HNF 4 hepatocyte nuclear factor 4 transcriptional control hnf6 gene growth hormone
0.53388375.11435618.html.plaintext.txt	302	Mol Endocrinol 14285 294AbstractFree Full Text Pontoglio M Sreenan S Roe M Pugh W Ostrega D Doyen A Pick AJ Baldwin A Velho G Froguel P Levisetti M Bonner Weir S Bell GI Yaniv M Polonsky KS 1998 Defective insulin secretion hepatocyte nuclear factor 1 deficient mice
0.53388375.11435618.html.plaintext.txt	303	J Clin Invest 1012215 2222AbstractFree Full Text Wang HY Maechler P Hagenfeldt KA Wollheim CB 1998 Dominant negative suppression HNF 1 function results defective insulin gene transcription impaired metabolism secretion coupling pancreatic ss cell line
0.53388375.11435618.html.plaintext.txt	304	EMBO J 176701 6713AbstractFree Full Text Jacquemin P Durviaux SM Jensen J Godfraind C Gradwohl G Guillemot F Madsen OD Carmeliet P Dewerchin M Collen D Rousseau GG Lemaigre FP 2000 Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation controls expression proendocrine gene ngn3
0.53388375.11435618.html.plaintext.txt	305	Mol Cell Biol 204445 4454AbstractFree Full Text Sladek FM Zhong W Lai E Darnell Jr JE 1990 Liver enriched transcription factor HNF 4 novel member steroid hormone receptor superfamily
0.53388375.11435618.html.plaintext.txt	306	Genes Dev 42353 2365Abstract Green VJ Kokkotou E Ladias JAA 1998 Critical structural elements multitarget protein interactions transcriptional activator AF 1 hepatocyte nuclear factor 4
0.53388375.11435618.html.plaintext.txt	307	J Biol Chem 27329950 29957AbstractFree Full Text Hadzopoulou Cladaras M Kistanova E Evagelopoulou C Zeng S Cladaras C Ladias JAA 1997 Functional domains nuclear receptor hepatocyte nuclear factor 4
0.53388375.11435618.html.plaintext.txt	308	J Biol Chem 272539 550AbstractFree Full Text Ktistaki E Talianidis I 1997 Chicken ovalbumin upstream promoter transcription factors act auxiliary cofactors hepatocyte nuclear factor 4 enhance hepatic gene expression
0.53388375.11435618.html.plaintext.txt	309	Mol Cell Biol 172790 2797Abstract Ueda A Takeshita F Yamashiro S Yoshimura T 1998 Positive regulation human macrophage stimulating protein gene transcription identification new hepatocyte nuclear factor 4 HNF 4 binding element evidence indicates direct association NF Y HNF 4
0.53388375.11435618.html.plaintext.txt	310	J Biol Chem 27319339 19347AbstractFree Full Text Wang JC Stafford JM Granner DK 1998 SRC 1 GRIP1 coactivate transcription hepatocyte nuclear factor 4
0.53388375.11435618.html.plaintext.txt	311	J Biol Chem 27330847 30850AbstractFree Full Text Sladek FM Ruse MD Nepomuceno L Huang SM Stallcup MR 1999 Modulation transcriptional activation coactivator interaction splicing variation F domain nuclear receptor hepatocyte nuclear factor 4 1
0.53388375.11435618.html.plaintext.txt	312	Mol Cell Biol 196509 6522AbstractFree Full Text Yoshida E Aratani S Itou H Miyagishi M Takiguchi M Osumu T Murakami K Fukamizu A 1997 Functional association CBP HNF4 trans activation
0.53388375.11435618.html.plaintext.txt	313	Biochem Biophys Res Commun 241664 669CrossRefMedline Dell H Hadzopoulou Cladaras M 1999 CREB binding protein transcriptional coactivator hepatocyte nuclear factor 4 enhances apolipoprotein gene expression
0.53388375.11435618.html.plaintext.txt	314	J Biol Chem 2749013 9021AbstractFree Full Text Soutoglou E Katrakili N Talianidis I 2000 Acetylation regulates transcription factor activity multiple levels
0.53388375.11435618.html.plaintext.txt	315	Mol Cell 5745 751Medline Arany Z Sellers WR Livingston DM Eckner R 1994 E1A associated p300 CREB associated CBP belong conserved family coactivators
0.53388375.11435618.html.plaintext.txt	316	Cell 77799 800Medline Chakravarti D LaMorte VJ Nelson MC Nakajima T Schulman IG Juguilon H Montminy M Evans RM 1996 Role CBPP300 nuclear receptor signaling
0.53388375.11435618.html.plaintext.txt	317	Nature 38399 102CrossRefMedline Li M Pascual G Glass CK 2000 Peroxisome proliferator activated receptor dependent repression inducible nitric oxide synthase gene
0.53388375.11435618.html.plaintext.txt	318	Mol Cell Biol 204699 4707AbstractFree Full Text Li J O Malley BW Wong J 2000 p300 requires histone acetyltransferase activity SRC 1 interaction domain facilitate thyroid hormone receptor activation chromatin
0.53388375.11435618.html.plaintext.txt	319	Mol Cell Biol 202031 2042AbstractFree Full Text McInerney EM Rose DW Flynn SE Westin S Mullen TM Krones A Inostroza J Torchia J Nolte RT AssaMunt N Milburn MV Glass CK Rosenfeld MG 1998 Determinants coactivator LXXLL motif specificity nuclear receptor transcriptional activation
0.53388375.11435618.html.plaintext.txt	320	Genes Dev 123357 3368AbstractFree Full Text Jiang G Nepomuceno L Hopkins K Sladek FM 1995 Exclusive homodimerization orphan receptor hepatocyte nuclear factor 4 defines new subclass nuclear receptors
0.53388375.11435618.html.plaintext.txt	321	Mol Cell Biol 155131 5143Abstract Stoffel M Duncan SA 1997 The maturity onset diabetes young MODY1 transcription factor HNF 4 regulates expression genes required glucose transport metabolism
0.53388375.11435618.html.plaintext.txt	322	Proc Natl Acad Sci USA 9413209 13214AbstractFree Full Text Yamagata K Furuta H Oda N Kaisaki PJ Menzel S Cox NJ Fajans SS Signorini S Stoffel M Bell GI 1996 Mutations In hepatocyte nuclear factor 4 gene maturity onset diabetes young MODY1
0.53388375.11435618.html.plaintext.txt	323	Nature 384458 460CrossRefMedline Sladek FM Dallas Yang Q Nepomuceno L 1998 MODY1 mutation Q268X hepatocyte nuclear factor 4 allows dimerization solution causes abnormal subcellular localization
0.53388375.11435618.html.plaintext.txt	324	Diabetes 47985 990Abstract Hani EH Suaud L Boutin P Chevre J C Durand E Philippi A Demenais F Vionnet N Furuta H Velho G Bell GI Laine B Froguel P 1998 A missense mutation hepatocyte nuclear factor 4 resulting reduced transactivation activity human late onset non insulin dependent diabetes mellitus
0.53388375.11435618.html.plaintext.txt	325	J Clin Invest 101521 526AbstractFree Full Text Suaud L Hemimou Y Formstecher P Laine B 1999 Functional study E276Q mutant hepatocyte nuclear factor 4 found type 1 maturity onset diabetes young impaired synergy chicken ovalbumin upstream promoter transcription factor II hepatocyte nuclear factor 1 promoter
0.53388375.11435618.html.plaintext.txt	326	Diabetes 481162 1167Abstract Navas MA Munoz Elias EJ Kim J Shih D Stoffel M 1999 Functional characterization MODY1 gene mutations HNF4R127W HNF4V255M HNF4E276Q
0.53388375.11435618.html.plaintext.txt	327	Diabetes 481459 1465Abstract Lausen J Thomas H Lemm I Bulman M Borgschulze M Lingott A Hattersley AT Ryffel GU 2000 Naturally occurring mutations human HNF4 gene impair function transcription factor varying degree
0.53388375.11435618.html.plaintext.txt	328	Nucleic Acids Res 28430 437AbstractFree Full Text Laine B Eeckhoute J Suaud L Briche I Furuta H Bell GI Formstecher P 2000 Functional properties R154X HNF 4 protein generated mutation associated maturity onset diabetes young type 1
0.53388375.11435618.html.plaintext.txt	329	FEBS Lett 47941 45CrossRefMedline Yang Q Yamagata K Yamamoto K Cao Y Miyagawa J Fukamizu A Hanafusa T Matsuzawa Y 2000 R127W HNF 4alpha loss function mutation rare polymorphism causes type II diabetes Japanese family MODY1
0.53388375.11435618.html.plaintext.txt	330	Diabetologia 43520 524CrossRefMedline Ikonen T Palvimo JJ Janne OA 1997 Interaction amino carboxyl terminal regions rat androgen receptor modulates transcriptional activity influenced nuclear receptor coactivators
0.53388375.11435618.html.plaintext.txt	331	J Biol Chem 27229821 29828AbstractFree Full Text Kobayashi Y Kitamoto T Masuhiro Y Watanabe M Kase T Metzger D Yanagisawa J Kato S 2000 p300 mediates functional synergism AF 1 AF 2 estrogen receptor ss interacting directly N terminal AB domains
0.53388375.11435618.html.plaintext.txt	332	J Biol Chem 27515645 15651AbstractFree Full Text Diaz Guerra M JM Bergot M O Martinez A Cuif M H Kahn A Raymondjean M 1993 Functional characterization L type pyruvate kinase gene glucose response complex
0.53388375.11435618.html.plaintext.txt	333	Mol Cell Biol 137725 7733Abstract Talianidis I Tambakaki A Toursounova J Zannis VI 1995 Complex interactions SP1 bound multiple distal regulatory sites HNF 4 bound proximal promoter lead transcriptional activation liver specific human apo CIII gene
0.53388375.11435618.html.plaintext.txt	334	Biochemistry 3410298 10309Medline Ribeiro A Pastier D Kardassis D Chambaz J Cardot P 1999 Cooperative binding upstream stimulatory factor hepatic nuclear factor 4 drives transcription human apolipoprotein A II gene
0.53388375.11435618.html.plaintext.txt	335	J Biol Chem 2741216 1225AbstractFree Full Text Kardassis D Tzameli I Hadzopoulou Cladaras M Talianidis I Zannis V 1997 Distal apolipoprotein C III regulatory elements F J act general modular enhancer proximal promoters contain hormone response elements synergism hepatic nuclear factor 4 molecules bound proximal promoter distal enhancer sites
0.53388375.11435618.html.plaintext.txt	336	Arterioscler Thromb Vasc Biol 17222 232AbstractFree Full Text Ktistaki E Talianidis I 1997 Modulation hepatic gene expression hepatocyte nuclear factor 1
0.53388375.11435618.html.plaintext.txt	337	Science 277109 112AbstractFree Full Text Yamagata K Oda N Kaisaki PJ Menzel S Furuta H Vaxillaire M Southam L Cox RD Lathrop GM Boriraj VV Chen XN Cox NJ Oda Y Yano H LeBeau MM Yamada S Nishigori H Takeda J Fajans SS Hattersley AT Iwasaki N Hansen T Pedersen O Polonsky KS Turner RC Velho G Chevre JC Froguel P Bell GI 1996 Mutations hepatocyte nuclear factor 1 gene maturity onset diabetes young MODY3
0.53388375.11435618.html.plaintext.txt	338	Nature 384455 458CrossRefMedline Doria A Plengvidhya N 2000 Recent advances genetics maturity onset diabetes young forms autosomal dominant diabetes
0.53388375.11435618.html.plaintext.txt	339	Curr Opin Endocrinol Metab 7203 210CrossRef Vaxillaire M Abderrahmani A Boutin P Bailleul B Froguel P Yaniv M Pontoglio M 1999 Anatomy homeoprotein revealed analysis human MODY3 mutations
0.53388375.11435618.html.plaintext.txt	340	J Biol Chem 27435639 35646AbstractFree Full Text Suaud L Formstecher P Laine B 1999 The activity activation function 2 human hepatocyte nuclear factor 4 HNF 4 differently modulated F domains various origins
0.53388375.11435618.html.plaintext.txt	341	Biochem J 340161 169CrossRefMedline
0.278518.10967120.html.plaintext.txt	0	Hepatocyte Nuclear Factor 4 Regulates Expression Pancreatic Cell Genes Implicated Glucose Metabolism Nutrient induced Insulin Secretion Haiyan Wang Pierre Maechler Peter A
0.278518.10967120.html.plaintext.txt	1	From Division de Biochimie Clinique Department de Medecine Interne Centre Medical Universitaire CH 1211 Geneva 4 Switzerland
0.278518.10967120.html.plaintext.txt	2	Received publication July 25 2000
0.278518.10967120.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.278518.10967120.html.plaintext.txt	4	Mutations HNF4 gene associated subtype 1 maturity onset diabetes young MODY1 characterized impaired insulin secretory response glucose pancreatic cells
0.278518.10967120.html.plaintext.txt	5	Hepatocyte nuclear factor 4 HNF4 transcription factor critical liver development hepatocyte specific gene expression
0.278518.10967120.html.plaintext.txt	6	However role HNF4 regulation pancreatic cell gene expression correlation metabolism secretion coupling previously investigated
0.278518.10967120.html.plaintext.txt	7	The tetracycline inducible system employed achieve tightly controlled expression wild type WT dominant negative mutant DN HNF4 INS 1 cells
0.278518.10967120.html.plaintext.txt	8	The induction WT HNF4 resulted left shift glucose stimulated insulin secretion whereas DN HNF4 selectively impaired nutrient stimulated insulin release
0.278518.10967120.html.plaintext.txt	9	Induction DN HNF4 also caused defective mitochondrial function substantiated reduced 14Cpyruvate oxidation attenuated substrate evoked mitochondrial membrane hyperpolarization blunted nutrient generated cellular ATP production
0.278518.10967120.html.plaintext.txt	10	Quantitative evaluation HNF4 regulated pancreatic cell gene expression revealed altered mRNA levels insulin glucose transporter 2 L pyruvate kinase aldolase B 2 oxoglutarate dehydrogenase E1 subunit mitochondrial uncoupling protein 2
0.278518.10967120.html.plaintext.txt	11	The patterns HNF4 regulated gene expression strikingly similar downstream transcription factor HNF1
0.278518.10967120.html.plaintext.txt	12	Indeed HNF4 changed HNF1 mRNA levels HNF1 promoter luciferase activity altered HNF4 binding
0.278518.10967120.html.plaintext.txt	13	These results demonstrate importance HNF4 cell metabolism secretion coupling
0.278518.10967120.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.278518.10967120.html.plaintext.txt	15	The hepatocyte nuclear factor 4 HNF41 transcription factor nuclear hormone receptor superfamily expressed liver kidney gut pancreatic islets 1 3
0.278518.10967120.html.plaintext.txt	16	Mutations human HNF4 gene lead maturity onset diabetes young subtype 1 MODY1 characterized autosomal dominant inheritance impaired glucose stimulated insulin secretion pancreatic cells 4 6
0.278518.10967120.html.plaintext.txt	17	These MODY1 mutations located various domains HNF4 protein result defective function transcription factor 6
0.278518.10967120.html.plaintext.txt	18	The clinical phenotype MODY1 patients indistinguishable MODY3 patients carry mutations HNF1 gene 5 6
0.278518.10967120.html.plaintext.txt	19	HNF4 acts upstream HNF1 transcriptional cascade drives liver specific gene expression hepatocyte differentiation 7 9
0.278518.10967120.html.plaintext.txt	20	A naturally occurring mutation HNF4 binding site HNF1 promoter identified MODY3 family 10 suggests transcriptional hierarchy could also involved pancreatic cell gene expression function
0.278518.10967120.html.plaintext.txt	21	HNF4 defines expression liver specific genes encoding apolipoproteins serum factors cytochrome P 450 isoforms proteins involved metabolism glucose fatty acids amino acids reviewed Ref
0.278518.10967120.html.plaintext.txt	22	However clinical characterization MODY1 subjects reveals primary defect impaired glucose stimulated insulin secretion pancreatic cells rather liver dysfunction 5 12 14
0.278518.10967120.html.plaintext.txt	23	Unfortunately little known HNF4 regulates cell restricted gene expression glucose metabolism associated insulin secretion
0.278518.10967120.html.plaintext.txt	24	Targeted disruption hnf4 gene results defective gastrulation mouse embryos due dysfunction visceral endoderm 15
0.278518.10967120.html.plaintext.txt	25	This early embryonic lethality prevents analysis HNF4 function pancreatic cells
0.278518.10967120.html.plaintext.txt	26	The precise role HNF4 pancreatic cells would best examined conditional cell specific deletion mouse hnf4 gene
0.278518.10967120.html.plaintext.txt	27	Another alternative regulate HNF4 function pancreatic cell lines gene manipulation
0.278518.10967120.html.plaintext.txt	28	In present study wild type HNF4 WT HNF4 dominant negative mutant DN HNF4 could induced INS 1 cells tight control reverse tetracycline dependent transactivator 16
0.278518.10967120.html.plaintext.txt	29	DN HNF4 represents epitope Myc tagged truncated HNF4 mutant protein lacking first 111 amino acids myc111HNF4 17
0.278518.10967120.html.plaintext.txt	30	The HNF4 protein consists N terminal ligand independent transactivation domain amino acids 1 24 DNA binding domain containing two zinc fingers amino acids 51 117 large hydrophobic portion amino acids 163 368 composed dimerization ligand binding cofactor binding ligand dependent transactivation domain 18 19
0.278518.10967120.html.plaintext.txt	31	DN HNF4 therefore suppresses endogenous WT HNF4 transcriptional activity formation heterodimers lacking DNA binding capacity 17
0.278518.10967120.html.plaintext.txt	32	We investigated quantitative manner consequences altered HNF4 function cell specific expression genes implicated glucose metabolism insulin secretion
0.278518.10967120.html.plaintext.txt	33	This allowed us elucidate molecular basis HNF4 target genes responsible impaired metabolism secretion coupling cells deficient HNF4 function
0.278518.10967120.html.plaintext.txt	34	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.278518.10967120.html.plaintext.txt	35	Generation Stable Cell Lines The rat insulinoma INS 1 cell line derived stable clones cultured RPMI 1640 11 mM glucose unless indicated otherwise 20
0.278518.10967120.html.plaintext.txt	36	The establishment first step stable clone INS r3 expresses reverse tetracycline dependent transactivator reported previously 21
0.278518.10967120.html.plaintext.txt	37	Plasmids used secondary stable transfection constructed subcloning cDNAs encoding rat WT HNF4 generous gift Dr
0.278518.10967120.html.plaintext.txt	38	New York DN HNF4 expression vector PUHD10 3 kind gift Dr
0.278518.10967120.html.plaintext.txt	39	Bujard University Heidelberg Germany
0.278518.10967120.html.plaintext.txt	40	DN HNF4 PCR amplified WT HNF4 using following primers ctaggatccttccgggctggcatgaagaaagaagcc ccagaattcctgcagatggttgtcctttag
0.278518.10967120.html.plaintext.txt	41	The PCR fragment subcloned pcDNA3
0.278518.10967120.html.plaintext.txt	42	1myc Invitrogen Netherlands sequenced
0.278518.10967120.html.plaintext.txt	43	Transfection clone selection screening procedures described previously 21
0.278518.10967120.html.plaintext.txt	44	Immunoblot Immunoblotting procedures performed described previously using enhanced chemiluminescence Pierce detection 22
0.278518.10967120.html.plaintext.txt	45	Dilutions antibody HNF4 kindly supplied Dr
0.278518.10967120.html.plaintext.txt	46	Sladek University California Riverside CA anti Myc tag 9E10 myeloma SP20 culture medium 16000 110
0.278518.10967120.html.plaintext.txt	47	Insulin Secretion Cellular Insulin Content Cells 24 well dishes cultured 2
0.278518.10967120.html.plaintext.txt	48	5 mM glucose medium without indicated doses doxycycline 14 48 h
0.278518.10967120.html.plaintext.txt	49	Insulin secretion measured period 30 min Krebs Ringerbicarbonate HEPES buffer KRBH 140 mM NaCl 3
0.278518.10967120.html.plaintext.txt	50	5 mM CaCl2 2 mM NaHCO3 10 mM HEPES 0
0.278518.10967120.html.plaintext.txt	51	1 bovine serum albumin containing indicated stimulators
0.278518.10967120.html.plaintext.txt	52	Insulin content determined extraction acid ethanol following procedures Asfari et al
0.278518.10967120.html.plaintext.txt	53	Insulin detected radioimmunoassay using rat insulin standard 22
0.278518.10967120.html.plaintext.txt	54	Intracellular ATP Cells 6 well dishes cultured 2
0.278518.10967120.html.plaintext.txt	55	5 mM glucose medium without 500 ngml doxycycline 48 h
0.278518.10967120.html.plaintext.txt	56	The production ATP measured 8 min stimulation KRBH
0.278518.10967120.html.plaintext.txt	57	ATP assay performed reported previously 22
0.278518.10967120.html.plaintext.txt	58	14CPyruvate Oxidation The production 14CO2 1 14Cpyruvate 2 14Cpyruvate measured 1 h KRBH containing either 0
0.278518.10967120.html.plaintext.txt	59	0 mM pyruvate described previously 23 24
0.278518.10967120.html.plaintext.txt	60	Mitochondrial Membrane Potential m After 48 h culture period 2
0.278518.10967120.html.plaintext.txt	61	5 mM glucose medium without 500 ngml doxycycline cells trypsinized 0
0.278518.10967120.html.plaintext.txt	62	27 mM EDTA cell suspension maintained 2 h spinner culture 2
0.278518.10967120.html.plaintext.txt	63	5 mM glucose RPMI 1640 plus 1 newborn calf serum 37 degrees C
0.278518.10967120.html.plaintext.txt	64	Mitochondrial membrane potential m measured described 25
0.278518.10967120.html.plaintext.txt	65	Briefly spinner culture period cells loaded 10 microgml rhodamine 123 Rh 123 10 min 37 degrees C
0.278518.10967120.html.plaintext.txt	66	After centrifugation cells resuspended transferred fluorimeter cuvette 37 degrees C gentle stirring LS 50B fluorimeter PerkinElmer Life Sciences fluorescence excited 490 nm measured 530 nm
0.278518.10967120.html.plaintext.txt	67	Total RNA Isolation Northern Blotting Cells 10 cm dishes cultured 2
0.278518.10967120.html.plaintext.txt	68	5 mM glucose medium without 500 ngml doxycycline 14 48 h followed additional 8 h culture medium 2
0.278518.10967120.html.plaintext.txt	69	Total RNA extracted blotted nylon membranes described previously 22
0.278518.10967120.html.plaintext.txt	70	The membrane prehybridized hybridized 32P labeled random primer cDNA probes technique Sambrook et al
0.278518.10967120.html.plaintext.txt	71	To ensure equal RNA loading even transfer membranes stripped re hybridized housekeeping gene probes actin cyclophilin
0.278518.10967120.html.plaintext.txt	72	cDNA fragments used probes L pyruvate kinase L PK glucose transporter 2 GLUT 2 glucokinase insulin PDX1 HNF4 upstream stimulatory factors USF c Jun CEBP mRNA detection digested corresponding expression vectors kindly provided Drs
0.278518.10967120.html.plaintext.txt	73	cDNA probes rat aldolase B glyceraldehyde 3 phosphate dehydrogenase dimerization cofactor HNF1 DcoH mitochondrial adenine nucleotide translocator 1 2 ANT1 ANT2 mitochondrial uncoupling protein 2 UCP 2 mitochondrial 2 oxoglutarate dehydrogenase OGDH E1 subunit glutamate dehydrogenase GDH Pax4 Pax6 Nkx2
0.278518.10967120.html.plaintext.txt	74	1 Isl1 insulin receptor substrate 2 IRS2 cyclin dependent kinase 4 Cdk4 cyclophilin prepared reverse transcriptase PCR confirmed sequencing
0.278518.10967120.html.plaintext.txt	75	Nuclear Extract Preparation Electrophoretic Mobility Shift Assay EMSA Cells 10 cm dishes grown culture medium without 500 ngml doxycycline 48 h
0.278518.10967120.html.plaintext.txt	76	The following double stranded oligonucleotides used probes 5 GGCTGAAGTCCAAAGTTCAGTCCCTTCGC 3 8
0.278518.10967120.html.plaintext.txt	77	EMSA procedures including conditions nuclear extract preparation probe labeling binding reactions unlabeled probe competition antibody supershift performed reported previously 22
0.278518.10967120.html.plaintext.txt	78	Transient Transfection Luciferase Assay The HNF1 gene promoter luciferase reporter plasmids WT HNF1Luc wild type AHNF1Luc HNF4 binding site deleted kindly provided Dr
0.278518.10967120.html.plaintext.txt	79	Miura Akita University Japan 27
0.278518.10967120.html.plaintext.txt	80	Transient transfection experiments luciferase reporter enzyme assays carried previously reported 22
0.278518.10967120.html.plaintext.txt	81	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.278518.10967120.html.plaintext.txt	82	WT HNF4 DN HNF4 Protein Was Induced INS 1 Cells Dose Time dependent Manner We obtained 10 8 clones positively expressing WT HNF4 DN HNF4 respectively
0.278518.10967120.html.plaintext.txt	83	The clones designated WT HNF4 28 DN HNF4 26 displayed highest induction levels transgene proteins chosen present study
0.278518.10967120.html.plaintext.txt	84	The time course dose response doxycycline effect WT HNF4 DN HNF4 expression illustrated Fig
0.278518.10967120.html.plaintext.txt	85	WT HNF4 protein could induced within range 2 50 fold endogenous protein level Fig
0.278518.10967120.html.plaintext.txt	86	Thus graded overexpression WT HNF4 could achieved culturing WT HNF4 28 cells varying doses doxycycline defined period
0.278518.10967120.html.plaintext.txt	87	Similar induction DN HNF4 protein detected nuclear extracts DN HNF4 26 cells Fig
0.278518.10967120.html.plaintext.txt	88	No leakage doxycycline dependent promoter observed since expression DN HNF4 protein detectable non induced DN HNF4 26 cells Fig
0.278518.10967120.html.plaintext.txt	89	Therefore dominant negative suppression HNF4 function INS 1 cells could rapidly achieved culturing DN HNF4 26 cells maximum dose doxycycline 500 ngml
0.278518.10967120.html.plaintext.txt	90	View larger version 28K Fig
0.278518.10967120.html.plaintext.txt	91	Dose response time course doxycycline effect WT HNF4 A DN HNF4 B expression
0.278518.10967120.html.plaintext.txt	92	For studying dose response cells cultured indicated doses Dox 48 h
0.278518.10967120.html.plaintext.txt	93	For studying time course cells cultured medium containing 500 ngml doxycycline harvested nuclear extracts indicated times
0.278518.10967120.html.plaintext.txt	94	Nuclear extracts WT HNF4 28 50 microglane A DN HNF4 26 10 microglane B resolved 9 SDS polyacrylamide gel electrophoresis transferred nitrocellulose immunoblotted antibodies HNF4 A Myc tag B respectively
0.278518.10967120.html.plaintext.txt	95	Effects WT HNF4 DN HNF4 Insulin Secretion Impaired glucose stimulated insulin secretion pancreatic cells primary defect causing hyperglycemia MODY1 patients carrying HNF4 mutations
0.278518.10967120.html.plaintext.txt	96	We therefore examined consequences induction WT HNF4 DN HNF4 insulin secretion INS 1 cells
0.278518.10967120.html.plaintext.txt	97	The graded overexpression WT HNF4 led left shift glucose stimulated insulin secretion Fig
0.278518.10967120.html.plaintext.txt	98	However maximal 12 mM glucose elicited insulin secretion remained unchanged Fig
0.278518.10967120.html.plaintext.txt	99	View larger version 16K Fig
0.278518.10967120.html.plaintext.txt	100	HNF4 regulates nutrient evoked insulin secretion INS 1 cells
0.278518.10967120.html.plaintext.txt	101	Insulin secretion quantified described Experimental Procedures normalized cellular DNA content
0.278518.10967120.html.plaintext.txt	102	A glucose stimulated insulin secretion WT HNF4 28 cells induced indicated doses doxycycline 14 h
0.278518.10967120.html.plaintext.txt	103	Data represent mean plus minus S
0.278518.10967120.html.plaintext.txt	104	six independent experiments
0.278518.10967120.html.plaintext.txt	105	Statistical significance doxycycline induced non induced cells obtained 2
0.278518.10967120.html.plaintext.txt	106	001 unpaired Students test
0.278518.10967120.html.plaintext.txt	107	B glucose leucine K elicited insulin secretion DN HNF4 26 cells induced 500 ngml doxycycline 48 h
0.278518.10967120.html.plaintext.txt	108	Insulin secretion measured 30 min incubation 2
0.278518.10967120.html.plaintext.txt	109	5 mM Basal 24 mM glucose KRBH 20 mM leucine 20 mM KCl added KRBH containing 2
0.278518.10967120.html.plaintext.txt	110	Data mean plus minus S
0.278518.10967120.html.plaintext.txt	111	Statistical significance doxycycline induced non induced cells observed 24 mM glucose 20 mM leucine stimulated conditions p 0
0.278518.10967120.html.plaintext.txt	112	Insulin content reduced 30 plus minus 8
0.278518.10967120.html.plaintext.txt	113	Glucose generates ATP metabolic coupling factors important insulin secretion glycolysis mitochondrial oxidation 28
0.278518.10967120.html.plaintext.txt	114	The physiological insulin secretagogue leucine transported directly mitochondria provide substrates tricarboxylic acid cycle 28
0.278518.10967120.html.plaintext.txt	115	K causes insulin secretion depolarization cell membrane resulting increase cytosolic Ca2 28
0.278518.10967120.html.plaintext.txt	116	We therefore examined insulin secretory responses three secretagogues act different levels signal transduction cascade following induction DN HNF4
0.278518.10967120.html.plaintext.txt	117	2B DN HNF4 selectively inhibited glucose leucine stimulated insulin secretion
0.278518.10967120.html.plaintext.txt	118	This could explained defective glucose leucine metabolism
0.278518.10967120.html.plaintext.txt	119	Effects DN HNF4 Cellular ATP Production Mitochondrial Oxidation To investigate whether impaired nutrient evoked insulin secretion correlated defective cellular ATP production analyzed impact DN HNF4 expression level ATP generated glucose leucine
0.278518.10967120.html.plaintext.txt	120	3A induction DN HNF4 indeed abolished ATP generation glucose leucine
0.278518.10967120.html.plaintext.txt	121	Since mitochondrial substrate leucine failed generate ATP induction DN HNF4 would seem HNF4 required maintaining normal mitochondrial function
0.278518.10967120.html.plaintext.txt	122	View larger version 17K Fig
0.278518.10967120.html.plaintext.txt	123	Induction DN HNF4 impairs cellular ATP production mitochondrial oxidation
0.278518.10967120.html.plaintext.txt	124	A cellular ATP levels DN HNF4 26 cells measured 8 min incubation 2
0.278518.10967120.html.plaintext.txt	125	5 Basal 24 mM glucose KRBH 20 mM leucine 20 mM KCl added KRBH containing 2
0.278518.10967120.html.plaintext.txt	126	Data represent mean plus minus S
0.278518.10967120.html.plaintext.txt	127	three independent experiments
0.278518.10967120.html.plaintext.txt	128	Glucose leucine stimulated ATP production significantly inhibited treatment 500 ngml doxycycline 48 h p 0
0.278518.10967120.html.plaintext.txt	129	B 2 14Cpyruvate oxidation measured 1 h incubation KRBH containing 0
0.278518.10967120.html.plaintext.txt	130	Data represent mean plus minus S
0.278518.10967120.html.plaintext.txt	131	performed triplicate one four similar experiments
0.278518.10967120.html.plaintext.txt	132	C 1 14Cpyruvate oxidation measured identical conditions preparation cells B
0.278518.10967120.html.plaintext.txt	133	Data represent mean plus minus S
0.278518.10967120.html.plaintext.txt	134	performed triplicate one three similar experiments
0.278518.10967120.html.plaintext.txt	135	To test hypothesis examined consequences DN HNF4 induction mitochondrial oxidation pyruvate
0.278518.10967120.html.plaintext.txt	136	Pyruvate derived carbons enter tricarboxylic acid cycle either acetyl CoA catalyzed pyruvate dehydrogenase oxaloacetate via pyruvate carboxylase
0.278518.10967120.html.plaintext.txt	137	By using pyruvate radiolabeled either first second carbon putative defects various steps pyruvate metabolism assessed
0.278518.10967120.html.plaintext.txt	138	The radiolabeled carbon 1 14Cpyruvate lost CO2 pyruvate dehydrogenase step pyruvate converted acetyl CoA
0.278518.10967120.html.plaintext.txt	139	Alternatively pyruvate enters tricarboxylic acid cycle via oxaloacetate label lost CO2 isocitrate dehydrogenase within one turn cycle
0.278518.10967120.html.plaintext.txt	140	Radiolabeled CO2 generated 2 14C either OGDH isocitrate dehydrogenase pyruvate enters tricarboxylic acid cycle acetyl CoA
0.278518.10967120.html.plaintext.txt	141	Overexpression DN HNF4 reduced CO2 formation 2 14Cpyruvate 41 Fig
0.278518.10967120.html.plaintext.txt	142	3B whereas CO2 formation 1 14Cpyruvate different non induced conditions Fig
0.278518.10967120.html.plaintext.txt	143	These results suggest defect mitochondrial metabolism point entry pyruvate tricarboxylic acid cycle rather defect appears reactions within tricarboxylic acid cycle
0.278518.10967120.html.plaintext.txt	144	This full agreement impairment leucine stimulation insulin secretion since leucine metabolism bypasses pyruvate enters tricarboxylic acid cycle solely acetyl CoA
0.278518.10967120.html.plaintext.txt	145	Decreased isocitrate dehydrogenase activity would also unlikely since impairment step would observed 1 14Cpyruvate 2 14Cpyruvate oxidation
0.278518.10967120.html.plaintext.txt	146	These oxidation experiments suggest steps following reaction beginning OGDH may responsible impaired 2 14Cpyruvate oxidation
0.278518.10967120.html.plaintext.txt	147	Effect DN HNF4a Mitochondrial Membrane Potential m INS 1 Cells The m measured suspension INS 1 cells monitoring rhodamine 123 fluorescence
0.278518.10967120.html.plaintext.txt	148	In control cells Dox addition 10 mM glucose 12
0.278518.10967120.html.plaintext.txt	149	5 mM final potently hyperpolarized m whereas 1 microM protonophore FCCP depolarized m Fig
0.278518.10967120.html.plaintext.txt	150	In cells expressing DN HNF4 Dox glucose response inhibited 65 p 0
0.278518.10967120.html.plaintext.txt	151	Impaired hyperpolarization m also observed glycolysis bypassed stimulating cells end product glycolysis pyruvate Fig
0.278518.10967120.html.plaintext.txt	152	4B indicating mitochondrial dysfunction
0.278518.10967120.html.plaintext.txt	153	Direct activation methyl succinate electron transport chain complex II resulted diminished response DN HNF4 induced cells Fig
0.278518.10967120.html.plaintext.txt	154	The amplitude complete m depolarization FCCP also reduced cells treated doxycycline 43 p 0
0.278518.10967120.html.plaintext.txt	155	01 suggesting mitochondria partially uncoupled suppression HNF4 function Fig
0.278518.10967120.html.plaintext.txt	156	View larger version 26K Fig
0.278518.10967120.html.plaintext.txt	157	Effect DN HNF4 mitochondrial membrane potential m INS 1 cells
0.278518.10967120.html.plaintext.txt	158	The m measured suspension 2 x 106 INS 1 cells per 2 ml KRBH using rhodamine 123 Rh 123 fluorescence spinner culture period
0.278518.10967120.html.plaintext.txt	159	5 mM final hyperpolarization m tested followed complete depolarization m using 1 microM uncoupler FCCP
0.278518.10967120.html.plaintext.txt	160	B end product glycolysis pyruvate 10 mM added 10 min FCCP
0.278518.10967120.html.plaintext.txt	161	C mitochondrial substrate methyl succinate 10 mM tested
0.278518.10967120.html.plaintext.txt	162	The effects various substrates 5 min addition well FCCP summarized statistics D
0.278518.10967120.html.plaintext.txt	163	Each trace A C representative 4 8 independent experiments
0.278518.10967120.html.plaintext.txt	164	Effects WT HNF4 DN HNF4 Pancreatic Cell Gene Expression The expression genes involved glucose metabolism Fig
0.278518.10967120.html.plaintext.txt	165	5 A B pancreatic cell development differentiation Fig
0.278518.10967120.html.plaintext.txt	166	5 C D quantitatively evaluated WT HNF4 28 Fig
0.278518.10967120.html.plaintext.txt	167	5 A C DN HNF4 26 cells Fig
0.278518.10967120.html.plaintext.txt	168	5A WT HNF4 mRNA could induced 2 8 50 fold endogenous level
0.278518.10967120.html.plaintext.txt	169	This graded overexpression WT HNF4 resulted stepwise increase expression three glucose responsive genes encoding respectively GLUT 2 L PK aldolase B Fig
0.278518.10967120.html.plaintext.txt	170	However mRNA level glyceraldehyde 3 phosphate dehydrogenase also responsive glucose remained unaltered Fig
0.278518.10967120.html.plaintext.txt	171	Induction WT HNF4 also caused incremental expression OGDH E1 subunit transcript Fig
0.278518.10967120.html.plaintext.txt	172	Consistently The mRNA levels GLUT 2 aldolase B L PK OGDH E1 subunit significantly reduced induction DN HNF4 Fig
0.278518.10967120.html.plaintext.txt	173	On hand induction DN HNF4 led increased UCP 2 mRNA expression Fig
0.278518.10967120.html.plaintext.txt	174	Therefore HNF4 regulates expression genes involved glycolysis mitochondrial metabolism
0.278518.10967120.html.plaintext.txt	175	The profile HNF4 targeted genes strikingly similar HNF1 29
0.278518.10967120.html.plaintext.txt	176	HNF4 may regulate expression genes implicated glucose metabolism HNF1 function hepatocytes 7 9
0.278518.10967120.html.plaintext.txt	177	View larger version 55K Fig
0.278518.10967120.html.plaintext.txt	178	Effects WT HNF1 DN HNF1 pancreatic cell gene expression
0.278518.10967120.html.plaintext.txt	179	Northern blotting used quantify gene expression WT HNF4 28 A C DN HNF4 26 B D cells induced indicated doses doxycycline cultured given concentrations glucose detailed Experimental Procedures
0.278518.10967120.html.plaintext.txt	180	RNA samples analyzed hybridization indicated cDNA probes
0.278518.10967120.html.plaintext.txt	181	Since HNF4 required liver development hepatocyte differentiation 9 investigated whether HNF4 regulates expression genes important pancreatic cell phenotype
0.278518.10967120.html.plaintext.txt	182	5D alter expression patterns PDX1 Pax4 Pax6 NKx2
0.278518.10967120.html.plaintext.txt	183	1 Isl 1 necessary normal pancreatic cell development differentiation 30
0.278518.10967120.html.plaintext.txt	184	Moreover HNF4 regulate mRNA levels USF c Jun CEBP Fig
0.278518.10967120.html.plaintext.txt	185	The expression transcription factors appeared responsive glucose Fig
0.278518.10967120.html.plaintext.txt	186	The expression another glucose responsive transcription factor DcoH slightly affected induction WT HNF4 expression DN HNF4 Fig
0.278518.10967120.html.plaintext.txt	187	5 C D suggesting involvement indirect mechanism
0.278518.10967120.html.plaintext.txt	188	Both Cdk4 IRS2 involved pancreatic cell development 31 32 expression regulated HNF4 Fig
0.278518.10967120.html.plaintext.txt	189	Induction DN HNF4 48 h caused 50 reduction insulin mRNA levels Fig
0.278518.10967120.html.plaintext.txt	190	This may secondary decreased HNF1 function since HNF1 required insulin gene transcription 29
0.278518.10967120.html.plaintext.txt	191	HNF4 Regulates Pancreatic Cell Gene Expression HNF1 Function We performed EMSA studying HNF4 binding activity HNF1 promoter luciferase reporter enzyme assay HNF1 promoter activity Northern blotting HNF1 mRNA expression
0.278518.10967120.html.plaintext.txt	192	Nuclear extracts prepared WT HNF4 28 DN HNF4 26 cells cultured 48 h presence absence 500 ngml doxycycline
0.278518.10967120.html.plaintext.txt	193	The murine HNF1 promoter segment contains HNF4 binding site used probe 8
0.278518.10967120.html.plaintext.txt	194	Induction WT HNF4 resulted dramatic increase signal density HNF4 binding Fig
0.278518.10967120.html.plaintext.txt	195	On hand induction DN HNF4 almost completely abolished binding activity endogenous HNF4 HNF1 promoter Fig
0.278518.10967120.html.plaintext.txt	196	DN HNF4 exerts dominant negative function forming DN HNF4WT HNF4 heterodimers lack DNA binding capacity 11
0.278518.10967120.html.plaintext.txt	197	The retarded DNA binding complexes corresponding endogenous WT HNF4 andor induced transgene WT HNF4 homodimers supershifted specific antibody HNF4 Fig
0.278518.10967120.html.plaintext.txt	198	View larger version 43K Fig
0.278518.10967120.html.plaintext.txt	199	Induction WT HNF1 DN HNF1 regulates HNF1 mRNA expression HNF1 promoter luciferase activity altered HNF4 binding
0.278518.10967120.html.plaintext.txt	200	EMSA A Northern blotting B luciferase enzyme reporter activity C assays performed WT HNF4 28 DN HNF4 26 cells cultured presence absence 500 ngml doxycycline 48 h
0.278518.10967120.html.plaintext.txt	201	A EMSA oligonucleotide duplex corresponding murine HNF1 promoter fragment containing HNF4 binding site used probe
0.278518.10967120.html.plaintext.txt	202	B Northern blot analysis cells cultured 2
0.278518.10967120.html.plaintext.txt	203	5 mM glucose medium 48 h continued 8 h indicated glucose concentrations
0.278518.10967120.html.plaintext.txt	204	RNA samples WT HNF4 28 upper panel DN HNF4 26 lower panel cells hybridized HNF1 cDNA probe
0.278518.10967120.html.plaintext.txt	205	C cells transiently transfected HNF1Luc AHNF1Luc calcium phosphate DNA co precipitation
0.278518.10967120.html.plaintext.txt	206	Luciferase activity measured non induced cells defined 100
0.278518.10967120.html.plaintext.txt	207	Data mean plus minus S
0.278518.10967120.html.plaintext.txt	208	Consistently induction WT HNF4 resulted 2 fold increase endogenous HNF1 mRNA level whereas DN HNF4 completely eliminated HNF1 expression Fig
0.278518.10967120.html.plaintext.txt	209	To confirm HNF4 directly regulates HNF1 transcription transiently transfected WT HNF4 28 DN HNF4 26 cells luciferase reporter construct containing either wild type HNF1 gene promoter HNF1Luc promoter lacks functional HNF4 binding site AHNF1Luc
0.278518.10967120.html.plaintext.txt	210	6C overexpression WT HNF4 caused 2
0.278518.10967120.html.plaintext.txt	211	5 fold increase luciferase reporter enzyme activity WT HNF4 28 cells transfected HNF1Luc
0.278518.10967120.html.plaintext.txt	212	Deletion HNF4 binding site HNF1 promoter AHNF1 abolished activation induced WT HNF4 Fig
0.278518.10967120.html.plaintext.txt	213	In contrast induction DN HNF4 caused 71 reduction wild type HNF1 promoter activity Fig
0.278518.10967120.html.plaintext.txt	214	The inhibitory effect DN HNF4 longer present DN HNF4 26 cells transfected AHNF1Luc Fig
0.278518.10967120.html.plaintext.txt	215	Therefore HNF4 directly controls HNF1 gene expression pancreatic cells hepatocytes
0.278518.10967120.html.plaintext.txt	216	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.278518.10967120.html.plaintext.txt	217	It demonstrated HNF4 controls expression large array liver specific genes encoding several apolipoproteins metabolic proteins serum factors essential hepatocyte differentiation liver development 9
0.278518.10967120.html.plaintext.txt	218	HNF4 also required HNF1 expression hepatocytes 7 9
0.278518.10967120.html.plaintext.txt	219	Another study embryonic stem cell differentiated embryoid bodies 33 shows absence HNF4 affects expression genes encoding GLUT 2 aldolase B L PK involved glucose transport glycolysis
0.278518.10967120.html.plaintext.txt	220	However little known HNF4 regulates pancreatic cell gene expression
0.278518.10967120.html.plaintext.txt	221	The primary cause MODY1 phenotype impaired glucose stimulated insulin secretion pancreatic cells 5
0.278518.10967120.html.plaintext.txt	222	The present study therefore designed investigate role HNF4 regulation expression cell genes implicated glucose metabolism associated insulin secretion
0.278518.10967120.html.plaintext.txt	223	We found overexpression WT HNF4 caused left shift glucose stimulated insulin secretion whereas dominant negative suppression HNF4 selectively blunted insulin release induced glucose leucine K depolarization
0.278518.10967120.html.plaintext.txt	224	The diminished nutrient evoked insulin secretion associated reduced ATP production DN HNF4 expressing cells
0.278518.10967120.html.plaintext.txt	225	The physiological insulin secretagogue leucine raises cytosolic mitochondrial Ca2 concentrations mitochondrial metabolism downstream glycolysis 28 34
0.278518.10967120.html.plaintext.txt	226	Therefore suggest loss HNF4 function leads defective mitochondrial metabolism consequence impaired insulin secretion
0.278518.10967120.html.plaintext.txt	227	The reduced mitochondrial oxidation 2 14Cpyruvate abrogation mitochondrial membrane hyperpolarization elicited glucose pyruvate methyl succinate indicate impaired mitochondrial tricarboxylic acid cycle enzyme activity partial uncoupling mitochondrial respiratory chain
0.278518.10967120.html.plaintext.txt	228	Quantitative Northern blot analysis allows us identify HNF4 target genes responsible defective metabolism secretion coupling
0.278518.10967120.html.plaintext.txt	229	HNF4 indeed regulates expression genes encoding GLUT 2 aldolase B L PK pancreatic cells Fig
0.278518.10967120.html.plaintext.txt	230	5 inferred previous studies hepatocytes embryonic stem cell differentiated embryoid bodies 8 9
0.278518.10967120.html.plaintext.txt	231	Most importantly demonstrate HNF4 alters mRNA expression mitochondrial OGDH E1 subunit UCP 2 Fig
0.278518.10967120.html.plaintext.txt	232	5 may indeed contribute significantly impaired metabolism secretion coupling
0.278518.10967120.html.plaintext.txt	233	The phenotype gene expression patterns DN HNF4 expressing cells strikingly similar DN HNF1 expressing cells 22 29
0.278518.10967120.html.plaintext.txt	234	This prompted us investigate whether HNF4 regulates cell expression HNF1 function hepatocytes 9
0.278518.10967120.html.plaintext.txt	235	We provide unprecedented evidence HNF4 required HNF1 expression pancreatic cells
0.278518.10967120.html.plaintext.txt	236	This conclusion based use artificial dominant negative hnf4 mutation
0.278518.10967120.html.plaintext.txt	237	The naturally occurring human mutations HNF4 function dominant negative manner 6 35
0.278518.10967120.html.plaintext.txt	238	It expected mutation repressive action endogenous HNF4 function would cause embryonic lethality case hnf4 knock mouse 15
0.278518.10967120.html.plaintext.txt	239	Haploinsufficiency reduced gene dosage HNF4 may thus explain mechanism leading MODY1 phenotype 33
0.278518.10967120.html.plaintext.txt	240	The INS 1 cell line expressing DN HNF4 provides convenient model explore impact impaired HNF4 function cell gene expression metabolism secretion coupling
0.278518.10967120.html.plaintext.txt	241	This goal cannot achieved introduction one human HNF4 mutations cell lines
0.278518.10967120.html.plaintext.txt	242	In fact induction nonsense mutation HNF4Q268X level similar DN HNF4 detectable consequences cell gene expression metabolism secretion coupling
0.278518.10967120.html.plaintext.txt	243	MODY1 patients display secretory defects cells also glucagon secreting cells pancreatic polypeptide secreting cells 36 37
0.278518.10967120.html.plaintext.txt	244	However general effect islet hormone release seem due effect development differentiation endocrine pancreas since altered HNF4 function affect expression PDX1 transcription factors determining pancreatic phenotype
0.278518.10967120.html.plaintext.txt	245	On hand loss HNF4 function may cause reduced cell insulin content secondary defective HNF1 function 22 29
0.278518.10967120.html.plaintext.txt	246	Sarret expert technical assistance
0.278518.10967120.html.plaintext.txt	247	Iynedjian glucokinase cDNA U
0.278518.10967120.html.plaintext.txt	248	Bujard PUHD 10 3 plasmid N
0.278518.10967120.html.plaintext.txt	249	This work supported Swiss National Science Foundation Grant 32 49755
0.278518.10967120.html.plaintext.txt	250	96 European Union Network grant Swiss Federal Office Education Science research grant Eli Lilly
0.278518.10967120.html.plaintext.txt	251	The costs publication article defrayed part payment page charges
0.278518.10967120.html.plaintext.txt	252	The article must therefore hereby marked advertisement accordance 18 U
0.278518.10967120.html.plaintext.txt	253	Section 1734 solely indicate fact
0.278518.10967120.html.plaintext.txt	254	To correspondence addressed
0.278518.10967120.html.plaintext.txt	255	41 22 702 5548 Fax 41 22 702 5543 E mail Claes
0.278518.10967120.html.plaintext.txt	256	Published JBC Papers Press August 30 2000 DOI 10
0.278518.10967120.html.plaintext.txt	257	The abbreviations used HNF4 hepatocyte nuclear factor 4 MODY maturity onset diabetes young WT wild type DN dominant negative PCR polymerase chain reaction USF upstream stimulatory factors OGDH 2 oxoglutarate dehydrogenase L PK L pyruvate kinase EMSA electrophoretic mobility shift assay FCCP carbonyl cyanide p trifluoromethoxyphenylhydrazone Dox doxycycline
0.278518.10967120.html.plaintext.txt	258	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.278518.10967120.html.plaintext.txt	259	48 67 79CrossRefMedline Order article via Infotrieve 3
0.278518.10967120.html.plaintext.txt	260	269 8944 8951AbstractFree Full Text 4
0.278518.10967120.html.plaintext.txt	261	1996 Nature 384 458 460CrossRefMedline Order article via Infotrieve 5
0.278518.10967120.html.plaintext.txt	262	1999 Diabetes 48 423 425Free Full Text 15
0.278518.10967120.html.plaintext.txt	263	1995 Science 268 1766 1769Medline Order article via Infotrieve 17
0.278518.10967120.html.plaintext.txt	264	272 13892 13898AbstractFree Full Text 18
0.278518.10967120.html.plaintext.txt	265	272 539 550AbstractFree Full Text 19
0.278518.10967120.html.plaintext.txt	266	19 6509 6522AbstractFree Full Text 20
0.278518.10967120.html.plaintext.txt	267	1992 Endocrinology 130 167 178Abstract 21
0.278518.10967120.html.plaintext.txt	268	17 6701 6713AbstractFree Full Text 23
0.278518.10967120.html.plaintext.txt	269	272 18621 18627AbstractFree Full Text 24
0.278518.10967120.html.plaintext.txt	270	273 16146 16154AbstractFree Full Text 25
0.278518.10967120.html.plaintext.txt	271	16 3833 3841AbstractFree Full Text 26
0.278518.10967120.html.plaintext.txt	272	1989 Molecular Cloning A Laboratory Manual pp
0.278518.10967120.html.plaintext.txt	273	84 Cold Spring Harbor Laboratory Cold Spring Harbor NY 27
0.278518.10967120.html.plaintext.txt	274	2000 Diabetologia 43 265 277CrossRefMedline Order article via Infotrieve 29
0.278518.10967120.html.plaintext.txt	275	19 1 8AbstractFree Full Text 30
0.278518.10967120.html.plaintext.txt	276	1998 Diabetes 47 1817 1823Abstract 31
0.278518.10967120.html.plaintext.txt	277	22 44 52CrossRefMedline Order article via Infotrieve 32
0.278518.10967120.html.plaintext.txt	278	23 32 40CrossRefMedline Order article via Infotrieve 33
0.278518.10967120.html.plaintext.txt	279	94 13209 31214AbstractFree Full Text 34
0.278518.10967120.html.plaintext.txt	280	24 15 24Medline Order article via Infotrieve 35
0.278518.10967120.html.plaintext.txt	281	101 521 526AbstractFree Full Text 36
0.278518.10967120.html.plaintext.txt	282	1997 Diabetes 46 1749 1754Abstract 37
0.278518.10967120.html.plaintext.txt	283	2000 Diabetes 49 961 968Abstract
0.278518.10967120.html.plaintext.txt	284	Copyright 2000 The American Society Biochemistry Molecular Biology Inc
0.43641222.9020096.html.plaintext.txt	0	Transcriptional Regulation Hepatocyte Growth Factor Gene Nuclear Receptors Chicken Ovalbumin Upstream Promoter Transcription Factor Estrogen Receptor
0.43641222.9020096.html.plaintext.txt	1	Received publication August 17 1996 revised form October 22 1996
0.43641222.9020096.html.plaintext.txt	2	Jie Gen Jiang Aaron Bell Youhua Liu Reza Zarnegar
0.43641222.9020096.html.plaintext.txt	3	From Division Cellular Molecular Pathology Department Pathology School Medicine University Pittsburgh Pittsburgh Pennsylvania 15261 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES Acknowledgments REFERENCES
0.43641222.9020096.html.plaintext.txt	4	Hepatocyte growth factor HGF multifunctional cytokine controls growth differentiation various tissues
0.43641222.9020096.html.plaintext.txt	5	Previously described existence negative cis acting regulatory elements within 1 0
0.43641222.9020096.html.plaintext.txt	6	7 kilobase pair kb portion 5 flanking region mouse HGF promoter
0.43641222.9020096.html.plaintext.txt	7	In present study show repressor element located position 872 860 base pairs comprises imperfect estrogen responsive element 5 AGGTCAGAAAGACCA 3
0.43641222.9020096.html.plaintext.txt	8	We demonstrate chicken ovalbumin upstream promoter transcription factor COUP TF nuclear orphan receptor belonging steroidthyroid hormone receptor superfamily binding site effectively silences transcriptional activity HGF promoter
0.43641222.9020096.html.plaintext.txt	9	We show estrogen receptor hand relieves repressive action COUP TF resulting induction HGF promoter
0.43641222.9020096.html.plaintext.txt	10	Using mice transgenic either 2
0.43641222.9020096.html.plaintext.txt	11	7 kb HGF promoter region linked chloramphenicol acetyltransferase reporter gene found injection estradiol stimulates HGF promoter activity tissues mammary gland ovary mice harboring 2
0.43641222.9020096.html.plaintext.txt	12	7 kb mouse HGF promoter region
0.43641222.9020096.html.plaintext.txt	13	Potential involvement CCAATenhancer binding protein CEBP family transcription factors regulation HGF gene expression also discussed
0.43641222.9020096.html.plaintext.txt	14	Hepatocyte growth factor HGF1 originally identified major mitogenic component serum platelets normal adult rat hepatocytes 1 2
0.43641222.9020096.html.plaintext.txt	15	Further investigations revealed HGF multifunctional cytokine broad range target cells 3 4
0.43641222.9020096.html.plaintext.txt	16	HGF elicits biological effects binding activating specific transmembrane tyrosine kinase 4 6 known Met HGF receptor 7
0.43641222.9020096.html.plaintext.txt	17	HGF gene expression tightly regulated transcriptional level restricted stromal cells fibroblasts macrophages leukocytes endothelial cells various tissues
0.43641222.9020096.html.plaintext.txt	18	Numerous studies shown growth factor involved growth regeneration several organs 8 10
0.43641222.9020096.html.plaintext.txt	19	In response tissue loss case partial hepatectomy hepatotoxin injury level HGF mRNA dramatically increases liver well organs lung spleen 9 10
0.43641222.9020096.html.plaintext.txt	20	HGF mRNA also increases remaining kidney lung unilateral nephrectomy pneumonectomy respectively 9 10
0.43641222.9020096.html.plaintext.txt	21	Recent investigations transgenic mice homozygous null mutation HGF gene knock mice proved HGF essential development various tissues liver muscle placenta 11 12
0.43641222.9020096.html.plaintext.txt	22	HGF expression modulated several cytokines hormones
0.43641222.9020096.html.plaintext.txt	23	For example shown MRC 5 fibroblasts HL 60 cells HGF expression regulated transforming growth factor 1 dexamethasone coculture epithelial cells 13 15
0.43641222.9020096.html.plaintext.txt	24	In contrast phorbol esters interleukin 1 tumor necrosis factor increase HGF mRNA level 16 19
0.43641222.9020096.html.plaintext.txt	25	Overexpression HGF mRNA various neoplastic tissues also reported
0.43641222.9020096.html.plaintext.txt	26	To understand transcriptional regulation HGF sequences human rat mouse HGF gene promoters determined major transcriptional start sites mapped 20 23
0.43641222.9020096.html.plaintext.txt	27	Several potential regulatory sites including NF IL6 also known CEBP identified 5 flanking region mouse HGF promoter laboratory 22 well others 20 24
0.43641222.9020096.html.plaintext.txt	28	We reported identification partial characterization transcriptional repressor promoter mouse HGF gene 25
0.43641222.9020096.html.plaintext.txt	29	We also localized negative regulatory region 5 flanking region mouse HGF promoter residing position 1 0
0.43641222.9020096.html.plaintext.txt	30	In current study show COUP TF binds imperfect estrogen response element ERE region represses HGF promoter activity
0.43641222.9020096.html.plaintext.txt	31	We show high expression estrogen receptor counteracts suppressive action COUP TF competing binding site
0.43641222.9020096.html.plaintext.txt	32	COUP TF belongs orphan nuclear receptor family originally found interaction response element chicken ovalbumin gene promoter 26 27 shown play positive negative roles gene regulation upon binding cognate DNA regulatory element 28
0.43641222.9020096.html.plaintext.txt	33	The COUP TF family consists COUP TF I COUP TF II binds AGGTCA repeat sequence also DNA half site several nuclear receptors estrogen receptor ER vitamin D3 receptor thyroid hormone receptor retinoic acid receptors RAR RXR peroxisome proliferator activated receptor hepatic nuclear factor 4 HNF4 28 31
0.43641222.9020096.html.plaintext.txt	34	In previous studies reported estrogen stimulates HGF mRNA expression mouse ovaries 32
0.43641222.9020096.html.plaintext.txt	35	Our current results implicate COUP TF potent repressor HGF gene transcription provide new insights molecular mechanisms regulate HGF gene expression
0.43641222.9020096.html.plaintext.txt	36	4 mouse HGF CAT 1386 29 1
0.43641222.9020096.html.plaintext.txt	37	0 mouse HGF CAT 964 29 0
0.43641222.9020096.html.plaintext.txt	38	7 mouse HGF CAT 699 29 constructs prepared described 22
0.43641222.9020096.html.plaintext.txt	39	85 mouse HGF CAT construct made double digesting 1
0.43641222.9020096.html.plaintext.txt	40	4 mouse HGF CAT construct HindIIIAflII
0.43641222.9020096.html.plaintext.txt	41	85 mouse DHGF CAT construct harboring internal deletion generated digesting 1
0.43641222.9020096.html.plaintext.txt	42	0 kb HGF CAT construct AflII BstXI
0.43641222.9020096.html.plaintext.txt	43	Blunt ends created either Klenow polymerase T4 DNA polymerase corresponding fragments purified agarose gel electrophoresis ligated
0.43641222.9020096.html.plaintext.txt	44	For heterologous promoter constructs synthesized oligonucleotides HERE1 HERE2 inserted BglII site pCAT promoter 32
0.43641222.9020096.html.plaintext.txt	45	Cell Culture DNA Transfection CAT Assay
0.43641222.9020096.html.plaintext.txt	46	Human endometrial carcinoma RL95 2 cells human hepatoma HepG2 cells mouse fibroblast NIH3T3 cells obtained American Type Culture Collection Rockville MD cultured described previously 22
0.43641222.9020096.html.plaintext.txt	47	For transfection recipient cells cultured six well plates 24 h transfected various mouse HGF promoterCAT chimeric plasmids heterologous promoter constructs using DNA calcium phosphate method according instructions CellPhect transfection kit Pharmacia Biotech Inc
0.43641222.9020096.html.plaintext.txt	48	The galactosidase reference plasmid pCH110 Pharmacia used internal standard transfection efficiency
0.43641222.9020096.html.plaintext.txt	49	After cell transfection carried 16 h cells washed twice serum free medium
0.43641222.9020096.html.plaintext.txt	50	Complete medium containing 10 fetal calf serum added cells incubated additional 24 h harvesting test CAT activity
0.43641222.9020096.html.plaintext.txt	51	For co transfection experiments NIH3T3 cells pHEO human estrogen receptor expression plasmid pRS COUP human COUP TF expression plasmid phenol red free medium charcoal stripped fetal calf serum used
0.43641222.9020096.html.plaintext.txt	52	The amount plasmid used transfection 5 microg one chimerical CAT construct 1 microg pCH110 different amounts estrogen receptor COUP TF expression vectors indicated
0.43641222.9020096.html.plaintext.txt	53	Protein concentration used standard transfection efficiency co transfection experiments including COUP TF expression vector
0.43641222.9020096.html.plaintext.txt	54	CAT activity determined modified assay described previously 22
0.43641222.9020096.html.plaintext.txt	55	Transfection experiments performed least three separate times two independent preparations purified plasmid DNA
0.43641222.9020096.html.plaintext.txt	56	Preparation Nuclear Extracts
0.43641222.9020096.html.plaintext.txt	57	Human endometrial carcinoma RL95 2 cells human hepatoma HepG2 cells mouse fibroblast NIH3T3 cells originally obtained ATCC
0.43641222.9020096.html.plaintext.txt	58	Cells cultured conditions described previously 22 32
0.43641222.9020096.html.plaintext.txt	59	The nuclear extracts prepared already reported 25
0.43641222.9020096.html.plaintext.txt	60	Briefly cells growing 90 confluence washed cold phosphate buffered saline dislodged rubber policeman phosphate buffered saline
0.43641222.9020096.html.plaintext.txt	61	Cells pelleted low speed centrifugation resuspended 5 volumes Buffer A containing protease inhibitors 10 mM HEPES pH 7
0.43641222.9020096.html.plaintext.txt	62	2 mM phenylmethylsulfonyl fluoride 0
0.43641222.9020096.html.plaintext.txt	63	5 mM dithiothreitol plus 1 microg leupeptin chymostatin per ml placed ice 10 min
0.43641222.9020096.html.plaintext.txt	64	Immediately lysis solution transferred glass Dounce homogenizer homogenized 10 strokes using type B pestle
0.43641222.9020096.html.plaintext.txt	65	The nuclei collected centrifuging 15 min 3300 x g resuspended volume Buffer B Buffer A
0.43641222.9020096.html.plaintext.txt	66	Buffer B Buffer A except Nonidet P 40 omitted
0.43641222.9020096.html.plaintext.txt	67	After nuclei recovered centrifugation Buffer C 20 mM HEPES pH 7
0.43641222.9020096.html.plaintext.txt	68	2 mM phenylmethylsulfonyl fluoride 0
0.43641222.9020096.html.plaintext.txt	69	5 mM dithiothreitol plus 1 microg leupeptin chymostatin per ml added resuspend nuclei
0.43641222.9020096.html.plaintext.txt	70	Nuclear protein extracted Buffer D Buffer C substituting 10 mM KCl 1
0.43641222.9020096.html.plaintext.txt	71	The extracted nuclei centrifuged 45 min 50000 x g 4 degrees C supernatant collected dialyzed 60 mM KCl TGM 10 mM Tris HCl pH 7
0.43641222.9020096.html.plaintext.txt	72	6 10 glycerol 3 mM MgCl2 3 mM EGTA buffer using mini dialysis system Life Technologies Inc
0.43641222.9020096.html.plaintext.txt	73	The insoluble materials removed centrifugation small aliquots protein extract quickly frozen stored 80 degrees C protein concentration determined protein assay Bio Rad
0.43641222.9020096.html.plaintext.txt	74	Rat liver nonparenchymal cells isolated differential centrifugation collagenase digested rat liver perfusate provided George Michalopoulos Department Pathology University Pittsburgh
0.43641222.9020096.html.plaintext.txt	75	Cells washed twice cold phosphate buffered saline used make nuclear extracts method described
0.43641222.9020096.html.plaintext.txt	76	The following oligonucleotides used gel mobility shift assays vitellogenin A2 ERE VitA2ERE 5 GATCTAGGTCACAGTGACCTA 3 33 COUP 5 GATCTTTCTATGGTGTCAAAGGTCAAACT 3 30
0.43641222.9020096.html.plaintext.txt	77	The following sequences derived mouse HGF gene promoter 22 HERE1 5 GATCAAGGTCAGAAAGACCAT 3 HERE2 5 GATCTGGTCAATCTAACCA 3 AP1 5 GATCTGCCTTGACTTAGCGAG 3 IL 6RE 5 GATCAGAGCTGGGATCTG 3 CRE 5 GATCTTAAGACGTCATTTA 3 NF IL6 5 GATCCTTCTGAGGAAAGCTGC 3 GRE 5 GATCTTCTGGTGCTATTTCTTCTCATT 3 TIE 5 GATCGGGCGAATTGGTGTTCTGC 3
0.43641222.9020096.html.plaintext.txt	78	A DNA fragment corresponding nucleotide position 964 812 bp 5 flanking region mouse HGF gene isolated chimeric 1
0.43641222.9020096.html.plaintext.txt	79	4 mouse HGF CAT construct 22 restriction digestion AatIAflII
0.43641222.9020096.html.plaintext.txt	80	The 154 bp fragment purified labeled 32PdATP 3000 Cimmol Amersham Corp
0.43641222.9020096.html.plaintext.txt	81	filling blunt ending Klenow enzyme Life Technologies Inc
0.43641222.9020096.html.plaintext.txt	82	The double stranded oligonucleotides used gel shift assays also labeled 32P end labeling T4 kinase
0.43641222.9020096.html.plaintext.txt	83	The labeled probes gel purified used gel mobility shift assays described previously 25
0.43641222.9020096.html.plaintext.txt	84	Two micrograms polydI dC Pharmacia used nonspecific competitor 10 microl reaction mixture
0.43641222.9020096.html.plaintext.txt	85	When antibodies used supershift experiments 1 microl incubated nuclear extracts 15 min room temperature carrying DNA binding shift assays
0.43641222.9020096.html.plaintext.txt	86	The binding reactions 20 microl total volumereaction carried room temperature 20 min loading 5 nondenaturing polyacrylamide 191 acrylamidebisacrylamide gels
0.43641222.9020096.html.plaintext.txt	87	The concentration nuclear protein extracts used reaction 2 microg labeled probe 0
0.43641222.9020096.html.plaintext.txt	88	For competition experiments 100 fold molar excess unlabeled DNA fragments oligonucleotides included reaction mixture
0.43641222.9020096.html.plaintext.txt	89	001 M EDTA constant voltage 190 V dried autoradiographed using intensifying screens
0.43641222.9020096.html.plaintext.txt	90	Transgenic mice harboring various lengths 2
0.43641222.9020096.html.plaintext.txt	91	1 kb HGF promoter region fused CAT reporter gene recently generated characterized laboratory
0.43641222.9020096.html.plaintext.txt	92	2 Two different HGF CAT transgenic mouse lines used present study evaluate HGF promoter activity response estradiol
0.43641222.9020096.html.plaintext.txt	93	7 HGF CAT transgenic mouse lines three different founders harbor 2
0.43641222.9020096.html.plaintext.txt	94	7 kb HGF promoter contains HERE1 element
0.43641222.9020096.html.plaintext.txt	95	7 HGF CAT transgenic lines two different founders carry 0
0.43641222.9020096.html.plaintext.txt	96	7 kb HGF promoter region lacks HERE1 element
0.43641222.9020096.html.plaintext.txt	97	Transgenic mice maintained animal facilities University Pittsburgh Medical Center
0.43641222.9020096.html.plaintext.txt	98	All animal experiments conducted accordance National Institutes Health standards established Guidelines Care Use Experimental Animals
0.43641222.9020096.html.plaintext.txt	99	Mice injected subcutaneously 100 mg 17 estradiol Sigma per kg body weight volume 0
0.43641222.9020096.html.plaintext.txt	100	1 ml buffered saline containing 0
0.43641222.9020096.html.plaintext.txt	101	At 24 h injection groups eight animals killed cervical dislocation ovary organs dissected immediately frozen CAT assays
0.43641222.9020096.html.plaintext.txt	102	Identification cis Acting Repressor HGF Promoter
0.43641222.9020096.html.plaintext.txt	103	We previously reported existence negative regulatory region 5 flanking region mouse HGF gene located nucleotides 964 699 bp 22
0.43641222.9020096.html.plaintext.txt	104	To define region two additional HGF CAT chimeric constructs containing 5 deletion 0
0.43641222.9020096.html.plaintext.txt	105	85 HGF CAT internal deletion 0
0.43641222.9020096.html.plaintext.txt	106	85 DHGF CAT generated using restriction enzyme AflII Fig
0.43641222.9020096.html.plaintext.txt	107	Four different HGF CAT chimeric constructs 1
0.43641222.9020096.html.plaintext.txt	108	7 HGF CAT subsequently tested promoter activity transfection human endometrial carcinoma RL95 2 cells human hepatoma HepG2 cells mouse fibroblast NIH3T3 cells
0.43641222.9020096.html.plaintext.txt	109	Promoter activity construct determined CAT assays revealed 0
0.43641222.9020096.html.plaintext.txt	110	85 HGF CAT constructs consistently stronger promoter activity 0
0.43641222.9020096.html.plaintext.txt	111	These results suggest region nucleotides 964 812 bp contains negative cis acting elements negative trans acting factors may interact 154 bp DNA fragment repress HGF gene transcription
0.43641222.9020096.html.plaintext.txt	112	Localization cis acting repressor element 5 upstream flanking region mouse HGF promoter
0.43641222.9020096.html.plaintext.txt	113	Mouse HGF CAT constructs consisting series 5 deletions internal deletion transiently transfected NIH3T3 HepG2 RL95 2 cells
0.43641222.9020096.html.plaintext.txt	114	Graphical representation relative CAT activity normalization galactosidase shown
0.43641222.9020096.html.plaintext.txt	115	The results presented average least three independent experiments performed duplicate
0.43641222.9020096.html.plaintext.txt	116	The transfected plasmids two independent preparations
0.43641222.9020096.html.plaintext.txt	117	Numbers indicate insert sizes kb mouse HGF promoter region 5 CAT reporter gene
0.43641222.9020096.html.plaintext.txt	118	DNA fragments inserted correct 5 3 orientation relative transcription initiation site nucleotide boundaries confirmed sequencing
0.43641222.9020096.html.plaintext.txt	119	View Larger Version Image 18K GIF file
0.43641222.9020096.html.plaintext.txt	120	trans Acting Factors Interact cis Acting Negative Element Distinct Binding Region
0.43641222.9020096.html.plaintext.txt	121	To examine whether trans acting factors specifically bind 154 bp DNA fragment performed gel mobility band shift analysis using end labeled 154 bp fragment nuclear protein extracts NIH3T3 cells
0.43641222.9020096.html.plaintext.txt	122	Examination DNA protein complexes polyacrylamide gel electrophoresis nondenaturing conditions revealed prominent specific band slow electrophoretic mobility
0.43641222.9020096.html.plaintext.txt	123	This complex totally abrogated presence 100 fold molar excess unlabeled self probe competitor Fig
0.43641222.9020096.html.plaintext.txt	124	Since computer analysis nucleotide sequence DNA fragment identified consensus binding sites ERE CRE carried gel mobility band shift assays presence synthetic oligonucleotides corresponding individual consensus sequences HERE1 CRE potential binding sites present 5 flanking region mouse HGF
0.43641222.9020096.html.plaintext.txt	125	2 binding completely abolished 100 fold molar excess HERE1 oligonucleotide 872 860 bp added reaction mixtures Fig
0.43641222.9020096.html.plaintext.txt	126	On hand CRE oligonucleotide 100 fold molar excess compete binding site Fig
0.43641222.9020096.html.plaintext.txt	127	Other oligonucleotides found mouse HGF promoter corresponding GRE TIE AP1 IL 6RE NF IL6 HERE2 mutated version HERE1 also failed compete 154 bp DNA fragment binding nuclear protein present NIH3T3 cells Fig
0.43641222.9020096.html.plaintext.txt	128	We confirmed results DNase I footprinting analysis using NIH3T3 cells mouse liver tissue nuclear protein extracts
0.43641222.9020096.html.plaintext.txt	129	Taken together data suggest HERE1 nucleotides 872 860 5 GGTCAGAAAGACC 3 involved formation protein DNA complex
0.43641222.9020096.html.plaintext.txt	130	This binding sequence similar estrogen response element 5 AGGTCANNNTGACCT 3 see also Fig
0.43641222.9020096.html.plaintext.txt	131	Specific interaction 5 flanking region mouse HGF gene negative regulatory activity nuclear protein extracts
0.43641222.9020096.html.plaintext.txt	132	The 154 bp DNA fragment exerted negative regulatory function labeled 32P incubated nuclear protein extract NPE NIH3T3 cells
0.43641222.9020096.html.plaintext.txt	133	The binding reactions performed room temperature 20 min presence nonspecific competitor polydI dC
0.43641222.9020096.html.plaintext.txt	134	Several double stranded synthetic oligonucleotide sequences including HERE1 GRE CRE TIE AP1 IL 6RE NF IL6 HERE2 added reaction mixture compete binding indicated
0.43641222.9020096.html.plaintext.txt	135	C binding complex F free 32P labeled DNA probe
0.43641222.9020096.html.plaintext.txt	136	View Larger Version Image 76K GIF file
0.43641222.9020096.html.plaintext.txt	137	Synthetic mouse HERE1 sequence confers repression heterologous promoter
0.43641222.9020096.html.plaintext.txt	138	Shown left diagrammatic representation chimeric CAT constructs
0.43641222.9020096.html.plaintext.txt	139	Synthetic oligonucleotides corresponding mouse HERE1 HERE2 cloned position upstream SV40 promoter SV
0.43641222.9020096.html.plaintext.txt	140	These constructs transiently transfected NIH3T3 cells followed CAT assay described Experimental Procedures
0.43641222.9020096.html.plaintext.txt	141	Depicted right graphic representation relative promoter activity determined CAT assays
0.43641222.9020096.html.plaintext.txt	142	Each bar represents mean three independent transfection experiments
0.43641222.9020096.html.plaintext.txt	143	The nucleotide sequences wild type ERE VitA2ERE mouse HERE1 mouse HERE2 shown comparison
0.43641222.9020096.html.plaintext.txt	144	View Larger Version Image 27K GIF file
0.43641222.9020096.html.plaintext.txt	145	To assess functionality element synthetic HERE1 HERE2 mutated version HERE1 5 GGTCAATCTAACC 3 oligonucleotides linked heterologous pCAT promoter reporter gene Promega contains SV40 promoter promoter activity three different cell lines using transient transfection CAT assays determined
0.43641222.9020096.html.plaintext.txt	146	The results summarized Fig
0.43641222.9020096.html.plaintext.txt	147	HERE1 efficiently repressed SV40 promoter activity HepG2 RL95 2 NIH3T3 cells whereas HERE2 failed specifically bind nuclear protein Fig
0.43641222.9020096.html.plaintext.txt	148	2 lane 11 function
0.43641222.9020096.html.plaintext.txt	149	These results indicate HERE1 negatively modulates HGF promoter activity element functions context autologous promoter Fig
0.43641222.9020096.html.plaintext.txt	150	1 also context heterologous promoter Fig
0.43641222.9020096.html.plaintext.txt	151	Identification Binding Proteins COUP TF
0.43641222.9020096.html.plaintext.txt	152	To identify HERE1 binding proteins labeled HERE1 used probe gel mobility shift assays nuclear extracts NIH3T3 RL95 2 cells
0.43641222.9020096.html.plaintext.txt	153	In NIH3T3 nuclear extract specific complex abolished unlabeled HERE1 VitA2ERE wild type ERE COUP binding sites Fig
0.43641222.9020096.html.plaintext.txt	154	4A lanes 3 5 HERE2 GRE Fig
0.43641222.9020096.html.plaintext.txt	155	We used COUP binding site well known COUP TF binds AGGTCA motif regardless configuration single half site direct well indirect repeats various spacings 29
0.43641222.9020096.html.plaintext.txt	156	Although RL95 2 cell nuclear extract formed two different bands HERE1 probe bands totally abolished 100 fold molar excess unlabeled HERE1 VitA2ERE COUP oligonucleotides Fig
0.43641222.9020096.html.plaintext.txt	157	4A lanes 9 11 HERE2 GRE Fig
0.43641222.9020096.html.plaintext.txt	158	It known RL95 2 NIH3T3 cells express small amounts ER major function ER transcriptional regulation target genes induction 30 32
0.43641222.9020096.html.plaintext.txt	159	Given fact COUP TF mainly exerts repression target genes binding VitA2ERE 30 35 36 opted determine protein complex formed HERE1 COUP TF
0.43641222.9020096.html.plaintext.txt	160	To test possibility performed supershift assays using antibody COUP TF estrogen receptor nonimmune serum using labeled HERE1 probe
0.43641222.9020096.html.plaintext.txt	161	4 anti COUP TF antibody totally abrogated complex formation HERE1 probe nuclear proteins different sources NIH3T3 HepG2 RL95 2 Fig
0.43641222.9020096.html.plaintext.txt	162	4B nonparenchymal liver cells Fig
0.43641222.9020096.html.plaintext.txt	163	4C known express HGF gene
0.43641222.9020096.html.plaintext.txt	164	The anti ER antibody nonimmune control serum show effects Fig
0.43641222.9020096.html.plaintext.txt	165	These results demonstrate orphan nuclear receptor COUP TF binds HERE1 site HGF promoter region
0.43641222.9020096.html.plaintext.txt	166	It interest note HERE1 HERE2 also bind estrogen receptor receptor highly expressed 32
0.43641222.9020096.html.plaintext.txt	167	We previously demonstrated using extract RL95 2 cells transfected ER expression vector 32
0.43641222.9020096.html.plaintext.txt	168	Taken together findings indicate HERE1 like VitA2ERE interacts ER COUP TF
0.43641222.9020096.html.plaintext.txt	169	Identification proteins binding HERE1 element COUP TF
0.43641222.9020096.html.plaintext.txt	170	A HERE1 element labeled 32P incubated nuclear protein extracts NIH3T3 RL95 2 cells
0.43641222.9020096.html.plaintext.txt	171	Double stranded oligonucleotides including self COUP VitA2ERE HERE2 GRE added reaction mixture compete binding indicated 100 x
0.43641222.9020096.html.plaintext.txt	172	B C supershift HERE1 bound nuclear proteins NIH3T3 HepG2 RL95 2 rat liver nonparenchymal cell NPC nuclear extracts anti COUP TF antibody shown
0.43641222.9020096.html.plaintext.txt	173	Anti ER antibody normal rabbit serum also used comparison
0.43641222.9020096.html.plaintext.txt	174	The binding assays done described Experimental Procedures
0.43641222.9020096.html.plaintext.txt	175	C specific complex NS nonspecific complex F free 32P labeled DNA probe Ab antibody S normal rabbit serum
0.43641222.9020096.html.plaintext.txt	176	View Larger Version Image 49K GIF file
0.43641222.9020096.html.plaintext.txt	177	Modulation HGF Promoter Activity COUP TF ER
0.43641222.9020096.html.plaintext.txt	178	To test whether estrogen receptor relieves repression HGF promoter activity mediated COUP TF co transfected various HGF CAT chimeric constructs estrogen expression vector NIH3T3 cells
0.43641222.9020096.html.plaintext.txt	179	5 promoter activity 0
0.43641222.9020096.html.plaintext.txt	180	0 HGF CAT constructs contain HERE1 increased presence ER dose dependent manner
0.43641222.9020096.html.plaintext.txt	181	However activity 0
0.43641222.9020096.html.plaintext.txt	182	7 HGF CAT constructs affected ER since contain HERE1 region Fig
0.43641222.9020096.html.plaintext.txt	183	Similar results obtained HERE1 tested responsiveness ER context SV40 heterologous promoter
0.43641222.9020096.html.plaintext.txt	184	CAT assays NIH3T3 cell extracts co transfected chimeric constructs HERE1 SV40 CAT HERE2 SV40 CAT revealed addition increasing amounts estrogen receptor expression vector overcame suppressive function conferred SV40 promoter COUP TF bound HERE1 also highly stimulated SV40 promoter activity Fig
0.43641222.9020096.html.plaintext.txt	185	Interestingly HERE2 suppress SV40 promoter since bind COUP TF see Fig
0.43641222.9020096.html.plaintext.txt	186	2 lane 11 bound ER low affinity reported previously 32
0.43641222.9020096.html.plaintext.txt	187	Furthermore overexpression COUP TF pRS COUP NIH3T3 cells counteracted stimulatory function ER HERE1 effect HERE2 SV40 CAT construct Fig
0.43641222.9020096.html.plaintext.txt	188	These results demonstrate mouse HGF gene transcriptionally suppressed COUP TF via binding HERE1 element nucleotide 872 bp 5 flanking region mouse HGF gene
0.43641222.9020096.html.plaintext.txt	189	High expression ER counteracts suppressive function COUP TF competing ER binding HERE1
0.43641222.9020096.html.plaintext.txt	190	Overexpression ER relieves repression HGF promoter exerted COUP TF
0.43641222.9020096.html.plaintext.txt	191	Four different HGF CAT constructs 0
0.43641222.9020096.html.plaintext.txt	192	0 HGF CAT co transfected various concentrations pHEO human estrogen receptor expression vector indicated NIH3T3 cells presence estradiol 107 M
0.43641222.9020096.html.plaintext.txt	193	CAT activity normalized galactosidase activity relative CAT activities presented averages three independent experiments performed duplicate
0.43641222.9020096.html.plaintext.txt	194	View Larger Version Image 48K GIF file
0.43641222.9020096.html.plaintext.txt	195	COUP TF estrogen receptor counteract one anothers effects binding HERE1
0.43641222.9020096.html.plaintext.txt	196	A chimeric SV40 CAT plasmids containing HERE1 HERE2 co transfected increasing amounts ER expression vector NIH3T3 cells
0.43641222.9020096.html.plaintext.txt	197	The estrogen response HERE1 SV40 CAT HERE2 SV40 CAT constructs examined CAT assay
0.43641222.9020096.html.plaintext.txt	198	SV40 CAT plasmid included control
0.43641222.9020096.html.plaintext.txt	199	The activity construct normalized galactosidase activity relative CAT activities presented averages three independent experiments
0.43641222.9020096.html.plaintext.txt	200	B overexpression COUP TF repressed ER dependent estrogen stimulated response HERE1
0.43641222.9020096.html.plaintext.txt	201	Chimeric plasmids A co transfected estrogen receptor expression vector pHEO 0
0.43641222.9020096.html.plaintext.txt	202	2 microgwell various concentrations pRS COUP COUP TF expression vector NIH3T3 cells
0.43641222.9020096.html.plaintext.txt	203	CAT activity normalized protein concentration relative CAT activities presented averages least three independent experiments
0.43641222.9020096.html.plaintext.txt	204	Estradiol concentration 107 M
0.43641222.9020096.html.plaintext.txt	205	View Larger Version Image 30K GIF file
0.43641222.9020096.html.plaintext.txt	206	Stimulation Mouse HGF Promoter Transgenic Mice Estradiol
0.43641222.9020096.html.plaintext.txt	207	We previously showed injection estradiol mice dramatically stimulated HGF mRNA expression mouse ovary 32
0.43641222.9020096.html.plaintext.txt	208	Our present data reveal molecular mechanism estradiol stimulates HGF promoter counteraction ER COUP TF directly regulates mouse HGF promoter
0.43641222.9020096.html.plaintext.txt	209	Only high levels ER counteract suppression caused COUP TF bound HERE1
0.43641222.9020096.html.plaintext.txt	210	To confirm HERE1 functional responsible stimulation HGF mRNA estradiol vivo analyzed transgenic mice harbor 2
0.43641222.9020096.html.plaintext.txt	211	7 kb mouse HGF promoter linked CAT reporter gene
0.43641222.9020096.html.plaintext.txt	212	7 HGF CAT promoter construct transgenic mice carries HERE1 element regulated mammary tissue ovary injection estradiol Fig
0.43641222.9020096.html.plaintext.txt	213	On hand activity 0
0.43641222.9020096.html.plaintext.txt	214	7 HGF CAT construct contain HERE1 element change upon treatment estradiol data shown
0.43641222.9020096.html.plaintext.txt	215	This result strongly suggests vivo high expression ER counteracts COUP TF stimulates HGF mRNA expression
0.43641222.9020096.html.plaintext.txt	216	Estradiol stimulates HGF promoter activity transgenic mice
0.43641222.9020096.html.plaintext.txt	217	Cell extracts CAT assays prepared mammary gland adjacent skin ovary 2
0.43641222.9020096.html.plaintext.txt	218	7 HGF CAT transgenic mice harbor 2
0.43641222.9020096.html.plaintext.txt	219	7 kb HGF promoter region nontransgenic mice injection 17 estradiol 100 mgkg body weight control saline solution
0.43641222.9020096.html.plaintext.txt	220	Fifty micrograms total protein extract tissue subjected CAT assay
0.43641222.9020096.html.plaintext.txt	221	A graphic representation relative CAT activity normalization protein concentration shown
0.43641222.9020096.html.plaintext.txt	222	The results presented average least three groups mice
0.43641222.9020096.html.plaintext.txt	223	TG transgenic mouse NTG nontransgenic mouse AS adjacent skin mammary gland MG mammary gland OV ovary tissue E2 17 estradiol
0.43641222.9020096.html.plaintext.txt	224	View Larger Version Image 16K GIF file
0.43641222.9020096.html.plaintext.txt	225	Our previous studies shown negative regulatory element located within 964 699 5 flanking region mouse HGF gene 22
0.43641222.9020096.html.plaintext.txt	226	In region estrogen response element HERE1 identified binds ER responsible estradiol stimulation mouse HGF promoter RL95 2 cells co transfected ER expression vector 32
0.43641222.9020096.html.plaintext.txt	227	We show element binds high affinity nuclear orphan receptor COUP TF belongs steroidthyroid receptor superfamily silences activity HGF promoter
0.43641222.9020096.html.plaintext.txt	228	We demonstrate estrogen receptor competes COUP TF binding site thereby relieving repressive action COUP TF
0.43641222.9020096.html.plaintext.txt	229	There two imperfect EREs found mouse HGF promoter region called HERE1 HERE2 22 32
0.43641222.9020096.html.plaintext.txt	230	HERE1 localized 5 flanking region HERE2 first intron HGF gene
0.43641222.9020096.html.plaintext.txt	231	By using gel mobility band shift supershift assays demonstrated HERE1 similar ERE found vitellogenin vit gene 37 binds ER also COUP TF Fig
0.43641222.9020096.html.plaintext.txt	232	Co transfection ER COUP TF expression vectors NIH3T3 cells revealed HERE1 confers repressive function COUP TF heterologous SV40 promoter ER overcome suppression COUP TF also stimulated SV40 promoter Fig
0.43641222.9020096.html.plaintext.txt	233	In homologous mouse HGF promoter ER counteracted negative effects COUP TF Fig
0.43641222.9020096.html.plaintext.txt	234	The molecular mechanisms COUP TF mediated transcriptional repression partially understood
0.43641222.9020096.html.plaintext.txt	235	COUP TF acts via several different mechanisms inhibit target gene transcription including competition nuclear receptors occupancy DNA binding sites active repression basal transcription active repression transactivator dependent transcription quenching transactivator dependent transcription transrepression activated transcription titration common coregulator RXR 31 38
0.43641222.9020096.html.plaintext.txt	236	Our data shown reveal COUP TF may regulate mouse HGF promoter active repression basal transcription HERE1 suppresses basal SV40 promoter ER may activate HGF transcriptional activity replacing COUP TF relieving promoter repression Fig
0.43641222.9020096.html.plaintext.txt	237	COUP TF belongs orphan thus far ligand found bind directly regulate activity factor nuclear receptor family resembles thyroid hormone receptorsteroid hormone receptor superfamily 31 36
0.43641222.9020096.html.plaintext.txt	238	The mode represses target gene involves binding COUP TF AGGTCA motif arranged various configurations
0.43641222.9020096.html.plaintext.txt	239	direct repeats DR inverted repeats IR different numbers spacers ranging 0 8 nucleotides 31
0.43641222.9020096.html.plaintext.txt	240	Interestingly AGGTCA half site depending configuration forms response elements nuclear receptors estrogen receptor binds IR3 thyroid hormone receptor binds IR0 DR4 retinoid receptors RAR binds IR0 DR2 RXR binds DR5 DR1 vitamin D receptor binds DR3 HNF4 peroxisome proliferator activated receptor 31
0.43641222.9020096.html.plaintext.txt	241	It believed COUP TF directly competes receptors binding AGGTCA sequence thus inhibits transactivating functions
0.43641222.9020096.html.plaintext.txt	242	Suppression COUP TF also achieved part heterodimerization COUP TF RXR essential transactivating partner vitamin D3 receptor thyroid hormone receptor RAR thereby titrating RXR transcriptionally inactive complex 31 38
0.43641222.9020096.html.plaintext.txt	243	It tempting speculate addition ER members nuclear receptor family mentioned may bind COUP TF binding site HGF promoter HERE1 thus activate HGF transcription tissue specific manner
0.43641222.9020096.html.plaintext.txt	244	The COUP TF site HGF promoter however composed estrogen response element IR3 apparently binds estrogen receptor
0.43641222.9020096.html.plaintext.txt	245	Previous observations laboratory showed administration 17 estradiol immature female mice caused significant induction HGF mRNA ovaries 32
0.43641222.9020096.html.plaintext.txt	246	The tissue cell type specific expression mouse HGF gene estrogen may due different amounts hormone receptors tissues shown studies 37
0.43641222.9020096.html.plaintext.txt	247	Our present studies show high expression estrogen receptor NIH3T3 cells sufficient counteract suppression COUP TF mouse HGF promoter Fig
0.43641222.9020096.html.plaintext.txt	248	HGF promoter activity lack thereof transgenic mice also supports hypothesis estradiol stimulated HGF promoter mice carrying 2
0.43641222.9020096.html.plaintext.txt	249	7 HGF CAT construct contains HERE1 particularly tissues high expression ER Fig
0.43641222.9020096.html.plaintext.txt	250	In regard important understand HGF gene expression relieved COUP TF repression tissues ER may operational
0.43641222.9020096.html.plaintext.txt	251	The factors known activate HGF expression include cytokines IL 1 IL 6 tumor necrosis factor polypeptide growth factors epidermal growth factor
0.43641222.9020096.html.plaintext.txt	252	These agents exert gene regulatory function directly AGGTCA motif DNA binding site COUP TF
0.43641222.9020096.html.plaintext.txt	253	Although molecular mechanisms agents induce target genes fully understood well established utilize members AP1 CEBP nuclear factor B NFKB signal transducer activator transcription STAT family transcription factors
0.43641222.9020096.html.plaintext.txt	254	Indeed previous report 22 demonstrated several NF IL6 CEBP response elements exist 5 flanking region HGF promoter region IL 6 induces HGF promoter activity stromal fibroblast cell line stably transfected HGF CAT chimeric construct
0.43641222.9020096.html.plaintext.txt	255	In recent investigations using gel shift supershift CAT assays found functional CEBP binding sites exist HGF promoter
0.43641222.9020096.html.plaintext.txt	256	We also found co transfection expression vectors encoding CEBP CEBP HGF CAT vectors dramatically 20 fold stimulates transcriptional activity various HGF CAT promoter constructs even constructs contain COUP TF binding sites thus indicating promoter activation due interference COUP TF binding
0.43641222.9020096.html.plaintext.txt	257	3 These observations provide explanation HGF promoter released repression exerted negative acting factors COUP TF
0.43641222.9020096.html.plaintext.txt	258	The CEBP family transcription factors known consist regulators important cellular functions ranging metabolism cell growth differentiation
0.43641222.9020096.html.plaintext.txt	259	The physiological significance transcriptional regulation HGF gene ER COUP TF also remains elucidated
0.43641222.9020096.html.plaintext.txt	260	Nevertheless shown HGF COUP TF play important role embryonic development
0.43641222.9020096.html.plaintext.txt	261	COUP TFs differentially expressed restricted manner organogenesis 40
0.43641222.9020096.html.plaintext.txt	262	Both COUP TF I COUP TF II genes essential since COUP TF I mutants die prenatally COUP TF II mutants die utero 41
0.43641222.9020096.html.plaintext.txt	263	Additionally HGF believed one major mediators stromal epithelial interactions controlling growth morphogenesis various tissues breast 39
0.43641222.9020096.html.plaintext.txt	264	Studies embryological development tissues revealed steroid hormone induced ductal morphogenesis growth accomplished via interactions stromal epithelial compartments tissues 34
0.43641222.9020096.html.plaintext.txt	265	Therefore functions COUP TF ER development may mediated part ability regulate HGF gene expression
0.43641222.9020096.html.plaintext.txt	266	Our data shown shed light significant interplay among transcription factors ER COUP TF CEBP polypeptide growth factors HGF
0.43641222.9020096.html.plaintext.txt	267	This work supported Grant CN55D American Cancer Society Grant R01ES 06109 National Institute Environmental Health Sciences R
0.43641222.9020096.html.plaintext.txt	268	The costs publication article defrayed part payment page charges
0.43641222.9020096.html.plaintext.txt	269	The article must therefore hereby marked advertisement accordance 18 U
0.43641222.9020096.html.plaintext.txt	270	Section 1734 solely indicate fact
0.43641222.9020096.html.plaintext.txt	271	Present address Division Renal Diseases Dept
0.43641222.9020096.html.plaintext.txt	272	Medicine Rhode Island Hospital School Medicine Brown University Providence RI 02903
0.43641222.9020096.html.plaintext.txt	273	To correspondence addressed Dept
0.43641222.9020096.html.plaintext.txt	274	S419 Biomedical Science Tower School Medicine University Pittsburgh Pittsburgh PA 15261
0.43641222.9020096.html.plaintext.txt	275	412 648 8657 Fax 412 648 1916 E mail rezazarpitt
0.43641222.9020096.html.plaintext.txt	276	1 The abbreviations used HGF hepatocyte growth factor COUP TF chicken ovalbumin upstream promoter transcription factor ERE estrogen responsive element HERE HGF estrogen responsive element ER estrogen receptor CAT chloramphenicol acetyltransferase kb kilobase pairs bp base pairs CRE cAMP responsive element GRE glucocorticoid response element IL interleukin IL 6RE IL 6 responsive element RAR retinoic acid receptor RXR retinoid X receptor TIE transforming growth factor inhibitory element DHGF deleted HGF promoter construct VitA2 vitellogenin A2 DR direct repeats IR inverted repeats AP1 activated protein 1 NF IL6 nuclear factor interleukin 6 CEBP CCAATenhancer binding protein
0.43641222.9020096.html.plaintext.txt	277	Zarnegar manuscript preparation
0.43641222.9020096.html.plaintext.txt	278	Zarnegar manuscript preparation
0.43641222.9020096.html.plaintext.txt	279	Tsai generously providing us anti COUP TF antibody COUP TF expression vector pRS COUP
0.43641222.9020096.html.plaintext.txt	280	DeFrances critical review manuscript
0.43641222.9020096.html.plaintext.txt	281	49 3314 3320 Abstract Nakamura T
0.43641222.9020096.html.plaintext.txt	282	1989 Nature 342 440 443 CrossRefMedline Order article via Infotrieve Zarnegar R
0.43641222.9020096.html.plaintext.txt	283	129 1177 1180 Medline Order article via Infotrieve Bottaro D
0.43641222.9020096.html.plaintext.txt	284	1991 Science 251 802 804 Medline Order article via Infotrieve Naldini L
0.43641222.9020096.html.plaintext.txt	285	1991 Oncogene 6 501 504 Medline Order article via Infotrieve Weidner K
0.43641222.9020096.html.plaintext.txt	286	121 145 154 Abstract Park M
0.43641222.9020096.html.plaintext.txt	287	84 6379 6383 Abstract Lindroos P
0.43641222.9020096.html.plaintext.txt	288	1991 Hepatology 13 743 750 Medline Order article via Infotrieve Matsumoto K
0.43641222.9020096.html.plaintext.txt	289	196 114 120 Medline Order article via Infotrieve Kono S
0.43641222.9020096.html.plaintext.txt	290	186 991 998 Medline Order article via Infotrieve Schmidt C
0.43641222.9020096.html.plaintext.txt	291	1995 Nature 373 699 702 CrossRefMedline Order article via Infotrieve Uehara Y
0.43641222.9020096.html.plaintext.txt	292	1995 Nature 373 702 705 CrossRefMedline Order article via Infotrieve Matsumoto K
0.43641222.9020096.html.plaintext.txt	293	267 24917 24920 AbstractFree Full Text Nishino T
0.43641222.9020096.html.plaintext.txt	294	53 1233 1238 Abstract Tamura M
0.43641222.9020096.html.plaintext.txt	295	268 8140 8145 AbstractFree Full Text Matsumoto K
0.43641222.9020096.html.plaintext.txt	296	89 3800 3804 Abstract Nishino T
0.43641222.9020096.html.plaintext.txt	297	181 323 330 Medline Order article via Infotrieve Gohda E
0.43641222.9020096.html.plaintext.txt	298	301 107 110 CrossRefMedline Order article via Infotrieve Miyazawa K
0.43641222.9020096.html.plaintext.txt	299	1991 Biochemistry 30 9170 9176 Medline Order article via Infotrieve Okajima A
0.43641222.9020096.html.plaintext.txt	300	213 113 119 Abstract Liu Y
0.43641222.9020096.html.plaintext.txt	301	267 24917 24920 AbstractFree Full Text Aravamudan B
0.43641222.9020096.html.plaintext.txt	302	195 346 353 CrossRefMedline Order article via Infotrieve Plaschke Schlutter A
0.43641222.9020096.html.plaintext.txt	303	270 830 836 AbstractFree Full Text Liu Y
0.43641222.9020096.html.plaintext.txt	304	6 4259 4267 Medline Order article via Infotrieve Wang L
0.43641222.9020096.html.plaintext.txt	305	1989 Nature 340 163 166 CrossRefMedline Order article via Infotrieve Conneely O
0.43641222.9020096.html.plaintext.txt	306	1994 Molecular Biology Intelligence Unit Mechanism Steroid Hormone Regulation Gene Transcription Tsai M
0.43641222.9020096.html.plaintext.txt	307	12 4153 4163 Abstract Liu Y
0.43641222.9020096.html.plaintext.txt	308	13 1836 1846 Abstract Mangelsdorf D
0.43641222.9020096.html.plaintext.txt	309	1995 Cell 83 841 850 Medline Order article via Infotrieve Liu Y
0.43641222.9020096.html.plaintext.txt	310	104 173 181 CrossRefMedline Order article via Infotrieve Klein Hitpass L
0.43641222.9020096.html.plaintext.txt	311	16 647 663 Abstract Beato M
0.43641222.9020096.html.plaintext.txt	312	1989 Cell 56 335 344 Medline Order article via Infotrieve Kadowaki Y
0.43641222.9020096.html.plaintext.txt	313	92 4432 4436 Abstract Pereira F
0.43641222.9020096.html.plaintext.txt	314	53 503 508 CrossRefMedline Order article via Infotrieve Meyer M
0.43641222.9020096.html.plaintext.txt	315	1989 Cell 57 433 442 Medline Order article via Infotrieve Leng X
0.43641222.9020096.html.plaintext.txt	316	16 2332 2340 Abstract Niranjan B
0.43641222.9020096.html.plaintext.txt	317	1995 Development 121 2897 2908 AbstractFree Full Text Qiu Y
0.43641222.9020096.html.plaintext.txt	318	91 4451 4455 Abstract Kastner P
0.43641222.9020096.html.plaintext.txt	319	1995 Cell 83 859 869 Medline Order article via Infotrieve 1997 The American Society Biochemistry Molecular Biology Inc
0.38261595.10606640.html.plaintext.txt	0	Naturally occurring mutations human HNF4 gene impair function transcription factor varying degree Jorn Lausen Heike Thomas Ira Lemm Michael Bulman1 Michael Borgschulze Anja Lingott Andrew T
0.38261595.10606640.html.plaintext.txt	1	Institut fur Zellbiologie Tumorforschung Universitatsklinikum Essen Hufelandstrasse 55 D 45122 Essen Germany 1Department Vascular Medicine Diabetes Research School Postgraduate Medicine Health Sciences University Exeter UK
0.38261595.10606640.html.plaintext.txt	2	Received October 15 1999 Revised Accepted November 19 1999
0.38261595.10606640.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES The hepatocyte nuclear factor HNF4 member nuclear receptor superfamily regulates genes play critical role embryogenesis metabolism
0.38261595.10606640.html.plaintext.txt	4	Recent studies shown mutations human HNF4 gene cause rare form type 2 diabetes maturity onset diabetes young MODY1
0.38261595.10606640.html.plaintext.txt	5	To investigate properties naturally occurring HNF4 mutations analysed five MODY1 mutations R154X R127W V255M Q268X E276Q one mutation D69A found HepG2 hepatoma cells
0.38261595.10606640.html.plaintext.txt	6	Activation reporter genes transfection assays DNA binding studies showed MODY1 associated mutations result variable reduction function whereas D69A mutation showed increased activity promoters
0.38261595.10606640.html.plaintext.txt	7	None MODY mutants acted dominant negative manner thus excluding inactivation wild type factor critical event MODY development
0.38261595.10606640.html.plaintext.txt	8	A MODY3 associated mutation HNF1 gene well known target gene HNF4 results dramatic loss HNF4 binding site promoter indicating mutations HNF4 gene might cause MODY impaired HNF1 gene function
0.38261595.10606640.html.plaintext.txt	9	Based data propose two hit model MODY development
0.38261595.10606640.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In vertebrates tissue specific transcription factor hepatocyte nuclear factor HNF4 expressed liver kidney gut endocrine pancreas 12
0.38261595.10606640.html.plaintext.txt	11	HNF4 member nuclear receptor superfamily designated NR2A1 3 belongs 2A subfamily together HNF4ss 4 HNF4 5 closest related genes Xenopus mammals respectively
0.38261595.10606640.html.plaintext.txt	12	HNF4 initially described orphan receptor lacking identified ligand recently fatty acyl CoA thioesters proposed ligands 6
0.38261595.10606640.html.plaintext.txt	13	The DNA binding domain HNF4 consists two zinc finger motifs specifically interact DNA element found many promoters enhancers target genes
0.38261595.10606640.html.plaintext.txt	14	These target genes encode serum proteins well enzymes involved lipid amino acid glucose metabolism also tissue specific transcription factor HNF1 1
0.38261595.10606640.html.plaintext.txt	15	Based HNF4 binding site HNF1 promoter regulatory hierarchy proposed HNF4 playing superior role 7
0.38261595.10606640.html.plaintext.txt	16	However HNF4 promoter contains HNF1 binding site reverse regulatory cascade may also possible 8
0.38261595.10606640.html.plaintext.txt	17	The gene regulatory potential HNF4 clearly documented transfection experiments forced expression HNF4 activates several endogenous genes extent activation determined type recipient cell used 79 11
0.38261595.10606640.html.plaintext.txt	18	HNF4 also plays important role early phases embryogenesis since present maternal component egg amphibian species Xenopus 12 well Drosophila 13
0.38261595.10606640.html.plaintext.txt	19	In mouse embryonic expression HNF4 already observed primary endoderm day 4
0.38261595.10606640.html.plaintext.txt	20	Furthermore undifferentiated murine embryonic stem cells HNF4 gene expressed apparently using alternative promoter 15
0.38261595.10606640.html.plaintext.txt	21	The essential early function HNF4 mammals proven fact disruption murine HNF4 gene leads embryonic lethality due dysfunction visceral endoderm 1617
0.38261595.10606640.html.plaintext.txt	22	Lack HNF4 expression typical feature human renal cell carcinoma 18 far tumour associated mutations found unpublished data
0.38261595.10606640.html.plaintext.txt	23	In contrast mutations human HNF4 gene cause maturity onset diabetes young MODY1 rare form non insulin dependent diabetes mellitus 19
0.38261595.10606640.html.plaintext.txt	24	This disease inherited autosomal dominant pattern affects people usually age 25 years characterised defective secretion insulin ss cells pancreas reviewed 20
0.38261595.10606640.html.plaintext.txt	25	The mutants described far include two nonsense mutations R154X 21 Q268X 19 two frameshift mutations F75delT 22 K99fsdelAA 23 result truncated HNF4 proteins
0.38261595.10606640.html.plaintext.txt	26	In addition five missense mutations identified G115S R127W 2425 V255M 26 E276Q 27 V393I 28 affect various domains HNF4 protein
0.38261595.10606640.html.plaintext.txt	27	As HNF4 expressed ss cells 1 mutated HNF4 proteins expected pleiotropic phenotypes
0.38261595.10606640.html.plaintext.txt	28	However additional severe clinical phenotypes reported mutant carriers except secondary complications associated diabetes
0.38261595.10606640.html.plaintext.txt	29	Recently MODY1 associated decrease triglyceride concentration observed diabetic patients considered effect impaired expression hepatic apoCIII apoB 23
0.38261595.10606640.html.plaintext.txt	30	MODY3 identical clinical features MODY1 patients associated mutations gene encoding tissue specific transcription factor HNF1 reviewed 20
0.38261595.10606640.html.plaintext.txt	31	This fact supports hypothesis HNF4 HNF1 cooperate network transcription factors 2 strengthened finding MODY3 mutation HNF4 binding site HNF1 promoter 29
0.38261595.10606640.html.plaintext.txt	32	In present work analysed functional activity several MODY associated HNF4 mutations well novel mutation found human hepatoma cell line HepG2
0.38261595.10606640.html.plaintext.txt	33	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Plasmid constructions Expression vectors
0.38261595.10606640.html.plaintext.txt	34	To construct pOP mycHNF42 expression vector myc tag containing hexameric repeat Myc epitope amplified pCS2MT vector 30 5 primer 5 ATAAGAATGCGGCCGCGCTATGG AGCAAAAGCTC 3 3 primer 5 ATAAGAATGGCGGCCGCTCTAGAGGGGTACCAGGCCTTG 3 introducing two NotI underlined sites KpnI site italic respectively
0.38261595.10606640.html.plaintext.txt	35	The NotI fragment PCR product used replace cat gene pOP13CAT expression vector Stratagene
0.38261595.10606640.html.plaintext.txt	36	The human HNF42 cDNA amplified RcHNF42 expression vector 5 5 primer generating KpnI site italic 5 GGGGTACCATGCGACTCTCCAA AACC 3 SP6 primer 5 CTATTTAGGTGACACTATAG 3 cloned KpnI NotI fragment frame downstream myc tag
0.38261595.10606640.html.plaintext.txt	37	PCR performed Taq DNA polymerase Gibco BRL standard conditions
0.38261595.10606640.html.plaintext.txt	38	HNF4 mutants generated site directed mutagenesis Quick ChangeTM site directed mutagenesis kit Stratagene pOP mycHNF42 construct using following primer pairs D69A 5 GAGCTGTGCCGGCTGCAAG 3 5 CTT GCAGCCGGCACAGCTC 3 R154X 5 GTCCTGTCCTG ACAGATCACC 3 5 GGTGATCTGTCAGGACAGGAC 3 V255M 5 GATGAGCCGGATGTCCATACG 3 5 CGTA TGGACATCCGGCTCATC 3 E276Q 5 GATGACAATC AGTATGCCTACC 3 5 GGTAGGCATACTGATTGTCA TC 3 Q268X 5 CGATCTGCAGCTCCTAGAAGGG 3 5 CCCTTCTAGGAGCTGCAGATCG 3 R127W 5 CGG GACTGGATCAGCACTCG 3 5 CGAGTGCTGATCCAG TCCCG 3
0.38261595.10606640.html.plaintext.txt	39	The authenticity DNA fragments amplified PCR verified sequencing
0.38261595.10606640.html.plaintext.txt	40	The H4 tk luc 31 HNF1 594 207lucI 32 reporter gene constructs described pre viously
0.38261595.10606640.html.plaintext.txt	41	To establish rat apo AI 100014lucI reporter gene apo AI promoter 3334 cloned genomic DNA C2 cells PCR primer 5 CGCGGATCCGCGTTAGCGTTGCCAACACAGGGT 3 5 CGTAA GCTTCTCCCCCGGAGCTCTCCAACA 3 introducing BamHI HindIII restriction sites underlined respectively used insert promoter fragment nucleotides 1000 14 pXP1 luciferase vector 35
0.38261595.10606640.html.plaintext.txt	42	The human HNF1 promoter amplified 6 kb genomic fragment subcloned Bluescript SK previously isolated genomic phage library
0.38261595.10606640.html.plaintext.txt	43	The primers used PCR T3 primer 5 CATTAACCCTCACTAAAGGGA 3 primer introducing 5 HindIII restriction site 138 nt transcription start site 36
0.38261595.10606640.html.plaintext.txt	44	A SacI HindIII frag ment nucleotides 325138 cloned luciferase reporter gene vector based pGL Basic II gift Ludger Klein Hitpass named hHNF1 325138lucII
0.38261595.10606640.html.plaintext.txt	45	The hHNF1 325138mut reporter made site directed mutagenesis described using primers 5 GCTGAAGTCCCAAGTTCAGTCCC 3 5 GGGACTG AACTTGGGACTTCAGC 3
0.38261595.10606640.html.plaintext.txt	46	The exchanged nucleotides underlined represent MODY3 mutation found HNF1 promoter 29
0.38261595.10606640.html.plaintext.txt	47	The authenticity DNA fragments amplified PCR verified sequencing
0.38261595.10606640.html.plaintext.txt	48	Cell culture transfection immunofluorescence 293 E1A transformed embryonic human kidney cells HeLa cells cultured 37 degrees C Dulbecco modified Eagle medium DMEM penicillin 100 Uml strep tomycin 100 Uml 10 heat inactivated foetal calf serum Biochrome
0.38261595.10606640.html.plaintext.txt	49	For transient transfection 293 cells DNA calcium phosphate co precipitation method used 37
0.38261595.10606640.html.plaintext.txt	50	Twenty micrograms expression vector transfected 10 cm cell culture dish 0
0.38261595.10606640.html.plaintext.txt	51	1 mM chloroquine obtain optimal transfection efficiency
0.38261595.10606640.html.plaintext.txt	52	HeLa cells transfected Lipofectamine Gibco BRL using 2 microg reporter gene 0
0.38261595.10606640.html.plaintext.txt	53	3 microg expression vector 6 microl Lipofectamine 3
0.38261595.10606640.html.plaintext.txt	54	In transfection experiments final DNA concentration equalised addition pOP13 vector
0.38261595.10606640.html.plaintext.txt	55	Immunofluorescence performed essentially previously described 38 using HeLa 293 cells transfected 3
0.38261595.10606640.html.plaintext.txt	56	An aliquot 250 microl hybridoma supernatant monoclonal myc specific antibody 9E10 diluted 14 culture medium used primary antibody
0.38261595.10606640.html.plaintext.txt	57	The Cy3 conjugated secondary antibody code
0.38261595.10606640.html.plaintext.txt	58	415 166 100 Jackson ImmunoResearch visualised fluorescence microscopy
0.38261595.10606640.html.plaintext.txt	59	Extract preparation gel shifts High salt nuclear extracts cultured cells gel shift assays performed described 4
0.38261595.10606640.html.plaintext.txt	60	The reaction mixture gel shifts contained 2 microg total protein 150 ng salmon sperm DNA 104 c
0.38261595.10606640.html.plaintext.txt	61	32P labelled H4 oligonucleotide 37
0.38261595.10606640.html.plaintext.txt	62	For competition experiments oligonucleotides containing wild type mutated HNF4 binding site human HNF1 promoter used 5 CGGCTGAAGTCCAAAGTTCAGTCCCTTCGT 3 5 CTAGACGAAGGGACTGAAC TTTGGACTTCAGCCGAGCT 3
0.38261595.10606640.html.plaintext.txt	63	In mutated oligo nucleotide underlined base changed A T C G residue respectively
0.38261595.10606640.html.plaintext.txt	64	Competition performed 0
0.38261595.10606640.html.plaintext.txt	65	5 microl rat liver nuclear extracts per reaction 39 using labelled wild type oligonucleotide 104 c
0.38261595.10606640.html.plaintext.txt	66	increasing amounts unlabelled wild type mutant oligonucleotide
0.38261595.10606640.html.plaintext.txt	67	The total amount unlabelled DNA kept constant 150 ng adding salmon sperm DNA
0.38261595.10606640.html.plaintext.txt	68	Western blotting Western blotting performed using anti myc tag antibody 9E10 primary antibody horseradish peroxidase antibody secondary antibody detected using ECL system Amersham
0.38261595.10606640.html.plaintext.txt	69	Pellets incubated DNase I prior SDS PAGE
0.38261595.10606640.html.plaintext.txt	70	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Mutation HNF4 gene human hepatoma cell line HepG2 In search mutations HNF4 gene various tumour cell lines human origin observed altered migration PCR amplified fragment exon 2 upon denaturing gel electro phoresis
0.38261595.10606640.html.plaintext.txt	71	Direct sequencing PCR product revealed A well C residue position 206 bp downstream translation start site coding strand HepG2 DNA whereas nucleotide A found SK RC 8 cell line used control
0.38261595.10606640.html.plaintext.txt	72	Thus codon 69 encodes usual aspartic acid GAC D well amino acid alanine GCC A
0.38261595.10606640.html.plaintext.txt	73	The heterozygosity codon 69 initially found HepG2 cell line maintained laboratory several years also present HepG2 sample obtained CLS passage 30 Cell Line Services Heidelberg Germany well HepG2 variant C3A obtained ATTC CRL 10741 American Tissue Type Collection Manassas USA
0.38261595.10606640.html.plaintext.txt	74	Thus conclude heterozygous D69A mutation feature specific human hepatoma cell line HepG2
0.38261595.10606640.html.plaintext.txt	75	The mutation D69A changes amino acid P box CDGCKG first zinc finger DNA binding domain Fig
0.38261595.10606640.html.plaintext.txt	76	This element identical members HNF4 gene family considered hallmark nuclear receptor subfamily 1
0.38261595.10606640.html.plaintext.txt	77	To investigate whether mutated allele transcribed amplified cDNA HepG2 RNA using primer pair specific exons 2 4 HNF4 gene
0.38261595.10606640.html.plaintext.txt	78	Sequencing PCR product revealed A well C nucleotide position 206 implying transcription alleles
0.38261595.10606640.html.plaintext.txt	79	View larger version 35K Figure 1
0.38261595.10606640.html.plaintext.txt	80	Naturally occurring mutations within human HNF4 gene
0.38261595.10606640.html.plaintext.txt	81	The domain structure HNF4 protein given 1
0.38261595.10606640.html.plaintext.txt	82	The D69A mutation found HepG2 cells affects amino acid within P box first zinc finger DNA binding domain
0.38261595.10606640.html.plaintext.txt	83	The diabetes associated mutations whose functional properties analysed paper given
0.38261595.10606640.html.plaintext.txt	84	The D69A mutation detected MODY associated family Fig
0.38261595.10606640.html.plaintext.txt	85	A MODY3 associated mutation destroys HNF4 binding site HNF1 promoter The concept HNF4 HNF1 act together pathways strengthened fact HNF1 represents MODY3 gene
0.38261595.10606640.html.plaintext.txt	86	In MODY3 patients mutations found open reading frame HNF1 gene also nucleotide 58 promoter region 29
0.38261595.10606640.html.plaintext.txt	87	This region highly conserved Xenopus mammals corresponds HNF4 binding site 37
0.38261595.10606640.html.plaintext.txt	88	To analyse effect mutation prepared HNF1 promoter luciferase reporter gene containing sequence 325 138 human HNF1 gene well corresponding construct containing MODY3 mutation Fig
0.38261595.10606640.html.plaintext.txt	89	In transfection experiments using HeLa cells lack endogeneous HNF4 proteins wild type HNF1 promoter driven luciferase activity stimulated 35 fold increasing amounts expression vector encoding HNF4
0.38261595.10606640.html.plaintext.txt	90	In contrast reporter containing MODY3 mutation stimulated 4 fold addition HNF4 expression vector Fig
0.38261595.10606640.html.plaintext.txt	91	This demonstrates single nucleotide change 58 leads dramatic loss activation potential HNF1 promoter HNF4
0.38261595.10606640.html.plaintext.txt	92	To analyse whether effect mainly represented loss binding HNF4 site performed bandshift assays using corresponding labelled oligonucleotide rat liver nuclear extracts
0.38261595.10606640.html.plaintext.txt	93	Figure 2C demonstrates DNA protein complex shifted antibody specific HNF4
0.38261595.10606640.html.plaintext.txt	94	This complex competed efficiently adding increasing amounts unlabelled oligonucleotide whereas addition unlabelled competitor representing mutated HNF4 binding site effect
0.38261595.10606640.html.plaintext.txt	95	From input oligonucleotides competitors estimate MODY3 mutation HNF4 binding site reduces binding affinity HNF4 least factor 30
0.38261595.10606640.html.plaintext.txt	96	Based finding HNF1 promoter valuable reporter analyse function HNF4 derivatives within natural promoter context
0.38261595.10606640.html.plaintext.txt	97	View larger version 31K Figure 2
0.38261595.10606640.html.plaintext.txt	98	The MODY3 mutation HNF4 binding site HNF1 promoter results loss function
0.38261595.10606640.html.plaintext.txt	99	A Schematic representation hHNF1 325138lucII construct containing human HNF1 promoter given
0.38261595.10606640.html.plaintext.txt	100	The HNF4 binding site MODY3 mutation 58 human HNF1 promoter 29 marked
0.38261595.10606640.html.plaintext.txt	101	B Comparison transactivation wild type wt mutant mut HNF1 promoter transient transfection assays increasing amounts expression vector encoding wild type HNF4 HeLa cells
0.38261595.10606640.html.plaintext.txt	102	The total amount transfected DNA adjusted adding pOP13 vector DNA
0.38261595.10606640.html.plaintext.txt	103	Fold induction refers activity seen without HNF4 expression vector
0.38261595.10606640.html.plaintext.txt	104	The error bars indicate standard deviation six determinations
0.38261595.10606640.html.plaintext.txt	105	C Gel shift experiments done 0
0.38261595.10606640.html.plaintext.txt	106	5 microl rat liver extract using labelled HNF4 binding site probe
0.38261595.10606640.html.plaintext.txt	107	The retarded DNA protein complex supershift obtained HNF4 specific antibody marked arrow arrowhead respectively
0.38261595.10606640.html.plaintext.txt	108	The addition increasing amounts unlabelled wild type mutated oligonucleotide representing HNF4 binding site A given
0.38261595.10606640.html.plaintext.txt	109	The transactivation potentials HNF4 mutants To assess functional consequences mutations HNF4 gene introduced six mutations shown Figure 1 expression vector encoding myc tagged human HNF4 protein
0.38261595.10606640.html.plaintext.txt	110	Two mutants R154X Q268X nonsense mutants resulting truncated proteins whereas others missense mutants
0.38261595.10606640.html.plaintext.txt	111	Initially transfected saturating amounts expression vector together luciferase reporter gene containing either four HNF4 binding sites front thymidine kinase promoter human HNF1 promoter extending 325 138
0.38261595.10606640.html.plaintext.txt	112	The data given Figure 3 show missense mutant R127W retains 50 wild type activity whereas three missense mutants V255M E276Q D69A active wild type
0.38261595.10606640.html.plaintext.txt	113	In contrast nonsense mutants R154X Q268X completely lost transactivation potential
0.38261595.10606640.html.plaintext.txt	114	To look subtle changes activity mutated HNF4 proteins performed saturation curves missense mutants using increasing concentrations corresponding expression vectors compared wild type
0.38261595.10606640.html.plaintext.txt	115	Figure 4A shows R127W mutant less active concentrations tested whereas V255M E276Q mutants gave decreased transactivation values low expression vector input
0.38261595.10606640.html.plaintext.txt	116	However performance D69A mutant identical wild type protein
0.38261595.10606640.html.plaintext.txt	117	The experiments shown Figure 4A performed luciferase reporter containing human HNF1 promoter identical results obtained using reporter containing four HNF4 binding sites linked thymidine kinase promoter
0.38261595.10606640.html.plaintext.txt	118	As mutant D69A show difference transactivation potential tested two luciferase reporter constructs known activated HNF4
0.38261595.10606640.html.plaintext.txt	119	Using Xenopus HNF1 promoter 37 well rat apolipoprotein AI promoter 3334 D69A mutant 2 3 fold active wild type Fig
0.38261595.10606640.html.plaintext.txt	120	View larger version 68K Figure 3
0.38261595.10606640.html.plaintext.txt	121	Transactivation potential wild type mutated HNF4 transient transfection experiments saturation
0.38261595.10606640.html.plaintext.txt	122	The reporter constructs hHNF1 325138lucII A H4 tk luc B co transfected HeLa cells saturating amounts expression vector 300 ng encoding wild type mutated HNF4
0.38261595.10606640.html.plaintext.txt	123	Fold induction refers activity without HNF4 derivative
0.38261595.10606640.html.plaintext.txt	124	The error bars indicate standard deviation six determinations
0.38261595.10606640.html.plaintext.txt	125	View larger version 20K Figure 4
0.38261595.10606640.html.plaintext.txt	126	Saturation curves transactivation potential wild type mutated HNF4 transfection assays
0.38261595.10606640.html.plaintext.txt	127	A Increasing amounts expression vectors encoding HNF4 mutants given co transfected reporter construct hHNF1 325138lucII
0.38261595.10606640.html.plaintext.txt	128	The dotted solid lines represent activity mutant wild type respectively
0.38261595.10606640.html.plaintext.txt	129	B The expression vector encoding HNF4 mutant D69A co transfected either Xenopus HNF1 594207 promoter construct rat apoAI 100014lucI reporter
0.38261595.10606640.html.plaintext.txt	130	Fold induction refers activity without HNF4 derivative error bars indicate standard deviation six determinations
0.38261595.10606640.html.plaintext.txt	131	The mutated HNF4 proteins act dominant negative factors As HNF4 acts homodimer wondered whether mutated factors dominant negative effect wild type protein
0.38261595.10606640.html.plaintext.txt	132	Using HNF1 promoter driven luciferase reporter transfected expression vector encoding wild type andor R127W mutant HeLa cells
0.38261595.10606640.html.plaintext.txt	133	As Figure 5A illustrates transactivation potential mixture containing 30 ng wild type 30 ng mutant gave transactivation expected potentials components alone
0.38261595.10606640.html.plaintext.txt	134	Even amount mutant compared wild type increased transactivation always expected individual components data shown
0.38261595.10606640.html.plaintext.txt	135	Identical data obtained missense mutants
0.38261595.10606640.html.plaintext.txt	136	Using nonsense mutant R154X transactivation potential see Fig
0.38261595.10606640.html.plaintext.txt	137	3 addition 30 ng mutant 30 ng wild type alter transactivation wild type factor shown Figure 5B
0.38261595.10606640.html.plaintext.txt	138	Even 3 fold excess mutant wild type factor failed change activity mediated wild type HNF4 data shown
0.38261595.10606640.html.plaintext.txt	139	Similarly Q268X mutant also interfere transactivation potential wild type HNF4 co transfection experiments data shown
0.38261595.10606640.html.plaintext.txt	140	View larger version 42K Figure 5
0.38261595.10606640.html.plaintext.txt	141	Transactivation potential co transfected wild type mutant HNF4 human HNF1 promoter
0.38261595.10606640.html.plaintext.txt	142	Co transfection wild type HNF4 either R127W A R154X B done amount expression vector given
0.38261595.10606640.html.plaintext.txt	143	In experiment amount reporter gene construct total DNA transfected constant
0.38261595.10606640.html.plaintext.txt	144	Fold induction refers activity HNF4 derivative error bars indicate standard deviation six determinations
0.38261595.10606640.html.plaintext.txt	145	The nonsense mutants R154X Q268X deficient DNA binding The nonsense mutations R154X Q268X encode truncated HNF4 proteins retain entire DNA binding domain see Fig
0.38261595.10606640.html.plaintext.txt	146	To investigate DNA binding properties mutants prepared extracts 293 cells transfected corresponding expression vector
0.38261595.10606640.html.plaintext.txt	147	In western blots using antibody specific myc tag could detect R154X mutant protein nuclear salt extract insoluble pellet mutants
0.38261595.10606640.html.plaintext.txt	148	However Q268X mutant protein could seen insoluble pellet nuclear salt extract Fig
0.38261595.10606640.html.plaintext.txt	149	This insolubility Q268X protein also reported elsewhere using rat protein backbone 40
0.38261595.10606640.html.plaintext.txt	150	Therefore band shift assays binding oligonucleotide containing HNF4 binding site detected nuclear salt extracts Q268X mutant
0.38261595.10606640.html.plaintext.txt	151	In contrast R154X mutant showed retarded band although exclusively lane antibody indicating weak DNA binding stabilised upon antibody binding
0.38261595.10606640.html.plaintext.txt	152	Efficient binding obtained extracts transfected either wild type transcription factor missense mutants HNF4 Fig
0.38261595.10606640.html.plaintext.txt	153	View larger version 48K Figure 6
0.38261595.10606640.html.plaintext.txt	154	Western blot gel shift assay nuclear extracts transfected 293 cells
0.38261595.10606640.html.plaintext.txt	155	293 human embryonic kidney cells transfected expression vectors encoding wild type mutant HNF4 nuclear salt extracts prepared 24 h western blots A gel retardation assays B
0.38261595.10606640.html.plaintext.txt	156	The pellet fractions salt extracts solubilised DNase I digestion used western blots
0.38261595.10606640.html.plaintext.txt	157	Only pellet fractions E276Q Q268X shown
0.38261595.10606640.html.plaintext.txt	158	To visualise transfected HNF4 variants myc specific antibody 9E10 used western blots whereas monoclonal antibody H455 raised amino acids 1 114 rat HNF4 18 used gel retardation assays
0.38261595.10606640.html.plaintext.txt	159	The band 36 kDa detected western blot pellet fractions non specific also seen untransfected cells
0.38261595.10606640.html.plaintext.txt	160	Cellular localisation HNF4 mutants To monitor whether mutated HNF4 proteins show distinct distribution within cell determined cellular localisation immunofluorescence transfected HeLa 293 cells using antibody specific myc tag
0.38261595.10606640.html.plaintext.txt	161	Wild type HNF4 found 95 98 nuclear compartment distribution found missense mutants data shown
0.38261595.10606640.html.plaintext.txt	162	On hand myc tag antibody rarely detected signal derived transfected nonsense mutants R154X Q268X HeLa cells data shown
0.38261595.10606640.html.plaintext.txt	163	As truncated proteins detected western blots derived transfected cells assume myc tag accessible immunohistochemistry antibody constructs
0.38261595.10606640.html.plaintext.txt	164	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES By screening HNF4 gene human carcinoma cell lines identified D69A mutation HepG2 hepatoma cell line
0.38261595.10606640.html.plaintext.txt	165	As mutation affects allele expressed cell line increases transactivation potential HNF4 protein promoters finding relevant HepG2 cells one frequently used human models hepatic cell function
0.38261595.10606640.html.plaintext.txt	166	The HepG2 cell line established 1980 41
0.38261595.10606640.html.plaintext.txt	167	Our efforts identify whether mutation already germline occurred either tumour development establishment cell line unsuccessful due lack appropriate material
0.38261595.10606640.html.plaintext.txt	168	However mutation observed MODY patient date identify mutation HNF4 gene human hepatoma cells analysed unpublished data collaboration D
0.38261595.10606640.html.plaintext.txt	169	The D69A mutation alters amino acid P box first zinc finger
0.38261595.10606640.html.plaintext.txt	170	As residue conserved HNF4 proteins insects mammals 1 would assume plays crucial role
0.38261595.10606640.html.plaintext.txt	171	Our transfection experiments showed increased activity promoters
0.38261595.10606640.html.plaintext.txt	172	However effect quite small one may wonder residue conserved throughout evolution
0.38261595.10606640.html.plaintext.txt	173	We also investigated functional consequence mutation HNF4 binding site promoter HNF1 gene identified MODY3 family 29
0.38261595.10606640.html.plaintext.txt	174	By gel retardation assays could show mutated HNF4 binding site least 30 fold lower affinity HNF4 compared wild type binding site
0.38261595.10606640.html.plaintext.txt	175	Consistent dramatically reduced binding transfection experiments observed mutated promoter hardly stimulated HNF4
0.38261595.10606640.html.plaintext.txt	176	This finding establishes MODY3 mutation generating mutated HNF4 binding site largely destroys ability transactivation HNF4 thus represents loss function mutation HNF1 gene
0.38261595.10606640.html.plaintext.txt	177	It gives evidence HNF4 HNF1 cooperate ss cells pancreas thus genes constitute sensitive target development diabetes
0.38261595.10606640.html.plaintext.txt	178	Furthermore result indicates HNF1 promoter relevant reporter assay function HNF4 mutants transfection experiments
0.38261595.10606640.html.plaintext.txt	179	The importance HNF4 binding site HNF1 promoter shown transgenic Xenopus mutated HNF4 binding site Xenopus HNF1 promoter precludes expression HNF1 promoter transgenes pronephros 42
0.38261595.10606640.html.plaintext.txt	180	Our functional analysis mutated HNF4 proteins occur MODY patients reveals broad range effects performance transcription factor
0.38261595.10606640.html.plaintext.txt	181	The two nonsense mutants R154X Q268X lack transactivation potential interfere activity wild type factor
0.38261595.10606640.html.plaintext.txt	182	This conclusion previously made report investigating Q268X function 4043
0.38261595.10606640.html.plaintext.txt	183	As Q268X potential heterodimerise wild type HNF4 protein vitro proposed inability mutant affect activity wild type vivo may due altered subcellular localisation mutant compared wild type
0.38261595.10606640.html.plaintext.txt	184	The truncated proteins derived Q268X R154X retain DNA binding domain R154X binds DNA gel retardation assay Fig
0.38261595.10606640.html.plaintext.txt	185	This finding agreement systematic deletion analysis various domains HNF4 44 absence C terminal sequence amino acids 340 465 sequences located carboxyl residue 174 inhibit DNA binding truncated HNF4 variants
0.38261595.10606640.html.plaintext.txt	186	According result DNA binding activity observed R154X mutant expected
0.38261595.10606640.html.plaintext.txt	187	In contrast nonsense mutants three missense mutants also associated diabetes retain substantial transactivation potential Fig
0.38261595.10606640.html.plaintext.txt	188	In fact saturation mutants V255M E276Q gave identical transactivation compared wild type differed decreased activity low expression vector input
0.38261595.10606640.html.plaintext.txt	189	Under experimental conditions mutant R127W gave 2 3 fold lower transactivation concentrations tested
0.38261595.10606640.html.plaintext.txt	190	After completion work functional analysis three missense mutants published 45
0.38261595.10606640.html.plaintext.txt	191	The lack functional defect R127W V255M mutants report may overlooked use single concentration expression vector transfection assay
0.38261595.10606640.html.plaintext.txt	192	More significantly authors found transactivation E276Q mutant
0.38261595.10606640.html.plaintext.txt	193	This discrepancy may explained fact introduced mutation HNF4 protein rat since human protein carrying mutation found active another group 46 agreement finding
0.38261595.10606640.html.plaintext.txt	194	In fact authors 46 established major effect E276Q mutant involves impaired synergy mutated factor chicken ovalbumin upstream transcription factor II COUP TFII
0.38261595.10606640.html.plaintext.txt	195	A fourth MODY missense mutant HNF4 V393I shown 2 fold reduced transactivation activity 28
0.38261595.10606640.html.plaintext.txt	196	Thus missense mutants associated diabetes reduced transactivation potential whereas missense mutant found HepG2 cells increased activity least promoters Fig
0.38261595.10606640.html.plaintext.txt	197	Taken together functional data various HNF4 mutants associated diabetes show broad effect activity transcription factor
0.38261595.10606640.html.plaintext.txt	198	The consistent feature observed loss function
0.38261595.10606640.html.plaintext.txt	199	Mixing transcription factor reduced transactivation potential wild type factor yields intermediate activity assayed saturation additive value sub saturating conditions Fig
0.38261595.10606640.html.plaintext.txt	200	Such behaviour expected transcription factor acting dimer
0.38261595.10606640.html.plaintext.txt	201	Surprisingly none naturally occurring mutants analysed exhibited clear dominant negative effect Fig
0.38261595.10606640.html.plaintext.txt	202	5B would involve inactivation wild type factor although mechanism seems quite probable transcription factor acting dimer
0.38261595.10606640.html.plaintext.txt	203	Since different artificial mutants HNF4 generated several laboratories act dominant negative factors wild type factor 4347 49 speculate mutations compatible human development would inactivate essential functions wild type factor
0.38261595.10606640.html.plaintext.txt	204	This assumption strengthened fact knockout mice die early embryonic stages prior gastrulation 16
0.38261595.10606640.html.plaintext.txt	205	However quite puzzling loss function mutation one allele presence wild type allele leads development disease
0.38261595.10606640.html.plaintext.txt	206	Assuming gene dosage effect one would expect clinical differences nonsense mutations destroy gene e
0.38261595.10606640.html.plaintext.txt	207	R154X Q268X missense mutations hardly affect function HNF4
0.38261595.10606640.html.plaintext.txt	208	Such differences apparent could hidden individual differences various patients
0.38261595.10606640.html.plaintext.txt	209	As MODY1 patients born diabetes initially measurable abnormal function ss cells pancreas seem unlikely mutated HNF4 deficient specific function interaction COUP TF 46
0.38261595.10606640.html.plaintext.txt	210	It probable additional events occur time
0.38261595.10606640.html.plaintext.txt	211	Therefore speculate function wild type allele occasionally lost ss cells involving either somatic mutation epigenetic event
0.38261595.10606640.html.plaintext.txt	212	We imagine loss function wild type allele leads selective advantage thus allowing overgrowth original ss cell population
0.38261595.10606640.html.plaintext.txt	213	Such scenario reminiscent development tumours inherited cancer syndromes one tumour suppressor allele mutated germline inactivation wild type allele major step tumour formation 5051
0.38261595.10606640.html.plaintext.txt	214	Such two hit model also seems occur non malignant diseases notably inherited human autosomal dominant polycystic kidney disease characterised loss mutation normal allele 5253
0.38261595.10606640.html.plaintext.txt	215	Clearly speculation mechanism MODY development verified direct approaches
0.38261595.10606640.html.plaintext.txt	216	It would crucial show expression wild type HNF4 gene ss cells MODY patient gradually lost
0.38261595.10606640.html.plaintext.txt	217	However analysis cannot readily performed human system
0.38261595.10606640.html.plaintext.txt	218	Furthermore one identify HNF4 dependent processes maintain balance proliferation differentiation apoptosis within pancreatic ss cell population
0.38261595.10606640.html.plaintext.txt	219	ACKNOWLEDGEMENTS We thank Hassan Nakhei preparing rat apo AI 100014lucI reporter Fabian Esser liver nuclear extracts Bernhard Horsthemke human genomic library isolate HNF1 promoter
0.38261595.10606640.html.plaintext.txt	220	This work supported Deutsche Forschungsgemeinschaft Ry 54 1 British Diabetic Association
0.38261595.10606640.html.plaintext.txt	221	FOOTNOTES To correspondence addressed
0.38261595.10606640.html.plaintext.txt	222	Tel 49 201 723 3110 Fax 49 201 723 5905 Email gerhart
0.38261595.10606640.html.plaintext.txt	223	de Present address Ira Lemm McArdle Laboratory Cancer Research University Wisconsin Madison WI USA
0.38261595.10606640.html.plaintext.txt	224	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1 SladekF
0.38261595.10606640.html.plaintext.txt	225	1994 Liver Specific Gene Expression
0.38261595.10606640.html.plaintext.txt	226	3 Nuclear Receptors Nomenclature Committee 1999 Cell 97 161 163
0.38261595.10606640.html.plaintext.txt	227	1998 Nature 392 512 516
0.38261595.10606640.html.plaintext.txt	228	1992 Nature 355 457 461
0.38261595.10606640.html.plaintext.txt	229	1997 Development 124 279 287
0.38261595.10606640.html.plaintext.txt	230	1996 Nature 384 458 460
0.38261595.10606640.html.plaintext.txt	231	1999 Diabetes 48 423 425
0.38261595.10606640.html.plaintext.txt	232	1997 Diabetes 46 1652 1657
0.38261595.10606640.html.plaintext.txt	233	1997 Diabetologia 40 980 983
0.38261595.10606640.html.plaintext.txt	234	1997 Diabetologia 40 859 862
0.38261595.10606640.html.plaintext.txt	235	1997 Diabetes 46 1648 1651
0.38261595.10606640.html.plaintext.txt	236	1996 Development 122 1975 1984
0.38261595.10606640.html.plaintext.txt	237	1988 Biotechniques 6 454 458
0.38261595.10606640.html.plaintext.txt	238	1997 Diabetes 46 528 535
0.38261595.10606640.html.plaintext.txt	239	1998 Diabetes 47 985 990
0.38261595.10606640.html.plaintext.txt	240	1980 Science 209 497 499
0.38261595.10606640.html.plaintext.txt	241	1999 Diabetes 48 1459 1465
0.38261595.10606640.html.plaintext.txt	242	1999 Diabetes 48 1162 1167
0.38261595.10606640.html.plaintext.txt	243	1997 Science 278 1043 1050
0.49796134.10652338.html.plaintext.txt	0	Transcription Activation Orphan Nuclear Receptor Chicken Ovalbumin Upstream Promoter Transcription Factor I COUP TFI DEFINITION OF THE DOMAIN INVOLVED IN THE GLUCOCORTICOID RESPONSE OF THE PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE Takashi Sugiyama Jen Chywan Wang Donald K
0.49796134.10652338.html.plaintext.txt	1	From Department Molecular Physiology Biophysics Vanderbilt University School Medicine Nashville Tennessee 37232 0615
0.49796134.10652338.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.49796134.10652338.html.plaintext.txt	3	Chicken ovalbumin upstream promoter transcription factors COUP TFs orphan members nuclear receptor superfamily play key role regulation organogenesis neurogenesis cellular differentiation embryogenic development
0.49796134.10652338.html.plaintext.txt	4	COUP TFs also involved regulation several genes encode metabolic enzymes
0.49796134.10652338.html.plaintext.txt	5	Although COUP TFs function potent transcription repressors least three different molecular mechanisms activation gene expression COUP TFs
0.49796134.10652338.html.plaintext.txt	6	First previously shown COUP TF required accessory factor complete induction phosphoenolpyruvate carboxykinase gene transcription glucocorticoids
0.49796134.10652338.html.plaintext.txt	7	This action mediated binding COUP TF glucocorticoid accessory factor 1 gAF1 3 gAF3 elements phosphoenolpyruvate carboxykinase gene glucocorticoid response unit
0.49796134.10652338.html.plaintext.txt	8	In addition COUP TF1 binds DNA elements certain genes transactivates directly
0.49796134.10652338.html.plaintext.txt	9	Finally COUP TF1 serves coactivator DNA bound hepatic nuclear factor 4
0.49796134.10652338.html.plaintext.txt	10	Here show region COUP TFI located amino acids 184 423 involved three mechanisms transactivation COUP TFI
0.49796134.10652338.html.plaintext.txt	11	Furthermore show GRIP1 SRC 1 potentiate activity COUP TFI COUP TFI associates coactivators vivo using region required transcription activation
0.49796134.10652338.html.plaintext.txt	12	Finally overexpression GRIP1 SRC 1 convert COUP TFI transcriptional repressor transcriptional activator HeLa cells
0.49796134.10652338.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.49796134.10652338.html.plaintext.txt	14	The nuclear hormone receptor superfamily composed many diverse subsets transcriptional factors including receptors steroids retinoids thyroid hormones
0.49796134.10652338.html.plaintext.txt	15	Also included large number structurally functionally related transcription regulatory proteins termed orphan receptors named natural ligands identified 1 3
0.49796134.10652338.html.plaintext.txt	16	Chicken ovalbumin upstream promoter transcription factor COUP TF1 one studied orphan receptors
0.49796134.10652338.html.plaintext.txt	17	COUP TFI also termed EAR3 COUP TFII also termed ARP 1 closely related transcription factors expressed ubiquitously involved regulation several important biological processes neurogenesis organogenesis cell fate determination metabolic homeostasis 4 6
0.49796134.10652338.html.plaintext.txt	18	Targeted disruptions mouse COUP TFI COUP TFII result perinatal embryonic lethality respectively 7 8
0.49796134.10652338.html.plaintext.txt	19	COUP TFs also involved regulation transcription genes encode various metabolic enzymes phosphoenolpyruvate carboxykinase PEPCK EC 4
0.49796134.10652338.html.plaintext.txt	20	32 cholesterol 7 hydroxylase CYP7A EC 1
0.49796134.10652338.html.plaintext.txt	21	17 9 mitochondrial 3 hydroxy 3 methylglutaryl CoA synthase EC 4
0.49796134.10652338.html.plaintext.txt	22	COUP TFs homodimerize heterodimerize retinoid X receptor nuclear receptors bind wide variety response elements contain imperfect AGGTCA direct repeats separated variable number nucleotides 7 11
0.49796134.10652338.html.plaintext.txt	23	Although COUP TF initially identified activator chicken ovalbumin gene COUP TFs generally serve negative regulators conjunction nuclear hormone receptors retinoic acid receptor thyroid hormone receptor vitamin D receptor peroxisome proliferator activated receptor hepatocyte nuclear factor 4 HNF 4 11 13
0.49796134.10652338.html.plaintext.txt	24	Several mechanisms account repressive effects COUP TFs
0.49796134.10652338.html.plaintext.txt	25	COUP TFs bind number nuclear hormone receptor response elements thus compete receptors DNA elements
0.49796134.10652338.html.plaintext.txt	26	COUP TFs may also repress transcription forming nonproductive complexes retinoid X receptor essential heterodimer partner number nuclear hormone receptors
0.49796134.10652338.html.plaintext.txt	27	In addition least two direct mechanisms repression described
0.49796134.10652338.html.plaintext.txt	28	In one example termed active repression COUP TFs bind specific DNA elements repress forming direct interaction corepressors nuclear receptor corepressor silencing mediator retinoic acid thyroid hormone receptor SMRT 14
0.49796134.10652338.html.plaintext.txt	29	Finally COUP TFs repress transcription directly binding ligand binding domain nuclear hormone receptors process called transrepression 13 15
0.49796134.10652338.html.plaintext.txt	30	COUP TFs also activate transcription various promoter contexts 9 10 16 21
0.49796134.10652338.html.plaintext.txt	31	COUP TFII stimulates transcriptional activity rat CYP7A promoter binding nucleotide sequence located 74 54 relative transcription start site contains direct repeat two hormone response element half sites separated 4 nucleotides DR4 9
0.49796134.10652338.html.plaintext.txt	32	Furthermore COUP TFs function accessory factors hormonal response genes glucocorticoid response PEPCK estrogen response trout estrogen receptor gene 19
0.49796134.10652338.html.plaintext.txt	33	Finally COUP TFs also function coactivators
0.49796134.10652338.html.plaintext.txt	34	For instance COUP TFs potentiate HNF 4 mediated transactivation hepatocyte nuclear factor 1 HNF 1 gene promoter direct interaction HNF 4 without requirement DNA binding 17
0.49796134.10652338.html.plaintext.txt	35	A similar coactivator function described vHNF also termed HNF 1 gene promoter COUP TFs bind DNA directly potentiate transcriptional activity vHNF gene promoter DNA independent interaction Oct 1 20
0.49796134.10652338.html.plaintext.txt	36	Our interest directed role COUP TF plays hormonal regulation PEPCK gene
0.49796134.10652338.html.plaintext.txt	37	PEPCK catalyzes conversion oxaloacetate phosphoenolpyruvate rate controlling step hepatic gluconeogenesis
0.49796134.10652338.html.plaintext.txt	38	PEPCK gene transcription positively regulated glucocorticoids glucagon cAMP retinoic acid whereas insulin inhibits transcription PEPCK gene 22 24
0.49796134.10652338.html.plaintext.txt	39	Induction transcription PEPCK gene glucocorticoids achieved complex glucocorticoid response unit GRU see Fig
0.49796134.10652338.html.plaintext.txt	40	The GRU includes linear array 5 3 two glucocorticoid accessory factor binding sites gAF1 gAF22 two glucocorticoid receptor GR binding sites GR1 GR2 third accessory factor binding site gAF3 25 26
0.49796134.10652338.html.plaintext.txt	41	An intact cAMP response element located 93 86 also required full glucocorticoid response thus part GRU see Fig
0.49796134.10652338.html.plaintext.txt	42	The proteins mediate accessory activities gAF1 gAF2 gAF3 identified
0.49796134.10652338.html.plaintext.txt	43	Both HNF 4 COUP TF bind gAF1 element act accessory factors glucocorticoid response 27
0.49796134.10652338.html.plaintext.txt	44	A number factors bind gAF2 although binding hepatic nuclear factor 3 HNF 3 specifically correlates ability gAF2 element induce glucocorticoid response 28
0.49796134.10652338.html.plaintext.txt	45	COUP TF also binds gAF3 acts accessory factor element 26
0.49796134.10652338.html.plaintext.txt	46	Thus COUP TF serves accessory factor required induction PEPCK gene transcription glucocorticoids gAF1 element gAF3 element see Fig
0.49796134.10652338.html.plaintext.txt	47	The goal study begin elucidate mechanism COUP TF acts transactivator transcription
0.49796134.10652338.html.plaintext.txt	48	We first identify minimal region molecule amino acids 184 423 confers transactivation function COUP TFI
0.49796134.10652338.html.plaintext.txt	49	This distinct previously described repression domain COUP TFI 13
0.49796134.10652338.html.plaintext.txt	50	The activation domain mediates gAF1 gAF3 accessory activity glucocorticoid response PEPCK gene responsible transactivation CYP7A COUP TFII binding site enables COUP TFI function coactivator HNF 4
0.49796134.10652338.html.plaintext.txt	51	GRIP1 SRC 1 potentiate transactivation function COUP TFI
0.49796134.10652338.html.plaintext.txt	52	However system wherein COUP TF repressive coactivators cannot convert COUP TFI activator
0.49796134.10652338.html.plaintext.txt	53	GRIP1 SRC 1 interact COUP TFI vivo interactions require intact activation domain defined function experiments
0.49796134.10652338.html.plaintext.txt	54	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.49796134.10652338.html.plaintext.txt	55	Plasmid Construction The preparation PEPCK promoter CAT reporter construct pPL32 described previously 29
0.49796134.10652338.html.plaintext.txt	56	The plasmids pGAL4gAF1 pGAL4gAF2 derived pPL32 polymerase chain reaction megaprimer method
0.49796134.10652338.html.plaintext.txt	57	The plasmids pGAL4gAF3 pGALgAF1 gAF3 series site directed mutations pABGAL4 COUP TFI pRSV COUP TFI constructed using Quick Change site directed mutagenesis kit Stratagene
0.49796134.10652338.html.plaintext.txt	58	The sequences oligonucleotides used study shown Table I
0.49796134.10652338.html.plaintext.txt	59	Expression plasmids full length human COUP TFI pRSV hCOUP TFI 11 pRSV hCOUP TFD15 13 gifts Dr
0.49796134.10652338.html.plaintext.txt	60	Ming Jer Tsai Baylor College Medicine Houston TX
0.49796134.10652338.html.plaintext.txt	61	Plasmids encode GAL4 COUP TFI chimeras including GAL4 human COUP TFI pABGAL147 hCOUP TFI 11 pABGAL147 COUP TFD15 pABGAL147 COUP TFD35 13 also provided Dr
0.49796134.10652338.html.plaintext.txt	62	View table Table I Oligonucleotides Used This Study All sequences written 5 3 direction
0.49796134.10652338.html.plaintext.txt	63	A KpnIHindIII fragment pLcat62 30 inserted KpnIHindIII sites pGL3 Basic vector Promega Madison WI generate LPK LUC reporter plasmid
0.49796134.10652338.html.plaintext.txt	64	Three copies COUP TF binding site CYP7A promoter positions 74 54 relative transcription start site placed upstream minimal L pyruvate kinase promoter fragment within LPK LUC reporter plasmid generate plasmid CYP7ADR43LPK LUC using oligonucleotides CYP7Aa CYP7Ab
0.49796134.10652338.html.plaintext.txt	65	The 5 overhangs XhoIBamHI fragment GAL45E1b CAT plasmid 31 filled using Klenow reaction subcloned SmaI sites pGL3 Basic vector Promega generate GAL45E1b LUC
0.49796134.10652338.html.plaintext.txt	66	To generate constructs expression proteins yeast cDNAs encode wild type protein mutation C terminal region COUP TFI amplified polymerase chain reaction using primers COUP TFIa COUP TFIb COUP TFIa COUP TFIc respectively generate EcoRI BamHI site
0.49796134.10652338.html.plaintext.txt	67	Each polymerase chain reaction product digested EcoRI BamHI subcloned pGBT9 plasmid CLONTECH
0.49796134.10652338.html.plaintext.txt	68	The resulting plasmids named pGBT9 COUP TFI156423 pGBT9 COUP TFI156408 respectively
0.49796134.10652338.html.plaintext.txt	69	Yeast plasmids pGBD424 GRIPFL 32 pGAD424 SRC 1a 33 gifts Dr
0.49796134.10652338.html.plaintext.txt	70	Michael Stallcup University Southern California Los Angeles CA
0.49796134.10652338.html.plaintext.txt	71	The DNA sequence constructs verified dideoxy sequencing
0.49796134.10652338.html.plaintext.txt	72	All oligonucleotides produced Perceptive Biosystems Expedite 8909 DNA synthesizer located Vanderbilt University Diabetes Research Training Center DNA chemistry core laboratory
0.49796134.10652338.html.plaintext.txt	73	Transient Transfection The maintenance transfection H4IIE HepG2 HeLa cells measurement CAT activity described previously 25 34 35
0.49796134.10652338.html.plaintext.txt	74	In transfection experiments using LUC reporters firefly luciferase activity normalized Renilla luciferase activity using Promega dual luciferase kit control transfection efficiency
0.49796134.10652338.html.plaintext.txt	75	The mammalian expression vector pSV2GR provided Dr
0.49796134.10652338.html.plaintext.txt	76	Keith Yamamoto University California San Francisco CA
0.49796134.10652338.html.plaintext.txt	77	Yeast Two Hybrid Assays In vivo protein protein interaction assays performed using Matchmaker yeast two hybrid system CLONTECH
0.49796134.10652338.html.plaintext.txt	78	A yeast plasmid pGBT9 COUP TFI156423 pGBT9 COUP TFI156408 transformed yeast strain SFY526 transformants selected synthetic dropout plates contained medium lacking tryptophan
0.49796134.10652338.html.plaintext.txt	79	Yeast plasmids pGAD424 GRIP1FL pGAD424 SRC 1a transformed yeast strain SFY526 contained either pGBT9 COUP TFI156423 pGBT9 COUP TFI156408
0.49796134.10652338.html.plaintext.txt	80	These transformants selected synthetic dropout plates medium lacking leucine tryptophan
0.49796134.10652338.html.plaintext.txt	81	The colonies grew selection media subjected liquid assays expression galactosidase described technical manual Matchmaker yeast two hybrid system CLONTECH
0.49796134.10652338.html.plaintext.txt	82	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.49796134.10652338.html.plaintext.txt	83	GAL4 COUP TFI Confers Both gAF1 gAF3 Activity We previously demonstrated accessory factor activity COUP TF required maximal induction PEPCK gene glucocorticoids
0.49796134.10652338.html.plaintext.txt	84	COUP TF accomplishes binding gAF1 gAF3 elements Refs
0.49796134.10652338.html.plaintext.txt	85	We first examined whether COUP TFI mediate accessory activity tethered GAL4 DNA binding domain GAL4DBD establish system would allow us map domain required accessory factor activity COUP TF
0.49796134.10652338.html.plaintext.txt	86	Constructs made wherein either gAF1 gAF3 alone pGAL4gAF1 pGAL4gAF3 respectively gAF1 gAF3 together pGAL4gAF1 AF3 replaced yeast GAL4 DNA binding sites context wild type PEPCK promoter CAT fusion gene construct pPL32 Fig
0.49796134.10652338.html.plaintext.txt	87	The substitution gAF1 gAF3 GAL4 DNA binding element resulted 70 80 reduction glucocorticoid response compared pPL32 compare lines 2 4 line 1 Fig
0.49796134.10652338.html.plaintext.txt	88	This loss function equivalent obtained mutations abolish gAF1 gAF3 activity 25 27 36
0.49796134.10652338.html.plaintext.txt	89	Cotransfection vector encodes GAL4DBD pGAL4gAF1 pGAL4gAF3 pGAL4gAF1 AF3 reporter constructs little effect glucocorticoid response lines 1 3 5 Fig
0.49796134.10652338.html.plaintext.txt	90	By contrast cotransfection reporter gene plasmid encodes chimeric protein consisting region COUP TFI GAL4DBD GAL4 COUP TFI156423 restored glucocorticoid response level found cells transfected pPL32 compare lines 2 4 6 Fig
0.49796134.10652338.html.plaintext.txt	91	Indeed presence GAL4 COUP TFI156423 pGAL4gAF3 construct provided glucocorticoid response significantly greater provided pPL32
0.49796134.10652338.html.plaintext.txt	92	This may explained fact COUP TF binds relatively low affinity gAF3 26
0.49796134.10652338.html.plaintext.txt	93	Thus GAL4DBD provides higher affinity binding site COUP TF context pGAL4gAF3 construct present context wild type promoter
0.49796134.10652338.html.plaintext.txt	94	The gAF1 gAF3 elements cannot function accessory factor elements either placed position normally occupied gAF2 37
0.49796134.10652338.html.plaintext.txt	95	GAL4 COUP TFI156423 cotransfected pGAL4gAF2 reporter plasmid determine whether accessory activity provided GAL4 COUP TFI156423 sensitive location within PEPCK gene promoter GRU
0.49796134.10652338.html.plaintext.txt	96	GAL4 COUP TFI156423 unable provide accessory factor activity glucocorticoid response bound gAF2 element compare line 8 Fig
0.49796134.10652338.html.plaintext.txt	97	These results indicate GAL4 COUP TFI confers accessory activity gAF1 gAF3
0.49796134.10652338.html.plaintext.txt	98	Furthermore GAL4 COUP TFI activity restricted location within promoter manner similar authentic COUP TF 26
0.49796134.10652338.html.plaintext.txt	99	View larger version 13K Fig
0.49796134.10652338.html.plaintext.txt	100	Schematic diagram PEPCK gene promoter GRU
0.49796134.10652338.html.plaintext.txt	101	The cis acting elements associated trans acting factors required complete glucocorticoid response shown
0.49796134.10652338.html.plaintext.txt	102	The location cis element respect transcription start site shown schematic PEPCK promoter
0.49796134.10652338.html.plaintext.txt	103	Also shown sequences gAF1 gAF3 elements relative locations
0.49796134.10652338.html.plaintext.txt	104	CEBP CAATenhancer binding protein
0.49796134.10652338.html.plaintext.txt	105	View larger version 49K Fig
0.49796134.10652338.html.plaintext.txt	106	A GAL4 COUP TF1 chimeric protein confers accessory activity PEPCK glucocorticoid response gAF1 gAF3
0.49796134.10652338.html.plaintext.txt	107	Mutations made context full length wild type WT PEPCK gene promoter construct pPL32 gAF1 gAF3 replaced DNA binding site yeast transcription factor GAL4
0.49796134.10652338.html.plaintext.txt	108	As shown panel A ability mutant constructs lines 2 4 confer glucocorticoid response compared wild type construct line 1
0.49796134.10652338.html.plaintext.txt	109	H4IIE cells transfected 10 microg reporter plasmid 5 microg pSV2GR expression vector indicated additional 5 microg vector expresses either GAL4DBD GAL4 COUP TF chimeric protein
0.49796134.10652338.html.plaintext.txt	110	The cells treated overnight without 0
0.49796134.10652338.html.plaintext.txt	111	5 microM dexamethasone Dex CAT activity measured cell extracts
0.49796134.10652338.html.plaintext.txt	112	A schematic representation domains COUP TFI shown top panel B
0.49796134.10652338.html.plaintext.txt	113	Vectors express GAL4DBD GAL4 COUP TF1 fusion protein cotransfected mutant reporters described assess whether GAL4 COUP TF1 restore complete glucocorticoid response
0.49796134.10652338.html.plaintext.txt	114	The data represent mean plus minus S
0.49796134.10652338.html.plaintext.txt	115	n 3 8 fold induction dexamethasone treated response divided untreated response CAT activity
0.49796134.10652338.html.plaintext.txt	116	None mutations depicted affects basal expression reporter gene
0.49796134.10652338.html.plaintext.txt	117	The EF Region COUP TFI Confers Accessory Activity Glucocorticoid Response Both gAF1 gAF3 A number constructs made wherein portions D EF regions COUP TFI see diagram Fig
0.49796134.10652338.html.plaintext.txt	118	2B fused GAL4DBD map domains COUP TFI confer accessory activity glucocorticoid response
0.49796134.10652338.html.plaintext.txt	119	These constructs cotransfected pGAL4gAF1 pGAL4gAF3 pGAL4gAF1 AF3 reporter plasmids ability various GAL4 COUP constructs confer accessory activity glucocorticoid response monitored
0.49796134.10652338.html.plaintext.txt	120	The results experiments summarized Fig
0.49796134.10652338.html.plaintext.txt	121	In tests expression three reporter plasmids identical
0.49796134.10652338.html.plaintext.txt	122	Deletion extreme C terminus residues 409 423 resulted complete loss accessory activity Fig
0.49796134.10652338.html.plaintext.txt	123	However deletion D hinge region located amino acids 156 183 affect glucocorticoid response Fig
0.49796134.10652338.html.plaintext.txt	124	Interestingly constructs represent variety deletions COUP TF resulted complete loss accessory activity Fig
0.49796134.10652338.html.plaintext.txt	125	Gel shift analyses confirmed equivalent expression GAL4 COUP TFI mutants described Fig
0.49796134.10652338.html.plaintext.txt	126	3 well ability constructs bind DNA data shown
0.49796134.10652338.html.plaintext.txt	127	Thus EF region COUP TFI located amino acids 184 423 critical accessory factor activity provided either gAF1 gAF3
0.49796134.10652338.html.plaintext.txt	128	View larger version 29K Fig
0.49796134.10652338.html.plaintext.txt	129	The EF region COUP TF1 required complete induction PEPCK gene glucocorticoids
0.49796134.10652338.html.plaintext.txt	130	Ten microg reporter constructs contain mutations wherein gAF1 gAF3 replaced GAL4 DNA binding site cotransfected H4IIE cells 5 microg plasmids express various GAL4 COUP TF1 fusion proteins 5 microg pSV2GR expression vector
0.49796134.10652338.html.plaintext.txt	131	The cells treated overnight without 0
0.49796134.10652338.html.plaintext.txt	132	5 microM dexamethasone Dex CAT activity measured cell extracts
0.49796134.10652338.html.plaintext.txt	133	A plus represents complete restoration glucocorticoid response conferred GAL4 COUP TF1 construct depicted line 1
0.49796134.10652338.html.plaintext.txt	134	A minus indicates fusion protein unable confer accessory activity glucocorticoid response
0.49796134.10652338.html.plaintext.txt	135	Each transfection performed least three times
0.49796134.10652338.html.plaintext.txt	136	The basal rate transcription reporter genes similar experiments
0.49796134.10652338.html.plaintext.txt	137	The EF Region COUP TFI Also Confers Transactivation Activity COUP TFI The enzyme CYP7A catalyzes first rate controlling step pathway converts cholesterol bile acids liver 9
0.49796134.10652338.html.plaintext.txt	138	COUP TF transactivates rat CYP7A gene promoter binding sequence TGGTCActcaAGTTCA comprised two imperfect direct repeat nuclear hormone receptor half sites separated 4 base pairs DR4 9
0.49796134.10652338.html.plaintext.txt	139	A construct made wherein three copies CYP7A COUP TF binding site positions 74 54 placed upstream minimal L pyruvate kinase promoter fragment turn positioned 5 luciferase reporter gene CYP7ADR43LPK LUC
0.49796134.10652338.html.plaintext.txt	140	This construct used test whether COUP TFI provides direct activation transcription context heterologous promoter
0.49796134.10652338.html.plaintext.txt	141	Surprisingly full length pRSV COUP TFI construct construct deletion hinge region pRSV COUP TFID167183 increased expression LPK LUC vector cotransfected HeLa cells Fig
0.49796134.10652338.html.plaintext.txt	142	This vector contain known COUP TF binding sites could weak cryptic COUP TFI binding sites particularly since COUP TF binds wide range sequences 7 11
0.49796134.10652338.html.plaintext.txt	143	Most importantly pRSV COUP TFI pRSV COUP TFID167183 reporter gene vectors potentiated expression much greater degree empty vector luciferase activity CYP7ADR43LPK LUC reporter construct cotransfected HeLa cells
0.49796134.10652338.html.plaintext.txt	144	In contrast cotransfection C terminal deletion mutant pRSV COUP TFID15 internal ligand binding domain deletion mutant pRSV COUP TFID184281 affect expression reporter plasmid Fig
0.49796134.10652338.html.plaintext.txt	145	Thus EF region COUP TFI required accessory factor activity PEPCK gene promoter Fig
0.49796134.10652338.html.plaintext.txt	146	3 also important activating function COUP TFI CYP7A gene hormone response elements
0.49796134.10652338.html.plaintext.txt	147	Furthermore activity appear cell specific equivalent results obtained HeLa H4IIE cells H4IIE cell data shown
0.49796134.10652338.html.plaintext.txt	148	View larger version 18K Fig
0.49796134.10652338.html.plaintext.txt	149	The EF region COUP TF1 required transactivation DR4 element CYP7A gene promoter
0.49796134.10652338.html.plaintext.txt	150	A reporter construct made wherein three copies DR4 element CYP7A gene promoter ligated upstream minimal pyruvate kinase gene promoter luciferase reporter gene CYP7ADR43LPK LUC
0.49796134.10652338.html.plaintext.txt	151	HeLa cells cotransfected 10 microg LPK LUC CYP7ADR43LPK LUC reporter constructs without 5 microg vectors express COUP TF1 various mutations protein along 5 microg pSVGR1 expression vector 0
0.49796134.10652338.html.plaintext.txt	152	1 microg pRL SV40 vector Renilla luciferase
0.49796134.10652338.html.plaintext.txt	153	Empty expression vectors also transfected total amount DNA transfection experimental group identical
0.49796134.10652338.html.plaintext.txt	154	The luciferase activities measured cell lysates 18 h transfection
0.49796134.10652338.html.plaintext.txt	155	The fold increase basal activity LPK LUC indicated bar
0.49796134.10652338.html.plaintext.txt	156	The data represent mean firefly luciferase activity normalized Renilla luciferase activity plus minus S
0.49796134.10652338.html.plaintext.txt	157	represent least three independent experiments
0.49796134.10652338.html.plaintext.txt	158	The EF Region COUP TFI Potentiates HNF 4 Activity Its Activity Coactivator COUP TFs act coactivators HNF 4 mediated transactivation elements bind HNF 4 COUP TFs 17
0.49796134.10652338.html.plaintext.txt	159	A series expression plasmids encode wild type COUP TFI various mutations COUP TFI cotransfected HeLa cells GAL4 HNF 4 GAL4DBD reporter gene GAL45E1b LUC contained five copies GAL4 binding site define regions required coactivator activity COUP TFI
0.49796134.10652338.html.plaintext.txt	160	The activity GAL4 HNF 4 increased 30 fold cotransfected HeLa cells full length pRSV COUP TFI pRSV COUP TFID167183 constructs
0.49796134.10652338.html.plaintext.txt	161	By contrast pRSV COUP TFD15 pRSV COUP TFID184281 effective GAL4DBD construct Fig
0.49796134.10652338.html.plaintext.txt	162	These observations considered results described suggest functional domains COUP TFI required three mechanisms COUP TF activation located amino acids 184 423
0.49796134.10652338.html.plaintext.txt	163	Furthermore functional property appear require specific cellular environment since qualitatively similar results observed H4IIE cells transfected data shown
0.49796134.10652338.html.plaintext.txt	164	View larger version 15K Fig
0.49796134.10652338.html.plaintext.txt	165	The EF region COUP TF1 required coactivator activity orphan receptor HNF 4
0.49796134.10652338.html.plaintext.txt	166	HeLa cells cotransfected reporter construct contains five GAL4 DNA binding sites positioned upstream minimal E1b promoter ligated luciferase reporter gene 0
0.49796134.10652338.html.plaintext.txt	167	5 microg construct expresses either GAL4DBD GAL4DBD ligated HNF 4 5 microg construct expresses COUP TF various mutations protein 0
0.49796134.10652338.html.plaintext.txt	168	1 microg pRL SV40 vector
0.49796134.10652338.html.plaintext.txt	169	Empty expression vectors also transfected total amount DNA constant experimental group
0.49796134.10652338.html.plaintext.txt	170	Luciferase activities measured cell lysates 18 h transfection
0.49796134.10652338.html.plaintext.txt	171	The data represent mean firefly luciferase activity normalized Renilla luciferase activity plus minus S
0.49796134.10652338.html.plaintext.txt	172	least three separate transfections
0.49796134.10652338.html.plaintext.txt	173	The Coactivators GRIP1 SRC 1 Potentiate Transactivation COUP TF1 Many nuclear hormone receptors activate transcription interaction coactivators 38
0.49796134.10652338.html.plaintext.txt	174	We tested whether coactivators SRC 1 GRIP1 known interact variety nuclear hormone receptors could potentiate COUP TF activation
0.49796134.10652338.html.plaintext.txt	175	Expression plasmids encode either GRIP1 SRC 1 cotransfected HeLa cells reporter plasmid CYP7ADR43LPK LUC without plasmid encodes full length COUP TFI
0.49796134.10652338.html.plaintext.txt	176	6 neither GRIP1 SRC 1 potentiated reporter gene absence expressed COUP TFI whereas GRIP1 SRC 1 potentiated transactivation mediated COUP TFI expression 2 3 fold
0.49796134.10652338.html.plaintext.txt	177	The effects two coactivators additive plasmids encode cotransfected together reporter construct data shown
0.49796134.10652338.html.plaintext.txt	178	These results suggest coactivators GRIP1 SRC 1 coactivate COUP TFI mediated transactivation
0.49796134.10652338.html.plaintext.txt	179	This response also cell type specific similar results obtained H4IIE cells transfected data shown
0.49796134.10652338.html.plaintext.txt	180	View larger version 18K Fig
0.49796134.10652338.html.plaintext.txt	181	GRIP1 SRC 1 potentiate transactivation activity COUP TF1
0.49796134.10652338.html.plaintext.txt	182	HeLa cells cotransfected 10 microg CYP7ADR43LPK LUC reporter construct 5 microg vectors express either GRIP1 SRC 1 pGBD424 GRIPFL pGAD424SRC 1a respectively 32 33 0
0.49796134.10652338.html.plaintext.txt	183	1 microg pRL SV40 vector
0.49796134.10652338.html.plaintext.txt	184	Luciferase activities measured cell lysates 18 h transfection
0.49796134.10652338.html.plaintext.txt	185	The data represent mean firefly luciferase activity normalized Renilla luciferase activity plus minus S
0.49796134.10652338.html.plaintext.txt	186	COUP TFI Interacts GRIP1 SRC 1 Vivo We used yeast two hybrid system examine whether COUP TFI interacts either GRIP1 SRC 1 define regions COUP TFI required interaction
0.49796134.10652338.html.plaintext.txt	187	Galactosidase activity induced chimeric fusion protein encodes GAL4 activation domain GRIP1 SRC 1 coexpressed GAL4DBD COUP156423
0.49796134.10652338.html.plaintext.txt	188	In contrast GAL4 activation domain alone induce galactosidase activity Fig
0.49796134.10652338.html.plaintext.txt	189	These data indicate EF region COUP TFI interacts SRC 1 GRIP1
0.49796134.10652338.html.plaintext.txt	190	There detectable galactosidase activity experiment performed GAL4 COUP TFI156408 Fig
0.49796134.10652338.html.plaintext.txt	191	7 result demonstrates C terminal 15 amino acids required protein protein interaction COUP TF coactivators
0.49796134.10652338.html.plaintext.txt	192	These results establish correlation activation function COUP TF ability COUP TF bind SRC 1 GRIP1 since 15 amino acid region required activities
0.49796134.10652338.html.plaintext.txt	193	View larger version 15K Fig
0.49796134.10652338.html.plaintext.txt	194	COUP TF1 interacts GRIP1 SRC 1 vivo
0.49796134.10652338.html.plaintext.txt	195	Yeast cells co transformed plasmids pGBT9 COUP156423 pGBT9 COUP156408 pGAD424 pGAD424 GRIP1 pGAD424 SRC 1 described Materials Methods
0.49796134.10652338.html.plaintext.txt	196	Colonies grown synthetic dropout plates lacking Leu Trp subjected liquid assay galactosidase Gal activity
0.49796134.10652338.html.plaintext.txt	197	The data represent mean units galactosidase activity plus minus S
0.49796134.10652338.html.plaintext.txt	198	least three separate determinations
0.49796134.10652338.html.plaintext.txt	199	The C terminal 15 Amino Acid Segment COUP TFI Is Required Activation Is Dispensable Active Repression Shibata et al
0.49796134.10652338.html.plaintext.txt	200	14 demonstrate C terminus COUP TFI interacts corepressors nuclear receptor corepressor SMRT interaction postulated cause COUP TF function active repressor DNA dependent manner
0.49796134.10652338.html.plaintext.txt	201	13 demonstrate C terminal 15 amino acid segment could deleted slight reduction ability COUP TF actively repress basal transcription thymidine kinase minimal promoter
0.49796134.10652338.html.plaintext.txt	202	Thus exception C terminal 15 amino acids region required repression overlaps activation region COUP TFI defined
0.49796134.10652338.html.plaintext.txt	203	We next tested whether GAL4 COUP TFI156423 GAL4 COUP TFID15 could repress basal transcription GAL45E1b LUC reporter gene contains five GAL4 DNA binding sites positioned upstream E1b minimal promoter
0.49796134.10652338.html.plaintext.txt	204	Cotransfection GAL4 COUP TF constructs repressed basal transcriptional activity provided reporter compare lane 1 lanes 2 5 Fig
0.49796134.10652338.html.plaintext.txt	205	Therefore C terminal 15 amino acids required repression result consistent previous reports 13 14
0.49796134.10652338.html.plaintext.txt	206	These data demonstrate repression activation domains COUP TF different least C terminal 15 amino acids
0.49796134.10652338.html.plaintext.txt	207	View larger version 24K Fig
0.49796134.10652338.html.plaintext.txt	208	The overexpression coactivators fails alter active repression activity COUP TF1
0.49796134.10652338.html.plaintext.txt	209	HeLa cells cotransfected 10 microg GAL45E1b LUC reporter construct 0
0.49796134.10652338.html.plaintext.txt	210	1 microg pRL SV40 vector 5 microg vectors express either GAL4 COUP TFI GAL4 COUP TFID15 chimeric proteins 5 microg vectors express either GRIP1 SRC 1 indicated
0.49796134.10652338.html.plaintext.txt	211	Empty expression vectors cotransfected total DNA concentration identical group
0.49796134.10652338.html.plaintext.txt	212	Eighteen hours transfection luciferase activities measured cell lysates
0.49796134.10652338.html.plaintext.txt	213	The data represent mean firefly luciferase activity normalized Renilla luciferase activity plus minus S
0.49796134.10652338.html.plaintext.txt	214	Overexpression Coactivators Does Not Reverse Repressive Effect COUP TFI The bifunctional activity COUP TF could explained context dependent equilibrium corepressors coactivators
0.49796134.10652338.html.plaintext.txt	215	By view overexpression coactivators could allow COUP TF switch transrepressor transactivator 14
0.49796134.10652338.html.plaintext.txt	216	As test hypothesis GRIP1 Fig
0.49796134.10652338.html.plaintext.txt	217	8 lanes 3 6 SRC 1 Fig
0.49796134.10652338.html.plaintext.txt	218	8 lanes 4 7 cotransfected HeLa cells GAL4 COUP TFI156423 GAL4 COUP TFID15 GAL45E1b LUC reporter gene
0.49796134.10652338.html.plaintext.txt	219	Overexpression coactivators override active repressive effect COUP TF
0.49796134.10652338.html.plaintext.txt	220	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.49796134.10652338.html.plaintext.txt	221	COUP TF extensively studied repressor transcription also activates transcription 1 binding nuclear receptor DNA response element directly activating gene expression CYP7A gene promoter 9 2 binding DNA element indirectly influencing expression context several transcription factors PEPCK gene GRU 26 27 3 forming protein protein interaction DNA bound factor HNF 4 HNF 1 gene promoter 17
0.49796134.10652338.html.plaintext.txt	222	We show analyzing number deletion mutations span COUP TFI molecule broad region located amino acids 184 423 required three activation functions
0.49796134.10652338.html.plaintext.txt	223	Furthermore broad region required interaction COUP TFI coactivators SRC 1 GRIP1
0.49796134.10652338.html.plaintext.txt	224	It seems likely amino acids scattered throughout segment form surfaces required direct transactivation interaction factors
0.49796134.10652338.html.plaintext.txt	225	Although three functions equally disrupted mutations cannot conclude precisely domains involved
0.49796134.10652338.html.plaintext.txt	226	It perhaps surprising entire EF domain also referred ligand binding domain required activation since members nuclear receptor superfamily domain must intact transactivation 39
0.49796134.10652338.html.plaintext.txt	227	In addition transactivation domain provides functions including nuclear localization interactions various coactivators 40
0.49796134.10652338.html.plaintext.txt	228	Although COUP orphan receptor bind known ligand functions ligand binding domain may compromised different mutations made EF domain
0.49796134.10652338.html.plaintext.txt	229	The coactivators GRIP1 SRC 1 interact activation function 2 AF2 domain near C terminus many nuclear receptors 39
0.49796134.10652338.html.plaintext.txt	230	It noteworthy C terminal 15 amino acids COUP TFI required transactivation within domain COUP TFI homologous AF2 domain
0.49796134.10652338.html.plaintext.txt	231	There significant overlap amino acid segments COUP TF1 involved opposing actions transcription repression activation
0.49796134.10652338.html.plaintext.txt	232	The C terminal 15 amino acid segment protein dispensable repression see Fig
0.49796134.10652338.html.plaintext.txt	233	13 essential activation functions
0.49796134.10652338.html.plaintext.txt	234	On hand deletion C terminal 35 amino acids apparently required transactivation also renders COUP TFI incapable serving repressor
0.49796134.10652338.html.plaintext.txt	235	The corepressors nuclear receptor corepressor SMRT bind 35 amino acid segment confer repression activity COUP TFI 14
0.49796134.10652338.html.plaintext.txt	236	It clear whether segments molecule also involved repression
0.49796134.10652338.html.plaintext.txt	237	By contrast EF domains COUP TFII including C terminal 15 amino acids required active repression 15
0.49796134.10652338.html.plaintext.txt	238	We studied COUP TFII transactivator accumulated evidence suggests subtle differences two COUP molecules account quite different biologic responses
0.49796134.10652338.html.plaintext.txt	239	Repression transactivation presumably facilitated protein protein interactions occur EF region COUP TFI
0.49796134.10652338.html.plaintext.txt	240	Given activation repression require overlapping sequences must mechanism place allows different sets proteins interact COUP TFI
0.49796134.10652338.html.plaintext.txt	241	By view either coactivator complex corepressor complex bound activation repression domains within ligand binding domain COUP TFI
0.49796134.10652338.html.plaintext.txt	242	It possible equilibrium exists two complexes excess one complex determines direction response
0.49796134.10652338.html.plaintext.txt	243	This explanation seems unlikely several reasons
0.49796134.10652338.html.plaintext.txt	244	First equilibrium coactivator corepressor complexes determines direction COUP TFI response particular time given cell COUP TFI binding sites mediate either positive negative response
0.49796134.10652338.html.plaintext.txt	245	This obviously case e
0.49796134.10652338.html.plaintext.txt	246	Furthermore show overexpression SRC 1 GRIP1 fails switch COUP TFI repressor activator least one specific instance
0.49796134.10652338.html.plaintext.txt	247	The local intranuclear environment may determine direction COUP TFI activity
0.49796134.10652338.html.plaintext.txt	248	For example given DNA sequence function allosteric effector influence activity bound transcription factor 41
0.49796134.10652338.html.plaintext.txt	249	11 demonstrate COUP TFI exists different conformations bound different DNA binding sites
0.49796134.10652338.html.plaintext.txt	250	Hence specific DNA sequence may put COUP TFI conformation exposes surfaces binding either coactivator corepressor complexes
0.49796134.10652338.html.plaintext.txt	251	This plasticity would allow COUP TFI binding site CYP7A gene promoter used present study function positive element whereas another DR4 element slightly different sequence could serve negative element binds COUP TFI 42
0.49796134.10652338.html.plaintext.txt	252	Protein protein interactions context specific promoter may also important determinant direction COUP TFI activity
0.49796134.10652338.html.plaintext.txt	253	Whether COUP TFI acts coactivator HNF 4 transrepressor nuclear hormone receptors retinoic acid receptor determined protein protein interactions allow COUP TFI associate either SRC 1GRIP1 nuclear receptor corepressorSMRT
0.49796134.10652338.html.plaintext.txt	254	The interaction COUP TFI HNF 4 interest regard
0.49796134.10652338.html.plaintext.txt	255	The domain required HNF 4 coactivator activity COUP TFI also required interaction SRC 1 GRIP1 vivo Figs
0.49796134.10652338.html.plaintext.txt	256	It possible COUP TFI interacts E region HNF 4 amino acids 227 271 thus provides surface either directly indirectly coactivators associates basal transcription machinery 17
0.49796134.10652338.html.plaintext.txt	257	Interestingly coactivator activity COUP TFI seen DNA sequences recognized HNF 4 COUP TFI 17
0.49796134.10652338.html.plaintext.txt	258	Thus COUP TFI may serve coactivator HNF 4 exists specific conformation induced DNA binding
0.49796134.10652338.html.plaintext.txt	259	Thus although GAL4 COUP TFI acts repressor context GAL45E1bCAT reporter acts positive accessory factor context pGAL4gAF1 reporter compare Figs
0.49796134.10652338.html.plaintext.txt	260	Thus action COUP TFI probably determined combinatorial effects DNA sequence binds specific interactions proteins influenced specific promoter contexts
0.49796134.10652338.html.plaintext.txt	261	COUP TF important component PEPCK gene GRU
0.49796134.10652338.html.plaintext.txt	262	In addition glucocorticoids PEPCK gene transcription regulated number hormones
0.49796134.10652338.html.plaintext.txt	263	Each hormone response mediated set cis elements termed hormone response units
0.49796134.10652338.html.plaintext.txt	264	Many elements within one hormone response unit also components another
0.49796134.10652338.html.plaintext.txt	265	In addition number pleiotropic elements bind different sets protein complexes
0.49796134.10652338.html.plaintext.txt	266	For example gAF1 gAF3 components GRU bind COUP TF gAF1 also bind HNF 4 also retinoic acid response elements 1 2
0.49796134.10652338.html.plaintext.txt	267	In case two elements bind retinoic acid receptorretinoid X receptor heterodimers together comprise retinoic acid response unit
0.49796134.10652338.html.plaintext.txt	268	It curious although different combinations proteins bind DNA contact points used 43 44
0.49796134.10652338.html.plaintext.txt	269	Similarly insulin response unit cAMP response unit share elements GRU proteins bind elements specific hormone response 45 46
0.49796134.10652338.html.plaintext.txt	270	This overlapping structure PEPCK promoter termed metabolic control domain hypothesize structure allows complex integrated response PEPCK gene encodes protein essential gluconeogenesis wide variety environmental signals 26 37
0.49796134.10652338.html.plaintext.txt	271	Our current view different hormone response signals result recruitment different sets proteins multiple elements within promoter presumably tether different combinatorial sets coactivators promoter 37
0.49796134.10652338.html.plaintext.txt	272	For example glucocorticoid response requires recruitment ligand bound GR associated accessory factors coactivators promoter
0.49796134.10652338.html.plaintext.txt	273	The retinoic acid response requires recruitment retinoic acid receptorretinoid X receptor associated coactivators presumably SRC 1 like coactivators
0.49796134.10652338.html.plaintext.txt	274	These processes however exclusive
0.49796134.10652338.html.plaintext.txt	275	For example case retinoic acid response GR coactivators recruited hence set proteins bound PEPCK promoter response retinoic acid different complexes recruited glucocorticoid response
0.49796134.10652338.html.plaintext.txt	276	Indeed structural requirements responses different since 5 base pair insertion gAF2 GR1 effectively rotates helix one half turn decreases glucocorticoid response effect retinoic acid response 37
0.49796134.10652338.html.plaintext.txt	277	The binding absence binding AFs gAF1 gAF2 gAF3 effect basal activity 26 28 37 great interest determine whether proteins interact COUP TF HNF 4 HNF 3 confer accessory activity glucocorticoid response particularly since transcription factors specifically required confer accessory factor activity particular location within promoter
0.49796134.10652338.html.plaintext.txt	278	We recently demonstrated HNF 4 binds SRC 1 GRIP1 proteins act coactivators HNF 4 mediated transactivation heterologous promoters co accessory factors glucocorticoid response PEPCK gene promoter 47
0.49796134.10652338.html.plaintext.txt	279	Here show coactivators bind COUP TFI potentiate activation COUP TF
0.49796134.10652338.html.plaintext.txt	280	27 demonstrate either HNF 4 COUP TF act accessory factor gAF1 element
0.49796134.10652338.html.plaintext.txt	281	This observation may explained observations COUP TF HNF 4 utilize coactivators promote transactivation activities study Ref
0.49796134.10652338.html.plaintext.txt	282	In summary characterized domain required COUP TF mediated transcriptional activation three different systems determined SRC 1 GRIP1 bind domain serve coactivators
0.49796134.10652338.html.plaintext.txt	283	This takes us step closer understanding complex PEPCK gene GRU assembled functions
0.49796134.10652338.html.plaintext.txt	284	We thank Cathy Caldwell excellent technical assistance Deborah Caplenor Brown preparation manuscript Kazuya Yamada invaluable advice
0.49796134.10652338.html.plaintext.txt	285	This work supported National Institutes Health Grant DK 35107 Vanderbilt Diabetes Research Training Center Grant DK 20593
0.49796134.10652338.html.plaintext.txt	286	The costs publication article defrayed part payment page charges
0.49796134.10652338.html.plaintext.txt	287	The article must therefore hereby marked advertisement accordance 18 U
0.49796134.10652338.html.plaintext.txt	288	Section 1734 solely indicate fact
0.49796134.10652338.html.plaintext.txt	289	To correspondence addressed
0.49796134.10652338.html.plaintext.txt	290	615 322 7004 Fax 615 322 7236 E mail daryl
0.49796134.10652338.html.plaintext.txt	291	2 We originally designated accessory factor elements AF1 AF2 AF3 order discovery
0.49796134.10652338.html.plaintext.txt	292	The subsequent definition transactivation domains nuclear receptor subfamily AF1 AF2 48 created potentially confusing situation
0.49796134.10652338.html.plaintext.txt	293	To avoid discuss interaction AF1 AF2 transcription domain glucocorticoid receptor AF1 element AF2 AF3 elements GRU designate elements gAF1 denote glucocorticoid accessory factor 1 element etc
0.49796134.10652338.html.plaintext.txt	294	The abbreviations used COUP TF chicken ovalbumin upstream promoter transcription factor PEPCK phosphoenolpyruvate carboxykinase CYP7A cholesterol 7 hydroxylase HNF hepatocyte nuclear factor SMRT silencing mediator retinoic acid thyroid hormone receptor GRU glucocorticoid response unit AF accessory factor gAF1 gAF2 gAF3 glucocorticoid AF binding sites GR glucocorticoid receptor GR1 GR2 GR binding sites GRIP1 GR interacting protein 1 SRC 1 steroid receptor coactivator 1 CAT chloramphenicol acetyltransferase
0.49796134.10652338.html.plaintext.txt	295	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1
0.49796134.10652338.html.plaintext.txt	296	1991 Science 251 561 565Medline Order article via Infotrieve 2
0.49796134.10652338.html.plaintext.txt	297	1989 Nature 340 163 166CrossRefMedline Order article via Infotrieve 3
0.49796134.10652338.html.plaintext.txt	298	1 207 216Medline Order article via Infotrieve 4
0.49796134.10652338.html.plaintext.txt	299	1995 Cell 83 859 860Medline Order article via Infotrieve 5
0.49796134.10652338.html.plaintext.txt	300	1995 Cell 83 835 895Medline Order article via Infotrieve 6
0.49796134.10652338.html.plaintext.txt	301	1995 Cell 83 841 850Medline Order article via Infotrieve 7
0.49796134.10652338.html.plaintext.txt	302	18 229 240AbstractFree Full Text 8
0.49796134.10652338.html.plaintext.txt	303	11 1925 1937AbstractFree Full Text 9
0.49796134.10652338.html.plaintext.txt	304	272 9833 9839AbstractFree Full Text 10
0.49796134.10652338.html.plaintext.txt	305	326 587 592Medline Order article via Infotrieve 11
0.49796134.10652338.html.plaintext.txt	306	267 15849 15860AbstractFree Full Text 13
0.49796134.10652338.html.plaintext.txt	307	11 714 724AbstractFree Full Text 15
0.49796134.10652338.html.plaintext.txt	308	268 11125 11133AbstractFree Full Text 19
0.49796134.10652338.html.plaintext.txt	309	271 23572 23576AbstractFree Full Text 22
0.49796134.10652338.html.plaintext.txt	310	265 10173 10176Free Full Text 23
0.49796134.10652338.html.plaintext.txt	311	66 581 611CrossRefMedline Order article via Infotrieve 25
0.49796134.10652338.html.plaintext.txt	312	10 4712 4719Medline Order article via Infotrieve 26
0.49796134.10652338.html.plaintext.txt	313	271 31909 31914AbstractFree Full Text 27
0.49796134.10652338.html.plaintext.txt	314	8 96 104Medline Order article via Infotrieve 30
0.49796134.10652338.html.plaintext.txt	315	265 19885 19891AbstractFree Full Text 31
0.49796134.10652338.html.plaintext.txt	316	1989 Nature 338 39 44CrossRefMedline Order article via Infotrieve 32
0.49796134.10652338.html.plaintext.txt	317	93 4948 4952AbstractFree Full Text 33
0.49796134.10652338.html.plaintext.txt	318	12 302 313AbstractFree Full Text 35
0.49796134.10652338.html.plaintext.txt	319	12 1487 1498AbstractFree Full Text 38
0.49796134.10652338.html.plaintext.txt	320	9 222 232CrossRefMedline Order article via Infotrieve 39
0.49796134.10652338.html.plaintext.txt	321	12 3343 3356AbstractFree Full Text 40
0.49796134.10652338.html.plaintext.txt	322	10 384 391CrossRefMedline Order article via Infotrieve 41
0.49796134.10652338.html.plaintext.txt	323	1998 Nature 392 885 888CrossRefMedline Order article via Infotrieve 42
0.49796134.10652338.html.plaintext.txt	324	268 4152 4160AbstractFree Full Text 43
0.49796134.10652338.html.plaintext.txt	325	271 6260 6264AbstractFree Full Text 45
0.49796134.10652338.html.plaintext.txt	326	1990 Science 249 533 537Medline Order article via Infotrieve 46
0.49796134.10652338.html.plaintext.txt	327	266 19095 19102AbstractFree Full Text 47
0.49796134.10652338.html.plaintext.txt	328	273 30847 30850AbstractFree Full Text 48
0.49796134.10652338.html.plaintext.txt	329	Copyright 2000 The American Society Biochemistry Molecular Biology Inc
0.29775548.12697672.html.plaintext.txt	0	Hepatocyte Nuclear Factor 4 Isoforms Originated P1 Promoter Are Expressed Human Pancreatic ss Cells Exhibit Stronger Transcriptional Potentials P2 Promoter Driven Isoforms J
0.29775548.12697672.html.plaintext.txt	1	Institut National de la Sante et de la Recherche Medicale Unit 459 J
0.29775548.12697672.html.plaintext.txt	2	Diabetes Cell Therapy Unit ERIM 106 Institut National de la Sante et de la Recherche Medicale T
0.29775548.12697672.html.plaintext.txt	3	Warembourg Lille F 59045 France
0.29775548.12697672.html.plaintext.txt	4	Address correspondence requests reprints B
0.29775548.12697672.html.plaintext.txt	5	Laine Institut National de la Sante et de la Recherche Medicale Unit 459 Laboratoire de Biologie Cellulaire Universite H
0.29775548.12697672.html.plaintext.txt	6	Warembourg 1 Place de Verdun F 59045 Lille France
0.29775548.12697672.html.plaintext.txt	7	Abstract Top Abstract Introduction Materials Methods Results Discussion References The nuclear receptor hepatocyte nuclear factor HNF 4 involved transcriptional network plays important role pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	8	Mutations HNF4 gene correlated maturity onset diabetes young 1
0.29775548.12697672.html.plaintext.txt	9	HNF4 isoforms result alternative splicing alternate usage promoters P1 P2
0.29775548.12697672.html.plaintext.txt	10	It recently reported HNF4 transcription driven almost exclusively P2 promoter pancreatic islets
0.29775548.12697672.html.plaintext.txt	11	We observed transcripts P1 P2 promoters expressed human pancreatic ss cells pancreatic ss cell lines RIN m5F HIT T15
0.29775548.12697672.html.plaintext.txt	12	Expression HNF4 proteins originating P1 promoter confirmed immunodetection
0.29775548.12697672.html.plaintext.txt	13	Due presence activation function module AF 1 HNF4 isoforms originating P1 promoter exhibit stronger transcriptional activities recruit coactivators efficiently isoforms driven P2 promoter
0.29775548.12697672.html.plaintext.txt	14	Conversely activities isoforms produced promoters similarly repressed corepressor small heterodimer partner
0.29775548.12697672.html.plaintext.txt	15	These behaviors observed promoter HNF1 required ss cell function
0.29775548.12697672.html.plaintext.txt	16	Our results highlight expression P1 promoter driven isoforms important control pancreatic ss cell function
0.29775548.12697672.html.plaintext.txt	17	Introduction Top Abstract Introduction Materials Methods Results Discussion References HEPATOCYTE NUCLEAR FACTOR HNF 4 orphan nuclear receptor nuclear receptor 2A1 NR2A1 activates expression genes involved transport metabolism many nutrients including lipids glucose 1 2
0.29775548.12697672.html.plaintext.txt	18	HNF4 required normal hepatic function 3
0.29775548.12697672.html.plaintext.txt	19	It also plays important role pancreatic ss cells HNF4 directly activates insulin gene promoter 4 required glucose induced insulin secretion 5
0.29775548.12697672.html.plaintext.txt	20	Mutations HNF4 gene correlated maturity onset diabetes young 1 characterized autosomal dominant mode inheritance early onset usually age 25 yr impaired glucose induced insulin secretion due dysfunction pancreatic ss cells 6
0.29775548.12697672.html.plaintext.txt	21	HNF4 involved together transcription factors including HNF1 complex transcription factor network thought crucial function pancreatic ss cells 7 8 9
0.29775548.12697672.html.plaintext.txt	22	In mammals HNF4 encoded two different genes HNF4 HNF4 10
0.29775548.12697672.html.plaintext.txt	23	The HNF4 gene potentially encodes nine distinct isoforms
0.29775548.12697672.html.plaintext.txt	24	Their structure nomenclature presented Ref
0.29775548.12697672.html.plaintext.txt	25	HNF4 isoforms result alternate promoter usage alternative splicing
0.29775548.12697672.html.plaintext.txt	26	1A promoter P1 initiates transcripts contain exon 1A isoforms 1 6 whereas promoter P2 initiates transcripts contain exon 1D isoforms 7 9 Refs
0.29775548.12697672.html.plaintext.txt	27	Isoforms 2 8 alternatively spliced variants isoforms 1 7 respectively
0.29775548.12697672.html.plaintext.txt	28	They contain 30 bp insert 3 sequence Fig
0.29775548.12697672.html.plaintext.txt	29	Compared four isoforms isoforms 3 9 completely different 3 sequence much less expressed whereas isoforms 4 6 poorly expressed yet identified vivo 1 13
0.29775548.12697672.html.plaintext.txt	30	The expression HNF4 isoforms varies development differentiation tissue origin 1 14 15 16
0.29775548.12697672.html.plaintext.txt	31	The expression HNF4 mainly initiates P1 promoter adult liver kidney 15
0.29775548.12697672.html.plaintext.txt	32	Recently two different groups documented expression transcripts P2 promoter insulinoma INS 1 cells well mouse human pancreatic islets detect transcripts P1 promoter leading conclusion HNF4 transcription driven almost exclusively P2 promoter endocrine pancreas 11 12 17
0.29775548.12697672.html.plaintext.txt	33	Strongly contrasting data observed HNF4 transcripts initiated P1 promoter substantially expressed alongside P2 promoter transcripts human pancreatic ss cells rodent pancreatic ss cell lines RIN m5F HIT T15
0.29775548.12697672.html.plaintext.txt	34	Only HNF4 isoforms initiated P1 promoter contain activation function module AF 1 encoded exon 1A
0.29775548.12697672.html.plaintext.txt	35	The AF 1 plays key role HNF4 transcriptional potential recruitment coactivators essential HNF4 function 18 19 20
0.29775548.12697672.html.plaintext.txt	36	We show lack AF 1 HNF4 isoforms initiated P2 promoter markedly decreases transcriptional potential interaction several coactivators
0.29775548.12697672.html.plaintext.txt	37	Conversely lack AF 1 affect repression HNF4 activity small heterodimer partner SHP
0.29775548.12697672.html.plaintext.txt	38	This finding highlights functional consequences expression HNF4 P1 promoter transcripts pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	39	View larger version 20K Figure 1
0.29775548.12697672.html.plaintext.txt	40	Expression HNF4 transcripts human pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	41	A Schematic representation HNF4 gene showing promoters P1 P2 black boxes respective first exon named 1A 1D hatched boxes
0.29775548.12697672.html.plaintext.txt	42	Lines linking exons indicate splicing events splicing exon 1A exon 2 yields isoforms 1 3 whereas splicing resulting insertion exon 1B dotted lines yields isoforms 4 6
0.29775548.12697672.html.plaintext.txt	43	Use exon 1C demonstrated presented
0.29775548.12697672.html.plaintext.txt	44	Splicing exon 1D exon 2 yields isoforms 7 9
0.29775548.12697672.html.plaintext.txt	45	Use second donor site 3 end exon 9 yields 30 bp insert squares exon 9 isoforms 2 8
0.29775548.12697672.html.plaintext.txt	46	B Schematic representation mature transcripts HNF4 isoforms 1 2 7 8 showing 30 bp insert isoforms 2 8
0.29775548.12697672.html.plaintext.txt	47	For clarity sake isoforms 3 6 9 expressed low levels shown
0.29775548.12697672.html.plaintext.txt	48	Positions primers used RT PCR indicated
0.29775548.12697672.html.plaintext.txt	49	C RT PCR analysis HNF4 transcripts containing exon 1D using primers d b
0.29775548.12697672.html.plaintext.txt	50	D RT PCR analysis HNF4 transcripts containing exon 1A using primers b
0.29775548.12697672.html.plaintext.txt	51	E Determination relative amounts isoforms 1 andor 7 vs
0.29775548.12697672.html.plaintext.txt	52	isoforms 2 andor 8 transcripts using primers e f
0.29775548.12697672.html.plaintext.txt	53	F RT PCR analysis HNF4 transcript
0.29775548.12697672.html.plaintext.txt	54	G RT PCR control ss actin
0.29775548.12697672.html.plaintext.txt	55	C G Lane 1 molecular mass markers base pairs lane 2 human pancreatic islets lane 3 isolated human pancreatic ss cells lane 4 human exocrine pancreas lane 5 rat insulinoma RIN m5F cells lane 6 hamster insulinoma HIT T15 cells
0.29775548.12697672.html.plaintext.txt	56	For RT PCR analyses negative control shown lane 7
0.29775548.12697672.html.plaintext.txt	57	H Lack cross amplification P2 promoter transcripts primers ab 1 2 PCR performed cloned HNF42 8 respectively
0.29775548.12697672.html.plaintext.txt	58	I Control specificity amplification reverse transcribed RNAs human pancreatic islets primers ab
0.29775548.12697672.html.plaintext.txt	59	1 RT PCR performed D 2 RT PCR performed D except step reverse transcription carried absence Moloney murine leukemia virus reverse transcriptase
0.29775548.12697672.html.plaintext.txt	60	RNA three donors yielded identical results
0.29775548.12697672.html.plaintext.txt	61	J Expression P1 promoter transcripts using primers h g designed specifically amplify exons 1A 2
0.29775548.12697672.html.plaintext.txt	62	1 Reverse transcribed RNA 2 non reverse transcribed RNA human pancreatic islets
0.29775548.12697672.html.plaintext.txt	63	Materials Methods Top Abstract Introduction Materials Methods Results Discussion References Insulinoma cell lines Cells obtained American Type Culture Collection Manassas VA
0.29775548.12697672.html.plaintext.txt	64	RIN m5F cells rat origin ATCC CRL 2058 grown described Ref
0.29775548.12697672.html.plaintext.txt	65	HIT T15 cells hamster origin ATCC CRL 1777 grown described Ref
0.29775548.12697672.html.plaintext.txt	66	Human pancreas processing Human pancreases n 5 harvested adult brain dead donors accord French Regulations local Institutional Ethical Committee
0.29775548.12697672.html.plaintext.txt	67	Pancreatic islets isolated ductal distension pancreas digestion tissue liberase Roche Molecular Biochemicals Mannheim Germany described Ref
0.29775548.12697672.html.plaintext.txt	68	Exocrine fraction obtained described Ref
0.29775548.12697672.html.plaintext.txt	69	Islet enrichment single ss cell preparation Pancreatic islet enriched fractions purity 90 plus minus 5 obtained semipurified preparations handpicking dithizone stained islets binocular microscope
0.29775548.12697672.html.plaintext.txt	70	Single ss cell suspensions obtained gentle pipetting islets 4 6 min enzymatic dissociation buffer containing 3
0.29775548.12697672.html.plaintext.txt	71	6 gliter papain Splittix Bio Media Boussens France
0.29775548.12697672.html.plaintext.txt	72	2 vol enzyme inhibiting solution consisting Splitstop Bio Media plus fetal calf serum 31 volvol respectively 80 islet cells appeared single cells
0.29775548.12697672.html.plaintext.txt	73	Cell sorting achieved described Ref
0.29775548.12697672.html.plaintext.txt	74	Semiquantitative RT PCR Total RNA prepared using Macherey Nagel Duren Germany RNA extraction kit according manufacturer protocol
0.29775548.12697672.html.plaintext.txt	75	Reverse transcription PCR performed described Ref
0.29775548.12697672.html.plaintext.txt	76	21 conditions adjusted maintain amplification within exponential range
0.29775548.12697672.html.plaintext.txt	77	Primers used HNF4 transcripts shown Table 1 primers coactivator peroxisome proliferator activated receptor coactivator PGC 1 transcripts following sequences sense 5 gtggatgaagacggattgcc 3 antisense 5 ttctagttgtctagagtcttgg 3
0.29775548.12697672.html.plaintext.txt	78	PCR products electrophoresed 2 agarose gel band intensity analyzed Kaiser camera equipped Gel Analyst 3
0.29775548.12697672.html.plaintext.txt	79	01 software provided Vasse SARL Templemars France
0.29775548.12697672.html.plaintext.txt	80	Plasmid constructs Plasmid pcDNA3 human HNF42 described Ref
0.29775548.12697672.html.plaintext.txt	81	Plasmid pcDNA3 human HNF42 Y6DF19D obtained site directed mutagenesis pcDNA3 human HNF42 F19D 20
0.29775548.12697672.html.plaintext.txt	82	The human HNF48 cDNA obtained PCR using human HNF42 cDNA PCR matrix
0.29775548.12697672.html.plaintext.txt	83	The sense primer encompassed sequence 149 exon 1D 11 sequence hybridizing first 23 nucleotides exon 2 common 2 8 HNF4 isoforms
0.29775548.12697672.html.plaintext.txt	84	The antisense primer hybridized sequence 1412 1433 HNF42 cDNA taking adenosine ATG codon initiation methionine position 1 27
0.29775548.12697672.html.plaintext.txt	85	This cDNA introduced EcoRI XbaI sites pcDNA3 generate expression plasmid pcDNA3 human HNF48
0.29775548.12697672.html.plaintext.txt	86	Constructs verified DNA sequencing
0.29775548.12697672.html.plaintext.txt	87	The human HNF1 promoter cloned pGL3 gift Dr
0.29775548.12697672.html.plaintext.txt	88	Bell Howard Hughes Medical Institute Chicago IL
0.29775548.12697672.html.plaintext.txt	89	Plasmids expressing fusion proteins glutathione S transferase GST PGC 1 36 797 GST p300 340 528 GST glucocorticoid receptor interacting protein GRIP 11122 1462 GST full length SHP gifts Drs
0.29775548.12697672.html.plaintext.txt	90	Spiegelman Dana Farber Cancer Institute Harvard Medical School Boston MA Grossman Dana Farber Cancer Institute Stallcup University Southern California Los Angeles CA Gustafsson Karolinska Institute Huddinge Sweden respectively
0.29775548.12697672.html.plaintext.txt	91	The expression plasmids pCMVss NHA p300 pCMVss control vector pSG5 SHP gifts Drs
0.29775548.12697672.html.plaintext.txt	92	Grossman Gustafsson respectively
0.29775548.12697672.html.plaintext.txt	93	EMSAs When used control specificity HNF42 8 synthesized vitro described Ref
0.29775548.12697672.html.plaintext.txt	94	EMSAs performed described Ref
0.29775548.12697672.html.plaintext.txt	95	28 using 32P labeled HNF4 response element HNF1 promoter either vitro synthesized proteins nuclear extracts HIT T15 HepG2 cells prepared described Ref
0.29775548.12697672.html.plaintext.txt	96	Supershifts performed incubating proteins either 455 antiserum 1 H455 monoclonal antibody 15 addition labeled probe
0.29775548.12697672.html.plaintext.txt	97	Transient transfections RIN m5F cells transiently transfected LipofectAmine reagent 3 microl microg DNA according Invitrogen SARL Cergy Pontoise France recommendations
0.29775548.12697672.html.plaintext.txt	98	HIT T15 HeLa cells transiently transfected polyethylenimine reagent 4 microl microg DNA according Euromedex Souffelweyersheim France recommendations
0.29775548.12697672.html.plaintext.txt	99	Normalization differences transfection efficiencies performed previously described using either Renilla luciferase reporter plasmid RIN m5F HeLa cells 29 ss galactosidase reporter plasmid HIT T15 cells 30
0.29775548.12697672.html.plaintext.txt	100	Luciferase assays performed Dual Luciferase kit Promega Corp
0.29775548.12697672.html.plaintext.txt	101	Madison WI RIN m5F HeLa cells described Ref
0.29775548.12697672.html.plaintext.txt	102	Statistical analysis performed using Student test unpaired data using Prism software Intuitive Software Science San Diego CA
0.29775548.12697672.html.plaintext.txt	103	Western blot analysis Western assays performed described Ref
0.29775548.12697672.html.plaintext.txt	104	26 revealed 455 antiserum 1
0.29775548.12697672.html.plaintext.txt	105	In vitro protein protein interaction assays GST pull assays performed described previously 26 using 35S methionine labeled vitro synthesized HNF4 bacterially expressed GST fusion proteins
0.29775548.12697672.html.plaintext.txt	106	Interactions quantified using ImageQuant software PhosphorImager apparatus Molecular Dynamics Inc
0.29775548.12697672.html.plaintext.txt	107	Results Top Abstract Introduction Materials Methods Results Discussion References Transcripts initiated P1 HNF4 promoter readily expressed human pancreatic ss cells Figure 1A depicts schematic representation HNF4 gene P1 P2 promoters
0.29775548.12697672.html.plaintext.txt	108	Expression P1 P2 promoter transcripts analyzed RT PCR
0.29775548.12697672.html.plaintext.txt	109	Promoter P2 transcripts selectively amplified sense primer hybridizing exon 1D antisense primer hybridizing exon 5 primers d b Fig
0.29775548.12697672.html.plaintext.txt	110	Transcripts promoter P1 selectively amplified sense primer hybridizing exon 1A primer b Fig
0.29775548.12697672.html.plaintext.txt	111	As expected data obtained pancreatic islets INS 1 cells 11 12 17 detected transcripts promoter P2 human islets isolated human pancreatic ss cells RIN m5F HIT T15 insulinoma cells Fig
0.29775548.12697672.html.plaintext.txt	112	In exocrine pancreas band corresponding promoter P2 transcripts barely detectable Fig
0.29775548.12697672.html.plaintext.txt	113	1C lane 4 although band ss actin intensity similar obtained endocrine cells Fig
0.29775548.12697672.html.plaintext.txt	114	Interestingly promoter P1 transcripts human islets isolated human pancreatic ss cells yielded highly visible bands indicating HNF4 promoter P1 transcripts substantially expressed human endocrine pancreas Fig
0.29775548.12697672.html.plaintext.txt	115	1D lanes 2 3 respectively
0.29775548.12697672.html.plaintext.txt	116	Reproducible data obtained five different donors
0.29775548.12697672.html.plaintext.txt	117	Similar results obtained RIN m5F HIT T15 RNA Fig
0.29775548.12697672.html.plaintext.txt	118	Again human exocrine pancreas promoter P1 transcripts expressed low levels Fig
0.29775548.12697672.html.plaintext.txt	119	Two groups detect P1 promoter transcripts pancreatic islets INS 1 cells 11 12 17 following controls confirmed accuracy results showing expression P1 promoter transcripts
0.29775548.12697672.html.plaintext.txt	120	First checked specificity amplification P1 promoter transcripts ab primer set cloned HNF42 yielded highly visible band band could detected cloned HNF48 Fig
0.29775548.12697672.html.plaintext.txt	121	1H lanes 1 2 respectively
0.29775548.12697672.html.plaintext.txt	122	Second using cloned HNF42 HNF48 verified primer sets ab db exhibited similar amplification efficiency data shown
0.29775548.12697672.html.plaintext.txt	123	Third using human pancreatic islets made sure band obtained P1 transcripts result genomic plasmidic contamination RNA isolation reverse transcription amplicon could detected step reverse transcription RNAs performed absence Moloney murine leukemia virus reverse transcriptase Fig
0.29775548.12697672.html.plaintext.txt	124	Conversely use another set primers h g designed specifically amplify exon 1A 2 yielded RNAs human islets band obtained reverse transcription omitted Fig
0.29775548.12697672.html.plaintext.txt	125	1J thus confirming transcripts HNF4 P1 promoter readily expressed endocrine pancreas
0.29775548.12697672.html.plaintext.txt	126	Human pancreatic ss cells express HNF4 isoforms 1 2 7 8 HNF4 HNF4 transcripts promoter P1 mainly represent isoforms 1 2 transcripts promoter P2 mainly represent isoforms 7 8 determined low levels isoforms 3 6 9 expressed cells tested
0.29775548.12697672.html.plaintext.txt	127	Indeed using primers specifically amplify isoforms 3 6 9 isoforms 4 5 6 couples primers P6 P7 P9 P10 respectively described Ref
0.29775548.12697672.html.plaintext.txt	128	14 faint bands could detected data shown
0.29775548.12697672.html.plaintext.txt	129	In addition analyzing transcripts P1 promoter failed detect band 612 bp expected size amplicons transcripts containing exon 1B Fig
0.29775548.12697672.html.plaintext.txt	130	This result confirms low expression isoforms 4 6
0.29775548.12697672.html.plaintext.txt	131	Because insertion 10 amino acid residues carboxy terminal sequence HNF42 shown facilitate recruitment coactivators 31 analyzed expression isoforms containing 30 bp insert ss cells
0.29775548.12697672.html.plaintext.txt	132	Primers e f hybridizing exons 9 10 respectively designed amplify two fragments larger one containing 30 bp insert isoforms 2 8 Fig
0.29775548.12697672.html.plaintext.txt	133	The levels expression isoforms 2 andor 8 equivalent isoforms 1 andor 7 human pancreatic islets isolated human pancreatic ss cells Fig
0.29775548.12697672.html.plaintext.txt	134	Similar results obtained RIN m5F HIT T15 RNA Fig
0.29775548.12697672.html.plaintext.txt	135	Next analyzed HNF4 expression using primers specifically amplify carboxy terminal domain isoform Table 1
0.29775548.12697672.html.plaintext.txt	136	1F show HNF4 well expressed human pancreatic islets isolated human pancreatic ss cells RIN m5F HIT T15 cells poorly expressed human exocrine pancreas
0.29775548.12697672.html.plaintext.txt	137	Immunodetection HNF4 proteins originated P1 promoter pancreatic ss cells To ascertain expression HNF4 proteins encoded P1 promoter transcripts containing exon 1A used monoclonal antibody H455 specifically recognizes amino terminal sequence isoforms 1 2 isoforms 7 8 15
0.29775548.12697672.html.plaintext.txt	138	Because antibody suitable Western blot assays Ryffel G
0.29775548.12697672.html.plaintext.txt	139	personal communication HNF4 expression studied EMSA performed HNF4 response element HNF1 promoter HNF1 probe
0.29775548.12697672.html.plaintext.txt	140	The specificity H455 monoclonal antibody confirmed using vitro synthesized HNF42 HNF48 supershifted complex formed HNF42 formed HNF48 Fig
0.29775548.12697672.html.plaintext.txt	141	Conversely complexes formed HNF4 isoforms could supershifted 455 antiserum raised identical carboxy terminal sequence Fig
0.29775548.12697672.html.plaintext.txt	142	Nuclear extracts HepG2 cells predominantly express HNF41 2 yielded complex could supershifted 455 antiserum H455 monoclonal antibody Fig
0.29775548.12697672.html.plaintext.txt	143	Pancreatic ss cells express much lower amounts HNF4 HepG2 cells 32 compelled us use 4 fold higher amounts HIT T15 nuclear proteins HepG2 nuclear proteins
0.29775548.12697672.html.plaintext.txt	144	This accounts unspecific background observed analyzing former material Fig
0.29775548.12697672.html.plaintext.txt	145	Nevertheless HIT T15 nuclear extracts could easily detect retarded band Fig
0.29775548.12697672.html.plaintext.txt	146	2B lane 1 corresponding complex mainly formed HNF4 complex exhibited electrophoretic mobility yielded HNF4 proteins HepG2 cells could supershifted 455 antiserum Fig
0.29775548.12697672.html.plaintext.txt	147	2B lane 2 could obtained using mutated HNF1 probe unable bind HNF4 data shown
0.29775548.12697672.html.plaintext.txt	148	Addition H455 monoclonal antibody resulted concomitant decrease retarded band formation strong supershifted band could obtained antibody raised irrelevant peptide sequence Xpress tag Fig
0.29775548.12697672.html.plaintext.txt	149	This result unambiguously shows endogenous expression HNF41 andor 2 proteins confirms HNF4 P1 promoter transcripts readily expressed pancreatic ss cell line HIT T15
0.29775548.12697672.html.plaintext.txt	150	This cell line also expresses HNF4 complexed DNA comigrates complexes formed DNA HNF41 2 33
0.29775548.12697672.html.plaintext.txt	151	HNF4 recognized 455 H455 antibodies could account partial supershift observed lanes 2 3 previously observed nuclear extracts intestinal villi crypts 33
0.29775548.12697672.html.plaintext.txt	152	View larger version 47K Figure 2
0.29775548.12697672.html.plaintext.txt	153	Immunodetection HNF4 isoforms derived P1 promoter pancreatic ss cell line HIT T15
0.29775548.12697672.html.plaintext.txt	154	EMSAs performed HNF4 response element HNF1 promoter either vitro synthesized HNF42 HNF48 A nuclear extracts HIT T15 20 microg HepG2 5 microg cells B
0.29775548.12697672.html.plaintext.txt	155	DNA protein complexes incubated either 455 antiserum recognizes common C terminal end isoforms 1 2 7 8 monoclonal H455 antibody recognizes N terminal sequence isoforms 1 2 unrelated Xpress antibody
0.29775548.12697672.html.plaintext.txt	156	Arrow arrowhead denote DNA HNF4 shifted complexes supershifted complexes respectively
0.29775548.12697672.html.plaintext.txt	157	Weak transcriptional potentials HNF48 produced P2 promoter pancreatic ss cells HNF41 2 whose transcripts include exon 1A contain activation function AF 1 module amino terminal end Fig
0.29775548.12697672.html.plaintext.txt	158	This module includes structural motifs characteristic acidic activators plays key role transcriptional potential HNF4 isoforms 1 2 1819
0.29775548.12697672.html.plaintext.txt	159	The amino terminal sequence HNF47 8 encoded exon 1D contain motifs seems lack activation function AF 1 module
0.29775548.12697672.html.plaintext.txt	160	We addressed consequences sequence difference HNF4 transcriptional potential pancreatic ss cell lines comparing transcriptional activities HNF4 isoforms 2 8 RIN m5F HIT T15 insulinoma cells
0.29775548.12697672.html.plaintext.txt	161	To better define effect lack AF 1 HNF4 transcriptional potential cells also analyzed activity HNF42 Y6DF19D mutated AF 1 module Fig
0.29775548.12697672.html.plaintext.txt	162	The mutated residues crucial AF 1 function hepatoma HepG2 cells 18 embryonal kidney HEK 293T cells Eeckhoute J
0.29775548.12697672.html.plaintext.txt	163	In RIN m5F cells HNF1 promoter activated 6
0.29775548.12697672.html.plaintext.txt	164	In HIT T15 cells HNF42 activated HNF1 promoter Fig
0.29775548.12697672.html.plaintext.txt	165	The differences transactivation due low expression HNF48 HNF42 Y6DF19D Fig
0.29775548.12697672.html.plaintext.txt	166	These results support hypothesis lower transcriptional activity HNF48 due lack AF 1 module
0.29775548.12697672.html.plaintext.txt	167	View larger version 14K Figure 3
0.29775548.12697672.html.plaintext.txt	168	Lack mutation AF 1 activation function decreased HNF4 transcriptional potential pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	169	A Schematic representation HNF42 AF 1 module black box HNF42 Y6DF19D mutated AF 1 black box white diamonds HNF48 lacking AF 1
0.29775548.12697672.html.plaintext.txt	170	The sequence 1 16 isoform 8 hatched box share homology sequence 1 29 isoform 2 11
0.29775548.12697672.html.plaintext.txt	171	RIN m5F HIT T15 cells B C respectively transiently transfected 300 ng human HNF1 promoter Firefly luciferase reporter plasmid 25 ng indicated HNF4 expression plasmids 10 ng either pGL3 Renilla luciferase RIN m5F pCMV ss galactosidase HIT T15
0.29775548.12697672.html.plaintext.txt	172	Fold induction refers activities without HNF4 derivative empty expression vector
0.29775548.12697672.html.plaintext.txt	173	Error bars indicate SD values Renilla luciferase ss galactosidase normalized Firefly luciferase activities three experiments performed quadruplicate
0.29775548.12697672.html.plaintext.txt	174	Significance difference values obtained HNF42 indicated P 0
0.29775548.12697672.html.plaintext.txt	175	D Western blotting overexpressed HNF4 proteins revealed 455 antiserum
0.29775548.12697672.html.plaintext.txt	176	HNF48 driven P2 promoter exhibits reduced interaction cooperation several coactivators As nuclear hormone receptors HNF4 transcriptional potential modulated coactivators corepressors
0.29775548.12697672.html.plaintext.txt	177	The HNF4 AF 1 interacts coactivator p300 18 19 20 AF 1 nuclear receptors p300 GRIP 1 34
0.29775548.12697672.html.plaintext.txt	178	We therefore investigated effects lack AF 1 HNF48 mutation module HNF42 Y6DF19D interaction coregulators
0.29775548.12697672.html.plaintext.txt	179	In study included p300 GRIP 1 PGC 1 HNF4 coactivators 31 35 36 37 SHP HNF4 corepressor 38
0.29775548.12697672.html.plaintext.txt	180	GRIP 1 p300 SHP reported expressed endocrine pancreas 7 39 40 PGC 1 expression human pancreatic ss cells insulinoma cell lines evidenced RT PCR Fig
0.29775548.12697672.html.plaintext.txt	181	HNF48 interacted much less efficiently HNF42 p300 GRIP 1 Fig
0.29775548.12697672.html.plaintext.txt	182	Conversely difference isoforms observed studying physical interaction PGC 1 SHP Fig
0.29775548.12697672.html.plaintext.txt	183	Results obtained HNF42 Y6DF19D support lower interaction isoform 8 p300 GRIP 1 due lack AF 1 isoform
0.29775548.12697672.html.plaintext.txt	184	View larger version 35K Figure 4
0.29775548.12697672.html.plaintext.txt	185	Effects lack AF 1 activation function AF 1 mutation physical interaction HNF4 coregulators
0.29775548.12697672.html.plaintext.txt	186	A PGC 1 expression analyzed RT PCR
0.29775548.12697672.html.plaintext.txt	187	Lane 1 Human pancreatic islets lane 2 human exocrine pancreas lane 3 isolated human pancreatic ss cells lane 4 rat insulinoma RIN m5F cells lane 5 hamster insulinoma HIT T15 cells
0.29775548.12697672.html.plaintext.txt	188	B Physical interactions coregulators
0.29775548.12697672.html.plaintext.txt	189	In vitro synthesized 35S methionine labeled HNF42 HNF48 HNF42 Y6DF19D incubated immobilized GST PGC 1 36 797 GST p300 340 528 GST GRIP 1 1122 1462 GST full length SHP
0.29775548.12697672.html.plaintext.txt	190	After extensive washing proteins eluted sodium dodecyl sulfate loading buffer analyzed SDS PAGE PhosphorImager Molecular Dynamics Inc
0.29775548.12697672.html.plaintext.txt	191	Values photographs indicate binding HNF42 Y6DF19D HNF48 relative HNF42 three independent experiments
0.29775548.12697672.html.plaintext.txt	192	Inputs corresponding 10 amounts labeled proteins used assays taken account binding quantifications
0.29775548.12697672.html.plaintext.txt	193	Next studied effect lack AF 1 cooperation HNF4 p300 required activation transcription 35
0.29775548.12697672.html.plaintext.txt	194	To circumvent technical difficulties due cotransfection multiple expression plasmids pancreatic cells avoid interference endogenous HNF4 HNF4 study carried HeLa cells
0.29775548.12697672.html.plaintext.txt	195	When p300 overexpressed HNF1 promoter activated 5
0.29775548.12697672.html.plaintext.txt	196	6 fold HNF48 HNF42 Y6DF19D Fig
0.29775548.12697672.html.plaintext.txt	197	The marked difference transactivation potentials HNF4 isoforms 2 8 due difference expression proteins Fig
0.29775548.12697672.html.plaintext.txt	198	The coactivator p300 effect activity HNF1 promoter absence HNF4 enhanced transcriptional potential HNF42 2 fold vs
0.29775548.12697672.html.plaintext.txt	199	2 fold HNF48 HNF42 Y6DF19D respectively Fig
0.29775548.12697672.html.plaintext.txt	200	Therefore AF 1 module either lacking mutated physical interaction functional cooperation p300 HNF4 decreased
0.29775548.12697672.html.plaintext.txt	201	As expected results obtained pull assays transcriptional activities isoforms 2 8 repressed similar extents SHP Fig
0.29775548.12697672.html.plaintext.txt	202	View larger version 16K Figure 5
0.29775548.12697672.html.plaintext.txt	203	The transcriptional potentials HNF42 8 differently enhanced coactivator p300 similarly repressed corepressor SHP
0.29775548.12697672.html.plaintext.txt	204	HeLa cells transiently transfected 250 ng human HNF1 promoter Firefly luciferase reporter plasmid 10 ng Renilla luciferase expression plasmid either 12
0.29775548.12697672.html.plaintext.txt	205	5 ng indicated HNF4 expression plasmids together 250 ng p300 expression plasmid A 25 ng indicated HNF4 expression plasmids together 250 ng SHP expression plasmid B
0.29775548.12697672.html.plaintext.txt	206	The total amounts transfected DNA equalized corresponding empty vectors
0.29775548.12697672.html.plaintext.txt	207	Fold induction refers activity HNF4 mediator
0.29775548.12697672.html.plaintext.txt	208	Error bars indicate SD values Renilla luciferase normalized Firefly luciferase activities three experiments performed triplicate
0.29775548.12697672.html.plaintext.txt	209	The extent activation repression presented values bar relative activity isoform mutant set 100 without cotransfected mediator
0.29775548.12697672.html.plaintext.txt	210	C Western blotting overexpressed HNF4 proteins revealed 455 antiserum
0.29775548.12697672.html.plaintext.txt	211	Discussion Top Abstract Introduction Materials Methods Results Discussion References In recent studies failed detect transcripts P1 promoter pancreatic islets insulinoma INS 1 cells authors concluded HNF4 transcription driven almost exclusively P2 promoter pancreatic islets 11 12 17
0.29775548.12697672.html.plaintext.txt	212	But HNF4 expression documented human pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	213	In study human islets isolated pancreatic ss cells observed transcripts P1 promoter significantly expressed P2 promoter
0.29775548.12697672.html.plaintext.txt	214	This indicates HNF4 expression exclusively initiate P2 promoter human pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	215	Similar results observed rat RIN m5F hamster HIT T15 pancreatic ss cell lines
0.29775548.12697672.html.plaintext.txt	216	Several controls confirmed accuracy results
0.29775548.12697672.html.plaintext.txt	217	Importantly confirmed expression P1 transcripts pancreatic ss cell line HIT T15 immunodetecting HNF4 proteins containing amino terminal sequence encoded exon 1A
0.29775548.12697672.html.plaintext.txt	218	Lack detection promoter P1 transcripts islets Ferrer group 12 17 may explained low amplification efficiency P1 promoter transcripts
0.29775548.12697672.html.plaintext.txt	219	This may account weak intensity obtained exon 1A2 band liver relative exon 1D2 band islets Fig
0.29775548.12697672.html.plaintext.txt	220	17 although isoforms 1 2 far abundant liver isoforms 7 8 islets
0.29775548.12697672.html.plaintext.txt	221	In concordance considerable difference expression 32 primers amplifying exons 8 10 contained four isoforms 1 2 7 8 yielded bands much stronger intensity isoforms 1 2 liver isoforms 7 8 islets Fig
0.29775548.12697672.html.plaintext.txt	222	A mutation HNF4 P1 promoter significantly decreasing promoter activity associated diabetes 41
0.29775548.12697672.html.plaintext.txt	223	This suggests promoter P1 transcription may important normal pancreatic ss cell function
0.29775548.12697672.html.plaintext.txt	224	In addition HNF42 clone isolated human pancreatic islet cDNA library also arguing expression HNF4 P1 promoter transcripts endocrine pancreas Furuta H
0.29775548.12697672.html.plaintext.txt	225	Controversial results obtained concerning HNF4 expression exocrine pancreas 12 32
0.29775548.12697672.html.plaintext.txt	226	We confirmed results described Ref
0.29775548.12697672.html.plaintext.txt	227	32 stating HNF4 poorly expressed exocrine pancreas
0.29775548.12697672.html.plaintext.txt	228	Compared isoform 7 isoform 1 stronger transcriptional activator nonpancreatic ss cells except promoters genes expressed early liver 15 16 42
0.29775548.12697672.html.plaintext.txt	229	Our functional studies showed transcriptional potential HNF42 significantly stronger isoform 8 models pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	230	Interestingly results obtained promoter HNF1 plays crucial role cells 7 9 43 44
0.29775548.12697672.html.plaintext.txt	231	Because HNF1 expression regulated HNF4 pancreatic ss cells 5 45 suggest expression HNF4 P1 promoter producing isoforms 1 2 probably major importance pancreatic ss cells
0.29775548.12697672.html.plaintext.txt	232	From data obtained HNF42 containing mutated AF 1 infer difference transcriptional potential isoforms 2 8 due lack AF 1 module latter isoform
0.29775548.12697672.html.plaintext.txt	233	Furthermore lack AF 1 HNF4 resulted decreased interaction p300 GRIP 1 coactivators
0.29775548.12697672.html.plaintext.txt	234	Interaction p300 studied using fragment amino acids 340 528 interacts HNF4 AF 1 AF 2 20
0.29775548.12697672.html.plaintext.txt	235	Despite interaction AF 2 observed marked decrease binding HNF4 lacking AF 1 thus highlighting substantial contribution AF 1 interaction p300
0.29775548.12697672.html.plaintext.txt	236	Consistent result observed p300 enhanced transcriptional potential isoform 2 efficiently isoform 8 HNF42 mutated AF 1
0.29775548.12697672.html.plaintext.txt	237	Interestingly AF 1 module also required synergistic action p300 GRIP 1 enhance HNF4 transcriptional activity 42
0.29775548.12697672.html.plaintext.txt	238	In contrast coactivators corepressor SHP interacted similarly HNF42 8 repressed transcriptional activity similar extents
0.29775548.12697672.html.plaintext.txt	239	This strongly suggests SHP mediated recruitment transcriptional inhibitors AF 1 dependent
0.29775548.12697672.html.plaintext.txt	240	Silencing mediator retinoic acid thyroid hormone receptors SMRT another HNF4 corepressor 46 shown interact similarly HNF41 HNF47 42
0.29775548.12697672.html.plaintext.txt	241	It appears therefore HNF4 AF 1 interacts coactivators whereas AF 2 interacts coactivators corepressors mutually exclusive fashion
0.29775548.12697672.html.plaintext.txt	242	Because balance coactivators corepressors crucial HNF4 transcriptional activity 38 46 lack AF 1 isoforms 7 8 probably results shift toward lower ability recruit coactivators subsequent lower coactivator mediated enhancement HNF4 transcriptional potential
0.29775548.12697672.html.plaintext.txt	243	SHP highly expressed human pancreatic islets Moerman E
0.29775548.12697672.html.plaintext.txt	244	unpublished results may serve important checkpoint balance activity transcriptional network pancreatic ss cells 7 8
0.29775548.12697672.html.plaintext.txt	245	In cells HNF4 AF 2 high probability occupied SHP transcriptional activity isoforms containing AF 1 may efficiently enhanced coactivators
0.29775548.12697672.html.plaintext.txt	246	Thus even AF 1 dependent cofactor mediated modulations HNF4 transcriptional activity observed study Ref
0.29775548.12697672.html.plaintext.txt	247	42 remain shown pancreatic ss cells results strongly argue essential role promoter P1 driven HNF4 isoforms cells
0.29775548.12697672.html.plaintext.txt	248	A cross regulatory loop HNF1 HNF4 evidenced pancreatic ss cells reviewed Refs
0.29775548.12697672.html.plaintext.txt	249	In model proposed Ferrer 9 activation HNF1 promoter HNF4 crucial maintain HNF1 expression threshold level required hold HNF1HNF4 circuit switch ON state consequently avoid ss cell dysfunction development maturity onset diabetes young 9
0.29775548.12697672.html.plaintext.txt	250	Expression HNF4 P1 promoter transcripts pancreatic ss cells probably crucial maintain circuit switch ON state
0.29775548.12697672.html.plaintext.txt	251	Indeed HNF4 expressed limiting amount ss cells among isoforms 1 2 7 8 first two contain AF 1 module confers stronger transcriptional potential leads efficient recruitment coactivators
0.29775548.12697672.html.plaintext.txt	252	Thus expression isoforms 1 2 likely crucial importance transcriptional network controlling pancreatic islet function
0.29775548.12697672.html.plaintext.txt	253	Acknowledgments Professors Ryffel Spiegelman Gustafsson Stallcup Bell Grossman acknowledged providing H455 monoclonal antibody pGEX PGC1 pGEX SHP pGEX GRIP 1 pGL3 HNF1 pCMCss pGEX p300 plasmids respectively
0.29775548.12697672.html.plaintext.txt	254	Brand helpful discussion L
0.29775548.12697672.html.plaintext.txt	255	Footnotes This work supported grant European Foundation Study Diabetes
0.29775548.12697672.html.plaintext.txt	256	contributed equally work
0.29775548.12697672.html.plaintext.txt	257	Abbreviations AF Activation function GRIP glucocorticoid receptor interacting protein GST glutathione S transferase HNF hepatocyte nuclear factor PGC peroxisome proliferator activated receptor coactivator SHP small heterodimer partner
0.29775548.12697672.html.plaintext.txt	258	Accepted publication December 24 2002
0.29775548.12697672.html.plaintext.txt	259	References Top Abstract Introduction Materials Methods Results Discussion References Sladek FM Seidel SD 2001 Hepatocyte nuclear factor 4
0.29775548.12697672.html.plaintext.txt	260	In Burris TP McCabe ERB eds
0.29775548.12697672.html.plaintext.txt	261	Nuclear receptors genetic disease
0.29775548.12697672.html.plaintext.txt	262	San Francisco Academic Press chap 9 pp
0.29775548.12697672.html.plaintext.txt	263	309 361 Stoffel M Duncan SA 1997 The maturity onset diabetes young MODY1 transcription factor HNF 4 regulates expression genes required glucose transport metabolism
0.29775548.12697672.html.plaintext.txt	264	Proc Natl Acad Sci USA 9413209 13214AbstractFree Full Text Hayhurst GP Lee YH Lambert G Ward JM Gonzalez FJ 2001 Hepatocyte nuclear factor 4 nuclear receptor 2A1 essential maintenance hepatic gene expression lipid homeostasis
0.29775548.12697672.html.plaintext.txt	265	Mol Cell Biol 211393 1403AbstractFree Full Text Bartoov Shifman R Hertz R Wang H Wollheim CB Bar Tana J Walker MD 2002 Activation insulin gene promoter direct effect hepatocyte nuclear factor 4
0.29775548.12697672.html.plaintext.txt	266	J Biol Chem 27725914 25919AbstractFree Full Text Wang H Maechler P Antinozzi PA Hagenfeldt KA Wollheim CB 2000 HNF4 regulates expression pancreatic ss cell genes implicated glucose metabolism nutrient induced insulin secretion
0.29775548.12697672.html.plaintext.txt	267	J Biol Chem 27535953 35959AbstractFree Full Text Fajans SS Bell GI Polonsky KS 2001 Molecular mechanisms clinical pathophysiology maturity onset diabetes young
0.29775548.12697672.html.plaintext.txt	268	N Engl J Med 345971 980Free Full Text Shih DQ Screenan S Munoz KN Philipson L Pontoglio M Yaniv M Polonsky KS Stoffel M 2001 Loss HNF 1 function mice leads abnormal expression genes involved pancreatic islet development metabolism
0.29775548.12697672.html.plaintext.txt	269	Diabetes 502472 2480AbstractFree Full Text Shih DQ Stoffel M 2001 Dissecting transcriptional network pancreatic islets development differentiation
0.29775548.12697672.html.plaintext.txt	270	Proc Natl Acad Sci USA 9814189 14191Free Full Text Ferrer J 2002 A genetic switch pancreatic ss cells implications differentiation haploinsufficiency
0.29775548.12697672.html.plaintext.txt	271	Diabetes 512355 2362AbstractFree Full Text Drewes T Senkel S Holewa B Ryffel GU 1996 Human hepatocyte nuclear factor 4 isoforms encoded distinct differentially expressed genes
0.29775548.12697672.html.plaintext.txt	272	Mol Cell Biol 16925 931Abstract Thomas H Jaschkowitz K Bulman M Frayling TM Mitchell SM Roosen S Lingott Frieg A Tack CJ Ellard S Ryffel GU Hattersley AT 2001 A distant upstream promoter HNF 4 gene connects transcription factors involved maturity onset diabetes young
0.29775548.12697672.html.plaintext.txt	273	Hum Mol Genet 102089 2097AbstractFree Full Text Boj SF Parrizas M Maestro MA Ferrer J 2001 A transcription factor regulatory circuit differentiated pancreatic cells
0.29775548.12697672.html.plaintext.txt	274	Proc Natl Acad Sci USA 9814481 14486AbstractFree Full Text Furuta H Iwasaki N Oda N Hinokio Y Horikawa Y Yamagata K Yano N Sugahiro J Ogata M Ohgawara H Omori Y Iwamoto Y Bell GI 1997 Organization partial sequence hepatocyte nuclear factor 4 MODY1 gene identification missense mutation R127W Japanese family MODY
0.29775548.12697672.html.plaintext.txt	275	Diabetes 461652 1657Abstract Suaud L Joseph B Formstecher P Laine B 1997 mRNA expression HNF 4 isoforms HNF 1HNF 1ss variants differentiation human cell lines mimic highly specialized phenotypes intestinal epithelium
0.29775548.12697672.html.plaintext.txt	276	Biochem Biophys Res Commun 235820 825CrossRefMedline Nakhei H Lingott A Lemm I Ryffel GU 1998 An alternative splice variant tissue specific transcription factor HNF4 predominates undifferentiated murine cell types
0.29775548.12697672.html.plaintext.txt	277	Nucleic Acids Res 26497 504AbstractFree Full Text Torres Padilla ME Fougere Deschatrette C Weiss MC 2001 Expression HNF4 isoforms mouse liver development regulated sequential promoter usage constitutive 3 end splicing
0.29775548.12697672.html.plaintext.txt	278	Mech Dev 109183 193CrossRefMedline Hansen SK Parrizas M Jensen ML Pruhova S Ek J Boj SF Johansen A Maestro MA Rivera F Eiberg H Andel M Lebl J Pedersen O Ferrer J Hansen T 2002 Genetic evidence HNF 1 dependent transcriptional control HNF 4 essential human pancreatic ss cell function
0.29775548.12697672.html.plaintext.txt	279	J Clin Invest 110827 833AbstractFree Full Text Green VJ Kokkotou E Ladias JAA 1998 Critical structural elements multitarget protein interactions transcriptional activator AF 1 hepatocyte nuclear factor 4
0.29775548.12697672.html.plaintext.txt	280	J Biol Chem 27329950 29957AbstractFree Full Text Kistanova E Dell H Tsantili P Falvey E Cladaras C Hadzopoulou Cladaras M 2001 The activation function 1 hepatocyte nuclear factor 4 acidic activator mediates interactions bulky hydrophobic residues
0.29775548.12697672.html.plaintext.txt	281	Biochem J 356635 642CrossRefMedline Eeckhoute J Formstecher P Laine B 2001 MODY1 diabetes associated mutations R154X E276Q HNF4 gene impair recruitment p300 key transcriptional coactivator
0.29775548.12697672.html.plaintext.txt	282	Mol Endocrinol 151200 1210AbstractFree Full Text Riachy R Vandewalle B Kerr Conte J Moerman E Sacchetti P Lukowiak B Gmyr V Bouckenooghe T Dubois M Pattou F 2002 125 Dihydroxyvitamin D3 protects RINm5F human islet cells cytokine induced apoptosis
0.29775548.12697672.html.plaintext.txt	283	Implication antiapoptotic protein A20
0.29775548.12697672.html.plaintext.txt	284	Endocrinology 1434809 4819AbstractFree Full Text Laine B Eeckhoute J Suaud L Briche I Furuta H Bell GI Formstecher P 2000 Functional properties R154X HNF 4 protein generated mutation associated maturity onset diabetes young type 1
0.29775548.12697672.html.plaintext.txt	285	FEBS Lett 47941 45CrossRefMedline Linetsky E Bottino R Lehmann R Alejandro R Inverardi L Ricordi C 1997 Improved human islet isolation using new enzyme blend liberase
0.29775548.12697672.html.plaintext.txt	286	Diabetes 461120 1123Abstract Gmyr V Kerr Conte J Vandewalle B Proye C Lefebvre J Pattou F 2001 Human pancreatic ductal cells large scale isolation expansion
0.29775548.12697672.html.plaintext.txt	287	Cell Transplant 10109 121Medline Lukowiak B Vandewalle B Riachy R Kerr Conte J Gmyr V Belaich SLJ Pattou F 2001 Identification purification functional human ss cells new specific zinc fluorescent probe
0.29775548.12697672.html.plaintext.txt	288	J Histochem Cytochem 49519 527AbstractFree Full Text Suaud L Hemimou Y Formstecher P Laine B 1999 Functional study E276Q mutant hepatocyte nuclear factor 4 found type 1 maturity onset diabetes young impaired synergy chicken ovalbumin upstream promoter transcription factor II hepatocyte nuclear factor 1 promoter
0.29775548.12697672.html.plaintext.txt	289	Diabetes 481162 1167Abstract Chartier FC Bossu JP Laudet V Fruchart JC Laine B 1994 Cloning sequencing cDNA encoding human hepatocyte nuclear factor 4 indicate presence two isoforms human liver
0.29775548.12697672.html.plaintext.txt	290	Gene 147269 272CrossRefMedline Bossu J P Chartier FL Fruchart J C Auwerx J Staels B Laine B 1996 Two regulatory elements similar structure placed tandem account repressive activity first intron human apolipoprotein A II gene
0.29775548.12697672.html.plaintext.txt	291	Biochem J 318547 553Medline Oxombre B Moerman E Eeckhoute J Formstecher P Laine B 2002 Mutations hepatocyte nuclear factor 4 gene associated diabetes result greater loss HNF4 function pancreatic ss cells nonpancreatic ss cells reduced activation apolipoprotein CIII promoter hepatic cells
0.29775548.12697672.html.plaintext.txt	292	J Mol Med 80423 430CrossRefMedline Suaud L Formstecher P Laine B 1999 The activity activation function 2 human hepatocyte nuclear factor 4 HNF 4 differently modulated F domains various origins
0.29775548.12697672.html.plaintext.txt	293	Biochem J 340161 169CrossRefMedline Sladek FM Ruse MD Nepomuceno L Huang SM Stallcup MR 1999 Modulation transcriptional activation coactivator interaction splicing variation F domain nuclear receptor hepatocyte nuclear factor 41
0.29775548.12697672.html.plaintext.txt	294	Mol Cell Biol 196509 6522AbstractFree Full Text Miquerol L Lopez S Cartier N Tulliez M Raymondjean M Kahn A 1994 Expression L type pyruvate kinase gene hepatocyte nuclear factor 4 transcription factor exocrine endocrine pancreas
0.29775548.12697672.html.plaintext.txt	295	J Biol Chem 2698944 8951AbstractFree Full Text Sauvaget D Chauffeton V Citadelle D Chatelet FP Cywiner Golenzer C Chambaz J Pincon Raymond M Cardot P Le Beyec J Ribeiro A 2002 Restriction apolipoprotein A IV gene expression intestine villus depends hormone responsive element parallels differential expression hepatic nuclear factor 4 isoforms
0.29775548.12697672.html.plaintext.txt	296	J Biol Chem 27734540 34548AbstractFree Full Text Kumar R Thompson EB 2003 Transactivation functions N terminal domains nuclear hormone receptors protein folding coactivator interactions
0.29775548.12697672.html.plaintext.txt	297	Mol Endocrinol 171 10AbstractFree Full Text Soutoglou E Katrakili N Talianidis I 2000 Acetylation regulates transcription factor activity multiple levels
0.29775548.12697672.html.plaintext.txt	298	Mol Cell 5745 751Medline Wang JC Stafford JM Granner DK 1998 SRC 1 GRIP1 coactivate transcription hepatocyte nuclear factor 4
0.29775548.12697672.html.plaintext.txt	299	J Biol Chem 27330847 30850AbstractFree Full Text Yoon JC Puigserver P Chen G Donovan J Wu Z Rhee J Adelmant G Stafford J Kahn CR Granner DK Newgard CB Spiegelman BM 2001 Control hepatic gluconeogenesis transcriptional coactivator PGC 1
0.29775548.12697672.html.plaintext.txt	300	Nature 413131 138CrossRefMedline Lee YK Dell H Dowhan DH Hadzopoulou Cladaras M Moore DD 1999 The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 retinoid X receptor transactivation two mechanisms repression
0.29775548.12697672.html.plaintext.txt	301	Mol Cell Biol 2000 20187 195 Voegel JJ Heine MJS Zechel C Chambon P Gronemeyer H 1996 TIF2 160 kDa transcriptional mediator ligand dependent activation function AF 2 nuclear receptors
0.29775548.12697672.html.plaintext.txt	302	EMBO J 153667 3675Abstract Ban N Yamada Y Someya Y Miyawaki K Ihara Y Hosokawa M Toyokuni S Tsuda K Seino Y 2002 Hepatocyte nuclear factor 1 recruits transcriptional co activator p300 GLUT2 gene promoter
0.29775548.12697672.html.plaintext.txt	303	Diabetes 511409 1418AbstractFree Full Text Price JA Fossey SC Sale MM Brewer CS Freedman BI Wuerth JP Bowden DW 2000 Analysis HNF4 gene Caucasian type II diabetic nephropathic patients
0.29775548.12697672.html.plaintext.txt	304	Diabetologia 43364 372CrossRefMedline Torres Padilla ME Sladek FM Weiss MC 2002 Developmentally regulated N terminal variants nuclear receptor HNF4 mediate multiple interactions coactivator corepressorHDAC complexes
0.29775548.12697672.html.plaintext.txt	305	J Biol Chem 27744677 44687AbstractFree Full Text Pontoglio M Sreenan S Roe M Pugh W Ostrega D Doyen A Pick AJ Baldwin A Velho G Froguel P Levisetti M Bonner Weir S Bell GI Yaniv M Polonsky KS 1998 Defective insulin secretion hepatocyte nuclear factor 1 deficient mice
0.29775548.12697672.html.plaintext.txt	306	J Clin Invest 1012215 2222AbstractFree Full Text Hagenfeldt Johansson KA Herrera PL Wang H Gjinovci A Ishihara H Wollheim CB 2001 ss Cell targeted expression dominant negative hepatocyte nuclear factor 1 induces maturity onset diabetes young MODY3 like phenotype transgenic mice
0.29775548.12697672.html.plaintext.txt	307	Endocrinology 1425311 5320AbstractFree Full Text Gragnoli C Lindner T Cockburn BN Kaisaki PJ Gragnoli F Marozzi G Bell GI 1997 Maturity onset diabetes young due mutation hepatocyte nuclear factor 4 binding site promoter hepatocyte nuclear factor 1 gene
0.29775548.12697672.html.plaintext.txt	308	Diabetes 461648 1651Abstract Ruse Jr MD Privalsky ML Sladek FM 2002 Competitive cofactor recruitment orphan receptor hepatocyte nuclear factor 41 modulation F domain
0.29775548.12697672.html.plaintext.txt	309	Mol Cell Biol 221626 1638AbstractFree Full Text
0.49359712.9421506.html.plaintext.txt	0	An alternative splice variant tissue specific transcription factor HNF4alpha predominates undifferentiated murine cell types An alternative splice variant tissue specific transcription factor HNF4 alpha predominates undifferentiated murine cell types Hassan Nakhei Anja Lingott Ira Lemm Gerhart U
0.49359712.9421506.html.plaintext.txt	1	Universitatsklinikum Essen Institut fur Zellbiologie Tumorforschung Hufelandstraszlige 55 D 45122 Essen Germany
0.49359712.9421506.html.plaintext.txt	2	Received September 25 1997 Revised Accepted November 26 1997
0.49359712.9421506.html.plaintext.txt	3	The transcription factor hepatocyte nuclear factor 4alpha HNF4alpha tissue specific transcription factor mainly expressed liver kidney intestine endocrine pancreas also essential regulator early embryonic events
0.49359712.9421506.html.plaintext.txt	4	Based protein structure HNF4alpha classified orphan member nuclear receptor superfamily
0.49359712.9421506.html.plaintext.txt	5	Comparing HNF4alpha transcription factors differentiated dedifferentiated murine hepatocyte cell line MHSV 12 identified dedifferentiated cells novel splice variant HNF4alpha7
0.49359712.9421506.html.plaintext.txt	6	This variant characterized alternative first exon lower transactivation potential transient transfection assays using HNF4 dependent reporter genes
0.49359712.9421506.html.plaintext.txt	7	HNF4alpha7 mRNA corresponding protein expressed undifferentiated pluripotent embryonal carcinoma cell line F9 whereas HNF4alpha1 appears differentiation F9 cells visceral endoderm
0.49359712.9421506.html.plaintext.txt	8	HNF4alpha7 mRNA also found totipotent embryonic stem cells
0.49359712.9421506.html.plaintext.txt	9	However function HNF4alpha7 seems restricted embryonic cells HNF4alpha7 mRNA also present adult tissues notably stomach
0.49359712.9421506.html.plaintext.txt	10	All features suggest presence distinct splice variants HNF4alpha modulates activity HNF4alpha cell type specific way
0.49359712.9421506.html.plaintext.txt	11	Hepatocyte nuclear factor 4 HNF4 constitutes transcription factor family 1 2 whose first member HNF4alpha identified factor interacting promoter elements mediating liver specific transcription 3
0.49359712.9421506.html.plaintext.txt	12	Based zinc finger motif DNA binding domain potential ligand binding domain HNF4 classified member nuclear orphan receptor superfamily 4
0.49359712.9421506.html.plaintext.txt	13	HNF4alpha turned present also non hepatic cells kidney intestine stomach pancreas 5 7
0.49359712.9421506.html.plaintext.txt	14	The importance HNF4alpha gene control tissues distinct liver documented fact human inherited disease based expression mutated HNF4alpha gene endocrine pancreas leading maturity onset diabetes young MODY1 8
0.49359712.9421506.html.plaintext.txt	15	In addition role HNF4alpha tissue specific transcription factor functions also early embryogenesis Xenopus egg identified HNF4alpha protein maternal transcription factor contributes zygotic activation gene encoding HNF1alpha 9
0.49359712.9421506.html.plaintext.txt	16	In mouse embryos HNF4alpha transcripts identified primary endoderm early day 4
0.49359712.9421506.html.plaintext.txt	17	5 later liver diverticulum gut nephrogenic tissues starting day 8
0.49359712.9421506.html.plaintext.txt	18	The early embryonic requirement HNF4alpha well established mouse knock HNF4alpha gene leads disturbance gastrulation thus early embryonic lethality 11
0.49359712.9421506.html.plaintext.txt	19	The embryonic role HNF4 seems evolutionary conserved maternal HNF4 mRNA identified Drosophila egg
0.49359712.9421506.html.plaintext.txt	20	Furthermore large chromosomal deletion spanning HNF4 locus results defects gut malpighian tubules developing Drosophila malformations interpreted HNF4 plays similar functions invertebrates vertebrates 7
0.49359712.9421506.html.plaintext.txt	21	In addition HNF4alpha recently identified two members HNF4 family
0.49359712.9421506.html.plaintext.txt	22	HNF4beta Xenopus 2 HNF4gamma humans 1
0.49359712.9421506.html.plaintext.txt	23	Both new members HNF4 family seem distinct overlapping functions compared HNF4alpha since gene products show differential expression pattern distinct transactivation potential HNF4 dependent reporter genes
0.49359712.9421506.html.plaintext.txt	24	Further complexity gene control HNF4alpha transcription factors apparently given differential splicing 10 initially identified exons HNF4alpha gene 6 8
0.49359712.9421506.html.plaintext.txt	25	Thus far six distinct splice variants HNF4alpha identified human murine cDNA samples
0.49359712.9421506.html.plaintext.txt	26	We use nomenclature recently used human splice variants 12 HNF4alpha1 represents initially identified transcript 3 HNF4alpha2 HNF4alpha6 splice variants identified subsequently
0.49359712.9421506.html.plaintext.txt	27	HNF4alpha2 splice variant contains larger exon 9 resulting insertion 10 additional amino acids Pro rich C terminal part identified rat 13 mouse 14 human 1 15
0.49359712.9421506.html.plaintext.txt	28	HNF4alpha3 initially refered HNF 4C 16 identified human liver cDNA characterized shorter distinct C terminus whereas HNF4alpha4 found human kidney liver RNA contains N terminal region two additional exons 1B 1C 1 12
0.49359712.9421506.html.plaintext.txt	29	The fifth splice variant HNF4alpha5 carries exon 1B 1C found HNF4alpha4 together larger exon 9 found HNF4alpha2 whereas HNF4alpha6 combines exon 1B exon 1C C terminal truncation found HNF4alpha3 12
0.49359712.9421506.html.plaintext.txt	30	We speculate splice variants unique properties allowing modulation HNF4alpha activity
0.49359712.9421506.html.plaintext.txt	31	Indeed shown transient transfection assays using HNF4 dependent reporter genes HNF4alpha4 lower transactivation potential compared HNF4alpha2 1
0.49359712.9421506.html.plaintext.txt	32	However stressed HNF4alpha variants identified mRNAs existence corresponding proteins proven
0.49359712.9421506.html.plaintext.txt	33	The broad spectrum tissues expressing HNF4alpha argues function HNF4alpha establishment differentiation various cell types data concerning role HNF4alpha investigated hepatic cells
0.49359712.9421506.html.plaintext.txt	34	Most notably presence HNF4alpha expression correlated differentiated phenotype hepatocytes reviewed 17
0.49359712.9421506.html.plaintext.txt	35	In fact shown introduction HNF4alpha dedifferentiated hepatocytes lead redifferentiation shown activation several liver specific functions 18 20 whereas forced expression dominant negative mutant regulates several liver specific genes differentiated hepatoma cells 21 22
0.49359712.9421506.html.plaintext.txt	36	In present report analyzed murine cell line MHSV 12 highly differentiated hepatic phenotype reversibly decreased serum containing culture medium 23
0.49359712.9421506.html.plaintext.txt	37	We reasoned change hepatic differentiation might correlate altered expression HNF4alpha
0.49359712.9421506.html.plaintext.txt	38	Using cells succeeded define novel HNF4alpha7 splice variant expressed tissue specific manner notably found major component embryonic stem cells
0.49359712.9421506.html.plaintext.txt	39	MATERIALS AND METHODS Nucleotide sequence accession number
0.49359712.9421506.html.plaintext.txt	40	The sequence splice variant HNF4alpha7 deposited GenBank accession number AF015275
0.49359712.9421506.html.plaintext.txt	41	Cell cultures transfections
0.49359712.9421506.html.plaintext.txt	42	All culture media contained penicillin 100 Uml streptomycin 100 Uml
0.49359712.9421506.html.plaintext.txt	43	The MHSV 12 cell clone maintained chemically defined MX83 medium supplemented 1 microgml transferrin 10 microgml insulin 1 microgml hydrocortisone 100 ngml EGF described 23
0.49359712.9421506.html.plaintext.txt	44	For splitting cells trypsinized cultured Dulbeccos modified Eagles medium DMEM 10 heat inactivated calf serum one day adding MX83 medium
0.49359712.9421506.html.plaintext.txt	45	F9 cells propagated gelatine coated cell culture dishes DMEM 10 heat inactivated calf serum
0.49359712.9421506.html.plaintext.txt	46	To induce visceral endoderm differentiation F9 cells seeded bacterial dishes presence 2 x 10 7 M retinoic acid 24 25
0.49359712.9421506.html.plaintext.txt	47	Embryonic stem cells ES cells E14 1 cultured mitomycin treated feeder cells DMEM containing 15 heat inactivated fetal calf serum supplemented MEM non essential amino acids Sigma 2 mM glutamine 100 microM beta mercaptoethanol
0.49359712.9421506.html.plaintext.txt	48	For transient transfection C2 cells DNA calcium phosphate coprecipitation method used 26 whereas Hela MHSV 12 cells lipofectin transfection protocol applied 1
0.49359712.9421506.html.plaintext.txt	49	Extract preparation gel retardation assays
0.49359712.9421506.html.plaintext.txt	50	High salt extracts crude nuclear pellets cultured cells prepared described 27 gel retardation assays 28 performed using HNF4 binding site human apolipoprotein B promoter 2 Xenopus HNF1alpha promoter 26
0.49359712.9421506.html.plaintext.txt	51	The monoclonal antibody recognizing AB domain HNF4alpha1 described 29
0.49359712.9421506.html.plaintext.txt	52	The polyclonal antibodies anti ABC anti F raised N terminus rat HNF4alpha1 protein 29 peptide F domain Xenopus HNF4alpha protein 2 respectively
0.49359712.9421506.html.plaintext.txt	53	These polyclonal antisera produced rabbits Eurogentec
0.49359712.9421506.html.plaintext.txt	54	For 5 RACE RNA purified RNA CleantmSystem AGS Heidelberg MHSV 12 cells grown serum containing DMEM 5 microg aliquots reverse transcribed HN7 primer cDNA using Superscripttm II plus kit GIBCOBRL
0.49359712.9421506.html.plaintext.txt	55	The 5 end cDNA amplified 5 AmpliFINDERtm RACE kit CLONTECH ligating oligonucleotide H2N TGGGCCTCTAGACTTAAG 5 3 end cDNA
0.49359712.9421506.html.plaintext.txt	56	This tag used priming oligonucleotide P11 5 ACCCGGAGATCTGAATTC 3 PCR product cloned
0.49359712.9421506.html.plaintext.txt	57	For RT PCR cDNA synthesized random primer using 5 microg RNA
0.49359712.9421506.html.plaintext.txt	58	To detect HNF4alpha transcripts reverse primer HN7 5 CCTTAAGGCTTCCTTCTTCATGCCAGCCCGG 3 forward primers HN6 5 GGAATTCCGGCATGGATATGGCCGACTACAGCGC HN18 5 GGGTACCCTTGGTCATGGTCAGTG 3 used see Fig
0.49359712.9421506.html.plaintext.txt	59	The oligonucleotide HN7 HN6 contain linker sequences underlined 5 end present cDNA
0.49359712.9421506.html.plaintext.txt	60	To quantitate GAPDH mRNA oligonucleotides 5 ACCACAGTCCATGCCATCAC 3 5 TCCACCACCCTGTTGCTGTA 3 used forward reverse primers respectively
0.49359712.9421506.html.plaintext.txt	61	To quantitate HNF4alpha transcripts illustrated Figures 6 7 PCR reactions contained addition 200 microM dNTP labeled triphosphate
0.49359712.9421506.html.plaintext.txt	62	1 microCi50 microl reaction alpha 32PdCTP
0.49359712.9421506.html.plaintext.txt	63	This allows quantification PCR fragments phosphor imager
0.49359712.9421506.html.plaintext.txt	64	In addition sensitive detection permits lower cycle number thus avoids reaching saturation PCR 30
0.49359712.9421506.html.plaintext.txt	65	All reactions done 62 72 degrees C annealing extension respectively
0.49359712.9421506.html.plaintext.txt	66	RESULTS A novel HNF4alpha protein dedifferentiated hepatocytes
0.49359712.9421506.html.plaintext.txt	67	It well established composition culture medium profound effect differentiation state hepatocytes 23
0.49359712.9421506.html.plaintext.txt	68	In general presence serum leads substantial dedifferentiation hepatic phenotype
0.49359712.9421506.html.plaintext.txt	69	To explore whether cultivation conditions hepatocytes effect expression tissue specific transcription factors known responsible hepatic phenotype determined presence liver transcription factors immortalized murine hepatic cell line MHSV 12
0.49359712.9421506.html.plaintext.txt	70	This cell line found express abundantly transcripts liver specific proteins albumin aldolase A B well tyrosine amino transferase liver specific expression pattern reversibly decreased serum containing medium 23
0.49359712.9421506.html.plaintext.txt	71	Analyzing expression HNF1alpha MHSV 12 cell line cultured various conditions detect change transcription factor data shown
0.49359712.9421506.html.plaintext.txt	72	However probing HNF4alpha gel retardation assays using various antibodies detected significant differences illustrated Figure 1 A extracts MHSV 12 cells grown serum free MX83 medium maintains highly differentiated hepatic phenotype 23 HNF4alpha could readily detected gel retardation experiments lane 1 DNA protein complex could supershifted antibody raised AB domain F domain HNF4alpha lanes 2 3 respectively
0.49359712.9421506.html.plaintext.txt	73	In contrast extracts derived MHSV 12 cells cultivated presence serum leads dramatic dedifferentiation 23 observed HNF4alpha protein detected gel retardation assays lane 4 react antibody specific AB domain HNF4alpha lane 5
0.49359712.9421506.html.plaintext.txt	74	However extracts presence HNF4alpha protein could verified antibody specific F domain lane 6
0.49359712.9421506.html.plaintext.txt	75	These results imply properties HNF4alpha change MHSV 12 cells depending culture conditions
0.49359712.9421506.html.plaintext.txt	76	The HNF4alpha protein MHSV 12 cells reacts AB domain specific antibody depending conditions used culture cells
0.49359712.9421506.html.plaintext.txt	77	Nuclear extracts MHSV 12 cells used gel retardation assays HNF4 binding site apolipoprotein promoter
0.49359712.9421506.html.plaintext.txt	78	The addition specific antibodies given arrow head points complex supershifted AB domain specific antibody
0.49359712.9421506.html.plaintext.txt	79	A Extracts prepared cells grown either chemically defined MX83 medium lacking serum lanes 1 3 DMEM containing calf serum lanes 4 6
0.49359712.9421506.html.plaintext.txt	80	B Extracts derived cells maintained complete MX83 medium lanes 7 8 MX83 medium lacking either epidermal growth factor lanes 1 2 hydrocortisone lanes 3 4 insulin lanes 5 6
0.49359712.9421506.html.plaintext.txt	81	C Nuclear proteins extracted cells grown DMEM 10 serum
0.49359712.9421506.html.plaintext.txt	82	Dexamethasone dex antagonist RU486 added cells 10 7M 3 x 10 4M respectively indicated
0.49359712.9421506.html.plaintext.txt	83	The type HNF4alpha protein present MHSV 12 cells dependent glucocorticoids
0.49359712.9421506.html.plaintext.txt	84	To identify components culture medium change properties HNF4alpha protein cultivated MHSV 12 cells MX83 medium lacking defined components analyzed extracts cells gel retardation assay using AB domain specific antibody
0.49359712.9421506.html.plaintext.txt	85	As Figure 1 B illustrates omission hydrocortisone culture medium results cell extracts HNF4alpha protein mostly cannot supershifted AB domain specific antibody lanes 3 4
0.49359712.9421506.html.plaintext.txt	86	In contrast extracts derived cultures grown absence EGF lanes 1 2 insulin lanes 5 6 contain HNF4alpha predominantly supershifted AB domain specific antibody
0.49359712.9421506.html.plaintext.txt	87	Consequently presence hydrocortisone serum free medium leads expression HNF4alpha form recognized AB domain specific antibody
0.49359712.9421506.html.plaintext.txt	88	In complementary approach investigated effect glucocorticoid hormone HNF4alpha expression MHSV 12 cells grown serum
0.49359712.9421506.html.plaintext.txt	89	As shown gel retardation assay Figure 1 C 24 h incubation dexamethasone leads substantial amount HNF4alpha protein recognized AB domain specific antibody lane 5
0.49359712.9421506.html.plaintext.txt	90	Since dexamethasone mediated change inhibited RU486 well known antagonist binding glucocorticoid receptor competitor glucocorticoid lane 8 assume effect mediated nuclear hormone receptor
0.49359712.9421506.html.plaintext.txt	91	The findings cells grown without serum well data cultures maintained serum imply glucocorticoid mediated event alters properties HNF4alpha protein way recognized AB specific antibody
0.49359712.9421506.html.plaintext.txt	92	The novel HNF4alpha7 protein encoded differential splice variant HNF4alpha gene
0.49359712.9421506.html.plaintext.txt	93	The differential recognition HNF4alpha AB domain specific antibody could either reflect protein modification change amino acid sequence N terminus HNF4alpha protein
0.49359712.9421506.html.plaintext.txt	94	To distinguish two alternatives transfected expression vector encoding originally described rat HNF4alpha protein 3 MHSV 12 cells grown presence serum
0.49359712.9421506.html.plaintext.txt	95	absence hydrocortisone abolishes supershift AB domain specific antibody
0.49359712.9421506.html.plaintext.txt	96	Analyzing increasing amounts extracts derived transfected cell lines gel retardation assays observed concentration dependent appearance HNF4alpha protein supershifted AB domain specific antibody marked arrow head lanes 2 5 Fig
0.49359712.9421506.html.plaintext.txt	97	2 whereas extracts mock transfected cells HNF4alpha protein could supershifted AB specific antibody lanes 8 11
0.49359712.9421506.html.plaintext.txt	98	Using F domain specific antibody qualitative difference could seen HNF4alpha transfected cells control supershifted band stronger extract transfected cells compare lanes 3 6 lanes 9 12
0.49359712.9421506.html.plaintext.txt	99	These results rule possibility protein modification plays major role rather imply transfected HNF4alpha encodes protein distinct amino acid sequence protein expressed undifferentiated MHSV 12 cells
0.49359712.9421506.html.plaintext.txt	100	The transfected HNF4alpha protein recognized AB specific antibody MHSV 12 cells grown serum containing DMEM
0.49359712.9421506.html.plaintext.txt	101	An expression vector encoding rat HNF4alpha1 protein HNF4alphaCMV alternatively RcCMV vector alone transfected MHSV 12 cells grown DMEM 10 calf serum
0.49359712.9421506.html.plaintext.txt	102	Aliquots 2 4 microl nuclear extracts prepared transfected cells analyzed gel retardation assays HNF4 binding site apolipoprotein promoter
0.49359712.9421506.html.plaintext.txt	103	The arrow marks DNA HNF4alpha complex supershifted antibody specific F domain
0.49359712.9421506.html.plaintext.txt	104	The arrow head points transfected HNF4alpha protein detected monoclonal anti AB antibody
0.49359712.9421506.html.plaintext.txt	105	Comparison HNF4alpha1 HNF4alpha7 splice variants
0.49359712.9421506.html.plaintext.txt	106	A Schematic drawings alpha1 alpha7 splice variants mouse HNF4alpha gene
0.49359712.9421506.html.plaintext.txt	107	The boxes designate domains protein defined 3
0.49359712.9421506.html.plaintext.txt	108	The position primers used indicated
0.49359712.9421506.html.plaintext.txt	109	B Alignment nucleotide sequence alpha1 alpha7 splice variants
0.49359712.9421506.html.plaintext.txt	110	The frame stop codon TGA preceeding open reading frame initiation codon ATG HNF4alpha7 underlined
0.49359712.9421506.html.plaintext.txt	111	The nucleotide sequence HNF4alpha1 published 14
0.49359712.9421506.html.plaintext.txt	112	The initiation codon HNF4alpha1 based sequence comparisons HNF4alpha proteins various species 1
0.49359712.9421506.html.plaintext.txt	113	The position first intron 6 marked arrow
0.49359712.9421506.html.plaintext.txt	114	C The N terminal part amino acid sequence alpha1 alpha7 splice variants aligned
0.49359712.9421506.html.plaintext.txt	115	The cystein residues forming zinc finger domain underlined
0.49359712.9421506.html.plaintext.txt	116	To prove assumption MHSV 12 cells endogenous HNF4alpha protein differs amino acid sequence cloned sequence analyzed HNF4alpha mRNA derived cells cultivated presence serum
0.49359712.9421506.html.plaintext.txt	117	As difference HNF4alpha protein detected monoclonal antibody raised N terminal AB domain suspected distinct 5 end HNF4alpha mRNA
0.49359712.9421506.html.plaintext.txt	118	Therefore generated reverse transcription cDNA starting D domain primer HN7 Fig
0.49359712.9421506.html.plaintext.txt	119	3 A ligated DNA 5 end oligonucleotide could used second primer start site
0.49359712.9421506.html.plaintext.txt	120	Using 5 RACE strategy succeeded cloning two independent cDNA fragments analyzed sequencing
0.49359712.9421506.html.plaintext.txt	121	The sequence longer cDNA clone shown Figure 3 B revealed 5 end 107 47 completely different published nucleotide sequence mouse HNF4alpha whereas 3 end nucleotide 48 274 highly identical known sequence
0.49359712.9421506.html.plaintext.txt	122	The loss identity exactly position shorter cDNA clone data shown thus excluding cloning artefact
0.49359712.9421506.html.plaintext.txt	123	As loss identity corresponds cases position exon 1 exon 2 boundary 6 anticipate new cDNA encodes novel splice variant HNF4alpha gene refer HNF4alpha7
0.49359712.9421506.html.plaintext.txt	124	The 5 end HNF4alpha7 cDNA encodes frame open reading frame preceeded frame stop codon Fig
0.49359712.9421506.html.plaintext.txt	125	Comparing amino acid sequence HNF4alpha1 HNF4alpha7 proteins reveals N termini completely different HNF4alpha7 splice variant 23 amino acids shorter previously described HNF4alpha1 protein Fig
0.49359712.9421506.html.plaintext.txt	126	The novel N terminal sequence HNF4alpha7 shows significant identity sequence data bank
0.49359712.9421506.html.plaintext.txt	127	The balance HNF4alpha1 HNF4alpha7 splice variants changes MHSV 12 differentiation status
0.49359712.9421506.html.plaintext.txt	128	Comparing extracts derived MHSV 12 cells grown without serum presence serum observed western blots HNF4alpha slightly shorter presence serum thus size predicted HNF4alpha7 splice variant data shown
0.49359712.9421506.html.plaintext.txt	129	The presence splice variant confirmed RT PCR using primers specific alpha7 splice variant
0.49359712.9421506.html.plaintext.txt	130	Figure 4 reveals expression HNF4alpha7 splice variant MHSV 12 cells cultured presence serum lane 1
0.49359712.9421506.html.plaintext.txt	131	Apparently significant amounts HNF4alpha7 variant also found cells grown serum free medium lane 2
0.49359712.9421506.html.plaintext.txt	132	However RT PCR reactions performed close saturation therefore heavily overestimate amount HNF4alpha7 transcripts
0.49359712.9421506.html.plaintext.txt	133	In contrast previously described HNF4alpha1 splice variant exclusively detected MHSV 12 cells grown serum free medium compare lanes 4 5
0.49359712.9421506.html.plaintext.txt	134	These data confirm serum induced change differentiation state hepatic cells accompanied alteration HNF4alpha splice variants
0.49359712.9421506.html.plaintext.txt	135	In differentiated cells grown serum free conditions HNF4alpha1 small extent HNF4alpha7 transcripts present whereas dedifferentiated cells grown serum contain almost exclusively HNF4alpha7 splice variant
0.49359712.9421506.html.plaintext.txt	136	The presence HNF4alpha1 HNF4alpha7 splice variants MHSV 12 cells
0.49359712.9421506.html.plaintext.txt	137	By RT PCR using primer pair HN18HN7 lanes 1 2 HN6HN7 lanes 4 5 presence alpha7 alpha1 splice variant determined respectively
0.49359712.9421506.html.plaintext.txt	138	The RNA used either prepared cells grown serumfree MX83 medium lanes 2 4 cells maintained DMEM 10 serum lanes 1 5
0.49359712.9421506.html.plaintext.txt	139	The PCR products separated 1
0.49359712.9421506.html.plaintext.txt	140	8 agarose gel stained ethidium bromide
0.49359712.9421506.html.plaintext.txt	141	pBR322 plasmid DNA restricted Alw441 Mva1 loaded lane 3 size marker
0.49359712.9421506.html.plaintext.txt	142	The marker fragment migrating HNF4alpha1 HNF4alpha7 PCR product 383bp size
0.49359712.9421506.html.plaintext.txt	143	The position primers given Figure 3A
0.49359712.9421506.html.plaintext.txt	144	HNF4alpha1 HNF4alpha7 distinct transactivation potential
0.49359712.9421506.html.plaintext.txt	145	To address question whether novel splice variant differential transactivation potential compared transactivation potential transfection experiments splice variant HNF4alpha1
0.49359712.9421506.html.plaintext.txt	146	Using luciferase reporter construct containing four HNF4 binding sites front tk promoter 31 observed dedifferentiated hepatoma cell line C2 lacks HNF4alpha 31 2 fold lower transactivation potential HNF4alpha7 compared HNF4alpha1 Fig
0.49359712.9421506.html.plaintext.txt	147	In Hela cells even greater difference transactivation potential two splice variants observed Fig
0.49359712.9421506.html.plaintext.txt	148	In fact using high concentrations HNF4alpha7 expression vector transactivation luciferase reporter seen
0.49359712.9421506.html.plaintext.txt	149	Taken together results establish MHSV 12 cells grown serum leads dramatic dedifferentiation hepatic phenotype contain HNF4alpha7 variant significantly lower transactivation potential
0.49359712.9421506.html.plaintext.txt	150	The HNF4alpha7 transcription factor functional transactivator reduced activation potential compared HNF4alpha1
0.49359712.9421506.html.plaintext.txt	151	A The dedifferentiated hepatoma cell line C2 lacking HNF4alpha transiently transfected 50 ng expression vector encoding HNF4alpha protein 2 microg H4 tk luc reporter contains four copies HNF4 binding site human alpha1 anti trypsin gene front thymidine kinase promoter previously described 31
0.49359712.9421506.html.plaintext.txt	152	RcCMV InVitrogen expression vector without insert whereas rHNF4alpha1 contains rat transcription factor 3 used construct mHNF4alpha1 mHNF4alpha7 constructs
0.49359712.9421506.html.plaintext.txt	153	mHNF4alpha1 mouse rat chimeric protein amino acids 1 102 derived mouse alpha1 protein amino acids 103 C terminus rat protein
0.49359712.9421506.html.plaintext.txt	154	mHNF4alpha7 corresponding chimeric protein containing N terminus alpha7 splice variant fused C terminus rat protein
0.49359712.9421506.html.plaintext.txt	155	For constructs AccI site codon 102 HNF4alpha1 protein used see Fig
0.49359712.9421506.html.plaintext.txt	156	B Increasing amounts expression vector encoding mHNF4alpha1 mHNF4alpha7 transfected Hela cells H4 tk luc reporter
0.49359712.9421506.html.plaintext.txt	157	The amount plasmid DNA kept constant adding RcCMV
0.49359712.9421506.html.plaintext.txt	158	The error bars given refer independent transfection experiments
0.49359712.9421506.html.plaintext.txt	159	Tissue specific expression pattern HNF4alpha1 HNF4alpha7
0.49359712.9421506.html.plaintext.txt	160	RNA isolated mouse tissues analyzed RT PCR presence HNF4alpha7 HNF4alpha1 splice variants using HN18HN7 HN6HN7 primer pairs respectively see Fig 3A
0.49359712.9421506.html.plaintext.txt	161	To control quality RNA presence GAPDH mRNA analyzed aliquots RT reactions
0.49359712.9421506.html.plaintext.txt	162	The print outs phosphor imager represent PCR reactions generated using 35 HNF4alpha1 HNF4alpha7 30 GAPDH cycles
0.49359712.9421506.html.plaintext.txt	163	To estimate abundance HNF4alpha1 HNF4alpha7 transcripts signals counted phosphor imager corrected amount GAPDH mRNA
0.49359712.9421506.html.plaintext.txt	164	To ascertain PCR reactions still linear range values given high expressing tissues liver kidney stomach intestine calculated experiments using 30 cycles amplification
0.49359712.9421506.html.plaintext.txt	165	Differential expression HNF4alpha1 HNF4alpha7 embryonic cell lines
0.49359712.9421506.html.plaintext.txt	166	A The undifferentiated embryonal carcinoma cell line F9 F9 cells differentiated 7 days visceral endoderm treated dexamethasone indicated
0.49359712.9421506.html.plaintext.txt	167	The HNF4alpha7 HNF4alpha1 transcripts detected RT PCR Figure 6 using 35 cycles amplification
0.49359712.9421506.html.plaintext.txt	168	The GAPDH RNA amplified 25 cycles
0.49359712.9421506.html.plaintext.txt	169	B The HNF4 binding site HNF1alpha promoter used gel retardation assays nuclear extracts F9 cells
0.49359712.9421506.html.plaintext.txt	170	The addition various antibodies given
0.49359712.9421506.html.plaintext.txt	171	The arrow designates complexes containing HNF4alpha1 HNF4alpha7 whereas arrow head points supershift containing HNF4alpha1
0.49359712.9421506.html.plaintext.txt	172	C RNA prepared embryonic stem cell line E14 1 grown feeder cells lane 2 feeder cells alone lane 3 analyzed RT PCR presence HNF4alpha7 35 cycles GAPDH 25 cycles mRNA A
0.49359712.9421506.html.plaintext.txt	173	In lane 1 RNA added RT reaction
0.49359712.9421506.html.plaintext.txt	174	HNF4alpha1 HNF4alpha7 show distinct tissue specific expression pattern
0.49359712.9421506.html.plaintext.txt	175	To explore significance novel HNF4alpha7 splice variant investigated RT PCR presence HNF4alpha1 HNF4alpha7 transcripts different mouse tissues
0.49359712.9421506.html.plaintext.txt	176	To allow reliable quantification made PCR reaction 32P labeled dCTP permits low cycling numbers thus ensures quantitative measurements
0.49359712.9421506.html.plaintext.txt	177	As shown Figure 6 transcripts identified liver stomach lanes 1 3 whereas kidney smaller extent intestine HNF4alpha1 transcript detected
0.49359712.9421506.html.plaintext.txt	178	In pancreas small amounts HNF4alpha7 transcripts present
0.49359712.9421506.html.plaintext.txt	179	But significance finding questionable GAPDH mRNA cannot seen probably pancreatic RNase sufficiently inhibited RNA preparation
0.49359712.9421506.html.plaintext.txt	180	However traces HNF4alpha7 RNA also detected ovary heart bladder brain HNF4alpha1 transcripts normal levels GAPDH RNA observed
0.49359712.9421506.html.plaintext.txt	181	Clearly HNF4alpha1 HNF4alpha7 splice variants expressed differentially various tissues analyzed
0.49359712.9421506.html.plaintext.txt	182	By quantification PCR products phosphor imager estimate stomach third HNF4alpha transcripts correspond HNF4alpha7 splice variant lane 3
0.49359712.9421506.html.plaintext.txt	183	Furthermore abundance HNF4alpha7 transcripts differs factor 1000 fold high low expressing tissues
0.49359712.9421506.html.plaintext.txt	184	HNF4alpha7 expressed embryonic stem cells mouse
0.49359712.9421506.html.plaintext.txt	185	Our initial experiments leading identification HNF4alpha7 splice variant implied correlation novel splice variant undifferentiated phenotype hepatocytes
0.49359712.9421506.html.plaintext.txt	186	Therefore investigated presence HNF4alpha7 murine embryonal carcinoma cell line F9 resembles pluripotent stem cells inner cell mass early mouse embryo
0.49359712.9421506.html.plaintext.txt	187	This cell line differentiated distinct endodermal cell types upon retinoic acid treatment
0.49359712.9421506.html.plaintext.txt	188	Most interestingly stem cells differentiated retinoic acid treatment visceral endoderm cultured suspension aggregates cell types share properties hepatocytes 24 32
0.49359712.9421506.html.plaintext.txt	189	Based RT PCR succeeded show undifferentiated F9 cells contain exclusively HNF4alpha7 splice variant Fig
0.49359712.9421506.html.plaintext.txt	190	7 A lanes 1 2 whereas differentiated cell population contains HNF4alpha1 well HNF4alpha7 splice variants lanes 3 4
0.49359712.9421506.html.plaintext.txt	191	From three independent experiments estimated quantification phosphor imager 15 fold increase HNF4alpha7 mRNA upon differentiation visceral endoderm whereas level HNF4alpha1 transcripts increased undetectable levels value 60 amount HNF4alpha7 transcript
0.49359712.9421506.html.plaintext.txt	192	Since immortalized hepatic MHSV 12 cells grown presence serum balance HNF4alpha1 HNF4alpha7 altered addition glucocorticoid dexamethasone Fig
0.49359712.9421506.html.plaintext.txt	193	1 wondered whether similar effect seen F9 cells
0.49359712.9421506.html.plaintext.txt	194	As Figure 7 A demonstrates expression pattern HNF4alpha1 HNF4alpha7 changed upon dexamethasone treatment either undifferentiated differentiated F9 cells
0.49359712.9421506.html.plaintext.txt	195	To determine whether presence HNF4alpha7 transcript embryonal cell line F9 also reflects expression corresponding protein prepared nuclear extracts F9 cells
0.49359712.9421506.html.plaintext.txt	196	In gel retardation assays extracts undifferentiated F9 cells Fig
0.49359712.9421506.html.plaintext.txt	197	7 B could detect supershift F domain specific antibody lane 3 ABC domain specific antibody lane 4 reaction AB domain specific antibody lane 2
0.49359712.9421506.html.plaintext.txt	198	In contrast F9 cells differentiated visceral endoderm supershift seen three antibodies lanes 6 7 8
0.49359712.9421506.html.plaintext.txt	199	This result consistent RT PCR analysis implies undifferentiated F9 cells contain HNF4alpha7 protein whereas HNF4alpha1 well HNF4alpha7 proteins present differentiated F9 cells
0.49359712.9421506.html.plaintext.txt	200	To investigate early embryonic expression HNF4alpha7 searched corresponding transcript totipotent embryonic stem cell line E14 1
0.49359712.9421506.html.plaintext.txt	201	The RT PCR analysis given Figure 7 C demonstrates presence HNF4alpha7 mRNA embryonal stem cell lane 2 whereas RNA sample derived feeder cells used ES cell culture lack HNF4alpha7 transcripts lane 3
0.49359712.9421506.html.plaintext.txt	202	Probing ES cell RNA HNF4alpha1 mRNA detect transcript data shown
0.49359712.9421506.html.plaintext.txt	203	From analysis F9 cells ES cells conclude presence HNF4alpha7 mRNA characteristic undifferentiated embryonic cells
0.49359712.9421506.html.plaintext.txt	204	The novel splice variant HNF4alpha7 expressed exclusive HNF4alpha transcript undifferentiated embryonal carcinoma cell line F9 ES cell line E14 1
0.49359712.9421506.html.plaintext.txt	205	The transcript also found hepatocyte cell line MHSV 12 established immortalization embryonic hepatocytes
0.49359712.9421506.html.plaintext.txt	206	In immortalized hepatic cell culture HNF4alpha7 predominates provided cells cultured conditions lead dedifferentiation
0.49359712.9421506.html.plaintext.txt	207	In context important stress MHSV 12 cell line dedifferentiated serum addition far hepatic characters dedifferentiated hepatoma cell lines C2 H5 lack HNF4alpha HNF1alpha transcription factors 18 32
0.49359712.9421506.html.plaintext.txt	208	Recently expression HNF4alpha investigated ES cell line D3 33
0.49359712.9421506.html.plaintext.txt	209	Under differentiating conditions allowing formation embryoid bodies appearance HNF4alpha RNA observed signal detected undifferentiated embryonic stem cells
0.49359712.9421506.html.plaintext.txt	210	The lack HNF4alpha transcripts undifferentiated ES cells probably reflects insensitivity Northern blots compared RT PCR assay authors used full length cDNA probe would hybridize also HNF4alpha7 splice variant
0.49359712.9421506.html.plaintext.txt	211	The presence HNF4alpha7 various embryonic cell types suggests novel HNF4alpha splice variant function early embryogenesis
0.49359712.9421506.html.plaintext.txt	212	Early embryonic expression HNF4alpha gene starting primary endoderm embryonic day 4
0.49359712.9421506.html.plaintext.txt	213	5 mouse documented situ hybridization 10
0.49359712.9421506.html.plaintext.txt	214	As probe used experiments differentiate alpha1 alpha7 splice variant identity signal respect splice variants clear
0.49359712.9421506.html.plaintext.txt	215	However another situ hybridization used genomic fragment exon 1 original HNF4alpha transcript 6 thus retrospect HNF4alpha1 specific probe
0.49359712.9421506.html.plaintext.txt	216	With probe HNF4alpha transcripts first localised day 7 p
0.49359712.9421506.html.plaintext.txt	217	visceral extraembryonic endoderm
0.49359712.9421506.html.plaintext.txt	218	This detection later time point embryogenesis could well reflect fact probe could hybridize HNF4alpha7 splice variant
0.49359712.9421506.html.plaintext.txt	219	Similarly relatively late appearance HNF4alpha binding activity gel retardation assays starting 8
0.49359712.9421506.html.plaintext.txt	220	25 might also interpreted lack reactivity antibody HNF4alpha7 splice variant
0.49359712.9421506.html.plaintext.txt	221	Therefore indirect evidence earlier appearance HNF4alpha7 compared HNF4alpha1 seen differentiating F9 cells Fig
0.49359712.9421506.html.plaintext.txt	222	7A B matches available data developing embryo
0.49359712.9421506.html.plaintext.txt	223	Analyzing 200 unfertilized mouse eggs could identify HNF4alpha7 mRNA whereas GAPDH mRNA readily detectable data shown
0.49359712.9421506.html.plaintext.txt	224	As unfertilized mouse eggs 20 times larger ES cells input RNA RT PCR corresponds 4000 ES cells
0.49359712.9421506.html.plaintext.txt	225	Since ES cell aliquot could identify HNF4alpha7 mRNA assume HNF4alpha7 transcripts absent egg accumulate zygotic transcription early mouse embryogenesis
0.49359712.9421506.html.plaintext.txt	226	This consistent appearance HNF4alpha transcripts situ hybridization experiments probe detecting HNF4alpha1 HNF4alpha7 day 4
0.49359712.9421506.html.plaintext.txt	227	Therefore seems unlikely HNF4alpha mRNA maternal component mammals
0.49359712.9421506.html.plaintext.txt	228	This contrast Drosophila HNF4 7 Xenopus HNF4beta mRNA 2 known present maternal transcripts
0.49359712.9421506.html.plaintext.txt	229	However HNF4alpha protein might maternal component mammalian egg situation found HNF4alpha protein Xenopus whose corresponding mRNA disappeared egg stage 2 34
0.49359712.9421506.html.plaintext.txt	230	An early function HNF4alpha gene expression mammals established disruption gene results impaired gastrulation early embryonic lethality 11
0.49359712.9421506.html.plaintext.txt	231	As targeting vector used knock experiments lacked exon 2 3 HNF4alpha1 well HNF4alpha7 transcripts devoid DNA binding domain
0.49359712.9421506.html.plaintext.txt	232	Therefore clear moment HNF4alpha transcripts plays essential function early embryonic stage
0.49359712.9421506.html.plaintext.txt	233	It also considered partial rescue HNF4alpha knock embryos observed supplementing developing embryo normal visceral endoderm 35 might effect relieving one two HNF4alpha splice variants
0.49359712.9421506.html.plaintext.txt	234	We assume presence HNF4alpha7 undifferentiated embryonal carcinoma cell line F9 embryonic stem cell E14 1 reflects already first step embryonic gene regulation
0.49359712.9421506.html.plaintext.txt	235	Consistent interpretation presence transcripts encoding tissue specific transcription factor HNF1alpha reported undifferentiated F9 cells 25 36
0.49359712.9421506.html.plaintext.txt	236	Since well established HNF1alpha potential target gene HNF4alpha 18 20 26 37 consider possibility HNF4alpha7 triggers HNF1alpha expression early stage
0.49359712.9421506.html.plaintext.txt	237	However significance potential effect questionable HNF1alpha transcripts aberrant size HNF1alpha protein detected F9 cells 25
0.49359712.9421506.html.plaintext.txt	238	Our analysis demonstrates HNF4alpha7 restricted embryonic tissues also found abundantly stomach adult mouse Fig
0.49359712.9421506.html.plaintext.txt	239	In contrast liver intestine HNF4alpha7 transcripts constitute minor fraction compared HNF4alpha1 ovary heart bladder brain traces found
0.49359712.9421506.html.plaintext.txt	240	It interesting investigate whether tissues HNF4alpha7 restricted subpopulation cells e
0.49359712.9421506.html.plaintext.txt	241	Our finding transactivation potential HNF4alpha splice variants differs transient transfection assays extent effect depends cell type used Fig
0.49359712.9421506.html.plaintext.txt	242	5 indicates two HNF4alpha splice variants cooperate differentially transcription factors
0.49359712.9421506.html.plaintext.txt	243	As HNF4alpha1 HNF4alpha7 splice variants distinct N termini expect domain determines differential cooperation
0.49359712.9421506.html.plaintext.txt	244	Therefore exclude reported interaction COUP TFI COUP TFII 38 well binding HNF1alpha 39 mechanisms mediating distinct properties HNF4alpha1 HNF4alpha7 since interactions involve C terminus common HNF4alpha1 HNF4alpha7
0.49359712.9421506.html.plaintext.txt	245	However specific binding observed basal transcription factor TFIIB 40 might trigger distinct properties two splice variants formation complex requires N terminus HNF4alpha 38 40
0.49359712.9421506.html.plaintext.txt	246	Alternatively HNF4alpha1 HNF4alpha7 may exert distinct activities due differential heterodimerization members HNF4 family 1 2
0.49359712.9421506.html.plaintext.txt	247	But would expect differential heterodimerization members nuclear receptor superfamily since HNF4alpha seems usually heterodimerize components 41 42
0.49359712.9421506.html.plaintext.txt	248	Analyzing expression HNF4alpha splice variants revealed HNF4alpha7 complex regulatory network
0.49359712.9421506.html.plaintext.txt	249	In hepatic cell line MHSV 12 glucocorticoid plays major role lack hormone seems critical component appearance HNF4alpha7
0.49359712.9421506.html.plaintext.txt	250	Clearly glucocorticoid hormone alters balance HNF4alpha1 HNF4alpha7 splice variants
0.49359712.9421506.html.plaintext.txt	251	As glucocorticoids known trigger final stage hepatic differentiation birth 43 investigated expression two HNF4alpha splice variants
0.49359712.9421506.html.plaintext.txt	252	Using liver extracts 2 days birth 2 days birth could see change data shown
0.49359712.9421506.html.plaintext.txt	253	In fact HNF4 binding activity observed gel retardation assays could supershifted AB specific antibody stages analyzed data support major change HNF4alpha splice variants birth although glucocorticoid action essential step developmental stage
0.49359712.9421506.html.plaintext.txt	254	A lack glucocorticoid control also seen F9 cells
0.49359712.9421506.html.plaintext.txt	255	Neither undifferentiated differentiated F9 cells addition dexamethasone altered level HNF4alpha1 HNF4alpha7 mRNA Fig
0.49359712.9421506.html.plaintext.txt	256	On hand F9 cells retinoic acid mediated differentiation visceral endoderm leads increase HNF4alpha7 mRNA significantly also appearance HNF4alpha1 splice variant
0.49359712.9421506.html.plaintext.txt	257	This change HNF4alpha expression also seen protein level HNF4 binding activity reacting anti AB antibody detected differentiated cells Fig
0.49359712.9421506.html.plaintext.txt	258	Our data show splice variant HNF4alpha7 contains distinct first exon
0.49359712.9421506.html.plaintext.txt	259	As original exon 1 murine HNF4alpha gene shown contain initiation site promoter 6 44 assume novel exon 1 found HNF4alpha7 indicates second promoter HNF4alpha gene
0.49359712.9421506.html.plaintext.txt	260	Therefore propose differential expression two splice variants mainly due differential use two distinct promoters HNF4alpha gene ACKNOWLEDGMENTS
0.49359712.9421506.html.plaintext.txt	261	Temme instructing us cultivate MHSV 12 cells B
0.49359712.9421506.html.plaintext.txt	262	Rickert providing E14 1 cell cultures A
0.49359712.9421506.html.plaintext.txt	263	Poleev murine RNA samples T
0.49359712.9421506.html.plaintext.txt	264	Zevnic preparing unfertilized mouse eggs E
0.49359712.9421506.html.plaintext.txt	265	Pogge von Strandmann critical reading manuscript
0.49359712.9421506.html.plaintext.txt	266	This work supported Deutsche Forschungsgemeinschaft
0.49359712.9421506.html.plaintext.txt	267	eds Liver Gene Expression R
0.49359712.9421506.html.plaintext.txt	268	et al 1997 Diabetes 46 1652 1657
0.49359712.9421506.html.plaintext.txt	269	1992 Development 116 783 797
0.49359712.9421506.html.plaintext.txt	270	1995 Carcinogenesis 16 143 145
0.49359712.9421506.html.plaintext.txt	271	1997 Development 124 279 287
0.49359712.9421506.html.plaintext.txt	272	To correspondence addressed
0.49359712.9421506.html.plaintext.txt	273	Tel 49 201 723 3110 Fax 49 201 723 5905 Email gerhart
0.49359712.9421506.html.plaintext.txt	274	de This page run Oxford University Press Great Clarendon Street Oxford OX2 6DP part OUP Journals Comments feedback www adminatoup
0.49359712.9421506.html.plaintext.txt	275	uk u d Last modification 6 Jan 1998 Copyright Oxford University Press 1998
0.22347338.15375188.html.plaintext.txt	0	Chicken Ovalbumin Upstream Promoter Transcription Factor Is Negative Regulator Steroidogenesis Bovine Adrenal Glomerulosa Cells Carine F
0.22347338.15375188.html.plaintext.txt	1	Buholzer Jean Francois Arrighi Shahnaz Abraham Vincent Piguet Alessandro M
0.22347338.15375188.html.plaintext.txt	2	Division Endocrinology Diabetology Nutrition C
0.22347338.15375188.html.plaintext.txt	3	Department Dermatology Venereology J
0.22347338.15375188.html.plaintext.txt	4	University Hospital CH 1211 Geneva 14 Switzerland
0.22347338.15375188.html.plaintext.txt	5	Address correspondence requests reprints Professor Alessandro M
0.22347338.15375188.html.plaintext.txt	6	Capponi Division Endocrinology Diabetology Nutrition University Hospital 24 rue Micheli du Crest CH 1211 Geneva 14 Switzerland
0.22347338.15375188.html.plaintext.txt	7	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The octapeptide hormone angiotensin II AngII ACTH stimulate mineralocorticoid biosynthesis zona glomerulosa adrenal cortex part promoting transcription gene coding steroidogenic acute regulatory StAR protein
0.22347338.15375188.html.plaintext.txt	8	We examined whether chicken ovalbumin upstream promoter transcription factor COUP TF member orphan nuclear receptor family transcription factors involved transcriptional regulation
0.22347338.15375188.html.plaintext.txt	9	We analyzed COUP TF StAR mRNA protein levels bovine adrenal glomerulosa cells primary culture
0.22347338.15375188.html.plaintext.txt	10	COUP TF protein readily detectable nonstimulated cells AngII markedly reduced expression time concentration dependent manner IC50 1 nM 46 plus minus 4
0.22347338.15375188.html.plaintext.txt	11	4 control levels 6 h n 3 P 0
0.22347338.15375188.html.plaintext.txt	12	This repression paralleled marked decrease COUP TF mRNA levels reaching 18 plus minus 8
0.22347338.15375188.html.plaintext.txt	13	01 6 h 20 fold increase aldosterone output
0.22347338.15375188.html.plaintext.txt	14	In bovine glomerulosa cells overexpressing COUP TFI II induction StAR mRNA protein elicited AngII completely suppressed control levels aldosterone response significantly reduced 4
0.22347338.15375188.html.plaintext.txt	15	1 fold basal value mock infected cells 1
0.22347338.15375188.html.plaintext.txt	16	7 fold COUP TFI COUP TFII expressing cells respectively n 3 P 0
0.22347338.15375188.html.plaintext.txt	17	Finally using electrophoretic mobility shift assays chromatin immunoprecipitation shown direct interaction COUP TF proximal StAR promoter
0.22347338.15375188.html.plaintext.txt	18	These results suggest COUP TF exerts tonic inhibition steroidogenesis repressing StAR protein expression activators aldosterone biosynthesis lift inhibition part repressing COUP TF levels
0.22347338.15375188.html.plaintext.txt	19	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES THE MAIN MINERALOCORTICOID aldosterone synthesized primarily zona glomerulosa adrenal cortex control three major physiological stimuli octapeptide hormone angiotensin II AngII ACTH extracellular potassium K 1
0.22347338.15375188.html.plaintext.txt	20	Aldosterone synthesized cholesterol common precursor steroid hormones stored within intracellular lipid droplets cholesterol esters mobilized mitochondrion cholesterol ester hydrolase upon stimulation 2
0.22347338.15375188.html.plaintext.txt	21	The rate limiting step activation steroidogenesis delivery cholesterol mitochondrial outer membrane inner membrane cytochrome P450 side chain cleavage enzyme located 3
0.22347338.15375188.html.plaintext.txt	22	Within mitochondria cholesterol undergoes enzymatic cascade leading eventually formation aldosterone
0.22347338.15375188.html.plaintext.txt	23	This crucial step intramitochondrial cholesterol transfer performed steroidogenic acute regulatory StAR protein 4 5
0.22347338.15375188.html.plaintext.txt	24	The ultimate demonstration indispensable role StAR protein came congenital lipoid adrenal hyperplasia inherited disease leads dramatic deficiency steroid hormones loss function mutations discovered StAR gene 6
0.22347338.15375188.html.plaintext.txt	25	Because StAR protein mediates rate limiting step steroidogenesis expression must finely regulated
0.22347338.15375188.html.plaintext.txt	26	Indeed human NCI H295R adrenocortical carcinoma cells hormone stimulated StAR protein synthesis steroid production prevented inhibition RNA synthesis 7
0.22347338.15375188.html.plaintext.txt	27	In bovine adrenal glomerulosa cells primary culture mimicking calcium signal gener ated AngII leads increased expression StAR mRNA protein 8
0.22347338.15375188.html.plaintext.txt	28	Similarly treatment human NCI H295R cells AngII results increase StAR mRNA levels within 30 min maximal levels reached within 6 h 7 9
0.22347338.15375188.html.plaintext.txt	29	These results clearly indicate transcriptional regulation AngII StAR gene expression
0.22347338.15375188.html.plaintext.txt	30	Various consensus response elements identified StAR gene promoter 10
0.22347338.15375188.html.plaintext.txt	31	Although promoter mapping studies provided extensive information activators StAR gene role transcription factors repress StAR protein expression received less attention
0.22347338.15375188.html.plaintext.txt	32	The best characterized repressor StAR gene DAX 1 dosage sensitive sex reversal adrenal hypoplasia congenita critical region X chromosome gene 1 member orphan nuclear receptor family 11 12 13
0.22347338.15375188.html.plaintext.txt	33	Our laboratory recently demonstrated AngII powerfully represses DAX 1 expression bovine adrenal glomerulosa cells thus leading increased StAR expression aldosterone production 14
0.22347338.15375188.html.plaintext.txt	34	Another potential candidate negative regulation StAR gene chicken ovalbumin upstream promoter transcription factor COUP TF usually present two isoforms COUP TFI COUP TFII 15 16
0.22347338.15375188.html.plaintext.txt	35	These orphan members steroid receptor superfamily play distinct crucial roles fetal development nervous 17 cardiovascular 18 systems
0.22347338.15375188.html.plaintext.txt	36	In addition well established developmental effects fetal life following pieces evidence suggest direct indirect interaction COUP TF promoter StAR gene thus involvement COUP TF adult steroidogenic cell function
0.22347338.15375188.html.plaintext.txt	37	First COUP TF colocalizes nuclei adrenal cells DAX 1 steroidogenic factor 1 SF 1 two transcription factors involved steroidogenesis StAR regulation expression modulated adrenocortical adenomas COUP TFI lower aldosterone producing tumors normal tissue 19 20 COUP TFII appearing increased aldosteronoma cells 21
0.22347338.15375188.html.plaintext.txt	38	In normal adrenocortical tissue COUP TFI II expression levels appear qualitatively equivalent 20
0.22347338.15375188.html.plaintext.txt	39	Second recently shown SF 1 COUP TF activate repress respectively bovine CYP17 gene transcription Y 1 mouse adrenocortical cells 22 23
0.22347338.15375188.html.plaintext.txt	40	Third similar competition SF 1 COUP TF composite binding site demonstrated genes involved steroidogenesis including human aldosterone synthase aromatase murine DAX 1 genes 23 24 25
0.22347338.15375188.html.plaintext.txt	41	Taken together data raise question possible negative role COUP TF regulation StAR gene expression
0.22347338.15375188.html.plaintext.txt	42	In present work therefore examined whether COUP TFs involved regulation basal AngII ACTH induced aldosterone biosynthesis bovine adrenal glomerulosa cells primary culture
0.22347338.15375188.html.plaintext.txt	43	Our results show clearly COUP TF negative regulator mineralocorticoid biosynthesis
0.22347338.15375188.html.plaintext.txt	44	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES COUP TF Protein Levels Bovine Glomerulosa Cells Modulation AngII Forskolin We first examined whether bovine adrenal glomerulosa cells primary culture express COUP TF protein
0.22347338.15375188.html.plaintext.txt	45	1A robust COUP TF signal detected upon Western blot analysis nuclear proteins nonstimulated cells
0.22347338.15375188.html.plaintext.txt	46	When glomerulosa cells challenged 6 h AngII concentration dependent decrease COUP TF protein levels observed inhibition 46 plus minus 4
0.22347338.15375188.html.plaintext.txt	47	4 control levels reached 10 nM AngII n 3 P 0
0.22347338.15375188.html.plaintext.txt	48	Cultured bovine glomerulosa cells produced significant amounts aldosterone medium 2
0.22347338.15375188.html.plaintext.txt	49	2 fmol microg protein6 h AngII stimulation 6 h increased aldosterone production 20 fold 44
0.22347338.15375188.html.plaintext.txt	50	2 fmol microg6 h n 3 P 0
0.22347338.15375188.html.plaintext.txt	51	A similar activation aldosterone production obtained forskolin used mimicker ACTH 42
0.22347338.15375188.html.plaintext.txt	52	5 fmol microg6 h n 3 P 0
0.22347338.15375188.html.plaintext.txt	53	To determine kinetics effect AngII COUP TF protein expression incubated glomerulosa cells 10 nM AngII various periods time ranging 0 15 h
0.22347338.15375188.html.plaintext.txt	54	2 inhibitory effect AngII time dependent COUP TF protein levels started decrease 30 min complete abolition reached within 15 h treatment
0.22347338.15375188.html.plaintext.txt	55	View larger version 21K Fig
0.22347338.15375188.html.plaintext.txt	56	AngII Represses COUP TF Protein Levels Concentration Dependent Manner
0.22347338.15375188.html.plaintext.txt	57	Bovine adrenal glomerulosa cells stimulated 6 h AngII various concentrations
0.22347338.15375188.html.plaintext.txt	58	COUP TF determined nuclear extracts aldosterone measured incubation medium described Materials Methods
0.22347338.15375188.html.plaintext.txt	59	A Representative Western blot COUP TF
0.22347338.15375188.html.plaintext.txt	60	B Densitometric analysis COUP TF levels AngII stimulated glomerulosa cells
0.22347338.15375188.html.plaintext.txt	61	C Aldosterone production response AngII 10 nM forskolin Fk 25 microM
0.22347338.15375188.html.plaintext.txt	62	Each value mean plus minus SEM three experiments performed separate cell preparations
0.22347338.15375188.html.plaintext.txt	63	View larger version 26K Fig
0.22347338.15375188.html.plaintext.txt	64	Time Dependent Repression COUP TF Protein AngII
0.22347338.15375188.html.plaintext.txt	65	Bovine adrenal glomerulosa cells treated AngII 10 nM indicated periods time COUP TF protein determined nuclear extracts described Materials Methods
0.22347338.15375188.html.plaintext.txt	66	A Representative Western blot COUP TF
0.22347338.15375188.html.plaintext.txt	67	B Densitometric analysis COUP TF levels AngII stimulated cells function time expressed percentage control values Ctrl time zero
0.22347338.15375188.html.plaintext.txt	68	Each point mean value two separate experiments
0.22347338.15375188.html.plaintext.txt	69	AngII Induced Repression COUP TF Is Independent Protein Synthesis AngII induced inhibition COUP TF protein expression paralleled decrease COUP TF mRNA levels inhibition 18 plus minus 8
0.22347338.15375188.html.plaintext.txt	70	01 reached 10 nM AngII 6 h shown Fig
0.22347338.15375188.html.plaintext.txt	71	To determine whether de novo protein synthesis required AngII mediated COUP TF repression treated bovine glomerulosa cells 6 h 10 nM AngII presence 10 microgml cycloheximide protein synthesis inhibitor
0.22347338.15375188.html.plaintext.txt	72	Blockade protein synthesis affected neither inhibitory effect AngII COUP TF mRNA expression Fig
0.22347338.15375188.html.plaintext.txt	73	3 A B repression COUP TF protein levels glomerulosa cells Fig
0.22347338.15375188.html.plaintext.txt	74	These observations suggest de novo protein synthesis required AngII induced repression COUP TF
0.22347338.15375188.html.plaintext.txt	75	In series experiments forskolin potent AngII repressing COUP TF mRNA data shown protein levels Fig
0.22347338.15375188.html.plaintext.txt	76	View larger version 29K Fig
0.22347338.15375188.html.plaintext.txt	77	Effect AngII Cycloheximide CHX Treatment COUP TF mRNA Protein Levels
0.22347338.15375188.html.plaintext.txt	78	Bovine adrenal glomerulosa cells treated 6 h AngII 10 nM absence presence 10 microgml cycloheximide
0.22347338.15375188.html.plaintext.txt	79	COUP TF mRNA protein levels determined Northern blot Western blot analysis respectively described Materials Methods
0.22347338.15375188.html.plaintext.txt	80	A Representative Northern blot COUP TF mRNA
0.22347338.15375188.html.plaintext.txt	81	B Densitometric analysis COUP TF mRNA levels glomerulosa cells
0.22347338.15375188.html.plaintext.txt	82	C Representative Western blot COUP TF
0.22347338.15375188.html.plaintext.txt	83	D Densitometric analysis COUP TF protein levels glomerulosa cells
0.22347338.15375188.html.plaintext.txt	84	Values means plus minus SEM three separate experiments
0.22347338.15375188.html.plaintext.txt	85	AngII Does Not Affect COUP TF mRNA Stability To determine whether AngII affects COUP TF mRNA stability incubated control AngII stimulated adrenal glomerulosa cells presence 1 microgml actinomycin D transcription inhibitor various periods time determined COUP TF mRNA levels Northern blot analysis
0.22347338.15375188.html.plaintext.txt	86	4 presence actinomycin COUP TFI mRNA decayed half life approximately 8 h AngII alter COUP TFI mRNA stability 24 h period
0.22347338.15375188.html.plaintext.txt	87	View larger version 31K Fig
0.22347338.15375188.html.plaintext.txt	88	Effect Actinomycin D COUP TFI mRNA Levels AngII Treated Bovine Adrenal Glomerulosa Cells
0.22347338.15375188.html.plaintext.txt	89	Bovine adrenal glomerulosa cells treated 2
0.22347338.15375188.html.plaintext.txt	90	5 microgml actinomycin D absence presence AngII 10 nM indicated periods time
0.22347338.15375188.html.plaintext.txt	91	COUP TFI mRNA levels determined Northern blot analysis described Materials Methods
0.22347338.15375188.html.plaintext.txt	92	A Representative Northern blot COUP TFI
0.22347338.15375188.html.plaintext.txt	93	B Densitometric analysis COUP TFI mRNA levels
0.22347338.15375188.html.plaintext.txt	94	Values means plus minus SEM three separate experiments
0.22347338.15375188.html.plaintext.txt	95	Effect COUP TF Overexpression StAR Expression Mineralocorticoid Production Lentiviral vectors proven highly useful infection tools
0.22347338.15375188.html.plaintext.txt	96	Indeed HIV derived lentiviral vectors efficiently integrate nondividing cells 31 32
0.22347338.15375188.html.plaintext.txt	97	Because bovine glomerulosa cells primary culture practically quiescent view relatively low transfection efficacy obtained cells usual transfection reagents used HIV derived vectors overexpress COUP TFI II glomerulosa cells
0.22347338.15375188.html.plaintext.txt	98	We first infected bovine glomerulosa cells lentiviral vectors encoding green fluorescent protein GFP control human phospholgycerate kinase hPGK promoter
0.22347338.15375188.html.plaintext.txt	99	The infected cells analyzed GFP fluorescence flow cytometric analysis 5 d infection
0.22347338.15375188.html.plaintext.txt	100	Ninety one percent cells infected 500 ng p24 expressed GFP data shown
0.22347338.15375188.html.plaintext.txt	101	Bovine glomerulosa cells primary culture infected lentiviral vectors encoding murine COUP TFI COUP TFII control hPGK promoter
0.22347338.15375188.html.plaintext.txt	102	Five days infection cells incubated presence 10 nM AngII 6 h StAR COUP TFI COUP TFII mRNA levels determined RT PCR bovine mouse specific primers
0.22347338.15375188.html.plaintext.txt	103	As expected endogenous signal detected noninfected mock infected cells used murine probes Fig
0.22347338.15375188.html.plaintext.txt	104	In contrast infected cells displayed robust expression mouse COUP TFI II mRNA determined RT PCR mouse specific primers
0.22347338.15375188.html.plaintext.txt	105	5B AngII treatment 6 h induced increase StAR mRNA levels noninfected mock infected cells 172 plus minus 14 165 plus minus 10 controls respectively n 3 P 0
0.22347338.15375188.html.plaintext.txt	106	This increase entirely blocked cells overexpressing either COUP TFI 104 plus minus 12 controls n 3 significantly different NS P 0
0.22347338.15375188.html.plaintext.txt	107	05 COUP TFII 82 plus minus 24 controls n 3 NS Fig
0.22347338.15375188.html.plaintext.txt	108	View larger version 32K Fig
0.22347338.15375188.html.plaintext.txt	109	Effect COUP TFI II Overexpression StAR mRNA Levels Aldosterone Production Bovine Adrenal Glomerulosa Cells
0.22347338.15375188.html.plaintext.txt	110	The COUP TFI II isoforms overexpressed bovine adrenal glomerulosa cells using lentiviral vectors
0.22347338.15375188.html.plaintext.txt	111	StAR mRNA levels aldosterone production determined control Ctrl AngII stimulated 10 nM 6 h noninfected NI mock infected Mock COUP TFI COUP TFII infected cells described Materials Methods
0.22347338.15375188.html.plaintext.txt	112	A Representative ethidium bromide staining murine COUP TFI II mRNA amplified RT PCR control glomerulosa cells cells infected pRRL sin ppt hPGK viral vector either mock encoding COUP TFI II
0.22347338.15375188.html.plaintext.txt	113	B Densitometric analysis StAR mRNA control cells cells challenged AngII
0.22347338.15375188.html.plaintext.txt	114	C Basal AngII stimulated aldosterone production medium control infected bovine glomerulosa cells
0.22347338.15375188.html.plaintext.txt	115	Values means plus minus SEM three separate experiments
0.22347338.15375188.html.plaintext.txt	116	Paralleling effect StAR mRNA conditions COUP TF overexpression observed AngII induced increase StAR protein levels nontransfected mock transfected cells 161 plus minus 5
0.22347338.15375188.html.plaintext.txt	117	5 controls respectively n 3 P 0
0.22347338.15375188.html.plaintext.txt	118	01 values entirely blocked cells overexpressing COUP TFI 87 plus minus 3
0.22347338.15375188.html.plaintext.txt	119	2 controls n 3 NS Fig
0.22347338.15375188.html.plaintext.txt	120	View larger version 29K Fig
0.22347338.15375188.html.plaintext.txt	121	Effect COUP TFI Overexpression StAR Protein Levels Bovine Adrenal Glomerulosa Cells
0.22347338.15375188.html.plaintext.txt	122	COUP TFI overexpressed bovine adrenal glomerulosa cells using classical transient transfection technique described Materials Methods
0.22347338.15375188.html.plaintext.txt	123	StAR protein levels determined Western blot 10 nM AngII treatment cells 6 h
0.22347338.15375188.html.plaintext.txt	124	A Representative Western blot
0.22347338.15375188.html.plaintext.txt	125	B Densitometric analysis StAR protein levels
0.22347338.15375188.html.plaintext.txt	126	Values means plus minus SEM three separate experiments
0.22347338.15375188.html.plaintext.txt	127	Staining gel Coomassie blue ensure equal amounts protein loaded
0.22347338.15375188.html.plaintext.txt	128	Basal aldosterone production rate amounted 3
0.22347338.15375188.html.plaintext.txt	129	4 fmol microg protein6 h untreated noninfected mock infected cells rose 17
0.22347338.15375188.html.plaintext.txt	130	6 fmol microg protein6 h noninfected cells 16
0.22347338.15375188.html.plaintext.txt	131	4 fmol microg protein6 h mock infected cells AngII challenge n 3 P 0
0.22347338.15375188.html.plaintext.txt	132	In contrast AngII increased aldosterone production 5
0.22347338.15375188.html.plaintext.txt	133	0 fmol microg protein6 h cells overexpressing COUP TFI 4
0.22347338.15375188.html.plaintext.txt	134	7 fmol microg protein6 h cells overexpressing COUP TFII n 3 P 0
0.22347338.15375188.html.plaintext.txt	135	AngII response noninfected cells Fig
0.22347338.15375188.html.plaintext.txt	136	Effect COUP TFI StAR Promoter Activity To gain insight regulation StAR gene expression COUP TFs performed dual luciferase reporter assay bovine adrenal glomerulosa cells primary culture
0.22347338.15375188.html.plaintext.txt	137	3 kb human StAR promoter region directing expression luciferase reporter gene Fig
0.22347338.15375188.html.plaintext.txt	138	7A transfected bovine glomerulosa cells
0.22347338.15375188.html.plaintext.txt	139	Treatment cells AngII 10 8 M 6 h significantly increased StAR promoter activity 2
0.22347338.15375188.html.plaintext.txt	140	7B AngII induced effect completely abolished cells cotransfected either COUP TFI 0
0.22347338.15375188.html.plaintext.txt	141	mock transfected cells treatments
0.22347338.15375188.html.plaintext.txt	142	View larger version 34K Fig
0.22347338.15375188.html.plaintext.txt	143	COUP TFI II Prevent StAR Promoter Activity Directly Interacting StAR Promoter Bovine Adrenal Glomerulosa Cells
0.22347338.15375188.html.plaintext.txt	144	A COUP TFI II cotransfected StAR luc reporter construct bovine glomerulosa cells primary culture described Materials Methods
0.22347338.15375188.html.plaintext.txt	145	B Densitometric analysis relative StAR promoter activity mock transfected COUP TFI COUP TFII overexpressing cells presence absence 10 nM AngII
0.22347338.15375188.html.plaintext.txt	146	C EMSA nuclear extracts derived control bovine adrenal glomerulosa cells cells stimulated 10 nM AngII incubated labeled StAR promoter fragment probe see Materials Methods absence presence purified COUP TFI antibody submitted PAGE followed autoradiography
0.22347338.15375188.html.plaintext.txt	147	The EMSA representative three separate experiments yielding similar results
0.22347338.15375188.html.plaintext.txt	148	D ChIP assay performed bovine adrenal glomerulosa cells using purified COUP TFI antibody immunoprecipitation specific primers corresponding StAR promoter real time PCR described detail Materials Methods
0.22347338.15375188.html.plaintext.txt	149	Representative agarose gel amplification product
0.22347338.15375188.html.plaintext.txt	150	E Densitometric analysis ChIP assay
0.22347338.15375188.html.plaintext.txt	151	Values means plus minus SEM three separate experiments
0.22347338.15375188.html.plaintext.txt	152	Interaction COUP TFI StAR Promoter To examine whether transcription factor COUP TFI interacts directly StAR promoter action performed EMSAs
0.22347338.15375188.html.plaintext.txt	153	Because direct competition SF 1 COUP TF known binding gene promoters used 23 bp DNA fragment containing proximal SF 1 response element bovine StAR promoter probe
0.22347338.15375188.html.plaintext.txt	154	7C lanes 2 3 nuclear extracts bovine glomerulosa cells shifted labeled probe generating least two bands
0.22347338.15375188.html.plaintext.txt	155	When nuclear extracts preincubated purified antibody directed COUP TFI intensity shifted bands dramatically reduced thus suggesting COUP TFI binds proximal StAR promoter vitro lanes 4 5
0.22347338.15375188.html.plaintext.txt	156	No significant differences intensity shifted bands observed nuclear extracts AngII treated cells lanes 3 5 qualitative assay
0.22347338.15375188.html.plaintext.txt	157	Finally interaction confirmed vivo analysis physical interaction COUP TFI StAR promoter using chromatin immunoprecipitation ChIP assay
0.22347338.15375188.html.plaintext.txt	158	7 D E immunoprecipitation COUP TFI antibody nuclear extracts glomerulosa cells followed real time PCR StAR promoter yielded band expected size agarose gel indicating StAR promoter immunoprecipitated COUP TFI thus strongly suggesting interaction COUP TFI proximal StAR promoter
0.22347338.15375188.html.plaintext.txt	159	Furthermore ChIP performed chromatin extracted AngII treated cells marked significant decrease intensity StAR promoter band observed 61
0.22347338.15375188.html.plaintext.txt	160	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The StAR protein plays rate limiting pivotal role activation steroidogenesis 5
0.22347338.15375188.html.plaintext.txt	161	The present study undertaken attempt investigate mechanisms known induction StAR protein expression adrenal glomerulosa cells response two physiological activators aldosterone biosynthesis octapeptide hormone AngII ACTH 9 33
0.22347338.15375188.html.plaintext.txt	162	Specifically examined possible role COUP TF proteins process
0.22347338.15375188.html.plaintext.txt	163	Four main conclusions drawn present work 1 COUP TF proteins abundantly present bovine adrenal glomerulosa cells primary culture repressed AngII forskolin 2 COUP TFI II repress AngII induced StAR mRNA protein expression 3 COUP TFI II overexpression prevents AngII induced mineralocorticoid biosynthesis 4 COUP TFI interacts directly proximal StAR promoter
0.22347338.15375188.html.plaintext.txt	164	First agreement previous immunohistochemical studies performed mice 18 detected high basal COUP TF protein levels resting bovine adrenal glomerulosa cells
0.22347338.15375188.html.plaintext.txt	165	In man recent studies shown COUP TF expression inversely correlated steroid production adrenocortical tumors 20
0.22347338.15375188.html.plaintext.txt	166	These data suggested transcription factor could function repressor steroidogenesis mechanism action physiological activators steroid production AngII ACTH mimicked forskolin could operate part reduction COUP TF protein levels
0.22347338.15375188.html.plaintext.txt	167	Indeed shown present study AngII forskolin strongly diminished COUP TF mRNA protein expression range concentrations similar used induce aldosterone production
0.22347338.15375188.html.plaintext.txt	168	Second observed COUP TFI II repressed StAR mRNA protein expression
0.22347338.15375188.html.plaintext.txt	169	Because StAR protein controls rate limiting step steroidogenesis hypothesized COUP TF might act level
0.22347338.15375188.html.plaintext.txt	170	COUP TF known negatively regulate transcriptional activity SF 1 repress various actors steroidogenic cascade 23 34 gene encoding cytochrome P450 steroid 17 hydroxylase competing SF 1 binding repeated cAMP responsive sequences spaced six nucleotides repCRS2 35
0.22347338.15375188.html.plaintext.txt	171	Furthermore COUP TF SF 1 also shown bind overlapping binding sites involved regulation oxytocin gene bovine ovary 36
0.22347338.15375188.html.plaintext.txt	172	Although multiple SF 1 binding elements required hormonal induction identified StAR protein gene 5 flanking promoter region 10 37 38 COUP TF reported far bind StAR promoter affect activity
0.22347338.15375188.html.plaintext.txt	173	Interestingly laboratory demonstrated recently levels another orphan nuclear receptor DAX 1 known repress StAR protein expression also interacting negatively SF 1 either directly indirectly 12 regulated AngII forskolin bovine adrenal glomerulosa cells effect correlated inversely StAR protein expression aldosterone biosynthesis 14
0.22347338.15375188.html.plaintext.txt	174	We therefore examined whether COUP TF could repress StAR expression levels overexpressing transcription factor bovine glomerulosa cells
0.22347338.15375188.html.plaintext.txt	175	To overcome usually low rates efficiency observed cells utilizing classical transfection reagents used HIV derived lentiviral system yielding high levels gene delivery primary cells 27 28
0.22347338.15375188.html.plaintext.txt	176	Indeed infected bovine glomerulosa cells expressed high amounts exogenous murine COUP TFI II mRNA could distinguished endogenous COUP TF mRNAs using species specific primers RT PCR amplification
0.22347338.15375188.html.plaintext.txt	177	Moreover show overexpression either isoform COUP TF resulted complete suppression AngII induced StAR mRNA protein induction finding strongly suggesting direct indirect repressor role COUP TF StAR promoter activity
0.22347338.15375188.html.plaintext.txt	178	These results indeed confirmed luciferase reporter gene assay StAR promoter cells overexpressing COUP TF showed dramatic reduction AngII induced StAR promoter activity
0.22347338.15375188.html.plaintext.txt	179	COUP TFI COUP TFII equally effective repressing StAR mRNA expression although latter shown expressed cortex adrenal gland organogenesis mice 18
0.22347338.15375188.html.plaintext.txt	180	However COUP TFI COUP TFII shown present normal tumoral human adrenocortical tissue immunohistological studies 19 21 observed similar expression pattern mRNA isoforms bovine glomerulosa cells data shown
0.22347338.15375188.html.plaintext.txt	181	Third functional level observed inverse relationship mRNA COUP TF levels AngII induced aldosterone output finding corroborates hypothesis hormone acts lifting repression exerted COUP TF StAR gene expression
0.22347338.15375188.html.plaintext.txt	182	Interestingly overexpression COUP TFs affect either basal StAR expression basal aldosterone production
0.22347338.15375188.html.plaintext.txt	183	This result actually expected view robust expression endogenous COUP TFs bovine glomerulosa cells presumably already exert maximal repressor effect parameters resting state
0.22347338.15375188.html.plaintext.txt	184	Only conditions stimulation AngII endogenous COUP TFs repressed effect overexpressing exogenous COUP TF visible preventing normal StAR induction steroid production elicited hormone
0.22347338.15375188.html.plaintext.txt	185	In addition COUP TF certainly sole regulator StAR expression factors DAX 1 SF 1 14 probably also contribute basal StAR gene expression
0.22347338.15375188.html.plaintext.txt	186	This finding also agreement clinical observations showing COUP TFI II protein levels markedly reduced steroid producing human adrenal tumors assessed Western blot analysis 19 contrasts immunohistological observations indicating COUP TFII highly expressed nuclei aldosteronoma cells 21
0.22347338.15375188.html.plaintext.txt	187	One possible explanation discrepancy could found different methodologies used studies immunoblotting yields quantitative measures immunocytochemistry
0.22347338.15375188.html.plaintext.txt	188	Fourth shown direct physical interaction COUP TF proximal StAR promoter vitro vivo
0.22347338.15375188.html.plaintext.txt	189	In EMSAs performed probe corresponding region proximal StAR promoter known critical control SF 1 StAR gene expression intensity two bands dramatically reduced preincubation nuclear extracts anti COUP TF antibody
0.22347338.15375188.html.plaintext.txt	190	This finding indicated COUP TF interact either directly indirectly StAR promoter
0.22347338.15375188.html.plaintext.txt	191	Whether two shifted bands represent complexes COUP TF proteins remains elucidated
0.22347338.15375188.html.plaintext.txt	192	Finally ChIP assays allowed us clearly demonstrate quantify direct binding COUP TF proximal StAR promoter
0.22347338.15375188.html.plaintext.txt	193	The decrease StAR promoter yield ChIP assay observed AngII treatment matches exactly repression COUP TF observed thus confirming AngII lifts direct repression exerted COUP TF StAR promoter
0.22347338.15375188.html.plaintext.txt	194	In summary data presented work indicates transcription factor COUP TF essentially known play developmental role adrenal cortex also implicated modulating differentiated function adrenal glomerulosa cells namely aldosterone biosynthesis
0.22347338.15375188.html.plaintext.txt	195	Under basal conditions COUP TF exerts tonic inhibition steroidogenesis repressing StAR protein expression thus preventing cholesterol substrate supply mitochondria
0.22347338.15375188.html.plaintext.txt	196	Challenge glomerulosa cells physiological activators mineralocorticoid production lifts inhibition reducing COUP TF protein levels COUP TF binding StAR promoter thus allowing StAR protein expressed higher amounts intramitochondrial cholesterol transfer occur eventually aldosterone synthesis proceed
0.22347338.15375188.html.plaintext.txt	197	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Bovine Adrenal Zona Glomerulosa Cell Culture Treatments Bovine adrenal glands obtained local slaughterhouse
0.22347338.15375188.html.plaintext.txt	198	Zona glomerulosa cells prepared enzymatic dispersion dispase purified Percoll density gradient reported previously 26
0.22347338.15375188.html.plaintext.txt	199	Primary cultures purified glomerulosa cells maintained DMEM described detail elsewhere 26
0.22347338.15375188.html.plaintext.txt	200	The cells grown 10 cm petri dishes 1 x 107 cells per dish kept serum free medium 24 h experiments performed third day culture
0.22347338.15375188.html.plaintext.txt	201	Cells washed incubated 37 C serum free medium containing various agents varying periods time appropriate
0.22347338.15375188.html.plaintext.txt	202	At end incubation period media collected cells processed protein total RNA extraction described
0.22347338.15375188.html.plaintext.txt	203	Generation Lentiviral Vectors Infection Bovine Adrenal Glomerulosa Cells Lentiviral vectors generated described previously 27 28
0.22347338.15375188.html.plaintext.txt	204	5 kb fragments excised original mouse plasmids pCDNA3 COUP TFI pCDNA3 COUP TFII BamHI XhoI restriction enzymes
0.22347338.15375188.html.plaintext.txt	205	The digested fragments separated agarose subsequently purified JetQuick extraction kit Genomed GmbH Basel Switzerland
0.22347338.15375188.html.plaintext.txt	206	COUP TF cDNAs inserted pRRL sin ppt hPGK vector digested BamHI SalI
0.22347338.15375188.html.plaintext.txt	207	Lentiviral vectors obtained transient transfection 293T human embryonic kidney cells
0.22347338.15375188.html.plaintext.txt	208	A total 2 x 106 293T cells seeded 10 cm petri dishes 24 h transfection DMEM containing 10 fetal calf serum glutamine presence chloroquine final concentration 25 microM 5 CO2 atmosphere
0.22347338.15375188.html.plaintext.txt	209	Plasmid DNA 20 microg used transfection one 10 cm dish using calcium phosphate precipitation method 2
0.22347338.15375188.html.plaintext.txt	210	5 microg envelope coding plasmid pMDG 7
0.22347338.15375188.html.plaintext.txt	211	5 microg packaging plasmid pCMVR8
0.22347338.15375188.html.plaintext.txt	212	91 expresses Gag Pol Tat Rev 10 microg either COUP TFI COUP TFII expressing pRRL sin ppt hPGK plasmid
0.22347338.15375188.html.plaintext.txt	213	The cells washed PBS 14 16 h incubated serum free DMEM 10 CO2 atmosphere
0.22347338.15375188.html.plaintext.txt	214	The conditioned medium collected another 24 h filtered 0
0.22347338.15375188.html.plaintext.txt	215	45 microm pore polyvinylidene difluoride filters
0.22347338.15375188.html.plaintext.txt	216	The vectors concentrated 100 fold one round centrifugation 50 000 x g 90 min resuspended 20 min room temperature PBS
0.22347338.15375188.html.plaintext.txt	217	Titers HIV vectors determined p24 antigen ELISA
0.22347338.15375188.html.plaintext.txt	218	Titers found range 5 x 106 107 infectious unitsml
0.22347338.15375188.html.plaintext.txt	219	Stock vectors stored 80 C used infection bovine glomerulosa cells
0.22347338.15375188.html.plaintext.txt	220	All infections performed 12 well plates 200000 glomerulosa cells per well 500 ng p24 used COUP TF
0.22347338.15375188.html.plaintext.txt	221	Determination Aldosterone Production Aldosterone content incubation media measured direct RIA using commercially available kit Diagnostic Systems Laboratories Webster TX
0.22347338.15375188.html.plaintext.txt	222	Aldosterone production normalized expressed per microgram cellular protein
0.22347338.15375188.html.plaintext.txt	223	Western Blot Analysis For determination protein expression levels bovine glomerulosa cells washed twice ice cold PBS nuclear extracts prepared according procedure Schreiber et al
0.22347338.15375188.html.plaintext.txt	224	Mitochondrial extracts prepared described elsewhere 30
0.22347338.15375188.html.plaintext.txt	225	Proteins quantified using protein microassay Bio Rad Munich Germany
0.22347338.15375188.html.plaintext.txt	226	Equal amounts protein 15 microg resolved 10 SDS PAGE transferred onto polyvinylidene difluoride membranes
0.22347338.15375188.html.plaintext.txt	227	Western blot analysis carried rabbit antisera directed either COUP TF kindly provided Professor Ming Jer Tsai Houston TX StAR kindly provided Professor Douglas Stocco Lubbock TX
0.22347338.15375188.html.plaintext.txt	228	Immunoreactive proteins visualized enhanced chemiluminescence method Amersham Biosciences Otelfingen Switzerland
0.22347338.15375188.html.plaintext.txt	229	Northern Blot Analysis Glomerulosa cell total RNA extracted using RNAgents kit Promega Corp
0.22347338.15375188.html.plaintext.txt	230	Zurich Switzerland according instructions manufacturer
0.22347338.15375188.html.plaintext.txt	231	For Northern blot analysis 30 microg RNA size fractionated 1 formaldehyde agarose gel vacuum transferred onto Nytran membranes Schleicher Schuell Dassel Germany fixed UV cross linking
0.22347338.15375188.html.plaintext.txt	232	The integrity 18 S 28 S RNA checked ethidium bromide staining gel
0.22347338.15375188.html.plaintext.txt	233	Hybridization performed using previously cloned 1
0.22347338.15375188.html.plaintext.txt	234	The cDNA labeled 32PdCTP using Rediprime II random primer labeling kit Amersham Biosciences
0.22347338.15375188.html.plaintext.txt	235	Northern blots prehybridized Rapid Hybridization Buffer Amersham Biosciences 65 C 30 min
0.22347338.15375188.html.plaintext.txt	236	The 32P labeled probe specific activity 2 x 106 cpmng DNA added incubation continued 2
0.22347338.15375188.html.plaintext.txt	237	Blots washed 5 min 15 min successively room temperature 2x saline sodium citrate SSC 0
0.22347338.15375188.html.plaintext.txt	238	1 SDS 15 min 1x SSC 0
0.22347338.15375188.html.plaintext.txt	239	The final wash performed 65 C 15 min 1x SSC 0
0.22347338.15375188.html.plaintext.txt	240	RNA cDNA hybrids visualized Hyperfilms Amersham Biosciences 12 14 h exposure period
0.22347338.15375188.html.plaintext.txt	241	Blots stripped reprobed mouse glyceraldehyde 3 phosphate dehydrogenase GAPDH cDNA Ambion Lugano Switzerland assess RNA loading
0.22347338.15375188.html.plaintext.txt	242	Semiquantitative RT PCR RT PCR used evaluate StAR COUP TF mRNA abundance response various treatments
0.22347338.15375188.html.plaintext.txt	243	Total RNA 100 ng amplified one step RT PCR Access system Promega Corp
0.22347338.15375188.html.plaintext.txt	244	Madison WI according instructions manufacturer
0.22347338.15375188.html.plaintext.txt	245	The primers bovine StAR 5 TGA AGA GCT TGT GGA GCG CA 3forward 5 TGC GAG AGG ACC TGG TTG AT 3reverse corresponding positions 538 557 902 921 respectively GenBank accession
0.22347338.15375188.html.plaintext.txt	246	Y17259 mouse COUP TFI 5 ATG CAC TCA CAA ACG GGG AT 3 forward 5 ACT GTG CGA AGA GAG GGC AAT 3 reverse corresponding positions 514 533 1121 1141 respectively GenBank accession
0.22347338.15375188.html.plaintext.txt	247	U07625 mouse COUP TFII 5 AAG CTG TAC AGA GAG GCA GGA 3 forward 5 AGA GCT TTC CGA ACC GTG TT 3 reverse corresponding positions 475 495 1106 1125 respectively GenBank accession
0.22347338.15375188.html.plaintext.txt	248	X76653 GAPDH 5 ATG GTG AAG GTC GGA GTG 3 forward 5 TGC AGA GAT GAT GAC CCT C 3 reverse corresponding positions 82 99 426 444 GenBank accession
0.22347338.15375188.html.plaintext.txt	249	Primers yielded products expected size corresponding 362 bp GAPDH 383 bp StAR 627 bp COUP TFI 650 bp COUP TFII
0.22347338.15375188.html.plaintext.txt	250	PCR products 10 microl analyzed 1
0.22347338.15375188.html.plaintext.txt	251	2 agarose gel quantified densitometry using Computing Densitometer Molecular Dynamics Inc
0.22347338.15375188.html.plaintext.txt	252	All mRNA levels normalized GAPDH mRNA
0.22347338.15375188.html.plaintext.txt	253	Dual Luciferase Reporter Assay System The StAR luc reporter construct kindly provided Dr
0.22347338.15375188.html.plaintext.txt	254	3 kb StAR promoter region cloned plasmid vector pGL2 Promega Corp
0.22347338.15375188.html.plaintext.txt	255	contains firefly luciferase reporter gene
0.22347338.15375188.html.plaintext.txt	256	Other plasmids used experiments included pGL2 basic vector negative control contains promoter sequence pGL2 control used positive control places luciferase gene control simian virus 40 SV40 promoter pRL SV40 vector places Renilla luciferase control SV40 promoter used internal control pCR3
0.22347338.15375188.html.plaintext.txt	257	1 vector murine COUP TFI COUP TFII cDNA subcloned control cytomegalovirus promoter kindly provided Professor Ming Jer Tsai Houston TX
0.22347338.15375188.html.plaintext.txt	258	Bovine glomerulosa cells cotransfected various vectors according manufacturer protocol Effectene Transfection Reagent kit QIAGEN GmbH Hilden Germany
0.22347338.15375188.html.plaintext.txt	259	Cells harvested 48 h transfection extracts made Passive lysis buffer Promega Corp
0.22347338.15375188.html.plaintext.txt	260	Luciferase Renilla activities quantified using Luminoskan Ascent Labsystems Catalys AG Wallisellen Switzerland
0.22347338.15375188.html.plaintext.txt	261	The luciferase assay results normalized Renilla activity compensate variations transfection efficiency
0.22347338.15375188.html.plaintext.txt	262	Each treatment group contained least triplicate cultures
0.22347338.15375188.html.plaintext.txt	263	EMSA Double stranded DNA 5 gatCACAGCCTTCAGCTGGAGGTATTT annealed 5 gatcAAATACCTCCAGCTGAAGGCTGTG corresponding nucleotides 49 26 bovine StAR promoter according sequence published Rust et al
0.22347338.15375188.html.plaintext.txt	264	39 32PdATP labeled Klenow Promega Corp
0.22347338.15375188.html.plaintext.txt	265	Nuclear protein extracts 15 microg incubated 20 min room temperature 30 000 cpmmin labeled probe 2 microg polydIC EMSA binding buffer
0.22347338.15375188.html.plaintext.txt	266	The reaction mixture loaded onto nondenaturing 5 polyacrylamide gel 2 h 200 V cold room
0.22347338.15375188.html.plaintext.txt	267	Gels dried exposed autoradiography films Kodak Biomax MR Sigma Aldrich GmbH Steinheim Germany 72 h
0.22347338.15375188.html.plaintext.txt	268	In supershift experiments 1 microg purified rabbit polyclonal anti COUP TFI kindly provided Dr
0.22347338.15375188.html.plaintext.txt	269	Dufau Bethesda MD anti SF 1 kindly provided Professor K
0.22347338.15375188.html.plaintext.txt	270	Morohashi Okasaki Japan antibody added mixture 30 min labeled probe
0.22347338.15375188.html.plaintext.txt	271	ChIP Assay Chromatin cross linking performed adding 1 formaldehyde bovine glomerulosa cells room temperature 8 min
0.22347338.15375188.html.plaintext.txt	272	The reaction stopped adding glycine final concentration 0
0.22347338.15375188.html.plaintext.txt	273	Cells washed twice ice cold PBS collected 5 ml PBS harvested brief centrifugation
0.22347338.15375188.html.plaintext.txt	274	Cells resuspended ice cold cell lysis buffer 10 mM Tris HCl pH 8
0.22347338.15375188.html.plaintext.txt	275	5 Nonidet P 40 protease inhibitors incubated ice 5 min briefly centrifuged
0.22347338.15375188.html.plaintext.txt	276	Cells resuspended nuclear lysis buffer 10 mM Tris HCl pH 8
0.22347338.15375188.html.plaintext.txt	277	0 1 mM EDTA 1 Triton X 100 0
0.22347338.15375188.html.plaintext.txt	278	5 M NaCl protease inhibitors incubated room temperature 5 min vortexing vigorously several times washed PBS
0.22347338.15375188.html.plaintext.txt	279	Sonication cells performed 30 times 30 sec TEN buffer 10 mM Tris HCl pH 8
0.22347338.15375188.html.plaintext.txt	280	0 1 mM EDTA 100 mM NaCl Branson 250 sonifier followed centrifugation 15 min 14000 rpm Eppendorf table centrifuge
0.22347338.15375188.html.plaintext.txt	281	Supernatant collected diluted 5 fold dilutionincubation buffer 20 mM HEPES pH 8
0.22347338.15375188.html.plaintext.txt	282	1 NaDOC 1 Triton X 100 100 microgml salmon sperm DNA 1 mgml BSA protease inhibitors followed immunoclearing 20 microl protein A Sepharose CL 4B Pharmacia Biotech AB Uppsala Sweden 30 min room temperature 5 microl specific anti COUP TFI antibody added overnight incubation 4 C
0.22347338.15375188.html.plaintext.txt	283	The mixture cleared precipitated material centrifugation 10000 rpm 10 min
0.22347338.15375188.html.plaintext.txt	284	Supernatant incubated 12 microl Protein A Sepharose Amersham Biosciences 1 h room temperature
0.22347338.15375188.html.plaintext.txt	285	Precipitate recovered centrifugation 3000 rpm 1 min washed seven times RIPA buffer 50 mM HEPES pH 7
0.22347338.15375188.html.plaintext.txt	286	7 NaDOC 1 Nonidet P 40 TE buffer 10 mM Tris HCl pH 8
0.22347338.15375188.html.plaintext.txt	287	0 1 mM EDTA extracted twice 100 microl elution buffer 100 mM Tris HCl pH 8
0.22347338.15375188.html.plaintext.txt	288	Eluates pooled treated proteinase K 100 microgml 2 h 42 C heated 65 C overnight reverse formaldehyde cross linking treated phenol extraction ethanol precipitation
0.22347338.15375188.html.plaintext.txt	289	The DNA pellet dissolved 15 microl TE buffer
0.22347338.15375188.html.plaintext.txt	290	DNA 5 microl used real time PCR
0.22347338.15375188.html.plaintext.txt	291	The primers located proximal part bovine StAR promoter forward 5 AGA CTC CTG GTG AGG CAA TC 3 reverse 5 CTG CGG CCA GAT GAT GTG TT 3 according GenBank sequence accession
0.22347338.15375188.html.plaintext.txt	292	Y17260 yielding amplification product 137 bp
0.22347338.15375188.html.plaintext.txt	293	Analysis Data Results expressed means plus minus SEM
0.22347338.15375188.html.plaintext.txt	294	The mean values compared ANOVA using Fisher test
0.22347338.15375188.html.plaintext.txt	295	05 considered statistically significant
0.22347338.15375188.html.plaintext.txt	296	Quantification immunoblots autoradiograms performed using Molecular Dynamics Computing Densitometer
0.22347338.15375188.html.plaintext.txt	297	ACKNOWLEDGMENTS We thank Dr
0.22347338.15375188.html.plaintext.txt	298	Ming Jer Tsai Baylor College Medicine Houston TX generous gift COUP TF cDNA antibody Dr
0.22347338.15375188.html.plaintext.txt	299	Maria Dufau National Institutes Health Bethesda MD anti COUP TF antibody used ChIP assay Manuella Rey Rachel Porcelli excellent technical assistance
0.22347338.15375188.html.plaintext.txt	300	FOOTNOTES This work supported Swiss National Science Foundation Grant 3100A0 100797 A
0.22347338.15375188.html.plaintext.txt	301	grant Fondation Gustave Prevot A
0.22347338.15375188.html.plaintext.txt	302	First Published Online September 16 2004
0.22347338.15375188.html.plaintext.txt	303	Abbreviations AngII Angiotensin II ChIP chromatin immunoprecipitation COUP TF chicken ovalbumin upstream promoter transcription factor DAX 1 dosage sensitive sex reversal adrenal hypoplasia congenita critical region X chromosome gene 1 GAPDH glyceraldehyde 3 phosphate dehydrogenase GFP green fluorescent protein hPGK human phospholgycerate kinase SDS sodium dodecyl sulfate SF 1 steroidogenic factor 1 SSC saline sodium citrate StAR steroidogenic acute regulatory SV40 simian virus 40
0.22347338.15375188.html.plaintext.txt	304	Received publication February 10 2004
0.22347338.15375188.html.plaintext.txt	305	Accepted publication September 10 2004
0.22347338.15375188.html.plaintext.txt	306	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Muller J 1988 Regulation aldosterone biosynthesis
0.22347338.15375188.html.plaintext.txt	307	Berlin Springer Verlag Cherradi N Pardo B Greenberg AS Kraemer FB Capponi AM 2003 Angiotensin II activates cholesterol ester hydrolase bovine adrenal glomerulosa cells phosphorylation mediated p42p44 mitogen activated protein kinase
0.22347338.15375188.html.plaintext.txt	308	Endocrinology 1444905 4915AbstractFree Full Text Jefcoate CR McNamara BC Artemenko I Yamazaki T 1992 Regulation cholesterol movement mitochondrial cytochrome P450scc steroid hormone synthesis
0.22347338.15375188.html.plaintext.txt	309	J Steroid Biochem Mol Biol 43751 767CrossRef Clark BJ Stocco DM 1996 StAR tissue specific acute mediator steroidogenesis
0.22347338.15375188.html.plaintext.txt	310	Trends Endocrinol Metab 7227 233CrossRef Stocco DM 2001 StAR protein regulation steroid hormone biosynthesis
0.22347338.15375188.html.plaintext.txt	311	Annu Rev Physiol 63193 213CrossRefMedline Bose HS Sugawara T Strauss JF Miller WL 1996 The pathophysiology genetics congenital lipoid adrenal hyperplasia
0.22347338.15375188.html.plaintext.txt	312	N Engl J Med 3351870 1878AbstractFree Full Text Clark BJ Pezzi V Stocco DM Rainey WE 1995 The steroidogenic acute regulatory protein induced angiotensin II K H295R adrenocortical cells
0.22347338.15375188.html.plaintext.txt	313	Mol Cell Endocrinol 115215 219CrossRefMedline Cherradi N Brandenburger Y Rossier MF Vallotton MB Stocco DM Capponi AM 1998 Atrial natriuretic peptide inhibits calcium induced steroidogenic acute regulatory protein gene transcription adrenal glomerulosa cells
0.22347338.15375188.html.plaintext.txt	314	Mol Endocrinol 12962 972AbstractFree Full Text Clark BJ Combs R 1999 Angiotensin II cyclic adenosine 35 monophosphate induce human steroidogenic acute regulatory protein transcription common steroidogenic factor 1 element
0.22347338.15375188.html.plaintext.txt	315	Endocrinology 1404390 4398AbstractFree Full Text Caron KM Ikeda Y Soo SC Stocco DM Parker KL Clark BJ 1997 Characterization promoter region mouse gene encoding steroidogenic acute regulatory protein
0.22347338.15375188.html.plaintext.txt	316	Mol Endocrinol 11138 147AbstractFree Full Text Lalli E Sassone Corsi P 1999 DAX 1 adrenal cortex
0.22347338.15375188.html.plaintext.txt	317	Curr Opin Endocrinol Diabetes 6185 190CrossRef Zazopoulos E Lalli E Stocco D Sassone Corsi P 1997 DNA binding transcriptional repression DAX 1 blocks steroidogenesis
0.22347338.15375188.html.plaintext.txt	318	Nature 390311 315CrossRefMedline Lalli E Sassone Corsi P 2003 DAX 1 unusual orphan receptor crossroads steroidogenic function sexual differentiation
0.22347338.15375188.html.plaintext.txt	319	Mol Endocrinol 171445 1453AbstractFree Full Text Osman H Murigande C Nadakal A Capponi AM 2002 Repression DAX 1 induction SF 1 expression two mechanisms contributing activation aldosterone biosynthesis adrenal glomerulosa cells
0.22347338.15375188.html.plaintext.txt	320	J Biol Chem 27741259 41267AbstractFree Full Text Cooney AJ Lee TC Lin SC Tsai SY Tsai MJ 2001 Physiological function orphans GCNF COUP TF
0.22347338.15375188.html.plaintext.txt	321	Trends Endocrinol Metab 12247 251CrossRefMedline Tsai SY Tsai MJ 1997 Chick ovalbumin upstream promoter transcription factors COUP TFs coming age
0.22347338.15375188.html.plaintext.txt	322	Endocr Rev 18229 240AbstractFree Full Text Qiu Y Pereira FA DeMayo FJ Lydon JP Tsai SY Tsai MJ 1997 Null mutation mCOUP TFI results defects morphogenesis glossopharyngeal ganglion axonal projection arborization
0.22347338.15375188.html.plaintext.txt	323	Genes Dev 111925 1937AbstractFree Full Text Pereira FA Qiu Y Zhou G Tsai MJ Tsai SY 1999 The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.22347338.15375188.html.plaintext.txt	324	Genes Dev 131037 1049AbstractFree Full Text Shibata H Ando T Suzuki T Kurihara I Hayashi K Hayashi M Saito I Murai M Saruta T 1998 COUP TFI expression human adrenocortical adenomas possible role steroidogenesis
0.22347338.15375188.html.plaintext.txt	325	J Clin Endocrinol Metab 834520 4523AbstractFree Full Text Shibata H Ikeda Y Mukai T Morohashi K Kurihara I Ando T Suzuki T Kobayashi S Murai M Saito I Saruta T 2001 Expression profiles coup tf dax 1 sf 1 human adrenal gland adrenocortical tumors possible implications steroidogenesis
0.22347338.15375188.html.plaintext.txt	326	Mol Genet Metab 74206 216CrossRefMedline Suzuki T Takahashi K Darnel AD Moriya T Murakami O Narasaka T Takeyama J Sasano H 2000 Chicken ovalbumin upstream promoter transcription factor II human adrenal cortex disorders
0.22347338.15375188.html.plaintext.txt	327	J Clin Endocrinol Metab 852752 2757AbstractFree Full Text Lehmann T Biernacka Lukanty J Trzeciak WH 2000 Expression three negative regulators CYP17 gene transcription adrenocortical cells
0.22347338.15375188.html.plaintext.txt	328	Endocr Res 261019 1026Medline Shibata H Kurihara I Kobayashi S Yokota K Suda N Saito I Saruta T 2003 Regulation differential COUP TF coregulator interactions adrenal cortical steroidogenesis
0.22347338.15375188.html.plaintext.txt	329	J Steroid Biochem Mol Biol 85449 456CrossRefMedline Ivell R Bathgate RA Walther N Kimura T 1998 The molecular basis oxytocin oxytocin receptor gene expression reproductive tissues
0.22347338.15375188.html.plaintext.txt	330	Adv Exp Med Biol 449297 306Medline Yu RN Ito M Jameson JL 1998 The murine Dax 1 promoter stimulated SF 1 steroidogenic factor 1 inhibited COUP TF chicken ovalbumin upstream promoter transcription factor via composite nuclear receptor regulatory element
0.22347338.15375188.html.plaintext.txt	331	Mol Endocrinol 121010 1022AbstractFree Full Text Python CP Rossier MF Vallotton MB Capponi AM 1993 Peripheral type benzodiazepines inhibit calcium channels aldosterone production adrenal glomerulosa cells
0.22347338.15375188.html.plaintext.txt	332	Endocrinology 1321489 1496Abstract Zufferey R Nagy D Mandel RJ Naldini L Trono D 1997 Multiply attenuated lentiviral vector achieves efficient gene delivery vivo
0.22347338.15375188.html.plaintext.txt	333	Nat Biotechnol 15871 875Medline Zarei S Leuba F Arrighi JF Hauser C Piguet V 2002 Transduction dendritic cells antigen encoding lentiviral vectors permits antigen processing MHC class I dependent presentation
0.22347338.15375188.html.plaintext.txt	334	J Allergy Clin Immunol 109988 994CrossRefMedline Schreiber E Matthias P Muller MM Schaffner W 1989 Rapid detection octamer binding proteins mini extracts prepared small number cells
0.22347338.15375188.html.plaintext.txt	335	Nucleic Acids Res 176419Medline Cherradi N Rossier MF Vallotton MB Timberg R Friedberg I Orly J Wang XJ Stocco DM Capponi AM 1997 Submitochondrial distribution three key steroidogenic proteins steroidogenic acute regulatory protein P450 side chain cleavage 3ss hydroxysteroid dehydrogenase isomerase enzymes upon stimulation intracellular calcium adrenal glomerulosa cells
0.22347338.15375188.html.plaintext.txt	336	J Biol Chem 2727899 7907AbstractFree Full Text Lewis P Hensel M Emerman M 1992 Human immunodeficiency virus infection cells arrested cell cycle
0.22347338.15375188.html.plaintext.txt	337	EMBO J 113053 3058Abstract Lewis PF Emerman M 1994 Passage mitosis required oncoretroviruses human immunodeficiency virus
0.22347338.15375188.html.plaintext.txt	338	J Virol 68510 516Abstract Cherradi N Brandenburger Y Rossier MF Capponi AM 1998 Regulation mineralocorticoid biosynthesis calcium StAR protein
0.22347338.15375188.html.plaintext.txt	339	Endocr Res 24355 362Medline Parker KL Schimmer BP 1995 Transcriptional regulation genes encoding cytochrome P 450 steroid hydroxylases
0.22347338.15375188.html.plaintext.txt	340	Vitam Horm 51339 370Medline Bakke M Lund J 1995 Transcriptional regulation bovine CYP17 gene two nuclear orphan receptors determine activity cAMP responsive sequence 2
0.22347338.15375188.html.plaintext.txt	341	Endocr Res 21509 516Medline Wehrenberg U Ivell R Jansen M von Goedecke S Walther N 1994 Two orphan receptors binding common site involved regulation oxytocin gene bovine ovary
0.22347338.15375188.html.plaintext.txt	342	Proc Natl Acad Sci USA 911440 1444Abstract Sugawara T Kiriakidou M Mcallister JM Kallen CB Strauss JF 1997 Multiple steroidogenic factor 1 binding elements human steroidogenic acute regulatory protein gene 5 flanking region required maximal promoter activity cyclic AMP responsiveness
0.22347338.15375188.html.plaintext.txt	343	Biochemistry 367249 7255CrossRefMedline Manna PR Wang XJ Stocco DM 2003 Involvement multiple transcription factors regulation steroidogenic acute regulatory protein gene expression
0.22347338.15375188.html.plaintext.txt	344	Steroids 681125 1134CrossRefMedline Rust W Stedronsky K Tillmann G Morley S Walther N Ivell R 1998 The role SF 1Ad4BP control bovine gene steroidogenic acute regulatory StAR protein
0.22347338.15375188.html.plaintext.txt	345	J Mol Endocrinol 21189 200AbstractFree Full Text
0.35218814.9731707.html.plaintext.txt	0	Stat 5b Orphan Nuclear Receptors Regulate Expression 2 Macroglobulin 2M Gene Rat Ovarian Granulosa Cells Maya Dajee Georg H
0.35218814.9731707.html.plaintext.txt	1	Baylor College Medicine Houston Texas 77030 Department Genetics G
0.35218814.9731707.html.plaintext.txt	2	Institute Microbiology Biochemistry Genetics Friedrich Alexander University D91058 Erlanger Nurenberg Germany
0.35218814.9731707.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES 2 Macroglobulin 2M serine protease inhibitor cytokine inactivator associated inflammation tissue remodeling
0.35218814.9731707.html.plaintext.txt	4	The gene encoding protein selectively induced rat corpus luteum luteotropic hormone cytokine PRL
0.35218814.9731707.html.plaintext.txt	5	The promoter 2M gene contains two regulatory regions bind diverse set transcription factors confer functional activity ovarian granulosa luteal cells
0.35218814.9731707.html.plaintext.txt	6	The PRL response element PRLRE binds PRL activated tyrosine phosphorylated signal transducers activators transcription Stat 5b Stat 5a
0.35218814.9731707.html.plaintext.txt	7	5 Deletion Stat binding sites mutation either one sites within context intact promoter abolished PRL inducibility 2M promoter reporter constructs granulosa luteal cells
0.35218814.9731707.html.plaintext.txt	8	Cotransfection vector expressing dominant negative truncated form Stat 5b abolished PRL induced activation 2M transgenes
0.35218814.9731707.html.plaintext.txt	9	5 Deletion Stat binding sites abolished promoter reporter activity response PRL
0.35218814.9731707.html.plaintext.txt	10	Internal deletion second functional domain 3 PRLRE also abolished PRL inducibility markedly reduced basal activity indicating functional interactions two regions might occur
0.35218814.9731707.html.plaintext.txt	11	The 3 region shown bind orphan members nuclear receptor superfamily steroidogenic factor 1 SF 1 chicken ovalbumin upstream promoter transcription factor COUP TF called orphan receptor response element ORRE
0.35218814.9731707.html.plaintext.txt	12	When site specific mutations made either SF 1 binding site two COUP TF direct repeat DR1 DR2 binding sites context intact promoter specific changes functional activity novel region 2M promoter observed
0.35218814.9731707.html.plaintext.txt	13	Mutation SF 1 site drastically reduced basal activity 2M promoter
0.35218814.9731707.html.plaintext.txt	14	Mutation COUP TF sites caused basal activity 2M promoter increase markedly
0.35218814.9731707.html.plaintext.txt	15	Neither mutation altered PRL inducibility constructs
0.35218814.9731707.html.plaintext.txt	16	Lastly differentiation cultured granulosa cells required functional activity PRLRE ORRE
0.35218814.9731707.html.plaintext.txt	17	Collectively results document first time Stat 5b SF 1 COUP TF exert specific effects function 2M promoter basal activity controlled balance SF 1 positive COUP TF negative activities PRL inducibility mediated activation Stat 5b
0.35218814.9731707.html.plaintext.txt	18	These results add 2M list nonsteroidal genes regulated SF 1 gonads provide first evidence COUP TF specific role regulating ovarian gene activity
0.35218814.9731707.html.plaintext.txt	19	In addition ORRE PRLRE act independently rather synergistically regulate basal PRL induced expression 2M ovarian luteal cells
0.35218814.9731707.html.plaintext.txt	20	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Tissue specific expression genes dependent cellular set transcription factors well selective activation factors hormones growth factors cytokines
0.35218814.9731707.html.plaintext.txt	21	One transcription factor dictates ovarian gonadal development steroidogenic factor 1 SF 1 orphan member nuclear receptor superfamily 1
0.35218814.9731707.html.plaintext.txt	22	SF 1 binds monomer CAAGGTCA like motifs interacts factors regulate expression steroid hydroxylase genes 2 3 4 5
0.35218814.9731707.html.plaintext.txt	23	During development preovulatory follicles granulosa cells culture FSH induces expression two steroid hydroxylase genes encoding aromatase CYP19 Ref
0.35218814.9731707.html.plaintext.txt	24	SF 1 also regulates expression genes encoding peptides including Mullerian Inhibiting Substance 8 oxytocin 9
0.35218814.9731707.html.plaintext.txt	25	Thus SF 1 appears play critical role regulating genes expressed differentiated granulosa cells response FSH 6
0.35218814.9731707.html.plaintext.txt	26	When granulosa cells luteinize respond different set extracellular signals one cytokine PRL
0.35218814.9731707.html.plaintext.txt	27	In ovary 10 11 12 target tissues 13 14 15 PRL activates JAK Janus kinaseSTAT signal transducers activators transcription pathway
0.35218814.9731707.html.plaintext.txt	28	One gene selectively regulated PRL luteal cells encodes 2 macroglobulin 2M large tetrameric protein traps inactivates proteases cytokines
0.35218814.9731707.html.plaintext.txt	29	The inducibility gene interleukin 6 IL 6 rat liver 16 PRL rat luteal cells 11 provided unique opportunity delineate cellular signaling mechanisms used cytokine control tissue specific expression gene
0.35218814.9731707.html.plaintext.txt	30	In previous analyses shown Stat 5 activated PRL binds specific activating sequences GAS sites present promoter 2M gene originally referred IL 6 response element IL6 RE based activation gene IL 6 rat liver 16
0.35218814.9731707.html.plaintext.txt	31	Because luciferase reporter construct containing 1
0.35218814.9731707.html.plaintext.txt	32	2 kb 2M promoter showed high basal activity transfected differentiated granulosa cells absence PRL sought identify additional factors involved regulating promoter gene extent high basal well PRL inducibility dependent hormone induced differentiation granulosa cells culture 10
0.35218814.9731707.html.plaintext.txt	33	As result additional analyses 2M promoter observed 109 bp region directly 3 Stat 5 binding sites deleted 2M promoter reporter construct lost high basal activity PRL regulated induction
0.35218814.9731707.html.plaintext.txt	34	When sequence region examined noted contained putative binding sites SF 1 chicken ovalbumin upstream promoter transcription factor COUP TF
0.35218814.9731707.html.plaintext.txt	35	Like SF 1 COUP TF member orphan nuclear receptor superfamily 17 18
0.35218814.9731707.html.plaintext.txt	36	However unlike SF 1 presumed expressed ubiquitously shown exhibit complex interactions binding heterodimer members nuclear receptor superfamily 19
0.35218814.9731707.html.plaintext.txt	37	COUP TF homodimers bind wide spectrum response elements containing core half site AGGGTCA motif spacing orientation determine relative binding affinity COUP TF 19
0.35218814.9731707.html.plaintext.txt	38	Recent evidence indicates Stat proteins may interact functionally transcription factors coregulatory molecules including members nuclear receptor superfamily 20 21 22 23 24
0.35218814.9731707.html.plaintext.txt	39	Based close juxtaposition functional activities PRL response element PRLRE putative orphan receptor binding sites seemed reasonable predict factors binding regions might interact control maximal expression 2M gene granulosa luteal cells
0.35218814.9731707.html.plaintext.txt	40	Based considerations tissue specific expression gene rat ovary following studies undertaken determine Stat 5 proteins present functional differentiated granulosa cells either SF 1 COUP TF bound intact 2M promoter either SF 1 COUP TF interacted functionally Stat 5 proteins confer maximal expression gene response PRL
0.35218814.9731707.html.plaintext.txt	41	The functional activities Stat binding sites orphan receptor binding sites analyzed generating site specific mutations context intact promoter transfecting differentiated granulosa cells specific intact mutant promoter luciferase reporter constructs
0.35218814.9731707.html.plaintext.txt	42	Activities related binding specific nuclear factors stage differentiation granulosa cells
0.35218814.9731707.html.plaintext.txt	43	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Two Regions Proximal Promoter 2M Gene Are Required Functional Activity Granulosa Cells To identify characterize functional regions 2M promoter conferring PRL high basal activity granulosa cells specific deletion constructs generated remove sequences either 5 371 bp 209 bp 3 209 Stat binding sites deleted PRLRE 159 bp Fig
0.35218814.9731707.html.plaintext.txt	44	2 kb 2M luciferase construct well deletion constructs transiently transfected differentiated granulosa cells cultured FSH testosterone 48 h
0.35218814.9731707.html.plaintext.txt	45	After 4 h granulosa cells treated without PRL 6 h
0.35218814.9731707.html.plaintext.txt	46	Luciferase activity measured normalized amount protein present sample expressed activity microg protein
0.35218814.9731707.html.plaintext.txt	47	Constructs 5 deletions 371 209 bp retained PRL inducibility high basal activity Fig
0.35218814.9731707.html.plaintext.txt	48	Deletion Stat binding sites reduced basal activity abolished PRL inducible activity Fig
0.35218814.9731707.html.plaintext.txt	49	Deletion 109 bp region 3 PRLRE 209 reduced basal activity seen minimal 48 bp 2M promoter abolished PRL inducibility
0.35218814.9731707.html.plaintext.txt	50	These results indicated PRLRE well 109 bp region immediately downstream PRLRE might interact functionally confer maximal promoter activity granulosa cells
0.35218814.9731707.html.plaintext.txt	51	View larger version 20K Figure 1
0.35218814.9731707.html.plaintext.txt	52	Two Regions 2M Promoter Are Required Functional Activity
0.35218814.9731707.html.plaintext.txt	53	Each indicated vectors transfected triplicate differentiated granulosa cells cultured presence FSH 50 ngml testosterone 10 ngml 48 h
0.35218814.9731707.html.plaintext.txt	54	After 4 h incubation PRL1 microgmlwas added 6 h
0.35218814.9731707.html.plaintext.txt	55	Luciferase activity light units measured 20 microl cell lysate normalized amount protein
0.35218814.9731707.html.plaintext.txt	56	The relative luciferase activity represented mean light units microg plus minus SEM
0.35218814.9731707.html.plaintext.txt	57	Stat Binding Sites Are Critical PRL Induction 2M Promoter To specifically determine function Stat binding sites context intact 1
0.35218814.9731707.html.plaintext.txt	58	2 kb 2M promoter Stat binding sites mutated sites deleted
0.35218814.9731707.html.plaintext.txt	59	2 kb 2M construct mutant promoter luciferase pSV constructs 16 transfected differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	60	2 PRL induced 2 3 fold increase luciferase activity intact promoter reporter construct
0.35218814.9731707.html.plaintext.txt	61	Although level luciferase activity promoter pSV promoter reporter constructs low compared pGL3 constructs Fig
0.35218814.9731707.html.plaintext.txt	62	1 inducibility PRL similar
0.35218814.9731707.html.plaintext.txt	63	Deletion Stat binding sites mutation either site abolished inducibility PRL
0.35218814.9731707.html.plaintext.txt	64	Basal activity markedly altered except reduced activity proximal Stat 5 mutant construct
0.35218814.9731707.html.plaintext.txt	65	These results clearly show Stat binding sites required PRL inducibility promoter activity granulosa cells high basal activity constructs
0.35218814.9731707.html.plaintext.txt	66	View larger version 21K Figure 2
0.35218814.9731707.html.plaintext.txt	67	Both Stat Factor Binding Sites Are Required 2M Promoter Activity
0.35218814.9731707.html.plaintext.txt	68	To determine function Stat binding sites context endogenous intact promoter either one Stat binding sites mutated deleted
0.35218814.9731707.html.plaintext.txt	69	These constructs transfected differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	70	Luciferase activity measured 20 microl cell lysate normalized amount protein
0.35218814.9731707.html.plaintext.txt	71	PRL Induced DNA Binding Activity Contains Stat 5a Stat 5b To determine specific factors binding PRLRE used electrophoretic mobility shift assays EMSAs labeled oligonucleotide probe consisted two copies proximal Stat binding site 2M promoter 2MGAS2 16
0.35218814.9731707.html.plaintext.txt	72	Because activated phosphorylated Stat proteins bind DNA whereas nonphosphorylated Stats activated factors readily detected EMSAs
0.35218814.9731707.html.plaintext.txt	73	Accordingly whole cell extracts WCEs prepared differentiated granulosa cells 15 min PRL treatment incubated labeled 2M GAS2 probe resolved electrophoresis
0.35218814.9731707.html.plaintext.txt	74	One slow migrating proteinDNA complex formed WCE PRL treated cells observed WCE prepared untreated cells Fig
0.35218814.9731707.html.plaintext.txt	75	To identify Stat factors present slow migrating complex WCEs preincubated antibodies either Stat 5a Stat 5b
0.35218814.9731707.html.plaintext.txt	76	The PRL induced complex partially supershifted Stat 5a antibody shown previously 10
0.35218814.9731707.html.plaintext.txt	77	A specific Stat 5b antibody resulted retardation entire PRL induced proteinDNA complex Fig
0.35218814.9731707.html.plaintext.txt	78	3A asterisk observed extracts isolated PRL stimulated corpora lutea 11
0.35218814.9731707.html.plaintext.txt	79	These data indicate differentiated granulosa luteal cells luteal tissue pregnant rats 11 12 PRL activates Stat 5b well Stat 5a Stat 5b predominant isoform cells
0.35218814.9731707.html.plaintext.txt	80	View larger version 54K Figure 3
0.35218814.9731707.html.plaintext.txt	81	Activation Phosphorylation Stat5b Differentiated Granulosa Cells PRL
0.35218814.9731707.html.plaintext.txt	82	A PRL induced DNA binding activity present granulosa cells contains Stat 5a Stat 5b
0.35218814.9731707.html.plaintext.txt	83	WCEs isolated untreated PRL treated 15 min granulosa cells incubated labeled oligonucleotide 2MGAS2 5 GATCATCC TTCTGGGAATTCTGATATCCTTCTGGGAATTCTG 3 analyzed EMSA
0.35218814.9731707.html.plaintext.txt	84	The arrow indicates specific PRL induced DNA protein complex formed
0.35218814.9731707.html.plaintext.txt	85	WCEs PRL treated granulosa cells preincubated antisera Stat 5a Stat 5b antibodies 30 min4 C addition radiolabeled double stranded oligonucleotide 2MGAS2
0.35218814.9731707.html.plaintext.txt	86	The PRL induced DNA protein complex super shifted partially Stat 5a antibody completely Stat 5b antibody
0.35218814.9731707.html.plaintext.txt	87	B C PRL induces tyrosine phosphorylation Stat 5b
0.35218814.9731707.html.plaintext.txt	88	For immunoprecipitations 30 microl immobilized Protein A tryacryl beads incubated 200 microg WCEs 1 h 4 C shaking
0.35218814.9731707.html.plaintext.txt	89	After brief spin supernatant incubated 1 microl Stat 5b antibody 20 microl beads 24 h 4 C shaking
0.35218814.9731707.html.plaintext.txt	90	Each samples washed three times WCE buffer remove unbound proteins
0.35218814.9731707.html.plaintext.txt	91	Bound proteins eluted beads addition equal volume SDS loading buffer boiled 100 C 10 min
0.35218814.9731707.html.plaintext.txt	92	Samples electrophoresed 10 SDS polyacylamide gel transferred immobilion membrane blotted antiphosphotyrosine antibody B
0.35218814.9731707.html.plaintext.txt	93	The blot stripped immunoblotted anti Stat 5b antibody C
0.35218814.9731707.html.plaintext.txt	94	PRL Induces Tyrosine Phosphorylation Stat 5b To demonstrate activated Stat 5b granulosa cells phosphorylated consequence PRL stimulation immunoprecipitation experiments performed
0.35218814.9731707.html.plaintext.txt	95	WCEs prepared granulosa cells selected time points PRL treatment
0.35218814.9731707.html.plaintext.txt	96	WCEs incubated specific Stat 5b antibody
0.35218814.9731707.html.plaintext.txt	97	The immunoprecipitate resolved SDS PAGE tyrosine phosphorylated Stat 5b identified antiphosphotyrosine antibody PY20 used Western blotting procedure
0.35218814.9731707.html.plaintext.txt	98	3B WCEs untreated cells contain detectable amounts tyrosine phosphorylated Stat 5b whereas WCEs prepared within 15 min PRL treatment contained significant levels phospho Stat 5b
0.35218814.9731707.html.plaintext.txt	99	Phosphorylated Stat 5b remained present lower levels 6 h 20 h PRL treatment Fig
0.35218814.9731707.html.plaintext.txt	100	To ensure relatively equal amounts Stat 5b present immunoprecipitate blot reprobed anti Stat 5b antibody
0.35218814.9731707.html.plaintext.txt	101	3C similar amounts Stat 5b immunoprecipitated samples
0.35218814.9731707.html.plaintext.txt	102	These data show PRL rapidly stimulates tyrosine phosphorylation Stat 5b granulosa luteal cells even presence continuous exposure PRL amount phospho Stat 5b decreases progressively time coincident reduced DNA binding activity data shown Ref
0.35218814.9731707.html.plaintext.txt	103	Stat 5b Is Key Regulator 2M Gene Expression Ovary Having established Stat 5b rather Stat 5a major Stat 5 protein activated granulosa luteal cells knowing Stat 3 fails bind 2M PRLRE 10 11 sought determine whether disruption Stat 5b binding promoter would abolish promoter activity
0.35218814.9731707.html.plaintext.txt	104	For cotransfected differentiated granulosa cells vectors expressing either wild type Stat 5b truncated splice variant form Stat 5b Stat 5b 40C shown act dominant negative fashion suppress Stat 5b function cells 25 26
0.35218814.9731707.html.plaintext.txt	105	A reporter construct containing four copies proximal Stat binding site ligated minimal 2M promoter luciferase gene 4XGAS 2M chosen reporter construct since previous studies 10 16 shown exhibit greater response PRL treatment intact 2M promoter
0.35218814.9731707.html.plaintext.txt	106	When wild type Stat 5b expression vectors cotransfected 4XGAS 2M luciferase construct PRL induced response similar cells cotransfected empty vector Fig
0.35218814.9731707.html.plaintext.txt	107	4 indicating endogenous amounts Stat 5b already excess
0.35218814.9731707.html.plaintext.txt	108	In contrast PRL induced activation promoter reporter construct significantly repressed cotransfection vector expressing truncated variant Stat 5b Fig
0.35218814.9731707.html.plaintext.txt	109	These data indicate PRL induction 2M differentiated granulosa cells dependent activation Stat 5b truncated splice variant Stat 5b act dominant negative factor granulosa cells cells 25 26
0.35218814.9731707.html.plaintext.txt	110	View larger version 18K Figure 4
0.35218814.9731707.html.plaintext.txt	111	Truncated Stat 5b Acts Dominant Negative Factor Differentiated Granulosa Cells
0.35218814.9731707.html.plaintext.txt	112	Expression vectors long Stat 5b truncated form Stat 5b 40C Stat 5b cotransfected 4xGAS 2M promoter reporter construct containing four copies proximal Stat binding site
0.35218814.9731707.html.plaintext.txt	113	Luciferase activity presented mean plus minus SEM activity obtained construct done triplicate
0.35218814.9731707.html.plaintext.txt	114	SF 1 COUP TF Are Present Granulosa Cells Bind Proximal Promoter 2M Gene The 109 bp fragment 153 43 bp deleted totally abolished functional activity promoter reporter constructs Fig
0.35218814.9731707.html.plaintext.txt	115	1 209 2M analyzed potential transcription factor binding sites
0.35218814.9731707.html.plaintext.txt	116	Putative binding sites orphan members nuclear transcription factor family SF 1 COUP TF Fig
0.35218814.9731707.html.plaintext.txt	117	5A present 45 bp region fragment
0.35218814.9731707.html.plaintext.txt	118	The sites COUP TF included imperfect direct repeat DR separated one nucleotide designated DR1 another direct repeat contains variant repeat AGGGTCA separated two nucleotides designated DR2
0.35218814.9731707.html.plaintext.txt	119	On opposite strand DR1 DR2 putative SF 1 site identified contains one nucleotide mismatch consensus hexameric sequence CAAGGTCA Fig
0.35218814.9731707.html.plaintext.txt	120	Based sequence identity binding studies described referred region orphan receptor response element ORRE
0.35218814.9731707.html.plaintext.txt	121	View larger version 52K Figure 5
0.35218814.9731707.html.plaintext.txt	122	Sequence Functional Binding Sites COUP TF SF 1 2M ORRE
0.35218814.9731707.html.plaintext.txt	123	A Sequence comparison ORRE consensus binding sites members nuclear orphan receptor family
0.35218814.9731707.html.plaintext.txt	124	The ORRE contains two potential COUP TF binding sites designated direct repeats DR DR1 DR2
0.35218814.9731707.html.plaintext.txt	125	The SF 1 binding site present opposite strand DR1 DR2
0.35218814.9731707.html.plaintext.txt	126	Consensus sequences represented bold
0.35218814.9731707.html.plaintext.txt	127	Identical nucleotides indicated lines
0.35218814.9731707.html.plaintext.txt	128	B SF 1 COUP TF bind 2M promoter
0.35218814.9731707.html.plaintext.txt	129	WCEs obtained differentiated granulosa cells incubated labeled oligonuleotide ORRE various cold competitors indicated analyzed EMSA
0.35218814.9731707.html.plaintext.txt	130	The sequence oligonucleotide described Materials Methods
0.35218814.9731707.html.plaintext.txt	131	Arrows indicate specific DNA protein complexes formed
0.35218814.9731707.html.plaintext.txt	132	WCEs differentiated granulosa cells preincubated antisera COUP TF SF 1 30 min4 C addition radiolabeled ORRE
0.35218814.9731707.html.plaintext.txt	133	Antisera COUP TF reacts Complex A antisera SF 1 reacts complex B
0.35218814.9731707.html.plaintext.txt	134	Supershifts indicated
0.35218814.9731707.html.plaintext.txt	135	To determine whether factors present differentiated granulosa cells could bind ORRE EMSAs performed
0.35218814.9731707.html.plaintext.txt	136	A 50 mer oligonucleotide spanning ORRE used labeled probe incubated WCE obtained untreated PRL treated granulosa cells
0.35218814.9731707.html.plaintext.txt	137	Since identical complexes observed either WCE data shown results obtained WCE exposed PRL presented Fig
0.35218814.9731707.html.plaintext.txt	138	As shown two major proteinDNA complexes formed
0.35218814.9731707.html.plaintext.txt	139	The slower migrating complex designated complex A consists two bands thin arrow faster migrating complex designated complex B thick arrow
0.35218814.9731707.html.plaintext.txt	140	Formation complexes inhibited addition 100 fold molar excess unlabeled ORRE oligonucleotide indicating complexes contains proteins capable binding probe
0.35218814.9731707.html.plaintext.txt	141	When 20 bp oligonucleotide encompassing consensus COUP TF binding site Materials Methods added reaction formation complex A complex B abolished Fig
0.35218814.9731707.html.plaintext.txt	142	When oligonucleotides spanning either putative COUP TF binding DR1 DR2 regions Materials Methods 2M promoter added neither altered formation complex A complex B 100 fold molar excess
0.35218814.9731707.html.plaintext.txt	143	However oligonucleotides containing DR1 SF 1 DR1SF 1 DR2 SF 1 DR2SF 1 Materials Methods added reduced formation complex A well complex B
0.35218814.9731707.html.plaintext.txt	144	To confirm identification proteins present granulosa cell extracts WCEs incubated specific antisera either COUP TF SF 1
0.35218814.9731707.html.plaintext.txt	145	Antisera COUP TF specifically supershifed bands complex A
0.35218814.9731707.html.plaintext.txt	146	Previous data show antiserum recognizes COUP TFI COUP TF II 27
0.35218814.9731707.html.plaintext.txt	147	This COUP TF antiserum also diminished binding vitro translated COUP TF ORRE data shown
0.35218814.9731707.html.plaintext.txt	148	The SF 1 specific antiserum retarded complex B complex A indicating specific interaction antibody major protein DNA complex
0.35218814.9731707.html.plaintext.txt	149	Collectively data indicate SF 1 complex B COUP TF complex A bind 2M promoter
0.35218814.9731707.html.plaintext.txt	150	Furthermore functional binding sites appear overlapping rather distinct
0.35218814.9731707.html.plaintext.txt	151	Mutation SF 1 Binding Site Alters COUP TF Binding ORRE To determine whether nucleotides required binding SF 1 COUP TF 2M promoter overlapping mutations within ORRE generated Materials Methods
0.35218814.9731707.html.plaintext.txt	152	Mutations DR1 DR2 Mutant 1 M1 made selectively eliminate putative binding sites COUP TF mutations SF 1 binding site generated block binding SF 1 M2 Materials Methods
0.35218814.9731707.html.plaintext.txt	153	When EMSAs performed M1 labeled probe Fig
0.35218814.9731707.html.plaintext.txt	154	6A left panel one major complex formed arrow
0.35218814.9731707.html.plaintext.txt	155	This complex competed 50 fold 100 fold molar excess unlabeled M1
0.35218814.9731707.html.plaintext.txt	156	The antibody COUP TF failed affect mobility major complex binding M1 whereas antibody SF 1 supershifted major complex
0.35218814.9731707.html.plaintext.txt	157	These results indicate mutations within DR1 DR2 inhibited COUP TF binding without altering binding SF 1 ORRE
0.35218814.9731707.html.plaintext.txt	158	View larger version 60K Figure 6
0.35218814.9731707.html.plaintext.txt	159	Binding Characteristics Mutant SF 1 COUP TF Binding Regions
0.35218814.9731707.html.plaintext.txt	160	A Analysis mutant SF 1 COUP TF binding sites
0.35218814.9731707.html.plaintext.txt	161	WCEs obtained differentiated granulosa cells incubated labeled oligonuleotide containing either mutation DR1 DR2 M1 mutation SF 1 site M2 analyzed EMSA
0.35218814.9731707.html.plaintext.txt	162	The sequences M1 M2 described Materials Methods
0.35218814.9731707.html.plaintext.txt	163	Arrow indicates specific DNA protein complex formed M1
0.35218814.9731707.html.plaintext.txt	164	WCEs differentiated granulosa cells preincubated antisera COUP TFSF 1 30 min4 C addition radiolabeled M1M2
0.35218814.9731707.html.plaintext.txt	165	Supershift specific complex antisera SF 1 indicated
0.35218814.9731707.html.plaintext.txt	166	B Mutation SF 1 site alters affinity COUP TF ORRE
0.35218814.9731707.html.plaintext.txt	167	WCEs obtained differentiated granulosa cells incubated labeled oligonuleotide ORRE
0.35218814.9731707.html.plaintext.txt	168	The oligonuleotide containing mutation SF 1 site M2 used cold competitor various concentrations
0.35218814.9731707.html.plaintext.txt	169	The arrow indicates specific DNA protein complex formed ORRE
0.35218814.9731707.html.plaintext.txt	170	WCEs differentiated granulosa cells preincubated antisera COUP TF 30 min4 C addition radiolabeled ORRE
0.35218814.9731707.html.plaintext.txt	171	Supershift specific complex antisera COUP TF indicated
0.35218814.9731707.html.plaintext.txt	172	When SF 1 mutant M2 oligonucleotide used labeled probe EMSAs specific protein DNA complexes containing SF 1 COUP TF observed Fig
0.35218814.9731707.html.plaintext.txt	173	The absence SF 1 binding expected
0.35218814.9731707.html.plaintext.txt	174	However absence COUP TF unexpected DR1 DR2 sites intact
0.35218814.9731707.html.plaintext.txt	175	Thus mutation SF 1 site altered binding SF 1 also COUP TF
0.35218814.9731707.html.plaintext.txt	176	When labeled M2 incubated vitro translated COUP TF binding COUP TF markedly diminished compared intact ORRE data shown
0.35218814.9731707.html.plaintext.txt	177	Based observations concluded SF 1 site 2M promoter appeared enhance stabilize directly bind COUP TF
0.35218814.9731707.html.plaintext.txt	178	To determine mutation SF 1 site within 2M promoter altered binding affinity COUP TF ORRE additional EMSAs run intact 50 mer ORRE used labeled probe
0.35218814.9731707.html.plaintext.txt	179	As previously unlabeled ORRE reduced formation complexes A B whereas COUP TF antibody supershifted complex A complex B Fig
0.35218814.9731707.html.plaintext.txt	180	When SF 1 mutant M2 oligonucleotide used 100 500 1000 fold molar excess reduction binding SF 1 observed
0.35218814.9731707.html.plaintext.txt	181	However M2 compete binding COUP TF thin arrow albeit less effectively unlabeled ORRE
0.35218814.9731707.html.plaintext.txt	182	A 1000 fold molar excess M2 required achieve inhibition 100 fold molar excess intact ORRE Fig
0.35218814.9731707.html.plaintext.txt	183	These results indicate mutation SF 1 site reduces affinity stability completely prevent binding COUP TF 2M promoter
0.35218814.9731707.html.plaintext.txt	184	SF 1 COUP TF Exert Opposing Effects Functional Activity 2M Promoter SF 1 known positive regulator many genes 2 3 4 5 6 7 8 9 whereas effects COUP TF complex either positive negative 17 28
0.35218814.9731707.html.plaintext.txt	185	In addition exhibit tissue specific effects indicated phenotypes mutant mice lacking SF 1 1 COUP TFIII Refs
0.35218814.9731707.html.plaintext.txt	186	To analyze functional roles SF 1 COUP TF regulating activation 2M promoter specific mutations abolished binding SF 1 COUP TF Fig
0.35218814.9731707.html.plaintext.txt	187	6 generated within 3712M promoter reporter construct using PCR directed mutagenesis techniques Materials Methods
0.35218814.9731707.html.plaintext.txt	188	These constructs transfected differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	189	After 4 h cells treated withwithout PRL 6 h
0.35218814.9731707.html.plaintext.txt	190	Luciferase activity measured normalized amount protein present sample expressed activity microg protein
0.35218814.9731707.html.plaintext.txt	191	As expected PRL induced 2 3 fold increase luciferase activity intact 371 2M promoter reporter construct Fig
0.35218814.9731707.html.plaintext.txt	192	Mutation SF 1 site mSF 1 prevents SF 1 binding reduces affinity COUP TF binding Fig
0.35218814.9731707.html.plaintext.txt	193	6AB markedly decreased basal activity reporter gene prevent 3 fold increase response PRL Fig
0.35218814.9731707.html.plaintext.txt	194	In contrast COUP TF mutant mCOUPTF construct retains intact SF 1 binding site fails bind COUP TF showed 5 fold increase basal promoter activity
0.35218814.9731707.html.plaintext.txt	195	Although fold increase PRL somewhat reduced effect PRL observed
0.35218814.9731707.html.plaintext.txt	196	When SF 1 COUP TF sites mSF mCOUPTF mutated basal PRL stimulated luciferase activities similar intact promoter reporter construct
0.35218814.9731707.html.plaintext.txt	197	Collectively data document within ORRE 2M promoter SF 1 acts positive regulator whereas COUP TF acts repressor transcriptional activation
0.35218814.9731707.html.plaintext.txt	198	Combined data EMSAs results indicate although mutation SF 1 site decreases affinity COUP TF binding 2M promoter COUP TF binds region albeit reduced affinity retains potent repressor activity
0.35218814.9731707.html.plaintext.txt	199	Thus nuclear receptors appear control basal activity 2M promoter granulosa luteal cells markedly alter response PRL
0.35218814.9731707.html.plaintext.txt	200	View larger version 18K Figure 7
0.35218814.9731707.html.plaintext.txt	201	SF 1 COUP TF Are Required 2M Promoter Activity
0.35218814.9731707.html.plaintext.txt	202	Mutations specific bases within SF 1 andor COUP TF binding sites generated using PCR mutagenesis technique
0.35218814.9731707.html.plaintext.txt	203	Each indicated vectors transfected triplicate differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	204	Luciferase activity lights units microg presented mean plus minus SEM activity obtained construct done triplicate
0.35218814.9731707.html.plaintext.txt	205	Molecular Mechanisms FSH T Control Expression 2M Granulosa Cells The identification SF 1 COUP TF factors binding regulating functional activity ORRE 2M promoter prompted us determine whether factors regulated basal activity promoter different stages granulosa cell differentiation
0.35218814.9731707.html.plaintext.txt	206	Specifically FSH shown regulate expression numerous genes granulosa cells contain SF 1 binding sites
0.35218814.9731707.html.plaintext.txt	207	The list genes includes aromatase 6 P450scc 7 MIS 8 recently receptor PRL 31
0.35218814.9731707.html.plaintext.txt	208	This latter observation indicated basal activity 2M promoter also PRL inducibility 2M gene might dependent several aspects FSH mediated differentiation granulosa cells
0.35218814.9731707.html.plaintext.txt	209	Therefore analyzed compared basal PRL induced expression 2M immature granulosa cells cells differentiated presence FSH T
0.35218814.9731707.html.plaintext.txt	210	The expression endogenous 2M gene compared activity 2M promoter luciferase reported constructs transfected similar immature differentiated cells
0.35218814.9731707.html.plaintext.txt	211	Furthermore expression endogenous gene transgene related expression PRL receptors PRLRs activation Stat 5 relative levels SF 1 COUP TF
0.35218814.9731707.html.plaintext.txt	212	To analyze expression endogenous gene granulosa cells isolated estradiol primed immature rats
0.35218814.9731707.html.plaintext.txt	213	The cells either cultured serum free medium without hormones 24 h cultured FSHT 48 h
0.35218814.9731707.html.plaintext.txt	214	PRL added hormone free undifferentiated hormone induced differentiated cell cultures 24 h
0.35218814.9731707.html.plaintext.txt	215	Total RNA isolated 2M transcripts analyzed Northern blots
0.35218814.9731707.html.plaintext.txt	216	8A 2M mRNA present undifferentiated cells absence presence PRL
0.35218814.9731707.html.plaintext.txt	217	In contrast PRL induce 2M mRNA differentiated cells
0.35218814.9731707.html.plaintext.txt	218	Thus absence FSHT PRL unable stimulate transcription endogenous 2M gene confirming previous studies vivo 11 vitro 32 33
0.35218814.9731707.html.plaintext.txt	219	View larger version 23K Figure 8
0.35218814.9731707.html.plaintext.txt	220	FSHT Induced Differentiation Granulosa Cells Is Required Expression 2M mRNA Promoter Activity
0.35218814.9731707.html.plaintext.txt	221	A PRL fails induce 2M transcripts undifferentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	222	Undifferentiated FSHT 24 h differentiated FSHT 48 h granulosa cells placed culture followed addition PRL 1 microgml 24 h
0.35218814.9731707.html.plaintext.txt	223	Total RNA 20 microg used Northern blot analysis
0.35218814.9731707.html.plaintext.txt	224	B Functional activity 2M promoter dependent granulosa cell differentiation
0.35218814.9731707.html.plaintext.txt	225	The 3712M construct transfected triplicate granulosa cells cultured presence absence FSH T
0.35218814.9731707.html.plaintext.txt	226	After 4 h incubation PRL 1 microgml added 6 h
0.35218814.9731707.html.plaintext.txt	227	Luciferase activity lights units microg presented mean plus minus SEM activity obtained construct done triplicate
0.35218814.9731707.html.plaintext.txt	228	Similar cultures set transfected 3712M promoter reporter construct analyze activity chimeric genes absence presence PRL
0.35218814.9731707.html.plaintext.txt	229	8B basal luciferase activity 371 2M promoter reporter construct low undifferentiated granulosa cells increased addition PRL
0.35218814.9731707.html.plaintext.txt	230	In contrast basal luciferase activity 10 fold higher differentiated cells PRL induced 2 3 fold increase activity
0.35218814.9731707.html.plaintext.txt	231	The marked differences activity transgene two stages granulosa cell differentiation related transfection efficiency since SV40 enhancer promoter construct gave similar activity 20000 mean light units plus minus SEM per microg protein transfected culture
0.35218814.9731707.html.plaintext.txt	232	Based observations FSH T induced differentiation altered basal PRL regulated activities sought determine changes PRL response system ratio SF 1 COUP TF might account marked differences
0.35218814.9731707.html.plaintext.txt	233	To determine whether PRL could stimulate activation Stat 5b5a undifferentiated granulosa cells WCEs isolated FSHT treated 48 h untreated 24 h granulosa cells PRL treatment 15 30 min
0.35218814.9731707.html.plaintext.txt	234	Several proteinDNA complexes formed WCE prepared immature granulosa cells exposure PRL added labeled 2MGAS2 probe
0.35218814.9731707.html.plaintext.txt	235	However extracts prepared within 15 min PRL addition FSHT treated cells Fig
0.35218814.9731707.html.plaintext.txt	236	9A formed specific slow migrating complex composed primarily Stat 5b lesser amounts Stat 5a Figs
0.35218814.9731707.html.plaintext.txt	237	Immunoblot analysis using WCEs prepared FSHT treated 48 h untreated 24 h granulosa cells PRL treatment 1530 min Stat 5b antibody shows similar levels protein immature FSHT stimulated cells data shown
0.35218814.9731707.html.plaintext.txt	238	Thus although Stat 5b protein present undifferentiated granulosa cells PRL unable activate cells
0.35218814.9731707.html.plaintext.txt	239	View larger version 43K Figure 9
0.35218814.9731707.html.plaintext.txt	240	PRL Receptor Activity mRNA Content Undifferentiated Differentiated Granulosa Cells
0.35218814.9731707.html.plaintext.txt	241	A PRL fails activate Stat 5b undifferentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	242	WCEs isolated cultured granulosa cells PRL treatment 15 min undifferentiated FSHT 24 h differentiated FSHT 48 h cells
0.35218814.9731707.html.plaintext.txt	243	WCEs incubated radiolabeled double stranded oligonucleotide 2MGAS2
0.35218814.9731707.html.plaintext.txt	244	The proteinDNA complexes analyzed EMSA
0.35218814.9731707.html.plaintext.txt	245	B Expression PRLR mRNAs undifferentiated differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	246	RNA isolated uncultured undifferentiated FSHT 24 h differentiated FSHT 48 h granulosa cells
0.35218814.9731707.html.plaintext.txt	247	Specific primers long short form PRLRs used RT PCR assay using 350 ng RNA
0.35218814.9731707.html.plaintext.txt	248	PCR amplification performed 20 cycles described Materials Methods
0.35218814.9731707.html.plaintext.txt	249	PCR products resolved nondenaturing gel quantified using Storm860 PhosphoImager
0.35218814.9731707.html.plaintext.txt	250	One explanation transactivation 2M differentiated cells immature cells level PRLRs cells
0.35218814.9731707.html.plaintext.txt	251	Three forms PRLRs identified rat
0.35218814.9731707.html.plaintext.txt	252	The short receptor alternatively spliced product long form L PRLR
0.35218814.9731707.html.plaintext.txt	253	The Nb2 form expressed T cells identical L PRLR lacks 198 aa cytoplasmic domain
0.35218814.9731707.html.plaintext.txt	254	Studies shown long form functional ovary
0.35218814.9731707.html.plaintext.txt	255	Specific primers long short form PRLRs used RT PCR assay using RNA isolated uncultured cells undifferentiated granulosa cells FSHT 24 h differentiated cells FSHT 48 h
0.35218814.9731707.html.plaintext.txt	256	The amplified receptor mRNA products normalized endogenous ribosomal L19 amplified band Fig
0.35218814.9731707.html.plaintext.txt	257	The long form PRLR detected significant levels immature granulosa cells culture
0.35218814.9731707.html.plaintext.txt	258	However absence hormone levels PRLR decreased progressively 24 48 h culture Fig
0.35218814.9731707.html.plaintext.txt	259	In contrast cells cultured FSHT 48 h expressed 5 fold message long PRLR exhibited detectable amounts short form receptor Fig
0.35218814.9731707.html.plaintext.txt	260	These data indicate ability PRL induce 2M differentiated cells related part induction maintenance PRLR cells
0.35218814.9731707.html.plaintext.txt	261	However since PRL induce 2M immature cells also express long form PRLR additional factors regulating either PRL signaling cascade A kinase system must regulated FSHT granulosa cells differentiate
0.35218814.9731707.html.plaintext.txt	262	Based opposing actions SF 1 COUP TF regulating basal activity Fig
0.35218814.9731707.html.plaintext.txt	263	7 sought determine whether changes relative amounts factors might related increase 2M mRNA expression differentiated cells compared immature cells
0.35218814.9731707.html.plaintext.txt	264	EMSAs performed using labeled ORRE extracts prepared either immatureundifferentiated granulosa cells 2M induced FSHT treateddifferentiated granulosa cell extracts Fig
0.35218814.9731707.html.plaintext.txt	265	Quantification specific complexes performed determine relative amounts SF 1 COUP TF binding ORRE
0.35218814.9731707.html.plaintext.txt	266	10B relative increase SF 1 binding 6 fold compared COUP TF detected FSHT treated granulosa lutein cells
0.35218814.9731707.html.plaintext.txt	267	These results indicated relative increase positive regulator SF 1 may enhance basal promoter activity
0.35218814.9731707.html.plaintext.txt	268	View larger version 28K Figure 10
0.35218814.9731707.html.plaintext.txt	269	Levels SF 1 COUP TF Binding Activity Undifferentiated Differentiated Granulosa Cells
0.35218814.9731707.html.plaintext.txt	270	A Relative increase SF 1 COUP TF binding ORRE differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	271	WCEs obtained immature differentiated FSHT 48 h granulosa cells incubated labeled ORRE oligonuleotide
0.35218814.9731707.html.plaintext.txt	272	The proteinDNA complexes analyzed EMSA
0.35218814.9731707.html.plaintext.txt	273	B Quantitative representation SF 1 COUP TF binding ORRE
0.35218814.9731707.html.plaintext.txt	274	The SF 1 COUP TF proteinDNA complexes quantified Storm860 PhosphoImager
0.35218814.9731707.html.plaintext.txt	275	FSH dependent differentiation granulosa cells increases relative amount SF 1 binding ORRE compared COUP TF
0.35218814.9731707.html.plaintext.txt	276	Ratios relative units SF 1 COUP TF binding indicated parentheses
0.35218814.9731707.html.plaintext.txt	277	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The expression 2M rat ovary dependent differentiation granulosa cells luteal cells 10 11 well presence activation binding diverse set transcription factors promoter 2M gene
0.35218814.9731707.html.plaintext.txt	278	In study identified functionally characterized interactions two regions 2M promoter
0.35218814.9731707.html.plaintext.txt	279	One region contains PRLRE comprised two Stat factor binding sites binds Stat 5a Stat 5b Refs
0.35218814.9731707.html.plaintext.txt	280	The region contains ORRE binds orphan nuclear receptors SF 1 2 3 4 COUP TF 17 18
0.35218814.9731707.html.plaintext.txt	281	We show herein maximal functional activity 2M promoter depends independent activation region binding interactions specific transcription factors hormonal stimulation differentiated granulosa luteal cell phenotype
0.35218814.9731707.html.plaintext.txt	282	When studies described herein originally initiated shown Stat 5a expressed rat granulosa cells activated PRL bound PRLRE 2M promoter
0.35218814.9731707.html.plaintext.txt	283	We extended observations showing Stat binding sites critical PRL induced activity 2M promoter
0.35218814.9731707.html.plaintext.txt	284	Neither site alone context intact promoter exhibits significant functional activity
0.35218814.9731707.html.plaintext.txt	285	These results indicate two sites may interact stabilize increase binding coregulatory molecules interact transcriptional machinery
0.35218814.9731707.html.plaintext.txt	286	As new information complexity Stat 5 family transcription factors reported 34 35 reagents new family members allowed us extend initial observations
0.35218814.9731707.html.plaintext.txt	287	Using antibodies specific Stat 5b show present rat granulosa cells expressed higher levels Stat 5a activated PRL binds PRLRE 2M gene
0.35218814.9731707.html.plaintext.txt	288	These results obtained granulosa luteal cells culture support observed luteal cells vivo 10 11
0.35218814.9731707.html.plaintext.txt	289	Antibodies Stat 5b allowed us document differentiated granulosa cells Stat 5b tyrosine phosphorylated translocated nucleus response PRL
0.35218814.9731707.html.plaintext.txt	290	In addition truncated splice variant forms Stat proteins cloned
0.35218814.9731707.html.plaintext.txt	291	For Stats truncated forms identified Stat 1 36 37 Stat 3 38 Stat 5 25 26 mutants lacking transactivation domain shown exert dominant negative functions transcription assays 25 26 36 37 38
0.35218814.9731707.html.plaintext.txt	292	When coexpressed truncated Stat 5b variant 2M promoter luciferase reporter construct PRL induced activity markedly impaired supporting hypothesis Stat 5 major PRL regulated activator 2M promoter activity differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	293	Taken together results provide evidence PRL mediated signaling events transactivate 2M gene granulosa luteal cells occur mechanisms similar regulate cytokine signal transduction target gene activity tissues mammary gland 13 39 40 liver 35 41
0.35218814.9731707.html.plaintext.txt	294	That Stat 5 especially Stat 5b plays major role transducing PRL action ovarian cells supported recently generation mutant mice
0.35218814.9731707.html.plaintext.txt	295	Although female mice null Stat 5a exhibit overt ovarian phenotype 42 mice null Stat 5b alone 43 infertile exhibit abnormal ovarian functions
0.35218814.9731707.html.plaintext.txt	296	Based luteal cell specific expression 2M vivo well regulation PRL Stat 5b cultured cells predict corpora lutea infertile mice either fail express 2M express markedly reduced level
0.35218814.9731707.html.plaintext.txt	297	Our results also provided new evidence indicate regions addition PRLRE regulate expression 2M granulosa luteal cells
0.35218814.9731707.html.plaintext.txt	298	The region directly 3 PRLRE binds SF 1 COUP TF designated herein ORRE 2M promoter
0.35218814.9731707.html.plaintext.txt	299	When region 2M promoter deleted leaving PRLRE intact transgene activity reduced baseline PRL inducibility abolished
0.35218814.9731707.html.plaintext.txt	300	Based initial observations predicted Stat 5 binding PRLRE interacted synergistically orphan receptors binding 3 regulatory region confer maximal promoter activity
0.35218814.9731707.html.plaintext.txt	301	This initial hypothesis supported observations others shown Stats synergistically interact variety transcription factors coregulatory molecules
0.35218814.9731707.html.plaintext.txt	302	In mammary epithelial cells Stat 5 interacts glucocorticoid receptor activation ss casein gene PRL 23 44
0.35218814.9731707.html.plaintext.txt	303	In liver cells Stat 3 synergizes interacts glucocorticoid receptor activation 2M gene IL 6 24
0.35218814.9731707.html.plaintext.txt	304	Stat 1 Sp1 interact activate ICAM I promoter human tracheobronchial epithelial cells 21
0.35218814.9731707.html.plaintext.txt	305	In addition Stat 2 shown bind CBPp300 enhance gene activation interferon 20
0.35218814.9731707.html.plaintext.txt	306	When site specific mutations generated either Stat 5 SF 1 COUP TF binding sites within context intact 2M promoter different set functional interactions observed
0.35218814.9731707.html.plaintext.txt	307	Mutation either one Stat 5 binding sites markedly reduced PRL inducibility
0.35218814.9731707.html.plaintext.txt	308	As mentioned results indicate functional activity PRLRE dependent binding Stat 5 site two sites interact confer maximal PRL inducibility
0.35218814.9731707.html.plaintext.txt	309	However mutation Stat sites alter high basal activity observed intact 2M promoter reporter constructs compared 48 2M minimal promoter construct
0.35218814.9731707.html.plaintext.txt	310	Contrary initial hypothesis results indicated Stat sites acted independently factors binding ORRE
0.35218814.9731707.html.plaintext.txt	311	However site specific mutations SF 1 site two COUP TF binding sites generated marked changes basal activities mutant constructs observed
0.35218814.9731707.html.plaintext.txt	312	The mutant SF 1 construct failed bind SF 1 exhibited markedly reduced basal activity whereas COUP TF mutant construct failed bind COUP TF bind SF 1 exhibited elevated basal activity
0.35218814.9731707.html.plaintext.txt	313	These results indicated SF 1 transcriptional activator enhances 2M promoter activity whereas COUP TF acted corepressor antagonize activity SF 1 thereby reduce functional activity intact 2M promoter
0.35218814.9731707.html.plaintext.txt	314	Thus 2M gene added growing list genes regulated SF 1 ovarian cells highlights importance SF 1 many diverse functions within gonads adrenals suggested phenotype mice null SF 1 1
0.35218814.9731707.html.plaintext.txt	315	Furthermore observations provide first evidence COUP TF present functional ovarian granulosa cells regulate expression ovarian gene
0.35218814.9731707.html.plaintext.txt	316	Although actions COUP TF complex shown stimulatory inhibitory 17 data indicate COUP TF acts corepressor SF 1 action intact promoter 2M gene
0.35218814.9731707.html.plaintext.txt	317	This observation supports results obtained one study effects SF 1 blunted COUP TF 5
0.35218814.9731707.html.plaintext.txt	318	Although mechanism COUP TF blocks actions SF 1 2M promoter entirely defined data show interesting juxtaposition interaction SF 1 COUP TF binding sites
0.35218814.9731707.html.plaintext.txt	319	Of note mutation SF 1 site reduced 10 fold binding affinity COUP TF DR1 DR2 regions 2M promoter
0.35218814.9731707.html.plaintext.txt	320	From conclude binding COUP TF DR1 DR2 overlaps SF 1 site adjacent sites
0.35218814.9731707.html.plaintext.txt	321	However despite dramatic reduction binding affinity COUP TF SF 1 mutant region COUP TF retained potent repressor activity revealed markedly reduced basal activity SF 1 mutant construct
0.35218814.9731707.html.plaintext.txt	322	These interactions SF 1 COUP TF indicate change relative levels activity factors could markedly alter basal activity 2M gene thus expression
0.35218814.9731707.html.plaintext.txt	323	Both PRLRE ORRE dependent differentiation granulosa cells
0.35218814.9731707.html.plaintext.txt	324	In case PRLRE granulosa cell differentiation obligatory part increased expression PRLRs cell surface
0.35218814.9731707.html.plaintext.txt	325	Increased PRLR number enhances activation Stat 5b constituitively expressed amount immature well differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	326	In case ORRE molecular basis enhanced activity region differentiated cells opposed immature cells remains determined likely involves altered functional activity complex interactions SF 1 COUP TF ORRE
0.35218814.9731707.html.plaintext.txt	327	As shown herein amounts relative ratios two factors binding 2M ORRE different immature differentiated granulosa cells
0.35218814.9731707.html.plaintext.txt	328	There relative 6 fold increase SF 1 binding differentiated granulosa cells compared immature granulosa cells
0.35218814.9731707.html.plaintext.txt	329	Therefore increased basal activity 2M promoter may depend increased binding transcriptional activator
0.35218814.9731707.html.plaintext.txt	330	In addition functional changes likely involve selective phosphorylation either factor coregulatory molecule
0.35218814.9731707.html.plaintext.txt	331	Phosphorylation SF 1 would predicted increase activity ORRE whereas phosphorylation COUP TF might decrease repressor activity ORRE
0.35218814.9731707.html.plaintext.txt	332	The phosphorylation either factor might alter recruitment coregulatory molecules
0.35218814.9731707.html.plaintext.txt	333	Phosphorylation SF 1 shown occur differentiated granulosa cells 45 therefore may critical event increasing basal activity 2M well increasing expression PRLR
0.35218814.9731707.html.plaintext.txt	334	In combination two events promote enhanced transcription 2M PRL
0.35218814.9731707.html.plaintext.txt	335	As mentioned cells express SF 1 express COUP TF
0.35218814.9731707.html.plaintext.txt	336	Therefore possible cells repressor activity COUP TF unopposed transcription factor thereby reducing expression gene
0.35218814.9731707.html.plaintext.txt	337	In summary shown expression 2M gene ovarian granulosa luteal cells involves PRL induced activation Stat 5ba also opposing interactions SF 1 COUP TF ORRE
0.35218814.9731707.html.plaintext.txt	338	The close juxtaposition regions initially indicated might functional synergism factors binding PRLRE ORRE
0.35218814.9731707.html.plaintext.txt	339	However using site specific mutations rather deletion analyses able show regions act independently context intact 2M promoter
0.35218814.9731707.html.plaintext.txt	340	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Materials 17ss Estradiol purchased Sigma Chemical Co
0.35218814.9731707.html.plaintext.txt	341	Louis MO testosterone Steroids Keene NH ovine LH NIH oLH 23 ovine FSH NIH oFSH 76 ovine PRL National Hormone Pituitary Program Baltimore MD forskolin 10 microM dissolved ethanol Calbiochem San Deigo CA Biotrans nylon membrane 0
0.35218814.9731707.html.plaintext.txt	342	2 microm 32Pdeoxy CTP ICN Biochemical Cleveland OH
0.35218814.9731707.html.plaintext.txt	343	TNT coupled reticulocyte lysate system large fragments E
0.35218814.9731707.html.plaintext.txt	344	coli polymerase T4 poly nucleotide kinase restriction enzymes purchased Promega Corp
0.35218814.9731707.html.plaintext.txt	345	Madison WI T4 DNA ligase ss Agarase New England Biolabs Beverly MA luciferin BMB Indianapolis IN coenzyme A Pharmacia Piscataway NJ Immobilon P Millipore Corp
0.35218814.9731707.html.plaintext.txt	346	Bedford MA protein assay reagents electrophoresis supplies Bio Rad Richmond CA tissue culture reagents GIBCO Grand Island NY rainbow molecular weight markers enhanced chemiluminescence ECL detection system Amersham Arlington Heights IL RNA ladder 0
0.35218814.9731707.html.plaintext.txt	347	5 kb Bethesda Research Laboratories Life Technologies Inc
0.35218814.9731707.html.plaintext.txt	348	Immobolized protein A tryacryl beads purchased Pierce Rockford IL
0.35218814.9731707.html.plaintext.txt	349	5 kb fragment 2M cDNA obtained 4
0.35218814.9731707.html.plaintext.txt	350	2 kb full length clone isolated rat liver cDNA expression library 46
0.35218814.9731707.html.plaintext.txt	351	This cDNA recognizes single transcript 5
0.35218814.9731707.html.plaintext.txt	352	2 kb 2M message Northern analysis tissues examined date
0.35218814.9731707.html.plaintext.txt	353	Kodak film XAR 5 Eastman Kodak Co
0.35218814.9731707.html.plaintext.txt	354	COUP TFI cDNA kindly provided Dr
0.35218814.9731707.html.plaintext.txt	355	Ming Jer Tsai Baylor College Medicine Houston TX
0.35218814.9731707.html.plaintext.txt	356	cDNA Stat 5b splice variant Stat 5b40C generous gifts Dr
0.35218814.9731707.html.plaintext.txt	357	Fey Department Genetics University Erlangen Nurenberg Erlangen Germany
0.35218814.9731707.html.plaintext.txt	358	A rabbit antiserum IgG fraction generated C terminal peptide Stat 5a generously provided Dr
0.35218814.9731707.html.plaintext.txt	359	Jeffrey Rosen Baylor College Medicine Houston TX
0.35218814.9731707.html.plaintext.txt	360	Antibodies phosphotyrosine PY20 obtained Transduction Laboratory Lexington KY
0.35218814.9731707.html.plaintext.txt	361	Antibodies obtained several sources
0.35218814.9731707.html.plaintext.txt	362	Antibodies Stat 5b generous gifts Dr
0.35218814.9731707.html.plaintext.txt	363	Lothar Henninghausen Laboratory Biochemistry Metabolism National Institute Diabetes Digestive Kidney Diseases NIH Bethesda MD antibodies SF 1 Ad4BP Dr
0.35218814.9731707.html.plaintext.txt	364	Ken ichirou Morohashi Kyushu University Fukuoka Japan antibodies COUP TF Dr
0.35218814.9731707.html.plaintext.txt	365	Ming Jer Tsai Baylor College Medicine Houston TX
0.35218814.9731707.html.plaintext.txt	366	Animals Intact immature Sprague Dawley 23 days old female rats obtained Harlan Indianapolis IN maintained 16 h light 8 h dark schedule food water ad libitum
0.35218814.9731707.html.plaintext.txt	367	Animals treated accordance NIH Guide Care Use Laboratory Animals
0.35218814.9731707.html.plaintext.txt	368	All protocols approved Institutional Committee Animal Care Use Baylor College Of Medicine Houston TX
0.35218814.9731707.html.plaintext.txt	369	Rats delivered day 23 age weighed 50 55 g
0.35218814.9731707.html.plaintext.txt	370	Rats injected sc days 24 26 1
0.35218814.9731707.html.plaintext.txt	371	Granulosa Cell Culture Ovaries isolated immature rats primed 17ss estradiol punctured 22 gauge needle isolate granulosa cells
0.35218814.9731707.html.plaintext.txt	372	The granulosa cells pooled treated trypsin 20 microgml 1 min followed addition soybean trypsin inhibitor 300 microgml DNAse 100 microgml remove necrotic cells 47
0.35218814.9731707.html.plaintext.txt	373	After washing cells twice cultured 48 h DMEM Ham F12 DMEMF12 11 supplemented low dose oFSH 50 ngml T 10 ngml 37 C 95 air 5 CO2
0.35218814.9731707.html.plaintext.txt	374	Granulosa cells cultured 24 h absence FSH T 48 h presence FSH T 47 48
0.35218814.9731707.html.plaintext.txt	375	At time period cells treated PRL 1 microgml forskolin 10 microM
0.35218814.9731707.html.plaintext.txt	376	At indicated time points total RNA isolated Northern analyses WCEs prepared EMSAs immunoblots cells used transient transfections various expression vectors
0.35218814.9731707.html.plaintext.txt	377	RNA Isolation Northern Analysis Extraction buffer containing 1 Nonidet P 40 used isolation cytoplasmic RNA granulosa cells 49
0.35218814.9731707.html.plaintext.txt	378	RNA samples extracted phenol chloroform ethanol precipitated resuspended water containing 0
0.35218814.9731707.html.plaintext.txt	379	1 dimethyl pyrocarbonate quantitated measuring absorbance 260 nm
0.35218814.9731707.html.plaintext.txt	380	For Northern blot analyses 20 microg RNA denatured 55 C 15 min 45 formamide 5
0.35218814.9731707.html.plaintext.txt	381	4 formaldehyde resolved electrophoresis room temperature formaldehyde agarose gel
0.35218814.9731707.html.plaintext.txt	382	To confirm equal loading RNA samples determine migration standards RNA ladder gel stained acridine orange
0.35218814.9731707.html.plaintext.txt	383	After transfer RNA nylon membranes blots baked prehybridized hybridized P32 labeled 2M cDNA probe
0.35218814.9731707.html.plaintext.txt	384	Blots washed four times 5 minwash room temperature 2x saline sodium citrate 0
0.35218814.9731707.html.plaintext.txt	385	1 SDS followed two washes 15 min 0
0.35218814.9731707.html.plaintext.txt	386	1 SDS 55 C exposed film 80 C
0.35218814.9731707.html.plaintext.txt	387	Immunoprecipitations Immunoblot Analyses Protein A tryacryl beads 30 microl incubated 200 microg WCEs 1 h 4 C shaking
0.35218814.9731707.html.plaintext.txt	388	After brief spin supernatant incubated 1 microl Stat 5b antibody 20 microl diluted beads 24 h 4 C shaking
0.35218814.9731707.html.plaintext.txt	389	Each samples washed three times WCE buffer remove unbound protein
0.35218814.9731707.html.plaintext.txt	390	Bound proteins eluted beads addition equal volume SDS loading buffer boiled 100 C 10 min
0.35218814.9731707.html.plaintext.txt	391	Samples resolved 10 one dimensional SDS PAGE 20 mA 6 7 h
0.35218814.9731707.html.plaintext.txt	392	Electrophoretic transfer Immobilon polyvinylidene difluoride PVDF membrane performed 12 V overnight 4 C
0.35218814.9731707.html.plaintext.txt	393	After blocking 5 milk 2 h filters incubated PY20 antiphosphotyrosine antibody 1250
0.35218814.9731707.html.plaintext.txt	394	The filters washed Tris buffered saline 0
0.35218814.9731707.html.plaintext.txt	395	05 Tween 20 mM Tris 150 mM NaCl pH 7
0.35218814.9731707.html.plaintext.txt	396	The blots incubated 110000 antirabbit horseradish peroxidase antimouse horseradish peroxidase
0.35218814.9731707.html.plaintext.txt	397	Filters washed six times 5 min TBST
0.35218814.9731707.html.plaintext.txt	398	ECL reagents used detect specific proteins described Amersham
0.35218814.9731707.html.plaintext.txt	399	The blot stripped 2 SDS 50 mM ss mercaptoethanol 50 mM Tris pH 6
0.35218814.9731707.html.plaintext.txt	400	After extensive washes TBST blot reprobed anti Stat 5b antibody 110000
0.35218814.9731707.html.plaintext.txt	401	Plasmid Constructs The luciferase constructs pSVoA1
0.35218814.9731707.html.plaintext.txt	402	2 kb2M 1152 54 bp Stat mutants described previously 16
0.35218814.9731707.html.plaintext.txt	403	All luciferase constructs Fig
0.35218814.9731707.html.plaintext.txt	404	1 generated initially isolating 1
0.35218814.9731707.html.plaintext.txt	405	2 kb HindIII fragment pSVoA1
0.35218814.9731707.html.plaintext.txt	406	2 kb2M ligating pGL3 basic luciferase vector Promega obtain 1
0.35218814.9731707.html.plaintext.txt	407	3712M generated ligating 425 bp fragment StuIHindIII digest 1
0.35218814.9731707.html.plaintext.txt	408	2 kb fragment pGL3 Basic SmaIHindIII site
0.35218814.9731707.html.plaintext.txt	409	209 2M generated ligating 298 bp fragment RsaIHindIII digest 1
0.35218814.9731707.html.plaintext.txt	410	2 kb fragment pGL3 Basic SmaIHindIII site
0.35218814.9731707.html.plaintext.txt	411	1592M generated digesting 3712M EcoRI SacI deletes PRLRE
0.35218814.9731707.html.plaintext.txt	412	209 2M digested EcoRIPvuII generate 2092M ORRE deleted
0.35218814.9731707.html.plaintext.txt	413	482M minimal 2M promoter created PvuII digest 3712M
0.35218814.9731707.html.plaintext.txt	414	4XGAS2M containing four copies proximal Stat binding site described previously 16 24
0.35218814.9731707.html.plaintext.txt	415	Stat 5b splice variant Stat 5b Stat 5b 40C cloned expression vector pSVsport GIBCO BRL Grandland NY described previously 32
0.35218814.9731707.html.plaintext.txt	416	The mutations indicated lower case within ORRE Fig
0.35218814.9731707.html.plaintext.txt	417	5a 2M promoter created PCR using 317 2M template
0.35218814.9731707.html.plaintext.txt	418	The primers used include mutant antisense oligonucleotides either COUP TF M1 site SF 1 site M2 external sense antisense primers would hybridize end promoter region
0.35218814.9731707.html.plaintext.txt	419	The double mutant generated external primers mutant oligonucleotide COUP TF mutant construct template
0.35218814.9731707.html.plaintext.txt	420	The sequence oligonucleotides follows
0.35218814.9731707.html.plaintext.txt	421	mCOUP TF 5 ATtGttTAATTAttGCCAAGGTTAATTCCT aAttCGTTAGtCAG 3
0.35218814.9731707.html.plaintext.txt	422	mSF 1 5 ATGGCCTAATTACCGCCAAttTTAATTCCTGA CCCGTTAGTCCAG 3
0.35218814.9731707.html.plaintext.txt	423	double mutant 5 ATTGCCAAttTTAATTCCTAA 3
0.35218814.9731707.html.plaintext.txt	424	sense 5 CGGGGTACCCCGCCTCCTTGCCAACTATT CC 3
0.35218814.9731707.html.plaintext.txt	425	antisense 5 GTGCAAACAGCTGCTCCCACCC 3
0.35218814.9731707.html.plaintext.txt	426	Figure 11 schematic representation PCR directed mutagenesis
0.35218814.9731707.html.plaintext.txt	427	The cloning procedure described PCR protocols 50
0.35218814.9731707.html.plaintext.txt	428	The PCR products separated purified 1
0.35218814.9731707.html.plaintext.txt	429	5 low melt agarose gel using overnight ss agarase digestion 50
0.35218814.9731707.html.plaintext.txt	430	After second round PCR purified products isolated digested KpnI PvuII ligated using sites present multiple cloning cassette 371 2M construct
0.35218814.9731707.html.plaintext.txt	431	All plasmids sequenced directions Sanger dideoxy method 50
0.35218814.9731707.html.plaintext.txt	432	View larger version 8K Figure 11
0.35218814.9731707.html.plaintext.txt	433	Transient Transfection Assay Plasmid DNA purified bacteria alkaline lysis centrifugation CsCl gradients 51
0.35218814.9731707.html.plaintext.txt	434	Differentiated granulosa cells culture transfected different plasmid constructs using calcium phosphate precipitation technique 52
0.35218814.9731707.html.plaintext.txt	435	After 30 min incubation room temperature 300 microl precipitate added cultures 3 ml incubated 4 h 37 C
0.35218814.9731707.html.plaintext.txt	436	Each construct transfected triplicate treatment
0.35218814.9731707.html.plaintext.txt	437	SV40 luciferase construct containing SV40 promoter enhancer elements used positive control transfection experiments
0.35218814.9731707.html.plaintext.txt	438	Cells washed twice Ca Mg free HBSS feeding fresh DMEMF12 media containing FSH 50 ngml T 10 ngml without PRL 1 microgml forskolin 10 microM 6 h
0.35218814.9731707.html.plaintext.txt	439	Cells washed 1x PBS lysed lysis buffer 0
0.35218814.9731707.html.plaintext.txt	440	The soluble protein obtained centrifugation assayed luciferase activity using Monolight 2010 Luminometer Analytical Luminesence Laboratories San Diego CA
0.35218814.9731707.html.plaintext.txt	441	The luciferase activity 20 microl sample normalized amount protein measured Bradford assay Bio Rad expressed relative light units microg protein
0.35218814.9731707.html.plaintext.txt	442	Oligonucleotides Nomenclature The functionally active PRLRE 2M promoter contains two Stat binding sites AACTGGAAA TTCTGGGAA GAS sequences described previously 24 10
0.35218814.9731707.html.plaintext.txt	443	The sequence 2MGAS2 oligonucleotide used EMSA 5 GATCATCCTTCTGGGAATTCTGATATCCTTCTGGGAATTC TG3
0.35218814.9731707.html.plaintext.txt	444	The ORRE sequence shown Fig
0.35218814.9731707.html.plaintext.txt	445	5A used generate mutant oligonucleotides
0.35218814.9731707.html.plaintext.txt	446	M1 5 CTGaCTAACGaaTtAGGAATTAACCTTGGCAATAA TTAaaCaAT 3
0.35218814.9731707.html.plaintext.txt	447	M2 5 ATGGCCTAATTACCGCCAAttTTAATTCCTGACCC GTTAGCCAG 3
0.35218814.9731707.html.plaintext.txt	448	Sequences oligonucleotides used EMSAs follows
0.35218814.9731707.html.plaintext.txt	449	DR1SF 1 5 CTGGCTAACGGGTCAGGAATTAACCTTGG 3
0.35218814.9731707.html.plaintext.txt	450	DR2SF 1 5 GGAATTAACCTTGGCGGTAATTAGGCCAT 3
0.35218814.9731707.html.plaintext.txt	451	Consensus COUP TF 5 TGTCTTAGAGGTCAAAGGTCAAAT 3 28
0.35218814.9731707.html.plaintext.txt	452	Hexameric SF 1 5 GAGTCTCCCAAGGTCATCCTTGT TT 3 6
0.35218814.9731707.html.plaintext.txt	453	Oligonucleotides synthesized purified provided Genosys Inc
0.35218814.9731707.html.plaintext.txt	454	Whole Cell Extracts EMSA Granulosa cells cultured FSH T 24 h 48 h treated without PRL 1 microgml 15 min 6 h 20 h
0.35218814.9731707.html.plaintext.txt	455	The cells harvested scraping lysed three cycles freeze thawing prepare soluble extracts 53
0.35218814.9731707.html.plaintext.txt	456	Protein samples measured Bradford Bio Rad
0.35218814.9731707.html.plaintext.txt	457	All samples stored 70 C EMSA immunoblot analyses done
0.35218814.9731707.html.plaintext.txt	458	EMSAs performed described previously 54
0.35218814.9731707.html.plaintext.txt	459	Briefly WCE 10 15 microg per lane incubated 30 min room temperature 50000 60000 cpm end labeled double stranded oligonucleotide without competitor DNA 5 microg polydeoxyinosinic deoxycytidylicacid final volume 20 microl buffer containing 100 mM KCl 15 mM Tris HCl pH 7
0.35218814.9731707.html.plaintext.txt	460	5 5 mM dithiothreitol 1 mM EDTA 5 mM MgCl2 12 glycerol
0.35218814.9731707.html.plaintext.txt	461	When antibodies used WCEs incubated 1 microl antiserum 30 min ice addition labeled probe
0.35218814.9731707.html.plaintext.txt	462	Binding reactions resolved 5 acrylamide 0
0.35218814.9731707.html.plaintext.txt	463	Gels dried vacuum heat exposed Kodak XAR film 80 C
0.35218814.9731707.html.plaintext.txt	464	RT PCR For RT reaction 350 ng RNA reverse transcribed previously described 55 56
0.35218814.9731707.html.plaintext.txt	465	PCR performed previously described 55
0.35218814.9731707.html.plaintext.txt	466	The sequence primers used PRLRs follows
0.35218814.9731707.html.plaintext.txt	467	Forward primer 5 ATACTGGAGTAGATGGAGCCAGGAGAGTTC 3 specific
0.35218814.9731707.html.plaintext.txt	468	Reverse LPRLR 5 CTTCCGTGACCAGAGTCACTGTCG GGATCT 3
0.35218814.9731707.html.plaintext.txt	469	Reverse SPRLR 5 TCCTATTTGAGTCTGCAGCTTCAGTAGTCA 3
0.35218814.9731707.html.plaintext.txt	470	Primers L19 used internal control
0.35218814.9731707.html.plaintext.txt	471	PCR performed 20 cycles Perkin ElmerCetus Norwalk CT denaturing temperature 92 C 1 min annealing temperature 60 C 2 min extension temperature 72 C 3 min
0.35218814.9731707.html.plaintext.txt	472	Reaction 20 microl electrophoresed 5 polyacrylamide gel 0
0.35218814.9731707.html.plaintext.txt	473	The gels dried bands quantified Storm860 PhosphoImager Molecular Dynamics Sunnyvale CA
0.35218814.9731707.html.plaintext.txt	474	Specific PCR products amplified LPRLR 422 bp SPRLR 332 bp normalized L19 band sample
0.35218814.9731707.html.plaintext.txt	475	Gels also exposed HyperFilm Amersham 6 24 h room temperature
0.35218814.9731707.html.plaintext.txt	476	ACKNOWLEDGMENTS The authors wish thank Dr
0.35218814.9731707.html.plaintext.txt	477	Ming Jer Tsai Department Cell Biology Baylor College Medicine helpful suggestions reagents provided course experiments
0.35218814.9731707.html.plaintext.txt	478	Lothar Henninghausen Laboratory Biochemistry Metabolism National Institute Diabetes Digestive Kidney Diseases NIH Bethesda MD antibodies Stat 5b Dr
0.35218814.9731707.html.plaintext.txt	479	Ken ichirou Morohashi Kyushu University Fukuoka 812 Japan SF 1 Ad4BP antibodies
0.35218814.9731707.html.plaintext.txt	480	FOOTNOTES Address requests reprints JoAnne S
0.35218814.9731707.html.plaintext.txt	481	Richards Department Cell Biology Baylor College Medicine One Baylor Plaza Houston Texas 77030
0.35218814.9731707.html.plaintext.txt	482	Received publication February 20 1998
0.35218814.9731707.html.plaintext.txt	483	Revision received April 22 1998
0.35218814.9731707.html.plaintext.txt	484	Accepted publication May 12 1998
0.35218814.9731707.html.plaintext.txt	485	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Luo X Ikeda Y Parker KL 1994 A cell specific nuclear receptor essential adrenal gonadal development sexual differentiation
0.35218814.9731707.html.plaintext.txt	486	Cell 77481 490Medline Morohashi K Honda S Inomata Y Handa H Omura T 1992 A common trans acting factor Ad4 binding protein promoters steroidogenic P 450
0.35218814.9731707.html.plaintext.txt	487	J Biol Chem 26717913 17919AbstractFree Full Text Lala DS Rice DA Parker KL 1992 Steroidogenic factor 1 key regulator steroidogenic enzyme expression mouse homolog fushi tarazu factor 1
0.35218814.9731707.html.plaintext.txt	488	Mol Endocrinol 61249 1258Abstract Honda S Morohashi K Nomura M Takeya H Kitajima M Omura T 1993 Ad4BP regulating steroidogenic P 450 gene member steroid hormone receptor super family
0.35218814.9731707.html.plaintext.txt	489	J Biol Chem 2687494 7502AbstractFree Full Text Bakke M Lund J 1995 Mutually exclusive interactions two orphan receptors determine activity cyclic adenosine 35 monophosphate responsive sequence bovine CYP17 gene
0.35218814.9731707.html.plaintext.txt	490	Mol Endocrinol 9327 339Abstract Fitzpatrick SL Richards JS 1997 Identification cyclic adenosine 35 monophosphate response element rat aromatase promoter required transcriptional activation rat granulosa cells R2C Leydig cells
0.35218814.9731707.html.plaintext.txt	491	Mol Endocrinol 81309 1319Abstract Liu Z Simpson ER 1997 Steroidogenic factor 1 SF 1 SP1 required regulation bovine CYP11A gene expression bovine luteal cells adrenal Y1 cells
0.35218814.9731707.html.plaintext.txt	492	Mol Endocrinol 11127 137AbstractFree Full Text Shen W H Moore CCD Ikeda Y Parker KL Ingraham HA 1994 Nuclear receptor steroidogenic factor 1 regulates MIS gene expression link sex determination cascade
0.35218814.9731707.html.plaintext.txt	493	Cell 77651 661Medline Wehrenberg U Ivell R Jansen M von GS Walther N 1994 Two orphan receptors binding common site involved regulation oxytocin gene bovine ovary
0.35218814.9731707.html.plaintext.txt	494	Proc Natl Acad Sci USA 911440 14444Abstract Dajee M Kazansky AV Raught B Hocke G Fey GH Richards JS 1996 Prolactin induction alpha 2 macroglobulin gene rat ovarian granulosa cells Stat 5 activation binding IL 6RE
0.35218814.9731707.html.plaintext.txt	495	Mol Endocrinol 10171 184Abstract Russel D Norman R Dajee M Liu X Henninghausen L Richards JS 1996 Prolactin inducded activation binding Stat proteins IL 6RE 2 macroglobulin 2M promoter rat ovary
0.35218814.9731707.html.plaintext.txt	496	Biol Reprod 551029 1038Abstract Ruff SJ Leers SS Melner MH Cohen S 1996 Induction activation Stat 5 ovaries pseudopregnant rats
0.35218814.9731707.html.plaintext.txt	497	Endocrinology 1374095 4099Abstract Standke G Meier V Groner B 1994 Mammary gland factor activated prolactin mammary epithelial cells acute phase response factor activated interleukin 6 liver cells share DNA binding transactivation potential
0.35218814.9731707.html.plaintext.txt	498	Mol Endocrinol 8469 477Abstract Wang Y O Neal KD Yu Lee L 1997 Multiple PRL receptor cytoplasmic residues Stat 1 mediate PRL signaling interferon regulatory factor 1 promoter
0.35218814.9731707.html.plaintext.txt	499	Mol Endocrinol 111353 1364AbstractFree Full Text DaSilva L Rui H Erwin Ra Howard OMZ Kirken RA Malabarba MG Hackett RH Larner AC Farrar WL 1996 Prolactin recruits STAT1 STAT3 STAT5 independent conserved receptor tyrosines TYR402 TYR479 TYR515 TYR580
0.35218814.9731707.html.plaintext.txt	500	Mol Cell Endocrinol 117131 140CrossRefMedline Hattori M Abraham LJ Northemann W Fey GH 1990 Acute phase reaction induces specific complex hepatic nuclear proteins interleukin 6 response element rat 2 macroglobulin gene
0.35218814.9731707.html.plaintext.txt	501	Proc Natl Acad Sci USA 872364 2368Abstract Tsai SY Tsai M J 1997 Chick ovalbumin upstream promoter transcription factor COUP TF coming age
0.35218814.9731707.html.plaintext.txt	502	Endocr Rev 18229 240AbstractFree Full Text Enmark E Gustafsson J A 1996 Orphan nuclear receptors first eight years
0.35218814.9731707.html.plaintext.txt	503	Mol Endocrinol 101293 1307Medline Cooney AJ Tsai SY O Malley BW Tsai M J 1992 Chick ovalbumin upstream promoter transcription factor COUP TF dimer binds different GGTCA response elements allowing COUP TF repress hormonal induction vitaminD3 thyroid hormone retinoic acid receptors
0.35218814.9731707.html.plaintext.txt	504	Mol Cell Biol 124153 4263Abstract Battacharaya S Eckner R Grossman S Oldread E Arany Z D Andrea A Livingston DM 1996 Cooperation Stat 2 p300CBP signaling induced interferon
0.35218814.9731707.html.plaintext.txt	505	Nature 383344 346CrossRefMedline Look DC Pelletier MR Tidwell RM Roswit WT Holtzman MJ 1995 Stat 1 depends transcriptional synergy Sp1
0.35218814.9731707.html.plaintext.txt	506	J Biol Chem 27030264 30267AbstractFree Full Text Schaefer TS Sanders LK Nathans D 1995 Cooperative transcriptional activity Jun Stat 3ss short form Stat 3
0.35218814.9731707.html.plaintext.txt	507	Proc Natl Acad Sci USA 929097 9101Abstract Stocklin E Wissler M Gouilleux F Groner B 1996 Functional interactions Stat 5 glucocorticoid receptor
0.35218814.9731707.html.plaintext.txt	508	Nature 383726 728CrossRefMedline Hocke GM Barry D Fey GH 1992 Synergistic action interleukin 6 glucocorticoids mediated interleukin 6 response element rat 2 macroglobulin gene
0.35218814.9731707.html.plaintext.txt	509	Mol Cell Biol 122282 2294Abstract Wang D Stravopodis D Teglund S Kitazawa J Ihle J 1996 Naturally occurring dominant negative variants Stat 5
0.35218814.9731707.html.plaintext.txt	510	Mol Cell Biol 166141 6148Abstract Morrigel R Gouilleux V Jahne R Berchtold S Gartmann C Liu X Hennighausen L Sotiropoulos A Groner B Gouilleux F 1996 Deletion carboxyl terminal transactivation domain MGF Stat 5 results sustained DNA binding dominant negative phenotype
0.35218814.9731707.html.plaintext.txt	511	Mol Cell Biol 1165691 5700 Mietus SM Sladek FM Ginsburg GS Kuo F Ladias JA Darnell JE Karathanasis SK 1992 Antagonism apolipoprotein AI regulatory protein I COUP TF HNF4 modulates apolipoprotein CIII gene expression liver intestinal cells
0.35218814.9731707.html.plaintext.txt	512	Mol Cell Biol 121708 1718Abstract Leng X Cooney AJ Tsai SY Tsai M J 1996 Molecular mechanisms COUP TF mediated transcriptional repression evidence transrepression active repression
0.35218814.9731707.html.plaintext.txt	513	Mol Cell Biol 162332 2340Abstract Qui Y Pereira FA DeMayo FJ Lydon JP Tsai SY Tsai M J 1997 Null mutation mCOUP TFI results defects morphogenesis glosspharyngeal ganglion axonal projection arborization
0.35218814.9731707.html.plaintext.txt	514	Genes Dev 111925 1937AbstractFree Full Text Deleted proof Hu Z Zhuang L Guan X Meng J Dufau ML 1997 Steroidogenic factor 1 essential transcriptional activator gonad specific expression promoter I rat prolactin receptor gene
0.35218814.9731707.html.plaintext.txt	515	J Biol Chem 17014263 14271CrossRef Gaddy Kurten D Hickey GJ Fey G Gauldie J Richards JS 1989 Hormonal regulation tissue specific localization 2 macroglobulin rat ovarian follicles corpora lutea
0.35218814.9731707.html.plaintext.txt	516	Endocrinology 1252985 2995Abstract Gaddy Kurten D Richards JS 1991 Regulation 2 macroglobulin luteinizing hormone prolactin cell differentiation rat ovary
0.35218814.9731707.html.plaintext.txt	517	Mol Endocrinol 51280 1291Abstract Liu X Robinson GW Gouilleux F Groner B Henninghausen L 1995 Cloning expression Stat 5 novel homologue Stat 5b involved prolactin signal transduction mouse mammary tissue
0.35218814.9731707.html.plaintext.txt	518	Proc Natl Acad Sci USA 928831 8835Abstract Ripperger J Fritz S Hocke G Lottspeich F Fey G 1995 Transcription factors Stat 3 Stat 5b present rat liver nuclei late acute phase response bind interleukin 6 response elements
0.35218814.9731707.html.plaintext.txt	519	J Biol Chem 27029998 30006AbstractFree Full Text Kuang AA Novak KD Kang SM Bruhn K Lenardo MJ 1993 Interaction NF kappa B serum response factor binding elements activates interleukin 2 receptor alpha chain enhancer specifically T lymphocytes
0.35218814.9731707.html.plaintext.txt	520	Mol Cell Biol 132536 2545Abstract Schindler C Darnell JE 1995 Transcriptional responses polypeptide ligands JAKStat pathway
0.35218814.9731707.html.plaintext.txt	521	Annu Rev Biochem 64621 651CrossRefMedline Caldenhoven E Dijk TB Solari R Armstrong J Raaijmakers J Lammers JW Koenderman L Groot RT 1996 Stat 3ss spice variant transcription factor Stat 3 dominant negative regulator transcription
0.35218814.9731707.html.plaintext.txt	522	J Biol Chem 27113221 13227AbstractFree Full Text Kazansky AV Raught B Lindsey SM Wang Y F Rosen JM 1995 Regulation MGFStat 5a mammary gland development
0.35218814.9731707.html.plaintext.txt	523	Mol Endocrinol 91598 1608Abstract Liu X Robinson GW Henninghausen L 1996 Activation Stat 5a Stat 5b tyrosine phosphorylation tightly linked mammary gland differentiation
0.35218814.9731707.html.plaintext.txt	524	Mol Endocrinol 101496 1506Abstract Akira S Nishio Y Inoue M Wang XJ Wei S Matsusaka T Yoshida K Sudo T Naruto M Kishimoto T 1994 Molecular cloning APRF novel INF stimulated gene factor Stat 3 p91 related transcription factor involved gp130 mediated signaling pathway
0.35218814.9731707.html.plaintext.txt	525	Cell 7763 71Medline Liu X Robinson GW Wagner K U Garret L Wynshaw Boris A Henninghausen L 1997 Stat 5a mandatory adult mammary gland development lactogenesis
0.35218814.9731707.html.plaintext.txt	526	Genes Dev 11179 186Abstract Udy GB Towers RP Snell RG Wilkins RJ Park S H Ram PA Waxman DJ Davey HW 1997 Requirement Stat 5b sexual dimorphism body growth rates liver gene expression
0.35218814.9731707.html.plaintext.txt	527	Proc Natl Acad Sci USA 947239 7244AbstractFree Full Text Doppler W Groner B Ball RK 1989 Prolactin glucocorticoid hormones synergistically induce expression transfected rat ss casein gene promoter constructs mammary epithelial cell line
0.35218814.9731707.html.plaintext.txt	528	Proc Natl Acad Sci USA 86104 108Abstract Carlone DL Richards JS 1997 Functional interactions phosphorylation levels 35 cyclic adenosine monophosphate regulatory element binding protein steroidogenic factor 1 mediate hormone regulated constitutive expression aromatase gonadal cells
0.35218814.9731707.html.plaintext.txt	529	Mol Endocrinol 11292 304AbstractFree Full Text Gehring MR Sheils BR Northemann W de Bruijn MHL Kan CC Chain AC Noonan DJ Fey GH 1987 Sequence rat 2 macroglobulin gene acute phase control messenger RNA
0.35218814.9731707.html.plaintext.txt	530	J Biol Chem 262446 454AbstractFree Full Text Ratoosh SL Richards JS 1985 Regulation content phosphorylation RII cyclic adenosine 3 5 monophosphate follicle stimulating hormone estradiol cultured granulosa cells
0.35218814.9731707.html.plaintext.txt	531	Endocrinology 117917 927Abstract Orly J Sato G Erickson GF 1980 Serum suppresses expression hormonally induced functions cultured granulosa cells
0.35218814.9731707.html.plaintext.txt	532	Cell 20817 827Medline Pelham HRB 1982 A regulatory upstream promoter element Drosophila hsp 70 heat shock gene
0.35218814.9731707.html.plaintext.txt	533	Cell 30517 528Medline Ausubel FM Brent R Kingston RE Moore DD Seidman JG Smith JA Struhl K eds 1987 Current Protocols Molecular Biology
0.35218814.9731707.html.plaintext.txt	534	John Wiley Sons New York Sambrook J Fritsch EF Maniatis T 1989 Molecular Cloning A Laboratory Manual
0.35218814.9731707.html.plaintext.txt	535	Cold Spring Harbor Laboratory Cold Spring Harbor NY Graham R van der Eb A 1973 A new technique assay infectivity human adenovirus 5 DNA
0.35218814.9731707.html.plaintext.txt	536	Virology 52456 457Medline Welte T Garimorth K Philipp S Doppler W 1994 Prolactin dependent activation tyrosine phosphorylated DNA binding factor mouse mammary epithelial cells
0.35218814.9731707.html.plaintext.txt	537	Mol Endocrinol 81091 1102Abstract Garner MM Revzin A 1981 A gel electrophoresis method quantifying binding proteins specific DNA regions application components E
0.35218814.9731707.html.plaintext.txt	538	coli lactose operon regulatory gene
0.35218814.9731707.html.plaintext.txt	539	Nucleic Acids Res 93047 3060Abstract Park OK Mayo KE 1991 Transient expression progesterone receptor messenger RNA ovarian granulosa cells preovulatory luteinizing hormone surge
0.35218814.9731707.html.plaintext.txt	540	Mol Endocrinol 5967 978Abstract Orly J Rei Z Greenberg N Richards JS 1994 Tyrosine kinase inhibitor AG18 arrests follicle stimulating hormone induced granulosa cell differentiation use reverse transcriptase polymerase chain reaction assay multiple messenger ribonucleic acids
0.35218814.9731707.html.plaintext.txt	541	Endocrinology 1342336 2346Abstract
0.297294.12740371.html.plaintext.txt	0	AMP activated Protein Kinase Regulates HNF4 Transcriptional Activity Inhibiting Dimer Formation Decreasing Protein Stability Yu Holly Hong Usha S
0.297294.12740371.html.plaintext.txt	1	Varanasi Wenbo Yang Todd Leff
0.297294.12740371.html.plaintext.txt	2	From Department Pathology Center Integrative Metabolic Endocrine Research Wayne State University School Medicine Detroit Michigan 48201 Department Molecular Science Pfizer Global Research Development Ann Arbor Michigan 48105
0.297294.12740371.html.plaintext.txt	3	Received publication April 18 2003 revised form May 1 2003
0.297294.12740371.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES AMP activated protein kinase AMPK central component cellular signaling system regulates multiple metabolic enzymes pathways response reduced intracellular energy levels
0.297294.12740371.html.plaintext.txt	5	The transcription factor hepatic nuclear factor 4 HNF4 orphan nuclear receptor regulates expression genes involved energy metabolism liver intestine endocrine pancreas
0.297294.12740371.html.plaintext.txt	6	Inheritance single null allele HNF4 causes diabetes humans
0.297294.12740371.html.plaintext.txt	7	Here demonstrate AMPK directly phosphorylates HNF4 represses transcriptional activity
0.297294.12740371.html.plaintext.txt	8	AMPK mediated phosphorylation HNF4 serine 304 2 fold effect reducing ability transcription factor form homodimers bind DNA increasing degradation rate vivo
0.297294.12740371.html.plaintext.txt	9	These results demonstrate HNF4 downstream target AMPK raise possibility one effects AMPK activation reduced expression HNF4 target genes
0.297294.12740371.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The transcription factor HNF41 NR2A1 member nuclear receptor superfamily plays key role regulating expression metabolic genes multiple tissues including liver intestine kidney endocrine pancreas review see Ref
0.297294.12740371.html.plaintext.txt	11	In humans nonsense mutation single allele HNF4 gene causes inherited form diabetes known maturity onset diabetes young MODY review see Ref
0.297294.12740371.html.plaintext.txt	12	This syndrome characterized insufficient insulin secretion 3 4 indicating significant defect pancreatic function
0.297294.12740371.html.plaintext.txt	13	Surprisingly major deficit liver function despite important role HNF4 hepatic gene expression 5
0.297294.12740371.html.plaintext.txt	14	These observations suggest HNF4 regulates pancreatic genes involved glucose sensing andor insulin production
0.297294.12740371.html.plaintext.txt	15	This hypothesis supported experiments demonstrating HNF4 regulates expression genes encoding enzymes glucose metabolism insulin secretion 6 8
0.297294.12740371.html.plaintext.txt	16	Because MODY1 patients single null allele produce dominant negative acting protein 9 physiological abnormalities patients must caused relatively mild 50 decrease amount HNF4 protein
0.297294.12740371.html.plaintext.txt	17	Taken together observations raise possibility modification HNF4 causes reduction transcriptional activity could significant effects pancreatic function
0.297294.12740371.html.plaintext.txt	18	HNF4 also shown recently play important role regulation hepatic glucose output key component maintenance plasma glucose levels
0.297294.12740371.html.plaintext.txt	19	10 recently demonstrated transcriptional regulation gene key gluconeogenic enzyme phosphoenolpyruvate carboxykinase cAMP mediated transcriptional co activator PGC 1 acting HNF4
0.297294.12740371.html.plaintext.txt	20	These findings suggest HNF4 may play role transcriptional response liver metabolic hormones factors regulating activity HNF4 could effect hepatic glucose output
0.297294.12740371.html.plaintext.txt	21	AMPK mammalian homolog yeast SNF1 protein kinase 11
0.297294.12740371.html.plaintext.txt	22	In yeast SNF1 complex nuclear protein regulates expression genes involved glucose metabolism activated phosphorylation glucose removed growth medium 12
0.297294.12740371.html.plaintext.txt	23	In mammalian cells AMPK acts fuel sensor monitors AMP ATP levels
0.297294.12740371.html.plaintext.txt	24	It activated high AMPATP ratios states low energy charge
0.297294.12740371.html.plaintext.txt	25	Once activated enzyme reduces activity ATP consuming anabolic pathways increases activity catabolic ATP producing pathways acting reestablish normal cellular energy balance review see Ref
0.297294.12740371.html.plaintext.txt	26	Depending tissue variety physiological circumstances cause AMPK activation including hypoglycemia 14 ischemia 15 heat shock 16 exercise 17 19
0.297294.12740371.html.plaintext.txt	27	AMPK activation associated several key aspects metabolism including exercise induced glucose uptake fatty acid oxidation muscle 17 20 21 reduced lipid 22 23 glucose synthesis liver 12 24 altered glucose stimulated insulin secretion endocrine pancreas 14 25
0.297294.12740371.html.plaintext.txt	28	AMPK heterotrimer consisting catalytic subunit two non catalytic subunits 26 27 exist multiple isoforms 28 30
0.297294.12740371.html.plaintext.txt	29	Kinase activity regulated allosterically AMP binding also direct phosphorylation mediated uncharacterized AMP sensitive protein kinase
0.297294.12740371.html.plaintext.txt	30	A potential role AMPK nucleus suggested several observations
0.297294.12740371.html.plaintext.txt	31	The first similarity mammalian kinase yeast SNF1 transcriptional regulator described
0.297294.12740371.html.plaintext.txt	32	Second AMPK heterotrimers containing 2 subunit isoform preferentially found nucleus 31
0.297294.12740371.html.plaintext.txt	33	In addition AMPK shown phosphorylate transcriptional coactivator p300 regulate ability mediate nuclear receptor transcriptional activity 32
0.297294.12740371.html.plaintext.txt	34	It reported previously 33 AMPK activation reduces HNF4 target gene transcription
0.297294.12740371.html.plaintext.txt	35	These findings together fact proteins participate regulation similar metabolic pathways raise possibility HNF4 directly regulated AMPK
0.297294.12740371.html.plaintext.txt	36	The experiments described examine possibility AMPK phosphorylates HNF4 regulates transcriptional activity
0.297294.12740371.html.plaintext.txt	37	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Plasmid Construction The HNF4 expression construct pH4c WT contains C terminal FLAG tagged full length human HNF4 cDNA sequence cloned CMV promoter based vector pCDNA3
0.297294.12740371.html.plaintext.txt	38	The S304A S304D mutants introduced pH4c WT using Quik Change site directed mutagenesis kit Stratagene La Jolla CA according manufacturers instructions confirmed DNA sequencing produce plasmids pH4c 304A pH4c 304D
0.297294.12740371.html.plaintext.txt	39	The pH4c series plasmids used experiments presented Figs
0.297294.12740371.html.plaintext.txt	40	For experiments designed examine HNF4 protein stability Fig
0.297294.12740371.html.plaintext.txt	41	4 B C full length N terminal FLAG tagged wild type 304A 304D cDNA sequences cloned tetracycline regulated vector pTRE shuttle2 Clontech Palo Alto CA form pH4i WT pH4i 304A pH4i 304D
0.297294.12740371.html.plaintext.txt	42	GFP HNF4 protein expressed pCDNA3
0.297294.12740371.html.plaintext.txt	43	1 vector containing N terminal fusion EGFP coding sequences Clontech Palo Alto CA fused full length HNF4 cDNA
0.297294.12740371.html.plaintext.txt	44	GST HNF4 protein produced pET23a vector Novagen Madison WI containing N terminal fusion glutathione S transferase sequences full length HNF4 cDNA
0.297294.12740371.html.plaintext.txt	45	HNF4A D plasmids contain PCR amplified subfragments HNF4 Fig
0.297294.12740371.html.plaintext.txt	46	1C His T7 tag N terminal fusions pET28a vector
0.297294.12740371.html.plaintext.txt	47	The subfragments also cloned pCMV Tag2b plasmid Stratagene La Jolla CA expression eukaryotic cells
0.297294.12740371.html.plaintext.txt	48	The HNF4 responsive reporter plasmid pL854 contains promoter sequences human apoCIII gene 854 22 linked luciferase pGL3 basic vector Promega Madison WI
0.297294.12740371.html.plaintext.txt	49	The galactosidase plasmid contains CMV driven galactosidase gene
0.297294.12740371.html.plaintext.txt	50	View larger version 31K FIG
0.297294.12740371.html.plaintext.txt	51	HNF4 phosphorylated AMPK vitro
0.297294.12740371.html.plaintext.txt	52	A autoradiogram full length human HNF4 phosphorylated AMPK vitro kinase reaction
0.297294.12740371.html.plaintext.txt	53	HNF4 protein produced vitro transcriptiontranslation system incubated purified rat liver AMPK 32PATP
0.297294.12740371.html.plaintext.txt	54	For comparison quantity hormone sensitive lipase HSL known substrate kinase phosphorylated parallel reaction
0.297294.12740371.html.plaintext.txt	55	B amino acid sequence consensus phosphorylation site AMPK 53 showing three best matches human HNF4 sequence bottom
0.297294.12740371.html.plaintext.txt	56	Potential phosphorylation residues shown boldface
0.297294.12740371.html.plaintext.txt	57	The amino acid numbers based GenBankTM entry XM029795
0.297294.12740371.html.plaintext.txt	58	C schematic map HNF4 protein showing location DNA binding domain DBD ligand binding domain LBD location serine 304 residue
0.297294.12740371.html.plaintext.txt	59	The four sub fragments receptor used phosphorylation studies shown
0.297294.12740371.html.plaintext.txt	60	D vitro phosphorylation four HNF4 subfragments shown C presence absence AMP indicated
0.297294.12740371.html.plaintext.txt	61	Lower panels Western blots WB showing total protein amounts reactions
0.297294.12740371.html.plaintext.txt	62	View larger version 25K FIG
0.297294.12740371.html.plaintext.txt	63	AMPK phosphorylates HNF4 serine 304
0.297294.12740371.html.plaintext.txt	64	A autoradiogram HNF4 C fragment phosphorylated vitro AMPK
0.297294.12740371.html.plaintext.txt	65	Wild type Ser 304 mutant C fragments HNF4 produced vitro transcriptiontranslation system incubated purified rat liver AMPK 32PATP presence absence AMP indicated
0.297294.12740371.html.plaintext.txt	66	Lower panels Western blots WB showing total protein amounts reactions
0.297294.12740371.html.plaintext.txt	67	B phosphorylation full length wild type Ser 304 mutant HNF4 AMPK vitro A
0.297294.12740371.html.plaintext.txt	68	Numbers lane indicate degree phosphorylation relative wild type protein absence kinase AMP
0.297294.12740371.html.plaintext.txt	69	The degree phosphorylation calculated quantified autoradiograph Western blot bands ratio phosphorylated total protein
0.297294.12740371.html.plaintext.txt	70	C vivo phosphorylation HNF4 C fragment AMPK
0.297294.12740371.html.plaintext.txt	71	BHK cells transfected either vector Vec alone constructions producing FLAG tagged wild type S304A mutant HNF4 C protein
0.297294.12740371.html.plaintext.txt	72	Transfected cells treated AMPK activator AICAR indicated 32Porthophosphate
0.297294.12740371.html.plaintext.txt	73	HNF4 C fragment protein immunoprecipitated anti FLAG antibodies subjected electrophoresis transfer nitrocellulose autoradiography upper panel Western analysis lower panel
0.297294.12740371.html.plaintext.txt	74	View larger version 69K FIG
0.297294.12740371.html.plaintext.txt	75	Phosphorylation Ser 304 blocks dimerization DNA binding
0.297294.12740371.html.plaintext.txt	76	A phosphomimetic HNF4 S304D mutation defective ability bind DNA
0.297294.12740371.html.plaintext.txt	77	In vitro transcriptiontranslation reactions programmed plasmids producing full length wild type S304A S304D HNF4 proteins pH4c series plasmids empty vector Vec
0.297294.12740371.html.plaintext.txt	78	The DNA binding activities three HNF4 proteins analyzed gel mobility shift assay using proximal HNF4 binding site apoCIII promoter labeled probe
0.297294.12740371.html.plaintext.txt	79	The lower panel Western blot showing input amount HNF4 protein used DNA binding reactions
0.297294.12740371.html.plaintext.txt	80	B S304D mutant HNF4 protein defective ability form HNF4 homodimers
0.297294.12740371.html.plaintext.txt	81	A GST pull assay performed vitro produced GST HNF4 fusion protein wild type full length
0.297294.12740371.html.plaintext.txt	82	The plasmid producing 78 kDa GST fusion protein co translated plasmids producing 52 kDa wild type S304A S304D indicated presence 35Smethionine
0.297294.12740371.html.plaintext.txt	83	Lanes 1 3 subjected GST pull procedure using glutathione beads whereas lanes 4 6 loaded directly gel without pull
0.297294.12740371.html.plaintext.txt	84	Lanes 7 8 translations two input plasmids alone
0.297294.12740371.html.plaintext.txt	85	C gel mobility shift assay showing phosphomimetic HNF4 S304D mutation defective forming functional dimers
0.297294.12740371.html.plaintext.txt	86	In vitro translated GFP HNF4 fusion protein 81 kDa 52 kDa wild type S304A S304D mutants co translated indicated analyzed gel mobility shift assay
0.297294.12740371.html.plaintext.txt	87	The DNA protein complexes possible dimer combinations indicated right
0.297294.12740371.html.plaintext.txt	88	Equivalent amounts protein used DNA binding reactions determined Western blot analysis data shown
0.297294.12740371.html.plaintext.txt	89	D gel shift analysis wild type mutant HNF4 proteins produced vivo
0.297294.12740371.html.plaintext.txt	90	CHO cells transfected indicated plasmids treated AMPK activator AICAR indicated nuclear extracts prepared subjected gel mobility shift analysis using apoCIII promoter proximal HNF4 binding site probe
0.297294.12740371.html.plaintext.txt	91	Equivalent amounts nuclear extract loaded lane
0.297294.12740371.html.plaintext.txt	92	Lower panel Western blot showing exogenous HNF4 amounts time harvest 20 h post transfection using anti FLAG antibody
0.297294.12740371.html.plaintext.txt	93	View larger version 26K FIG
0.297294.12740371.html.plaintext.txt	94	Phosphorylation HNF4 Ser 304 reduces protein stability
0.297294.12740371.html.plaintext.txt	95	A Western blot showing effect AMPK activation appearance proteolytic degradation fragments HNF4 CHO cells transiently transfected indicated pH4c series construction W wild type A S304A D S304D
0.297294.12740371.html.plaintext.txt	96	These constructions produce C terminal FLAG tagged HNF4
0.297294.12740371.html.plaintext.txt	97	AICAR 500 microM present indicated last 24 h transfection second addition 2 h cells harvested
0.297294.12740371.html.plaintext.txt	98	Upper panel anti FLAG antibody showing full length HNF4 smaller molecular weight fragments
0.297294.12740371.html.plaintext.txt	99	Lower panel membrane reprobed anti actin antibodies loading control
0.297294.12740371.html.plaintext.txt	100	B Western blot showing effect S304 mutations rate HNF4 protein degradation
0.297294.12740371.html.plaintext.txt	101	CHO cells transiently transfected pH4i plasmids pH4i WT pH4i 304A pH4i 304D producing N terminal FLAG tagged HNF4 protein control tetracycline regulated promoter
0.297294.12740371.html.plaintext.txt	102	Cells treated doxycycline 18 h post transfection shut expression HNF4 protein harvested indicated times thereafter
0.297294.12740371.html.plaintext.txt	103	Western analysis performed using anti FLAG antibody detect HNF4 reprobed anti GFP antibody detect amount EGFP protein produced co transfected pEGFP N1 reference plasmid
0.297294.12740371.html.plaintext.txt	104	C results densitometric analysis blots B
0.297294.12740371.html.plaintext.txt	105	The HNF4GFP ratio calculated lane data construction normalized 2 h time point set 100
0.297294.12740371.html.plaintext.txt	106	The data plotted log values relative HNF4 protein amount
0.297294.12740371.html.plaintext.txt	107	The calculated half life values regression lines shown hours
0.297294.12740371.html.plaintext.txt	108	View larger version 15K FIG
0.297294.12740371.html.plaintext.txt	109	Phosphomimetic S304D mutation reduces transcriptional activity HNF4
0.297294.12740371.html.plaintext.txt	110	CHO cells transfected HNF4 responsive luciferase reporter increasing amounts micrograms either wild type S304A S304D HNF4 producing plasmids indicated
0.297294.12740371.html.plaintext.txt	111	Relative transcription calculated ratio luciferase galactosidase activity cotransfected reference plasmid normalized activity vector control
0.297294.12740371.html.plaintext.txt	112	Values means three replicates error bars represent standard deviation
0.297294.12740371.html.plaintext.txt	113	Cell Culture Transfection Reporter Assay Transient transfections vivo labeling conducted baby hamster kidney cell line BHK 21 cultured Dulbeccos modified Eagles medium supplemented 10 fetal bovine serum
0.297294.12740371.html.plaintext.txt	114	Chinese hamster ovary CHO cells used transfection transcription assays nuclear extract preparation
0.297294.12740371.html.plaintext.txt	115	CHO cells maintained Dulbeccos modified Eagles mediumF 12 medium supplemented 10 fetal bovine serum
0.297294.12740371.html.plaintext.txt	116	All transfections carried LipofectAMINE 2000 Invitrogen
0.297294.12740371.html.plaintext.txt	117	Transfections reporter assays conducted 24 well plates triplicate condition
0.297294.12740371.html.plaintext.txt	118	Cells harvested 20 h post transfection using lysis buffer Promega Madison WI lysates analyzed Tropix Dual Light Luciferase galactosidase assay kit Tropix Inc
0.297294.12740371.html.plaintext.txt	119	Bedford MA using EG G Berthold Microlumat 96P luminometer
0.297294.12740371.html.plaintext.txt	120	In Vitro Vivo Phosphorylation In vitro phosphorylation assays conducted vitro translated proteins produced using TNT Quick Coupled transcriptiontranslation system Promega Madison WI
0.297294.12740371.html.plaintext.txt	121	TNT reactions carried 60 min 30 degrees C immunoprecipitated anti FLAG Sigma anti T7 Novagen Inc
0.297294.12740371.html.plaintext.txt	122	Madison WI antibodies protein AG agarose beads Santa Cruz Biotechnology Santa Cruz CA
0.297294.12740371.html.plaintext.txt	123	After washing five times HNTG buffer 20 mM HEPES pH 7
0.297294.12740371.html.plaintext.txt	124	5 50 mM NaCl 5 glycerol 1 Triton 1
0.297294.12740371.html.plaintext.txt	125	5 mM MgCl2 1 mM EDTA purified beads subjected vitro phosphorylation reaction using 100 milliunits purified rat liver AMPK Upstate Inc
0.297294.12740371.html.plaintext.txt	126	Lake Placid NY per reaction
0.297294.12740371.html.plaintext.txt	127	Reactions carried buffer containing 5 mM HEPES pH 7
0.297294.12740371.html.plaintext.txt	128	5 mM MgCl250 microM ATP 10 microCi 32PATP mixture protein kinase Cprotein kinase A inhibitors without 300 microM AMP incubated 30 degrees C 30 min
0.297294.12740371.html.plaintext.txt	129	The reactions stopped washing beads three times HNTG buffer adding 30 microl 2x SDS loading buffer Invitrogen
0.297294.12740371.html.plaintext.txt	130	The protein products separated SDS PAGE transferred nitrocellulose membranes subjected autoradiography Western blot analysis using anti FLAG antibody conjugated horseradish peroxidase Sigma detected SuperSignal West Pico chemiluminescent system Pierce
0.297294.12740371.html.plaintext.txt	131	In vivo phosphorylation labeling conducted BHK cells
0.297294.12740371.html.plaintext.txt	132	S304A mutant along control vector transfected 100 mm plates
0.297294.12740371.html.plaintext.txt	133	Each plate split two 60 mm plates 16 h post transfection
0.297294.12740371.html.plaintext.txt	134	In vivo labeling conducted 1 mCi 37 MBq 32Porthophosphate per plate 1 h 40 h post transfection without 500 microM 5 aminoimidazol 4 carboxoxamide 1 D ribofuranoside AICAR
0.297294.12740371.html.plaintext.txt	135	Cells harvested 600 microl HNTG buffer mixed 30 min 4 degrees C
0.297294.12740371.html.plaintext.txt	136	The cell lysates immunoprecipitated anti FLAG monoclonal antibody Sigma 50 microl protein AG agarose beads 2 h 4 degrees C
0.297294.12740371.html.plaintext.txt	137	The beads washed five times buffer
0.297294.12740371.html.plaintext.txt	138	Bound proteins eluted 30 microl 2x SDS loading buffer 95 degrees C 5 min separated 4 12 gradient SDS PAGE gel transferred nitrocellulose membrane detected autoradiography Western blot using anti FLAG antibody conjugated horseradish peroxidase described
0.297294.12740371.html.plaintext.txt	139	Gel Mobility Shift Pull Assays CHO cells transfected full length wild type mutant HNF4 harvested 20 h post transfection without 12 h treatment AICAR
0.297294.12740371.html.plaintext.txt	140	Nuclear extracts prepared essentially described 34
0.297294.12740371.html.plaintext.txt	141	The recombinant HNF4 proteins produced vitro using TNT Quik Coupled transcriptiontranslation system described manufacturer Promega Madison WI
0.297294.12740371.html.plaintext.txt	142	For dimerization experiments different HNF4 proteins produced two plasmids templates producing wild type mutant HNF4 proteins used co translation reactions ratios determined pilot translations produce equal amounts protein
0.297294.12740371.html.plaintext.txt	143	For GST pull assays 25 microl translation reactions incubated 15 microl glutathione Sepharose 4B Amersham Biosciences BC 150 buffer 20 mM Tris HCl pH 7
0.297294.12740371.html.plaintext.txt	144	5 mM phenylmethylsulfonyl fluoride 1x protease inhibitor mixture Roche Diagnostics 30 min room temperature rotary platform
0.297294.12740371.html.plaintext.txt	145	The beads washed five times BC 150 buffer boiled 25 microl SDS sample buffer resolved 4 20 gradient gels Invitrogen
0.297294.12740371.html.plaintext.txt	146	Gels stained Coomassie Blue incubated Amplify Amersham Biosciences 30 min dried fluorographed
0.297294.12740371.html.plaintext.txt	147	The synthetic double stranded oligonucleotides used DNA binding reaction labeled 32PdCTP using Rediprime II random labeling system Amersham Biosciences
0.297294.12740371.html.plaintext.txt	148	The double stranded DNA binding probe contains proximal HNF4 binding site human apoCIII gene 35
0.297294.12740371.html.plaintext.txt	149	DNA binding reactions carried 20 mM HEPES pH 7
0.297294.12740371.html.plaintext.txt	150	06 Nonidet P 40 1 mM dithiothreitol 1 microg double stranded polydI dC 20000 cpm labeled probe 0
0.297294.12740371.html.plaintext.txt	151	25 ng either 2 5 microg nuclear extract 1 microl TNT reaction
0.297294.12740371.html.plaintext.txt	152	Reactions incubated 20 min room temperature analyzed precast 6 DNA retardation gels Invitrogen 0
0.297294.12740371.html.plaintext.txt	153	5x TBE 125 V 45 min room temperature
0.297294.12740371.html.plaintext.txt	154	Protein Stability Experiments For experiments shown Fig
0.297294.12740371.html.plaintext.txt	155	4 B C CHO cells transfected 12 well plates described using LipofectAMINE Plus Invitrogen 1 ng tetracycline regulated HNF4 expressing plasmids pH4i WT pH4i 304A pH4i 304D together 20 ng pTET OFF 40 ng pEGFP N1 Clontech Palo Alto CA per well
0.297294.12740371.html.plaintext.txt	156	18 h transfection doxycycline added 1 microgml culture media stop transcription recombinant HNF4 cells harvested 2 4 6 8 h later lysis HNTG buffer
0.297294.12740371.html.plaintext.txt	157	Gel electrophoresis Western blot analysis detect FLAG HNF4 GFP protein carried described
0.297294.12740371.html.plaintext.txt	158	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Activation AMPK cultured hepatocytes AMP analog AICAR caused decrease activity HNF4 target gene expression reduction amount HNF4 33
0.297294.12740371.html.plaintext.txt	159	To explore possibility effects due direct regulation HNF4 AMPK tested whether AMPK could phosphorylate HNF4
0.297294.12740371.html.plaintext.txt	160	An vitro phosphorylation assay containing full length HNF4 partially purified AMPK carried
0.297294.12740371.html.plaintext.txt	161	1A demonstrate HNF4 efficiently phosphorylated AMPK showing approximately degree phosphorylation similar amount well characterized AMPK substrate hormone sensitive lipase
0.297294.12740371.html.plaintext.txt	162	Mapping AMPK Phosphorylation Site HNF4 When HNF4 amino acid sequence screened consensus target sequence AMPK phosphorylation three potential sites found Fig
0.297294.12740371.html.plaintext.txt	163	1B best match site surrounding serine 304
0.297294.12740371.html.plaintext.txt	164	To determine whether sites targets AMPK phosphorylation mutated alanine examined vitro phosphorylation assay
0.297294.12740371.html.plaintext.txt	165	None mutants abolished phosphorylation AMPK data shown indicating multiple AMPK phosphorylation sites HNF4
0.297294.12740371.html.plaintext.txt	166	To examine phosphorylation individual segments protein independently four overlapping fragments HNF4 generated subclones HNF4 cDNA Fig
0.297294.12740371.html.plaintext.txt	167	When vitro AMPK assays conducted four subfragments phosphorylated degree Fig
0.297294.12740371.html.plaintext.txt	168	1D showed expected enhancement phosphorylation presence AMP allosteric activator kinase
0.297294.12740371.html.plaintext.txt	169	However results normalized total amount protein assay HNF4C fragment containing Ser 304 site showed highest degree AMP dependent phosphorylation data shown
0.297294.12740371.html.plaintext.txt	170	A significant amount phosphorylation also observed HNF4A fragment
0.297294.12740371.html.plaintext.txt	171	The HNF4A fragment contains one three potential consensus sites AMPK Fig
0.297294.12740371.html.plaintext.txt	172	However mutation threonine 15 alanine sequence reduce phosphorylation HNF4A fragment suggesting presence one cryptic AMPK sites part protein
0.297294.12740371.html.plaintext.txt	173	To determine whether C fragment phosphorylated Ser 304 residue S304A mutant transferred C fragment examined vitro phosphorylation assay
0.297294.12740371.html.plaintext.txt	174	2A mutation serine 304 completely abolished phosphorylation C fragment
0.297294.12740371.html.plaintext.txt	175	Although Ser 304 site also present D fragment Fig 1C appear good substrate kinase context fragment phosphorylated much lower degree C fragment Fig
0.297294.12740371.html.plaintext.txt	176	When S304A mutation examined quantitatively context full length protein reduced phosphorylation 50 Fig
0.297294.12740371.html.plaintext.txt	177	Together results suggest S304A phosphorylation site AMPK vitro additional sites present N C termini protein
0.297294.12740371.html.plaintext.txt	178	In vivo HNF4 phosphoprotein substrate multiple kinases 36 37
0.297294.12740371.html.plaintext.txt	179	To explore phosphorylation HNF4 AMPK vivo wild type S304A versions HNF4C fragment cloned eukaryotic expression vector transfected baby hamster kidney BHK cells
0.297294.12740371.html.plaintext.txt	180	In vivo phosphorylation labeling carried transfected cells presence absence AICAR
0.297294.12740371.html.plaintext.txt	181	AICAR converted cells AMP analog ZMP 5 aminoimidazole 4 carboxamide 1 E D ribofuranotide activates kinase 38
0.297294.12740371.html.plaintext.txt	182	The wild type HNF4C fragment phosphorylated labeling reaction treatment cells AICAR caused 2 fold increase phosphorylation Fig
0.297294.12740371.html.plaintext.txt	183	This phosphorylation completely absent S304A version fragment used indicating Ser 304 phosphorylated vivo AMPK
0.297294.12740371.html.plaintext.txt	184	In vivo phosphorylation experiments using full length HNF4 protein showed degree phosphorylation wild type Ser 304 mutant protein data shown
0.297294.12740371.html.plaintext.txt	185	This may due combination high basal phosphorylation HNF4 multiple kinases vivo 36 37 likelihood additional AMPK phosphorylation sites HNF4 Fig
0.297294.12740371.html.plaintext.txt	186	Functional Effects HNF4 Phosphorylation To explore potential functional effects phosphorylation HNF4 serine 304 aspartic acid residue introduced site vitro mutagenesis generate charge mimic phosphoserine residue
0.297294.12740371.html.plaintext.txt	187	The effect phosphorylation Ser 304 ability HNF4 form functional homodimers bind DNA examined gel mobility shift assay wild type phosphomimetic S304D versions HNF4 proteins synthesized vitro translation
0.297294.12740371.html.plaintext.txt	188	Both wild type S304A version HNF4 bound HNF4 response element derived human apoCIII promoter Fig
0.297294.12740371.html.plaintext.txt	189	However S304D mutant HNF4 showed dramatically reduced ability bind DNA despite similar amounts protein present reaction Fig
0.297294.12740371.html.plaintext.txt	190	Gel mobility shift experiments using HNF4 protein phosphorylated AMPK vitro showed mild reduction DNA binding activity data shown
0.297294.12740371.html.plaintext.txt	191	The effect phosphorylation ability HNF4 bind DNA would less pronounced S304D mutation less 100 HNF4 protein phosphorylated vitro kinase reaction
0.297294.12740371.html.plaintext.txt	192	Although efficiency reactions unknown likely fraction HNF4 molecules become phosphorylated Ser 304 leaving non phosphorylated protein free form dimers bind DNA
0.297294.12740371.html.plaintext.txt	193	In addition also possible dimers composed one phosphorylated one non phosphorylated HNF4 molecule competent bind DNA
0.297294.12740371.html.plaintext.txt	194	Because HNF4 binds DNA homodimer defective DNA binding S304D mutant could due either reduced dimer formation diminished affinity mutant dimers DNA
0.297294.12740371.html.plaintext.txt	195	To examine directly effect mutant dimerization absence DNA vitro association assay using 35S labeled HNF4 monomers different sizes carried
0.297294.12740371.html.plaintext.txt	196	A fusion protein GST wild type HNF4 protein size 78 kDa co translated either wild type mutant full length HNF4 protein 52 kDa
0.297294.12740371.html.plaintext.txt	197	The GST HNF4 fusion protein purified reaction glutathione resin together dimerized 52 kDa wild type mutant HNF4
0.297294.12740371.html.plaintext.txt	198	3B demonstrated wild type S304A HNF4 readily formed dimers wild type GST HNF4 protein arrow lanes 1 2
0.297294.12740371.html.plaintext.txt	199	In contrast S304D protein showed reduced ability interact wild type GST HNF4 compare lane 3 lanes 1 2
0.297294.12740371.html.plaintext.txt	200	Densitometry analysis Western blot demonstrated lower input amount S304D protein lane 6 account reduction amount S304D bound wild type GST HNF4 protein data shown
0.297294.12740371.html.plaintext.txt	201	To examine ability dimers composed one unphosphorylated monomer one phosphorylated monomer form bind DNA wild type S304D mutant HNF4 proteins different sizes mixed together resulting dimers analyzed gel mobility shift
0.297294.12740371.html.plaintext.txt	202	3C demonstrate dimers composed one wild type GFP HNF4 molecule 81 kDa one S304D molecule 52 kDa form competent bind DNA lane 6 less efficiency dimers wild type GFP HNF4 either wild type S304A HNF4 proteins Fig
0.297294.12740371.html.plaintext.txt	203	3C compare lane 6 lanes 3 9
0.297294.12740371.html.plaintext.txt	204	3A homodimers S304D HNF4 failed form Fig
0.297294.12740371.html.plaintext.txt	205	3C compare lane 4 lanes 1 7
0.297294.12740371.html.plaintext.txt	206	Taken together results demonstrate vitro negative charge serine 304 inhibits dimer formation effect pronounced monomers contain additional negative charge
0.297294.12740371.html.plaintext.txt	207	To examine effects Ser 304 phosphorylation dimer formation DNA binding vivo wild type S304A S304D expression constructs transfected CHO cells low amounts endogenous HNF4
0.297294.12740371.html.plaintext.txt	208	After transfection AMPK activated AICAR treatment nuclear extracts prepared gel mobility shift assays
0.297294.12740371.html.plaintext.txt	209	As observed vitro S304D phosphomimetic mutant showed reduced DNA binding activity Fig
0.297294.12740371.html.plaintext.txt	210	In addition mild reduction DNA binding wild type protein upon AICAR treatment Fig
0.297294.12740371.html.plaintext.txt	211	3D compare lanes 4 5 occur phosphorylation defective S304A protein Fig
0.297294.12740371.html.plaintext.txt	212	However much reduction DNA binding activity correlates changes amount HNF4 present various transfections Fig
0.297294.12740371.html.plaintext.txt	213	For example amount S304D protein significantly lower wild type protein Fig
0.297294.12740371.html.plaintext.txt	214	3D compare lane 8 lane 4 lower panel
0.297294.12740371.html.plaintext.txt	215	Likewise amount wild type HNF4 reduced AMPK activation Fig
0.297294.12740371.html.plaintext.txt	216	3D compare lanes 4 5 lower panel
0.297294.12740371.html.plaintext.txt	217	The reduction HNF4 amounts AICAR treatment occur phosphorylation defective S304A mutation Fig
0.297294.12740371.html.plaintext.txt	218	3D compare lanes 6 7 lower panel suggesting effect due phosphorylation serine 304
0.297294.12740371.html.plaintext.txt	219	These changes HNF4 protein amounts suggest addition negative charge serine 304 reduces stability HNF4 protein cells
0.297294.12740371.html.plaintext.txt	220	Potential effects AMPK activation HNF4 protein stability explored examining appearance proteolytic products wild type mutant HNF4 proteins transiently transfected CHO cells treated AICAR
0.297294.12740371.html.plaintext.txt	221	Western blot analysis shows absence AICAR detectable amounts degradation fragments appear lysates cells transfected phosphomimetic S304D HNF4 Fig
0.297294.12740371.html.plaintext.txt	222	The activation AMPK AICAR addition induced appearance degradation fragments wild type phosphorylation defective S304A protein Fig
0.297294.12740371.html.plaintext.txt	223	These findings indicate phosphorylation HNF4 serine 304 increased proteolytic degradation protein
0.297294.12740371.html.plaintext.txt	224	In addition results strongly support conclusion AMPK phosphorylates HNF4 serine 304 vivo
0.297294.12740371.html.plaintext.txt	225	To measure rate degradation wild type mutant HNF4 proteins tetracycline regulated expression system used transiently express wild type 304 mutant HNF4 transfected CHO cells
0.297294.12740371.html.plaintext.txt	226	18 h post transfection HNF4 expression specifically extinguished addition doxycycline amount HNF4 protein remaining cells determined regular intervals following 8 h
0.297294.12740371.html.plaintext.txt	227	4 B C demonstrate phosphomimetic S304D mutant protein degraded rapidly either wild type S304A proteins
0.297294.12740371.html.plaintext.txt	228	Taken together vitro vivo results suggest phosphorylation HNF4 Ser 304 two effects HNF4 reduce ability form functional dimers reduce stability HNF4 vivo
0.297294.12740371.html.plaintext.txt	229	The HNF4 dimerization DNA binding results presented predict AMPK mediated phosphorylation HNF4 serine 304 would negative effect transcriptional activity
0.297294.12740371.html.plaintext.txt	230	To determine whether case plasmids expressing wild type Ser 304 mutant proteins transfected CHO cells together HNF4 responsive reporter plasmid
0.297294.12740371.html.plaintext.txt	231	As predicted DNA binding studies S304D mutant showed significantly less transcriptional activity wild type HNF4 protein Fig
0.297294.12740371.html.plaintext.txt	232	The S304A mutant slightly active wild type protein suggesting possibility basal level phosphorylation reduces activity wild type protein
0.297294.12740371.html.plaintext.txt	233	These results indicate AMPK negative regulates HNF4 activity phosphorylation serine 304 suggest AMPK activity could influence expression HNF4 target genes
0.297294.12740371.html.plaintext.txt	234	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Here report transcription factor HNF4 novel substrate AMP activated protein kinase
0.297294.12740371.html.plaintext.txt	235	Given central role AMPK mediating response changes cellular energy balance fact HNF4 regulates genes involved energy metabolism findings suggest mechanism expression specific set metabolic genes might linked cellular energy status
0.297294.12740371.html.plaintext.txt	236	Although directly demonstrated AMPK regulates HNF4 mediated gene expression vivo previous study reported activation AMPK activity primary liver cells correlated reduced expression HNF4 target genes 33
0.297294.12740371.html.plaintext.txt	237	Our findings offer potential mechanistic explanation relationship HNF4 target gene regulation AMPK activation
0.297294.12740371.html.plaintext.txt	238	The kinase phosphorylates HNF4 serine 304 Figs
0.297294.12740371.html.plaintext.txt	239	1 2 causes reduction ability HNF4 form dimers bind DNA Fig
0.297294.12740371.html.plaintext.txt	240	In vivo addition negative charge residue substitution aspartic acid residue reduced ability HNF4 activate transcription cotransfected HNF4 dependent reporter Fig
0.297294.12740371.html.plaintext.txt	241	In addition effects HNF4 dimerization DNA binding phosphorylation HNF4 Ser 304 conversion Ser 304 aspartic acid also caused increase degradation rate reduction amount HNF4 protein Fig
0.297294.12740371.html.plaintext.txt	242	Our results consistent previous findings showing activation AMPK primary hepatocytes resulted reduction amount endogenous HNF4 33
0.297294.12740371.html.plaintext.txt	243	Taken together findings suggest model one branches AMPK signaling pathway results phosphorylation HNF4 serine 304 leading reduction amount activity HNF4 subsequent reduction expression HNF4 target genes
0.297294.12740371.html.plaintext.txt	244	Although work reported focused phosphorylation serine 304 residue HNF4 clear site HNF4 phosphorylated AMPK
0.297294.12740371.html.plaintext.txt	245	The HNF4A fragment N terminal half protein strongly phosphorylated vitro site able map
0.297294.12740371.html.plaintext.txt	246	This site sites may responsible remaining phosphorylation full length protein occurs Ser 304 residue mutated alanine Fig
0.297294.12740371.html.plaintext.txt	247	We currently mapping AMPK site N terminus HNF4 determine functional significance
0.297294.12740371.html.plaintext.txt	248	In addition regulation HNF4 activity describe reported previously HNF4 DNA binding activity repressed protein kinase A mediated phosphorylation residues DNA binding domain 37
0.297294.12740371.html.plaintext.txt	249	It also reported phosphorylation HNF4 tyrosine residues affected transcriptional activity sub nuclear localization 39
0.297294.12740371.html.plaintext.txt	250	These findings together reported suggest HNF4 highly regulated transcription factor multiple signaling pathways influence activity
0.297294.12740371.html.plaintext.txt	251	An interesting question concerning phosphorylation HNF4 AMPK vivo cellular location occurs
0.297294.12740371.html.plaintext.txt	252	HNF4 strongly associated nucleus whereas known AMPK substrates cytoplasmic enzymes
0.297294.12740371.html.plaintext.txt	253	Although possible HNF4 also phosphorylated cytoplasm appealing compartment interaction would nucleus
0.297294.12740371.html.plaintext.txt	254	Several observations support possibility
0.297294.12740371.html.plaintext.txt	255	First specific isoforms kinase reported present nucleus 31 40
0.297294.12740371.html.plaintext.txt	256	Second transcriptional components reported potential substrates kinase co activator p300 32 carbohydrate response transcription factor ChREBP 41
0.297294.12740371.html.plaintext.txt	257	Finally yeast homolog mammalian AMPK SNF 1 present nucleus review see Ref
0.297294.12740371.html.plaintext.txt	258	13 associated chromatin possibly gene specific pattern 42
0.297294.12740371.html.plaintext.txt	259	Together observations suggest intriguing possibility least version mammalian AMPK may component transcriptional complex specific genes regulated cellular energy balance
0.297294.12740371.html.plaintext.txt	260	What would physiological outcome reduced HNF4 target gene expression The answer question depends tissue considered
0.297294.12740371.html.plaintext.txt	261	In endocrine pancreas reduction HNF4 activity would predicted significant effect ability islet secrete appropriate amount insulin
0.297294.12740371.html.plaintext.txt	262	This possibility illustrated phenotype MODY1 patients one normal allele HNF4 gene presumably reduced amount active HNF4 protein 3
0.297294.12740371.html.plaintext.txt	263	These patients defective insulin secretion response appears primary effect reduced HNF4 levels pancreatic cells 4 43
0.297294.12740371.html.plaintext.txt	264	Consistent apparent role HNF4 pancreatic physiology observations HNF4 regulates variety cell genes involved glucose sensing insulin secretion 6 8
0.297294.12740371.html.plaintext.txt	265	Like HNF4 AMPK also clearly plays role physiology endocrine pancreas
0.297294.12740371.html.plaintext.txt	266	It likely cell senses glucose concentration fluctuations amount intracellular ATP generated glucose oxidation
0.297294.12740371.html.plaintext.txt	267	The insulin secretory machinery gauges amount insulin secrete sensing ATP level fluctuations review see Ref
0.297294.12740371.html.plaintext.txt	268	It possible changes cellular energy balance cells occur normal physiology effect HNF4 phosphorylation activity fluctuation HNF4 activity part normal physiological regulation islet
0.297294.12740371.html.plaintext.txt	269	Consistent possibility observation low glucose levels induce AMPK activity cell lines derived pancreatic cells suggestion changes kinase activity involved insulin secretion 25
0.297294.12740371.html.plaintext.txt	270	Alternatively possible AMPK mediated changes HNF4 activity relevant pathological conditions AMPK aberrantly activated HNF4 activity suppressed normal levels
0.297294.12740371.html.plaintext.txt	271	This situation could potentially result physiological circumstance analogous MODY1 phenotype
0.297294.12740371.html.plaintext.txt	272	Another tissue AMPK mediated changes HNF4 target gene expression could significant metabolic effect liver
0.297294.12740371.html.plaintext.txt	273	It understood many years HNF4 plays important role liver regulating genes involved lipid 45 amino acid 46 47 glucose metabolism 48 49 coagulation cascade 50
0.297294.12740371.html.plaintext.txt	274	It reported recently HNF4 plays key role induction hepatic gluconeogenesis mediating transcriptional effects co activator PGC1 10
0.297294.12740371.html.plaintext.txt	275	On hand reduction HNF4 levels due haploinsufficiency MODY1 patients cause major liver abnormalities 5 51 although changes amounts liver derived serum proteins observed 52
0.297294.12740371.html.plaintext.txt	276	It clear AMPK mediated phosphorylation HNF4 could potentially important effects liver pancreatic islet physiology
0.297294.12740371.html.plaintext.txt	277	We currently examining HNF4 phosphorylation hepatic pancreatic cell lines determine whether AMPK dependent phosphorylation Ser 304 occurs physiological conditions ascertain potential metabolic role phosphorylation events described
0.297294.12740371.html.plaintext.txt	278	FOOTNOTES The costs publication article defrayed part payment page charges
0.297294.12740371.html.plaintext.txt	279	This article must therefore hereby marked advertisement accordance 18 U
0.297294.12740371.html.plaintext.txt	280	Section 1734 solely indicate fact
0.297294.12740371.html.plaintext.txt	281	Pediatrics University Michigan Medical School Ann Arbor MI 48109
0.297294.12740371.html.plaintext.txt	282	To correspondence addressed Dept
0.297294.12740371.html.plaintext.txt	283	PathologyCIMER Wayne State University Medical School 540 E
0.297294.12740371.html.plaintext.txt	284	313 577 3006 Fax 313 577 0057 E mail tleffatmed
0.297294.12740371.html.plaintext.txt	285	1 The abbreviations used HNF4 hepatic nuclear factor 4 AMPK AMP activated protein kinase GST glutathione S transferase CMV cytomegalovirus CHO Chinese hamster ovary MODY maturity onset diabetes young AICAR 5 aminoimidazol 4 carboxoxamide 1 D ribofuranoside BHK baby hamster kidney GFP green fluorescent protein EGFP enhanced GFP
0.297294.12740371.html.plaintext.txt	286	ACKNOWLEDGMENTS We thank Satya Reddy Galina Malkin Neelam Srivastava expert technical assistance Dr
0.297294.12740371.html.plaintext.txt	287	David Taylor providing HNF4 GST construction
0.297294.12740371.html.plaintext.txt	288	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Sladek R
0.297294.12740371.html.plaintext.txt	289	47 23 87Medline Order article via Infotrieve Ryffel G
0.297294.12740371.html.plaintext.txt	290	27 11 29AbstractFree Full Text Yamagata K
0.297294.12740371.html.plaintext.txt	291	1996 Nature 384 458 460CrossRefMedline Order article via Infotrieve Herman W
0.297294.12740371.html.plaintext.txt	292	1997 Diabetes 46 1749 1754Abstract Lindner T
0.297294.12740371.html.plaintext.txt	293	100 1400 1405AbstractFree Full Text Stoffel M
0.297294.12740371.html.plaintext.txt	294	94 13209 13214AbstractFree Full Text Duncan S
0.297294.12740371.html.plaintext.txt	295	1998 Science 281 692 695AbstractFree Full Text Wang H
0.297294.12740371.html.plaintext.txt	296	275 35953 35959AbstractFree Full Text Sladek F
0.297294.12740371.html.plaintext.txt	297	1998 Diabetes 47 985 990Abstract Yoon J
0.297294.12740371.html.plaintext.txt	298	2001 Nature 413 131 138CrossRefMedline Order article via Infotrieve Woods A
0.297294.12740371.html.plaintext.txt	299	269 19509 19515AbstractFree Full Text Woods A
0.297294.12740371.html.plaintext.txt	300	20 6704 6711AbstractFree Full Text Hardie D
0.297294.12740371.html.plaintext.txt	301	67 821 855CrossRefMedline Order article via Infotrieve da Silva Xavier G
0.297294.12740371.html.plaintext.txt	302	97 4023 4028AbstractFree Full Text Marsin A
0.297294.12740371.html.plaintext.txt	303	10 1247 1255CrossRefMedline Order article via Infotrieve Corton J
0.297294.12740371.html.plaintext.txt	304	4 315 324Medline Order article via Infotrieve Hayashi T
0.297294.12740371.html.plaintext.txt	305	1998 Diabetes 47 1369 1373Abstract Mu J
0.297294.12740371.html.plaintext.txt	306	Cell 7 1085 1094CrossRefMedline Order article via Infotrieve Musi N
0.297294.12740371.html.plaintext.txt	307	2001 Diabetes 50 921 927AbstractFree Full Text Merrill G
0.297294.12740371.html.plaintext.txt	308	273 E1107 E1112Medline Order article via Infotrieve Bergeron R
0.297294.12740371.html.plaintext.txt	309	276 E938 E944Medline Order article via Infotrieve Foretz M
0.297294.12740371.html.plaintext.txt	310	273 14767 14771AbstractFree Full Text Henin N
0.297294.12740371.html.plaintext.txt	311	9 541 546AbstractFree Full Text Hubert A
0.297294.12740371.html.plaintext.txt	312	481 209 212CrossRefMedline Order article via Infotrieve Salt I
0.297294.12740371.html.plaintext.txt	313	335 533 539Medline Order article via Infotrieve Woods A
0.297294.12740371.html.plaintext.txt	314	271 10282 10290AbstractFree Full Text Gao G
0.297294.12740371.html.plaintext.txt	315	271 8675 8681AbstractFree Full Text Woods A
0.297294.12740371.html.plaintext.txt	316	397 347 351CrossRefMedline Order article via Infotrieve Thornton C
0.297294.12740371.html.plaintext.txt	317	273 12443 12450AbstractFree Full Text Stapleton D
0.297294.12740371.html.plaintext.txt	318	409 452 456CrossRefMedline Order article via Infotrieve Salt I
0.297294.12740371.html.plaintext.txt	319	334 177 187Medline Order article via Infotrieve Yang W
0.297294.12740371.html.plaintext.txt	320	276 38341 38344AbstractFree Full Text Leclerc I
0.297294.12740371.html.plaintext.txt	321	2001 Diabetes 50 1515 1521AbstractFree Full Text Dignam J
0.297294.12740371.html.plaintext.txt	322	11 1475 1489Abstract Reddy S
0.297294.12740371.html.plaintext.txt	323	274 33050 33056AbstractFree Full Text Jiang G
0.297294.12740371.html.plaintext.txt	324	340 1 9CrossRefMedline Order article via Infotrieve Viollet B
0.297294.12740371.html.plaintext.txt	325	17 4208 4219Abstract Sullivan J
0.297294.12740371.html.plaintext.txt	326	353 33 36CrossRefMedline Order article via Infotrieve Ktistaki E
0.297294.12740371.html.plaintext.txt	327	92 9876 9880Abstract Turnley A
0.297294.12740371.html.plaintext.txt	328	72 1707 1716CrossRefMedline Order article via Infotrieve Kawaguchi T
0.297294.12740371.html.plaintext.txt	329	277 3829 3835AbstractFree Full Text Lo W
0.297294.12740371.html.plaintext.txt	330	2001 Science 293 1142 1146AbstractFree Full Text Ilag L
0.297294.12740371.html.plaintext.txt	331	2000 Diabetes 49 961 968Abstract Ishihara H
0.297294.12740371.html.plaintext.txt	332	2000 IUBMB Life 49 391 395CrossRefMedline Order article via Infotrieve Hayhurst G
0.297294.12740371.html.plaintext.txt	333	21 1393 1403AbstractFree Full Text Inoue Y
0.297294.12740371.html.plaintext.txt	334	277 25257 25265AbstractFree Full Text Nitsch D
0.297294.12740371.html.plaintext.txt	335	90 5479 5483Abstract Diaz Guerra M
0.297294.12740371.html.plaintext.txt	336	13 7725 7733Abstract Hall R
0.297294.12740371.html.plaintext.txt	337	92 412 416Abstract Figueiredo M
0.297294.12740371.html.plaintext.txt	338	270 11828 11838AbstractFree Full Text Iwasaki N
0.297294.12740371.html.plaintext.txt	339	1998 Diabetes Care 21 2144 2148Abstract Shih D
0.297294.12740371.html.plaintext.txt	340	2000 Diabetes 49 832 837Abstract Hardie D
0.23938537.9148920.html.plaintext.txt	0	Twin Hydroxymethyluracil A Base Pair Steps Define Binding Site DNA bending Protein TF1
0.23938537.9148920.html.plaintext.txt	1	Received publication February 12 1997
0.23938537.9148920.html.plaintext.txt	2	Figueiredo Aldo Galeone Luciano Mayol E
0.23938537.9148920.html.plaintext.txt	3	From Department Biology Center Molecular Genetics University California San Diego La Jolla California 92093 0634 Dipartimento di Chimica delle Sostanze Naturali Universita degli Studi di Napoli Federico II Via Domenico Montesano 49 80131 Napoli Italy ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES REFERENCES
0.23938537.9148920.html.plaintext.txt	4	The DNA bending protein TF1 Bacillus subtilis bacteriophage SPO1 encoded homolog bacterial HU proteins Escherichia coli integration host factor
0.23938537.9148920.html.plaintext.txt	5	We recently proposed TF1 binds high affinity Kd 3 nM preferred sites within hydroxymethyluracil hmU containing phage genome identifies binding sites based sequence dependent DNA flexibility
0.23938537.9148920.html.plaintext.txt	6	Here show two hmU A base pair steps coinciding two previously proposed sites DNA distortion critical complex formation
0.23938537.9148920.html.plaintext.txt	7	The affinity TF1 reduced 10 fold hmU A base pair steps replaced A hmU G C C G steps modest changes affinity result substitutions made base pairs TF1 binding site
0.23938537.9148920.html.plaintext.txt	8	Replacement hmU residues thymine decreases affinity TF1 greatly remarkably high affinity restored two hmU A base pair steps corresponding previously suggested sites distortion reintroduced otherwise T containing DNA
0.23938537.9148920.html.plaintext.txt	9	T DNA constructs 3 base bulges spaced apart 9 base pairs duplex also generate nM affinity TF1
0.23938537.9148920.html.plaintext.txt	10	We suggest twin hmU A base pair steps located proposed sites distortion key target site selection TF1 recognition based largely entirely sequence dependent DNA flexibility
0.23938537.9148920.html.plaintext.txt	11	The genome Bacillus subtilis bacteriophage SPO1 contains 5 hydroxymethyluracil hmU1 place thymine discrimination T hmU containing DNA important phage multiplication 1 2
0.23938537.9148920.html.plaintext.txt	12	For one phage encoded protein DNA binding bending protein TF1 discrimination essentially absolute high affinity TF1 Kd order magnitude nM preferred sites within hmU containing phage genome greatly reduced corresponding T containing DNA 3 4
0.23938537.9148920.html.plaintext.txt	13	We recently showed affinity TF1 hmU DNA matched T containing DNA constructs contain sets two consecutive mismatches separated 9 bp duplex indicating hmU content appropriately placed flexible loops contribute similarly complex formation
0.23938537.9148920.html.plaintext.txt	14	We proposed therefore DNA complex TF1 distorted two sites separated 9 bp duplex DNA sites corresponding two hmU A base pair steps TF1 identifies target sites recognition sequence dependent DNA flexibility 5
0.23938537.9148920.html.plaintext.txt	15	Here examine requirement hmU residues across 37 mer DNA duplex representing preferred binding site within phage genome 4 specifically evaluate sequence requirements two inferred sites DNA distortion
0.23938537.9148920.html.plaintext.txt	16	TF1 overexpressed Escherichia coli DL39 6 purified described 5
0.23938537.9148920.html.plaintext.txt	17	Oligonucleotides hmU content synthesized described 7 purified high pressure liquid chromatography
0.23938537.9148920.html.plaintext.txt	18	T containing oligonucleotides purchased purified denaturing polyacrylamide gel electrophoresis
0.23938537.9148920.html.plaintext.txt	19	The top strand shared among bulge constructs 32P labeled 5 end T4 polynucleotide kinase
0.23938537.9148920.html.plaintext.txt	20	Complementary oligonucleotides mixed equimolar concentrations heated 90 degrees C slowly cooled 4 degrees C several hours form duplex DNA
0.23938537.9148920.html.plaintext.txt	21	Electrophoretic mobility shift experiments carried described 5
0.23938537.9148920.html.plaintext.txt	22	Experiments perfect duplex hmU hybrid ThmU DNA done room temperature unless noted otherwise
0.23938537.9148920.html.plaintext.txt	23	Experiments bulge constructs performed 4 degrees C prevent dissociation duplexes
0.23938537.9148920.html.plaintext.txt	24	After electrophoresis gels dried protein DNA complexes quantified using phosphorimaging
0.23938537.9148920.html.plaintext.txt	25	DNA migrating bands corresponding free complexed DNA considered free DNA 5 calculating equilibrium dissociation constants Kd 5
0.23938537.9148920.html.plaintext.txt	26	Values Kd reported average least three experiments plus minus S
0.23938537.9148920.html.plaintext.txt	27	closely related DNA constructs yielding suboptimal complex formation triplicate determinations deemed unnecessary
0.23938537.9148920.html.plaintext.txt	28	The sequence 37 mer DNA construct corresponding preferred binding site within phage SPO1 genome 4 shown Fig
0.23938537.9148920.html.plaintext.txt	29	Because ability TF1 form nested complexes longer DNA fragments length DNA constructs chosen accommodate one TF1 dimer 5
0.23938537.9148920.html.plaintext.txt	30	The affinity TF1 37 mer hmU containing duplex Kd 3 nM Fig
0.23938537.9148920.html.plaintext.txt	31	1A reduced 10 fold upon replacement two hmU A base pair steps corresponding potential sites distortion A hmU G C C G steps Figs
0.23938537.9148920.html.plaintext.txt	32	Altering sequence center binding site Figs
0.23938537.9148920.html.plaintext.txt	33	1 2 panels C flanks distal proposed sites bending Figs
0.23938537.9148920.html.plaintext.txt	34	1 2 panels D significantly affect complex formation
0.23938537.9148920.html.plaintext.txt	35	The observed sequence specificity proposed sites distortion consistent direct participation hmU A base pair steps complex formation DNA bending
0.23938537.9148920.html.plaintext.txt	36	Sequences 37 mer oligonucleotides
0.23938537.9148920.html.plaintext.txt	37	A sequence top strand corresponding preferred binding site within SPO1 genome shown hmU A base pair steps correspond proposed sites distortion boldface
0.23938537.9148920.html.plaintext.txt	38	B 10 fold reduction affinity associated replacement target hmU A steps
0.23938537.9148920.html.plaintext.txt	39	C D sequences oligonucleotides substitutions C distal D hmU A base pair steps substitutions underlined
0.23938537.9148920.html.plaintext.txt	40	Substitutions flanks target additional hmU A base pair steps additional substitutions required prevent introduction new hmU A steps
0.23938537.9148920.html.plaintext.txt	41	Top strands shown annealed complementary hmU containing bottom strands generate perfect duplexes
0.23938537.9148920.html.plaintext.txt	42	Dissociation constants Kd nM shown right
0.23938537.9148920.html.plaintext.txt	43	View Larger Version Image 36K GIF file
0.23938537.9148920.html.plaintext.txt	44	Electrophoretic analysis hmU DNA titrated TF1
0.23938537.9148920.html.plaintext.txt	45	The affinity TF1 37 mer duplex corresponding preferred binding site panel A reduced upon replacement hmU A base pair steps A hmU panel B
0.23938537.9148920.html.plaintext.txt	46	Altering central base pairs GC rich panel C sequence distal proposed sites DNA distortion wild type wt GC panel D little effect complex formation
0.23938537.9148920.html.plaintext.txt	47	Protein concentrations indicated panel D identical panels
0.23938537.9148920.html.plaintext.txt	48	View Larger Version Image 109K GIF file
0.23938537.9148920.html.plaintext.txt	49	To evaluate contribution hmU residues DNA binding affinity TF1 DNA constructs designed central hmU containing blocks 13 11 bp encompassing proposed sites DNA distortion Fig
0.23938537.9148920.html.plaintext.txt	50	3 constructs Th2 Th3 9 7 bp excluding hmU A steps candidate sites specific distortion Fig
0.23938537.9148920.html.plaintext.txt	51	3 constructs Th4 Th5 embedded T containing surrounding sequence
0.23938537.9148920.html.plaintext.txt	52	Constructs proposed sites distortion lie within hmU containing blocks Th2 Th3 yielded Kd 5 6 nM compared 3 nM hmU DNA
0.23938537.9148920.html.plaintext.txt	53	A 5 fold reduction affinity observed DNA shorter hmU containing blocks Th4 Th5
0.23938537.9148920.html.plaintext.txt	54	A DNA duplex central 13 bp T containing block flanked hmU containing sequence Fig
0.23938537.9148920.html.plaintext.txt	55	3 construct Th1 bound TF1 10 fold lower affinity relative hmU DNA
0.23938537.9148920.html.plaintext.txt	56	DNA duplexes T hmU content
0.23938537.9148920.html.plaintext.txt	57	Blocks hmU content underlined
0.23938537.9148920.html.plaintext.txt	58	DNA constructs named left dissociation constants Kd nM shown right
0.23938537.9148920.html.plaintext.txt	59	The symbol denotes complex dissociation electrophoresis rapid allow reliable determination
0.23938537.9148920.html.plaintext.txt	60	View Larger Version Image 63K GIF file
0.23938537.9148920.html.plaintext.txt	61	For DNA 2 4 bp hmU containing blocks significantly lower affinity observed DNA constructs T A base pair steps proposed sites bending Fig
0.23938537.9148920.html.plaintext.txt	62	3 constructs Th8 Th9 otherwise identical constructs hmU A base pair steps Fig
0.23938537.9148920.html.plaintext.txt	63	3 constructs Th6 Th7 Kd 5 nM
0.23938537.9148920.html.plaintext.txt	64	Remarkably TF1 found essentially undiminished affinity DNA two hmU A base pair steps completely surrounded T containing DNA Kd 4 nM Fig
0.23938537.9148920.html.plaintext.txt	65	We note also affinity TF1 hmU DNA Th7Th6 construct room temperature 4 degrees C Figs
0.23938537.9148920.html.plaintext.txt	66	A 7 10 fold reduction affinity observed one strand contained requisite hmU A sequence Fig
0.23938537.9148920.html.plaintext.txt	67	3 constructs Th7T TTh6 Fig
0.23938537.9148920.html.plaintext.txt	68	Our interpretation observations hmU content affords increased flexibility recognized TF1 hmU A base pair steps symmetrically disposed center binding site targets specific distortion protein DNA complex
0.23938537.9148920.html.plaintext.txt	69	Twin hmU A base pair steps corresponding presumptive sites distortion required complex formation
0.23938537.9148920.html.plaintext.txt	70	The affinity TF1 hmU DNA A reproduced DNA construct target hmU A base pair steps surrounded T DNA Th76 B
0.23938537.9148920.html.plaintext.txt	71	Constructs one strand contains hmU A sequence 10 fold lower affinity Th7T C
0.23938537.9148920.html.plaintext.txt	72	View Larger Version Image 113K GIF file
0.23938537.9148920.html.plaintext.txt	73	The nM affinity TF1 hmU DNA reproduced T DNA base bulges separated 9 bp duplex
0.23938537.9148920.html.plaintext.txt	74	The affinity TF1 perfect duplex hmU DNA reproduced T DNA set 4 nt loops A
0.23938537.9148920.html.plaintext.txt	75	1 2 base bulges lowercase c underlined combination mismatch reproduce nM affinity TF1 B 2 3 base bulges C
0.23938537.9148920.html.plaintext.txt	76	legend Fig
0.23938537.9148920.html.plaintext.txt	77	All experiments carried 4 degrees C
0.23938537.9148920.html.plaintext.txt	78	View Larger Version Image 33K GIF file
0.23938537.9148920.html.plaintext.txt	79	The high affinity TF1 hmU DNA Kd 3 nM reproduced T DNA contains two appropriately positioned flexible sites generated sets tandem mismatches Ref
0.23938537.9148920.html.plaintext.txt	80	Improved complex formation relative perfect duplex T DNA would also expected T DNA constructs energetic cost bending lessened incorporation bulge loops
0.23938537.9148920.html.plaintext.txt	81	nucleotides formally unopposed complementary strand Fig
0.23938537.9148920.html.plaintext.txt	82	Constructs sets 1 2 nt bulges combined one mismatched base pair positioned 9 bp apart indeed generated high affinity TF1 Fig
0.23938537.9148920.html.plaintext.txt	83	5B note sets 2 nt loops one mismatch generated suboptimal binding compared sets 4 nt loops two consecutive mismatches
0.23938537.9148920.html.plaintext.txt	84	The high affinity TF1 fully restored DNA constructs sets 2 3 nt bulges suboptimal binding DNA pair 1 nt bulges Fig
0.23938537.9148920.html.plaintext.txt	85	Replacing T containing top strand bulge constructs corresponding hmU containing strand affect complex formation data shown
0.23938537.9148920.html.plaintext.txt	86	Bulge loops considered generate directed kinks helix axis 8 9
0.23938537.9148920.html.plaintext.txt	87	Consistent presence kinks observed reduction electrophoretic mobility bulged DNA constructs magnitude depended size bulge data shown
0.23938537.9148920.html.plaintext.txt	88	The mobility protein DNA complexes similar irrespective nature DNA construct
0.23938537.9148920.html.plaintext.txt	89	The TF1 double mutant protein TF1 E15GT32I binds DNA 40 fold higher affinity wild type TF1 10 due interactions outside central 25 bp region binding site 5
0.23938537.9148920.html.plaintext.txt	90	The presence bulge loops T DNA affected affinity TF1 E15GT32I wild type TF1 similar ways consistent unaltered interactions mutant protein central DNA segment includes proposed sites bending data shown
0.23938537.9148920.html.plaintext.txt	91	The structure TF1 reveals presence flexible ribbon arms directly involved DNA binding 112 structure closely related HU protein 12 13 recently reported structure integration host factor IHF complex DNA 14
0.23938537.9148920.html.plaintext.txt	92	At tip DNA binding arms TF1 contains Phe residue position 61 place Arg found members protein family
0.23938537.9148920.html.plaintext.txt	93	TF1F61R reduced preference hmU DNA T DNA 15 seen retain high affinity hmU DNA Kd 9
0.23938537.9148920.html.plaintext.txt	94	Substituting Phe 61 Tyr little effect affinity Kd 6
0.23938537.9148920.html.plaintext.txt	95	Replacing Phe 61 polar uncharged residue Ser Gln significantly reduces DNA binding affinity site selectivity 15
0.23938537.9148920.html.plaintext.txt	96	Notably affinity hmU DNA TF1F61S Kd 236 plus minus 19 nM TF1F61Q Kd 685 plus minus 48 nM increased 5 fold T DNA 2 3 base bulges Kd 36 plus minus 2 90 plus minus 7 nM respectively Fig
0.23938537.9148920.html.plaintext.txt	97	This contrast wild type TF1 bound hmU DNA bulge DNA constructs 12 13 02 03 approximately affinity Fig
0.23938537.9148920.html.plaintext.txt	98	T DNA sets 4 nt loops also reproduces affinity wild type TF1 hmU DNA Fig
0.23938537.9148920.html.plaintext.txt	99	5 significantly enhance complex formation TF1F61S Kd 200 nM TF1F61Q Kd 570 nM beyond observed hmU DNA
0.23938537.9148920.html.plaintext.txt	100	Apparently hmU content flexible loops T DNA contribute similarly complex formation TF1 mutant proteins deficient binding bending hmU DNA 15 16 whereas DNA static kink generates increase affinity
0.23938537.9148920.html.plaintext.txt	101	Our previous conjecture TF1 principally identifies preferred binding sites recognition sequence dependent DNA flexure based analysis affinities DNA constructs sets 4 nt loops 5
0.23938537.9148920.html.plaintext.txt	102	For mode target site selection prediction would sequence sites distortion significantly affect complex formation
0.23938537.9148920.html.plaintext.txt	103	This prediction appears borne terms preferred base pair steps context hmU DNA Figs
0.23938537.9148920.html.plaintext.txt	104	1 2 particularly significant effect hmU A base pair steps T containing surrounding sequence Figs
0.23938537.9148920.html.plaintext.txt	105	We propose hmU content confers site specific flexibility DNA duplex recognized TF1
0.23938537.9148920.html.plaintext.txt	106	hmU A base pair steps situated presumptive sites DNA bending make principal contributions complex formation TF1
0.23938537.9148920.html.plaintext.txt	107	hmU residues positions generate measurable yet suboptimal affinities presumably either due longer range effects DNA flexure alternative placement TF1
0.23938537.9148920.html.plaintext.txt	108	An effect hmU residues deformability double helix corroborated increased affinity observed members family type II DNA binding proteins HU IHF unrelated eukaryotic protein HMG1 17
0.23938537.9148920.html.plaintext.txt	109	Changes complex formation major minor groove binding proteins antibiotics induced introduction modified bases also interpreted terms effects DNA deformability exocyclic substituents 18 20
0.23938537.9148920.html.plaintext.txt	110	Inferences increased flexure DNA containing modified bases stress need analysis associated structures conformational energetics
0.23938537.9148920.html.plaintext.txt	111	Structural nuclear magnetic resonance analysis A hmU base pair flanked G C base pairs indicates significant deviations classical B form DNA 21 although nearest neighbors influence structure 22
0.23938537.9148920.html.plaintext.txt	112	13C 31P nuclear magnetic resonance relaxation experiments may provide required insights dynamics duplex DNA size protein binding site features poorly extractable measurements using techniques fluorescence polarization DNA cyclization 23 24
0.23938537.9148920.html.plaintext.txt	113	The suggested locations DNA bends TF1 DNA complex coincide two hmU A base pair steps
0.23938537.9148920.html.plaintext.txt	114	Considering unique properties T A step terms diversity structure 25 26 would particular interest determine whether inherent deformability T A step accentuated hmU A
0.23938537.9148920.html.plaintext.txt	115	For protein bends DNA large angle 16 surprising find greater affinity DNA whose axis kinked unpaired bases Fig
0.23938537.9148920.html.plaintext.txt	116	Indeed similar results previously reported HU 27
0.23938537.9148920.html.plaintext.txt	117	We note T DNA constructs pairs suitably placed 4 nt loops 3 nt bulge loops generate affinity wild type TF1
0.23938537.9148920.html.plaintext.txt	118	However different structures energetics deformation indicated significantly higher affinity bulge constructs TF1 mutant proteins TF1F61S TF1F61Q impaired DNA binding bending
0.23938537.9148920.html.plaintext.txt	119	These observations consistent static kink introduced bulge loops compared looser flexible structure imposed symmetric loops 8 9 24 28 suggest pre bent DNA bulge loop constructs also permit complex formation certain TF1 mutant proteins whereas binding bending DNA sets 4 nt loops hmU content require protein mediated introduction stabilization DNA kinks
0.23938537.9148920.html.plaintext.txt	120	Replacement Phe 61 tip DNA binding arms polar uncharged residue may render TF1 mutant proteins either incapable producing specific DNA kinks process would aided locally presence DNA bulge loops deficient securing resulting DNA conformation demands would lessened DNA predisposed orientation
0.23938537.9148920.html.plaintext.txt	121	If TF1 like IHF employs totally conserved Pro residue intercalate specific base pairs binding site 14 deficiency TF1F61S TF1F61Q DNA binding bending may reside inability stabilize severely bent DNA conformation
0.23938537.9148920.html.plaintext.txt	122	Phe 61 contributes striking preference TF1 hmU DNA T DNA 15
0.23938537.9148920.html.plaintext.txt	123	TF1F61R also high affinity hmU DNA reduced preference hmU DNA T DNA 15
0.23938537.9148920.html.plaintext.txt	124	In addition IHF higher affinity specific binding site hmU DNA compared T DNA 17 relies heavily indirect readout recognize binding sites 14
0.23938537.9148920.html.plaintext.txt	125	If TF1 IHF engage DNA targets isomorphous fashion preference hmU DNA characteristic TF1 may due specific interactions Phe 61 hmU residues TF1 binding site
0.23938537.9148920.html.plaintext.txt	126	Rather inability TF1 stabilize T DNA duplex severely kinked intercalation Pro residues may alleviated pliable hmU DNA
0.23938537.9148920.html.plaintext.txt	127	On hand possibility TF1 use Phe 61 directly inducing DNA kinks two hmU A base pair steps remains established disproved direct structure determination
0.23938537.9148920.html.plaintext.txt	128	This work supported grants University California San Diego National Institute General Medical Sciences University Naples Ministero dellUniversita e della Ricerca Scientifica e Tecnologica MURST Consiglio Nazionale delle Ricerche
0.23938537.9148920.html.plaintext.txt	129	The costs publication article defrayed part payment page charges
0.23938537.9148920.html.plaintext.txt	130	The article must therefore hereby marked advertisement accordance 18 U
0.23938537.9148920.html.plaintext.txt	131	Section 1734 solely indicate fact
0.23938537.9148920.html.plaintext.txt	132	Pathobiological Sciences School Veterinary Medicine University Wisconsin Madison Madison WI 53706 1102
0.23938537.9148920.html.plaintext.txt	133	1 The abbreviations used hmU 5 hydroxymethyluracil IHF integration host factor bp base pairs nt nucleotide
0.23938537.9148920.html.plaintext.txt	134	Kearns submitted publication
0.23938537.9148920.html.plaintext.txt	135	139 407 422 Medline Order article via Infotrieve Choy H
0.23938537.9148920.html.plaintext.txt	136	191 59 73 Medline Order article via Infotrieve Johnson G
0.23938537.9148920.html.plaintext.txt	137	1977 Biochemistry 16 1473 1485 Medline Order article via Infotrieve Greene J
0.23938537.9148920.html.plaintext.txt	138	4 1345 1349 Abstract Grove A
0.23938537.9148920.html.plaintext.txt	139	260 196 206 CrossRefMedline Order article via Infotrieve Hard T
0.23938537.9148920.html.plaintext.txt	140	1989 Biochemistry 28 396 406 Medline Order article via Infotrieve Conte M
0.23938537.9148920.html.plaintext.txt	141	91 11660 11664 AbstractFree Full Text Lilley D
0.23938537.9148920.html.plaintext.txt	142	92 7140 7142 Free Full Text Andera L
0.23938537.9148920.html.plaintext.txt	143	236 139 150 CrossRefMedline Order article via Infotrieve Jia X
0.23938537.9148920.html.plaintext.txt	144	263 259 268 CrossRefMedline Order article via Infotrieve White S
0.23938537.9148920.html.plaintext.txt	145	5 281 288 Medline Order article via Infotrieve Vis H
0.23938537.9148920.html.plaintext.txt	146	254 692 703 CrossRefMedline Order article via Infotrieve Rice P
0.23938537.9148920.html.plaintext.txt	147	1996 Cell 87 1295 1306 Medline Order article via Infotrieve Sayre M
0.23938537.9148920.html.plaintext.txt	148	216 819 833 Medline Order article via Infotrieve Schneider G
0.23938537.9148920.html.plaintext.txt	149	221 777 794 CrossRefMedline Order article via Infotrieve Grove A
0.23938537.9148920.html.plaintext.txt	150	260 120 125 CrossRefMedline Order article via Infotrieve Diekmann S
0.23938537.9148920.html.plaintext.txt	151	84 8257 8261 Abstract Bailly C
0.23938537.9148920.html.plaintext.txt	152	253 1 7 CrossRefMedline Order article via Infotrieve Bailly C
0.23938537.9148920.html.plaintext.txt	153	93 13623 13628 AbstractFree Full Text Mellac S
0.23938537.9148920.html.plaintext.txt	154	1993 Biochemistry 32 7779 7786 Medline Order article via Infotrieve Pasternack L
0.23938537.9148920.html.plaintext.txt	155	24 2740 2745 AbstractFree Full Text Millar D
0.23938537.9148920.html.plaintext.txt	156	76 2080 2094 CrossRef Kahn J
0.23938537.9148920.html.plaintext.txt	157	1994 Nature 368 163 166 CrossRefMedline Order article via Infotrieve Hunter C
0.23938537.9148920.html.plaintext.txt	158	230 1025 1054 CrossRefMedline Order article via Infotrieve Wolffe A
0.23938537.9148920.html.plaintext.txt	159	1997 Frontiers Molecular Biology IRL Press Oxford press Pontiggia A
0.23938537.9148920.html.plaintext.txt	160	7 343 350 Medline Order article via Infotrieve Bhattacharyya A
0.23938537.9148920.html.plaintext.txt	161	17 6821 6840 Abstract 1997 The American Society Biochemistry Molecular Biology Inc
0.43622568.9092518.html.plaintext.txt	0	Orphan Receptors Chicken Ovalbumin Upstream Promoter Transcription Factor II COUP TFII Retinoid X Receptor RXR Activate Bind Rat Cholesterol 7 Hydroxylase Gene CYP7A
0.43622568.9092518.html.plaintext.txt	1	Received publication November 5 1996 revised form February 4 1997
0.43622568.9092518.html.plaintext.txt	2	Diane Stroup Maurizio Crestani John Y
0.43622568.9092518.html.plaintext.txt	3	From Department Biochemistry Molecular Pathology Northeastern Ohio Universities College Medicine Rootstown Ohio 44272 0095 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS REFERENCES
0.43622568.9092518.html.plaintext.txt	4	The cholesterol 7 hydroxylase gene CYP7A transcriptionally regulated number factors including hormones bile acids diurnal rhythm
0.43622568.9092518.html.plaintext.txt	5	Previous studies identified region nucleotides nt 74 55 rat CYP7A promoter enhanced bile acid repression SV40 early promoter assayed luciferase reporter gene transiently transfected HepG2 cells
0.43622568.9092518.html.plaintext.txt	6	The rat CYP7A promoterreporter activity strongly stimulated cotransfection expression plasmid encoding nuclear hormone receptor chicken ovalbumin upstream promoter transcription factor II COUP TFII dose dependent manner
0.43622568.9092518.html.plaintext.txt	7	Site directed mutagenesis region nt 74 55 altered stimulation
0.43622568.9092518.html.plaintext.txt	8	Recombinant COUP TFII expressed HepG2 COS 1 cells found bind nt 74 55 nt 149 128 probes electrophoretic mobility shift assay EMSA supershifting corresponding band COUP TFII specific antibodies
0.43622568.9092518.html.plaintext.txt	9	The region nt 176 117 previously mapped retinoic acid response region found bind retinoid X receptor RXR
0.43622568.9092518.html.plaintext.txt	10	EMSA supershift assays wild type mutant oligomers using antibody RXR revealed sequences nt 145 134 important RXR binding
0.43622568.9092518.html.plaintext.txt	11	We conclude COUP TFII stimulates transcriptional activity rat CYP7A promoter binding sequences nt 74 54 nt 149 128
0.43622568.9092518.html.plaintext.txt	12	RXR may stimulate CYP7A gene transcription binding direct repeat hormone response element separated one nucleotide located nt 146 134
0.43622568.9092518.html.plaintext.txt	13	Cholesterol 7 hydroxylase EC 1
0.43622568.9092518.html.plaintext.txt	14	17 catalyzes first rate limiting step pathway converts cholesterol bile acids
0.43622568.9092518.html.plaintext.txt	15	The catabolism cholesterol bile acids liver main mechanism elimination cholesterol body thus plays important role maintaining cholesterol homeostasis 1
0.43622568.9092518.html.plaintext.txt	16	The gene CYP7A transcriptionally regulated number factors including bile acids cholesterol hormones circadian rhythm 2 6
0.43622568.9092518.html.plaintext.txt	17	The CYP7A promoter structure typical DNA dependent RNA polymerase II promoter upstream TATA box several cis acting elements regulate transcriptional activity promoter 7 9
0.43622568.9092518.html.plaintext.txt	18	Transient transfection assay chimeric CYP7A promoterluciferase constructs HepG2 cells revealed region nt 416 32 rat CYP7A gene contained promoter regulatory domains conferring activation transcription dexamethasone retinoic acid suppression bile acids phorbol esters insulin 2 3 9 10
0.43622568.9092518.html.plaintext.txt	19	We mapped two footprints protected DNase I digestion using rat liver nuclear extracts 11
0.43622568.9092518.html.plaintext.txt	20	Footprint Fp1 A located nt 81 35 FpB located nt 148 129
0.43622568.9092518.html.plaintext.txt	21	Nucleotide sequences two regions highly conserved among homologous CYP7A genes different species
0.43622568.9092518.html.plaintext.txt	22	These footprints contain liver enriched transcription factors binding sites hormone response elements
0.43622568.9092518.html.plaintext.txt	23	A putative bile acid response element BARE mapped FpA region lead us propose bile acid responsive nuclear receptor may mediating bile acid response 11
0.43622568.9092518.html.plaintext.txt	24	The molecular mechanism bile acid repression still unknown
0.43622568.9092518.html.plaintext.txt	25	Determining factors interact BARE sequences first step elucidating nature bile acid response
0.43622568.9092518.html.plaintext.txt	26	A nuclear protein factor found bind repeated sequence 65TCAAGTTCAAG 54 named direct repeat binding protein DRBP
0.43622568.9092518.html.plaintext.txt	27	Binding DRBP BARE diminished liver nuclear extract prepared rats fed deoxycholate used EMSA 11
0.43622568.9092518.html.plaintext.txt	28	The sequence nt 73 57 contains imperfect direct repeat hormone response element HRE AGGTCA separated four nucleotides DR4
0.43622568.9092518.html.plaintext.txt	29	According 3 4 5 rule binding specificity steroidthyroid hormone family transcription factors 12 DR4 would predicted act thyroid hormone response element hence 7TRE tentative name DR4 sequence 11
0.43622568.9092518.html.plaintext.txt	30	However CYP7A promoter constructs containing sequences respond thyroid hormones HepG2 cells 2
0.43622568.9092518.html.plaintext.txt	31	A number nuclear factors affinity DR4 sequences including TR XONR LXR form heterodimers RXR 13 14
0.43622568.9092518.html.plaintext.txt	32	COUP TFII ARP 1 orphan nuclear receptor family promiscuous binding specificities also bind DR4 sequence 15 16
0.43622568.9092518.html.plaintext.txt	33	COUP TFs believed influence developmental changes supported report COUP TFII promoter responds differentiation signal retinoic acid 17
0.43622568.9092518.html.plaintext.txt	34	Recently mapped complex retinoic acid response region located 176 117 rat CYP7A promoter 10
0.43622568.9092518.html.plaintext.txt	35	Using transient transfection assay CYP7A promoterreporter activity HepG2 cells screened number known steroidthyroid hormone nuclear receptors effects gene transcription
0.43622568.9092518.html.plaintext.txt	36	COUP TFII produced one strongest effects transcription
0.43622568.9092518.html.plaintext.txt	37	Here provide evidence orphan receptor COUP TFII activates transcription rat CYP7A binding nt 74 54 nt 149 128 RXR homodimer may bind DR1 motif 146 134
0.43622568.9092518.html.plaintext.txt	38	DNA oligomers synthesized National Biosciences Plymouth MN Life Technologies Inc
0.43622568.9092518.html.plaintext.txt	39	DNA restriction modifying enzymes reporter lysis buffer luciferase assay system reporter vectors pGL2 Basic pGL2 Promoter purchased Promega Madison WI
0.43622568.9092518.html.plaintext.txt	40	The radioactive isotopes 32PdCTP 3000 Cimol 35SdATP 1200 Cimmol Sequenase sequencing grade obtained ICN Costa Mesa CA DuPont NEN respectively
0.43622568.9092518.html.plaintext.txt	41	The DNA purification systems used GeneClean kit BIO 101 Inc
0.43622568.9092518.html.plaintext.txt	42	La Jolla CA Qiagen plasmid kit acquired Qiagen Inc
0.43622568.9092518.html.plaintext.txt	43	Expression plasmids transcription factors generous gifts Dr
0.43622568.9092518.html.plaintext.txt	44	Chen pLen4S HNF4 pL H3 HNF3 Dr
0.43622568.9092518.html.plaintext.txt	45	Johnson pMEXCEBP CEBP pMEXCRP2
0.43622568.9092518.html.plaintext.txt	46	Antiserum COUP TFII kind gift Dr
0.43622568.9092518.html.plaintext.txt	47	Affinity purified rabbit polyclonal antibodies RAR sc 773 cross reacts RAR 1 2 1 2 1 2 isoforms RXR sc 774 cross reacts RXR isoforms CEBP sc 61 c erbA1 sc 76 obtained Santa Cruz Biotechnology Inc
0.43622568.9092518.html.plaintext.txt	48	Other reagents Sigma
0.43622568.9092518.html.plaintext.txt	49	The human hepatoma cell line HepG2 ATCC HB8065 African green monkey kidney cells COS 1 ATCC CRL1650 obtained American Type Culture Collection Rockville MD
0.43622568.9092518.html.plaintext.txt	50	The cells grown 11 mixture Dulbeccos modified Eagles medium F12 Life Technologies Inc
0.43622568.9092518.html.plaintext.txt	51	supplemented 100 unitsml penicillin G streptomycin sulfate Celox Corp
0.43622568.9092518.html.plaintext.txt	52	Hopkins MN 10 vv heat inactivated fetal calf serum JRH Biosciences Lenexa KS
0.43622568.9092518.html.plaintext.txt	53	The sequences CYP7A promoter nt 200 32 amplified polymerase chain reaction PCR using p 41632 3 template
0.43622568.9092518.html.plaintext.txt	54	Primers designed introduce 5 KpnI 3 XhoI site cloning luciferase reporter vector pGL2 Basic Promega resulting plasmid p 20032
0.43622568.9092518.html.plaintext.txt	55	The mutations sequences nt 74 54 see Fig
0.43622568.9092518.html.plaintext.txt	56	1A introduced linking two fragments synthesized PCR mutagenic primers containing restriction sites 5 3 end using p 41632 template
0.43622568.9092518.html.plaintext.txt	57	The region nt 74 54 replaced SpeI site linking nt 41674 SpeI nt 53SpeI32 fragments generate p 4167454 SpeI
0.43622568.9092518.html.plaintext.txt	58	To delete SpeI site p 4167454 SpeI digested SpeI treated Mung bean nuclease religated generate deletion mutant p 4167454
0.43622568.9092518.html.plaintext.txt	59	p2007454 obtained PCR using p 4167454 template
0.43622568.9092518.html.plaintext.txt	60	p 416LSM7471 linker scanning mutation constructed ligating nt 70 32 SpeIXhoI fragment 416 7454Spe digested SpeI XhoI
0.43622568.9092518.html.plaintext.txt	61	p 4167465 isolated spontaneously arising deletion mutant
0.43622568.9092518.html.plaintext.txt	62	p 416LSM 5954 p 416LSM7066 p 416IM6463 insertion mutation constructed similarly p 416LSM7471
0.43622568.9092518.html.plaintext.txt	63	All promoterreporter constructs cloned pGL2 Basic vector
0.43622568.9092518.html.plaintext.txt	64	All constructs confirmed sequencing Sequenase 2
0.43622568.9092518.html.plaintext.txt	65	Effect overexpressing recombinant COUP TFII transcriptional activity nt 416 32 fragment rat CYP7A promoter
0.43622568.9092518.html.plaintext.txt	66	A schematic representation mutations introduced region nt 74 nt 54 rat CYP7A promoter described Experimental Procedures
0.43622568.9092518.html.plaintext.txt	67	Wild type sequence nt 81 48 diagrammed top
0.43622568.9092518.html.plaintext.txt	68	All clones promoter sequences nt 416 32 ligated pGL2 Basic
0.43622568.9092518.html.plaintext.txt	69	Restriction sites underlined dashes sequence represent deleted base pairs non homologous sequences indicated lowercase letters
0.43622568.9092518.html.plaintext.txt	70	The DR4 overlined direct repeat described 11 boxed
0.43622568.9092518.html.plaintext.txt	71	B increasing mass expression plasmid pTF3A encoding COUP TFII cotransfected CYP7luciferase reporter plasmids diagrammed panel A
0.43622568.9092518.html.plaintext.txt	72	The total mass plasmid kept constant addition vector without promoter
0.43622568.9092518.html.plaintext.txt	73	Confluent monolayers HepG2 cells transfected 5 microg indicated reporter plasmids various amounts pTF3A 0
0.43622568.9092518.html.plaintext.txt	74	5 microg pCMV described Experimental Procedures overlaid DMEMF12 medium without serum glycerol shock
0.43622568.9092518.html.plaintext.txt	75	The cells harvested 40 h glycerol shock luciferase activity assayed corrected transfection efficiency galactosidase activity
0.43622568.9092518.html.plaintext.txt	76	The activation COUP TFII transcriptional activities expressed percentage corrected luciferase activity without coexpressed COUP TFII
0.43622568.9092518.html.plaintext.txt	77	The percentage activation differed wild type p 0
0.43622568.9092518.html.plaintext.txt	78	01 p 20032 versus p 200 7454 p 41632 versus remainder mutants determined Students test error bars omitted clarity
0.43622568.9092518.html.plaintext.txt	79	Data representative two individual experiments
0.43622568.9092518.html.plaintext.txt	80	C basal transcriptional activities CYP7A promoterluciferase reporter plasmids mutations region nt 74 54
0.43622568.9092518.html.plaintext.txt	81	Error bars indicate standard deviation triplicate samples construct
0.43622568.9092518.html.plaintext.txt	82	indicates statistical significance difference wild type p 0
0.43622568.9092518.html.plaintext.txt	83	To control variation measured activities due differences individual plasmid preparations relative activities p 41632 p 4167454Spe p 4167465 p 4165954 p 4167454 CYP7A promoterluciferase gene constructs assayed three separate plasmid preparations transfected triplicate two different experiments described Experimental Procedures
0.43622568.9092518.html.plaintext.txt	84	The results obtained essentially shown panel C
0.43622568.9092518.html.plaintext.txt	85	View Larger Version Image 28K GIF file
0.43622568.9092518.html.plaintext.txt	86	Confluent cultures HepG2 cells grown 12 well tissue culture plates transfected DNA calcium phosphate method described previously 3 11
0.43622568.9092518.html.plaintext.txt	87	Luciferase activities determined luciferase assay kit Promega according manufacturer instructions using Lumat LB9501 luminometer Berthold Systems Inc
0.43622568.9092518.html.plaintext.txt	88	Luciferase activities normalized transfection efficiencies dividing relative light units galactosidase activity expressed cotransfected pCMV plasmid Clontech
0.43622568.9092518.html.plaintext.txt	89	Galactosidase activities determined using O nitrophenyl D galactopyranoside substrate 18
0.43622568.9092518.html.plaintext.txt	90	The average corrected luciferase activity cell extracts given error bars indicate standard deviation activity triplicate samples
0.43622568.9092518.html.plaintext.txt	91	All transfections repeated least two times
0.43622568.9092518.html.plaintext.txt	92	Statistical significances analyzed Students test using Sigma Plot software Jandel Scientific San Rafael CA
0.43622568.9092518.html.plaintext.txt	93	Preparation Nuclear Extracts
0.43622568.9092518.html.plaintext.txt	94	Nuclei HepG2 COS 1 cells isolated essentially described 19 20
0.43622568.9092518.html.plaintext.txt	95	Recombinant COUP TFII prepared transfecting confluent HepG2 sub confluent COS 1 cells 100 mm tissue culture plates 20 microg pTF3A 1 microg pCMV
0.43622568.9092518.html.plaintext.txt	96	The monolayers overlaid DMEMF12 containing 5 mM butyric acid 10 fetal calf serum glycerol shock nuclei harvested 40 h later
0.43622568.9092518.html.plaintext.txt	97	Transfection efficiency monitored galactosidase activity
0.43622568.9092518.html.plaintext.txt	98	Electrophoretic Mobility Shift Assay EMSA
0.43622568.9092518.html.plaintext.txt	99	Double stranded synthetic probes EMSA prepared heating equal molar amounts complementary synthetic oligomers 95 degrees C 2 x SSC 0
0.43622568.9092518.html.plaintext.txt	100	0 allowing cool room temperature
0.43622568.9092518.html.plaintext.txt	101	The resulting double stranded fragments designed single stranded 5 overhangs end labeling incorporating 32PdCTP 3000 Cimol Klenow fragment DNA polymerase I
0.43622568.9092518.html.plaintext.txt	102	Oligonucleotides blunted non labeled dNTPs used cold competitors EMSA
0.43622568.9092518.html.plaintext.txt	103	Labeled fragments isolated 15 polyacrylamide gel purified two G 50 spin columns
0.43622568.9092518.html.plaintext.txt	104	Binding reactions initiated addition 2 microg nuclear extracts 100000 cpm oligomer probe dissolved 20 microl buffer containing 12 mM HEPES pH 7
0.43622568.9092518.html.plaintext.txt	105	9 50 mM KCl 1 mM EDTA 1 mM dithiothreitol 15 glycerol 2 microg polydI dC polydI dC
0.43622568.9092518.html.plaintext.txt	106	After incubation time indicated legends Figs
0.43622568.9092518.html.plaintext.txt	107	2 3 4 5 samples run 4 polyacrylamide gels dried autoradiographed
0.43622568.9092518.html.plaintext.txt	108	EMSAs quantitated IP Lab Gel software Signal Analytics Corp
0.43622568.9092518.html.plaintext.txt	109	Vienna VA conjunction PhosphorImager 445Si Molecular Dynamics Sunnyvale CA
0.43622568.9092518.html.plaintext.txt	110	Effect overexpressing recombinant COUP TFII EMSA pattern probes based sequence nt 74 54
0.43622568.9092518.html.plaintext.txt	111	A diagram oligonucleotide probes
0.43622568.9092518.html.plaintext.txt	112	Shown DR4 overlined sequence AGTTCAAG homology nt 149 118 boxed
0.43622568.9092518.html.plaintext.txt	113	B EMSA HepG2 cell extract
0.43622568.9092518.html.plaintext.txt	114	Shown autoradiogram EMSA performed nuclear extracts prepared HepG2 cells HepG2 HepG2 cells transfected pTF3A HepG2 COUP TFII oligomer probes based sequences nt 74 55
0.43622568.9092518.html.plaintext.txt	115	Reactions incubated 30 degrees C 15 min
0.43622568.9092518.html.plaintext.txt	116	Arrow indicates bands change overexpression COUP TFII
0.43622568.9092518.html.plaintext.txt	117	C EMSA comparing shift pattern HepG2 cell nuclear extract COS 1 cells
0.43622568.9092518.html.plaintext.txt	118	Experiment performed panel B
0.43622568.9092518.html.plaintext.txt	119	Autoradiogram overexposed relative panel B show fainter band shift nt 72 59 nt 65 54 probes
0.43622568.9092518.html.plaintext.txt	120	Arrow indicates band increases increased COUP TFII expression
0.43622568.9092518.html.plaintext.txt	121	View Larger Version Image 39K GIF file
0.43622568.9092518.html.plaintext.txt	122	EMSA presence COUP TF CEBP c erbA specific antibodies using probe based sequence nt 74 55
0.43622568.9092518.html.plaintext.txt	123	Autoradiogram EMSA performed oligomer probe based nt 74 55 sequence nuclear extracts prepared HepG2 cells overexpressed COUP TFII
0.43622568.9092518.html.plaintext.txt	124	The supershift assay performed 1 microl specific antibody COUP TF c erbA CEBP added indicated samples samples incubated overnight 4 degrees C
0.43622568.9092518.html.plaintext.txt	125	Arrow labeled COUP TFIIantibody indicates band shift identified antibody COUP TFII DNA complex arrow labeled COUP TFII corresponds band indicated arrow panels B C arrow labeled DRBP points bands previously shown bind nt 65 54 panel C
0.43622568.9092518.html.plaintext.txt	126	View Larger Version Image 61K GIF file
0.43622568.9092518.html.plaintext.txt	127	EMSA presence RAR RXR COUP TF specific antibodies using nt 149 128 probe
0.43622568.9092518.html.plaintext.txt	128	EMSA performed using nt 149 128 probe generated digesting double stranded synthetic oligomer nt 149 118 MspI diagrammed top imperfect HRE half sites underlined end labeling described Experimental Procedures gel isolating nt 149 128 fragment
0.43622568.9092518.html.plaintext.txt	129	The probe incubated 5 microg nuclear extracts untreated HepG2 cells HepG2 cells treated 10 microM trans retinoic acid HepG2 retinoic acid 24 h harvesting
0.43622568.9092518.html.plaintext.txt	130	View Larger Version Image 78K GIF file
0.43622568.9092518.html.plaintext.txt	131	EMSA supershift presence RXR specific antibodies using probes based sequence nt 149 128
0.43622568.9092518.html.plaintext.txt	132	Shown wild type WT oligomer probe sequence top trinucleotide transversion mutations indicated
0.43622568.9092518.html.plaintext.txt	133	Numbers lanes correspond nucleotides mutated according following rule A C C A G T T G
0.43622568.9092518.html.plaintext.txt	134	For example 145143 corresponds nt 149 128 probe nt 145 G changed T nt 144 G changed T nt 143 A changed C
0.43622568.9092518.html.plaintext.txt	135	Mutation wild type indicated lowercase letters
0.43622568.9092518.html.plaintext.txt	136	Supershifted probes indicated arrow
0.43622568.9092518.html.plaintext.txt	137	View Larger Version Image 113K GIF file
0.43622568.9092518.html.plaintext.txt	138	Activation CYP7A Promoter Activity Recombinant COUP TFII Identification Negative Element
0.43622568.9092518.html.plaintext.txt	139	Cotransfection rat CYP7A promoter fragment nt 416 32 fused luciferase gene p41632 Fig
0.43622568.9092518.html.plaintext.txt	140	1A plasmid encoding recombinant COUP TFII pTF3A found strongly stimulate reporter activity Fig
0.43622568.9092518.html.plaintext.txt	141	The dose response curve resulting cotransfecting increasing amounts pTF3A p 20032 indistinguishable stimulation curve p 41632 Fig
0.43622568.9092518.html.plaintext.txt	142	1B despite lower overall luciferase reporter activity Fig
0.43622568.9092518.html.plaintext.txt	143	1C indicating COUP TF activation elements downstream position nt 200
0.43622568.9092518.html.plaintext.txt	144	1A reduced stimulatory effect COUP TFII Fig
0.43622568.9092518.html.plaintext.txt	145	To define sequences important COUP TFII activation number deletion linker scanning mutations LSM introduced nt 74 54 region
0.43622568.9092518.html.plaintext.txt	146	The dose dependent stimulation promoter activity reporter plasmids COUP TFII fell roughly three groups
0.43622568.9092518.html.plaintext.txt	147	In first group wild type promoter fragments p 41632 p 20032 showed greatest stimulation transcriptional activity effect positive points curve Fig
0.43622568.9092518.html.plaintext.txt	148	The second group includes p 416LSM7471 p 416LSM7066 p 4167465 p 416LSM5954 p 4167454 p2007454 displayed considerably flatter dose response curves Fig
0.43622568.9092518.html.plaintext.txt	149	The mutations group destroyed one putative HRE half sites AGGTCA either completely deleting sequence p 4167465 p 4167454 p2007454 replacing sequence SpeI restriction site preserving relative spacing sequences either side mutation p 416LSM7471 p 416LSM7066 p 416LSM5954 Fig
0.43622568.9092518.html.plaintext.txt	150	Reporter plasmids HRE half sites deleted p 4167454 p2007454 retained significant stimulation COUP TFII approximately 3 4 fold suggesting may additional COUP TFII sites elsewhere promoter
0.43622568.9092518.html.plaintext.txt	151	Consistent hypothesis putative COUP TFII activation elements downstream position nt 200 p 2007454 stimulated approximately extent p 4167454 deletion 216 base pairs longer Fig
0.43622568.9092518.html.plaintext.txt	152	The third category represented insertion mutant IM p 416IM6463 displayed activation intermediate first second groups
0.43622568.9092518.html.plaintext.txt	153	This plasmid HRE half sites intact spacing increased 4 5 base pairs Fig
0.43622568.9092518.html.plaintext.txt	154	1A strongly activated somewhat lesser extent wild type reaching maximum 1740 plus minus 99 verses 2960 plus minus 209 respectively transcription factor plasmid mass reporter plasmid mass ratio 0
0.43622568.9092518.html.plaintext.txt	155	The various mutations affected basal activity
0.43622568.9092518.html.plaintext.txt	156	Mutant reporter plasmids p 4167454 p 416LSM7471 p 416LSM5954 p 4167465 p2007454 increased basal promoter activity relative parental plasmids p 41632 p 20032 would observed repressor binding site mutated
0.43622568.9092518.html.plaintext.txt	157	With one exception basal promoter activity also fell three groups corresponding COUP TFII responsiveness reporter plasmid Fig
0.43622568.9092518.html.plaintext.txt	158	The promoterreporter constructs lowest response COUP TFII highest basal activities p 4167454 p 416LSM7471
0.43622568.9092518.html.plaintext.txt	159	p 416IM6463 basal transcriptional activity significantly higher wild type
0.43622568.9092518.html.plaintext.txt	160	The exception p 416LSM7066 activated COUP TFII extent p 416LSM5954 p 4167465 display transcriptional activation p 41632
0.43622568.9092518.html.plaintext.txt	161	The activation p 4167454 p 41632 observed kidney cell line COS 1
0.43622568.9092518.html.plaintext.txt	162	Interaction COUP TFII CYP7A Promoter nt 74 54
0.43622568.9092518.html.plaintext.txt	163	To determine COUP TF activates transcriptional activity directly binding sequence nt 74 54 ability COUP TF interact CYP7A sequences vitro measured EMSA
0.43622568.9092518.html.plaintext.txt	164	Also promoter fragments nt 200 74 screened determine additional COUP TFII binding sites
0.43622568.9092518.html.plaintext.txt	165	Nuclear extracts prepared HepG2 cells transfected pTF3A expression plasmid specifically encoding COUP TFII
0.43622568.9092518.html.plaintext.txt	166	The gel shift patterns nt 72 59 nt 65 54 oligomers similar HepG2 cells regardless COUP TFII overexpression Fig
0.43622568.9092518.html.plaintext.txt	167	Two extra bands shifted nt 74 53 probe enhanced COUP TFII overexpression Fig
0.43622568.9092518.html.plaintext.txt	168	The nt 74 53 included putative DR4 overlined Fig
0.43622568.9092518.html.plaintext.txt	169	2A nt 72 59 nt 65 54 oligomers
0.43622568.9092518.html.plaintext.txt	170	The diffuse nature bands attributed low abundance nuclear factors
0.43622568.9092518.html.plaintext.txt	171	Recombinant COUP TFII expressed kidney cell line COS 1 bound nt 74 53 Fig
0.43622568.9092518.html.plaintext.txt	172	2C indicating binding COUP TF dependent liver specific factors
0.43622568.9092518.html.plaintext.txt	173	The increased band shift COS 1 extracts attributed higher activity MT2 promoter pTF3A drives transcription recombinant gene encoding COUP TFII COS 1 cells relative HepG2 cells
0.43622568.9092518.html.plaintext.txt	174	This presumably results higher levels expression recombinant COUP TFII cell line
0.43622568.9092518.html.plaintext.txt	175	Overexpression COUP TFII associated reduction DRBP binding even probes unable shifted COUP TFII nt 7259 6554
0.43622568.9092518.html.plaintext.txt	176	The reduction DRBP binding may attributed reduced proportion DRBP given mass protein COS 1 nuclear extracts overexpressed recombinant COUP TFII
0.43622568.9092518.html.plaintext.txt	177	Alternatively COUP TFII interacts DRBP solution overexpressed COUP TFII may sequestering DRBP forms larger complexes probe nt 7453
0.43622568.9092518.html.plaintext.txt	178	COUP TFII shift probes lacking COUP TFII binding site nt 7259 6554 Fig
0.43622568.9092518.html.plaintext.txt	179	It apparent COUP TFII interacts DR4 nt 74 53 DRBP interacts AGTTCAAG sequence Fig
0.43622568.9092518.html.plaintext.txt	180	To confirm COUP TFII binds sequence antiserum raised COUP TF added EMSA using nt 74 55 oligomer probe nuclear extract HepG2 cells
0.43622568.9092518.html.plaintext.txt	181	The band increased intensity shifted nuclear extracts HepG2 overexpressing COUP TFII supershifted anti COUP TF antibody Fig
0.43622568.9092518.html.plaintext.txt	182	3 indicating COUP TFII interacting directly region
0.43622568.9092518.html.plaintext.txt	183	Extracts prepared cells overexpressing recombinant CEBP LAP HNF4 HNF3 produce changes band shift pattern data shown antiserum directed CEBP potential binding site nt 52 41 c erbA homologue thyroid receptor regulated phosphorylation events change gel shift pattern Fig
0.43622568.9092518.html.plaintext.txt	184	Antibody RAR RXR supershift nt 74 53 probe
0.43622568.9092518.html.plaintext.txt	185	However performed extracts prepared HepG2 cells treated trans retinoic acid ligand RAR nt 74 54 probe weakly supershifted anti RXR data shown
0.43622568.9092518.html.plaintext.txt	186	DRBP major nuclear factor binds sequence affected antibody indicating proteins responsible band distinct COUP TFII RXR
0.43622568.9092518.html.plaintext.txt	187	These results confirm COUP TFII binds DR4 motif bind thyroid hormone receptor
0.43622568.9092518.html.plaintext.txt	188	CEBP LAP HNF4 HNF3 bind region CYP7A promoter
0.43622568.9092518.html.plaintext.txt	189	Interaction COUP TFII RXR CYP7A Promoter nt 149 128
0.43622568.9092518.html.plaintext.txt	190	The probe nt 149 128 shifted one band HepG2 nuclear extracts
0.43622568.9092518.html.plaintext.txt	191	Antibody COUP TFII supershifted oligomer changed pattern bands complex disrupted Fig
0.43622568.9092518.html.plaintext.txt	192	The amount probe supershifted increased increasing amounts antibody indicating antibody excess
0.43622568.9092518.html.plaintext.txt	193	Antibody RXR supershifted band HepG2 nuclear extract treated retinoic acid
0.43622568.9092518.html.plaintext.txt	194	The antibody directed RAR supershift probe even extract prepared HepG2 cells treated trans retinoic acid
0.43622568.9092518.html.plaintext.txt	195	Retinoic acid treatment may increased expression endogenous RXR showed supershift anti RXR
0.43622568.9092518.html.plaintext.txt	196	Once determined antibody specific RXR supershifted nt 149 128 probe nucleotides important binding RXR determined EMSA mutant oligonucleotides antibody RXR
0.43622568.9092518.html.plaintext.txt	197	Double stranded oligonucleotides synthesized three bases changed transversions
0.43622568.9092518.html.plaintext.txt	198	Trinucleotide mutations nt 145 134 completely abolished reduced supershift antibody RXR Fig
0.43622568.9092518.html.plaintext.txt	199	Mutations nt 133131 effect supershift antibody RXR
0.43622568.9092518.html.plaintext.txt	200	These results indicate RXR interacting DR1 motif located nt 146 134
0.43622568.9092518.html.plaintext.txt	201	Cotransfection assays COUP TFII expression plasmid wild type mutant CYP7A proximal promoter constructs EMSA results indicate COUP TFII interacts nt 74 53 nt 149 128 rat CYP7A promoter
0.43622568.9092518.html.plaintext.txt	202	The region nt 146 134 shown EMSA bind RXR contains HRE half sites separated one nucleotide DR1 preferred binding site RXR homodimer 14
0.43622568.9092518.html.plaintext.txt	203	The pattern response mutants nt 74 54 suggested nt 74 54 element strongest potential COUP TF activation transcription
0.43622568.9092518.html.plaintext.txt	204	The deletion sequences nt 74 54 results increase transcriptional activity CYP7A promoterreporter plasmids
0.43622568.9092518.html.plaintext.txt	205	This sequence previously found mediate bile acid response interact DRBP whose binding sensitive deoxycholate feeding rats
0.43622568.9092518.html.plaintext.txt	206	6 model shows binding sites transcription factors rat CYP7A proximal promoter
0.43622568.9092518.html.plaintext.txt	207	Interactions transactivators COUP TFII RXR DRBP competition binding bile acid response elements may regulate CYP7A gene transcription bile acids hormones
0.43622568.9092518.html.plaintext.txt	208	The CCAAT enhancer binding proteins CEBP CEBP LAP 21 consensus binding site flank COUP TFII binding site nt 74 54
0.43622568.9092518.html.plaintext.txt	209	The CEBP family transcription factors temporally regulated thus important developmental regulators gene expression
0.43622568.9092518.html.plaintext.txt	210	COUP TFII may recruit CEBP apolipoprotein A1 promoter 22
0.43622568.9092518.html.plaintext.txt	211	The DBP B site also LAP binding site located nt 149 118 region 23
0.43622568.9092518.html.plaintext.txt	212	However antibody directed CEBP LAP supershift nt 149118 probe
0.43622568.9092518.html.plaintext.txt	213	This consistent lack effect transcription factors CYP7A promoter activity observed
0.43622568.9092518.html.plaintext.txt	214	The juxtaposition COUP TF CEBP binding sites nt 7454 nt 149118 may prevent weak binding factors
0.43622568.9092518.html.plaintext.txt	215	Diagram CYP7A proximal promoter DRBP COUP TFII RXR recognition sites indicated relation transcription start site D site binding protein DBP liver activating protein LAP binding sites
0.43622568.9092518.html.plaintext.txt	216	DBP LAP CEBP binding sites determined previously 4 23
0.43622568.9092518.html.plaintext.txt	217	View Larger Version Image 18K GIF file
0.43622568.9092518.html.plaintext.txt	218	In light well characterized negative effect COUP TFII gene promoters removing COUP TFII binding site CYP7A promoter may explain much higher activity deletion mutants Fig
0.43622568.9092518.html.plaintext.txt	219	However several recent reports support finding COUP TFII also function transactivator 24 27
0.43622568.9092518.html.plaintext.txt	220	COUP TFII binds stable homodimer many variations GGTCA sequences direct repeats interferes vitamin D3 thyroid hormone retinoic acid receptors competing AGGTCA sites cognate sequences steroidthyroid hormone receptors 15
0.43622568.9092518.html.plaintext.txt	221	However negative effect COUP TFII due interfering positive factor expression COUP TFII repress transcriptional activity CYP7A promoter
0.43622568.9092518.html.plaintext.txt	222	COUP TFII activated transcription CYP7A promoter COUP TFII expression plasmid reporter plasmid ratios tried
0.43622568.9092518.html.plaintext.txt	223	The deletion strong proximal COUP TFII site nt 74 55 may allow enhancers promoter interact readily transcriptional machinery resulting higher transcriptional activity
0.43622568.9092518.html.plaintext.txt	224	COUP TFII reported interact TFIIB 28 affect transcriptional activity interacting transcription factors
0.43622568.9092518.html.plaintext.txt	225	For example COUP TFII required activation apolipoprotein A1 promoter RXR 22
0.43622568.9092518.html.plaintext.txt	226	As COUP TFII RXR recognized nt 149 128 probe possible COUP TFII may interact RXR
0.43622568.9092518.html.plaintext.txt	227	The heterodimer COUP TFII RXR known bind DR1 motif transrepress gene transcription 13
0.43622568.9092518.html.plaintext.txt	228	Despite finding COUP TF binds region responsive bile acid repression role COUP TFII bile acid regulation CYP7A clear requires study
0.43622568.9092518.html.plaintext.txt	229	The region nt 65 54 confer bile acid response SV40 promoter probe bind COUP TFII vitro Fig
0.43622568.9092518.html.plaintext.txt	230	However DRBP COUP TFII apparently share binding sequence 3 COUP TFII half site overlaps DRBP binding site Fig
0.43622568.9092518.html.plaintext.txt	231	COUP TF clearly influences cholesterol metabolism transcription factor previously shown affect transcription promoters apolipoprotein AI 16 apolipoprotein AII apolipoprotein B 29 apolipoprotein CIII 29 30 cholesteryl ester transfer protein gene 27
0.43622568.9092518.html.plaintext.txt	232	The physiological role sequences nt 74 54 may restrain CYP7A expression
0.43622568.9092518.html.plaintext.txt	233	This regulation may necessary cytotoxicity bile acids need preserve cholesterol synthesis steroid hormones membrane components
0.43622568.9092518.html.plaintext.txt	234	The exact interactions factors involved yet defined however data consistent model COUP TFII RXR DRBP interact bind negative element region nt 74 54 positive element nt 149 118 10 lead regulation CYP7A gene transcription response signals bile acids hormones
0.43622568.9092518.html.plaintext.txt	235	This work contributes increasing body evidence indicating COUP TF prominent role transcriptional regulation lipid metabolism factor binding nt 74 54 nt 149 128 regions important determinants CYP7A transcription
0.43622568.9092518.html.plaintext.txt	236	This research supported part National Institutes Health Grants GM31584 DK44442
0.43622568.9092518.html.plaintext.txt	237	The costs publication article defrayed part payment page charges
0.43622568.9092518.html.plaintext.txt	238	The article must therefore hereby marked advertisement accordance 18 U
0.43622568.9092518.html.plaintext.txt	239	Section 1734 solely indicate fact
0.43622568.9092518.html.plaintext.txt	240	Public Health Service Individual National Research Service Award HL09156
0.43622568.9092518.html.plaintext.txt	241	To correspondence addressed Dept
0.43622568.9092518.html.plaintext.txt	242	Biochemistry Molecular Pathology Northeastern Ohio Universities College Medicine P
0.43622568.9092518.html.plaintext.txt	243	Box 95 Rootstown OH 44272 0095
0.43622568.9092518.html.plaintext.txt	244	1 The abbreviations used Fp footprint CEBP CAATenhancer binding protein COUP TFII chicken ovalbumin upstream promoter transcription factor II DR direct repeat sequence DRBP direct repeat binding protein EMSA electrophoretic mobility shift assay HNF hepatocyte nuclear factor HRE hormone response element LUC luciferase nt nucleotides RAR retinoic acid receptor RXR retinoid X receptor TRE thyroid hormone response element PCR polymerase chain reaction DMEM Dulbeccos modified Eagles medium LSM linker scanning mutation IM insertion mutant
0.43622568.9092518.html.plaintext.txt	245	The transcription factor expression plasmids generous gifts Drs
0.43622568.9092518.html.plaintext.txt	246	Johnson CEBP LAP M
0.43622568.9092518.html.plaintext.txt	247	Antibody COUP TFII obtained Dr
0.43622568.9092518.html.plaintext.txt	248	1996 Advances Molecular Cellular Biology Bittar E
0.43622568.9092518.html.plaintext.txt	249	269 316 JAI Press Greenwich London Crestani M
0.43622568.9092518.html.plaintext.txt	250	36 2419 2432 Abstract Crestani M
0.43622568.9092518.html.plaintext.txt	251	198 546 553 CrossRefMedline Order article via Infotrieve Lavery D
0.43622568.9092518.html.plaintext.txt	252	265 12012 12019 AbstractFree Full Text Ramirez M
0.43622568.9092518.html.plaintext.txt	253	14 2809 2821 Abstract Crestani M
0.43622568.9092518.html.plaintext.txt	254	306 451 460 CrossRefMedline Order article via Infotrieve Chiang J
0.43622568.9092518.html.plaintext.txt	255	Acta 1132 337 339 Medline Order article via Infotrieve Wang D
0.43622568.9092518.html.plaintext.txt	256	37 1831 1841 Abstract Crestani M
0.43622568.9092518.html.plaintext.txt	257	225 585 592 CrossRefMedline Order article via Infotrieve Chiang J
0.43622568.9092518.html.plaintext.txt	258	269 17502 17507 AbstractFree Full Text Umesono K
0.43622568.9092518.html.plaintext.txt	259	1991 Cell 65 1255 1266 Medline Order article via Infotrieve Mangelsdorf D
0.43622568.9092518.html.plaintext.txt	260	1994 The Retinoids Biology Chemistry Medicine Sporn M
0.43622568.9092518.html.plaintext.txt	261	319 349 Raven Press New York Mangelsdorf D
0.43622568.9092518.html.plaintext.txt	262	1995 Cell 83 841 850 Medline Order article via Infotrieve Cooney A
0.43622568.9092518.html.plaintext.txt	263	12 4153 4163 Abstract Ladias J
0.43622568.9092518.html.plaintext.txt	264	1991 Science 251 561 565 Medline Order article via Infotrieve Soosaar A
0.43622568.9092518.html.plaintext.txt	265	391 95 100 CrossRefMedline Order article via Infotrieve Sambrook J
0.43622568.9092518.html.plaintext.txt	266	1989 Molecular Cloning A Laboratory Manual 2nd Ed
0.43622568.9092518.html.plaintext.txt	267	16 66 Cold Spring Harbor Press Cold Spring Harbor NY Dent C
0.43622568.9092518.html.plaintext.txt	268	1993 Transcription Factors A Practical Approach Latchman D
0.43622568.9092518.html.plaintext.txt	269	10 12 IRS Press Oxford Sierra F
0.43622568.9092518.html.plaintext.txt	270	1993 Gene Transcription A Practical Approach Hames B
0.43622568.9092518.html.plaintext.txt	271	125 152 IRL Press Oxford Faisst S
0.43622568.9092518.html.plaintext.txt	272	20 3 26 Medline Order article via Infotrieve Ge R
0.43622568.9092518.html.plaintext.txt	273	269 13185 13192 AbstractFree Full Text Lee Y
0.43622568.9092518.html.plaintext.txt	274	269 14681 14689 AbstractFree Full Text Kimura A
0.43622568.9092518.html.plaintext.txt	275	268 11125 11133 AbstractFree Full Text Kadowaki Y
0.43622568.9092518.html.plaintext.txt	276	92 4432 4436 Abstract Malik S
0.43622568.9092518.html.plaintext.txt	277	23 1536 1543 Abstract Gaudet F
0.43622568.9092518.html.plaintext.txt	278	270 29916 29922 AbstractFree Full Text Ing N
0.43622568.9092518.html.plaintext.txt	279	267 17617 17623 AbstractFree Full Text Ladias J
0.43622568.9092518.html.plaintext.txt	280	267 15849 15860 AbstractFree Full Text Mietus Snyder M
0.43622568.9092518.html.plaintext.txt	281	12 1708 1718 Abstract 1997 The American Society Biochemistry Molecular Biology Inc
0.3001008.11117523.html.plaintext.txt	0	COUP TFI Chicken Ovalbumin Upstream Promoter Transcription Factor I Regulates Cell Migration Axogenesis Differentiating P19 Embryonal Carcinoma Cells Francoise Adam Tony Sourisseau Raphael Metivier Yann Le Page Christine Desbois Denis Michel Gilles Salbert
0.3001008.11117523.html.plaintext.txt	1	Equipe Information et Programmation Cellulaire F
0.3001008.11117523.html.plaintext.txt	2	Equipe d Endocrinologie Moleculaire de la Reproduction R
0.3001008.11117523.html.plaintext.txt	3	UPRES A CNRS 6026 Universite de Rennes I Campus de Beaulieu 35042 Rennes Cedex France
0.3001008.11117523.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The developmental expression patterns nuclear orphan receptors COUP TFs chicken ovalbumin upstream promoter transcription factors correlated neurogenesis several animal species
0.3001008.11117523.html.plaintext.txt	5	Nevertheless role COUP TFs neurogenesis remains unknown
0.3001008.11117523.html.plaintext.txt	6	We studied functional involvement COUP TFI retinoic acid RA induced neuronal differentiation P19 embryonal carcinoma cells two complementary approaches 1 deregulated expression COUP TFI 2 inactivation endogenous COUP TFs means dominant negative COUP TFI mutant
0.3001008.11117523.html.plaintext.txt	7	Low levels wild type wtCOUP TFI transgene expression inhibit neural cell fate primarily enhanced neuron outgrowth RA treated P19 aggregates
0.3001008.11117523.html.plaintext.txt	8	In contrast high COUP TFI expression impeded neuronal differentiation P19 cells induced RA resulting cell cultures lacking neurons
0.3001008.11117523.html.plaintext.txt	9	This morphological effect correlated elevated level E cadherin mRNA
0.3001008.11117523.html.plaintext.txt	10	The dominant negative COUP TFI mutant induced cell packing RA treatment inhibited neurite extension neuron outgrowth aggregates
0.3001008.11117523.html.plaintext.txt	11	A RGD peptide interference assay indicated endogenous COUP TFs could favor migration neurons integrin dependent mechanism
0.3001008.11117523.html.plaintext.txt	12	Accordingly vitronectin mRNA levels shown regulated COUP TFI RT PCR analysis COUP TFI stimulated mouse vitronectin promoter activity transient transfection assays
0.3001008.11117523.html.plaintext.txt	13	Taken together data indicate COUP TFI simply global repressor retinoid functions shows high selectivity regulating genes involved cellular adhesion migration processes particularly important neuronal differentiation
0.3001008.11117523.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Pattern formation organogenesis metazoan orchestrated transcriptional regulators cell adhesion molecules signal transduction systems tightly maintained along evolution
0.3001008.11117523.html.plaintext.txt	15	The nuclear receptor superfamily review see Ref
0.3001008.11117523.html.plaintext.txt	16	1 includes ancient members retinoid X receptor RXR 2 FTZ F1 3 chicken ovalbumin upstream promoter transcription factor COUP TF 4 5 important developmental regulators vertebrates arthropods 6 7 8 9 10 11 12 13 14 15 reported cnidarians 16
0.3001008.11117523.html.plaintext.txt	17	The COUP TFI orphan receptor originally characterized transcriptional activator chicken ovalbumin gene 17
0.3001008.11117523.html.plaintext.txt	18	Since COUP TFI closely related receptors COUP TFII 18 extensively studied terms biochemical properties
0.3001008.11117523.html.plaintext.txt	19	DNA binding dimerization transcriptional activation repression tissue distribution particular emphasis developmental processes review see Ref
0.3001008.11117523.html.plaintext.txt	20	In species examined presence COUP TF development sea urchin mouse expression orphan receptor clearly associated neurogenesis 20 21 22 23 24 25
0.3001008.11117523.html.plaintext.txt	21	Nonetheless precise role COUP TFI regulation neuronal growth differentiation still unknown
0.3001008.11117523.html.plaintext.txt	22	Recent studies suggest COUP TFI involved regulation cell cell contacts 26 modulates axonal growth 14 27
0.3001008.11117523.html.plaintext.txt	23	Indeed COUP TFI gene disruption mouse results decreased arborization spinal nerves 14 abnormal morphogenesis ninth cranial nerve ganglion 14 defects guidance axons emanating thalamic neurons normally project cortical layer IV 27
0.3001008.11117523.html.plaintext.txt	24	Disruption mouse COUP TFII gene induced early lethality day 10 postcoitum thus making difficult analyze role COUP TFII neurogenesis 28
0.3001008.11117523.html.plaintext.txt	25	Even certain degree redundancy COUP TFI COUP TFII likely exist case retinoid receptors 29 knock experiments suggest mouse COUP TF gene ensures nonredundant functions
0.3001008.11117523.html.plaintext.txt	26	Several studies pointed possibility COUP TF genes could part retinoid signaling pathways vivo cell culture systems 30 31 32 33
0.3001008.11117523.html.plaintext.txt	27	Notably regulation COUP TFI COUP TFII genes occurs differentiation programs triggered retinoic acid RA mouse teratocarcinoma cells P19 embryonal carcinoma EC cells 32
0.3001008.11117523.html.plaintext.txt	28	Pluripotent P19 EC cells induced differentiate three germ layer derivatives
0.3001008.11117523.html.plaintext.txt	29	ectoderm endoderm mesoderm appropriate inducers culture conditions used 34 35 36
0.3001008.11117523.html.plaintext.txt	30	When P19 cells grown aggregates RA induces neuroectodermal like differentiation pathway generates neurons glial fibroblast like cells 34 37
0.3001008.11117523.html.plaintext.txt	31	Therefore P19 cells widely used screen genes involved neuronal differentiation 38 39 40
0.3001008.11117523.html.plaintext.txt	32	We report consequences supraphysiological doses COUP TFI functional inactivation endogenous COUP TFs RA induced differentiation P19 cells
0.3001008.11117523.html.plaintext.txt	33	Morphological studies show early high expression wild type wtCOUP TFI impedes neural differentiation
0.3001008.11117523.html.plaintext.txt	34	Remarkably inhibition endogenous COUP TFs expression dominant negative COUP TFI mutant resulted strengthening cell cell contacts decreased axonal growth slower migration neurons
0.3001008.11117523.html.plaintext.txt	35	These data suggest major function COUP TFI development controlling cell adhesion
0.3001008.11117523.html.plaintext.txt	36	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES C141S COUP TFI Acts Dominant Negative Mutant Inhibiting wtCOUP TFI Binding DNA Mutation C141S replacing fourth cysteine residue second zinc finger serine likely disrupt zinc coordination thus disorganize overall folding DNA binding domain DBD
0.3001008.11117523.html.plaintext.txt	37	In accordance hypothesis COUP TF mutant bind DNA 41
0.3001008.11117523.html.plaintext.txt	38	Since major dimerization interface nuclear receptors contained ligand binding domain postulated mutant COUP TFI still able dimerize wtCOUP TFI
0.3001008.11117523.html.plaintext.txt	39	To test hypothesis used yeast two hybrid system Fig
0.3001008.11117523.html.plaintext.txt	40	1A glutathione S transferase GST pull assay Fig
0.3001008.11117523.html.plaintext.txt	41	These two complementary approaches generated similar results showed heterodimers wt mutant COUP TFI formed
0.3001008.11117523.html.plaintext.txt	42	Indeed yeast system ss galactosidase activity detected Gal4DBDCOUP TFI construct used conjunction either Gal4ADCOUP TFI Gal4AD mutCOUP TFI Fig
0.3001008.11117523.html.plaintext.txt	43	These data confirmed pull assays showing 35S labeled mutCOUP TFI retained GST wtCOUP TF I matrix Fig
0.3001008.11117523.html.plaintext.txt	44	As mutant COUP TFI defective DNA binding seemed reasonable assume wtCOUP TFImutCOUP TFI heterodimer would bind less stably DNA wtCOUP TFI homodimer
0.3001008.11117523.html.plaintext.txt	45	This verified electromobility shift assays EMSA vitro translated proteins incubated high affinity COUP TF binding site DR 1 42 probe Fig
0.3001008.11117523.html.plaintext.txt	46	In vitro transcriptiontranslation reactions run fixed amount pcDNAwtCOUP TFI vector 100 ng 1X Fig
0.3001008.11117523.html.plaintext.txt	47	1C increasing amounts pcDNAmutCOUP TFI 0 900 ng total amount vector DNA adjusted 1 microg empty pcDNA expression vector
0.3001008.11117523.html.plaintext.txt	48	Whereas strong binding wtCOUP TFI homodimers seen DR 1 probe retarded complex observed presence mutCOUP TFI Fig
0.3001008.11117523.html.plaintext.txt	49	Cotranslation wtCOUP TFI increasing amounts mutCOUP TFI resulted progressive decrease amount retarded complex suggesting mutCOUP TFI could used dominant negative mutant inhibit wtCOUP TFI activity
0.3001008.11117523.html.plaintext.txt	50	View larger version 23K Figure 1
0.3001008.11117523.html.plaintext.txt	51	Mutant C141S COUP TFI Dimerizes wtCOUP TFI Inhibits Its DNA Binding Activity
0.3001008.11117523.html.plaintext.txt	52	A mutCOUP TFI interacts wtCOUP TFI yeast two hybrid system
0.3001008.11117523.html.plaintext.txt	53	Y190 yeast cells transformed different vectors shown
0.3001008.11117523.html.plaintext.txt	54	The resulting ss galactosidase activities assayed shown Miller units
0.3001008.11117523.html.plaintext.txt	55	Each bar represent mean plus minus SEM four values obtained two independent experiments
0.3001008.11117523.html.plaintext.txt	56	B mutCOUP TFI retained GST wtCOUP TFI matrix
0.3001008.11117523.html.plaintext.txt	57	4 microl 35S labeled vitro translated mutCOUP TFI allowed interact either GST alone lane 2 GST COUP TFI fusion protein lane 3 immobilized glutathione agarose beads
0.3001008.11117523.html.plaintext.txt	58	After extensive washing retained fractions analyzed SDS PAGE
0.3001008.11117523.html.plaintext.txt	59	For comparison one fifth volume 35S labeled mutCOUP TFI used interaction fusion protein loaded directly gel input lane 1
0.3001008.11117523.html.plaintext.txt	60	The position mutCOUP TFI protein indicated arrow
0.3001008.11117523.html.plaintext.txt	61	C mutCOUP TFI inhibits wtCOUP TFI DNA binding EMSA
0.3001008.11117523.html.plaintext.txt	62	In vitro cotranslated wtCOUP TFI mutCOUP TFI incubated 32P labeled DR 1 probe electrophoresis
0.3001008.11117523.html.plaintext.txt	63	wtCOUP TFI homodimers generated retarded complex indicated arrow
0.3001008.11117523.html.plaintext.txt	64	The ratio wt mutCOUP TFI expression vector used vitro transcriptiontranslation shown 1X corresponds 100 ng vector
0.3001008.11117523.html.plaintext.txt	65	Total amount vector DNA systematically adjusted 1 microg empty expression vector
0.3001008.11117523.html.plaintext.txt	66	D COUP TFI C141S inhibits wtCOUP TFs cotransfection assays
0.3001008.11117523.html.plaintext.txt	67	CHO cells cotransfected ApoA1 tk CAT reporter gene different combinations pECE RAR pECE RXR pcDNA wtCOUP TFI pcDNA mutCOUP TFI expression vectors
0.3001008.11117523.html.plaintext.txt	68	Results shown mean plus minus SEM n 3 relative CAT activities
0.3001008.11117523.html.plaintext.txt	69	E Western blot analysis COUP TFII expression yeast CHO Hela HepG2 cells
0.3001008.11117523.html.plaintext.txt	70	An arrow indicates position COUP TFII
0.3001008.11117523.html.plaintext.txt	71	To determine whether mutated COUP TFI protein could alter wtCOUP TFI mediated transcriptional regulation cotransfected Chinese hamster ovary CHO cells retinoid responsive reporter gene ApoA1 tk CAT without retinoid receptor expression vectors various combinations wt mutant COUP TFI plasmids
0.3001008.11117523.html.plaintext.txt	72	This reporter gene contains DR 2 element overlapping DR 1 element known activated retinoid receptors activation counteracted COUP TF probably binding DR 1 site 45
0.3001008.11117523.html.plaintext.txt	73	Surprisingly cotransfected reporter gene increasing amounts mutCOUP TFI vector alone chloramphenicol acetyl transferase CAT activities markedly increased Fig
0.3001008.11117523.html.plaintext.txt	74	This first observation suggested CHO cells express endogenous COUP TFs likely repress basal activity reporter gene mutated COUP TFI block repression
0.3001008.11117523.html.plaintext.txt	75	In respect seemed logical counteract positive effect mutCOUP TFI cotransfecting wtCOUP TFI vector Fig
0.3001008.11117523.html.plaintext.txt	76	Retinoid receptors able activate transcription reporter gene presence 10 6 M RA activation even higher mutCOUP TFI expressed Fig
0.3001008.11117523.html.plaintext.txt	77	These data imply first endogenous COUP TFs able partially repress retinoid receptors second mutCOUP TFI negatively interfere retinoid receptor mediated transcriptional activation
0.3001008.11117523.html.plaintext.txt	78	This provides evidence specificity mutCOUP TFI action
0.3001008.11117523.html.plaintext.txt	79	Finally mutCOUP TFI expression able abolish retinoid receptor inhibition mediated exogenous wtCOUP TFI Fig
0.3001008.11117523.html.plaintext.txt	80	These transfection experiments thus allow interpretation mutCOUP TFI specifically interferes wtCOUP TF functions thus may alter nuclear receptor signaling pathways
0.3001008.11117523.html.plaintext.txt	81	Since transfection data suggested CHO cells express endogenous COUP TF genes ran Western blot analysis found indeed CHO cells express detectable levels COUP TFII shown Fig
0.3001008.11117523.html.plaintext.txt	82	This true also Hela cells whereas HepG2 cells express COUP TFII Fig
0.3001008.11117523.html.plaintext.txt	83	Analysis COUP TFI expression showed HepG2 cells CHO Hela cells positive COUP TFI Western blot data shown
0.3001008.11117523.html.plaintext.txt	84	Thus view transfection data mutant COUP TFI likely able interfere COUP TFI COUP TFII functions since CHO cells express COUP TFII note similar transfection experiment one shown Fig
0.3001008.11117523.html.plaintext.txt	85	1D run Hela cells gave identical results
0.3001008.11117523.html.plaintext.txt	86	Even vitro data suggestive direct inhibitory effect mutCOUP TFI wild type counterpart one cannot exclude mutCOUP TFI modulates wtCOUP TFI nuclear receptors titrating corepressors coactivators
0.3001008.11117523.html.plaintext.txt	87	However transfection data suggest mutCOUP TFI titrate coactivators required transcriptional response retinoids
0.3001008.11117523.html.plaintext.txt	88	Stable COUP TFI Expression Transfected P19 Cells The use cytomegalovirus CMV promoter drive expression either wild type mutated COUP TFI P19 cells allowed us assess effects low vs
0.3001008.11117523.html.plaintext.txt	89	high levels transgene expression
0.3001008.11117523.html.plaintext.txt	90	Indeed CMV promoter activated cAMP teratocarinoma cell line PCC7 43 well P19 cells Fig
0.3001008.11117523.html.plaintext.txt	91	2A note CMV promoter also activated 3 4 fold basal activity RA P19 cells data shown
0.3001008.11117523.html.plaintext.txt	92	High levels COUP TFI mRNA detected cells transfected wt mutant COUP TFI vectors treated 1 mM cAMP 24 h Fig
0.3001008.11117523.html.plaintext.txt	93	2A whereas low detectable levels seen absence cAMP Fig
0.3001008.11117523.html.plaintext.txt	94	No COUP TFI expression detected control cells treated cAMP agreement fact undifferentiated P19 cells express COUP TFI 32
0.3001008.11117523.html.plaintext.txt	95	The presence COUP TFI transfected cells checked protein level electromobility shift assay Fig
0.3001008.11117523.html.plaintext.txt	96	For experiments used DR 1 binding site COUP TF protein extracts aggregated cells treated either cAMP 48 h Fig
0.3001008.11117523.html.plaintext.txt	97	2 B C different combinations cAMP RA 48 h indicated Fig
0.3001008.11117523.html.plaintext.txt	98	Extracts P19 control cells pcDNA treated cAMP generated single complex DR 1 probe noted asterisk Fig
0.3001008.11117523.html.plaintext.txt	99	2B might due interaction EAR2 COUP TF related orphan receptor DR 1 element according Jonk et al
0.3001008.11117523.html.plaintext.txt	100	When used extracts wtCOUP TFI transfected cells treated cAMP slower migrating complex appeared arrow Fig
0.3001008.11117523.html.plaintext.txt	101	2B reflected interaction exogenous COUP TFI DR 1 probe shown antibody supershift Fig
0.3001008.11117523.html.plaintext.txt	102	The specificity DNA recognition overexpressed wtCOUP TFI assessed competition experiments EMSA Fig
0.3001008.11117523.html.plaintext.txt	103	2C using DR 1 element probe
0.3001008.11117523.html.plaintext.txt	104	The various competitors could ranked follows high affinity low affinity DR 1 DR 7 DR 5 ERE AP 1 GRE two last showing low affinity COUP TF
0.3001008.11117523.html.plaintext.txt	105	These data accordance known affinities COUP TF different binding sites 21 41 44
0.3001008.11117523.html.plaintext.txt	106	Treatment P19 control cell aggregates 10 6 M RA resulted appearance major complex mainly corresponding COUP TFIDNA interaction shown supershift obtained presence COUP TFI antibodies Fig
0.3001008.11117523.html.plaintext.txt	107	The lack supershift presence COUP TFII antibodies suggests induction COUP TFII gene might delayed compared induction COUP TFI gene
0.3001008.11117523.html.plaintext.txt	108	In another experiment compared levels DR 1 binding activity different cell lines Fig
0.3001008.11117523.html.plaintext.txt	109	Cells containing wtCOUP TFI transgene expressed low levels orphan receptor absence drugs high levels wt COUP TFI observed presence 1 mM 8 Br cAMP arrow Fig
0.3001008.11117523.html.plaintext.txt	110	The amount complex generated transgene expression even higher one formed endogenous COUP TFs induction 10 6 M RA
0.3001008.11117523.html.plaintext.txt	111	Finally cells treated RA cAMP amount COUP TFDNA complex slightly higher cells treated cAMP alone
0.3001008.11117523.html.plaintext.txt	112	Interestingly presence high amounts COUP TFI inhibited putative EAR2DNA interaction Fig
0.3001008.11117523.html.plaintext.txt	113	Similar results described Jonk et al
0.3001008.11117523.html.plaintext.txt	114	In cells expressing mutated form COUP TFI cAMP induce formation retarded complex Fig
0.3001008.11117523.html.plaintext.txt	115	2E accordance fact COUP TF C141S bind DNA 41
0.3001008.11117523.html.plaintext.txt	116	Formation endogenous COUP TFDNA complex inhibited expression mutated COUP TF Fig
0.3001008.11117523.html.plaintext.txt	117	2E presence RA completely abolished presence RA cAMP indicating mutated COUP TF works dominant negative mutant sequestering endogenous COUP TFs
0.3001008.11117523.html.plaintext.txt	118	View larger version 43K Figure 2
0.3001008.11117523.html.plaintext.txt	119	Stable Expression COUP TFI Transfected P19 EC Cells
0.3001008.11117523.html.plaintext.txt	120	A RT PCR analysis transgene expression
0.3001008.11117523.html.plaintext.txt	121	Control cells pcDNA wild type wt mutant mut COUP TF expressing cells grown 24 h monolayer presence absence cAMP indicated RNA extraction RT PCR analysis COUP TFI invariant PO gene expression
0.3001008.11117523.html.plaintext.txt	122	Results show ethidium bromide staining 2 agarose gel
0.3001008.11117523.html.plaintext.txt	123	B C EMSAs control pcDNA wtCOUP TFI cells treated aggregates 48 h cAMP
0.3001008.11117523.html.plaintext.txt	124	An asterisk indicates putative Ear2DNA complex see text arrow shows position COUP TFIDNA complex open circle shows position supershifted complex presence COUP TFI antibodies Ab
0.3001008.11117523.html.plaintext.txt	125	The oligonucleotides indicated panel C added competitors 20 fold molar excess
0.3001008.11117523.html.plaintext.txt	126	D DR 1 binding activity P19 cell aggregates treated 10 6 M RA 48 h
0.3001008.11117523.html.plaintext.txt	127	E DR 1 binding activities different cell lines cultured aggregates 48 h treated indicated trans retinoic acid RA andor cAMP
0.3001008.11117523.html.plaintext.txt	128	Symbols Fig
0.3001008.11117523.html.plaintext.txt	129	Note mutant COUP TFI inhibits endogenous COUP TFs binding probe
0.3001008.11117523.html.plaintext.txt	130	RA Induced Neural Differentiation Is Severely Affected wtCOUP TFI Overexpressing Cells Morphological characteristics undifferentiated P19 cells modified expression either wt mutated COUP TFI transgenes Fig
0.3001008.11117523.html.plaintext.txt	131	Indeed remained small cells high nucleus cytoplasm ratio
0.3001008.11117523.html.plaintext.txt	132	Furthermore difference doubling time 13 h three cell lines data shown
0.3001008.11117523.html.plaintext.txt	133	We next asked whether COUP TFI known inhibit retinoid pathways cell culture systems 43 44 45 could modulate neural differentiation P19 cells
0.3001008.11117523.html.plaintext.txt	134	Ten passages initial transfection cells aggregated presence 1 mM cAMP stimulate expression CMV COUP TFI transgenes 1 microM trans RA
0.3001008.11117523.html.plaintext.txt	135	After 3 days aggregates dissociated individual cells plated onto cell culture dishes Fig
0.3001008.11117523.html.plaintext.txt	136	After dissociation aggregates replated cells observed next 48 h differentiation Fig
0.3001008.11117523.html.plaintext.txt	137	After 24 h pcDNA cell culture already constituted two different populations phase dark cells growing attached plastic phase bright cells growing top first layer cells extending neurites
0.3001008.11117523.html.plaintext.txt	138	This observed treatments RA RAcAMP
0.3001008.11117523.html.plaintext.txt	139	During following hours underlying cells became confluent RA treated cells neurite network increased Fig
0.3001008.11117523.html.plaintext.txt	140	In RAcAMP treated pcDNA cells underlying monolayer never became confluent neurite extension still went
0.3001008.11117523.html.plaintext.txt	141	wtCOUP TFI expressing cells behaved like pcDNA cells treated RA
0.3001008.11117523.html.plaintext.txt	142	Conversely RAcAMP treated wtCOUP TFI cells differentiate neuron like cells phase dark cells attached plastic observed Fig
0.3001008.11117523.html.plaintext.txt	143	Thus early overexpression wtCOUP TFI clearly inhibited neuronal differentiation seem block differentiation pathways
0.3001008.11117523.html.plaintext.txt	144	Similar results obtained first treated wtCOUP TFI cells cAMP 2 days adding RA data shown indicating high levels COUP TFI RA addition block neuronal differentiation pathway thus COUP TFI global inhibitor retinoid functions
0.3001008.11117523.html.plaintext.txt	145	When mutant COUP TFI cells treated RA alone cells remained closely associated compact clusters 48 h reduced number phase dark fibroblast like cells astrocytes developed compared control cells
0.3001008.11117523.html.plaintext.txt	146	No neurite outgrowth could detected first 24 h suggesting delay neural differentiation
0.3001008.11117523.html.plaintext.txt	147	After 2 days mutCOUP TFI culture morphologically similar pcDNA cell culture exception plastic attached cells yet form confluent monolayer Fig
0.3001008.11117523.html.plaintext.txt	148	In presence RA cAMP cells 98 attach plastic dissociation aggregates died within 24 h rendering impossible phenotypic analysis cells
0.3001008.11117523.html.plaintext.txt	149	Such cell death treatment RA cAMP also observed much lower extent 50 survival control cells
0.3001008.11117523.html.plaintext.txt	150	These results suggest either high levels mutated COUP TFI cytotoxic cytostatic endogenous COUP TFs required cell survival differentiation
0.3001008.11117523.html.plaintext.txt	151	This last possibility would consistent observation wtCOUP TFI expressing cells undergo cell death treated RA cAMP Fig
0.3001008.11117523.html.plaintext.txt	152	Finally cells treated cAMP alone differentiate previously observed 46 show high levels cell death Fig
0.3001008.11117523.html.plaintext.txt	153	View larger version 105K Figure 3
0.3001008.11117523.html.plaintext.txt	154	Overexpression mutCOUP TFI Induces Cell Death Differentiating Cells
0.3001008.11117523.html.plaintext.txt	155	Cellular aggregates treated RA cAMP 3 days dissociated plating onto tissue culture grade plastic photographed 24 48 h later
0.3001008.11117523.html.plaintext.txt	156	Photographs show details different cultures representative content entire plates
0.3001008.11117523.html.plaintext.txt	157	Neurons seen phase bright cells growing top phase dark cells magnification x345
0.3001008.11117523.html.plaintext.txt	158	For comparison top panels show micrographs undifferentiated cells pcDNA wtCOUP TFI mutCOUP TFI left right
0.3001008.11117523.html.plaintext.txt	159	Note cells treated cAMP alone differentiate bottom panels
0.3001008.11117523.html.plaintext.txt	160	Induction POU III gene Brn 2 RA previously shown crucial step neural differentiation P19 cells 47 48
0.3001008.11117523.html.plaintext.txt	161	Semiquantitative RT PCR analysis Brn 2 expression different cell lines reveal change RA induced Brn 2 mRNA levels Fig
0.3001008.11117523.html.plaintext.txt	162	These data correlate well morphological analysis wtCOUP TFI cells RA induction almost neurons seen cotreatment RA cAMP see Fig
0.3001008.11117523.html.plaintext.txt	163	This apparent discrepancy suggests high levels COUP TFI inhibit P19 cell neuronal differentiation blockade differentiation state Brn 2 gene already expressed
0.3001008.11117523.html.plaintext.txt	164	49 suggested existence intermediate epithelial precursor neuroectodermal differentiation pathway P19 cells expressing high levels E cadherin
0.3001008.11117523.html.plaintext.txt	165	We thus examined E cadherin mRNA levels RT PCR found indeed RA able dramatically suppress E cadherin expression control cells well cells expressing mutCOUP TFI lesser extent wtCOUP TFI cells Fig
0.3001008.11117523.html.plaintext.txt	166	Conversely presence cAMP RA able inhibit E cadherin expression wtCOUP TFI cells
0.3001008.11117523.html.plaintext.txt	167	View larger version 49K Figure 4
0.3001008.11117523.html.plaintext.txt	168	RT PCR Analysis Expression Selected Retinoid Responsive Genes
0.3001008.11117523.html.plaintext.txt	169	RT PCR analysis run RNA extracted aggregates pcDNA wt mutant COUP TFI cells treated indicated 48 h
0.3001008.11117523.html.plaintext.txt	170	Bmp 4 Bone morphogenetic protein 4 E cad E cadherin
0.3001008.11117523.html.plaintext.txt	171	Inhibition Endogenous COUP TFs Results Impaired Axogenesis Since excessive cell death occurred mutCOUP TFI expressing cells treated simultaneously RA cAMP could evaluate effects high expression mutCOUP TFI neural differentiation
0.3001008.11117523.html.plaintext.txt	172	However low levels mutCOUP TFI sufficient lead delayed neurite extension see Fig
0.3001008.11117523.html.plaintext.txt	173	3 indicating putative role endogenous COUP TFs control axonal growth
0.3001008.11117523.html.plaintext.txt	174	To test hypothesis treated aggregated cells RA alone 3 days plated aggregates without dissociation tissue culture grade plastic dishes presence 1 mM cAMP
0.3001008.11117523.html.plaintext.txt	175	Cells maintained culture 5 days antineurofilament immunohistochemistry Fig
0.3001008.11117523.html.plaintext.txt	176	5 extensive neuritic outgrowth seen control cells wtCOUP TFI cells presence cAMP
0.3001008.11117523.html.plaintext.txt	177	Neurite extension observed also mutCOUP TFI cells cultured absence cAMP
0.3001008.11117523.html.plaintext.txt	178	Strikingly neurite bundles well individual neurites completely absent enhanced expression mutCOUP TFI 1 mM cAMP despite presence numerous neurofilament positive cell bodies Fig
0.3001008.11117523.html.plaintext.txt	179	Similar results obtained cells plated dissociated aggregates
0.3001008.11117523.html.plaintext.txt	180	Interestingly observed Fig
0.3001008.11117523.html.plaintext.txt	181	5 removal cAMP medium 3 days allowed neurite extension showing inhibition axogenesis dominant negative COUP TF reversed
0.3001008.11117523.html.plaintext.txt	182	View larger version 90K Figure 5
0.3001008.11117523.html.plaintext.txt	183	P19 Cell Endogenous COUP TFs Control Axogenesis
0.3001008.11117523.html.plaintext.txt	184	Aggregated cells plated 3 day RA treatment cultured 5 days presence 1 mM cAMP anti NF200 immunohistochemistry magnification x400
0.3001008.11117523.html.plaintext.txt	185	Note absence neurites mutCOUP TFI cells treated cAMP despite presence neurofilament NF200 positive cell bodies dark staining
0.3001008.11117523.html.plaintext.txt	186	Photographs show details different cultures representative content entire plates
0.3001008.11117523.html.plaintext.txt	187	COUP TFI Promotes Neuronal Migration During course preceding experiment noticed clear difference spreading aggregates stable cell lines neurons tend stay closely associated mutCOUP TFI cells
0.3001008.11117523.html.plaintext.txt	188	We next decided analyze detail behavior cells plating undissociated aggregates previously treated 3 days RA Fig
0.3001008.11117523.html.plaintext.txt	189	After 2 days aggregates completely disappeared wtCOUP TFI cell cultures whereas still observable mutCOUP TFI cell cultures compare wtCOUP TFI peptide mutCOUP TFI peptide Fig
0.3001008.11117523.html.plaintext.txt	190	Cells fixed examined presence neurons antineurofilament immunohistochemistry Fig
0.3001008.11117523.html.plaintext.txt	191	The results revealed neurons migrated underlying monolayer case wtCOUP TFI cells mutCOUP TFI cells Fig
0.3001008.11117523.html.plaintext.txt	192	6A despite equivalent spreading monolayer plastic surface
0.3001008.11117523.html.plaintext.txt	193	Quantification phenomenon revealed 100 aggregates totally spread extensive neuron outgrowth wtCOUP TFI cells 44 control cells 18 mutCOUP TFI cells Fig
0.3001008.11117523.html.plaintext.txt	194	View larger version 54K Figure 6
0.3001008.11117523.html.plaintext.txt	195	COUP TFI Promotes Neuronal Migration
0.3001008.11117523.html.plaintext.txt	196	A Aggregates cells treated 3 days 1 microM RA plated onto tissue culture grade plastic cultured 24 h RGDS SDGRG peptides added indicated concentrations
0.3001008.11117523.html.plaintext.txt	197	After additional day culture cells fixed stained presence NF200 immunohistochemistry magnification x220
0.3001008.11117523.html.plaintext.txt	198	Neurons neurites intensely stained either spread top astrocytes wtCOUP TFI peptide packed together mutCOUP TFI peptide wtCOUP TFI RGDS 0
0.3001008.11117523.html.plaintext.txt	199	B The percentage aggregates presenting either migrating neurons core aggregates completely spread organization determined shown percentage aggregates neuron outgrowth function cell lines absence peptide control presence SDGRG RGDS peptides 0
0.3001008.11117523.html.plaintext.txt	200	Results shown mean plus minus SEM 150 aggregates cell line scored three independent experiments
0.3001008.11117523.html.plaintext.txt	201	We used peptide interference assay determine extent behavior P19 derived neurons dependent extracellular matrix ECMreceptor interactions
0.3001008.11117523.html.plaintext.txt	202	fibronectin vitronectin share RGD motif involved recognition different integrin ss heterodimers 50
0.3001008.11117523.html.plaintext.txt	203	Integrins play major roles cell motility migration 50 51 could thus involved P19 neuron migration
0.3001008.11117523.html.plaintext.txt	204	At high dosage 1 mgml RGDS peptide totally inhibited cell spreading migration plastic surface whereas control peptide SDGRG
0.3001008.11117523.html.plaintext.txt	205	This observed three cell lines see Fig
0.3001008.11117523.html.plaintext.txt	206	More interestingly low dosage 0
0.3001008.11117523.html.plaintext.txt	207	1 mgml astrocyte fibroblast spreading migration inhibited RGDS peptide neuron migration surface cells clearly counteracted Fig
0.3001008.11117523.html.plaintext.txt	208	In resulting cultures neuron cell bodies stayed closely associated case mutCOUP TFI cells untreated RGDS peptide
0.3001008.11117523.html.plaintext.txt	209	Nonetheless grouped neurons still extended neurites seem project underlying cells data shown
0.3001008.11117523.html.plaintext.txt	210	These experiments suggest endogenous COUP TFI promotes neuronal migration mechanism involving integrin receptors
0.3001008.11117523.html.plaintext.txt	211	This function COUP TFI seems unrelated control axogenesis since neurite growth maintained RGDS treated cells
0.3001008.11117523.html.plaintext.txt	212	COUP TFI Modulates ECM Synthesis To test differential adhesionmigration cell lines purified substrates next plated 3 days RA treated aggregates onto plastic dishes coated poly D lysine laminin fibronectin neurobasal medium complemented N2 instead serum avoid possible interference purified substrates serum contained molecules
0.3001008.11117523.html.plaintext.txt	213	The morphology cells observed following days cells photographed 3 days plating Fig
0.3001008.11117523.html.plaintext.txt	214	The time lapse necessary cell attachment identical minutes cell lines substrates
0.3001008.11117523.html.plaintext.txt	215	The cultures became different thereafter showing almost migration control mutCOUP TFI aggregates attached poly D lysine limited migration laminin fibronectin Fig
0.3001008.11117523.html.plaintext.txt	216	wtCOUP TFI cells showed much higher rate migration three substrates Fig
0.3001008.11117523.html.plaintext.txt	217	Unlike laminin fibronectin natural substrates cell attachment migration neurite outgrowth 52 53 54 poly D lysine allow cell migration except wtCOUP TFI cells Fig
0.3001008.11117523.html.plaintext.txt	218	These data strongly suggested wtCOUP TFI cells modified synthesis ECM molecules making autonomous migration spreading
0.3001008.11117523.html.plaintext.txt	219	We tested last hypothesis RT PCR analysis components ECM known interact integrins RGD sequence 50 fibronectin vitronectin
0.3001008.11117523.html.plaintext.txt	220	Results showed expression fibronectin affected wt mutant COUP TFI Fig
0.3001008.11117523.html.plaintext.txt	221	Most notably vitronectin gene seemed directly regulated wtCOUP TFI since mRNA levels dramatically increased wtCOUP TFI cells treated cAMP alone RA RA cAMP
0.3001008.11117523.html.plaintext.txt	222	Increased vitronectin mRNA levels detected aggregate monolayer cell cultures indicating COUP TF could modulate vitronectin gene independently cell cell interactions occurring aggregates
0.3001008.11117523.html.plaintext.txt	223	These results strongly support idea COUP TFI may regulate neurogenesis modulation vitronectin levels ECM molecule involved neurite extension motoneuron differentiation possibly glial guided neuronal migration see Discussion Refs
0.3001008.11117523.html.plaintext.txt	224	Alignment human mouse vitronectin promoter sequences showed presence two conserved nuclear receptor half binding sites Fig
0.3001008.11117523.html.plaintext.txt	225	Furthermore prediction transcription factor binding sites Transfac database revealed presence recognition sequences Sp1 mouse promoter HNF 3 promoters two proteins shown cooperate COUP TFI 58 59
0.3001008.11117523.html.plaintext.txt	226	To determine whether COUP TFI could directly regulate vitronectin promoter used 52847 fragment mouse vitronectin gene coupled luciferase reporter gene 60
0.3001008.11117523.html.plaintext.txt	227	This plasmid cotransfected P19 cells increasing amounts either wtCOUP TFI mutCOUP TFI expression vectors Fig
0.3001008.11117523.html.plaintext.txt	228	Basal expression reporter gene high P19 cells since luciferase activity 100 fold background
0.3001008.11117523.html.plaintext.txt	229	This activity enhanced transfection wtCOUP TFI expression vector whereas mutCOUP TFI able stimulate transcription vitronectin promoter
0.3001008.11117523.html.plaintext.txt	230	These results implicate direct role COUP TFI control vitronectin gene put concrete form role COUP TFI regulation ECM synthesis
0.3001008.11117523.html.plaintext.txt	231	View larger version 127K Figure 7
0.3001008.11117523.html.plaintext.txt	232	wtCOUP TFI Enhances Migration Different Cell Substratum
0.3001008.11117523.html.plaintext.txt	233	Undissociated aggregates cells treated 3 days 1 microM RA plated onto plastic coated poly D lysine laminin fibronectin indicated photographed 3 days plating phase contrast
0.3001008.11117523.html.plaintext.txt	234	The black arrowheads indicate position initially plated aggregates still visible pcDNA mutCOUP TFI cells
0.3001008.11117523.html.plaintext.txt	235	Note higher spreading wtCOUP TFI cells three substrates magnification x180
0.3001008.11117523.html.plaintext.txt	236	This magnification allow visualization neurites wtCOUP TFI cells examination higher magnification showed presence numerous neurons extending neurites whatever substrate
0.3001008.11117523.html.plaintext.txt	237	View larger version 41K Figure 8
0.3001008.11117523.html.plaintext.txt	238	COUP TFI Regulates Synthesis Vitronectin
0.3001008.11117523.html.plaintext.txt	239	A RT PCR analysis run RNA extracted aggregates agg
0.3001008.11117523.html.plaintext.txt	240	monolayer cell cultures mon
0.3001008.11117523.html.plaintext.txt	241	pcDNA wt mutant COUP TFI cells treated indicated 48 h
0.3001008.11117523.html.plaintext.txt	242	B Alignment human mouse proximal promoter regions vitronectin gene black dots indicate identical nucleotides mouse human dashes represent gaps introduced maximize sequence homology
0.3001008.11117523.html.plaintext.txt	243	The conserved nuclear receptor NR half binding sites boxed well putative binding sites transcription factors
0.3001008.11117523.html.plaintext.txt	244	C The mouse vitronectin promoter activated COUP TFI transient transfection assays
0.3001008.11117523.html.plaintext.txt	245	P19 cells cotransfected mouse vitronectin promoter fragment 52847 linked luciferase coding sequence indicated amounts wt mutCOUP TFI expression vectors
0.3001008.11117523.html.plaintext.txt	246	Results shown mean plus minus SEM n 3 relative luciferase activities raw luciferase activities divided ss galactosidase activities
0.3001008.11117523.html.plaintext.txt	247	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The data presented provide first insights molecular mechanisms underlying involvement COUP TFI neurogenesis suggest major function COUP TFI regulation cell cell cell matrix interactions
0.3001008.11117523.html.plaintext.txt	248	Previous studies suggested COUP TF might global repressor functions retinoids signaling molecules
0.3001008.11117523.html.plaintext.txt	249	The remarkable DNA binding flexibility COUP TF orphan receptors led observation repress several signaling pathways cell culture systems mainly competition liganded nuclear receptor binding sites 44 45 61 especially RA response elements 44 45 62
0.3001008.11117523.html.plaintext.txt	250	Additional evidence potential negative role COUP TFs retinoid signaling came experiments showing COUP TF I form heterodimers RXR DNA thus sequestering promiscuous partner RARs 63
0.3001008.11117523.html.plaintext.txt	251	The existence regulatory loop suggested data demonstrating RA acid induces represses instance expression COUP TF genes different systems P19 cells Xenopus zebrafish mouse embryos 30 31 32 33
0.3001008.11117523.html.plaintext.txt	252	The relevance P19 cell model system early differentiation widely admitted review see Ref
0.3001008.11117523.html.plaintext.txt	253	These cells behave much like ES cells treated RA 65 66 use allowed characterization genes show spatially temporally restricted expression patterns mouse development 38 40 66 67
0.3001008.11117523.html.plaintext.txt	254	Remarkably several genes cloned P19 cells induced differentiate along neuroectodermal pathway exclusively expressed nervous system 38 39 67
0.3001008.11117523.html.plaintext.txt	255	The data presented thus likely reflect physiological functions COUP TFs
0.3001008.11117523.html.plaintext.txt	256	Our experiments clearly indicate early expression COUP TFI P19 cells specifically affects neuronal cell fate
0.3001008.11117523.html.plaintext.txt	257	Indeed neuronal cells absent wtCOUP TFI cells treated RA cAMP even cells express Brn 2
0.3001008.11117523.html.plaintext.txt	258	Monolayers cell line differentiate nonneural cell types expressed high amounts Stra8 transcripts response RA data shown
0.3001008.11117523.html.plaintext.txt	259	These results suggest COUP TFI modulates expression RA regulated genes differentiation dependent manner
0.3001008.11117523.html.plaintext.txt	260	Hence timing COUP TF expression needs tightly controlled development avoid inappropriate gene induction cells normally committed neural fate
0.3001008.11117523.html.plaintext.txt	261	In respect must mentioned RA treatment Xenopus embryos induces earlier expression xCOUP TF A gene compared control embryos 33
0.3001008.11117523.html.plaintext.txt	262	It tempting speculate part teratogenic effects RA mediated COUP TF orphan receptors since injection COUP TF mRNA Xenopus embryos leads developmental defects anterior neural structures mimic induced early RA exposure 68
0.3001008.11117523.html.plaintext.txt	263	By inhibiting activity endogenous COUP TFs able confirm involvement orphan receptors regulation cell adhesion migration
0.3001008.11117523.html.plaintext.txt	264	The clear differences phenotypes stable cell lines could partly explained changes expression levels ECM molecules
0.3001008.11117523.html.plaintext.txt	265	Our data suggest COUP TFI could favor neuron migration glial cells RGD dependent mechanism
0.3001008.11117523.html.plaintext.txt	266	Vitronectin recognized integrin RGD motif involved neural development 56 69
0.3001008.11117523.html.plaintext.txt	267	The integrin receptor vss1 recognizes vitronectin required efficient migration embryonic cortical neurons along radial glial fibers 55
0.3001008.11117523.html.plaintext.txt	268	Perturbation experiments using antibodies vitronectin would certainly shed light potential involvement vitronectin indirectly COUP TFI neuronal migration
0.3001008.11117523.html.plaintext.txt	269	A close relationship vitronectin COUP TFs also suggested observations
0.3001008.11117523.html.plaintext.txt	270	First case COUP TFII vitronectin expressed developing motoneurons P19 cells control morphogen sonic hedgehog 23 70 56
0.3001008.11117523.html.plaintext.txt	271	Second perturbation experiments antibodies vitronectin inhibit motoneuron differentiation vitro vivo 56
0.3001008.11117523.html.plaintext.txt	272	Third vitronectin also shown expressed surface neural crest cells NCCs required migration cells 71 COUP TFI expressed early mouse embryo premigratory migratory NCCs 14
0.3001008.11117523.html.plaintext.txt	273	And fourth vitronectin supports axogenesis PC12 cells 69
0.3001008.11117523.html.plaintext.txt	274	The experiments described favor direct control vitronectin gene COUP TF suggest COUP TF could transduce sonic hedgehog signal extracellular environment least differentiating motoneurons
0.3001008.11117523.html.plaintext.txt	275	The present report provides evidence COUP TFs regulators cell adhesion mechanisms required differentiation embryonal carcinoma cells
0.3001008.11117523.html.plaintext.txt	276	That COUP TFs could result modify migratory behavior cells appealing hypothesis view expression patterns development
0.3001008.11117523.html.plaintext.txt	277	Indeed transcription factors exclusively expressed nervous system also found number tissues time tissue modeling cell movements widespread event 19
0.3001008.11117523.html.plaintext.txt	278	We propose COUP TFs conserved members nuclear receptor family throughout evolution 19 modulate cell adhesion dependent morphogenetic processes metazoan
0.3001008.11117523.html.plaintext.txt	279	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Plasmid Construction The human COUP TFI cDNA gift M
0.3001008.11117523.html.plaintext.txt	280	Pfafhl La Jolla CA transferred Bluescript pcDNA3 Invitrogen San Diego CA BamHIXhoI double digest
0.3001008.11117523.html.plaintext.txt	281	The mutant C141S hCOUP TFI cDNA 41 also inserted pcDNA
0.3001008.11117523.html.plaintext.txt	282	This mutant serine instead fourth cysteine second zinc finger hCOUP TFI DBD thus lost DNA binding ability 41
0.3001008.11117523.html.plaintext.txt	283	For yeast two hybrid GST pull assays SmaIEcoRI fragment wtCOUP TFI cDNA cloned frame Gal4DBD coding sequence pAS2 1 vector CLONTECH Laboratories Inc
0.3001008.11117523.html.plaintext.txt	284	Palo Alto CA GST coding sequence pGEX 2T Pharmacia Biotech Piscataway NJ vector respectively
0.3001008.11117523.html.plaintext.txt	285	The corresponding fusion proteins lack first 56 N terminal residues COUP TFI called Gal4DBDCOUP TFI GSTCOUP TFI
0.3001008.11117523.html.plaintext.txt	286	The full length wtCOUP TFI mutCOUP TFI cDNAs inserted frame Gal4 activation domain coding sequence pACT2 vector CLONTECH Laboratories Inc
0.3001008.11117523.html.plaintext.txt	287	Two Hybrid Assay The yeast strain used study Y190 MATa ura 3 52 3 200 ade 2 201 lys 2 801 trp 1 901 leu 2 3 112 gal 4 gal 80 cyhr 2 LYS2 GAL1UAS HIS3TATA HIS3 URA3 GAL1UAS GAL1TATA LacZ
0.3001008.11117523.html.plaintext.txt	288	Yeast cells transformed using lithium acetate method 72 transformants selected growth complete minimum medium lacking uracil histidine tryptophan necessary leucine
0.3001008.11117523.html.plaintext.txt	289	The slight endogenous activity 3 gene inhibited 25 mM 3 aminotriazole
0.3001008.11117523.html.plaintext.txt	290	Reconstitution Gal4 transactivation activity via interaction fusion proteins first tested growth selective media
0.3001008.11117523.html.plaintext.txt	291	To confirm interaction Lac Z activity tested filter lift assay transferring colonies filter paper Whatman Clifton NJ
0.3001008.11117523.html.plaintext.txt	292	The filters frozen 15 sec liquid nitrogen thawed room temperature incubated Whatman 3MM soaked Z buffer 60 mM Na2HPO4 40 mM NaH2PO4 10 mM KCl 1 mM MgSO4 50 mM 2 mercaptoethanol containing 0
0.3001008.11117523.html.plaintext.txt	293	Quantification ss galactosidase activity assayed previously described 72 using O nitrophenyl ss D galactopyranoside substrate
0.3001008.11117523.html.plaintext.txt	294	Activity expressed Miller units 73
0.3001008.11117523.html.plaintext.txt	295	GST Pull Down Assay GST COUP TFI fusion protein GST expressed pGEX2 T Escherichia coli prepared according protocols supplied Pharmacia Biotech
0.3001008.11117523.html.plaintext.txt	296	Concentration fusion protein GST crude lysates estimated separation 10 polyacrylamide SDS PAGE followed quantification total protein concentration Bradford test
0.3001008.11117523.html.plaintext.txt	297	Crude bacterial extracts containing amounts GST GST COUP TFI incubated overnight 4 C 50 microl glutathione agarose beads Sigma St
0.3001008.11117523.html.plaintext.txt	298	Louis MO NENT buffer 20 mM Tris pH 8 100 mM NaCl 1 mM EDTA 0
0.3001008.11117523.html.plaintext.txt	299	Beads washed five times NENT resuspended 300 microl NENT plus protease inhibitors 10 microgml leupeptin pepstatin aprotinin 1 mM phenylmethylsulfonylfluoride
0.3001008.11117523.html.plaintext.txt	300	Four microliters 35S labeled mutCOUP TFI expressed TNT rabbit reticulocyte lysate system Promega Corp
0.3001008.11117523.html.plaintext.txt	301	Madison WI incubated 20 microl 2
0.3001008.11117523.html.plaintext.txt	302	5 microg GST COUP TFI GST bound agarose matrix 3 h 4 C binding buffer 50 mM Tris pH 8 50 mM NaCl 0
0.3001008.11117523.html.plaintext.txt	303	02 BSA protease inhibitors
0.3001008.11117523.html.plaintext.txt	304	Beads washed 10 times washing buffer 50 mM Tris pH 8 150 mM NaCl 0
0.3001008.11117523.html.plaintext.txt	305	02 Tween 20 protease inhibitors
0.3001008.11117523.html.plaintext.txt	306	Bound proteins eluted boiling SDS sample buffer resolved SDS PAGE
0.3001008.11117523.html.plaintext.txt	307	Cell Culture Transfections P19 EC cells gift H
0.3001008.11117523.html.plaintext.txt	308	Gronemeyer IGBMC Strasbourg France maintained already described 37
0.3001008.11117523.html.plaintext.txt	309	Cells grown DMEM supplemented 10 FCS
0.3001008.11117523.html.plaintext.txt	310	For RA induced differentiation monolayer P19 cells plated density 104 cells per well 24 well plates
0.3001008.11117523.html.plaintext.txt	311	For RA induced neuronal differentiation cells grown density 106 cells100 mm bacteriological grade petri dish allowed aggregate 3 days
0.3001008.11117523.html.plaintext.txt	312	Aggregates treated trypsinEDTA dissociated cells replated tissue culture grade six well plates cultured 3 4 days absence drugs
0.3001008.11117523.html.plaintext.txt	313	Drugs used 1 microM trans retinoic acid 1 mM 8 Br cAMP Sigma unless indicated
0.3001008.11117523.html.plaintext.txt	314	For stable transfections 106 cells plated 100 mm dishes transfected described 74 10 microg expression vector
0.3001008.11117523.html.plaintext.txt	315	After 24 h cells grown presence 400 microgml G 418 Roche Molecular Biochemicals Indianapolis IN
0.3001008.11117523.html.plaintext.txt	316	After 10 days selection clones resistant cells dissociated pooled names pcDNA wtCOUP TF mutCOUP TF cells transfected respectively empty expression vector different nuclear receptor expression vectors
0.3001008.11117523.html.plaintext.txt	317	Cells systematically grown presence G 418 400 microgml avoid loss transgene
0.3001008.11117523.html.plaintext.txt	318	For growth different substrates three Sigma easygrip untreated plastic dishes Falcon Becton Dickinson Co
0.3001008.11117523.html.plaintext.txt	319	Combourg France coated 1 h either poly D lysine 0
0.3001008.11117523.html.plaintext.txt	320	1 mgml laminin 10 microgml fibronectin 10 microgml
0.3001008.11117523.html.plaintext.txt	321	After 3 days incubation DMEM10 FCS 10 6 M RA aggregates pelleted resuspended Neurobasal medium Life Technologies Inc
0.3001008.11117523.html.plaintext.txt	322	Gaithersburg MD supplemented N2 complement Life Technologies Inc
0.3001008.11117523.html.plaintext.txt	323	seeding coated plates
0.3001008.11117523.html.plaintext.txt	324	For transient transfections assays used 800 ng reporter gene containing base pairs 528 47 mouse vitronectin gene linked luciferase coding sequence 60 together 150 ng ss galactosidase expression vector pCH110 various amounts wt mutant COUP TFI expression vectors
0.3001008.11117523.html.plaintext.txt	325	Cells transfected calcium phosphate procedure 74 allowed express reporter gene 36 h luciferase activity assayed luciferin Promega Corp
0.3001008.11117523.html.plaintext.txt	326	The raw luciferase activities divided corresponding ss galactosidase activities correct transfection efficiencies
0.3001008.11117523.html.plaintext.txt	327	CHO Hela cells transiently transfected 12 well plates 1 microg ApoA1 tk CAT reporter gene various expression vectors
0.3001008.11117523.html.plaintext.txt	328	The resulting CAT activity assayed previously described 45 normalized ss galactosidase expression
0.3001008.11117523.html.plaintext.txt	329	Peptide Interference Assay For peptide interference assays RGDS peptide control peptide SDGRG Sigma added 24 h plating RA treated aggregates onto tissue culture plastic dishes
0.3001008.11117523.html.plaintext.txt	330	Antineurofilament immunohistochemistry run 24 h later paraformaldehyde fixed cells
0.3001008.11117523.html.plaintext.txt	331	The percentage aggregates showed neuronal outgrowth determined scoring time least 50 aggregates per cell line three independent experiments
0.3001008.11117523.html.plaintext.txt	332	EMSA In vitro translated proteins made TNT reticulocyte lysate system Promega Corp
0.3001008.11117523.html.plaintext.txt	333	Whole cell extracts WCEs P19 EC transfected cells prepared used EMSA described 21
0.3001008.11117523.html.plaintext.txt	334	Briefly 4 microg WCEs preincubated 1 microg polydI dC eventually competitors 20 microl binding buffer 20 mM HEPES pH 7
0.3001008.11117523.html.plaintext.txt	335	9 1 mM dithiothreitol 50 mM KCl 10 glycerol 2
0.3001008.11117523.html.plaintext.txt	336	5 mM MgCl2 room temperature 15 min
0.3001008.11117523.html.plaintext.txt	337	For supershifting experiments 1 microl antibodies COUP TFI COUP TFII Santa Cruz Biotechnology Inc
0.3001008.11117523.html.plaintext.txt	338	Santa Cruz CA preincubated 30 min WCEs addition binding buffer
0.3001008.11117523.html.plaintext.txt	339	The samples incubated 32P labeled probes 15000 dpm 20 min room temperature
0.3001008.11117523.html.plaintext.txt	340	Protein DNA complexes separated free probe nondenaturing electrophoresis 4 polyacrylamide gels 0
0.3001008.11117523.html.plaintext.txt	341	5 x TBE 45 mM Tris base 45 mM boric acid 1 mM EDTA 4 C
0.3001008.11117523.html.plaintext.txt	342	The oligonucleotides synthesized Eurogentec Seraing Belgium used double stranded gel shift experiments DR 1 5 TCGAGGGTCAGAGGTCACGA 3 DR 5 ss RARE 5 GATGGGTTCACCGAAAGTTCACTC 3 DR 7 hARR 21 5 GATCTAGGTTGACATTTCTCCTTGACCTTTTAGATC 3 ERE rtER gene 75 5 TTGCTGTGTCATGTTGACCTGCTCTAGAGA 3 AP 1 5 TCGACGCTTGATGACTCAGCCGGAA 3 GRE 5 CCAGAACACAGTGTTCTGAG CTAAAATAACACATTCAG 3
0.3001008.11117523.html.plaintext.txt	343	Immunohistochemistry Immunohistochemistry procedures run directly six well tissue culture plates
0.3001008.11117523.html.plaintext.txt	344	Cells fixed 4 paraformaldehyde solution PBS 12 min incubated 10 min 4 paraformaldehyde 0
0.3001008.11117523.html.plaintext.txt	345	2 Triton X 100 solution PBS
0.3001008.11117523.html.plaintext.txt	346	After washing blocking cells incubated antineurofilament 200 NF 200 Sigma diluted 1100 1 h
0.3001008.11117523.html.plaintext.txt	347	After incubation antirabbit IgGperoxidase conjugate Sigma presence NF 200 revealed diaminobenzidine
0.3001008.11117523.html.plaintext.txt	348	Western Blot Analysis COUP TFI COUP TFII expression levels assayed Western blot anti COUP TFI anti COUP TFII Santa Cruz Biotechnology Inc
0.3001008.11117523.html.plaintext.txt	349	For assays 80 microg whole cell extracts run gels treated described previously 41
0.3001008.11117523.html.plaintext.txt	350	Semiquantitative RT PCR Analysis Total RNA P19 cells purified using Trizol reagent Life Technologies Inc
0.3001008.11117523.html.plaintext.txt	351	Two micrograms RNA used reverse transcription 5 microM random hexamer oligonucleotides 30 min 37 C 15 min 42 C
0.3001008.11117523.html.plaintext.txt	352	For PCR reactions 120 reverse transcription reaction mixture used
0.3001008.11117523.html.plaintext.txt	353	Number cycles indicated primer set annealing temperatures varied according set primer used
0.3001008.11117523.html.plaintext.txt	354	The following upstream downstream primers used numbering made 1 A initiation codon except indicated Brn 2 accession number X66602 5 TGCAAGCTGAAGCCTTTGTTG 3 11371157 Brn 2 5 CCTTTTCTCTTTCTGTCTCCTG 3 14061385 32 cycles E cadherin 5 CTATGATGAAGAAGGAGGTGG 3 22682288 E cadherin 5 CACTGCCCTCGTAATCGAAC 3 25212502 32 cycles COUP TFI 5 AAGCACTA CGGCCAATTCAC 3 283302 COUP TFI 5 AGCTCGCAGATGTTCTCGAT 3 662643 27 cycles PO 36B4 5 CAGCTCTGGAGAAACTGCTG 3 217236 PO 36B4 5 GTGTACTCAGTCTCCACAGA 3 772753 26 cycles Bmp4 5 GTAACCGAATGCTGATGGTC 3 1130 Bmp4 5 TTTTCTGGGATGCTGGTGAG 3 452433 32 cycles Fibronectin 5 CCAGGACAACAGCATCAG 3 22372254 Fibronectin 5 TAGGTCACCCTGTACCTG 3 25752558 32 cycles Vitronectin 5 TACTATCAGAGCTGCTG 3 136152 Vitronectin 5 AGTTGATGCGAGTGAAG 3 640624 32 cycles
0.3001008.11117523.html.plaintext.txt	355	The acidic ribosomal phosphoprotein PO gene 76 also called 36B4 77 used control gene since expression shown invariant upon RA induced differentiation P19 EC cells 78
0.3001008.11117523.html.plaintext.txt	356	ACKNOWLEDGMENTS We grateful Hinrich Gronemeyer IGBMC Strasbourg France gift P19 cells
0.3001008.11117523.html.plaintext.txt	357	We thank Magnus Pfahl Sidney Kimmel Cancer Center La Jolla CA David Loskutoff Scripps Research Institute La Jolla CA generous gift hCOUP TFI RAR RXR ApoA1 tk CAT vitronectin promoterluciferase plasmids
0.3001008.11117523.html.plaintext.txt	358	We would also like thank Yves Pichon Francois Tiaho Pascal Benquet helpful discussions Marie Helene Salmon technical assistance
0.3001008.11117523.html.plaintext.txt	359	We also thank Jean Loup Duband invaluable help
0.3001008.11117523.html.plaintext.txt	360	FOOTNOTES Address requests reprints Dr
0.3001008.11117523.html.plaintext.txt	361	Gilles Salbert Equipe Information et Programmation Cellulaire Universite de Rennes I UPRES A CNRS 6026 Campus de Beaulieu 35042 Rennes Cedex France
0.3001008.11117523.html.plaintext.txt	362	This work supported funds Centre Nationale de la Recherche Scientifique Direction de la Recherche et des Etudes Doctorales Ministere de l Enseignement et de la Recherche T
0.3001008.11117523.html.plaintext.txt	363	Received publication January 26 2000
0.3001008.11117523.html.plaintext.txt	364	Revision received July 24 2000
0.3001008.11117523.html.plaintext.txt	365	Accepted publication August 22 2000
0.3001008.11117523.html.plaintext.txt	366	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mangelsdorf DJ Thummel C Beato M Herrlich P Schutz G Umesono K Blumberg B Kastner P Mark M Chambon P Evans RM 1995 The nuclear receptor superfamily second decade
0.3001008.11117523.html.plaintext.txt	367	Cell 83835 839Medline Mangelsdorf DJ Borgmeyer U Heyman RA Zhou JY Ong ES Oro AE Kakizuka A Evans RM 1992 Characterization three RXR genes mediate action 9 cis retinoic acid
0.3001008.11117523.html.plaintext.txt	368	Genes Dev 6329 344Abstract Lala DS Rice DA Parker KL 1992 Steroidogenic factor 1 key regulator steroidogenic enzyme expression mouse homolog fushi tarazu factor 1
0.3001008.11117523.html.plaintext.txt	369	Mol Endocrinol 61249 1258Abstract Miyajima N Kadowaki Y Fukushige SI Semba SK Yamanashi Y Matsubara KI Toyoshima K Yamamoto T 1988 Identification two novel members erbA superfamily molecular cloning gene products two highly related
0.3001008.11117523.html.plaintext.txt	370	Nucleic Acids Res 1611057 11074Abstract Wang LH Tsai SY Cook RG Beattie WG Tsai MJ O Malley BW 1989 Coup transcription factor member steroid receptor superfamily
0.3001008.11117523.html.plaintext.txt	371	Nature 340163 166CrossRefMedline Hoshizaki DK Blackburn T Price C Ghosh M Miles K Ragucci M Sweis R 1994 Embryonic fat cell lineage Drosophila melanogaster
0.3001008.11117523.html.plaintext.txt	372	Development 1202489 2499AbstractFree Full Text Hoshizaki DK Lunz R Ghosh M Johnson W 1995 Identification fat cell enhancer activity Drosophila melanogaster using P element enhancer traps
0.3001008.11117523.html.plaintext.txt	373	Genome 38497 506Medline Ikeda Y Luo X Abbud R Nilson JH Parker KL 1995 The nuclear receptor steroidogenic factor 1 essential formation ventromedial hypothalamic nucleus
0.3001008.11117523.html.plaintext.txt	374	Mol Endocrinol 9478 486Abstract Kastner P Grondona J Mark M Gransmuller A LeMeur M Decimo D Vonesh JL Dolle P Chambon P 1994 Genetic analysis RXR developmental function convergence RXR RAR signaling heart eye morphogenesis
0.3001008.11117523.html.plaintext.txt	375	Cell 78987 1003Medline Kramer S West SR Hiromi Y 1995 Cell fate control Drosophila retina orphan receptor seven role decisions mediated ras signaling pathway
0.3001008.11117523.html.plaintext.txt	376	Development 1211361 1372AbstractFree Full Text Lavorgna G Karim FD Thummel CS Wu C 1993 Potential role FTZ F1 steroid receptor superfamily member control Drosophila metamorphosis
0.3001008.11117523.html.plaintext.txt	377	Proc Natl Acad Sci USA 903004 3008Abstract Luo J Ikeda Y Parker KL 1994 A cell specific nuclear receptor essential adrenal gonadal development sexual differentiation
0.3001008.11117523.html.plaintext.txt	378	Cell 77481 490Medline Mlodzik M Hiromi Y Weber U Goodman CS Rubin GM 1990 The Drosophila seven gene member steroid receptor gene superfamily controls photoreceptor cell fates
0.3001008.11117523.html.plaintext.txt	379	Cell 60211 224Medline Qiu Y Pereira FA De Mayo FJ Lydon JP Tsai SY Tsai MJ 1997 Null mutation mCOUP TFI results defects morphogenesis glossopharyngeal ganglion axonal projection arborization
0.3001008.11117523.html.plaintext.txt	380	Genes Dev 111925 1937AbstractFree Full Text Sucov HM Dyson E Gumeringer CL Price J Chien KR Evans RM 1994 RXR mutant mice establish genetic basis vitamin A signaling heart morphogenesis
0.3001008.11117523.html.plaintext.txt	381	Genes Dev 81007 1018Abstract Escriva H Safi R Hanni C Langlois M C Saumitou Laprade P Stehelin D Capron A Pierce R Laudet V 1997 Ligand binding acquired evolution nuclear receptors
0.3001008.11117523.html.plaintext.txt	382	Proc Natl Acad Sci USA 946803 6808AbstractFree Full Text Sagami I Tsai SY Wang H Tsai MJ O Malley BW 1986 Identification two factors required transcription ovalbumin gene
0.3001008.11117523.html.plaintext.txt	383	Mol Cell Biol 64259 4267Medline Ladias JAA Karathanasis SK 1991 Regulation apolipoprotein A1 gene ARP 1 novel member steroid receptor superfamily
0.3001008.11117523.html.plaintext.txt	384	Science 251561 565Medline Tsai SY Tsai MJ 1997 Chicken ovalbumin upstream promoter transcription factor COUP TFs coming age
0.3001008.11117523.html.plaintext.txt	385	Endocr Rev 18229 240AbstractFree Full Text Fjose A Nornes S Weber U Mlodzik M 1993 Functional conservation vertebrate seven related genes neurogenesis eye development
0.3001008.11117523.html.plaintext.txt	386	EMBO J 121403 1414Abstract Lu X P Salbert G Pfahl M 1994 An evolutionary conserved COUP TF binding element neural specific gene COUP TF expression patterns support major role COUP TFI neural development
0.3001008.11117523.html.plaintext.txt	387	Mol Endocrinol 81774 1788Abstract Lutz B Kuratani S Cooney AJ Wawersik S Tsai SY Eichele G Tsai MJ 1994 Developmental regulation orphan receptor COUP TFII gene spinal motor neurons
0.3001008.11117523.html.plaintext.txt	388	Development 12025 36AbstractFree Full Text Pereira FA Qiu Y Tsai MJ Tsai SY 1995 Chicken ovalbumin upstream promoter transcription factor COUP TF expression mouse embryogenesis
0.3001008.11117523.html.plaintext.txt	389	J Steroid Biochem Mol Biol 53503 508CrossRefMedline Qiu Y Cooney AJ Kuratani S DeMayo FJ Tsai SY Tsai M J 1994 Spatiotemporal expression patterns chicken ovalbumin upstream promoter transcription factors developing mouse central nervous system evidence role segmental patterning diencephalon
0.3001008.11117523.html.plaintext.txt	390	Proc Natl Acad Sci USA 914451 4455Abstract Vlahou A Gonzales Rimbau M Flytzanis CN 1996 Maternal mRNA encoding orphan steroid receptor SpCOUP TFI localized sea urchin eggs
0.3001008.11117523.html.plaintext.txt	391	Development 122521 526AbstractFree Full Text Connor H Nornes H Neuman T 1995 Expression screening reveals orphan receptor chick ovalbumin upstream promoter transcription factor I regulator neuritesubstrate cell contacts aggregation
0.3001008.11117523.html.plaintext.txt	392	J Biol Chem 27015066 15070AbstractFree Full Text Zhou C Qiu Y Pereira FA Crair MC Tsai SY Tsai MJ 1999 The nuclear orphan receptor COUP TFI required differentiation subplate neurons guidance thalamocortical axons
0.3001008.11117523.html.plaintext.txt	393	Neuron 24847 859Medline Pereira FA Qiu Y Zhou G Tsai MJ Tsai SY 1999 The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.3001008.11117523.html.plaintext.txt	394	Genes Dev 131037 1049AbstractFree Full Text Kastner P Mark M Chambon P 1995 Nonsteroid nuclear receptors genetic studies telling us Cell 83859 869Medline Brubaker K McMillan M Neuman T Nornes HO 1996 All trans retinoic acid affects expression orphan receptors COUP TFI COUP TFII developing neural tube
0.3001008.11117523.html.plaintext.txt	395	Dev Brain Res 93198 202Medline Fjose A Weber U Mlodzick M 1995 A novel vertebrate svp related nuclear receptor expressed step gradient developing rhombomeres affected retinoic acid
0.3001008.11117523.html.plaintext.txt	396	Mech Dev 52233 246CrossRefMedline Jonk LJC de Jonge MEJ Pals CE Wissink S Vervaart JMA Schoorlemmer J Kruijer W 1994 Cloning expression development three murine members COUP family nuclear orphan receptors
0.3001008.11117523.html.plaintext.txt	397	Mech Dev 4781 97CrossRefMedline Van der Wees J Matharu PJ de Roos K Destree OHJ Godsave SF Durston AJ Sweeney GE 1996 Developmental expression differential regulation retinoic acid Xenopus COUP TF A COUP TF B
0.3001008.11117523.html.plaintext.txt	398	Mech Dev 54173 184CrossRefMedline Jones Villeneuve EMV McBurney MW Rogers KA Kalnins VI 1982 Retinoic acid induces embryonal carcinoma cells differentiate neurons glial cells
0.3001008.11117523.html.plaintext.txt	399	J Cell Biol 94253 262Abstract McBurney MW Jones Villeneuve EMV Edwards MKS Anderson PJ 1982 Control muscle neuronal differentiation cultured embryonal carcinoma cell line
0.3001008.11117523.html.plaintext.txt	400	Nature 299165 167Medline Mummery CL Feijen A Moolenaar WH van den Brink CE de Laat SW 1986 Establishment differentiated mesodermal line P19 EC cells expressing functional PDGF EGF receptors
0.3001008.11117523.html.plaintext.txt	401	Exp Cell Res 165229 242Medline MacPherson PA McBurney MW 1995 P19 embryonal carcinoma cells source cultured neurons amenable genetic manipulation
0.3001008.11117523.html.plaintext.txt	402	Methods Companion Methods Enzymol 7238 252CrossRef Imai Y Suzuki Y Tohyama M Wanaka A Takagi T 1994 Cloning expression neural differentiation associated gene p205 embryonal carcinoma cell line P19 developing mouse
0.3001008.11117523.html.plaintext.txt	403	Brain Res Mol Brain Res 24313 319Medline Imai Y Suzuki Y Matsui T Tohyama M Wanaka A Takagi T 1995 Cloning retinoic acid induced gene GT1 embryonal carcinoma cell line P19 neuron specific expression mouse brain
0.3001008.11117523.html.plaintext.txt	404	Brain Res Mol Brain Res 311 9CrossRefMedline Jonk LJ de Jonge ME Vervaart JM Wissink S Kruijer W 1994 Isolation developmental expression retinoic acid induced genes
0.3001008.11117523.html.plaintext.txt	405	Dev Biol 161604 614CrossRefMedline Lazennec G Kern L Valotaire Y Salbert G 1997 The nuclear receptors COUP TF ARP 1 positevely regulate trout estrogen receptor gene enhancing autoregulation
0.3001008.11117523.html.plaintext.txt	406	Mol Cell Biol 175053 5066Abstract Kadowaki Y Toyoshima K Yamamoto T 1992 Ear3COUP TF binds tightly response element tandem repeat separated one nucleotide
0.3001008.11117523.html.plaintext.txt	407	Biochem Biophys Res Commun 183492 498Medline Neuman K Soosaar A Nornes HO Neuman T 1995 Orphan receptor COUP TFI antagonizes retinoic acid induced neuronal differentiation
0.3001008.11117523.html.plaintext.txt	408	J Neurosci Res 4139 48Medline Cooney AJ Tsai SY O Malley BW Tsai MJ 1992 Chicken ovalbumin upstream promoter transcription factor COUP TF dimers bind different GGTCA response elements allowing COUP TF repress hormonal induction vitamin D3 thyroid hormone retinoic acid receptors
0.3001008.11117523.html.plaintext.txt	409	Mol Cell Biol 124153 4163Abstract Tran P Zhang XK Salbert G Hermann T Lehmann J Pfahl M 1992 COUP orphan receptors negative regulators retinoic acid response pathways
0.3001008.11117523.html.plaintext.txt	410	Mol Cell Biol 124666 4676Abstract Remboutsika E Lutz Y Gansmuller A Vonesch J L Losson R Chambon P 1999 The putative nuclear receptor mediator TIF1 tightly associated euchromatin
0.3001008.11117523.html.plaintext.txt	411	J Cell Sci 1121671 1683AbstractFree Full Text Fujii H Hamada H 1993 A CNS specific POU transcription factor Brn 2 required establishing mammalian neural cell lineages
0.3001008.11117523.html.plaintext.txt	412	Neuron 111197 1206Medline Suzuki T Kim H S Kurabayashi M Hamada H Fujii H Aikawa M Watanabe M Sakomura Y Yazaki Y Nagai R 1996 Preferential differentiation P19 mouse embryonal carcinoma cells smooth muscle cells
0.3001008.11117523.html.plaintext.txt	413	Circ Res 78395 404AbstractFree Full Text Schmidt JW Brugge JS Nelson WJ 1992 pp60 src tyrosine kinase modulates P19 embryonal carcinoma cell fate inhibiting neuronal epithelial differentiation
0.3001008.11117523.html.plaintext.txt	414	J Cell Biol 1161019 1033Abstract Hynes RO 1992 Integrins versatility modulation signaling cell adhesion
0.3001008.11117523.html.plaintext.txt	415	Cell 6911 25Medline Galileo DS Majors J Horwitz AF Sanes JR 1992 Retrovirally introduced antisense integrin RNA inhibits neuroblast migration vivo
0.3001008.11117523.html.plaintext.txt	416	Neuron 91117 1131Medline Calof AL Lander AD 1991 Relationship neuronal migration cell substratum adhesion laminin merosin promote olfactory neuronal migration anti adhesive
0.3001008.11117523.html.plaintext.txt	417	J Cell Biol 115779 794Abstract Perris R Paulsson M Bronner Fraser M 1989 Molecular mechanisms avian neural crest cell migration fibronectin laminin
0.3001008.11117523.html.plaintext.txt	418	Dev Biol 136222 238Medline Tomaselli KJ Reichardt LF Bixby JL 1986 Distinct molecular interactions mediate neuronal process outgrowth non neuronal cell surfaces extracellular matrices
0.3001008.11117523.html.plaintext.txt	419	J Cell Biol 1032659 2672Abstract Anton ES Kreidberg JA Rakic P 1999 Distinct function 3 v integrin receptors neuronal migration laminar organization cerebral cortex
0.3001008.11117523.html.plaintext.txt	420	Neuron 22277 289Medline Martinez Morales JR Barbas JA Marti E Bovolenta P Edgar D Rodriguez Tebar A 1997 Vitronectin expressed ventral region neural tube promotes differentiation motor neurons
0.3001008.11117523.html.plaintext.txt	421	Development 1245139 5147AbstractFree Full Text Neugebauer KM Emmett CJ Venstrom KA Reichardt LF 1991 Vitronectin thrombospondin promote retinal neurite outgrowth developmental regulation role integrins
0.3001008.11117523.html.plaintext.txt	422	Neuron 6345 358Medline Legraverand C Eguchi H Strom A Lahuna O Mode A Tollet P Westin S Gustafsson J A 1994 Transactivation rat CYP2C13 gene promoter involves HFN 1 HNF 3 members orphan receptor subfamily
0.3001008.11117523.html.plaintext.txt	423	Biochemistry 339889 9897Medline Rohr O Aunis D Schaeffer E 1997 COUP TF Sp1 interact cooperate transcriptional activation human immunodeficiency virus type 1 long terminal repeat human microglial cells
0.3001008.11117523.html.plaintext.txt	424	J Biol Chem 27231149 31155AbstractFree Full Text Seiffert D Curriden SA Jenne D Binder BR Loskutoff DJ 1996 Differential regulation vitronectin mice humans vitro
0.3001008.11117523.html.plaintext.txt	425	J Biol Chem 2715474 5480AbstractFree Full Text Liu Y Yang N Teng CT 1993 COUP TF acts competitive repressor estrogen mediated activation mouse lactoferrin gene
0.3001008.11117523.html.plaintext.txt	426	Mol Cell Biol 131836 1846Abstract Cooney AJ Leng X Tsai SY O Malley BW Tsai MJ 1993 Multiple mechanisms chicken ovalbumin upstream promoter transcription factor dependent repression transactivation vitamin D thyroid hormone retinoic acid receptors
0.3001008.11117523.html.plaintext.txt	427	J Biol Chem 2684152 4160AbstractFree Full Text Kliewer SA Umesono K Heyman RA Mangelsdorf DJ Dyck JA Evans RM 1992 Retinoid X receptor COUP TFI interactions modulate retinoic acid signaling
0.3001008.11117523.html.plaintext.txt	428	Proc Natl Acad Sci USA 891448 1452Abstract Bain G Ray WJ Yao M Gottlieb DI 1994 From embryonal carcinoma cells neurons P19 pathway
0.3001008.11117523.html.plaintext.txt	429	Bioessays 16343 348Medline Bain G Kitchens D Yao M Huettner JE Gottlieb DI 1995 Embryonic stem cells express neuronal properties vitro
0.3001008.11117523.html.plaintext.txt	430	Dev Biol 168342 357CrossRefMedline Bouillet P Oulad Abdelghani M Vicaire S Garnier J M Schuhbauer B Dolle P Chambon P 1995 Efficient cloning cDNAs retinoic acid responsive genes P19 embryonal carcinoma cells characterization novel mouse gene Stra1 mouse LERK 2Eplg2
0.3001008.11117523.html.plaintext.txt	431	Dev Biol 170420 433CrossRefMedline Bouillet P Sapin V Chazaud C Messaddeq N Decimo D Dolle P Chambon P 1997 Developmental expression pattern Stra6 retinoic acid responsive gene encoding new type membrane protein
0.3001008.11117523.html.plaintext.txt	432	Mech Dev 63173 186CrossRefMedline Schuh TJ Kimelman D 1995 COUP TFI potential regulator retinoic acid modulated development Xenopus embryo
0.3001008.11117523.html.plaintext.txt	433	Mech Dev 5139 49CrossRefMedline Grabham PW Gallimore PH Grand RJ 1992 Vitronectin major serum protein essential NGF mediated neurite outgrowth PC12 cells
0.3001008.11117523.html.plaintext.txt	434	Exp Cell Res 202337 344Medline Krishnan V Elberg G Tsai M J Tsai SY 1997 Identification novel sonic hedgehog response element chicken ovalbumin upstream promoter transcription factor II promoter
0.3001008.11117523.html.plaintext.txt	435	Mol Endocrinol 111458 1466AbstractFree Full Text Delannet M Martin F Bossy B Cheresh DA Reichardt LF Duband J L 1994 Specific roles Vss1 Vss3 Vss5 integrins avian neural crest cell adhesion migration vitronectin
0.3001008.11117523.html.plaintext.txt	436	Development 1202687 2702AbstractFree Full Text Petit F Le Goff P Cravedi JP Valotaire Y Pakdel F 1997 Two complementary bioassays screening estrogenic potency xenobiotics recombinant yeast trout estrogen receptor trout hepatocyte cultures
0.3001008.11117523.html.plaintext.txt	437	J Mol Endocrinol 19321 335AbstractFree Full Text Sambrook J Fritsch EF Maniatis T 1989 Monitoring expression ss galactosidase activity
0.3001008.11117523.html.plaintext.txt	438	In Molecular Cloning A Laboratory Manual
0.3001008.11117523.html.plaintext.txt	439	Cold Spring Harbor Laboratory Press Cold Spring Harbor NY p 17
0.3001008.11117523.html.plaintext.txt	440	35 Pfahl M Tzukerman M Zhang X K Lehmann JM Hermann T Wills K Graupner G 1990 Rapid procedures retinoic acid receptor cloning analysis
0.3001008.11117523.html.plaintext.txt	441	Methods Enzymol 153256 270 Lazennec G Kern L Salbert G Saligaut D Valotaire Y 1996 Cooperation human estrogen receptor ER MCF 7 cell specific transcription factors elicits high activity estrogen inducible enhancer trout ER gene
0.3001008.11117523.html.plaintext.txt	442	Mol Endocrinol 10116 1126 Krowczynska AM Coutts M Makrides S Brawerman G 1989 The mouse homologue human acidic ribosomal phosphoprotein PO highly conserved polypeptide translational control
0.3001008.11117523.html.plaintext.txt	443	Nucleic Acids Res 176408Medline Clifford J Chiba H Sobieszczuk D Metzger D Chambon P 1996 RXR null F9 embryonal carcinoma cells resistant differentiation anti proliferative apoptotic effects retinoids
0.3001008.11117523.html.plaintext.txt	444	EMBO J 154142 4155Abstract Boudjelal M Taneja R Matsubara S Bouillet P Dolle P Chambon P 1997 Overexpression Stra13 novel retinoic acid inducible gene basic helix loop helix family inhibits mesodermal promotes neuronal differentiation P19 cells
0.3001008.11117523.html.plaintext.txt	445	Genes Dev 112052 2065AbstractFree Full Text
0.3133714.11145965.html.plaintext.txt	0	The Mouse Fetoprotein Transcription Factor FTF Gene Promoter Is Regulated Three GATA Elements Tandem E Box Nkx Motifs FTF Turn Activates Hnf3 Hnf4 Hnf1 Gene Promoters Jean Francois Pare Sylvie Roy Luc Galarneau Luc Belanger
0.3133714.11145965.html.plaintext.txt	1	From Le Centre de Recherche en Cancerologie de lUniversite Laval LHotel Dieu de Quebec Departement de Biologie Medicale Faculte de Medecine Quebec G1R 2J6 Canada
0.3133714.11145965.html.plaintext.txt	2	Received publication November 28 2000
0.3133714.11145965.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.3133714.11145965.html.plaintext.txt	4	Fetoprotein transcription factor FTF orphan nuclear receptor activates 1 fetoprotein gene early liver developmental growth
0.3133714.11145965.html.plaintext.txt	5	Here sought define better position FTF transcriptional cascades leading hepatic differentiation
0.3133714.11145965.html.plaintext.txt	6	The mouse FTF gene isolated assigned chromosome 1 band E4 one mFTF pseudogene also found
0.3133714.11145965.html.plaintext.txt	7	Exonintron mapping shows mFTF gene structure similar close homologue SF1 two N terminal exons mFTF gene exon mapping also delimits several FTF mRNA 5 3 splice variants
0.3133714.11145965.html.plaintext.txt	8	The mFTF transcription initiation site located adult liver 238 nucleotides first translation initiator codon six canonical GATA E box Nkx motifs clustered 50140 base pairs bp cap site DNAprotein binding assays also pinpointed HNF4 binding element 36 bp FTF binding element 257 bp
0.3133714.11145965.html.plaintext.txt	9	Transfection assays point mutations showed mFTF promoter activated GATA HNF4 FTF Nkx basic helix loop helix factors marked cooperativity GATA HNF4
0.3133714.11145965.html.plaintext.txt	10	A tandem GATAE box activatory motif proximal mFTF promoter strikingly similar composite motif coactivated differentiation inducers hematopoietic lineage tandem GATA Nkx motif distal mFTF promoter also similar composite motif transducing differentiation signals transforming growth factor like receptors cardiogenic lineage
0.3133714.11145965.html.plaintext.txt	11	Three genes encoding transcription factors critical early hepatic differentiation Hnf3 Hnf4 Hnf1 contain dual FTF binding elements proximal promoters three promoters activated FTF transfection assays
0.3133714.11145965.html.plaintext.txt	12	Direct DNA binding action cooperativity demonstrated FTF HNF3 Hnf3 promoter FTF HNF4 Hnf1 promoter
0.3133714.11145965.html.plaintext.txt	13	These combined results suggest FTF early intermediary endodermal specification signals downstream genes establish amplify hepatic phenotype
0.3133714.11145965.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.3133714.11145965.html.plaintext.txt	15	5 days mouse embryogenesis endodermal cells ventral foregut interact cardiac mesoderm become committed hepatic differentiation program newly specified cells migrate proliferate mesenchyme septum transversum liver morphogenesis becomes apparent E10
0.3133714.11145965.html.plaintext.txt	16	Initial induction hepatic functions driven part growth factors FGF1 family secreted cardiac mesodermal cells acting via transmembrane receptor kinases endodermal cell surface 3
0.3133714.11145965.html.plaintext.txt	17	The process also involves potentiating transcription factors among GATA factors appear essential endodermal determination across vertebrates well invertebrates Ref
0.3133714.11145965.html.plaintext.txt	18	Following liver specification transcriptional activation cascades develop among early hepatic transcription factors creating interactive regulatory networks amplify induction signals imprint liver phenotype HNF4 gene product example activates Hnf1 gene whose product enhances Hnf4 gene promoter HNF1 HNF4 activate broad spectrum liver functions 5 6
0.3133714.11145965.html.plaintext.txt	19	One earliest events marking endodermal specification liver function activation 1 fetoprotein AFP locus one four albumin related genes tandemly organized genome differentially expressed development 7
0.3133714.11145965.html.plaintext.txt	20	The AFP gene first activated foregut endoderm 8 therefore transcription factors transduce early cell specification signals unfold AFP chromatin likely exert high ranking liver differentiation functions
0.3133714.11145965.html.plaintext.txt	21	One prime candidate regard orphan nuclear receptor originally pinpointed potent highly specific mandatory activator proximal AFP gene promoter 9 11
0.3133714.11145965.html.plaintext.txt	22	The fetoprotein transcription factor FTF NR5A2 FTF designation per Genome Data Base Nomenclature Committee accession number 9837397 NR5A2 per Nuclear Receptor Nomenclature Committee 12 belongs subgroup nuclear receptors related archetypal Drosophila segmentation gene Ftz F1 13 bind monomers DNA motif PyCAAGGPyCPu Py C T Pu A G11
0.3133714.11145965.html.plaintext.txt	23	FTF widespread tightly conserved among vertebrates 14 17 closest mammalian relative SF1 18 mainly expressed steroidogenic cell lineages whereas FTF mainly expressed gut derivatives
0.3133714.11145965.html.plaintext.txt	24	Early developmental patterns FTF expression several species 14 17 19 activation AFP locus hepatocyte progenitors suggested important role FTF endodermal differentiation pathways
0.3133714.11145965.html.plaintext.txt	25	To gain better insight FTF functions position liver induction pathways isolated functionally characterized mouse FTF gene promoter search upstream FTF gene regulators also searched new FTF downstream gene targets
0.3133714.11145965.html.plaintext.txt	26	The combined results make compelling case FTF key intermediary initial signals liver specification cascade activations transcription factors enhance hepatic differentiation
0.3133714.11145965.html.plaintext.txt	27	cis activating elements pin pointed mFTF promoter may lead new important effectors endodermal differentiation pathways
0.3133714.11145965.html.plaintext.txt	28	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.3133714.11145965.html.plaintext.txt	29	Isolation Mapping Mouse FTF Gene A mouse 129 SV genomic DNA library bacteriophage DASH II Stratagene screened plaque hybridization using rat FTF cDNA 11 probe
0.3133714.11145965.html.plaintext.txt	30	The PCR method used screen mouse 129 SV P1 bacteriophage library Genome Systems following primers mouse FTF gene introns 5 AGTTGAATCTCTGCTGCCCGTGTCC 3 intron 2 5 TAGCCCGAGAGTGTAAAACCAGGAA 3 intron 3
0.3133714.11145965.html.plaintext.txt	31	DASH II DNA FTF positive clones prepared plate lysate method P1 clone DNA prepared alkaline lysis procedure
0.3133714.11145965.html.plaintext.txt	32	DNA digested various restriction enzymes DNA fragments ligated pBluescript SK Stratagene used transform Escherichia coli DH5 plasmid DNA isolated positive subclones identified Southern analysis using mouse FTFLRH 1 11 cDNA fragments
0.3133714.11145965.html.plaintext.txt	33	DNA sequenced strands dideoxynucleotide method exonintron boundaries mapped mFTFLRH1 cDNA sequence 11 mFTF genomic sequences deposited GenBankTM accession number AF239709 BankIt 322861
0.3133714.11145965.html.plaintext.txt	34	The mFTF gene transcription start site mapped primer extension mouse liver RNA using 25 mer oligonucleotide FTF PE1 spanning mouse FTF gene sequence 37 61 underlined Fig
0.3133714.11145965.html.plaintext.txt	35	FTF PE1 radiolabeled 106 cpmng 32PATP T4 polynucleotide kinase Life Technologies Inc
0.3133714.11145965.html.plaintext.txt	36	purified gel electrophoresis electroelution 5 x 105 cpm FTF PE1 primer annealed 200 microg total RNA adult mouse liver overnight 50 degrees C 32 microl Superscript II reverse transcriptase buffer Life Technologies Inc
0.3133714.11145965.html.plaintext.txt	37	reaction cooled 42 degrees C pursued 2 h presence 10 mM dithiothreitol 1 mM dNTPs 100 units Superscript II reverse transcriptase
0.3133714.11145965.html.plaintext.txt	38	Reverse transcription products subjected RNase A digestion phenolchloroform extraction ethanolsodium acetate precipitation analyzed electrophoresis denaturing 6 polyacrylamide gels reference DNA sequences used FTF PE1 primer DNA FTF gene plasmid 4F CAT
0.3133714.11145965.html.plaintext.txt	39	Chromosomal localization mouse FTF gene carried fluorescence situ hybridization Genome Systems
0.3133714.11145965.html.plaintext.txt	40	Mouse FTF genomic DNA P1 clone labeled digoxigenin dUTP nick translation mixed sheared mouse DNA hybridized metaphase chromosomes normal mouse embryo fibroblasts 50 formamide 10 dextran sulfate 2 x SSC
0.3133714.11145965.html.plaintext.txt	41	Hybridization signals revealed fluoresceinated anti digoxigenin antibodies followed counterstaining 46 diamidino 2 phenylindole
0.3133714.11145965.html.plaintext.txt	42	Of 80 metaphases analyzed 72 exhibited specific labeling FTF gene assignment confirmed cohybridization telomeric probe specific chromosome 1
0.3133714.11145965.html.plaintext.txt	43	FTF Gene Constructs FTF gene promoter activity analyzed FTFCAT reporter constructs spanning 4 kb 280 bp contiguous DNA 5 adjacent mouse FTF transcription start site
0.3133714.11145965.html.plaintext.txt	44	A HindIII BamHI fragment pSV0 CAT 9 cloned HindIII BamHI digested pBluescript SK generate vector SK CAT EcoRI FTF gene fragment 3
0.3133714.11145965.html.plaintext.txt	45	9 kb 79 bp leftmost fragment Fig
0.3133714.11145965.html.plaintext.txt	46	1A isolated blunted inserted HindIII blunted SK CAT generate construct 4F CAT
0.3133714.11145965.html.plaintext.txt	47	To obtain pF CAT 4F CAT vector digested PstI leave FTF gene segment 18479 upstream CAT PstI 280185 FTF segment inserted 184 correct orientation
0.3133714.11145965.html.plaintext.txt	48	Mutations FTF gene promoter derived PCRs using plasmid 4F CAT oligonucleotides listed Table I two complementary oligonucleotides 125 ng overlapping targeted region mixed 50 ng 4F CAT DNA amplified Pfu DNA polymerase Stratagene 30 95 degrees C 1 min 55 degrees C 2 minkb DNA template 68 degrees C 18 cycles followed 1 h 37 degrees C 10 units DpnI Stratagene
0.3133714.11145965.html.plaintext.txt	49	The PCR products transformed E
0.3133714.11145965.html.plaintext.txt	50	coli DH5 mutations confirmed sequencing
0.3133714.11145965.html.plaintext.txt	51	Mutant 4FmG123 derived 4FmG3
0.3133714.11145965.html.plaintext.txt	52	Hnf1 Hnf3 Hnf4 Promoter Vectors Reporter vector pH1 CAT driven Hnf1 promoter obtained PCR amplification mouse Hnf1 gene region 17410 using mouse genomic DNA following primers 5 GGCTCGAGTGCTCACTCCCAATTGCAGGCCATGACTCC 3 5 CCAAGCTTGGCCAGTGAATCAGGGCCCCTGCCTGCTC 3
0.3133714.11145965.html.plaintext.txt	53	The PCR product digested XhoI HindIII cloned SK CAT generate pH1 CAT
0.3133714.11145965.html.plaintext.txt	54	Mutations introduced pH1 CAT PCRs described FTF constructs using oligonucleotides H1mF1 H1mF2 Table I pH1 CAT plasmid DNA derivative pH1mF1 CAT
0.3133714.11145965.html.plaintext.txt	55	HNF3 CAT reporters pH3 CAT H3mF1 constructs HNF3 18469 UF2 H3 mutant described elsewhere 20 vector H3mF12 derived H3mF1 using PCR pTZ18U internal primer oligonucleotide H3mF2 Table I
0.3133714.11145965.html.plaintext.txt	56	The PCR product digested ScaI SacI used replace ScaISacI segment H3mF1
0.3133714.11145965.html.plaintext.txt	57	HNF4 reporter vector pH4 luc luciferase expression vector carrying 363182 bp mouse Hnf4 gene segment 6
0.3133714.11145965.html.plaintext.txt	58	View table Table I Oligonucleotides used mutagenesis
0.3133714.11145965.html.plaintext.txt	59	Electrophoretic Mobility Shift Assays Transient Cell Transfections Bandshift assays conducted described 10 11 total nuclear proteins adult rat liver oligonucleotides listed Table II using 0
0.3133714.11145965.html.plaintext.txt	60	2 ng 32P labeled probe 3 microg nuclear proteins 5 500 fold molar excess cold competitor oligonucleotides
0.3133714.11145965.html.plaintext.txt	61	For FTF binding assays probe competitors coincubated nuclear extract 30 min 4 degrees C HNF4 supershift assays 1 microl anti HNF4 serum Santa Cruz Biotechnology preincubated nuclear extract 1 h room temperature probe competitors added additional 30 min
0.3133714.11145965.html.plaintext.txt	62	View table Table II Oligonucleotides used electrophoretic mobility shift assay
0.3133714.11145965.html.plaintext.txt	63	Transfection assays carried calcium phosphate procedure detailed previously 9 10 using HepG2 Hep3B HeLa F9 cells maintained Dulbeccos modified Eagles medium Life Technologies Inc
0.3133714.11145965.html.plaintext.txt	64	containing 10 fetal bovine serum Wisent 1 penicillinstreptomycin F9 cultures used gelatin coated dishes
0.3133714.11145965.html.plaintext.txt	65	5 x 106 cells 6 cm Petri dishes 75 cm2 flasks transfected 24 h later 2 5 microg CAT reporter plasmid 2 10 microg transcription factor expression vector 1
0.3133714.11145965.html.plaintext.txt	66	5 microg RSV lacZ standardize transfection efficiency
0.3133714.11145965.html.plaintext.txt	67	Cells washed 16 h harvested 48 h transfection
0.3133714.11145965.html.plaintext.txt	68	CAT activity measured thin layer chromatography phosphorimaging
0.3133714.11145965.html.plaintext.txt	69	Luciferase activity measured EG G Berthold Lumat LB9507 luminometer
0.3133714.11145965.html.plaintext.txt	70	Expression vectors transcription factors used viral enhancer promoter elements cytomegalovirus FTF HNF4 CEBP HNF1 HNF3 HNF3 HNF6 SP1 Nkx2
0.3133714.11145965.html.plaintext.txt	71	5 Rous sarcoma virus GATA1 GATA2 GATA4 GATA5 GATA6 simian virus 40 COUP TFII FTF vector carried full length human FTF cDNA 16 21
0.3133714.11145965.html.plaintext.txt	72	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.3133714.11145965.html.plaintext.txt	73	Genetic Mapping Mouse FTF Locus We retrieved three independent clones ZF2 ZF6 ZF25 mouse genomic library screened rat FTF cDNA probe clones ZF2 ZF25 gave stronger signals Southern blots characterized
0.3133714.11145965.html.plaintext.txt	74	Clone ZF2 contained contiguous sequence closely matching mouse FTFLRH 1 cDNA sequence 11 many base changes deletions insertions introns indicative retro pseudogene
0.3133714.11145965.html.plaintext.txt	75	Clone ZF25 contained FTF coding interspersed DNA sequences corresponding exon 3 6 domain Fig
0.3133714.11145965.html.plaintext.txt	76	Intronic oligonucleotides used screening mouse P1 library yielded insert extending 35 kb upstream ZF25
0.3133714.11145965.html.plaintext.txt	77	The P1 insert revealed additional exons cluster transcription factor recognition sites 5 flanking exon 1 suggestive promoter domain Fig
0.3133714.11145965.html.plaintext.txt	78	Intronexon boundaries mapped P1 clones conformed GTAG splicing rule
0.3133714.11145965.html.plaintext.txt	79	Mouse FTF exons 3 6 correspond SF1 exons 1 4 18 two additional 5 FTF exons encode longer FTF N terminal AB domain 11 conserved exonintron junctions SF1 FTF predict FTF 3 gene domain contains three exons 7 9 mouse encoding C terminus amino acids 390 560 11
0.3133714.11145965.html.plaintext.txt	80	mFTF exons 1 4 6 similar size zebrafish ff1 exons 1 3 5 17
0.3133714.11145965.html.plaintext.txt	81	View larger version 45K Fig
0.3133714.11145965.html.plaintext.txt	82	Genetic mapping mouse FTF locus
0.3133714.11145965.html.plaintext.txt	83	A restriction sites E EcoRI S StuI mapping mFTF gene exons I VI superscript numbers encoded amino acids ZF1 ZF2 DNA binding zinc finger 1 2 domains arrow translation initiation
0.3133714.11145965.html.plaintext.txt	84	The dashed line gene segment measured PCR unmapped restriction enzymes
0.3133714.11145965.html.plaintext.txt	85	B transcription initiation site promoter sequence
0.3133714.11145965.html.plaintext.txt	86	Left mFTF mRNA start site located primer extension mouse liver RNA FTF antisense primer 3761 sequencing ladders used primer 4F CAT plasmid DNA major reverse transcription product marked arrow
0.3133714.11145965.html.plaintext.txt	87	Right mFTF promoter sequence compared corresponding zebrafish FTF gene sequence zff1 17 dots indicate conserved nucleotides transcription factor recognition elements marked bold arrows 1 mRNA initiation sites underlined sequence oligonucleotide used primer extension
0.3133714.11145965.html.plaintext.txt	88	C chromosomal mapping mFTF gene fluorescence situ hybridization using mouse P1 FTF probe middle panel cohybridization chromosome 1 telomeric probe arrows point specific signals assign mFTF gene chromosome 1 band E4
0.3133714.11145965.html.plaintext.txt	89	The mFTF gene transcription initiation site identified primer extension adult mouse liver RNA using antisense primer 6137 underlined Fig
0.3133714.11145965.html.plaintext.txt	90	1B predominant transcription start site mapped Fig
0.3133714.11145965.html.plaintext.txt	91	1B G residue 79 nt upstream previously reported 5 end mouse FTF cDNA 238 nt upstream first translation initiation codon 11 extension primers downstream 79 bp yielded smears reverse transcription products terminating around 79 mRNA structure perhaps blocked polymerase extension alternative start sites around 79 cannot excluded
0.3133714.11145965.html.plaintext.txt	92	Chromosomal assignment mFTF gene carried fluorescence situ hybridization P1 FTF genomic probe minimizing cross hybridization mouse FTF pseudogene
0.3133714.11145965.html.plaintext.txt	93	Out 80 metaphases analyzed 72 showed single specific labeling middle portion chromosome 1 identified 46 diamidino 2 phenylindole staining cohybridization specific telomeric probe measurements chromosomal distances 10 fluorescence situ hybridization metaphases located mouse FTF gene chromosome 1 band E4 Fig
0.3133714.11145965.html.plaintext.txt	94	Functional Analysis mFTF Gene Promoter Functional analyses initiated mFTF gene construct 4F CAT carrying FTF gene segment 4 kb79 bp
0.3133714.11145965.html.plaintext.txt	95	Transfection assays showed strong reporter gene activity HepG2 Hep3B hepatoma cells express endogenous FTF 21 detectable activity FTF negative HeLa F9 cells inset Fig
0.3133714.11145965.html.plaintext.txt	96	Reporter CAT activity also higher Hep3B HepG2 cells correlating higher expression endogenous FTF Hep3B cells 21
0.3133714.11145965.html.plaintext.txt	97	These results thus indicated mFTF gene segment 4 kb79 bp correctly reproduced hepatic specificity relative activities endogenous FTF gene promoter functions
0.3133714.11145965.html.plaintext.txt	98	Electromobility shift assays conducted presumptive HNF4 FTF recognition sequences located 36 257 Fig
0.3133714.11145965.html.plaintext.txt	99	1B slightly divergent consensus binding sites
0.3133714.11145965.html.plaintext.txt	100	Radiolabeled DNA probe 3650 oligonucleotide FH4 Table II yielded single retarded liver complex competed cold oligo FH4 efficiently optimized HNF4 binding site oligo DR1 Fig
0.3133714.11145965.html.plaintext.txt	101	2A lanes 1 7 100 fold excess mutated FH4 sequence oligo mFH4 Table II Fig
0.3133714.11145965.html.plaintext.txt	102	Furthermore retarded complex completely supershifted anti HNF4 antibodies Fig
0.3133714.11145965.html.plaintext.txt	103	These results showed FTF promoter segment 3650 highly specific HNF4 recognition site lower affinity canonical HNF4 DR1 element
0.3133714.11145965.html.plaintext.txt	104	Similar assays using probe strong FTF binding element AFP gene promoter 10 11 oligonucleotide FTF Table II indicated mFTF gene segment 254268 oligo FF Table II also efficiently bind FTF lower affinity FTF site Fig
0.3133714.11145965.html.plaintext.txt	105	View larger version 53K Fig
0.3133714.11145965.html.plaintext.txt	106	A bandshift reactions showing interaction liver transcription factor HNF4 mFTF gene sequence 3650 oligo FH4 Table II mFH4 mutated FH4 sequence DR1 optimized HNF4 binding site binding FTF promoter sequence 254268 oligo FF Table II FTF mFTF wild type mutated FTF binding sequence AFP promoter
0.3133714.11145965.html.plaintext.txt	107	Reactions used 3 microg rat liver nuclear proteins arrows point four rat FTF isoforms 10 11 5 100 fold excess numbers lanes cold competitors C competitor lane 11 shows supershift reaction preincubation extract anti HNF4 antiserum bandshift removed indicating FH4 element highly restricted HNF4
0.3133714.11145965.html.plaintext.txt	108	B transient transfection assays conducted HepG2 Hep3B hepatoma cells mFTF gene reporter constructs 4F CAT pF CAT cotransfected transcription factor expression vectors C control cotransfections void vector pCI
0.3133714.11145965.html.plaintext.txt	109	Results averages plus minus 1 S
0.3133714.11145965.html.plaintext.txt	110	three sets duplicate triplicate transfections using two plasmid preparations referred pCI controls given independent value 1 HepG2 Hep3B transfections
0.3133714.11145965.html.plaintext.txt	111	Inset autoradiograms CAT assays using FTF gene construct 4F CAT transiently transfected four cell lines indicated arrows chloramphenicol acetylated products 0
0.3133714.11145965.html.plaintext.txt	112	mFTF gene activation HNF4 FTF tested transient transfection Hep3B HepG2 cells
0.3133714.11145965.html.plaintext.txt	113	Cotransfection construct 4F CAT HNF4 expression vector resulted 5 6 fold enhancement reporter gene activity cell lines Fig
0.3133714.11145965.html.plaintext.txt	114	2B lane 3 cotransfection FTF expression vector also resulted significant increase CAT activity Hep3B cells Fig
0.3133714.11145965.html.plaintext.txt	115	2B lane 4 HepG2 cells perhaps HepG2 cells express abundant SF1 binds activates DNA motif FTF 11 21
0.3133714.11145965.html.plaintext.txt	116	Three consensus GATA binding sites WGATAR conspicuous proximal mFTF gene domain 80138 Fig
0.3133714.11145965.html.plaintext.txt	117	1B tested activatory effects GATA expression vectors including GATA6 GATA4 variants expressed foregut endoderm liver primordium 22 23
0.3133714.11145965.html.plaintext.txt	118	Cotransfection GATA6 GATA4 GATA1 GATA2 GATA5 well raised 4F CAT activity 2 3 fold HepG2 Hep3B cells Fig
0.3133714.11145965.html.plaintext.txt	119	2B lane 2 coexpression GATA6 GATA4 HNF4 showed additive cooperative effects enhancing FTF promoter activity much 12 fold Hep3B cells Fig
0.3133714.11145965.html.plaintext.txt	120	We also found significant activation 4F CAT construct Nkx2
0.3133714.11145965.html.plaintext.txt	121	2B lane 5 consistent recognition cognate high affinity 24 Nkx2
0.3133714.11145965.html.plaintext.txt	122	5 binding element 99105 bp Fig
0.3133714.11145965.html.plaintext.txt	123	1B coexpression GATA4 Nkx2
0.3133714.11145965.html.plaintext.txt	124	5 enhanced 4F CAT activity slightly factor alone shown
0.3133714.11145965.html.plaintext.txt	125	No stimulation mFTF promoter activity detected expression vectors encoding SP1 HNF1 HNF3 HNF3 HNF6 CEBP Fig
0.3133714.11145965.html.plaintext.txt	126	2B lanes 7 12 binding sequences factors apparent mFTF promoter sequence c Myc USF1 USF2 expression vectors shown
0.3133714.11145965.html.plaintext.txt	127	Generally similar results obtained cotransfections using shorter FTF gene construct pF CAT carrying 280 bp 5 flanking DNA Fig
0.3133714.11145965.html.plaintext.txt	128	2B lanes 13 17 suggested direct action activating factors cognate DNA motifs clustered around cap site
0.3133714.11145965.html.plaintext.txt	129	Basal activity pF CAT similar 4F CAT provided indication regulatory components operating 280 bp 4 kb
0.3133714.11145965.html.plaintext.txt	130	To prove role mFTF promoter activity point mutations introduced HNF4 GATA Nkx elements natural 4 kb context construct 4F CAT mutations also introduced tandem E box motifs 66 58 bp
0.3133714.11145965.html.plaintext.txt	131	Mutation HNF4 sequence FmH4 Table I reduced basal mFTF promoter activity HepG2 Hep3B cells Fig
0.3133714.11145965.html.plaintext.txt	132	3B lane 2 cotransfection assays abolished mFTF promoter activation HNF4 Fig
0.3133714.11145965.html.plaintext.txt	133	Mutations targeting three GATA elements mutant mG123 proximal GATA site mG3 also reduced basal FTF promoter activity Fig
0.3133714.11145965.html.plaintext.txt	134	3B lanes 3 5 mG3 attenuated response cotransfected GATA4 Fig
0.3133714.11145965.html.plaintext.txt	135	3C lanes 2 versus 7 whereas mutation distal GATA sites mG12 abolished induction GATA4 Fig
0.3133714.11145965.html.plaintext.txt	136	Mutation Nkx element also eliminated promoter activation Nkx2
0.3133714.11145965.html.plaintext.txt	137	These combined data showed mFTF promoter activation cotransfection assays using HNF4 GATA Nkx2
0.3133714.11145965.html.plaintext.txt	138	5 vectors resulted direct action factors cognate DNA binding elements surrounding FTF cap site
0.3133714.11145965.html.plaintext.txt	139	Notably contrast proximal GATA HNF4 mutants mG3 mH4 distal GATA Nkx mutants mG12 mNk showed significant increase basal promoter activity HepG2 Hep3B cells Fig
0.3133714.11145965.html.plaintext.txt	140	3B lanes 2 3 versus 4 6
0.3133714.11145965.html.plaintext.txt	141	Also two E box motifs mutated mE12 strong reduction basal FTF promoter activity observed Fig
0.3133714.11145965.html.plaintext.txt	142	3B lane 9 whereas single mutation either distal proximal E box opposite effects basal promoter activity mE1 versus mE2 Fig
0.3133714.11145965.html.plaintext.txt	143	Double mutant mE12 maintained similar relative responses exogenous GATA4 HNF4 Fig
0.3133714.11145965.html.plaintext.txt	144	3C lanes 1 versus 9 2 versus 10 like GATA mutants HNF4 vice versa Fig
0.3133714.11145965.html.plaintext.txt	145	3C lanes 1 versus 6 2 versus 5 data shown suggesting factor activate mFTF gene promoter independently
0.3133714.11145965.html.plaintext.txt	146	View larger version 27K Fig
0.3133714.11145965.html.plaintext.txt	147	Mutational analysis mFTF gene promoter
0.3133714.11145965.html.plaintext.txt	148	A diagram 4F CAT mutations using PCR primers shown Table I introduced GATA G1 G2 G3 E box E1 E2 Nkx HNF4 promoter sites Fig
0.3133714.11145965.html.plaintext.txt	149	B mutation effects basal mFTF promoter activity transient transfection assays results averages plus minus 1 S
0.3133714.11145965.html.plaintext.txt	150	three sets transfections three plasmid preparations referred wild type 4F CAT activity given independent value 1 HepG2 Hep3B cells
0.3133714.11145965.html.plaintext.txt	151	C mutation effects 4F CAT response cotransfected expression vectors results averages plus minus 1 S
0.3133714.11145965.html.plaintext.txt	152	three transfections two preparations plasmids referred void vector pCi transfected parallel given independent value 1 HepG2 Hep3B cells
0.3133714.11145965.html.plaintext.txt	153	FTF Binds Activates Hnf3 Hnf4 Hnf1 Promoters Among liver enriched transcription factors HNF3 HNF4 HNF1 exert preponderant functions establishment maintenance hepatic phenotype 4 5 25
0.3133714.11145965.html.plaintext.txt	154	We observed promoter sequence Hnf3 Hnf4 Hnf1 genes contained putative FTF binding sites proximal Hnf1 promoter potential FTF recognition elements 47 99 bp side HNF4 binding element Fig
0.3133714.11145965.html.plaintext.txt	155	5 Hnf3 promoter also two proximal FTF like sequences organized tandem 35 58 downstream HNF3 autoregulatory element Fig
0.3133714.11145965.html.plaintext.txt	156	20 Hnf4 promoter two FTF like sequences 224 290 upstream HNF1 recognition element Fig
0.3133714.11145965.html.plaintext.txt	157	Electromobility shift assays confirmed FTF motifs identified Hnf1 Hnf3 Hnf4 promoters efficient competitors bandshift reactions using high affinity AFPFTF binding sequence probe Figs
0.3133714.11145965.html.plaintext.txt	158	Furthermore transfection assays Hnf1 Hnf3 Hnf4 promoter constructs activated cotransfection FTF expression vector Fig
0.3133714.11145965.html.plaintext.txt	159	5B lane 3 similar extent known direct activators
0.3133714.11145965.html.plaintext.txt	160	Hnf1 promoter HNF4 Fig
0.3133714.11145965.html.plaintext.txt	161	4B lane 3 Hnf4 promoter HNF1 Fig
0.3133714.11145965.html.plaintext.txt	162	5B lane 2 Hnf3 promoter HNF3 Fig
0.3133714.11145965.html.plaintext.txt	163	In addition mutation two FTF binding sites Hnf1 Hnf3 promoters eliminated promoter response exogenous FTF Fig
0.3133714.11145965.html.plaintext.txt	164	5A lane 8 HNF4 HNF3 Fig
0.3133714.11145965.html.plaintext.txt	165	Transfection assays confirmed coactivatory effects HNF4 COUP Hnf1 promoter 27 Fig
0.3133714.11145965.html.plaintext.txt	166	4B lanes 3 5 showed cooperativity FTF HNF3 activating Hnf3 promoter Fig
0.3133714.11145965.html.plaintext.txt	167	5A lane 4 FTF HNF4 COUP activating Hnf1 promoter Fig
0.3133714.11145965.html.plaintext.txt	168	Notably Hnf4 promoter responded strongly GATA6 HepG2 cells Fig
0.3133714.11145965.html.plaintext.txt	169	5B contains apparent GATA binding sites may indicate activatory protein protein interaction GATA6 SF1 28
0.3133714.11145965.html.plaintext.txt	170	SF1 highly expressed HepG2 cells 21 presumably occupies FTF binding sites Hnf4 promoter
0.3133714.11145965.html.plaintext.txt	171	View larger version 40K Fig
0.3133714.11145965.html.plaintext.txt	172	Activation Hnf1 promoter FTF
0.3133714.11145965.html.plaintext.txt	173	A left bandshift reactions conducted like Fig
0.3133714.11145965.html.plaintext.txt	174	2 rat liver nuclear extract oligonucleotides shown Table II H1FTF 1 H1FTF 2 correspond FTF sites 1 2 Hnf1 promoter
0.3133714.11145965.html.plaintext.txt	175	Right diagram FTF site mutations introduced Hnf1 promoter construct pH1 CAT mutated sequences H1mF1 andor H1mF2 shown Table I
0.3133714.11145965.html.plaintext.txt	176	B transfection assays Hep3B HepG2 cells showing response pH1 CAT FTF site mutants coexpressed transcription factors results averages plus minus 1 S
0.3133714.11145965.html.plaintext.txt	177	three transfections using two plasmid preparations referred parallel transfection void vector pCI column C given independent value 1 HepG2 Hep3B cells basal activities pH1 CAT H1mF1 H1mF2 H1mF12 vary significantly
0.3133714.11145965.html.plaintext.txt	178	View larger version 37K Fig
0.3133714.11145965.html.plaintext.txt	179	Activation Hnf3 Hnf4 promoters FTF
0.3133714.11145965.html.plaintext.txt	180	A diagram regulatory elements Hnf3 promoter 26 FTF site mutations cf
0.3133714.11145965.html.plaintext.txt	181	sequences Table I introduced reporter construct pH3 CAT
0.3133714.11145965.html.plaintext.txt	182	Autoradiogram FTF binding Hnf3 promoter sites H3FTF 1 H3FTF 2 shown bandshift reactions using radiolabeled AFPFTF probe FTF incubated 3 microg rat liver nuclear proteins 20 fold molar excess unlabeled oligonucleotides sequences given Table II C competitor
0.3133714.11145965.html.plaintext.txt	183	Histograms transfection assays HepG2 cells showing effect FTF site mutations basal pH3 CAT activity lanes C HNF3 promoter inducibility cotransfected FTF andor HNF3 results averages plus minus 1 S
0.3133714.11145965.html.plaintext.txt	184	four sets transfections using two plasmid preparations referred pH3 CATpCI cotransfection lane 1 given value 1
0.3133714.11145965.html.plaintext.txt	185	B autoradiogram bandshift reactions showing FTF binding Hnf4 promoter element FTF 2 oligo H4FTF 2 Table II results similar oligo H4FTF 1 reactions conducted A 20 500 fold molar excess cold competitors
0.3133714.11145965.html.plaintext.txt	186	Histogram transfection assays HepG2 cells showing enhancement pH4 luc activity coexpressed FTF HNF1 GATA6 additive effects found three factors results averages plus minus 1 S
0.3133714.11145965.html.plaintext.txt	187	three transfections using two plasmid preparations referred void vector pCI C given value 1
0.3133714.11145965.html.plaintext.txt	188	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.3133714.11145965.html.plaintext.txt	189	FTF Gene Structure Splice Products This first molecular cloning mammalian FTF genomic locus
0.3133714.11145965.html.plaintext.txt	190	The partial mFTF gene structure established indicates intronexon organization similar Sf1 gene duplicated ancestral gene 14
0.3133714.11145965.html.plaintext.txt	191	Like man mouse Sf1 FTF genes reside different chromosomes 16 29 30
0.3133714.11145965.html.plaintext.txt	192	The mouse FTF gene structure largely conserved zebrafish 17 apparent evolutionary remodeling exon 2 3 domain discussed
0.3133714.11145965.html.plaintext.txt	193	The mouse exon mapping indicates 5 exon heterogeneity FTF cDNAs cloned different species
0.3133714.11145965.html.plaintext.txt	194	Clones human FTF cDNAs uniformly lack sequence corresponding mouse exon 2 hFTF cDNA clone initially reported Ref
0.3133714.11145965.html.plaintext.txt	195	16 corresponds human FTF cDNA variant hB1F2 Ref
0.3133714.11145965.html.plaintext.txt	196	31 reviewed original sequence data found one compressed C missing position 344 Ref
0.3133714.11145965.html.plaintext.txt	197	16 disrupting hFTF N terminal reading frame
0.3133714.11145965.html.plaintext.txt	198	One human FTF variant hB1F 29 CPF 31 lacks exons 2 3
0.3133714.11145965.html.plaintext.txt	199	Rat FTF rFTZ F1 32 also exists two 5 transcripts one 21 amino acids shorter probably skipping exon 2
0.3133714.11145965.html.plaintext.txt	200	In zebrafish one FTF transcript ff1 I 17 contains 17 amino acid exon 1 corresponding mouse exon 1 spliced exon corresponding mouse exon 4
0.3133714.11145965.html.plaintext.txt	201	also skipping mouse homologue 2 3 domain
0.3133714.11145965.html.plaintext.txt	202	Thus FTF transcripts 5 splicing variants lack N terminal protein AB domain flanking FTF DNA binding domain
0.3133714.11145965.html.plaintext.txt	203	FTF splice variant 14 hB1F CPF abundant variant 13 hFTF hB1F2 CPF 1 human liver 29 shorter rat FTF variant presumably 13 rFTZ F12 also abundant longer transcript rFTZ F11 32
0.3133714.11145965.html.plaintext.txt	204	These observations may indicate FTF N terminal AB domain fulfills particular activatory functions would fit transfection data showing comparable transactivations full length FTF cDNA versus FTF devoid first 3 exons pf1 versus pf4 Ref
0.3133714.11145965.html.plaintext.txt	205	FTF also exists C terminal splice variants human Xenopus short variants hFTFs xFF1rAs diverge noncoding sequences 3 splice junction exon 6 16 33
0.3133714.11145965.html.plaintext.txt	206	Other FTF cloning products include human FTF clone CPF 2 31 truncated exon 6 restart exon 7 zebrafish ff1 clones B also interrupt C terminal exon 17
0.3133714.11145965.html.plaintext.txt	207	Such transcripts devoid AF2 activatory domain could principle exert dominant negative functions 11 21 33 however significant amounts products detected vivo 17 33
0.3133714.11145965.html.plaintext.txt	208	The FTF exons 2 3 domain considered
0.3133714.11145965.html.plaintext.txt	209	Regulation mFTF Gene Promoter This report also first functional characterization FTF gene promoter
0.3133714.11145965.html.plaintext.txt	210	Many cis acting elements pinpointed stringently conserved zebrafish 17 evolutionary conservation suggests elements fulfill important regulatory functions
0.3133714.11145965.html.plaintext.txt	211	Given broad phylogenetic role GATA factors endodermal specification 4 triple GATA binding domain also suggests tight connections GATA FTF pathway endodermal differentiation conceivably could extend invertebrate FTFFtz F1 homologues best knowledge FTF first liver enriched transcription factor gene directly activated GATA
0.3133714.11145965.html.plaintext.txt	212	In cotransfection assays GATA HNF4 highly efficient partners coactivating mFTF promoter consistent abundant coexpression GATA4 HNF4 FTF mammalian liver
0.3133714.11145965.html.plaintext.txt	213	However FTF also abundant tissues adult exocrine pancreas HNF4 significantly expressed
0.3133714.11145965.html.plaintext.txt	214	Furthermore development FTF gene expression precedes HNF4 FTF unambiguously detected situ hybridization E7
0.3133714.11145965.html.plaintext.txt	215	0 foregut endoderm2 consistent AFP gene transcription beginning least E8
0.3133714.11145965.html.plaintext.txt	216	0 8 HNF4 knockout experiments also indicate FTF AFP genes efficiently expressed without HNF4 early stages liver differentiation 25
0.3133714.11145965.html.plaintext.txt	217	Therefore FTF promoter segment analyzed would bypass HNF4 prehepatic endodermal stages
0.3133714.11145965.html.plaintext.txt	218	Point mutations selecting downstream GATA site adjacent E box element resulted lower levels basal FTF promoter activity indicating hepatoma cells proximal FTF regulatory domain 8561 subject regulation GATA basic helix loop helix bHLH factors
0.3133714.11145965.html.plaintext.txt	219	bHLH proteins play important differentiation functions diverse cell lineages plausible activators FTF gene early stage development
0.3133714.11145965.html.plaintext.txt	220	The tandem GATAE box motif also intriguingly similar composite element hematopoietic lineage orientation spacing coactivated protein complex made GATA1 bHLH factor Tal1 several bridging molecules include LIM domain protein Lmo2 34
0.3133714.11145965.html.plaintext.txt	221	GATA1 Tal1 Lmo2 required proper development erythropoietic lineage genes activated composite GATAE box motif predicted play critical differentiation functions blood cell lineage
0.3133714.11145965.html.plaintext.txt	222	FTF could thus plausibly qualify first target gene GATAE box multiprotein activatory complex endodermal lineage
0.3133714.11145965.html.plaintext.txt	223	Furthermore second FTF promoter E box element present two nucleotides downstream first one appears regulate FTF promoter activity Fig
0.3133714.11145965.html.plaintext.txt	224	3B lane 8 strikingly reproduces variant hematopoietic GATAE box motif second E box serves attenuate adjacent GATA1 Tal1 multiprotein activatory complex 35
0.3133714.11145965.html.plaintext.txt	225	Differential mFTF promoter activity tissues developmental stages might finely respond changing combinations activatory repressor components forming GATAE boxes complex
0.3133714.11145965.html.plaintext.txt	226	We note second E box conserved zebrafish promoter see Fig
0.3133714.11145965.html.plaintext.txt	227	1B usage much less restricted among adult tissues abundant FTF transcripts ff1 I detected ovary testis muscle 17
0.3133714.11145965.html.plaintext.txt	228	The distal GATANkx mFTF promoter domain 99 138 bp conveys clear inductive responses exogenous GATA Nkx2
0.3133714.11145965.html.plaintext.txt	229	5 cotransfection assays mutations elements reduce rather enhance basal FTF promoter activity hepatoma cells
0.3133714.11145965.html.plaintext.txt	230	This suggests distal GATANkx segment may less efficiently used hepatocytes cell types liver differentiation states
0.3133714.11145965.html.plaintext.txt	231	Like bHLH factors Nk2 related homeoproteins Nkx2
0.3133714.11145965.html.plaintext.txt	232	5 broadly serve mammalian cells execute differentiation programs Nkx factors also represented hepatic cells 36
0.3133714.11145965.html.plaintext.txt	233	Notably combination GATA4Nkx2
0.3133714.11145965.html.plaintext.txt	234	5 factors enhanced mFTF promoter well known induce pleiotropic differentiation program cardiogenic lineage cooperatively activate heart specific gene promoters via tandem motifs similar distal FTF promoter 37
0.3133714.11145965.html.plaintext.txt	235	Interestingly cardiogenic pathways use GATA4Nkx2
0.3133714.11145965.html.plaintext.txt	236	5 terminal transducers differentiation cascades triggered cell surface TGF related receptors 38 similar TGF signals operate endodermal specification 39 TGF FGF relays 3 could plausibly reach distal FTF promoter domain activate preferential use specific cells times
0.3133714.11145965.html.plaintext.txt	237	An Alternative mFTF Promoter FTF translational analyses vitro vivo 11 clearly established rodent FTF exon 1 transcribed prenatal liver therefore promoter characterized used fetal stages development hFTF exon1 transcripts also present fetal human liver 29
0.3133714.11145965.html.plaintext.txt	238	But data lower vertebrates point second FTF promoter downstream exon 1 used preferentially early stages development
0.3133714.11145965.html.plaintext.txt	239	FTF cloning embryonic cDNA libraries yielded transcripts translation start site corresponding either Met62 codon mouse exon 3 amphibian xFF1rA rrFTZ F1 14 40 zebrafish ff1 variant II 17 also initiates translation Met62 Met94 codon mouse exon 4 frog rrFTZ F1 chicken OR2
0.3133714.11145965.html.plaintext.txt	240	Furthermore N terminal exon xFF1rA ff1 II rrFTZ F1 contains 3 end sequence matching mouse exon 3 segment Met62 Val89 see Fig
0.3133714.11145965.html.plaintext.txt	241	1A 17 40 5 side sequence becomes unrelated mouse exon 3 17 33 40 spans 500 nucleotides xFF1rAs 14 33
0.3133714.11145965.html.plaintext.txt	242	This readily suggests FTF gene transcription starts intronic domain exon 2 3 structure evolutionarily rearranged
0.3133714.11145965.html.plaintext.txt	243	In addition fishamphibian transcripts containing exon 1 undetectable embryonic stages whereas transcripts excluding exon 1 increase abundantly early embryos decline 14 17
0.3133714.11145965.html.plaintext.txt	244	Thus indicate least lower vertebrates FTF gene transcription proceeds upstream promoter characterized internal early promoter yet mapped independently regulated
0.3133714.11145965.html.plaintext.txt	245	The early promoter also seems broadly activated fish amphibian avian embryonic cells especially brain steroidogenic tissues whereas upstream promoter less promiscuous active gut derivatives 14 15 17 40
0.3133714.11145965.html.plaintext.txt	246	We note SF1 transcripts found fish 41 alternate ancestral FTF gene promoter possibly evolved early vertebrates better fulfill FTF SF1 functions time space
0.3133714.11145965.html.plaintext.txt	247	Whether second mFTF gene promoter may actively operate exons 1 3 remains conjectural
0.3133714.11145965.html.plaintext.txt	248	But FTF isoforms referred translational variants fluctuating adult liver fetal liver embryonic stem cells 11 might also indicate modulations promoter splicing products instance four rat FTF isoforms 10 see Fig
0.3133714.11145965.html.plaintext.txt	249	2A interpreted translational variants Met1 Met62 Met83 Met87 11 could also accounted exon variants 12 13 14 34
0.3133714.11145965.html.plaintext.txt	250	An alternative mFTF promoter might take charge FTF transcription detected early 2 cell stage embryo cells E3
0.3133714.11145965.html.plaintext.txt	251	5 blastocyst unpublished results lacZ marked mFTF genomic locus
0.3133714.11145965.html.plaintext.txt	252	Novel FTF activated Gene Targets The Hnf3 Hnf4 Hnf1 genes encode transcription factors critically involved early liver differentiation promoters three genes found activated FTF
0.3133714.11145965.html.plaintext.txt	253	Combined temporal patterns expression four factors 19 25 42 43 fact FTF promoter Hnf3 Hnf4 Hnf1 promoters contain bona fide GATA inducible sites results clearly suggest FTF lies GATA HNF3 HNF4 HNF1 transcriptional cascades liver cell differentiation
0.3133714.11145965.html.plaintext.txt	254	Thus FTF initiates hepatic functions AFP promoter would also enhance transcription factors engaged liver induction networks
0.3133714.11145965.html.plaintext.txt	255	We recall AFP gene activity restricted early proliferative stages liver development FTF regulation domain AFP promoter deactivated hormonal signals interrupt liver cell growth 9 11 44 implies FTF function may dependent upon enhanced cell growth stimuli
0.3133714.11145965.html.plaintext.txt	256	Although potential FTF liver gene targets recently proposed 21 29 31 45 46 uncertain whether FTF effects actually proceed nongrowing hepatocytes since results obtained cotransfection growing cultured cells
0.3133714.11145965.html.plaintext.txt	257	For one hepatitis B viral core promoter strongly activated three FTF binding elements 21 29 could evolved FTF activation sites adapt sustained hepatitis B virus replication proliferative stages hepatitis
0.3133714.11145965.html.plaintext.txt	258	FTF action Hnf3 Hnf4 Hnf1 promoters may exerted transiently early developmental growth stages substituted alternative factors mature nondividing hepatocytes Hnf3 Hnf4 Hnf1 promoters contain substitute proximal elements expected operate efficiently adult stage conditions
0.3133714.11145965.html.plaintext.txt	259	But FTF clearly plays role hepatocyte bile acid synthesis pathways FTF activates rate limiting Cyp7A gene promoter adult hepatocytes 47 FTF direct target CYP7A feedback repression FTF heterodimeric partner SHP induced bile acid receptor FXR 48 50
0.3133714.11145965.html.plaintext.txt	260	FTF could thus use alternative regulatory means modulate differentially early developmental late metabolic liver program
0.3133714.11145965.html.plaintext.txt	261	It interesting Hnf1 Hnf3 Hnf4 hepatitis B virus AFP promoters Cyp7A contain close doublet FTF binding sites Fig
0.3133714.11145965.html.plaintext.txt	262	2 This may point novel regulatory means DNA bound FTF monomers operating cell growth transient FTF FTF interactions via cell cycle dependent FTF modification ligand coregulator intriguing possibility
0.3133714.11145965.html.plaintext.txt	263	The proximal FTF site HNF1 promoter particularly interesting regard developmental growth signaling
0.3133714.11145965.html.plaintext.txt	264	That site stringently conserved Xenopus Hnf1 promoter 51 undergoes developmental enhancement 52 closely parallel Xenopus FTF gene xFF1rA 14
0.3133714.11145965.html.plaintext.txt	265	Furthermore FTF site xHnf1 promoter lies 30 bp domain essential promoter activity deletant 238207 Ref
0.3133714.11145965.html.plaintext.txt	266	51 contained short 69 bp promoter segment inducible activin A 53 also cell surface receptor ligand TGF superfamily
0.3133714.11145965.html.plaintext.txt	267	The 69 bp domain carries conserved HNF4 binding site 5 51 however dispensable activation 69 bp domain endodermal cells 54
0.3133714.11145965.html.plaintext.txt	268	It thus tempting infer endodermal activin A response element xHnf1 promoter indeed FTF xFF1rA
0.3133714.11145965.html.plaintext.txt	269	Given fast kinetics xHnf1 promoter induction activin A 6 h 53 may imply TGF andor FGF signaling could reach FTF gene promoter discussed previously FTF protein
0.3133714.11145965.html.plaintext.txt	270	In conclusion combined analysis FTF promoter regulatory elements gene targets suggests FTF early intermediary endodermal chain events leading hepatic differentiation
0.3133714.11145965.html.plaintext.txt	271	Our results consistent simplified scheme Fig
0.3133714.11145965.html.plaintext.txt	272	6 GATA cooperates bHLH homeodomain factors activate FTF gene hepatocyte precursors FTF gene product turn activates early liver functions AFP transcription factors enhancing cross regulatory networks set hepatic phenotype
0.3133714.11145965.html.plaintext.txt	273	FTF gene disruption mouse embryonic lethal E7
0.3133714.11145965.html.plaintext.txt	274	52 important see FTF mutant ES cells contribute hepatocyte lineage chimeric mice
0.3133714.11145965.html.plaintext.txt	275	View larger version 12K Fig
0.3133714.11145965.html.plaintext.txt	276	FTF relationships genes involved liver differentiation
0.3133714.11145965.html.plaintext.txt	277	Robert Costa collaboration gift plasmids Dr
0.3133714.11145965.html.plaintext.txt	278	Stephen Duncan useful information materials Dr
0.3133714.11145965.html.plaintext.txt	279	Frances Sladek pH4 luc vector Julie Vezina Daniel Malenfant experimental assistance Denise Rioux Marie France Voyer excellent secretarial support
0.3133714.11145965.html.plaintext.txt	280	This work supported part Grant MT 6478 Canadian Institutes Health Research
0.3133714.11145965.html.plaintext.txt	281	The costs publication article defrayed part payment page charges
0.3133714.11145965.html.plaintext.txt	282	The article must therefore hereby marked advertisement accordance 18 U
0.3133714.11145965.html.plaintext.txt	283	Section 1734 solely indicate fact
0.3133714.11145965.html.plaintext.txt	284	Recipient doctoral studentship Fonds de la Recherche en Sante du Quebec Fonds pour la Formation de Chercheurs et lAide la Recherche
0.3133714.11145965.html.plaintext.txt	285	To correspondence addressed Cancer Research Centre LHotel Dieu de Quebec Quebec G1R 2J6 Canada
0.3133714.11145965.html.plaintext.txt	286	418 691 5543 Fax 418 691 5489 E mail luc
0.3133714.11145965.html.plaintext.txt	287	Published JBC Papers Press January 5 2001 DOI 10
0.3133714.11145965.html.plaintext.txt	288	The abbreviations used FGF fibroblast growth factor AFP 1 fetoprotein bHLH basic helix loop helix FTF fetoprotein transcription factor mFTF mouse FTF HNF hepatocyte nuclear factor SF1 steroidogenic factor 1 CAT chloramphenicol acetyltransferase PCR polymerase chain reaction bp base pair kb kilobase pairs nt nucleotide oligo oligonucleotide TGF transforming growth factor
0.3133714.11145965.html.plaintext.txt	289	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.3133714.11145965.html.plaintext.txt	290	53 427 455Medline Order article via Infotrieve 2
0.3133714.11145965.html.plaintext.txt	291	8 526 531CrossRefMedline Order article via Infotrieve 3
0.3133714.11145965.html.plaintext.txt	292	1999 Science 284 1998 2003AbstractFree Full Text 4
0.3133714.11145965.html.plaintext.txt	293	209 1 10CrossRefMedline Order article via Infotrieve 5
0.3133714.11145965.html.plaintext.txt	294	1992 Nature 355 457 461CrossRefMedline Order article via Infotrieve 6
0.3133714.11145965.html.plaintext.txt	295	269 5481 5484AbstractFree Full Text 8
0.3133714.11145965.html.plaintext.txt	296	8 1398 1407Medline Order article via Infotrieve 10
0.3133714.11145965.html.plaintext.txt	297	Nuclear Receptors Nomenclature Committee
0.3133714.11145965.html.plaintext.txt	298	1999 Cell 97 161 163Medline Order article via Infotrieve 13
0.3133714.11145965.html.plaintext.txt	299	1991 Science 252 848 851Medline Order article via Infotrieve 14
0.3133714.11145965.html.plaintext.txt	300	197 261 268CrossRefMedline Order article via Infotrieve 16
0.3133714.11145965.html.plaintext.txt	301	82 269 270Medline Order article via Infotrieve 17
0.3133714.11145965.html.plaintext.txt	302	348 439 446CrossRefMedline Order article via Infotrieve 18
0.3133714.11145965.html.plaintext.txt	303	89 185 188CrossRefMedline Order article via Infotrieve 20
0.3133714.11145965.html.plaintext.txt	304	74 5032 5039AbstractFree Full Text 22
0.3133714.11145965.html.plaintext.txt	305	1998 Development 125 4909 4917AbstractFree Full Text 23
0.3133714.11145965.html.plaintext.txt	306	1999 Development 126 723 732Abstract 24
0.3133714.11145965.html.plaintext.txt	307	270 15628 15633AbstractFree Full Text 25
0.3133714.11145965.html.plaintext.txt	308	14 464 474AbstractFree Full Text 26
0.3133714.11145965.html.plaintext.txt	309	13 1388 1401AbstractFree Full Text 29
0.3133714.11145965.html.plaintext.txt	310	273 29022 29031AbstractFree Full Text 30
0.3133714.11145965.html.plaintext.txt	311	1995 Genomics 25 565 567CrossRefMedline Order article via Infotrieve 31
0.3133714.11145965.html.plaintext.txt	312	96 6660 6665AbstractFree Full Text 32
0.3133714.11145965.html.plaintext.txt	313	69 323 328CrossRefMedline Order article via Infotrieve 33
0.3133714.11145965.html.plaintext.txt	314	16 3145 3157AbstractFree Full Text 35
0.3133714.11145965.html.plaintext.txt	315	17 5151 5160AbstractFree Full Text 36
0.3133714.11145965.html.plaintext.txt	316	273 2917 2925AbstractFree Full Text 37
0.3133714.11145965.html.plaintext.txt	317	16 5687 5696AbstractFree Full Text 38
0.3133714.11145965.html.plaintext.txt	318	19 7096 7105AbstractFree Full Text 39
0.3133714.11145965.html.plaintext.txt	319	2000 Development 127 3079 3090AbstractFree Full Text 40
0.3133714.11145965.html.plaintext.txt	320	248 203 212CrossRefMedline Order article via Infotrieve 41
0.3133714.11145965.html.plaintext.txt	321	91 421 426CrossRefMedline Order article via Infotrieve 42
0.3133714.11145965.html.plaintext.txt	322	1993 Development 119 1301 1315AbstractFree Full Text 43
0.3133714.11145965.html.plaintext.txt	323	1991 Development 113 589 599Abstract 44
0.3133714.11145965.html.plaintext.txt	324	1975 Nature 256 657 659Medline Order article via Infotrieve 45
0.3133714.11145965.html.plaintext.txt	325	274 20869 20873AbstractFree Full Text 46
0.3133714.11145965.html.plaintext.txt	326	275 17793 17799AbstractFree Full Text 47
0.3133714.11145965.html.plaintext.txt	327	28 3587 3593AbstractFree Full Text 48
0.3133714.11145965.html.plaintext.txt	328	Cell 6 507 515Medline Order article via Infotrieve 49
0.3133714.11145965.html.plaintext.txt	329	Cell 6 517 526Medline Order article via Infotrieve 50
0.3133714.11145965.html.plaintext.txt	330	2000 Cell 102 731 744Medline Order article via Infotrieve 51
0.3133714.11145965.html.plaintext.txt	331	1996 Development 122 1975 1984AbstractFree Full Text 54
0.3133714.11145965.html.plaintext.txt	332	90 65 75CrossRefMedline Order article via Infotrieve
0.3133714.11145965.html.plaintext.txt	333	Copyright 2001 The American Society Biochemistry Molecular Biology Inc
0.2872687.12193589.html.plaintext.txt	0	ACCELERATED PUBLICATION Crystal Structure HNF4 Ligand Binding Domain Complex Endogenous Fatty Acid Ligand Sirano Dhe Paganon Karen Duda Melanie Iwamoto Young In Chi Steven E
0.2872687.12193589.html.plaintext.txt	1	From Joslin Diabetes Center Department Medicine Harvard Medical School Boston Massachusetts 02215
0.2872687.12193589.html.plaintext.txt	2	Received publication July 23 2002 revised form August 20 2002
0.2872687.12193589.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES
0.2872687.12193589.html.plaintext.txt	4	HNF4 orphan member nuclear receptor family prominent functions liver gut kidney pancreatic cells
0.2872687.12193589.html.plaintext.txt	5	We solved x ray crystal structure HNF4 ligand binding domain adopts canonical fold
0.2872687.12193589.html.plaintext.txt	6	Two conformational states present within homodimer open form helix 12 12 extended collinear 10 closed form 12 folded body domain
0.2872687.12193589.html.plaintext.txt	7	Although protein crystallized without added ligands ligand binding pockets closed open forms contain fatty acids
0.2872687.12193589.html.plaintext.txt	8	The carboxylic acid headgroup fatty acid ion pairs guanidinium group Arg226 one end ligand binding pocket aliphatic chain fills long narrow channel lined hydrophobic residues
0.2872687.12193589.html.plaintext.txt	9	These findings suggest fatty acids endogenous ligands HNF4 establish framework understanding HNF4 activity enhanced ligand binding diminished MODY1 mutations
0.2872687.12193589.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES
0.2872687.12193589.html.plaintext.txt	11	Nuclear receptors ligand activated transcription factors regulate diverse physiological processes reproduction development metabolism
0.2872687.12193589.html.plaintext.txt	12	Ligand binding induces conformational changes coordinately dissociates corepressors recruits coactivators enhance transcriptional activity 1 2
0.2872687.12193589.html.plaintext.txt	13	Physiologically relevant ligands known less half 48 nuclear receptors encoded human genome include steroid hormones retinoids thyroid hormone vitamin D3 fatty acids
0.2872687.12193589.html.plaintext.txt	14	HNF4 considered orphan member nuclear receptor superfamily endogenous ligand known 3
0.2872687.12193589.html.plaintext.txt	15	Originally identified liver HNF4 also present kidney gut pancreatic islets
0.2872687.12193589.html.plaintext.txt	16	It functions transcriptional cascades downstream TGF activated SMAD signaling GATA HNF3forkhead family transcription factors upstream HNF1POU homeodomain transcription factor
0.2872687.12193589.html.plaintext.txt	17	In addition HNF1 many target genes HNF4 liver include coagulation factors proteins involved lipid cholesterol metabolism transport
0.2872687.12193589.html.plaintext.txt	18	Selective targets present kidney intestine include erythropoietin intestinal fatty acid binding protein respectively
0.2872687.12193589.html.plaintext.txt	19	Targeted disruption Hnf4 mice leads defective gastrulation underscoring important role HNF4 developing gut 4
0.2872687.12193589.html.plaintext.txt	20	In humans clinically apparent phenotype associated Hnf4 mutations Mendelian form diabetes mellitus associated abnormalities lipoprotein lipid concentrations 5 6
0.2872687.12193589.html.plaintext.txt	21	Positional cloning methods revealed relationship HNF4 atypical form diabetes referred maturity onset diabetes young MODY1 5
0.2872687.12193589.html.plaintext.txt	22	Mutations least six distinct genes linked MODY 7
0.2872687.12193589.html.plaintext.txt	23	Although MODY1 rare 20 families identified 5 8 9 associated phenotype instructive
0.2872687.12193589.html.plaintext.txt	24	Like forms MODY MODY1 characterized autosomal dominant inheritance early onset 25 years age abnormal pancreatic cell function
0.2872687.12193589.html.plaintext.txt	25	Because reduced cell function leads insulin deficiency reasonable conclude HNF4 activity tightly coupled insulin synthesis secretion
0.2872687.12193589.html.plaintext.txt	26	Since nuclear receptors established valuable class drug targets follows selective agonists HNF4 might useful new therapeutic strategies improving insulin secretion MODY patients potentially others prevalent forms type 2 diabetes
0.2872687.12193589.html.plaintext.txt	27	To learn HNF4 functions health disease important step drug discovery crystallized ligand binding domain LBD1 HNF4 solved three dimensional structure
0.2872687.12193589.html.plaintext.txt	28	HNF4 forms antiparallel three layered helical sandwich akin nuclear receptor LBDs
0.2872687.12193589.html.plaintext.txt	29	The serendipitous presence tightly associated fatty acid binding pocket reveals potential mechanisms ligand binding
0.2872687.12193589.html.plaintext.txt	30	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES
0.2872687.12193589.html.plaintext.txt	31	Protein Production Crystallization DNA encoding LBD rat HNF4 residues 133 382 subcloned pET 28a vector Novagen PCR
0.2872687.12193589.html.plaintext.txt	32	Protein expressed Escherichia coli BL21DE3 Invitrogen grown either LB synthetic medium containing L selenomethionine SeMet isolated bacterial lysates using Talon cobalt affinity resin Clontech
0.2872687.12193589.html.plaintext.txt	33	The His6 affinity tag removed bovine thrombin 10 unitsml protein purified ion exchange chromatography Mono Q fast protein liquid chromatography
0.2872687.12193589.html.plaintext.txt	34	Crystals obtained room temperature vapor diffusion method 10 microl sitting drops containing equal volumes protein 25 mgml crystallization buffer 0
0.2872687.12193589.html.plaintext.txt	35	7 M ammonium acetate 16 MPD 2 methyl 24 pentanediol 10 mM dithiothreitol
0.2872687.12193589.html.plaintext.txt	36	Data Collection Structure Determination Diffraction data collected 100 K National Synchotron Light Source Brookhaven NY beamline X12C
0.2872687.12193589.html.plaintext.txt	37	Oscillation images collected every 1 degrees data integrated scaled using DENZO HKL software package 10
0.2872687.12193589.html.plaintext.txt	38	The structure determined using MAD phasing SeMet substituted protein
0.2872687.12193589.html.plaintext.txt	39	The expected bijvoet dispersive differences 11 based six bound seleniums monomer 250 residues 5
0.2872687.12193589.html.plaintext.txt	40	The program SOLVE 12 found 20 24 possible selenium sites
0.2872687.12193589.html.plaintext.txt	41	The phases improved 4 fold averaging solvent flattening utilizing programs MLPHARE DM CCP4 suite 13
0.2872687.12193589.html.plaintext.txt	42	The model built using O 14 refined CNS 15 applying restrained 4 fold non crystallographic symmetry overall B factor corrections bulk solvent corrections Table I
0.2872687.12193589.html.plaintext.txt	43	Fatty Acid Analyses HNF4 samples 200 mg combined 10 fold excess vv 15 NaOH 50 methanol heated 30 min 100 degrees C
0.2872687.12193589.html.plaintext.txt	44	Esterification accomplished combining cooled solutions 20 volumes 46 methanol 6 N HCl heating 10 min 80 degrees C
0.2872687.12193589.html.plaintext.txt	45	The fatty acid methyl esters extracted 50 methyl butyl ether hexane analyzed gas chromatography GC Sherlock MIS 170 270 degrees C Bacterial Identification Fatty Acid Laboratory University Florida plantpath
0.2872687.12193589.html.plaintext.txt	46	RESULTS AND DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES
0.2872687.12193589.html.plaintext.txt	47	Domain Architecture Structural Homology The amino carboxyl terminal boundaries LBD HNF4 delineated sequence comparisons members nuclear receptor family
0.2872687.12193589.html.plaintext.txt	48	Although attempted express longer versions including entire LBD plus F domain 133 455 degraded shorter fragments
0.2872687.12193589.html.plaintext.txt	49	Since susceptibility proteolysis suggested F domain least partially disordered expressed crystallized LBD domain 133 382
0.2872687.12193589.html.plaintext.txt	50	Crystals belonging tetragonal space group P41212 unit cell b 102
0.2872687.12193589.html.plaintext.txt	51	7 A reached maximal dimensions 0
0.2872687.12193589.html.plaintext.txt	52	2 mm sitting drops within 5 days
0.2872687.12193589.html.plaintext.txt	53	The structure solved using MAD phasing selenomethionine substituted protein Table I
0.2872687.12193589.html.plaintext.txt	54	View table Table I Data refinement statistics
0.2872687.12193589.html.plaintext.txt	55	Four protein molecules assembled asymmetric unit pair identical homodimers
0.2872687.12193589.html.plaintext.txt	56	Each LBD HNF4 contains 9 10 helices two strands adopt helical sandwich motif common LBDs nuclear receptors Fig
0.2872687.12193589.html.plaintext.txt	57	194 core carbons ligand binding domains HNF4 RXR Protein Data Bank number 1FBY 16 close structural relative superimpose root mean square deviation 1
0.2872687.12193589.html.plaintext.txt	58	Following conventional nomenclature helix 2 2 variably present nuclear receptor LBDs absent HNF4 6 consists single helical turn 10 11 contiguous
0.2872687.12193589.html.plaintext.txt	59	Acidic residues Glu261 Asp262 create bulge 5 may important dimerization 17
0.2872687.12193589.html.plaintext.txt	60	Electron density apparent residues except amino 133 140 carboxyl 368 382 termini domain within loop helices 1 3 13 loop residues 157 165
0.2872687.12193589.html.plaintext.txt	61	View larger version 38K Fig
0.2872687.12193589.html.plaintext.txt	62	Structure HNF4 ligand binding domain
0.2872687.12193589.html.plaintext.txt	63	A ribbon diagram homodimer reveals LBD fold
0.2872687.12193589.html.plaintext.txt	64	Helices shaded turquoise 1 9 yellow 10 red 12 reveal two distinct conformations open left closed right
0.2872687.12193589.html.plaintext.txt	65	Strands colored green fatty acids ligand binding pockets colored magenta
0.2872687.12193589.html.plaintext.txt	66	B ligand elements secondary structure colored similarly schematic representations open closed conformations orientations comparison
0.2872687.12193589.html.plaintext.txt	67	Fatty Acids Ligand Binding Pocket HNF4 Although add potential ligands crystallization trials initial electron density maps showed density ligand binding pocket domain accounted protein
0.2872687.12193589.html.plaintext.txt	68	The excess electron density present molecules asymmetric unit resembled small molecule associated guanidinium group Arg226
0.2872687.12193589.html.plaintext.txt	69	Matrix assisted laser desorption ionization time flight mass spectrometric analyses HNF4 revealed addition expected parent ion expressed protein presence non covalently associated saturated monounsaturated fatty acids data shown
0.2872687.12193589.html.plaintext.txt	70	To confirm identities lipids quantify relative amounts purified HNF4 solutions submitted fatty acid analysis GC
0.2872687.12193589.html.plaintext.txt	71	Recombinant rat HNF4 133 382 contained mixture fatty acids including 160 170 cyclo 1817c 140 Fig
0.2872687.12193589.html.plaintext.txt	72	Similar sets fatty acids bound longer form rat HNF4 containing entire carboxyl terminal F domain residues 133 455 data shown LBD human HNF4 residues 140 382 differs rat domain seven positions Fig
0.2872687.12193589.html.plaintext.txt	73	These findings demonstrate human rat proteins associate spontaneously endogenous fatty acids F domain influence binding
0.2872687.12193589.html.plaintext.txt	74	View larger version 19K Fig
0.2872687.12193589.html.plaintext.txt	75	Fatty acids bound HNF4 LBD
0.2872687.12193589.html.plaintext.txt	76	Fatty acids extracted rat HNF4 133 385 human HNF4 140 385 E
0.2872687.12193589.html.plaintext.txt	77	coli BL21 cells converted corresponding methyl esters analyzed GC
0.2872687.12193589.html.plaintext.txt	78	The results plotted percentages total sorted according relative abundance bacteria
0.2872687.12193589.html.plaintext.txt	79	120 140 160 saturated lauric myristic palmitic acids respectively 1617c monounsaturated palmitoleic acid cyclo refers cyclopropyl group 2OH 3OH hydroxyl groups 2 3 positions respectively iso extra methyl group penultimate carbon
0.2872687.12193589.html.plaintext.txt	80	Both fatty acids listed mixtures could resolved
0.2872687.12193589.html.plaintext.txt	81	To determine whether LBDs select specific fatty acids larger pool subjected E
0.2872687.12193589.html.plaintext.txt	82	coli BL21 cells similar GC analyses Fig
0.2872687.12193589.html.plaintext.txt	83	The bacterial fatty acids present greatest abundance also bound HNF4 although appears degree selectivity
0.2872687.12193589.html.plaintext.txt	84	For example fatty acids 160 1817c 161 iso140 3OH 190 cyclo 8c present greater relative abundance bacteria associated human rat HNF4 Fig
0.2872687.12193589.html.plaintext.txt	85	2 161 iso 140 3OH distinguished GC
0.2872687.12193589.html.plaintext.txt	86	In contrast fatty acids 170 cyclo 161 7c15 iso 2OH 15 iso 3OH 100 bound protein higher relative abundance presence E
0.2872687.12193589.html.plaintext.txt	87	Other fatty acids 1817c 140 neither selected Fig
0.2872687.12193589.html.plaintext.txt	88	Therefore although wide range fatty acids found within ligand binding pocket HNF4 appears exhibit selectivity toward subset found bacteria
0.2872687.12193589.html.plaintext.txt	89	Future experiments mammalian tissues required determine fatty acids bind relevant conditions whether capacity HNF4 serve fatty acid sensor physiological pathological ramifications
0.2872687.12193589.html.plaintext.txt	90	The fact fatty acids persistently bound even multistep purification indicated tightly associated
0.2872687.12193589.html.plaintext.txt	91	This borne additional attempts strip lipids protein fatty acids remained associated dialysis gel filtration chromatography data shown
0.2872687.12193589.html.plaintext.txt	92	The serendipitous presence fatty acids provided opportunity analyze ligands bind HNF4
0.2872687.12193589.html.plaintext.txt	93	The lipid carboxyl group readily identified next side chain Arg226 methylene chain could built C12
0.2872687.12193589.html.plaintext.txt	94	Density beyond point weak indicating remainder chain either flexible occupies multiple conformations
0.2872687.12193589.html.plaintext.txt	95	The cavity internal volume 370 A3 calculated program Voidoo 18 almost entirely occupied fatty acid
0.2872687.12193589.html.plaintext.txt	96	While volume within normal range nuclear receptor LBDs elongated relatively linear shape pocket atypical
0.2872687.12193589.html.plaintext.txt	97	Both oxygens fatty acid head group ion paired guanidinium group Arg226 one oxygen forms additional hydrogen bonds backbone NH Gly237 side chain OH Ser181 Fig
0.2872687.12193589.html.plaintext.txt	98	Residues line internal surface ligand binding pocket largely hydrophobic including arising 3 Ile175 Val178 Cys179 Met182 5 Leu219 Leu220 Ala223 1 Leu234 Leu236 2 Val242 loop 27 Leu249 7 Met252 Val255 Ser256 Ile259 10 Met342 Gln345 Ile346 Ile349 Fig
0.2872687.12193589.html.plaintext.txt	99	In closed conformation 12 HNF4 contact ligand contrast nuclear receptors 12 canonical agonist bound conformation often contact agonist
0.2872687.12193589.html.plaintext.txt	100	View larger version 67K Fig
0.2872687.12193589.html.plaintext.txt	101	Ligand binding dimer interface
0.2872687.12193589.html.plaintext.txt	102	A stereo diagram ligand binding pocket HNF4 structural elements colored described legend Fig
0.2872687.12193589.html.plaintext.txt	103	B schematic representation interactions within ligand binding pocket HNF4
0.2872687.12193589.html.plaintext.txt	104	Residues interact open closed forms labeled black gray box residues interact closed form white gray box interactions found open form white black box
0.2872687.12193589.html.plaintext.txt	105	C interactions homodimer interface
0.2872687.12193589.html.plaintext.txt	106	Although HNF4 RXR similar terms amino acid sequence ligand binding specificities distinct
0.2872687.12193589.html.plaintext.txt	107	This due part Phe313 RXR points inward directs bound 9 cis retinoic acid upward toward 5 19
0.2872687.12193589.html.plaintext.txt	108	The corresponding residue HNF4 Ala223 presumably decreased bulk side chain allows fatty acid ligand curl downwards toward 7
0.2872687.12193589.html.plaintext.txt	109	It thus particularly interesting note F313A substitution RXR leads constitutive activation due spontaneous binding endogenous fatty acid seen wild type HNF4 19
0.2872687.12193589.html.plaintext.txt	110	The fatty acid binding pocket RXR F313A adopts U shape density interpretable C18 position
0.2872687.12193589.html.plaintext.txt	111	In contrast side chains residues Met182 Met342 fill upper portion HNF4 ligand binding pocket prevent fatty acid looping around form U dont see density past C12 position
0.2872687.12193589.html.plaintext.txt	112	These two methionine residues HNF4 unique among nuclear receptors
0.2872687.12193589.html.plaintext.txt	113	Helix 12 Adopts Two Conformations The two molecules within dimer adopt distinct conformations
0.2872687.12193589.html.plaintext.txt	114	In first referred open state 12 fully extended contiguous collinear 10 Fig
0.2872687.12193589.html.plaintext.txt	115	The second molecule homodimer adopts closed conformation 12 situated body LBD
0.2872687.12193589.html.plaintext.txt	116	The conformation open state fixed crystal packing two open forms axis symmetry
0.2872687.12193589.html.plaintext.txt	117	In closed state residues Leu360 Leu361 Met364 Leu365 form hydrophobic face 12 interacts corresponding hydrophobic surface body domain created residues 3 Met182 Lys183 Leu186 Leu187 Leu189 Val190 4 Leu211 Ala215 Gly216 Leu219
0.2872687.12193589.html.plaintext.txt	118	Residues Gln362 Glu363 help anchor 12 hydrogen bonds Lys350 10 Arg212 4 respectively
0.2872687.12193589.html.plaintext.txt	119	Since fatty acid ligands similarly occupy ligand binding pockets molecules open closed conformations structural rearrangement appear required ligand mediated activation proposed nuclear receptors 17 20 21
0.2872687.12193589.html.plaintext.txt	120	It possible lock domain closed active state ligand coactivator must bound since structure lacks coactivator test hypothesis
0.2872687.12193589.html.plaintext.txt	121	The Dimer Interface As opposed many nuclear receptors form heterodimers HNF4 functions primarily homodimer 22
0.2872687.12193589.html.plaintext.txt	122	Consistent LBD HNF4 crystallizes canonical homodimer near perfect 2 fold symmetry interface Fig
0.2872687.12193589.html.plaintext.txt	123	A 1156 A2 surface monomer buried dimer interface
0.2872687.12193589.html.plaintext.txt	124	A coiled coil interaction 10 molecule dominates interface hydrophobic side chain side chain interactions Phe325Phe325 Leu329Leu329 Leu330Ile283 Leu332Leu330 Pro333Pro333 Trp340Trp340 along length Fig
0.2872687.12193589.html.plaintext.txt	125	Intermolecular salt bridges Glu269Lys300 Arg303Glu327 Arg322Asp312 hydrogen bonds Gln307Glu327 Glu311Gly323 Gln336Gln336 appear contribute stability interface
0.2872687.12193589.html.plaintext.txt	126	MODY1 Mutations Of 14 mutations HNF4 found patients MODY1 form diabetes 5 8 9 23 three encode substitutions within LBD V255M E276Q R324H
0.2872687.12193589.html.plaintext.txt	127	The side chain Val255 7 points ligand binding cavity participates ligand recognition
0.2872687.12193589.html.plaintext.txt	128	While questions raised functional consequences V255M substitution 24 structure suggests methionine side chain position would partially occlude ligand binding cavity potentially alter binding affinity specificity
0.2872687.12193589.html.plaintext.txt	129	Contact Val255 backbone atoms 10 vicinity Met342 also predicted stabilize protein fold
0.2872687.12193589.html.plaintext.txt	130	Therefore V255M substitution might also decrease protein stability reduce concentration cells ability homodimerize
0.2872687.12193589.html.plaintext.txt	131	Side chains two MODY1 associated residues Glu276 amino terminus 8 Arg324 910 loop form ionic interaction Glu276 forms second ionic interaction Arg317 also 910 loop
0.2872687.12193589.html.plaintext.txt	132	Neither residues involved directly ligand binding mutations may influence dimerization
0.2872687.12193589.html.plaintext.txt	133	While residues dimer interface 910 loops two molecules interact
0.2872687.12193589.html.plaintext.txt	134	Since residues help tether 910 loops likely loss interactions Glu276 Arg324 would destabilize dimerization
0.2872687.12193589.html.plaintext.txt	135	Conclusions The LBD HNF4 structurally similar LBDs nuclear receptors
0.2872687.12193589.html.plaintext.txt	136	The presence fatty acid ligand binding pocket especially noteworthy help resolve controversy surrounding putative ligands HNF4
0.2872687.12193589.html.plaintext.txt	137	From structural point view fatty acid appears ideally suited ligand HNF4
0.2872687.12193589.html.plaintext.txt	138	The carboxylic acid headgroup fatty acid ion pairs guanidinium group Arg226 protein fix orientation aliphatic portion fatty acid occupies long narrow pocket lined hydrophobic side chains
0.2872687.12193589.html.plaintext.txt	139	Considering mode binding obvious complex ligands might bind HNF4
0.2872687.12193589.html.plaintext.txt	140	It thus reasonable presume fatty acids related molecules might endogenous ligands HNF4
0.2872687.12193589.html.plaintext.txt	141	The high apparent affinity recombinant HNF4 fatty acids suggests similar situation native protein mammalian cells providing mechanism HNF4 function biosensor fatty acids within cell
0.2872687.12193589.html.plaintext.txt	142	The structural features fatty acid binding HNF4 provide useful starting point identifying potential pharmacophores search may prove challenging due kinetics ligand binding
0.2872687.12193589.html.plaintext.txt	143	Saxena beamline X12C National Synchrotron Light Source Brookhaven National Laboratory valuable assistance
0.2872687.12193589.html.plaintext.txt	144	This work supported part National Institutes Health Grant R01 DK43123 S
0.2872687.12193589.html.plaintext.txt	145	The costs publication article defrayed part payment page charges
0.2872687.12193589.html.plaintext.txt	146	The article must therefore hereby marked advertisement accordance 18 U
0.2872687.12193589.html.plaintext.txt	147	Section 1734 solely indicate fact
0.2872687.12193589.html.plaintext.txt	148	The atomic coordinates structure factors code 1M7W deposited Protein Data Bank Research Collaboratory Structural Bioinformatics Rutgers University New Brunswick NJ httpwww
0.2872687.12193589.html.plaintext.txt	149	Both authors supported Mary K
0.2872687.12193589.html.plaintext.txt	150	These authors contributed equally work
0.2872687.12193589.html.plaintext.txt	151	Supported National Institutes Health Training Grant T32 DK07260
0.2872687.12193589.html.plaintext.txt	152	To correspondence addressed
0.2872687.12193589.html.plaintext.txt	153	Published JBC Papers Press August 21 2002 DOI 10
0.2872687.12193589.html.plaintext.txt	154	The abbreviations used LBD ligand binding domain SeMet L selenomethionine MAD multiwavelength anomalous diffraction GC gas chromatography RXR retinoid X receptor
0.2872687.12193589.html.plaintext.txt	155	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES 1
0.2872687.12193589.html.plaintext.txt	156	2001 Science 294 1866 1870AbstractFree Full Text 2
0.2872687.12193589.html.plaintext.txt	157	2002 Cell 108 465 474Medline Order article via Infotrieve 3
0.2872687.12193589.html.plaintext.txt	158	2001 Nuclear Receptors Genetic Disease Burris T
0.2872687.12193589.html.plaintext.txt	159	309 361 Academic Press London 4
0.2872687.12193589.html.plaintext.txt	160	1996 Nature 384 458 460CrossRefMedline Order article via Infotrieve 6
0.2872687.12193589.html.plaintext.txt	161	2000 Diabetes 49 832 837Abstract 7
0.2872687.12193589.html.plaintext.txt	162	345 971 980Free Full Text 8
0.2872687.12193589.html.plaintext.txt	163	CO2 MlinktypeDOI CrossRefMedline Order article via Infotrieve 9
0.2872687.12193589.html.plaintext.txt	164	1999 Diabetologia 42 1131 1137CrossRefMedline Order article via Infotrieve 10
0.2872687.12193589.html.plaintext.txt	165	1991 Science 254 51 58Medline Order article via Infotrieve 12
0.2872687.12193589.html.plaintext.txt	166	4 849 861CrossRefMedline Order article via Infotrieve 13
0.2872687.12193589.html.plaintext.txt	167	Collaborative Computational Project 4
0.2872687.12193589.html.plaintext.txt	168	1994 Acta Crystallography Sect
0.2872687.12193589.html.plaintext.txt	169	50 760 776CrossRefMedline Order article via Infotrieve 14
0.2872687.12193589.html.plaintext.txt	170	A 47 110 119CrossRefMedline Order article via Infotrieve 15
0.2872687.12193589.html.plaintext.txt	171	54 905 921CrossRefMedline Order article via Infotrieve 16
0.2872687.12193589.html.plaintext.txt	172	19 2592 2601AbstractFree Full Text 17
0.2872687.12193589.html.plaintext.txt	173	Cell 5 545 555Medline Order article via Infotrieve 18
0.2872687.12193589.html.plaintext.txt	174	Cell 5 289 298Medline Order article via Infotrieve 20
0.2872687.12193589.html.plaintext.txt	175	1995 Nature 378 681 689CrossRefMedline Order article via Infotrieve 21
0.2872687.12193589.html.plaintext.txt	176	1998 Nature 395 137 143CrossRefMedline Order article via Infotrieve 22
0.2872687.12193589.html.plaintext.txt	177	302 831 851CrossRefMedline Order article via Infotrieve 23
0.2872687.12193589.html.plaintext.txt	178	27 11 29AbstractFree Full Text 24
0.2872687.12193589.html.plaintext.txt	179	1999 Diabetes 48 1459 1465Abstract
0.2872687.12193589.html.plaintext.txt	180	Copyright 2002 The American Society Biochemistry Molecular Biology Inc
0.32730934.11069927.html.plaintext.txt	0	Role Accessory Factors Steroid Receptor Coactivator 1 Regulation Phosphoenolpyruvate Carboxykinase Gene Transcription Glucocorticoids John M
0.32730934.11069927.html.plaintext.txt	1	Stafford Mary Waltner Law Daryl K
0.32730934.11069927.html.plaintext.txt	2	From Department Molecular Physiology Biophysics Vanderbilt University School Medicine Nashville Veterans Administration Hospital Nashville Tennessee 37232
0.32730934.11069927.html.plaintext.txt	3	Received publication October 13 2000 revised form November 6 2000
0.32730934.11069927.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.32730934.11069927.html.plaintext.txt	5	In liver glucocorticoids induce 10 15 fold increase rate transcription phosphoenolpyruvate carboxykinase PEPCK gene encodes key gluconeogenic enzyme
0.32730934.11069927.html.plaintext.txt	6	This induction requires multicomponent glucocorticoid response unit GRU comprised four glucocorticoid accessory factor AF elements two glucocorticoid receptor binding sites
0.32730934.11069927.html.plaintext.txt	7	We show AFs bind gAF1 gAF2 gAF3 elements hepatocyte nuclear factor HNF4chicken ovalbumin upstream promoter transcription factor 1 HNF3 interact steroid receptor coactivator 1 SRC1
0.32730934.11069927.html.plaintext.txt	8	This suggests AFs function part recruiting coactivators GRU
0.32730934.11069927.html.plaintext.txt	9	The binding GAL4 SRC1 chimeric protein completely restores glucocorticoid induction lost one elements replaced GAL4 binding site
0.32730934.11069927.html.plaintext.txt	10	Thus SRC1 recruited directly gAF1 gAF2 gAF3 requirement corresponding AF bypassed
0.32730934.11069927.html.plaintext.txt	11	Surprisingly glucocorticoid receptor still required SRC1 recruited directly GAL4 site suggesting role receptor activating SRC1 context GRU
0.32730934.11069927.html.plaintext.txt	12	Structural variants GAL4 SRC1 used identify requirements basic helix loop helix histone acetyltransferase domains SRC1 specific region promoter coactivator recruited
0.32730934.11069927.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.32730934.11069927.html.plaintext.txt	14	Mammals must readily adaptable mechanism maintaining glucose homeostasis face fluctuations nutrient supply
0.32730934.11069927.html.plaintext.txt	15	Hormones glucocorticoids control transcription genes encode enzymes help provide adaptive response environmental changes 3 5
0.32730934.11069927.html.plaintext.txt	16	These hormone responses originally thought mediated direct interaction hormone receptor simple DNA element hormone response element HRE1 6 8
0.32730934.11069927.html.plaintext.txt	17	In recent years become apparent complex structures involved
0.32730934.11069927.html.plaintext.txt	18	Hormone response units comprised HREs accessory factor AF elements found many genes involved metabolic regulation 9 14
0.32730934.11069927.html.plaintext.txt	19	AFs DNA binding transcription factors act concert hormone receptor provide flexible regulation gene transcription required metabolic homeostasis 5 6 15 16
0.32730934.11069927.html.plaintext.txt	20	In addition function hormone mediated gene transcription AFs also play central role determining metabolites regulate transcription
0.32730934.11069927.html.plaintext.txt	21	For instance glucose stimulated transcription L PK gene requires glucose response element binds transcription factors upstream stimulating factor family
0.32730934.11069927.html.plaintext.txt	22	This glucose response however regulated positively negatively binding HNF4 COUP TF respectively adjacent accessory element 17 20
0.32730934.11069927.html.plaintext.txt	23	In addition Osborne co workers show absence cholesterol SREBP activates transcription low density lipoprotein receptor hydroxymethylglutaryl CoA reductase gene promoters 21 23
0.32730934.11069927.html.plaintext.txt	24	An SREBP response element SRE alone however sufficient activation either gene
0.32730934.11069927.html.plaintext.txt	25	The activation low density liproprotein receptor gene promoter SREBP requires sterol response element also SP1 binding element 21 24
0.32730934.11069927.html.plaintext.txt	26	SP1 binding promoter correlates transcription gene absence cholesterol 9
0.32730934.11069927.html.plaintext.txt	27	Similarly activation hydroxymethylglutaryl CoA reductase gene expression SREBP requires sterol response element element binds nuclear factor Y 9 22 23
0.32730934.11069927.html.plaintext.txt	28	The role AFs well characterized regulation PEPCK gene transcription glucocorticoids
0.32730934.11069927.html.plaintext.txt	29	In adipose tissue PEPCK involved glycerogenesis glucocorticoids repress basal cAMP induced PEPCK gene transcription 25 26
0.32730934.11069927.html.plaintext.txt	30	By contrast PEPCK gene stimulated glucocorticoids liver PEPCK important control point gluconeogenesis 16 27
0.32730934.11069927.html.plaintext.txt	31	In liver glucocorticoids induce 10 fold increase rate transcription PEPCK gene multicomponent glucocorticoid response unit GRU located promoter region 28
0.32730934.11069927.html.plaintext.txt	32	The GRU consists tandem array four AF elements gAF1 3 cAMP response element bind HNF4COUP TF HNF3 COUP TF CEBP respectively two nonconsensus glucocorticoid receptor binding sites GR1 GR2 13 28 32
0.32730934.11069927.html.plaintext.txt	33	Interestingly neither HNF3 HNF4 expressed adipose tissue whereas expressed high levels liver 33 35
0.32730934.11069927.html.plaintext.txt	34	Thus accessory factors HNF3 HNF4 appear play additional important role facilitating tissue specific induction PEPCK gene transcription
0.32730934.11069927.html.plaintext.txt	35	A mutation one accessory elements results 50 60 reduction glucocorticoid stimulated PEPCK gene transcription H4IIE hepatoma cells 28 32 36 37
0.32730934.11069927.html.plaintext.txt	36	Any combination two mutations gAF1gAF3 gAF2 nearly abolishes response 28 37
0.32730934.11069927.html.plaintext.txt	37	The physiologic importance gAFs evident role glucose production
0.32730934.11069927.html.plaintext.txt	38	Overexpression HNF3 variant reduces response PEPCK gene glucocorticoids 50 nearly abolishes glucocorticoid induced glucose production hepatoma cells 14
0.32730934.11069927.html.plaintext.txt	39	These gAF elements functionally equivalent context PEPCK gene promoter 28 31 38
0.32730934.11069927.html.plaintext.txt	40	gAF1 gAF3 exchanged finding consistent observation COUP TF binds elements
0.32730934.11069927.html.plaintext.txt	41	However gAF1gAF3 cannot replaced gAF2 vice versa 37
0.32730934.11069927.html.plaintext.txt	42	Furthermore spacing gAF2 GR1 must maintained whereas important gAF1 gAF3 37
0.32730934.11069927.html.plaintext.txt	43	HNF3 AF binds gAF2 interacts GR vitro 37
0.32730934.11069927.html.plaintext.txt	44	Thus direct contact HNF3 GR may important stabilizing GR binding GR1 GR2 elements PEPCK gene promoter bind GR low affinity relative consensus GRE 36
0.32730934.11069927.html.plaintext.txt	45	In fact nonconsensus elements GR1 GR2 either alone combination cannot mediate glucocorticoid response placed context heterologous promoter 36
0.32730934.11069927.html.plaintext.txt	46	Thus glucocorticoid response PEPCK gene completely dependent gAF elements factors bind sites
0.32730934.11069927.html.plaintext.txt	47	However mechanism AFs control direction magnitude PEPCK gene transcription response glucocorticoids remains largely unknown
0.32730934.11069927.html.plaintext.txt	48	The recruitment coactivator molecules provides crucial step integration functions steroid hormone receptors AFs basal transcription machinery 2 39 40
0.32730934.11069927.html.plaintext.txt	49	Coactivators generally bind DNA instead associate DNA bound activator proteins
0.32730934.11069927.html.plaintext.txt	50	Some coactivators CREB cAMP response element binding protein binding protein CBP mediate functions diverse group transcription factors
0.32730934.11069927.html.plaintext.txt	51	Others steroid receptor coactivator 1 SRC1 glucocorticoid receptor interacting protein GRIP1 functionally specific interact activator proteins involved steroid hormone mediated gene transcription 41 42
0.32730934.11069927.html.plaintext.txt	52	In study show AFs bound gAF1 gAF2 elements PEPCK gene promoter recruit coactivator molecule SRC1
0.32730934.11069927.html.plaintext.txt	53	HNF4 COUP TF interact SRC1 domains required AF activity 1 2
0.32730934.11069927.html.plaintext.txt	54	We show HNF3 also interacts SRC1 domain required AF activity PEPCK gene promoter
0.32730934.11069927.html.plaintext.txt	55	Mutations either gAF1 gAF2 prevent HNF4COUP TF HNF3 binding including replacement gAF element GAL4 binding site gAFGAL4 result 50 60 reduction response PEPCK gene glucocorticoids 43
0.32730934.11069927.html.plaintext.txt	56	The binding GAL4 SRC1 chimeric protein gAF1GAL4 gAF2GAL4 element PEPCK luciferase reporter gene construct completely restores glucocorticoid induction
0.32730934.11069927.html.plaintext.txt	57	Thus SRC1 recruited directly gAF1 gAF2 requirement corresponding AF functionally bypassed
0.32730934.11069927.html.plaintext.txt	58	Surprisingly even SRC1 recruited PEPCK gene promoter manner active involvement ligand bound GR still required suggesting role receptor activating SRC1 context enhanceosome
0.32730934.11069927.html.plaintext.txt	59	Finally show bHLH HAT domains SRC1 function differently according component PEPCK gene GRU coactivator recruited
0.32730934.11069927.html.plaintext.txt	60	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.32730934.11069927.html.plaintext.txt	61	Plasmid Construction The reporter construct PEPCK LUC made excising PEPCK gene promoter 467 65 pPL32 CAT 44 AflIIIBglII inserting MluIBglII sites pGL3 basic Promega
0.32730934.11069927.html.plaintext.txt	62	The procedure used generate gAF1GAL4 PEPCK LUC gAF2GAL4 PEPCK LUC gAF3GAL4 PEPCK LUC reporter constructs respective chloramphenicol acetyltransferase reporters described previously 43
0.32730934.11069927.html.plaintext.txt	63	The gAF1GAL4 PEPCK LUC constructs block mutations GR1 GR2 elements constructed using Quick Change site directed mutagenesis kit Stratagene
0.32730934.11069927.html.plaintext.txt	64	The GAL4 SRC1 deletion constructs also made Quick Change site directed mutagenesis kit using GAL4 SRC1 construct template
0.32730934.11069927.html.plaintext.txt	65	Oligonucleotides used generate constructs made Expedite 8909 oligonucleotide synthesizer Perspective Biosystems Framingham MA
0.32730934.11069927.html.plaintext.txt	66	The sequences oligonucleotides used study shown Table I
0.32730934.11069927.html.plaintext.txt	67	All constructs verified sequencing
0.32730934.11069927.html.plaintext.txt	68	The reporter plasmid GAL45 E1b LUC described previously 1 2
0.32730934.11069927.html.plaintext.txt	69	The GAL4 HNF3 constructs also described previously expressed approximately equal levels transient transfection experiments 43
0.32730934.11069927.html.plaintext.txt	70	View table Table I Oligonucleotides used sense strand 5 3
0.32730934.11069927.html.plaintext.txt	71	Transient Transfection The maintenance transfection H4IIE cells measurements luciferase activity performed described previously 44 45 except H4IIE cells maintained alpha modified Eagles medium 10 fetal bovine serum growth medium incubation calcium phosphate precipitated DNA 3 h Me2SO shock
0.32730934.11069927.html.plaintext.txt	72	Subsequently cells washed incubated overnight serum free medium without 500 nM dexamethasone described figure legends
0.32730934.11069927.html.plaintext.txt	73	In experiments performed H4IIE cells glucocorticoid response varied 7 20 fold dexamethasonewithout dexamethasone
0.32730934.11069927.html.plaintext.txt	74	The variation passage batch dependent
0.32730934.11069927.html.plaintext.txt	75	For reason expressed data experiment percentage wild type glucocorticoid response allowed comparison experiments done cells grown different times
0.32730934.11069927.html.plaintext.txt	76	For experiments involved mapping domains GAL4 SRC1 required accessory factor activity 5 microg reporter construct gAF1GAL4 PEPCK LUC gAF2GAL4 PEPCK LUC cotransfected 2
0.32730934.11069927.html.plaintext.txt	77	5 microg GR expression vector 0
0.32730934.11069927.html.plaintext.txt	78	0 microg expression plasmid encoding various GAL4 SRC1 structural variants
0.32730934.11069927.html.plaintext.txt	79	The total amount DNA transfected experiment kept constant using varying amounts empty vector
0.32730934.11069927.html.plaintext.txt	80	These experiments repeated 3 5 times optimal hormonal responses titration experiment pooled results shown Figs
0.32730934.11069927.html.plaintext.txt	81	The optimal concentration GAL4 SRC consistently 0
0.32730934.11069927.html.plaintext.txt	82	25 microg optimal concentration structural variants varied 0
0.32730934.11069927.html.plaintext.txt	83	Luciferase activity determined using Promega luciferase assay system normalized protein concentration whole cell extracts
0.32730934.11069927.html.plaintext.txt	84	Transient transfections HeLa COS cells performed described previously 2 43
0.32730934.11069927.html.plaintext.txt	85	The expression vector GAL4 SRC1 provided Dr
0.32730934.11069927.html.plaintext.txt	86	Peter Kushner University California San Francisco
0.32730934.11069927.html.plaintext.txt	87	Statistical analysis performed using Students test assuming two tailed variance
0.32730934.11069927.html.plaintext.txt	88	Gel Mobility Shift Assay The gel mobility shift assays performed described previously except 7
0.32730934.11069927.html.plaintext.txt	89	5 microg nuclear extracts used incubations rather whole cell extracts 43
0.32730934.11069927.html.plaintext.txt	90	Nuclear extracts prepared described 30 46
0.32730934.11069927.html.plaintext.txt	91	Briefly extracts incubated presence absence GAL4 DNA binding domain GAL4 DBD antibody Lex A antibody control Santa Cruz Biotechnology Santa Cruz CA 15 min room temperature 10 microl reaction mixed 10 microl reaction buffer containing 30000 cpm 32P labeled DNA probe 5 CACACGGAGGACTGTCCTCCGACCA 3 20 mM HEPES pH 7
0.32730934.11069927.html.plaintext.txt	92	6 100 mM NaCl 5 mM MgCl2 10 microM ZnS04 6 glycerol 0
0.32730934.11069927.html.plaintext.txt	93	6 microg polydI dC Amersham Pharmacia Biotech 2 microg salmon sperm DNA another 15 min room temperature
0.32730934.11069927.html.plaintext.txt	94	The reaction mixtures loaded onto 6 polyacrylamide gel 0
0.32730934.11069927.html.plaintext.txt	95	5 x Tris buffered EDTA electrophoresed 20 mA 150 min room temperature
0.32730934.11069927.html.plaintext.txt	96	The gels dried exposed x ray film Eastman Kodak Co
0.32730934.11069927.html.plaintext.txt	97	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.32730934.11069927.html.plaintext.txt	98	Direct Recruitment Coactivator GAL4 SRC1 Can Replace AF Function HNF4 COUP TF gAF1 Previous studies PEPCK gene GRU show gAF element specifically required precise organization elements GRU necessary full glucocorticoid response 28 37
0.32730934.11069927.html.plaintext.txt	99	Glucocorticoids cause 15 fold induction reporter enzyme activity PEPCK gene promoter luciferase reporter construct contains gAF elements expressed transiently H4IIE hepatoma cells Fig
0.32730934.11069927.html.plaintext.txt	100	H4IIE cells significant amounts endogenous accessory factors potential coregulators SRC1 provide response
0.32730934.11069927.html.plaintext.txt	101	2 The presence large amounts wild type proteins however makes difficult analyze effects transiently expressed variants PEPCK gene transcription
0.32730934.11069927.html.plaintext.txt	102	Mutations gAF1 element prevent HNF4COUP TF binding including replacement gAF1 GAL4 binding site gAF1GAL4 result 50 60 reduction response PEPCK gene glucocorticoids noted previously Fig
0.32730934.11069927.html.plaintext.txt	103	The GAL4 binding site bind chimeric proteins contain domains interest thus serve surrogate gAF element
0.32730934.11069927.html.plaintext.txt	104	This useful endogenous PEPCK AFs cannot function surrogate gAF element thus effectively removed analytical system
0.32730934.11069927.html.plaintext.txt	105	View larger version 16K Fig
0.32730934.11069927.html.plaintext.txt	106	GAL4 SRC1 mediates accessory factor activity gAF1 element
0.32730934.11069927.html.plaintext.txt	107	H4IIE cells transfected 5 microg PEPCK LUC reporter construct wild type PEPCK gene promoter position 467 65 relative transcription start site fused LUC 2
0.32730934.11069927.html.plaintext.txt	108	5 microg expression plasmid GR
0.32730934.11069927.html.plaintext.txt	109	Alternatively cells transfected 5 microg reporter construct based PEPCK LUC gAF2 element mutated GAL4 DNA binding element gAF1GAL4
0.32730934.11069927.html.plaintext.txt	110	These cells cotransfected 0
0.32730934.11069927.html.plaintext.txt	111	5 microg expression plasmid encoding either GAL4 DBD GAL4 SRC1
0.32730934.11069927.html.plaintext.txt	112	Transfected cells incubated serum free medium without hormone overnight
0.32730934.11069927.html.plaintext.txt	113	Cells harvested luciferase assays performed described Experimental Procedures
0.32730934.11069927.html.plaintext.txt	114	These results represent mean plus minus S
0.32730934.11069927.html.plaintext.txt	115	The reduction glucocorticoid response caused replacement gAF1 element GAL4 element cannot restored expression GAL4 DBD indicating GAL4 DBD cannot act AF surrogate gAF1 element Fig
0.32730934.11069927.html.plaintext.txt	116	By contrast binding chimeric proteins consisting GAL4 DBD either HNF4 COUP TF restores glucocorticoid response 1 43
0.32730934.11069927.html.plaintext.txt	117	It possible HNF4 COUP TF recruit coactivator molecules form glucocorticoid specific enhanceosome whereas GAL4 DBD
0.32730934.11069927.html.plaintext.txt	118	These coactivators turn could stabilize enhanceosome complex andor provide necessary activation promoter region 47
0.32730934.11069927.html.plaintext.txt	119	In support model shown HNF4 COUP TF AFs bind gAF1 gAF3 interact SRC1 domains demonstrated required accessory factor activity 1 2
0.32730934.11069927.html.plaintext.txt	120	We hypothesized role HNF4COUP TF gAF1 recruit coactivators SRC1 direct recruitment latter gAF1 element making chimeric protein GAL4 DBD full length SRC1 GAL4 SRC1 also mediate glucocorticoid response
0.32730934.11069927.html.plaintext.txt	121	Indeed binding GAL4 SRC1 completely restores glucocorticoid induction gAF1GAL4 PEPCK LUC construct Fig
0.32730934.11069927.html.plaintext.txt	122	Thus requirement AF bypassed SRC1 recruited directly gAF1
0.32730934.11069927.html.plaintext.txt	123	Surprisingly little increase basal promoter reporter activity GAL4 SRC1 expression absence glucocorticoids Fig
0.32730934.11069927.html.plaintext.txt	124	This implies even SRC1 constitutively recruited GAL4 binding element active involvement ligand bound GR still required suggesting role receptor activating SRC1 context enhanceosome
0.32730934.11069927.html.plaintext.txt	125	We others also show coactivator cAMP response element binding protein CREB binding protein CBP interacts HNF4 2 48
0.32730934.11069927.html.plaintext.txt	126	A fusion construct expressing GAL4 CBP chimeric protein also restores lost glucocorticoid response gAF1GAL4 PEPCK LUC construct data shown
0.32730934.11069927.html.plaintext.txt	127	Thus one role AF bound gAF1 element appears recruitment cognate coactivators
0.32730934.11069927.html.plaintext.txt	128	In set experiments similar shown Fig
0.32730934.11069927.html.plaintext.txt	129	1 found GAL4 SRC1 also replace COUP TF gAF3 construct gAF3 element changed GAL4 binding element gAF3GAL4 PEPCK LUC data shown
0.32730934.11069927.html.plaintext.txt	130	This result surprising since gAF1 gAF3 elements interchangeable bind COUP TF
0.32730934.11069927.html.plaintext.txt	131	The amino acid region 408 423 COUP TFI necessary protein function AF PEPCK gene GRU 1
0.32730934.11069927.html.plaintext.txt	132	This region COUP TFI also essential interaction SRC1 1
0.32730934.11069927.html.plaintext.txt	133	These observations suggest GAL4 SRC1 replaces essential function AFs bind elements native promoter
0.32730934.11069927.html.plaintext.txt	134	Coactivator Recruitment Does Not Relieve Requirement Active Involvement Ligand bound GR Glucocorticoid Response The ligand bound GR could serve primarily signal transducer recruitment coactivators assembly glucocorticoid specific enhanceosome
0.32730934.11069927.html.plaintext.txt	135	If ligand bound GR would longer required enhanceosome assembled
0.32730934.11069927.html.plaintext.txt	136	The low basal reporter gene activity cells expressing GAL4 SRC1 surprising coactivator constitutively bound promoter yet reporter gene inactive absence glucocorticoid treatment Fig
0.32730934.11069927.html.plaintext.txt	137	We therefore reasoned must active involvement ligand bound GR GAL4 SRC1 function surrogate AF
0.32730934.11069927.html.plaintext.txt	138	In set experiments performed concomitantly described Fig
0.32730934.11069927.html.plaintext.txt	139	1 PEPCK promoter reporter gene constructs made block mutations created either GR2 GREs Fig
0.32730934.11069927.html.plaintext.txt	140	Since GR1 important GR2 glucocorticoid response 36 able create graded system 40 GR2 mutated function GR eliminated GR1 GR2 mutated respectively
0.32730934.11069927.html.plaintext.txt	141	Mutation GR2 GREs severely blunts eliminates glucocorticoid response respectively even GAL4 SRC1 tethered promoter surrogate gAF1 element Fig
0.32730934.11069927.html.plaintext.txt	142	View larger version 25K Fig
0.32730934.11069927.html.plaintext.txt	143	The PEPCK gene glucocorticoid response requires GR binding even coactivator recruitment
0.32730934.11069927.html.plaintext.txt	144	These experiments performed described Fig
0.32730934.11069927.html.plaintext.txt	145	1 except reporter constructs illustrated inset used
0.32730934.11069927.html.plaintext.txt	146	In inset crosses GR1 GR2 elements represent block mutations elements prevent GR form binding
0.32730934.11069927.html.plaintext.txt	147	For simplicity results represented relative fold induction wild type PEPCK LUC glucocorticoids taken 100
0.32730934.11069927.html.plaintext.txt	148	These results represent mean plus minus S
0.32730934.11069927.html.plaintext.txt	149	GAL4 SRC1 Can Also Replace AF Function gAF3 bound Factor The gAF13 gAF2 elements interchangeable PEPCK gene GRU 36 37
0.32730934.11069927.html.plaintext.txt	150	As expected 60 glucocorticoid response lost gAF2 changed GAL4 binding element gAF2GAL4 PEPCK LUC Fig
0.32730934.11069927.html.plaintext.txt	151	This AF activity cannot restored coexpression GAL4 DBD completely restored GAL4 HNF3 43
0.32730934.11069927.html.plaintext.txt	152	Despite functional distinction gAF13 gAF2 GAL4 SRC1 recruitment gAF2GAL4 PEPCK LUC completely restores glucocorticoid response lost mutation element Fig
0.32730934.11069927.html.plaintext.txt	153	Thus GAL4 SRC1 act surrogate AF gAF2 well provides functional bypass requirement HNF3
0.32730934.11069927.html.plaintext.txt	154	View larger version 14K Fig
0.32730934.11069927.html.plaintext.txt	155	GAL4 SRC1 mediates accessory factor activity gAF2 element
0.32730934.11069927.html.plaintext.txt	156	Experiments performed described Fig
0.32730934.11069927.html.plaintext.txt	157	1 except reporter plasmid gAF2 element PEPCK mutated GAL4 DNA binding element gAF2GAL4 PEPCK LUC used
0.32730934.11069927.html.plaintext.txt	158	These results represent mean plus minus S
0.32730934.11069927.html.plaintext.txt	159	HNF3 Interacts SRC1 Vivo As mentioned previously HNF4 COUP TF AFs bind gAF1 gAF3 interact SRC1
0.32730934.11069927.html.plaintext.txt	160	We proposed GAL4 SRC1 could serve surrogate AF gAF1 gAF3 elements changed GAL4 binding element respectively SRC1 recruited promoter appropriate position paper Refs
0.32730934.11069927.html.plaintext.txt	161	If SRC1 replaces distinct function HNF3 GRU possible HNF3 also interacts SRC1
0.32730934.11069927.html.plaintext.txt	162	To test expression vector SRC1 cotransfected HeLa cells GAL4 HNF3 variants thereof luciferase reporter plasmid contained minimal E1b promoter positioned downstream five GAL4 binding elements GAL45 E1b LUC
0.32730934.11069927.html.plaintext.txt	163	All GAL4 constructs expressed low levels 0
0.32730934.11069927.html.plaintext.txt	164	5 microg vector allow maximal coactivation SRC1
0.32730934.11069927.html.plaintext.txt	165	Cotransfection SRC1 potentiates transactivation mediated GAL4 HNF3 additional 7 fold relative expression empty control vector Fig
0.32730934.11069927.html.plaintext.txt	166	Coexpression SRC1 coactivate GAL4 DBD seen previous work Fig
0.32730934.11069927.html.plaintext.txt	167	View larger version 17K Fig
0.32730934.11069927.html.plaintext.txt	168	SRC1 potentiates activity GAL4 HNF3 fusion proteins
0.32730934.11069927.html.plaintext.txt	169	Expression plasmids encode SRC1 5 microg GAL4 HNF3 fusion proteins 0
0.32730934.11069927.html.plaintext.txt	170	5 microg cotransfected HeLa cells along reporter construct GAL45 E1b LUC 2
0.32730934.11069927.html.plaintext.txt	171	The additional increase activity provided SRC1 presented relative activity GAL4 DBD expressed fold coactivation equal amounts DNA control vectors transfected
0.32730934.11069927.html.plaintext.txt	172	These results represent mean plus minus S
0.32730934.11069927.html.plaintext.txt	173	The region HNF3 encompassing amino acids 361 458 required AF activity protein 43
0.32730934.11069927.html.plaintext.txt	174	The interaction SRC1 GAL4 HNF3361 458 results 12 fold coactivation whereas GAL4 HNF3 361 442 cannot act AF 43 ineffective Fig
0.32730934.11069927.html.plaintext.txt	175	Thus region HNF3 required AF activity GRU may act recruiting SRC1 finding consonant ability GAL4 SRC1 replace function HNF3 gAF2GAL4 PEPCK LUC reporter construct
0.32730934.11069927.html.plaintext.txt	176	Promoter Element specific Requirements bHLHPAS HAT Domains GAL4 SRC1 It difficult analyze effect transiently expressed SRC1 variants presence significant amounts endogenous wild type protein
0.32730934.11069927.html.plaintext.txt	177	However system described previous figures GAL4 SRC1 recruited GAL4 element gAFGAL4 PEPCK GAL45 E1b promoters respectively useful variants GAL4 SRC1 specifically targeted promoters effectively removing endogenous SRC1 analytical system
0.32730934.11069927.html.plaintext.txt	178	This system used identify minimal functional domains SRC1 required PEPCK glucocorticoid response
0.32730934.11069927.html.plaintext.txt	179	SRC1 originally identified cDNA lacked region encoding 41 N terminal amino acids 40
0.32730934.11069927.html.plaintext.txt	180	The protein encoded cDNA function coactivator HNF42 although still presumably binds HNF4 nuclear receptor binding motifs NRBI IV present truncated protein
0.32730934.11069927.html.plaintext.txt	181	By contrast full length SRC1 serve coactivator HNF4 GAL4 chimeric protein replace HNF4 AF gAF1GAL4 PEPCK LUC construct Fig
0.32730934.11069927.html.plaintext.txt	182	Expression variant GAL4 SRC1 lacks N terminal 45 amino acids GAL4 SRC1 bHLH replace HNF4 AF Fig
0.32730934.11069927.html.plaintext.txt	183	This GAL4 SRC1 bHLH protein provides AF activity GAL4 DBD alone deletion gAF1 element Fig
0.32730934.11069927.html.plaintext.txt	184	Thus ability GAL4 SRC1 serve surrogate AF gAF1 element correlates ability coactivate HNF4 AF binds element wild type promoter 30 43
0.32730934.11069927.html.plaintext.txt	185	View larger version 24K Fig
0.32730934.11069927.html.plaintext.txt	186	The bHLH HAT domains SRC1 required gAF1 glucocorticoid response
0.32730934.11069927.html.plaintext.txt	187	Panel A experiments performed described Fig
0.32730934.11069927.html.plaintext.txt	188	1 except equal amounts GAL4 DBD GAL4 SRC1 structural variants indicated used
0.32730934.11069927.html.plaintext.txt	189	The results represented relative fold induction wild type PEPCK LUC glucocorticoids taken 100
0.32730934.11069927.html.plaintext.txt	190	These results represent mean plus minus S
0.32730934.11069927.html.plaintext.txt	191	The asterisks represent statistically significant differences p 0
0.32730934.11069927.html.plaintext.txt	192	Panel B expression DNA binding various GAL4 SRC1 fusion proteins determined COS cells transfected 20 microg expression plasmids encode various GAL4 SRC1 fusion constructs
0.32730934.11069927.html.plaintext.txt	193	Nuclear extracts prepared gel mobility shift assay used analyze expression levels described Experimental Procedures
0.32730934.11069927.html.plaintext.txt	194	The arrows indicate various GAL4 SRC1 fusion proteins
0.32730934.11069927.html.plaintext.txt	195	Each protein complex eliminated preincubation extracts polyclonal antibody directed GAL4 DBD unrelated antibody raised Lex A
0.32730934.11069927.html.plaintext.txt	196	SRC1 resident acetyltransferase activity protein protein interaction surfaces could serve structural adapter molecule GRU enhanceosome also promote transcription acetylation chromatin components transcription factors 49 51
0.32730934.11069927.html.plaintext.txt	197	A deletion construct GAL4 SRC1 acetyltransferase domain deleted GAL4 SRCHAT restore glucocorticoid responsiveness reporter gene Fig
0.32730934.11069927.html.plaintext.txt	198	A chimeric construct five C terminal amino acids encompassing NRBIV deleted GAL4 SRC1IV provides glucocorticoid response comparable GAL4 SRC1 Fig
0.32730934.11069927.html.plaintext.txt	199	This region important interaction SRC1 GR although NRBI III also contributes physical interaction 52
0.32730934.11069927.html.plaintext.txt	200	The expression GAL4 SRC1 variants confirmed gel mobility shift experiment nuclear extracts prepared GAL4 SRC1 fusion protein expressing cells tested
0.32730934.11069927.html.plaintext.txt	201	The empty vector used control ensure endogenous mammalian proteins bind GAL4 binding element
0.32730934.11069927.html.plaintext.txt	202	COS cells used experiment low transfection efficiency H4IIE hepatoma cells
0.32730934.11069927.html.plaintext.txt	203	All structural variants GAL4 SRC1 expressed efficiently approximately equal levels Fig
0.32730934.11069927.html.plaintext.txt	204	The identity protein DNA complexes GAL4 SRC1 variants determined preincubation nuclear extract polyclonal antibody raised GAL4 DBD
0.32730934.11069927.html.plaintext.txt	205	This preincubation anti GAL4 DBD antibody prevents complex forming unrelated antibody anti Lex A without effect Fig
0.32730934.11069927.html.plaintext.txt	206	No protein DNA complexes seen nuclear extracts prepared COS cells transfected pRC RSV vector control GAL4 SRC1 Fig
0.32730934.11069927.html.plaintext.txt	207	It known GAL4 SRC1 bHLH migrates slightly slowly
0.32730934.11069927.html.plaintext.txt	208	All proteins migrate expected determined Western blot analysis gel run denaturing conditions data shown
0.32730934.11069927.html.plaintext.txt	209	The gAF1 gAF2 elements functionally distinct PEPCK gene GRU 36 37 thus speculated might different requirements SRC1 recruited respective sites
0.32730934.11069927.html.plaintext.txt	210	As seen gAF1 acetyltransferase activity SRC1 also required gAF2 since GAL4 SRC1HAT mediate AF activity Fig
0.32730934.11069927.html.plaintext.txt	211	As gAF1 element NRBIV region GAL4 SRC1 also dispensable gAF2 Fig
0.32730934.11069927.html.plaintext.txt	212	However contrast functional requirements GAL4 SRC1 gAF1 bHLHPAS domain critical surrogate AF activity provided protein bHLHPAS region completely dispensable gAF2 Fig
0.32730934.11069927.html.plaintext.txt	213	The distinct requirements various regions GAL4 SRC1 gAF1 compared gAF2 supports contention gAF1 gAF2 elements distinct roles glucocorticoid response 36
0.32730934.11069927.html.plaintext.txt	214	This result also suggests GAL4 SRC1 replaces essential distinct function HNF4COUP TF HNF3 gAF1 gAF2 respectively
0.32730934.11069927.html.plaintext.txt	215	View larger version 21K Fig
0.32730934.11069927.html.plaintext.txt	216	The HAT domain SRC1 required glucocorticoid response gAF2 bHLH domain
0.32730934.11069927.html.plaintext.txt	217	Experiments performed described Fig
0.32730934.11069927.html.plaintext.txt	218	3 except equal amounts GAL4 DBD G4 DBD GAL4 SRC1 G4 SRC1 structural variants indicated used
0.32730934.11069927.html.plaintext.txt	219	This result demonstrates element specific requirements SRC1 PEPCK gene GRU confirms GAL4 SRC bHLH transcriptionally inactive
0.32730934.11069927.html.plaintext.txt	220	Results represented relative fold induction wild type PEPCK LUC glucocorticoids taken 100
0.32730934.11069927.html.plaintext.txt	221	These results represent mean plus minus S
0.32730934.11069927.html.plaintext.txt	222	The asterisk represents statistically significant difference p 0
0.32730934.11069927.html.plaintext.txt	223	The element specific requirements GAL4 SRC1 gAF1 gAF2 demonstrate multiple functions coactivators required PEPCK glucocorticoid response
0.32730934.11069927.html.plaintext.txt	224	These requirements may determined local promoter environment coactivator recruited
0.32730934.11069927.html.plaintext.txt	225	This high degree specificity may also reflect promoter specific requirements bHLHPAS HAT domains SRC1 different promoters
0.32730934.11069927.html.plaintext.txt	226	None GAL4 SRC1 variants significantly activate basal PEPCK gene promoter reporter activity Figs
0.32730934.11069927.html.plaintext.txt	227	1 3 however GAL4 SRC1 low basal transactivation potential simple promoter contains multimerized GAL4 binding elements 53
0.32730934.11069927.html.plaintext.txt	228	We used system test inherent capacity GAL4 SRC1 variants activate basal transcription
0.32730934.11069927.html.plaintext.txt	229	The coexpression GAL4 SRC1 GAL45 E1b LUC reporter HeLa cells results 10 fold activation expression reporter compared achieved GAL4 DBD alone cotransfected Fig
0.32730934.11069927.html.plaintext.txt	230	GAL4 SRC1 bHLH activates reporter 4 fold Fig
0.32730934.11069927.html.plaintext.txt	231	This region appears general activation domain SRC1 since important AF activity PEPCK gAF1 context simple promoter Figs
0.32730934.11069927.html.plaintext.txt	232	View larger version 15K Fig
0.32730934.11069927.html.plaintext.txt	233	Basal transcriptional activity structural variants GAL4 SRC1
0.32730934.11069927.html.plaintext.txt	234	HeLa cells transfected 2
0.32730934.11069927.html.plaintext.txt	235	5 microg GAL45 E1b LUC along 5 microg indicated GAL4 SRC1 construct GAL4 DBD
0.32730934.11069927.html.plaintext.txt	236	This result identifies promoter specific requirements SRC1 acetyltransferase activity PEPCK gene transcription demonstrates GAL4 SRC1HAT transcriptionally inactive
0.32730934.11069927.html.plaintext.txt	237	Results presented relative activity GAL4 DBD represent average plus minus S
0.32730934.11069927.html.plaintext.txt	238	The gAF1 activity GAL4 SRC fusion protein also shown
0.32730934.11069927.html.plaintext.txt	239	By contrast PEPCK gene GRU GAL4 SRCHAT act AF either gAF1 gAF2 protein increases expression simple promoter 100 x effectively DBD Fig
0.32730934.11069927.html.plaintext.txt	240	The heightened activation produced deletion HAT domain may reflect different protein targets enzyme activity two promoters
0.32730934.11069927.html.plaintext.txt	241	Deletion NRBIV effect basal transcription mediated GAL4 SRC1 Fig
0.32730934.11069927.html.plaintext.txt	242	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.32730934.11069927.html.plaintext.txt	243	The accessory factors HNF4 COUP TF HNF3 required maximal induction PEPCK gene transcription glucocorticoids 13 28 32 interacts coactivator SRC1 exactly regions required AF function paper Refs
0.32730934.11069927.html.plaintext.txt	244	This series observations strongly suggests recruitment SRC1 important glucocorticoid response
0.32730934.11069927.html.plaintext.txt	245	Recruitment SRC1 however exclude recruitment coactivators CBP AFs
0.32730934.11069927.html.plaintext.txt	246	We envision together AFs provide surface recruitment coactivator complex includes SRC1 CBP probably proteins
0.32730934.11069927.html.plaintext.txt	247	The PEPCK gene GRU shares DNA elements hormone response units provide response retinoic acid cAMP insulin 38 different transcription factors recruited AF elements response hormones 37 54 55
0.32730934.11069927.html.plaintext.txt	248	It probable constellation coregulators recruited effectors also different yet somehow array hormone response units provides coordinated response metabolic challenges imposed hypoglycemia PEPCK gene activated hyperglycemia gene repressed
0.32730934.11069927.html.plaintext.txt	249	The ability GAL4 SRC1 replace function AFs bound gAF1 gAF2 gAF3 GRU shows precise factor binds elements less critical ability proteins assemble functional enhanceosome
0.32730934.11069927.html.plaintext.txt	250	There however specificity associated AFs GRU
0.32730934.11069927.html.plaintext.txt	251	The observation PEPCK gene GRU uses liver enriched factors HNF4 HNF3 recruit coregulatory molecules rather ubiquitously expressed factors provides insight tissue specificity gene transcription response glucocorticoids may arise
0.32730934.11069927.html.plaintext.txt	252	In regard noteworthy adipose tissue express HNF4 HNF3 express GR glucocorticoids repress basal cAMP induced PEPCK gene transcription 25 26
0.32730934.11069927.html.plaintext.txt	253	Thus tissue specific expression AFs may provide directionality gene transcription response glucocorticoids well contributing magnitude response
0.32730934.11069927.html.plaintext.txt	254	The precise role ligand bound GR mediating response less clear
0.32730934.11069927.html.plaintext.txt	255	A previous vivo footprint analysis showed gAF elements GRU occupied absence glucocorticoids 56
0.32730934.11069927.html.plaintext.txt	256	Here show GAL4 SRC1 able function surrogate AF GR present Figs
0.32730934.11069927.html.plaintext.txt	257	Upon exposure ligand GR may help promote formation functional enhanceosome interacting SRC1 recruit components basal transcription machinery
0.32730934.11069927.html.plaintext.txt	258	GR may also activate SRC1 latter recruited GRU AFs HNF4 COUP TF HNF3
0.32730934.11069927.html.plaintext.txt	259	The activation coactivators nuclear receptors unprecedented
0.32730934.11069927.html.plaintext.txt	260	The function peroxisome proliferator activated receptor coactivator PGC1 stimulated association peroxisome proliferator activated receptor 57
0.32730934.11069927.html.plaintext.txt	261	This protein protein interaction promotes conformational change PGC1 permits recruitment additional coactivators SRC1 CBPp300 57
0.32730934.11069927.html.plaintext.txt	262	We propose binding GR PEPCK gene GRU promotes activation SRC1 assembly functional enhanceosome similar fashion
0.32730934.11069927.html.plaintext.txt	263	The interaction GR SRC1 appears facilitated localization GR DNA binding elements
0.32730934.11069927.html.plaintext.txt	264	When GR1 GR2 elements intact GAL4 SRC1 able serve surrogate AF gAF1
0.32730934.11069927.html.plaintext.txt	265	As ability GR recruited promoter reduced lost introducing mutations GR2 GR1 GR2 elements respectively ability GAL4 SRC1 serve surrogate AF reduced lost coordinate manner Fig
0.32730934.11069927.html.plaintext.txt	266	All p160 family coactivators contain three central LXXLL motifs NRBI III important interaction nuclear receptors 58 59
0.32730934.11069927.html.plaintext.txt	267	SRC1a used experiments additional C terminal LXXLL motif NRBIV exhibits strong vitro binding class I nuclear receptors estrogen receptor GR 39 52 59 60
0.32730934.11069927.html.plaintext.txt	268	One might imagine NRBIV domain could help stabilize GR binding low affinity GR1 GR2 elements
0.32730934.11069927.html.plaintext.txt	269	If deletion NRBIV region SRC1 GAL4 SRC1IV reduce effectiveness GAL4 SRC1 surrogate AF
0.32730934.11069927.html.plaintext.txt	270	Deletion region without effect however GAL4 SRC1IV functions comparably full length chimeric protein Figs
0.32730934.11069927.html.plaintext.txt	271	show although NRBIV nuclear receptor interaction motif interacts strongly estrogen receptor vitro deletion region little functional consequence estrogen receptor activation providing NRBI III region intact 60
0.32730934.11069927.html.plaintext.txt	272	This suggests multiple LXXLL motifs facilitate vivo effects SRC1 nuclear receptors
0.32730934.11069927.html.plaintext.txt	273	Rather stabilizing GR binding SRC1 GR interaction may important activation SRC1
0.32730934.11069927.html.plaintext.txt	274	By model AFs HNF4 COUP TF1 HNF3 would serve recruit SRC1 turn activated additional presence ligand bound GR
0.32730934.11069927.html.plaintext.txt	275	The recruitment GAL4 SRC1 variants protein promoter constructs GAL4 binding elements gAFGAL4 PEPCK GAL45 E1b promoters respectively allowed us look promoter DNA element specific requirements SRC coactivation
0.32730934.11069927.html.plaintext.txt	276	The bHLH region GAL4 SRC1 required AF activity gAF1 element Fig
0.32730934.11069927.html.plaintext.txt	277	GAL4 SRC1 bHLH also provides low rate basal transcriptional activation simple E1b promoter Fig
0.32730934.11069927.html.plaintext.txt	278	The bHLHPAS domain SRC1 highly conserved among p160 family coactivators PAS motif serves protein protein interaction surface transcription factors Per ARNT SIM 61 62
0.32730934.11069927.html.plaintext.txt	279	The importance bHLHPAS domain SRC1 context PEPCK gene GRU may indicate requirement interaction additional PAS containing factor necessary SRC1 function
0.32730934.11069927.html.plaintext.txt	280	Interestingly region required GAL4 SRC1 recruited gAF2 Fig
0.32730934.11069927.html.plaintext.txt	281	This result supports idea gAF elements associated factors distinct roles response PEPCK gene glucocorticoids
0.32730934.11069927.html.plaintext.txt	282	The acetyltransferase domain GAL4 SRC1 required gAF1 gAF2 Figs
0.32730934.11069927.html.plaintext.txt	283	5a 6 however target acetyltransferase activity PEPCK gene GRU unknown
0.32730934.11069927.html.plaintext.txt	284	Acetylation chromatin components transcription factors correlates activation gene transcription 49 50 63 65
0.32730934.11069927.html.plaintext.txt	285	The chromatin structure PEPCK gene promoter already free nucleosomes exposure hormone H4IIE cells 66 thus unlikely target acetyltransferase activity required SRC1
0.32730934.11069927.html.plaintext.txt	286	There several potential targets acetyltransferase activity SRC1 GRU
0.32730934.11069927.html.plaintext.txt	287	HNF4 acetylated CBP reaction promotes DNA binding nuclear retention HNF4 64
0.32730934.11069927.html.plaintext.txt	288	The androgen receptor also acetylated CBP 67 thus possible nuclear receptors GR may also acetylated
0.32730934.11069927.html.plaintext.txt	289	Different targets acetyltransferase activity SRC1 chromatin components versus transcription factors may also explain GAL4 SRC1HAT strongly activates simple promoter functional PEPCK gAF elements tested Figs
0.32730934.11069927.html.plaintext.txt	290	The use GAL4 SRC1 chimeric protein recruit coactivator specific DNA elements allowed us demonstrate promoter specific requirements SRC1 simple PEPCK gene promoters also element specific requirements domains SRC1 gAF1 gAF2 PEPCK gene GRU
0.32730934.11069927.html.plaintext.txt	291	A summary differences illustrated Fig
0.32730934.11069927.html.plaintext.txt	292	HNF4COUP TF HNF3 mediate distinct functions AFs yet capable interacting coactivator SRC1
0.32730934.11069927.html.plaintext.txt	293	SRC1 may serve scaffolding molecule activator acetyltransferase activity
0.32730934.11069927.html.plaintext.txt	294	Which functions required seems determined local promoter environment SRC1 recruited
0.32730934.11069927.html.plaintext.txt	295	Furthermore function SRC1 coactivator simply determined site recruitment GRU also depends upon activation GR
0.32730934.11069927.html.plaintext.txt	296	This role recruitment activation coactivators may implications genes employ AFs mediate responses metabolic signals
0.32730934.11069927.html.plaintext.txt	297	Indeed AFs required glucocorticoid response PEPCK gene involved regulating hormone responses many genes encode enzymes required metabolic homeostasis 10 14 68 69
0.32730934.11069927.html.plaintext.txt	298	Thus functional interactions HNF3 HNF4 SRC1 described PEPCK gene GRU may broad role metabolic adaptation
0.32730934.11069927.html.plaintext.txt	299	View larger version 15K Fig
0.32730934.11069927.html.plaintext.txt	300	A comparison accessory factor activity basal transactivation mediated GAL4 SRC structural variants
0.32730934.11069927.html.plaintext.txt	301	Peter Kushner University California San Francisco providing expression vector GAL4 SRC1 Dr
0.32730934.11069927.html.plaintext.txt	302	Jen Chywan Wang helpful advice Cathy Caldwell technical assistance Deborah Caplenor Brown helping prepare manuscript
0.32730934.11069927.html.plaintext.txt	303	This work supported National Institutes Health Grants DK20593 Vanderbilt Diabetes Research Training Center DK35107 GM07347 Vanderbilt Medical Scientist Training Program Veterans Administration Research Service
0.32730934.11069927.html.plaintext.txt	304	The costs publication article defrayed part payment page charges
0.32730934.11069927.html.plaintext.txt	305	The article must therefore hereby marked advertisement accordance 18 U
0.32730934.11069927.html.plaintext.txt	306	Section 1734 solely indicate fact
0.32730934.11069927.html.plaintext.txt	307	To correspondence addressed Dept
0.32730934.11069927.html.plaintext.txt	308	Molecular Physiology Biophysics 707 Light Hall Vanderbilt University School Medicine Nashville TN 37232
0.32730934.11069927.html.plaintext.txt	309	615 322 7004 Fax 615 322 7236 E mail daryl
0.32730934.11069927.html.plaintext.txt	310	Published JBC Papers Press November 7 2000 DOI 10
0.32730934.11069927.html.plaintext.txt	311	Granner unpublished observation
0.32730934.11069927.html.plaintext.txt	312	The abbreviations used HRE hormone response element AF accessory factor PEPCK phosphoenolpyruvate carboxykinase GRU glucocorticoid response unit CBP cAMP response element binding protein CREB binding protein SRC1 steroid receptor coactivator 1 DBD DNA binding domain GR glucocorticoid receptor HNF hepatocyte nuclear factor COUP TF chicken ovalbumin upstream promoter transcription factor bHLH basic helix loop helix HAT histone acetyltransferase SREBP sterol response element binding protein
0.32730934.11069927.html.plaintext.txt	313	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.32730934.11069927.html.plaintext.txt	314	275 3446 3454AbstractFree Full Text 2
0.32730934.11069927.html.plaintext.txt	315	273 30847 30850AbstractFree Full Text 3
0.32730934.11069927.html.plaintext.txt	316	268 12952 12957AbstractFree Full Text 4
0.32730934.11069927.html.plaintext.txt	317	265 10173 10176Free Full Text 6
0.32730934.11069927.html.plaintext.txt	318	61 1131 1173CrossRefMedline Order article via Infotrieve 7
0.32730934.11069927.html.plaintext.txt	319	1991 Cell 65 1255 1266Medline Order article via Infotrieve 8
0.32730934.11069927.html.plaintext.txt	320	1983 Cell 33 489 499Medline Order article via Infotrieve 9
0.32730934.11069927.html.plaintext.txt	321	97 6340 6344AbstractFree Full Text 10
0.32730934.11069927.html.plaintext.txt	322	16 713 723Medline Order article via Infotrieve 11
0.32730934.11069927.html.plaintext.txt	323	1995 DNA Cell Biol 14 385 396Medline Order article via Infotrieve 13
0.32730934.11069927.html.plaintext.txt	324	275 14717 14721AbstractFree Full Text 15
0.32730934.11069927.html.plaintext.txt	325	270 23235 23238Free Full Text 16
0.32730934.11069927.html.plaintext.txt	326	54 885 909CrossRefMedline Order article via Infotrieve 17
0.32730934.11069927.html.plaintext.txt	327	459 9 14CrossRefMedline Order article via Infotrieve 20
0.32730934.11069927.html.plaintext.txt	328	270 1161 1169AbstractFree Full Text 22
0.32730934.11069927.html.plaintext.txt	329	263 3380 3387AbstractFree Full Text 23
0.32730934.11069927.html.plaintext.txt	330	271 12247 12253AbstractFree Full Text 24
0.32730934.11069927.html.plaintext.txt	331	92 6102 6106AbstractFree Full Text 25
0.32730934.11069927.html.plaintext.txt	332	CO2 DlinktypeDOI CrossRefMedline Order article via Infotrieve 27
0.32730934.11069927.html.plaintext.txt	333	1992 Diabetes Care 15 369 365Abstract 28
0.32730934.11069927.html.plaintext.txt	334	10 4712 4719Medline Order article via Infotrieve 29
0.32730934.11069927.html.plaintext.txt	335	274 5880 5887AbstractFree Full Text 30
0.32730934.11069927.html.plaintext.txt	336	271 31909 31914AbstractFree Full Text 32
0.32730934.11069927.html.plaintext.txt	337	268 5353 5356AbstractFree Full Text 33
0.32730934.11069927.html.plaintext.txt	338	12 482 491AbstractFree Full Text 37
0.32730934.11069927.html.plaintext.txt	339	12 1487 1498AbstractFree Full Text 38
0.32730934.11069927.html.plaintext.txt	340	93 10069 10073AbstractFree Full Text 40
0.32730934.11069927.html.plaintext.txt	341	1995 Science 270 1354 1357Abstract 41
0.32730934.11069927.html.plaintext.txt	342	93 4948 4952AbstractFree Full Text 42
0.32730934.11069927.html.plaintext.txt	343	9 222 232CrossRefMedline Order article via Infotrieve 43
0.32730934.11069927.html.plaintext.txt	344	13 604 618AbstractFree Full Text 44
0.32730934.11069927.html.plaintext.txt	345	8 96 104Medline Order article via Infotrieve 45
0.32730934.11069927.html.plaintext.txt	346	1986 Cell 47 767 776Medline Order article via Infotrieve 47
0.32730934.11069927.html.plaintext.txt	347	94 7879 7884AbstractFree Full Text 48
0.32730934.11069927.html.plaintext.txt	348	241 664 669CrossRefMedline Order article via Infotrieve 49
0.32730934.11069927.html.plaintext.txt	349	1997 Nature 389 194 198CrossRefMedline Order article via Infotrieve 50
0.32730934.11069927.html.plaintext.txt	350	1997 Cell 90 595 606Medline Order article via Infotrieve 51
0.32730934.11069927.html.plaintext.txt	351	93 10626 10631AbstractFree Full Text 52
0.32730934.11069927.html.plaintext.txt	352	12 302 313AbstractFree Full Text 53
0.32730934.11069927.html.plaintext.txt	353	273 12101 12108AbstractFree Full Text 54
0.32730934.11069927.html.plaintext.txt	354	1990 Science 249 533 537Medline Order article via Infotrieve 55
0.32730934.11069927.html.plaintext.txt	355	271 6260 6264AbstractFree Full Text 56
0.32730934.11069927.html.plaintext.txt	356	268 24976 24985AbstractFree Full Text 57
0.32730934.11069927.html.plaintext.txt	357	1999 Science 286 1368 1371AbstractFree Full Text 58
0.32730934.11069927.html.plaintext.txt	358	1997 Nature 387 733 736CrossRefMedline Order article via Infotrieve 59
0.32730934.11069927.html.plaintext.txt	359	12 3357 3368AbstractFree Full Text 60
0.32730934.11069927.html.plaintext.txt	360	17 232 243AbstractFree Full Text 61
0.32730934.11069927.html.plaintext.txt	361	273 2895 2904AbstractFree Full Text 62
0.32730934.11069927.html.plaintext.txt	362	18 4079 4088AbstractFree Full Text 63
0.32730934.11069927.html.plaintext.txt	363	96 9485 9490AbstractFree Full Text 64
0.32730934.11069927.html.plaintext.txt	364	275 12515 12520AbstractFree Full Text 65
0.32730934.11069927.html.plaintext.txt	365	1999 Cell 98 675 686Medline Order article via Infotrieve 66
0.32730934.11069927.html.plaintext.txt	366	9 1289 1297Medline Order article via Infotrieve 67
0.32730934.11069927.html.plaintext.txt	367	275 20853 20860AbstractFree Full Text 68
0.32730934.11069927.html.plaintext.txt	368	1996 Nature 384 458 460CrossRefMedline Order article via Infotrieve 69
0.32730934.11069927.html.plaintext.txt	369	94 13209 13214AbstractFree Full Text
0.32730934.11069927.html.plaintext.txt	370	Copyright 2001 The American Society Biochemistry Molecular Biology Inc
0.40115005.12522137.html.plaintext.txt	0	Suppression Hepatitis B Virus Core Promoter Nuclear Orphan Receptor TR4 Wen Jye Lin Jie Li Yi Fen Lee Shauh Der Yeh Saleh Altuwaijri Jing Hsiung Ou Chawnshang Chang
0.40115005.12522137.html.plaintext.txt	1	From George Whipple Lab Cancer Research Departments Pathology Urology Radiation Oncology Cancer Center University Rochester Medical Center Rochester New York 14642 Department Molecular Microbiology Immunology University Southern California Los Angeles California 90033
0.40115005.12522137.html.plaintext.txt	2	Received publication June 14 2002 revised form January 8 2003
0.40115005.12522137.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.40115005.12522137.html.plaintext.txt	4	The TR4 orphan receptor member nuclear receptor superfamily modulates gene expression via binding AGGTCA direct repeat hormone response element
0.40115005.12522137.html.plaintext.txt	5	Here report functional study TR4 interaction core promoter hepatitis B virus HBV
0.40115005.12522137.html.plaintext.txt	6	The electrophoretic mobility shift assay shows TR4 bind direct repeat 1 sequence element AGGTTAAAGGTCT nucleotide coordinates 1757 1769 TR4RE HBV HBV core promoter
0.40115005.12522137.html.plaintext.txt	7	TR4 also enhance activity synthetic luciferase reporter linked four copies TR4RE HBV either liver HepG2 non liver H1299 cells dose dependent manner
0.40115005.12522137.html.plaintext.txt	8	Surprisingly TR4 represses activity luciferase reporter containing entire HBV genome sequences
0.40115005.12522137.html.plaintext.txt	9	Moreover mutation TR4RE HBV site HBV core promoter diminishes TR4 suppression effect
0.40115005.12522137.html.plaintext.txt	10	This TR4 induced suppression HBV core promoter activity confirmed primer extension analysis HBV core RNAs showing TR4 represses pre core core mRNAs
0.40115005.12522137.html.plaintext.txt	11	Further dissection repressive mechanism indicates TR4 may suppress HBV core promoter activity via repressing HNF4 mediated transactivation protein protein interactions without inhibition HNF4 DNA binding
0.40115005.12522137.html.plaintext.txt	12	Furthermore results indicate N C terminal regions TR4 protein required TR4 HNF4 interaction
0.40115005.12522137.html.plaintext.txt	13	It possible TR4 HNF4 interaction may block HNF4 function results suppression HBV gene expression
0.40115005.12522137.html.plaintext.txt	14	Together results demonstrate TR4 serve negative modulator transcriptional regulation HBV core gene expression
0.40115005.12522137.html.plaintext.txt	15	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.40115005.12522137.html.plaintext.txt	16	Hepatitis B virus HBV1 small virus 3
0.40115005.12522137.html.plaintext.txt	17	2 kb partially double stranded DNA genome containing four open reading frames surface antigen core antigen polymerase X protein 1 2
0.40115005.12522137.html.plaintext.txt	18	HBV major pathogen causing acute chronic liver diseases cirrhosis hepatocellular carcinoma 3 4
0.40115005.12522137.html.plaintext.txt	19	HBV transcripts regulated transcriptional control four different promoters two enhancer elements 5
0.40115005.12522137.html.plaintext.txt	20	HBV replicated RNA intermediate template reverse transcription 1
0.40115005.12522137.html.plaintext.txt	21	The core promoter controls expression 3
0.40115005.12522137.html.plaintext.txt	22	5 kb core mRNA C mRNA template replication expression pre core mRNA pre C mRNA translation HBeAg precursor 6
0.40115005.12522137.html.plaintext.txt	23	Recently multiple binding sites liver specific ubiquitous transcription factors several hormone response elements HRE identified core promoter region including Sp1 7 8 TATA binding protein 9 HNF3 10 HNF4 11 CEBP 12 members nuclear receptor superfamily retinoid X receptor RXR peroxisome proliferator activated receptor PPAR COUP TF1 ARP1 13
0.40115005.12522137.html.plaintext.txt	24	For example HNF4 RXRPPAR stimulate expression 3
0.40115005.12522137.html.plaintext.txt	25	5 kb core RNA COUP TF1 suppresses expression pre C RNA C RNA TR2 preferentially represses expression pre C RNA 14
0.40115005.12522137.html.plaintext.txt	26	These findings suggest nuclear receptors may play important roles viral transcription
0.40115005.12522137.html.plaintext.txt	27	The detailed mechanisms core promoter differentially regulated nuclear receptors remain unclear
0.40115005.12522137.html.plaintext.txt	28	The testicular orphan receptor 4 TR4 NR2C2 orphan member nuclear receptor superfamily 15 17
0.40115005.12522137.html.plaintext.txt	29	This family includes classic steroid hormone receptors thyroid hormone receptor retinoid receptors many nuclear orphan receptors whose physiological ligands identified 18
0.40115005.12522137.html.plaintext.txt	30	Members superfamily typically contain two major conserved domains DNA binding domain DBD ligand binding domain LBD 18
0.40115005.12522137.html.plaintext.txt	31	Most nuclear receptors bind cognate ligands translocate nucleus bind specific HREs turn downstream target genes
0.40115005.12522137.html.plaintext.txt	32	TR4 isolated human prostate testis cDNA libraries considered orphan receptor ligand found 15
0.40115005.12522137.html.plaintext.txt	33	Our previous data showed TR4 recognizes different AGGTCA direct repeat DR sequences either inducing suppressing target genes
0.40115005.12522137.html.plaintext.txt	34	For example TR4 induces reporters containing DR1 site human ciliary neurotrophic factor receptor promoter DR4 site myosin heavy chain promoter 19 20
0.40115005.12522137.html.plaintext.txt	35	In contrast TR4 suppresses RXRretinoic acid receptor DR1 vitamin D3 receptor DR3 RXRPPAR DR1 mediated transactivation shown reporter assay 21 23
0.40115005.12522137.html.plaintext.txt	36	These results suggest TR4 may act negative regulator target genes containing hormone response elements HREs competition nuclear receptors binding HREs 21 23
0.40115005.12522137.html.plaintext.txt	37	In addition previous data showed TR4 could also suppress androgen receptor mediated transactivation via protein protein interaction 22
0.40115005.12522137.html.plaintext.txt	38	The distribution TR4 expression ubiquitous many tissues including central nervous system adrenal gland spleen thyroid gland liver 16 19 23
0.40115005.12522137.html.plaintext.txt	39	Also many nuclear receptors expressed liver HNF4 24 RXRPPAR 25 26
0.40115005.12522137.html.plaintext.txt	40	These findings suggest nuclear receptors liver coordinately regulate gene expression interacting HRE sequences promoters target genes
0.40115005.12522137.html.plaintext.txt	41	Our data show TR4 interfere number nuclear receptors competing binding HREs 21 22
0.40115005.12522137.html.plaintext.txt	42	In report analyzed DR1 site HBV core promoter
0.40115005.12522137.html.plaintext.txt	43	We tested whether TR4 plays role regulating activity core promoter binding HRE DR1 site
0.40115005.12522137.html.plaintext.txt	44	We showed TR4 binds DR1 site HBV core promoter strongly activates reporter containing synthetic DR1 response elements
0.40115005.12522137.html.plaintext.txt	45	Moreover demonstrated TR4 could suppress pre C C RNA expression also confirmed luciferase assay using reporter containing entire core promoter
0.40115005.12522137.html.plaintext.txt	46	Our data suggest TR4 may suppress HBV core promoter activity via interruption HNF4 induced HBV core promoter protein protein interaction HNF4
0.40115005.12522137.html.plaintext.txt	47	These data demonstrate TR4 function repressor liver cells suppress HBV gene expression replication
0.40115005.12522137.html.plaintext.txt	48	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.40115005.12522137.html.plaintext.txt	49	Plasmids The plasmids CpFL4LUC CpLUC XpHNF4LUC CpM2LUC gifts Dr
0.40115005.12522137.html.plaintext.txt	50	McLachlan The Scripps Research Institute described previously 13
0.40115005.12522137.html.plaintext.txt	51	The plasmid pCDNAI HNF4 gift Dr
0.40115005.12522137.html.plaintext.txt	52	Hadzopoulou Cladaras Boston University Boston MA
0.40115005.12522137.html.plaintext.txt	53	Guan University Michigan Medical School Ann Arbor MI
0.40115005.12522137.html.plaintext.txt	54	The pCMX TR4 pET14b TR4 pSG5 VDR pCMV TR2 plasmids constructed described previously 27 28
0.40115005.12522137.html.plaintext.txt	55	pWTDHBV contains head tail dimer wild type HBV genome DNA adw2 8
0.40115005.12522137.html.plaintext.txt	56	The GST TR4 TR4 N DBD TR4 LBD fusion constructs described previous study 29
0.40115005.12522137.html.plaintext.txt	57	The GAL4 HNF4 expression plasmid one hybrid assay made inserting PCR generated BamHIXbaI fragment amino acids 1 465 HNF4 pCDNAI HNF4 pM containing GAL4 DBD 1 147 Invitrogen
0.40115005.12522137.html.plaintext.txt	58	Electrophoretic Mobility Shift Assay The EMSA reaction performed described previously 20
0.40115005.12522137.html.plaintext.txt	59	Briefly TR4 HNF4 proteins EMSA transcribed translated TNT reticulocyte lysates Promega according manufacturers instructions
0.40115005.12522137.html.plaintext.txt	60	The oligonucleotide probes EMSA end labeled 32PATP T4 polynucleotide kinase New England BioLabs
0.40115005.12522137.html.plaintext.txt	61	HepG2 cell nuclear extracts prepared according procedure Andrew Faller 30
0.40115005.12522137.html.plaintext.txt	62	The EMSA reactions performed 10 microg nuclear extracts 2 microl TNT lysates EMSA buffer containing 10 mM Hepes pH 7
0.40115005.12522137.html.plaintext.txt	63	9 6 vv glycerol 2 vv Ficoll 100 mM KCl 0
0.40115005.12522137.html.plaintext.txt	64	5 mM MgCl2 1 mM dithiothreitol
0.40115005.12522137.html.plaintext.txt	65	The reaction mixtures proteins DNA incubated 15 min room temperature
0.40115005.12522137.html.plaintext.txt	66	For antibody supershift assay mixtures incubated another 15 min presence absence mouse anti TR4 monoclonal antibody 15
0.40115005.12522137.html.plaintext.txt	67	The protein DNA complexes analyzed 5 native polyacrylamide gel
0.40115005.12522137.html.plaintext.txt	68	Cell Culture Transfections Luciferase Assays HepG2 cells Huh7 human differentiated hepatoma cells H1299 cells HepG2
0.40115005.12522137.html.plaintext.txt	69	1 cells human de differentiated hepatoma cells maintained Dulbeccos modified Eagles medium RPMI supplemented 10 fetal bovine serum 2 mM glutamine 100 unitsml penicillin 100 microgml streptomycin 31
0.40115005.12522137.html.plaintext.txt	70	The cells plated 105well 12 well dishes Falcon transfected 1
0.40115005.12522137.html.plaintext.txt	71	2 microg DNAwell using SuperFect according manufacturers protocol Qiagen
0.40115005.12522137.html.plaintext.txt	72	The internal control plasmid pRL TK Promega co transfected transfection experiments
0.40115005.12522137.html.plaintext.txt	73	After 48 h transfection cells harvested luciferase assays performed using Dual Luciferase kit Promega
0.40115005.12522137.html.plaintext.txt	74	The HBV transfection experiment carried described previously 8
0.40115005.12522137.html.plaintext.txt	75	Primer Extension Assay The primer map C gene transcripts 5 GGTGAGCAATGCTCAGGAGACTCTAAGG 3 corresponds coordinates 2024 2051 HBV genomic sequence
0.40115005.12522137.html.plaintext.txt	76	The reaction performed previously described 32
0.40115005.12522137.html.plaintext.txt	77	Briefly The HBV DNA pWTD containing wild type HBV genome adw2 co transfected nuclear receptors Huh7 hepatoma cells using calcium phosphate precipitation method
0.40115005.12522137.html.plaintext.txt	78	The pXGH vector served internal control normalization transfection efficiency
0.40115005.12522137.html.plaintext.txt	79	After 48 h transfection RNA isolated primer extension assay 32
0.40115005.12522137.html.plaintext.txt	80	GST Pull Assay The GST TR4 fusion protein GST protein purified glutathione Sepharose beads according manufacturers instructions Amersham Biosciences
0.40115005.12522137.html.plaintext.txt	81	HNF4 synthesized using vitro TNT translation system Promega presence 35Smethionine 5 microl HNF4 protein incubated GST TR4 TR4 N DBD TR4 LBD GST beads GST pull assay described previously 22
0.40115005.12522137.html.plaintext.txt	82	Co immunoprecipitation TR4 HNF4 Proteins COS1 cells cultured Dulbeccos modified Eagles medium co transfected 10 microg pCMX TR4 either 10 microg pCDNAI pCDNAI HNF4
0.40115005.12522137.html.plaintext.txt	83	48 h transfection cells lysed immunoprecipitation buffer 10 mM Tris HCl pH 7
0.40115005.12522137.html.plaintext.txt	84	5 Nonidet P 40 containing 1 microgml protease inhibitors Roche Molecular Biochemicals ice 30 min
0.40115005.12522137.html.plaintext.txt	85	The cellular lysates centrifuged 12000 x g 10 min
0.40115005.12522137.html.plaintext.txt	86	The protein concentration measured using Bradford reagent Bio Rad 500 microg protein precleared using protein AG Sepharose beads Santa Cruz Biotechnology mixture immunoprecipitated either anti TR4 monoclonal antibody normal mouse IgG 1100 4 degrees C overnight
0.40115005.12522137.html.plaintext.txt	87	Protein AG beads added protein lysates rotated 4 degrees C another hour
0.40115005.12522137.html.plaintext.txt	88	The immunocomplexes bound beads pelleted washed immunoprecipitation buffer three times subjected SDS PAGE Western blot analysis using goat anti HNF4 polyclonal antibody Santa Cruz Biotechnology
0.40115005.12522137.html.plaintext.txt	89	The results visualized enhanced chemiluminescence ECL
0.40115005.12522137.html.plaintext.txt	90	The blot stripped 62
0.40115005.12522137.html.plaintext.txt	91	8 2 SDS 65 degrees C 30 min blotted anti TR4 monoclonal antibody
0.40115005.12522137.html.plaintext.txt	92	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.40115005.12522137.html.plaintext.txt	93	TR4 Protein Binds Specifically TR4RE HBV Consensus Site HBV Core Promoter Previous studies showed activity HBV core promoter could differentially regulated RXR PPAR via recognizing consensus binding sites HBV core promoter 13 14
0.40115005.12522137.html.plaintext.txt	94	Our previous data also showed TR4 better affinity RXR recognize DR1 HRE promoter cellular retinol binding protein II gene 21
0.40115005.12522137.html.plaintext.txt	95	To examine whether TR4 bind potential DR1 HRE named TR4RE HBV nucleotide coordinates 1751 1778 HBV ayw DNA sequence HBV core promoter 13 electrophoretic mobility shift assay EMSA performed vitro translated TR4 protein using radiolabeled TR4RE HBV oligonucleotides probes
0.40115005.12522137.html.plaintext.txt	96	1 specific supershift complex seen anti TR4 monoclonal antibody using mock lysates Fig
0.40115005.12522137.html.plaintext.txt	97	In contrast TR4 CpFL supershift complex observed presence anti TR4 antibody using vitro translated TR4 lysates lanes 3 4
0.40115005.12522137.html.plaintext.txt	98	Moreover replaced wild type TR4RE HBV various mutants found TR4 could bind specifically wild type TR4RE HBV mutated TR4RE HBVs except M3 mutant marginal binding lanes 5 10
0.40115005.12522137.html.plaintext.txt	99	The M1 double mutant nucleotides changed A T 1765 G A 1767 represents HBV mutant frequently found patients chronic hepatitis 33
0.40115005.12522137.html.plaintext.txt	100	TR4 able bind M1 M2 mutants lanes 5 6 indicating second mutated nucleotide DR1 AGGTCA motif essential TR4 binding TR4RE HBV
0.40115005.12522137.html.plaintext.txt	101	In addition TR4 specific antibody supershift TR4 TR4RE HBV complex lane 4 binding reduced presence 100 fold unlabeled TR4RE HBV probe probe androgen response element probes TR4RE HBV mutant probes lanes 11 15 suggesting binding TR4 TR4RE HBV specific
0.40115005.12522137.html.plaintext.txt	102	View larger version 65K Fig
0.40115005.12522137.html.plaintext.txt	103	TR4 binds CpFL element HBV core promoter vitro
0.40115005.12522137.html.plaintext.txt	104	TR4 proteins vitro synthesized TNT reticulocyte lysates Promega incubated CpFL CpFL mutant probes 30 min presence absence anti TR4 monoclonal antibody various 100 fold unlabeled probes indicated
0.40115005.12522137.html.plaintext.txt	105	The reaction mixtures resolved 5 acrylamide native gel results visualized autoradiography
0.40115005.12522137.html.plaintext.txt	106	ARE denotes androgen response element
0.40115005.12522137.html.plaintext.txt	107	To examine whether endogenous TR4 protein interact TR4RE HBV nuclear extracts isolated human HepG2 cells used EMSA
0.40115005.12522137.html.plaintext.txt	108	2 supershift complex seen nuclear extracts incubated double mutant M1 probe presence anti TR4 antibody Fig
0.40115005.12522137.html.plaintext.txt	109	The wild type TR4RE HBV probe clearly binds TR4 indicated TR4 TR4RE HBV antibody supershift complex lanes 3 4
0.40115005.12522137.html.plaintext.txt	110	This result shows TR4 protein present liver cells interacts TR4RE HBV suggesting interaction may play role regulating HBV core promoter activity
0.40115005.12522137.html.plaintext.txt	111	View larger version 34K Fig
0.40115005.12522137.html.plaintext.txt	112	The nuclear orphan receptor TR4 endogenous DR 1 binding protein HepG2 cells
0.40115005.12522137.html.plaintext.txt	113	The CpFL probe containing DR 1 site nucleotide coordinates 1751 1780 M1 mutant probe incubated 10 microg protein nuclear extracts isolated HepG2 cells
0.40115005.12522137.html.plaintext.txt	114	The EMSA reaction carried room temperature 30 min presence absence anti TR4 anti HNF4 antibody
0.40115005.12522137.html.plaintext.txt	115	The reaction complexes analyzed 5 acrylamide 0
0.40115005.12522137.html.plaintext.txt	116	25 x TBE gels results visualized autoradiography
0.40115005.12522137.html.plaintext.txt	117	TR4 Enhances Activity Luciferase Reporter Linked TR4RE HBV Liver HepG2 Non liver H1299 Cells Our previous data showed DR1 consensus sequence RXRE promoter cellular retinol binding protein II could recognized suppressed TR4 21
0.40115005.12522137.html.plaintext.txt	118	We interested determining whether binding TR4 TR4RE HBV could also allow TR4 regulate HBV core promoter activity
0.40115005.12522137.html.plaintext.txt	119	A reporter construct containing four synthetic copies TR4RE HBV CpFL4Luc including HNF4 consensus binding site used determine role TR4 13
0.40115005.12522137.html.plaintext.txt	120	CpFL4 plasmids co transfected either parental vector TR4 expression vector liver HepG2 HepG2
0.40115005.12522137.html.plaintext.txt	121	TR4 transactivate CpFL4Luc activity dose dependent fashion HepG2 HepG2
0.40115005.12522137.html.plaintext.txt	122	To confirm increase reporter activity due nonspecific activation TR4 also used TR4 deletion mutants VDR reporter assay
0.40115005.12522137.html.plaintext.txt	123	3 A C activity reporter induced presence full length functional TR4 VDR presence TR4 mutants lacking C terminus N terminus suggesting CpFL TR4RE HBV elements core HBV promoter may sufficient TR4 regulate HBV core promoter activity
0.40115005.12522137.html.plaintext.txt	124	View larger version 25K Fig
0.40115005.12522137.html.plaintext.txt	125	Effects TR4 reporter containing CpFLDR1 element HBV core promoter
0.40115005.12522137.html.plaintext.txt	126	A HepG2 cells co transfected 500 ng CpFL4Luc reporter increasing amounts TR4 VDR 100 200 400 ng
0.40115005.12522137.html.plaintext.txt	127	The cells VDR transfection treated 100 nM vitamin D 24 h harvested luciferase assay
0.40115005.12522137.html.plaintext.txt	128	The luciferase assay performed described Experimental Procedures
0.40115005.12522137.html.plaintext.txt	129	1 cells transfected CpFL4Luc TR4 VDR treated harvested A
0.40115005.12522137.html.plaintext.txt	130	C D HepG2 cells H1299 cells co transfected CpFL4 Luc full length TR4 NC terminal deletion TR4 TR4delN TR4delC
0.40115005.12522137.html.plaintext.txt	131	The reporter assay carried described A
0.40115005.12522137.html.plaintext.txt	132	Data represent means plus minus S
0.40115005.12522137.html.plaintext.txt	133	three independent experiments
0.40115005.12522137.html.plaintext.txt	134	TR4 Directly Suppresses HBV Core Promoter Activity TR4RE HBV Site The EMSA reporter assay CpFL4Luc suggest TR4 may significant role transcriptional regulation HBV core promoter
0.40115005.12522137.html.plaintext.txt	135	However functional role TR4 synthetic promoter context necessarily reveal TR4 action natural HBV core promoter context
0.40115005.12522137.html.plaintext.txt	136	We therefore examined effects TR4 reporter construct containing whole context HBV genome sequence CpLuc 13
0.40115005.12522137.html.plaintext.txt	137	Unexpectedly TR4 suppressed CpLuc reporter activity HepG2 cells Fig
0.40115005.12522137.html.plaintext.txt	138	In contrast co transfection another nuclear receptor HNF4 induced CpLuc reporter activity consistent earlier report 13
0.40115005.12522137.html.plaintext.txt	139	To confirm suppression mediated TR4 binding TR4RE HBV HBV core promoter also used CpM2Luc containing mutated TR4RE HBV analyze TR4 suppression 13
0.40115005.12522137.html.plaintext.txt	140	4B TR4 suppression reporter activity abolished mutation TR4RE HBV site
0.40115005.12522137.html.plaintext.txt	141	In contrast HNF4 able induce mutant CpM2Luc reporter activity possibly due presence another functionally intact HNF4 binding site lane 4 versus 6 13 34
0.40115005.12522137.html.plaintext.txt	142	View larger version 20K Fig
0.40115005.12522137.html.plaintext.txt	143	TR4 represses HBV core promoter activity
0.40115005.12522137.html.plaintext.txt	144	A HepG2 cells co transfected 750 ng CpLuc 250 ng TR4 HNF4 vectors combination two nuclear receptors
0.40115005.12522137.html.plaintext.txt	145	The luciferase activity measured 48 h transfection
0.40115005.12522137.html.plaintext.txt	146	B reporters CpLuc 750 ng CpM2Luc co transfected TR4 250 ng HNF4 250 ng indicated harvested luciferase activity 48 h transfection
0.40115005.12522137.html.plaintext.txt	147	Data represent mean plus minus S
0.40115005.12522137.html.plaintext.txt	148	three independent experiments
0.40115005.12522137.html.plaintext.txt	149	PSp Sp Xp Cp represent promoters genes encoding HBV surface antigen X protein coree antigens respectively
0.40115005.12522137.html.plaintext.txt	150	Because responsiveness HBV core promoter TR4 abrogated mutation possible TR4 mediated suppression HBV core promoter mainly dependent upon binding TR4 TR4RE HBV
0.40115005.12522137.html.plaintext.txt	151	Because earlier reports current data show TR4 HNF4 bind TR4RE HBV site overlapped HNF4 consensus binding site 13 postulated TR4 may exert repressive effects core promoter competition nuclear receptors HNF4 binding TR4RE HBV
0.40115005.12522137.html.plaintext.txt	152	We therefore examined potential mutual influence HBV core promoter
0.40115005.12522137.html.plaintext.txt	153	When co transfected equal amounts HNF4 TR4 CpLuc reporter HepG2 hepatoma cells TR4 repressed HNF4 induced HBV core promoter activity Fig
0.40115005.12522137.html.plaintext.txt	154	4A column 3 versus 4 suggesting HNF4 TR4 may compete consensus binding site HBV core promoter
0.40115005.12522137.html.plaintext.txt	155	Similar suppression HNF4 mediated transactivation also occurred used another reporter containing HNF4 binding site found HBV enhancer IX promoter overlapped enhancer I XpHNF4Luc HBV coordinates 1133 1159 data shown 13
0.40115005.12522137.html.plaintext.txt	156	Using EMSA vitro translated TR4 HNF4 presence 32PTR4RE HBV also found binding 32PTR4RE HBV TR4 protein suppressed addition HNF4 Fig
0.40115005.12522137.html.plaintext.txt	157	5 demonstrates TR4 HNF4 bind TR4RE HBV site DNA binding activity TR4 markedly reduced presence HNF4
0.40115005.12522137.html.plaintext.txt	158	In contrast observe change HNF4 binding added TR4 implying simple competition may fully account TR4 mediated repression HNF4 function
0.40115005.12522137.html.plaintext.txt	159	This raises possibility TR4 may directly block HNF4 transactivation protein protein interactions HNF4 instead competing DNA binding sites
0.40115005.12522137.html.plaintext.txt	160	4 5 suggest TR4 bind TR4RE HBV site well interact HNF4 influence HBV core promoter expression
0.40115005.12522137.html.plaintext.txt	161	View larger version 57K Fig
0.40115005.12522137.html.plaintext.txt	162	HNF4 suppresses TR4 binding CpFL element HBV core promoter vitro
0.40115005.12522137.html.plaintext.txt	163	TR4 HNF4 proteins vitro synthesized TNT reticulocyte lysates Promega
0.40115005.12522137.html.plaintext.txt	164	1 microl TR4 protein incubated CpFL probes 15 min EMSA reaction buffer 10 mM Hepes pH 7
0.40115005.12522137.html.plaintext.txt	165	96 vv glycerol 2 vv Ficoll 100 mM KCl 0
0.40115005.12522137.html.plaintext.txt	166	5 mM MgCl2 1 mM dithiothreitol presence absence HNF4 protein
0.40115005.12522137.html.plaintext.txt	167	The reaction mixtures resolved 5 acrylamide native gel results visualized autoradiography
0.40115005.12522137.html.plaintext.txt	168	The double asterisks indicate repression TR4 DNA HNF4
0.40115005.12522137.html.plaintext.txt	169	Interaction HNF4 TR4 The data shown suggest TR4 may regulate transcriptional activity HNF4 mechanism independent competition DNA binding
0.40115005.12522137.html.plaintext.txt	170	To prove hypothesis constructed plasmid encoding GAL4 HNF4 fusion protein examined effect TR4 expression HNF4 mediated transactivation GAL4 one hybrid system 35
0.40115005.12522137.html.plaintext.txt	171	In assay transcriptional activity GAL4 HNF4 independent binding HNF4 TR4 cognate binding site DR1 HRE
0.40115005.12522137.html.plaintext.txt	172	If TR4 directly regulate HNF4 transcriptional activity see activity GAL4 HNF4 would significantly changed presence TR4 expression
0.40115005.12522137.html.plaintext.txt	173	HepG2 cells co transfected GAL4 HN4 pG4LUC reporter presence absence expression TR4 N C terminal deletion TR4 mutants
0.40115005.12522137.html.plaintext.txt	174	6A reporter activity GAL HNF4 alone increased 3 fold similarly shown previous study 35
0.40115005.12522137.html.plaintext.txt	175	Interestingly expression TR4 significantly increased GAL4 HNF4 mediated transcriptional activation Fig
0.40115005.12522137.html.plaintext.txt	176	6A indicating TR4 directly regulate transcriptional activity HNF4 independent event DNA binding possibly mediated protein protein interactions
0.40115005.12522137.html.plaintext.txt	177	As expected PG4LUC reporter activity GAL4 TR4 increased significant level Fig
0.40115005.12522137.html.plaintext.txt	178	6A columns 1 versus 6 suggesting TR4 influences HNF4 transcriptional activity specific manner
0.40115005.12522137.html.plaintext.txt	179	Nevertheless clear regulation involving interaction TR4 HNF4 would result either activation suppression HNF4 function
0.40115005.12522137.html.plaintext.txt	180	In contrast N C terminal deletion TR4 mutants show effects GAL4 HNF4 mediated transactivation suggesting two regions TR4 protein may required TR4 action regulation
0.40115005.12522137.html.plaintext.txt	181	View larger version 30K Fig
0.40115005.12522137.html.plaintext.txt	182	Interaction TR4 HNF4
0.40115005.12522137.html.plaintext.txt	183	A diagrammatic representation GAL4 hybrid assay
0.40115005.12522137.html.plaintext.txt	184	This assay used test effect TR4 HNF4 mediated transcriptional activity
0.40115005.12522137.html.plaintext.txt	185	HepG2 cells co transfected PG4LUC contains four tandem repeats GAL4 binding sites GAL4 HNF4 TR4 TR4 deletion mutants
0.40115005.12522137.html.plaintext.txt	186	B vitro synthesized 35Smethionine labeled HNF4 protein incubated GST GST TR4 GST TR4 N DBD GST TR4 LBD fusion protein bound glutathione Sepharose beads
0.40115005.12522137.html.plaintext.txt	187	The beads extensively washed reaction applied 12 SDS PAGE followed autoradiography
0.40115005.12522137.html.plaintext.txt	188	C COS1 cells transfected pCMX TR4 either parental vector pCDNAI HNF4
0.40115005.12522137.html.plaintext.txt	189	After transfection cells cultured 48 h lysed immunoprecipitation assay HNF4 signal detected Western blotting goat anti HNF4 antibody
0.40115005.12522137.html.plaintext.txt	190	The results visualized enhanced chemiluminescence ECL
0.40115005.12522137.html.plaintext.txt	191	Then blot stripped blotted anti TR4 monoclonal antibody
0.40115005.12522137.html.plaintext.txt	192	D HepG2 cells transfected CpLUC HNF4 TR4 TR4 deletion mutants described Fig
0.40115005.12522137.html.plaintext.txt	193	Next hypothesized TR4 may directly regulate HNF4 transcriptional activity interacting HNF4
0.40115005.12522137.html.plaintext.txt	194	To test hypothesis applied GST pull assay determine potential interaction HNF4 TR4
0.40115005.12522137.html.plaintext.txt	195	6B HNF4 protein pulled detected SDS PAGE mixture 35S labeled vitro translated HNF4 protein incubated GST TR4 GST TR4 N DBD GST TR4 LBD fusion protein immobilized glutathione linked Sepharose beads
0.40115005.12522137.html.plaintext.txt	196	6B lane 3 clearly demonstrated HNF4 interacts TR4 vitro
0.40115005.12522137.html.plaintext.txt	197	However interaction deletion mutants GST TR4 fusion protein HNF4 much weaker suggesting instead direct competition binding TR4RE HBV TR4 may interact HNF4 could possibly result repression HNF4 function
0.40115005.12522137.html.plaintext.txt	198	To confirm interaction liver cells co transfected TR4 HNF4 COS1 cells used co immunoprecipitation assay immunoprecipitate TR4 HNF4 complex anti TR4 monoclonal antibody
0.40115005.12522137.html.plaintext.txt	199	6C lane 4 clearly observe HNF4 bands precipitated complex Western blotting co expressing TR4 HNF4 proteins COS1 cells
0.40115005.12522137.html.plaintext.txt	200	This result suggests TR4 bind HNF4
0.40115005.12522137.html.plaintext.txt	201	In summary results presented demonstrate TR4 capable regulating HNF4 transcriptional activity interacting HNF4
0.40115005.12522137.html.plaintext.txt	202	Also full length TR4 essential regulation
0.40115005.12522137.html.plaintext.txt	203	We compared effects TR4 HNF4 mediated transactivation CpLUC reporter deletion mutants TR4 HepG2 cells using transient transfection assay Fig
0.40115005.12522137.html.plaintext.txt	204	As expected similar result shown Fig
0.40115005.12522137.html.plaintext.txt	205	4A TR4 suppresses HNF4 mediated transactivation Fig
0.40115005.12522137.html.plaintext.txt	206	However N C terminal deletion TR4 exhibit similarly suppressive effects full length TR4 column 4 versus 7 8 implying two domains essential protein protein interaction TR4 HNF4 interaction required repressive action TR4 transcriptional activity HNF4
0.40115005.12522137.html.plaintext.txt	207	Suppression HBV Pre core Core mRNA Expression TR4 To confirm suppression HBV core promoter activity TR4 applied primer extension assay see TR4 also influence mRNA expression two HBV transcripts HBV core promoter
0.40115005.12522137.html.plaintext.txt	208	The first transcript pre C mRNA precursor HBeAg transcript C mRNA serving template reverse transcription 6 36
0.40115005.12522137.html.plaintext.txt	209	HBV RNA extracted Huh 7 co transfection TR4 HBV vectors mapped radiolabeled HBV primer position 2024 2051 HBV genome 8
0.40115005.12522137.html.plaintext.txt	210	7 expression pre C C mRNAs decreased presence TR4
0.40115005.12522137.html.plaintext.txt	211	This result therefore confirms reporter assays showing TR4 suppress HBV core promoter transcription via binding TR4RE HBV site HBV core promoter
0.40115005.12522137.html.plaintext.txt	212	View larger version 27K Fig
0.40115005.12522137.html.plaintext.txt	213	Primer extension analysis effect TR4 HBV pre core core RNA expression
0.40115005.12522137.html.plaintext.txt	214	HBV RNA isolated Huh 7 cells transfected HBV DNA TR4 parental vector TR4 indicated analyzed primer extension assay described Experimental Procedures
0.40115005.12522137.html.plaintext.txt	215	Briefly products primer extension subjected electrophoresis 8 sequencing gel
0.40115005.12522137.html.plaintext.txt	216	The locations core pre core human growth hormone hGH RNA indicated
0.40115005.12522137.html.plaintext.txt	217	The hGH served internal control
0.40115005.12522137.html.plaintext.txt	218	The results visualized autoradiography quantified Sigma scan software
0.40115005.12522137.html.plaintext.txt	219	The value quantification represents three independent experiments
0.40115005.12522137.html.plaintext.txt	220	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.40115005.12522137.html.plaintext.txt	221	Earlier studies identified two consensus DR1 binding sites nuclear receptors HBV promoter
0.40115005.12522137.html.plaintext.txt	222	One site TGAACCTTTACCC nucleotide coordinates 1138 1150 located core domain enhancer I recognized HNF4 COUP TF1 RXR PPAR 37
0.40115005.12522137.html.plaintext.txt	223	The site AGGTTAAAGGTCT nucleotide coordinates 1757 1769 located core promoter recognized HNF4 TR4 described current studies 13
0.40115005.12522137.html.plaintext.txt	224	The detailed mechanisms nuclear receptors modulate HBV gene expression via two DR1 sites remain unclear
0.40115005.12522137.html.plaintext.txt	225	Our data strongly suggest TR4 preferentially binds DR1 site core promoter TR4 suppression abrogated site mutated Fig
0.40115005.12522137.html.plaintext.txt	226	The selective binding TR4 2nd DR1 site may key step TR4 prevent nuclear receptors binding site thereby repressing transcription
0.40115005.12522137.html.plaintext.txt	227	However cannot rule possibility TR4 may also regulate HBV gene expression DR1 site enhancer I data indicate TR4 recognize site data shown
0.40115005.12522137.html.plaintext.txt	228	Moreover TR4 binding 2nd DR1 site prevented two mutations 1756 A T 1767 G A frequently found patients chronic hepatitis one may speculate HBV may utilize two mutations escape suppression mediated TR4 andor transcriptional repressors
0.40115005.12522137.html.plaintext.txt	229	Alternatively creation new mutations consensus DR1 sites may able increase opportunity modulators regulate HBV expression via mutated DR1 sites 32
0.40115005.12522137.html.plaintext.txt	230	TR4 highly homologous another orphan receptor TR2 15
0.40115005.12522137.html.plaintext.txt	231	Earlier studies indicated TR2 TR4 could modulate expression set genes binding HREs 19 38
0.40115005.12522137.html.plaintext.txt	232	14 reported TR2 could repress pre C RNA C RNA expression
0.40115005.12522137.html.plaintext.txt	233	Our current data show TR4 repress pre C RNA C RNA expression
0.40115005.12522137.html.plaintext.txt	234	Moreover compared marginal suppression TR2 CpLuc reporter activity TR4 much stronger suppressive effect CpLuc reporter activity data shown suggesting TR4 may play significant role regulation
0.40115005.12522137.html.plaintext.txt	235	Also data suggest simple competition binding DR1 site two nuclear receptors may fully account distinct regulation HBV core gene expression nuclear receptors regulate target genes binding DR sites 19 38
0.40115005.12522137.html.plaintext.txt	236	The detailed mechanisms underlying distinct regulation HBV gene expression two closely related orphan receptors remain unclear
0.40115005.12522137.html.plaintext.txt	237	The interaction TR4 HNF4 suggests TR4 affects HBV gene expression multiple levels importantly including DNA binding protein protein interactions
0.40115005.12522137.html.plaintext.txt	238	Nevertheless previous reports also suggested COUP TF could differentially modulate target gene expression via similar HREs
0.40115005.12522137.html.plaintext.txt	239	For example COUP TF1 induce 7 hydroxylase promoter activity via DR4 binding site repress myosin heavy chain promoter activity via similar DR4 binding site 39
0.40115005.12522137.html.plaintext.txt	240	Similar differential modulation target gene expression also occurred TR4 via binding similar DR1 binding sites 21 23
0.40115005.12522137.html.plaintext.txt	241	The contrasting effects TR4 synthetic TR4RE HBV versus entire HBV promoter Fig
0.40115005.12522137.html.plaintext.txt	242	3 versus 4 suggest promoter context especially sequences TR4RE HBV may also play important roles TR4 modulate HBV core promoter activity
0.40115005.12522137.html.plaintext.txt	243	It possible sequences flanking TR4RE HBV may recruit one repressors cooperate TR4 form protein complex repress HBV core promoter
0.40115005.12522137.html.plaintext.txt	244	In addition examined effects TR4 HBV core promoter activity non liver cells found TR4 able induce luciferase activity Cpluc reporter H1299 cells data shown
0.40115005.12522137.html.plaintext.txt	245	This interesting finding implies cellular factors liver cells may modulate transcriptional activity TR4 regulation HBV core promoter
0.40115005.12522137.html.plaintext.txt	246	However detailed mechanisms distinct regulation TR4 remain unclear
0.40115005.12522137.html.plaintext.txt	247	TR4 may modulate target gene expression via two distinct mechanisms
0.40115005.12522137.html.plaintext.txt	248	First TR4 suppress target gene expression via competition nuclear receptors RXR DR1 VDR DR3 retinoic acid receptor DR5 consensus HRE sites 21 22
0.40115005.12522137.html.plaintext.txt	249	Previous studies showed ligand activated RXRPPAR PPAR increase HBV core promoter activity TR4RE HBV site DR1 13 14
0.40115005.12522137.html.plaintext.txt	250	Therefore appears TR4 may compete binding site nuclear receptors resulting repression HBV core promoter activity regulation involve interaction TR4 nuclear receptors 21 22
0.40115005.12522137.html.plaintext.txt	251	Second TR4 also modulate gene expression via protein protein interactions nuclear receptors
0.40115005.12522137.html.plaintext.txt	252	For example TR4 suppress androgen target genes interactions androgen receptor 40
0.40115005.12522137.html.plaintext.txt	253	In current study found TR4 cannot bind DR1 site HBV core promoter HNF4 Fig
0.40115005.12522137.html.plaintext.txt	254	5 also interact HNF4 Fig
0.40115005.12522137.html.plaintext.txt	255	The TR4 mediated repression resulted interaction confirmed using TR4 deletion mutants several parallel experiments may support might multiple mechanisms TR4 proceeds repressive regulation
0.40115005.12522137.html.plaintext.txt	256	Previous studies showed TR2 close member TR4 family RIP140 receptor interacting protein 140 one TR4 interacting proteins interact recruit histone deacetylases gene silencing 22 41 42
0.40115005.12522137.html.plaintext.txt	257	It possible TR4 may carry repression similar mechanisms would interesting direction future study test involvement histone deacetylases regulation
0.40115005.12522137.html.plaintext.txt	258	On hand HBV infected liver cells repressive function TR4 may unfavorable HBV replication core promoter controls transcription template C RNA viral DNA synthesis
0.40115005.12522137.html.plaintext.txt	259	We speculate functional association TR4 HNF4 could unique way relieve TR4 mediated repression HNF reduce TR4 binding DR1 site either competition DNA binding protein protein interactions Fig
0.40115005.12522137.html.plaintext.txt	260	The underlying mechanisms nuclear receptors differentially influence transcription activation HBV genes infection require extensive study
0.40115005.12522137.html.plaintext.txt	261	8 TR4 directly bind TR4RE HBV therefore prevent nuclear receptors activating HBV core promoter
0.40115005.12522137.html.plaintext.txt	262	Alternatively TR4 interact nuclear receptors HNF4 form inactive protein complex
0.40115005.12522137.html.plaintext.txt	263	Either two activities may result suppression HBV core promoter
0.40115005.12522137.html.plaintext.txt	264	View larger version 18K Fig
0.40115005.12522137.html.plaintext.txt	265	Schematic diagram regulation HBV core promoter TR4 DR1 TR4RE HBV site
0.40115005.12522137.html.plaintext.txt	266	This figure depicts simple model HBV core promoter regulation promoter via TR4RE HBV TR4
0.40115005.12522137.html.plaintext.txt	267	A The binding TR4 TR4RE may restrict accessibility site essential nuclear receptors transcriptional activation
0.40115005.12522137.html.plaintext.txt	268	Also interaction HNF4 TR4 inhibits HNF4 transcriptional activity results suppression HBV core promoter activity
0.40115005.12522137.html.plaintext.txt	269	B natural infection unknown mechanism interaction HNF4 2R4 may prevent TR4 binding DR1 site Fig
0.40115005.12522137.html.plaintext.txt	270	Therefore regulation relieve TR4 mediated repression allow HNF4 nuclear receptors proceed transcriptional activation
0.40115005.12522137.html.plaintext.txt	271	In conclusion study provides evidence TR4 transcriptional repressor HBV core promoter
0.40115005.12522137.html.plaintext.txt	272	The interaction TR4 HNF4 extends scope nuclear receptor regulation HBV core promoter
0.40115005.12522137.html.plaintext.txt	273	The transcriptional activation core promoter key step initiate life cycle HBV infection 34
0.40115005.12522137.html.plaintext.txt	274	By identifying physiological ligands TR4 may able control agonist antagonist binding TR4 modulate HBV gene expression may provide novel strategy develop anti HBV drugs
0.40115005.12522137.html.plaintext.txt	275	Alan McLachlan HBV reporter plasmids Dr
0.40115005.12522137.html.plaintext.txt	276	Margarita Hadzopoulou Cladaras HNF4 plasmid Dr
0.40115005.12522137.html.plaintext.txt	277	Kung Liang Guan pG4LUC
0.40115005.12522137.html.plaintext.txt	278	We grateful Karen Wolf Erik R
0.40115005.12522137.html.plaintext.txt	279	Sampson preparation manuscript
0.40115005.12522137.html.plaintext.txt	280	This work supported National Institutes Health Grants DK56984 DK47258 C
0.40115005.12522137.html.plaintext.txt	281	The costs publication article defrayed part payment page charges
0.40115005.12522137.html.plaintext.txt	282	The article must therefore hereby marked advertisement accordance 18 U
0.40115005.12522137.html.plaintext.txt	283	Section 1734 solely indicate fact
0.40115005.12522137.html.plaintext.txt	284	Both authors contributed equally work
0.40115005.12522137.html.plaintext.txt	285	To correspondence addressed George Whipple Lab Cancer Research Departments Pathology Urology Radiation Oncology Cancer Center University Rochester Medical Center 601 Elmwood Ave
0.40115005.12522137.html.plaintext.txt	286	585 273 4500 Fax 585 756 4133 E mail changurmc
0.40115005.12522137.html.plaintext.txt	287	Published JBC Papers Press January 8 2003 DOI 10
0.40115005.12522137.html.plaintext.txt	288	The abbreviations used HBV hepatitis B virus TR4 testicular receptor 4 HNF4 hepatocyte nuclear factor 4 DR direct repeat RXR retinoid X receptor PPAR peroxisome proliferator activated receptor TR2 testicular receptor 2 C mRNA core mRNA pre C mRNA pre core mRNA C core HRE hormone response element COUP TF1 chicken ovalbumin upstream promoter transcription factor 1 VDR vitamin D receptor DBD DNA binding domain LBD ligand binding domain EMSA electrophoretic mobility shift assay GST glutathione S transferase
0.40115005.12522137.html.plaintext.txt	289	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1
0.40115005.12522137.html.plaintext.txt	290	56 651 693CrossRefMedline Order article via Infotrieve 2
0.40115005.12522137.html.plaintext.txt	291	1985 Nature 317 489 495Medline Order article via Infotrieve 3
0.40115005.12522137.html.plaintext.txt	292	6 311 325Medline Order article via Infotrieve 4
0.40115005.12522137.html.plaintext.txt	293	1989 Cell 59 1145 1156Medline Order article via Infotrieve 5
0.40115005.12522137.html.plaintext.txt	294	168 21 39Medline Order article via Infotrieve 6
0.40115005.12522137.html.plaintext.txt	295	61 3109 3113Medline Order article via Infotrieve 7
0.40115005.12522137.html.plaintext.txt	296	75 8400 8406AbstractFree Full Text 9
0.40115005.12522137.html.plaintext.txt	297	1999 Cell 97 161 163Medline Order article via Infotrieve 18
0.40115005.12522137.html.plaintext.txt	298	19 207 226AbstractFree Full Text 19
0.40115005.12522137.html.plaintext.txt	299	272 3109 3116AbstractFree Full Text 20
0.40115005.12522137.html.plaintext.txt	300	272 12215 12220AbstractFree Full Text 21
0.40115005.12522137.html.plaintext.txt	301	273 13437 13443AbstractFree Full Text 22
0.40115005.12522137.html.plaintext.txt	302	274 16198 16205AbstractFree Full Text 23
0.40115005.12522137.html.plaintext.txt	303	273 10948 10957AbstractFree Full Text 24
0.40115005.12522137.html.plaintext.txt	304	Acta 1302 93 109Medline Order article via Infotrieve 26
0.40115005.12522137.html.plaintext.txt	305	270 30129 30133AbstractFree Full Text 28
0.40115005.12522137.html.plaintext.txt	306	6 491 511Medline Order article via Infotrieve 29
0.40115005.12522137.html.plaintext.txt	307	277 14622 14628AbstractFree Full Text 30
0.40115005.12522137.html.plaintext.txt	308	19 2499Medline Order article via Infotrieve 31
0.40115005.12522137.html.plaintext.txt	309	64 2360 2368Medline Order article via Infotrieve 32
0.40115005.12522137.html.plaintext.txt	310	73 1239 1244AbstractFree Full Text 33
0.40115005.12522137.html.plaintext.txt	311	75 8937 8948AbstractFree Full Text 35
0.40115005.12522137.html.plaintext.txt	312	272 539 550AbstractFree Full Text 36
0.40115005.12522137.html.plaintext.txt	313	189 195 200CrossRefMedline Order article via Infotrieve 39
0.40115005.12522137.html.plaintext.txt	314	268 4152 4160AbstractFree Full Text 40
0.40115005.12522137.html.plaintext.txt	315	96 14724 14729AbstractFree Full Text 41
0.40115005.12522137.html.plaintext.txt	316	15 1318 1328AbstractFree Full Text 42
0.40115005.12522137.html.plaintext.txt	317	275 40782 40787AbstractFree Full Text
0.40115005.12522137.html.plaintext.txt	318	Copyright 2003 The American Society Biochemistry Molecular Biology Inc
0.40663978.15331348.html.plaintext.txt	0	Mechanism rifampicin pregnane X receptor inhibition human cholesterol 7 hydroxylase gene transcription Tiangang Li John Y
0.40663978.15331348.html.plaintext.txt	1	Department Biochemistry Molecular Pathology Northeastern Ohio University College Medicine Rootstown Ohio
0.40663978.15331348.html.plaintext.txt	2	Submitted 14 June 2004 accepted final form 25 August 2004
0.40663978.15331348.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES Bile acids steroids drugs activate steroid xenobiotic receptor pregnane X receptor PXR NR1I2 induces human cytochrome P4503A4 CYP3A4 drug metabolism cholesterol 7 hydroxylase CYP7A1 bile acid synthesis liver
0.40663978.15331348.html.plaintext.txt	4	Rifampicin human PXR agonist inhibits bile acid synthesis used treat cholestatic diseases
0.40663978.15331348.html.plaintext.txt	5	The objective study elucidate mechanism PXR inhibits CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	6	The mRNA expression levels CYP7A1 several nuclear receptors known regulate CYP7A1 gene assayed human primary hepatocytes quantitative real time PCR Q PCR
0.40663978.15331348.html.plaintext.txt	7	Rifampicin reduced CYP7A1 small heterodimer partner SHP NR02B mRNA expression suggesting SHP involved PXR inhibition CYP7A1
0.40663978.15331348.html.plaintext.txt	8	Rifampicin inhibited CYP7A1 reporter activity PXR binding site localized bile acid response element I
0.40663978.15331348.html.plaintext.txt	9	Mammalian two hybrid assays revealed PXR interacted hepatic nuclear factor 4 HNF4 NR2A1 rifampicin required
0.40663978.15331348.html.plaintext.txt	10	Coimmunoprecipitation assay confirmed PXR interaction HNF4
0.40663978.15331348.html.plaintext.txt	11	PXR also interacted peroxisome proliferator activated receptor coactivator PGC 1 interacted HNF4 induced CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	12	Rifampicin enhanced PXR interaction HNF4 reduced PGC 1 interaction HNF4
0.40663978.15331348.html.plaintext.txt	13	Chromatin immunoprecipitation assay showed PXR HNF4 PGC 1 bound CYP7A1 chromatin rifampicin dissociated PGC 1 chromatin
0.40663978.15331348.html.plaintext.txt	14	These results suggest activation PXR rifampicin promotes PXR interaction HNF4 blocks PGC 1 activation HNF4 results inhibition CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	15	Rifampicin inhibition bile acid synthesis may protective mechanism drug bile acid induced cholestasis
0.40663978.15331348.html.plaintext.txt	16	bile acid synthesis gene regulation nuclear receptors peroxisome proliferator activated receptor coactivator
0.40663978.15331348.html.plaintext.txt	17	BILE ACID FEEDBACK INHIBITS bile acid synthesis inhibiting transcription cholesterol 7 hydroxylase CYP3A4 rate limiting enzyme bile acid biosynthetic pathway
0.40663978.15331348.html.plaintext.txt	18	This tightly regulated feedback mechanism necessary bile acids highly toxic cholesterol needed maintaining cellular structure function
0.40663978.15331348.html.plaintext.txt	19	Recent studies 4 revealed bile acid feedback far reaching impacts liver metabolism regulates bile acid synthesis digestive system also regulates cholesterol lipoprotein triglyceride glucose metabolisms
0.40663978.15331348.html.plaintext.txt	20	The discovery lithocholic acid LCA endogenous ligand pregnane X receptor PXR suggests bile acids may also regulate drug metabolism liver intestine induction CYP450 enzymes 27 34
0.40663978.15331348.html.plaintext.txt	21	PXR human ortholog steroid xenobiotic receptor SXR induce CYP3A CYP2B CYP2C families steroid drug metabolizing enzymes liver intestine 17
0.40663978.15331348.html.plaintext.txt	22	Despite high sequence identity ligand binding domain human mouse PXR different ligand selectivity
0.40663978.15331348.html.plaintext.txt	23	Pregnenolone 16 carbonitrile PCN dexamethasone strong agonists mouse PXR weaker agonists human PXR
0.40663978.15331348.html.plaintext.txt	24	In contrast rifampicin antibiotic used treat intrahepatic cholestasis activates human PXR mouse PXR 18
0.40663978.15331348.html.plaintext.txt	25	Previous studies 6 20 laboratory show PCN dexamethasone strongly reduced CYP7A1 activity mRNA protein expression levels rat livers
0.40663978.15331348.html.plaintext.txt	26	This finding recently confirmed reports PCN inhibited Cyp7a1 mRNA levels mouse liver effect Cyp7a1 mRNA expression Pxr knockout mice 27
0.40663978.15331348.html.plaintext.txt	27	These results suggest PXR may mediate LCA PCN inhibition mouse Cyp7a1 gene transcription
0.40663978.15331348.html.plaintext.txt	28	It proposed activation PXR drugs bile acids might protect liver drug bile acid induced cholestasis 27 34
0.40663978.15331348.html.plaintext.txt	29	Our previous studies identified two bile acid response elements BAREs BARE I BARE II
0.40663978.15331348.html.plaintext.txt	30	These two BAREs essential basal transcriptional activity also conferring bile acid feedback inhibition reviewed Ref
0.40663978.15331348.html.plaintext.txt	31	They contain several AGGTCA like repeating sequences potential binding sites nuclear receptors
0.40663978.15331348.html.plaintext.txt	32	A direct repeat spaced four bases DR4 rat BARE I binding site orphan receptor chicken ovalbumin upstream transcription factor II COUP TFII NR2F2 also liver orphan receptor LXR NR1H3
0.40663978.15331348.html.plaintext.txt	33	However COUP TFII LXR bind human BARE I due lack DR4 motif 5
0.40663978.15331348.html.plaintext.txt	34	The factor binds human BARE I identified
0.40663978.15331348.html.plaintext.txt	35	The BARE II contains 18 bp sequence completely conserved rats humans
0.40663978.15331348.html.plaintext.txt	36	Hepatic nuclear factor HNF4 binds DR1 human fetoprotein transcription factor FTF NR5A2 mouse liver related homolog LRH binds overlapping half site sequence BARE II
0.40663978.15331348.html.plaintext.txt	37	HNF4 nuclear receptor able stimulate human CYP7A1 gene factors tested FTF COUP TFII LXR inhibited human CYP7A1 gene 2 5 29
0.40663978.15331348.html.plaintext.txt	38	Bile acids known activate nuclear receptor farnesoid X receptor FXR NR1H4 binds inverted repeat IR1 sequences induces several genes involved lipid metabolism reviewed Ref
0.40663978.15331348.html.plaintext.txt	39	However FXR inhibits CYP7A1 gene inducing negative receptor small heterodimer partnet SHP interacts FTF inhibits transactivation CYP7A1 gene 3
0.40663978.15331348.html.plaintext.txt	40	The FXRSHPFTF mechanism consistent lacking inhibition Cyp7a1 induction Shp mRNA expression Fxr null mice fed bile acids 26
0.40663978.15331348.html.plaintext.txt	41	However bile acid feeding still inhibits Cyp7a1 expression Shp null mice 15 33 suggesting mechanisms alternative FXRSHPFTF pathway must exist bile acids inhibit Cyp7a1 mRNA expression Shp null mice 33
0.40663978.15331348.html.plaintext.txt	42	The alternative mechanisms include cytokineMAPKJNK pathway protein kinase CcJun pathway FXRFGF19FGFR4 pathway PXR mediated pathway 4
0.40663978.15331348.html.plaintext.txt	43	Rifampicin used treat pruritus intrahepatic cholestasis primary biliary cirrhosis 1 12
0.40663978.15331348.html.plaintext.txt	44	Rifampicin induces 6 hydroxylation bile acids CYP3A4
0.40663978.15331348.html.plaintext.txt	45	The objective research study PXR inhibit CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	46	First applied quantitative real time PCR Q PCR assay mRNA expression CYP7A1 several nuclear receptors known regulate CYP7A1 expression human primary hepatocytes established model studying human CYP7A1 gene regulation
0.40663978.15331348.html.plaintext.txt	47	We used reporter assays mutagenesis Q PCR EMSAs identify PXR response element human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	48	Mammalian two hybrid assay coimmunoprecipitation co IP assay used study PXR interaction HNF4 peroxisome proliferator activated receptor coactivator PGC 1
0.40663978.15331348.html.plaintext.txt	49	Chromatin immunoprecipitation assay ChIP used verify HNF4 PXR binding native CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	50	Results revealed novel mechanism PXR HNF4 PGC 1 regulation CYP7A1 gene transcription bile acid drug induced cholestasis
0.40663978.15331348.html.plaintext.txt	51	MATERIALS AND METHODS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES Cell culture
0.40663978.15331348.html.plaintext.txt	52	The human hepatoblastoma cells HepG2 HB8065 obtained American Type Culture Collection Manassas VA
0.40663978.15331348.html.plaintext.txt	53	The cells grown 11 mixture Dulbeccos modified Eagles medium F 12 5050 Life Technologies supplemented 100 Uml penicillin Gstreptomycin sulfate Celox Hopkins MN 10 volvol heat inactivated fetal calf serum Irvine Scientific Santa Ana CA
0.40663978.15331348.html.plaintext.txt	54	Primary human hepatocytes isolated human donors HH1088 2 yr female HH1089 52 yr male HH1115 22 yr male HH1117 68 yr female HH1118 73 yr female HH1119 29 yr female HH1122 46 yr old female HH1148 60 yr old male obtained Liver Tissue Procurement Distribution System National Institutes Health S
0.40663978.15331348.html.plaintext.txt	55	Strom University Pittsburgh Pittsburgh PA
0.40663978.15331348.html.plaintext.txt	56	Cells maintained Hank modified medium HMM modified Williams E medium Clonetics supplemented 10 7 M insulin dexamethasone used within 24 h receiving
0.40663978.15331348.html.plaintext.txt	57	Reporter receptor expression plasmids
0.40663978.15331348.html.plaintext.txt	58	Human CYP7A1luciferase Luc reporter constructs ph 1887Luc ph 298Luc ph 150Luc constructed described previously 32
0.40663978.15331348.html.plaintext.txt	59	Expression plasmid steroid receptor coactivator SRC 1 PCR3
0.40663978.15331348.html.plaintext.txt	60	Tsai Baylor College Medicine Houston TX
0.40663978.15331348.html.plaintext.txt	61	Expression plasmid human PGC 1 pcDNA3HA PGC 1 obtained A
0.40663978.15331348.html.plaintext.txt	62	Kralli The Scripp Research Institute La Jolla CA
0.40663978.15331348.html.plaintext.txt	63	Expression plasmid human FTF pCDM8 hFTF obtained D
0.40663978.15331348.html.plaintext.txt	64	Moore Baylor College expression plasmids retinoid X receptor RXR pcDNA3 hRXR HNF4 pCMX rHNF4 human PXR pSG5 hPXR 19 provided R
0.40663978.15331348.html.plaintext.txt	65	Evans Scripps Research Institute W
0.40663978.15331348.html.plaintext.txt	66	Chin Eli Lily Research Laboratories Indianapolis ID S
0.40663978.15331348.html.plaintext.txt	67	Kliewer University Texas Southwestern Medical Center Dallas TX respectively
0.40663978.15331348.html.plaintext.txt	68	For mammalian two hybrid assays reporter used 5xUAS TK Luc contains five copies upstream activating sequence UAS fused upstream thymidine kinase minimum promoter TK luciferase reporter gene 30
0.40663978.15331348.html.plaintext.txt	69	Two hybrid constructs contained ligand binding domain LBD nuclear receptors nuclear receptor interacting domain RID coactivators fused Gal4 DNA binding domain DBD VP16 activation domain AD vector
0.40663978.15331348.html.plaintext.txt	70	Mammalian two hybrid fusion plasmids used follows pCMX VP16 rHNF4 D E regions amino acids AA 125 364 D
0.40663978.15331348.html.plaintext.txt	71	Moore Baylor College Medicine pCMX VP16 hCPF D E regions B
0.40663978.15331348.html.plaintext.txt	72	Shen Tularik South San Francisco CA Gal4 PXR LBD AA 107 434 Gal4 SRC 1 RID AA 595 780 VP16 PXR LBD AA 107 437 A
0.40663978.15331348.html.plaintext.txt	73	Takeshita Toranomon Hospital Tokyo Japan 30 Gal4 PGC 1 full length FL A
0.40663978.15331348.html.plaintext.txt	74	Kralli The Scripp Research Institute
0.40663978.15331348.html.plaintext.txt	75	Gal4 HNF4 fusion plasmids pBx HNF4 FL AA 1 455 pBx HNF4 130 455 D E F regions obtained I
0.40663978.15331348.html.plaintext.txt	76	Talianidis Institute Molecular Biology Biotechnology Foundation Resarch Technology Hellas Herakleion Crete Greece pcDNA3X Gal4 HNF4 1 129 AB DBD C obtained M
0.40663978.15331348.html.plaintext.txt	77	Crestani University Milan Italy
0.40663978.15331348.html.plaintext.txt	78	Primary hepatocytes plated six well plates
0.40663978.15331348.html.plaintext.txt	79	Cells treated rifampicin 10 microM Sigma St
0.40663978.15331348.html.plaintext.txt	80	Louis MO chenodeoxycholic acid CDCA 30 microM Sigma serum free media grown 24 h
0.40663978.15331348.html.plaintext.txt	81	Total RNA isolated cells using Tri Reagent Sigma according manufacturers protocol
0.40663978.15331348.html.plaintext.txt	82	Reverse transcription reactions performed using RETROscript kit according manufacturers instructions Ambion Austin TX
0.40663978.15331348.html.plaintext.txt	83	For Q PCR samples prepared according PCR SYBRgreen Master Mix 2X protocol Applied Biosystems Foster City CA
0.40663978.15331348.html.plaintext.txt	84	Amplification human highly basic protein 21 ubiquitin C 16 used reactions internal reference gene
0.40663978.15331348.html.plaintext.txt	85	Primers designed using Primer Express 1
0.40663978.15331348.html.plaintext.txt	86	Quantitative PCR analysis conducted ABI Prism 7700 sequence detection system
0.40663978.15331348.html.plaintext.txt	87	Relative mRNA expression quantified using comparative threshold cycle Ct Ct method according ABI manual
0.40663978.15331348.html.plaintext.txt	88	HepG2 cells grown 80 confluence 24 well tissue culture plates
0.40663978.15331348.html.plaintext.txt	89	Unless otherwise indicated transient transfection assay human CYP7A1Luciferase reporter plasmid 1 microg transfected expression plasmid 0
0.40663978.15331348.html.plaintext.txt	90	5 microg using calcium phosphate DNA coprecipitation method
0.40663978.15331348.html.plaintext.txt	91	The pCMV galactosidase plasmid 0
0.40663978.15331348.html.plaintext.txt	92	1 microg transfected internal standard normalizing transfection efficiency assay
0.40663978.15331348.html.plaintext.txt	93	In samples empty expression vectors added equalize total amounts plasmid DNA transfected assay
0.40663978.15331348.html.plaintext.txt	94	Four hours transfection cells incubated serum free media treated LCA Steraloids Newport RI rifampicin concentrations indicated experiment 40 h
0.40663978.15331348.html.plaintext.txt	95	Cells harvested assay luciferase reporter activity using Luciferase Assay System Promega
0.40663978.15331348.html.plaintext.txt	96	Luciferase activity determined using Lumat LB 9501 luminometer Berthold Systems Pittsburgh PA normalized dividing relative light units galactosidase activity
0.40663978.15331348.html.plaintext.txt	97	Each assay done triplicate individual experiments repeated least three times
0.40663978.15331348.html.plaintext.txt	98	Data plotted means plus minus SD
0.40663978.15331348.html.plaintext.txt	99	Statistical analyses treated vs
0.40663978.15331348.html.plaintext.txt	100	untreated controls vehicle empty plasmids performed using Students test
0.40663978.15331348.html.plaintext.txt	101	05 considered statistically significant
0.40663978.15331348.html.plaintext.txt	102	Cell viability assays performed using TOX1 kit Sigma
0.40663978.15331348.html.plaintext.txt	103	HepG2 cells human primary hepatocytes HH1165 cultured 48 well plates treated increasing amounts LCA 1 15 microM CDCA 10 50 microM rifampicin 5 20 microM 48 h
0.40663978.15331348.html.plaintext.txt	104	3 45 dimethylthiazol 2 yl 25 diphenyltetrazolium bromide MTT added media incubated additional 2 h
0.40663978.15331348.html.plaintext.txt	105	The resulting purple crystals MTT dissolved MTT dissolving solution absorbance measured 570 nm using spectrophotometer
0.40663978.15331348.html.plaintext.txt	106	Mutations introduced ph 298Luc plasmid using PCR based QuikChange Site directed Mutagenesis Kit Stratagene La Jolla CA
0.40663978.15331348.html.plaintext.txt	107	Two complementary oligonucleotides containing mutations see Fig
0.40663978.15331348.html.plaintext.txt	108	PCR reactions set according manufacturers instruction using 50 ng template DNA 125 ng primers
0.40663978.15331348.html.plaintext.txt	109	PCR cycling parameters set follows denaturing 95 degrees C 2 min followed 18 cycles 95 degrees C 30 55 degrees C 1 min 68 degrees C 18 min
0.40663978.15331348.html.plaintext.txt	110	The reaction mixture digested Dpn I 2 h remove template DNA transformed XL1 Blue super competent cells Stratagene selection mutant clones
0.40663978.15331348.html.plaintext.txt	111	Mutations clone confirmed DNA sequencing
0.40663978.15331348.html.plaintext.txt	112	View larger version 24K Fig
0.40663978.15331348.html.plaintext.txt	113	Effects hepatocyte nuclear factor HNF4 PXRRXR peroxisome proliferator activated receptor coactivator PGC 1 human CYP7A1 promoter activities
0.40663978.15331348.html.plaintext.txt	114	HepG2 cells cultured 80 confluence
0.40663978.15331348.html.plaintext.txt	115	Human CYP7A1luciferase reporter ph 298Luc 1 microg transiently transfected HepG2 cells
0.40663978.15331348.html.plaintext.txt	116	5 microg cotransfected indicated
0.40663978.15331348.html.plaintext.txt	117	Cells incubated serum free media 40 h harvested luciferase activity assays described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	118	The error bars represent SD mean triplicate assays individual experiment n 3 P 0
0.40663978.15331348.html.plaintext.txt	119	Reporter plasmid 5x UAS TK LUC 1 microg transfected various two hybrid plasmids 0
0.40663978.15331348.html.plaintext.txt	120	5 microg CMV gal plasmid 0
0.40663978.15331348.html.plaintext.txt	121	Cells treated rifampicin 10 microM LCA 10 microM vehicle DMSO
0.40663978.15331348.html.plaintext.txt	122	Luciferase activity assayed described Transient transfection assay
0.40663978.15331348.html.plaintext.txt	123	Nuclear receptors synthesized vitro using Quick coupled TranscriptionTranslation Systems Promega programmed receptor expression plasmids according manufacturers instruction
0.40663978.15331348.html.plaintext.txt	124	Double stranded synthetic probes PXR binding site CYP3A4 BARE I BARE II human CYP7A1 gene prepared heating equal molar amounts complementary oligonucleotides 95 degrees C 2x SSC 0
0.40663978.15331348.html.plaintext.txt	125	5 M NaCl 15 mM sodium citrate pH 7
0.40663978.15331348.html.plaintext.txt	126	0 slowly cooled room temperature
0.40663978.15331348.html.plaintext.txt	127	The resulting double stranded fragments labeled 32PdCTP filling reaction using Klenow fragment DNA polymerase I
0.40663978.15331348.html.plaintext.txt	128	Labeled double stranded probes purified G 50 spin columns
0.40663978.15331348.html.plaintext.txt	129	For binding reaction 50000 countsmin cpm labeled probe 5 l vitro translated protein incubated room temperature 20 min 20 microl binding buffer containing 12 mM HEPES pH 7
0.40663978.15331348.html.plaintext.txt	130	9 50 mM KCl 1 mM EDTA 1 mM dithiothreitol 15 glycerol 2 microg poly dI dC
0.40663978.15331348.html.plaintext.txt	131	Samples loaded 5 polyacrylamine gel electrophoresis performed room temperature constant 200 V 1
0.40663978.15331348.html.plaintext.txt	132	The gel dried autoradiographed using Phosphor Imager 445Si Molecular Dynamics Sunnyvale CA
0.40663978.15331348.html.plaintext.txt	133	Primary human hepatocytes obtained T75 culture flasks ChIP assays performed day cells received
0.40663978.15331348.html.plaintext.txt	134	HepG2 cells grown 100 mm culture dishes 80 confluence
0.40663978.15331348.html.plaintext.txt	135	Ten micrograms PXR RXR FTF HNF4 HA tagged PGC 1 expression plasmids transfected using calcium phosphate DNA coprecipitation method described Transient transfection assay
0.40663978.15331348.html.plaintext.txt	136	Four hours transfection cells incubated serum free media containing vehicle DMSO 10 microM rifampicin 40 h
0.40663978.15331348.html.plaintext.txt	137	ChIP assays performed using ChIP assay kit Upstate Biotec NY according manufacturers protocol
0.40663978.15331348.html.plaintext.txt	138	Briefly cells cross linked 1 formaldehyde 10 min washed ice cold PBS containing protease inhibitors 1 mM PMSF 1 microgml aprotinin 1 microgml pepstanin A Sigma twice
0.40663978.15331348.html.plaintext.txt	139	Cells scraped incubated 1 SDS lysis buffer 1 SDS 10 mM EDTA 50 mM Tris HCl pH 8
0.40663978.15331348.html.plaintext.txt	140	1 30 min ice sonicated using Branson sonifier 250 microtip setting 6 15 pulses 40 output total 1
0.40663978.15331348.html.plaintext.txt	141	Cell lysates collected centrifugation diluted 10 fold ChIP dilution buffer 0
0.40663978.15331348.html.plaintext.txt	142	Ten percent cell lysates saved used input immunoprecipitation
0.40663978.15331348.html.plaintext.txt	143	After diluted cell lysate precleared protein A agarose DNA protein complexes precipitated incubating cell lysates 10 microg antibodies goat HNF4 6556 goat PXR 7737 goat PGC 1 5815 goat CPF 5995 Santa Cruz Biotechnology Santa Cruz CA target proteins overnight followed 3 h incubation protein A G agarose beads treatment
0.40663978.15331348.html.plaintext.txt	144	Protein A G added nonimmunoprecipitation control
0.40663978.15331348.html.plaintext.txt	145	The beads washed low salt wash buffer 0
0.40663978.15331348.html.plaintext.txt	146	1 SDS 1 Triton X 100 2 mM EDTA 20 mM Tris HCl pH 8
0.40663978.15331348.html.plaintext.txt	147	1 150 mM NaCl high salt wash buffer 0
0.40663978.15331348.html.plaintext.txt	148	1 SDS 1 Triton X 100 2 mM EDTA 20 mM Tris HCl pH 8
0.40663978.15331348.html.plaintext.txt	149	1 500 mM NaCl LiCl wash buffer 0
0.40663978.15331348.html.plaintext.txt	150	25 M LiCl 1 Nonidet P 40 NP 40 1 deoxycholate 1 mM EDTA 10 mM Tris HCl pH 8
0.40663978.15331348.html.plaintext.txt	151	1 buffer 10 mM Tris HCl 1 mM EDTA pH 8
0.40663978.15331348.html.plaintext.txt	152	Samples eluted twice 250 microl ChIP elution buffer 1 SDS 0
0.40663978.15331348.html.plaintext.txt	153	1 M NaHCO3 eluates combined
0.40663978.15331348.html.plaintext.txt	154	The cross links reversed adjusting NaCl concentration 200 mM incubating eluates 65 degrees C 4 h followed 1 h incubation 0
0.40663978.15331348.html.plaintext.txt	155	04 microg microl proteinase K
0.40663978.15331348.html.plaintext.txt	156	DNA extracted using phenolchloroform precipitated using isopropanol
0.40663978.15331348.html.plaintext.txt	157	A 391 bp DNA fragment containing BARE I BARE II PCR amplified 45 cycles analyzed 2 agarose gel
0.40663978.15331348.html.plaintext.txt	158	The PCR primers used follows forward primer 5 ATCACCGTCTCTCTGGCAAAGCAC reverse primer 5 CCATTAACTTGAGCTTGGTTGACAAAG
0.40663978.15331348.html.plaintext.txt	159	The amplified fragment 391 bp 432 41 containing BARE I BARE II
0.40663978.15331348.html.plaintext.txt	160	HepG2 cells cultured T150 flasks transfected 10 g PXR expression plasmid using Ca2 phosphate coimmunoprecipitation method
0.40663978.15331348.html.plaintext.txt	161	Human primary hepatocytes HH1148 T75 flasks treated either vehicle DMSO rifampicin 10 microM 24 h collected incubated modified RIPA buffer 50 mM Tris HCl 1 NP 40 0
0.40663978.15331348.html.plaintext.txt	162	25 deoxycholate 150 mM NaCl 1 mM EDTA containing protease inhibitors 1 mM PMSF 1 microgml aprotinin 1 microgml pepstanin Sigma 30 min
0.40663978.15331348.html.plaintext.txt	163	Clear cell lyates collected centrifugation 10000 g 4 degrees C 15 min
0.40663978.15331348.html.plaintext.txt	164	Clear lysates precleared protein G beads incubated 15 microg rabbit anti HNF4 antibody Santa Cruz Biotechnology 4 degrees C rotation overnight followed additional incubation 2 h protein G beads
0.40663978.15331348.html.plaintext.txt	165	The beads washed three times RIPA buffer boiled 2x protein loading buffer 5 min
0.40663978.15331348.html.plaintext.txt	166	Samples divided equal amounts andloaded SDS PAGE gels Western immunoblot analysis using goat antibodies HNF4 6556 Santa Cruz Biotechnology PGC 1 5815 PXR 7737
0.40663978.15331348.html.plaintext.txt	167	RESULTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES CYP7A1 nuclear receptors PGC 1 mRNAs expressed human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	168	We first used Q PCR assays detect mRNA expression levels CYP7A1 several transcription factors known regulate CYP7A1 transcription human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	169	The averaging Ct plus minus SD determined seven hepatocyte preparations HH1088 HH1089 HH1115 HH1117 HH1118 HH1119 HH1122 wereas follows CYP7A1 16
0.40663978.15331348.html.plaintext.txt	170	The Ct fractional cycle number amount amplified target reaches fixed threshold
0.40663978.15331348.html.plaintext.txt	171	The Ct value exponentially related copy number
0.40663978.15331348.html.plaintext.txt	172	High Ct value indicates low copy number
0.40663978.15331348.html.plaintext.txt	173	The Ct value Ct target gene minus Ct reference gene ubiquitin C
0.40663978.15331348.html.plaintext.txt	174	These data indicated CYP7A1 mRNA levels low detectable assay
0.40663978.15331348.html.plaintext.txt	175	SHP mRNA levels 100 fold higher CYP7A1
0.40663978.15331348.html.plaintext.txt	176	PXR mRNA levels lower FXR HNF4 PGC 1 abundant human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	177	These experiments revealed human primary hepatocytes expressed low levels CYP7A1 abundant nuclear receptors coactivator known regulate CYP7A1 gene expression
0.40663978.15331348.html.plaintext.txt	178	Therefore human primary hepatocyte suitable studying CYP7A1 gene regulation nuclear receptors
0.40663978.15331348.html.plaintext.txt	179	Rifampicin CDCA reduce CYP7A1 mRNA expression human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	180	Q PCR used assay effect CDCA FXR ligand rifampicin human PXR ligand CYP7A1 mRNA expression levels human primary hepatocytes HH1106
0.40663978.15331348.html.plaintext.txt	181	Comparative Ct Ct method used quantify change mRNA expression levels CDCA rifampicin Table 1
0.40663978.15331348.html.plaintext.txt	182	CDCA 30 microM markedly reduced CYP7A1 mRNA expression 95 rifampicin 10 microM reduced CYP7A1 mRNA expression 80
0.40663978.15331348.html.plaintext.txt	183	As positive control CDCA induction SHP mRNA levels determined
0.40663978.15331348.html.plaintext.txt	184	As expected CDCA induced SHP mRNA sixfold
0.40663978.15331348.html.plaintext.txt	185	The observed inverse relationship CYP7A1 SHP mRNA expression levels bile acid consistent hypothesis SHP mechanism mediates bile acid inhibition CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	186	Interestingly rifampicin completely abolished SHP mRNA expression
0.40663978.15331348.html.plaintext.txt	187	As positive control PXR induction CYP3A4 mRNA expression levels measured human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	188	The CYP3A4 mRNA levels low detected vehicle CDCA treated human hepatocytes Ct 40
0.40663978.15331348.html.plaintext.txt	189	Rifampicin remarkably induced CYP3A4 mRNA levels 50 fold consistent previous report 9
0.40663978.15331348.html.plaintext.txt	190	The strong induction SHP CDCA CYP3A4 rifampicin indicates compounds concentrations tested cause toxic effect human primary hepatocytes demonstrated MTT assays
0.40663978.15331348.html.plaintext.txt	191	The lack inverse relationship CYP7A1 SHP mRNA expression rifampicin provides strong evidence SHP involved PXR inhibition CYP7A1
0.40663978.15331348.html.plaintext.txt	192	These results may suggest ligand activated PXR reduced SHP gene transcription human livers
0.40663978.15331348.html.plaintext.txt	193	Quantitative PCR analysis CYP7A1 mRNA expression human primary hepatocytes HH1106
0.40663978.15331348.html.plaintext.txt	194	Human PXR rifampicin inhibit CYP7A1 reporter activity HepG2 cells
0.40663978.15331348.html.plaintext.txt	195	We studied effect human PXR rifampicin human CYP7A1 gene transcription transient transfection assay HepG2 cells using human CYP7A1luciferase reporter construct ph 298Luc
0.40663978.15331348.html.plaintext.txt	196	MTT assays revealed LCA 1 15 microM CDCA 10 50 microM rifampicin 5 20 microM reduce HepG2 cell viability concentration range tested
0.40663978.15331348.html.plaintext.txt	197	Rifampicin 10 microM slightly inhibited CYP7A1 reporter activity assayed HepG2 cells Fig
0.40663978.15331348.html.plaintext.txt	198	Because HepG2 cells express low levels PXR barely detectable Western blot analysis Q PCR data shown overexpressed human PXR RXR HepG2 cells reporter assays
0.40663978.15331348.html.plaintext.txt	199	1B rifampicin strongly reduced reporter activity 80 PXR expressing HepG2 cells
0.40663978.15331348.html.plaintext.txt	200	These results suggest PXR involved rifampicin inhibition CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	201	View larger version 19K Fig
0.40663978.15331348.html.plaintext.txt	202	Rifampicin activated pregnane X receptor PXR suppresses cholesterol 7 hydroxylase CYP7A1 reporter activity transient transfection assays HepG2 cells
0.40663978.15331348.html.plaintext.txt	203	HepG2 cells cultured 80 confluence
0.40663978.15331348.html.plaintext.txt	204	Human CYP7A1luciferase reporter ph 298Luc 1 microg transiently transfected HepG2 cells
0.40663978.15331348.html.plaintext.txt	205	Cells treated vehicle DMSO rifampicin 40 h harvested luciferase activity assays described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	206	A effect rifampicin 10 microM human CYP7A1Luc reporter activity HepG2 cells
0.40663978.15331348.html.plaintext.txt	207	Data plotted means plus minus SD n 3
0.40663978.15331348.html.plaintext.txt	208	B effects PXR ligands 10 microM human CYP7A1Luc reporter activity HepG2 cells transfected PXRretinoid X receptor RXR expression plasmids 0
0.40663978.15331348.html.plaintext.txt	209	5 microg empty vector pcDNA3 PXR ligands added indicated
0.40663978.15331348.html.plaintext.txt	210	The error bars represent SD mean triplicate assays individual experiment n 3
0.40663978.15331348.html.plaintext.txt	211	Identification negative PXR response element
0.40663978.15331348.html.plaintext.txt	212	To localize promoter region confers negative rifampicin PXR effect human CYP7A1 gene 5 deletion constructs human CYP7A1Luc reporter containing sequences 188724 29824 15024 assayed HepG2 cells transfected PXR RXR
0.40663978.15331348.html.plaintext.txt	213	Reporter activities three constructs inhibited 80 rifampicin data shown
0.40663978.15331348.html.plaintext.txt	214	It concluded PXR response element located region downstream 150 contains BARE I BARE II
0.40663978.15331348.html.plaintext.txt	215	We thus performed EMSA using oligonucleotide probes designed based nucleotide sequences BARE I BARE II
0.40663978.15331348.html.plaintext.txt	216	When human BARE I probe used EMSA Fig
0.40663978.15331348.html.plaintext.txt	217	2A mixture vitro synthesized PXR RXR shifted single band Fig
0.40663978.15331348.html.plaintext.txt	218	Neither PXR RXR alone bound BARE I probe Fig
0.40663978.15331348.html.plaintext.txt	219	A probe contains strong PXR binding site human CYP3A4 gene ER6 Fig
0.40663978.15331348.html.plaintext.txt	220	2A used positive control PXR binding Fig
0.40663978.15331348.html.plaintext.txt	221	Excess unlabeled BARE I unlabeled CYP3A4 oligonucleotide completely abolished shifted band
0.40663978.15331348.html.plaintext.txt	222	A mutant BARE I probe mutations introduced alter AGCTCA half site sequence bind PXRRXR
0.40663978.15331348.html.plaintext.txt	223	Figure 2C shows unlabeled CYP3A4 oligonucleotide could completely compete PXR binding labeled BARE I probe 100 fold excess
0.40663978.15331348.html.plaintext.txt	224	On hand 200 fold excess unlabeled BARE I required completely complete PXR binding labeled 3A4 probe
0.40663978.15331348.html.plaintext.txt	225	PXR known bind various motifs including DR3 DR4 ER6 11
0.40663978.15331348.html.plaintext.txt	226	Analysis nucleotide sequences human BARE I revealed putative DR3 motif Fig
0.40663978.15331348.html.plaintext.txt	227	2A known bind human PXR 17
0.40663978.15331348.html.plaintext.txt	228	View larger version 46K Fig
0.40663978.15331348.html.plaintext.txt	229	EMSA PXRRXR binding human rat bile acid response element BARE I probes
0.40663978.15331348.html.plaintext.txt	230	A nucleotide sequences probes used EMSA
0.40663978.15331348.html.plaintext.txt	231	Rat BARE I sequence shown comparison
0.40663978.15331348.html.plaintext.txt	232	Arrows sequences indicate hormone response element half site
0.40663978.15331348.html.plaintext.txt	233	Lower case letters indicate mutations
0.40663978.15331348.html.plaintext.txt	234	DR direct repeat ER everted repeat
0.40663978.15331348.html.plaintext.txt	235	B PXRRXR binding human BARE I probes
0.40663978.15331348.html.plaintext.txt	236	P32 labeled probes 5 x 104 cyclesmin cpm 5 microl vitro synthesized proteins TNT lysate mixed applied lane indicated
0.40663978.15331348.html.plaintext.txt	237	Excess 100 fold unlabeled probes used cold competitor
0.40663978.15331348.html.plaintext.txt	238	Probe CYP3A4 contains PXRRXR binding site ER6 human CYP3A4 gene
0.40663978.15331348.html.plaintext.txt	239	Probe Mut contains mutant human BARE I shown A
0.40663978.15331348.html.plaintext.txt	240	C cold competition PXRRXR binding human BARE I probe CYP3A4 probe
0.40663978.15331348.html.plaintext.txt	241	Increasing amount excess unlabeled probes 1 microl P32 labeled probes 5 x 104 cpm incubated 5 microl vitro synthesized proteins TNT lysate 20 min applied lane indicated
0.40663978.15331348.html.plaintext.txt	242	We introduced mutations human CYP7A1Luc reporter test whether PXR binding site functional
0.40663978.15331348.html.plaintext.txt	243	Mutation AGCTCA sequence theBARE I markedly reduced reporter activity 90 Fig
0.40663978.15331348.html.plaintext.txt	244	This hormone response element half site apparently essential basal human CYP7A1 gene transcriptional activity
0.40663978.15331348.html.plaintext.txt	245	When transfection assays performed HepG2 cells cotransfected PXRRXR rifampicin significantly inhibit mutant reporter activity Fig
0.40663978.15331348.html.plaintext.txt	246	These results confirmed BARE I functional negative PXR response element
0.40663978.15331348.html.plaintext.txt	247	It also concluded BARE II PXR response element PXR bind BARE II data shown rifampicin inhibit mutant reporter intact BARE II Fig
0.40663978.15331348.html.plaintext.txt	248	View larger version 15K Fig
0.40663978.15331348.html.plaintext.txt	249	Mutation BARE I human CYP7A1 gene abolished PXR inhibition
0.40663978.15331348.html.plaintext.txt	250	A wild type human CYP7A1Luc reporter ph 298Luc mutant reporter mutations BARE I region introduced site directed mutagenesis shown Fig
0.40663978.15331348.html.plaintext.txt	251	2 transfected HepG2 cells
0.40663978.15331348.html.plaintext.txt	252	Basal reporter activity assayed n 3 mutant vs
0.40663978.15331348.html.plaintext.txt	253	B mutant reporter plasmid transfected HepG2 cells cotransfected PXRRXR expression plasmids
0.40663978.15331348.html.plaintext.txt	254	Not significant rifampicin vs
0.40663978.15331348.html.plaintext.txt	255	Cells treated vehicle DMSO 10 microM rifampicin indicated
0.40663978.15331348.html.plaintext.txt	256	Rifampicin inhibits HNF4 PGC 1 stimulation human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	257	We studied effect rifampicin CYP7A1 reporter activity affected HNF4 PXR PGC 1
0.40663978.15331348.html.plaintext.txt	258	4 HNF4 stimulated human CYP7A1 reporter activity fivefold lane 2
0.40663978.15331348.html.plaintext.txt	259	PGC 1 alone stimulated human CYP7A1 reporter activity threefold lane 3
0.40663978.15331348.html.plaintext.txt	260	Combination HNF4 PGC 1 stimulated activity eightfold lane 5
0.40663978.15331348.html.plaintext.txt	261	It remarkable addition rifampicin almost completely abolished reporter activity PXR expression HepG2 cells lanes 4 6 8
0.40663978.15331348.html.plaintext.txt	262	These data revealed PXR strong repressor CYP7A1 gene activated ligand whereas HNF4 PGC 1 positive regulators human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	263	PXR interacts HNF4 PGC 1
0.40663978.15331348.html.plaintext.txt	264	We reported previously HNF4 bound BARE II COUP TFII bound BARE I synergistically stimulated rat CYP7A1 gene transcription 29
0.40663978.15331348.html.plaintext.txt	265	We proposed model factors bound BARE I BARE II interact regulate CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	266	We therefore wanted test hypothesis PXR binds BARE I might also interact HNF4 regulate human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	267	We used mammalian two hybrid assay study interaction Gal4 PXR LBD fusion VP16 HNF4 fusion HepG2 cells
0.40663978.15331348.html.plaintext.txt	268	In assay Gal4 PXR LBD fusion protein binds Gal4 DBD DNA binding site UAS luciferase reporter Gal4 5XUAS TK Luc TK minimal promoter expresses low basal activity mammalian cells
0.40663978.15331348.html.plaintext.txt	269	If Gal4 PXR fusion protein interacts VP16 HNF4 fusion protein Gal4 reporter activity stimulated
0.40663978.15331348.html.plaintext.txt	270	The effect PXR ligand interaction also tested assay
0.40663978.15331348.html.plaintext.txt	271	5A show Gal4 PXR LBD AA 107 434 interacts strongly VP16 HNF4 D BD AA 125 364 presence rifampicin
0.40663978.15331348.html.plaintext.txt	272	As control specificity interaction Gal4 PXR interacts weakly VP16 FTF
0.40663978.15331348.html.plaintext.txt	273	It noted FTF binding site overlaps HNF4 binding site BARE II
0.40663978.15331348.html.plaintext.txt	274	We used Gal4 HNF4 VP16 PXR hybrids two hybrid assays
0.40663978.15331348.html.plaintext.txt	275	Figure 5B shows Gal4 HNF4 full length VP16 PXR LBD interact without addition HNF4 ligand 4 fold background
0.40663978.15331348.html.plaintext.txt	276	It noted HNF4 intrinsic activity endogenous HNF4 ligand known certain
0.40663978.15331348.html.plaintext.txt	277	Addition rifampicin somewhat enhanced interaction
0.40663978.15331348.html.plaintext.txt	278	The interactions Gal4 HNF4 VP16 PXR fusion proteins much weaker Gal4 PXRVP16 HNF4 hybrids Fig
0.40663978.15331348.html.plaintext.txt	279	5A indicated much lower reporter activities
0.40663978.15331348.html.plaintext.txt	280	The NH2 terminal region AB DBD AA 1 129 HNF4 notinteract PXR whereas COOH terminal region LBD AA 130 455 HNF4
0.40663978.15331348.html.plaintext.txt	281	These data revealed LBD HNF4 interacts LBD PXR
0.40663978.15331348.html.plaintext.txt	282	View larger version 24K Fig
0.40663978.15331348.html.plaintext.txt	283	Mammalian 2 hybrid assays PXR interaction HNF4
0.40663978.15331348.html.plaintext.txt	284	A mammalian 2 hybrid assay ligand dependent interaction PXR HNF4
0.40663978.15331348.html.plaintext.txt	285	5 microg Gal4 PXR ligand binding domain LBD VP16 empty vector VP16 fetoprotein transcription factor FTF LBD VP16 HNF4 0
0.40663978.15331348.html.plaintext.txt	286	5 microg cotransfected 5x upstream activating sequence UAS thymidine kinase TK LUC reporter plasmid 1 microg HepG2 cells
0.40663978.15331348.html.plaintext.txt	287	Cells treated vehicle DMSO 10 microM rifampicin 40 h harvested luciferase activity assays described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	288	The error bars represent SD mean triplicate assays individual experiment n 3 P 0
0.40663978.15331348.html.plaintext.txt	289	B mammalian 2 hybrid assay ligand dependent interaction PXR HNF4
0.40663978.15331348.html.plaintext.txt	290	5 microg containing full length NH2 terminal AB C 1 129 amino acid AA COOH terminal D E F 130 455 AA HNF4 VP16 PXR LBD 0
0.40663978.15331348.html.plaintext.txt	291	5 microg cotransfected 5x UAS TK LUC reporter plasmid 1 microg HepG2 cells indicated
0.40663978.15331348.html.plaintext.txt	292	Empty vector VP16 used negative control
0.40663978.15331348.html.plaintext.txt	293	Cells treated vehicle DMSA 10 microM rifampicin 40 h harvested luciferase activity assays described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	294	The error bars represent SE mean triplicate assays individual experiment n 3 P 0
0.40663978.15331348.html.plaintext.txt	295	PXR interacts PGC 1 rifampicin attenuates PGC 1 interaction HNF4 PXR
0.40663978.15331348.html.plaintext.txt	296	PGC 1 originally identified coactivator PPAR
0.40663978.15331348.html.plaintext.txt	297	Since several nuclear receptors including HNF4 LXR RXR Estrogen receptor ER ER related receptor found interact PGC 1 regulate gluconeogenesis energy metabolism 23 25
0.40663978.15331348.html.plaintext.txt	298	It known whether PGC 1 interacts PXR
0.40663978.15331348.html.plaintext.txt	299	We therefore performed mammalian two hybrid assays study PXR interaction PGC 1
0.40663978.15331348.html.plaintext.txt	300	Figure 6A shows Gal4 PGC 1 strongly interacts VP16 PXR indicated 400 fold stimulation Gal4 reporter activity Gal4 basal activity
0.40663978.15331348.html.plaintext.txt	301	A ubiquitous steroid receptor coactivator SRC 1 interacts much weaker 20 fold VP16 PXR
0.40663978.15331348.html.plaintext.txt	302	Because coactivator known interact nuclear receptor binding LBD ligand enhances interaction studied effect rifampicin PXR interaction HNF4 PGC 1
0.40663978.15331348.html.plaintext.txt	303	Figure 6B shows rifampicin induced fourfold stimulation PXR PGC 1 interaction
0.40663978.15331348.html.plaintext.txt	304	Interestingly overexpression HNF4 strongly inhibited PXR PGC 1 interaction PXR ligand added
0.40663978.15331348.html.plaintext.txt	305	This indicates rifampicin promotes PXR HNF4 interaction excludes PGC 1 interaction PXR
0.40663978.15331348.html.plaintext.txt	306	Figure 6C shows Gal4 PGC 1 interacts strongly VP 16 HNF4 500 fold rifampicin effect interaction
0.40663978.15331348.html.plaintext.txt	307	This expected rifampicin ligand HNF4
0.40663978.15331348.html.plaintext.txt	308	When PXR expression plasmid cotransfected addition rifampicin strongly inhibited HNF4 PGC 1 interaction
0.40663978.15331348.html.plaintext.txt	309	These results also suggest rifampicin promotes PXR interaction HNF4 prevents PGC 1 interaction HNF4
0.40663978.15331348.html.plaintext.txt	310	These results reveal first time PGC 1 strong coactivator PXR rifampicin promotes PXR interaction HNF4 blocks PGC 1 interaction HNF4 PXR
0.40663978.15331348.html.plaintext.txt	311	View larger version 17K Fig
0.40663978.15331348.html.plaintext.txt	312	Mammalian 2 hybrid assay PXR HNF4 interaction PGC 1
0.40663978.15331348.html.plaintext.txt	313	A mammalian 2 hybrid assay PXR interaction PGC 1
0.40663978.15331348.html.plaintext.txt	314	5 microg VP16 PXR LBD Gal4 empty vector Gal4 SRC 1 RID Gal4 PGC 1 cotransfected 5x UAS TK LUC reporter plasmid 1 microg HepG2 cells indicated
0.40663978.15331348.html.plaintext.txt	315	Cells incubated 40 h harvested luciferase activity assay described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	316	The error bars represent SD mean triplicate assays individual experiment n 3 P 0
0.40663978.15331348.html.plaintext.txt	317	B HNF4 disrupts PGC 1 PXR interaction
0.40663978.15331348.html.plaintext.txt	318	VP16 PXR LBD Gal4 empty vector Gal4 PGC 1 expression plasmid pCMX HNF4 cotransfected 5x UAS TK LUC reporter plasmid 1 microg HepG2 cells indicated
0.40663978.15331348.html.plaintext.txt	319	Cells treated vehicle DMSO 10 microM rifampicin indicated 40 h harvested luciferase activity assay n 3 P 0
0.40663978.15331348.html.plaintext.txt	320	C PGC 1 interacts HNF4 rifampicin activated PXR disrupts HNF4 interaction PGC 1
0.40663978.15331348.html.plaintext.txt	321	5 microg VP16 PXR LBD Gal4 empty vector Gal4 PGC 1 expression plasimd pSG5 hPXR cotransfected 5x UAS TK Luc reporter plasmid HepG2 cells
0.40663978.15331348.html.plaintext.txt	322	The error bars represent SD mean triplicate assays individual experiment n 3 P 0
0.40663978.15331348.html.plaintext.txt	323	HNF4 PXR bind CYP7A1 gene interact PGC 1 native CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	324	To test binding interaction HNF4 PXR PGC 1 CYP7A1 gene vivo performed ChIP assays using human primary hepatocytes HepG2 cells
0.40663978.15331348.html.plaintext.txt	325	PCR primers designed amplify 391 bp fragment contains BARE I BARE II sequences
0.40663978.15331348.html.plaintext.txt	326	Figure 7A shows antibody PXR HNF4 precipitated CYP7A1 chromatins primary human hepatocytes
0.40663978.15331348.html.plaintext.txt	327	For ChIP assay using HepG2 cells PGC 1 HNF4 PXRRXR overexpressed increase receptor expression levels
0.40663978.15331348.html.plaintext.txt	328	Figure 7B shows anti PXR HNF4 antibody precipitates CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	329	These results confirmed PXR HNF4 bound native CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	330	PGC 1 antibody also precipitated CYP7A1 chromatin Fig
0.40663978.15331348.html.plaintext.txt	331	Because PGC 1 coactivator lacks DBD PGC 1 must interact either HNF4 andor PXR CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	332	We also ChIP assay using antibody FTF confirmed FTF bound BARE II
0.40663978.15331348.html.plaintext.txt	333	We studied effect rifampicin binding transcription factors CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	334	Rifampicin treatments affect binding HNF4 PXR CYP7A1 chromatin PGC 1 absent chromatin Fig
0.40663978.15331348.html.plaintext.txt	335	As control ChIP assays showed rifampicin alter FTF binding chromatin
0.40663978.15331348.html.plaintext.txt	336	These data consistent mammalian two hybrid assay data suggest rifampicin disrupts PGC 1 interaction HNF4 PXR
0.40663978.15331348.html.plaintext.txt	337	View larger version 25K Fig
0.40663978.15331348.html.plaintext.txt	338	rifampicin impairs recruitment PGC 1 CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	339	A chromatin immunoprecipitation assay ChIP PXR HNF4 binding human CYP7A1 gene primary human hepatocytes
0.40663978.15331348.html.plaintext.txt	340	Anti PXR anti HNF4 antibody Ab used precipitate DNA protein complex primary human hepatocytes HH1119
0.40663978.15331348.html.plaintext.txt	341	A 391 bp fragment containing BARE I BARE II PCR amplified analyzed 2 agarose gel
0.40663978.15331348.html.plaintext.txt	342	Protein G used alone nonimmunoprecipitation control
0.40663978.15331348.html.plaintext.txt	343	Ten percent total cell lysate used input
0.40663978.15331348.html.plaintext.txt	344	B ChIP assay HNF4 PXR FTF PGC 1 binding human CYP7A1 chromatin using HepG2 cells
0.40663978.15331348.html.plaintext.txt	345	HepG2 cells transfected 10 microg PXR RXR HNF4 HA PGC 1 FTF expression plasmids treated vehicle DMSO 10 microM rifampicin 40 h
0.40663978.15331348.html.plaintext.txt	346	ChIP assays performed described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	347	Anti PXR anti HNF4 anti HA anti FTF antibodies used precipitate DNA protein complexes
0.40663978.15331348.html.plaintext.txt	348	A 391 bp fragment containing BARE I BARE II PCR amplified analyzed 2 agarose gel
0.40663978.15331348.html.plaintext.txt	349	Protein G used alone nonimmunocontrol shown
0.40663978.15331348.html.plaintext.txt	350	Co IP assay HNF interaction PXR PGC 12
0.40663978.15331348.html.plaintext.txt	351	To confirm physical interaction HNF4 PXR cells anti HNF4 antibody used immunoprecipitate HNF4 cell extracts isolated HepG2 human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	352	If PXR interacts HNF4 cells PXR co IP anti HNF4 antibody detected Western immunoblot analysis using antibody PXR
0.40663978.15331348.html.plaintext.txt	353	Because PXR protein levels low HepG2 cells HepG2 cells transfected PXR expression plasmid
0.40663978.15331348.html.plaintext.txt	354	8A shows antibody PXR detected small amounts PXR HepG2 cell extracts precipitated anti HNF4 antibody
0.40663978.15331348.html.plaintext.txt	355	Rifampicin treatment markedly increased PXR protein IP
0.40663978.15331348.html.plaintext.txt	356	Anti HNF4 antibody detected similar amounts HNF4 vehicle rifampicin treated cell extracts
0.40663978.15331348.html.plaintext.txt	357	We also co IP assay using human primary hepatocytes overexpression PXR
0.40663978.15331348.html.plaintext.txt	358	Figure 8B shows co IP assay using anti HNF4 antibody precipitate cell extracts human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	359	Anti PXR antibody detected small amount PXR protein IP
0.40663978.15331348.html.plaintext.txt	360	Rifampicin pretreatment hepatocytes markedly increased amounts PXR co IP HNF4
0.40663978.15331348.html.plaintext.txt	361	Anti PGC 1 antibody detected PGC 1 protein IP rifampicin pretreatment markedly reduced amounts PGC 1 protein IP
0.40663978.15331348.html.plaintext.txt	362	These data confirmed rifampicin enhanced PXR interaction HNF4 revealed mammalian two hybrid assays shown Fig
0.40663978.15331348.html.plaintext.txt	363	Rifampicin reduced PGC 1 co IP HNF4
0.40663978.15331348.html.plaintext.txt	364	These results consistent finding two hybrid assays Fig
0.40663978.15331348.html.plaintext.txt	365	6 B C ChIP assays Fig
0.40663978.15331348.html.plaintext.txt	366	7B rifampicin promoted PXR interaction HNF4 excluded PGC 1 interaction HNF4
0.40663978.15331348.html.plaintext.txt	367	View larger version 27K Fig
0.40663978.15331348.html.plaintext.txt	368	Coimmunoprecipitation assay HNF4 interaction PXR PGC 1
0.40663978.15331348.html.plaintext.txt	369	A coimmunoprecipitation assay using HepG2 cell extracts
0.40663978.15331348.html.plaintext.txt	370	HepG2 cells transfected PXR expression plasmid treated either vehicle DMSO 10 microM rifampicin 40 h
0.40663978.15331348.html.plaintext.txt	371	Rabbit anti HNF4 antibody ab added immunoprecipitate cell lysates described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	372	Western immunoblot analyses performed using goat anti PXR anti HNF4 antibody detect PXR HNF4 precipitates
0.40663978.15331348.html.plaintext.txt	373	B coimmunoprecipitation assay using human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	374	Human primary hepatoctyes HH1148 treated DMSO 10 microM rifampicin 40 h
0.40663978.15331348.html.plaintext.txt	375	Rabbit anti HNF4 antibody added cells lysates described MATERIALS AND METHODS
0.40663978.15331348.html.plaintext.txt	376	Western immunoblot analyses performed using goat anti HNF4 PXR PGC 1 antibody detect proteins immunoprecipitates
0.40663978.15331348.html.plaintext.txt	377	Protein G added negative control
0.40663978.15331348.html.plaintext.txt	378	DISCUSSION TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES In report studied mechanism rifampicin PXR inhibition human CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	379	We established human primary hepatocyte suitable model studying CYP7A1 gene regulation nuclear receptors PGC 1
0.40663978.15331348.html.plaintext.txt	380	Q PCR analysis reveals CYP7A1 mRNA expression levels repressed human primary hepatocytes likely negative effects several negative regulators human CYP7A1 gene FTF COUP TFII PXR Prox1 see SHP may dominant positive effect activators HNF4 PGC 1
0.40663978.15331348.html.plaintext.txt	381	Q PCR analysis showed CDCA strongly reduced CYP7A1 induced SHP mRNA expression human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	382	This inverse relationship CDCA effect CYP7A1 SHP expression consistent FXRSHP mechanism bile acid inhibition CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	383	In contrast rifampicin strongly reduced CYP7A1 SHP mRNA expression human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	384	This result provides strong evidence SHP involved PXR inhibition CYP7A1 reduction negative factor result induction CYP7A1 expression
0.40663978.15331348.html.plaintext.txt	385	Our preliminary results show rifampicin activated PXR inhibits human SHP reporter activity data shown
0.40663978.15331348.html.plaintext.txt	386	In bile acid drug induced cholestasis PXR may activated induce CYP3A4 catalyzes 6 hydroxylation bile acids renal excretion
0.40663978.15331348.html.plaintext.txt	387	PXR also induces dehydroepiandrosterone sulfotransferase excretes sulfate conjugated bile acids
0.40663978.15331348.html.plaintext.txt	388	Our findings suggest PXR inhibition CYP7A1 gene transcription may additional mechanism reducing intrahepatic bile acid concentrations protect liver toxic effects bile acids xenobiotics
0.40663978.15331348.html.plaintext.txt	389	PXR inhibition SHP may also part PXR protection mechanism SHP could interact PXR inhibit CYP3A4 induction 22
0.40663978.15331348.html.plaintext.txt	390	Our cell based mammalian two hybrid assay co IP ChIP assays confirm interactions PXR HNF4 PGC 1
0.40663978.15331348.html.plaintext.txt	391	The interaction PXR HNF4 novel consistent model factors bound BARE I BARE II interact coordinately regulate basal transcription CYP7A1 gene 8
0.40663978.15331348.html.plaintext.txt	392	HNF4 known play central role regulation bile acid synthesis 3
0.40663978.15331348.html.plaintext.txt	393	There reports HNF4 required PXR mediated xenobiotic induction CYP3A4 mice 31 HNF4 regulates PXR expression xenobiotic response fetal liver development 14
0.40663978.15331348.html.plaintext.txt	394	Therefore PXR HNF4 interaction may physiologically important coordinated regulation xenobiotic bile acid metabolisms
0.40663978.15331348.html.plaintext.txt	395	Both two hybrid assay co IP assay using HepG2 primary hepatocyte extracts show rifampicin markedly enhances PXR interaction HNF4
0.40663978.15331348.html.plaintext.txt	396	The interaction PXR PGC 1 strong HNF4 PGC 1
0.40663978.15331348.html.plaintext.txt	397	This first report PXR target PGC 1
0.40663978.15331348.html.plaintext.txt	398	Rifampicin required PXR interact PGC 1 affect HNF4 PXR binding CYP7A1 chromatin
0.40663978.15331348.html.plaintext.txt	399	On hand rifampicin dissociates PGC 1 CYP7A1 chromatin likely due enhancing PXR interaction HNF4
0.40663978.15331348.html.plaintext.txt	400	Our results suggest model PXR HNF4 PGC 1 regulation CYP7A1 gene Fig
0.40663978.15331348.html.plaintext.txt	401	HNF4 PGC 1 important transactivators human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	402	PGC 1 interacts HNF4 binds BARE II activates human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	403	According study PXR binds BARE I interacts PGC 1 may important basal transcription CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	404	It noted model suggest ternary complex formation among PXR HNF4 PGC 1
0.40663978.15331348.html.plaintext.txt	405	PGC 1 coactivator binds LBD PXR HNF4
0.40663978.15331348.html.plaintext.txt	406	Therefore likely PGC 1 interacts simultaneously nuclear receptors
0.40663978.15331348.html.plaintext.txt	407	Ubiquitous coactivators SRC 1 CBP known interact PXR HNF4 however data show much stronger interaction PXR PGC 1 SRC 1
0.40663978.15331348.html.plaintext.txt	408	Nuclear receptorcoactivator complexes may facilitate recruitment histone acetytransferase remodel chromatin allow recruitment coactivatormediator complexes assemble general transcriptional machinery regulates RNA polymerase II activity 10
0.40663978.15331348.html.plaintext.txt	409	On basis results propose model activation PXR rifampicin would allow PXR interact directly HNF4 exclude PGC 1 interacting HNF4 resulting suppression CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	410	Corepressors SMRT NCoR1 shown inhibit nuclear receptor activity 7
0.40663978.15331348.html.plaintext.txt	411	Our preliminary results show interaction SMRT NCoR1 HNF4 PXR weak
0.40663978.15331348.html.plaintext.txt	412	It also possible rifampicin activated PXR may compete HNF4 PGC 1 thus inhibiting CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	413	This mechanism PXR inhibition gene transcription likely PGC 1 interaction PXR HNF4 require ligand rifampicin activated PXR HNF4 known strongly induce inhibit CYP3A4 gene transcription
0.40663978.15331348.html.plaintext.txt	414	View larger version 35K Fig
0.40663978.15331348.html.plaintext.txt	415	A model rifampicin PXR regulation CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	416	Top HNF4 PGC 1 important activators human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	417	PGC 1 interacts HNF4 binds BARE II transactivates human CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	418	According study PXR able bind BARE I
0.40663978.15331348.html.plaintext.txt	419	Coactivators SRC 1 cAMP response element binding protein binding protein CBP histone acetytransferase HAT may also recruited remodel chromatin recruit coactivator complexes induce basal transcription CYP7A1 gene RNA polymerase II
0.40663978.15331348.html.plaintext.txt	420	Bottom rifampicin activates PXR promote interaction HNF4
0.40663978.15331348.html.plaintext.txt	421	This interaction may disrupt interaction PGC 1 HNF4 may also PXR result suppression CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	422	Corepressors histone deacetylase HDAC may also recruited inhibit CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	423	Very recently homeobox transcription factor Prox1 shown interact specifically FTF inhibits CYP7A1 gene 24
0.40663978.15331348.html.plaintext.txt	424	Prox1 expressed liver intestine may play important role liver development also regulation bile acid synthesis
0.40663978.15331348.html.plaintext.txt	425	Our Q PCR analysis detects high levels Prox1 mRNA human primary hepatocytes indicating Prox1 might dominant repressor CYP7A1 gene expression human livers
0.40663978.15331348.html.plaintext.txt	426	However known whether bile acids drugs affect Prox1 interaction FTF HNF4 PXR
0.40663978.15331348.html.plaintext.txt	427	Another recent report 28 shows Prox1 interacts FTF inhibits SHP gene expression Prox1 specifically interacts histone deacetylase HDAC3
0.40663978.15331348.html.plaintext.txt	428	HDACs known form complexes nuclear receptors corepressors inhibit gene transcription 13
0.40663978.15331348.html.plaintext.txt	429	The roles transcriptional repressors mediating bile acid inhibition CYP7A1 gene transcription remain elucidated
0.40663978.15331348.html.plaintext.txt	430	In summary study provides first evidence PXR able interact HNF4 PGC 1 plays role mediating rifampicin bile acid inhibition CYP7A1 gene transcription
0.40663978.15331348.html.plaintext.txt	431	On ligand binding PXR interacts HNF4 blocks PGC 1 interaction HNF4 results inhibition CYP7A1 gene
0.40663978.15331348.html.plaintext.txt	432	The PXR pathway may important preventing bile acid drug induced cholestasis inhibiting bile acid synthesis well stimulating bile acid transport excretion detoxification
0.40663978.15331348.html.plaintext.txt	433	Thus PXR plays central role coordinated regulation bile acid homeostasis drug metabolism
0.40663978.15331348.html.plaintext.txt	434	This may mechanism using rifampicin steroids treat pruritus intrahepatic cholestasis primary biliary cirrhosis 1 12
0.40663978.15331348.html.plaintext.txt	435	Efficacious PXR agonists may developed treating chronic liver diseases
0.40663978.15331348.html.plaintext.txt	436	GRANTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES This study supported National Institute Diabetes Digestive Kidney Diseases Grants DK 44442 DK 58379
0.40663978.15331348.html.plaintext.txt	437	ACKNOWLEDGMENTS We thank Dr
0.40663978.15331348.html.plaintext.txt	438	Strom providing human primary hepatocytes
0.40663978.15331348.html.plaintext.txt	439	Spalding Yoder gratefully acknowledged
0.40663978.15331348.html.plaintext.txt	440	FOOTNOTES Address correspondence J
0.40663978.15331348.html.plaintext.txt	441	Biochemistry Molecular Pathology Northeastern Ohio Univ
0.40663978.15331348.html.plaintext.txt	442	College Medicine 4209 State Route 44 P
0.40663978.15331348.html.plaintext.txt	443	Box 95 Rootstown OH 44272 E mail jchiangatneoucom
0.40663978.15331348.html.plaintext.txt	444	The costs publication article defrayed part payment page charges
0.40663978.15331348.html.plaintext.txt	445	The article must therefore hereby marked advertisement accordance 18 U
0.40663978.15331348.html.plaintext.txt	446	Section 1734 solely indicate fact
0.40663978.15331348.html.plaintext.txt	447	REFERENCES TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES Bachs L Pares A Elena M Piera C Rodes J
0.40663978.15331348.html.plaintext.txt	448	Comparison rifampicin phenobarbitone treatment pruritus biliary cirrhosis
0.40663978.15331348.html.plaintext.txt	449	ISIMedline Chen W Owsley E Yang Y Stroup D Chiang JY
0.40663978.15331348.html.plaintext.txt	450	Nuclear receptor mediated repression human cholesterol 7 hydroxylase gene transcription bile acids
0.40663978.15331348.html.plaintext.txt	451	J Lipid Res 42 1402 1412 2001
0.40663978.15331348.html.plaintext.txt	452	AbstractFree Full Text Chiang JY
0.40663978.15331348.html.plaintext.txt	453	Bile Acid regulation gene expression roles nuclear hormone receptors
0.40663978.15331348.html.plaintext.txt	454	Endocr Rev 23 443 463 2002
0.40663978.15331348.html.plaintext.txt	455	AbstractFree Full Text Chiang JY
0.40663978.15331348.html.plaintext.txt	456	Regulation bile acid synthesis pathways nuclear receptors mechanisms
0.40663978.15331348.html.plaintext.txt	457	J Hepatol 40 539 551 2004
0.40663978.15331348.html.plaintext.txt	458	CrossRefISIMedline Chiang JY Kimmel R Stroup D
0.40663978.15331348.html.plaintext.txt	459	Regulation cholesterol 7 hydroxylase gene CYP7A1 transcription liver orphan receptor LXR
0.40663978.15331348.html.plaintext.txt	460	CrossRefISIMedline Chiang JYL Miller WF Lin GM
0.40663978.15331348.html.plaintext.txt	461	Regulation cholesterol 7 hydroxylase liverPurification cholesterol 7 hydroxylase immunochemical evidence induction cholesterol 7 hydroxylase cholestyramine circadian rhythm
0.40663978.15331348.html.plaintext.txt	462	J Biol Chem 265 3889 3897 1990
0.40663978.15331348.html.plaintext.txt	463	AbstractFree Full Text Cohen RN Putney A Wondisford FE Hollenberg AN
0.40663978.15331348.html.plaintext.txt	464	The nuclear corepressors recognize distinct nuclear receptor complexes
0.40663978.15331348.html.plaintext.txt	465	Mol Endocrinol 14 900 914 2000
0.40663978.15331348.html.plaintext.txt	466	AbstractFree Full Text Crestani M Sadeghpour A Stroup D Gali G Chiang JYL
0.40663978.15331348.html.plaintext.txt	467	Transcriptional activation cholesterol 7 hydroxylase gene CYP7A nuclear hormone receptors
0.40663978.15331348.html.plaintext.txt	468	J Lipid Res 39 2192 2200 1998
0.40663978.15331348.html.plaintext.txt	469	Free Full Text Drocourt L Ourlin JC Pascussi JM Maurel P Vilarem MJ
0.40663978.15331348.html.plaintext.txt	470	Expression CYP3A4 CYP2B6 CYP2C9 regulated vitamin D receptor pathway primary human hepatocytes
0.40663978.15331348.html.plaintext.txt	471	J Biol Chem 277 25125 25132 2002
0.40663978.15331348.html.plaintext.txt	472	AbstractFree Full Text Glass CK Rose DW Rosenfeld MG
0.40663978.15331348.html.plaintext.txt	473	Curr Opin Cell Biol 9 222 232 1997
0.40663978.15331348.html.plaintext.txt	474	CrossRefISIMedline Handschin C Meyer UA
0.40663978.15331348.html.plaintext.txt	475	Induction drug metabolism role nuclear receptors
0.40663978.15331348.html.plaintext.txt	476	Pharmacol Rev 55 649 673 2003
0.40663978.15331348.html.plaintext.txt	477	AbstractFree Full Text Hofmann AF
0.40663978.15331348.html.plaintext.txt	478	Rifampicin treatment cholestatic pruritus
0.40663978.15331348.html.plaintext.txt	479	Free Full Text Ishizuka T Lazar MA
0.40663978.15331348.html.plaintext.txt	480	The N CoRhistone deacetylase 3 complex required repression thyroid hormone receptor
0.40663978.15331348.html.plaintext.txt	481	Mol Cell Biol 23 5122 5131 2003
0.40663978.15331348.html.plaintext.txt	482	AbstractFree Full Text Kamiya A Inoue Y Gonzalez FJ
0.40663978.15331348.html.plaintext.txt	483	Role hepatocyte nuclear factor 4 control pregnane X receptor fetal liver development
0.40663978.15331348.html.plaintext.txt	484	Hepatology 37 1375 1384 2003
0.40663978.15331348.html.plaintext.txt	485	CrossRefISIMedline Kerr TA Saeki S Schneider M Schaefer K Berdy S Redder T Shan B Russell DW Schwarz M
0.40663978.15331348.html.plaintext.txt	486	Loss nuclear receptor SHP impairs eliminate negative feedback regulation bile acid synthesis
0.40663978.15331348.html.plaintext.txt	487	Selection optimal internal controls gene expression profiling liver disease
0.40663978.15331348.html.plaintext.txt	488	Biotechniques 35 456 458 460 2003
0.40663978.15331348.html.plaintext.txt	489	ISIMedline Kliewer SA Goodwin B Willson TM
0.40663978.15331348.html.plaintext.txt	490	The nuclear pregnane X receptor key regulator xenobiotic metabolism
0.40663978.15331348.html.plaintext.txt	491	Endocr Rev 23 687 702 2002
0.40663978.15331348.html.plaintext.txt	492	AbstractFree Full Text Kliewer SA Willson TM
0.40663978.15331348.html.plaintext.txt	493	Regulation xenobiotic bile acid metabolism nuclear pregnane X receptor
0.40663978.15331348.html.plaintext.txt	494	J Lipid Res 43 359 364 2002
0.40663978.15331348.html.plaintext.txt	495	AbstractFree Full Text Lehmann JM McKee DD Watson MA Willson TM Moore JT Kliewer SA
0.40663978.15331348.html.plaintext.txt	496	The human orphan nuclear receptor PXR activated compounds regulate CYP3A4 gene expression cause drug interactions
0.40663978.15331348.html.plaintext.txt	497	J Clin Invest 102 1016 1023 1998
0.40663978.15331348.html.plaintext.txt	498	AbstractFree Full Text Li YC Wang DP Chiang JYL
0.40663978.15331348.html.plaintext.txt	499	Regulation cholesterol 7 hydroxylase liver cDNA cloning sequencing regulation cholesterol 7 hydroxylase mRNA
0.40663978.15331348.html.plaintext.txt	500	J Biol Chem 265 12012 12019 1990
0.40663978.15331348.html.plaintext.txt	501	AbstractFree Full Text Menke JG Macnaul KL Hayes NS Baffic J Chao YS Elbrecht A Kelly LJ Lam MH Schmidt A Sahoo S Wang J Wright SD Xin P Zhou G Moller DE Sparrow CP
0.40663978.15331348.html.plaintext.txt	502	A novel liver X receptor agonist establishes species differences regulation cholesterol 7 hydroxylase CYP7a
0.40663978.15331348.html.plaintext.txt	503	Endocrinology 143 2548 2558
0.40663978.15331348.html.plaintext.txt	504	AbstractFree Full Text Ourlin JC Lasserre F Pineau T Fabre JM Sa Cunha A Maurel P Vilarem MJ Pascussi JM
0.40663978.15331348.html.plaintext.txt	505	The small heterodimer partner interacts pregnane X receptor represses transcriptional activity
0.40663978.15331348.html.plaintext.txt	506	Mol Endocrinol 17 1693 1703 2003
0.40663978.15331348.html.plaintext.txt	507	AbstractFree Full Text Puigserver P Spiegelman BM
0.40663978.15331348.html.plaintext.txt	508	Peroxisome proliferator activated receptor gamma coactivator 1 PGC 1 transcriptional coactivator metabolic regulator
0.40663978.15331348.html.plaintext.txt	509	AbstractFree Full Text Qin J Gao DM Jiang QF Zhou Q Kong YY Wang Y Xie YH
0.40663978.15331348.html.plaintext.txt	510	Prox1 corepressor human liver receptor homologue 1 suppresses transcription cholesterol 7 hydroxylase gene
0.40663978.15331348.html.plaintext.txt	511	Mol Endocrinol 18 2424 2439 2004
0.40663978.15331348.html.plaintext.txt	512	AbstractFree Full Text Schreiber SN Knutti D Brogli K Uhlmann T Kralli A
0.40663978.15331348.html.plaintext.txt	513	The transcriptional coactivator PGC 1 regulates expression activity orphan nuclear receptor estrogen related receptor ERR
0.40663978.15331348.html.plaintext.txt	514	J Biol Chem 278 9013 9018 2003
0.40663978.15331348.html.plaintext.txt	515	AbstractFree Full Text Sinal CJ Tohkin M Miyata M Ward JM Lambert G Gonzalez FJ
0.40663978.15331348.html.plaintext.txt	516	Targeted disruption nuclear receptor FXRBAR impairs bile acid lipid homeostasis
0.40663978.15331348.html.plaintext.txt	517	ISIMedline Staudinger JL Goodwin B Jones SA Hawkins Brown D MacKenzie KI LaTour A Liu Y Klaassen CD Brown KK Reinhard J Willson TM Koller BH Kliewer SA
0.40663978.15331348.html.plaintext.txt	518	The nuclear receptor PXR lithocholic acid sensor protects liver toxicity
0.40663978.15331348.html.plaintext.txt	519	Proc Natl Acad Sci USA 98 3369 3374 2001
0.40663978.15331348.html.plaintext.txt	520	AbstractFree Full Text Steffensen KR Holter E Bavner A Nilsson M Pelto Huikko M Tomarev S Treuter E
0.40663978.15331348.html.plaintext.txt	521	Functional conservation interactions homeodomain cofactor mammalian FTZ F1 homologue
0.40663978.15331348.html.plaintext.txt	522	AbstractFree Full Text Stroup D Chiang JYL
0.40663978.15331348.html.plaintext.txt	523	HNF4 COUP TFII interact modulate transcription cholesterol 7 hydroxylase gene CYP7A
0.40663978.15331348.html.plaintext.txt	524	AbstractFree Full Text Takeshita A Taguchi M Koibuchi N Ozawa Y
0.40663978.15331348.html.plaintext.txt	525	Putative role orphan nuclear receptor SXR steroid xenobiotic receptor mechanism CYP3A4 inhibition xenobiotics
0.40663978.15331348.html.plaintext.txt	526	J Biol Chem 277 32453 32458 2002
0.40663978.15331348.html.plaintext.txt	527	AbstractFree Full Text Tirona RG Lee W Leake BF Lan LB Cline CB Lamba V Parviz F Duncan SA Inoue Y Gonzalez FJ Schuetz EG Kim RB
0.40663978.15331348.html.plaintext.txt	528	The orphan nuclear receptor HNF4 determines PXR CAR mediated xenobiotic induction CYP3A4
0.40663978.15331348.html.plaintext.txt	529	CrossRefISIMedline Wang DP Stroup D Marrapodi M Crestani M Galli G Chiang JYL
0.40663978.15331348.html.plaintext.txt	530	Transcriptional regulation human cholesterol 7 hydroxylase gene CYP7A HepG2 cells
0.40663978.15331348.html.plaintext.txt	531	J Lipid Res 37 1831 1841 1996
0.40663978.15331348.html.plaintext.txt	532	Abstract Wang L Lee YK Bundman D Han Y Thevananther S Kim CS Chua SS Wei P Heyman RA Karin M Moore DD
0.40663978.15331348.html.plaintext.txt	533	Redundant pathways negative feedback regulation bile Acid production
0.40663978.15331348.html.plaintext.txt	534	ISIMedline Xie W Radominska Pandya A Shi Y Simon CM Nelson MC Ong ES Waxman DJ Evans RM
0.40663978.15331348.html.plaintext.txt	535	An essential role nuclear receptors SXRPXR detoxification cholestatic bile acids
0.40663978.15331348.html.plaintext.txt	536	Proc Natl Acad Sci USA 98 3375 3380 2001
0.24508433.7797489.html.plaintext.txt	0	1995 The American Society Biochemistry Molecular Biology Inc
0.24508433.7797489.html.plaintext.txt	1	Expression Screening Reveals Orphan Receptor Chick Ovalbumin Upstream Promoter Transcription Factor I Regulator NeuriteSubstrate Cell Contacts Cell Aggregation
0.24508433.7797489.html.plaintext.txt	2	Henry Connor Howard Nornes Toomas Neuman
0.24508433.7797489.html.plaintext.txt	3	From 1Department Anatomy Neurobiology Colorado State University Fort Collins Colorado 80523 ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION FOOTNOTES REFERENCES
0.24508433.7797489.html.plaintext.txt	4	A rat homologue chick ovalbumin upstream promoter transcription factor I COUP TF I isolated using expression cloning method developed iso late neurite outgrowth inhibitors
0.24508433.7797489.html.plaintext.txt	5	Overexpression COUP TF I 3T3 fibroblasts resulted reduction stable contact formation neurites transfected cells
0.24508433.7797489.html.plaintext.txt	6	Additionally COUP TF I enhanced retinoic acid response element dependent reporter gene expression 3T3 fibroblasts indicating COUP TF I modulate transcriptional activation cells
0.24508433.7797489.html.plaintext.txt	7	Our data suggest COUP TF transcription factors involved regulation cell surface molecules neurogenesis
0.24508433.7797489.html.plaintext.txt	8	Nuclear hormone receptors function ligand dependent transcription factors crucial role establishing initial cellular diversity nervous system
0.24508433.7797489.html.plaintext.txt	9	Among best characterized members superfamily nuclear hormone receptors receptors retinoids thyroid hormones steroid hormones glucocorticoids whose importance neurogenesis well described review see Beato1989 Evans Arriza1989 McEwen et al
0.24508433.7797489.html.plaintext.txt	10	Hormone receptors activate repress gene transcription binding cis acting hormone response elements HREGreen Chambon 1988 Beato 1989
0.24508433.7797489.html.plaintext.txt	11	Besides ligand dependent transcription factors hormone receptor superfamily comprises several orphan receptors ligands known review see Evans1988 Green Chambon1988
0.24508433.7797489.html.plaintext.txt	12	Orphan receptors chicken ovalbumin upstream promoter transcription factor COUP TF homologues isolated Drosophila Mlodzik et al
0.24508433.7797489.html.plaintext.txt	13	1990 sea urchin Chan et al
0.24508433.7797489.html.plaintext.txt	14	1992 zebrafish Fjose et al
0.24508433.7797489.html.plaintext.txt	15	1993 Xenopus Matharu Sweeney 1992 chick Lutz et al
0.24508433.7797489.html.plaintext.txt	16	1994 mammals Miyajima et al
0.24508433.7797489.html.plaintext.txt	17	1991 Ladias Karathanasis 1991
0.24508433.7797489.html.plaintext.txt	18	One possible function COUP TF transcription factors regulate activity ligand activated hormone receptors heterodimer formation competition specific response elements Cooney et al
0.24508433.7797489.html.plaintext.txt	19	Analyses nuclear hormone receptors various systems clearly demonstrate regulation gene expression transcription factors depends presence different ligands also interactions activators repressors
0.24508433.7797489.html.plaintext.txt	20	The role COUP TF orphan receptors neurogenesis virtually unknown
0.24508433.7797489.html.plaintext.txt	21	In Drosophila expression COUP TF homologue seven required development specific subset photoreceptor neurons eye development Mlodzik et al
0.24508433.7797489.html.plaintext.txt	22	1994 COUP TFs expressed complex spatial temporal pattern development nervous system
0.24508433.7797489.html.plaintext.txt	23	The central nervous system adult vertebrates inhibitory axonal growth
0.24508433.7797489.html.plaintext.txt	24	During development inhibitory regions regulate formation neuronal pathways connections Tosney Landmesser 1984 Davies et al
0.24508433.7797489.html.plaintext.txt	25	Several factors responsible neurite outgrowth inhibition characterized Caroni Schwab 1988 Cox et al
0.24508433.7797489.html.plaintext.txt	26	1990 Raper Kapfhammer 1990 Luo et al
0.24508433.7797489.html.plaintext.txt	27	We developed screening system cloning inhibitory molecules transfection cDNA library substrate cells subsequently cocultured neuronal cells screened functional expression neurite outgrowth inhibition
0.24508433.7797489.html.plaintext.txt	28	This approach allows isolation cDNAs surface molecules cause direct inhibition neurite outgrowth well cDNAs factors involved regulating expression molecules inhibit facilitate neurite outgrowth
0.24508433.7797489.html.plaintext.txt	29	This screening system enabled us isolate rat homologue orphan receptor COUP TF I whose overexpression results decreased contact stability neurites substrate cells
0.24508433.7797489.html.plaintext.txt	30	These data suggest possible involvement COUP TF I regulation neurite contacts cell aggregation
0.24508433.7797489.html.plaintext.txt	31	Cell Culture Mouse NIH 3T3 fibroblasts neuroblastoma glioma hybrid NG108 15 Hamprecht 1977 cells grown Dulbeccos modified Eagles medium Life Technologies Inc
0.24508433.7797489.html.plaintext.txt	32	supplemented 10 fetal bovine serum Sigma
0.24508433.7797489.html.plaintext.txt	33	Neuronal differentiation NG108 15 cells achieved culture serum free Dulbeccos modified Eagles medium 72 h
0.24508433.7797489.html.plaintext.txt	34	To establish cell lines overexpressing COUP TF I cDNA cloned expression vector pRcCMV Invitrogen using HindIII linkers transfected 3T3 cells followed selection G418 600 microgml Life Technologies Inc
0.24508433.7797489.html.plaintext.txt	35	Generation Subtraction cDNA Library PolyA RNA isolated FastTrack Invitrogen brains spinal cords embryonic day 17 postnatal day 5 adult rats also chronically injured spinal cords
0.24508433.7797489.html.plaintext.txt	36	24 microg PolyA RNA postnatal day 5 adult injured spinal cord 8 microg used synthesize first strand cDNA using oligodT primer NotI restriction site 5 end 5 CTAGATCGCGAGCGGCCGCCCTTTTTTTTTTTTTTTTT andSuperScript RNaseH reverse transcriptase 200 units microg PolyA RNA Life Technologies Inc
0.24508433.7797489.html.plaintext.txt	37	The first strand synthesis reaction labeled using PdCTP 5 microCi 3000 Cimmol Amersham Corp
0.24508433.7797489.html.plaintext.txt	38	facilitate tracing DNA
0.24508433.7797489.html.plaintext.txt	39	First strand cDNA hybridized embryonic day 17 polyA RNA 200 microg sealed ampules total volume 100 microl buffer 0
0.24508433.7797489.html.plaintext.txt	40	8 300 mM NaCl 2 mM EDTA 0
0.24508433.7797489.html.plaintext.txt	41	2 SDS 18 h 70 degrees C
0.24508433.7797489.html.plaintext.txt	42	The hybridization mix diluted final molarity 0
0.24508433.7797489.html.plaintext.txt	43	08 M sodium phosphate loaded onto DNA grade hydroxylapatite column 4 ml volume Bio Rad washed extensively 0
0.24508433.7797489.html.plaintext.txt	44	08 M sodium phosphate buffer pH 6
0.24508433.7797489.html.plaintext.txt	45	Single stranded cDNAs eluted 10 ml 0
0.24508433.7797489.html.plaintext.txt	46	5 ml exhibiting radioactivity background pooled cDNAs concentrated butanol extraction followed chromatography STE buffer 100 mM NaCl 10 mM Tris HCl pH 7
0.24508433.7797489.html.plaintext.txt	47	4 1 mM EDTA Sephadex G 25 column Pharmacia Biotech Inc
0.24508433.7797489.html.plaintext.txt	48	Single stranded cDNAs mixed 100 microg polyA RNA embryonic day 17 second cycle hybridization
0.24508433.7797489.html.plaintext.txt	49	After second cycle first strand cDNAs hybridized 5 microg original PolyA RNA isolated postnatal day 5 adult injured rats nervous systems resulting DNARNA hybrids used template second strand synthesis RNaseH Escherichia coli DNA polymerase I Life Technologies Inc
0.24508433.7797489.html.plaintext.txt	50	Blunt ends created T4 DNA polymerase HindIII adapter 5 AGCTTGGCACGAG 3 3 ACCGTGCTC 5 ligated cDNA
0.24508433.7797489.html.plaintext.txt	51	Longer cDNAs 700 bp isolated digestion NotI followed size selection Sephacryl S 400 column Pharmacia subsequently cloned HindIII NotI restriction sites expression vector pRcCMV Invitrogen
0.24508433.7797489.html.plaintext.txt	52	The library divided 20 aliquots used transform E
0.24508433.7797489.html.plaintext.txt	53	coli DH5 cells MAX Efficiency Life Technologies Inc
0.24508433.7797489.html.plaintext.txt	54	Each aliquot yielded 5 8 10 colonies combined grown large scale plasmid isolation plasmid maxi kit Qiagen
0.24508433.7797489.html.plaintext.txt	55	The cDNA expression library 2 10 independent clones average insert size 1
0.24508433.7797489.html.plaintext.txt	56	Isolation Cell Clones cDNA Transfection cDNA library fibroblasts performed calcium phosphate coprecipitation technique using 20 microg DNA100 mm tissue culture plates Falcon cell density 2 10 cells per plate incubation time 15 16 h
0.24508433.7797489.html.plaintext.txt	57	Each aliquot cDNA library n 20 used transfect cells 20 plates
0.24508433.7797489.html.plaintext.txt	58	The cDNA library transfected NIH 3T3 fibroblast cells
0.24508433.7797489.html.plaintext.txt	59	Selection transfected cells performed 600 microgml G418 Life Technologies Inc
0.24508433.7797489.html.plaintext.txt	60	14 21 days prior testing neurite outgrowth inhibition
0.24508433.7797489.html.plaintext.txt	61	Screening neurite outgrowth inhibition involved coculture transfected fibroblasts neuroblastoma glioma hybrid cell line NG108 15 differentiated 72 h serum free culture medium prior coculture
0.24508433.7797489.html.plaintext.txt	62	Differentiated NG108 15 cells rapidly established extensive robust network contacts control NIH 3T3 cells indicating fibroblasts provide good substrate contact formation
0.24508433.7797489.html.plaintext.txt	63	Inhibitory clones identified fewer contacts surrounding neurites
0.24508433.7797489.html.plaintext.txt	64	Inhibitory clones isolated propagated
0.24508433.7797489.html.plaintext.txt	65	Genomic DNA prepared isolated clones TurboGen Invitrogen used template amplification cDNAs polymerase chain reaction
0.24508433.7797489.html.plaintext.txt	66	Primers cDNA amplification corresponding flanking sequences pRcCMV vector 5 primer 5 AGCTCTCTGGCTAACTAGAGAAC 3 primer 5 AGCGAGCTCTAGCATTTAGGTGA prepared 35 cycles polymerase chain reaction performed using following conditions 92 degrees C 1
0.24508433.7797489.html.plaintext.txt	67	2 min 58 degrees C 2 min 72 degrees C 4 min
0.24508433.7797489.html.plaintext.txt	68	Amplified DNAs cloned EcoRV site Bluescript plasmid Stratagene sequencing
0.24508433.7797489.html.plaintext.txt	69	Isolated cDNAs vector pRcCMV sequences subcloned pRcCMV expression vector HindIII NotI sites retested neurite inhibition
0.24508433.7797489.html.plaintext.txt	70	Northern Blot Analyses Total RNA isolated using acid guanidiniumphenolchloroform extraction procedure Chomczynski Sacchi 1987
0.24508433.7797489.html.plaintext.txt	71	The RNA 25 microglane fractionated 1
0.24508433.7797489.html.plaintext.txt	72	2 agarose formaldehyde gel transferred nylon membrane Hybond N Amersham
0.24508433.7797489.html.plaintext.txt	73	Full length COUP TF I radiolabeled P using Multiprime DNA labeling system Amersham used probe
0.24508433.7797489.html.plaintext.txt	74	The blots washed high stringency 0
0.24508433.7797489.html.plaintext.txt	75	2 SSC 65 degrees C exposed x ray film 3 days
0.24508433.7797489.html.plaintext.txt	76	Transferred RNAs monitored methylene blue staining filters hybridization
0.24508433.7797489.html.plaintext.txt	77	Analyses Contact Stability Transfected Fibroblasts Neurites NG108 15 Cells Fibroblasts plated 12 well dishes density 2 10 cellswell 72 h prior coculture
0.24508433.7797489.html.plaintext.txt	78	Differentiated NG108 15 cells added density 2 10 cells per well
0.24508433.7797489.html.plaintext.txt	79	2 h coculture initiation fibroblast colonies identified number contacts fibroblasts NG108 15 cells recorded three time points 1 starting time 0 2 0
0.24508433.7797489.html.plaintext.txt	80	5 h starting time 2
0.24508433.7797489.html.plaintext.txt	81	The number contacts used determine direction magnitude change dynamics cell cell interaction
0.24508433.7797489.html.plaintext.txt	82	Analysis data performed one tailed test
0.24508433.7797489.html.plaintext.txt	83	Transfections CAT Assays Cells 3 10 60 mm dishes cotransfected overnight combination plasmid DNA total 15 microg calcium phosphate coprecipitation method
0.24508433.7797489.html.plaintext.txt	84	The DNA mix consisted expression plasmid pRcCMV pRc COUP TF I 9 microg CAT reporter gene construct DR 1 RARE CRBP I 3 microg pRcCMV lacZ 3 microg
0.24508433.7797489.html.plaintext.txt	85	The pRcCMV lacZ construct used facilitate normalization CAT activity transfection efficiency
0.24508433.7797489.html.plaintext.txt	86	Transfections performed triplicate
0.24508433.7797489.html.plaintext.txt	87	Transfection medium replaced 18 h control media media supplemented 10M retinoic acid
0.24508433.7797489.html.plaintext.txt	88	Cells harvested 48 h later processed CAT lacZ assays according methods Sambrook et al
0.24508433.7797489.html.plaintext.txt	89	Protein concentration determined protein assay reagent Bio Rad using bovine serum albumin standard
0.24508433.7797489.html.plaintext.txt	90	Samples CAT assays resolved thin layer chromatography visualized x ray film quantitated liquid scintillation counting
0.24508433.7797489.html.plaintext.txt	91	For construction reporter plasmids oligonucleotides containing corresponding HREs synthesized trimerized cloned EcoRV site Bluescript II KS Stratagene
0.24508433.7797489.html.plaintext.txt	92	Orientation oligonucleotides determined sequencing
0.24508433.7797489.html.plaintext.txt	93	The Bluescript vectors containing oligonucleotides digested HindIIIXbaI fragments separated 10 polyacrylamide gel TBE buffer electroeluted ligated HindIIIXbaI site pBLCAT2 Luckow Schutz 1987
0.24508433.7797489.html.plaintext.txt	94	The following oligonucleotides based DR 1 Kadowaki et al
0.24508433.7797489.html.plaintext.txt	95	1992 CRBP I Tran et al
0.24508433.7797489.html.plaintext.txt	96	1992 synthesized DR 1 5 GGCTTCAGGTCAGAGGTCAGAGA 5 GGTCTCTGACCTCTGACCTGAAG RARE 5 GGTGTAGGGTTCACCGAAAGTTCACTCA 5 GGTGAGTGAACTTTCGGTGAACCCTACA CRBP I 5 CCATCCAGGTCAAAAAGTCAGGA 5 GGTCCTGACTTTTTGACCTGGAT
0.24508433.7797489.html.plaintext.txt	97	The HRE sequences underlined
0.24508433.7797489.html.plaintext.txt	98	Preparation Whole Cell Extracts Electrophoretic Mobility Shift Assay EMSA These methods performed 4 degrees C previously described Scholer et al
0.24508433.7797489.html.plaintext.txt	99	Briefly extraction buffer contained 20 mM Hepes pH 7
0.24508433.7797489.html.plaintext.txt	100	5 mM dithiothreitol 25 glycerol protease inhibitors phenylmethylsulfonyl fluoride 0
0.24508433.7797489.html.plaintext.txt	101	7 microgml aprotinin 1 microgml bestatin 40 microgml
0.24508433.7797489.html.plaintext.txt	102	Sonicated extracts cleared centrifugation 5 min
0.24508433.7797489.html.plaintext.txt	103	Binding conditions EMSA 10 mM Hepes pH 7
0.24508433.7797489.html.plaintext.txt	104	8 1 mM spermidine 5 mM MgCl 50 mM KCl 0
0.24508433.7797489.html.plaintext.txt	105	5 mM dithiothreitol 9 glycerol 0
0.24508433.7797489.html.plaintext.txt	106	8 microg polydI dC 50000 cpm P labeled oligonucleotide 10 microg cell extract
0.24508433.7797489.html.plaintext.txt	107	After incubation 15 min 25 degrees C DNA protein complexes separated 5 polyacrylamide gel followed autoradiography
0.24508433.7797489.html.plaintext.txt	108	Three different batches extracts used EMSA analyses batch differences observed
0.24508433.7797489.html.plaintext.txt	109	Cloning COUP TF I Expression screening subtraction cDNA library performed isolate genes inhibit neurite outgrowth
0.24508433.7797489.html.plaintext.txt	110	The cDNA library pRcCMV expression vector transfected NIH 3T3 fibroblasts 3 weeks antibiotic selection several clones less contacts neurites isolated
0.24508433.7797489.html.plaintext.txt	111	These clones propagated transfected cDNAs isolated using polymerase chain reaction retested neurite outgrowth inhibition
0.24508433.7797489.html.plaintext.txt	112	Sequence analysis revealed one cDNA rat homologue human orphan receptor COUP TF I lacking 40 amino acids transactivation domain localized near amino terminus DNA binding domain COUP TF I
0.24508433.7797489.html.plaintext.txt	113	Full length COUP TF I cDNA isolated high stringency screening brain cDNA library cloned ZAPII vector Stratagene
0.24508433.7797489.html.plaintext.txt	114	The rCOUP TF I cDNA encodes protein predicted molecular mass 45
0.24508433.7797489.html.plaintext.txt	115	8 kilodaltons Genbank accession number U10995 98 identical human COUP TF I amino acid level 95 identity nucleotide level
0.24508433.7797489.html.plaintext.txt	116	COUP TF I Interacts HREs Fibroblasts Expression COUP TF I analyzed Northern blot using six COUP TF I three pRcCMV vector transfected clones
0.24508433.7797489.html.plaintext.txt	117	Vector transfected untransfected fibroblasts express detectable levels COUP TF I Fig
0.24508433.7797489.html.plaintext.txt	118	Three transfected clones expressed introduced COUP TF I high levels Fig
0.24508433.7797489.html.plaintext.txt	119	1A lanes6 7 9 two clones expressed moderate levels Fig
0.24508433.7797489.html.plaintext.txt	120	1A lanes3 5 one clone express COUP TF I detectable level Fig
0.24508433.7797489.html.plaintext.txt	121	Figure 1 Expression activity COUP TF I transfected fibroblasts
0.24508433.7797489.html.plaintext.txt	122	A Northern blot analyses COUP TF I expression control 3T3 fibroblasts lane1 fibroblast clones transfected COUP TF I cDNA cloned pRcCMV expression vector lanes2 8 pRcCMV vector lanes9 10
0.24508433.7797489.html.plaintext.txt	123	Expression COUP TF I high clones 7 9 lanes6 8 respectively varied undetectable moderate clones 2 5 lanes2 5 respectively
0.24508433.7797489.html.plaintext.txt	124	B EMSA analysis control fibroblasts lane 1 fibroblasts transfected pRcCMV expression vector lane2 COUP TF I cDNA pRcCMV lane3
0.24508433.7797489.html.plaintext.txt	125	Cell extracts analyzed EMSA using oligonucleotides DR 1 RARE CRBP I
0.24508433.7797489.html.plaintext.txt	126	As control binding specificity 100 times molar excess corresponding unlabeled oligonucleotides added binding reaction lane4
0.24508433.7797489.html.plaintext.txt	127	C transient CAT activity DR 1 TK CAT DR 1 RARE TK CAT RARE CRBP I TK CAT CRBP reporter constructs presence pRcCMV CMV COUP TF I expressing plasmid pRcCMV COUP TF I COUP
0.24508433.7797489.html.plaintext.txt	128	Subsets transfection group treated 10M retinoic acid RA
0.24508433.7797489.html.plaintext.txt	129	All cells cotransfected pRcCMVlacZ constructs facilitate normalization CAT gene expression transfection efficiency
0.24508433.7797489.html.plaintext.txt	130	All treatments done triplicate numbers represent values two experiments
0.24508433.7797489.html.plaintext.txt	131	Values normalized based upon transfection efficiency expressed relative results obtained transfection pRcCMV transfected cells corresponding reporter plasmid activities set 1
0.24508433.7797489.html.plaintext.txt	132	Results analyzed one tailed test
0.24508433.7797489.html.plaintext.txt	133	Since COUP TF I form inactive complexes retinoid X receptors RXR binds HREs different genes homodimer repress hormone response Cooney et al
0.24508433.7797489.html.plaintext.txt	134	1992 used EMSA analysis examine whether overexpression COUP TF I fibroblasts affects formation HRE binding complexes
0.24508433.7797489.html.plaintext.txt	135	Since effects COUP TF I depend HRE sequence analyzed two natural one synthetic HRE RARE direct repeat 5 bp spacer activated RAR inhibited COUP TF I Tran et al
0.24508433.7797489.html.plaintext.txt	136	1992 CRBP I RARE direct repeat 2 bp spacer optimally activated RARRXR heterodimers RXR homodimers Hermann et al
0.24508433.7797489.html.plaintext.txt	137	1992 DR 1 direct repeat contains 1 bp spacer high affinity COUP TF I Kadowaki et al
0.24508433.7797489.html.plaintext.txt	138	1992 RXRs Mangelsdorf et al
0.24508433.7797489.html.plaintext.txt	139	Our results demonstrated pattern protein DNA complexes changed COUP TF I overexpressing cells compared controls Fig
0.24508433.7797489.html.plaintext.txt	140	A unique DNA protein complex Fig
0.24508433.7797489.html.plaintext.txt	141	1B arrow detected extracts made COUP TF I overexpressing cells
0.24508433.7797489.html.plaintext.txt	142	Antibodies developed laboratory COUP TF I supershifted complex data shown verifying presence COUP TF I complex
0.24508433.7797489.html.plaintext.txt	143	The role COUP TF I activator inhibitor transcription 3T3 cells examined transient CAT assays using RARE CRBP I DR 1 oligonucleotides coupled TK promoter CAT reporter gene
0.24508433.7797489.html.plaintext.txt	144	Results cotransfections reporter constructs pRcCMV COUP TF I expression vectors shown Fig
0.24508433.7797489.html.plaintext.txt	145	Cotransfection COUP TF I significantly induced p 0
0.24508433.7797489.html.plaintext.txt	146	05 RARE containing reporter construct activity Fig
0.24508433.7797489.html.plaintext.txt	147	Addition retinoic acid induced expression p 0
0.24508433.7797489.html.plaintext.txt	148	01 RARE reporter gene construct cells cotransfected pRcCMV control expression vector levels similar p 0
0.24508433.7797489.html.plaintext.txt	149	05 cells cotransfected COUP TF I presence absence retinoic acid
0.24508433.7797489.html.plaintext.txt	150	No significant effects COUP TF I retinoic acid treatment reporter gene expression constructs detected
0.24508433.7797489.html.plaintext.txt	151	In experiments COUP TF I functioned positive regulator RARE coupled reporter gene expression 3T3 fibroblasts
0.24508433.7797489.html.plaintext.txt	152	COUP TF I Overexpression Changes Contact Stability Transfected Fibroblasts Neurites The growth rate neurites NG108 15 cells rapid robust makes good model studying cell cell interaction contact stability
0.24508433.7797489.html.plaintext.txt	153	Analyses neurite contact stability performed fibroblast clones overexpressing COUP TF I
0.24508433.7797489.html.plaintext.txt	154	Fibroblasts transfected pRcCMV vector naive fibroblasts used controls
0.24508433.7797489.html.plaintext.txt	155	There general increase number contacts course experimental period
0.24508433.7797489.html.plaintext.txt	156	This increase different naive control fibroblasts fibroblasts transfected expression vector 205 plus minus 64 versus 160 plus minus 37 respectively p 0
0.24508433.7797489.html.plaintext.txt	157	However fibroblasts transfected COUP TF I clones 5 8 9 exhibited significantly p 0
0.24508433.7797489.html.plaintext.txt	158	05 lower increase contact number 51 plus minus 14 18 plus minus 20 38 plus minus 27 respectively Fig
0.24508433.7797489.html.plaintext.txt	159	2 indicative lower contact stability
0.24508433.7797489.html.plaintext.txt	160	While differences level expression COUP TF I apparent clones 5 8 9 Fig
0.24508433.7797489.html.plaintext.txt	161	1A lanes5 7 9 respectively contact stability dependent upon level expression COUP TF I cDNA p 0
0.24508433.7797489.html.plaintext.txt	162	Neuroblastoma glioma NG108 15 cells rapidly growing neurites large growth cones filopodia
0.24508433.7797489.html.plaintext.txt	163	After contact control fibroblasts growth cones maintain form Fig
0.24508433.7797489.html.plaintext.txt	164	In contrast processes NG108 15 cells exhibit retraction become small contact COUP TF I expressing cells indicative growth cone collapse contact instability Fig
0.24508433.7797489.html.plaintext.txt	165	The increased number contacts cultures comes NG108 15 cells vicinity fibroblasts
0.24508433.7797489.html.plaintext.txt	166	Since differentiated NG108 15 cells observed equal probability establish maintain contacts fibroblasts test determines stability cell cell contact
0.24508433.7797489.html.plaintext.txt	167	Figure 2 Cells expressing COUP TF I exhibit lower p 0
0.24508433.7797489.html.plaintext.txt	168	05 contact stability cocultured NG108 15 cells
0.24508433.7797489.html.plaintext.txt	169	Contact stability assayed three groups 1 naive fibroblasts control 2 cells transfected pRcCMV vector CMV 3 3 three clones transfected COUP TF I cDNA COUP 5 COUP 8 COUP 9
0.24508433.7797489.html.plaintext.txt	170	The number contacts cell types time 0 2
0.24508433.7797489.html.plaintext.txt	171	5 h used calculate percentage change number contacts colony cells observed
0.24508433.7797489.html.plaintext.txt	172	The bars represent average percentage change number contacts observed group represent data three separate experiments
0.24508433.7797489.html.plaintext.txt	173	The number observations n group given
0.24508433.7797489.html.plaintext.txt	174	Figure 3 Interactions neurites control COUP TF I overexpressing 3T3 fibroblasts
0.24508433.7797489.html.plaintext.txt	175	2 h addition NG108 15 cells 0 fibroblast clones identified photographed various times culture period given panel
0.24508433.7797489.html.plaintext.txt	176	Fibroblasts transfected pRcCMV control vector F upperCMVpanel provide good substrate support processes NG108 15 cells N
0.24508433.7797489.html.plaintext.txt	177	The processes robust contacts arrows persistent prolonged culture
0.24508433.7797489.html.plaintext.txt	178	In contrast cells overexpressing COUP TF I cDNA F lowerCOUPpanel sustain significant attachment processes NG108 15 cells
0.24508433.7797489.html.plaintext.txt	179	During culture period contacts arrows maintained
0.24508433.7797489.html.plaintext.txt	180	Members steroid hormone receptor superfamily interact complex manner stimulate repress gene expression depending upon type number factors present also context gene promoter Cooney et al
0.24508433.7797489.html.plaintext.txt	181	We shown overexpression orphan receptor COUP TF I alter cell cell interaction fibroblasts block neuronal differentiation PCC7 cells Neuman et al
0.24508433.7797489.html.plaintext.txt	182	Expression COUP TF I fibroblasts correlated detectable alterations normal cell behaviors presumably associated alteration modification expression cell surface proteins
0.24508433.7797489.html.plaintext.txt	183	The exact nature change unknown since differences detected comparisons isolated membrane proteins control COUP TF I expressing cells indication involvement secretory factors
0.24508433.7797489.html.plaintext.txt	184	Discerning mechanism COUP TF I altered surface properties hampered due lack characterization fibroblasts regard members steroid hormone receptor superfamily endogenously expressed represent potential heterodimerization partners
0.24508433.7797489.html.plaintext.txt	185	However data transient CAT assays indicated COUP TF I induced transcriptional activity RARE coupled reporter gene constructs
0.24508433.7797489.html.plaintext.txt	186	Together data consistent model COUP TF I interacts nuclear hormone receptors causing changes gene expression
0.24508433.7797489.html.plaintext.txt	187	Several scenarios possible including COUP TF I homodimers binding retinoic acid response elements COUP TF Iretinoic acid receptor heterodimer formation Tran et al
0.24508433.7797489.html.plaintext.txt	188	1992 subsequent alteration gene expression
0.24508433.7797489.html.plaintext.txt	189	Retinoic acid alters expression genes promote cell growth attachment
0.24508433.7797489.html.plaintext.txt	190	1991 also important regulation hox genes Linney 1992 shown interact promoters cell adhesion molecules
0.24508433.7797489.html.plaintext.txt	191	N CAM cytotactin Jones et al
0.24508433.7797489.html.plaintext.txt	192	Our data consistent model perturbation variety processes including differentiation aggregation cell cell interaction regulated expression COUP TF I
0.24508433.7797489.html.plaintext.txt	193	This work supported Spinal Cord Society
0.24508433.7797489.html.plaintext.txt	194	The costs publication article defrayed part payment page charges
0.24508433.7797489.html.plaintext.txt	195	This article must therefore hereby marked advertisement accordance 18 U
0.24508433.7797489.html.plaintext.txt	196	Section 1734 solely indicate fact
0.24508433.7797489.html.plaintext.txt	197	The nucleotide sequences reported paper submitted GenBankEMBL Data Bank accession numbers U10995
0.24508433.7797489.html.plaintext.txt	198	To correspondence addressed Dept
0.24508433.7797489.html.plaintext.txt	199	Anatomy Neurobiology Colorado State University Fort Collins CO 80523
0.24508433.7797489.html.plaintext.txt	200	303 491 5791 Fax 303 491 7907 E mail toomaslamar
0.24508433.7797489.html.plaintext.txt	201	The abbreviations used HRE hormone response element COUP TF chick ovalbumin upstream promoter transcription factor CAT chloramphenicol acetyltransferase EMSA electrophoretic mobility shift assay RARE retinoic acid response element bp base pairs RAR retinoid acid receptor RXR retinoid X receptor
0.24508433.7797489.html.plaintext.txt	202	1989 Cell56 335 344 Medline Order article via Infotrieve Caroni P
0.24508433.7797489.html.plaintext.txt	203	106 1281 1288 Abstract Chan S
0.24508433.7797489.html.plaintext.txt	204	89 10568 10572 Abstract Chomczynski P
0.24508433.7797489.html.plaintext.txt	205	162 156 159 CrossRefMedline Order article via Infotrieve Cooney A
0.24508433.7797489.html.plaintext.txt	206	12 4153 4163 Abstract Cooney A
0.24508433.7797489.html.plaintext.txt	207	268 4152 4160 AbstractFree Full Text Cox E
0.24508433.7797489.html.plaintext.txt	208	1990 Neuron4 31 37 Medline Order article via Infotrieve Davies J
0.24508433.7797489.html.plaintext.txt	209	1990 Neuron4 11 20 Medline Order article via Infotrieve Evans R
0.24508433.7797489.html.plaintext.txt	210	1988 Science240 889 895 Medline Order article via Infotrieve Evans R
0.24508433.7797489.html.plaintext.txt	211	1989 Neuron2 1105 1112 Medline Order article via Infotrieve Fjose A
0.24508433.7797489.html.plaintext.txt	212	12 1403 1414 Abstract Green S
0.24508433.7797489.html.plaintext.txt	213	1988 Genetics4 309 314 Hamprecht B
0.24508433.7797489.html.plaintext.txt	214	49 99 170 Medline Order article via Infotrieve Herman
0.24508433.7797489.html.plaintext.txt	215	6 1153 1162 Abstract Jones F
0.24508433.7797489.html.plaintext.txt	216	89 2091 2095 Abstract Jones F
0.24508433.7797489.html.plaintext.txt	217	89 2086 2090 Abstract Jones F
0.24508433.7797489.html.plaintext.txt	218	90 6557 6561 Abstract Jonk L
0.24508433.7797489.html.plaintext.txt	219	47 81 97 CrossRefMedline Order article via Infotrieve Kadowaki Y
0.24508433.7797489.html.plaintext.txt	220	183 492 498 Medline Order article via Infotrieve Ladias J
0.24508433.7797489.html.plaintext.txt	221	1991 Science251 561 565 Medline Order article via Infotrieve Linney E
0.24508433.7797489.html.plaintext.txt	222	27 309 350 Medline Order article via Infotrieve Lu X
0.24508433.7797489.html.plaintext.txt	223	8 1774 1788 Abstract Luckow B
0.24508433.7797489.html.plaintext.txt	224	15 5490 Medline Order article via Infotrieve Luo Y
0.24508433.7797489.html.plaintext.txt	225	1993 Cell75 217 227 Medline Order article via Infotrieve Lutz B
0.24508433.7797489.html.plaintext.txt	226	1994 Development120 25 36 AbstractFree Full Text Mangelsdorf D
0.24508433.7797489.html.plaintext.txt	227	1990 Nature345 224 229 CrossRefMedline Order article via Infotrieve Mangelsdorf D
0.24508433.7797489.html.plaintext.txt	228	Acta1129 331 334 Medline Order article via Infotrieve McEwen B
0.24508433.7797489.html.plaintext.txt	229	40 1 14 CrossRef Miyajima N
0.24508433.7797489.html.plaintext.txt	230	16 11057 11074 Abstract Mlodzik M
0.24508433.7797489.html.plaintext.txt	231	1990 Cell60 211 224 Medline Order article via Infotrieve Neuman K
0.24508433.7797489.html.plaintext.txt	232	41 39 48 Medline Order article via Infotrieve Qiu Y
0.24508433.7797489.html.plaintext.txt	233	91 4451 4455 Abstract Raper J
0.24508433.7797489.html.plaintext.txt	234	1990 Neuron4 21 29 Medline Order article via Infotrieve Richie H
0.24508433.7797489.html.plaintext.txt	235	18 6857 6862 Abstract Sambrook J
0.24508433.7797489.html.plaintext.txt	236	1989 Molecular Cloning A Laboratory Manual 2nd Ed
0.24508433.7797489.html.plaintext.txt	237	67 Cold Spring Harbor Laboratory Press Cold Spring Harbor NY Scholer H
0.24508433.7797489.html.plaintext.txt	238	8 2543 2550 Abstract Tosney K
0.24508433.7797489.html.plaintext.txt	239	4 2518 2527 Abstract Tran P
0.24508433.7797489.html.plaintext.txt	240	12 4666 4676 Abstract Vasios G
0.24508433.7797489.html.plaintext.txt	241	10 1149 1158 Abstract Wang L
0.24508433.7797489.html.plaintext.txt	242	1989 Nature340 163 166 CrossRefMedline Order article via Infotrieve Wang L
0.24508433.7797489.html.plaintext.txt	243	1 207 216 Medline Order article via Infotrieve Zhang X
0.24508433.7797489.html.plaintext.txt	244	1992 Nature355 441 446 CrossRefMedline Order article via Infotrieve 1995 The American Society Biochemistry Molecular Biology Inc
0.31626305.15548577.html.plaintext.txt	0	The COUP TF nuclear receptors regulate cell migration mammalian basal forebrain Marco Tripodi Alessandro Filosa Maria Armentano Michele Studer
0.31626305.15548577.html.plaintext.txt	1	TIGEM Telethon Institute Genetics Medicine Via P
0.31626305.15548577.html.plaintext.txt	2	Castellino 111 80131 Napoli Italy
0.31626305.15548577.html.plaintext.txt	3	Author correspondence e mail studerattigem
0.31626305.15548577.html.plaintext.txt	4	SUMMARY TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES Cells migrate via diverse pathways different modes reach final destinations development
0.31626305.15548577.html.plaintext.txt	5	Tangential migration shown contribute significantly generation neuronal diversity mammalian telencephalon
0.31626305.15548577.html.plaintext.txt	6	GABAergic interneurons best characterized neurons migrate tangentially ventral telencephalon dorsally cortex
0.31626305.15548577.html.plaintext.txt	7	However molecular mechanisms nature migratory pathways beginning unravelled
0.31626305.15548577.html.plaintext.txt	8	In study first identified novel dorsal ventral migratory route cells migrate interganglionic sulcus located basal telencephalon lateral medial ganglionic eminences towards pre optic area anterior hypothalamus diencephalon
0.31626305.15548577.html.plaintext.txt	9	Next help transplantations gain function studies organotypic cultures shown COUP TFI COUP TFII expressed distinct non overlapping migratory routes
0.31626305.15548577.html.plaintext.txt	10	Ectopic expression COUP TFs induces increased rate cell migration cell dispersal suggesting roles cellular adhesion migration processes
0.31626305.15548577.html.plaintext.txt	11	Moreover cells follow distinct migratory path dorsal versus ventral dependent expression COUP TFI COUP TFII suggesting intrinsic role COUP TFs guiding migrating neurons towards target regions
0.31626305.15548577.html.plaintext.txt	12	Therefore propose COUP TFs directly involved tangential cell migration developing brain regulation short long range guidance cues
0.31626305.15548577.html.plaintext.txt	13	Key words COUP TFs Cell migration Forebrain Mouse
0.31626305.15548577.html.plaintext.txt	14	Introduction TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES It well recognized radial tangential migration contribute significantly neuronal diversity within telencephalon reviewed Marin Rubenstein 2003
0.31626305.15548577.html.plaintext.txt	15	Projection neurons originate ventricular zone cortical anlage pallium migrate radially form developing cortex GABAergic interneurons originate restricted regions ventricular zone subcortical telencephalon subpallium migrate tangentially reach final destination defined telencephalic regions
0.31626305.15548577.html.plaintext.txt	16	Within subpallium medial ganglionic eminence MGE appears major source cortical interneurons Anderson et al
0.31626305.15548577.html.plaintext.txt	17	Furthermore shown vivo neurons derive lateral ganglionic eminence LGE caudal ganglionic eminence CGE contribute generation projection neurons striatum GABAergic interneurons cortex respectively Nery et al
0.31626305.15548577.html.plaintext.txt	18	Although overlap structures populated neurons originating three ganglionic eminences GEs nuclei derived progeny eminence distinct vary neurochemical profiles Nery et al
0.31626305.15548577.html.plaintext.txt	19	As source cellular diversity anterior entopeduncular area located MGE hypothalamus contributes generation oligodendrocytes cortex hippocampus He et al
0.31626305.15548577.html.plaintext.txt	20	Therefore interneurons oligodendrocytes appear follow mainly ventral dorsal migratory route reaching target tissues known whether cells also migrate dorsal ventral direction
0.31626305.15548577.html.plaintext.txt	21	The identification migratory pathways gangliothalamic body connecting GEs thalamus Letinic Kostovic 1997 Rakic Sidman 1969 rostral migratory stream LGE olfactory bulb Altman 1969 Lois Alvarez Buylla 1994 Luskin 1993 makes plausible GEs generate neurons directed embryonic brain regions besides dorsal telencephalon
0.31626305.15548577.html.plaintext.txt	22	As suggested various studies directional migration achieved short range guidance cues long range diffusible gradients Tessier Lavigne Goodman 1996
0.31626305.15548577.html.plaintext.txt	23	Contact guidance relies permissive environment gradients diffusible guidance molecules superimposed achieve directional migration
0.31626305.15548577.html.plaintext.txt	24	However distribution molecular nature short long range molecules substratum interneurons use migration towards cortex poorly understood
0.31626305.15548577.html.plaintext.txt	25	Motogenic factors hepatocyte growth factor neurotrophin molecules BDNF NT4 shown influence numbers cells migrating away subpallium Polleux et al
0.31626305.15548577.html.plaintext.txt	26	Guidance molecules repulsive attractive activities likely involved guiding migrating cells subpallium pallium within subpallium Marin et al
0.31626305.15548577.html.plaintext.txt	27	For substratum one report shown blocking function TAG1 adhesion molecule results marked reduction GABAergic neurons cortex Denaxa et al
0.31626305.15548577.html.plaintext.txt	28	However Tag1 mutant mice major alteration tangential migration interneurons Marin Rubenstein 2003 treatment cortical slices phosphoinositide specific phospholipase C PI PLC enzyme cleaves GPI anchored proteins TAG1 alter interneuron migration Tanaka et al
0.31626305.15548577.html.plaintext.txt	29	Therefore nothing known nature short range guidance contact cues involved tangential migration
0.31626305.15548577.html.plaintext.txt	30	The nuclear orphan receptor COUP TFI favours migration neurons integrin dependent mechanism cell cultures Adam et al
0.31626305.15548577.html.plaintext.txt	31	Overexpression COUP TFI retinoic acid treated neuronal aggregates coated different cell substrata polylysine laminin fibronectin results higher rate migration compared controls whereas overexpression mutated form COUP TFI effects cell migration
0.31626305.15548577.html.plaintext.txt	32	Moreover increased levels vitronectin extracellular matrix ECM molecule involved neurite extension motor neuron differentiation possibly neuronal migration detected aggregate monolayer cell cultures overexpression COUP TFI
0.31626305.15548577.html.plaintext.txt	33	This data show COUP TFI stimulates transcription vitronectin promoter vitro strongly suggests role COUP TFI regulation ECM synthesis process neuronal migration
0.31626305.15548577.html.plaintext.txt	34	Although COUP TFI shown involved cortical regionalization axon pathfinding developing telencephalon Zhou et al
0.31626305.15548577.html.plaintext.txt	35	2001 role promoting cell migration vivo established far
0.31626305.15548577.html.plaintext.txt	36	Here show COUP TFI COUP TFII expressed migrating cells specific pathways basal telencephalon mouse embryos stage interneuron migration robust
0.31626305.15548577.html.plaintext.txt	37	Moreover expression COUP TFI cortex co localizes GABAergic marker calbindin suggesting subpopulation COUP TFI positive cells cortex GABAergic interneurons
0.31626305.15548577.html.plaintext.txt	38	With help transplantation tracing techniques organotypic slice cultures first show presence dorsal ventral migratory pathway originates region interganglionic sulcus
0.31626305.15548577.html.plaintext.txt	39	We demonstrate COUP TFI expressed basal telencephalon neurons migrating dorsally towards cortex also ventrally towards pre optic area POa hypothalamus
0.31626305.15548577.html.plaintext.txt	40	Finally ectopic expression COUP TFI COUP TFII GEs show increased rate migrating cells
0.31626305.15548577.html.plaintext.txt	41	While COUP TFI appears control dorsal ventral migration basal telencephalon COUP TFII specific modulating tangential migration intermediate zone cortex suggesting distinct functions COUP TFs regulating cell migration developing forebrain
0.31626305.15548577.html.plaintext.txt	42	Materials methods TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES Generation polyclonal antibodies COUP TFI COUP TFII To eliminate possibility crossreactions antibodies COUP TFI COUP TFII identify less conserved exposed immune reactive regions proteins performed silico analysis using Blastp PredAccServer Protein Hydropathic Profile Antigenic following Kolasker Tangaonkar algorithm software
0.31626305.15548577.html.plaintext.txt	43	GST fusion proteins produced using pGEX cloning vector N termini COUP TFI COUP TFII comprising first 203 amino acids cloned EcoRI SphI COUP TFI MslI SphI COUP TFII restriction sites pGEX
0.31626305.15548577.html.plaintext.txt	44	The fusion proteins grown BL21 cells purified affinity chromatography glutathione coated columns injected rabbits
0.31626305.15548577.html.plaintext.txt	45	The immunization protocol consisted five rounds injections final bleeding carried Primm srl Milan Italy
0.31626305.15548577.html.plaintext.txt	46	The specificities antibodies tested blocking respective immunogens using control frozen sections
0.31626305.15548577.html.plaintext.txt	47	No signals detected data shown
0.31626305.15548577.html.plaintext.txt	48	Slice culture experiments Organotypic slice cultures embryonic mouse telencephalon prepared previously described Anderson et al
0.31626305.15548577.html.plaintext.txt	49	Brain slices 250 microm thick used grafting experiments see tracing fluorescent carbocyanide dye 11 dioctadecyl 3333 tetramethylindocarbocyanine perchlorate DiI Molecular Probes electroporation lipofectamine injections see
0.31626305.15548577.html.plaintext.txt	50	Grafting experiments For grafting experiments MGE LGE region MGELGE border MLGE removed donor brain slices derived green fluorescent protein GFP expressing transgenic embryo Hadjantonakis et al
0.31626305.15548577.html.plaintext.txt	51	1998 transferred position host wild type brain slice
0.31626305.15548577.html.plaintext.txt	52	The chimaeric slices examined 1 hour transplant stereoscope GFP filter confirm transplants successfully correctly integrated host slices grafts integrate integrated incorrect location used study
0.31626305.15548577.html.plaintext.txt	53	The medium changed every day 60 hours slices fixed 4 paraformaldehyde
0.31626305.15548577.html.plaintext.txt	54	Electroporation lipofectamine mediated injection For fate map GFP expressing vector electroporated GEs embryonic day E 13
0.31626305.15548577.html.plaintext.txt	55	5 brain slices using method conditions described previously Stuhmer et al
0.31626305.15548577.html.plaintext.txt	56	For gain function approach used PolyFect Transfection Kit Qiagen Hilden Germany containing 250 ng microl expression vectors CMV GFP CMV COUP TFs IRES GFP
0.31626305.15548577.html.plaintext.txt	57	Full length mouse COUP TFI COUP TFII kindly donated M
0.31626305.15548577.html.plaintext.txt	58	Tsai Baylor College USA cloned BamHI XhoI sites pIRES hrGFP 2a expression vector Stratagene California USA
0.31626305.15548577.html.plaintext.txt	59	We injected constructs desired region brain slices microscopic guidance micro syringe Hamilton Reno Nevada USA held micromanipulator system using 33 gauge blunt ended needle Hamilton
0.31626305.15548577.html.plaintext.txt	60	The slices cultured 60 hours fixed 4 paraformaldehyde either observed confocal microscopy Leica DMIRE2 embedded OCT sectioning cryostat
0.31626305.15548577.html.plaintext.txt	61	Immunohistochemistry immunofluorescence The brains sectioned treated immunostaining according standard procedures
0.31626305.15548577.html.plaintext.txt	62	Combined immunohistochemistry situ hybridization cryosections carried described previously Hirsch et al
0.31626305.15548577.html.plaintext.txt	63	The times incubation primary antibodies ranged 90 minutes anti COUP TFs anti reelin overnight
0.31626305.15548577.html.plaintext.txt	64	The following antibodies used rabbit COUP TFI 1500 rabbit COUP TFII 11000 mouse reelin clone G10 1500 kind gift A
0.31626305.15548577.html.plaintext.txt	65	Goffinet mouse calbindin clone CB 955 Sigma 1500 mouse GABA clone GB 69 Sigma 11000 mouse ss tubulin type III clone SDL
0.31626305.15548577.html.plaintext.txt	66	Sections alternatively incubated biotinylated secondary antibody Vector 1200 processed ABC histochemical method Vector fluorescent secondary antibody Molecular probes 1400 Alexafluor 488 rabbit Alexafluor 594 rabbit Alexafluor 594 mouse 1 hour room temperature
0.31626305.15548577.html.plaintext.txt	67	The immunohistochemistry treated sections dried dehydrated mounted coverslip Permount Fisher immunofluorescence treated sections mounted Vectashield Vector
0.31626305.15548577.html.plaintext.txt	68	The GFP detected endogenous fluorescence
0.31626305.15548577.html.plaintext.txt	69	Cell counting In grafting experiments cells counted images obtained 6 microm sections slices acquired CCD camera attached conventional microscope
0.31626305.15548577.html.plaintext.txt	70	To count cells standardized box 40x enlargement slice used transplant three sections evaluated section cells two different regions counted
0.31626305.15548577.html.plaintext.txt	71	In gain function experiments image whole slice obtained confocal microscopy reconstruction confocal planes
0.31626305.15548577.html.plaintext.txt	72	The GFP positive cells migrated towards cortex towards POa counted reconstructed image normalized total number GFP positive cells e
0.31626305.15548577.html.plaintext.txt	73	cortexcortex basal ganglia POaPOa basal ganglia
0.31626305.15548577.html.plaintext.txt	74	The data control overexpressing cells within slice compared paired Students tests used analysis
0.31626305.15548577.html.plaintext.txt	75	Results TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES COUP TFI COUP TFII expressed distinct domains developing telencephalon To analyse expression COUP TFs cellular level developing telencephalon generated polyclonal antibodies COUP TFI COUP TFII
0.31626305.15548577.html.plaintext.txt	76	Because high sequence homology COUP TFI COUP TFII members steroidthyroid superfamily chose N termini proteins show highest sequence divergence see Materials methods details
0.31626305.15548577.html.plaintext.txt	77	Western blotting immunohistochemistry demonstrated crossreactivities two members family data shown
0.31626305.15548577.html.plaintext.txt	78	To study expression profile COUP TFs period neural migration performed immunohistochemistry E13
0.31626305.15548577.html.plaintext.txt	79	5 mouse forebrains tangential migration well pronounced
0.31626305.15548577.html.plaintext.txt	80	At stage COUP TFI expression localized layers neocortex piriform cortex ventricular subventricular zones LGE ventricular zone MGE POa scattered cells various regions basal telencephalon Fig
0.31626305.15548577.html.plaintext.txt	81	By contrast COUP TFII expression mainly restricted marginal zone neocortex piriform cortex POa basal telencephalon
0.31626305.15548577.html.plaintext.txt	82	Scattered COUP TFII positive cells also identified LGE cortico striatal boundary intermediate zone neocortex arrowheads Fig
0.31626305.15548577.html.plaintext.txt	83	Expression COUP TFI COUP TFII also seen interganglionic region MGE LGE fused appearance CGE asterisk Fig
0.31626305.15548577.html.plaintext.txt	84	For convenience define area MLGE border henceforth
0.31626305.15548577.html.plaintext.txt	85	Double labelling COUP TFI COUP TFII COUP TFI COUP TFII highlighted increased expression COUP TFs region insets Fig
0.31626305.15548577.html.plaintext.txt	86	View larger version 87K Fig
0.31626305.15548577.html.plaintext.txt	87	COUP TFs expressed migrating cells
0.31626305.15548577.html.plaintext.txt	88	Adjacent coronal sections E13
0.31626305.15548577.html.plaintext.txt	89	5 mouse brain medio caudal level immunostained anti COUP TFI A COUP TFII antibodies A
0.31626305.15548577.html.plaintext.txt	90	The asterisks A A indicate expression interganglionic region MLGE
0.31626305.15548577.html.plaintext.txt	91	The insets show enlargement region double labelling COUP TFs COUP TFI mRNACOUP TFII antibody A COUP TFI antibodyCOUP TFII mRNA A
0.31626305.15548577.html.plaintext.txt	92	The arrow A indicates expression boundary COUP TFI level medial cortex whereas region COUP TFII expressed putative cortical hem region ch A
0.31626305.15548577.html.plaintext.txt	93	An arrow A indicates expression marginal zone ncx arrowheads show expression cortico striatal boundary intermediate zone ncx
0.31626305.15548577.html.plaintext.txt	94	B B Two different enlargements regions indicated A A
0.31626305.15548577.html.plaintext.txt	95	Most COUP TF positive cells show polarized soma arrows B B indicative migrating cells
0.31626305.15548577.html.plaintext.txt	96	C C Expression COUP TFs POa region
0.31626305.15548577.html.plaintext.txt	97	Note COUP TFI mostly restricted ventricular zone two streams migrating cells indicated arrows
0.31626305.15548577.html.plaintext.txt	98	High expression COUP TFII mainly localized mantle zone dorsally migrating stream arrow C
0.31626305.15548577.html.plaintext.txt	99	ch cortical hem region cp choroid plexus LGE lateral ganglionic eminence MGE medial ganglionic eminence mz mantle zone ncx neocortex pcx piriform cortex POa pre optic area VZ ventricular zone
0.31626305.15548577.html.plaintext.txt	100	Higher magnifications region MLGE border POa showed scattered COUP TF positive cells grouped streams cells polarized bodies indicative migrating neurons Fig
0.31626305.15548577.html.plaintext.txt	101	Although proteins localized area double detection COUP TFI COUP TFII indicated expression populations overlapped partially data shown
0.31626305.15548577.html.plaintext.txt	102	In POa region COUP TFs presented complementary expression Fig
0.31626305.15548577.html.plaintext.txt	103	While COUP TFI expressed high levels ventricular zone streams cells oriented dorsally ventrally arrows Fig
0.31626305.15548577.html.plaintext.txt	104	1C COUP TFII mainly expressed mantle zone cells dorsal POa region arrow Fig
0.31626305.15548577.html.plaintext.txt	105	An additional complementary expression evident level caudomedial wall telencephalon
0.31626305.15548577.html.plaintext.txt	106	While cortical COUP TFI expression stopped abruptly level hem region Fig
0.31626305.15548577.html.plaintext.txt	107	1A COUP TFII specifically expressed region choroid plexus Fig
0.31626305.15548577.html.plaintext.txt	108	In summary COUP TFI COUP TFII showed distinct mostly non overlapping expression profiles developing telencephalon E13
0.31626305.15548577.html.plaintext.txt	109	Furthermore COUP TFs appeared expressed migrating cells stages several tangential migratory pathways within developing telencephalon well pronounced
0.31626305.15548577.html.plaintext.txt	110	COUP TFs detected specific non overlapping cellular populations developing cortex To characterize types cells COUP TFs expressed performed series double immunofluorescence studies COUP TFs cell type specific markers Fig
0.31626305.15548577.html.plaintext.txt	111	View larger version 130K Fig
0.31626305.15548577.html.plaintext.txt	112	COUP TFI expressed GABAergic interneurons COUP TFII expressed Cajal Retzius cells
0.31626305.15548577.html.plaintext.txt	113	Double immunofluorescence COUP TFs green cell type specific markers red coronal sections E13
0.31626305.15548577.html.plaintext.txt	114	COUP TFI AB COUP TFII DE co labels calbindin MZ ncx AD pcx BE
0.31626305.15548577.html.plaintext.txt	115	COUP TFII FGH COUP TFI CI co labels reelin MZ neocortex CF caudomedial cortical wall G I
0.31626305.15548577.html.plaintext.txt	116	The inset G schematic diagram section indicates position panels G I
0.31626305.15548577.html.plaintext.txt	117	The arrows indicate double positive cells
0.31626305.15548577.html.plaintext.txt	118	Note H cells double positive I none cells double positive
0.31626305.15548577.html.plaintext.txt	119	MZ marginal zone ncx neocortex pcx piriform cortex
0.31626305.15548577.html.plaintext.txt	120	The expression data described previously suggested COUP TFs expressed migrating neurons
0.31626305.15548577.html.plaintext.txt	121	To test hypothesis used antibody calbindin labels subpopulation GABAergic interneurons
0.31626305.15548577.html.plaintext.txt	122	5 majority calbindin positive cells co labelled COUP TFI positive cells neocortex piriform cortex Fig
0.31626305.15548577.html.plaintext.txt	123	2AB COUP TFII positive cells Fig
0.31626305.15548577.html.plaintext.txt	124	Similar results obtained anti GABA antibody data shown
0.31626305.15548577.html.plaintext.txt	125	Thus marginal zone cortex GABAergic neurons positive COUP TFI negative COUP TFII
0.31626305.15548577.html.plaintext.txt	126	To assess whether COUP TFII positive cells marginal zone rather Cajal Retzius cells used antibody reelin
0.31626305.15548577.html.plaintext.txt	127	All COUP TFII positive cells co expressed reelin Fig
0.31626305.15548577.html.plaintext.txt	128	2F whereas COUP TFI positive cells positive reelin cortex Fig
0.31626305.15548577.html.plaintext.txt	129	5 co localization COUP TFII reelin also detected caudomedial wall telencephalic vesicles Fig
0.31626305.15548577.html.plaintext.txt	130	2GH recently described one sources Cajal Retzius cells Takiguchi Hayashi et al
0.31626305.15548577.html.plaintext.txt	131	This case COUP TFI co expression COUP TFI reelin ever detected region Fig
0.31626305.15548577.html.plaintext.txt	132	Taken together data strongly suggest cortex COUP TFI expressed GABAergic interneurons whereas COUP TFII expressed Cajal Retzius cells
0.31626305.15548577.html.plaintext.txt	133	COUP TFI COUP TFII expressed neurons migrating tangentially basal telencephalon cortex We previously shown COUP TFI positive cells cortex GABAergic interneurons
0.31626305.15548577.html.plaintext.txt	134	It well established GEs major source neocortical interneurons reviewed Corbin et al
0.31626305.15548577.html.plaintext.txt	135	2001 Marin Rubenstein 2001
0.31626305.15548577.html.plaintext.txt	136	Therefore assess whether COUP TFI positive cells located basal telencephalon interneurons migrating cortex series grafts GEs E13
0.31626305.15548577.html.plaintext.txt	137	5 GFP expressing transgenic brain slices homotopically transplanted wild type E13
0.31626305.15548577.html.plaintext.txt	138	3A expression COUP TFI COUP TFII subsequently monitored adjacent sections slices
0.31626305.15548577.html.plaintext.txt	139	An example MLGE graft shown Fig
0.31626305.15548577.html.plaintext.txt	140	3B demonstrates fate fluorescent cells 60 hours incubation point GFP positive cells distributed mantle layer basal telencephalon various layers cortex
0.31626305.15548577.html.plaintext.txt	141	High magnification lateral medial cortex showed GFP positive cells present marginal intermediate zones Fig
0.31626305.15548577.html.plaintext.txt	142	Interestingly GFP positive cells also present deeper layers radial orientation towards surface cortex arrows Fig
0.31626305.15548577.html.plaintext.txt	143	These cells previously reported migrate marginal zone ventricular zone moving radially take positions cortical anlage Nadarajah et al
0.31626305.15548577.html.plaintext.txt	144	After double labelling anti COUP TFI 75 GFP positive cells n250 also positive COUP TFI including ventricle directed cells Fig
0.31626305.15548577.html.plaintext.txt	145	Adjacent sections grafted brain slices showed co localization COUP TFII GFP Fig
0.31626305.15548577.html.plaintext.txt	146	This agreement observation COUP TFII positive cells cortex non GABAergic therefore originate basal telencephalon
0.31626305.15548577.html.plaintext.txt	147	Thus data confirm COUP TFI cortex expressed GABAergic interneurons originating subpallium whereas COUP TFII expression pallial origin
0.31626305.15548577.html.plaintext.txt	148	View larger version 113K Fig
0.31626305.15548577.html.plaintext.txt	149	COUP TFI positive cells MZ cortex originate basal telencephalon
0.31626305.15548577.html.plaintext.txt	150	A A grafting experiment performed E13
0.31626305.15548577.html.plaintext.txt	151	5 dorsally migrating cells analysed
0.31626305.15548577.html.plaintext.txt	152	The box delineates area shown C H
0.31626305.15548577.html.plaintext.txt	153	B Example MLGE transplant shows GFP positive cells migrating dorsally ctx laterally pcx ventrally POahypo
0.31626305.15548577.html.plaintext.txt	154	C H Double immunofluorescence GFP green COUP TFs red shows GFP positive cells originating graft double positive COUP TFI MZ arrowheads C E ventricle oriented cells deriving MZ arrows C E
0.31626305.15548577.html.plaintext.txt	155	Arrows insets show labelling cells intermediate zone IZ
0.31626305.15548577.html.plaintext.txt	156	F H Double immunofluorescence GFP green COUP TFII red shows co localization two proteins
0.31626305.15548577.html.plaintext.txt	157	ctx cortex MZ marginal zone pcx piriform cortex POahypo pre opic areaanterior hypothalamus
0.31626305.15548577.html.plaintext.txt	158	COUP TFI expressed neurons migrating tangentially towards ventral regions telencephalon In transplantation experiments described observed grafted region included MLGE region significant number neurons also migrated towards piriform cortex towards ventral regions POa anterior hypothalamus Fig
0.31626305.15548577.html.plaintext.txt	159	In grafts GFP positive cells also identified POa Fig
0.31626305.15548577.html.plaintext.txt	160	4B suggesting cells deriving interganglionic region migrate various directions dorsally laterally ventrally
0.31626305.15548577.html.plaintext.txt	161	By double labelling GFP positive cells anti COUP TFI anti COUP TFII antibodies found double positive cells COUP TFI COUP TFII ventral migratory path Fig
0.31626305.15548577.html.plaintext.txt	162	This suggests subpopulation COUP TFI positive cells located POaanterior hypothalamus might originate GEs
0.31626305.15548577.html.plaintext.txt	163	Furthermore migrating cells neurons demonstrated double staining GFP neuronal marker Tuj1 Fig
0.31626305.15548577.html.plaintext.txt	164	Finally subpopulation COUP TFI positive cells ventral stream positive GABA Fig
0.31626305.15548577.html.plaintext.txt	165	4F suggesting ventrally migrating cells GABAergic interneurons
0.31626305.15548577.html.plaintext.txt	166	View larger version 111K Fig
0.31626305.15548577.html.plaintext.txt	167	Dorsal ventral migration within basal telencephalon
0.31626305.15548577.html.plaintext.txt	168	A A grafting experiment performed E13
0.31626305.15548577.html.plaintext.txt	169	5 ventrally migrating cells analysed
0.31626305.15548577.html.plaintext.txt	170	The box delineates area shown C E
0.31626305.15548577.html.plaintext.txt	171	B Example graft GFP positive cells reached POa
0.31626305.15548577.html.plaintext.txt	172	Arrows C show co localization COUP TFI red GFP green whereas co labelling COUP TFII red identified D within migratory cells
0.31626305.15548577.html.plaintext.txt	173	E E Arrows E indicate migrating cells neurons double labelling GFP green Tuj1 red
0.31626305.15548577.html.plaintext.txt	174	E merge panels E E
0.31626305.15548577.html.plaintext.txt	175	F Double immunofluorescence COUP TFI green GABA red shows COUP TFI positive cells arrows GABAergic ventral migratory stream
0.31626305.15548577.html.plaintext.txt	176	G By electroporation GFP expressing construct MLGE region GFP positive cells migrate ventrally cells express COUP TFI arrows H
0.31626305.15548577.html.plaintext.txt	177	Similarly inserting DiI crystal MLGE region fluorescent cells detected ventrally POahypothalamic region I
0.31626305.15548577.html.plaintext.txt	178	These cells co express COUP TFI J
0.31626305.15548577.html.plaintext.txt	179	The arrow indicates leading process
0.31626305.15548577.html.plaintext.txt	180	Note diffuse red signal J result DiI signal fixation
0.31626305.15548577.html.plaintext.txt	181	To validate origin ventral stream used two experimental approaches
0.31626305.15548577.html.plaintext.txt	182	We first electroporated GFP expression vector MLGE region E13
0.31626305.15548577.html.plaintext.txt	183	5 brain slices followed fate electroporated cells 60 hours incubation Fig
0.31626305.15548577.html.plaintext.txt	184	GFP positive cells located ventrally respect injected side showed leading process co labelled COUP TFI COUP TFII Fig
0.31626305.15548577.html.plaintext.txt	185	Similarly upon placing crystal DiI MLGE region Fig
0.31626305.15548577.html.plaintext.txt	186	4I fluorescent cells subsequently identified ventral regions cells positive COUP TFI Fig
0.31626305.15548577.html.plaintext.txt	187	The morphology DiICOUP TFI positive cells fits well morphology tangentially migrating cells observed authors Nadarajah Parnavelas 2002
0.31626305.15548577.html.plaintext.txt	188	Indeed nuclei cells oriented sense migration process lagging behind soma arrow Fig
0.31626305.15548577.html.plaintext.txt	189	Finally assess whether ventrally directed migration also originates caudal levels grafted CGE GFP E13
0.31626305.15548577.html.plaintext.txt	190	5 mouse brain wild type brain stage n5 Fig
0.31626305.15548577.html.plaintext.txt	191	After 60 hours incubation GFP positive cells migrated graft two main streams medial stream directed towards third ventricle lateral stream directed laterally ventrally hypothalamic region Fig
0.31626305.15548577.html.plaintext.txt	192	Both streams contained single neurons short polarized leading processes indicative migrating cells Fig
0.31626305.15548577.html.plaintext.txt	193	Adjacent sections brain slices showed co labelling GFP COUP TFI Fig
0.31626305.15548577.html.plaintext.txt	194	5CD whereas COUP TFII positive cells co localized GFP positive cells Fig
0.31626305.15548577.html.plaintext.txt	195	View larger version 121K Fig
0.31626305.15548577.html.plaintext.txt	196	Cells originating caudal ganglionic eminence migrate ventrally
0.31626305.15548577.html.plaintext.txt	197	A Summary type graft results obtained 60 hours incubation
0.31626305.15548577.html.plaintext.txt	198	B A caudal ganglionic eminence CGE transplant shows GFP positive cells migrating ventrally two streams medial stream lateral stream
0.31626305.15548577.html.plaintext.txt	199	The arrows indicate cells reached anterior hypothalamus
0.31626305.15548577.html.plaintext.txt	200	C F Double immunofluorescence GFP green COUP TFI CD COUP TFII red EF adjacent sections graft shown B
0.31626305.15548577.html.plaintext.txt	201	Note GFP positive cells leading process oriented ventrally arrows COUP TFI double positive GFP insets CD
0.31626305.15548577.html.plaintext.txt	202	ant hypo anterior hypothalamus LS lateral stream MS medial stream
0.31626305.15548577.html.plaintext.txt	203	Taken together data show cells located basal telencephalon migrate tangentially dorsally developing neocortex previously described also ventrally basal diencephalon including pre optic hypothalamic regions
0.31626305.15548577.html.plaintext.txt	204	Furthermore results show COUP TFI COUP TFII expressed populations migrating neurons suggesting functional role COUP TFI patterning tangential migration
0.31626305.15548577.html.plaintext.txt	205	Ectopic expression COUP TFI basal telencephalon promotes cells migrate dorsal ventral directions At stage demonstrated subpopulation COUP TFI positive cells basal telencephalon cells process migrating however demonstrate COUP TFI directly involved migration
0.31626305.15548577.html.plaintext.txt	206	To address issue set functional assay E13
0.31626305.15548577.html.plaintext.txt	207	5 brain slice cultures ectopically expressed COUP TFI GEs different dorso ventral antero posterior locations
0.31626305.15548577.html.plaintext.txt	208	The migrating cells followed 60 hours incubation
0.31626305.15548577.html.plaintext.txt	209	On one side control injected construct expressing GFP control CMV promoter contralateral side injected construct expressing COUP TFI followed IRES GFP sequence
0.31626305.15548577.html.plaintext.txt	210	In way could follow fate injected cells following GFP fluorescence slices Fig
0.31626305.15548577.html.plaintext.txt	211	6B shows average value GFP positive cells cortex POa expressed percentage total number positive cells control 2838 cells COUP TFI 2318 cells n25 see also Materials methods details
0.31626305.15548577.html.plaintext.txt	212	In cases examined COUP TFI injected sides showed statistically significant increase number cells cortex compared control side Fig
0.31626305.15548577.html.plaintext.txt	213	Ventral migration observed caudal sections constructs focally injected subventricular zone MLGE region Fig
0.31626305.15548577.html.plaintext.txt	214	In controls 24 17 GFP positive cells scored average cortex POa respectively Fig
0.31626305.15548577.html.plaintext.txt	215	6B whereas non migrating cells maintained compact clusters next injection site
0.31626305.15548577.html.plaintext.txt	216	The injection CMV COUP TFI IRES GFP construct contralateral side slices resulted GFP positive cells dispersed mantle layer arrowheads Fig
0.31626305.15548577.html.plaintext.txt	217	6D still process migrating dorsally towards marginal zone cortex ventrally towards POa arrows Fig
0.31626305.15548577.html.plaintext.txt	218	Moreover higher number GFP positive cells scored cortex POa 72 46 respectively compared control side
0.31626305.15548577.html.plaintext.txt	219	Thus presence higher levels COUP TFI injected cells showed significantly increased spreading migrating compared normal situation Fig
0.31626305.15548577.html.plaintext.txt	220	6B suggesting COUP TFI modulates cell migration basal telencephalon
0.31626305.15548577.html.plaintext.txt	221	View larger version 73K Fig
0.31626305.15548577.html.plaintext.txt	222	COUP TFI modulates dorsal ventral migration brain slices
0.31626305.15548577.html.plaintext.txt	223	A Summary type experiments performed E13
0.31626305.15548577.html.plaintext.txt	224	On one side GFP expressing vector injected control contralateral side injection COUP TFI IRES GFP expressing vector shows increased rate migrating cells
0.31626305.15548577.html.plaintext.txt	225	B The average value GFPGFPtot ratio black columns GFP COUP TFIGFPtot ratio white columns injected slices calculated independently cortex ventrally POa see also Materials methods
0.31626305.15548577.html.plaintext.txt	226	Bars indicate standard errors mean
0.31626305.15548577.html.plaintext.txt	227	In COUP TFI injected side 72 plus minus 4 GFP positive cells migrate cortex versus 24 plus minus 4 GFP positive cells control side
0.31626305.15548577.html.plaintext.txt	228	For POa ectopic expression COUP TFI 46 plus minus 3 GFP positive cells induced migrate versus 17 plus minus 3 control situation
0.31626305.15548577.html.plaintext.txt	229	Significant P values indicated cortex P0
0.31626305.15548577.html.plaintext.txt	230	Example control C COUP TFI overexpressing D brain slice 60 hours incubation
0.31626305.15548577.html.plaintext.txt	231	The vectors focally injected MLGE region
0.31626305.15548577.html.plaintext.txt	232	Note control situation C cells found cortex C majority remain compacted injection point
0.31626305.15548577.html.plaintext.txt	233	D After injection high levels COUP TFI MLGE region GFP positive cells dispersed arrowheads around injection point pronounced contingent cells migrates dorsal ventral directions
0.31626305.15548577.html.plaintext.txt	234	Ectopic expression COUP TFII ganglionic eminences induces higher rate migration intermediate zone cortex Next tested whether COUP TFII also able promote cell migration basal telencephalon
0.31626305.15548577.html.plaintext.txt	235	We generated additional construct COUP TFII IRES GFP cassette regulation CMV promoter
0.31626305.15548577.html.plaintext.txt	236	The control CMV GFP CMV COUP TFII IRES GFP expressing constructs injected subventricular zone striatum opposite sides E13
0.31626305.15548577.html.plaintext.txt	237	7B shows presence ectopic expression COUP TFII average number GFP positive cells found cortex 60 total number 467 cells significantly higher control situation 32 total number 875 cells
0.31626305.15548577.html.plaintext.txt	238	An example injection performed whole striatum shown Fig
0.31626305.15548577.html.plaintext.txt	239	As expected high number GFP positive cells migrated injection point marginal intermediate zones neocortex
0.31626305.15548577.html.plaintext.txt	240	After injection COUP TFII expressing construct statistically significant increase GFP positive cells found uniquely intermediate layer neocortex GFP positive cells ever identified marginal zone arrowheads asterisk Fig
0.31626305.15548577.html.plaintext.txt	241	However contrast previous experiments GFP positive cells ever located ventrally POa region even focally injected construct MLGE region data shown
0.31626305.15548577.html.plaintext.txt	242	Thus ectopic expression COUP TFII basal telencephalon promotes migrating neurons undertake preferential route intermediate zone neocortex avoiding marginal zone suggesting cell autonomous property COUP TFII guiding cortical neurons specific layer cortex
0.31626305.15548577.html.plaintext.txt	243	View larger version 83K Fig
0.31626305.15548577.html.plaintext.txt	244	COUP TFII regulates migration intermediate zone neocortex
0.31626305.15548577.html.plaintext.txt	245	A Summary type experiments performed E13
0.31626305.15548577.html.plaintext.txt	246	The respective vectors depicted left part diagram
0.31626305.15548577.html.plaintext.txt	247	B The average values GFPGFPtot ratio black column COUP TFII GFPGFPtot ratio white column cortex injected slices
0.31626305.15548577.html.plaintext.txt	248	Bars indicate standard errors mean
0.31626305.15548577.html.plaintext.txt	249	In COUP TFII injected side 60 plus minus 4 injected cells migrate cortex versus 25 plus minus 5 GFP positive cells control side
0.31626305.15548577.html.plaintext.txt	250	Examples control C COUP TFII mis expressing D brain slices vectors injected Str
0.31626305.15548577.html.plaintext.txt	251	C Arrows indicate GFP positive cells MZ whereas arrowheads indicate IZ migratory stream
0.31626305.15548577.html.plaintext.txt	252	D Arrowheads indicate higher amount GFP positive migrating cells IZ neocortex whereas cells seen MZ asterisk
0.31626305.15548577.html.plaintext.txt	253	Dotted line shows putative boundary neocortex striatum
0.31626305.15548577.html.plaintext.txt	254	All cells external dotted line counted cells located cortex
0.31626305.15548577.html.plaintext.txt	255	IZ intermediate zone MZ marginal zone Str striatum
0.31626305.15548577.html.plaintext.txt	256	Discussion TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES Interneurons migrate dorso ventrally telencephalon diencephalon Cell migration within telencephalon subdivided broadly radial non radial tangential
0.31626305.15548577.html.plaintext.txt	257	While radial migration uses radial glia scaffold upon cortical neurons migrate developing cortical plate GABAergic interneurons originate GEs use tangential migration migrate long distances reach destinations cortex Marin Rubenstein 2003 Rakic 1990
0.31626305.15548577.html.plaintext.txt	258	In report identified novel migratory path knowledge never reported
0.31626305.15548577.html.plaintext.txt	259	Using grafting experiments DNA electroporation tracer injections shown cells located interganglionic region MGE LGE fuse together capability migrating ventrally towards pre optic hypothalamic regions diencephalon Figs 3 4 5
0.31626305.15548577.html.plaintext.txt	260	As path originates interganglionic region specific caudal levels likely missed studies using similar approaches Anderson et al
0.31626305.15548577.html.plaintext.txt	261	The novelty path twofold first cells migrate tangentially dorsal ventral along subventricular zone MGE
0.31626305.15548577.html.plaintext.txt	262	opposite directions respect MGE derived cortical interneurons second cells exit basal telencephalon migrate basal diencephalon
0.31626305.15548577.html.plaintext.txt	263	These cells different gonadotropin releasing hormone neurons originate olfactory placode migrate along vomeronasal nerve fibres reach POa hypothalamus Wray et al
0.31626305.15548577.html.plaintext.txt	264	Migration GABAergic neurons GEs dorsal thalamus observed human brains however rodent embryos reveal similar migratory pathway Letinic Rakic 2001
0.31626305.15548577.html.plaintext.txt	265	With help retroviral cell tracing Marin collaborators Marin et al
0.31626305.15548577.html.plaintext.txt	266	2000 shown cells emanating MGE adjacent POaanterior entopeduncular area express transcription factor Nkx2
0.31626305.15548577.html.plaintext.txt	267	1 migrate developing striatum differentiate local circuit neurons
0.31626305.15548577.html.plaintext.txt	268	It would interesting find whether Nkx2
0.31626305.15548577.html.plaintext.txt	269	1 also involved opposite migratory path described report
0.31626305.15548577.html.plaintext.txt	270	Furthermore shown cells originating CGE migrate via different streams basal diencephalon particular hypothalamus Fig
0.31626305.15548577.html.plaintext.txt	271	As opposed MLGE transplant stream ventrally migrating cells quite compact cells migrating CGE take medial latero ventral route
0.31626305.15548577.html.plaintext.txt	272	We know fate ventrally migrating cells
0.31626305.15548577.html.plaintext.txt	273	In vivo ultrasound guided labelling transplantation Nery et al
0.31626305.15548577.html.plaintext.txt	274	2001 total cortices manipulated toto characterized later stages would help us understand final destinies migrating cells
0.31626305.15548577.html.plaintext.txt	275	Is basal telencephalon chemorepulsive Transplantation experiments co culture assays shown POa hypothalamic regions prevent interneurons migrating ventral direction secreting repulsive molecules responsible dorsal migration interneurons towards cortex Marin et al
0.31626305.15548577.html.plaintext.txt	276	However cues mediating action identified yet
0.31626305.15548577.html.plaintext.txt	277	Here show cells originating dorsal caudal regions capable migrating ventrally towards POaanterior hypothalamus
0.31626305.15548577.html.plaintext.txt	278	How reconcile different results First previous studies showed majority interneurons originated MGE avoided migrating ventral directions
0.31626305.15548577.html.plaintext.txt	279	This expected circumscribed graft section two GEs well separated Marin et al
0.31626305.15548577.html.plaintext.txt	280	However dorsal ventral cell migration describe report originates restricted region interganglionic sulcus caudal levels
0.31626305.15548577.html.plaintext.txt	281	It plausible order follow migration originates MGE LGE region included studies
0.31626305.15548577.html.plaintext.txt	282	Therefore hypothesize cells originating different rostrocaudal levels different responses environment expressing position dependent receptors
0.31626305.15548577.html.plaintext.txt	283	Accordingly COUP TFs expressed ventrally migrating cells rostral levels two GEs well separated data shown
0.31626305.15548577.html.plaintext.txt	284	Thus POa hypothalamus different roles repulsion versus attraction according type cells encounter
0.31626305.15548577.html.plaintext.txt	285	A novel role COUP TFs neuronal migration developing forebrain COUP TFs orphan nuclear receptors steroidthyroid superfamily shown involved neurogenesis axogenesis neural differentiation Park et al
0.31626305.15548577.html.plaintext.txt	286	In cortex COUP TFI mainly known role regionalization guidance thalamocortical projections Zhou et al
0.31626305.15548577.html.plaintext.txt	287	2001 whereas COUP TFII fundamental player angiogenesis heart development Pereira et al
0.31626305.15548577.html.plaintext.txt	288	In report provided first insights functional roles COUP TFI COUP TFII neuronal migration vivo
0.31626305.15548577.html.plaintext.txt	289	In previous report shown COUP TFI could regulate cell adhesion mechanisms required differentiation embryonal carcinoma cells Adam et al
0.31626305.15548577.html.plaintext.txt	290	Because substrates cells plated suggested COUP TFI could modify synthesis ECM molecules making cells autonomous migration spreading
0.31626305.15548577.html.plaintext.txt	291	Our expression data vivo functional data organotypic cultures support results context cell migration assumes fundamental role achieving neuronal diversity
0.31626305.15548577.html.plaintext.txt	292	By using different approaches first shown expression COUP TFs highly motile neurons GABAergic reelin positive cells Fig
0.31626305.15548577.html.plaintext.txt	293	2 confirmed co localization COUP TFI migrating neurons series grafting experiments Figs 3 4 5 finally directly demonstrated role COUP TFs modulating cell migration gain function approach Figs 6 7
0.31626305.15548577.html.plaintext.txt	294	Our data also demonstrate COUP TFs control directional migration
0.31626305.15548577.html.plaintext.txt	295	Indeed cells expressing higher levels COUP TFs thus GFP tend spread lose aspect aggregates also follow specific migratory pathways dorsal andor ventral intrinsic cells expressing COUP TFs Fig
0.31626305.15548577.html.plaintext.txt	296	Therefore hypothesize dual role COUP TFs
0.31626305.15548577.html.plaintext.txt	297	First regulate short range cues ECM andor adhesive molecules way modulate neighbouring environment
0.31626305.15548577.html.plaintext.txt	298	Changes permissive environment would allow random dispersion migratory cells
0.31626305.15548577.html.plaintext.txt	299	Indeed absence COUP TFI GABAergic cells migrate cortex although less organised fashion normal situation M
0.31626305.15548577.html.plaintext.txt	300	Therefore favour hypothesis COUP TFI involved modulating cell migration inducing cells initiate migration
0.31626305.15548577.html.plaintext.txt	301	Second propose COUP TFs control diffusible guidance molecules andor receptors involved cell migration
0.31626305.15548577.html.plaintext.txt	302	Indeed ectopic expression COUP TFI led correct directional migration targeted cells
0.31626305.15548577.html.plaintext.txt	303	dorsal cortex ventral POa Fig
0.31626305.15548577.html.plaintext.txt	304	6D suggesting cells mis expressing COUP TFI able respond COUP TFI dependent guidance cues
0.31626305.15548577.html.plaintext.txt	305	More striking behaviour MGE migrating cells mis expression COUP TFII
0.31626305.15548577.html.plaintext.txt	306	In case neurons committed migrate marginal intermediate layers neocortex see control Fig
0.31626305.15548577.html.plaintext.txt	307	7C migrated higher rates solely intermediate layer avoiding specifically marginal layer Fig
0.31626305.15548577.html.plaintext.txt	308	7D suggesting COUP TFII regulates guidance cues required migration intermediate zone neocortex
0.31626305.15548577.html.plaintext.txt	309	This behaviour accordance COUP TFII expression pattern grafting experiments described study
0.31626305.15548577.html.plaintext.txt	310	Indeed COUP TFII positive cells marginal zone Cajal Retzius cells seen co expression reelin well established Cajal Retzius cells originate exclusively pallium Hevner et al
0.31626305.15548577.html.plaintext.txt	311	1999 Takiguchi Hayashi et al
0.31626305.15548577.html.plaintext.txt	312	Conclusions TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES In summary data show novel role COUP TF nuclear receptors tangential migration developing forebrain
0.31626305.15548577.html.plaintext.txt	313	COUP TFI previously reported required axon guidance telencephalon romboencephalon Qiu et al
0.31626305.15548577.html.plaintext.txt	314	Here show COUP TFs involved modulating rates directions tangentially migrating cells basal telencephalon cortex basal telencephalon basal diencephalon
0.31626305.15548577.html.plaintext.txt	315	Interestingly cells follow migratory path dependent expression COUP TFI COUP TFII suggesting intrinsic role COUP TFs guiding migrating cells towards target region
0.31626305.15548577.html.plaintext.txt	316	Finally speculate COUP TFs regulators series factors short range non diffusible contact guidance cues long range diffusible guidance cues
0.31626305.15548577.html.plaintext.txt	317	ACKNOWLEDGMENTS We thank A
0.31626305.15548577.html.plaintext.txt	318	Nagy GFP expressing mice A
0.31626305.15548577.html.plaintext.txt	319	Goffinet anti reelin antibody M
0.31626305.15548577.html.plaintext.txt	320	Tsai COUP TFI COUP TFII full length cDNAs
0.31626305.15548577.html.plaintext.txt	321	Fishell helpful comments manuscript whole Studer laboratory fruitful discussions
0.31626305.15548577.html.plaintext.txt	322	This work supported Telethon Foundation Fondo per gli Investimenti della Ricerca di Base FIRB RBNE01WY7P RBAU01RW82 RBNE01BBYW
0.31626305.15548577.html.plaintext.txt	323	Footnotes These authors contributed equally work
0.31626305.15548577.html.plaintext.txt	324	REFERENCES TOP SUMMARY Introduction Materials methods Results Discussion Conclusions REFERENCES
0.31626305.15548577.html.plaintext.txt	325	COUP TFI chicken ovalbumin upstream promoter transcription factor I regulates cell migration axogenesis differentiating P19 embryonal carcinoma cells
0.31626305.15548577.html.plaintext.txt	326	Autoradiographic histological studies postnatal neurogenesis
0.31626305.15548577.html.plaintext.txt	327	Cell proliferation migration anterior forebrain special reference persisting neurogenesis olfactory bulb
0.31626305.15548577.html.plaintext.txt	328	Interneuron migration basal forebrain neocortex dependence Dlx genes
0.31626305.15548577.html.plaintext.txt	329	Distinct cortical migrations medial lateral ganglionic eminences
0.31626305.15548577.html.plaintext.txt	330	Telencephalic cells take tangent non radial migration mammalian forebrain
0.31626305.15548577.html.plaintext.txt	331	The adhesion molecule TAG 1 mediates migration cortical interneurons ganglionic eminence along corticofugal fiber system
0.31626305.15548577.html.plaintext.txt	332	Generating green fluorescent mice germline transmission green fluorescent ES cells
0.31626305.15548577.html.plaintext.txt	333	Multipotent stem cells mouse basal forebrain contribute GABAergic neurons oligodendrocytes cerebral cortex embryogenesis
0.31626305.15548577.html.plaintext.txt	334	Cajal Retzius cells mouse transcription factors neurotransmitters birthdays suggest pallial origin
0.31626305.15548577.html.plaintext.txt	335	Control noradrenergic differentiation Phox2a expression MASH1 central peripheral nervous system
0.31626305.15548577.html.plaintext.txt	336	Tangential migration neocortical development
0.31626305.15548577.html.plaintext.txt	337	The medial ganglionic eminence gives rise population early neurons developing cerebral cortex
0.31626305.15548577.html.plaintext.txt	338	Transient fetal structure gangliothalamic body connects telencephalic germinal zone thalamic regions developing human brain
0.31626305.15548577.html.plaintext.txt	339	CO2 ZlinktypeDOI CrossRefMedline
0.31626305.15548577.html.plaintext.txt	340	Telencephalic origin human thalamic GABAergic neurons
0.31626305.15548577.html.plaintext.txt	341	Long distance neuronal migration adult mammalian brain
0.31626305.15548577.html.plaintext.txt	342	Restricted proliferation migration postnatally generated neurons derived forebrain subventricular zone
0.31626305.15548577.html.plaintext.txt	343	A long remarkable journey tangential migration telencephalon
0.31626305.15548577.html.plaintext.txt	344	Cell migration forebrain
0.31626305.15548577.html.plaintext.txt	345	Origin molecular specification striatal interneurons
0.31626305.15548577.html.plaintext.txt	346	Directional guidance interneuron migration cerebral cortex relies subcortical Slit12 independent repulsion cortical attraction
0.31626305.15548577.html.plaintext.txt	347	What Cajal Retzius cell A reassessment classical cell type based recent observations developing neocortex
0.31626305.15548577.html.plaintext.txt	348	Modes neuronal migration developing cerebral cortex
0.31626305.15548577.html.plaintext.txt	349	Ventricle directed migration developing cerebral cortex
0.31626305.15548577.html.plaintext.txt	350	The caudal ganglionic eminence source distinct cortical subcortical cell populations
0.31626305.15548577.html.plaintext.txt	351	Molecular mechanism chicken ovalbumin upstream promoter transcription factor COUP TF actions
0.31626305.15548577.html.plaintext.txt	352	The orphan nuclear receptor COUP TFII required angiogenesis heart development
0.31626305.15548577.html.plaintext.txt	353	Control cortical interneuron migration neurotrophins PI3 kinase signaling
0.31626305.15548577.html.plaintext.txt	354	Hepatocyte growth factorscatter factor motogen interneurons migrating ventral dorsal telencephalon
0.31626305.15548577.html.plaintext.txt	355	Null mutation mCOUP TFI results defects morphogenesis glossopharyngeal ganglion axonal projection arborization
0.31626305.15548577.html.plaintext.txt	356	Principles neural cell migration
0.31626305.15548577.html.plaintext.txt	357	Telencephalic origin pulvinar neurons fetal human brain
0.31626305.15548577.html.plaintext.txt	358	Ectopic expression Dlx genes induces glutamic acid decarboxylase Dlx expression
0.31626305.15548577.html.plaintext.txt	359	Generation reelin positive marginal zone cells caudomedial wall telencephalic vesicles
0.31626305.15548577.html.plaintext.txt	360	Multimodal tangential migration neocortical GABAergic neurons independent GPI anchored proteins
0.31626305.15548577.html.plaintext.txt	361	The molecular biology axon guidance
0.31626305.15548577.html.plaintext.txt	362	In utero fate mapping reveals distinct migratory pathways fates neurons born mammalian basal forebrain
0.31626305.15548577.html.plaintext.txt	363	Permissive corridor diffusible gradients direct medial ganglionic eminence cell migration neocortex
0.31626305.15548577.html.plaintext.txt	364	A subset peripherin positive olfactory axons delineates luteinizing hormone releasing hormone neuronal migratory pathway developing mouse
0.31626305.15548577.html.plaintext.txt	365	The migration luteinizing hormone releasing hormone neurons developing rat associated transient caudal projection vomeronasal nerve
0.31626305.15548577.html.plaintext.txt	366	The nuclear orphan receptor COUP TFI required differentiation subplate neurons guidance thalamocortical axons
0.31626305.15548577.html.plaintext.txt	367	COUP TFI intrinsic factor early regionalization neocortex
0.31626305.15548577.html.plaintext.txt	368	Related articles Development
0.31626305.15548577.html.plaintext.txt	369	A coup neuronal cell migration Development 2004 131 2402
0.33547345.15611122.html.plaintext.txt	0	Ubc9 Protein Inhibitor Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter Transcription Factor I mediated Human CYP11B2 Gene Transcription Isao Kurihara Hirotaka Shibata Sakiko Kobayashi Noriko Suda Yayoi Ikeda Kenichi Yokota Ayano Murai Ikuo Saito William E
0.33547345.15611122.html.plaintext.txt	1	From Department Internal Medicine School Medicine Keio University Tokyo 160 8582 Japan Health Center Keio University 35 Shinanomachi Shinjuku ku Tokyo 160 8582 Japan Department Fine Morphology Yokohama City University Graduate School Medicine Yokohama 236 0004 Japan Division Reproductive Endocrinology University Texas Southwestern Medical Center Dallas Texas 75390 9032
0.33547345.15611122.html.plaintext.txt	2	Received publication October 18 2004 revised form December 14 2004
0.33547345.15611122.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Aldosterone synthase CYP11B2 involved final steps aldosterone biosynthesis expressed exclusively adrenal zona glomerulosa cells
0.33547345.15611122.html.plaintext.txt	4	Using electrophoretic mobility shift assay demonstrate COUP TFI binds 129 114 element Ad5 human CYP11B2 promoter
0.33547345.15611122.html.plaintext.txt	5	Transient transfection H295R adrenal cells demonstrated COUP TFI enhanced CYP11B2 reporter activity
0.33547345.15611122.html.plaintext.txt	6	However reporter construct mutated Ad5 sequences showed reduced basal COUP TFI enhanced activity suggesting binding COUP TFI Ad5 important CYP11B2 transactivation
0.33547345.15611122.html.plaintext.txt	7	To elucidate molecular mechanisms COUP TFI mediated activity subsequently screened COUP TFI interacting proteins human adrenal cDNA library using yeast two hybrid system identified Ubc9 PIAS1 small ubiquitin related modifier 1 SUMO 1 conjugase ligase activities respectively
0.33547345.15611122.html.plaintext.txt	8	The coimmunoprecipitation assays confirmed COUP TFI forms complex Ubc9 PIAS1 mammalian cells
0.33547345.15611122.html.plaintext.txt	9	Immunohistochemistry showed Ubc9 PIAS1 markedly expressed rat adrenal glomerulosa cells
0.33547345.15611122.html.plaintext.txt	10	Coexpression Ubc9 PIAS1 synergistically enhanced COUP TFI mediated CYP11B2 reporter activity indicating proteins function coactivators COUP TFI
0.33547345.15611122.html.plaintext.txt	11	However sumoylation defective mutants Ubc9 C93S PIAS1 C351S continued function coactivators COUP TFI indicating sumoylation activity separable coactivator ability
0.33547345.15611122.html.plaintext.txt	12	In addition chromatin immunoprecipitation assays demonstrated ectopically expressed COUP TFI Ubc9 PIAS1 recruited endogenous CYP11B2 promoter
0.33547345.15611122.html.plaintext.txt	13	Moreover reduction Ubc9 PIAS1 protein levels small interfering RNA inhibited CYP11B2 transactivation COUP TFI
0.33547345.15611122.html.plaintext.txt	14	Our data support physiological role Ubc9 PIAS1 transcriptional coactivators COUP TFI mediated CYP11B2 transcription
0.33547345.15611122.html.plaintext.txt	15	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Aldosterone exclusively produced adrenal zona glomerulosa cells due unique expression aldosterone synthase cytochrome P450 CYP11B2 enzyme required final steps aldosterone biosynthesis
0.33547345.15611122.html.plaintext.txt	16	In aldosterone producing adrenal cortical adenomas patients primary aldosteronism overexpression CYP11B2 demonstrated transcriptional level 1 2
0.33547345.15611122.html.plaintext.txt	17	Although reason aberrant expression CYP11B2 adenomas known mutations CYP11B2 gene appear cause 3 4
0.33547345.15611122.html.plaintext.txt	18	We therefore postulated transcription factors andor coregulators may play important roles CYP11B2 overexpression tumors
0.33547345.15611122.html.plaintext.txt	19	The trans acting factors regulate CYP11B2 expression remain poorly defined
0.33547345.15611122.html.plaintext.txt	20	The orphan nuclear receptor steroidogenic factor 1 SF 11 shown play crucial regulator steroid hydroxylase genes including CYP17 CYP11B1 5 6
0.33547345.15611122.html.plaintext.txt	21	However SF 1 actually represses rather activates expression hCYP11B2 7 9
0.33547345.15611122.html.plaintext.txt	22	In addition transcription factors expressed adrenal cortex include NGFI B family orphan nuclear receptors Nurr1 NGFI B NOR 1
0.33547345.15611122.html.plaintext.txt	23	The NGFI B family receptors highly expressed adrenal zona glomerulosa cells well aldosterone producing adenomas 8 10 11
0.33547345.15611122.html.plaintext.txt	24	These three nuclear receptors rapidly induced early response genes enhance transcription binding consensus sequence named NBRE 1 well Ad5 element hCYP11B2 promoter
0.33547345.15611122.html.plaintext.txt	25	In addition CREB ATF 1 enhance transcription hCYP11B2 gene binding CRE 9 12 13
0.33547345.15611122.html.plaintext.txt	26	Our previous data 12 showed human adrenocortical H295R nuclear proteins containing chicken ovalbumin upstream promoter transcription factors COUP TFs bound 129 114 sequence designated Ad5 element hCYP11B2 promoter electrophoretic mobility shift assays
0.33547345.15611122.html.plaintext.txt	27	The COUP TFI originally identified activator chicken ovalbumin gene 14 15 however COUP TFs mostly function transcriptional repressor many target genes
0.33547345.15611122.html.plaintext.txt	28	COUP TFs inhibit transcription nuclear receptor retinoic acid receptor thyroid hormone receptor 14
0.33547345.15611122.html.plaintext.txt	29	Furthermore COUP TFI represses basal transcriptional activity active repression utilizing transcriptional corepressors N CoR SMRT 16
0.33547345.15611122.html.plaintext.txt	30	We investigators previously demonstrated COUP TFI SF 1 regulate bovine CYP17 expression mutually exclusive manner 17 18
0.33547345.15611122.html.plaintext.txt	31	We previously reported COUP TFI expressed normal adrenal cortex expression levels COUP TFI inversely correlated CYP17 correlated N CoR adrenal cortical adenomas 18 23
0.33547345.15611122.html.plaintext.txt	32	We therefore screened COUP TFI interacting proteins human adrenocortical adenoma cDNA library using yeast two hybrid system identified Ubc9 24 PIAS1 small ubiquitin related modifier 1 SUMO 1 conjugating enzyme SUMO 1 ligase respectively
0.33547345.15611122.html.plaintext.txt	33	The SUMO post translationally modifies many proteins roles diverse processes including regulation transcription chromatin structure DNA repair 25 30
0.33547345.15611122.html.plaintext.txt	34	The SUMO modification generally associated increased protein degradation
0.33547345.15611122.html.plaintext.txt	35	Rather similar non proteolytic roles ubiquitin SUMO modification regulates protein localization activity
0.33547345.15611122.html.plaintext.txt	36	The SUMO E1 activating E2 conjugating enzymes E3 ligase involved sumoylation machinery
0.33547345.15611122.html.plaintext.txt	37	In contrast ubiquitin system dozens E2 enzymes identified Ubc9 known SUMO E2 conjugating enzyme
0.33547345.15611122.html.plaintext.txt	38	Several SUMO E3 ligases identified promote transfer SUMO E2 specific substrates
0.33547345.15611122.html.plaintext.txt	39	To date three unrelated proteins suggested SUMO E3 ligase activity protein inhibitors activated STAT1 PIAS1 proteins 31 33 RanBP2 34 35 polycomb group protein Pc2 36
0.33547345.15611122.html.plaintext.txt	40	The present study described Ubc9 PIAS1 function transcriptional coactivators COUP TFI hCYP11B2 gene transcription sumoylation independent manner
0.33547345.15611122.html.plaintext.txt	41	These proteins shown form complex nucleus exhibit unique localization adrenal zona glomerulosa cells
0.33547345.15611122.html.plaintext.txt	42	We demonstrated COUP TFI Ubc9 PIAS1 recruited endogenous CYP11B2 promoter thus contributing aldosterone biosynthesis adrenal zona glomerulosa cells
0.33547345.15611122.html.plaintext.txt	43	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Plasmid Constructs Several COUP TF constructs pG BKT7 COUP TFI pGBKT7 COUP TFI 55 315 pGBKT7 COUP TFI 86 183 pGBKT7 COUP TFI 150 183 pGBKT7 COUP TFI 315 423 pGBKT7 COUP TFI 55 423 pRSV COUP TFI pRSV COUP TFI35 pDsRed COUP TFI pGBKT7 COUP TFII described previously 16 24 Fig
0.33547345.15611122.html.plaintext.txt	44	Several constructs including pG BKT7 Ubc9 pGADT7 Ubc9 pcDNA3
0.33547345.15611122.html.plaintext.txt	45	1His Ubc9 1 58 pAS1cyh2 TR 168 456 described previously 16 24
0.33547345.15611122.html.plaintext.txt	46	pGBT9 Ad4BPSF 1 pGBT9 DAX 1 p3xFLAG CMV10 PIAS1 generous gifts Professor Ken ichirou Morohashi National Institute Basic Biology Japan
0.33547345.15611122.html.plaintext.txt	47	pGL3 Basic human CYP11B2 15212 pGL3 Basic human CYP11B2 mutAd5 pGL2 wtAd5 pGL2 m5Ad5 pGL2 m7Ad5 described previously 7 8
0.33547345.15611122.html.plaintext.txt	48	pGADT7 PIAS1 5 651 first identified COUP TFI interacting protein human adrenocortical adenoma cDNA library
0.33547345.15611122.html.plaintext.txt	49	Several PIAS1 fragments PIAS1 1 651 1 150 1 300 1 405 301 651 406 651 5 73564 651 subcloned pGADT7 vector using PCR amplification primers containing oligonucleotide linkers restriction enzyme sites Fig
0.33547345.15611122.html.plaintext.txt	50	Mutagenesis PIAS1 performed QuikChange site directed mutagenesis kit Stratagene mutant PIAS1 C351S generated
0.33547345.15611122.html.plaintext.txt	51	pEGFP PIAS1 pEGFP PIAS1 C351S generated utilizing PCR amplifications pGADT7 PIAS1 pGADT7 PIAS1 C351S respectively
0.33547345.15611122.html.plaintext.txt	52	View larger version 19K FIG
0.33547345.15611122.html.plaintext.txt	53	Diagram various deletion mutants COUP TFI A PIAS1 B
0.33547345.15611122.html.plaintext.txt	54	A COUP TFI fragments shown cloned pGBKT7 expression vector described Experimental Procedures
0.33547345.15611122.html.plaintext.txt	55	Based nuclear hormone receptors reference sequence amino acids 1 85 86 149 150 183 184 423 designated domains AB C D EF respectively
0.33547345.15611122.html.plaintext.txt	56	B The PIAS1 fragments shown cloned pGADT7 pEGFP pcDNA3
0.33547345.15611122.html.plaintext.txt	57	1His expression vectors described Experimental Procedures
0.33547345.15611122.html.plaintext.txt	58	The N terminus PIAS1 contains NR box coactivator motif interacts nuclear receptors whereas C terminus PIAS1 contains two CoRNR motifs corepressor interacts nuclear receptors
0.33547345.15611122.html.plaintext.txt	59	In middle PIAS1 proteins RING finger domain necessary SUMO 1 ligase activity localized
0.33547345.15611122.html.plaintext.txt	60	Cloning Ubc9 PIAS1 Yeast Two hybrid System Yeast two hybrid screening conducted MATCHMAKER Two Hybrid System 3 kit Clontech COUP TFI amino acids 55 423 bait
0.33547345.15611122.html.plaintext.txt	61	A human adrenocortical adenoma cDNA library prepared shown previously 24
0.33547345.15611122.html.plaintext.txt	62	Yeast strain AH109 containing pGBKT7 COUP TFI 55 423 transformed human adrenocortical adenoma cDNA library pGADT7 Clontech plated synthetic complete medium lacking tryptophan adenine leucine histidine
0.33547345.15611122.html.plaintext.txt	63	His Ade colonies exhibiting galactosidase activity filter lift assay characterized according manufacturers protocol Clontech
0.33547345.15611122.html.plaintext.txt	64	Galactosidase activity determined chlorophenol red D galactopyranoside described previously 16 24
0.33547345.15611122.html.plaintext.txt	65	To recover library plasmids total DNA yeast isolated ZymoprepTM yeast plasmid Miniprep kit Zymo Research Orange CA used transform Escherichia coli HB101 presence ampicillin
0.33547345.15611122.html.plaintext.txt	66	To ensure correct cDNAs identified library plasmids isolated transformed Y187 containing pGBKT7 COUP TFI 55 423 galactosidase activity determined
0.33547345.15611122.html.plaintext.txt	67	The specificity interaction 2 3 PIAS1 5 651 2 4 Ubc9 1 158 part 20 positive clones COUP TFI determined mating Y187 contains pGBKT7 lamin Clontech
0.33547345.15611122.html.plaintext.txt	68	The galactosidase activities diploids examined filter lift chlorophenol red D galactopyranoside methods
0.33547345.15611122.html.plaintext.txt	69	The sequence 2 3 2 4 clones identical GenBankTM submitted sequence PIAS1 Ubc9 respectively
0.33547345.15611122.html.plaintext.txt	70	The yeast two hybrid system also used determine protein protein interaction COUP TFICOUP TFIIAd4BPDAX 1TR clones
0.33547345.15611122.html.plaintext.txt	71	Western Blot Analysis Coimmunoprecipitation The cells lysed lysis buffer 10 mM Tris HCl pH 8
0.33547345.15611122.html.plaintext.txt	72	0 150 mM NaCl 1 Triton X 100 5 mM EDTA 2 mM phenylmethylsulfonyl fluoride Western blots performed immunoprecipitation IP steps confirm protein expression corresponding antibodies described previously 24
0.33547345.15611122.html.plaintext.txt	73	The samples Western blots diluted 1 ml IP buffer 20 mM Tris HCl pH 7
0.33547345.15611122.html.plaintext.txt	74	5 150 mM NaCl 10 mM dithiothreitol 5 ng microl aprotinin 0
0.33547345.15611122.html.plaintext.txt	75	5 mM phenylmethylsulfonyl fluoride 0
0.33547345.15611122.html.plaintext.txt	76	1 Tween 20 precleared protein G plus agarose beads Santa Cruz Biotechnology Santa Cruz CA antibodies added 1 h
0.33547345.15611122.html.plaintext.txt	77	Immune complexes adsorbed protein G plus agarose beads washed four times IP buffer
0.33547345.15611122.html.plaintext.txt	78	Proteins separated 12
0.33547345.15611122.html.plaintext.txt	79	5 polyacrylamide gels transferred onto Hybond ECL nitrocellulose membranes Amersham Biosciences
0.33547345.15611122.html.plaintext.txt	80	The primary antibodies used immunoprecipitation rabbit polyclonal anti COUP TFI antibody generous gift Dr
0.33547345.15611122.html.plaintext.txt	81	Ming Jer Tsai 15 antibodies used Western blots anti COUP TFI anti Xpress Invitrogen anti FLAG Sigma anti Ubc9 BD Biosciences Pharmingen anti PIAS1 Santa Cruz Biotechnology anti tubulin Oncogene Research Product antibodies
0.33547345.15611122.html.plaintext.txt	82	Fluorescence Imaging The images EGFP tagged Ubc9 DsRed COUP TFI described previously 24
0.33547345.15611122.html.plaintext.txt	83	COS 1 cells transiently transfected expression vectors pEGFP PIAS1 pDsRed COUP TFI
0.33547345.15611122.html.plaintext.txt	84	Live cell microscopy GFP fusion DsRed fusion proteins performed confocal microscope Axiovert 100M Carl Zeiss Co
0.33547345.15611122.html.plaintext.txt	85	Imaging GFP DsRed performed excitation 488 543 nm respectively argon laser emissions viewed band passes ranging 500 550 nm 550 600 nm respectively band pass regulation LSM510 Carl Zeiss Co
0.33547345.15611122.html.plaintext.txt	86	All images processed TIFF tagged image file format files Photoshop 7
0.33547345.15611122.html.plaintext.txt	87	0 using standard image processing techniques
0.33547345.15611122.html.plaintext.txt	88	Northern Blot Analysis The human tissue Northern blots Clontech hybridized 42 degrees C overnight 32P labeled cDNA probes full length 1
0.33547345.15611122.html.plaintext.txt	89	1 kb glyceraldehyde 3 phosphate dehydrogenase Clontech cDNAs according manufacturers protocol
0.33547345.15611122.html.plaintext.txt	90	The membranes washed final stringency 0
0.33547345.15611122.html.plaintext.txt	91	1 SDS 50 degrees C analyzed BAS 3000 image scanner Fuji Film Co
0.33547345.15611122.html.plaintext.txt	92	The mRNA levels determined comparison glyceraldehyde 3 phosphate dehydrogenase mRNA levels
0.33547345.15611122.html.plaintext.txt	93	Immunohistochemistry Formalin fixed tissues embedded paraffin sectioned 6 microm mounted silane coated slides
0.33547345.15611122.html.plaintext.txt	94	For immunohistochemistry sections dewaxed rehydrated followed blocking endogenous peroxidase using 3 vv hydrogen peroxidase phosphate buffered saline subjected microwave antigen retrieval 0
0.33547345.15611122.html.plaintext.txt	95	Thereafter washed phosphate buffered saline blocked blocking solution containing 5 bovine serum albumin phosphate buffered saline 30 min
0.33547345.15611122.html.plaintext.txt	96	They subsequently incubated overnight 4 degrees C primary antibodies diluted appropriately blocking solution
0.33547345.15611122.html.plaintext.txt	97	Primary antibodies immunohistochemistry included rabbit anti COUP TFI anti Ubc9 BD Biosciences Pharmingen anti PIAS1 Santa Cruz Biotechnology
0.33547345.15611122.html.plaintext.txt	98	After two washes phosphate buffered saline immunoreactivities detected using Vectastatin ABC Elite kit Vector Laboratories CA Vecta DAB substrate kit Vector Laboratories
0.33547345.15611122.html.plaintext.txt	99	As negative controls sections incubated preimmune control serum place primary antibody
0.33547345.15611122.html.plaintext.txt	100	Electrophoretic Mobility Shift Analysis Nuclear extracts prepared described previously 8 11 12
0.33547345.15611122.html.plaintext.txt	101	For vitro transcriptiontranslation 0
0.33547345.15611122.html.plaintext.txt	102	5 microg pGBT9 Ad4BPSF 1 pFL COUP TFI used conjunction TNT coupled reticulocyte lysate system Promega directed manufacturer
0.33547345.15611122.html.plaintext.txt	103	EMSA conditions described previously 8 11 12 using 5 microg H295R nuclear extract 0
0.33547345.15611122.html.plaintext.txt	104	0 microl reticulocyte extract
0.33547345.15611122.html.plaintext.txt	105	Protein DNA complexes separated free probe electrophoresis 2 h 4 polyacrylamide 2
0.33547345.15611122.html.plaintext.txt	106	5 glycerol gel using 1x TGE running buffer 50 mM Tris Cl 38 mM glycine 2
0.33547345.15611122.html.plaintext.txt	107	For detection supershift complex anti SF 1 generous gift Dr
0.33547345.15611122.html.plaintext.txt	108	Ken ichirou Morohashi anti COUP TFI generous gift Dr
0.33547345.15611122.html.plaintext.txt	109	Ming Jer Tsai antibodies used
0.33547345.15611122.html.plaintext.txt	110	Mammalian Cell Culture Transient Transfections Luciferase Assays H295R cells derived human adrenocortical carcinoma cells 8 12 37 used luciferase assays
0.33547345.15611122.html.plaintext.txt	111	H295R cells routinely maintained Dulbeccos modified Eagles mediumF 12 Invitrogen supplemented 2
0.33547345.15611122.html.plaintext.txt	112	5 NuSerum Collaborative Bio Bedford NA 1 ITS insulin transferrin selenium culture supplement Invitrogen
0.33547345.15611122.html.plaintext.txt	113	Twenty four hours transfection 1 x 105 cells per well 24 well dish plated medium
0.33547345.15611122.html.plaintext.txt	114	All transfections H295R cells carried using Lipofectamine 2000 Invitrogen indicated amounts expression plasmids according manufacturers protocol
0.33547345.15611122.html.plaintext.txt	115	Cells harvested 48 h transfection cell extracts assayed Firefly Renilla luciferase activities Dual Luciferase Reporter Assay System Promega
0.33547345.15611122.html.plaintext.txt	116	Relative luciferase activity determined ratio FireflyRenilla luciferase activities data expressed mean plus minus S
0.33547345.15611122.html.plaintext.txt	117	triplicate values obtained representative experiment independently repeated least three times
0.33547345.15611122.html.plaintext.txt	118	RNA Interference H295R cells transfection siRNAs luciferase assays performed described previously 8 12 37
0.33547345.15611122.html.plaintext.txt	119	H295R cells plated 24 well plates grown reaching 70 80 confluence transfected 30 pmol negative control sequence Ubc9 PIAS1 specific siRNA duplex using Lipofectamine 2000 Invitrogen following manufacturers instructions
0.33547345.15611122.html.plaintext.txt	120	Whole cell extracts prepared described previously follows siRNA Ubc9a sense 5 GGC CAG CCA UCA CAA UCA ATT 3 siRNA Ubc9a antisense 5 UUG AUU GUG AUG GCU GGC CTC 3 siRNA Ubc9b sense 5 GGA ACU UCU AAA UGA ACC ATT 3 siRNA Ubc9b antisense 5 UGG UUC AUU UAG AAG UUC CTG 3 siRNA PIAS1a sense 5 GGU CCA GUU AAG GUU UUG UTT 3 siRNA PIAS1a antisense 5 ACA AAA CCU UAA CUG GAC CTG 3 siRNA PIAS1b sense 5 GGU UAC CUU CCA CCU ACA ATT 3 siRNA PIAS1b antisense 5 UUG UAG GUG GAA GGU AAC CTG 3 Silencer Negative Control 1 siRNA Ambion used
0.33547345.15611122.html.plaintext.txt	121	Chromatin Immunoprecipitation ChIP assay performed described previously 38
0.33547345.15611122.html.plaintext.txt	122	The cross linked sheared chromatin solution used immunoprecipitation 3 microg anti COUP TFI anti Xpress antibody anti FLAG antibody normal IgG
0.33547345.15611122.html.plaintext.txt	123	The immunoprecipitated DNAs purified phenol chloroform extraction precipitated ethanol amplified PCR using primers flanking human CYP11B2 Ad5 region 335 52 transcription initiation site 3 untranslated region 1939 2198 transcription initiation site CYP11B2 Ad5 sense primer 5 CCT CTC ATC TCA CGA 3 335 321 CYP11B2 Ad5 antisense primer 5 AAC CTG CTC TGG AAA 3 66 52 CYP11B2 control sense primer 5 CAT TAA GCG GGA TCC 3 19391953 CYP11B2 control antisense primer 5 CAA GAC CTG GTC CAT 3 21842198
0.33547345.15611122.html.plaintext.txt	124	DNA samples serial dilution amplified PCR determine linear range amplification data shown
0.33547345.15611122.html.plaintext.txt	125	Statistics All experiments performed triplicate several times
0.33547345.15611122.html.plaintext.txt	126	The error bars graphs individual experiments correspond S
0.33547345.15611122.html.plaintext.txt	127	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Identification Ubc9 PIAS1 COUP TFI interacting Proteins Yeast Two hybrid System To search proteins might regulate activity COUP TFI performed yeast two hybrid screen COUP TFI encoding amino acids 55 423 bait cDNA library prepared human adrenocortical adenoma described previously 24
0.33547345.15611122.html.plaintext.txt	128	In manner identified full length clone Ubc9 partial clone PIAS1 SUMO E2 conjugating enzyme E3 ligase respectively
0.33547345.15611122.html.plaintext.txt	129	This report describes function expression COUP TFI Ubc9 PIAS1 transcriptional regulation human aldosterone synthase gene CYP11B2
0.33547345.15611122.html.plaintext.txt	130	We recently shown Ubc9 specifically interacted COUP TFI mapped interaction domains C terminus Ubc9 encoding amino acids 59 158 interacted C terminus COUP TFI encoding 383 403 24
0.33547345.15611122.html.plaintext.txt	131	In present study performed yeast two hybrid assays demonstrate PIAS1 interacts specifically COUP TFI
0.33547345.15611122.html.plaintext.txt	132	Both Ubc9 PIAS1 interacted COUP TFI interactions specific interaction Gal4 DBD COUP TFI amino acids 55 423 fusion Gal4 activation domain Gal4 AD empty vector observed Fig
0.33547345.15611122.html.plaintext.txt	133	In contrast positive control showed strong interaction Gal4 DBD COUP TFI Gal4 AD COUP TFI COUP TFI readily forms homodimers data shown
0.33547345.15611122.html.plaintext.txt	134	In addition Ubc9 PIAS1 interact unrelated bait corresponding lamin data shown
0.33547345.15611122.html.plaintext.txt	135	Besides interacting COUP TFI Ubc9 PIAS1 also interacted COUP TFII SF 1 DAX 1 unliganded TR 168 456 Fig
0.33547345.15611122.html.plaintext.txt	136	View larger version 24K FIG
0.33547345.15611122.html.plaintext.txt	137	Interaction Ubc9 PIAS1 several nuclear receptors yeast two hybrid assays
0.33547345.15611122.html.plaintext.txt	138	A interaction Ubc9 PIAS1 several nuclear receptors COUP TFI COUP TFII SF 1 DAX 1 TR yeast
0.33547345.15611122.html.plaintext.txt	139	B interaction various COUP TFI fragments PIAS1 yeast
0.33547345.15611122.html.plaintext.txt	140	C interaction various PIAS1 fragments COUP TFI yeast
0.33547345.15611122.html.plaintext.txt	141	Galactosidase activity assayed liquid cultures three separate experiments triplicate samples
0.33547345.15611122.html.plaintext.txt	142	Values expressed average Miller units plus minus S
0.33547345.15611122.html.plaintext.txt	143	To identify interaction domains precisely various fragments COUP TFI PIAS1 cotransformed yeast galactosidase liquid assays performed quantitate protein protein interaction Fig
0.33547345.15611122.html.plaintext.txt	144	Both Gal4 DBD COUP TFI encoding amino acids 86 183 amino acids 150 183 strongly interacted full length PIAS1 suggesting DNA binding domain hinge regions COUP TFI necessary interact Ubc9
0.33547345.15611122.html.plaintext.txt	145	In contrast C terminal fragments PIAS1 encoding amino acids 301 651 amino acids 406 651 strongly interacted COUP TFI whereas PIAS1 fragments encoding amino acids 1 150 1 300 1 405 5 73564 651 showed minimal interaction COUP TFI
0.33547345.15611122.html.plaintext.txt	146	Although N C termini PIAS1 contain nuclear receptor interacting domains named nuclear receptor box NR box CoRNR motifs respectively domains involved interaction COUP TFI
0.33547345.15611122.html.plaintext.txt	147	Taken together interaction data described C terminal fragments PIAS1 encoding amino acids 406 563 interacted DNA binding hinge regions COUP TFI yeast
0.33547345.15611122.html.plaintext.txt	148	Interaction Subcellular Localization Ubc9 PIAS1 COUP TFI Mammalian Cells We previously showed Ubc9 interacts specifically directly COUP TFI 24
0.33547345.15611122.html.plaintext.txt	149	The association COUP TFI Ubc9 PIAS1 investigated coimmunoprecipitation assays Fig
0.33547345.15611122.html.plaintext.txt	150	COS 1 cells transfected Xpress tagged Ubc9 pcDNA3
0.33547345.15611122.html.plaintext.txt	151	1His Ubc9 FLAG tagged PIAS1 p3xFLAG CMV 10 PIAS1 RSV promoter driven COUP TFI expression vectors pRSV COUP TFI
0.33547345.15611122.html.plaintext.txt	152	Polyclonal anti COUP TFI antibody first used precipitate protein complexes containing COUP TFI presence PIAS1 protein detected lysates cells transfected RSV COUP TFI FLAG tagged PIAS1 RSV COUP TFI FLAG tagged PIAS1 alone Fig
0.33547345.15611122.html.plaintext.txt	153	Similarly RSV COUP TFI FLAG PIAS1 Xpress Ubc9 expressed together exogenously overexpressed proteins shown form complex Fig
0.33547345.15611122.html.plaintext.txt	154	To determine Ubc9 PIAS1 COUP TFI could interact within cellular environment COS 1 cells transfected EGFP EGFP tagged PIAS1 EGFP tagged PIAS1 C351S DsRed DsRed tagged COUP TFI alone various combinations photographed using fluorescence microscope Fig
0.33547345.15611122.html.plaintext.txt	155	COS 1 cells transfected EGFP alone displayed diffuse green fluorescence data shown
0.33547345.15611122.html.plaintext.txt	156	EGFP tagged PIAS1 DsRed tagged COUP TFI showed predominantly nuclear localization occasional dot formation
0.33547345.15611122.html.plaintext.txt	157	When cells cotransfected EGFP tagged PIAS1 DsRed tagged COUP TFI expression proteins colocalized nucleus altered compared expression obtained either transfected alone
0.33547345.15611122.html.plaintext.txt	158	In addition expression EGFP tagged PIAS1 C351S DsRed COUP TFI colocalized nucleus Fig
0.33547345.15611122.html.plaintext.txt	159	3 E G indicating presence sumoylation activity affect nuclear localization COUP TFI
0.33547345.15611122.html.plaintext.txt	160	View larger version 32K FIG
0.33547345.15611122.html.plaintext.txt	161	Ubc9 PIAS1 associated colocalized nuclei transfected COS 1 cells
0.33547345.15611122.html.plaintext.txt	162	A coimmunoprecipitation assays
0.33547345.15611122.html.plaintext.txt	163	COS 1 cells transfected pRSV COUP TFI pX press Ubc9 pcDNA3
0.33547345.15611122.html.plaintext.txt	164	1His Ubc9 andor pFLAG PIAS1 expression constructs p3xFLAG PIAS1 amount DNA kept constant addition empty expression vectors
0.33547345.15611122.html.plaintext.txt	165	Whole cell extracts subjected immunoprecipitation IP anti COUP TF antibody immunoprecipitates subsequently analyzed immunoblotting blots anti COUP TF upper anti FLAG middle anti Xpress antibodies lower
0.33547345.15611122.html.plaintext.txt	166	B G subcellular localization COUP TFI PIAS1
0.33547345.15611122.html.plaintext.txt	167	EGFP PIAS1 B D EGFP PIAS1C351S E G cotransfected DsRed COUP TFI COS 1 cells
0.33547345.15611122.html.plaintext.txt	168	These proteins colocalized nuclei transfected COS 1 cells
0.33547345.15611122.html.plaintext.txt	169	Tissue Distribution mRNA COUP TFI Ubc9 PIAS1 Northern Blot Analysis We next examined expression COUP TFI Ubc9 PIAS1 mRNA human endocrine tissues Fig
0.33547345.15611122.html.plaintext.txt	170	Because Ubc9 PIAS1 cloned human adrenocortical adenoma cDNA library confirmed mRNAs expressed normal human adrenal cortex Fig
0.33547345.15611122.html.plaintext.txt	171	Ubc9 mRNA widely distributed many endocrine tissues expression profile Ubc9 similar COUP TFI shown previously 24
0.33547345.15611122.html.plaintext.txt	172	PIAS1 mRNA also relatively highly expressed steroidogenic tissues testis ovary adrenal cortex Fig
0.33547345.15611122.html.plaintext.txt	173	View larger version 74K FIG
0.33547345.15611122.html.plaintext.txt	174	Tissue distribution COUP TFI Ubc9 PIAS1 mRNA demonstrated Northern blot analyses
0.33547345.15611122.html.plaintext.txt	175	A human tissue Northern blot Clontech probed 1
0.33547345.15611122.html.plaintext.txt	176	1 kb glyceraldehyde 3 phosphate dehydrogenase cDNA
0.33547345.15611122.html.plaintext.txt	177	Each lane contained 2 microg polyA RNA pancreas Pa adrenal medulla Am thyroid Tr adrenal cortex Ac testis Te thymus Tm small intestine Sm stomach Stlanes 1 8 spleen Sp thymus Tm prostate Pr testis Te ovary Ov small intestine Si colon Co peripheral leukocytes Le lanes 9 16
0.33547345.15611122.html.plaintext.txt	178	The positions RNA size indicated arrows
0.33547345.15611122.html.plaintext.txt	179	COUP TFI Ubc9 PIAS1 glyceraldehyde 3 phosphate dehydrogenase cDNA used probe blot
0.33547345.15611122.html.plaintext.txt	180	Immunohistochemistry COUP TFI Ubc9 PIAS1 Rat Adrenal Glands We next examined immunohistochemistry COUP TFI Ubc9 PIAS1 rat adrenal glands Fig
0.33547345.15611122.html.plaintext.txt	181	Strikingly Ubc9 PIAS1 exclusively expressed nuclei zona glomerulosa cells adult rat adrenal cortex Fig
0.33547345.15611122.html.plaintext.txt	182	5 B C whereas COUP TFI expressed nuclei three zones adrenocortical cells Fig
0.33547345.15611122.html.plaintext.txt	183	In addition expression profiles shown developmentally regulated
0.33547345.15611122.html.plaintext.txt	184	At 2 weeks birth Ubc9 expressed three zones adrenal cortex expression Ubc9 gradually becomes localized zona glomerulosa cells development progresses 3 weeks birth data shown
0.33547345.15611122.html.plaintext.txt	185	At 8 weeks birth Ubc9 specifically expressed zona glomerulosa cells slightly expressed interstitial stromal cells zona fasciculata reticularis Fig
0.33547345.15611122.html.plaintext.txt	186	These expression profiles Ubc9 altered male female rat adrenal glands data shown
0.33547345.15611122.html.plaintext.txt	187	These results indicate Ubc9 PIAS1 mainly expressed nuclei adrenal glomerulosa cells aldosterone exclusively synthesized
0.33547345.15611122.html.plaintext.txt	188	View larger version 79K FIG
0.33547345.15611122.html.plaintext.txt	189	Immunohistochemistry COUP TFI Ubc9 PIAS1 adult rat adrenal glands
0.33547345.15611122.html.plaintext.txt	190	A COUP TFI localized nuclei adrenal cortical cells
0.33547345.15611122.html.plaintext.txt	191	Both Ubc9 B PIAS1 C colocalized nuclei rat adrenal zona glomerulosa cells 8 weeks birth
0.33547345.15611122.html.plaintext.txt	192	COUP TFI Binds Ad5 Element 129 114 Human CYP11B2 Gene Promoter Competes SF 1 Binding Mutually Exclusive Manner We previously mapped human CYP11B2 DNA sequences required basal transcription optimal transcriptional responses angiotensin II K cAMP position 129 114 12
0.33547345.15611122.html.plaintext.txt	193	To define precisely DNA protein interactions occurring within region electrophoretic mobility shift analysis EMSA performed using synthetic 32P labeled oligonucleotide probe encompassing sequence nuclear extract derived H295R cell line Fig
0.33547345.15611122.html.plaintext.txt	194	In presence H295R cell nuclear extract 4 protein DNA complexes formed
0.33547345.15611122.html.plaintext.txt	195	Formation complexes 1 2 3 completely inhibited presence 200 fold molar excess non radiolabeled probe lane 3 Fig
0.33547345.15611122.html.plaintext.txt	196	We observed displacement lower levels cold probe 10 fold displaced one half radiolabeled binding data shown
0.33547345.15611122.html.plaintext.txt	197	These data indicate three complexes represent specific protein DNA interactions
0.33547345.15611122.html.plaintext.txt	198	Formation fourth complex migrating immediately complex 3 unaffected maneuver suggesting complex arises nonspecific DNA binding Fig
0.33547345.15611122.html.plaintext.txt	199	Complex 3 recognized antibody directed SF 1 lane 4 Fig
0.33547345.15611122.html.plaintext.txt	200	6A whereas complexes 1 2 recognized antibodies directed COUP TF lane 5 Fig
0.33547345.15611122.html.plaintext.txt	201	View larger version 60K FIG
0.33547345.15611122.html.plaintext.txt	202	Binding COUP TF SF 1 CYP11B2 129 114 Ad5 cis element
0.33547345.15611122.html.plaintext.txt	203	A electrophoretic mobility shift analysis EMSA performed using H295R nuclear extract NE 5
0.33547345.15611122.html.plaintext.txt	204	0 microg 32P labeled oligonucleotide probe corresponding human CYP11B2 129 114
0.33547345.15611122.html.plaintext.txt	205	Protein DNA complexes shown arrows separated free probe shown arrowheads electrophoresis 4 native polyacrylamide gel
0.33547345.15611122.html.plaintext.txt	206	Non radiolabeled self competitor DNA added 200 fold molar excess lane 3 identify nonspecific protein DNA interactions NS
0.33547345.15611122.html.plaintext.txt	207	Lanes 4 6 show binding activity presence antisera directed either SF 1 S COUP TF C
0.33547345.15611122.html.plaintext.txt	208	The position resulting supershifted complexes indicated bracket
0.33547345.15611122.html.plaintext.txt	209	B EMSA performed described using vitro translated SF 1 COUP TFI COUP TFII source protein
0.33547345.15611122.html.plaintext.txt	210	To confirm SF 1 COUP TF bind element binding activity vitro translated proteins assessed
0.33547345.15611122.html.plaintext.txt	211	In vitro translated SF 1 bound Ad5 probe producing complex mobility similar complex 3 lane 1 Fig
0.33547345.15611122.html.plaintext.txt	212	In presence either vitro translated COUP TFI COUP TFII complex mobility similar complex 1 formed lanes 3 6 Fig
0.33547345.15611122.html.plaintext.txt	213	All three vitro synthesized proteins recognized respective antibodies lanes 2 4 5 Fig
0.33547345.15611122.html.plaintext.txt	214	These data suggest complexes 1 3 represent binding COUP TF SF 1 respectively
0.33547345.15611122.html.plaintext.txt	215	The nature proteins forming complexes 2 unknown present
0.33547345.15611122.html.plaintext.txt	216	Because formation complex abolished presence anti COUP TF antibody reproduced recombinant COUP TFI II complex 2 may represent binding either heterodimer COUP TF another unidentified protein binding protein related distinct COUP TF
0.33547345.15611122.html.plaintext.txt	217	COUP TFI mediated Human CYP11B2 Gene Transactivation Is Potentiated Ubc9 PIAS1 Independently sumoylation Activities To explore COUP TF regulates human CYP11B2 gene transcription transiently transfected exogenous COUP TFI H295R cells measured luciferase activity CYP11B2 reporter gene
0.33547345.15611122.html.plaintext.txt	218	Overexpression COUP TFI activated CYP11B2 gene transcription dose dependent manner lanes 2 4 Fig
0.33547345.15611122.html.plaintext.txt	219	The mutation Ad5 sequences COUP TFI binding disrupted abrogated basal COUP TFI mediated transactivation gene thus suggesting Ad5 sequences crucial COUP TFI mediated CYP11B2 transactivation Fig
0.33547345.15611122.html.plaintext.txt	220	In addition overexpression COUP TFI35 35 amino acids deleted C terminus effectively removing repressor domain activate reporter activity lanes 5 7 Fig
0.33547345.15611122.html.plaintext.txt	221	7A indicating deleted region COUP TFI C terminus indispensable activation CYP11B2 gene
0.33547345.15611122.html.plaintext.txt	222	View larger version 15K FIG
0.33547345.15611122.html.plaintext.txt	223	COUP TFI functions transcriptional activator human CYP11B2 gene transcription Ad5 element H295R cells
0.33547345.15611122.html.plaintext.txt	224	A H295R cells transiently transfected 0
0.33547345.15611122.html.plaintext.txt	225	6 microg total DNA including COUP TFI lane 2 30 ng lane 3 100 ng lane 4 300 ng COUP TFI35 cDNA lane 5 30 ng lane 6 100 ng lane 7 300 ng 0
0.33547345.15611122.html.plaintext.txt	226	3 microg CYP11B2 15212 luciferase reporter DNA well 24 well dish indicated
0.33547345.15611122.html.plaintext.txt	227	Forty eight hours post transfection cells harvested extracts assayed luciferase activity
0.33547345.15611122.html.plaintext.txt	228	B H295R cells transiently transfected 0
0.33547345.15611122.html.plaintext.txt	229	6 microg total DNA including COUP TFI lane 2 30 ng lane 3 100 ng lane 4 300 ng COUP TFI35 cDNA lane 5 30 ng lane 6 100 ng lane 7 300 ng 0
0.33547345.15611122.html.plaintext.txt	230	3 microgof CYP11B2 reporter mutated Ad5 sequences used mutated Ad5 129 114 luciferase instead wild type CYP11B2 reporter
0.33547345.15611122.html.plaintext.txt	231	Forty eight hours post transfection cells harvested extracts assayed luciferase activity
0.33547345.15611122.html.plaintext.txt	232	Assays performed three separate experiments triplicate samples
0.33547345.15611122.html.plaintext.txt	233	Furthermore cotransfection Ubc9 PIAS1 COUP TFI transactivated COUP TFI mediated activation CYP11B2 gene transcription lanes 5 8 Fig
0.33547345.15611122.html.plaintext.txt	234	8A whereas Ubc9 PIAS1 alone influence reporter gene activity lanes 2 3 Fig
0.33547345.15611122.html.plaintext.txt	235	Cotransfection Ubc9 PIAS1 COUP TFI showed transactivating effect COUP TFI mediated CYP11B2 transcription synergistic Fig
0.33547345.15611122.html.plaintext.txt	236	In addition coexpression Ubc9 1 58 PIAS1 1 150 contain COUP TFI interacting domain effects COUP TFI mediated transactivation lanes 7 10 Fig
0.33547345.15611122.html.plaintext.txt	237	8A indicating interaction COUP TFI Ubc9 PIAS1 crucial COUP TFI mediated transactivation CYP11B2 promoter
0.33547345.15611122.html.plaintext.txt	238	These findings indicate Ubc9 PIAS1 function transcriptional coactivators COUP TFI CYP11B2 gene transcription
0.33547345.15611122.html.plaintext.txt	239	Although Ubc9 PIAS1 enzymes responsible SUMO modification sumoylation defective mutants Ubc9 C93S PIAS1 C351S continued function activators COUP TFI lanes 6 9 Fig
0.33547345.15611122.html.plaintext.txt	240	These findings suggest Ubc9 PIAS1 function coactivators COUP TFI mediated CYP11B2 gene transcription sumoylation independent manner
0.33547345.15611122.html.plaintext.txt	241	View larger version 19K FIG
0.33547345.15611122.html.plaintext.txt	242	Both Ubc9 PIAS1 cooperatively potentiate COUP TFI enhanced CYP11B2 gene transcription
0.33547345.15611122.html.plaintext.txt	243	A H295R cells transfected 0
0.33547345.15611122.html.plaintext.txt	244	43 microg total DNA including 30 ng empty vector pRSV COUP TFI pRSV COUP TFI 100 ng Ubc9 PIAS1 construct 0
0.33547345.15611122.html.plaintext.txt	245	3 microgof CYP11B2 15212 luciferase reporter DNA well 24 well dish indicated
0.33547345.15611122.html.plaintext.txt	246	Forty eight hours post transfection cells harvested extracts assayed luciferase activity
0.33547345.15611122.html.plaintext.txt	247	B H295R cells transfected 0
0.33547345.15611122.html.plaintext.txt	248	93 microg total DNA including 30 ng empty vector pRSV COUP TFI pRSV COUP TFI 0
0.33547345.15611122.html.plaintext.txt	249	3 microgof CYP11B2 15212 luciferase reporter DNA Ubc9 lane 5 100 ng lane 6 300 ng andor PIAS1 lane 3 100 ng lanes 4 6 300 ng
0.33547345.15611122.html.plaintext.txt	250	Forty eight hours post transfection cells harvested extracts assayed luciferase activity
0.33547345.15611122.html.plaintext.txt	251	Assays performed three separate experiments triplicate samples
0.33547345.15611122.html.plaintext.txt	252	Binding Ubc9 PIAS1 COUP TFI Not SF 1 Are Crucial COUP TFI mediated CYP11B2 Gene Transactivation The Ad5 sequence contains direct repeat consensus AGGTCA variant AGGCTG nuclear receptor half site DR0 non coding strand
0.33547345.15611122.html.plaintext.txt	253	To define precise nucleotides required binding SF 1 COUP TFI series oligonucleotides containing progressive stepwise 2 bp mutations across putative half sites m1 m9 radiolabeled used EMSA Fig
0.33547345.15611122.html.plaintext.txt	254	When H295R nuclear extracts used source protein top panel Fig
0.33547345.15611122.html.plaintext.txt	255	9A m1 m4 formed specific complexes similar formed using wild type probe
0.33547345.15611122.html.plaintext.txt	256	The m5 m8 failed form complexes 1 2 although complex 3 still observed using m7 m8 probe
0.33547345.15611122.html.plaintext.txt	257	Similar results observed using vitro translated proteins Fig
0.33547345.15611122.html.plaintext.txt	258	SF 1 bound mutant oligonucleotides except m5 m6 whereas COUP TFI COUP TFII failed bind m5 m8
0.33547345.15611122.html.plaintext.txt	259	These data support hypothesis complexes 1 3 represent binding COUP TF SF 1 respectively abilities vitro synthesized proteins H295R nuclear extracts bind various mutant oligonucleotides identical
0.33547345.15611122.html.plaintext.txt	260	Further mutations within consensus nuclear receptor half site AGGTCA m5 m8 disrupt binding COUP TF likely sequence represents key site COUP TF binding site
0.33547345.15611122.html.plaintext.txt	261	Utilizing Ad5 luciferase reporters containing wild type m5 m7 sequences investigated Ubc9 PIAS1 affect COUP TFI regulated CYP11B2 promoter activities
0.33547345.15611122.html.plaintext.txt	262	In compared finding Ubc9 PIAS1 potentiated COUP TFI mediated transactivation wild type Ad5 promoter lanes 4 7 Fig
0.33547345.15611122.html.plaintext.txt	263	9B proteins activated neither m5 m7 Ad5 reporter activities lanes 8 21 Fig
0.33547345.15611122.html.plaintext.txt	264	These findings indicate Ubc9 PIAS1 enhance Ad5 reporter activity mediated COUP TFI SF 1
0.33547345.15611122.html.plaintext.txt	265	View larger version 32K FIG
0.33547345.15611122.html.plaintext.txt	266	Mutational analysis COUP TFI SF 1 binding CYP11B2 Ad5 element
0.33547345.15611122.html.plaintext.txt	267	A series oligonucleotides containing progressive 2 bp mutations across Ad5 sequence m1 m9 radiolabeled used EMSA
0.33547345.15611122.html.plaintext.txt	268	The positions mutations relative wild type sequence wt indicated top figure
0.33547345.15611122.html.plaintext.txt	269	EMSA performed using H295R nuclear extract top panel vitro synthesized SF 1 COUP TFI COUP TFII lower panels
0.33547345.15611122.html.plaintext.txt	270	The positions specific DNA protein complexes indicated arrows
0.33547345.15611122.html.plaintext.txt	271	The boxed sequence top figure indicates core recognition motif
0.33547345.15611122.html.plaintext.txt	272	Neither COUP TFI SF 1 bind m5 Ad5 sequence whereas SF 1 COUP TFI bind m7 Ad5 sequence
0.33547345.15611122.html.plaintext.txt	273	B effects introduction two kinds mutations CYP11B2 Ad5 element COUP TFI mediated transcription
0.33547345.15611122.html.plaintext.txt	274	H295R cells transiently transfected 0
0.33547345.15611122.html.plaintext.txt	275	93 microg total DNA including 30 ng COUP TFI 0
0.33547345.15611122.html.plaintext.txt	276	3 microg reporter DNA wtAd5 mtAd5 m7Ad5
0.33547345.15611122.html.plaintext.txt	277	Forty eight hours post transfection cells harvested extracts assayed luciferase activity
0.33547345.15611122.html.plaintext.txt	278	Assays performed three separate experiments triplicate samples
0.33547345.15611122.html.plaintext.txt	279	Endogenous Ubc9 PIAS1 Are Required CYP11B2 Transcriptional Activation COUP TFI If Ubc9 PIAS1 coactivators COUP TFI reducing endogenous level Ubc9 PIAS1 decrease transcriptional activity COUP TFI transient transfection assays
0.33547345.15611122.html.plaintext.txt	280	7 8 overexpression COUP TFI activated human CYP11B2 reporter activities 6 fold lane 3 Fig
0.33547345.15611122.html.plaintext.txt	281	Cotransfection siRNA two sets Ubc9 Ubc9a lane 5 Ubc9b lane 6 Fig
0.33547345.15611122.html.plaintext.txt	282	10A two sets PIAS1 PIAS1a lane 7 PIAS1b lane 8 Fig
0.33547345.15611122.html.plaintext.txt	283	10A negative control lane 4 Fig
0.33547345.15611122.html.plaintext.txt	284	10A effectively reduced endogenous levels Ubc9 PIAS1 proteins effect tubulin protein level seen Western blot Fig
0.33547345.15611122.html.plaintext.txt	285	Reduction endogenous Ubc9 PIAS1 protein level decreased COUP TFI mediated transactivation 30 50
0.33547345.15611122.html.plaintext.txt	286	These findings indicate endogenous Ubc9 PIAS1 normally function transcriptional coactivators COUP TFI mediated transactivation
0.33547345.15611122.html.plaintext.txt	287	View larger version 24K FIG
0.33547345.15611122.html.plaintext.txt	288	Endogenous Ubc9 PIAS1 required COUP TFI mediated CYP11B2 transactivation
0.33547345.15611122.html.plaintext.txt	289	A knockdown Ubc9 PIAS1 protein reduces COUP TFI mediated transcription human CYP11B2 reporter
0.33547345.15611122.html.plaintext.txt	290	H295R cells 24 well dishes transiently transfected using Lipofectamine 2000 0
0.33547345.15611122.html.plaintext.txt	291	33 microg total DNA including 30 ng COUP TFI 0
0.33547345.15611122.html.plaintext.txt	292	3 microgof CYP11B2 reporter DNA 30 pmol either Ubc9a Ubc9b PIAS1a PIAS1b negative control N
0.33547345.15611122.html.plaintext.txt	293	72 h transfection cells harvested luciferase reporter assays performed according manufacturers instructions
0.33547345.15611122.html.plaintext.txt	294	B Western blot analysis endogenous Ubc9 PIAS1 protein level efficiently reduced transfection either Ubc9 Ubc9a Ubc9b PIAS1 PIAS1a PIAS1b specific siRNA duplex
0.33547345.15611122.html.plaintext.txt	295	COUP TFI Ubc9 PIAS1 Are Specifically Recruited Ad5 Element Human CYP11B2 Gene Promoter As mentioned COUP TFI Ubc9 PIAS1 complex activated human CYP11B2 gene transcription
0.33547345.15611122.html.plaintext.txt	296	Chromatin immunoprecipitation ChIP assays used test whether Ubc9 PIAS1 recruited endogenous CYP11B2 gene promoter H295R cells
0.33547345.15611122.html.plaintext.txt	297	The cross linked sheared chromatin preparations subjected immunoprecipitation various antibodies precipitated DNA analyzed PCR amplification Ad5 element CYP11B2 promoter
0.33547345.15611122.html.plaintext.txt	298	We confirmed size sonicated DNA 300 600 bp bands looked uniform data shown
0.33547345.15611122.html.plaintext.txt	299	When COUP TFI Xpress Ubc9 FLAG PIAS1 aberrantly overexpressed H295R cells antibodies COUP TFI Xpress FLAG efficiently immunoprecipitated Ad5 element CYP11B2 promoter
0.33547345.15611122.html.plaintext.txt	300	Normal IgG antibody failed precipitate CYP11B2 promoter Fig
0.33547345.15611122.html.plaintext.txt	301	In contrast Ad5 element CYP11B2 promoter 3 untranslated control region CYP11B2 gene detected association COUP TFI Ubc9 PIAS1 Fig
0.33547345.15611122.html.plaintext.txt	302	Thus Ubc9 PIAS1 COUP TFI recruited native COUP TFI regulated CYP11B2 promoter demonstrating functional interaction COUP TFI Ubc9 PIAS1 occurring vivo setting
0.33547345.15611122.html.plaintext.txt	303	The results ChIP RNA interference experiments strongly support physiological role Ubc9 PIAS1 COUP TFI dependent transcription human CYP11B2 gene
0.33547345.15611122.html.plaintext.txt	304	View larger version 63K FIG
0.33547345.15611122.html.plaintext.txt	305	COUP TFI Ubc9 PIAS1 recruited native CYP11B2 promoter containing Ad5 element H295R cells
0.33547345.15611122.html.plaintext.txt	306	For ChIP assays COUP TFI Xpress Ubc9 FLAG PIAS1 aberrantly overexpressed H295R cells sheared chromatin immunoprecipitated anti COUP TFI anti Xpress anti FLAG normal IgG
0.33547345.15611122.html.plaintext.txt	307	The coprecipitated DNA amplified PCR using primers amplify CYP11B2 promoter containing Ad5 element 3 untranslated control region
0.33547345.15611122.html.plaintext.txt	308	COUP TFI Ubc9 PIAS1 interact 335 52 DNA segment containing Ad5 element 19392198 region hCYP11B2 3 untranslated region Control H295R cells
0.33547345.15611122.html.plaintext.txt	309	Both mock immunoprecipitation lane 1 No Ab immunoprecipitation normal IgG lane 2 served negative controls
0.33547345.15611122.html.plaintext.txt	310	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In report identified described Ubc9 PIAS1 interact COUP TFI function coactivators COUP TFI mediated transcription human CYP11B2 gene
0.33547345.15611122.html.plaintext.txt	311	We detected COUP TFI Ubc9 PIAS1 form complex nuclei mammalian cells
0.33547345.15611122.html.plaintext.txt	312	Expression Ubc9 PIAS1 markedly detected rat adrenal zona glomerulosa cells CYP11B2 exclusively expressed
0.33547345.15611122.html.plaintext.txt	313	Transient transfection assays together small interfering RNA ChIP assays indicated physiological role Ubc9 PIAS1 COUP TFI dependent transactivation human CYP11B2 gene normal adrenal glomerulosa cells
0.33547345.15611122.html.plaintext.txt	314	Both Ubc9 PIAS1 SUMO 1 conjugating enzyme E2 SUMO 1 ligase E3 activity respectively 25 30
0.33547345.15611122.html.plaintext.txt	315	The C93S substitution Ubc9 C351S substitution PIAS1 abrogate sumoylation activity continued interact COUP TFI potentiate transcriptional activation mediated COUP TFI indicating sumoylation enzyme activities required function coactivators COUP TFI
0.33547345.15611122.html.plaintext.txt	316	Ubc9 PIAS1 Function Transcriptional Coactivators COUP TFI CYP11B2 Transcription Both Ubc9 PIAS1 meet criteria transcriptional coactivator proteins modulation COUP TFI transcriptional properties
0.33547345.15611122.html.plaintext.txt	317	2 3 Ubc9 PIAS1 specifically interacted COUP TFI yeast mammalian cells
0.33547345.15611122.html.plaintext.txt	318	The Ubc9 previously shown interact C terminal putative ligand binding domain COUP TFI 388 403 described transcriptional repressor domain 24
0.33547345.15611122.html.plaintext.txt	319	The present study showed PIAS1 interacted DNA binding domain hinge region COUP TFI 86 183
0.33547345.15611122.html.plaintext.txt	320	Coimmunoprecipitation subcellular localization experiments showed Ubc9 PIAS1 colocalized COUP TFI transfected COS 1 cells Fig
0.33547345.15611122.html.plaintext.txt	321	These findings suggest Ubc9 PIAS1 specifically interact COUP TFI form complex mammalian cells
0.33547345.15611122.html.plaintext.txt	322	Second overexpression Ubc9 PIAS1 effect reporter activities absence transfected COU TFI Fig
0.33547345.15611122.html.plaintext.txt	323	However Ubc9 PIAS1 potentiated transactivation mediated COUP TFI
0.33547345.15611122.html.plaintext.txt	324	Subsequently coexpression Ubc9 PIAS1 deletion mutant Ubc9 1 58 PIAS1 1 150 impairs COUP TFI binding affect transactivation mediated COUP TFI indicating interaction COUP TFI Ubc9 PIAS1 required COUP TFI mediated transactivation
0.33547345.15611122.html.plaintext.txt	325	In addition coexpression Ubc9 PIAS1 synergistically enhanced COUP TFI mediated transactivation
0.33547345.15611122.html.plaintext.txt	326	Third reduction endogenous Ubc9 PIAS1 small interfering RNA decreased COUP TFI mediated transactivation human CYP11B2 promoter activity indicating endogenous Ubc9 PIAS1 normally contributes COUP TFI mediated transactivation
0.33547345.15611122.html.plaintext.txt	327	Fourth ChIP assays clearly showed COUP TFI Ubc9 PIAS1 recruited native COUP TFI regulated CYP11B2 promoter demonstrating functional coupling COUP TFI Ubc9 PIAS1 vivo
0.33547345.15611122.html.plaintext.txt	328	Therefore Ubc9 PIAS1 possess characteristics expected transcriptional coactivator proteins COUP TF vivo
0.33547345.15611122.html.plaintext.txt	329	To confirm Ubc9 PIAS1 coactivators COUP TFI ruled several possible ways proteins might enhance COUP TFI mediated transactivation
0.33547345.15611122.html.plaintext.txt	330	First SUMO 1 conjugation plays important role protein modification effects Ubc9 PIAS1 COUP TFI transactivation might result effects Ubc9 PIAS1 COUP TFI protein concentrations
0.33547345.15611122.html.plaintext.txt	331	Our preliminary experiments showed overexpression Ubc9 PIAS1 alter COUP TFI protein concentration H295R cells data shown
0.33547345.15611122.html.plaintext.txt	332	Second also possible overexpression Ubc9 PIAS1 increases concentrations coactivators decreases concentrations corepressors shown interact COUP TFI results showed overexpression proteins alter protein concentrations SRC 1 GRIP 1 SMRT cells data shown
0.33547345.15611122.html.plaintext.txt	333	Because experiments performed transient transfection able conclude unequivocally Ubc9 PIAS1 effects coregulator concentrations investigation required
0.33547345.15611122.html.plaintext.txt	334	Third another possibility overexpression Ubc9 PIAS1 increased DNA binding affinity COUP TFI
0.33547345.15611122.html.plaintext.txt	335	To exclude possibility performed electrophoretic mobility shift assays determine whether bacterially vitro transcription translated Ubc9 PIAS1 proteins affect binding COUP TFI response element DNA Ad5 human CYP11B2 promoter region
0.33547345.15611122.html.plaintext.txt	336	The results showed Ubc9 PIAS1 effects COUP TFI binding Ad5 element data shown
0.33547345.15611122.html.plaintext.txt	337	Fourth proposed SUMO 1 conjugation targets proteins different cellular localizations
0.33547345.15611122.html.plaintext.txt	338	SF 1 directed nuclear speckles sequestered nucleolus presence SUMO 1 thus resulting transcriptional repression 39
0.33547345.15611122.html.plaintext.txt	339	It therefore possible coexpression Ubc9 PIAS1 alters subcellular localization COUP TFI
0.33547345.15611122.html.plaintext.txt	340	However based subcellular localization data Fig
0.33547345.15611122.html.plaintext.txt	341	3 localization COUP TFI continues nucleus without re localization
0.33547345.15611122.html.plaintext.txt	342	Taken together mentioned findings Ubc9 PIAS1 clearly function novel coactivators COUP TFI vivo
0.33547345.15611122.html.plaintext.txt	343	However detailed molecular mechanisms largely unknown investigation required
0.33547345.15611122.html.plaintext.txt	344	Role Ubc9 PIAS1 Sumoylation SUMO 1 conjugation sumoylation reported play important role many cellular processes 25 30
0.33547345.15611122.html.plaintext.txt	345	Sumoylation resembles ubiquitination enzymes involved three processes distinct
0.33547345.15611122.html.plaintext.txt	346	SUMO 1 conjugated target proteins consensus sequence KXE hydrophobic amino acid X amino acid
0.33547345.15611122.html.plaintext.txt	347	COUP TFI SUMO consensus sequence however several proteins Mdm2 CREB also modified sites KXE 26
0.33547345.15611122.html.plaintext.txt	348	Further investigation required elucidate whether COUP TFI sumoylated vivo
0.33547345.15611122.html.plaintext.txt	349	Our data showed wild type sumoylation defective mutants Ubc9 C93S PIAS1 C351S similarly enhanced COUP TFI regulated CYP11B2 promoter activities indicating proteins possess dual distinct functions SUMO dependent SUMO independent pathways coactivator function
0.33547345.15611122.html.plaintext.txt	350	However possible ectopically produced Ubc9 PIAS1 regulate COUP TFI mediated transactivation sumoylation COUP TFI also conjugation SUMO 1 one cellular factors involved transcriptional regulation
0.33547345.15611122.html.plaintext.txt	351	Recent data raised intriguing possibility SUMO modification may specific impact ability transcription factors function synergistically 27 40 41
0.33547345.15611122.html.plaintext.txt	352	Previous studies glucocorticoid receptor GR identified region referred synergy control motif mutation led selective increase activity GR promoters bearing multiple single sites
0.33547345.15611122.html.plaintext.txt	353	The synergy control motif contains consensus SUMO acceptor site recent data shown fact major site addition SUMO GR
0.33547345.15611122.html.plaintext.txt	354	Considerable numbers transcription factors including GR 41 44 androgen receptor 32 33 45 51 progesterone receptor 47 52 mineralocorticoid receptor 53 54 peroxisome proliferator activated receptor 55 steroidogenic factor 1 SF 1 39 56 modulated SUMO 1 attachment SUMO modified transcription factors mostly resulted attenuation transcription
0.33547345.15611122.html.plaintext.txt	355	Recent studies demonstrated one molecular mechanisms sumoylation mediated repression protein modified SUMO 1 recruited histone deacetylases transcriptional corepressors thus repressing transcription 29 38 57 59
0.33547345.15611122.html.plaintext.txt	356	However also opposite examples SUMO modified proteins lead transcriptional activation rather repression
0.33547345.15611122.html.plaintext.txt	357	Transcriptional coactivators SRC 1 GRIP1 shown modified SUMO 1 thus resulting enhanced transcriptional coactivator capacities 60 61
0.33547345.15611122.html.plaintext.txt	358	Therefore sumoylation necessarily induce transcriptional repression depending substrates
0.33547345.15611122.html.plaintext.txt	359	The molecular mechanisms could explain SUMO modification affects transcriptional regulation largely unknown
0.33547345.15611122.html.plaintext.txt	360	COUP TFI Ubc9 PIAS1 Complexes Are Crucial Aldosterone Synthesis We identified three important cis elements hCYP11B2 promoter CRE 71 64 cis element termed Ad5 129 114 third cis element termed NBRE 1 766 759 8 9 12
0.33547345.15611122.html.plaintext.txt	361	The CRE common hCYP11B1 hCYP11B2 regulated protein kinase A calmodulin dependent kinase dependent mechanisms
0.33547345.15611122.html.plaintext.txt	362	Neither Ad5 NBRE 1 cis elements found 5 flanking sequence hCYP11B2 present hCYP11B1 8 9 12
0.33547345.15611122.html.plaintext.txt	363	The present results confirmed Ad5 element crucial CYP11B2 transactivation deletion element dramatically reduces basal COUP TFI mediated transactivation Fig
0.33547345.15611122.html.plaintext.txt	364	Based present previous reports 8 9 12 COUP TFI andor Nurr1NGFI B play important roles transactivation human CYP11B2 gene binding Ad5 element
0.33547345.15611122.html.plaintext.txt	365	The physiological importance particular transcription factors investigated vivo
0.33547345.15611122.html.plaintext.txt	366	Our preliminary data demonstrated levels expression Ubc9 PIAS1 altered aldosterone producing adenomas patients primary aldosteronism compared normal adrenals
0.33547345.15611122.html.plaintext.txt	367	2 However significance Ubc9 PIAS1 aldosterone producing adenomas remains investigated
0.33547345.15611122.html.plaintext.txt	368	We recently shown effects K angiotensin II Ang II hCYP11B2 transcription occur two pathways increased expression Nurr1NGFI B phosphorylation ATF 1CREB 13
0.33547345.15611122.html.plaintext.txt	369	Ang II treatment rapidly induces levels mRNA protein Nurr1NGFI B thereby transactivating hCYP11B2 gene 8 9
0.33547345.15611122.html.plaintext.txt	370	Both Nurr1 NGFI B markedly increased transcription hCYP11B2 binding NBRE 1 Ad5 sites unique hCYP11B2
0.33547345.15611122.html.plaintext.txt	371	62 recently reported COUP TF negative regulator steroidogenesis bovine adrenal glomerulosa cells
0.33547345.15611122.html.plaintext.txt	372	They also showed Ang II treatment dramatically decreased levels COUP TF cells thus activating StAR gene expression
0.33547345.15611122.html.plaintext.txt	373	Based findings tempting speculate levels expression COUP TFI Ubc9 PIAS1 regulated Ang II treatment
0.33547345.15611122.html.plaintext.txt	374	We therefore investigated possibilities H295R cells however Ang II treatment affect expression levels COUP TFI Ubc9 PIAS1 real time reverse transcription PCR Western blot analysis data shown
0.33547345.15611122.html.plaintext.txt	375	The reason Ang II treatment showed different effects COUP TFI levels report known however different cellular context bovine adrenal zona glomerulosa cells human H295R cells may one reason
0.33547345.15611122.html.plaintext.txt	376	We know physiological role COUP TFI Ubc9 PIAS1 Ang II K regulation hCYP11B2 expression study investigated
0.33547345.15611122.html.plaintext.txt	377	In conclusion identified novel COUP TFI interacting proteins Ubc9 PIAS1 proteins function coactivators COUP TFI human CYP11B2 transactivation
0.33547345.15611122.html.plaintext.txt	378	The unique localization profiles proteins adrenal zona glomerulosa cells consistent crucial physiological role aldosterone biosynthesis
0.33547345.15611122.html.plaintext.txt	379	Therefore COUP TFI Ubc9 PIAS1 complexes shed new light controlling long term capacity adrenal gland produce aldosterone
0.33547345.15611122.html.plaintext.txt	380	In addition studies provide new mechanisms COUP TFI act transcriptional activator novel interaction Ubc9 PIAS1
0.33547345.15611122.html.plaintext.txt	381	FOOTNOTES This work supported Grant Aid Scientific Research C Japan Society Promotion Science No
0.33547345.15611122.html.plaintext.txt	382	Grant Aid Research Project Disorders Adrenocortical Hormone Production Ministry Health Labor Welfare Japan T
0.33547345.15611122.html.plaintext.txt	383	Grant DK043140 National Institutes Health W
0.33547345.15611122.html.plaintext.txt	384	The costs publication article defrayed part payment page charges
0.33547345.15611122.html.plaintext.txt	385	This article must therefore hereby marked advertisement accordance 18 U
0.33547345.15611122.html.plaintext.txt	386	Section 1734 solely indicate fact
0.33547345.15611122.html.plaintext.txt	387	To correspondence addressed
0.33547345.15611122.html.plaintext.txt	388	62312 Fax 81 3 5363 3635 E mail hiro 405atcb3
0.33547345.15611122.html.plaintext.txt	389	1 The abbreviations used SF 1 steroidogenic factor 1 STAT signal transducers activators transcription PIAS1 protein inhibitors activated STAT 1 COUP TFI chicken ovalbumin upstream promoter transcription factor I SUMO small ubiquitin related modifier NBRE NGFIB response element CREB cAMP response element binding protein EMSA electrophoretic mobility shift assay siRNA small interfering RNA ChIP chromatin immunoprecipitation E1 ubiquitin activating enzyme E2 SUMO carrier protein E3 SUMO protein isopeptide ligase CMV cytomegalovirus IP immunoprecipitation GFP green fluorescent protein EGFP enhanced GFP RSV Rous sarcoma virus GR glucocorticoid receptor Ang II angiotensin II DsRed Discosoma sp
0.33547345.15611122.html.plaintext.txt	390	ACKNOWLEDGMENTS We grateful Dr
0.33547345.15611122.html.plaintext.txt	391	Ming Jer Tsai plasmid contributions
0.33547345.15611122.html.plaintext.txt	392	Masaru Murai generously supplying human adrenal tissues
0.33547345.15611122.html.plaintext.txt	393	We acknowledge assistance Colin Clyne Yen Zhang mobility shift assays
0.33547345.15611122.html.plaintext.txt	394	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Ogishima T
0.33547345.15611122.html.plaintext.txt	395	266 10731 10734AbstractFree Full Text Shibata H
0.33547345.15611122.html.plaintext.txt	396	128 235 242Medline Order article via Infotrieve Takeda Y
0.33547345.15611122.html.plaintext.txt	397	84 1633 1637AbstractFree Full Text Pilon C
0.33547345.15611122.html.plaintext.txt	398	84 4228 4231AbstractFree Full Text Val P
0.33547345.15611122.html.plaintext.txt	399	80 2378 2380Abstract Bassett M
0.33547345.15611122.html.plaintext.txt	400	28 125 135AbstractFree Full Text Bassett M
0.33547345.15611122.html.plaintext.txt	401	18 279 290AbstractFree Full Text Bassett M
0.33547345.15611122.html.plaintext.txt	402	217 67 74CrossRefMedline Order article via Infotrieve Lu L
0.33547345.15611122.html.plaintext.txt	403	89 4113 4118AbstractFree Full Text Bassett M
0.33547345.15611122.html.plaintext.txt	404	279 37622 37630AbstractFree Full Text Clyne C
0.33547345.15611122.html.plaintext.txt	405	11 638 649AbstractFree Full Text Condon J
0.33547345.15611122.html.plaintext.txt	406	2002 Endocrinology 143 3651 3657AbstractFree Full Text Tsai S
0.33547345.15611122.html.plaintext.txt	407	18 229 240AbstractFree Full Text Wang L
0.33547345.15611122.html.plaintext.txt	408	1989 Nature 340 163 166CrossRefMedline Order article via Infotrieve Shibata H
0.33547345.15611122.html.plaintext.txt	409	11 714 724AbstractFree Full Text Bakke M
0.33547345.15611122.html.plaintext.txt	410	9 327 339Abstract Shibata H
0.33547345.15611122.html.plaintext.txt	411	85 449 456CrossRefMedline Order article via Infotrieve Shibata H
0.33547345.15611122.html.plaintext.txt	412	24 881 885Medline Order article via Infotrieve Shibata H
0.33547345.15611122.html.plaintext.txt	413	83 4520 4523AbstractFree Full Text Shibata H
0.33547345.15611122.html.plaintext.txt	414	26 1039 1044Medline Order article via Infotrieve Shibata H
0.33547345.15611122.html.plaintext.txt	415	74 206 216CrossRefMedline Order article via Infotrieve Shibata H
0.33547345.15611122.html.plaintext.txt	416	32 69 86AbstractFree Full Text Muller S
0.33547345.15611122.html.plaintext.txt	417	2 202 210CrossRefMedline Order article via Infotrieve Johnson E
0.33547345.15611122.html.plaintext.txt	418	73 355 382CrossRefMedline Order article via Infotrieve Verger A
0.33547345.15611122.html.plaintext.txt	419	4 137 142AbstractFree Full Text Gill G
0.33547345.15611122.html.plaintext.txt	420	13 108 113CrossRefMedline Order article via Infotrieve Gill G
0.33547345.15611122.html.plaintext.txt	421	18 2046 2059AbstractFree Full Text Seeler J
0.33547345.15611122.html.plaintext.txt	422	4 690 699CrossRefMedline Order article via Infotrieve Kahyo T
0.33547345.15611122.html.plaintext.txt	423	Cell 8 713 718Medline Order article via Infotrieve Kotaja N
0.33547345.15611122.html.plaintext.txt	424	14 1986 2000AbstractFree Full Text Nishida T
0.33547345.15611122.html.plaintext.txt	425	277 41311 41317AbstractFree Full Text Kirsh O
0.33547345.15611122.html.plaintext.txt	426	21 2682 2691AbstractFree Full Text Pichler A
0.33547345.15611122.html.plaintext.txt	427	2002 Cell 108 109 120Medline Order article via Infotrieve Kagey M
0.33547345.15611122.html.plaintext.txt	428	2003 Cell 113 127 137Medline Order article via Infotrieve Rainey W
0.33547345.15611122.html.plaintext.txt	429	151 151 160CrossRefMedline Order article via Infotrieve Shiio Y
0.33547345.15611122.html.plaintext.txt	430	100 13225 13230AbstractFree Full Text Chen W
0.33547345.15611122.html.plaintext.txt	431	279 38730 38735AbstractFree Full Text Iniguez Lluhi J
0.33547345.15611122.html.plaintext.txt	432	20 6040 6050AbstractFree Full Text Le Drean Y
0.33547345.15611122.html.plaintext.txt	433	2002 Endocrinology 143 3482 3489AbstractFree Full Text Tian S
0.33547345.15611122.html.plaintext.txt	434	367 907 911CrossRefMedline Order article via Infotrieve Gottlicher M
0.33547345.15611122.html.plaintext.txt	435	1996 Steroids 61 257 262CrossRefMedline Order article via Infotrieve Kaul S
0.33547345.15611122.html.plaintext.txt	436	277 12541 12549AbstractFree Full Text Poukka H
0.33547345.15611122.html.plaintext.txt	437	274 19441 19446AbstractFree Full Text Poukka H
0.33547345.15611122.html.plaintext.txt	438	97 14145 14150AbstractFree Full Text Tan J
0.33547345.15611122.html.plaintext.txt	439	14 14 26AbstractFree Full Text Gross M
0.33547345.15611122.html.plaintext.txt	440	2004 Oncogene 23 3059 3066CrossRefMedline Order article via Infotrieve Kotaja N
0.33547345.15611122.html.plaintext.txt	441	277 17781 17788AbstractFree Full Text Kotaja N
0.33547345.15611122.html.plaintext.txt	442	22 5222 5234AbstractFree Full Text Tan J
0.33547345.15611122.html.plaintext.txt	443	277 16993 17001AbstractFree Full Text Abdel Hafiz H
0.33547345.15611122.html.plaintext.txt	444	277 33950 33956AbstractFree Full Text Tallec L
0.33547345.15611122.html.plaintext.txt	445	17 2529 2542AbstractFree Full Text Tirard M
0.33547345.15611122.html.plaintext.txt	446	32 825 841AbstractFree Full Text Ohshima T
0.33547345.15611122.html.plaintext.txt	447	279 29551 29557AbstractFree Full Text Komatsu T
0.33547345.15611122.html.plaintext.txt	448	18 2451 2462AbstractFree Full Text Nathan D
0.33547345.15611122.html.plaintext.txt	449	100 13118 13120Free Full Text Holmstrom S
0.33547345.15611122.html.plaintext.txt	450	100 15758 15763AbstractFree Full Text Yang S
0.33547345.15611122.html.plaintext.txt	451	Cell 13 611 617CrossRefMedline Order article via Infotrieve Chauchereau A
0.33547345.15611122.html.plaintext.txt	452	278 12335 12343AbstractFree Full Text Kotaja N
0.33547345.15611122.html.plaintext.txt	453	277 30283 30288AbstractFree Full Text Buholzer C
0.33547345.15611122.html.plaintext.txt	454	19 65 75AbstractFree Full Text This Article Abstract Full Text PDF All Versions Article 28086721 recent M411820200v1 Purchase Article View Shopping Cart Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Copyright Permissions Google Scholar Articles Kurihara I
0.33547345.15611122.html.plaintext.txt	455	Articles citing Article PubMed PubMed Citation Articles Kurihara I
0.33547345.15611122.html.plaintext.txt	456	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular Cellular Proteomics Journal Lipid Research Biochemistry Molecular Biology Education Copyright 2005 American Society Biochemistry Molecular Biology
0.308273.11095681.html.plaintext.txt	0	Fission yeast retrotransposon Tf1 integration targeted 5 ends open reading frames Ralf Behrens Jacky Hayles Paul Nurse
0.308273.11095681.html.plaintext.txt	1	Imperial Cancer Research Fund Cell Cycle Laboratory 44 Lincoln Inn Fields London WC2A 3PX UK
0.308273.11095681.html.plaintext.txt	2	Received August 9 2000 Revised Accepted October 18 2000
0.308273.11095681.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Target site selection transposable elements usually random involves specificity DNA sequence DNA binding host factor
0.308273.11095681.html.plaintext.txt	4	We investigated target site selection long terminal repeat containing retrotransposon Tf1 fission yeast Schizosaccharomyces pombe
0.308273.11095681.html.plaintext.txt	5	By monitoring induced transposition events found Tf1 integration sites distributed throughout genome
0.308273.11095681.html.plaintext.txt	6	Mapping insertions revealed Tf1 integrate open reading frames occurred preferentially longer intergenic regions integration biased towards region 100 420 bp upstream translation start site
0.308273.11095681.html.plaintext.txt	7	Northern blot analysis showed transcription genes adjacent Tf1 insertions significantly changed
0.308273.11095681.html.plaintext.txt	8	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Transposable elements discrete DNA segments translocate non homologous insertion sites
0.308273.11095681.html.plaintext.txt	9	Although usually insert many different sites elements display degree target selectivity
0.308273.11095681.html.plaintext.txt	10	This serves facilitate element propagation avoid insertions essential genes host
0.308273.11095681.html.plaintext.txt	11	A target site may selected direct interactions transposable element target DNA association accessory proteins may element andor host encoded reviewed 1
0.308273.11095681.html.plaintext.txt	12	Well studied examples transposable element targeting include Drosophila P elements Saccharomyces cerevisiae long terminal repeat LTR containing retrotransposons Ty1 Ty5
0.308273.11095681.html.plaintext.txt	13	P elements preference 5 untranslated regions regions 100 200 bp upstream transcription start site
0.308273.11095681.html.plaintext.txt	14	This region specific integration result changes expression level adjacent genes exploited genetic screens review see 23
0.308273.11095681.html.plaintext.txt	15	In case Ty1 Ty4 90 native insertions genome found upstream regions genes transcribed RNA polymerase III Pol III tRNA genes 4
0.308273.11095681.html.plaintext.txt	16	Ty1 integrates 70 700 bp upstream transcription start site genes demonstrated due interactions retrotransposon component RNA Pol III transcriptional apparatus andor recognition chromatin structures associated RNA Pol III transcription 5 9
0.308273.11095681.html.plaintext.txt	17	Furthermore Ty1 integration also occurs within pre existing LTRs 10 well upstream within variety Pol II transcribed genes result alterations expression levels genes 11 13
0.308273.11095681.html.plaintext.txt	18	For Ty3 target specificity appears depend ability Ty3 integration machinery compete Pol III interactions TFIIIB TFIIIC transcription factors 1415
0.308273.11095681.html.plaintext.txt	19	Ty3 inserts Pol III transcribed genes integrates site specific manner within base pairs transcription start site
0.308273.11095681.html.plaintext.txt	20	Ty5 typically integrates near telomeres silent mating loci HML HMR 1617 thought integration complexes recognise chromatin DNA bound proteins 18
0.308273.11095681.html.plaintext.txt	21	The LTR retrotransposon Tf1 isolated fission yeast Schizosaccharomyces pombe 19 contains single open reading frame ORF 20 encoding Gag protease reverse transcriptase integrase proteins 1921
0.308273.11095681.html.plaintext.txt	22	Tf1 integrates genomic DNA due transposition events shown transposition activity independent temperature 21
0.308273.11095681.html.plaintext.txt	23	Like Ty3 Tf1 member gypsy family transposable elements 19 remains determined whether also preference Pol III promoters
0.308273.11095681.html.plaintext.txt	24	Here report analysis target site specificity Tf1
0.308273.11095681.html.plaintext.txt	25	By examining genomic distribution induced transposition events found Tf1 preferentially targeted intergenic regions close 5 end ORFs preference pol III promoters
0.308273.11095681.html.plaintext.txt	26	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES Media strains plasmids Strains grown complete media YES minimal media EMM 22
0.308273.11095681.html.plaintext.txt	27	Amino acids pyrimidines supplemented final concentration 225 microgml
0.308273.11095681.html.plaintext.txt	28	Vitamin B1 thiamine 15 microM added EMM repress nmt1 promoter
0.308273.11095681.html.plaintext.txt	29	Phloxin B Sigma added 5 mgl facilitate screening cdc25 revertants
0.308273.11095681.html.plaintext.txt	30	5 Fluoroorotic acid 5 FOA Milford Laboratories plates made adding 1 mgml 5 FOA EMM
0.308273.11095681.html.plaintext.txt	31	YES 5 FOA G418 plates contained 1 mgml 5 FOA 0
0.308273.11095681.html.plaintext.txt	32	5 mgml corrected purity Geneticin Gibco
0.308273.11095681.html.plaintext.txt	33	The following yeast strains used ura4 D18 leu1 32 h strain 513 cdc25 22 ura4 297 leu1 32 h strain 2586
0.308273.11095681.html.plaintext.txt	34	1A described earlier 20
0.308273.11095681.html.plaintext.txt	35	View larger version 22K Figure 1
0.308273.11095681.html.plaintext.txt	36	Determination genomic Tf1 neo insertions
0.308273.11095681.html.plaintext.txt	37	A The transposition assay plasmid pHL414 contained URA3 gene S
0.308273.11095681.html.plaintext.txt	38	cerevisiae Tf1 neo element fused inducible nmt promoter
0.308273.11095681.html.plaintext.txt	39	The neo gene inserted Tf1 confers G418 resistance
0.308273.11095681.html.plaintext.txt	40	The large white box represents single full length ORF Tf1
0.308273.11095681.html.plaintext.txt	41	The positions protein domains Gag protease PR reverse transcriptase RT integrase IN indicated
0.308273.11095681.html.plaintext.txt	42	Triangles within grey boxes represent LTRs
0.308273.11095681.html.plaintext.txt	43	The plasmid contains autonomous replication sequence S
0.308273.11095681.html.plaintext.txt	44	B Southern blot analysis Tf1 transposition clones
0.308273.11095681.html.plaintext.txt	45	DNA G418 resistant clones cut restriction enzymes indicated blotted hybridised Tf1 specific probe shown schematic presentation nmt Tf1 neo fusion construct
0.308273.11095681.html.plaintext.txt	46	As controls DNA isogenic strain without Tf1 insertion wt strain carrying pHL414 plasmid pHL414 presence thiamine used
0.308273.11095681.html.plaintext.txt	47	Of 40 analysed transposition clones 10 representative clones shown
0.308273.11095681.html.plaintext.txt	48	Molecular weights shown left gel
0.308273.11095681.html.plaintext.txt	49	C The genomic locations induced Tf1 neo insertion events determined using IPCR S
0.308273.11095681.html.plaintext.txt	50	IPCR primers see Materials Methods RB30 RB32 primer set 1 RB20 RB39 primer set 2 sequencing primers SQ shown arrows
0.308273.11095681.html.plaintext.txt	51	HindIII restriction sites indicated genes represented black boxes
0.308273.11095681.html.plaintext.txt	52	Tf1 transposition assay The transposition assay described previously 20
0.308273.11095681.html.plaintext.txt	53	Strain 513 carrying pHL414 plasmid first streaked single colonies EMM leucine thiamine plates
0.308273.11095681.html.plaintext.txt	54	Individual colonies picked used inoculate growth patches EMM leucine plates
0.308273.11095681.html.plaintext.txt	55	After 2 days 32 degrees C patches used inoculate culture EMM leucine optical density 595 nm OD595 0
0.308273.11095681.html.plaintext.txt	56	These cultures grown another 2 days 32 degrees C plating EMM 5 FOA uracil leucine density 500 cells per plate
0.308273.11095681.html.plaintext.txt	57	After 3 days 32 degrees C 5 FOA resistant colonies replica plated onto YES 5 FOA G418 plates incubated 2 days obtain colonies undergone transposition event
0.308273.11095681.html.plaintext.txt	58	From four independent transposition assays 10 G418 resistent colonies picked analysed Southern blotting
0.308273.11095681.html.plaintext.txt	59	Small large colonies selected order take account Tf1 integration could affected growth rate clones
0.308273.11095681.html.plaintext.txt	60	Southern blotting Southern blots 23 genomic DNA putative transposition clones hybridised 32P labelled EcoRI fragment 19 Tf1 Fig
0.308273.11095681.html.plaintext.txt	61	DNA extracted strain 513 hybridise probe strain isogenic strain 972 contain Tf1 copy 19
0.308273.11095681.html.plaintext.txt	62	The URA3 probe used 1040 bp HinfI fragment URA3 gene 24
0.308273.11095681.html.plaintext.txt	63	A 673 bp probe neo gene obtained PCR Expand High Fidelity PCR system Boehringer Mannheim using pFA6 kanMX6 plasmid template 25
0.308273.11095681.html.plaintext.txt	64	Determination Tf1 insertion sites To isolate regions flanking insertion sites retrotransposon 2 microg DNA clones shown Southern blotting undergone transposition event digested HindIII cuts within neo gene Tf1 neo
0.308273.11095681.html.plaintext.txt	65	DNA diluted 1 ng microl T4 Ligase NEB added 1 U microl mix incubated 16 degrees C overnight
0.308273.11095681.html.plaintext.txt	66	After phenol chloroform extraction ethanol precipitation 100 ng self ligated DNA used template inverse PCR IPCR Expand High Fidelity PCR system Boehringer Mannheim
0.308273.11095681.html.plaintext.txt	67	Self ligated fragments amplified 35 cycles 50 microl reaction using either two inverse primer sets Fig
0.308273.11095681.html.plaintext.txt	68	Primer set 1 annealing 55 degrees C 30 RB30 5 GGAGTACGGATAAAATGCTTGATGG 3 RB32 5 CGGTTTGGTTGATGCGAGTG 3 corresponding sequences neo gene downstream HindIII site
0.308273.11095681.html.plaintext.txt	69	Primer set 2 annealing 53 degrees C 30 RB20 5 TGTCCCAGTAAGAATCACCTCTCTG 3 RB39 5 AGGAGAAAACTCACCGAGGCAG 3 corresponding sequence unique EcoRI fragment Tf1 sequence neo gene upstream HindIII site Tf1 neo respectively
0.308273.11095681.html.plaintext.txt	70	The extension reaction carried 68 degrees C extension times chosen according size fragments predicted Southern blot analysis
0.308273.11095681.html.plaintext.txt	71	PCR products gel purified Qiagen sequenced using Big Dye Terminator cycle sequencing Perkin Elmer
0.308273.11095681.html.plaintext.txt	72	Oligonucleotides derived LTR neo gene used primers
0.308273.11095681.html.plaintext.txt	73	From sequencing data Tf1 genomic insertion site determined using S
0.308273.11095681.html.plaintext.txt	74	pombe genome database Sanger Centre httpwww
0.308273.11095681.html.plaintext.txt	75	Screen disruption wee1 cdc25 temperature sensitive strain Strain 2586 transformed plasmid pHL414 transformants streaked single colonies EMM leucine thiamine plates 25 degrees C
0.308273.11095681.html.plaintext.txt	76	An individual colony inoculated 10 ml EMM leucine thiamine grown 25 degrees C overnight
0.308273.11095681.html.plaintext.txt	77	After washing cells twice water 100 ml EMM leucine inoculated cell density OD595 0
0.308273.11095681.html.plaintext.txt	78	1 incubated permissive temperature 25 degrees C 24 h
0.308273.11095681.html.plaintext.txt	79	Cells plated EMM leucine uracil 5 FOA Phloxin B density 107 cells per plate incubated restrictive temperature 36 degrees C 4 days
0.308273.11095681.html.plaintext.txt	80	5 FOA resistant colonies replica plated onto YES 5 FOA G418 incubated 2 days 36 degrees C
0.308273.11095681.html.plaintext.txt	81	G418 resistant revertants examined wee1 phenotype light microscopy analysed disruption wee1 gene Southern blotting
0.308273.11095681.html.plaintext.txt	82	Genomic DNA revertants digested AlwNI blotted hybridised Tf1 specific wee1 specific probes 2086 bp KpnI BglII fragment wee1 ORF see Fig
0.308273.11095681.html.plaintext.txt	83	View larger version 40K Figure 4
0.308273.11095681.html.plaintext.txt	84	Screen Tf1 insertion wee1 gene
0.308273.11095681.html.plaintext.txt	85	The pHL414 plasmid transformed cdc25 temperature sensitive strain transposition induced permissive temperature
0.308273.11095681.html.plaintext.txt	86	G418 resistant revertants grew restrictive temperature analysed disruption wee1 gene
0.308273.11095681.html.plaintext.txt	87	Genomic DNA clones m1 m2 digested AlwNI analysed Southern blotting using wee1 Tf1 specific see Fig
0.308273.11095681.html.plaintext.txt	88	The blot shows Tf1 insertions genomic fragment wee1 gene
0.308273.11095681.html.plaintext.txt	89	As control DNA strain without Tf1 insertion included wt
0.308273.11095681.html.plaintext.txt	90	Molecular weights shown left gel
0.308273.11095681.html.plaintext.txt	91	The wee1 ORF presented box arrow indicating translation start site AlwNI restriction sites vicinity wee1 gene indicated
0.308273.11095681.html.plaintext.txt	92	RNA preparation northern blot analysis Northern blots RNA 26 hybridised 32P labelled probes prepared random oligo priming using Prime It kit Stratagene
0.308273.11095681.html.plaintext.txt	93	As loading control blots either stained methylene blue 1
0.308273.11095681.html.plaintext.txt	94	5 kb rRNAs hybridised probe his3 ORF DraI EcoRV fragment
0.308273.11095681.html.plaintext.txt	95	Probes following predicted ORFs obtained PCR using genomic DNA strain 513 template ubc4 SPBC119
0.308273.11095681.html.plaintext.txt	96	The size probes ranged 230 1038 bp contain intronic sequences
0.308273.11095681.html.plaintext.txt	97	RESULTS AND DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES In order investigate target site preference Tf1 LTR retrotransposon insertion used plasmid pHL414 kindly provided H
0.308273.11095681.html.plaintext.txt	98	Levin 20 contained Tf1 control nmt1 promoter Fig
0.308273.11095681.html.plaintext.txt	99	The transposon contained neo gene allowing insertional events selected basis stable G418 resistance plasmid contained S
0.308273.11095681.html.plaintext.txt	100	cerevisiae URA3 gene complement S
0.308273.11095681.html.plaintext.txt	101	The plasmid transformed ura4 cells transposition induced depleting thiamine medium order activate nmt1 promoter
0.308273.11095681.html.plaintext.txt	102	Next cells plated 5 FOA select uracil auxotrophs ensure original plasmid lost cells colonies selected G418 resistance ensuring Tf1 still present cells
0.308273.11095681.html.plaintext.txt	103	Usually G418 resistance occur Tf1 transposition event plasmid chromosome taken place
0.308273.11095681.html.plaintext.txt	104	The majority Tf1 insertions different locations genome To investigate distribution Tf1 insertions within genome analysed 40 putative transposition events Southern blotting Fig
0.308273.11095681.html.plaintext.txt	105	Of 34 85 showed unique restriction patterns indicating insertions occurred sites distributed throughout genome
0.308273.11095681.html.plaintext.txt	106	The remaining six insertions 15 consisted three pairs pair identical restriction pattern differed two pairs
0.308273.11095681.html.plaintext.txt	107	The two insertions three pairs could occurred genomic fragment
0.308273.11095681.html.plaintext.txt	108	However could also coincidentally occurred different fragments similar size case clones 31 33 showed similar restriction pattern mapped different locations chromosome I Table 1
0.308273.11095681.html.plaintext.txt	109	Probing blots URA3 specific probe gave signal showing pHL414 plasmid present clones either free plasmid integrated genome data shown
0.308273.11095681.html.plaintext.txt	110	We also confirmed integrity transposon reprobing blots neo gene data shown
0.308273.11095681.html.plaintext.txt	111	These results indicate Tf1 insertion occurs sites distributed throughout genome
0.308273.11095681.html.plaintext.txt	112	Location 27 Tf1 insertion sites Tf1 inserted preferentially 320 bp band 5 end ORFs Next used IPCR S
0.308273.11095681.html.plaintext.txt	113	pombe genome database determine genomic location 27 Tf1 insertion sites Fig
0.308273.11095681.html.plaintext.txt	114	The mapped Tf1 copies flanked 5 bp duplications insertion site indicating result true transposition event due recombination 21
0.308273.11095681.html.plaintext.txt	115	As shown Table 1 insertions occurred intergenic regions
0.308273.11095681.html.plaintext.txt	116	Our analysis available S
0.308273.11095681.html.plaintext.txt	117	Sgouros personal communication based sequence information made available S
0.308273.11095681.html.plaintext.txt	118	pombe Genome Project EU Consortium suggested 62 genome consists coding sequences comparison S
0.308273.11095681.html.plaintext.txt	119	cerevisiae predict 83 would non essential 27
0.308273.11095681.html.plaintext.txt	120	Thus would expect 52 transposition clones would insertion non essential ORF
0.308273.11095681.html.plaintext.txt	121	Given lack event conclude Tf1 integration random significantly biased towards intergenic regions
0.308273.11095681.html.plaintext.txt	122	To investigate whether insertion Tf1 within intergenic regions random analysed distribution insertion sites respect 5 3 region nearest gene
0.308273.11095681.html.plaintext.txt	123	In order divided targeted intergenic regions half allocated insertions 5 3 region closest ORF
0.308273.11095681.html.plaintext.txt	124	On basis 10 15 insertions tandem ORFs 12 Tf1 insertions divergent ORFs mapped closer 5 3 end ORF
0.308273.11095681.html.plaintext.txt	125	Correspondingly Figure 2A shows 22 Tf1 insertions 5 region five insertions 3 region representative ORF
0.308273.11095681.html.plaintext.txt	126	The 5 region Tf1 targeted genes mean size 980 bp determined calculating mean size Tf1 targeted intergenic regions flanked ORFs divergent orientation 1
0.308273.11095681.html.plaintext.txt	127	Thus transposition 5 region genes completely random 33 insertions would found region 320 bp
0.308273.11095681.html.plaintext.txt	128	However analysis revealed 82 1822 insertions band 100 420 nt upstream translation start site ORF
0.308273.11095681.html.plaintext.txt	129	This significant bias Tf1 integration towards 320 bp band close 5 end ORFs supported lack insertion convergent ORFs
0.308273.11095681.html.plaintext.txt	130	Taking account frequency average size different intergenic regions would expected find 10 11 Tf1 insertions intergenic regions flanked divergent ORFs 27 1
0.308273.11095681.html.plaintext.txt	131	1 kb 12 13 insertions regions flanked tandem ORFs 45 0
0.308273.11095681.html.plaintext.txt	132	8 kb four five insertions regions convergent ORFs 28 0
0.308273.11095681.html.plaintext.txt	133	We found 12 insertions divergent ORFs 15 insertions tandem ORFs insertion convergent ORFs Table 1
0.308273.11095681.html.plaintext.txt	134	This suggests Tf1 avoids convergent intergenic regions entirely presumably preference 5 ends ORFs
0.308273.11095681.html.plaintext.txt	135	View larger version 14K Figure 2
0.308273.11095681.html.plaintext.txt	136	Analysis Tf1 integration sites within intergenic regions
0.308273.11095681.html.plaintext.txt	137	A The location mapped Tf1 insertion sites regard closest ORF 5 3 end shown
0.308273.11095681.html.plaintext.txt	138	Bars indicate single Tf1 insertions
0.308273.11095681.html.plaintext.txt	139	Long bars used represent two Tf1 insertions occurred distance closest ORF clone 8 141 bp clone 39 144 bp clone 2 258 bp clone 29 261 bp clone 21 307 bp clone 26 308 bp
0.308273.11095681.html.plaintext.txt	140	The arrow indicates 5 end ORF grey box
0.308273.11095681.html.plaintext.txt	141	B Composition 5 bp Tf1 target site duplication
0.308273.11095681.html.plaintext.txt	142	The total average base usage 5 bp duplicated target site indicated
0.308273.11095681.html.plaintext.txt	143	The total number analysed target sites 27 orientation target site 5 3 parallel Tf1 element
0.308273.11095681.html.plaintext.txt	144	If Tf1 simply preference 5 ends ORFs would expected mean size Tf1 targeted intergenic regions would equivalent mean size corresponding regions genome
0.308273.11095681.html.plaintext.txt	145	However found mean size Tf1 targeted intergenic regions flanked divergent 1
0.308273.11095681.html.plaintext.txt	146	5 kb n 15 ORFs larger mean size regions genome 1
0.308273.11095681.html.plaintext.txt	147	This difference highly significant regions flanked tandem ORFs P 0
0.308273.11095681.html.plaintext.txt	148	01 two tailed paired test showed good significance regions flanked divergent ORFs P 0
0.308273.11095681.html.plaintext.txt	149	Thus analysis suggests Tf1 integrated preferentially particular large intergenic regions directly related preference region 5 ends ORFs
0.308273.11095681.html.plaintext.txt	150	We examined next whether Tf1 inserted 5 ends ORFs targeting directly indirectly particular DNA sequence
0.308273.11095681.html.plaintext.txt	151	The retroelement show preference AT rich regions reported Ty1 elements 28
0.308273.11095681.html.plaintext.txt	152	We determined AT content 64 plus minus 1 S
0.308273.11095681.html.plaintext.txt	153	pombe genome analysing 10 randomly picked cosmids
0.308273.11095681.html.plaintext.txt	154	Regions comprising 500 100 20 bp either side insertion sites average AT content 67 plus minus 2 68 plus minus 5 67 plus minus 9 respectively
0.308273.11095681.html.plaintext.txt	155	Analysis duplicated Tf1 insertion site 21 revealed consensus sequence suggest four bases used equally
0.308273.11095681.html.plaintext.txt	156	The second position found enriched T depleted G third position depleted G C fourth position depleted C Fig
0.308273.11095681.html.plaintext.txt	157	Further target site showed elevated AT content second 74 third 84 fourth 74 position compared AT content S
0.308273.11095681.html.plaintext.txt	158	To consider possibility Tf1 targeted host DNA binding factor searched potential binding sites 500 bp upstream downstream different insertion sites using MACAW software well multiple alignment PROFILE searches could find consensus sequence
0.308273.11095681.html.plaintext.txt	159	It shown previously Ty1 elements insert high frequency within pre existing LTRs 10
0.308273.11095681.html.plaintext.txt	160	pombe Tf1 solo LTRs distributed throughout genome occur frequency 1
0.308273.11095681.html.plaintext.txt	161	5 LTRs every 27 intergenic region determined genome analysis
0.308273.11095681.html.plaintext.txt	162	The Tf1 insertions clones 5 15 40 distance 27 bp 473 bp 2
0.308273.11095681.html.plaintext.txt	163	6 kb LTR respectively thereby closer LTR least one two adjacent ORFs
0.308273.11095681.html.plaintext.txt	164	In clone 12 Tf1 inserted even within LTR
0.308273.11095681.html.plaintext.txt	165	Although significance findings difficult evaluate remains possibility Tf1 preference LTRs either targeted directly LTR sequences chromatin feature targeted ancient retroelements regions
0.308273.11095681.html.plaintext.txt	166	For budding yeast Ty1 Ty3 elements preference 5 ends tRNA genes reported previously 67
0.308273.11095681.html.plaintext.txt	167	However observe preference Tf1
0.308273.11095681.html.plaintext.txt	168	Furthermore analysis revealed Tf1 integration biased towards particular chromosome region chromosome Table 1 exception two Tf1 insertion events occurred within distance 3 kb clones 21 39
0.308273.11095681.html.plaintext.txt	169	In region evidence local recombination event presence particular sequences like LTRs rRNA tRNA genes
0.308273.11095681.html.plaintext.txt	170	Tf1 integration significant effect transcription adjacent genes It reported Ty1 inserts 5 untranslated regions activate inactivate confer constitutive expression mating type regulation neighbouring transcriptional units 13
0.308273.11095681.html.plaintext.txt	171	P elements mutate genes similar way preferentially inserting 5 untranslated region well region 100 200 bp upstream transcription start site 2
0.308273.11095681.html.plaintext.txt	172	To analyse effects Tf1 insertion transcription adjacent genes examined eight transposition clones northern blot analysis Table 2
0.308273.11095681.html.plaintext.txt	173	As shown Figure 3 changes transcription level examined genes 2 fold size transcripts remained unchanged compared control
0.308273.11095681.html.plaintext.txt	174	These results suggest unlike Ty1 P elements Tf1 preferentially target 5 UTRs retrotransposon insert close ORFs without interfering transcription
0.308273.11095681.html.plaintext.txt	175	Since little known size promoter regions S
0.308273.11095681.html.plaintext.txt	176	pombe speculate might small genes remain unaffected upstream Tf1 insertion
0.308273.11095681.html.plaintext.txt	177	Alternatively Tf1 might affected function transcription regulation elements upon insertion retroelement controls expression adjacent genes LTR located promoter enhancer elements described Ty1 elements 2930
0.308273.11095681.html.plaintext.txt	178	Northern blot analysis genes adjacent Tf1 insertions
0.308273.11095681.html.plaintext.txt	179	The transcription level size transcript two genes adjacent Tf1 insertion analysed northern blot
0.308273.11095681.html.plaintext.txt	180	The names gene transcripts detected transposition m control clones wt shown right gels
0.308273.11095681.html.plaintext.txt	181	No transcript detected SPCC777
0.308273.11095681.html.plaintext.txt	182	As loading control rRNA stained methylene blue 3
0.308273.11095681.html.plaintext.txt	183	8 kb band his3 transcript level monitored
0.308273.11095681.html.plaintext.txt	184	Tf1 disrupt wee1 ORF screen cdc25 revertants To investigate frequency Tf1 insertion particular gene screened transposon induced revertants temperature sensitive cdc25 22 mutant generally revertants due inactivation wee1 ORF 31
0.308273.11095681.html.plaintext.txt	185	We induced transposition pHL414 plasmid cdc25 temperature sensitive strain permissive temperature followed selection cells able grow restrictive temperature 5 FOA G418
0.308273.11095681.html.plaintext.txt	186	We screened 8 x 106 cells carrying Tf1 insertion would expected obtain approximately 1700 Tf1 integrations wee1 ORF transposition completely random
0.308273.11095681.html.plaintext.txt	187	However obtained two transposition clones grew 36 degrees C revertant phenotype due Tf1 insertion within close wee1 gene shown Southern blotting Fig
0.308273.11095681.html.plaintext.txt	188	This result consistent previous findings Tf1 targets 5 ends ORFs without affecting expression encoded protein
0.308273.11095681.html.plaintext.txt	189	In preliminary experiments used modified transposition protocol screened transposition clones auxotrophic glutamate adenine histidine lysine
0.308273.11095681.html.plaintext.txt	190	No auxotrophic mutants transposon insertion found
0.308273.11095681.html.plaintext.txt	191	Physiological stress alter Tf1 transposition In order see could increase randomise transposition induced transposition subjecting S
0.308273.11095681.html.plaintext.txt	192	pombe cells various treatments reported increase transposition Ty1 elements 32 34
0.308273.11095681.html.plaintext.txt	193	We investigated transposition damaging DNA 20 microgml bleomycin 4
0.308273.11095681.html.plaintext.txt	194	2 mM 4 nitroquinoline 1 oxide ii osmotic stress 100 mM ss mercaptoethanol 10 dimethyl sulphoxide iii changing chromatin structure depolymerising microtubules 100 microgml thiabendazole 25 microgml methyl ss cyclodextrin iv meiosis v nitrogen starvation vi block release assays using hydroxyurea temperature shifts
0.308273.11095681.html.plaintext.txt	195	However none treatments resulted significant changes quantity quality Tf1 transposition data shown monitored determining transposition efficiency 21 using screen cdc25 revertants respectively
0.308273.11095681.html.plaintext.txt	196	Tf1 might target 5 ends ORFs interacting host factor We shown Tf1 insert ORFs Tf1 insertion occurred preferentially large intergenic regions bias towards 320 bp region located 100 bp upstream translation start site
0.308273.11095681.html.plaintext.txt	197	Northern blot analysis genes adjacent Tf1 insertions reveal significant changes transcription level size corresponding transcript
0.308273.11095681.html.plaintext.txt	198	Consistent results propose Tf1 targeted region specific close 5 ends ORFs DNA binding host factor
0.308273.11095681.html.plaintext.txt	199	This could component associated chromatin structure shown previously Tf1 transposition decreased presence histone deacytelase inhibitor Trichostatin A 35
0.308273.11095681.html.plaintext.txt	200	Furthermore retrotransposon encodes chromo motif chromatin organisation modifier 36 could mediate interactions chromatin associated factors 37
0.308273.11095681.html.plaintext.txt	201	Alternatively addition transcription related factor could target Tf1 5 ends ORFs described Ty1 elements 57 938
0.308273.11095681.html.plaintext.txt	202	In case Tf1 however factor likely associated Pol II transcription complex Tf1 insertion biased towards Pol III transcribed genes
0.308273.11095681.html.plaintext.txt	203	However failed detect DNA binding factor sites although may degenerate short detected
0.308273.11095681.html.plaintext.txt	204	pombe genome densely packed ORFs size intergenic regions limited see earlier larger intergenic regions may contain higher number target sequences factors involved regulation chromatin structure andor transcription
0.308273.11095681.html.plaintext.txt	205	Therefore Tf1 might preferably insert large intergenic regions host factors targeting retroelement likely present regions
0.308273.11095681.html.plaintext.txt	206	The isolation Tf1 insertions study based expression neo gene
0.308273.11095681.html.plaintext.txt	207	Thus possible Tf1 targets detected silent regions genome centromere telomeres mating type loci 39 41
0.308273.11095681.html.plaintext.txt	208	Analysis unselected transposition events therefore important task future studies
0.308273.11095681.html.plaintext.txt	209	Application Tf1 tool molecular biology Transposons proven helpful molecular tools
0.308273.11095681.html.plaintext.txt	210	They used insertional mutagens tag genes 42 generate transcriptional translational fusions 43
0.308273.11095681.html.plaintext.txt	211	Our analysis shown Tf1 suitable insertional mutagenesis however altering target site specificity Tf1 random mutagenesis might turn useful tool application 44
0.308273.11095681.html.plaintext.txt	212	In respect would also important know whether target site specificity Tf1 changed mutant strains altered chromatin structure case Ty elements 3045 47
0.308273.11095681.html.plaintext.txt	213	Similarly treating cells Trichostatin A results reduced Tf1 transposition 35 could alter target site preference
0.308273.11095681.html.plaintext.txt	214	In addition providing information transposition target site selectivity Tf1 system could provide useful tool probe dissect chromatin structure vivo already suggested retrotransposons 1747
0.308273.11095681.html.plaintext.txt	215	ACKNOWLEDGEMENTS We grateful H
0.308273.11095681.html.plaintext.txt	216	Levin kindly providing pHL414 plasmid John Sgouros Sanger Centre provding information S
0.308273.11095681.html.plaintext.txt	217	We thank David Ish Horowicz Joyce Muller Heidi Browing Damian Brunner members cell cycle laboratory help comments manuscript
0.308273.11095681.html.plaintext.txt	218	also supported fellowship Boehringer Ingelheim Fonds
0.308273.11095681.html.plaintext.txt	219	FOOTNOTES To correspondence addressed
0.308273.11095681.html.plaintext.txt	220	Tel 44 20 7269 3276 Fax 44 20 7269 3610 Email r
0.308273.11095681.html.plaintext.txt	221	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES 1 CraigN
0.308273.11095681.html.plaintext.txt	222	1989 Genetics 123 269 279
0.308273.11095681.html.plaintext.txt	223	1989 Genetics 123 655 665
0.308273.11095681.html.plaintext.txt	224	eds Molecular Cellular Biology Yeast Saccharochomyces cerevisiae Genome Dynamics Protein Synthesis Energetics
0.308273.11095681.html.plaintext.txt	225	Cold Spring Harbor Laboratory Press Cold Spring Harbor NY
0.308273.11095681.html.plaintext.txt	226	1995 Science 267 1488 1491
0.308273.11095681.html.plaintext.txt	227	1992 Biotechnology 24 122 139
0.308273.11095681.html.plaintext.txt	228	1994 Yeast 10 1793 1808
0.308273.11095681.html.plaintext.txt	229	1999 Science 285 901 906
0.308273.11095681.html.plaintext.txt	230	1988 Genetics 120 95 108
0.308273.11095681.html.plaintext.txt	231	1986 Nature 319 339 340
0.308273.11095681.html.plaintext.txt	232	1996 Genetics 142 761 776
0.3009156.9547266.html.plaintext.txt	0	The activation function 2 domain hepatic nuclear factor 4 regulated short C terminal proline rich repressor domain
0.3009156.9547266.html.plaintext.txt	1	Chemical Pathology Unit Sir William Dunn School Pathology University Oxford South Parks Road Oxford OX1 3RE UK
0.3009156.9547266.html.plaintext.txt	2	Received January 26 1998 Revised Accepted March 19 1998
0.3009156.9547266.html.plaintext.txt	3	Hepatic nuclear factor 4 HNF4 transcription factor whose expression crucial mouse embryonic development liver specific gene expression prevention one form maturity onset diabetes young
0.3009156.9547266.html.plaintext.txt	4	Its domain structure defined previously similar members nuclear receptor superfamily
0.3009156.9547266.html.plaintext.txt	5	A repressor domain localised region 14 amino acids residues 428 441 near C terminus HNF4 sufficient repress activity activation function 2 AF2 domain
0.3009156.9547266.html.plaintext.txt	6	Multiple mutations within repressor domain enhance activity
0.3009156.9547266.html.plaintext.txt	7	Interestingly repressor domain shares homology repressor domain progesterone receptor
0.3009156.9547266.html.plaintext.txt	8	In detailed mutagenesis study AF2 core demonstrate L 366 conserved AF2 core HNF4 number orphan nuclear receptors essential full activity AF2 domain
0.3009156.9547266.html.plaintext.txt	9	Furthermore double mutation E 363 L 366 suggests residues might act cooperative manner
0.3009156.9547266.html.plaintext.txt	10	Hepatic nuclear factor 4 HNF4 first isolated protein involved regulating number liver specific genes 1
0.3009156.9547266.html.plaintext.txt	11	It shares amino acid sequence homology nuclear receptor superfamily
0.3009156.9547266.html.plaintext.txt	12	Since ligand yet found HNF4 classified orphan nuclear receptor
0.3009156.9547266.html.plaintext.txt	13	Extensive work carried nuclear receptors e
0.3009156.9547266.html.plaintext.txt	14	oestrogen retinoic acid receptors shown modular structure distinct regions carrying specific functions 2
0.3009156.9547266.html.plaintext.txt	15	The N terminal region AB contains activation function 1 AF1 whose activity cell type well promoter context specific 3
0.3009156.9547266.html.plaintext.txt	16	A highly conserved zinc finger domain required DNA binding present region C region D acting hinge 2
0.3009156.9547266.html.plaintext.txt	17	The C terminal half receptors contains long hydrophobic domain region E encodes various functions
0.3009156.9547266.html.plaintext.txt	18	These include receptor dimerisation ligand binding ligand dependent activation function 2 AF2 2
0.3009156.9547266.html.plaintext.txt	19	The AF2 domain contains core region seven amino acids PhiPhiKHgraPhiPhiaL Phi hydrophobic residue KHgr residue acidic residue L leucine critical activation conserved many nuclear receptors 4
0.3009156.9547266.html.plaintext.txt	20	The extreme C terminal region receptors region F varies length receptors function unknown
0.3009156.9547266.html.plaintext.txt	21	In HNF4 region extended contains proline rich domain 1
0.3009156.9547266.html.plaintext.txt	22	HNF4 expressed many tissues including liver kidney pancreas intestine 1510
0.3009156.9547266.html.plaintext.txt	23	There number isoforms generated alternative splicing 5
0.3009156.9547266.html.plaintext.txt	24	For example HNF4alpha gene humans encodes three isoforms alpha1 alpha 2 alpha4
0.3009156.9547266.html.plaintext.txt	25	There addition distinct gamma subtype encoded HNF4gamma gene 5
0.3009156.9547266.html.plaintext.txt	26	The rat HNF4 isoforms 1 455 1 465 equivalent human alpha1 alpha2 respectively 16
0.3009156.9547266.html.plaintext.txt	27	In Xenopus laevis HNF4 encoded two distinct alpha beta genes 7
0.3009156.9547266.html.plaintext.txt	28	Deletion HNF4 embryonic lethal mice since resulted induction cell death embryonic ectoderm impairment gastrulation mouse embryos carrying homozygous knockout HNF4alpha gene 8
0.3009156.9547266.html.plaintext.txt	29	In regulation factor IX gene point mutations disrupt HNF4 binding site result haemophilia B 910
0.3009156.9547266.html.plaintext.txt	30	Recently heterozygotes carrying mutations HNF4alpha allele linked one form maturity onset diabetes young MODY1 11
0.3009156.9547266.html.plaintext.txt	31	HNF4 also involved regulation number genes required carbohydrate lipid metabolism well erythropoiesis 112
0.3009156.9547266.html.plaintext.txt	32	These genes include apolipoprotein CIII pyruvate kinase alpha1 antitrypsin erythropoietin
0.3009156.9547266.html.plaintext.txt	33	Previous work aimed investigating C terminal activation domain HNF4 transcription showed large deletions C terminal region abolished transactivation 1213
0.3009156.9547266.html.plaintext.txt	34	HNF4 also shown interact basal transcription factor TFIIB 13
0.3009156.9547266.html.plaintext.txt	35	Recent evidence suggested E363 L366 AF2 core important activity AF2 domain 14
0.3009156.9547266.html.plaintext.txt	36	However study limited single mutations either position context GAL4 HNF4 deletion fusion constructs amino acids 128 370 lacked essential domains N terminal AF1 domain DNA binding domain repressor domain extended C terminal region characterised report
0.3009156.9547266.html.plaintext.txt	37	In report demonstrate extensive mutagenesis context full length HNF4 full length HNF4 fused GAL4 DNA binding domain Leu 366 AF2 core essential full AF2 activity
0.3009156.9547266.html.plaintext.txt	38	By investigating effect double mutation involving E363 L366 show residues may act cooperatively
0.3009156.9547266.html.plaintext.txt	39	In addition precisely mapped location repressor domain initially described ref
0.3009156.9547266.html.plaintext.txt	40	14 postulated lie residues 371 455 amino acids 428 441 defined amino acid residues within domain required activity
0.3009156.9547266.html.plaintext.txt	41	MATERIALS AND METHODS Reporter plasmids GAL4 HNF4 fusion constructs
0.3009156.9547266.html.plaintext.txt	42	Reporter plasmids pCAT4 pAPF1 HIV CAT 115 used determine transactivation activities GAL4 HNF4 fusion constructs native HNF4 constructs respectively
0.3009156.9547266.html.plaintext.txt	43	pCAT4 reporter plasmid four GAL4 response elements inverted CCAAT box TATA element controlling CAT reporter gene pBluescript backbone pAPF1 HIV CAT contains two HNF4 response elements direct repeat 57 80 HIV LTR controlling CAT reporter gene
0.3009156.9547266.html.plaintext.txt	44	To monitor transfection efficiency internal control plasmid pGLtkLUC 16 used
0.3009156.9547266.html.plaintext.txt	45	The plasmid pGAL4 1 147 17 contains DNA binding domain DBD yeast GAL4 protein driven immediate early human cytomegalovirus CMV promoter
0.3009156.9547266.html.plaintext.txt	46	The GAL4 HNF4 full length fusion constructs C terminal deletion constructs HNF4 constructed PCR amplification appropriate fragment HNF4 derived plasmid pCB6HNF4 16 using Pfu polymerase Stratagene
0.3009156.9547266.html.plaintext.txt	47	After purification PCR products BamHIKpnI restriction digest carried followed frame ligation GAL4 DBD using BamHIKpnI restriction sites pGAL4 1 147
0.3009156.9547266.html.plaintext.txt	48	All GAL4 HNF4 full length fusion proteins carrying point mutation E 363 L 366 repressor domain mutants constructed PCR based mutagenesis using Pfu polymerase Pritlove unpublished data
0.3009156.9547266.html.plaintext.txt	49	Native opposed GAL4 HNF4 fusion constructs full length HNF4 constructs point mutations E 363 L 366 constructed removing GAL4 DBD GAL4 1 147 appropriate GAL4 HNF4 fusion construct HindIIIBamHI restriction digest
0.3009156.9547266.html.plaintext.txt	50	The fusion construct GAL4 HNF4 1 372428 441 made first amplifying pGAL4 HNF4 1 372 fragment followed ligation step insert double stranded oligonucleotide repressor domain HNF4 residues 428 441
0.3009156.9547266.html.plaintext.txt	51	The sequence constructs verified fluorescent dideoxy sequencing
0.3009156.9547266.html.plaintext.txt	52	Cell culture transient transfections enzymatic gel mobility shift assays
0.3009156.9547266.html.plaintext.txt	53	HeLa HepG2 cells cultured using 60 mm dishes minimal essential medium MEM supplemented 10 foetal calf serum
0.3009156.9547266.html.plaintext.txt	54	Transient transfections carried using standard calcium phosphate precipitation method 10
0.3009156.9547266.html.plaintext.txt	55	Briefly total 15 microg DNA transfected consisting 10 microg reporter plasmid 2 microg expression plasmid 2 microg internal control plasmid 1 microg salmon sperm DNA Sigma
0.3009156.9547266.html.plaintext.txt	56	Sixteen hours transfection cells washed twice PBS fresh medium added
0.3009156.9547266.html.plaintext.txt	57	Cells harvested 48 h post transfection
0.3009156.9547266.html.plaintext.txt	58	Luciferase assays carried according manufacturer using luciferase assay kit Promega quantitated using Wallac LKB 1250 luminometer
0.3009156.9547266.html.plaintext.txt	59	Chloramphenicol acetyl transferase assays performed standard methods 10 determine reporter activity construct
0.3009156.9547266.html.plaintext.txt	60	TLC plates quantitated using Storm phosphorimager analysed using Image Quant software
0.3009156.9547266.html.plaintext.txt	61	Gel mobility shift assays performed essentially described 17 using DNA probe containing single GAL4 binding site HeLa cell extracts used determine relative transactivation activities constructs Figure 2
0.3009156.9547266.html.plaintext.txt	62	P values calculated using students test comparing mean standard deviation mutants
0.3009156.9547266.html.plaintext.txt	63	When comparing mutants full length fusion protein native wild type full length HNF4 protein P values calculated z values
0.3009156.9547266.html.plaintext.txt	64	RESULTS Mapping C terminal activation function 2 AF2 HNF4
0.3009156.9547266.html.plaintext.txt	65	Analysis amino acid sequence rat HNF4 identified consensus amino acid sequence PhiPhiKHgraPhiPhiaL amino acid residues 360 366 found number orphan ligand nuclear receptors Fig
0.3009156.9547266.html.plaintext.txt	66	This conserved sequence known activation function 2 AF2 core known form amphipathic alpha helix required ligand dependent activation nuclear receptors e
0.3009156.9547266.html.plaintext.txt	67	1 revealed Leu position 366 last residue AF2 core HNF4 conserved number orphan receptors Fig
0.3009156.9547266.html.plaintext.txt	68	1 underlined L whereas acidic residue E D found corresponding position number nuclear receptors known ligands
0.3009156.9547266.html.plaintext.txt	69	In addition extreme C terminal region HNF4 specifically amino acids 400 447 rich proline residues previously proposed contain proline rich activation domain 1
0.3009156.9547266.html.plaintext.txt	70	Alignment amino acid sequence around activation function 2 AF2 core HNF4 different species number orphan nuclear receptors receptors known ligands
0.3009156.9547266.html.plaintext.txt	71	Phi represents hydrophobic residue KHgr amino acid residue acidic residue
0.3009156.9547266.html.plaintext.txt	72	The invariant glutamic acid E conserved nuclear receptors known ligands HNF4 highlighted bold
0.3009156.9547266.html.plaintext.txt	73	The leucine L conserved HNF4 number orphan nuclear receptors underlined
0.3009156.9547266.html.plaintext.txt	74	laevis d Drosophila h human m mouse
0.3009156.9547266.html.plaintext.txt	75	The definitions symbols ARP1 EAR COUP TF1 Svp TR VDR RAR RXR accession numbers found ref
0.3009156.9547266.html.plaintext.txt	76	Mapping C terminal activation function 2 AF2 HNF4
0.3009156.9547266.html.plaintext.txt	77	A Schematic representation GAL4 DBD full length HNF4 fusion HNF4 C terminal deletion fusions 366 455 15 amino acids intervals
0.3009156.9547266.html.plaintext.txt	78	B Transactivation HeLa dotted histogram HepG2 blank histogram cells relative full length HNF4 fusion set 100 experiments
0.3009156.9547266.html.plaintext.txt	79	The mean three independent transfection experiments shown plus minus standard deviation
0.3009156.9547266.html.plaintext.txt	80	In context GAL4 HNF4 fusion constructs F used represent GAL4 1 147
0.3009156.9547266.html.plaintext.txt	81	pCAT4 see Materials Methods transfection control
0.3009156.9547266.html.plaintext.txt	82	In order determine proline rich region contained activation domain establish role conserved amino acid sequence 360 366 GAL4 HNF4 fusion proteins constructed successive 15 amino acid deletions C terminus HNF4 residue 366 Fig
0.3009156.9547266.html.plaintext.txt	83	Unexpectedly deletions residue 381 produced fusion proteins higher activities full length fusion protein HeLa HepG2 cells Fig
0.3009156.9547266.html.plaintext.txt	84	For example activity deletion F 1 410 three half times full length fusion protein HeLa cells
0.3009156.9547266.html.plaintext.txt	85	However amino acids 366 380 deleted Fig
0.3009156.9547266.html.plaintext.txt	86	2B F 1 365 activity decreased 12 full length fusion protein
0.3009156.9547266.html.plaintext.txt	87	These results suggested repressor domain spanning residues 380 455
0.3009156.9547266.html.plaintext.txt	88	However evidence proline rich activation domain residues 400 447 previously suggested 1
0.3009156.9547266.html.plaintext.txt	89	The fact transactivation reduced near background level residues 366 380 deleted suggested Leu 366 conserved number orphan receptors last residue consensus sequence PhiPhiKHgraPhiPhiaL Fig
0.3009156.9547266.html.plaintext.txt	90	To exclude possibility increased activities C terminal deletion fusions due higher levels protein expression constructs others gel mobility shift assay carried described Materials Methods
0.3009156.9547266.html.plaintext.txt	91	As shown Figure 3 gel shifted fusion complexes constructs present comparable amounts insufficient variation yield account difference activity observed Figure 2
0.3009156.9547266.html.plaintext.txt	92	Thus gel shift analysis protein levels carried constructs report
0.3009156.9547266.html.plaintext.txt	93	A gel mobility shift assay using HeLa cell extracts determine protein expression levels full length C terminal deletion fusion constructs shown except F 1 425 Figure 2
0.3009156.9547266.html.plaintext.txt	94	Lane 1 HeLa cell extract cells transfected reporter pCAT4 internal control pGLtkLUC plasmids lane 2 GAL 1 147 lane 3 F 1 455 lane 4 F 1 365 lane 5 F 1 380 lane 6 F 1 395 lane 7 F 1 410 lane 8 F 1 440
0.3009156.9547266.html.plaintext.txt	95	The position gel shifted fusion complexes shown free probe position presumptive degradation products comigrating GAL4 1 147 DNA binding domain GAL4 indicated arrows
0.3009156.9547266.html.plaintext.txt	96	To identify critical residues region residues 359 380 fusion proteins deletions three amino acid intervals residues 359 380 constructed tested transient transfection assay HeLa cells Fig
0.3009156.9547266.html.plaintext.txt	97	Deleting amino acids 369 380 effect activity C terminal activation domain Fig
0.3009156.9547266.html.plaintext.txt	98	4B compare F 1 380 F 1 368
0.3009156.9547266.html.plaintext.txt	99	Deleting next three amino acids 366 368 resulted significant decrease activity background level Fig
0.3009156.9547266.html.plaintext.txt	100	Two deletions F 1 362 F 1 359 also background activity
0.3009156.9547266.html.plaintext.txt	101	We conclude region amino acids 365 368 critical transactivation
0.3009156.9547266.html.plaintext.txt	102	Leu L 366 last amino acid residue proposed amphipathic alpha helix formed AF2 core Fig 1 18 thus may important residue
0.3009156.9547266.html.plaintext.txt	103	Determining critical amino acid residues AF2 core HNF4 HeLa cells
0.3009156.9547266.html.plaintext.txt	104	A Schematic representation GAL4 DBD full length HNF4 fusion C terminal deletion fusions 359 380 three amino acid intervals
0.3009156.9547266.html.plaintext.txt	105	Intermediate constructs 368 380 shown since activities constructs significantly different fusion F 1 368 results shown
0.3009156.9547266.html.plaintext.txt	106	B Transactivation relative full length HNF4 fusion set 100 see legend Fig
0.3009156.9547266.html.plaintext.txt	107	To investigate significance L366 detail point mutations L 366 A D Q I made context GAL4 DBD full length HNF4 fusion proteins Fig
0.3009156.9547266.html.plaintext.txt	108	5A context native full length HNF4 Fig
0.3009156.9547266.html.plaintext.txt	109	All mutations L366 resulted decreased activity compared wild type GAL4 DBD HNF4 fusion protein native HNF4 Fig
0.3009156.9547266.html.plaintext.txt	110	In context native HNF4 Fig
0.3009156.9547266.html.plaintext.txt	111	5D activity mutant L 366 I mutants differed least activity wild type still statistically significantly different P 0
0.3009156.9547266.html.plaintext.txt	112	01 wild type z value test Materials Methods
0.3009156.9547266.html.plaintext.txt	113	When activities mutants 366 A Q compared mutant 366 I also found statistically significantly differentP 0
0.3009156.9547266.html.plaintext.txt	114	However transactivation activities mutants 366 D I statistically significantly different P 0
0.3009156.9547266.html.plaintext.txt	115	Comparing activities set point mutants L 366 context GAL4 HNF4 fusion Fig
0.3009156.9547266.html.plaintext.txt	116	5B shows mutants 366 Q D statistically significantly different I P 0
0.3009156.9547266.html.plaintext.txt	117	01 cases although significant difference seen 366 I A P 0
0.3009156.9547266.html.plaintext.txt	118	05 mutants 366 A D Q
0.3009156.9547266.html.plaintext.txt	119	These results show L 366 critical full transactivation
0.3009156.9547266.html.plaintext.txt	120	The roles L366 E363 activity C terminal AF2 domain HNF4 HeLa cells
0.3009156.9547266.html.plaintext.txt	121	A Schematic representation GAL4 DBD wild type GAL4 HNF4 full length fusion construct arrows showing point mutations L366 A D Q I
0.3009156.9547266.html.plaintext.txt	122	F E363 A shows GAL4 HNF4 full length construct bolded 363E A mutation AF2 core
0.3009156.9547266.html.plaintext.txt	123	F E363AL366A shows double mutant B Relative transactivation see legend Fig
0.3009156.9547266.html.plaintext.txt	124	C Schematic representation native full length HNF4 mutants studied A
0.3009156.9547266.html.plaintext.txt	125	D Transactivation relative wild type native full length HNF4 set 100
0.3009156.9547266.html.plaintext.txt	126	APF1 HIV CAT transfection control see Materials Methods
0.3009156.9547266.html.plaintext.txt	127	Position 4 E 363 HNF4 consensus AF2 core acidic residue orphan nuclear receptors known ligands Fig
0.3009156.9547266.html.plaintext.txt	128	From crystal structure ligand binding domain RARgamma bound trans retinoic acid position critical formation salt bridge helix 4 12 18 essential AF2 activity
0.3009156.9547266.html.plaintext.txt	129	Thus investigated point mutant 363 E A HNF4 context GAL4 HNF4 fusion protein Fig
0.3009156.9547266.html.plaintext.txt	130	Transactivation statistically significantly lower wild type fusion protein cases P 0
0.3009156.9547266.html.plaintext.txt	131	These results indicate E 363 also important full transactivation
0.3009156.9547266.html.plaintext.txt	132	We next determined effect double mutation E363AL366A context GAL4 full length HNF4 fusion Fig
0.3009156.9547266.html.plaintext.txt	133	Unexpectedly activity double mutant comparable single mutants either position Fig
0.3009156.9547266.html.plaintext.txt	134	5B F E363AL366A compared F L366A F E363A suggesting E363 L366 may act cooperatively regulating activity AF2 domain
0.3009156.9547266.html.plaintext.txt	135	The AF2 activity HNF4 regulated repressor domain near C terminus
0.3009156.9547266.html.plaintext.txt	136	A repressor domain near C terminus progesterone receptor PR recently shown inhibit activity PR absence progesterone 19
0.3009156.9547266.html.plaintext.txt	137	Alignment PR repressor domain sequence residues 917 928 entire HNF4 protein sequence identified potential 12 amino acid long sequence homology Fig
0.3009156.9547266.html.plaintext.txt	138	6A boxed region near C terminus HNF4 residues 430 441
0.3009156.9547266.html.plaintext.txt	139	This potential repressor region showed 40 identity sequence repressor domain PR also near C terminus
0.3009156.9547266.html.plaintext.txt	140	This homology previous results defining repressor domain residues 380 455 see prompted us investigate effect fusing short region HNF4 containing residues 430 441 downstream high activity C terminal deletion mutant
0.3009156.9547266.html.plaintext.txt	141	Thus 14 long peptide residues 428 441 HNF4 fused frame downstream GAL4 HNF4 1 372 Fig
0.3009156.9547266.html.plaintext.txt	142	6B activity reduced 300 22 full length fusion protein Fig
0.3009156.9547266.html.plaintext.txt	143	6C compare F 1 372428 441 F 1 455 P 0
0.3009156.9547266.html.plaintext.txt	144	This suggested peptide 428 441 may function repressor domain isolation
0.3009156.9547266.html.plaintext.txt	145	A study C terminal repressor HNF4
0.3009156.9547266.html.plaintext.txt	146	A Homology boxed C terminal repressor domain PR potential repressor domain extended C terminal region HNF4 see text
0.3009156.9547266.html.plaintext.txt	147	indicates C terminus PR
0.3009156.9547266.html.plaintext.txt	148	Amino acids numbered HNF4 PR
0.3009156.9547266.html.plaintext.txt	149	B Schematic representation GAL DBD full length fusion F 1 455 1 371 C terminal deletion fusion 1 372 C terminal deletion fusion containing frame fusion proposed repressor domain 428 441 HNF4
0.3009156.9547266.html.plaintext.txt	150	C Transactivation HeLa cells relative full length fusion set 100 see legend Fig
0.3009156.9547266.html.plaintext.txt	151	The role repressor domain investigated mutagenesis context full length HNF4 fusion protein
0.3009156.9547266.html.plaintext.txt	152	Two constructs multiple point mutations run five six alanine residues proposed repressor domain Fig
0.3009156.9547266.html.plaintext.txt	153	The activity N terminal mutant YKLLPG AAAAAA 427 432 increased 2
0.3009156.9547266.html.plaintext.txt	154	3 times compared wild type full length fusion Fig
0.3009156.9547266.html.plaintext.txt	155	The C terminal mutation ITTIV AAAAA 434 438 showed increase activity 3
0.3009156.9547266.html.plaintext.txt	156	5 times wild type full length fusion protein Fig
0.3009156.9547266.html.plaintext.txt	157	Both mutants significantly different wild type P 0
0.3009156.9547266.html.plaintext.txt	158	These results confirm presence repressor domain amino acids 428 441
0.3009156.9547266.html.plaintext.txt	159	Mutation amino acids repressor domain HNF4 enhances activity
0.3009156.9547266.html.plaintext.txt	160	A Schematic representation GAL 4 DBD full length HNF4 fusion F 1 455 two full length HNF4 fusions multiple mutations alanine shown repressor domain HNF4
0.3009156.9547266.html.plaintext.txt	161	B Transactivation HeLa cells relative wild type full length HNF4 fusion
0.3009156.9547266.html.plaintext.txt	162	For details see legend Fig
0.3009156.9547266.html.plaintext.txt	163	In report studied C terminal activation region HNF4 concentrating attention two short regions
0.3009156.9547266.html.plaintext.txt	164	These firstly well known AF2 core conserved nuclear receptors 4 secondly novel short repressor domain
0.3009156.9547266.html.plaintext.txt	165	These regions studied either deletion analysis site directed mutagenesis HNF4 fused GAL4 DNA binding domain
0.3009156.9547266.html.plaintext.txt	166	Cotransfection fusion constructs chloramphenicol acetyl transferase reporter plasmid containing upstream GAL4 binding sites either HeLa HepG2 cells transiently used study activities deleted mutated constructs Materials Methods
0.3009156.9547266.html.plaintext.txt	167	Previous studies C terminal activation domain HNF4 suggested AF2 core residues 360 366 important activity 12 14
0.3009156.9547266.html.plaintext.txt	168	Furthermore mutation L366 E HNF4 deletion fusion construct amino acids 128 370 suggested residue 366 important activity AF2 domain 14
0.3009156.9547266.html.plaintext.txt	169	However result preliminary studied HNF4 deletion construct lacked three essential domains N terminal AF1 domain DNA binding domain C terminal repressor domain see
0.3009156.9547266.html.plaintext.txt	170	It arguable results might typical intact HNF4
0.3009156.9547266.html.plaintext.txt	171	Another potential criticism previous study 14 conclusions importance particular amino acid residues AF2 core particular based studies single point mutant position 363 366 might representative mutants studied
0.3009156.9547266.html.plaintext.txt	172	Here set study multiple mutations position 366 AF2 core study double mutant involving positions 363 366 gain insight role AF2 core
0.3009156.9547266.html.plaintext.txt	173	The results successive C terminal deletions Fig
0.3009156.9547266.html.plaintext.txt	174	2 fine deletion mapping Fig
0.3009156.9547266.html.plaintext.txt	175	4 initially suggested L366 might important activity C terminal AF2 domain
0.3009156.9547266.html.plaintext.txt	176	Therefore four different point mutations L A D Q I constructed definitively assess role L 366 full length HNF4 Fig
0.3009156.9547266.html.plaintext.txt	177	5C D GAL4 full length HNF4 fusion constructs Fig
0.3009156.9547266.html.plaintext.txt	178	All mutations decreased transactivation activity indicating Leu 366 required full activity
0.3009156.9547266.html.plaintext.txt	179	However contrast previous report activity mutant 366 reduced sim5 wild type detected activities varying sim35 75 wild type
0.3009156.9547266.html.plaintext.txt	180	This suggested surprisingly transactivation activity absolutely dependent Leu 366 even although conserved number orphan receptors Fig
0.3009156.9547266.html.plaintext.txt	181	A D Q I clearly functional least transient transactivation assay
0.3009156.9547266.html.plaintext.txt	182	This result artefact fusion intact HNF4 GAL4 DNA binding domain since essentially similar quantitative results obtained irrespective whether full length HNF4 full length HNF4 fused GAL4 DNA binding domain studied compare Fig
0.3009156.9547266.html.plaintext.txt	183	However fact conservative amino acid substitution 366 L I showed highest activity assay sim60 70 whereas non conservative amino acid substitutions 366 L A D Q showed lower activities 35 60 still argues functional importance Leu 366 Fig
0.3009156.9547266.html.plaintext.txt	184	E363 also highly conserved HNF4 nuclear receptors known ligands although substituted D orphan receptors Fig
0.3009156.9547266.html.plaintext.txt	185	E363 selected mutation known involved formation salt bridge critical transactivation RARgamma 18
0.3009156.9547266.html.plaintext.txt	186	Mutation E363 A HNF4 Fig
0.3009156.9547266.html.plaintext.txt	187	5 indicated residue like residue 366 required full activity
0.3009156.9547266.html.plaintext.txt	188	Our result position differed previous report activity reduced 5 wild type 14 significant residual activity observed 50 70 wild type Fig
0.3009156.9547266.html.plaintext.txt	189	5C D depending whether full length HNF4 construct GAL4 full length HNF4 fusion construct used transactivation assay
0.3009156.9547266.html.plaintext.txt	190	We attribute difference fact full length HNF4 used studies whereas HNF4 deletion constructs used previous report 14
0.3009156.9547266.html.plaintext.txt	191	It significant double mutant 363 366 also retained sim50 activity assay Fig
0.3009156.9547266.html.plaintext.txt	192	The fact double mutant failed demonstrate additive effect two point mutants assayed separately consistent E363 L366 cooperating regulate activity AF2 domain
0.3009156.9547266.html.plaintext.txt	193	These experiments illustrates importance E363 L366 AF2 core yet also demonstrate core partly redundant least transactivation assay
0.3009156.9547266.html.plaintext.txt	194	It remains possible redundancy observed mutations studied results compensatory effect AF1 domain known transactivate 14 present full length HNF4 constructs
0.3009156.9547266.html.plaintext.txt	195	Our initial C terminal deletion experiments suggested presence repressor activity within residues 380 455 Fig
0.3009156.9547266.html.plaintext.txt	196	2B previously proposed lie residues 371 455 14
0.3009156.9547266.html.plaintext.txt	197	By aligning amino acid sequence PR repressor domain 19 entire HNF4 sequence short region residues 430 441 showing 40 identity previously characterised repressor domain PR localised HNF4 Fig
0.3009156.9547266.html.plaintext.txt	198	This presumptive repressor domain first shown confer repressor activity Fig
0.3009156.9547266.html.plaintext.txt	199	Thus short peptide amino acid 428 441 containing HNF4 repressor domain fused frame downstream high activity C terminal deletion fusion construct transactivation severely inhibited decreasing 300 22
0.3009156.9547266.html.plaintext.txt	200	This unlikely result decreased protein expression particular fusion construct since gel shift analysis panel deletion constructs showed reasonably similar levels protein expression Fig
0.3009156.9547266.html.plaintext.txt	201	3 This implied peptide containing amino acids 428 441 sufficient act repressor
0.3009156.9547266.html.plaintext.txt	202	Further evidence repressor domain came study two constructs multiple point mutations Fig
0.3009156.9547266.html.plaintext.txt	203	It interesting note experiment isolated repressor domain fused F 1 372 Fig
0.3009156.9547266.html.plaintext.txt	204	6B AF2 core intact hence activity closer full length fusion 100 might expected whereas activity 22 observed Fig
0.3009156.9547266.html.plaintext.txt	205	This suggests repressor domain potent inhibitory effect fused closer AF2 core normal location
0.3009156.9547266.html.plaintext.txt	206	Perhaps close proximity repressor domain AF2 core may restrict accessibility potential coactivator proteins AF2 core either binding corepressor protein simply masking critical residues AF2 core
0.3009156.9547266.html.plaintext.txt	207	In case PR repressor domain repressor domain shown mediate function unknown corepressor 19
0.3009156.9547266.html.plaintext.txt	208	Experiments attempt determine HNF4 repressor domain functioned corepressor unfortunately inconclusive data shown
0.3009156.9547266.html.plaintext.txt	209	It obviously interesting know repressor domain HNF4 functions required regulate activity HNF4 vivo
0.3009156.9547266.html.plaintext.txt	210	An attractive speculative mechanism might involve phosphorylation threonine residues sequence ITTI residues 434 437
0.3009156.9547266.html.plaintext.txt	211	A corepressor might bind repressor domain phosphorylated state dissociate dephosphorylated state
0.3009156.9547266.html.plaintext.txt	212	Thus mutations disrupt threonine residues would prevent phosphorylation thus preventing repression thereby enhancing activity HNF4
0.3009156.9547266.html.plaintext.txt	213	In summary characterisation AF2 domain C terminal region HNF4 given new insights function residues 363 366
0.3009156.9547266.html.plaintext.txt	214	By extensive mutagenesis shown L366 essential full AF2 activity
0.3009156.9547266.html.plaintext.txt	215	An E363AL366A double mutant suggested E363 L366 may act cooperatively regulate activity AF2 domain
0.3009156.9547266.html.plaintext.txt	216	We also shown activity AF2 domain regulated repressor domain located within proline rich region
0.3009156.9547266.html.plaintext.txt	217	We localised repressor domain within amino acid residues 428 441 HNF4 showed necessary sufficient repressor activity transient transfection studies HeLa cells
0.3009156.9547266.html.plaintext.txt	218	Furthermore multiple point mutations within repressor domain context full length HNF4 fusion construct abolished repressor activity
0.3009156.9547266.html.plaintext.txt	219	The repressor domain shares homology recently reported C terminal repressor domain progesterone receptor 19
0.3009156.9547266.html.plaintext.txt	220	This work supported MRC VPI Wellcome Trust NHD GGB grant number 049537Z96
0.3009156.9547266.html.plaintext.txt	221	Murphy helpful discussions provision pGAL4 1 147 Dr M
0.3009156.9547266.html.plaintext.txt	222	To correspondence addressed
0.3009156.9547266.html.plaintext.txt	223	Tel 44 1865 275559 Fax 44 1865 275556 Email george
0.3009156.9547266.html.plaintext.txt	224	uk This page run Oxford University Press Great Clarendon Street Oxford OX2 6DP part OUP Journals Comments feedback www adminatoup
0.3009156.9547266.html.plaintext.txt	225	uk u d Last modification 17 Apr 1998 Copyright Oxford University Press 1998
0.37755975.10194766.html.plaintext.txt	0	The Phosphoenolpyruvate Carboxykinase Gene Glucocorticoid Response Unit Identification Functional Domains Accessory Factors HNF3ss Hepatic Nuclear Factor 3ss HNF4 Necessity Proper Alignment Their Cognate Binding Sites Jen Chywan Wang Per Erik Stromstedt1 Takashi Sugiyama Daryl K
0.37755975.10194766.html.plaintext.txt	1	Department Molecular Physiology Biophysics Vanderbilt University Medical School Nashville Tennessee 37232 0615
0.37755975.10194766.html.plaintext.txt	2	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Complete induction hepatic phosphoenolpyruvate carboxykinase PEPCK gene transcription glucocorticoids requires complex glucocorticoid response unit GRU
0.37755975.10194766.html.plaintext.txt	3	The GRU comprised two glucocorticoid receptor GR binding sites GR1 GR2 four accessory factor binding sites AF1 AF2 AF3 cAMP response element CRE bind distinct transcription factors
0.37755975.10194766.html.plaintext.txt	4	Hepatic nuclear factor 4 HNF4 chicken ovalbumin upstream promoter transcription factor COUP TF bind AF1 element account AF1 activity
0.37755975.10194766.html.plaintext.txt	5	Members hepatic nuclear factor 3 HNF3 family bind AF2 element provide AF2 activity
0.37755975.10194766.html.plaintext.txt	6	In report show functions AF1 AF2 dependent positions promoter since cannot substitute exchanged without reduction response glucocorticoids
0.37755975.10194766.html.plaintext.txt	7	We also identified domains HNF4 HNF3ss required AF1 AF2 activities respectively
0.37755975.10194766.html.plaintext.txt	8	The carboxy terminal transactivation domain HNF4 amino acids 128 374 confers AF1 activity carboxy terminal transactivation domain HNF3ss amino acids 361 458 mediates AF2 activity
0.37755975.10194766.html.plaintext.txt	9	These domains HNF4 HNF3ss appear distinct roles response glucocorticoids unique structural requirements judged failure classes transactivation domains serve accessory factors
0.37755975.10194766.html.plaintext.txt	10	These results suggest regulation PEPCK gene glucocorticoids requires specific interactions GR accessory factors coactivators transactivation domains AF1 AF2 fundamental importance assembly multiprotein complex
0.37755975.10194766.html.plaintext.txt	11	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The hepatic phosphoenolpyruvate carboxykinase PEPCK gene encodes rate controlling enzyme hepatic gluconeogenesis multihormonal control transcriptional level 1 2
0.37755975.10194766.html.plaintext.txt	12	Transcription PEPCK gene stimulated glucocorticoids retinoic acids glucagon via cAMP insulin glucose repress PEPCK gene transcription 1 2 3 4 5
0.37755975.10194766.html.plaintext.txt	13	A complex glucocorticoid response unit GRU PEPCK gene promoter required complete glucocorticoid response
0.37755975.10194766.html.plaintext.txt	14	The GRU consists two adjacent glucocorticoid receptor GR binding sites GR1 GR2 four accessory elements AF1 AF2 AF3 cAMP response element CRE see Fig
0.37755975.10194766.html.plaintext.txt	15	GR1 GR2 alone combination unable confer glucocorticoid response placed context heterologous promoter 9
0.37755975.10194766.html.plaintext.txt	16	Although none four accessory elements mediates glucocorticoid response deletion mutation accessory element PEPCK promoter causes 50 70 reduction glucocorticoid response 6 8 10
0.37755975.10194766.html.plaintext.txt	17	Furthermore combination two mutations AF1 AF2 AF3 essentially abolishes glucocorticoid response 6
0.37755975.10194766.html.plaintext.txt	18	Thus PEPCK GR1 GR2 unlike simple glucocorticoid response elements GREs mediate glucocorticoid response inactive absence least two accessory elements
0.37755975.10194766.html.plaintext.txt	19	View larger version 10K Figure 1
0.37755975.10194766.html.plaintext.txt	20	Schematic Diagram PEPCK GRU
0.37755975.10194766.html.plaintext.txt	21	The PEPCK GRU includes two GR binding sites GR1 GR2 four accessory elements AF1 AF2 AF3 CRE associated trans acting factors lower panel
0.37755975.10194766.html.plaintext.txt	22	The position cis element relative transcription initiation site indicated figure
0.37755975.10194766.html.plaintext.txt	23	AF1 activity provided either two members nuclear receptor superfamily hepatic nuclear factor 4 HNF4 chicken ovalbumin upstream promoter transcription factor COUP TF 11
0.37755975.10194766.html.plaintext.txt	24	COUP TF also binds AF3 element serves accessory factor glucocorticoid response 6
0.37755975.10194766.html.plaintext.txt	25	Members hepatic nuclear factor 3 HNF3 CCAAT enhancer binding protein CEBP families bind AF2 element 12 13
0.37755975.10194766.html.plaintext.txt	26	The binding HNF3 CEBP element correlates AF2 activity 14
0.37755975.10194766.html.plaintext.txt	27	Hence HNF3 identified accessory factor glucocorticoid response
0.37755975.10194766.html.plaintext.txt	28	Finally CRE binding protein CREB CEBP family members bind CRE 12 15 16
0.37755975.10194766.html.plaintext.txt	29	Although physical interaction GR CREB identified vitro 8 appears CEBPss functions accessory factor glucocorticoid response CRE 16A
0.37755975.10194766.html.plaintext.txt	30	In experiments reported paper show AF1 cannot substitute AF2 vice versa exchange elements PEPCK GRU results 50 reduction glucocorticoid response
0.37755975.10194766.html.plaintext.txt	31	Thus AF1 AF2 function position dependent manner
0.37755975.10194766.html.plaintext.txt	32	We also identify domains within HNF4 AF1 factor HNF3ss AF2 factor required accessory factor activity
0.37755975.10194766.html.plaintext.txt	33	In cases previously identified transactivation domains critical accessory factor activity
0.37755975.10194766.html.plaintext.txt	34	Several distinct transactivation domains identified proteins cannot replace HNF3 HNF4 activities context PEPCK GRU
0.37755975.10194766.html.plaintext.txt	35	These results indicate glucocorticoid stimulated PEPCK gene transcription requires functional interactions GR transactivation domains least two accessory factors two components third coregulatory protein interactions require specific spatial organization components GRU
0.37755975.10194766.html.plaintext.txt	36	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES AF1 AF2 Function Position Dependent Manner Constructs made various combinations AF1 AF2 substitutions context wild type PEPCK promoter ligated chloramphenicol acetyltransferase CAT reporter gene pAF1 2 also referred pPL32 previous publications compare roles AF1 AF2 PEPCK GRU Fig
0.37755975.10194766.html.plaintext.txt	37	When AF2 element replaced AF1 element pAF1 1 conversely AF2 element put AF1 site pAF2 2 glucocorticoid responses 60 70 lower obtained wild type pAF1 2 reporter Fig
0.37755975.10194766.html.plaintext.txt	38	These responses equivalent glucocorticoid response obtained either AF1 AF2 deleted mutated 7 10
0.37755975.10194766.html.plaintext.txt	39	Thus results show AF1 element inert position AF2 element AF2 element inactive AF1 site PEPCK GRU suggest AF1 AF2 distinct functions
0.37755975.10194766.html.plaintext.txt	40	These results consistent previous observations 17
0.37755975.10194766.html.plaintext.txt	41	Next AF1 element AF2 element switched pAF2 1 Fig
0.37755975.10194766.html.plaintext.txt	42	2 determine whether relative positions within GRU critical
0.37755975.10194766.html.plaintext.txt	43	If specific spatial alignment AF1 AF2 members GRU important complete glucocorticoid response presence transcription factors required construct confer glucocorticoid response similar wild type pAF1 2 reporter
0.37755975.10194766.html.plaintext.txt	44	However pAF2 1 reporter construct conferred much weaker glucocorticoid response pAF1 2
0.37755975.10194766.html.plaintext.txt	45	Thus positional alignment AF1 AF2 PEPCK gene promoter appears critical mediating optimal accessory factor activity
0.37755975.10194766.html.plaintext.txt	46	View larger version 16K Figure 2
0.37755975.10194766.html.plaintext.txt	47	The Alignment AF1 AF2 Is Critical
0.37755975.10194766.html.plaintext.txt	48	H4IIE cells cotransfected 10 microg various reporter constructs either pAF1 2 pPL32 pAF1 1 pAF2 2 pAF2 1 5 microg expression plasmid encodes GR
0.37755975.10194766.html.plaintext.txt	49	Cells treated without 500 nM dexamethasone DEX 18 24 h CAT activity measured
0.37755975.10194766.html.plaintext.txt	50	Results presented relative wild type glucocorticoid response pPL32 represent mean plus minus SE number experiments indicated
0.37755975.10194766.html.plaintext.txt	51	The Carboxy Terminal Transactivation Domain HNF3ss Confers AF2 Activity The distinct specific roles AF1 AF2 GRU suggested results obtained previous experiment prompted us localize domains required accessory factor activities HNF4 HNF3
0.37755975.10194766.html.plaintext.txt	52	We first focused attention HNF3
0.37755975.10194766.html.plaintext.txt	53	A reporter construct made wherein AF2 element replaced yeast GAL4 binding site pGAL4AF2 Fig
0.37755975.10194766.html.plaintext.txt	54	3A context wild type promoter construct
0.37755975.10194766.html.plaintext.txt	55	The response dexamethasone cells transfected pGAL4AF2 30 wild type pPL32 Fig
0.37755975.10194766.html.plaintext.txt	56	3A similar obtained AF2 element deleted mutated 50 70 reduction 7 10
0.37755975.10194766.html.plaintext.txt	57	Cotransfection pGAL4AF2 construct expression vectors encode GAL4 DNA binding domain DBD ligated various domains HNF3ss performed identify regions within HNF3ss required AF2 activity Fig
0.37755975.10194766.html.plaintext.txt	58	HNF3ss used study represents major constituent binds AF2 element H4IIE hepatoma cells 14
0.37755975.10194766.html.plaintext.txt	59	View larger version 23K Figure 3
0.37755975.10194766.html.plaintext.txt	60	The C Terminal Transactivation Domain HNF3ss Is Sufficient AF2 Activity
0.37755975.10194766.html.plaintext.txt	61	A H4IIE cells transfected pPL32 wild type PEPCK promoter reporter construct pGAL4AF2 wherein AF2 element replaced GAL4 binding site
0.37755975.10194766.html.plaintext.txt	62	In subsequent experiments amount DNA transfected described Materials Methods
0.37755975.10194766.html.plaintext.txt	63	All cells cotransfected GR expression vector
0.37755975.10194766.html.plaintext.txt	64	Cells treated without 500 nM dexamethasone DEX 18 24 h CAT activity measured
0.37755975.10194766.html.plaintext.txt	65	Results presented fold induction represent average plus minus SE
0.37755975.10194766.html.plaintext.txt	66	number experiments indicated parenthesis
0.37755975.10194766.html.plaintext.txt	67	B Expression plasmids encoding one various GAL4 HNF3ss fusion proteins GR expression vector cotransfected pGAL4AF2 cells treated without 500 nM dexamethasone
0.37755975.10194766.html.plaintext.txt	68	The results presented described
0.37755975.10194766.html.plaintext.txt	69	The schematic structure HNF3ss protein also shown
0.37755975.10194766.html.plaintext.txt	70	The shaded areas represent domains critical transactivation activity HNF3ss 20
0.37755975.10194766.html.plaintext.txt	71	The conserved regions HNF3 ss I IV also shown
0.37755975.10194766.html.plaintext.txt	72	Cotransfection H4IIE cells pGAL4AF2 reporter construct expression plasmid encodes full length HNF3ss fused GAL4 DBD effect glucocorticoid response CAT expression equivalent detected cells transfected simple GAL4 DBD construct data shown
0.37755975.10194766.html.plaintext.txt	73	This result perhaps surprising since GAL4 HNF3ss chimeric protein contains two separate DBDs
0.37755975.10194766.html.plaintext.txt	74	A similar phenomenon low transcriptional activity observed chimeric proteins contain GAL4 DBD either full length CEBP CEBPss ATF 2 tested 18 19
0.37755975.10194766.html.plaintext.txt	75	Strong transcriptional activity observed DBDs CEBP CEBPss ATF 2 deleted 18 19
0.37755975.10194766.html.plaintext.txt	76	We therefore constructed series expression plasmids encode proteins GAL4 DBD ligated various segments HNF3ss lack DBD latter
0.37755975.10194766.html.plaintext.txt	77	GAL4 HNF3ss 1 157 like GAL4 DBD influence glucocorticoid response Fig
0.37755975.10194766.html.plaintext.txt	78	In contrast cotransfection cells pGAL4AF2 construct expression plasmid encoding GAL4 HNF3ss257 458 restored glucocorticoid response level near found cells transfected pPL32 Fig
0.37755975.10194766.html.plaintext.txt	79	Thus C terminal domain HNF3ss mediates AF2 activity
0.37755975.10194766.html.plaintext.txt	80	Two additional plasmids wherein smaller segments C terminal portion HNF3ss fused GAL4 DBD cotransfected pGAL4AF2 localize minimal domain required AF2 activity
0.37755975.10194766.html.plaintext.txt	81	While expression GAL4 HNF3ss361 458 provided robust glucocorticoid response H4IIE cells nearly equal obtained pPL32 GAL4 HNF3ss257 360 expression failed enhance glucocorticoid response Fig
0.37755975.10194766.html.plaintext.txt	82	Hence accessory activity AF2 conferred region located amino acids 361 458
0.37755975.10194766.html.plaintext.txt	83	The 361 458 domain includes primary transactivation domain HNF3ss 20
0.37755975.10194766.html.plaintext.txt	84	Two regions within domain highly conserved among HNF3 family members
0.37755975.10194766.html.plaintext.txt	85	369 387 conserved box II
0.37755975.10194766.html.plaintext.txt	86	445 458 conserved box III see Fig
0.37755975.10194766.html.plaintext.txt	87	The transactivation capacity HNF3ss severely reduced either two conserved boxes deleted mutated 20
0.37755975.10194766.html.plaintext.txt	88	We therefore made expression plasmid GAL4 HNF3ss388 458 wherein conserved box II deleted GAL4 HNF3ss361 442 wherein conserved box III deleted Fig
0.37755975.10194766.html.plaintext.txt	89	Cotransfection GAL4 HNF3ss388 458 pGAL4AF2 H4IIE cells provided partial glucocorticoid response cotransfection GAL4 HNF3ss361 442 provide accessory factor activity Fig
0.37755975.10194766.html.plaintext.txt	90	These data suggest although box III contributes activity AF2 boxes II III required full AF2 activity compare lines 2 4 Fig
0.37755975.10194766.html.plaintext.txt	91	View larger version 18K Figure 4
0.37755975.10194766.html.plaintext.txt	92	Conserved Regions II III HNF3 Are Required AF2 Activity
0.37755975.10194766.html.plaintext.txt	93	A H4IIE cells transfected pPL32 wild type PEPCK promoter reporter construct pGAL4AF2 wherein AF2 element replaced GAL4 binding site
0.37755975.10194766.html.plaintext.txt	94	All cells cotransfected GR expression vector
0.37755975.10194766.html.plaintext.txt	95	Cells treated without 500 nM dexamethasone DEX 18 24 h CAT activity measured
0.37755975.10194766.html.plaintext.txt	96	Results presented relative wild type glucocorticoid response pPL32 top panel represent average plus minus SE number experiments indicated
0.37755975.10194766.html.plaintext.txt	97	B An expression plasmid encoding one various GAL4 HNF3ss fusion proteins cotransfected GR expression vector pGAL4AF2
0.37755975.10194766.html.plaintext.txt	98	Cells treated results presented without 500 nM dexamethasone described
0.37755975.10194766.html.plaintext.txt	99	The schematic structure HNF3ss protein shown described Fig
0.37755975.10194766.html.plaintext.txt	100	The inherent capacity activation basal transcription GAL4 HNF3ss fusion protein expression vectors monitored cotransfecting CAT reporter plasmid contains five copies GAL4 binding site positioned upstream E1B TATA box GAL45E1bCAT Fig
0.37755975.10194766.html.plaintext.txt	101	HepG2 cells previously used map transactivation domain HNF3ss 20 also used study since transfection large amounts DNA required detect basal activity H4IIE cells
0.37755975.10194766.html.plaintext.txt	102	The relative activity GAL4 HNF3ss chimeric proteins presented Fig
0.37755975.10194766.html.plaintext.txt	103	For comparison qualitative indication AF2 activity constructs also presented
0.37755975.10194766.html.plaintext.txt	104	The activity GAL4 HNF3ss361 458 2 fold higher GAL4 HNF3ss388 458 15 fold higher GAL4 HNF3ss361 442 Fig
0.37755975.10194766.html.plaintext.txt	105	Thus transactivation capacity three GAL4 HNF3ss fusion proteins correlates well ability support AF2 activity
0.37755975.10194766.html.plaintext.txt	106	Interestingly expression GAL4 HNF3ss257 458 mediates AF2 activity provided little basal activity Fig
0.37755975.10194766.html.plaintext.txt	107	5 line 3 perhaps repression domain basal activity located
0.37755975.10194766.html.plaintext.txt	108	The N terminal portion HNF3ss contains region conserved among HNF3 family members box IV
0.37755975.10194766.html.plaintext.txt	109	14 93 may important transactivation activity 34 37
0.37755975.10194766.html.plaintext.txt	110	However GAL4 HNF3ss1 157 mediate AF2 activity activate GAL45E1bCAT reporter gene Fig
0.37755975.10194766.html.plaintext.txt	111	This consistent previous results also suggest conserved region cannot function independent activation domain 20
0.37755975.10194766.html.plaintext.txt	112	The expression GAL4 HNF3ss chimeric proteins confirmed independent gel mobility shift experiment using nuclear extracts prepared GAL4 HNF3ss fusion protein expressing cells
0.37755975.10194766.html.plaintext.txt	113	COS cells used experiment low transfection efficiency H4IIE hepatoma cells
0.37755975.10194766.html.plaintext.txt	114	All chimeric proteins expressed efficiently albeit somewhat different levels Fig
0.37755975.10194766.html.plaintext.txt	115	In fact GAL4 HNF3ss361 458 provides strongest AF2 activity expressed low level relative GAL4 HNF3ss chimeric proteins Fig
0.37755975.10194766.html.plaintext.txt	116	View larger version 16K Figure 5
0.37755975.10194766.html.plaintext.txt	117	Comparison Basal Transactivation AF2 Activities Various GAL4 HNF3ss Fusion Proteins
0.37755975.10194766.html.plaintext.txt	118	5 microg encode GAL4 HNF3ss fusion constructs cotransfected HepG2 cells reporter construct 2
0.37755975.10194766.html.plaintext.txt	119	5 microg contains five tandem copies GAL4 binding site inserted E1b promoter GAL45E1bCAT
0.37755975.10194766.html.plaintext.txt	120	Results presented relative activity GAL4 DBD protein average plus minus SE least five experiments
0.37755975.10194766.html.plaintext.txt	121	The AF2 activity GAL4 HNF3ss fusion protein also shown
0.37755975.10194766.html.plaintext.txt	122	The schematic structure HNF3ss protein shown described Fig
0.37755975.10194766.html.plaintext.txt	123	View larger version 56K Figure 6
0.37755975.10194766.html.plaintext.txt	124	Expression DNA Binding Various GAL4 HNF3ss Fusion Proteins
0.37755975.10194766.html.plaintext.txt	125	COS cells transfected expression plasmids 40 microg encode various GAL4 HNF4 fusion constructs 1 GAL4DBD 2 GAL4 HNF3ss1 157 3 GAL4 HNF3ss257 458 4 GAL4 HNF3ss257 360 5 GAL4 HNF3ss361 458 6 GAL4 HNF3ss361 442 7 GAL4 HNF3ss388 458
0.37755975.10194766.html.plaintext.txt	126	Whole cell extracts prepared gel mobility shift assay used analyze expression levels described Materials Methods
0.37755975.10194766.html.plaintext.txt	127	The arrow indicates various GAL4 HNF3ss fusion proteins
0.37755975.10194766.html.plaintext.txt	128	Each protein supershifted prior incubation antibody directed GAL4 DBD
0.37755975.10194766.html.plaintext.txt	129	The Transactivation Domain HNF4 Provides AF1 Activity The approach described also used localize functional domains HNF4 required AF1 activity
0.37755975.10194766.html.plaintext.txt	130	The glucocorticoid response H4IIE cells transfected pPL32 derived reporter construct AF1 element replaced GAL4 binding site pGAL4AF1 60 70 wild type Fig
0.37755975.10194766.html.plaintext.txt	131	7A effect similar seen AF1 deleted mutated 7 10
0.37755975.10194766.html.plaintext.txt	132	The glucocorticoid response change cells cotransfected pGAL4AF1 plasmid encodes GAL4 DBD Fig
0.37755975.10194766.html.plaintext.txt	133	However glucocorticoid response strongly enhanced plasmid encodes chimeric protein consisting full length HNF4 GAL4 DBD GAL4 HNF41 455 cotransfected cells pGAL4AF1 Fig
0.37755975.10194766.html.plaintext.txt	134	Cotransfection GAL4DBD HNF4 chimeric protein lacks C terminal 81 amino acids GAL4 HNF41 374 pGAL4AF1 reporter construct cells provided slightly greater glucocorticoid response GAL4 HNF41 455 Fig
0.37755975.10194766.html.plaintext.txt	135	segment HNF4 dispensable AF1 activity
0.37755975.10194766.html.plaintext.txt	136	Since entire C terminal transactivation domain HNF3ss required AF2 activity interest determine whether two transactivation domains HNF4 critical AF1 activity
0.37755975.10194766.html.plaintext.txt	137	One domains located within first 24 amino acids N terminal region protein second resides amino acids 128 370 21
0.37755975.10194766.html.plaintext.txt	138	Therefore GAL4 HNF41 45 contains N terminal transactivation domain GAL4 HNF4128 374 contains C terminal transactivation domain independently cotransfected pGAL4AF1 H4IIE cells determine whether either transactivation domain harbors AF1 activity
0.37755975.10194766.html.plaintext.txt	139	Expression GAL4 HNF41 45 cells provided significant AF1 activity Fig
0.37755975.10194766.html.plaintext.txt	140	In contrast glucocorticoid response cells transfected GAL4 HNF4128 374 similar observed cells express GAL4 HNF41 455 Fig
0.37755975.10194766.html.plaintext.txt	141	Thus C terminal transactivation domain HNF4 provides AF1 activity
0.37755975.10194766.html.plaintext.txt	142	361 366 highly conserved motif among members nuclear receptor superfamily essential activity mediated C terminal transactivation domain 21
0.37755975.10194766.html.plaintext.txt	143	Cotransfection GAL4 HNF41 360 expression plasmid lacks region pGAL4AF1 reporter construct enhance glucocorticoid response Fig
0.37755975.10194766.html.plaintext.txt	144	A single point mutation L366E causes severe reduction transactivation activity HNF4 21
0.37755975.10194766.html.plaintext.txt	145	The mutation fusion construct GAL4 HNF41 374L366E also abolishes AF1 activity Fig
0.37755975.10194766.html.plaintext.txt	146	In conclusion data indicate C terminal transactivation domain HNF4 indeed critical ability serve accessory factor 1 glucocorticoid response
0.37755975.10194766.html.plaintext.txt	147	View larger version 24K Figure 7
0.37755975.10194766.html.plaintext.txt	148	The C Terminal Transactivation Domain HNF4 Is Sufficient AF1 Activity
0.37755975.10194766.html.plaintext.txt	149	A H4IIE cells transfected pPL32 wild type PEPCK promoter reporter construct pGAL4AF1 wherein AF1 element replaced GAL4 binding site
0.37755975.10194766.html.plaintext.txt	150	All cells cotransfected GR expression vector treated without 500 nM dexamethasone DEX 18 24 h
0.37755975.10194766.html.plaintext.txt	151	CAT activity measured described
0.37755975.10194766.html.plaintext.txt	152	Results presented relative wild type glucocorticoid response pPL32 top panel represent average plus minus SE number experiments indicated
0.37755975.10194766.html.plaintext.txt	153	B An expression plasmid encoding one various GAL4 HNF4 fusion proteins GR expression vector cotransfected pGAL4AF1
0.37755975.10194766.html.plaintext.txt	154	A schematic representation structure HNF4 protein shown
0.37755975.10194766.html.plaintext.txt	155	The shaded areas represent transactivation domain HNF4 21
0.37755975.10194766.html.plaintext.txt	156	The asterisk indicates mutation site L366E one GAL4 HNF4fusion proteins
0.37755975.10194766.html.plaintext.txt	157	A comparison basal transactivation AF1 activity performed cotransfecting various GAL4 HNF4 fusion protein plasmids GAL45E1bCAT reporter construct H4IIE cells
0.37755975.10194766.html.plaintext.txt	158	In general transactivation capacities GAL4 HNF41 374 1 360 1 374L366E correlate ability provide AF1 activity Fig
0.37755975.10194766.html.plaintext.txt	159	Interestingly GAL4 HNF41 45 strongest activator GAL45E1bCAT reporter gene demonstrated low AF1 activity Fig
0.37755975.10194766.html.plaintext.txt	160	In contrast GAL4 HNF4128 374 mediates AF1 activity transactivation activity 8 fold lower GAL4 HNF41 45 Fig
0.37755975.10194766.html.plaintext.txt	161	These results suggest specific domain rather general transactivation capacity determinant AF1 activity
0.37755975.10194766.html.plaintext.txt	162	Although GAL4 HNF41 455 1 360 1 374L366E provided similar basal transcriptional activity GAL4 HNF41 455 mediates AF1 activity one three constructs contains C terminal transactivation domain
0.37755975.10194766.html.plaintext.txt	163	The basal transcriptional activity GAL4 HNF41 455 4 fold lower GAL4 HNF41 374 Fig
0.37755975.10194766.html.plaintext.txt	164	This result consistent presence repression domain basal transcriptional activity located
0.37755975.10194766.html.plaintext.txt	165	However repression domain slight effect AF1 activity Figs
0.37755975.10194766.html.plaintext.txt	166	The expression GAL4 HNF4 chimeric proteins confirmed independent assessment gel mobility shift experiments performed using nuclear extracts COS cells expressed distinct GAL4 HNF4 fusion proteins Fig
0.37755975.10194766.html.plaintext.txt	167	GAL4 HNF41 374 provides strongest AF1 activity expressed level similar GAL4 HNF41 374L366E GAL4 HNF41 360 expressesed level lower GAL4 HNF41 455 GAL4 HNF1 45 GAL4 HNF4128 374 Fig
0.37755975.10194766.html.plaintext.txt	168	These results indicate inability GAL4 HNF1 45 GAL4 HNF41 374L366E GAL4 HNF41 360 confer AF1 activity due inadequate expression cells
0.37755975.10194766.html.plaintext.txt	169	View larger version 16K Figure 8
0.37755975.10194766.html.plaintext.txt	170	Comparison Basal Transactivation AF1 Activities Various GAL4 HNF4 Fusion Proteins
0.37755975.10194766.html.plaintext.txt	171	Expression plasmids 2 microg encode various GAL4 HNF4 fusion constructs cotransfected H4IIE cells reporter construct 5 microg contains five tandem copies GAL4 binding site inserted E1b promoter GAL45E1bCAT
0.37755975.10194766.html.plaintext.txt	172	Results presented relative activity GAL4 DBD protein represent average plus minus SE least five experiments
0.37755975.10194766.html.plaintext.txt	173	The AF1 activity GAL4 HNF4fusion protein also shown
0.37755975.10194766.html.plaintext.txt	174	The asterisk indicates mutation site L366E GAL4 HNF4fusion protein
0.37755975.10194766.html.plaintext.txt	175	View larger version 44K Figure 9
0.37755975.10194766.html.plaintext.txt	176	Expression DNA Binding Various GAL4 HNF4 Fusion Proteins
0.37755975.10194766.html.plaintext.txt	177	COS cells transfected expression plasmids 40 microg encode various GAL4 HNF4 fusion constructs 1 GAL4 DBD 2 GAL4 HNF41 455 3 GAL4 HNF41 45 4 GAL4 HNF4128 374 5 GAL4 HNF41 374 6 GAL4 HNF41 374L366E 7 GAL4 HNF41 360
0.37755975.10194766.html.plaintext.txt	178	Whole cell extracts prepared gel mobility shift assay used analyze expression levels described Materials Methods
0.37755975.10194766.html.plaintext.txt	179	The result using GAL4 DBD also shown Fig
0.37755975.10194766.html.plaintext.txt	180	The arrow indicates various GAL4 HNF4 fusion proteins
0.37755975.10194766.html.plaintext.txt	181	Each protein supershifted prior incubation antibody directed GAL4 DBD
0.37755975.10194766.html.plaintext.txt	182	The Activity Other Transactivation Domains AF1 AF2 Respectively Plasmids encode fusion proteins GAL4 DBD various transactivation domains cotransfected either pGAL4AF1 pGAL4AF2 reporter genes Figs
0.37755975.10194766.html.plaintext.txt	183	10 11 determine whether classes transactivation domains substitute accessory factor activities HNF3 HNF4
0.37755975.10194766.html.plaintext.txt	184	Cotransfection H4IIE cells pGAL4AF1 construct expression plasmid encodes GAL4 E1A consists GAL4 DBD CR3 region adenovirus E1A protein provided 2 3 fold induction basal promoter activity data shown glucocorticoid response similar obtained GAL4 HNF41 374 Fig
0.37755975.10194766.html.plaintext.txt	185	GAL4 E1A also provided 3 5 fold increase basal promoter activity conferred AF2 activity cotransfected pGAL4AF2 cells data shown Fig
0.37755975.10194766.html.plaintext.txt	186	GAL4 VP16 contains GAL4 DBD C terminal acidic transactivation domain herpes simplex virus VP16 protein also resulted 2 3 fold increase basal promoter activity pGAL4AF1 3 5 fold increase pGAL4AF2 data shown
0.37755975.10194766.html.plaintext.txt	187	However GAL4 VP16 conferred partial AF1 activity failed provide AF2 activity Fig
0.37755975.10194766.html.plaintext.txt	188	GAL4 SP1 consists glutamine rich activation domain SP1 fused GAL4 DBD GAL4 CTF consists proline rich activation domain NF1CTF fused GAL4 DBD increase basal promoter activity data shown provide accessory factor activity either element Fig
0.37755975.10194766.html.plaintext.txt	189	Hence among four distinct classes transactivation domains E1A CR3 region provided strong AF1 activity none afforded complete AF2 activity
0.37755975.10194766.html.plaintext.txt	190	These results suggest high degree specificity associated transactivation domains HNF4 HNF3ss roles accessory factors PEPCK GRU
0.37755975.10194766.html.plaintext.txt	191	View larger version 18K Figure 10
0.37755975.10194766.html.plaintext.txt	192	Domain Specificity AF1 Activity
0.37755975.10194766.html.plaintext.txt	193	A H4IIE cells transfected pPL32 wild type PEPCK promoter reporter construct pGAL4AF1 wherein AF1 element replaced GAL4 binding site
0.37755975.10194766.html.plaintext.txt	194	All cells cotransfected GR expression vector
0.37755975.10194766.html.plaintext.txt	195	Cells treated without 500 nM dexamethasone DEX 18 24 h CAT activity measured
0.37755975.10194766.html.plaintext.txt	196	Results presented relative wild type glucocorticoid response pPL32 represent average plus minus SE number experiments indicated
0.37755975.10194766.html.plaintext.txt	197	B An expression plasmid encoding one various GAL4 DBD transactivation domain fusion proteins GR expression vector cotransfected pGAL4AF1
0.37755975.10194766.html.plaintext.txt	198	Other details described panel A
0.37755975.10194766.html.plaintext.txt	199	View larger version 18K Figure 11
0.37755975.10194766.html.plaintext.txt	200	Domain Specificity AF2 Activity
0.37755975.10194766.html.plaintext.txt	201	A H4IIE cells transfected pPL32 wild type PEPCK promoter reporter construct pGAL4AF2 wherein AF2 element replaced GAL4 binding site
0.37755975.10194766.html.plaintext.txt	202	All cells cotransfected GR expression vector
0.37755975.10194766.html.plaintext.txt	203	Cells treated without 500 nM dexamethasone DEX 18 24 h CAT activity measured
0.37755975.10194766.html.plaintext.txt	204	Results presented relative wild type glucocorticoid response pPL32 represent average plus minus SE number experiments indicated
0.37755975.10194766.html.plaintext.txt	205	B An expression plasmid encoding one various GAL4 DBD transactivation domain fusion proteins GR expression vector cotransfected pGAL4AF2
0.37755975.10194766.html.plaintext.txt	206	Other details described panel A
0.37755975.10194766.html.plaintext.txt	207	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Much learned analysis simple hormone response elements HREs placed single multimerized copies context heterologous promoter reporter gene constructs
0.37755975.10194766.html.plaintext.txt	208	It clear however whether receptor binding elements sufficient function native promoters
0.37755975.10194766.html.plaintext.txt	209	Multicomponent assemblies including HRE cis elements associated DNA binding proteins called accessory factors arrangement referred hormone response unit HRU appears much common 22
0.37755975.10194766.html.plaintext.txt	210	Additional complexity provided number coregulators bind hormone receptor andor accessory factors modulate rate transcription given gene
0.37755975.10194766.html.plaintext.txt	211	A specific HRU thus consists number protein DNA protein protein interactions involving hormone receptor accessory factors 30 identified coregulators
0.37755975.10194766.html.plaintext.txt	212	The PEPCK gene GRU example HRU described
0.37755975.10194766.html.plaintext.txt	213	A complete response PEPCK gene glucocorticoids requires presence four accessory factor elements associated proteins AF1 AF2 AF3 CRE two GREs GR1 GR2 associated ligand receptor complexes see Fig
0.37755975.10194766.html.plaintext.txt	214	The loss function one accessory element factor complexes results 50 reduction glucocorticoid response 6 8 10
0.37755975.10194766.html.plaintext.txt	215	Loss function combination two results complete loss glucocorticoid response
0.37755975.10194766.html.plaintext.txt	216	Similarly partial response obtained either GREs deleted GR1 quantitatively important GR2 9
0.37755975.10194766.html.plaintext.txt	217	It evident considerable redundancy built system
0.37755975.10194766.html.plaintext.txt	218	Having defined components GRU begin address several key questions
0.37755975.10194766.html.plaintext.txt	219	For example unique structural requirements respect orientation positioning spacing accessory factors respect GREs What domains responsible accessory factor action proteins Are coregulatory proteins involved And finally come together control rate transcription PEPCK gene The work paper addresses first two questions
0.37755975.10194766.html.plaintext.txt	220	In studies described apparent AF1 cannot substitute AF2 vice versa
0.37755975.10194766.html.plaintext.txt	221	Also two elements work well inverted respect rest GRU Fig
0.37755975.10194766.html.plaintext.txt	222	Therefore appears specific spatial organization AF1 AF2 within PEPCK gene GRU critical complete glucocorticoid response
0.37755975.10194766.html.plaintext.txt	223	These results also suggest AF1 AF2 distinct functions
0.37755975.10194766.html.plaintext.txt	224	If specific domains either activate transcription directly coregulatory intermediate present accessory factors bind elements namely HNF4 HNF3
0.37755975.10194766.html.plaintext.txt	225	AF1 activity conferred carboxy terminal transactivation domain HNF4
0.37755975.10194766.html.plaintext.txt	226	It known whether domain functions directly indirectly
0.37755975.10194766.html.plaintext.txt	227	The fact accessory function assumed activation domains E1A VP16 obvious similarity HNF4 domain Fig
0.37755975.10194766.html.plaintext.txt	228	9A suggests protein protein interaction involved
0.37755975.10194766.html.plaintext.txt	229	HNF4 binds TFIIB facilitates formation preinitiation complex 23 however HNF4 mutant lacks C terminal activation domain still binds TFIIB 23 effect may mediated N terminal transactivation domain region necessary accessory factor action studies Fig
0.37755975.10194766.html.plaintext.txt	230	Several coactivators steroid receptor coactivator 1 SRC 1 24 CBPp300 25 26 27 glucocorticoid receptor interacting protein 1 GRIP1TIF2 28 29 30 RAC3ACTR 31 32 33 associate C terminal activation domain various members nuclear receptor superfamily
0.37755975.10194766.html.plaintext.txt	231	These proteins including HNF4 similar C terminal transactivation domains 21
0.37755975.10194766.html.plaintext.txt	232	Indeed others recently shown SRC 1 GRIP1 CBPp300 function coactivators HNF4 34 35
0.37755975.10194766.html.plaintext.txt	233	The CR3 region E1A exhibits AF1 activity domain C terminal region HNF4 may interact common coactivator
0.37755975.10194766.html.plaintext.txt	234	The CR3 domain associates wide variety transcription factors components basal transcription machinery including TATA box binding protein TBP certain TBP associated factors TAF human TAF 135 36 Drosophila TAF 110 TAF 250 37 several DNA binding proteins including ATF2 USF SP1 38
0.37755975.10194766.html.plaintext.txt	235	However interaction CR3 region E1A SRC 1 GRIP1 CBPp300 reported
0.37755975.10194766.html.plaintext.txt	236	Therefore also possible distinct coactivators provide AF1 activity context PEPCK GRU thus HNF4 E1A may interact different coactivators
0.37755975.10194766.html.plaintext.txt	237	COUP TF also serves accessory factor 1 PEPCK glucocorticoid response AF1 AF3 elements 6 11
0.37755975.10194766.html.plaintext.txt	238	COUP TF functions positive negative regulator gene transcription 39 known whether COUP TF uses mechanism HNF4 provide AF1 activity
0.37755975.10194766.html.plaintext.txt	239	We currently identifying domains provide AF1 activity COUP TF analysis clarify issue whether unique common coactivators involved
0.37755975.10194766.html.plaintext.txt	240	AF2 activity provided C terminal transactivation domain HNF3ss contains two regions conserved various members HNF3 family transcription factors 20
0.37755975.10194766.html.plaintext.txt	241	445 458 contributes AF2 activity although region II
0.37755975.10194766.html.plaintext.txt	242	369 387 required complete AF2 activity Fig
0.37755975.10194766.html.plaintext.txt	243	These regions amino acid sequence motifs common known transactivation domains 20
0.37755975.10194766.html.plaintext.txt	244	However region III potent transactivator fused GAL 4 DBD Fig
0.37755975.10194766.html.plaintext.txt	245	No coactivator identified date specifically interacts C terminal transactivation domain HNF3ss
0.37755975.10194766.html.plaintext.txt	246	The CR3 domain E1A provides substantial AF2 activity Fig
0.37755975.10194766.html.plaintext.txt	247	11 VP16 contrast case AF1 inactive
0.37755975.10194766.html.plaintext.txt	248	Future experiments clarify whether distinction important
0.37755975.10194766.html.plaintext.txt	249	Furthermore recently found HNF3ss GR interact vitro 17
0.37755975.10194766.html.plaintext.txt	250	However C terminal transactivation domain HNF3ss interact GR glutathione S transferase pull experiments J
0.37755975.10194766.html.plaintext.txt	251	Granner unpublished observation
0.37755975.10194766.html.plaintext.txt	252	More studies required determine whether previously noted interaction HNF3ss GR physiologically important
0.37755975.10194766.html.plaintext.txt	253	The identification domains HNF4 HNF3ss necessary accessory factor activity brings us step closer understanding GRU works
0.37755975.10194766.html.plaintext.txt	254	In previous paper suggested AF1 might stabilize binding GR GR1 AF2 could required achieving maximal transactivation potential GRU 9
0.37755975.10194766.html.plaintext.txt	255	This hypothesis based observation AF1 element longer required PEPCK gene glucocorticoid response GR1 low affinity GR binding site replaced strong GR binding site 9
0.37755975.10194766.html.plaintext.txt	256	In contrast AF2 element still required complete glucocorticoid response situation
0.37755975.10194766.html.plaintext.txt	257	The observation AF1 AF2 cannot substitute one another elements must oriented certain way respect GR binding sites coupled identification transactivation domains HNF4 HNF3ss allow us test hypothesis assembly stereospecific nucleoprotein complex results stabilization GR binding promoter allows efficient activation basal transcription machinery
0.37755975.10194766.html.plaintext.txt	258	GR may act signal transducer triggers assembly nucleoprotein complex rather transactivator since neither GR1 GR2 mediate glucocorticoid response
0.37755975.10194766.html.plaintext.txt	259	Alternatively transactivation domain GR may contribute overall transcriptional capacity PEPCK GRU presence interaction andor transactivation domains accessory factors
0.37755975.10194766.html.plaintext.txt	260	The PEPCK gene GRU conceptually similar interferon ss IFNss enhanceosome
0.37755975.10194766.html.plaintext.txt	261	Viral induction IFNss gene requires functional interaction several regulatory elements designated PRD I II III IV
0.37755975.10194766.html.plaintext.txt	262	PRD II III IV bind transcription factors NFB IRF1 ATFc Jun heterodimer respectively
0.37755975.10194766.html.plaintext.txt	263	Substitution PRD IV PRD II markedly reduces viral induction 40 substitution AF1 AF2 elements reduces glucocorticoid response PEPCK gene
0.37755975.10194766.html.plaintext.txt	264	Interestingly transactivation domains either NFB IRF1 replaced transactivation domain VP16 viral induction IFNss enhanceosome markedly decreased even though constructs provide much stronger basal transcription activity 41
0.37755975.10194766.html.plaintext.txt	265	Furthermore replacement transactivation domain p65 IRF1 reduces viral induction IFNss enhanceosome activity 41 result also similar described paper
0.37755975.10194766.html.plaintext.txt	266	The assembly high order nucleoprotein complex required highly specific activation IFNss enhanceosome CBPp300 serves integrator complex 41 42 43
0.37755975.10194766.html.plaintext.txt	267	It conceivable activation PEPCK gene transcription glucocorticoids may use similar mechanism
0.37755975.10194766.html.plaintext.txt	268	The next challenge identification coactivators interact functional domains HNF3ss HNF4 mediate AF1 AF2 activities
0.37755975.10194766.html.plaintext.txt	269	The multicomponent GRU may evolved provide tissue specific expression versatile hormonal regulation hepatic PEPCK gene transcription response wide variety environmental cues
0.37755975.10194766.html.plaintext.txt	270	For example PEPCK gene transcription positively regulated glucocorticoids liver negatively regulated adipose tissue 1 44
0.37755975.10194766.html.plaintext.txt	271	The liver enriched transcription factors HNF3 HNF4 serve AF2 AF1 respectively factors present adipose tissue
0.37755975.10194766.html.plaintext.txt	272	Thus tissue specific accessory factors may allow differential regulation PEPCK gene transcription effector different tissues
0.37755975.10194766.html.plaintext.txt	273	A simple GRE represents either none switch whereas GRU allows graded response multiple GR binding sites accessory factors provide inherent intraunit redundancy
0.37755975.10194766.html.plaintext.txt	274	Interestingly PEPCK GRU part much complex assembly elements factors termed metabolic control domain MCD 45
0.37755975.10194766.html.plaintext.txt	275	The MCD consists response units several hormones metabolites provides integrated response demands organism tightly regulated gluconeogenesis
0.37755975.10194766.html.plaintext.txt	276	In addition role glucocorticoid response AF1 AF3 elements also function retinoic acid response elements RARE 1 2 binding heterodimeric complex consists retinoic acid receptor 9 cis retinoic acid receptor RARRXR 5 46 47
0.37755975.10194766.html.plaintext.txt	277	RARE1 RARE2 collectively constitute RARU mediate retinoic acid response necessary gluconeogenesis 48
0.37755975.10194766.html.plaintext.txt	278	The CRE accessory element glucocorticoid response part cAMP response unit mediates stimulatory effect glucagon 15 49 50 primary hormonal stimulator gluconeogenesis
0.37755975.10194766.html.plaintext.txt	279	Finally AF2 element part multicomponent IRU also mediates repressive effect insulin binding yet unidentified protein 51 thus participates regulation gluconeogenesis
0.37755975.10194766.html.plaintext.txt	280	Thus different sets proteins bind PEPCK MCD GRU integral part determine direction magnitude PEPCK gene transcription provide additivity synergism intra inter unit redundancy dominance one effect another
0.37755975.10194766.html.plaintext.txt	281	This complex system presumably evolved provide array responses necessary maintain rate gluconeogenesis compatible adaptive needs organism
0.37755975.10194766.html.plaintext.txt	282	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Plasmid Constructions Oligonucleotides used plasmid constructions listed Table 1 synthesized Expedite 8909 oligonucleotide synthesizer Perceptive Biosystems Framingham MA
0.37755975.10194766.html.plaintext.txt	283	The plasmids pGAL4AF1 pGAL4AF2 pAF1 1 pAF2 2 derived pPL32 PCR based mutagenesis using corresponding oligonucleotides 3 chloramphenicol acetyltransferase CAT primer
0.37755975.10194766.html.plaintext.txt	284	pPL32 fusion gene construct contains PEPCK gene promoter sequence nucleotides 467 69 relative transcription start site ligated CAT reporter gene 52
0.37755975.10194766.html.plaintext.txt	285	pPL32 cleaved HindIII BglII wild type PEPCK sequence replaced various PCR derived sequences
0.37755975.10194766.html.plaintext.txt	286	The entire sequence subcloned DNA fragment confirmed sequencing
0.37755975.10194766.html.plaintext.txt	287	The plasmid pAF2 1 generated method using pAF1 1 reporter plasmid template oligonucleotide AF2 2 primer
0.37755975.10194766.html.plaintext.txt	288	The reporter plasmid GAL45E1bCAT previously described 53
0.37755975.10194766.html.plaintext.txt	289	Oligonucleotides Used This Study
0.37755975.10194766.html.plaintext.txt	290	The expression plasmids GAL4 HNF4 chimeras generated two steps
0.37755975.10194766.html.plaintext.txt	291	First nucleotide sequences rat HNF4 corresponding
0.37755975.10194766.html.plaintext.txt	292	1 45 1 455 1 374 1 360 128 374 generated PCR using primers H4N1 H4C45 H4N1 H4C455 H4N1 H4C374 H4N1 H4C360 H4N128 H4C374 respectively
0.37755975.10194766.html.plaintext.txt	293	A single point mutation amino acid 366 L366E nucleotide sequence corresponding
0.37755975.10194766.html.plaintext.txt	294	1 374 generated PCR using primers H4N1 H4C374M366
0.37755975.10194766.html.plaintext.txt	295	These PCR fragments digested BamHI KpnI BamHI XbaI 1 45 fragment subcloned simian virus 40 SV40 enhancer driven GAL4 expression plasmid pSG424 54
0.37755975.10194766.html.plaintext.txt	296	The expression plasmids GAL4 HNF3ss generated method
0.37755975.10194766.html.plaintext.txt	297	The nucleotide sequences rat HNF3ss correspond
0.37755975.10194766.html.plaintext.txt	298	1 157 257 458 257 360 361 458 361 442 388 458 generated PCR using primers H3N1 H3C157 H3N257 H3C458X H3N257 H3C360 H3N361 H3C458 H3N361 H3C442 H3N388 H3C458K respectively
0.37755975.10194766.html.plaintext.txt	299	These PCR fragments digested BamHI KpnI BamHI XbaI 1 157 257 458 fragments subcloned pSG424
0.37755975.10194766.html.plaintext.txt	300	The sequence subcloned DNA fragments verified DNA sequencing
0.37755975.10194766.html.plaintext.txt	301	The expression plasmids GAL4 VP16 GAL4 E1A GAL4 SP1 GAL4 CTFNF1 described previously 53 55 56
0.37755975.10194766.html.plaintext.txt	302	pSV2GR expresses rat GR control SV40 promoter provided K
0.37755975.10194766.html.plaintext.txt	303	Yamamoto University California San Francisco
0.37755975.10194766.html.plaintext.txt	304	RSV Rous sarcoma virus ss galactosidase provided M
0.37755975.10194766.html.plaintext.txt	305	Magnuson Vanderbilt University Nashville TN
0.37755975.10194766.html.plaintext.txt	306	Cell Culture Transient Transfection CAT Assays The methods transfection maintenance H4IIE HepG2 hepatoma cells described previously 7 13
0.37755975.10194766.html.plaintext.txt	307	In experiments performed H4IIE cells dexamethasone response varied 7 20 fold dexamethasonewithout dexamethasone
0.37755975.10194766.html.plaintext.txt	308	The variation passage batch dependent
0.37755975.10194766.html.plaintext.txt	309	For reason expressed data percentage wild type dexamethasone response gave much consistent results
0.37755975.10194766.html.plaintext.txt	310	For experiments map accessory domains HNF3ss HNF4 10 microg reporter construct pGAL4AF2 pGAL4AF1 cotransfected 5 microg GR expression vector 1 2
0.37755975.10194766.html.plaintext.txt	311	5 5 10 microg expression plasmid encoding various GAL4 HNF3ss GAL4 HNF4 fusion proteins
0.37755975.10194766.html.plaintext.txt	312	The optimal hormonal responses titration experiment pooled
0.37755975.10194766.html.plaintext.txt	313	The optimal concentration expression plasmids encoding GAL4 HNF4 fusion proteins consistently 1 microg
0.37755975.10194766.html.plaintext.txt	314	However concentration required optimal glucocorticoid response using GAL4 HNF3ss expression plasmids encoding various GAL4DBD transactivation domain fusion proteins ranged 5 10 microg
0.37755975.10194766.html.plaintext.txt	315	In experiments using HepG2 cells CAT activity normalized ss galactosidase activity
0.37755975.10194766.html.plaintext.txt	316	ss Galactosidase activity measured adding 25 microl cell extract 175 microl assay buffer 60 mM Na2HPO4 40 mM NaH2PO4 10 mM KCl 1 mM MgSO4 50 mM ss mercaptoethanol 80 microl o nitrophenol ss D galactopyranoside ONPG solution 4 mgml ONPG 72 mM Na2HPO4 200 mM NaH2PO4
0.37755975.10194766.html.plaintext.txt	317	ss Galactosidase activity monitored absorbance 420 nm
0.37755975.10194766.html.plaintext.txt	318	COS 1 cells grown DMEM containing 10 FCS GIBCOBRL Gaithersburg MD
0.37755975.10194766.html.plaintext.txt	319	The calcium phosphate method used transfect COS cells
0.37755975.10194766.html.plaintext.txt	320	Briefly calcium chloride plasmid DNA precipitate added 1 1
0.37755975.10194766.html.plaintext.txt	321	After incubation 37 C 18 20 h cells washed PBS placed fresh culture medium incubated additional 24 h
0.37755975.10194766.html.plaintext.txt	322	Whole cell extracts COS cells prepared described previously 57
0.37755975.10194766.html.plaintext.txt	323	Briefly cells washed PBS collected centrifugation resuspended 50 60 microl lysis buffer 20 mM HEPES pH 7
0.37755975.10194766.html.plaintext.txt	324	4 M NaCl glycerol 25 1 mM EDTA 2
0.37755975.10194766.html.plaintext.txt	325	5 mM dithiothreitol 1 mM phenylmethylsulfonylfluoride
0.37755975.10194766.html.plaintext.txt	326	Cells kept ice 15 20 min frozen 70 C thawed ice
0.37755975.10194766.html.plaintext.txt	327	The cell suspension centifuged 10 min microfuge 4 C
0.37755975.10194766.html.plaintext.txt	328	The supernatant used gel mobility shift experiments
0.37755975.10194766.html.plaintext.txt	329	Gel Mobility Shift Assays The gel mobility shift assays performed described previously 58 certain modifications
0.37755975.10194766.html.plaintext.txt	330	Briefly whole cell extracts 5 microg incubated presence absence GAL4 DBD antibody Santa Cruz Biotechnology Santa Cruz CA 10 microl reaction 10 15 min mixed 10 microl reaction buffer containing 30000 cpm 32P labeled DNA probe 5 CACACGGAGGACTGTCCTCCGACCA 3 20 mM HEPES pH 7
0.37755975.10194766.html.plaintext.txt	331	7 100 mM NaCl 5 mM MgCl2 10 microM ZnCl2 6 glycerol 0
0.37755975.10194766.html.plaintext.txt	332	6 microg polydI dC Pharmacia Piscataway NJ 2 microg salmon sperm DNA another 10 15 min room temperature
0.37755975.10194766.html.plaintext.txt	333	The reaction mixtures loaded onto 4
0.37755975.10194766.html.plaintext.txt	334	5x Tris borateEDTA electrophoresis buffer TBE
0.37755975.10194766.html.plaintext.txt	335	After electrophoresis 20 mA 150 min room temperature gels dried exposed x ray film Eastman Kodak Rochester NY
0.37755975.10194766.html.plaintext.txt	336	ACKNOWLEDGMENTS We thank Drs
0.37755975.10194766.html.plaintext.txt	337	Frances Sladek Rob Costa providing HNF4 HNF3ss cDNA respectively
0.37755975.10194766.html.plaintext.txt	338	James Manley providing GAL4 CTF expression plasmid Dr
0.37755975.10194766.html.plaintext.txt	339	Yoel Sadovsky providing GAL4 SP1 expression plasmid
0.37755975.10194766.html.plaintext.txt	340	Roland Stein Mina Peshavaria Rob Hall providing reagents helpful discussions Drs
0.37755975.10194766.html.plaintext.txt	341	Calum Sutherland Don Scott critical reading manuscript Cathy Caldwell excellent technical assistance Deborah C
0.37755975.10194766.html.plaintext.txt	342	Brown helping prepare manuscript
0.37755975.10194766.html.plaintext.txt	343	FOOTNOTES Address requests reprints Dr
0.37755975.10194766.html.plaintext.txt	344	Granner Molecular Physiology Biophysics Vanderbilt School Medicine 707 Light Hall Nashville Tennessee 37232 0615
0.37755975.10194766.html.plaintext.txt	345	This work supported NIH Grant DK 35107 Vanderbilt Diabetes Research Training Center Grant DK 20593
0.37755975.10194766.html.plaintext.txt	346	1 Present address Astra Draco AB Cell Molecular Biology 221 00 Lund Sweden
0.37755975.10194766.html.plaintext.txt	347	Received publication August 24 1998
0.37755975.10194766.html.plaintext.txt	348	Revision received December 22 1998
0.37755975.10194766.html.plaintext.txt	349	Accepted publication January 8 1999
0.37755975.10194766.html.plaintext.txt	350	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Hanson RW Patel YM 1994 PEPCK gene enzyme
0.37755975.10194766.html.plaintext.txt	351	Adv Enzymol 69203 281Medline Hanson RW Reshef L 1997 Regulation phosphoenolpyruvate carboxykinase GTP gene expression
0.37755975.10194766.html.plaintext.txt	352	Annu Rev Biochem 66581 611CrossRefMedline Lamers WH Hanson RW Meisner HM 1982 Cyclic AMP stimulates transcription gene cytosolic phosphoenolpyruvate carboxykinase gene rat liver nuclei
0.37755975.10194766.html.plaintext.txt	353	Proc Natl Acad Sci USA 795137 5141Abstract Sasaki K Cripe TP Koch SR Andreone TD Petersen DD Beale EG Granner DK 1984 Multihormonal regulation phosphoenolpyruvate carboxykinase gene transcription
0.37755975.10194766.html.plaintext.txt	354	J Biol Chem 25915242 15251AbstractFree Full Text Lucas PC O Brien RM Mitchell JA Davis CM Imai E Forman BM Samuels HH Granner DK 1991 A retinoic acid response element part pleiotropic domain phosphoenolpyruvate carboxykinase gene
0.37755975.10194766.html.plaintext.txt	355	Proc Natl Acad Sci USA 882184 2188Abstract Scott DK Mitchell JA Granner DK 1996 The orphan receptor COUP TF binds third glucocorticoid accessory factor element within phosphoenolpyruvate carboxykinase gene promoter
0.37755975.10194766.html.plaintext.txt	356	J Biol Chem 27131909 31914AbstractFree Full Text Imai E Stromstedt PE Quinn PG Carlstedt Duke J Gustafsson JA Granner DK 1990 Characterization complex glucocorticoid response unit phosphoenolpyruvate carboxykinase gene
0.37755975.10194766.html.plaintext.txt	357	Mol Cell Biol 104712 4719Medline Imai E Miner JN Mitchell JA Yamamoto KR Granner DK 1993 Glucocorticoid receptor cAMP response element binding protein interaction response phosphoenolpyruvate carboxykinase gene glucocorticoids
0.37755975.10194766.html.plaintext.txt	358	J Biol Chem 2685353 5356AbstractFree Full Text Scott DK Stromstedt P E Wang J C Granner DK 1998 Further characterization glucocorticoid response unit phosphoenolpyruvate carboxykinase gene
0.37755975.10194766.html.plaintext.txt	359	The role glucocorticoid receptor binding sites
0.37755975.10194766.html.plaintext.txt	360	Mol Endocrinol 12482 491AbstractFree Full Text Mitchell JA Noisin E Hall RK O Brien R Imai E Granner DK 1994 Integration multiple signals complex hormone response unit phosphoenolpyruvate carboxykinase gene promoter
0.37755975.10194766.html.plaintext.txt	361	Mol Endocrinol 8585 594Abstract Hall RK Sladek FM Granner DK 1995 The orphan receptors COUP TF HNF 4 serve accessory factors required induction phosphoenolpyruvate carboxykinase gene transcription glucocortricoids
0.37755975.10194766.html.plaintext.txt	362	Proc Natl Acad Sci USA 92412 416Abstract O Brien RM Lucas PC Yamasaki T Noisin EL Granner DK 1994 Potential convergence insulin cAMP signal transduction systems phosphoenolpyruvate carboxykinase PEPCK gene promoter CCAATenhancer binding protein CEBP
0.37755975.10194766.html.plaintext.txt	363	J Biol Chem 26930419 30428AbstractFree Full Text O Brien RM Noisin EL Suwanicul A Yamasaki T Lucas PC Wang J C Powell DR Granner DK 1995 Hepatic nuclear factor 3 hormone regulated expression phosphoenolpyruvate carboxykinase insulin like growth factor binding protein 1 genes
0.37755975.10194766.html.plaintext.txt	364	Mol Cell Biol 151747 1758Abstract Wang J C Stromstedt P E O Brien RM Granner DK 1996 Hepatic nuclear factor 3 accessory factor required stimulation phosphoenolpyruvate carboxykinase gene transcription glucocorticoids
0.37755975.10194766.html.plaintext.txt	365	Mol Endocrinol 10794 800Abstract Liu J Park EA Gurney AL Roesler WJ Hanson RW 1991 cAMP induction PEPCK gene transcription mediated multiple promoter elements
0.37755975.10194766.html.plaintext.txt	366	J Biol Chem 26619095 19102AbstractFree Full Text Yamada K Duong DT Scott DK Wang J C Granner DK 1999 CCAATEnhancer binding protein accessory factor glucocorticoid response cAMP response element rat phosphoenolpyruvate carboxykinase gene promoter
0.37755975.10194766.html.plaintext.txt	367	J Biol Chem 2745880 5887AbstractFree Full Text Park EA Gurney AL Nizielski SE Hakimi P Cao Z Moorman A Hanson RW 1993 Relative roles CCAATenhancer binding protein beta cAMP regulatory element binding protein controlling transcription gene phosphoenolpyruvate carboxykinase GTP
0.37755975.10194766.html.plaintext.txt	368	J Biol Chem 268613 619AbstractFree Full Text Sugiyama T Scott DK Wang J C Granner DK 1998 Structural requirements glucocorticoid retinoic acid response units phosphoenolpyruvate carboxykinase gene promoter
0.37755975.10194766.html.plaintext.txt	369	Mol Endocrinol 121487 1498 Li XY Green MR 1996 Intramolecular inhibition activating transcription factor 2 function DNA binding domain
0.37755975.10194766.html.plaintext.txt	370	Genes Dev 10517 527Abstract Williams SC Baer M Dillner AJ Johnson PF 1995 CRP2 CEBP beta contains bipartite regulatory domain controls transcriptional activation DNA binding cell specificity
0.37755975.10194766.html.plaintext.txt	371	EMBO J 143170 3183Abstract Pani L Overdier JG Porcella A Qian X Lai E Costa RH 1992 Hepatic nuclear factor 3ss contains two transcriptional activation domains one novel conserved Drosophila forkhead protein
0.37755975.10194766.html.plaintext.txt	372	Mol Cell Biol 123723 3732Abstract Hadzopoulou Cladaras M Kistanova E Evagelopoulou C Zeng S Cladaras C Ladias JAA 1997 Functional domains nuclear receptor hepatocyte nuclear factor 4
0.37755975.10194766.html.plaintext.txt	373	J Biol Chem 272539 550AbstractFree Full Text Lucas PC Granner DK 1992 Hormone response domains gene transcription
0.37755975.10194766.html.plaintext.txt	374	Annu Rev Biochem 611131 1173CrossRefMedline Malik S Karathanasis SK 1996 TFIIB directed transcriptional activation orphan nuclear receptor hepatocyte nuclear factor 4
0.37755975.10194766.html.plaintext.txt	375	Mol Cell Biol 161824 1831Abstract Onate SA Tsai SY Tsai MJ O Malley BW 1995 Sequence characterization coactivator steroid hormone receptor superfamily
0.37755975.10194766.html.plaintext.txt	376	Science 2701354 1357Abstract Chakravarti D LaMorte VJ Nelson MC Nakajima T Schulman IG Juguilon H Montminy M Evans RM 1996 Role CBPP300 nuclear receptor signalling
0.37755975.10194766.html.plaintext.txt	377	Nature 38399 103CrossRefMedline Kamei Y Xu L Heinzel T Torchia J Kurokawa R Gloss B Lin S C Heyman RA Rose DW Glass CK Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation AP 1 inhibition nuclear receptors
0.37755975.10194766.html.plaintext.txt	378	Cell 85403 414Medline Hanstein B Eckner R DiRenzo J Halachmi S Liu H Searcy B Kurokawa R Brown M 1996 p300 Is component estrogen receptor coactivator complex
0.37755975.10194766.html.plaintext.txt	379	Proc Natl Acad Sci USA 9311540 11545AbstractFree Full Text Voegel JJ Heine MJ Zechel C Chambon P Gronemeyer H 1996 TIF2 160 kDa transcriptional mediator ligand dependent activation function AF 2 nuclear receptors
0.37755975.10194766.html.plaintext.txt	380	EMBO J 153667 3675Abstract Hong H Kohli K Trivedi A Johnson DL Stallcup MR 1996 GRIP1 novel mouse protein serves transcriptional coactivator yeast hormone binding domains steroid receptors
0.37755975.10194766.html.plaintext.txt	381	Proc Natl Acad Sci USA 934948 4952AbstractFree Full Text Hong H Kohli K Garabedian MJ Stallcup MR 1997 GRIP1 transcriptional coactivator AF 2 transactivation domain steroid thyroid retinoid vitamin D receptors
0.37755975.10194766.html.plaintext.txt	382	Mol Cell Biol 172735 2744Abstract Chen H Lin RJ Schiltz RL Chakravarti D Nash A Nagy L Privalsky ML Nakatani Y Evans RM 1997 Nuclear receptor coactivator ACTR novel histone acetyltransferase forms multimeric activation complex PCAF CBPp300
0.37755975.10194766.html.plaintext.txt	383	Cell 90569 580Medline Torchia J Rose DW Inostroza J Kamei Y Westin S Glass CK Rosenfeld MG 1997 The transcriptional co activator pCIP binds CBP mediates nuclear receptor function
0.37755975.10194766.html.plaintext.txt	384	Nature 387677 684CrossRefMedline Li H Gomes PJ Chen JD 1997 RAC3 steroidnuclear receptor associated coactivator related SRC 1 TIF2
0.37755975.10194766.html.plaintext.txt	385	Proc Natl Acad Sci USA 948479 8484AbstractFree Full Text Wang J C Stafford JM Granner DK 1998 SRC 1 GRIP1 coactivate transcription hepatocyte nuclear factor 4
0.37755975.10194766.html.plaintext.txt	386	J Biol Chem 27330847 30850AbstractFree Full Text Yoshida E Aratani S Itou H Miyagishi M Takiguchi M Osumu T Murakami K Fukamizu A 1997 Functional association CBP HNF4 Trans activation
0.37755975.10194766.html.plaintext.txt	387	Biochem Biophys Res Commun 241664 669CrossRefMedline Mazzarelli JM Mengus G Davidson I Ricciardi RP 1997 The transactivation domain adenovirus E1A interacts C terminus human TAFII135
0.37755975.10194766.html.plaintext.txt	388	J Virol 717978 7983Abstract Geisberg JV Chen JL Ricciardi RP 1995 Subregions adenovirus E1A transactivation domain target multiple components TFIID complex
0.37755975.10194766.html.plaintext.txt	389	Mol Cell Biol 156283 6290Abstract Liu F Green MR 1994 Promoter targeting adenovirus E1a interaction different cellular DNA binding domains
0.37755975.10194766.html.plaintext.txt	390	Nature 368520 525CrossRefMedline Tsai SY Tsai MJ 1997 Chick ovalbumin upstream promoter transcription factors COUP TFs coming age
0.37755975.10194766.html.plaintext.txt	391	Endocr Rev 18229 240AbstractFree Full Text Thanos D Maniatis T 1995 Virus induction human IFN beta gene expression requires assembly enhanceosome
0.37755975.10194766.html.plaintext.txt	392	Cell 831091 1100Medline Merika M Williams AJ Chen G Collins T Thanos D 1998 Recruitment CBPp300 IFNss enhanceosome required synergistic activation transcription
0.37755975.10194766.html.plaintext.txt	393	Mol Cell 1277 287Medline Carey M 1998 The enhanceosome transcription synergy
0.37755975.10194766.html.plaintext.txt	394	Cell 925 8Medline Tjian R Maniatis T 1994 Transcriptional activation complex puzzle easy pieces
0.37755975.10194766.html.plaintext.txt	395	Cell 775 8Medline Franckhauser VS Antras FJ Robin D Robin P Forest C 1997 Transcriptional posttranscriptional mechanisms glucocorticoid mediated repression phosphoenolpyruvate carboxykinase gene expression adipocytes
0.37755975.10194766.html.plaintext.txt	396	CO2 D Brien RM Granner DK 1993 From metabolic pathways metabolic control domains multiple factors bind PEPCK AF1retinoic acid response element
0.37755975.10194766.html.plaintext.txt	397	In Mornex R Jaffiol C Leclere J eds Progress Endocrinology
0.37755975.10194766.html.plaintext.txt	398	The Proceedings Ninth International Congress Endocrinology
0.37755975.10194766.html.plaintext.txt	399	The Parthenon Publishing Group Nice France vol
0.37755975.10194766.html.plaintext.txt	400	177777 782 Hall RK Scott DK Noisin EL Lucas PL Granner DK 1992 Activation phosphoenolpyruvate carboxykinase gene retinoic response element dependent retinoic acid receptorcoregulator complex
0.37755975.10194766.html.plaintext.txt	401	Mol Cell Biol 125527 5535Abstract Scott DK Mitchell JA Granner DK 1996 Identification charaterization second retinoic acid response element phosphoenolpyruvate carboxykinase gene promoter
0.37755975.10194766.html.plaintext.txt	402	J Biol Chem 2716260 6264AbstractFree Full Text Shin DJ McGrane MM 1997 Vitamin A regulates genes involved hepatic gluconeogenesis mice phosphoenolpyruvate carboxykinase fructose 16 bisphosphatase 6 phosphofructo 2 kinasefructose 26 bisphosphatase
0.37755975.10194766.html.plaintext.txt	403	J Nutr 1271274 1278AbstractFree Full Text Roesler WJ Graham JG Kolen K Klemm DJ McFie PJ 1995 The cAMP response element binding protein synergizes transcription factors mediate cAMP responsiveness
0.37755975.10194766.html.plaintext.txt	404	J Biol Chem 2708225 8232AbstractFree Full Text Roesler WJ Crosson SM Vinson C McFie PJ 1996 The alpha isoform CCAATenhancer binding protein required mediating cAMP responsiveness phosphoenolpyruvate carboxykinase promoter hepatoma cells
0.37755975.10194766.html.plaintext.txt	405	J Biol Chem 2718068 8074AbstractFree Full Text O Brien RM Lucas PC Forest CD Magnuson MA Granner DK 1990 Identification sequence PEPCK gene mediates negative effect insulin transcription
0.37755975.10194766.html.plaintext.txt	406	Science 249533 537Medline Petersen DD Magnuson MA Granner DK 1988 Location characterization two widely separated glucocorticoid response elements phosphoenolpyruvate carboxykinase gene
0.37755975.10194766.html.plaintext.txt	407	Mol Cell Biol 896 104Medline Lillie JW Green MR 1989 Transcription activation adenovirus E1a protein
0.37755975.10194766.html.plaintext.txt	408	Nature 33839 44CrossRefMedline Sadowski I Ptashne M 1989 A vector expressing GAL41 147 fusions mammalian cells
0.37755975.10194766.html.plaintext.txt	409	Nucleic Acids Res 177539Medline Han K Manley JL 1993 Transcriptional repression Drosophila even skipped protein definition minimal repression domain
0.37755975.10194766.html.plaintext.txt	410	Genes Dev 7491 503Abstract Sadovsky Y Webb P Lopez G Baxter JD Fitzpatrick PM Gizang GE Cavailles V Parker MG Kushner PJ 1995 Transcriptional activators differ responses overexpression TATA box binding protein
0.37755975.10194766.html.plaintext.txt	411	Mol Cell Biol 151554 1563Abstract Pagano M Draetta G Jansen Durr P 1992 Association cdk2 kinase transcription factor E2F S phase
0.37755975.10194766.html.plaintext.txt	412	Science 2551144 1147Medline Yoshima T Yura T Yanagi H 1998 Function C terminal transactivation domain human heat shock factor 2 modulated adjacent negative regulatory segment
0.37755975.10194766.html.plaintext.txt	413	Nucleic Acids Res 262580 2585AbstractFree Full Text
0.22450218.9837989.html.plaintext.txt	0	The embryonic expression tissue specific transcription factor HNF1alpha Xenopus rapid activation HNF4 delayed induction mesoderm inducers
0.22450218.9837989.html.plaintext.txt	1	Aristotelis Nastos Elke Pogge von Strandmann Heike Weber Gerhart U
0.22450218.9837989.html.plaintext.txt	2	Universitatsklinikum Essen Institut fur Zellbiologie Tumorforschung Hufelandstraszlige 55 D 45122 Essen Germany
0.22450218.9837989.html.plaintext.txt	3	Received September 4 1998 Revised Accepted October 27 1998
0.22450218.9837989.html.plaintext.txt	4	The tissue specific transcription factor HNF1alpha expressed kidney liver intestine stomach Xenopus
0.22450218.9837989.html.plaintext.txt	5	We show HNF1alpha gene transcriptionally activated onset zygotic gene transcription transcription maintained throughout development
0.22450218.9837989.html.plaintext.txt	6	Ectodermal explants blastulae animal caps express HNF1alpha mRNA upon stimulation mesoderm inducers activin A BMP4 well overexpression Smad2 Smad1 corresponding members intracellular TGF beta signal transducers respectively
0.22450218.9837989.html.plaintext.txt	7	Beside factors mediate response serinethreonine kinase receptors bFGF acts via tyrosine kinase receptors leads HNF1alpha expression
0.22450218.9837989.html.plaintext.txt	8	These embryonic inducers result delayed appearance HNF1alpha mRNA excluding direct activation HNF1alpha
0.22450218.9837989.html.plaintext.txt	9	In contrast maternally expressed nuclear receptors HNF4alpha HNF4beta activate initial HNF1alpha transcription since overexpression HNF4 leads rapid expression HNF1alpha mRNA animal caps
0.22450218.9837989.html.plaintext.txt	10	Similarly entire neurulae HNF4 overexpression results increased HNF1alpha transcription
0.22450218.9837989.html.plaintext.txt	11	Therefore assume initial activation dependent maternal HNF4alpha HNF4beta transcription factors whereas HNF1alpha induction growth factors reflects property factors induce differentiation mesodermal entodermal cell types expressing HNF1alpha
0.22450218.9837989.html.plaintext.txt	12	The differentiation tissue specific cell types development multicellular organism initiated fertilized egg maternal components laid oogenesis
0.22450218.9837989.html.plaintext.txt	13	Some important maternal determinants regulating early events include cell surface signalling molecules receptors well transcription factors
0.22450218.9837989.html.plaintext.txt	14	The interplay growth factors transcription factors best analyzed Drosophila 1 assumed define spatial activation specific genes development
0.22450218.9837989.html.plaintext.txt	15	In Xenopus well established maternal inductive signals emanating vegetal region cleaving embryo lead distinct pattern gene expression equatorial region thereby determine prospective mesodermal tissues embryo 2
0.22450218.9837989.html.plaintext.txt	16	These inductive factors fibroblast growth factors FGF members transforming growth factor beta TGF beta family bFGF activin A Vg1 significant members 2 6
0.22450218.9837989.html.plaintext.txt	17	Whereas FGF signal received membrane bound tyrosine kinase receptors TGF betas act exclusively serinethreonine kinases cell surface 7
0.22450218.9837989.html.plaintext.txt	18	Intracellular TGF beta signalling involves class proteins referred Smad proteins 7 10
0.22450218.9837989.html.plaintext.txt	19	In Xenopus embryos Smad1 Smad2 overexpression animal cap mimics effect TGF beta family members BMP4 bone morphogenetic protein activin A respectively 1112
0.22450218.9837989.html.plaintext.txt	20	In general Smad proteins seem phosphorylated C terminal serine residues activated type I receptor 1314 form heteromeric complexes Smad4 15 migrate nucleus regulate expression TGF beta responsive genes direct interaction specific transcription factors 16
0.22450218.9837989.html.plaintext.txt	21	Based data Smad proteins considered essential intracellular components TGF beta signalling
0.22450218.9837989.html.plaintext.txt	22	In approach link maternal components transcriptional activation tissue specific transcription factor investigated expression HNF1alpha Xenopus 17 19
0.22450218.9837989.html.plaintext.txt	23	This tissue specific transcription factor found vertebrates expressed endodermal tissues liver gut stomach also kidney mesodermal derivative 1720
0.22450218.9837989.html.plaintext.txt	24	As binding sites HNF1alpha present several genes specifically expressed tissues assumed HNF1alpha participates establishment differentiated state
0.22450218.9837989.html.plaintext.txt	25	Previously showed RNase protection analysis first HNF1alpha transcripts appear gastrula stage therefore HNF1alpha gene transcription zygotically activated 17
0.22450218.9837989.html.plaintext.txt	26	To reveal regulatory elements involved HNF1alpha gene activation injected promoter constructs fertilized eggs
0.22450218.9837989.html.plaintext.txt	27	We identified minimal promoter fragment Xenopus gene sufficient proper activation reporter gene swimming larvae 1819
0.22450218.9837989.html.plaintext.txt	28	The promoter elements mediating gene activation appear conserved vertebrate evolution injected rat HNF1alpha promoter also regulated Xenopus
0.22450218.9837989.html.plaintext.txt	29	By mutational analysis minimal regulatory unit Xenopus HNF1alpha promoter OZ element two HNF1 binding sites one binding site HNF4 characterized regulatory elements 1819
0.22450218.9837989.html.plaintext.txt	30	The HNF4 binding site seems play predominant role sufficient also essential activation reporter gene 18
0.22450218.9837989.html.plaintext.txt	31	HNF4 encoded small gene family HNF4alpha HNF4beta identified Xenopus 2122
0.22450218.9837989.html.plaintext.txt	32	Both HNF4 proteins expressed maternally present gradient animal vegetal pole 22
0.22450218.9837989.html.plaintext.txt	33	Overexpression rat HNF4alpha Xenopus leads ectopic appearance HNF1alpha protein head tail swimming larvae 18
0.22450218.9837989.html.plaintext.txt	34	These data support assumption HNF4 resides top transcriptional cascade leading activation HNF1alpha gene embryogenesis
0.22450218.9837989.html.plaintext.txt	35	Since ectopic HNF1alpha expression analyzed swimming larvae organogenesis already established known whether HNF4 able activate initial HNF1alpha transcription embryogenesis
0.22450218.9837989.html.plaintext.txt	36	We recently shown activin A induces HNF1alpha protein expression animal caps differentiate mesodermal endodermal cell types 23
0.22450218.9837989.html.plaintext.txt	37	By injecting various HNF1alpha promoter constructs could define HNF4 binding site apparent activin A responsive element HNF1alpha promoter 23
0.22450218.9837989.html.plaintext.txt	38	However since HNF1alpha induction animal caps measured protein level 3 days culture 23 open question whether activin A related factor Vg1 reported maternal components 24 26 trigger initial HNF1alpha gene activation developing embryo
0.22450218.9837989.html.plaintext.txt	39	In report investigate effects embryonic mesoderm inducers known present maternal components egg expression HNF1alpha gene compare inducing potential transcription factors HNF4 family
0.22450218.9837989.html.plaintext.txt	40	MATERIALS AND METHODS Microinjections synthetic capped mRNAs Xenopus eggs
0.22450218.9837989.html.plaintext.txt	41	The cDNAs Xenopus Smad1 human Smad2 kindly provided Gerald Thomsen Jeff Wrana cloned pCS2 expression vector 27 N terminus fused Myc Flag epitope respectively
0.22450218.9837989.html.plaintext.txt	42	For vitro mRNA synthesis clones linearized NotI transcribed SP6 polymerase
0.22450218.9837989.html.plaintext.txt	43	The BMP4 cDNA gift Walter Knochel 28 cloned pSP64T vector
0.22450218.9837989.html.plaintext.txt	44	To synthesize BMP4 mRNA vector cut BamHI transcription driven SP6 polymerase 23
0.22450218.9837989.html.plaintext.txt	45	The green fluorescent protein GFP2 cDNA cloned pCS2 vector kindly provided Enrique Amaya synthetic mRNA transcription driven SP6 polymerase linearization PvuII
0.22450218.9837989.html.plaintext.txt	46	The rat HNF4alpha 19 Xenopus HNF4beta 22 cDNAs cloned RcCMV vector Invitrogen
0.22450218.9837989.html.plaintext.txt	47	After linearization NaeI used T7 polymerase vitro transcription
0.22450218.9837989.html.plaintext.txt	48	Synthetic capped mRNAs microinjected 1 ng Smad1 Smad2 BMP4 HNF4alpha HNF4beta 200 pg GFP2 animal pole fertilized Xenopus eggs one cell stage embryos allowed develop late blastula early neurula stages
0.22450218.9837989.html.plaintext.txt	49	Animal pole explants non injected mRNA injected stage 9 embryos prepared described Weber et al
0.22450218.9837989.html.plaintext.txt	50	23 incubated 23 degrees C 3 6 24 48 72 h
0.22450218.9837989.html.plaintext.txt	51	These incubation periods correspond developmental stages 11 13 27 33 42 respectively
0.22450218.9837989.html.plaintext.txt	52	The human recombinant activin A kindly provided Yuzuru Eto Central Research Laboratory Ajinomoto Co
0.22450218.9837989.html.plaintext.txt	53	Kawasaki Japan used concentration 10 ngml
0.22450218.9837989.html.plaintext.txt	54	Recombinant human bFGF obtained Gibco BRL used given concentrations
0.22450218.9837989.html.plaintext.txt	55	Entire animal cap dissected embryos homogenized described 18
0.22450218.9837989.html.plaintext.txt	56	Aliquots 10 microg protein extract separated 12
0.22450218.9837989.html.plaintext.txt	57	5 SDS gel transferred nitrocellulose filters 30
0.22450218.9837989.html.plaintext.txt	58	Flag tagged Smad2 detected using monoclonal antibody M2 Kodak directed N terminal Flag tag according manufacturers instructions
0.22450218.9837989.html.plaintext.txt	59	Reverse transcription PCR RT PCR
0.22450218.9837989.html.plaintext.txt	60	Total RNA prepared using RNA clean system AGS Heidelberg Germany following instructions manufacturer
0.22450218.9837989.html.plaintext.txt	61	RT PCR whole embryos animal caps performed previously described 22
0.22450218.9837989.html.plaintext.txt	62	For detection specific RNAs following primers annealing temperatures cycle numbers used
0.22450218.9837989.html.plaintext.txt	63	HNF1alpha upstream 5prime CCTGAAGAGGCTGCTCATCAG 3prime downstream 5prime GTCCTGCATGTGTGAACTCTG 3prime 54 degrees C 35 cycles
0.22450218.9837989.html.plaintext.txt	64	Brachyury upstream 5prime GGATCGTTATCACCTCTG 3prime downstream 5prime GTGTAGTCTGTAGCAGCA 3prime 54 degrees C 30 cycles
0.22450218.9837989.html.plaintext.txt	65	Goosecoid upstream 5prime ACAACTGGAAGCACTGGA 3prime downstream 5prime TCTTATTCCAGAGGAACC 3prime 54 degrees C 30 cycles
0.22450218.9837989.html.plaintext.txt	66	Globin upstream 5prime GCCTACAACCTGAGAGTGG 3prime downstream 5prime CAGGCTGGTGAGCTGCCC 3prime 56 degrees C 30 cycles
0.22450218.9837989.html.plaintext.txt	67	Muscle actin upstream 5prime GCTGACAGAATGCAGAAG 3prime downstream 5prime TTGCTTGGAGGAGTGTGT 3prime 48 degrees C 30 cycles
0.22450218.9837989.html.plaintext.txt	68	Ornithine decarboxylase ODC upstream 5prime AATGGATTTCAGAGACCA 3prime downstream 5prime CCAAGGCTAAAGTTGCAG 3prime 44 degrees C 30 cycles
0.22450218.9837989.html.plaintext.txt	69	RESULTS HNF1alpha expression starts onset zygotic gene transcription mid blastula transition MBT
0.22450218.9837989.html.plaintext.txt	70	To identify factors involved embryonic activation HNF1alpha gene developing Xenopus embryo prerequisite determine temporal expression pattern HNF1alpha mRNA sensitive technique previously used 17
0.22450218.9837989.html.plaintext.txt	71	1 revealed HNF1alpha transcripts absent early cleaving embryo fertilized egg stage 1 mid blastula stage 8 stages whereas first transcripts detectable late blastula stage 9 stage corresponding initiation zygotic gene transcription Xenopus 31
0.22450218.9837989.html.plaintext.txt	72	The amount transcript remains constant late gastrula stage 12 stage increases 100 fold development swimming larva stage 42 stage
0.22450218.9837989.html.plaintext.txt	73	The amount ODC mRNA known remain constant Xenopus development 32 similar RNA samples
0.22450218.9837989.html.plaintext.txt	74	Temporal expression pattern HNF1alpha gene Xenopus embryogenesis
0.22450218.9837989.html.plaintext.txt	75	At indicated developmental stages defined 46 total RNA five embryos isolated analyzed RT PCR presence HNF1alpha ODC transcripts
0.22450218.9837989.html.plaintext.txt	76	The time point mid blastula transition MBT zygotic gene transcription starts indicated hours fertilization given
0.22450218.9837989.html.plaintext.txt	77	Control RT PCR reactions containing embryonic RNA stage 42 cont
0.22450218.9837989.html.plaintext.txt	78	RNA H2O HeLa cell RNA shown left
0.22450218.9837989.html.plaintext.txt	79	Therefore HNF1alpha zygotically expressed Xenopus transcription gene maintained developmental stages
0.22450218.9837989.html.plaintext.txt	80	Obviously initial HNF1alpha transcription onset zygotic gene transcription initiated regulatory components maternal origin
0.22450218.9837989.html.plaintext.txt	81	The activin A signalling pathway leads HNF1alpha induction
0.22450218.9837989.html.plaintext.txt	82	To analyze whether maternal inducer activin A might initiate HNF1alpha expression investigated time point activin A treatment leads HNF1alpha gene transcription explants animal pole balstula animal caps
0.22450218.9837989.html.plaintext.txt	83	Using RT PCR detected HNF1alpha mRNA animal pole explants 72 h treatment activin A data shown
0.22450218.9837989.html.plaintext.txt	84	This late appearance HNF1alpha mRNA similar induction seen previously analyzing effect protein level 23
0.22450218.9837989.html.plaintext.txt	85	As treatment animal pole explants activin A conjunction retinoic acid enhances activin A dependent HNF1alpha protein induction 23 determined time point HNF1alpha gene activation activin A presence retinoic acid
0.22450218.9837989.html.plaintext.txt	86	As indicated Figure 2 first HNF1alpha transcripts detectable 24 h incubation lane 4
0.22450218.9837989.html.plaintext.txt	87	Since conditions goosecoid brachyury transcripts visible already 3 h treatment lane 2 HNF1alpha expression cannot immediate response activin A signalling
0.22450218.9837989.html.plaintext.txt	88	As Smad2 known intracellular mediator activin A signalling 733 analyzed whether introduction downstream effector might also activate HNF1alpha gene transcription
0.22450218.9837989.html.plaintext.txt	89	Using mRNA encoding Flag tagged Smad2 protein could verify western blot using Flag tag specific monoclonal antibody Smad2 protein present injected embryos time animal cap explantation Fig
0.22450218.9837989.html.plaintext.txt	90	To analyze expression HNF1alpha mRNA Smad2 injected animal caps total RNA explants isolated different time points culturing
0.22450218.9837989.html.plaintext.txt	91	Based RT PCR analysis HNF1alpha transcripts absent animal caps derived Smad2 mRNA injected embryos 0 3 6 h incubation Fig
0.22450218.9837989.html.plaintext.txt	92	The first HNF1alpha transcripts appeared 24 h lane 6
0.22450218.9837989.html.plaintext.txt	93	Their amount rose maximum lane 7 48 h remained level 72 h culture lane 8
0.22450218.9837989.html.plaintext.txt	94	The level HNF1alpha induction observed uninjected animal caps treated activin A 72 h lane 2
0.22450218.9837989.html.plaintext.txt	95	Kinetics HNF1alpha gene activation animal caps treated activin A combination 10 5 M retinoic acid
0.22450218.9837989.html.plaintext.txt	96	For time point total RNA 10 animal caps isolated analyzed RT PCR presence HNF1alpha goosecoid gsc brachyury Xbra ODC transcripts
0.22450218.9837989.html.plaintext.txt	97	Control animal caps cultured buffer 24 h
0.22450218.9837989.html.plaintext.txt	98	As control RT PCR also done RNA isolated whole embryos aliquot lacking RNA H2O
0.22450218.9837989.html.plaintext.txt	99	The low level HNF1alpha transcript present 24 h control lane 1 likely due presence endodermal cells contaminating sample mesodermal markers goosecoid brachyury weakly induced
0.22450218.9837989.html.plaintext.txt	100	Kinetics HNF1alpha gene induction overexpression Smad2
0.22450218.9837989.html.plaintext.txt	101	Animal caps dissected Smad2 mRNA injected embryos incubated 0 3 6 24 48 72 h buffer lanes 3 8
0.22450218.9837989.html.plaintext.txt	102	For comparison animal caps derived uninjected embryos either cultured buffer alone lane 1 presence 10 ngml activin A lane 2
0.22450218.9837989.html.plaintext.txt	103	The leftover dissected blastulae group used protein extract preparation analyzed western blot analysis expression Flag tagged Smad2 protein
0.22450218.9837989.html.plaintext.txt	104	At indicated time points expression HNF1alpha brachyury Xbra goosecoid gsc globin muscle actin ODC measured RT PCR
0.22450218.9837989.html.plaintext.txt	105	In contrast brachyury goosecoid known activated early response activin ASmad2 signalling 34 expressed time point dissection lane 3 indicating successful initial mesodermal induction caused translated Flag tagged Smad2 mRNA
0.22450218.9837989.html.plaintext.txt	106	As expected expression marker genes declined longer culture periods replaced 24 h expression muscle actin lane 6 indicating late dorsal mesoderm 48 h late ventral mesodermal marker globin lane 7 reported Graff et al
0.22450218.9837989.html.plaintext.txt	107	These data show activated activin ASmad2 pathway leads late induction HNF1alpha gene expression
0.22450218.9837989.html.plaintext.txt	108	The BMP4Smad1 pathway leads HNF1alpha mRNA expression
0.22450218.9837989.html.plaintext.txt	109	Signalling BMPs also members TGF beta family another important maternal pathway early Xenopus embryo leading activation genes involved mesoderm induction reviewed 3536
0.22450218.9837989.html.plaintext.txt	110	To investigate potential role HNF1alpha induction injected Xenopus eggs RNA encoding BMP4 leads translation functional BMP4 protein early cleavage stages 37
0.22450218.9837989.html.plaintext.txt	111	To monitor successful expression introduced RNA co injected RNA encoding GFP
0.22450218.9837989.html.plaintext.txt	112	At blastula stage animal caps explanted exclusively GFP positive embryos cultured different time periods prior RNA extraction
0.22450218.9837989.html.plaintext.txt	113	Figure 4 demonstrates HNF1alpha transcripts detectable 48 h culture lane 8 whereas brachyury gene Xbra immediate response gene BMP4 signalling 38 transcribed already time animal cap explantation lane 4
0.22450218.9837989.html.plaintext.txt	114	The late appearance HNF1alpha transcripts also confirmed experiment injected RNA encoding Smad1 data shown mediator specific BMP4 signalling 34
0.22450218.9837989.html.plaintext.txt	115	Kinetics HNF1alpha gene induction BMP4
0.22450218.9837989.html.plaintext.txt	116	Animal caps dissected GFP2 BMP4 mRNA injected embryos incubated 0 3 6 24 48 72 h buffer
0.22450218.9837989.html.plaintext.txt	117	For comparison animal caps derived uninjected embryos either cultured buffer alone lane 1 presence 10 ngml activin A lane 3
0.22450218.9837989.html.plaintext.txt	118	In addition animal caps exclusively GFP2 injected embryos also cultured 72 h buffer lane 2
0.22450218.9837989.html.plaintext.txt	119	At indicated time points expression HNF1alpha brachyury Xbra globin ODC measured RT PCR
0.22450218.9837989.html.plaintext.txt	120	bFGF induces appearance HNF1alpha transcripts
0.22450218.9837989.html.plaintext.txt	121	The mesoderm inducer bFGF another maternal component FGF family 39 exerts effect binding corresponding tyrosine kinase receptors 40
0.22450218.9837989.html.plaintext.txt	122	To explore whether pathway able activate HNF1alpha gene expression incubated animal caps increasing concentrations bFGF analyzed level HNF1alpha mRNA
0.22450218.9837989.html.plaintext.txt	123	After 72 h incubation abundant HNF1alpha transcripts found caps treated 3 150 ngml bFGF data shown
0.22450218.9837989.html.plaintext.txt	124	Using highest concentration bFGF determined kinetics HNF1alpha mRNA appearance explanted animal caps
0.22450218.9837989.html.plaintext.txt	125	Figure 5 reveals HNF1alpha mRNA present 48 lane 5 72 h lane 6 bFGF treatment
0.22450218.9837989.html.plaintext.txt	126	A similar late appearance also observed globin transcripts whereas brachyury transcripts Xbra already seen 3 h bFGF addition lane 2 previously described 41
0.22450218.9837989.html.plaintext.txt	127	This delayed induction HNF1alpha excludes possibility bFGF signalling leads direct activation HNF1alpha gene
0.22450218.9837989.html.plaintext.txt	128	Kinetics HNF1alpha gene induction bFGF
0.22450218.9837989.html.plaintext.txt	129	Animal caps incubated presence bFGF time period indicated
0.22450218.9837989.html.plaintext.txt	130	Control caps also incubated 72 h buffer
0.22450218.9837989.html.plaintext.txt	131	Transcripts HNF1alpha brachyury Xbra globin ODC measured RT PCR
0.22450218.9837989.html.plaintext.txt	132	HNF4 overexpression animal caps leads rapid activation HNF1alpha transcription
0.22450218.9837989.html.plaintext.txt	133	Since known HNF4 activates HNF1alpha protein expression swimming larvae HNF4 protein expressed maternally 1822 explored whether HNF4 able activate initial HNF1alpha transcription
0.22450218.9837989.html.plaintext.txt	134	Therefore microinjected synthetic mRNA encoding rat HNF4alpha fertilized Xenopus eggs
0.22450218.9837989.html.plaintext.txt	135	Animal caps injected blastulae explanted total RNA either isolated immediately culturing buffer 3 72 h
0.22450218.9837989.html.plaintext.txt	136	By RT PCR detected HNF1alpha transcripts time explantion animal caps HNF4alpha injected embryos Fig
0.22450218.9837989.html.plaintext.txt	137	6 compare lane 3 lane 1
0.22450218.9837989.html.plaintext.txt	138	HNF1alpha mRNA accumulated injected animal pole explants 3 72 h culture absence external inducer lanes 4 6
0.22450218.9837989.html.plaintext.txt	139	Neither goosecoid brachyury marker genes early mesoderm activated HNF4alpha overexpression data shown
0.22450218.9837989.html.plaintext.txt	140	Analyzing older caps found transcripts dorsal ventral mesodermal markers muscle actin globin respectively data shown
0.22450218.9837989.html.plaintext.txt	141	Kinetics HNF1alpha gene activation animal caps overexpression rat HNF4alpha
0.22450218.9837989.html.plaintext.txt	142	Fertilized eggs injected rat HNF4alpha mRNA animal caps dissected stage 9 blastula
0.22450218.9837989.html.plaintext.txt	143	After culturing given time period RNA isolated animal caps analyzed RT PCR expression HNF1alpha ODC
0.22450218.9837989.html.plaintext.txt	144	As controls animal caps non injected embryos cultured 72 h either buffer lane 1 presence 10 ngml activin A lane 2 analyzed
0.22450218.9837989.html.plaintext.txt	145	Our data clearly establish tissue specific transcription factor HNF4 activates HNF1alpha gene transcription without delay animal caps event independent mesoderm induction since none mesodermal markers analyzed affected
0.22450218.9837989.html.plaintext.txt	146	HNF4 Smad2 increases HNF1alpha expression entire embryo
0.22450218.9837989.html.plaintext.txt	147	To explore whether HNF4 acts early activator HNF1alpha gene transcription also entire embryo overexpressed HNF4 microinjection synthetic mRNA encoding Xenopus HNF4beta fertilized eggs
0.22450218.9837989.html.plaintext.txt	148	As shown Figure 7A much higher level HNF1alpha transcripts HNF4beta injected embryos lanes 3 4 uninjected lane 1 GFP2 mRNA injected control larvae lane 2
0.22450218.9837989.html.plaintext.txt	149	We conclude overexpression Xenopus HNF4beta protein leads increased expression endogenous HNF1alpha gene
0.22450218.9837989.html.plaintext.txt	150	A similar induction observed injecting rat HNF4alpha mRNA data shown
0.22450218.9837989.html.plaintext.txt	151	Clearly data establish HNF4alpha well HNF4beta dramatically regulate early expression endogenous HNF1alpha gene
0.22450218.9837989.html.plaintext.txt	152	Overexpression HNF4 Smad2 early neurula embryos
0.22450218.9837989.html.plaintext.txt	153	A Fertilized eggs either injected GFP2 mRNA co injected GFP2 Xenopus HNF4beta mRNA
0.22450218.9837989.html.plaintext.txt	154	At neurula stage 14 total RNA uninjected lane 1 GFP2 lane 2 GFP2Xenopus HNF4beta injected lane 3 4 embryos isolated analyzed presence HNF1alpha ODC transcripts
0.22450218.9837989.html.plaintext.txt	155	B Fertilized eggs injected mRNA encoding Flag tagged Smad2 cultured early neurula stage 14
0.22450218.9837989.html.plaintext.txt	156	Protein extracts total RNA uninjected lane 1 mRNA injected lanes 2 3 embryos prepared
0.22450218.9837989.html.plaintext.txt	157	Expression Flag Smad2 protein analyzed western blot
0.22450218.9837989.html.plaintext.txt	158	In A B abundance HNF1alpha mRNA measured RT PCR less sensitive conditions shown Figure 1 avoid overexposure strong HNF1alpha signals lanes 3 4 A
0.22450218.9837989.html.plaintext.txt	159	To investigate whether Smad2 overexpression able activate early HNF1alpha transcription whole embryo shown HNF4 overexpression injected Flag tagged Smad2 mRNA fertilized eggs prepared extracts neurula stage injected uninjected stage 14 embryos
0.22450218.9837989.html.plaintext.txt	160	By western blot analysis using monoclonal antibody directed Flag epitope detect overexpressed Flag tagged Smad2 protein two independent batches mRNA injected embryos Fig
0.22450218.9837989.html.plaintext.txt	161	RT PCR non injected control Smad2 injected early neurula embryos could detect significant difference HNF1alpha transcription Fig
0.22450218.9837989.html.plaintext.txt	162	This establishes Smad2 unlike HNF4 able increase early HNF1alpha gene transcription entire embryo finding correlates late induction found animal caps Fig
0.22450218.9837989.html.plaintext.txt	163	DISCUSSION HNF1alpha expression embryogenesis
0.22450218.9837989.html.plaintext.txt	164	Our data show HNF1alpha transcripts appear stage 9 Xenopus development immediately onset zygotic gene transcription MBT Fig
0.22450218.9837989.html.plaintext.txt	165	This finding extends previous RNase protection analysis showing transcripts HNF1alpha gene stage 11 17 reflects higher sensitivity RT PCR method
0.22450218.9837989.html.plaintext.txt	166	Even using sensitive detection system failed detect maternal HNF1alpha mRNA
0.22450218.9837989.html.plaintext.txt	167	This establishes HNF1alpha expression depends entirely zygotic transcription thus activation maternal components
0.22450218.9837989.html.plaintext.txt	168	Transcription HNF1alpha initiated prior organogenesis low amounts transcripts yield significant protein levels 17 doubt HNF1alpha regulatory role early stages
0.22450218.9837989.html.plaintext.txt	169	This reminiscent early expression pattern Xenopus MyoD initial weak unrestricted expression mid blastula stage without significance muscle differentiation 42
0.22450218.9837989.html.plaintext.txt	170	HNF1alpha late response gene mesoderm inducers
0.22450218.9837989.html.plaintext.txt	171	The present data show HNF1alpha induction activin A BMP4 bFGF late response thus differs early responses seen goosecoid brachyury genes conditions
0.22450218.9837989.html.plaintext.txt	172	The much delayed response HNF1alpha expression upon addition mesoderm inducers implies appearance HNF1alpha mRNA reflects differentiation mesodermal endodermal cells express HNF1alpha
0.22450218.9837989.html.plaintext.txt	173	This interpretation also valid preloading animal caps Smad2 Smad1 essential intermediate components TGF beta signalling fails produce early response HNF1alpha gene Fig
0.22450218.9837989.html.plaintext.txt	174	Since shown previously animal caps activin A signal received HNF4 binding site injected HNF1alpha promoter constructs 23 assume HNF4 major factor acting mesodermal endodermal cells differentiated upon activin A treatment
0.22450218.9837989.html.plaintext.txt	175	Further evidence activin A signalling HNF4 induced activation HNF1alpha gene separate events early embryo provided observation gel retardation experiments using protein extracts Xenopus gastrulae combined overexpression Smad2 HNF4 proteins Smad2HNF4 interaction could identified data shown
0.22450218.9837989.html.plaintext.txt	176	In contrast complexes found transcription factor FAST1 TGF beta signalling molecule Smad2 bound activin response element Mix
0.22450218.9837989.html.plaintext.txt	177	Consistent direct interaction induced promoter also established activin A stimulation Mix
0.22450218.9837989.html.plaintext.txt	178	2 promoter early response 43
0.22450218.9837989.html.plaintext.txt	179	HNF4 initiates HNF1alpha gene transcription
0.22450218.9837989.html.plaintext.txt	180	The main focus work analyze mechanisms involved initial embryonic activation HNF1alpha gene
0.22450218.9837989.html.plaintext.txt	181	We revealed HNF4 able initiate HNF1alpha expression onset zygotic gene transcription blastula embryos whereas mesoderm inducers activin A BMP4 bFGF fail activate HNF1alpha gene expression early embryonic stages
0.22450218.9837989.html.plaintext.txt	182	Clearly HNF4alpha HNF4beta transcription factors good candidates initial activators since present maternal components 1822 HNF1alpha promoter contains functional HNF4 binding site 1819
0.22450218.9837989.html.plaintext.txt	183	This potential link verified overexpression rat HNF4alpha endogenously expressed Xenopus HNF4beta cases found increase HNF1alpha gene transcription early neurula stage Fig
0.22450218.9837989.html.plaintext.txt	184	This induction rapid animal caps injected HNF4alpha mRNA contained induced HNF1alpha mRNA already blastula stage explanted Fig
0.22450218.9837989.html.plaintext.txt	185	This implies HNF4 translated injected mRNA early cleavage stages prior MBT accumulated activated HNF1alpha transcription rapidly MBT
0.22450218.9837989.html.plaintext.txt	186	From observation conclude cells animal caps competent efficient HNF1alpha gene transcription triggered appropriate signal
0.22450218.9837989.html.plaintext.txt	187	The induction HNF1alpha HNF4 specific effect independent mesoderm induction mesoderm markers expressed HNF4 injected animal caps data shown
0.22450218.9837989.html.plaintext.txt	188	All findings support idea maternal HNF4 initial activator HNF1alpha gene Xenopus
0.22450218.9837989.html.plaintext.txt	189	A loss function study test assumption difficult perform since HNF4 protein already present egg thus RNA depletion experiments possible
0.22450218.9837989.html.plaintext.txt	190	Therefore introduced fusion protein containing HNF4 DNA binding domain putative ligand binding domain linked repressor domain even skipped Drosophila fertilized eggs
0.22450218.9837989.html.plaintext.txt	191	Although HNF4 repressor acted efficiently hepatoma cells expressed high levels injected embryos could detect significant reduction endogenous HNF1alpha mRNA accumulation data shown
0.22450218.9837989.html.plaintext.txt	192	We assume level HNF4 repressor translated prior MBT sufficient compete amount maternal HNF4alpha beta proteins 1822 accumulated several months oocyte maturation
0.22450218.9837989.html.plaintext.txt	193	In contrast experiments dominant negative variants transcription factors successfully used repress endogenous factors e
0.22450218.9837989.html.plaintext.txt	194	brachyury eomesodermin 4445 inhibition involved zygotically accumulated trans cription factors
0.22450218.9837989.html.plaintext.txt	195	In cases inhibition probably facilitated embryo preloaded repressors prior expression zygotic factor inhibited
0.22450218.9837989.html.plaintext.txt	196	Overexpression either rat Xenopus HNF4 leads increased transcription HNF1alpha gene early stages embryogenesis Fig
0.22450218.9837989.html.plaintext.txt	197	This contrast experiments done myogenic transcription factor MyoD case murine MyoD activated ectopic expression myogenic markers Xenopus embryos whereas overexpressed Xenopus MyoD hardly active 27
0.22450218.9837989.html.plaintext.txt	198	Thus contrast MyoD activity HNF4 species independent indicating high degree functional conservation HNF4 family members vertebrates 182122
0.22450218.9837989.html.plaintext.txt	199	Our data show differences activating potential distinct HNF4 isoforms early stages development injected beta isoform increases HNF1alpha transcription Fig
0.22450218.9837989.html.plaintext.txt	200	7 efficiently alpha isoform HNF4 Fig
0.22450218.9837989.html.plaintext.txt	201	This finding possibly reflects identical expression patterns HNF4alpha HNF4beta seen whole mount immunostaining early cleavage stages 22
0.22450218.9837989.html.plaintext.txt	202	Wrana various plasmids Y
0.22450218.9837989.html.plaintext.txt	203	Eto generous gift recombinant human activin A
0.22450218.9837989.html.plaintext.txt	204	This work supported Deutsche Forschungsgemeinschaft Ry53 3
0.22450218.9837989.html.plaintext.txt	205	1996 Development 122 2359 2366
0.22450218.9837989.html.plaintext.txt	206	1992 Development 116 783 797
0.22450218.9837989.html.plaintext.txt	207	1996 Development 122 1975 1984
0.22450218.9837989.html.plaintext.txt	208	1989 Development 106 775 785
0.22450218.9837989.html.plaintext.txt	209	1989 Molecular Cloning A Laboratory Manual 2nd Edn
0.22450218.9837989.html.plaintext.txt	210	Cold Spring Harbor Laboratory Press Cold Spring Harbor NY
0.22450218.9837989.html.plaintext.txt	211	1992 Development 114 711 720
0.22450218.9837989.html.plaintext.txt	212	1992 Development 115 573 585
0.22450218.9837989.html.plaintext.txt	213	1998 Development 125 857 867
0.22450218.9837989.html.plaintext.txt	214	1996 Development 122 2427 2435
0.22450218.9837989.html.plaintext.txt	215	1975 Normal Table Xenopus laevis Daudin 2nd Edn
0.22450218.9837989.html.plaintext.txt	216	ElsevierNorth Holland Amsterdam The Netherlands
0.22450218.9837989.html.plaintext.txt	217	To correspondence addressed
0.22450218.9837989.html.plaintext.txt	218	Tel 49 201 723 3110 Fax 49 201 723 5905 Email gerhart
0.22450218.9837989.html.plaintext.txt	219	de Present address The Randall Institute Developmental Biology Research Centre Kings College London WC2B 5RL UK This page run Oxford University Press Great Clarendon Street Oxford OX2 6DP part OUP Journals Comments feedback www adminatoup
0.22450218.9837989.html.plaintext.txt	220	uk u d Last modification 3 Dec 1998 Copyright Oxford University Press 1998
